,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
2487,GO:0005730,2.15259744868642e-15,1,121,835,nucleolus,CC,MAP2;PML;MTUS1;MAP3K14;GPRC5A;TXNRD1;CBX5;UTP20;VMP1;DDX17;TFCP2L1;ENC1;TP53;C9ORF3;SCD;DDX47;RBM19;RBM4;ZNF397;AKAP8;PPAN;PKMYT1;TGS1;PDCD11;NUAK1;DKC1;PUM3;NUP153;NBN;FAM111A;UTP15;CDK4;POP1;NUCKS1;HEATR1;GEMIN4;TSR1;TRA2A;POLR1A;THUMPD3;METTL1;POLA1;GRWD1;MDN1;DNTTIP2;NOP58;NOP2;DDX28;SETD4;RAN;UBTF;RRP7BP;ORC4;DDX3X;NUFIP1;RRN3;RRP12;MRTO4;TAF1D;SMC2;UTP14A;FEN1;GNL3L;NVL;APTX;RRP1;WDR3;WDR43;UTP18;ISG20L2;SDAD1;DDX10;ZNF106;DDX24;RRP36;RPF2;URB2;WEE1;NOL12;APEX1;ORC1;HSPA8;DDX21;SMUG1;HELQ;DGCR8;FANCD2;E2F8;ETV6;POLR2F;FCF1;WDR75;BMS1;MYO10;NIFK;NOL9;NOL11;NFKBIE;ESF1;UPF3B;POLR1E;RBBP5;NCL;NOP56;DDX56;MPHOSPH8;NSA2;NOP16;SURF2;TYMS;WDR36;MAK16;DAXX;TAF1;YPEL4;PSPC1;HNRNPM;CDKN1A;CTCF;TEX10;DHX15
9924,GO:0042254,9.34225744414259e-12,1,53,317,ribosome biogenesis,BP,UTP20;DDX17;DDX47;PPAN;PDCD11;DKC1;SHQ1;UTP15;HEATR1;GEMIN4;TSR1;LSG1;MDN1;NOP58;NOP2;DDX28;SETD4;RAN;RRP7BP;DDX3X;RRN3;MRTO4;UTP14A;GNL3L;NVL;RRP1;WDR3;WDR43;UTP18;ISG20L2;SDAD1;METTL16;RRP36;RPF2;URB2;DDX21;FCF1;SRFBP1;WDR75;BMS1;NOL9;NOL11;MRPS7;NOP56;DDX56;NSA2;NOP16;RRP15;WDR36;MAK16;ZNHIT6;TEX10;RPS12
6599,GO:0022613,6.7677749079982e-10,1,64,448,ribonucleoprotein complex biogenesis,BP,UTP20;DDX17;DDX47;GEMIN5;PPAN;RBM22;TGS1;PDCD11;DKC1;SHQ1;UTP15;HEATR1;GEMIN4;TSR1;LSG1;MDN1;NOP58;NOP2;DDX28;SETD4;RAN;RRP7BP;DDX3X;NUFIP1;RRN3;MRTO4;UTP14A;LUC7L;GNL3L;NVL;RRP1;LUC7L2;WDR3;WDR43;UTP18;ISG20L2;SDAD1;METTL16;RRP36;RPF2;URB2;HSP90AB1;DDX21;GEMIN8;FCF1;SRFBP1;WDR75;BMS1;ATR;NOL9;NOL11;MRPS7;NCBP1;NOP56;DDX56;NSA2;NOP16;RRP15;RC3H1;WDR36;MAK16;ZNHIT6;TEX10;RPS12
8793,GO:0034470,5.13856577589807e-09,1,56,396,ncRNA processing,BP,UTP20;DDX17;DDX47;CDKAL1;PDCD11;DKC1;SHQ1;UTP15;POP1;HEATR1;GEMIN4;TSR1;PUS3;THUMPD3;METTL1;URM1;MDN1;NOP58;NOP2;RRP7BP;MRTO4;UTP14A;YRDC;RRP1;USB1;WDR3;WDR43;UTP18;ISG20L2;METTL16;TYW1;RRP36;RPF2;TRMT5;SEPHS2;THADA;DDX21;TRMT1;DGCR8;FCF1;SRFBP1;WDR75;BMS1;NOL9;NOL11;TRMT61A;NCBP1;NOP56;DDX56;NSA2;RRP15;WDR4;WDR36;MAK16;TEX10;RPS12
1470,GO:0003723,1.59291303401255e-08,1,155,1484,RNA binding,MF,TFRC;UTP20;DDX17;TRIM56;TP53;DDX47;ABCF1;DUSP14;RBM19;CDKN2A;RBM4;GEMIN5;NQO1;PABPC4;LGALS3;ACO1;AKAP8;PPAN;RBM22;IFIT3;SRSF2;SUGP2;HNRNPF;PDCD11;DKC1;PUM3;PHAX;UTP15;POP1;NUCKS1;HEATR1;TARDBP;MIR17HG;TSR1;PUS3;NAA15;TRA2A;DHFR;THUMPD3;ZMAT2;CSRP1;METTL1;TSN;G3BP1;GRWD1;HNRNPA1L2;EIF5;CASC3;MRPL27;DNTTIP2;AKAP8L;NOP58;HSPB1;NOP2;DDX28;THOC1;RAN;UBTF;RANBP2;SUPT16H;DDX3X;NAP1L1;NUFIP1;ARHGEF28;RRP12;MRTO4;FASTKD3;UTP14A;DND1;RBMXL1;ZC3H7B;RBM12;LUC7L;SRBD1;GNL3L;YRDC;NVL;APTX;IBA57;RRP1;RARS;SRF;FNDC3B;LUC7L2;WDR3;WDR43;UTP18;EIF3J;ISG20L2;DDX10;LRPPRC;EFTUD2;ZNF106;TRUB2;DDX24;METTL16;RRP36;RPF2;NOL12;APEX1;HSPA8;HSP90AB1;DDX21;SYNCRIP;TRMT1;DGCR8;CCAR1;MAZ;ZNFX1;CCDC47;FCF1;SRFBP1;HMGN2;WDR75;BMS1;RBMS3;UBAP2L;HADHB;DDX60L;NIFK;NOL9;EIF2B5;NOL11;GPATCH4;HNRNPDL;ESF1;MRPS7;NCBP1;UPF3B;HNRNPR;NCL;NOP56;DDX56;NSA2;PURB;TLR3;NOP16;ZFP36L2;SRSF7;RC3H1;TYMS;WDR36;HNRNPU;MAK16;EIF2B1;METAP2;HIST1H4A;PSPC1;PPARGC1B;HNRNPM;RBM8A;GTF2H3;RPS12;BUD13;DHX15
7006,GO:0030684,1.59322917155215e-08,0.999999997242618,21,74,preribosome,CC,UTP20;PPAN;PDCD11;HEATR1;TSR1;MDN1;NOP58;RRP7BP;UTP14A;RRP1;WDR3;UTP18;RRP36;FCF1;SRFBP1;BMS1;NOP56;NSA2;RRP15;WDR36;MAK16
5338,GO:0016072,1.59378413382034e-08,1,43,284,rRNA metabolic process,BP,UTP20;DDX17;DDX47;PDCD11;DKC1;SHQ1;UTP15;HEATR1;GEMIN4;TSR1;MDN1;NOP58;NOP2;GTF3C6;RRP7BP;MRTO4;UTP14A;RRP1;WDR3;WDR43;UTP18;ISG20L2;METTL16;RRP36;RPF2;DDX21;FCF1;SRFBP1;WDR75;BMS1;NIFK;NOL9;NOL11;NCL;GTF3C4;NOP56;DDX56;NSA2;RRP15;WDR36;MAK16;TEX10;RPS12
8601,GO:0034097,3.24339052111895e-08,1,97,815,response to cytokine,BP,IL32;SAA1;FN1;PTGES;PML;MAP3K14;GCLC;TFRC;NLRC5;STAT5A;TRIM22;HLA-B;MMP9;XAF1;RUNX1;IL1R2;ACTG1;MAT2A;TRIM56;TRAF3;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;PTPN14;IFNGR1;CYLD;IKBKE;IL27RA;IL16;IFIT3;IL6ST;HNRNPF;IL7R;SYK;TJP2;RELB;LEPR;HLA-F;CDK4;SFRP1;CD274;MCM2;KEAP1;TRAF1;CCL20;MME;GBP5;MYBL2;CXCL16;LCP1;SOD2;IL24;SOCS1;PARP14;CDC42EP2;SRF;NPNT;PDGFB;BIRC3;IL20;ACKR3;RIF1;SETD2;IFNAR1;CXCR5;HSPA8;HSP90AB1;SYNCRIP;IL12RB2;GPER1;ADAM17;PSME2;PSMB9;HNRNPDL;DPYSL3;MYNN;TRAF2;NCL;IFI30;CSF1;TLR3;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;CD74;HNRNPU;PSMB10;CDKN1A;IRF1;GBP6;IRAK3
2871,GO:0006364,3.97337043872005e-08,0.999999990142865,39,255,rRNA processing,BP,UTP20;DDX17;DDX47;PDCD11;DKC1;SHQ1;UTP15;HEATR1;GEMIN4;TSR1;MDN1;NOP58;NOP2;RRP7BP;MRTO4;UTP14A;RRP1;WDR3;WDR43;UTP18;ISG20L2;METTL16;RRP36;RPF2;DDX21;FCF1;SRFBP1;WDR75;BMS1;NOL9;NOL11;NOP56;DDX56;NSA2;RRP15;WDR36;MAK16;TEX10;RPS12
2810,GO:0006270,4.84504385725191e-08,0.999999994234596,15,41,DNA replication initiation,BP,NBN;MCM5;MCM2;POLA1;TOPBP1;ORC4;MCM3;GINS4;MCM8;MCM6;ORC1;PRIM2;MCM4;POLE3;ORC2
8869,GO:0034660,1.10180376318195e-07,1,67,545,ncRNA metabolic process,BP,UTP20;DDX17;DDX47;CARS2;CDKAL1;PDCD11;DKC1;PHAX;SHQ1;UTP15;POP1;HEATR1;GEMIN4;TSR1;PUS3;THUMPD3;METTL1;URM1;MDN1;NOP58;NOP2;GTF3C6;RAN;RRP7BP;MRTO4;UTP14A;YRDC;GATC;RRP1;RARS;USB1;WDR3;WDR43;UTP18;ISG20L2;METTL16;TYW1;RRP36;RPF2;TRMT5;SEPHS2;THADA;MYBL1;DDX21;TRMT1;DGCR8;POLR2F;FCF1;SRFBP1;WDR75;BMS1;NIFK;NOL9;NOL11;TRMT61A;NCBP1;NCL;GTF3C4;NOP56;DDX56;NSA2;RRP15;WDR4;WDR36;MAK16;TEX10;RPS12
958,GO:0002376,2.33630089700242e-07,1,184,1863,immune system process,BP,IL32;MAFB;KRT1;SAA1;FTL;FTH1;HDAC9;C1R;FN1;PML;KIF23;MTUS1;MAP3K14;TFRC;C3;NLRC5;FGFR2;TRIM22;S100P;HLA-B;MMP9;FBN1;TAP1;XAF1;SLC7A2;RUNX1;IL1R2;B4GALT1;ACTG1;PBX1;G6PD;TSC22D3;FST;DDX17;TRIM56;TRAF3;SPG21;MID1;TP53;DAPK3;EXO1;EDN1;GBP1;DOCK10;SIPA1L3;PABPC4;LGALS3;IFNGR1;PDPN;AKAP8;TGFB2;CYLD;IKBKE;IL27RA;IL16;IFIT3;IL6ST;INHBA;IL7R;SYK;EMP2;TJP2;NAIP;RAB32;RELB;NBN;LEPR;FAM111A;HLA-F;SFRP1;HLA-DOB;CD274;MIR17HG;POLQ;H3F3A;AHR;HRNR;HELLS;PTPRB;PTGER4;MGAM;CD109;HERC6;DYNLL2;CCL20;SLCO4C1;MME;MUC16;FRK;GBP5;BTN2A1;RHOG;WNT4;CXCL16;LCP1;SIRPA;THOC1;DDX3X;ITGAV;SOCS1;PARP14;QPCT;ARMC6;LFNG;CDC42EP2;BAIAP2;WDR7;SRF;PDGFB;CHID1;NFE2L1;RTKN2;CLU;ENPP1;BIRC3;IL20;COMMD9;RIF1;SETD2;ANLN;THBD;ABCC9;IFNAR1;ERAP1;SLC11A2;CXCR5;HSPA8;HSP90AB1;ZBTB24;LAIR1;BRCA2;SYNCRIP;FANCD2;ETV6;L1CAM;SERPINB9;GPER1;HMGN2;ADAM17;MYO10;SENP1;PSME2;MSH6;LILRB3;PSMB9;EIF2B5;CMTM3;EBP;TRAF2;MSH3;RBBP5;CITED2;MFAP5;POLR3B;TAP2;IFI30;CSF1;AP3B1;GLIPR1;PURB;TLR3;ESR1;RNF19B;DNASE1;TNF;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;PSMB10;EIF2B1;DCTN5;HIST1H4A;PHLPP1;NRAS;PSPC1;MUC5B;PPARGC1B;CDKN1A;MUC6;IRF1;GBP6;IRAK3
2888,GO:0006396,2.37464187253489e-07,1,97,877,RNA processing,BP,UTP20;DDX17;DDX47;RBM4;GEMIN5;PABPC4;LGALS3;RBM22;TGS1;CDKAL1;SRSF2;SUGP2;HNRNPF;PDCD11;DKC1;SHQ1;UTP15;POP1;HEATR1;TARDBP;GEMIN4;TSR1;PUS3;TRA2A;THUMPD3;ZMAT2;METTL1;TSN;URM1;HNRNPA1L2;MDN1;CASC3;AKAP8L;NOP58;NOP2;THOC1;RRP7BP;NUFIP1;MRTO4;UTP14A;RBMXL1;ZC3H7B;LUC7L;YRDC;RRP1;LUC7L2;USB1;WDR3;WDR43;UTP18;ISG20L2;EFTUD2;TRUB2;METTL16;TYW1;RRP36;RPF2;TRMT5;TTF2;SEPHS2;THADA;HSPA8;DDX21;GEMIN8;SYNCRIP;TRMT1;DGCR8;CCAR1;POLR2F;FCF1;SRFBP1;WDR75;BMS1;NOL9;NOL11;TRMT61A;NCBP1;UPF3B;HNRNPR;NOP56;DDX56;NSA2;ESR1;RRP15;WDR4;SRSF7;WDR36;HNRNPU;MAK16;PSPC1;HNRNPM;RBM8A;GTF2H3;TEX10;RPS12;BUD13;DHX15
15216,GO:0071345,3.89340889327373e-07,1,87,749,cellular response to cytokine stimulus,BP,IL32;SAA1;FN1;PML;MAP3K14;TFRC;NLRC5;STAT5A;TRIM22;HLA-B;MMP9;XAF1;RUNX1;IL1R2;ACTG1;MAT2A;TRAF3;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;PTPN14;IFNGR1;CYLD;IL27RA;IL16;IFIT3;IL6ST;HNRNPF;IL7R;SYK;TJP2;LEPR;HLA-F;CDK4;SFRP1;MCM2;KEAP1;TRAF1;CCL20;MME;GBP5;MYBL2;LCP1;SOD2;IL24;SOCS1;PARP14;CDC42EP2;NPNT;PDGFB;BIRC3;IL20;ACKR3;RIF1;IFNAR1;CXCR5;HSPA8;HSP90AB1;SYNCRIP;IL12RB2;GPER1;ADAM17;PSME2;PSMB9;HNRNPDL;DPYSL3;MYNN;TRAF2;NCL;IFI30;CSF1;TLR3;TNF;ZFP36L2;SRSF7;RC3H1;CCL5;CD74;HNRNPU;PSMB10;CDKN1A;IRF1;GBP6;IRAK3
11023,GO:0044843,5.05304982530574e-07,0.999999823662087,39,233,cell cycle G1/S phase transition,BP,PML;CYP1A1;TP53;CDKN2A;INHBA;GPR132;MCM5;CDK4;MCM2;DHFR;RPA1;POLA1;PLK2;RANBP2;ORC4;DDX3X;CDC25A;MCM3;MDM4;MCM8;RRM2;MCM6;WEE1;APEX1;ORC1;PRIM2;E2F8;MCM4;ADAM17;PSME2;RFWD3;CCNA2;POLE3;ORC2;RBL1;KIF14;TYMS;TAF1;CDKN1A
40,GO:0000082,9.93151588885757e-07,0.999999647583999,37,221,G1/S transition of mitotic cell cycle,BP,PML;CYP1A1;TP53;CDKN2A;INHBA;GPR132;MCM5;CDK4;MCM2;DHFR;RPA1;POLA1;PLK2;RANBP2;ORC4;DDX3X;CDC25A;MCM3;MDM4;MCM8;RRM2;MCM6;WEE1;APEX1;ORC1;PRIM2;E2F8;MCM4;ADAM17;PSME2;RFWD3;POLE3;ORC2;RBL1;KIF14;TYMS;CDKN1A
15217,GO:0071346,1.59780261414583e-06,0.999999581457685,23,111,cellular response to interferon-gamma,BP,PML;NLRC5;TRIM22;HLA-B;ACTG1;MID1;DAPK3;EDN1;GBP1;IFNGR1;HLA-F;CCL20;GBP5;SOCS1;PARP14;CDC42EP2;HSP90AB1;SYNCRIP;IFI30;TLR3;CCL5;IRF1;GBP6
8710,GO:0034341,3.11885064709255e-06,0.999999114059218,24,125,response to interferon-gamma,BP,PML;NLRC5;TRIM22;HLA-B;ACTG1;MID1;DAPK3;EDN1;GBP1;IFNGR1;HLA-F;CCL20;GBP5;CXCL16;SOCS1;PARP14;CDC42EP2;HSP90AB1;SYNCRIP;IFI30;TLR3;CCL5;IRF1;GBP6
11710,GO:0046483,3.98128146608598e-06,0.999997393638277,397,4707,heterocycle metabolic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;TFRC;CYR61;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;CTGF;UTP20;FBN1;RUNX1;CYP1A1;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;SLC16A9;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;DDX47;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;SUGP2;PGD;RAD1;HNRNPF;PDCD11;DKC1;INHBA;IL7R;NUP50;PHAX;SYK;TJP2;NUP153;ZFP42;RELB;NBN;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;SLC5A6;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL1;TAF2;POLA1;TSN;SETDB1;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;ADM;USP43;ZNF407;ELMSAN1;NDC1;HNRNPA1L2;MDN1;CASC3;ZNF512;MME;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;EXOG;GTF3C6;DDX28;THOC1;RAN;UBTF;RRP7BP;RANBP2;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;GPHN;RRN3;CDC25A;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;UTP14A;ZNF267;CROT;RBMXL1;ZC3H7B;PGK1;TRIM37;FEN1;MCM3;LUC7L;CDCA5;SRBD1;GNL3L;ZNF586;YRDC;NVL;GATC;APTX;CDH13;GINS4;IBA57;RRP1;RARS;COMMD4;SRF;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;WDR43;MCM8;PDGFB;UTP18;BRCC3;FZD1;IRX4;NFE2L1;ISG20L2;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;DDX10;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;RIF1;METTL16;TYW1;MCM6;SRD5A1;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;SEPHS2;NNT;ZNF484;THADA;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;FCF1;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;SENP1;ATR;PSME2;MSH6;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;UGT1A4;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;UQCRB;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;PURB;TLR3;ESR1;RRP15;RAD51B;DNASE1;TNF;WDR4;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;FLAD1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;USP1;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;IRAK3;BUD13;COPS3;DHX15
1023,GO:0002520,4.05446226236544e-06,0.999997998933547,78,658,immune system development,BP,MAFB;HDAC9;PML;TFRC;FGFR2;MMP9;FBN1;RUNX1;PBX1;G6PD;FST;EXO1;DOCK10;SIPA1L3;PABPC4;LGALS3;PDPN;TGFB2;CYLD;IL27RA;INHBA;IL7R;SYK;TJP2;RELB;NBN;LEPR;SFRP1;MIR17HG;POLQ;H3F3A;PTGER4;CD109;HERC6;WNT4;THOC1;SOCS1;ARMC6;LFNG;WDR7;SRF;NFE2L1;RTKN2;IL20;RIF1;ANLN;SLC11A2;CXCR5;ZBTB24;BRCA2;FANCD2;ETV6;ADAM17;SENP1;PSME2;MSH6;LILRB3;PSMB9;EBP;MSH3;RBBP5;CITED2;MFAP5;CSF1;AP3B1;PURB;TLR3;TNF;ATAD5;ZFP36L2;RC3H1;CD74;PSMB10;HIST1H4A;PHLPP1;PPARGC1B;IRF1;IRAK3
17660,GO:1901360,4.5235184585918e-06,0.999997032136257,407,4854,organic cyclic compound metabolic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;TFRC;CYR61;CYP24A1;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;CTGF;UTP20;FBN1;RUNX1;CYP1A1;CLN6;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;SLC16A9;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;SCD;HMGCS1;DDX47;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;SUGP2;PGD;RAD1;HNRNPF;PDCD11;DKC1;INHBA;IL7R;NUP50;PHAX;SYK;TJP2;NUP153;ZFP42;RELB;NBN;LEPR;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;SLC5A6;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL1;TAF2;POLA1;TSN;SETDB1;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;ADM;USP43;ZNF407;ELMSAN1;NDC1;HNRNPA1L2;MDN1;CASC3;ZNF512;MME;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;EXOG;GTF3C6;DDX28;THOC1;RAN;UBTF;RRP7BP;RANBP2;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;GPHN;RRN3;CDC25A;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;UTP14A;ZNF267;CROT;RBMXL1;AKR1C2;ZC3H7B;PGK1;TRIM37;FEN1;MCM3;LUC7L;CDCA5;SRBD1;GNL3L;ZNF586;YRDC;NVL;GATC;APTX;CDH13;GINS4;IBA57;RRP1;RARS;COMMD4;SRF;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;WDR43;MCM8;PDGFB;UTP18;BRCC3;FZD1;IRX4;NFE2L1;ISG20L2;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;DDX10;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;RIF1;METTL16;TYW1;MCM6;SRD5A1;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;SEPHS2;NNT;ZNF484;THADA;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;FCF1;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;SENP1;ATR;PSME2;MSH6;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;UGT1A4;HNRNPDL;ESF1;ZNF608;TAF6L;EBP;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;UQCRB;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;PURB;TLR3;ESR1;RRP15;RAD51B;ARV1;DNASE1;TNF;WDR4;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;FLAD1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;USP1;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;IRAK3;BUD13;COPS3;DHX15
16267,GO:0090304,5.25164269943182e-06,0.999996565048427,359,4171,nucleic acid metabolic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;TFRC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;UTP20;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EXO1;EDN1;DDX47;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;SUGP2;RAD1;HNRNPF;PDCD11;DKC1;INHBA;IL7R;PHAX;SYK;ZFP42;RELB;NBN;FAM111A;PARP15;BRIP1;MCM5;SHQ1;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;KEAP1;NAA15;TRA2A;ZNF827;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL1;TAF2;POLA1;TSN;SETDB1;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;USP43;ZNF407;ELMSAN1;HNRNPA1L2;MDN1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;EXOG;GTF3C6;DDX28;THOC1;RAN;UBTF;RRP7BP;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;RRN3;CDC25A;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;UTP14A;ZNF267;RBMXL1;ZC3H7B;TRIM37;FEN1;MCM3;LUC7L;CDCA5;GNL3L;ZNF586;YRDC;NVL;GATC;APTX;CDH13;GINS4;RRP1;RARS;COMMD4;SRF;MDM4;LUC7L2;USB1;HIF1AN;NPNT;WDR3;ZNF234;WDR43;MCM8;PDGFB;UTP18;BRCC3;FZD1;IRX4;NFE2L1;ISG20L2;CLU;SMYD2;MACC1;ENPP1;ZNF316;DDX10;RRM2;COMMD9;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;RIF1;METTL16;TYW1;MCM6;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;SEPHS2;ZNF484;THADA;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;FCF1;CHEK1;SRFBP1;GPER1;FAF1;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;SENP1;ATR;PSME2;MSH6;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;ZNF12;RFWD3;NOL11;BAZ2B;NFKBIE;TRMT61A;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;PURB;TLR3;ESR1;RRP15;RAD51B;DNASE1;TNF;WDR4;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;ZBTB9;IRAK3;BUD13;COPS3;DHX15
2802,GO:0006260,5.56029003748743e-06,0.999997758704416,40,260,DNA replication,BP,EXO1;RAD1;NBN;FAM111A;BRIP1;MCM5;NUCKS1;MCM2;POLQ;RPA1;POLA1;GRWD1;RFC3;THOC1;TOPBP1;ORC4;SUPT16H;NAP1L1;CDC25A;SET;FEN1;MCM3;GINS4;MCM8;PDGFB;RRM2;MCM6;ORC1;PRIM2;BRCA2;E2F8;CHEK1;RRM1;MCM4;ATR;RFWD3;POLE3;TIMELESS;ORC2;TREX1
3134,GO:0006725,5.7488282062126e-06,0.999996099019597,397,4721,cellular aromatic compound metabolic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;TFRC;CYR61;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;CTGF;UTP20;FBN1;RUNX1;CYP1A1;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;SLC16A9;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;DDX47;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;SUGP2;PGD;RAD1;HNRNPF;PDCD11;DKC1;INHBA;IL7R;NUP50;PHAX;SYK;TJP2;NUP153;ZFP42;RELB;NBN;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL1;TAF2;POLA1;TSN;SETDB1;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;ADM;USP43;ZNF407;ELMSAN1;NDC1;HNRNPA1L2;MDN1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;EXOG;GTF3C6;DDX28;THOC1;RAN;UBTF;RRP7BP;RANBP2;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;GPHN;RRN3;CDC25A;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;UTP14A;ZNF267;CROT;RBMXL1;AKR1C2;ZC3H7B;PGK1;TRIM37;FEN1;MCM3;LUC7L;CDCA5;SRBD1;GNL3L;ZNF586;YRDC;NVL;GATC;APTX;CDH13;GINS4;IBA57;RRP1;RARS;COMMD4;SRF;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;WDR43;MCM8;PDGFB;UTP18;BRCC3;FZD1;IRX4;NFE2L1;ISG20L2;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;DDX10;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;RIF1;METTL16;TYW1;MCM6;SRD5A1;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;SEPHS2;NNT;ZNF484;THADA;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;FCF1;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;SENP1;ATR;PSME2;MSH6;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;UGT1A4;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;UQCRB;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;PURB;TLR3;ESR1;RRP15;RAD51B;DNASE1;TNF;WDR4;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;FLAD1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;USP1;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;IRAK3;BUD13;COPS3;DHX15
8854,GO:0034641,6.04444367174405e-06,0.999995888588876,425,5136,cellular nitrogen compound metabolic process,BP,MAFB;NRG1;HDAC9;TRIM16;PTGES;PML;CYP1B1;GCLC;TFRC;CYR61;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;CTGF;UTP20;FBN1;SLC7A2;RUNX1;CLN6;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;SLC16A9;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;DDX47;ABCF1;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;LGALS3;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;SUGP2;PGD;RAD1;HNRNPF;PDCD11;DKC1;INHBA;IL7R;NUP50;SLC22A5;PUM3;PHAX;SYK;TJP2;NUP153;ZFP42;RELB;NBN;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;MCM2;TARDBP;MIR17HG;GEMIN4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;SLC5A6;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL1;TAF2;POLA1;TSN;SETDB1;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;ADM;IMMP2L;USP43;ZNF407;ELMSAN1;NDC1;HNRNPA1L2;MDN1;EIF5;CASC3;ZNF512;MRPL27;MME;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;EXOG;GTF3C6;DDX28;THOC1;RAN;UBTF;RRP7BP;RANBP2;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;GPHN;RRN3;CDC25A;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;AJUBA;FASTKD3;UTP14A;DND1;ZNF267;CROT;RBMXL1;ZC3H7B;PGK1;TRIM37;FEN1;MCM3;LUC7L;CDCA5;SRBD1;GNL3L;ZNF586;YRDC;NVL;GATC;APTX;CDH13;GINS4;IBA57;RRP1;RARS;COMMD4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;EIF3J;FZD1;IRX4;NFE2L1;ISG20L2;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;DDX10;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;RIF1;METTL16;TYW1;MCM6;SRD5A1;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;SEPHS2;NNT;ZNF484;THADA;ERAP1;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;BACE2;ZBTB24;DNPEP;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;FCF1;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;SENP1;RBMS3;ATR;PSME2;MSH6;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;UGT1A4;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;UQCRB;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;PURB;TLR3;AZIN1;ESR1;RRP15;RAD51B;DNASE1;TNF;WDR4;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;USP1;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;IRAK3;BUD13;COPS3;DHX15
10406,GO:0043228,9.58424128509294e-06,0.999993450081655,290,3275,non-membrane-bounded organelle,CC,CRYAB;KRT1;SAA1;NEFL;KRT34;KRT4;MAP2;KRT13;PML;KIF23;AMOT;MTUS1;JPH2;MAP3K14;KRT2;GPRC5A;KRT15;NLRC5;TXNRD1;STARD13;CBX5;UTP20;VMP1;TAP1;MYO1B;ACTG1;NEFM;DDX17;TFCP2L1;KRTAP2-3;ENC1;DYNC2H1;MID1;TP53;DAPK3;C9ORF3;SCD;DDX47;SIPA1L3;ABCF1;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;CHP1;AKAP8;PPAN;CYLD;PKMYT1;TGS1;PDLIM1;RAD1;SLC9A3R1;PDCD11;NUAK1;DKC1;PUM3;PHAX;DNHD1;NUP153;ZFP42;RELB;NBN;FAM111A;MCM5;LSS;UTP15;CDK4;VPS41;KRT9;POP1;NUCKS1;HEATR1;MCM2;GEMIN4;DST;POLQ;TSR1;H3F3A;KEAP1;TRA2A;TCHH;RPA1;POLR1A;THUMPD3;TPM1;HELLS;METTL1;POLA1;SETDB1;G3BP1;GRWD1;OPHN1;NDC1;DYNLL2;MDN1;CASC3;SYNPO2L;PLK2;MRPL27;NEXN;DNTTIP2;KANK4;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;NOP2;SUV39H2;LCP1;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;RANBP2;TOPBP1;ORC4;SUPT16H;CORO1C;DDX3X;NUFIP1;GPHN;KLHL21;RRN3;RRP12;SOCS1;SET;ARNTL;MRTO4;TAF1D;AJUBA;SMC2;CGNL1;UTP14A;KRT24;FEN1;MCM3;CDC42EP2;CDCA5;GNL3L;BAIAP2;NVL;APTX;GINS4;RRP1;SRF;NPNT;WDR3;WDR43;UTP18;BRCC3;ODF2L;UTY;RTKN2;CEP95;ISG20L2;CLU;NUP160;SDAD1;DDX10;LRPPRC;EYA3;ZNF106;DDX24;TPM4;RIF1;MCM6;FGD6;SETD2;RRP36;ANLN;RPF2;ABCC9;URB2;JPH1;SRPRB;WEE1;TJP1;NOL12;BLOC1S2;APEX1;TET3;ORC1;HSPA8;DDX21;ARL6IP5;SMUG1;HELQ;MYH11;PRIM2;BRCA2;DGCR8;KRT10;SKA2;WDPCP;FANCD2;E2F8;CENPF;PLEKHA7;ETV6;POLR2F;FCF1;RAB3GAP1;CHEK1;BBS5;GPER1;HMGN2;RAD18;WDR75;BMS1;MCM4;ADAM17;MYO10;ATR;MSH6;HADHB;CEP152;NIFK;NOL9;ZNF12;RFWD3;NOL11;NFKBIE;SHTN1;DPYSL3;ESF1;MRPS7;UPF3B;POLR1E;TELO2;RBBP5;CITED2;NCL;NOP56;POLE3;DDX56;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;NSA2;KIF14;PURB;SYNPO2;ESR1;PARD3;NOP16;RAD51B;USP11;EHD1;CENPN;SURF2;NEDD9;RC3H1;TYMS;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;DAXX;DCTN5;HIST1H4A;TAF1;YPEL4;PSPC1;SMARCC1;HNRNPM;CDKN1A;ITGB1BP1;IRF1;CTCF;TEX10;RPS12;CENPO;DHX15
10410,GO:0043232,9.58424128509294e-06,0.999993450081655,290,3275,intracellular non-membrane-bounded organelle,CC,CRYAB;KRT1;SAA1;NEFL;KRT34;KRT4;MAP2;KRT13;PML;KIF23;AMOT;MTUS1;JPH2;MAP3K14;KRT2;GPRC5A;KRT15;NLRC5;TXNRD1;STARD13;CBX5;UTP20;VMP1;TAP1;MYO1B;ACTG1;NEFM;DDX17;TFCP2L1;KRTAP2-3;ENC1;DYNC2H1;MID1;TP53;DAPK3;C9ORF3;SCD;DDX47;SIPA1L3;ABCF1;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;CHP1;AKAP8;PPAN;CYLD;PKMYT1;TGS1;PDLIM1;RAD1;SLC9A3R1;PDCD11;NUAK1;DKC1;PUM3;PHAX;DNHD1;NUP153;ZFP42;RELB;NBN;FAM111A;MCM5;LSS;UTP15;CDK4;VPS41;KRT9;POP1;NUCKS1;HEATR1;MCM2;GEMIN4;DST;POLQ;TSR1;H3F3A;KEAP1;TRA2A;TCHH;RPA1;POLR1A;THUMPD3;TPM1;HELLS;METTL1;POLA1;SETDB1;G3BP1;GRWD1;OPHN1;NDC1;DYNLL2;MDN1;CASC3;SYNPO2L;PLK2;MRPL27;NEXN;DNTTIP2;KANK4;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;NOP2;SUV39H2;LCP1;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;RANBP2;TOPBP1;ORC4;SUPT16H;CORO1C;DDX3X;NUFIP1;GPHN;KLHL21;RRN3;RRP12;SOCS1;SET;ARNTL;MRTO4;TAF1D;AJUBA;SMC2;CGNL1;UTP14A;KRT24;FEN1;MCM3;CDC42EP2;CDCA5;GNL3L;BAIAP2;NVL;APTX;GINS4;RRP1;SRF;NPNT;WDR3;WDR43;UTP18;BRCC3;ODF2L;UTY;RTKN2;CEP95;ISG20L2;CLU;NUP160;SDAD1;DDX10;LRPPRC;EYA3;ZNF106;DDX24;TPM4;RIF1;MCM6;FGD6;SETD2;RRP36;ANLN;RPF2;ABCC9;URB2;JPH1;SRPRB;WEE1;TJP1;NOL12;BLOC1S2;APEX1;TET3;ORC1;HSPA8;DDX21;ARL6IP5;SMUG1;HELQ;MYH11;PRIM2;BRCA2;DGCR8;KRT10;SKA2;WDPCP;FANCD2;E2F8;CENPF;PLEKHA7;ETV6;POLR2F;FCF1;RAB3GAP1;CHEK1;BBS5;GPER1;HMGN2;RAD18;WDR75;BMS1;MCM4;ADAM17;MYO10;ATR;MSH6;HADHB;CEP152;NIFK;NOL9;ZNF12;RFWD3;NOL11;NFKBIE;SHTN1;DPYSL3;ESF1;MRPS7;UPF3B;POLR1E;TELO2;RBBP5;CITED2;NCL;NOP56;POLE3;DDX56;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;NSA2;KIF14;PURB;SYNPO2;ESR1;PARD3;NOP16;RAD51B;USP11;EHD1;CENPN;SURF2;NEDD9;RC3H1;TYMS;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;DAXX;DCTN5;HIST1H4A;TAF1;YPEL4;PSPC1;SMARCC1;HNRNPM;CDKN1A;ITGB1BP1;IRF1;CTCF;TEX10;RPS12;CENPO;DHX15
7604,GO:0031974,9.79277110446132e-06,0.999993202438942,363,4311,membrane-enclosed lumen,CC,CRYAB;IGFBP3;KRT1;SAA1;FTL;FTH1;DTX2;NRG1;HDAC9;TRIM16;MAP2;FN1;PTGES;PML;KIF23;MTUS1;MAP3K14;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;COL16A1;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;COL5A3;S100P;UTP20;MMP9;FBN1;VMP1;HSPG2;RUNX1;CLN6;PBX1;DDX17;SPON1;TFCP2L1;COL27A1;ENC1;TP53;DAPK3;PANK2;EXO1;EDN1;C9ORF3;SCD;DOCK10;DDX47;ABCF1;RBM19;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;AKAP8;PPAN;TGFB2;PRSS23;RBM22;CARS2;IKBKE;PKMYT1;TGS1;IL16;SRSF2;COL12A1;SUGP2;P3H2;RAD1;HNRNPF;PDCD11;NUAK1;DKC1;NUP50;PUM3;PHAX;TJP2;NUP153;ZFP42;RELB;NBN;VEZT;FAM111A;BRIP1;MCM5;SHQ1;UTP15;LDHAL6B;CDK4;POP1;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;COL4A1;USP16;AHR;COA7;KEAP1;TRA2A;HRNR;RPA1;POLR1A;THUMPD3;METTL21A;METTL1;TAF2;POLA1;SETDB1;LSG1;GRWD1;PARD3B;P4HA2;USP43;ELMSAN1;CADPS2;FOXRED2;MDN1;CASC3;SYNPO2L;MRPL27;MUC16;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;WNT4;NOP2;SUV39H2;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;HS3ST1;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;DDX3X;NUFIP1;ARMC5;RRN3;RRP12;CDC25A;SOCS1;SET;ARNTL;MRTO4;QPCT;TAF1D;SMC2;UTP14A;CROT;RBM12;TRIM37;FEN1;MCM3;CDCA5;GNL3L;BAIAP2;NVL;SH3RF2;APTX;COL5A2;GINS4;IBA57;RRP1;RARS;SRF;MDM4;LUC7L2;HIF1AN;WDR3;WDR43;MCM8;PDGFB;UTP18;BRCC3;CHID1;UTY;ISG20L2;CLU;SDAD1;SMYD2;BIRC3;DDX10;COMMD9;LRPPRC;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;KANSL1L;RIF1;MCM6;SETD2;RRP36;GLIS2;ANLN;RPF2;UBP1;TRMT5;TTF2;URB2;JPH1;WEE1;NOL12;ERAP1;APEX1;TNC;ORC1;HSPA8;HSP90AB1;DDX21;SMUG1;HELQ;NEDD4L;SGK1;PRIM2;ZFYVE27;ANAPC7;BRCA2;GEMIN8;SYNCRIP;NAV2;TRMT1;DGCR8;CCAR1;PPIP5K1;FANCD2;E2F8;CENPF;ETV6;FKBP5;HSF2;POLR2F;FCF1;CHEK1;SERPINB9;MMAA;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;HADHB;CEP152;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;ZNF12;RFWD3;NOL11;NFKBIE;TRMT61A;CBLL1;HNRNPDL;ESF1;TAF6L;MRPS7;NCBP1;UPF3B;AKR1B1;POLR1E;TRAF2;MSH3;TELO2;RBBP5;FAM208B;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;CSF1;RBL1;MPHOSPH8;CLOCK;NSA2;PURB;ESR1;NOP16;RAD51B;USP11;FEM1C;CENPN;WDR4;PDSS1;SURF2;NEDD9;SRSF7;TYMS;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;FLAD1;DAXX;DCTN5;HIST1H4A;TAF1;TBPL1;YPEL4;FTO;HIBCH;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;CENPO;GPX4;COPS3;DHX15
10411,GO:0043233,9.79277110446132e-06,0.999993202438942,363,4311,organelle lumen,CC,CRYAB;IGFBP3;KRT1;SAA1;FTL;FTH1;DTX2;NRG1;HDAC9;TRIM16;MAP2;FN1;PTGES;PML;KIF23;MTUS1;MAP3K14;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;COL16A1;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;COL5A3;S100P;UTP20;MMP9;FBN1;VMP1;HSPG2;RUNX1;CLN6;PBX1;DDX17;SPON1;TFCP2L1;COL27A1;ENC1;TP53;DAPK3;PANK2;EXO1;EDN1;C9ORF3;SCD;DOCK10;DDX47;ABCF1;RBM19;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;AKAP8;PPAN;TGFB2;PRSS23;RBM22;CARS2;IKBKE;PKMYT1;TGS1;IL16;SRSF2;COL12A1;SUGP2;P3H2;RAD1;HNRNPF;PDCD11;NUAK1;DKC1;NUP50;PUM3;PHAX;TJP2;NUP153;ZFP42;RELB;NBN;VEZT;FAM111A;BRIP1;MCM5;SHQ1;UTP15;LDHAL6B;CDK4;POP1;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;COL4A1;USP16;AHR;COA7;KEAP1;TRA2A;HRNR;RPA1;POLR1A;THUMPD3;METTL21A;METTL1;TAF2;POLA1;SETDB1;LSG1;GRWD1;PARD3B;P4HA2;USP43;ELMSAN1;CADPS2;FOXRED2;MDN1;CASC3;SYNPO2L;MRPL27;MUC16;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;WNT4;NOP2;SUV39H2;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;HS3ST1;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;DDX3X;NUFIP1;ARMC5;RRN3;RRP12;CDC25A;SOCS1;SET;ARNTL;MRTO4;QPCT;TAF1D;SMC2;UTP14A;CROT;RBM12;TRIM37;FEN1;MCM3;CDCA5;GNL3L;BAIAP2;NVL;SH3RF2;APTX;COL5A2;GINS4;IBA57;RRP1;RARS;SRF;MDM4;LUC7L2;HIF1AN;WDR3;WDR43;MCM8;PDGFB;UTP18;BRCC3;CHID1;UTY;ISG20L2;CLU;SDAD1;SMYD2;BIRC3;DDX10;COMMD9;LRPPRC;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;KANSL1L;RIF1;MCM6;SETD2;RRP36;GLIS2;ANLN;RPF2;UBP1;TRMT5;TTF2;URB2;JPH1;WEE1;NOL12;ERAP1;APEX1;TNC;ORC1;HSPA8;HSP90AB1;DDX21;SMUG1;HELQ;NEDD4L;SGK1;PRIM2;ZFYVE27;ANAPC7;BRCA2;GEMIN8;SYNCRIP;NAV2;TRMT1;DGCR8;CCAR1;PPIP5K1;FANCD2;E2F8;CENPF;ETV6;FKBP5;HSF2;POLR2F;FCF1;CHEK1;SERPINB9;MMAA;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;HADHB;CEP152;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;ZNF12;RFWD3;NOL11;NFKBIE;TRMT61A;CBLL1;HNRNPDL;ESF1;TAF6L;MRPS7;NCBP1;UPF3B;AKR1B1;POLR1E;TRAF2;MSH3;TELO2;RBBP5;FAM208B;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;CSF1;RBL1;MPHOSPH8;CLOCK;NSA2;PURB;ESR1;NOP16;RAD51B;USP11;FEM1C;CENPN;WDR4;PDSS1;SURF2;NEDD9;SRSF7;TYMS;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;FLAD1;DAXX;DCTN5;HIST1H4A;TAF1;TBPL1;YPEL4;FTO;HIBCH;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;CENPO;GPX4;COPS3;DHX15
14539,GO:0070013,9.79277110446132e-06,0.999993202438942,363,4311,intracellular organelle lumen,CC,CRYAB;IGFBP3;KRT1;SAA1;FTL;FTH1;DTX2;NRG1;HDAC9;TRIM16;MAP2;FN1;PTGES;PML;KIF23;MTUS1;MAP3K14;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;COL16A1;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;COL5A3;S100P;UTP20;MMP9;FBN1;VMP1;HSPG2;RUNX1;CLN6;PBX1;DDX17;SPON1;TFCP2L1;COL27A1;ENC1;TP53;DAPK3;PANK2;EXO1;EDN1;C9ORF3;SCD;DOCK10;DDX47;ABCF1;RBM19;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;AKAP8;PPAN;TGFB2;PRSS23;RBM22;CARS2;IKBKE;PKMYT1;TGS1;IL16;SRSF2;COL12A1;SUGP2;P3H2;RAD1;HNRNPF;PDCD11;NUAK1;DKC1;NUP50;PUM3;PHAX;TJP2;NUP153;ZFP42;RELB;NBN;VEZT;FAM111A;BRIP1;MCM5;SHQ1;UTP15;LDHAL6B;CDK4;POP1;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;COL4A1;USP16;AHR;COA7;KEAP1;TRA2A;HRNR;RPA1;POLR1A;THUMPD3;METTL21A;METTL1;TAF2;POLA1;SETDB1;LSG1;GRWD1;PARD3B;P4HA2;USP43;ELMSAN1;CADPS2;FOXRED2;MDN1;CASC3;SYNPO2L;MRPL27;MUC16;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;WNT4;NOP2;SUV39H2;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;HS3ST1;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;DDX3X;NUFIP1;ARMC5;RRN3;RRP12;CDC25A;SOCS1;SET;ARNTL;MRTO4;QPCT;TAF1D;SMC2;UTP14A;CROT;RBM12;TRIM37;FEN1;MCM3;CDCA5;GNL3L;BAIAP2;NVL;SH3RF2;APTX;COL5A2;GINS4;IBA57;RRP1;RARS;SRF;MDM4;LUC7L2;HIF1AN;WDR3;WDR43;MCM8;PDGFB;UTP18;BRCC3;CHID1;UTY;ISG20L2;CLU;SDAD1;SMYD2;BIRC3;DDX10;COMMD9;LRPPRC;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;KANSL1L;RIF1;MCM6;SETD2;RRP36;GLIS2;ANLN;RPF2;UBP1;TRMT5;TTF2;URB2;JPH1;WEE1;NOL12;ERAP1;APEX1;TNC;ORC1;HSPA8;HSP90AB1;DDX21;SMUG1;HELQ;NEDD4L;SGK1;PRIM2;ZFYVE27;ANAPC7;BRCA2;GEMIN8;SYNCRIP;NAV2;TRMT1;DGCR8;CCAR1;PPIP5K1;FANCD2;E2F8;CENPF;ETV6;FKBP5;HSF2;POLR2F;FCF1;CHEK1;SERPINB9;MMAA;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;HADHB;CEP152;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;ZNF12;RFWD3;NOL11;NFKBIE;TRMT61A;CBLL1;HNRNPDL;ESF1;TAF6L;MRPS7;NCBP1;UPF3B;AKR1B1;POLR1E;TRAF2;MSH3;TELO2;RBBP5;FAM208B;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;CSF1;RBL1;MPHOSPH8;CLOCK;NSA2;PURB;ESR1;NOP16;RAD51B;USP11;FEM1C;CENPN;WDR4;PDSS1;SURF2;NEDD9;SRSF7;TYMS;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;FLAD1;DAXX;DCTN5;HIST1H4A;TAF1;TBPL1;YPEL4;FTO;HIBCH;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;CENPO;GPX4;COPS3;DHX15
2803,GO:0006261,1.28576800675794e-05,0.999995881680741,25,137,DNA-dependent DNA replication,BP,NBN;MCM5;NUCKS1;MCM2;POLQ;RPA1;POLA1;RFC3;THOC1;TOPBP1;ORC4;FEN1;MCM3;GINS4;MCM8;MCM6;ORC1;PRIM2;BRCA2;E2F8;MCM4;RFWD3;POLE3;TIMELESS;ORC2
10897,GO:0044428,1.37052215350694e-05,0.999990381064278,327,3796,nuclear part,CC,CRYAB;DTX2;NRG1;HDAC9;TRIM16;MAP2;PTGES;PML;KIF23;AMOT;MTUS1;MAP3K14;GPRC5A;CYP24A1;MKL1;FOSL2;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;S100P;UTP20;VMP1;RUNX1;PBX1;DDX17;TFCP2L1;ENC1;TP53;DAPK3;EXO1;C9ORF3;SCD;DOCK10;DDX47;ABCF1;RBM19;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;LGALS3;AKAP8;PPAN;RBM22;IKBKE;PKMYT1;TGS1;IL16;SRSF2;SUGP2;RAD1;HNRNPF;PDCD11;NUAK1;DKC1;NUP50;PUM3;PHAX;TJP2;NUP153;ZFP42;RELB;NBN;VEZT;FAM111A;BRIP1;MCM5;SHQ1;UTP15;CDK4;POP1;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;DST;POLQ;TSR1;H3F3A;USP16;AHR;KEAP1;TRA2A;RPA1;POLR1A;THUMPD3;ZMAT2;METTL21A;METTL1;TAF2;POLA1;SETDB1;TMEM97;LSG1;GRWD1;PARD3B;P4HA2;USP43;ELMSAN1;NDC1;CADPS2;HNRNPA1L2;MDN1;CASC3;SYNPO2L;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;NOP2;SUV39H2;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;RANBP2;TOPBP1;ANAPC15;ORC4;SUPT16H;DDX3X;NUFIP1;ARMC5;RRN3;RRP12;CDC25A;SOCS1;SET;ARNTL;MRTO4;TAF1D;SMC2;UTP14A;RBM12;TRIM37;FEN1;MCM3;LUC7L;CDCA5;GNL3L;BAIAP2;NVL;SH3RF2;APTX;GINS4;RRP1;RARS;SRF;MDM4;LUC7L2;HIF1AN;WDR3;WDR43;MCM8;UTP18;BRCC3;UTY;ISG20L2;NUP160;SDAD1;SMYD2;BIRC3;DDX10;NUP54;LRPPRC;EYA3;EFTUD2;ZNF106;DDX24;KANSL1L;RIF1;MCM6;SETD2;RRP36;GLIS2;ANLN;RPF2;UBP1;TTF2;URB2;JPH1;DPY19L2P2;WEE1;NOL12;APEX1;ORC1;HSPA8;HSP90AB1;DDX21;SMUG1;HELQ;NEDD4L;SGK1;PRIM2;ZFYVE27;ANAPC7;BRCA2;GEMIN8;SYNCRIP;NAV2;TRMT1;DGCR8;CCAR1;PPIP5K1;FANCD2;E2F8;CENPF;ETV6;FKBP5;HSF2;POLR2F;FCF1;CHEK1;SERPINB9;GPER1;FAF1;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;CEP152;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;ZNF12;CMTM3;RFWD3;NOL11;NFKBIE;TRMT61A;CBLL1;HNRNPDL;ESF1;TAF6L;EBP;NCBP1;UPF3B;AKR1B1;POLR1E;TRAF2;MSH3;TELO2;RBBP5;FAM208B;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TAP2;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;NSA2;PURB;ESR1;NOP16;RAD51B;USP11;FEM1C;CENPN;DNASE1;WDR4;SURF2;NEDD9;SRSF7;TYMS;ARGLU1;WDR36;HNRNPU;RING1;MAK16;PSMB10;DAXX;DCTN5;HIST1H4A;TAF1;TBPL1;YPEL4;PHLPP1;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;TREX1;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;CENPO;GPX4;BUD13;COPS3;DHX15
7158,GO:0031012,1.42039168734619e-05,0.999994161416858,38,241,extracellular matrix,CC,KRT1;FN1;CYR61;COL16A1;FGFR2;COL5A3;CTGF;MMP9;FBN1;HSPG2;SPON1;CCDC80;COL27A1;LGALS3;TGFB2;LRFN4;COL12A1;P3H2;SFRP1;WNT10A;DST;COL4A1;ADAMTS9;WNT4;CDH13;COL5A2;NPNT;PDGFB;CLU;FRAS1;LRRN3;TNC;NAV2;L1CAM;RPTN;NTN1;MFAP5;HNRNPM
7606,GO:0031981,1.74420208899188e-05,0.999987777145447,305,3518,nuclear lumen,CC,CRYAB;DTX2;NRG1;HDAC9;TRIM16;MAP2;PML;KIF23;MTUS1;MAP3K14;GPRC5A;CYP24A1;MKL1;FOSL2;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;S100P;UTP20;VMP1;RUNX1;PBX1;DDX17;TFCP2L1;ENC1;TP53;DAPK3;EXO1;C9ORF3;SCD;DOCK10;DDX47;ABCF1;RBM19;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;AKAP8;PPAN;RBM22;IKBKE;PKMYT1;TGS1;IL16;SRSF2;SUGP2;RAD1;HNRNPF;PDCD11;NUAK1;DKC1;NUP50;PUM3;PHAX;TJP2;NUP153;ZFP42;RELB;NBN;VEZT;FAM111A;BRIP1;MCM5;SHQ1;UTP15;CDK4;POP1;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;USP16;AHR;KEAP1;TRA2A;RPA1;POLR1A;THUMPD3;METTL21A;METTL1;TAF2;POLA1;SETDB1;LSG1;GRWD1;PARD3B;P4HA2;USP43;ELMSAN1;CADPS2;MDN1;CASC3;SYNPO2L;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;NOP2;SUV39H2;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;TOPBP1;ANAPC15;ORC4;SUPT16H;DDX3X;NUFIP1;ARMC5;RRN3;RRP12;CDC25A;SOCS1;SET;ARNTL;MRTO4;TAF1D;SMC2;UTP14A;RBM12;TRIM37;FEN1;MCM3;CDCA5;GNL3L;BAIAP2;NVL;SH3RF2;APTX;GINS4;RRP1;RARS;SRF;MDM4;LUC7L2;HIF1AN;WDR3;WDR43;MCM8;UTP18;BRCC3;UTY;ISG20L2;SDAD1;SMYD2;BIRC3;DDX10;LRPPRC;EYA3;EFTUD2;ZNF106;DDX24;KANSL1L;RIF1;MCM6;SETD2;RRP36;GLIS2;ANLN;RPF2;UBP1;TTF2;URB2;JPH1;WEE1;NOL12;APEX1;ORC1;HSPA8;HSP90AB1;DDX21;SMUG1;HELQ;NEDD4L;SGK1;PRIM2;ZFYVE27;ANAPC7;BRCA2;GEMIN8;SYNCRIP;NAV2;TRMT1;DGCR8;CCAR1;PPIP5K1;FANCD2;E2F8;CENPF;ETV6;FKBP5;HSF2;POLR2F;FCF1;CHEK1;SERPINB9;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;CEP152;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;ZNF12;RFWD3;NOL11;NFKBIE;TRMT61A;CBLL1;HNRNPDL;ESF1;TAF6L;NCBP1;UPF3B;AKR1B1;POLR1E;TRAF2;MSH3;TELO2;RBBP5;FAM208B;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TAP2;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;NSA2;PURB;ESR1;NOP16;RAD51B;USP11;FEM1C;CENPN;WDR4;SURF2;NEDD9;SRSF7;TYMS;ARGLU1;WDR36;HNRNPU;RING1;MAK16;PSMB10;DAXX;DCTN5;HIST1H4A;TAF1;TBPL1;YPEL4;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;CENPO;GPX4;COPS3;DHX15
10988,GO:0044770,1.93973188473702e-05,0.999990284266645,62,511,cell cycle phase transition,BP,PML;CYP1A1;PBX1;TP53;CDKN2A;AKAP8;PKMYT1;INHBA;GPR132;NBN;MCM5;CDK4;MCM2;DHFR;RPA1;TAF2;POLA1;PLK2;AKAP8L;RANBP2;TOPBP1;ANAPC15;ORC4;DDX3X;CDC25A;AJUBA;MCM3;CDCA5;MDM4;MCM8;BRCC3;RRM2;MCM6;ANLN;WEE1;APEX1;ORC1;PRIM2;E2F8;CENPF;CHEK1;MCM4;ADAM17;PSME2;CEP152;PSMB9;RFWD3;TPRA1;CCNA2;POLE3;TIMELESS;ORC2;RBL1;KIF14;RAD51B;ATAD5;ZFP36L2;TYMS;FGFR1OP;PSMB10;TAF1;CDKN1A
2745,GO:0006139,2.05760646137615e-05,0.9999852184557,385,4604,nucleobase-containing compound metabolic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;TFRC;CYR61;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;CTGF;UTP20;FBN1;RUNX1;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;DDX47;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;SUGP2;PGD;RAD1;HNRNPF;PDCD11;DKC1;INHBA;IL7R;NUP50;PHAX;SYK;TJP2;NUP153;ZFP42;RELB;NBN;FAM111A;PARP15;BRIP1;MCM5;SHQ1;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL1;TAF2;POLA1;TSN;SETDB1;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;ADM;USP43;ZNF407;ELMSAN1;NDC1;HNRNPA1L2;MDN1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;EXOG;GTF3C6;DDX28;THOC1;RAN;UBTF;RRP7BP;RANBP2;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;GPHN;RRN3;CDC25A;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;UTP14A;ZNF267;CROT;RBMXL1;ZC3H7B;PGK1;TRIM37;FEN1;MCM3;LUC7L;CDCA5;SRBD1;GNL3L;ZNF586;YRDC;NVL;GATC;APTX;CDH13;GINS4;RRP1;RARS;COMMD4;SRF;MDM4;LUC7L2;USB1;HIF1AN;NPNT;WDR3;ZNF234;WDR43;MCM8;PDGFB;UTP18;BRCC3;FZD1;IRX4;NFE2L1;ISG20L2;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;DDX10;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;RIF1;METTL16;TYW1;MCM6;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;SEPHS2;NNT;ZNF484;THADA;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;FCF1;CHEK1;SRFBP1;GPER1;FAF1;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;SENP1;ATR;PSME2;MSH6;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;UQCRB;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;PURB;TLR3;ESR1;RRP15;RAD51B;DNASE1;TNF;WDR4;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;FLAD1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;IRAK3;BUD13;COPS3;DHX15
3275,GO:0006955,2.97414552147461e-05,0.999981401304811,123,1231,immune response,BP,IL32;KRT1;SAA1;FTL;FTH1;C1R;PML;MAP3K14;TFRC;C3;NLRC5;TRIM22;S100P;HLA-B;MMP9;TAP1;XAF1;RUNX1;IL1R2;B4GALT1;ACTG1;TRIM56;TRAF3;SPG21;MID1;DAPK3;EXO1;EDN1;GBP1;DOCK10;LGALS3;IFNGR1;AKAP8;TGFB2;CYLD;IKBKE;IL27RA;IL16;IFIT3;IL6ST;IL7R;SYK;EMP2;NAIP;RELB;NBN;HLA-F;HLA-DOB;CD274;HRNR;PTPRB;PTGER4;MGAM;CCL20;SLCO4C1;MME;MUC16;FRK;GBP5;BTN2A1;RHOG;CXCL16;LCP1;SIRPA;THOC1;DDX3X;ITGAV;SOCS1;PARP14;QPCT;LFNG;CDC42EP2;BAIAP2;CHID1;CLU;ENPP1;BIRC3;IL20;COMMD9;RIF1;SETD2;IFNAR1;ERAP1;CXCR5;HSPA8;HSP90AB1;LAIR1;SYNCRIP;SERPINB9;GPER1;HMGN2;ADAM17;MYO10;PSME2;MSH6;LILRB3;PSMB9;EIF2B5;CMTM3;TRAF2;POLR3B;TAP2;IFI30;CSF1;GLIPR1;TLR3;ESR1;RNF19B;DNASE1;TNF;ATAD5;RC3H1;CCL5;CD74;PSMB10;EIF2B1;NRAS;PSPC1;MUC5B;MUC6;IRF1;GBP6;IRAK3
6075,GO:0019221,3.13898919568296e-05,0.999983816847998,61,534,cytokine-mediated signaling pathway,BP,IL32;SAA1;FN1;PML;MAP3K14;NLRC5;STAT5A;TRIM22;HLA-B;MMP9;XAF1;RUNX1;IL1R2;TRAF3;IRS1;MID1;TP53;EDN1;GBP1;IFNGR1;CYLD;IL27RA;IL16;IFIT3;IL6ST;HNRNPF;IL7R;SYK;TJP2;LEPR;HLA-F;TRAF1;CCL20;LCP1;SOD2;IL24;SOCS1;PARP14;PDGFB;BIRC3;IL20;ACKR3;IFNAR1;CXCR5;HSPA8;HSP90AB1;IL12RB2;ADAM17;PSME2;PSMB9;HNRNPDL;TRAF2;IFI30;CSF1;TNF;CCL5;CD74;PSMB10;CDKN1A;IRF1;IRAK3
12085,GO:0048018,3.80834150803931e-05,0.999986471550973,26,167,receptor ligand activity,MF,IL32;SAA1;NRG1;EPGN;CTGF;FBN1;EDN1;LGALS3;TGFB2;IL16;INHBA;WNT10A;ADM;CCL20;WNT4;CXCL16;IL24;CDC42EP2;PDGFB;MACC1;IL20;CMTM3;RABEP2;CSF1;TNF;CCL5
1449,GO:0003676,4.11629184338996e-05,0.999970435266092,282,3231,nucleic acid binding,MF,MAFB;TRIM16;PML;TFRC;FOSL2;NLRC5;STAT5A;UTP20;RUNX1;PBX1;DDX17;TRIM56;TFCP2L1;TP53;EXO1;DDX47;ABCF1;DUSP14;RBM19;CDKN2A;RBM4;ZBED1;ZNF397;JRK;GEMIN5;NQO1;PABPC4;LGALS3;ACO1;AKAP8;PPAN;IRX2;ZNF208;RBM22;IFIT3;SRSF2;FOXD2;SUGP2;RAD1;HNRNPF;PDCD11;DKC1;PUM3;PHAX;NUP153;ZFP42;RELB;NBN;BRIP1;MCM5;UTP15;POP1;NUCKS1;HEATR1;MCM2;TARDBP;MIR17HG;POLQ;TSR1;H3F3A;PUS3;AHR;NAA15;TRA2A;ZNF827;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;CSRP1;METTL1;TAF2;POLA1;TSN;SETDB1;G3BP1;GRWD1;ZNF584;ZNF407;ELMSAN1;HNRNPA1L2;EIF5;CASC3;ZNF512;MRPL27;ZNF587;DNTTIP2;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;NOP2;SUV39H2;EXOG;GTF3C6;KDM6A;DDX28;THOC1;RAN;HMGXB3;UBTF;RANBP2;TOPBP1;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;ARHGEF28;RRN3;RRP12;SET;ARNTL;MRTO4;TAF1D;FASTKD3;UTP14A;DND1;ZNF267;RBMXL1;ZC3H7B;RBM12;FEN1;MCM3;LUC7L;SRBD1;GNL3L;ZNF586;YRDC;NVL;APTX;IBA57;RRP1;RARS;SRF;FNDC3B;LUC7L2;WDR3;ZNF234;WDR43;MCM8;UTP18;EIF3J;IRX4;UTY;NFE2L1;ISG20L2;USP6;MACC1;ENPP1;ZNF316;DDX10;LRPPRC;ZNF670;EFTUD2;ZNF106;TRUB2;DDX24;KANSL1L;METTL16;MCM6;RRP36;GLIS2;RPF2;UBP1;TTF2;ZNF484;NOL12;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;HELQ;PRIM2;ZBTB12;BRCA2;SYNCRIP;TRMT1;DGCR8;CCAR1;MAZ;ZNF33A;E2F8;ETV6;ZNFX1;HSF2;POLR2F;CCDC47;FCF1;SRFBP1;HMGN2;MLLT10;RAD18;WDR75;BMS1;MCM4;RBMS3;ATR;UBAP2L;MSH6;HADHB;DDX60L;PSMC3IP;NIFK;NOL9;EIF2B5;ZNF12;NOL11;BAZ2B;GPATCH4;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;NCBP1;MYNN;UPF3B;POLR1E;JRKL;MSH3;TELO2;RBBP5;POLR3B;HNRNPR;NCL;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;RBL1;ZNF286A;CLOCK;NSA2;PURB;TLR3;ESR1;NOP16;RAD51B;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;WDR36;HNRNPU;MAK16;EIF2B1;ZSCAN31;METAP2;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;BUD13;DHX15
12679,GO:0050864,4.46390232592306e-05,0.999988912295203,16,72,regulation of B cell activation,BP,TFRC;CYLD;IL27RA;INHBA;SYK;SFRP1;MIR17HG;AHR;THOC1;RIF1;MSH6;ATAD5;ZFP36L2;RC3H1;CD74;CDKN1A
3271,GO:0006950,4.54352714685791e-05,0.999967866313771,238,2667,response to stress,BP,IL32;CRYAB;SPRR3;KRT1;SAA1;NEFL;NRG1;HDAC9;C1R;FN1;PTGES;PML;CYP1B1;MAP3K14;GCLC;CYR61;C3;NLRC5;TXNRD1;FGFR2;TRIM22;CBX5;CTGF;HLA-B;MMP9;TAP1;HSPG2;XAF1;SLC7A2;CYP1A1;IL1R2;B4GALT1;ACTG1;G6PD;TSC22D3;DDX17;TRIM56;TRAF3;MID1;TP53;DAPK3;EXO1;EDN1;TPST1;GBP1;ABCF1;C1QTNF1;CDKN2A;RBM4;NQO1;PABPC4;LGALS3;IFNGR1;PDPN;AKAP8;TGFB2;CYLD;IKBKE;PDLIM1;IL27RA;IFIT3;RAD1;IL6ST;BAG1;NUAK1;INHBA;NUP50;SYK;NUP153;NAIP;RELB;NBN;FAM111A;BRIP1;HLA-F;CDK4;SFRP1;NUCKS1;PITHD1;DST;POLQ;H3F3A;ATP2B1;USP16;DHFR;RPA1;TPM1;CSRP1;ULK4;POLA1;PTGER4;ARRDC1-AS1;ADM;IMMP2L;CD109;USP43;GGCX;NDC1;CADPS2;FOXRED2;SLC1A3;CCL20;PLK2;RRAGB;MUC16;UBQLN2;FRK;GBP5;RFC3;WDR76;HSPB1;RHOG;WNT4;CXCL16;SUV39H2;THOC1;RANBP2;TOPBP1;SOD2;SUPT16H;DDX3X;IL24;SOCS1;PARP14;ARNTL;AJUBA;PGK1;FEN1;CDC42EP2;CDCA5;GADD45B;APTX;GINS4;SRF;MDM4;HIF1AN;MCM8;PDGFB;BRCC3;CHID1;FZD1;NFE2L1;CLU;NUP160;SMYD2;BIRC3;IL20;NUP54;EYA3;ACKR3;RIF1;SRD5A1;SETD2;THBD;ABCC9;SRPRB;IFNAR1;ERAP1;APEX1;TNC;HSPA8;SYT11;HSP90AB1;ARL6IP5;SMUG1;HELQ;SGK1;PXMP2;BRCA2;HPS5;SYNCRIP;FANCD2;E2F8;HSF2;POLR2F;CCDC47;CHEK1;SERPINB9;GPER1;RAD18;ADAM17;RBMS3;ATR;PSME2;MSH6;LILRB3;CFLAR;PSMB9;EIF2B5;RFWD3;DPYSL3;AKR1B1;UBE2J2;TRAF2;MSH3;RBBP5;CITED2;POLR3B;CCNA2;TIMELESS;IFI30;CSF1;AP3B1;RBL1;CLOCK;TLR3;ESR1;RAD51B;EHD1;DNASE1;TNF;ATAD5;ZFP36L2;CCL5;CD74;PSMB10;EIF2B1;DAXX;PANX1;HIST1H4A;TAF1;PHLPP1;FTO;NRAS;PSPC1;MUC5B;PPARGC1B;CDKN1A;USP1;MUC6;TREX1;IRF1;GTF2H3;GBP6;GPX4;IRAK3;COPS3;UFC1
10074,GO:0042555,4.86149802580087e-05,0.99999734323246,6,11,MCM complex,CC,MCM5;MCM2;MCM3;MCM8;MCM6;MCM4
2867,GO:0006360,4.86738491554901e-05,0.99998922962662,14,59,transcription by RNA polymerase I,BP,UTP15;HEATR1;POLR1A;UBTF;RRN3;TAF1D;WDR43;POLR2F;WDR75;NOL11;POLR1E;NCL;TAF1;GTF2H3
7638,GO:0032040,4.92887769102882e-05,0.999992605236435,10,33,small-subunit processome,CC,UTP20;PDCD11;HEATR1;NOP58;UTP14A;WDR3;UTP18;FCF1;NOP56;WDR36
4538,GO:0010608,6.55742870730066e-05,0.99996544099189,58,506,posttranscriptional regulation of gene expression,BP,ENC1;DAPK3;KBTBD8;RBM4;GEMIN5;PABPC4;ACO1;DKC1;NUP50;PUM3;NUP153;CDK4;TARDBP;MIR17HG;H3F3A;USP16;DHFR;TSN;NDC1;EIF5;CASC3;HSPB1;RAN;RANBP2;DDX3X;SET;AJUBA;FASTKD3;DND1;ZC3H7B;NUP160;NUP54;LRPPRC;METTL16;APEX1;HSPA8;SYNCRIP;DGCR8;POLR2F;RBMS3;PSME2;PSMB9;EIF2B5;DPH2;NCBP1;UPF3B;HNRNPR;NCL;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;HNRNPU;PSMB10;HIST1H4A;RBM8A
16314,GO:0090399,6.69503319565893e-05,0.99999611492356,6,11,replicative senescence,BP,TP53;CDKN2A;MME;CHEK1;ATR;CDKN1A
9937,GO:0042274,7.01145996139909e-05,0.999983583594639,14,70,ribosomal small subunit biogenesis,BP,UTP20;PDCD11;HEATR1;TSR1;RRP7BP;UTP14A;WDR3;UTP18;RRP36;FCF1;SRFBP1;BMS1;NOL11;MRPS7
6928,GO:0030515,7.27491661007049e-05,0.999989863268303,9,30,snoRNA binding,MF,DKC1;HEATR1;TSR1;NOP58;NUFIP1;WDR3;DDX21;BMS1;NOP56
282,GO:0000784,7.4589848868492e-05,0.99997665129692,20,114,nuclear chromosome, telomeric region,CC,PML;CBX5;NBN;MCM5;MCM2;H3F3A;RPA1;THOC1;ORC4;FEN1;MCM3;MCM6;APEX1;ORC1;BRCA2;MCM4;ATR;TELO2;ORC2;HIST1H4A
11498,GO:0045943,8.83817879508164e-05,0.999989828596935,8,21,positive regulation of transcription by RNA polymerase I,BP,UTP15;HEATR1;UBTF;WDR43;WDR75;NOL11;NCL;TAF1
2801,GO:0006259,9.94155586107853e-05,0.999939891534038,89,844,DNA metabolic process,BP,PML;TFRC;CTGF;TP53;EXO1;IL27RA;RAD1;DKC1;IL7R;NBN;FAM111A;BRIP1;MCM5;NUCKS1;MCM2;POLQ;RPA1;HELLS;POLA1;TSN;SETDB1;TK1;GRWD1;USP43;RFC3;EXOG;THOC1;RAN;TOPBP1;ORC4;SUPT16H;NAP1L1;CDC25A;SET;FEN1;MCM3;CDCA5;GNL3L;NVL;APTX;GINS4;MCM8;PDGFB;BRCC3;RRM2;EYA3;RIF1;MCM6;SETD2;APEX1;TET3;ORC1;HSP90AB1;SMUG1;HELQ;PRIM2;BRCA2;FANCD2;E2F8;CENPF;POLR2F;CHEK1;GPER1;RRM1;RAD18;MCM4;ATR;MSH6;PSMC3IP;RFWD3;MSH3;TELO2;POLE3;TIMELESS;ORC2;MPHOSPH8;RAD51B;DNASE1;ATAD5;TYMS;HNRNPU;HIST1H4A;FTO;CDKN1A;USP1;TREX1;CTCF;GTF2H3;COPS3
2906,GO:0006417,0.000114578427655459,0.999942576989197,47,387,regulation of translation,BP,ENC1;DAPK3;KBTBD8;RBM4;GEMIN5;ACO1;NUP50;PUM3;NUP153;CDK4;MIR17HG;H3F3A;USP16;DHFR;NDC1;EIF5;CASC3;HSPB1;RAN;RANBP2;DDX3X;AJUBA;FASTKD3;DND1;ZC3H7B;NUP160;NUP54;LRPPRC;METTL16;SYNCRIP;DGCR8;POLR2F;RBMS3;EIF2B5;DPH2;NCBP1;UPF3B;HNRNPR;NCL;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;HIST1H4A;RBM8A
6912,GO:0030490,0.000117175803699442,0.999975209773963,12,53,maturation of SSU-rRNA,BP,UTP20;PDCD11;HEATR1;TSR1;UTP14A;WDR3;UTP18;RRP36;FCF1;SRFBP1;BMS1;NOL11
10739,GO:0044085,0.000127754870789385,0.999908337177886,219,2479,cellular component biogenesis,BP,CRYAB;NEFL;NRG1;MAP2;FN1;PML;KIF23;CYR61;COL16A1;SACS;TRIM22;CTGF;UTP20;VMP1;RUNX1;MYO1B;B4GALT1;ACTG1;NEFM;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;EXO1;EDN1;GBP1;DDX47;C1QTNF1;CDKN2A;ACSL3;GEMIN5;STAG1;COBLL1;CHP1;PPAN;CNTNAP1;RBM22;CYLD;IKBKE;TGS1;SLC9A3R1;PDCD11;DKC1;DNHD1;EMP2;NUP153;NAIP;RAB32;NBN;BRIP1;SHQ1;UTP15;SFRP1;VPS41;HEATR1;MCM2;GEMIN4;POLQ;TSR1;H3F3A;USP16;RPA1;TPM1;HELLS;TAF2;ABCC4;KCNS3;PTGER4;TK1;LSG1;GRWD1;TRAF1;OPHN1;IMMP2L;NDC1;CADPS2;DYNLL2;MDN1;SYNPO2L;PLK2;UBQLN2;HSCB;GBP5;KANK4;MYBL2;NOP58;RHOG;WNT4;NOP2;LCP1;DDX28;SETD4;RAN;UBTF;RRP7BP;SOD2;CORO1C;DDX3X;NAP1L1;NUFIP1;RRN3;SET;MRTO4;TRPM7;AJUBA;FASTKD3;UTP14A;TRIM37;LUC7L;CDC42EP2;GNL3L;BAIAP2;NVL;CDH13;IBA57;RRP1;SRF;MDM4;LUC7L2;WDR3;WDR43;UGT8;UTP18;SDK1;FZD1;ANTXR1;RTKN2;ISG20L2;CLU;SDAD1;BIRC3;NUP54;METTL16;FGD6;RRP36;ANLN;RPF2;URB2;TJP1;LRRN3;KCTD3;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;NSF;MYH11;ZFYVE27;TMEM138;GEMIN8;WDPCP;MTMR2;CENPF;FCF1;RAB3GAP1;LNX2;SRFBP1;BBS5;FAF1;RRM1;WDR75;BMS1;MYO10;ATR;NTN1;CEP152;CFLAR;NIFK;NOL9;NOL11;SHTN1;DPYSL3;TAF6L;MRPS7;NCBP1;VPS36;TRAF2;RBBP5;NOP56;DDX56;UQCRB;NSA2;KIF14;MPP5;SYNPO2;ESR1;PARD3;GJC1;NOP16;RRP15;RAD51B;EHD1;CENPN;TNF;PDSS1;NEDD9;RC3H1;CCL5;CD74;WDR36;HNRNPU;MAK16;FGFR1OP;DAXX;PANX1;HIST1H4A;TAF1;TBPL1;ZNHIT6;ITGB1BP1;CTCF;GTF2H3;NDUFB9;TEX10;RPS12;CENPO;GPX4
1096,GO:0002682,0.00013618140469903,0.999915265632443,95,933,regulation of immune system process,BP,MAFB;KRT1;C1R;MTUS1;MAP3K14;TFRC;C3;NLRC5;HLA-B;FBN1;SLC7A2;RUNX1;ACTG1;TSC22D3;TRAF3;SPG21;TP53;EDN1;GBP1;LGALS3;IFNGR1;TGFB2;CYLD;IKBKE;IL27RA;IL6ST;INHBA;IL7R;SYK;TJP2;RELB;HLA-F;SFRP1;HLA-DOB;CD274;MIR17HG;H3F3A;AHR;PTGER4;CCL20;MUC16;GBP5;BTN2A1;SIRPA;THOC1;SOCS1;PARP14;BAIAP2;CLU;BIRC3;IL20;RIF1;IFNAR1;ERAP1;HSP90AB1;LAIR1;FANCD2;SERPINB9;GPER1;ADAM17;MYO10;SENP1;PSME2;MSH6;LILRB3;PSMB9;EIF2B5;CMTM3;TRAF2;RBBP5;POLR3B;CSF1;AP3B1;PURB;TLR3;ESR1;DNASE1;TNF;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;PSMB10;EIF2B1;HIST1H4A;PHLPP1;NRAS;PSPC1;MUC5B;PPARGC1B;CDKN1A;MUC6;IRF1;IRAK3
5335,GO:0016064,0.000138815444197635,0.999967872401473,13,57,immunoglobulin mediated immune response,BP,C1R;TFRC;C3;EXO1;IL27RA;NBN;THOC1;CLU;RIF1;MSH6;TNF;ATAD5;CD74
6212,GO:0019724,0.000138815444197635,0.999967872401473,13,57,B cell mediated immunity,BP,C1R;TFRC;C3;EXO1;IL27RA;NBN;THOC1;CLU;RIF1;MSH6;TNF;ATAD5;CD74
1781,GO:0004386,0.0001445787414063,0.999946871564248,24,137,helicase activity,MF,DDX17;DDX47;NBN;BRIP1;MCM5;MCM2;HELLS;G3BP1;DDX28;DDX3X;MCM3;GINS4;MCM8;DDX10;DDX24;MCM6;TTF2;DDX21;HELQ;NAV2;MCM4;DDX60L;DDX56;DHX15
9871,GO:0042113,0.000144587037173616,0.999946654222412,24,145,B cell activation,BP,HDAC9;TFRC;EXO1;DOCK10;CYLD;IL27RA;INHBA;IL7R;SYK;NBN;SFRP1;MIR17HG;AHR;THOC1;LFNG;RIF1;CXCR5;ADAM17;MSH6;ATAD5;ZFP36L2;RC3H1;CD74;CDKN1A
1475,GO:0003729,0.000162108464268202,0.999935400305225,27,180,mRNA binding,MF,TP53;RBM4;GEMIN5;PABPC4;ACO1;PUM3;TARDBP;MIR17HG;DHFR;TSN;G3BP1;DDX3X;LUC7L;LUC7L2;RBMS3;MRPS7;NCBP1;UPF3B;HNRNPR;NCL;PURB;ZFP36L2;RC3H1;TYMS;HNRNPU;HNRNPM;RBM8A
10916,GO:0044452,0.000167441440309275,0.999935866001538,25,163,nucleolar part,CC,MAP3K14;TXNRD1;TFCP2L1;NUAK1;DKC1;FAM111A;UTP15;POP1;HEATR1;POLR1A;NOP58;UBTF;RRP7BP;NUFIP1;TAF1D;WDR3;WDR43;UTP18;POLR2F;NOL11;NFKBIE;POLR1E;NOP56;WDR36;PSPC1
2114,GO:0004896,0.000168560634374913,0.999966411054257,11,43,cytokine receptor activity,MF,IL1R2;IFNGR1;IL27RA;IL6ST;IL7R;LEPR;ACKR3;IFNAR1;CXCR5;IL12RB2;CD74
10990,GO:0044772,0.000179227168953149,0.999902616427328,56,484,mitotic cell cycle phase transition,BP,PML;CYP1A1;PBX1;TP53;CDKN2A;PKMYT1;INHBA;GPR132;NBN;MCM5;CDK4;MCM2;DHFR;RPA1;TAF2;POLA1;PLK2;RANBP2;TOPBP1;ANAPC15;ORC4;DDX3X;CDC25A;AJUBA;MCM3;CDCA5;MDM4;MCM8;RRM2;MCM6;ANLN;WEE1;APEX1;ORC1;PRIM2;E2F8;CENPF;MCM4;ADAM17;PSME2;CEP152;PSMB9;RFWD3;TPRA1;CCNA2;POLE3;ORC2;RBL1;KIF14;RAD51B;ATAD5;ZFP36L2;TYMS;FGFR1OP;PSMB10;CDKN1A
6942,GO:0030545,0.000186532312641409,0.999926204450194,26,183,receptor regulator activity,MF,IL32;SAA1;NRG1;EPGN;CTGF;FBN1;EDN1;LGALS3;TGFB2;IL16;INHBA;WNT10A;ADM;CCL20;WNT4;CXCL16;IL24;CDC42EP2;PDGFB;MACC1;IL20;CMTM3;RABEP2;CSF1;TNF;CCL5
9912,GO:0042221,0.000194083557717759,0.999857620333378,244,2783,response to chemical,BP,IL32;CRYAB;SAA1;NEFL;NRG1;HDAC9;TRIM16;MAP2;KRT13;FN1;PTGES;PML;CYP1B1;AMOT;MTUS1;MAP3K14;GCLC;TFRC;CYR61;CYP24A1;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;TRIM22;S100P;CTGF;HLA-B;MMP9;FBN1;XAF1;SLC7A2;RUNX1;CYP1A1;IL1R2;FAT4;ACTG1;G6PD;MAT2A;DDX17;TRIM56;TRAF3;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;HMGCS1;RBM4;ACSL3;PTPN14;NQO1;LGALS3;IFNGR1;SLC4A11;ACO1;AKAP8;TGFB2;RBM22;CYLD;IKBKE;IL27RA;IL16;IFIT3;SRSF2;SLC30A6;IL6ST;HNRNPF;INHBA;IL7R;SLC22A5;SYK;TJP2;NAIP;RELB;LEPR;BRIP1;ABCG2;HLA-F;CDK4;SFRP1;NUCKS1;CD274;WNT10A;MCM2;MIR17HG;H3F3A;ATP2B1;COL4A1;AHR;KEAP1;SLC5A6;DHFR;TPM1;TAF2;ABCC4;TSN;SETDB1;PTGER4;TRAF1;OPHN1;ADM;CD109;FOXRED2;SLC1A3;CCL20;RRAGB;MME;UBQLN2;GBP5;RFC3;MYBL2;HSPB1;RHOG;WNT4;CXCL16;SUV39H2;LCP1;PTPRM;RAN;RANBP2;SOD2;DDX3X;IL24;GPHN;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;AKR1C2;ZC3H7B;PGK1;CDC42EP2;BAIAP2;APTX;CDH13;COL5A2;SRF;GDAP1;MDM4;HIF1AN;NPNT;QDPR;PDGFB;SDK1;FZD1;NFE2L1;CLU;ENPP1;BIRC3;IL20;PIK3R3;NFKBIB;EFTUD2;ZNF106;ACKR3;RIF1;SRD5A1;SETD2;THBD;ABCC9;SRPRB;IFNAR1;SLC11A2;APEX1;CXCR5;TNC;UMPS;HSPA8;TMEM199;HSP90AB1;DDX21;ARL6IP5;NEDD4L;ZFYVE27;PXMP2;SYNCRIP;DGCR8;FANCD2;CENPF;L1CAM;POLR2F;CCDC47;IL12RB2;SERPINB9;GPER1;ADAM17;ATR;NTN1;PSME2;CFLAR;PSMB9;EIF2B5;CMTM3;NFKBIE;UGT1A4;HNRNPDL;DPYSL3;EBP;NCBP1;MYNN;AKR1B1;UBE2J2;TRAF2;CITED2;NCL;CCNA2;TIMELESS;IFI30;CSF1;CLOCK;TLR3;ESR1;PARD3;EHD1;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;CD74;HNRNPU;PSMB10;EIF2B1;DAXX;PANX1;TAF1;NRAS;SMARCC1;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;SLC25A22;IRF1;GBP6;GPX4;IRAK3;DHX15
4253,GO:0009451,0.000203767119464024,0.999928458438978,21,132,RNA modification,BP,TGS1;CDKAL1;DKC1;PUS3;THUMPD3;METTL1;URM1;NOP58;NOP2;YRDC;LRPPRC;TRUB2;METTL16;TRMT5;SEPHS2;THADA;TRMT1;TRMT61A;NOP56;WDR4;FTO
15996,GO:0080134,0.000207191570268081,0.999867578827166,101,991,regulation of response to stress,BP,CRYAB;KRT1;SAA1;C1R;PML;C3;NLRC5;CTGF;SLC7A2;IL1R2;TRAF3;MID1;TP53;EDN1;C1QTNF1;CDKN2A;IFNGR1;PDPN;TGFB2;CYLD;IKBKE;IL6ST;BAG1;NUAK1;NUP50;SYK;NUP153;RELB;SFRP1;POLQ;DHFR;RPA1;ULK4;PTGER4;CD109;NDC1;PLK2;MUC16;UBQLN2;GBP5;WDR76;HSPB1;WNT4;THOC1;RANBP2;SOD2;SOCS1;PARP14;ARNTL;AJUBA;GADD45B;PDGFB;BRCC3;CHID1;FZD1;CLU;NUP160;SMYD2;BIRC3;IL20;NUP54;EYA3;ACKR3;RIF1;SETD2;THBD;IFNAR1;ERAP1;HSPA8;SYT11;HSP90AB1;ARL6IP5;FANCD2;CHEK1;SERPINB9;GPER1;ATR;PSME2;PSMB9;RFWD3;TRAF2;POLR3B;TIMELESS;RBL1;CLOCK;TLR3;ESR1;DNASE1;TNF;CCL5;CD74;PSMB10;DAXX;PHLPP1;NRAS;PSPC1;MUC5B;USP1;MUC6;IRF1;IRAK3
10115,GO:0042623,0.000213343339705683,0.999896664876497,40,290,ATPase activity, coupled,MF,TAP1;MYO1B;DDX17;DYNC2H1;DDX47;DNHD1;NBN;BRIP1;ABCG2;POLQ;ATP2B1;ABCC4;G3BP1;DYNLL2;RFC3;DDX28;ATP2C1;DDX3X;DDX10;DDX24;MCM6;ABCC9;TTF2;HSPA8;DDX21;NSF;HELQ;RAD18;MCM4;MYO10;MSH6;ABCA5;MSH3;DDX56;TAP2;KIF14;RAD51B;ABCA11P;GTF2H3;DHX15
2436,GO:0005634,0.00021398333696633,0.99983670730466,459,5698,nucleus,CC,CRYAB;IGFBP3;MAFB;KRT1;TRIM47;FTH1;DTX2;NRG1;HDAC9;KRT4;TRIM16;MAP2;KRT13;PTGES;PML;KIF23;AMOT;MTUS1;MAP3K14;KRT2;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;SACS;TRIM22;CBX5;S100P;UTP20;VMP1;XAF1;RUNX1;ACTG1;PBX1;G6PD;TSC22D3;DDX17;TFCP2L1;ENC1;IRS1;TP53;DAPK3;EXO1;C9ORF3;SCD;DOCK10;DDX47;ABCF1;RBM19;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;AKAP8;PPAN;IRX2;PRSS23;ZNF208;RBM22;IKBKE;PKMYT1;TGS1;IL16;SRSF2;FOXD2;SUGP2;PGD;RAD1;HNRNPF;BAG1;PDCD11;NUAK1;DKC1;NUP50;PUM3;PHAX;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RELB;NBN;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;UTP15;LDHAL6B;CDK4;KRT9;POP1;NUCKS1;PITHD1;HEATR1;MCM2;TARDBP;GEMIN4;DST;POLQ;TSR1;H3F3A;ATP2B1;PUS3;USP16;AHR;COA7;KEAP1;NAA15;TRA2A;ZNF827;HRNR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;METTL1;TAF2;POLA1;TSN;SETDB1;TMEM97;LSG1;G3BP1;GRWD1;ZNF584;PARD3B;P4HA2;USP43;ZNF407;ELMSAN1;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;MDN1;CASC3;SYNPO2L;RRAGB;ZNF512;ZNF587;UBQLN2;HSCB;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;NOP2;SUV39H2;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;TOPBP1;ANAPC15;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;ARMC5;RRN3;RRP12;CDC25A;SOCS1;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;SMC2;FASTKD3;UTP14A;DND1;ZNF267;RBMXL1;ZC3H7B;RBM12;TRIM37;FEN1;MCM3;LUC7L;CDCA5;GNL3L;ZNF586;BAIAP2;NVL;GADD45B;SH3RF2;APTX;GINS4;RRP1;RARS;COMMD4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;WDR3;ZNF234;WDR43;MCM8;UTP18;BRCC3;CHID1;IRX4;UTY;NFE2L1;ISG20L2;CLU;NUP160;SDAD1;SMYD2;MACC1;NAA50;BIRC3;ZNF316;DDX10;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;ZNF106;DDX24;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;MCM6;SETD2;RRP36;GLIS2;ANLN;RPF2;UBP1;TRMT5;TTF2;URB2;JPH1;DPY19L2P2;WEE1;ZNF484;NOL12;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;DNPEP;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;ZFYVE27;ANAPC7;BRCA2;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;DGCR8;SS18L2;KRT10;CCAR1;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;ETV6;ZNFX1;FKBP5;HSF2;POLR2F;FCF1;CHEK1;SRFBP1;SERPINB9;GPER1;HMGN2;FAF1;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;CEP152;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;NOL11;BAZ2B;NFKBIE;TRMT61A;CBLL1;HNRNPDL;ESF1;TAF6L;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;VPS36;JRKL;TRAF2;MSH3;TELO2;EDRF1;RBBP5;FAM208B;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TAP2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;KIF14;PURB;AZIN1;SYNPO2;ESR1;CLCC1;NOP16;RAD51B;USP11;FEM1C;CENPN;DNASE1;WDR4;ATAD5;SURF2;ZFP36L2;NEDD9;SRSF7;TYMS;ARGLU1;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;DAXX;ZSCAN31;DCTN5;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;SPIB;YPEL4;PHLPP1;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MRFAP1;TREX1;ZNF471;IRF1;CTCF;DIAPH3;RBM8A;GTF2H3;TEX10;RPS12;ZBTB9;CENPO;GPX4;IRAK3;BUD13;COPS3;DHX15
2864,GO:0006356,0.00022118758052211,0.999964102653618,9,30,regulation of transcription by RNA polymerase I,BP,UTP15;HEATR1;UBTF;RRN3;WDR43;WDR75;NOL11;NCL;TAF1
2446,GO:0005654,0.000224895944966842,0.999833254200624,262,3043,nucleoplasm,CC,CRYAB;DTX2;NRG1;HDAC9;TRIM16;PML;KIF23;CYP24A1;MKL1;FOSL2;TXNRD1;FGFR2;STAT5A;TRIM22;CBX5;S100P;UTP20;RUNX1;PBX1;DDX17;ENC1;TP53;DAPK3;EXO1;DOCK10;DDX47;ABCF1;RBM19;RBM4;ZBED1;PTPN14;GEMIN5;STAG1;AKAP8;RBM22;IKBKE;PKMYT1;TGS1;IL16;SRSF2;SUGP2;RAD1;HNRNPF;PDCD11;NUAK1;DKC1;NUP50;PUM3;PHAX;TJP2;NUP153;RELB;NBN;VEZT;BRIP1;MCM5;SHQ1;UTP15;CDK4;POP1;HEATR1;MCM2;TARDBP;GEMIN4;POLQ;TSR1;H3F3A;USP16;AHR;KEAP1;RPA1;POLR1A;METTL21A;METTL1;TAF2;POLA1;SETDB1;LSG1;PARD3B;P4HA2;USP43;ELMSAN1;CADPS2;MDN1;CASC3;SYNPO2L;RFC3;AKAP8L;MYBL2;NOP58;NOP2;SUV39H2;GTF3C6;KDM6A;THOC1;RAN;UBTF;TOPBP1;ANAPC15;ORC4;SUPT16H;DDX3X;NUFIP1;ARMC5;RRN3;CDC25A;SOCS1;SET;ARNTL;TAF1D;SMC2;UTP14A;RBM12;TRIM37;FEN1;MCM3;CDCA5;BAIAP2;NVL;SH3RF2;APTX;GINS4;RARS;SRF;MDM4;LUC7L2;HIF1AN;WDR3;WDR43;MCM8;UTP18;BRCC3;UTY;ISG20L2;SMYD2;BIRC3;LRPPRC;EYA3;EFTUD2;KANSL1L;RIF1;MCM6;SETD2;RRP36;GLIS2;ANLN;UBP1;TTF2;JPH1;WEE1;APEX1;ORC1;HSPA8;HSP90AB1;DDX21;SMUG1;NEDD4L;SGK1;PRIM2;ZFYVE27;ANAPC7;BRCA2;GEMIN8;SYNCRIP;NAV2;TRMT1;DGCR8;CCAR1;PPIP5K1;FANCD2;E2F8;CENPF;FKBP5;HSF2;POLR2F;FCF1;CHEK1;SERPINB9;MLLT10;RAD18;WDR75;BMS1;MCM4;SENP1;ATR;PSME2;UBAP2L;MSH6;CEP152;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;ZNF12;RFWD3;NOL11;TRMT61A;CBLL1;HNRNPDL;ESF1;TAF6L;NCBP1;UPF3B;AKR1B1;POLR1E;TRAF2;MSH3;TELO2;RBBP5;FAM208B;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;TAP2;TIMELESS;ORC2;RBL1;CLOCK;ESR1;RAD51B;USP11;FEM1C;CENPN;WDR4;SURF2;NEDD9;SRSF7;ARGLU1;WDR36;HNRNPU;RING1;PSMB10;DAXX;DCTN5;HIST1H4A;TAF1;TBPL1;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;CENPO;GPX4;COPS3;DHX15
14934,GO:0070761,0.000251103149560782,0.999993070448192,4,6,pre-snoRNP complex,CC,NOP58;NUFIP1;NOP56;ZNHIT6
13001,GO:0051385,0.000262485133953684,0.999969155863501,7,20,response to mineralocorticoid,BP,NEFL;CTGF;EDN1;ATP2B1;RAN;GPER1;CDKN1A
3272,GO:0006952,0.000270132765250141,0.999829292785987,92,918,defense response,BP,IL32;KRT1;SAA1;HDAC9;C1R;FN1;PTGES;PML;MAP3K14;C3;NLRC5;TRIM22;HLA-B;TAP1;HSPG2;XAF1;SLC7A2;IL1R2;B4GALT1;ACTG1;DDX17;TRIM56;TRAF3;MID1;DAPK3;EDN1;TPST1;GBP1;ABCF1;LGALS3;IFNGR1;AKAP8;CYLD;IKBKE;IL27RA;IFIT3;IL6ST;INHBA;SYK;NAIP;RELB;FAM111A;HLA-F;PTGER4;ARRDC1-AS1;CCL20;MUC16;FRK;GBP5;CXCL16;DDX3X;SOCS1;PARP14;CDC42EP2;CHID1;NFE2L1;CLU;BIRC3;IL20;SETD2;ABCC9;IFNAR1;ERAP1;SYT11;HSP90AB1;SYNCRIP;FANCD2;SERPINB9;GPER1;ADAM17;RBMS3;PSME2;LILRB3;PSMB9;POLR3B;IFI30;CSF1;CLOCK;TLR3;ESR1;DNASE1;TNF;CCL5;CD74;PSMB10;NRAS;PSPC1;MUC5B;MUC6;IRF1;GBP6;IRAK3
7007,GO:0030686,0.000270400607298036,0.999954252338445,9,32,90S preribosome,CC,UTP20;HEATR1;RRP7BP;WDR3;UTP18;RRP36;SRFBP1;BMS1;WDR36
7379,GO:0031424,0.00028259701238842,0.999919159448435,15,83,keratinization,BP,SPRR3;KRT1;SPRR2A;KRT34;KRT4;KRT13;KRT2;KRT15;KRTAP2-3;KRT9;TCHH;HRNR;KRT24;KRT10;RPTN
4473,GO:0010467,0.000294924323677072,0.99977515112202,352,4265,gene expression,BP,CRYAB;MAFB;NRG1;HDAC9;C1R;TRIM16;FN1;PML;CYP1B1;GCLC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;UTP20;FBN1;RUNX1;IL1R2;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;TP53;DAPK3;EDN1;C9ORF3;DDX47;ABCF1;C1QTNF1;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL16;SRSF2;FOXD2;SUGP2;HNRNPF;PDCD11;DKC1;INHBA;IL7R;NUP50;PUM3;PHAX;SYK;NUP153;NAIP;ZFP42;RELB;PARP15;BRIP1;SHQ1;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;WNT10A;TARDBP;MIR17HG;GEMIN4;TSR1;H3F3A;PUS3;USP16;AHR;KEAP1;NAA15;TRA2A;ZNF827;DHFR;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL1;TAF2;POLA1;RCE1;TSN;SETDB1;ZNF584;TRAF1;URM1;IMMP2L;ZNF407;ELMSAN1;NDC1;HNRNPA1L2;MDN1;EIF5;CASC3;ZNF512;MRPL27;MME;ZNF587;HSCB;FRK;DNTTIP2;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;GTF3C6;KDM6A;THOC1;RAN;UBTF;RRP7BP;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;UTP14A;DND1;ZNF267;RBMXL1;ZC3H7B;PGK1;TRIM37;LUC7L;ZNF586;YRDC;GATC;CDH13;RRP1;RARS;COMMD4;SRF;MDM4;LUC7L2;USB1;HIF1AN;NPNT;WDR3;ZNF234;WDR43;PDGFB;UTP18;EIF3J;FZD1;IRX4;UTY;NFE2L1;ISG20L2;CLU;NUP160;SMYD2;MACC1;NAA50;BIRC3;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;VGLL3;RIF1;METTL16;TYW1;SETD2;RRP36;GLIS2;RPF2;UBP1;UPK3B;TRMT5;TTF2;SEPHS2;ZNF484;THADA;APEX1;TNC;ZNF57;TET3;ORC1;MYBL1;HSPA8;DDX21;BACE2;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;FCF1;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;WDR75;BMS1;SENP1;RBMS3;PSME2;UBAP2L;CFLAR;NIFK;NOL9;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;TRMT61A;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;DDX56;TIMELESS;ORC2;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;PURB;TLR3;ESR1;RRP15;TNF;WDR4;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;ZBTB9;IRAK3;BUD13;DHX15
8683,GO:0034248,0.000315832875623973,0.999831240507018,49,425,regulation of cellular amide metabolic process,BP,CYR61;ENC1;DAPK3;KBTBD8;RBM4;GEMIN5;ACO1;NUP50;PUM3;NUP153;CDK4;MIR17HG;H3F3A;USP16;DHFR;NDC1;EIF5;CASC3;HSPB1;RAN;RANBP2;DDX3X;AJUBA;FASTKD3;DND1;ZC3H7B;CLU;NUP160;NUP54;LRPPRC;METTL16;SYNCRIP;DGCR8;POLR2F;RBMS3;EIF2B5;DPH2;NCBP1;UPF3B;HNRNPR;NCL;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;HIST1H4A;RBM8A
13777,GO:0060333,0.000325670834035745,0.999916320923541,13,64,interferon-gamma-mediated signaling pathway,BP,PML;NLRC5;TRIM22;HLA-B;MID1;GBP1;IFNGR1;HLA-F;SOCS1;PARP14;HSP90AB1;IFI30;IRF1
11101,GO:0045087,0.000326449462008793,0.999812916531724,61,561,innate immune response,BP,KRT1;SAA1;C1R;PML;C3;NLRC5;TRIM22;HLA-B;XAF1;ACTG1;TRIM56;TRAF3;MID1;DAPK3;EDN1;GBP1;LGALS3;IFNGR1;AKAP8;CYLD;IKBKE;IFIT3;SYK;NAIP;RELB;HLA-F;CCL20;MUC16;FRK;GBP5;CXCL16;DDX3X;SOCS1;PARP14;CDC42EP2;CHID1;CLU;BIRC3;SETD2;IFNAR1;ERAP1;HSP90AB1;SYNCRIP;SERPINB9;GPER1;PSME2;PSMB9;POLR3B;IFI30;CSF1;TLR3;ESR1;CCL5;PSMB10;NRAS;PSPC1;MUC5B;MUC6;IRF1;GBP6;IRAK3
8487,GO:0033627,0.000327619124590164,0.999935732471432,10,38,cell adhesion mediated by integrin,BP,CYP1B1;COL16A1;FBN1;TGFB2;SYK;ITGAV;NPNT;ADAM17;CCL5;ITGB1BP1
12269,GO:0048534,0.000329023727763933,0.999806443481382,67,621,hematopoietic or lymphoid organ development,BP,MAFB;HDAC9;PML;TFRC;FGFR2;MMP9;FBN1;RUNX1;PBX1;G6PD;FST;DOCK10;SIPA1L3;PABPC4;LGALS3;PDPN;TGFB2;CYLD;INHBA;IL7R;SYK;TJP2;RELB;LEPR;SFRP1;MIR17HG;H3F3A;PTGER4;CD109;HERC6;WNT4;SOCS1;ARMC6;LFNG;WDR7;SRF;NFE2L1;RTKN2;IL20;ANLN;SLC11A2;CXCR5;ZBTB24;BRCA2;FANCD2;ETV6;ADAM17;SENP1;PSME2;LILRB3;PSMB9;EBP;RBBP5;CITED2;MFAP5;CSF1;AP3B1;PURB;TLR3;TNF;ZFP36L2;RC3H1;CD74;PSMB10;HIST1H4A;PPARGC1B;IRF1
4267,GO:0009611,0.000330899478230013,0.999821841822504,50,419,response to wounding,BP,SPRR3;KRT1;SAA1;NEFL;NRG1;FN1;CYR61;FGFR2;CBX5;CTGF;CYP1A1;B4GALT1;ACTG1;TP53;EDN1;C1QTNF1;PABPC4;PDPN;TGFB2;SYK;NAIP;DST;H3F3A;DHFR;TPM1;CSRP1;ADM;CD109;GGCX;SLC1A3;CCL20;HSPB1;RHOG;WNT4;IL24;AJUBA;SRF;PDGFB;THBD;TNC;SYT11;HPS5;ADAM17;CFLAR;DPYSL3;AP3B1;RAD51B;EHD1;ZFP36L2;IRF1
480,GO:0001525,0.000347150602984747,0.999824002155368,42,321,angiogenesis,BP,KRT1;HDAC9;FN1;PML;CYP1B1;AMOT;CYR61;C3;FGFR2;EPGN;STARD13;CTGF;HSPG2;RUNX1;B4GALT1;EDN1;TGFB2;SYK;EMP2;LEPR;SFRP1;COL4A1;NAA15;PTPRB;ADAMTS9;ADM;PLK2;HSPB1;PTPRM;ITGAV;PGK1;CDH13;SRF;ACKR3;SETD2;UBP1;ERAP1;PDCL3;E2F8;NCL;TLR3;ITGB1BP1
17326,GO:0140098,0.000347398267093393,0.999826481753399,40,330,catalytic activity, acting on RNA,MF,DDX17;EXO1;DDX47;CARS2;TGS1;CDKAL1;POP1;POLR1A;THUMPD3;METTL1;TSN;G3BP1;NOP2;DDX28;DDX3X;FEN1;GATC;RARS;USB1;ISG20L2;DDX10;DDX24;METTL16;TYW1;TRMT5;APEX1;PDCL3;DDX21;HELQ;PRIM2;TRMT1;DGCR8;POLR2F;TRMT61A;POLR1E;POLR3B;DDX56;WDR4;FTO;DHX15
2409,GO:0005578,0.000349340479675579,0.999848811364439,29,188,proteinaceous extracellular matrix,CC,FN1;CYR61;COL16A1;COL5A3;CTGF;MMP9;FBN1;HSPG2;SPON1;CCDC80;COL27A1;LRFN4;COL12A1;P3H2;SFRP1;WNT10A;DST;COL4A1;ADAMTS9;WNT4;COL5A2;NPNT;FRAS1;LRRN3;TNC;NAV2;RPTN;NTN1;MFAP5
15781,GO:0072358,0.000357195041239491,0.9998001770424,56,461,cardiovascular system development,BP,KRT1;HDAC9;FN1;PML;CYP1B1;AMOT;CYR61;C3;FGFR2;EPGN;STARD13;CTGF;HSPG2;RUNX1;B4GALT1;EDN1;PTPN14;PDPN;TGFB2;SYK;EMP2;LEPR;SFRP1;COL4A1;AHR;NAA15;PTPRB;ADAMTS9;ADM;IMMP2L;PLK2;HSPB1;WNT4;PTPRM;KDM6A;ITGAV;PGK1;CDH13;SRF;HIF1AN;PDGFB;ANTXR1;ACKR3;SETD2;UBP1;ERAP1;PDCL3;WDPCP;E2F8;GPER1;CFLAR;NCL;TLR3;GJC1;DCTN5;ITGB1BP1
4475,GO:0010469,0.000371169803188698,0.999837527452705,29,218,regulation of signaling receptor activity,BP,IL32;NRG1;GPRC5A;EPGN;CTGF;FBN1;EDN1;TGFB2;IL16;INHBA;SHISA9;WNT10A;ADM;CCL20;WNT4;CXCL16;IL24;NETO1;CDC42EP2;PDGFB;MACC1;IL20;ADAM17;CMTM3;RABEP2;CSF1;TNF;CCL5;TAF1
15250,GO:0071389,0.000376523497795321,0.999988399041359,4,6,cellular response to mineralocorticoid stimulus,BP,EDN1;ATP2B1;RAN;GPER1
2477,GO:0005694,0.000380809445299287,0.999758289970346,89,882,chromosome,CC,PML;CBX5;ENC1;TP53;RBM19;CDKN2A;ZBED1;STAG1;AKAP8;RAD1;PUM3;ZFP42;NBN;FAM111A;MCM5;CDK4;NUCKS1;MCM2;POLQ;H3F3A;RPA1;HELLS;POLA1;SETDB1;GRWD1;PLK2;RFC3;AKAP8L;MYBL2;SUV39H2;KDM6A;THOC1;RAN;TOPBP1;ORC4;SUPT16H;NUFIP1;SMC2;FEN1;MCM3;CDCA5;APTX;GINS4;SRF;UTY;NUP160;LRPPRC;RIF1;MCM6;SETD2;APEX1;TET3;ORC1;PRIM2;BRCA2;SKA2;FANCD2;CENPF;CHEK1;HMGN2;RAD18;MCM4;ATR;MSH6;NIFK;RFWD3;TELO2;CITED2;POLE3;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;RAD51B;USP11;CENPN;HNRNPU;RING1;DAXX;DCTN5;HIST1H4A;TAF1;SMARCC1;IRF1;CTCF;CENPO
279,GO:0000781,0.000389136055704018,0.999852081864001,22,146,chromosome, telomeric region,CC,PML;CBX5;NBN;MCM5;MCM2;H3F3A;RPA1;THOC1;ORC4;FEN1;MCM3;RIF1;MCM6;APEX1;ORC1;BRCA2;CHEK1;MCM4;ATR;TELO2;ORC2;HIST1H4A
2589,GO:0005882,0.000396349620756851,0.999889828176441,14,69,intermediate filament,CC,KRT1;NEFL;KRT34;KRT4;KRT13;KRT2;KRT15;NEFM;KRTAP2-3;KRT9;DST;KRT24;KRT10;GPER1
6701,GO:0030097,0.000408432047234902,0.999760621627693,64,592,hemopoiesis,BP,MAFB;HDAC9;PML;TFRC;FGFR2;MMP9;FBN1;RUNX1;PBX1;G6PD;FST;DOCK10;SIPA1L3;PABPC4;LGALS3;TGFB2;CYLD;INHBA;IL7R;SYK;TJP2;RELB;LEPR;SFRP1;MIR17HG;H3F3A;PTGER4;CD109;HERC6;WNT4;SOCS1;ARMC6;LFNG;WDR7;SRF;NFE2L1;RTKN2;IL20;ANLN;SLC11A2;ZBTB24;BRCA2;FANCD2;ETV6;ADAM17;SENP1;PSME2;LILRB3;PSMB9;EBP;RBBP5;MFAP5;CSF1;AP3B1;PURB;TLR3;TNF;ZFP36L2;RC3H1;CD74;PSMB10;HIST1H4A;PPARGC1B;IRF1
2225,GO:0005125,0.000411606087697376,0.999883632501656,14,79,cytokine activity,MF,IL32;NRG1;EDN1;TGFB2;IL16;INHBA;CCL20;CXCL16;IL24;IL20;CMTM3;CSF1;TNF;CCL5
4384,GO:0010033,0.000415553788235573,0.999697751271868,194,2171,response to organic substance,BP,IL32;CRYAB;SAA1;NEFL;HDAC9;TRIM16;MAP2;KRT13;FN1;PTGES;PML;CYP1B1;MAP3K14;GCLC;TFRC;CYR61;CYP24A1;COL16A1;NLRC5;FGFR2;STAT5A;TRIM22;S100P;CTGF;HLA-B;MMP9;FBN1;XAF1;RUNX1;CYP1A1;IL1R2;FAT4;ACTG1;G6PD;MAT2A;DDX17;TRIM56;TRAF3;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;HMGCS1;ACSL3;PTPN14;NQO1;IFNGR1;AKAP8;TGFB2;CYLD;IKBKE;IL27RA;IL16;IFIT3;SRSF2;IL6ST;HNRNPF;INHBA;IL7R;SYK;TJP2;NAIP;RELB;LEPR;BRIP1;HLA-F;CDK4;SFRP1;NUCKS1;CD274;WNT10A;MCM2;MIR17HG;H3F3A;ATP2B1;COL4A1;AHR;KEAP1;DHFR;TAF2;ABCC4;TSN;SETDB1;PTGER4;TRAF1;ADM;CD109;FOXRED2;CCL20;RRAGB;MME;UBQLN2;GBP5;RFC3;MYBL2;HSPB1;WNT4;CXCL16;LCP1;RAN;RANBP2;SOD2;IL24;SOCS1;PARP14;ARNTL;AKR1C2;ZC3H7B;CDC42EP2;BAIAP2;CDH13;COL5A2;SRF;GDAP1;NPNT;QDPR;PDGFB;SDK1;FZD1;CLU;ENPP1;BIRC3;IL20;PIK3R3;NFKBIB;EFTUD2;ZNF106;ACKR3;RIF1;SRD5A1;SETD2;THBD;SRPRB;IFNAR1;APEX1;CXCR5;TNC;HSPA8;HSP90AB1;DDX21;ZFYVE27;SYNCRIP;DGCR8;POLR2F;CCDC47;IL12RB2;GPER1;ADAM17;PSME2;CFLAR;PSMB9;EIF2B5;HNRNPDL;DPYSL3;NCBP1;MYNN;AKR1B1;UBE2J2;TRAF2;CITED2;NCL;CCNA2;TIMELESS;IFI30;CSF1;CLOCK;TLR3;ESR1;PARD3;EHD1;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;CD74;HNRNPU;PSMB10;EIF2B1;DAXX;PANX1;TAF1;SMARCC1;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;IRF1;GBP6;IRAK3;DHX15
18265,GO:1903047,0.000415898118319146,0.999741814963123,80,760,mitotic cell cycle process,BP,PML;KIF23;EPGN;CYP1A1;PBX1;TP53;DAPK3;EDN1;CDKN2A;STAG1;AKAP8;PKMYT1;INHBA;NUP50;NUP153;NAIP;GPR132;NBN;MCM5;CDK4;MCM2;DHFR;RPA1;TAF2;POLA1;NDC1;PLK2;AKAP8L;MYBL2;RAN;RANBP2;TOPBP1;ANAPC15;ORC4;DDX3X;CDC25A;AJUBA;SMC2;MCM3;CDCA5;MDM4;MCM8;PDGFB;RTKN2;NUP160;NAA50;BIRC3;RRM2;NUP54;MCM6;SETD2;ANLN;WEE1;APEX1;ORC1;PRIM2;BRCA2;E2F8;CENPF;CHEK1;MCM4;ADAM17;PSME2;CEP152;PSMB9;RFWD3;TPRA1;CCNA2;POLE3;ORC2;RBL1;KIF14;RAD51B;ATAD5;ZFP36L2;TYMS;HNRNPU;FGFR1OP;PSMB10;CDKN1A
887,GO:0002250,0.000420469949256116,0.99981794551861,28,198,adaptive immune response,BP,C1R;TFRC;C3;TAP1;EXO1;IL27RA;IL6ST;IL7R;SYK;EMP2;RELB;NBN;THOC1;CLU;RIF1;ERAP1;LAIR1;ADAM17;MSH6;LILRB3;TRAF2;TAP2;RNF19B;TNF;ATAD5;RC3H1;CD74;IRF1
5855,GO:0017148,0.000424929449698442,0.999812492089411,29,215,negative regulation of translation,BP,ENC1;DAPK3;RBM4;NUP50;NUP153;MIR17HG;H3F3A;DHFR;NDC1;RAN;RANBP2;DDX3X;AJUBA;DND1;ZC3H7B;NUP160;NUP54;METTL16;SYNCRIP;DGCR8;POLR2F;NCBP1;HNRNPR;NCL;ESR1;ZFP36L2;RC3H1;TYMS;HIST1H4A
6597,GO:0022610,0.00042918598200662,0.999728230103589,87,803,biological adhesion,BP,IL32;SAA1;FN1;TENM3;PML;CYP1B1;MAP3K14;TFRC;CYR61;COL16A1;COL5A3;CTGF;FBN1;VMP1;FAT4;B4GALT1;ACTG1;SPON1;CCDC80;DAPK3;SVEP1;GBP1;C1QTNF1;CDKN2A;MEGF11;LGALS3;PDPN;TGFB2;CNTNAP1;CYLD;PDLIM1;PCDH7;COL12A1;IL6ST;NUAK1;IL7R;SYK;EMP2;VEZT;SFRP1;CD274;DST;TPM1;CSRP1;ADAMTS9;PARD3B;MUC16;HSPB1;WNT4;PTPRM;SIRPA;CORO1C;ATP2C1;ITGAV;SOCS1;TRPM7;AJUBA;BAIAP2;CDH13;SRF;NPNT;SDK1;ANTXR1;ACKR3;TNC;CNTNAP2;HSP90AB1;WDPCP;PLEKHA7;L1CAM;FAF1;ADAM17;MYO10;NTN1;CBLL1;CITED2;CSF1;AP3B1;KIF14;PARD3;TNF;NEDD9;RC3H1;CCL5;CD74;ITGB1BP1;IRF1
1126,GO:0002712,0.000469168208805916,0.99992532107287,8,27,regulation of B cell mediated immunity,BP,TFRC;C3;IL27RA;THOC1;RIF1;MSH6;TNF;ATAD5
1222,GO:0002889,0.000469168208805916,0.99992532107287,8,27,regulation of immunoglobulin mediated immune response,BP,TFRC;C3;IL27RA;THOC1;RIF1;MSH6;TNF;ATAD5
5834,GO:0017111,0.000476604570505845,0.999710392541644,72,648,nucleoside-triphosphatase activity,MF,KIF23;TAP1;MYO1B;DDX17;DYNC2H1;GBP1;DDX47;ABCF1;DNHD1;RAB32;NBN;BRIP1;MCM5;ABCG2;ARFRP1;MCM2;POLQ;TSR1;ATP2B1;HELLS;ABCC4;LSG1;G3BP1;DYNLL2;MDN1;EIF5;RRAGB;GBP5;RFC3;RHOG;DDX28;RAN;ATP2C1;DDX3X;RAB26;ABCF2;CGNL1;MCM3;GNL3L;GINS4;MCM8;DDX10;EFTUD2;DDX24;MCM6;ABCC9;TTF2;HSPA8;DDX21;NSF;HELQ;MYH11;NAV2;MMAA;RAD18;BMS1;MCM4;MYO10;MSH6;DDX60L;ABCA5;MSH3;DDX56;TAP2;KIF14;RAD51B;NRAS;THTPA;ABCA11P;GTF2H3;GBP6;DHX15
630,GO:0001817,0.00049369817984853,0.999732448668099,48,413,regulation of cytokine production,BP,SAA1;TRIM16;FN1;PML;CYP1B1;C3;NLRC5;RUNX1;IL1R2;TRIM56;TRAF3;GBP1;AKAP8;TGFB2;CYLD;IKBKE;IL27RA;IL6ST;INHBA;SYK;RELB;CD274;PTGER4;CCL20;GBP5;BTN2A1;HSPB1;DDX3X;SOCS1;CHID1;CLU;BIRC3;SETD2;DTX4;SYT11;HSP90AB1;POLR2F;IL12RB2;ADAM17;TRAF2;POLR3B;TLR3;TNF;CD74;PANX1;TREX1;IRF1;IRAK3
9936,GO:0042273,0.000539458877804807,0.999860795801577,12,67,ribosomal large subunit biogenesis,BP,PPAN;MDN1;NOP2;DDX28;MRTO4;SDAD1;RPF2;NOL9;NSA2;NOP16;RRP15;MAK16
11361,GO:0045670,0.000576658085643456,0.999877594488644,10,39,regulation of osteoclast differentiation,BP,MAFB;FBN1;TJP2;SFRP1;IL20;LILRB3;CSF1;TLR3;TNF;PPARGC1B
3376,GO:0007155,0.000603733321567775,0.999613947116314,86,800,cell adhesion,BP,IL32;SAA1;FN1;TENM3;PML;CYP1B1;MAP3K14;TFRC;CYR61;COL16A1;COL5A3;CTGF;FBN1;VMP1;FAT4;B4GALT1;ACTG1;SPON1;CCDC80;DAPK3;SVEP1;GBP1;C1QTNF1;CDKN2A;MEGF11;LGALS3;PDPN;TGFB2;CNTNAP1;CYLD;PDLIM1;PCDH7;COL12A1;IL6ST;NUAK1;IL7R;SYK;EMP2;VEZT;SFRP1;CD274;DST;TPM1;CSRP1;ADAMTS9;PARD3B;MUC16;HSPB1;WNT4;PTPRM;SIRPA;CORO1C;ATP2C1;ITGAV;SOCS1;TRPM7;AJUBA;BAIAP2;CDH13;SRF;NPNT;SDK1;ANTXR1;ACKR3;TNC;CNTNAP2;WDPCP;PLEKHA7;L1CAM;FAF1;ADAM17;MYO10;NTN1;CBLL1;CITED2;CSF1;AP3B1;KIF14;PARD3;TNF;NEDD9;RC3H1;CCL5;CD74;ITGB1BP1;IRF1
19829,GO:2000232,0.000632848456146333,0.999951902740888,5,11,regulation of rRNA processing,BP,SHQ1;UTP15;HEATR1;WDR43;WDR75
6826,GO:0030280,0.000643390175655271,0.99995091699539,5,11,structural constituent of epidermis,MF,KRT1;KRT2;HRNR;KRT10;RPTN
8684,GO:0034249,0.000644865447323486,0.999702890100472,30,230,negative regulation of cellular amide metabolic process,BP,ENC1;DAPK3;RBM4;NUP50;NUP153;MIR17HG;H3F3A;DHFR;NDC1;RAN;RANBP2;DDX3X;AJUBA;DND1;ZC3H7B;CLU;NUP160;NUP54;METTL16;SYNCRIP;DGCR8;POLR2F;NCBP1;HNRNPR;NCL;ESR1;ZFP36L2;RC3H1;TYMS;HIST1H4A
14681,GO:0070268,0.000657308937855286,0.999815740821798,13,71,cornification,BP,SPRR3;KRT1;SPRR2A;KRT34;KRT4;KRT13;KRT2;KRT15;KRT9;TCHH;KRT24;KRT10;RPTN
959,GO:0002377,0.000687483483982799,0.999807992504733,13,65,immunoglobulin production,BP,TFRC;EXO1;IL27RA;IL7R;NBN;POLQ;THOC1;RIF1;MSH6;TRAF2;MSH3;TNF;ATAD5
733,GO:0001959,0.000701231649528522,0.999735477295593,20,128,regulation of cytokine-mediated signaling pathway,BP,NLRC5;RUNX1;IL1R2;EDN1;IFNGR1;CYLD;SYK;TRAF1;SOCS1;PARP14;BIRC3;IFNAR1;HSP90AB1;ADAM17;TRAF2;CSF1;TNF;CCL5;CD74;IRAK3
407,GO:0001091,0.000701246114911531,0.999921921966872,6,16,RNA polymerase II basal transcription factor binding,MF,TP53;AHR;NOP58;ESR1;HNRNPU;ZNHIT6
5336,GO:0016070,0.000729534765915943,0.999437560453268,312,3757,RNA metabolic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;UTP20;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EXO1;EDN1;DDX47;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL16;SRSF2;FOXD2;SUGP2;HNRNPF;PDCD11;DKC1;INHBA;PHAX;SYK;ZFP42;RELB;PARP15;BRIP1;SHQ1;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;TARDBP;GEMIN4;TSR1;H3F3A;PUS3;USP16;AHR;KEAP1;NAA15;TRA2A;ZNF827;DHFR;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL1;TAF2;POLA1;TSN;SETDB1;ZNF584;TRAF1;URM1;ZNF407;ELMSAN1;HNRNPA1L2;MDN1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;DDX28;THOC1;RAN;UBTF;RRP7BP;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;UTP14A;ZNF267;RBMXL1;ZC3H7B;TRIM37;FEN1;LUC7L;ZNF586;YRDC;GATC;CDH13;RRP1;RARS;COMMD4;SRF;MDM4;LUC7L2;USB1;HIF1AN;NPNT;WDR3;ZNF234;WDR43;PDGFB;UTP18;FZD1;IRX4;NFE2L1;ISG20L2;CLU;SMYD2;MACC1;ZNF316;DDX10;RRM2;COMMD9;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;RIF1;METTL16;TYW1;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;SEPHS2;ZNF484;THADA;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;DDX21;ZBTB24;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;FCF1;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;BMS1;SENP1;PSME2;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;TRMT61A;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;DDX56;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;PURB;TLR3;ESR1;RRP15;TNF;WDR4;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;FTO;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;ZBTB9;IRAK3;BUD13;DHX15
10893,GO:0044422,0.000735551382770275,0.999429676205855,555,7174,organelle part,CC,CRYAB;IGFBP3;KRT1;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;RUNX1;MYO1B;CYP1A1;CLN6;B4GALT1;ACTG1;PBX1;NEFM;DDX17;SPON1;FAM69B;TFCP2L1;KRTAP2-3;COL27A1;ENC1;DYNC2H1;SPG21;MID1;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;DOCK10;DDX47;SIPA1L3;ABCF1;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;LGALS3;CHP1;AKAP8;PPAN;TGFB2;ST6GALNAC5;PRSS23;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL16;SRSF2;PCDH7;COL12A1;SLC30A6;SUGP2;P3H2;RAD1;HNRNPF;SLC9A3R1;PDCD11;NUAK1;DKC1;IL7R;NUP50;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;EMP2;TJP2;NUP153;ZFP42;RAB32;RELB;NBN;VEZT;FAM111A;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;VPS41;KRT9;AP3M2;POP1;HLA-DOB;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;COL4A1;USP16;AHR;COA7;KEAP1;TRA2A;SLC5A6;HRNR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;HELLS;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;REEP1;DRAM1;SETDB1;TMEM97;LSG1;GRWD1;PARD3B;MGAM;IMMP2L;CD109;P4HA2;USP43;ELMSAN1;GGCX;NDC1;CADPS2;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;CASC3;SYNPO2L;PLK2;RRAGB;MRPL27;SLCO4C1;MME;MUC16;NEXN;FRK;DNTTIP2;GBP5;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;LCP1;EXOG;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;RANBP2;HS3ST1;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;ATP2C1;DDX3X;RAB26;NUFIP1;ARMC5;KLHL21;RRN3;RRP12;CDC25A;ITGAV;SOCS1;SET;ARNTL;MRTO4;QPCT;TAF1D;ABCF2;AJUBA;SMC2;CGNL1;UTP14A;CROT;KRT24;LFNG;RBM12;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDCA5;HACD2;GNL3L;TTC1;BAIAP2;NVL;SH3RF2;APTX;COL5A2;GINS4;IBA57;RRP1;RARS;SRF;GDAP1;MDM4;LUC7L2;HIF1AN;NPNT;WDR3;WDR43;MCM8;PDGFB;UTP18;BRCC3;CHID1;ODF2L;KREMEN2;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;SDAD1;SMYD2;ENPP1;BIRC3;DDX10;MBOAT1;COMMD9;NUP54;LRPPRC;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;KANSL1L;RIF1;MCM6;SRD5A1;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;ABCC9;TRMT5;TTF2;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;NNT;WEE1;TJP1;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;TNC;ORC1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;SMUG1;SCD5;NSF;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;GEMIN8;SYNCRIP;NAV2;TRMT1;DGCR8;KRT10;CCAR1;SKA2;PPIP5K1;WDPCP;FANCD2;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;STEAP4;FKBP5;HSF2;POLR2F;FCF1;RAB3GAP1;CHEK1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;DPYSL3;ESF1;TAF6L;MRPS7;EBP;NCBP1;UPF3B;AKR1B1;POLR1E;UBE2J2;VPS36;TRAF2;MSH3;TELO2;RBBP5;FAM208B;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;MPHOSPH8;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;SYNPO2;ESR1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;FEM1C;CENPN;ARV1;DNASE1;WDR4;PDSS1;SURF2;NEDD9;SRSF7;TYMS;STARD7;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;DAXX;DCTN5;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;YPEL4;PHLPP1;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;SLC25A22;TREX1;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;CENPO;GPX4;BUD13;COPS3;DHX15
1868,GO:0004529,0.000746997270129068,0.999914063161867,6,17,exodeoxyribonuclease activity,MF,EXO1;RAD1;FEN1;APTX;APEX1;TREX1
5751,GO:0016895,0.000746997270129068,0.999914063161867,6,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,EXO1;RAD1;FEN1;APTX;APEX1;TREX1
12323,GO:0048646,0.000755781291347958,0.999524964985918,77,694,anatomical structure formation involved in morphogenesis,BP,MAFB;KRT1;HDAC9;FN1;PML;CYP1B1;AMOT;CYR61;C3;TXNRD1;FGFR2;EPGN;STARD13;CTGF;MMP9;HSPG2;RUNX1;ERVFRD-1;B4GALT1;ACTG1;EDN1;KBTBD8;PTPN14;MEGF11;PDPN;TGFB2;IRX2;CNTNAP1;COL12A1;INHBA;SYK;EMP2;LEPR;SFRP1;COL4A1;NAA15;TPM1;PTPRB;ADAMTS9;OPHN1;ADM;CD109;PLK2;HSPB1;WNT4;PTPRM;KDM6A;ITGAV;LFNG;PGK1;CDH13;COL5A2;PHACTR4;SRF;UGT8;SDK1;FZD1;ACKR3;SETD2;UBP1;ERAP1;PDCL3;MYH11;E2F8;MTMR2;ADAM17;CFLAR;CITED2;NCL;TLR3;MPP5;EHD1;TNF;RC3H1;TBPL1;PPARGC1B;ITGB1BP1
6579,GO:0022402,0.000769830878619173,0.999477083543284,111,1140,cell cycle process,BP,PML;KIF23;EPGN;CBX5;CTGF;CYP1A1;PBX1;TP53;DAPK3;EDN1;CDKN2A;STAG1;AKAP8;TGFB2;PKMYT1;RAD1;INHBA;NUP50;NUP153;NAIP;GPR132;NBN;BRIP1;MCM5;CDK4;SFRP1;MCM2;DHFR;RPA1;TAF2;POLA1;NDC1;DYNLL2;PLK2;RRAGB;RFC3;AKAP8L;MYBL2;WNT4;RAN;RANBP2;TOPBP1;ANAPC15;ORC4;DDX3X;KLHL21;CDC25A;AJUBA;SMC2;TRIM37;FEN1;MCM3;CDCA5;MDM4;MCM8;PDGFB;BRCC3;RTKN2;NUP160;NAA50;BIRC3;RRM2;NUP54;MCM6;KLHL9;SETD2;ANLN;WEE1;APEX1;CXCR5;ORC1;MYBL1;HSP90AB1;PRIM2;BRCA2;SKA2;FANCD2;E2F8;CENPF;CHEK1;GPER1;MCM4;ADAM17;PSME2;MSH6;CEP152;PSMC3IP;PSMB9;RFWD3;TPRA1;MSH3;CCNA2;POLE3;TIMELESS;ORC2;RBL1;KIF14;RAD51B;CENPN;ATAD5;ZFP36L2;TYMS;HNRNPU;RING1;FGFR1OP;PSMB10;TAF1;CDKN1A;IRF1;CTCF;CENPO
5514,GO:0016462,0.000790021470109986,0.999506714547646,74,686,pyrophosphatase activity,MF,KIF23;TAP1;MYO1B;DDX17;DYNC2H1;GBP1;DDX47;ABCF1;PRUNE2;DNHD1;RAB32;NBN;BRIP1;MCM5;ABCG2;ARFRP1;MCM2;POLQ;TSR1;ATP2B1;HELLS;ABCC4;LSG1;G3BP1;DYNLL2;MDN1;EIF5;RRAGB;GBP5;RFC3;RHOG;DDX28;RAN;ATP2C1;DDX3X;RAB26;ABCF2;CGNL1;MCM3;GNL3L;GINS4;MCM8;ENPP1;DDX10;EFTUD2;DDX24;MCM6;ABCC9;TTF2;HSPA8;DDX21;NSF;HELQ;MYH11;NAV2;MMAA;RAD18;BMS1;MCM4;MYO10;MSH6;DDX60L;ABCA5;MSH3;DDX56;TAP2;KIF14;RAD51B;NRAS;THTPA;ABCA11P;GTF2H3;GBP6;DHX15
721,GO:0001944,0.000816254078045991,0.999530697889977,54,455,vasculature development,BP,KRT1;HDAC9;FN1;PML;CYP1B1;AMOT;CYR61;C3;FGFR2;EPGN;STARD13;CTGF;HSPG2;RUNX1;B4GALT1;EDN1;PTPN14;PDPN;TGFB2;SYK;EMP2;LEPR;SFRP1;COL4A1;AHR;NAA15;PTPRB;ADAMTS9;ADM;IMMP2L;PLK2;HSPB1;WNT4;PTPRM;ITGAV;PGK1;CDH13;SRF;HIF1AN;PDGFB;ANTXR1;ACKR3;SETD2;UBP1;ERAP1;PDCL3;E2F8;GPER1;CFLAR;NCL;TLR3;GJC1;DCTN5;ITGB1BP1
5699,GO:0016817,0.000829170296251121,0.999481261369388,74,688,hydrolase activity, acting on acid anhydrides,MF,KIF23;TAP1;MYO1B;DDX17;DYNC2H1;GBP1;DDX47;ABCF1;PRUNE2;DNHD1;RAB32;NBN;BRIP1;MCM5;ABCG2;ARFRP1;MCM2;POLQ;TSR1;ATP2B1;HELLS;ABCC4;LSG1;G3BP1;DYNLL2;MDN1;EIF5;RRAGB;GBP5;RFC3;RHOG;DDX28;RAN;ATP2C1;DDX3X;RAB26;ABCF2;CGNL1;MCM3;GNL3L;GINS4;MCM8;ENPP1;DDX10;EFTUD2;DDX24;MCM6;ABCC9;TTF2;HSPA8;DDX21;NSF;HELQ;MYH11;NAV2;MMAA;RAD18;BMS1;MCM4;MYO10;MSH6;DDX60L;ABCA5;MSH3;DDX56;TAP2;KIF14;RAD51B;NRAS;THTPA;ABCA11P;GTF2H3;GBP6;DHX15
5700,GO:0016818,0.000829170296251121,0.999481261369388,74,688,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,KIF23;TAP1;MYO1B;DDX17;DYNC2H1;GBP1;DDX47;ABCF1;PRUNE2;DNHD1;RAB32;NBN;BRIP1;MCM5;ABCG2;ARFRP1;MCM2;POLQ;TSR1;ATP2B1;HELLS;ABCC4;LSG1;G3BP1;DYNLL2;MDN1;EIF5;RRAGB;GBP5;RFC3;RHOG;DDX28;RAN;ATP2C1;DDX3X;RAB26;ABCF2;CGNL1;MCM3;GNL3L;GINS4;MCM8;ENPP1;DDX10;EFTUD2;DDX24;MCM6;ABCC9;TTF2;HSPA8;DDX21;NSF;HELQ;MYH11;NAV2;MMAA;RAD18;BMS1;MCM4;MYO10;MSH6;DDX60L;ABCA5;MSH3;DDX56;TAP2;KIF14;RAD51B;NRAS;THTPA;ABCA11P;GTF2H3;GBP6;DHX15
111,GO:0000228,0.000868454812095016,0.999498084166293,54,495,nuclear chromosome,CC,PML;CBX5;ENC1;TP53;ZBED1;RAD1;ZFP42;NBN;MCM5;NUCKS1;MCM2;H3F3A;RPA1;POLA1;KDM6A;THOC1;TOPBP1;ORC4;NUFIP1;SMC2;FEN1;MCM3;CDCA5;APTX;GINS4;SRF;UTY;LRPPRC;RIF1;MCM6;APEX1;ORC1;PRIM2;BRCA2;CHEK1;MCM4;ATR;MSH6;NIFK;TELO2;CITED2;POLE3;TIMELESS;ORC2;MPHOSPH8;PURB;ESR1;HNRNPU;RING1;DAXX;HIST1H4A;TAF1;SMARCC1;IRF1
6869,GO:0030334,0.000881893886461948,0.999473231694584,61,540,regulation of cell migration,BP,IGFBP3;NRG1;HDAC9;FN1;CYP1B1;AMOT;MTUS1;CYR61;STAT5A;STARD13;MMP9;TP53;DAPK3;EDN1;DOCK10;LGALS3;PDPN;TGFB2;SLC9A3R1;EMP2;SFRP1;CD274;TPM1;ULK4;ADAMTS9;PTGER4;CCL20;PLK2;NEXN;HSPB1;WNT4;CXCL16;PTPRM;SOD2;CORO1C;IL24;ITGAV;AJUBA;CDH13;SRF;PDGFB;ACKR3;GLIPR2;APEX1;SGK1;CCAR1;WDPCP;GPER1;ADAM17;NTN1;CBLL1;SHTN1;DPYSL3;CITED2;CSF1;KIF14;TNF;CCL5;CD74;FGFR1OP;ITGB1BP1
5743,GO:0016887,0.00092349634418766,0.999498865389212,44,349,ATPase activity,MF,KIF23;TAP1;MYO1B;DDX17;DYNC2H1;DDX47;ABCF1;DNHD1;NBN;BRIP1;ABCG2;POLQ;ATP2B1;ABCC4;G3BP1;DYNLL2;MDN1;RFC3;DDX28;ATP2C1;DDX3X;ABCF2;DDX10;DDX24;MCM6;ABCC9;TTF2;HSPA8;DDX21;NSF;HELQ;RAD18;MCM4;MYO10;MSH6;ABCA5;MSH3;DDX56;TAP2;KIF14;RAD51B;ABCA11P;GTF2H3;DHX15
10910,GO:0044446,0.000927016790916392,0.999276882130835,547,7078,intracellular organelle part,CC,CRYAB;IGFBP3;KRT1;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;RUNX1;MYO1B;CYP1A1;CLN6;B4GALT1;ACTG1;PBX1;NEFM;DDX17;SPON1;FAM69B;TFCP2L1;KRTAP2-3;COL27A1;ENC1;DYNC2H1;SPG21;MID1;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;DOCK10;DDX47;SIPA1L3;ABCF1;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;LGALS3;CHP1;AKAP8;PPAN;TGFB2;ST6GALNAC5;PRSS23;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;CDKAL1;IL16;SRSF2;PCDH7;COL12A1;SLC30A6;SUGP2;P3H2;RAD1;HNRNPF;PDCD11;NUAK1;DKC1;IL7R;NUP50;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;EMP2;TJP2;NUP153;ZFP42;RAB32;RELB;NBN;VEZT;FAM111A;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;VPS41;KRT9;AP3M2;POP1;HLA-DOB;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;COL4A1;USP16;AHR;COA7;KEAP1;TRA2A;HRNR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;HELLS;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;REEP1;DRAM1;SETDB1;TMEM97;LSG1;GRWD1;PARD3B;MGAM;IMMP2L;CD109;P4HA2;USP43;ELMSAN1;GGCX;NDC1;CADPS2;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;CASC3;SYNPO2L;PLK2;RRAGB;MRPL27;SLCO4C1;MME;MUC16;FRK;DNTTIP2;GBP5;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;LCP1;EXOG;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;RANBP2;HS3ST1;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;ATP2C1;DDX3X;RAB26;NUFIP1;ARMC5;KLHL21;RRN3;RRP12;CDC25A;ITGAV;SOCS1;SET;ARNTL;MRTO4;QPCT;TAF1D;ABCF2;AJUBA;SMC2;CGNL1;UTP14A;CROT;KRT24;LFNG;RBM12;SNX5;TRIM37;FEN1;MCM3;LUC7L;CDCA5;HACD2;GNL3L;TTC1;BAIAP2;NVL;SH3RF2;APTX;COL5A2;GINS4;IBA57;RRP1;RARS;SRF;GDAP1;MDM4;LUC7L2;HIF1AN;WDR3;WDR43;MCM8;PDGFB;UTP18;BRCC3;CHID1;ODF2L;KREMEN2;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;SDAD1;SMYD2;ENPP1;BIRC3;DDX10;MBOAT1;COMMD9;NUP54;LRPPRC;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;KANSL1L;RIF1;MCM6;SRD5A1;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;TRMT5;TTF2;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;NNT;WEE1;TJP1;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;TNC;ORC1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;SMUG1;SCD5;NSF;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;GEMIN8;SYNCRIP;NAV2;TRMT1;DGCR8;KRT10;CCAR1;SKA2;PPIP5K1;WDPCP;FANCD2;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;STEAP4;FKBP5;HSF2;POLR2F;FCF1;RAB3GAP1;CHEK1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;DPYSL3;ESF1;TAF6L;MRPS7;EBP;NCBP1;UPF3B;AKR1B1;POLR1E;UBE2J2;VPS36;TRAF2;MSH3;TELO2;RBBP5;FAM208B;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;MPHOSPH8;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;SYNPO2;ESR1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;FEM1C;CENPN;ARV1;DNASE1;WDR4;PDSS1;SURF2;NEDD9;SRSF7;TYMS;STARD7;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;DAXX;DCTN5;PANX1;HIST1H4A;TAF1;TBPL1;YPEL4;PHLPP1;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;SLC25A22;TREX1;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;CENPO;GPX4;BUD13;COPS3;DHX15
17325,GO:0140097,0.000977977392386079,0.999573632153839,25,178,catalytic activity, acting on DNA,MF,EXO1;ZBED1;RAD1;DKC1;NBN;BRIP1;MCM5;MCM2;POLQ;POLA1;G3BP1;DDX3X;FEN1;APTX;GINS4;MCM6;APEX1;SMUG1;PRIM2;MCM4;POLE3;RAD51B;DNASE1;FTO;TREX1
3745,GO:0008284,0.000996087559347167,0.999406442597376,59,543,positive regulation of cell proliferation,BP,NRG1;FN1;TNS3;PML;TFRC;CYR61;FOSL2;FGFR2;STAT5A;EPGN;CTGF;MMP9;B4GALT1;PBX1;IRS1;EDN1;TGFB2;IL6ST;IL7R;SYK;EMP2;CDK4;SFRP1;CD274;MIR17HG;ABCC4;ADM;RHOG;NOP2;NAP1L1;IL24;ITGAV;ODC1;AKR1C2;CDH13;PDGFB;RTKN2;PDCL3;TNC;CCAR1;IL12RB2;GPER1;ADAM17;NTN1;CFLAR;AKR1B1;CCNA2;CSF1;KIF14;ESR1;TNF;ATAD5;CCL5;CD74;HNRNPU;FGFR1OP;NRAS;CDKN1A;ITGB1BP1
17655,GO:1901342,0.000997230195492552,0.999549602864946,27,190,regulation of vasculature development,BP,KRT1;HDAC9;PML;CYP1B1;AMOT;C3;STARD13;HSPG2;RUNX1;TGFB2;EMP2;SFRP1;ADAMTS9;ADM;PLK2;HSPB1;WNT4;PTPRM;PGK1;HIF1AN;PDGFB;ERAP1;PDCL3;GPER1;CFLAR;TLR3;ITGB1BP1
8483,GO:0033622,0.00102106918882055,0.999913384717823,5,11,integrin activation,BP,FN1;COL16A1;PTGER4;KIF14;ITGB1BP1
12122,GO:0048146,0.00103162124693663,0.999783150185826,9,37,positive regulation of fibroblast proliferation,BP,FN1;PML;FOSL2;CDK4;PDGFB;CCNA2;ESR1;CD74;CDKN1A
15535,GO:0071897,0.00104205003386887,0.99954356519979,25,178,DNA biosynthetic process,BP,CTGF;TP53;EXO1;DKC1;NBN;BRIP1;POLQ;RPA1;POLA1;TK1;USP43;RFC3;GNL3L;NVL;PDGFB;HSP90AB1;PRIM2;BRCA2;CENPF;ATR;POLE3;RAD51B;TYMS;HNRNPU;CDKN1A
3182,GO:0006807,0.00107068456828592,0.999165293077123,569,7380,nitrogen compound metabolic process,BP,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;C1R;TRIM16;FN1;TENM3;PTGES;PML;CYP1B1;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;TRIM22;CBX5;CTGF;UTP20;MMP9;FBN1;GNPTAB;HSPG2;SLC7A2;RUNX1;CYP1A1;CLN6;IL1R2;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;SPON1;TRIM56;OVCH2;TFCP2L1;TRAF3;ENC1;IRS1;MID1;SLC16A9;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;GBP1;DDX47;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;LGALS3;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PUM3;GALNT18;CAMK1G;PHAX;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RELB;NBN;TRIO;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;MIR17HG;GEMIN4;ABHD4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;APOL6;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;SLC5A6;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;TSN;ADAMTS9;SETDB1;PTGER4;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;OPHN1;ADM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;HERC6;HNRNPA1L2;FOXRED2;MDN1;SLC1A3;EIF5;CASC3;CCL20;PLK2;ZNF512;MRPL27;MME;ZNF587;MUC16;UBQLN2;HSCB;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;EXOG;PTPRM;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ZNF738;DDX3X;NAP1L1;NUFIP1;CPA4;IL24;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;TRPM7;AJUBA;FASTKD3;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;LFNG;ZC3H7B;PGK1;TRIM37;FEN1;MCM3;LUC7L;CDCA5;HACD2;SRBD1;PPP4R4;GNL3L;ZNF586;YRDC;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;SGK494;FZD1;IRX4;UTY;NFE2L1;ANTXR1;ISG20L2;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;IL20;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;ACKR3;RIF1;METTL16;TYW1;MCM6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;DTX4;GLIPR2;DPY19L2P2;SEPHS2;NNT;WEE1;ZNF484;THADA;ERAP1;SLC11A2;APEX1;PDCL3;TNC;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;ZBTB24;NSF;DNPEP;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;ANAPC7;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;KRT10;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;ADAM17;SENP1;RBMS3;ATR;PSME2;MSH6;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;UQCRB;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;RRP15;RNF19B;RAD51B;USP11;FEM1C;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
3765,GO:0008309,0.00107832440313239,0.999981414881335,3,4,double-stranded DNA exodeoxyribonuclease activity,MF,EXO1;FEN1;APEX1
19688,GO:1990904,0.00108000966395363,0.999333464194331,66,701,ribonucleoprotein complex,CC,CBX5;UTP20;ABCF1;RBM4;GEMIN5;PABPC4;LGALS3;PPAN;RBM22;TGS1;SRSF2;HNRNPF;PDCD11;DKC1;POP1;HEATR1;GEMIN4;TSR1;ZMAT2;G3BP1;HNRNPA1L2;MDN1;CASC3;MRPL27;NOP58;DDX28;RRP7BP;DDX3X;NUFIP1;SOCS1;ARNTL;MRTO4;AJUBA;UTP14A;LUC7L;GNL3L;NVL;RRP1;LUC7L2;WDR3;UTP18;EFTUD2;RRP36;TTF2;APEX1;HSPA8;SYNCRIP;FCF1;SRFBP1;BMS1;MRPS7;HNRNPR;NCL;NOP56;CLOCK;NSA2;RRP15;RC3H1;WDR36;HNRNPU;MAK16;ZNHIT6;HNRNPM;RBM8A;RPS12;DHX15
7373,GO:0031415,0.0010960268444621,0.999980999676911,3,4,NatA complex,CC,NAA15;NAA50;NAA16
12916,GO:0051239,0.00111393619128946,0.999184498345821,168,1834,regulation of multicellular organismal process,BP,MAFB;KRT1;SAA1;NEFL;NRG1;HDAC9;TRIM16;MAP2;FN1;TENM3;PML;CYP1B1;AMOT;JPH2;TFRC;CYR61;C3;NLRC5;FGFR2;STAT5A;STARD13;CTGF;MMP9;FBN1;HSPG2;RUNX1;IL1R2;FAT4;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;TRIM56;TRAF3;ENC1;DAPK3;EDN1;GBP1;C1QTNF1;RBM19;LGALS3;PDPN;AKAP8;TGFB2;CYLD;IKBKE;IL27RA;IL6ST;SLC9A3R1;INHBA;IL7R;SLC22A5;SYK;EMP2;TJP2;RELB;LEPR;CDK4;SFRP1;CD274;WNT10A;MIR17HG;H3F3A;ATP2B1;KEAP1;TPM1;ULK4;ADAMTS9;PTGER4;ADM;CD109;CCL20;PLK2;GBP5;BTN2A1;HSPB1;WNT4;PTPRM;THOC1;CORO1C;DDX3X;RRN3;SOCS1;ARNTL;LFNG;PGK1;LUC7L;BAIAP2;COL5A2;SRF;HIF1AN;NPNT;PDGFB;CHID1;KREMEN2;SDK1;FZD1;CLU;ENPP1;BIRC3;IL20;RIF1;SETD2;THBD;ABCC9;DTX4;GLIPR2;LRRN3;ERAP1;PDCL3;SYT11;HSP90AB1;NEDD4L;SGK1;ZFYVE27;BRCA2;TRAK2;WDPCP;FANCD2;MTMR2;CENPF;L1CAM;POLR2F;IL12RB2;GPER1;ADAM17;SENP1;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;SHTN1;DPYSL3;TRAF2;RBBP5;CITED2;POLR3B;DDX56;CSF1;AP3B1;CLOCK;KIF14;PURB;TLR3;ESR1;PARD3;GJC1;TNF;ATAD5;ZFP36L2;RC3H1;CD74;WDR36;PSMB10;PHF14;PANX1;HIST1H4A;PHLPP1;FTO;PPARGC1B;ITGB1BP1;TREX1;IRF1;IRAK3
11362,GO:0045671,0.00112425991352715,0.99986249899041,6,16,negative regulation of osteoclast differentiation,BP,MAFB;FBN1;TJP2;SFRP1;LILRB3;TLR3
15866,GO:0072562,0.00114832092925756,0.999752880442046,9,39,blood microparticle,CC,KRT1;C1R;FN1;TFRC;C3;ACTG1;CLU;HSPA8;DNPEP
3544,GO:0007568,0.00118392959024424,0.99944859301156,28,211,aging,BP,CRYAB;PML;GCLC;CTGF;CYP1A1;TFCP2L1;TP53;EDN1;CDKN2A;NQO1;NUAK1;ATP2B1;ADM;PLK2;MME;SOD2;ARNTL;SRF;APEX1;BRCA2;CHEK1;ATR;MSH6;EIF2B5;TPRA1;RBL1;TYMS;CDKN1A
13851,GO:0060429,0.00122419368571615,0.999201915623828,83,810,epithelium development,BP,SPRR3;KRT1;NRG1;SPRR2A;KRT34;KRT4;TRIM16;KRT13;PML;KRT2;CYR61;KRT15;FOSL2;FGFR2;STARD13;RUNX1;CYP1A1;FAT4;B4GALT1;PBX1;FST;TFCP2L1;KRTAP2-3;EDN1;SIPA1L3;LGALS3;PDPN;TGFB2;IRX2;SLC9A3R1;INHBA;TJP2;SFRP1;KRT9;RIPK4;WNT10A;COL4A1;KEAP1;TCHH;HRNR;OPHN1;ADM;CD109;WNT4;KDM6A;ARNTL;AJUBA;AKR1C2;KRT24;LFNG;PGK1;PHACTR4;SRF;NPNT;PDGFB;FZD1;FRAS1;IL20;SETD2;TJP1;TNC;BRCA2;KRT10;WDPCP;E2F8;BBS5;RPTN;ADAM17;NTN1;PSME2;CEP152;PSMB9;CITED2;TIMELESS;CSF1;CLOCK;MPP5;ESR1;TNF;TYMS;PSMB10;CDKN1A;ASTN2
11947,GO:0046977,0.00124035886047008,0.99997752526378,3,4,TAP binding,MF,TAP1;HLA-F;TAP2
11948,GO:0046978,0.00124035886047008,0.99997752526378,3,4,TAP1 binding,MF,TAP1;HLA-F;TAP2
5507,GO:0016447,0.00126803342669346,0.999725234190238,9,37,somatic recombination of immunoglobulin gene segments,BP,TFRC;EXO1;IL27RA;NBN;THOC1;RIF1;MSH6;MSH3;ATAD5
16110,GO:0090070,0.00129904139414804,0.99992435642576,4,8,positive regulation of ribosome biogenesis,BP,UTP15;HEATR1;WDR43;WDR75
19831,GO:2000234,0.00129904139414804,0.99992435642576,4,8,positive regulation of rRNA processing,BP,UTP15;HEATR1;WDR43;WDR75
5492,GO:0016423,0.00131147557928417,0.999872869146445,5,13,tRNA (guanine) methyltransferase activity,MF,THUMPD3;METTL1;TRMT5;TRMT1;WDR4
12121,GO:0048145,0.00137452486024882,0.999606800539528,12,62,regulation of fibroblast proliferation,BP,FTH1;FN1;PML;FOSL2;TP53;CDK4;SFRP1;PDGFB;CCNA2;ESR1;CD74;CDKN1A
12371,GO:0048731,0.00140123024348818,0.998920374645583,257,2946,system development,BP,CRYAB;MAFB;SPRR3;KRT1;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PML;CYP1B1;AMOT;JPH2;KRT2;TFRC;CYR61;C3;KRT15;FOSL2;FGFR2;STAT5A;EPGN;STARD13;COL5A3;CTGF;MMP9;FBN1;HSPG2;RUNX1;CYP1A1;FAT4;B4GALT1;PBX1;NEFM;G6PD;TSC22D3;FST;DDX17;TFCP2L1;KRTAP2-3;COL27A1;ENC1;DAPK3;TUFT1;EXO1;EDN1;HMGCS1;DOCK10;SIPA1L3;KBTBD8;ACSL3;PTPN14;PABPC4;MEGF11;LGALS3;PDPN;TGFB2;IRX2;CNTNAP1;CYLD;IL27RA;LRFN4;COL12A1;RAD1;IL6ST;SLC9A3R1;INHBA;IL7R;SYK;EMP2;TJP2;NAIP;ZFP42;RELB;NBN;LEPR;BRIP1;CDK4;SFRP1;KRT9;GPCPD1;WNT10A;MCM2;MIR17HG;POLQ;H3F3A;ATP2B1;COL4A1;AHR;NAA15;TCHH;HRNR;DHFR;TPM1;PTPRB;ULK4;ADAMTS9;PTGER4;OPHN1;ADM;IMMP2L;CD109;HERC6;SLC1A3;PLK2;MME;NEXN;HSPB1;RHOG;WNT4;LCP1;GPRIN1;PTPRM;KDM6A;THOC1;RAN;CORO1C;RAB26;RRN3;ITGAV;SOCS1;ARNTL;ODC1;ARMC6;KRT24;LFNG;PGK1;LUC7L;BAIAP2;WDR7;CDH13;COL5A2;PHACTR4;SRF;HIF1AN;NPNT;QDPR;PDGFB;UGT8;SDK1;FZD1;IRX4;NFE2L1;ANTXR1;RTKN2;CLU;SMYD2;ENPP1;FRAS1;IL20;ACKR3;RIF1;SRD5A1;SETD2;GLIS2;ANLN;UBP1;GLIPR2;JPH1;WEE1;LRRN3;ERAP1;SLC11A2;BLOC1S2;PDCL3;CXCR5;TNC;CNTNAP2;UMPS;HSP90AB1;ZBTB24;MYH11;NEDD4L;SGK1;ZFYVE27;BRCA2;NAV2;TRAK2;KRT10;WDPCP;FANCD2;E2F8;MTMR2;CENPF;ETV6;L1CAM;RAB3GAP1;BBS5;GPER1;RRM1;RPTN;ADAM17;SENP1;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;EIF2B5;SHTN1;DPYSL3;EBP;AKR1B1;JRKL;MSH3;RBBP5;CITED2;MFAP5;NCL;CCNA2;DDX56;TIMELESS;CSF1;AP3B1;CLOCK;KIF14;PURB;TLR3;MPP5;ESR1;PARD3;GJC1;EHD1;TNF;ATAD5;ZFP36L2;RC3H1;TYMS;CD74;WDR36;HNRNPU;RING1;PSMB10;EIF2B1;DCTN5;PHF14;PHLPP2;HIST1H4A;TAF1;PHLPP1;FTO;NRAS;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;USP1;IRF1;IRAK3
17895,GO:1902105,0.00141100725210282,0.999392114524165,23,160,regulation of leukocyte differentiation,BP,MAFB;FBN1;RUNX1;CYLD;INHBA;IL7R;SYK;TJP2;SFRP1;MIR17HG;SOCS1;IL20;FANCD2;LILRB3;CSF1;AP3B1;TLR3;TNF;ZFP36L2;RC3H1;CD74;PPARGC1B;IRF1
17663,GO:1901363,0.00144747747294675,0.998857490266726,373,4574,heterocyclic compound binding,MF,MAFB;TRIM16;PML;CYP1B1;KIF23;MAP3K14;GCLC;TFRC;CYP24A1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;UTP20;TAP1;RUNX1;MYO1B;CYP1A1;ACTG1;PBX1;G6PD;MAT2A;DDX17;TRIM56;TFCP2L1;DYNC2H1;TP53;DAPK3;PANK2;EXO1;GBP1;DDX47;ABCF1;DUSP14;RBM19;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;JRK;GEMIN5;NQO1;PABPC4;LGALS3;ACO1;AKAP8;PPAN;IRX2;ZNF208;RBM22;CARS2;IKBKE;PKMYT1;IFIT3;SRSF2;FOXD2;SUGP2;RAD1;HNRNPF;BAG1;PDCD11;NUAK1;DKC1;SLC22A5;PUM3;CAMK1G;PHAX;DNHD1;SYK;NUP153;NAIP;ZFP42;RAB32;RELB;NBN;TRIO;PARP15;BRIP1;MCM5;ABCG2;UTP15;ARFRP1;CDK4;POP1;RIPK4;NUCKS1;HEATR1;MCM2;TARDBP;MIR17HG;POLQ;TSR1;H3F3A;ATP2B1;PUS3;AHR;NAA15;TRA2A;ZNF827;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;CSRP1;METTL1;TAF2;ULK4;POLA1;ABCC4;TSN;SETDB1;TK1;LSG1;G3BP1;GRWD1;ZNF584;ZNF407;ELMSAN1;HNRNPA1L2;FOXRED2;MDN1;EIF5;CASC3;PLK2;RRAGB;ZNF512;MRPL27;ZNF587;FRK;DNTTIP2;GBP5;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;NOP2;SUV39H2;EXOG;GTF3C6;KDM6A;DDX28;THOC1;RAN;HMGXB3;UBTF;RANBP2;TOPBP1;ORC4;SUPT16H;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARHGEF28;GPHN;RRN3;RRP12;SET;ARNTL;MRTO4;TAF1D;ABCF2;TRPM7;SMC2;FASTKD3;UTP14A;DND1;ZNF267;RBMXL1;ZC3H7B;RBM12;PGK1;FEN1;MCM3;LUC7L;SRBD1;GNL3L;ZNF586;YRDC;NVL;GATC;APTX;IBA57;RRP1;RARS;SRF;FNDC3B;LUC7L2;QDPR;WDR3;ZNF234;WDR43;MCM8;UTP18;EIF3J;SGK494;IRX4;UTY;NFE2L1;ISG20L2;USP6;MACC1;ENPP1;CBWD5;ZNF316;DDX10;LRPPRC;ZNF670;EFTUD2;ZNF106;TRUB2;DDX24;KANSL1L;METTL16;TYW1;MCM6;SRD5A1;RRP36;GLIS2;RPF2;UBP1;ABCC9;TTF2;SRPRB;SEPHS2;NNT;WEE1;ZNF484;NOL12;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;EPHB6;SMUG1;ZBTB24;NSF;HELQ;MYH11;SGK1;PRIM2;ZBTB12;BRCA2;SYNCRIP;NAV2;TRMT1;DGCR8;DPYD;CCAR1;PPIP5K1;MAZ;ZNF33A;E2F8;ETV6;ZNFX1;FKBP5;HSF2;POLR2F;CCDC47;FCF1;CHEK1;SRFBP1;HMGN2;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;RBMS3;ATR;UBAP2L;MSH6;HADHB;DDX60L;PSMC3IP;NIFK;NOL9;EIF2B5;ZNF12;ABCA5;NOL11;BAZ2B;SDHD;GPATCH4;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;NCBP1;MYNN;UPF3B;POLR1E;UBE2J2;JRKL;MSH3;TELO2;RBBP5;CYP20A1;POLR3B;HNRNPR;NCL;GTF3C4;NOP56;POLE3;DDX56;TAP2;TIMELESS;ORC2;RBL1;ZNF286A;CLOCK;NSA2;KIF14;PURB;TLR3;ESR1;NOP16;RAD51B;EHD1;TNF;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;WDR36;HNRNPU;MAK16;FLAD1;EIF2B1;ZSCAN31;METAP2;HIST1H4A;TAF1;TBPL1;SPIB;NRAS;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;ABCA11P;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;GBP6;IRAK3;BUD13;DHX15
17896,GO:1902106,0.00144835617749119,0.999613424281602,11,52,negative regulation of leukocyte differentiation,BP,MAFB;FBN1;CYLD;INHBA;TJP2;SFRP1;LILRB3;TLR3;RC3H1;CD74;IRF1
5505,GO:0016445,0.00145057953619431,0.999643795549784,10,45,somatic diversification of immunoglobulins,BP,TFRC;EXO1;IL27RA;NBN;POLQ;THOC1;RIF1;MSH6;MSH3;ATAD5
7073,GO:0030855,0.00146176613775666,0.99915780751892,49,434,epithelial cell differentiation,BP,SPRR3;KRT1;NRG1;SPRR2A;KRT34;KRT4;TRIM16;KRT13;KRT2;KRT15;FOSL2;FGFR2;RUNX1;CYP1A1;FAT4;B4GALT1;TFCP2L1;KRTAP2-3;SIPA1L3;LGALS3;PDPN;SLC9A3R1;TJP2;KRT9;COL4A1;KEAP1;TCHH;HRNR;OPHN1;CD109;WNT4;ARNTL;AKR1C2;KRT24;PGK1;PDGFB;FZD1;IL20;TJP1;KRT10;WDPCP;E2F8;RPTN;CEP152;CLOCK;ESR1;TNF;TYMS;CDKN1A
14050,GO:0060759,0.00149121241090811,0.99939802940901,20,136,regulation of response to cytokine stimulus,BP,NLRC5;RUNX1;IL1R2;EDN1;IFNGR1;CYLD;SYK;TRAF1;SOCS1;PARP14;BIRC3;IFNAR1;HSP90AB1;ADAM17;TRAF2;CSF1;TNF;CCL5;CD74;IRAK3
609,GO:0001775,0.00149836875356354,0.999010184043183,85,865,cell activation,BP,MAFB;KRT1;SAA1;FTL;FTH1;HDAC9;MAP3K14;GCLC;KRT2;TFRC;C3;S100P;CTGF;MMP9;SLC7A2;RUNX1;B4GALT1;ACTG1;EXO1;EDN1;DOCK10;C1QTNF1;LGALS3;PDPN;CYLD;IL27RA;IL6ST;INHBA;IL7R;SYK;RELB;NBN;LEPR;SFRP1;CD274;MIR17HG;AHR;HRNR;HELLS;CSRP1;PTPRB;PTGER4;MGAM;SLCO4C1;MME;FRK;HSPB1;RHOG;WNT4;LCP1;SIRPA;THOC1;DDX3X;ITGAV;SOCS1;QPCT;LFNG;SRF;PDGFB;CLU;COMMD9;RIF1;THBD;CXCR5;HSPA8;HSP90AB1;LAIR1;FANCD2;GPER1;ADAM17;MSH6;LILRB3;CSF1;AP3B1;GLIPR1;TLR3;DNASE1;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;NRAS;CDKN1A;IRF1
11118,GO:0045120,0.00149893304783956,0.999854976915477,5,12,pronucleus,CC,AKAP8;RIF1;TET3;CENPF;CCNA2
8382,GO:0033273,0.00155215481206084,0.999548683518688,12,63,response to vitamin,BP,CYP24A1;CYP1A1;TP53;HMGCS1;SRSF2;BRIP1;SFRP1;ATP2B1;SETDB1;GDAP1;TNC;TYMS
10891,GO:0044420,0.00158408547871526,0.999441779791812,16,84,extracellular matrix component,CC,FN1;COL5A3;FBN1;HSPG2;CCDC80;COL27A1;COL12A1;P3H2;DST;COL4A1;COL5A2;NPNT;FRAS1;TNC;NTN1;MFAP5
12120,GO:0048144,0.00160081701222537,0.999532781347271,12,63,fibroblast proliferation,BP,FTH1;FN1;PML;FOSL2;TP53;CDK4;SFRP1;PDGFB;CCNA2;ESR1;CD74;CDKN1A
16109,GO:0090069,0.00164316002104024,0.999832136305712,5,13,regulation of ribosome biogenesis,BP,SHQ1;UTP15;HEATR1;WDR43;WDR75
1128,GO:0002714,0.00169214881346979,0.999763398256348,6,19,positive regulation of B cell mediated immunity,BP,TFRC;C3;RIF1;MSH6;TNF;ATAD5
1224,GO:0002891,0.00169214881346979,0.999763398256348,6,19,positive regulation of immunoglobulin mediated immune response,BP,TFRC;C3;RIF1;MSH6;TNF;ATAD5
16496,GO:0097159,0.00170261567408516,0.998651258297661,375,4612,organic cyclic compound binding,MF,MAFB;TRIM16;PML;CYP1B1;KIF23;MAP3K14;GCLC;TFRC;CYP24A1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;UTP20;TAP1;RUNX1;MYO1B;CYP1A1;ACTG1;PBX1;G6PD;MAT2A;DDX17;TRIM56;TFCP2L1;DYNC2H1;TP53;DAPK3;PANK2;EXO1;GBP1;DDX47;ABCF1;DUSP14;RBM19;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;JRK;GEMIN5;NQO1;PABPC4;LGALS3;ACO1;AKAP8;PPAN;IRX2;ZNF208;RBM22;CARS2;IKBKE;PKMYT1;IFIT3;SRSF2;FOXD2;SUGP2;RAD1;HNRNPF;BAG1;PDCD11;NUAK1;DKC1;SLC22A5;PUM3;CAMK1G;PHAX;DNHD1;SYK;NUP153;NAIP;ZFP42;RAB32;RELB;NBN;TRIO;PARP15;BRIP1;MCM5;ABCG2;UTP15;ARFRP1;CDK4;POP1;RIPK4;NUCKS1;HEATR1;MCM2;TARDBP;MIR17HG;POLQ;TSR1;H3F3A;ATP2B1;PUS3;AHR;NAA15;TRA2A;ZNF827;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;CSRP1;METTL1;TAF2;ULK4;POLA1;ABCC4;TSN;SETDB1;TK1;LSG1;G3BP1;GRWD1;ZNF584;ZNF407;ELMSAN1;HNRNPA1L2;FOXRED2;MDN1;EIF5;CASC3;PLK2;RRAGB;ZNF512;MRPL27;ZNF587;FRK;DNTTIP2;GBP5;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;NOP2;SUV39H2;EXOG;GTF3C6;KDM6A;DDX28;THOC1;RAN;HMGXB3;UBTF;RANBP2;TOPBP1;ORC4;SUPT16H;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARHGEF28;GPHN;RRN3;RRP12;SET;ARNTL;MRTO4;TAF1D;ABCF2;TRPM7;SMC2;FASTKD3;UTP14A;DND1;ZNF267;RBMXL1;AKR1C2;ZC3H7B;RBM12;PGK1;FEN1;MCM3;LUC7L;SRBD1;GNL3L;ZNF586;YRDC;NVL;GATC;APTX;IBA57;RRP1;RARS;SRF;FNDC3B;LUC7L2;QDPR;WDR3;ZNF234;WDR43;MCM8;UTP18;EIF3J;SGK494;IRX4;UTY;NFE2L1;ISG20L2;USP6;MACC1;ENPP1;CBWD5;ZNF316;DDX10;LRPPRC;ZNF670;EFTUD2;ZNF106;TRUB2;DDX24;KANSL1L;METTL16;TYW1;MCM6;SRD5A1;RRP36;GLIS2;RPF2;UBP1;ABCC9;TTF2;SRPRB;SEPHS2;NNT;WEE1;ZNF484;NOL12;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;EPHB6;SMUG1;ZBTB24;NSF;HELQ;MYH11;SGK1;PRIM2;ZBTB12;BRCA2;SYNCRIP;NAV2;TRMT1;DGCR8;DPYD;CCAR1;PPIP5K1;MAZ;ZNF33A;E2F8;ETV6;ZNFX1;FKBP5;HSF2;POLR2F;CCDC47;FCF1;CHEK1;SRFBP1;GPER1;HMGN2;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;RBMS3;ATR;UBAP2L;MSH6;HADHB;DDX60L;PSMC3IP;NIFK;NOL9;EIF2B5;ZNF12;ABCA5;NOL11;BAZ2B;SDHD;GPATCH4;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;NCBP1;MYNN;UPF3B;POLR1E;UBE2J2;JRKL;MSH3;TELO2;RBBP5;CYP20A1;POLR3B;HNRNPR;NCL;GTF3C4;NOP56;POLE3;DDX56;TAP2;TIMELESS;ORC2;RBL1;ZNF286A;CLOCK;NSA2;KIF14;PURB;TLR3;ESR1;NOP16;RAD51B;EHD1;TNF;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;WDR36;HNRNPU;MAK16;FLAD1;EIF2B1;ZSCAN31;METAP2;HIST1H4A;TAF1;TBPL1;SPIB;NRAS;PSPC1;SMARCC1;PPARGC1B;ARID3B;HNRNPM;ABCA11P;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;GBP6;IRAK3;BUD13;DHX15
133,GO:0000278,0.00170309893057364,0.998856818367422,90,913,mitotic cell cycle,BP,PML;KIF23;MAP3K14;EPGN;CYP1A1;PBX1;TP53;DAPK3;EDN1;CDKN2A;STAG1;AKAP8;CYLD;PKMYT1;SRSF2;SLC9A3R1;INHBA;NUP50;NUP153;NAIP;GPR132;NBN;MCM5;CDK4;MCM2;USP16;DHFR;RPA1;TAF2;POLA1;NDC1;PLK2;AKAP8L;MYBL2;RAN;RANBP2;TOPBP1;ANAPC15;ORC4;DDX3X;CDC25A;AJUBA;SMC2;MCM3;CDCA5;CDH13;MDM4;MCM8;PDGFB;RTKN2;NUP160;NAA50;BIRC3;RRM2;NUP54;MCM6;SETD2;ANLN;WEE1;APEX1;ORC1;MYBL1;PRIM2;BRCA2;SKA2;E2F8;CENPF;CHEK1;RRM1;MCM4;ADAM17;PSME2;CEP152;PSMB9;RFWD3;TPRA1;CCNA2;POLE3;ORC2;RBL1;KIF14;RAD51B;TNF;ATAD5;ZFP36L2;TYMS;HNRNPU;FGFR1OP;PSMB10;CDKN1A
506,GO:0001568,0.00170339088687402,0.999000846574332,51,436,blood vessel development,BP,KRT1;HDAC9;FN1;PML;CYP1B1;AMOT;CYR61;C3;FGFR2;EPGN;STARD13;CTGF;HSPG2;RUNX1;B4GALT1;EDN1;TGFB2;SYK;EMP2;LEPR;SFRP1;COL4A1;AHR;NAA15;PTPRB;ADAMTS9;ADM;PLK2;HSPB1;WNT4;PTPRM;ITGAV;PGK1;CDH13;SRF;HIF1AN;PDGFB;ANTXR1;ACKR3;SETD2;UBP1;ERAP1;PDCL3;E2F8;GPER1;CFLAR;NCL;TLR3;GJC1;DCTN5;ITGB1BP1
15224,GO:0071353,0.0017069792937879,0.99970367375669,7,26,cellular response to interleukin-4,BP,PML;CDK4;MCM2;KEAP1;IL24;PARP14;HSP90AB1
2976,GO:0006518,0.00175178345935887,0.99887716147957,71,783,peptide metabolic process,BP,PTGES;GCLC;G6PD;ENC1;DAPK3;C9ORF3;ABCF1;KBTBD8;RBM4;GEMIN5;PABPC4;ACO1;CARS2;CDKAL1;NUP50;PUM3;NUP153;CDK4;MIR17HG;H3F3A;USP16;DHFR;IMMP2L;NDC1;EIF5;CASC3;MRPL27;MME;HSPB1;RAN;RANBP2;DDX3X;MRTO4;AJUBA;FASTKD3;DND1;GATC;RARS;GDAP1;EIF3J;CLU;NUP160;NUP54;LRPPRC;EFTUD2;METTL16;ERAP1;HSPA8;BACE2;DNPEP;SYNCRIP;POLR2F;RBMS3;EIF2B5;MRPS7;DPH2;NCBP1;UPF3B;HNRNPR;NCL;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;EIF2B1;HIST1H4A;RBM8A;GTF2H3;RPS12
12257,GO:0048514,0.00177137957664436,0.998996046981855,45,376,blood vessel morphogenesis,BP,KRT1;HDAC9;FN1;PML;CYP1B1;AMOT;CYR61;C3;FGFR2;EPGN;STARD13;CTGF;HSPG2;RUNX1;B4GALT1;EDN1;TGFB2;SYK;EMP2;LEPR;SFRP1;COL4A1;NAA15;PTPRB;ADAMTS9;ADM;PLK2;HSPB1;WNT4;PTPRM;ITGAV;PGK1;CDH13;SRF;HIF1AN;ACKR3;SETD2;UBP1;ERAP1;PDCL3;E2F8;NCL;TLR3;GJC1;ITGB1BP1
6853,GO:0030316,0.00183774666537491,0.999457135221434,12,60,osteoclast differentiation,BP,MAFB;TFRC;FBN1;TJP2;SFRP1;CD109;IL20;LILRB3;CSF1;TLR3;TNF;PPARGC1B
1098,GO:0002684,0.00185697449967017,0.998837422013584,64,623,positive regulation of immune system process,BP,KRT1;C1R;MAP3K14;TFRC;C3;NLRC5;RUNX1;ACTG1;TRAF3;SPG21;TP53;EDN1;GBP1;LGALS3;TGFB2;CYLD;IKBKE;IL27RA;IL6ST;INHBA;IL7R;SYK;RELB;CD274;CCL20;MUC16;GBP5;BTN2A1;SIRPA;SOCS1;BAIAP2;CLU;BIRC3;IL20;RIF1;HSP90AB1;ADAM17;MYO10;PSME2;MSH6;PSMB9;EIF2B5;CMTM3;TRAF2;POLR3B;CSF1;AP3B1;TLR3;ESR1;TNF;ATAD5;RC3H1;CCL5;CD74;PSMB10;EIF2B1;NRAS;PSPC1;MUC5B;PPARGC1B;CDKN1A;MUC6;IRF1;IRAK3
11413,GO:0045785,0.00186063845722608,0.999068003775742,31,243,positive regulation of cell adhesion,BP,SAA1;FN1;MAP3K14;TFRC;CYR61;COL16A1;CCDC80;PDPN;TGFB2;CYLD;IL6ST;IL7R;SYK;EMP2;SFRP1;CD274;TPM1;WNT4;SIRPA;ITGAV;SOCS1;CDH13;NPNT;MYO10;CITED2;CSF1;AP3B1;TNF;CCL5;CD74;ITGB1BP1
3597,GO:0008026,0.00188078967401771,0.999345795578246,15,87,ATP-dependent helicase activity,MF,DDX17;DDX47;NBN;BRIP1;G3BP1;DDX28;DDX3X;DDX10;DDX24;MCM6;DDX21;HELQ;MCM4;DDX56;DHX15
14547,GO:0070035,0.00188078967401771,0.999345795578246,15,87,purine NTP-dependent helicase activity,MF,DDX17;DDX47;NBN;BRIP1;G3BP1;DDX28;DDX3X;DDX10;DDX24;MCM6;DDX21;HELQ;MCM4;DDX56;DHX15
2265,GO:0005178,0.00188991301858768,0.999373391284904,14,76,integrin binding,MF,NRG1;FN1;CYR61;COL16A1;CTGF;FBN1;SYK;EMP2;DST;LCP1;ITGAV;NPNT;ADAM17;ITGB1BP1
9023,GO:0035194,0.00189171088607682,0.999237017466988,19,140,posttranscriptional gene silencing by RNA,BP,RBM4;NUP50;NUP153;MIR17HG;H3F3A;TSN;NDC1;RAN;RANBP2;AJUBA;DND1;ZC3H7B;NUP160;NUP54;DGCR8;POLR2F;NCBP1;ESR1;HIST1H4A
8888,GO:0034694,0.0018935473363846,0.999733027463517,6,18,response to prostaglandin,BP,EDN1;AKAP8;SFRP1;PTGER4;AKR1C2;TNC
6961,GO:0030593,0.00196670704377934,0.999584820693712,8,37,neutrophil chemotaxis,BP,SAA1;EDN1;LGALS3;TGFB2;SYK;CCL20;CCL5;CD74
223,GO:0000462,0.001984899840105,0.999580349941934,8,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,UTP20;PDCD11;HEATR1;TSR1;UTP18;RRP36;FCF1;BMS1
7933,GO:0032502,0.00206880566872241,0.998364394922525,328,3903,developmental process,BP,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PML;CYP1B1;AMOT;JPH2;GCLC;KRT2;TFRC;CYR61;C3;KRT15;CYP24A1;MKL1;FOSL2;TXNRD1;FGFR2;STAT5A;EPGN;STARD13;COL5A3;CTGF;MMP9;FBN1;VMP1;HSPG2;RUNX1;CYP1A1;ERVFRD-1;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TSC22D3;FST;DDX17;TFCP2L1;KRTAP2-3;COL27A1;ENC1;DYNC2H1;MID1;TP53;DAPK3;TUFT1;PANK2;EXO1;EDN1;GBP1;HMGCS1;DOCK10;SIPA1L3;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;PTPN14;NQO1;PABPC4;MEGF11;LGALS3;ACO1;PDPN;TGFB2;IRX2;CNTNAP1;CYLD;IL27RA;FOXD2;LRFN4;COL12A1;RAD1;IL6ST;SLC9A3R1;NUAK1;INHBA;IL7R;PALM2;SYK;EMP2;TJP2;OLFML3;NAIP;ZFP42;RAB32;RELB;NBN;LEPR;TRIO;BRIP1;ARFRP1;CDK4;SFRP1;KRT9;RIPK4;GPCPD1;WNT10A;MCM2;MIR17HG;POLQ;H3F3A;ATP2B1;COL4A1;AHR;KEAP1;NAA15;TCHH;HRNR;DHFR;TPM1;HELLS;PTPRB;ULK4;ADAMTS9;PTGER4;OPHN1;ADM;IMMP2L;CD109;HERC6;SLC1A3;PLK2;SLCO4C1;MME;NEXN;FRK;MYBL2;HSPB1;RHOG;WNT4;SUV39H2;LCP1;GPRIN1;PTPRM;KDM6A;THOC1;RAN;SOD2;CORO1C;ATP2C1;RAB26;ARHGEF28;RRN3;ITGAV;SOCS1;ARNTL;ODC1;AJUBA;ARMC6;DND1;ZNF267;AKR1C2;KRT24;LFNG;PGK1;LUC7L;CDC42EP2;BAIAP2;GADD45B;WDR7;CDH13;COL5A2;GINS4;PHACTR4;SRF;HIF1AN;NPNT;QDPR;PDGFB;UGT8;KREMEN2;SDK1;FZD1;IRX4;NFE2L1;ANTXR1;RTKN2;CLU;SMYD2;ENPP1;FRAS1;IL20;DDX10;EYA3;TPM4;ACKR3;RIF1;FGD6;SRD5A1;SETD2;GLIS2;ANLN;UBP1;GLIPR2;JPH1;DPY19L2P2;WEE1;TJP1;LRRN3;ERAP1;SLC11A2;BLOC1S2;APEX1;PDCL3;CXCR5;TNC;CNTNAP2;TET3;UMPS;MYBL1;HSP90AB1;DDX21;EPHB6;ZBTB24;MYH11;NEDD4L;SGK1;ZFYVE27;BRCA2;SYNCRIP;NAV2;TRAK2;KRT10;WDPCP;FANCD2;E2F8;MTMR2;CENPF;ETV6;L1CAM;STEAP4;POLR2F;CCDC47;RAB3GAP1;CHEK1;BBS5;GPER1;RRM1;RPTN;ADAM17;MYO10;SENP1;ATR;NTN1;PSME2;MSH6;CEP152;LILRB3;CFLAR;PSMB9;EIF2B5;ABCA5;SHTN1;DPYSL3;EBP;CSRP2;AKR1B1;JRKL;TPRA1;MSH3;RBBP5;CITED2;MFAP5;NCL;CCNA2;DDX56;TIMELESS;CSF1;AP3B1;RBL1;CLOCK;KIF14;PURB;TLR3;MPP5;ESR1;PARD3;GJC1;EHD1;TNF;ATAD5;ZFP36L2;RC3H1;TYMS;CD74;WDR36;HNRNPU;RING1;PSMB10;EIF2B1;DCTN5;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;NRAS;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;USP1;IRF1;ASTN2;GPX4;IRAK3;COPS3
2895,GO:0006403,0.00211984930293648,0.998984853084762,27,209,RNA localization,BP,SRSF2;DKC1;NUP50;PHAX;NUP153;SHQ1;NDC1;HNRNPA1L2;CASC3;AKAP8L;NOP58;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;LRPPRC;SETD2;ATR;NCBP1;UPF3B;SRSF7;HNRNPU;ZNHIT6;RBM8A;BUD13
5502,GO:0016441,0.00213737160600741,0.999128010116888,19,141,posttranscriptional gene silencing,BP,RBM4;NUP50;NUP153;MIR17HG;H3F3A;TSN;NDC1;RAN;RANBP2;AJUBA;DND1;ZC3H7B;NUP160;NUP54;DGCR8;POLR2F;NCBP1;ESR1;HIST1H4A
3603,GO:0008043,0.00214596503752324,1,2,2,intracellular ferritin complex,CC,FTL;FTH1
14690,GO:0070288,0.00214596503752324,1,2,2,ferritin complex,CC,FTL;FTH1
231,GO:0000479,0.00215876647663737,0.999758595995228,5,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,UTP20;TSR1;FCF1;BMS1;NOL9
869,GO:0002204,0.00217831589156551,0.999539983789644,8,33,somatic recombination of immunoglobulin genes involved in immune response,BP,TFRC;EXO1;IL27RA;NBN;THOC1;RIF1;MSH6;ATAD5
870,GO:0002208,0.00217831589156551,0.999539983789644,8,33,somatic diversification of immunoglobulins involved in immune response,BP,TFRC;EXO1;IL27RA;NBN;THOC1;RIF1;MSH6;ATAD5
11158,GO:0045190,0.00217831589156551,0.999539983789644,8,33,isotype switching,BP,TFRC;EXO1;IL27RA;NBN;THOC1;RIF1;MSH6;ATAD5
13907,GO:0060526,0.00219345736914002,0.999951178432668,3,4,prostate glandular acinus morphogenesis,BP,FGFR2;SFRP1;ESR1
13908,GO:0060527,0.00219345736914002,0.999951178432668,3,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,FGFR2;SFRP1;ESR1
629,GO:0001816,0.00221147501812431,0.998696938400393,49,453,cytokine production,BP,SAA1;TRIM16;FN1;PML;CYP1B1;C3;NLRC5;RUNX1;IL1R2;TRIM56;TRAF3;GBP1;AKAP8;TGFB2;CYLD;IKBKE;IL27RA;IL6ST;INHBA;SYK;RELB;CD274;PTGER4;CCL20;GBP5;BTN2A1;HSPB1;DDX3X;ITGAV;SOCS1;CHID1;CLU;BIRC3;SETD2;DTX4;SYT11;HSP90AB1;POLR2F;IL12RB2;ADAM17;TRAF2;POLR3B;TLR3;TNF;CD74;PANX1;TREX1;IRF1;IRAK3
12621,GO:0050778,0.00222243712707397,0.998690068728379,49,454,positive regulation of immune response,BP,KRT1;C1R;TFRC;C3;NLRC5;RUNX1;ACTG1;TRAF3;SPG21;GBP1;LGALS3;TGFB2;CYLD;IKBKE;IL27RA;IL6ST;SYK;RELB;MUC16;GBP5;BTN2A1;BAIAP2;CLU;BIRC3;RIF1;HSP90AB1;MYO10;PSME2;MSH6;PSMB9;EIF2B5;CMTM3;TRAF2;POLR3B;TLR3;ESR1;TNF;ATAD5;RC3H1;CCL5;CD74;PSMB10;EIF2B1;NRAS;PSPC1;MUC5B;MUC6;IRF1;IRAK3
14898,GO:0070670,0.00223999253789026,0.999588713034565,7,27,response to interleukin-4,BP,PML;CDK4;MCM2;KEAP1;IL24;PARP14;HSP90AB1
1455,GO:0003688,0.00225118329802809,0.999745763430104,5,14,DNA replication origin binding,MF,MCM5;MCM2;GRWD1;ORC4;ORC2
4269,GO:0009615,0.00226037808214404,0.998895031310808,28,225,response to virus,BP,PML;MAP3K14;NLRC5;TRIM22;CYP1A1;DDX17;TRIM56;TRAF3;GBP1;IFNGR1;IKBKE;IFIT3;FAM111A;HSPB1;DDX3X;ODC1;CLU;BIRC3;SETD2;ABCC9;IFNAR1;DDX21;POLR3B;TLR3;TNF;CCL5;IRF1;IRAK3
15275,GO:0071426,0.00226675871039927,0.999100573009029,18,121,ribonucleoprotein complex export from nucleus,BP,SRSF2;NUP50;NUP153;NDC1;CASC3;AKAP8L;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
12619,GO:0050776,0.00227083359683535,0.998587077436509,60,584,regulation of immune response,BP,KRT1;C1R;TFRC;C3;NLRC5;HLA-B;RUNX1;ACTG1;TRAF3;SPG21;GBP1;LGALS3;IFNGR1;TGFB2;CYLD;IKBKE;IL27RA;IL6ST;IL7R;SYK;RELB;HLA-F;MUC16;GBP5;BTN2A1;THOC1;SOCS1;PARP14;BAIAP2;CLU;BIRC3;RIF1;IFNAR1;ERAP1;HSP90AB1;LAIR1;SERPINB9;MYO10;PSME2;MSH6;PSMB9;EIF2B5;CMTM3;TRAF2;POLR3B;TLR3;ESR1;TNF;ATAD5;RC3H1;CCL5;CD74;PSMB10;EIF2B1;NRAS;PSPC1;MUC5B;MUC6;IRF1;IRAK3
19730,GO:2000026,0.00227490881620215,0.998376358478763,121,1277,regulation of multicellular organismal development,BP,MAFB;KRT1;NEFL;NRG1;HDAC9;TRIM16;MAP2;FN1;TENM3;PML;CYP1B1;AMOT;JPH2;TFRC;CYR61;C3;FGFR2;STARD13;CTGF;FBN1;HSPG2;RUNX1;FAT4;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;ENC1;EDN1;RBM19;LGALS3;PDPN;TGFB2;CYLD;IL27RA;IL6ST;INHBA;IL7R;SYK;EMP2;TJP2;SFRP1;WNT10A;MIR17HG;H3F3A;KEAP1;ULK4;ADAMTS9;ADM;CD109;PLK2;HSPB1;WNT4;PTPRM;THOC1;RRN3;SOCS1;ARNTL;LFNG;PGK1;LUC7L;BAIAP2;COL5A2;SRF;HIF1AN;PDGFB;SDK1;FZD1;ENPP1;IL20;RIF1;GLIPR2;LRRN3;ERAP1;PDCL3;NEDD4L;ZFYVE27;BRCA2;TRAK2;WDPCP;FANCD2;MTMR2;CENPF;L1CAM;GPER1;SENP1;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;SHTN1;DPYSL3;RBBP5;CITED2;DDX56;CSF1;AP3B1;CLOCK;KIF14;PURB;TLR3;ESR1;PARD3;TNF;ATAD5;ZFP36L2;RC3H1;CD74;WDR36;PSMB10;PHF14;HIST1H4A;PHLPP1;PPARGC1B;ITGB1BP1;IRF1;IRAK3
4485,GO:0010501,0.00229662760977191,0.999448207665095,9,41,RNA secondary structure unwinding,BP,DDX17;DDX47;DDX28;DDX3X;DDX10;DDX24;DDX21;HELQ;DDX56
3632,GO:0008094,0.00233837849441261,0.999203482671337,14,79,DNA-dependent ATPase activity,MF,NBN;BRIP1;POLQ;G3BP1;RFC3;DDX3X;MCM6;TTF2;RAD18;MCM4;MSH6;MSH3;RAD51B;GTF2H3
4273,GO:0009628,0.00234388324373533,0.998424607947647,85,867,response to abiotic stimulus,BP,CRYAB;KRT13;PML;MAP3K14;GCLC;CTGF;CYP1A1;TSC22D3;TP53;EDN1;HMGCS1;RBM4;NQO1;CHP1;TGFB2;PDLIM1;RAD1;BAG1;NUP50;NUP153;RELB;BRIP1;CDK4;SFRP1;NUCKS1;ATP2B1;RPA1;PTGER4;ADM;NDC1;SLC1A3;MME;SUV39H2;RANBP2;TOPBP1;DDX3X;CDC25A;AJUBA;PGK1;NETO1;FEN1;SRF;MDM4;HIF1AN;BRCC3;NUP160;NUP54;EYA3;THBD;TNC;CNTNAP2;HSPA8;TMEM199;HSP90AB1;BRCA2;FANCD2;HSF2;CHEK1;RRM1;RAD18;ADAM17;ATR;PSME2;MSH6;CFLAR;PSMB9;EIF2B5;RFWD3;AKR1B1;CITED2;CCNA2;TIMELESS;CLOCK;TLR3;RAD51B;TNF;PSMB10;EIF2B1;DAXX;METAP2;TAF1;CDKN1A;USP1;IRF1;COPS3
10577,GO:0043527,0.00234445106528025,0.999922033593261,3,5,tRNA methyltransferase complex,CC,METTL1;TRMT61A;WDR4
6982,GO:0030643,0.00234815529973012,0.99994642164844,3,4,cellular phosphate ion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
15823,GO:0072501,0.00234815529973012,0.99994642164844,3,4,cellular divalent inorganic anion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
15824,GO:0072502,0.00234815529973012,0.99994642164844,3,4,cellular trivalent inorganic anion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
14995,GO:0070887,0.00241768049200952,0.998171880998744,184,2123,cellular response to chemical stimulus,BP,IL32;SAA1;HDAC9;MAP2;KRT13;FN1;PML;CYP1B1;MTUS1;MAP3K14;GCLC;TFRC;CYR61;CYP24A1;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;TRIM22;CTGF;HLA-B;MMP9;FBN1;XAF1;RUNX1;CYP1A1;IL1R2;FAT4;ACTG1;G6PD;MAT2A;DDX17;TRAF3;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;HMGCS1;PTPN14;NQO1;LGALS3;IFNGR1;AKAP8;TGFB2;RBM22;CYLD;IL27RA;IL16;IFIT3;IL6ST;HNRNPF;INHBA;IL7R;SYK;TJP2;LEPR;BRIP1;HLA-F;CDK4;SFRP1;NUCKS1;CD274;WNT10A;MCM2;MIR17HG;ATP2B1;COL4A1;AHR;KEAP1;DHFR;TPM1;TSN;PTGER4;TRAF1;CD109;CCL20;RRAGB;MME;GBP5;MYBL2;HSPB1;RHOG;WNT4;CXCL16;SUV39H2;LCP1;RAN;SOD2;DDX3X;IL24;SOCS1;PARP14;ARNTL;AJUBA;AKR1C2;ZC3H7B;PGK1;CDC42EP2;BAIAP2;COL5A2;SRF;GDAP1;MDM4;HIF1AN;NPNT;QDPR;PDGFB;FZD1;NFE2L1;CLU;ENPP1;BIRC3;IL20;PIK3R3;NFKBIB;EFTUD2;ZNF106;ACKR3;RIF1;SRD5A1;SRPRB;IFNAR1;APEX1;CXCR5;TNC;UMPS;HSPA8;TMEM199;HSP90AB1;ARL6IP5;ZFYVE27;PXMP2;SYNCRIP;DGCR8;FANCD2;POLR2F;IL12RB2;SERPINB9;GPER1;ADAM17;PSME2;CFLAR;PSMB9;UGT1A4;HNRNPDL;DPYSL3;NCBP1;MYNN;AKR1B1;TRAF2;CITED2;NCL;CCNA2;TIMELESS;IFI30;CSF1;CLOCK;TLR3;ESR1;PARD3;EHD1;TNF;ZFP36L2;SRSF7;RC3H1;CCL5;CD74;HNRNPU;PSMB10;DAXX;TAF1;SMARCC1;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;IRF1;GBP6;GPX4;IRAK3
19077,GO:1904894,0.00243305653332165,0.999405174853338,9,44,positive regulation of STAT cascade,BP,CYP1B1;IL6ST;IL7R;IL24;SOCS1;PARP14;IL20;AKR1B1;CCL5
409,GO:0001094,0.00245741850418838,0.999816163490095,4,9,TFIID-class transcription factor binding,MF,TP53;AHR;NOP58;ZNHIT6
301,GO:0000808,0.00247251863070934,0.999814712470577,4,9,origin recognition complex,CC,MCM2;ORC4;ORC1;ORC2
2453,GO:0005664,0.00247251863070934,0.999814712470577,4,9,nuclear origin of replication recognition complex,CC,MCM2;ORC4;ORC1;ORC2
15129,GO:0071166,0.00247426619976447,0.999009549049684,18,122,ribonucleoprotein complex localization,BP,SRSF2;NUP50;NUP153;NDC1;CASC3;AKAP8L;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
3334,GO:0007049,0.0024790625741517,0.998185387537203,141,1549,cell cycle,BP,PML;KIF23;MAP3K14;FGFR2;EPGN;CBX5;CTGF;CYP1A1;PBX1;TP53;DAPK3;EXO1;EDN1;CDKN2A;STAG1;AKAP8;TGFB2;CYLD;PKMYT1;SRSF2;RAD1;SLC9A3R1;INHBA;NUP50;NUP153;NAIP;ZFP42;GPR132;NBN;BRIP1;MCM5;CDK4;SFRP1;MCM2;TARDBP;USP16;AHR;DHFR;RPA1;HELLS;TAF2;POLA1;PARD3B;NDC1;DYNLL2;PLK2;RRAGB;RFC3;AKAP8L;MYBL2;WDR76;WNT4;SUV39H2;THOC1;RAN;RANBP2;TOPBP1;ANAPC15;ORC4;DDX3X;KLHL21;CDC25A;ARNTL;AJUBA;SMC2;LFNG;TRIM37;FEN1;MCM3;CDCA5;GADD45B;CDH13;PHACTR4;MDM4;MCM8;PDGFB;BRCC3;RTKN2;NUP160;NAA50;BIRC3;RRM2;NUP54;RIF1;MCM6;KLHL9;SETD2;ANLN;WEE1;APEX1;CXCR5;ORC1;MYBL1;HSPA8;HSP90AB1;PRIM2;BRCA2;CCAR1;SKA2;FANCD2;E2F8;CENPF;CHEK1;GPER1;RRM1;MCM4;ADAM17;ATR;PSME2;MSH6;CEP152;PSMC3IP;PSMB9;RFWD3;TPRA1;MSH3;CITED2;CCNA2;POLE3;TIMELESS;ORC2;RBL1;CLOCK;KIF14;PARD3;RAD51B;CENPN;TNF;ATAD5;ZFP36L2;NEDD9;TYMS;HNRNPU;RING1;FGFR1OP;PSMB10;TAF1;CDKN1A;IRF1;CTCF;CENPO
4590,GO:0010692,0.00248904263602351,0.999825914674355,4,8,regulation of alkaline phosphatase activity,BP,TGFB2;NPNT;TNF;PPARGC1B
11286,GO:0045577,0.00250800064493634,0.999615221043733,6,20,regulation of B cell differentiation,BP,CYLD;INHBA;SYK;SFRP1;MIR17HG;ZFP36L2
9844,GO:0042060,0.00252208029153824,0.998591228224798,40,346,wound healing,BP,SPRR3;KRT1;SAA1;NRG1;FN1;CYR61;FGFR2;CBX5;B4GALT1;ACTG1;TP53;EDN1;C1QTNF1;PABPC4;PDPN;TGFB2;SYK;H3F3A;TPM1;CSRP1;CD109;GGCX;CCL20;HSPB1;RHOG;WNT4;IL24;AJUBA;SRF;PDGFB;THBD;TNC;SYT11;HPS5;ADAM17;CFLAR;AP3B1;RAD51B;EHD1;IRF1
3460,GO:0007275,0.00252551817923929,0.998012581330733,283,3310,multicellular organism development,BP,CRYAB;MAFB;SPRR3;KRT1;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PML;CYP1B1;AMOT;JPH2;KRT2;TFRC;CYR61;C3;KRT15;FOSL2;TXNRD1;FGFR2;STAT5A;EPGN;STARD13;COL5A3;CTGF;MMP9;FBN1;VMP1;HSPG2;RUNX1;CYP1A1;FAT4;B4GALT1;PBX1;NEFM;G6PD;TSC22D3;FST;DDX17;TFCP2L1;KRTAP2-3;COL27A1;ENC1;DYNC2H1;MID1;TP53;DAPK3;TUFT1;EXO1;EDN1;HMGCS1;DOCK10;SIPA1L3;RBM19;KBTBD8;ACSL3;PTPN14;PABPC4;MEGF11;LGALS3;ACO1;PDPN;TGFB2;IRX2;CNTNAP1;CYLD;IL27RA;LRFN4;COL12A1;RAD1;IL6ST;SLC9A3R1;INHBA;IL7R;SYK;EMP2;TJP2;OLFML3;NAIP;ZFP42;RELB;NBN;LEPR;BRIP1;ARFRP1;CDK4;SFRP1;KRT9;GPCPD1;WNT10A;MCM2;MIR17HG;POLQ;H3F3A;ATP2B1;COL4A1;AHR;KEAP1;NAA15;TCHH;HRNR;DHFR;TPM1;HELLS;PTPRB;ULK4;ADAMTS9;PTGER4;OPHN1;ADM;IMMP2L;CD109;HERC6;SLC1A3;PLK2;SLCO4C1;MME;NEXN;HSPB1;RHOG;WNT4;LCP1;GPRIN1;PTPRM;KDM6A;THOC1;RAN;CORO1C;RAB26;RRN3;ITGAV;SOCS1;ARNTL;ODC1;ARMC6;DND1;ZNF267;KRT24;LFNG;PGK1;LUC7L;BAIAP2;GADD45B;WDR7;CDH13;COL5A2;GINS4;PHACTR4;SRF;HIF1AN;NPNT;QDPR;PDGFB;UGT8;KREMEN2;SDK1;FZD1;IRX4;NFE2L1;ANTXR1;RTKN2;CLU;SMYD2;ENPP1;FRAS1;IL20;EYA3;ACKR3;RIF1;SRD5A1;SETD2;GLIS2;ANLN;UBP1;GLIPR2;JPH1;WEE1;LRRN3;ERAP1;SLC11A2;BLOC1S2;PDCL3;CXCR5;TNC;CNTNAP2;TET3;UMPS;HSP90AB1;EPHB6;ZBTB24;MYH11;NEDD4L;SGK1;ZFYVE27;BRCA2;NAV2;TRAK2;KRT10;WDPCP;FANCD2;E2F8;MTMR2;CENPF;ETV6;L1CAM;CCDC47;RAB3GAP1;BBS5;GPER1;RRM1;RPTN;ADAM17;SENP1;ATR;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;EIF2B5;SHTN1;DPYSL3;EBP;CSRP2;AKR1B1;JRKL;TPRA1;MSH3;RBBP5;CITED2;MFAP5;NCL;CCNA2;DDX56;TIMELESS;CSF1;AP3B1;CLOCK;KIF14;PURB;TLR3;MPP5;ESR1;PARD3;GJC1;EHD1;TNF;ATAD5;ZFP36L2;RC3H1;TYMS;CD74;WDR36;HNRNPU;RING1;PSMB10;EIF2B1;DCTN5;PHF14;PHLPP2;HIST1H4A;TAF1;PHLPP1;FTO;NRAS;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;USP1;IRF1;GPX4;IRAK3;COPS3
1156,GO:0002761,0.00253285041218495,0.999170678424534,13,72,regulation of myeloid leukocyte differentiation,BP,MAFB;FBN1;RUNX1;INHBA;TJP2;SFRP1;IL20;LILRB3;CSF1;TLR3;TNF;CD74;PPARGC1B
2272,GO:0005201,0.00254912746643554,0.999389014488488,9,36,extracellular matrix structural constituent,MF,COL5A3;FBN1;COL27A1;TUFT1;COL12A1;COL4A1;COL5A2;MFAP5;MUC6
1282,GO:0003073,0.00258987595752727,0.999366281085185,9,41,regulation of systemic arterial blood pressure,BP,EDN1;C9ORF3;EMP2;TPM1;ADM;MME;SOD2;PDGFB;NAV2
10619,GO:0043588,0.00260939177081008,0.998677865521789,30,238,skin development,BP,SPRR3;KRT1;SPRR2A;KRT34;KRT4;TRIM16;KRT13;KRT2;KRT15;FOSL2;FGFR2;COL5A3;RUNX1;FST;KRTAP2-3;TGFB2;INHBA;KRT9;WNT10A;TCHH;HRNR;CD109;KRT24;COL5A2;SRF;FRAS1;IL20;KRT10;RPTN;TNF
6644,GO:0023026,0.00262791096293376,0.999789233303425,4,10,MHC class II protein complex binding,MF,HLA-DOB;HSPA8;HSP90AB1;CD74
2449,GO:0005657,0.00263391665040472,0.999176887422634,12,68,replication fork,CC,TP53;NBN;RPA1;POLA1;RFC3;MCM3;GINS4;PRIM2;RAD18;TIMELESS;PURB;RAD51B
12854,GO:0051145,0.00264821887078336,0.999419785923509,8,34,smooth muscle cell differentiation,BP,MKL1;FGFR2;ADM;WNT4;SRF;NPNT;PDGFB;GPER1
1454,GO:0003684,0.00266210085658782,0.99916913280975,12,66,damaged DNA binding,MF,TP53;RAD1;NBN;POLQ;RPA1;FEN1;APTX;APEX1;RAD18;MSH6;MSH3;GTF2H3
3659,GO:0008143,0.00269651759919839,0.999682182141569,5,14,poly(A) binding,MF,PABPC4;DDX3X;SYNCRIP;RBMS3;HNRNPU
11819,GO:0046685,0.00275371000814472,0.99946860754491,7,29,response to arsenic-containing substance,BP,NEFL;GCLC;CYP1A1;RBM4;DDX3X;DAXX;CDKN1A
1074,GO:0002637,0.00278301322563506,0.999382630943146,8,35,regulation of immunoglobulin production,BP,TFRC;IL27RA;THOC1;RIF1;MSH6;TRAF2;TNF;ATAD5
9024,GO:0035195,0.00279101771355189,0.99886404479168,18,134,gene silencing by miRNA,BP,RBM4;NUP50;NUP153;MIR17HG;H3F3A;NDC1;RAN;RANBP2;AJUBA;DND1;ZC3H7B;NUP160;NUP54;DGCR8;POLR2F;NCBP1;ESR1;HIST1H4A
986,GO:0002440,0.00279678444292782,0.998901161163321,17,114,production of molecular mediator of immune response,BP,TFRC;EXO1;TGFB2;IL27RA;IL7R;NBN;POLQ;THOC1;RIF1;MSH6;TRAF2;MSH3;TLR3;TNF;ATAD5;CD74;IRAK3
6313,GO:0019955,0.00281234966230523,0.999171688012869,11,58,cytokine binding,MF,TRIM16;IL1R2;GBP1;IFNGR1;PDPN;IL6ST;CD109;ITGAV;ACKR3;IFNAR1;CD74
228,GO:0000470,0.00286017283356866,0.999532090211116,6,24,maturation of LSU-rRNA,BP,NOP2;RPF2;NOL9;NSA2;RRP15;MAK16
2897,GO:0006405,0.0028712874452516,0.998800014201481,19,133,RNA export from nucleus,BP,SRSF2;NUP50;PHAX;NUP153;NDC1;CASC3;AKAP8L;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
920,GO:0002312,0.002921417348562,0.999198841120256,10,50,B cell activation involved in immune response,BP,TFRC;EXO1;DOCK10;IL27RA;NBN;THOC1;LFNG;RIF1;MSH6;ATAD5
4263,GO:0009605,0.00296094321133445,0.997862206206291,123,1341,response to external stimulus,BP,KRT1;SAA1;NRG1;C1R;PTGES;PML;AMOT;MTUS1;MAP3K14;GCLC;CYR61;C3;CYP24A1;NLRC5;FGFR2;TRIM22;SLC7A2;CYP1A1;IL1R2;G6PD;DDX17;TRIM56;TRAF3;TP53;EDN1;GBP1;HMGCS1;C1QTNF1;RBM4;ACSL3;NQO1;LGALS3;IFNGR1;PDPN;AKAP8;TGFB2;IKBKE;IL27RA;IL16;IFIT3;SRSF2;IL6ST;SYK;RAB32;FAM111A;BRIP1;CDK4;SFRP1;CD274;ATP2B1;SETDB1;PTGER4;ARRDC1-AS1;OPHN1;ADM;CD109;CADPS2;SLC1A3;CCL20;RRAGB;GBP5;HSPB1;RHOG;WNT4;CXCL16;PTPRM;DDX3X;IL24;ITGAV;ODC1;BAIAP2;CDH13;SRF;GDAP1;NPNT;PDGFB;CHID1;CLU;BIRC3;IL20;NFKBIB;ACKR3;SRD5A1;SETD2;THBD;ABCC9;IFNAR1;ERAP1;CXCR5;TNC;CNTNAP2;HSPA8;SYT11;DDX21;FANCD2;L1CAM;CHEK1;IL12RB2;SERPINB9;GPER1;HMGN2;ADAM17;NTN1;CMTM3;POLR3B;CSF1;CLOCK;TLR3;ESR1;DNASE1;TNF;TYMS;CCL5;CD74;METAP2;PANX1;TAF1;PHLPP1;NRAS;CDKN1A;IRF1;GBP6;IRAK3
10109,GO:0042609,0.00297325382049374,0.999892238151071,3,5,CD4 receptor binding,MF,SPG21;IL16;CD74
9,GO:0000018,0.00300399905614749,0.999107434240146,11,58,regulation of DNA recombination,BP,TFRC;IL27RA;IL7R;POLQ;THOC1;RIF1;SETD2;CHEK1;MSH6;MSH3;ATAD5
2898,GO:0006406,0.00301458999241241,0.998847859644666,16,103,mRNA export from nucleus,BP,SRSF2;NUP50;NUP153;NDC1;CASC3;AKAP8L;THOC1;RANBP2;NUP160;NUP54;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
15276,GO:0071427,0.00301458999241241,0.998847859644666,16,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,SRSF2;NUP50;NUP153;NDC1;CASC3;AKAP8L;THOC1;RANBP2;NUP160;NUP54;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
230,GO:0000478,0.00302108087900003,0.999626231422964,5,15,endonucleolytic cleavage involved in rRNA processing,BP,UTP20;TSR1;FCF1;BMS1;NOL9
4338,GO:0009888,0.00302581957709019,0.99783099102382,117,1231,tissue development,BP,SPRR3;KRT1;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;KRT13;FN1;PML;CYP1B1;JPH2;KRT2;CYR61;KRT15;FOSL2;TXNRD1;FGFR2;STARD13;CTGF;MMP9;RUNX1;CYP1A1;FAT4;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;KRTAP2-3;COL27A1;TUFT1;EDN1;SIPA1L3;KBTBD8;LGALS3;PDPN;TGFB2;IRX2;COL12A1;SLC9A3R1;INHBA;TJP2;CDK4;SFRP1;KRT9;RIPK4;GPCPD1;WNT10A;MIR17HG;COL4A1;KEAP1;TCHH;HRNR;TPM1;ADAMTS9;OPHN1;ADM;CD109;NEXN;WNT4;KDM6A;CORO1C;ATP2C1;ITGAV;ARNTL;AJUBA;AKR1C2;KRT24;LFNG;PGK1;LUC7L;COL5A2;PHACTR4;SRF;NPNT;PDGFB;FZD1;ENPP1;FRAS1;IL20;SETD2;GLIPR2;TJP1;TNC;MYH11;BRCA2;KRT10;WDPCP;E2F8;CENPF;BBS5;RPTN;ADAM17;NTN1;PSME2;CEP152;CFLAR;PSMB9;CITED2;TIMELESS;CSF1;CLOCK;MPP5;ESR1;GJC1;TNF;TYMS;HNRNPU;PSMB10;FTO;CDKN1A;ITGB1BP1;ASTN2
9925,GO:0042255,0.00304504080969503,0.99921356047336,9,54,ribosome assembly,BP,PPAN;MDN1;NOP2;DDX28;RRP7BP;DDX3X;MRTO4;RPF2;MRPS7
15190,GO:0071305,0.00305661201327055,0.999628826767258,5,14,cellular response to vitamin D,BP,CYP24A1;SFRP1;ATP2B1;GDAP1;TNC
962,GO:0002381,0.00311103690689555,0.999296922608469,8,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,TFRC;EXO1;IL27RA;NBN;THOC1;RIF1;MSH6;ATAD5
10367,GO:0043170,0.00315821603496521,0.997467534341,531,6855,macromolecule metabolic process,BP,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;C1R;TRIM16;FN1;TENM3;PML;CYP1B1;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;EPGN;TRIM22;CBX5;CTGF;UTP20;MMP9;FBN1;GNPTAB;HSPG2;RUNX1;CLN6;IL1R2;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;SPON1;TRIM56;OVCH2;TFCP2L1;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;EXO1;EDN1;TPST1;C9ORF3;GBP1;DDX47;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;SUGP2;P3H2;RAD1;IL6ST;HNRNPF;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;GALNT18;CAMK1G;PHAX;SYK;EMP2;NUP153;NAIP;ZFP42;RELB;NBN;TRIO;FAM111A;PARP15;BRIP1;MCM5;SHQ1;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;ZDHHC6;WNT10A;MCM2;TARDBP;MIR17HG;GEMIN4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;APOL6;KEAP1;NAA15;TRA2A;ZNF827;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;TSN;ADAMTS9;SETDB1;PTGER4;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;HERC6;HNRNPA1L2;FOXRED2;MDN1;EIF5;CASC3;CCL20;PLK2;ZNF512;MRPL27;MME;ZNF587;MUC16;UBQLN2;HSCB;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;EXOG;PTPRM;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ZNF738;DDX3X;NAP1L1;NUFIP1;CPA4;IL24;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;TRPM7;AJUBA;FASTKD3;UTP14A;DND1;ZNF267;RBMXL1;LFNG;ZC3H7B;PGK1;TRIM37;FEN1;MCM3;LUC7L;CDCA5;PPP4R4;GNL3L;ZNF586;YRDC;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;GINS4;RRP1;RARS;COMMD4;PHACTR4;SRF;MDM4;LUC7L2;USB1;HIF1AN;NPNT;WDR3;ZNF234;WDR43;MCM8;PDGFB;UTP18;BRCC3;CHID1;EIF3J;SGK494;FZD1;IRX4;UTY;NFE2L1;ANTXR1;ISG20L2;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;IL20;DDX10;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;ACKR3;RIF1;METTL16;TYW1;MCM6;KLHL9;SETD2;RRP36;GLIS2;RPF2;UBP1;UPK3B;TRMT5;TTF2;DTX4;GLIPR2;DPY19L2P2;SEPHS2;WEE1;ZNF484;THADA;ERAP1;APEX1;PDCL3;TNC;ZNF57;TET3;ORC1;MYBL1;HSPA8;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;ZBTB24;NSF;DNPEP;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;ANAPC7;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;SS18L2;KRT10;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;ADAM17;SENP1;RBMS3;ATR;PSME2;UBAP2L;MSH6;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;NFKBIE;TRMT61A;CBLL1;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;RRP15;RNF19B;RAD51B;USP11;FEM1C;DNASE1;TNF;WDR4;CAPN12;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;TEX10;RPS12;ZBTB9;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
6740,GO:0030155,0.00315985310841631,0.998115215130571,48,425,regulation of cell adhesion,BP,SAA1;FN1;PML;CYP1B1;MAP3K14;TFRC;CYR61;COL16A1;CCDC80;DAPK3;GBP1;C1QTNF1;CDKN2A;LGALS3;PDPN;TGFB2;CYLD;IL6ST;NUAK1;IL7R;SYK;EMP2;SFRP1;CD274;TPM1;WNT4;SIRPA;CORO1C;ITGAV;SOCS1;CDH13;SRF;NPNT;TNC;WDPCP;FAF1;MYO10;CBLL1;CITED2;CSF1;AP3B1;KIF14;TNF;RC3H1;CCL5;CD74;ITGB1BP1;IRF1
7172,GO:0031047,0.0031653249971721,0.998625104108983,20,155,gene silencing by RNA,BP,DDX17;RBM4;NUP50;NUP153;MIR17HG;H3F3A;TSN;NDC1;RAN;RANBP2;AJUBA;DND1;ZC3H7B;NUP160;NUP54;DGCR8;POLR2F;NCBP1;ESR1;HIST1H4A
999,GO:0002460,0.00319852848361824,0.998648659357597,19,135,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,C1R;TFRC;C3;EXO1;IL27RA;IL7R;EMP2;RELB;NBN;THOC1;CLU;RIF1;ADAM17;MSH6;TRAF2;TNF;ATAD5;RC3H1;CD74
12577,GO:0050710,0.0032099425409748,0.999362880241251,7,29,negative regulation of cytokine secretion,BP,FN1;PML;IL1R2;GBP1;PTGER4;SYT11;TNF
15187,GO:0071295,0.00321412647584008,0.999480969669288,6,20,cellular response to vitamin,BP,CYP24A1;BRIP1;SFRP1;ATP2B1;GDAP1;TNC
3677,GO:0008176,0.00323245770999472,1,2,2,tRNA (guanine-N7-)-methyltransferase activity,MF,METTL1;WDR4
17212,GO:0106004,0.00323245770999472,1,2,2,tRNA (guanine-N7)-methylation,BP,METTL1;WDR4
10111,GO:0042611,0.003235977173015,0.999705476663874,4,12,MHC protein complex,CC,HLA-B;HLA-F;HLA-DOB;CD74
12680,GO:0050865,0.00323908157620851,0.99822219282145,36,312,regulation of cell activation,BP,MAP3K14;GCLC;TFRC;CTGF;SLC7A2;RUNX1;C1QTNF1;LGALS3;PDPN;CYLD;IL27RA;IL6ST;INHBA;IL7R;SYK;SFRP1;CD274;MIR17HG;AHR;SIRPA;THOC1;SOCS1;PDGFB;RIF1;THBD;FANCD2;GPER1;MSH6;AP3B1;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;CDKN1A;IRF1
19788,GO:2000145,0.00329100647828409,0.997909795196557,61,572,regulation of cell motility,BP,IGFBP3;NRG1;HDAC9;FN1;CYP1B1;AMOT;MTUS1;CYR61;STAT5A;STARD13;MMP9;TP53;DAPK3;EDN1;DOCK10;LGALS3;PDPN;TGFB2;SLC9A3R1;EMP2;SFRP1;CD274;TPM1;ULK4;ADAMTS9;PTGER4;CCL20;PLK2;NEXN;HSPB1;WNT4;CXCL16;PTPRM;SOD2;CORO1C;IL24;ITGAV;AJUBA;CDH13;SRF;PDGFB;ACKR3;GLIPR2;APEX1;SGK1;CCAR1;WDPCP;GPER1;ADAM17;NTN1;CBLL1;SHTN1;DPYSL3;CITED2;CSF1;KIF14;TNF;CCL5;CD74;FGFR1OP;ITGB1BP1
11113,GO:0045111,0.00337952652223717,0.998694520267164,16,101,intermediate filament cytoskeleton,CC,KRT1;NEFL;KRT34;KRT4;KRT13;KRT2;KRT15;NEFM;KRTAP2-3;KRT9;DST;MDN1;KRT24;KRT10;GPER1;NOL9
12426,GO:0048856,0.00339655967220706,0.997295584109838,305,3619,anatomical structure development,BP,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PML;CYP1B1;AMOT;JPH2;KRT2;TFRC;CYR61;C3;KRT15;MKL1;FOSL2;TXNRD1;FGFR2;STAT5A;EPGN;STARD13;COL5A3;CTGF;MMP9;FBN1;VMP1;HSPG2;RUNX1;CYP1A1;ERVFRD-1;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TSC22D3;FST;DDX17;TFCP2L1;KRTAP2-3;COL27A1;ENC1;DYNC2H1;MID1;TP53;DAPK3;TUFT1;PANK2;EXO1;EDN1;GBP1;HMGCS1;DOCK10;SIPA1L3;RBM19;KBTBD8;RBM4;ACSL3;PTPN14;PABPC4;MEGF11;LGALS3;ACO1;PDPN;TGFB2;IRX2;CNTNAP1;CYLD;IL27RA;FOXD2;LRFN4;COL12A1;RAD1;IL6ST;SLC9A3R1;INHBA;IL7R;PALM2;SYK;EMP2;TJP2;OLFML3;NAIP;ZFP42;RELB;NBN;LEPR;BRIP1;ARFRP1;CDK4;SFRP1;KRT9;RIPK4;GPCPD1;WNT10A;MCM2;MIR17HG;POLQ;H3F3A;ATP2B1;COL4A1;AHR;KEAP1;NAA15;TCHH;HRNR;DHFR;TPM1;HELLS;PTPRB;ULK4;ADAMTS9;PTGER4;OPHN1;ADM;IMMP2L;CD109;HERC6;SLC1A3;PLK2;SLCO4C1;MME;NEXN;HSPB1;RHOG;WNT4;LCP1;GPRIN1;PTPRM;KDM6A;THOC1;RAN;CORO1C;ATP2C1;RAB26;RRN3;ITGAV;SOCS1;ARNTL;ODC1;AJUBA;ARMC6;DND1;ZNF267;AKR1C2;KRT24;LFNG;PGK1;LUC7L;CDC42EP2;BAIAP2;GADD45B;WDR7;CDH13;COL5A2;GINS4;PHACTR4;SRF;HIF1AN;NPNT;QDPR;PDGFB;UGT8;KREMEN2;SDK1;FZD1;IRX4;NFE2L1;ANTXR1;RTKN2;CLU;SMYD2;ENPP1;FRAS1;IL20;DDX10;EYA3;ACKR3;RIF1;FGD6;SRD5A1;SETD2;GLIS2;ANLN;UBP1;GLIPR2;JPH1;DPY19L2P2;WEE1;TJP1;LRRN3;ERAP1;SLC11A2;BLOC1S2;PDCL3;CXCR5;TNC;CNTNAP2;TET3;UMPS;HSP90AB1;EPHB6;ZBTB24;MYH11;NEDD4L;SGK1;ZFYVE27;BRCA2;NAV2;TRAK2;KRT10;WDPCP;FANCD2;E2F8;MTMR2;CENPF;ETV6;L1CAM;CCDC47;RAB3GAP1;BBS5;GPER1;RRM1;RPTN;ADAM17;MYO10;SENP1;ATR;NTN1;PSME2;MSH6;CEP152;LILRB3;CFLAR;PSMB9;EIF2B5;SHTN1;DPYSL3;EBP;CSRP2;AKR1B1;JRKL;TPRA1;MSH3;RBBP5;CITED2;MFAP5;NCL;CCNA2;DDX56;TIMELESS;CSF1;AP3B1;CLOCK;KIF14;PURB;TLR3;MPP5;ESR1;PARD3;GJC1;EHD1;TNF;ATAD5;ZFP36L2;RC3H1;TYMS;CD74;WDR36;HNRNPU;RING1;PSMB10;EIF2B1;DCTN5;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;PHLPP1;FTO;NRAS;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;USP1;IRF1;ASTN2;GPX4;IRAK3;COPS3
7852,GO:0032405,0.00343826697337583,0.999868610888949,3,5,MutLalpha complex binding,MF,ATR;MSH6;TREX1
8023,GO:0032650,0.00351332585586254,0.999839982948786,3,6,regulation of interleukin-1 alpha production,BP,IL1R2;CCL20;PANX1
2902,GO:0006412,0.00352180384933974,0.997765553323245,59,654,translation,BP,ENC1;DAPK3;ABCF1;KBTBD8;RBM4;GEMIN5;PABPC4;ACO1;CARS2;CDKAL1;NUP50;PUM3;NUP153;CDK4;MIR17HG;H3F3A;USP16;DHFR;NDC1;EIF5;CASC3;MRPL27;HSPB1;RAN;RANBP2;DDX3X;MRTO4;AJUBA;FASTKD3;DND1;GATC;RARS;EIF3J;NUP160;NUP54;LRPPRC;EFTUD2;METTL16;SYNCRIP;POLR2F;RBMS3;EIF2B5;MRPS7;DPH2;NCBP1;UPF3B;HNRNPR;NCL;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;EIF2B1;HIST1H4A;RBM8A;GTF2H3;RPS12
14,GO:0000027,0.0035839318291822,0.999377530137768,6,26,ribosomal large subunit assembly,BP,PPAN;MDN1;NOP2;DDX28;MRTO4;RPF2
6739,GO:0030154,0.003588604694954,0.997208624228109,220,2526,cell differentiation,BP,IGFBP3;MAFB;SPRR3;KRT1;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TENM3;PML;AMOT;KRT2;TFRC;CYR61;KRT15;CYP24A1;MKL1;FOSL2;FGFR2;CTGF;MMP9;FBN1;HSPG2;RUNX1;CYP1A1;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;FST;DDX17;TFCP2L1;KRTAP2-3;COL27A1;ENC1;TP53;DAPK3;PANK2;EDN1;GBP1;DOCK10;SIPA1L3;KBTBD8;RBM4;PABPC4;LGALS3;PDPN;TGFB2;CNTNAP1;CYLD;FOXD2;LRFN4;COL12A1;IL6ST;SLC9A3R1;INHBA;IL7R;SYK;EMP2;TJP2;RAB32;RELB;LEPR;TRIO;BRIP1;SFRP1;KRT9;WNT10A;MIR17HG;H3F3A;COL4A1;KEAP1;NAA15;TCHH;HRNR;DHFR;TPM1;ULK4;ADAMTS9;PTGER4;OPHN1;ADM;CD109;HERC6;SLC1A3;PLK2;SLCO4C1;NEXN;FRK;MYBL2;RHOG;WNT4;SUV39H2;GPRIN1;PTPRM;KDM6A;RAN;CORO1C;ARHGEF28;RRN3;ITGAV;SOCS1;ARNTL;ARMC6;DND1;AKR1C2;KRT24;LFNG;PGK1;BAIAP2;GADD45B;WDR7;COL5A2;PHACTR4;SRF;HIF1AN;NPNT;PDGFB;UGT8;SDK1;FZD1;NFE2L1;ANTXR1;CLU;ENPP1;IL20;EYA3;TPM4;ACKR3;SRD5A1;SETD2;GLIS2;ANLN;GLIPR2;DPY19L2P2;WEE1;TJP1;ERAP1;SLC11A2;BLOC1S2;TNC;CNTNAP2;MYBL1;HSP90AB1;DDX21;EPHB6;ZBTB24;MYH11;NEDD4L;SGK1;ZFYVE27;BRCA2;SYNCRIP;TRAK2;KRT10;WDPCP;FANCD2;E2F8;MTMR2;CENPF;ETV6;L1CAM;STEAP4;CCDC47;GPER1;RPTN;ADAM17;SENP1;NTN1;PSME2;CEP152;LILRB3;CFLAR;PSMB9;EIF2B5;ABCA5;SHTN1;DPYSL3;CSRP2;RBBP5;CITED2;DDX56;CSF1;AP3B1;RBL1;CLOCK;KIF14;PURB;TLR3;MPP5;ESR1;PARD3;GJC1;EHD1;TNF;ZFP36L2;RC3H1;TYMS;CD74;WDR36;HNRNPU;PSMB10;EIF2B1;HIST1H4A;TBPL1;SPIB;FTO;NRAS;PPARGC1B;CDKN1A;ITGB1BP1;IRF1
15243,GO:0071379,0.00363708673164676,0.999539546428656,5,14,cellular response to prostaglandin stimulus,BP,AKAP8;SFRP1;PTGER4;AKR1C2;TNC
6963,GO:0030595,0.00370468414768155,0.998596984128517,15,104,leukocyte chemotaxis,BP,SAA1;MTUS1;EDN1;LGALS3;TGFB2;IL16;SYK;CCL20;CXCL16;PDGFB;CXCR5;ADAM17;CSF1;CCL5;CD74
1595,GO:0004004,0.00373610613942111,0.998855050244416,11,59,ATP-dependent RNA helicase activity,MF,DDX17;DDX47;G3BP1;DDX28;DDX3X;DDX10;DDX24;DDX21;HELQ;DDX56;DHX15
7932,GO:0032501,0.00376117689863024,0.996978643852081,346,4183,multicellular organismal process,BP,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;SAA1;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PML;CYP1B1;AMOT;JPH2;GCLC;KRT2;TFRC;CYR61;C3;KRT15;CYP24A1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;STARD13;CBX5;COL5A3;S100P;CTGF;MMP9;FBN1;VMP1;HSPG2;SLC7A2;RUNX1;CYP1A1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;SPACA6;TSC22D3;FST;DDX17;TRIM56;TFCP2L1;KRTAP2-3;TRAF3;COL27A1;ENC1;DYNC2H1;MID1;TP53;DAPK3;TUFT1;PANK2;EXO1;EDN1;C9ORF3;GBP1;HMGCS1;DOCK10;SIPA1L3;C1QTNF1;RBM19;KBTBD8;RBM4;ACSL3;PTPN14;PABPC4;MEGF11;LGALS3;ACO1;PDPN;AKAP8;TGFB2;IRX2;CNTNAP1;CYLD;IKBKE;IL27RA;LRFN4;COL12A1;RAD1;IL6ST;SLC9A3R1;INHBA;IL7R;SLC22A5;SYK;EMP2;TJP2;OLFML3;NAIP;ZFP42;RELB;NBN;LEPR;BRIP1;ARFRP1;CDK4;SFRP1;KRT9;GPCPD1;CD274;WNT10A;MCM2;MIR17HG;POLQ;H3F3A;ATP2B1;COL4A1;AHR;KEAP1;NAA15;TCHH;HRNR;DHFR;TPM1;HELLS;CSRP1;PTPRB;ULK4;ADAMTS9;PTGER4;OPHN1;ADM;MGAM;IMMP2L;CD109;GGCX;NDC1;HERC6;SLC1A3;CCL20;PLK2;SLCO4C1;MME;NEXN;GBP5;BTN2A1;HSPB1;RHOG;WNT4;LCP1;GPRIN1;PTPRM;KDM6A;THOC1;RAN;SOD2;CORO1C;DDX3X;RAB26;RRN3;ITGAV;SOCS1;ARNTL;ODC1;ARMC6;DND1;ZNF267;AKR1C2;KRT24;LFNG;PGK1;NETO1;FEN1;LUC7L;BAIAP2;GADD45B;WDR7;CDH13;COL5A2;GINS4;PHACTR4;SRF;HIF1AN;NPNT;QDPR;MCM8;PDGFB;UGT8;CHID1;KREMEN2;SDK1;FZD1;IRX4;NFE2L1;ANTXR1;RTKN2;CLU;SMYD2;ENPP1;BIRC3;FRAS1;IL20;EYA3;TPM4;ACKR3;RIF1;SRD5A1;SETD2;GLIS2;ANLN;UBP1;THBD;ABCC9;DTX4;GLIPR2;JPH1;DPY19L2P2;WEE1;LRRN3;ERAP1;SLC11A2;BLOC1S2;PDCL3;CXCR5;TNC;CNTNAP2;TET3;UMPS;MYBL1;SYT11;HSP90AB1;DDX21;EPHB6;ZBTB24;MYH11;NEDD4L;SGK1;ZFYVE27;BRCA2;HPS5;SYNCRIP;NAV2;TRAK2;KRT10;WDPCP;FANCD2;E2F8;MTMR2;CENPF;ETV6;L1CAM;HSF2;POLR2F;CCDC47;RAB3GAP1;IL12RB2;BBS5;GPER1;RRM1;RPTN;ADAM17;SENP1;ATR;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;EIF2B5;ABCA5;SHTN1;DPYSL3;EBP;CSRP2;AKR1B1;JRKL;TRAF2;TPRA1;MSH3;RBBP5;CITED2;MFAP5;POLR3B;NCL;CCNA2;DDX56;TIMELESS;CSF1;AP3B1;CLOCK;KIF14;PURB;TLR3;MPP5;ESR1;PARD3;GJC1;RAD51B;EHD1;TNF;ATAD5;ZFP36L2;RC3H1;TYMS;CD74;WDR36;HNRNPU;RING1;PSMB10;EIF2B1;DCTN5;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;PHLPP1;FTO;CCDC50;NRAS;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;IRF1;DIAPH3;NDUFB9;GPX4;IRAK3;COPS3
6785,GO:0030216,0.00376198842181677,0.998343156126642,20,149,keratinocyte differentiation,BP,SPRR3;KRT1;SPRR2A;KRT34;KRT4;TRIM16;KRT13;KRT2;KRT15;FOSL2;RUNX1;KRTAP2-3;KRT9;TCHH;HRNR;CD109;KRT24;IL20;KRT10;RPTN
414,GO:0001101,0.00381794145834181,0.998060110400884,28,226,response to acid chemical,BP,TRIM16;KRT13;PTGES;GCLC;COL16A1;FGFR2;CTGF;TP53;EDN1;NQO1;AKAP8;NAIP;CDK4;SFRP1;COL4A1;DHFR;PTGER4;RRAGB;SOCS1;AKR1C2;BAIAP2;COL5A2;GDAP1;PDGFB;TNC;AKR1B1;TNF;TYMS
16674,GO:0097530,0.00387739925943676,0.998878386733096,10,57,granulocyte migration,BP,SAA1;EDN1;LGALS3;TGFB2;SYK;PTGER4;CCL20;CSF1;CCL5;CD74
2892,GO:0006400,0.00390701614404543,0.998708112086242,12,74,tRNA modification,BP,CDKAL1;PUS3;THUMPD3;METTL1;URM1;YRDC;TRMT5;SEPHS2;THADA;TRMT1;TRMT61A;WDR4
1863,GO:0004523,0.00392866121185124,0.999813648022197,3,6,RNA-DNA hybrid ribonuclease activity,MF,EXO1;FEN1;APEX1
9033,GO:0035239,0.0039340318721348,0.997500348420429,59,539,tube morphogenesis,BP,KRT1;HDAC9;FN1;PML;CYP1B1;AMOT;CYR61;C3;FGFR2;EPGN;STARD13;CTGF;HSPG2;RUNX1;FAT4;B4GALT1;PBX1;EDN1;TGFB2;IRX2;SYK;EMP2;LEPR;SFRP1;COL4A1;NAA15;PTPRB;ADAMTS9;ADM;PLK2;HSPB1;WNT4;PTPRM;KDM6A;ITGAV;PGK1;CDH13;PHACTR4;SRF;HIF1AN;NPNT;FZD1;ACKR3;SETD2;UBP1;ERAP1;PDCL3;TNC;E2F8;BBS5;NTN1;NCL;TIMELESS;CSF1;TLR3;ESR1;GJC1;TNF;ITGB1BP1
12159,GO:0048246,0.00394324578203127,0.99945553579922,5,18,macrophage chemotaxis,BP,SAA1;MTUS1;LGALS3;CSF1;CCL5
15395,GO:0071621,0.00395254015070478,0.998947021226412,9,49,granulocyte chemotaxis,BP,SAA1;EDN1;LGALS3;TGFB2;SYK;CCL20;CSF1;CCL5;CD74
14679,GO:0070266,0.0039904127707546,0.999171058777841,7,30,necroptotic process,BP,CYLD;TRPM7;BIRC3;CFLAR;TRAF2;TLR3;TNF
9070,GO:0035295,0.00408852949328098,0.997305117364381,69,654,tube development,BP,KRT1;HDAC9;FN1;TNS3;PML;CYP1B1;AMOT;CYR61;C3;FGFR2;EPGN;STARD13;CTGF;HSPG2;RUNX1;CYP1A1;FAT4;B4GALT1;PBX1;EDN1;PDPN;TGFB2;IRX2;SYK;EMP2;LEPR;BRIP1;SFRP1;MIR17HG;COL4A1;NAA15;PTPRB;ADAMTS9;ADM;PLK2;HSPB1;WNT4;PTPRM;KDM6A;ITGAV;PGK1;CDH13;PHACTR4;SRF;HIF1AN;NPNT;FZD1;ACKR3;SETD2;UBP1;ERAP1;PDCL3;TNC;E2F8;BBS5;NTN1;AKR1B1;CITED2;NCL;TIMELESS;CSF1;TLR3;ESR1;GJC1;TNF;TYMS;PHF14;CDKN1A;ITGB1BP1
996,GO:0002455,0.00411906288029039,0.999432728234604,5,17,humoral immune response mediated by circulating immunoglobulin,BP,C1R;C3;EXO1;CLU;TNF
2841,GO:0006310,0.00412452120927292,0.997921296701209,27,215,DNA recombination,BP,TFRC;EXO1;IL27RA;IL7R;NBN;BRIP1;NUCKS1;POLQ;RPA1;TSN;THOC1;FEN1;GINS4;MCM8;RIF1;SETD2;APEX1;HELQ;BRCA2;CHEK1;MSH6;PSMC3IP;RFWD3;MSH3;RAD51B;ATAD5;TREX1
1471,GO:0003724,0.00426170012198569,0.998668401150531,11,60,RNA helicase activity,MF,DDX17;DDX47;G3BP1;DDX28;DDX3X;DDX10;DDX24;DDX21;HELQ;DDX56;DHX15
12869,GO:0051168,0.00427019461299968,0.997939761667844,24,187,nuclear export,BP,TP53;PTPN14;CHP1;RBM22;SRSF2;NUP50;PHAX;NUP153;LSG1;NDC1;CASC3;AKAP8L;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
3682,GO:0008186,0.00428790347292087,0.998659094987093,11,60,RNA-dependent ATPase activity,MF,DDX17;DDX47;G3BP1;DDX28;DDX3X;DDX10;DDX24;DDX21;HELQ;DDX56;DHX15
4350,GO:0009913,0.00431922698666825,0.997948974621868,23,181,epidermal cell differentiation,BP,SPRR3;KRT1;SPRR2A;KRT34;KRT4;TRIM16;KRT13;KRT2;KRT15;FOSL2;RUNX1;KRTAP2-3;SLC9A3R1;KRT9;KEAP1;TCHH;HRNR;CD109;KRT24;IL20;KRT10;WDPCP;RPTN
6270,GO:0019860,0.00434133746502014,1,2,2,uracil metabolic process,BP,DPYD;TYMS
1175,GO:0002819,0.00444027785957578,0.998429110903299,13,82,regulation of adaptive immune response,BP,TFRC;C3;IL27RA;IL6ST;IL7R;THOC1;RIF1;MSH6;TRAF2;TNF;ATAD5;RC3H1;IRF1
10896,GO:0044427,0.00444838278582647,0.997017282305541,73,772,chromosomal part,CC,PML;CBX5;ENC1;TP53;CDKN2A;STAG1;RAD1;ZFP42;NBN;FAM111A;MCM5;CDK4;NUCKS1;MCM2;H3F3A;RPA1;HELLS;POLA1;PLK2;RFC3;AKAP8L;MYBL2;SUV39H2;KDM6A;THOC1;RAN;ORC4;NUFIP1;SMC2;FEN1;MCM3;CDCA5;APTX;GINS4;SRF;UTY;NUP160;RIF1;MCM6;APEX1;ORC1;PRIM2;BRCA2;SKA2;CENPF;CHEK1;HMGN2;RAD18;MCM4;ATR;MSH6;RFWD3;TELO2;CITED2;POLE3;TIMELESS;ORC2;RBL1;MPHOSPH8;PURB;ESR1;RAD51B;CENPN;HNRNPU;RING1;DAXX;DCTN5;HIST1H4A;TAF1;SMARCC1;IRF1;CTCF;CENPO
4370,GO:0009986,0.0044487199068632,0.997390678019011,42,374,cell surface,CC,CRYAB;NRG1;KRT4;AMOT;TFRC;FGFR2;HLA-B;B4GALT1;LRFN4;IL6ST;IL7R;EMP2;HLA-F;SFRP1;CD274;LAYN;ADAMTS9;CD109;SLC1A3;BTN2A1;WNT4;ITGAV;CDH13;APMAP;PDGFB;FZD1;ANTXR1;CLU;ENPP1;ACKR3;THBD;SLC11A2;CXCR5;CNTNAP2;HSP90AB1;BACE2;L1CAM;IL12RB2;ADAM17;TNF;CD74;HNRNPU
11802,GO:0046649,0.00446920497499683,0.997358823254434,43,394,lymphocyte activation,BP,MAFB;HDAC9;MAP3K14;TFRC;RUNX1;EXO1;DOCK10;LGALS3;CYLD;IL27RA;IL6ST;INHBA;IL7R;SYK;RELB;NBN;LEPR;SFRP1;CD274;MIR17HG;AHR;HELLS;PTGER4;WNT4;LCP1;SIRPA;THOC1;SOCS1;LFNG;SRF;RIF1;CXCR5;FANCD2;ADAM17;MSH6;AP3B1;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;CDKN1A;IRF1
10303,GO:0043043,0.00448335565909191,0.997110308069388,60,673,peptide biosynthetic process,BP,GCLC;ENC1;DAPK3;ABCF1;KBTBD8;RBM4;GEMIN5;PABPC4;ACO1;CARS2;CDKAL1;NUP50;PUM3;NUP153;CDK4;MIR17HG;H3F3A;USP16;DHFR;NDC1;EIF5;CASC3;MRPL27;HSPB1;RAN;RANBP2;DDX3X;MRTO4;AJUBA;FASTKD3;DND1;GATC;RARS;EIF3J;NUP160;NUP54;LRPPRC;EFTUD2;METTL16;SYNCRIP;POLR2F;RBMS3;EIF2B5;MRPS7;DPH2;NCBP1;UPF3B;HNRNPR;NCL;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;EIF2B1;HIST1H4A;RBM8A;GTF2H3;RPS12
16838,GO:0098687,0.00454159907245894,0.997472308626356,35,312,chromosomal region,CC,PML;CBX5;STAG1;NBN;MCM5;MCM2;H3F3A;RPA1;HELLS;SUV39H2;THOC1;ORC4;FEN1;MCM3;CDCA5;NUP160;RIF1;MCM6;APEX1;ORC1;BRCA2;SKA2;CENPF;CHEK1;MCM4;ATR;TELO2;ORC2;CENPN;HNRNPU;DAXX;DCTN5;HIST1H4A;CTCF;CENPO
11415,GO:0045787,0.00455510152840515,0.997466522438549,35,303,positive regulation of cell cycle,BP,PML;KIF23;FGFR2;EPGN;CTGF;CYP1A1;PBX1;TP53;EDN1;TGFB2;CDK4;PLK2;WNT4;THOC1;RANBP2;DDX3X;CDC25A;LFNG;FEN1;CDCA5;MDM4;PDGFB;APEX1;CXCR5;HSP90AB1;BRCA2;E2F8;CHEK1;GPER1;ADAM17;CITED2;KIF14;RAD51B;HNRNPU;CDKN1A
11106,GO:0045095,0.0046230467368061,0.999164458817046,6,24,keratin filament,CC,KRT1;KRT4;KRT13;KRT2;KRTAP2-3;GPER1
14449,GO:0061741,0.00470731206220381,1,2,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,CLU;HSPA8
11211,GO:0045321,0.00471093987957989,0.996825596696368,74,770,leukocyte activation,BP,MAFB;KRT1;FTL;FTH1;HDAC9;MAP3K14;TFRC;C3;S100P;MMP9;SLC7A2;RUNX1;B4GALT1;EXO1;EDN1;DOCK10;LGALS3;CYLD;IL27RA;IL6ST;INHBA;IL7R;SYK;RELB;NBN;LEPR;SFRP1;CD274;MIR17HG;AHR;HRNR;HELLS;PTPRB;PTGER4;MGAM;SLCO4C1;MME;FRK;RHOG;WNT4;LCP1;SIRPA;THOC1;DDX3X;ITGAV;SOCS1;QPCT;LFNG;SRF;CLU;COMMD9;RIF1;CXCR5;HSPA8;HSP90AB1;LAIR1;FANCD2;GPER1;ADAM17;MSH6;LILRB3;CSF1;AP3B1;GLIPR1;TLR3;DNASE1;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;NRAS;CDKN1A;IRF1
5590,GO:0016605,0.00474264435515506,0.998237152785242,14,86,PML body,CC,TRIM16;PML;CBX5;TP53;DAPK3;IKBKE;NBN;RPA1;AKAP8L;TOPBP1;ARNTL;ATR;RFWD3;DAXX
15504,GO:0071840,0.00478602869362747,0.99611943840491,384,4810,cellular component organization or biogenesis,BP,CRYAB;IGFBP3;NEFL;NRG1;HDAC9;KRT4;TRIM16;MAP2;KRT13;FN1;TENM3;PML;CYP1B1;KIF23;AMOT;GCLC;KRT2;TFRC;CYR61;C3;KRT15;COL16A1;FGFR2;EPGN;SACS;TRIM22;COL5A3;CTGF;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;RUNX1;MYO1B;ERVFRD-1;CLN6;FAT4;B4GALT1;ACTG1;NEFM;G6PD;SPACA6;MAT2A;DDX17;TFCP2L1;CCDC80;COL27A1;ENC1;DYNC2H1;MID1;TP53;DAPK3;PANK2;EXO1;EDN1;GBP1;DOCK10;DDX47;SIPA1L3;C1QTNF1;CDKN2A;ACSL3;GEMIN5;STAG1;COBLL1;LGALS3;CHP1;PDPN;AKAP8;PPAN;TGFB2;CNTNAP1;RBM22;CYLD;IKBKE;PKMYT1;TGS1;LRFN4;COL12A1;RAD1;SLC9A3R1;PDCD11;DKC1;INHBA;IL7R;NUP50;PALM2;DNHD1;SYK;EMP2;NUP153;NAIP;RAB32;NBN;BRIP1;MCM5;SHQ1;UTP15;CDK4;SFRP1;VPS41;KRT9;NUCKS1;HEATR1;MCM2;TARDBP;GEMIN4;DST;VPS8;POLQ;TSR1;H3F3A;COL4A1;USP16;HRNR;DHFR;RPA1;TPM1;HELLS;TAF2;ULK4;POLA1;ABCC4;REEP1;ADAMTS9;KCNS3;SETDB1;PTGER4;TK1;TMEM97;LSG1;G3BP1;GRWD1;TRAF1;PARD3B;OPHN1;ADM;IMMP2L;NDC1;CADPS2;DYNLL2;MDN1;SLC1A3;SYNPO2L;PLK2;MRPL27;UBQLN2;NEXN;HSCB;GBP5;KANK4;RFC3;AKAP8L;MYBL2;NOP58;RHOG;WNT4;CXCL16;NOP2;SUV39H2;LCP1;GPRIN1;PTPRM;SIRPA;KDM6A;DDX28;SETD4;RAN;UBTF;RRP7BP;RANBP2;ANAPC15;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;NAP1L1;NUFIP1;CPA4;GPHN;RRN3;ITGAV;SET;MRTO4;SNX11;TRPM7;AJUBA;SMC2;FASTKD3;CGNL1;UTP14A;SNX5;TRIM37;FEN1;LUC7L;CDC42EP2;CDCA5;GNL3L;BAIAP2;NVL;CDH13;COL5A2;GINS4;IBA57;RRP1;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;NPNT;WDR3;WDR43;PDGFB;UGT8;UTP18;BRCC3;SDK1;FZD1;TBC1D15;UTY;ANTXR1;RTKN2;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;NAA50;ENPP1;BIRC3;NUP54;EYA3;TPM4;RIF1;METTL16;MCM6;FGD6;SETD2;RRP36;ANLN;TIMM23B;RPF2;URB2;WEE1;TJP1;LRRN3;KCTD3;SLC11A2;BLOC1S2;APEX1;TNC;CNTNAP2;TET3;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;NSF;MYH11;NEDD4L;SGK1;M6PR;PRIM2;ZFYVE27;TMEM138;BRCA2;HPS5;GEMIN8;TRAK2;LIMCH1;SKA2;WDPCP;FANCD2;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;L1CAM;CCDC47;FCF1;RAB3GAP1;LNX2;CHEK1;SRFBP1;BBS5;GPER1;FAF1;RRM1;WDR75;BMS1;MCM4;ADAM17;MYO10;ATR;NTN1;MSH6;CEP152;CFLAR;PSMC3IP;NIFK;NOL9;ABCA5;NOL11;CBLL1;SHTN1;DPYSL3;TAF6L;MRPS7;NCBP1;UBE2J2;VPS36;TRAF2;MSH3;TELO2;RBBP5;MFAP5;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TAP2;UQCRB;AP3B1;RBL1;CLOCK;NSA2;KIF14;MPP5;SYNPO2;ESR1;PARD3;GJC1;NOP16;RRP15;RAD51B;EHD1;CENPN;ARV1;TNF;PDSS1;NEDD9;RC3H1;STARD7;CCL5;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;DAXX;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;ZNHIT6;NRAS;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;CTCF;TSGA13;DIAPH3;GTF2H3;NDUFB9;TEX10;RPS12;CENPO;GPX4;IRAK3;COPS3
15252,GO:0071392,0.00480206161579965,0.999131803248502,6,23,cellular response to estradiol stimulus,BP,SFRP1;SRD5A1;GPER1;CFLAR;CCNA2;ESR1
403,GO:0001083,0.00481406714745204,0.999791834285593,3,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,TP53;TAF2;TAF1
1024,GO:0002521,0.004823853986711,0.997307612355348,35,300,leukocyte differentiation,BP,MAFB;HDAC9;TFRC;MMP9;FBN1;RUNX1;DOCK10;CYLD;INHBA;IL7R;SYK;TJP2;RELB;LEPR;SFRP1;MIR17HG;PTGER4;CD109;WNT4;SOCS1;LFNG;SRF;IL20;FANCD2;ADAM17;LILRB3;CSF1;AP3B1;TLR3;TNF;ZFP36L2;RC3H1;CD74;PPARGC1B;IRF1
7008,GO:0030687,0.00483265311810203,0.999118398811226,6,24,preribosome, large subunit precursor,CC,PPAN;MDN1;RRP1;NSA2;RRP15;MAK16
7909,GO:0032472,0.00484597765587964,1,2,2,Golgi calcium ion transport,BP,ATP2C1;TMEM165
17793,GO:1901796,0.00493216482106291,0.997721898555241,21,161,regulation of signal transduction by p53 class mediator,BP,PML;TP53;EXO1;RAD1;NUAK1;NBN;BRIP1;RPA1;TAF2;RFC3;NOP2;TOPBP1;SUPT16H;RRN3;MDM4;SMYD2;RPF2;CHEK1;ATR;CD74;TAF1
221,GO:0000460,0.00493387778965508,0.998919291104044,7,33,maturation of 5.8S rRNA,BP,UTP20;PDCD11;FCF1;NOL9;NSA2;RRP15;MAK16
6768,GO:0030198,0.00493610750325978,0.99744864556152,28,213,extracellular matrix organization,BP,FN1;CYP1B1;CYR61;COL16A1;COL5A3;CTGF;MMP9;FBN1;HSPG2;B4GALT1;CCDC80;COL27A1;PDPN;TGFB2;COL12A1;COL4A1;ADAMTS9;LCP1;ITGAV;COL5A2;NPNT;PDGFB;ANTXR1;TNC;MYH11;CFLAR;MFAP5;TNF
7998,GO:0032610,0.00494036386072083,0.999719450795148,3,7,interleukin-1 alpha production,BP,IL1R2;CCL20;PANX1
3051,GO:0006611,0.00496907022407545,0.997656951227414,22,170,protein export from nucleus,BP,TP53;PTPN14;CHP1;RBM22;SRSF2;NUP50;NUP153;NDC1;CASC3;AKAP8L;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
11430,GO:0045823,0.00499485443615211,0.999279381476532,5,17,positive regulation of heart contraction,BP,CTGF;EDN1;TGFB2;TPM1;ADM
718,GO:0001940,0.00501796472072455,0.999779663967917,3,5,male pronucleus,CC,RIF1;TET3;CCNA2
11159,GO:0045191,0.00503743275434668,0.999080010810265,6,23,regulation of isotype switching,BP,TFRC;IL27RA;THOC1;RIF1;MSH6;ATAD5
2861,GO:0006353,0.00503757804017984,0.998023009621671,15,107,DNA-templated transcription, termination,BP,SRSF2;POLR1A;CASC3;THOC1;UBTF;TAF1D;TTF2;MAZ;POLR2F;NCBP1;UPF3B;POLR1E;SRSF7;RBM8A;GTF2H3
16445,GO:0097064,0.00506012808755407,0.998749069237402,8,37,ncRNA export from nucleus,BP,NUP50;PHAX;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
532,GO:0001650,0.00506229367421669,0.997883469638367,17,118,fibrillar center,CC,MAP3K14;TXNRD1;TFCP2L1;NUAK1;DKC1;FAM111A;UTP15;HEATR1;NOP58;UBTF;NUFIP1;WDR43;POLR2F;NFKBIE;POLR1E;NOP56;PSPC1
889,GO:0002252,0.00509997961253949,0.996569308206619,72,753,immune effector process,BP,KRT1;FTL;FTH1;C1R;PML;MAP3K14;TFRC;C3;NLRC5;TRIM22;S100P;MMP9;B4GALT1;ACTG1;DDX17;TRIM56;TRAF3;EXO1;GBP1;DOCK10;LGALS3;TGFB2;IL27RA;IFIT3;IL7R;SYK;EMP2;RELB;NBN;FAM111A;HRNR;PTPRB;PTGER4;MGAM;SLCO4C1;MME;FRK;RHOG;LCP1;SIRPA;THOC1;DDX3X;ITGAV;QPCT;LFNG;BAIAP2;CLU;BIRC3;COMMD9;RIF1;SETD2;ABCC9;HSPA8;HSP90AB1;LAIR1;SERPINB9;ADAM17;MYO10;MSH6;LILRB3;TRAF2;POLR3B;GLIPR1;TLR3;DNASE1;TNF;ATAD5;RC3H1;CD74;NRAS;IRF1;IRAK3
2236,GO:0005138,0.00510363824109581,0.99973359965142,3,6,interleukin-6 receptor binding,MF,IL6ST;ERAP1;ADAM17
6282,GO:0019883,0.00510857043718381,0.999485435370297,4,11,antigen processing and presentation of endogenous antigen,BP,TAP1;ERAP1;TAP2;CD74
14851,GO:0070576,0.00514303154053957,1,2,2,vitamin D 24-hydroxylase activity,MF,CYP24A1;CYP1A1
15924,GO:0072677,0.00515259966355651,0.999730098613108,3,6,eosinophil migration,BP,LGALS3;PTGER4;CCL5
10050,GO:0042493,0.00516246339975436,0.996644616443023,61,610,response to drug,BP,CRYAB;NEFL;HDAC9;CYP1B1;GCLC;TFRC;FGFR2;SLC7A2;CYP1A1;G6PD;TP53;EDN1;HMGCS1;NQO1;SLC4A11;TGFB2;RBM22;INHBA;SLC22A5;ABCG2;CDK4;SFRP1;AHR;SLC5A6;DHFR;ABCC4;SETDB1;SLC1A3;PTPRM;RANBP2;BAIAP2;APTX;QDPR;PDGFB;SDK1;FZD1;EFTUD2;SRD5A1;ABCC9;APEX1;TNC;UMPS;HSP90AB1;ARL6IP5;CENPF;ADAM17;ATR;CFLAR;NFKBIE;EBP;TRAF2;CCNA2;TIMELESS;TLR3;TNF;TYMS;DAXX;PANX1;TAF1;CDKN1A;SLC25A22
1114,GO:0002700,0.0053201159853333,0.998169617762,12,74,regulation of production of molecular mediator of immune response,BP,TFRC;TGFB2;IL27RA;THOC1;RIF1;MSH6;TRAF2;TLR3;TNF;ATAD5;CD74;IRAK3
2316,GO:0005314,0.00534168028860566,1,2,2,high-affinity glutamate transmembrane transporter activity,MF,SLC1A3;SLC25A22
5127,GO:0015501,0.00534168028860566,1,2,2,glutamate:sodium symporter activity,MF,SLC1A3;SLC25A22
11275,GO:0045509,0.00537625025820983,1,2,2,interleukin-27 receptor activity,MF,IL27RA;IL6ST
15782,GO:0072359,0.00538167525249959,0.996386626093807,71,680,circulatory system development,BP,KRT1;NRG1;HDAC9;FN1;PML;CYP1B1;AMOT;JPH2;CYR61;C3;FGFR2;EPGN;STARD13;CTGF;FBN1;HSPG2;RUNX1;FAT4;B4GALT1;G6PD;EDN1;PTPN14;PDPN;TGFB2;SYK;EMP2;LEPR;SFRP1;MIR17HG;COL4A1;AHR;NAA15;TPM1;PTPRB;ADAMTS9;ADM;IMMP2L;PLK2;NEXN;HSPB1;WNT4;PTPRM;KDM6A;ITGAV;PGK1;CDH13;SRF;HIF1AN;PDGFB;FZD1;IRX4;ANTXR1;SMYD2;ACKR3;SETD2;UBP1;ERAP1;PDCL3;MYH11;WDPCP;E2F8;BBS5;GPER1;CFLAR;CITED2;NCL;TLR3;GJC1;HNRNPU;DCTN5;ITGB1BP1
6911,GO:0030488,0.00539932186907534,0.99880200718467,7,32,tRNA methylation,BP,THUMPD3;METTL1;TRMT5;THADA;TRMT1;TRMT61A;WDR4
4264,GO:0009607,0.00546907300641341,0.996529400885854,54,551,response to biotic stimulus,BP,PTGES;PML;MAP3K14;NLRC5;FGFR2;TRIM22;CYP1A1;DDX17;TRIM56;TRAF3;TP53;EDN1;GBP1;IFNGR1;AKAP8;IKBKE;IL27RA;IFIT3;SYK;FAM111A;CDK4;CD274;PTGER4;ARRDC1-AS1;ADM;CCL20;HSPB1;DDX3X;IL24;ODC1;BAIAP2;CLU;BIRC3;NFKBIB;SETD2;THBD;ABCC9;IFNAR1;ERAP1;SYT11;DDX21;CCDC47;IL12RB2;SERPINB9;HMGN2;ADAM17;RBMS3;POLR3B;TLR3;TNF;CCL5;IRF1;GBP6;IRAK3
11939,GO:0046967,0.00552364589984297,1,2,2,cytosol to ER transport,BP,TAP1;TAP2
1157,GO:0002762,0.00556150857125295,0.998776655154729,7,29,negative regulation of myeloid leukocyte differentiation,BP,MAFB;FBN1;INHBA;TJP2;SFRP1;LILRB3;TLR3
16336,GO:0090502,0.00556187599104138,0.998299385682552,10,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,UTP20;EXO1;POP1;TSR1;FEN1;APEX1;DGCR8;FCF1;BMS1;NOL9
17656,GO:1901343,0.00557824449613313,0.998081528861341,12,68,negative regulation of vasculature development,BP,PML;AMOT;STARD13;HSPG2;TGFB2;ADAMTS9;PLK2;WNT4;PTPRM;PGK1;PDGFB;ITGB1BP1
3906,GO:0008544,0.00567036358072332,0.996919896072646,31,268,epidermis development,BP,SPRR3;KRT1;SPRR2A;KRT34;KRT4;TRIM16;KRT13;KRT2;KRT15;FOSL2;FGFR2;CTGF;RUNX1;FST;KRTAP2-3;TGFB2;SLC9A3R1;INHBA;KRT9;WNT10A;KEAP1;TCHH;HRNR;CD109;ATP2C1;KRT24;IL20;KRT10;WDPCP;RPTN;TNF
10918,GO:0044454,0.00568096505708355,0.996508942277892,47,464,nuclear chromosome part,CC,PML;CBX5;ENC1;TP53;RAD1;ZFP42;NBN;MCM5;NUCKS1;MCM2;H3F3A;RPA1;POLA1;KDM6A;THOC1;ORC4;NUFIP1;FEN1;MCM3;CDCA5;APTX;GINS4;SRF;UTY;RIF1;MCM6;APEX1;ORC1;PRIM2;BRCA2;MCM4;ATR;MSH6;TELO2;CITED2;POLE3;TIMELESS;ORC2;MPHOSPH8;PURB;ESR1;RING1;DAXX;HIST1H4A;TAF1;SMARCC1;IRF1
13658,GO:0060137,0.00573680788230343,0.999687372906664,3,6,maternal process involved in parturition,BP,CYP1A1;EDN1;ARNTL
906,GO:0002285,0.00574815258158475,0.997719439705863,15,100,lymphocyte activation involved in immune response,BP,TFRC;EXO1;DOCK10;LGALS3;IL27RA;RELB;NBN;PTGER4;LCP1;THOC1;LFNG;RIF1;MSH6;ATAD5;RC3H1
15478,GO:0071798,0.00581293686254174,1,2,2,response to prostaglandin D,BP,AKR1C2;TNC
15479,GO:0071799,0.00581293686254174,1,2,2,cellular response to prostaglandin D stimulus,BP,AKR1C2;TNC
12436,GO:0048869,0.00582539320021667,0.995392439498694,230,2682,cellular developmental process,BP,IGFBP3;MAFB;SPRR3;KRT1;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TENM3;PML;AMOT;KRT2;TFRC;CYR61;KRT15;CYP24A1;MKL1;FOSL2;FGFR2;CTGF;MMP9;FBN1;HSPG2;RUNX1;CYP1A1;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;FST;DDX17;TFCP2L1;KRTAP2-3;COL27A1;ENC1;TP53;DAPK3;PANK2;EDN1;GBP1;DOCK10;SIPA1L3;KBTBD8;CDKN2A;RBM4;PABPC4;LGALS3;PDPN;TGFB2;CNTNAP1;CYLD;FOXD2;LRFN4;COL12A1;IL6ST;SLC9A3R1;NUAK1;INHBA;IL7R;PALM2;SYK;EMP2;TJP2;RAB32;RELB;LEPR;TRIO;BRIP1;SFRP1;KRT9;WNT10A;MIR17HG;H3F3A;COL4A1;KEAP1;NAA15;TCHH;HRNR;DHFR;TPM1;ULK4;ADAMTS9;PTGER4;OPHN1;ADM;CD109;HERC6;SLC1A3;PLK2;SLCO4C1;MME;NEXN;FRK;MYBL2;RHOG;WNT4;SUV39H2;GPRIN1;PTPRM;KDM6A;RAN;CORO1C;ARHGEF28;RRN3;ITGAV;SOCS1;ARNTL;ARMC6;DND1;AKR1C2;KRT24;LFNG;PGK1;CDC42EP2;BAIAP2;GADD45B;WDR7;CDH13;COL5A2;PHACTR4;SRF;HIF1AN;NPNT;PDGFB;UGT8;SDK1;FZD1;NFE2L1;ANTXR1;CLU;ENPP1;IL20;EYA3;TPM4;ACKR3;FGD6;SRD5A1;SETD2;GLIS2;ANLN;GLIPR2;DPY19L2P2;WEE1;TJP1;ERAP1;SLC11A2;BLOC1S2;TNC;CNTNAP2;MYBL1;HSP90AB1;DDX21;EPHB6;ZBTB24;MYH11;NEDD4L;SGK1;ZFYVE27;BRCA2;SYNCRIP;TRAK2;KRT10;WDPCP;FANCD2;E2F8;MTMR2;CENPF;ETV6;L1CAM;STEAP4;CCDC47;CHEK1;GPER1;RPTN;ADAM17;MYO10;SENP1;ATR;NTN1;PSME2;CEP152;LILRB3;CFLAR;PSMB9;EIF2B5;ABCA5;SHTN1;DPYSL3;CSRP2;RBBP5;CITED2;DDX56;CSF1;AP3B1;RBL1;CLOCK;KIF14;PURB;TLR3;MPP5;ESR1;PARD3;GJC1;EHD1;TNF;ZFP36L2;RC3H1;TYMS;CD74;WDR36;HNRNPU;PSMB10;EIF2B1;HIST1H4A;TBPL1;SPIB;FTO;NRAS;PPARGC1B;CDKN1A;ITGB1BP1;IRF1
1046,GO:0002562,0.00587121896498533,0.998350156958366,9,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,TFRC;EXO1;IL27RA;NBN;THOC1;RIF1;MSH6;MSH3;ATAD5
5504,GO:0016444,0.00587121896498533,0.998350156958366,9,45,somatic cell DNA recombination,BP,TFRC;EXO1;IL27RA;NBN;THOC1;RIF1;MSH6;MSH3;ATAD5
6641,GO:0023023,0.00589311976517934,0.999363062361616,4,12,MHC protein complex binding,MF,HLA-DOB;HSPA8;HSP90AB1;CD74
18677,GO:1903964,0.00592024345741668,1,2,2,monounsaturated fatty acid metabolic process,BP,SCD;SCD5
18678,GO:1903966,0.00592024345741668,1,2,2,monounsaturated fatty acid biosynthetic process,BP,SCD;SCD5
15890,GO:0072593,0.00596222538813814,0.997194465613978,21,166,reactive oxygen species metabolic process,BP,CRYAB;CYP1B1;CYR61;CTGF;SLC7A2;CYP1A1;G6PD;TP53;EDN1;NQO1;SYK;DHFR;IMMP2L;SOD2;PDGFB;CLU;NNT;HSP90AB1;CFLAR;TNF;CDKN1A
2450,GO:0005658,0.00602126711510252,0.999665953653591,3,6,alpha DNA polymerase:primase complex,CC,POLA1;MCM3;PRIM2
7504,GO:0031670,0.00603780924934968,0.998291781534785,9,46,cellular response to nutrient,BP,CYP24A1;BRIP1;SFRP1;ATP2B1;BAIAP2;SRF;GDAP1;TNC;TAF1
3818,GO:0008409,0.00606500871145192,0.999096234906951,5,16,5'-3' exonuclease activity,MF,EXO1;POLQ;EXOG;FEN1;APTX
7597,GO:0031960,0.00615517745376734,0.997534671585197,15,103,response to corticosteroid,BP,NEFL;CTGF;EDN1;ATP2B1;ADM;RAN;SRD5A1;GPER1;CFLAR;TNF;ZFP36L2;TYMS;HNRNPU;PPARGC1B;CDKN1A
4516,GO:0010564,0.00616777567486372,0.995941469580808,62,622,regulation of cell cycle process,BP,PML;KIF23;EPGN;CBX5;CTGF;CYP1A1;PBX1;TP53;DAPK3;EDN1;CDKN2A;STAG1;PKMYT1;RAD1;GPR132;NBN;CDK4;SFRP1;PLK2;WNT4;RANBP2;TOPBP1;ANAPC15;DDX3X;KLHL21;CDC25A;TRIM37;FEN1;CDCA5;MDM4;PDGFB;BRCC3;RRM2;KLHL9;SETD2;ANLN;APEX1;CXCR5;HSP90AB1;BRCA2;E2F8;CENPF;CHEK1;GPER1;ADAM17;PSME2;CEP152;PSMB9;RFWD3;TPRA1;RBL1;KIF14;RAD51B;ATAD5;ZFP36L2;HNRNPU;RING1;FGFR1OP;PSMB10;TAF1;CDKN1A;CTCF
5913,GO:0018149,0.00619746102179929,0.998779547247121,6,28,peptide cross-linking,BP,SPRR3;KRT1;SPRR2A;FN1;KRT2;KRT10
227,GO:0000469,0.00620133707543583,0.99879175376437,6,26,cleavage involved in rRNA processing,BP,UTP20;TSR1;RRP36;FCF1;BMS1;NOL9
6786,GO:0030217,0.00625793704480135,0.997177576288038,19,138,T cell differentiation,BP,MAFB;RUNX1;CYLD;IL7R;SYK;RELB;LEPR;PTGER4;WNT4;SOCS1;LFNG;SRF;FANCD2;ADAM17;AP3B1;ZFP36L2;RC3H1;CD74;IRF1
15108,GO:0071103,0.00630215036527999,0.996702227992388,27,245,DNA conformation change,BP,TP53;CDKN2A;AKAP8;NBN;BRIP1;MCM5;MCM2;H3F3A;HELLS;G3BP1;GRWD1;AKAP8L;DDX3X;NAP1L1;SET;SMC2;CDCA5;GINS4;MCM6;GPER1;MCM4;CENPN;DAXX;HIST1H4A;CTCF;GTF2H3;CENPO
3699,GO:0008207,0.0063090922630482,0.999013094600476,5,19,C21-steroid hormone metabolic process,BP,ADM;WNT4;AKR1C2;SRD5A1;AKR1B1
3381,GO:0007160,0.00651084287335085,0.996926289202229,21,149,cell-matrix adhesion,BP,FN1;COL16A1;COL5A3;CTGF;DAPK3;CDKN2A;EMP2;SFRP1;ADAMTS9;WNT4;CORO1C;ITGAV;TRPM7;AJUBA;CDH13;SRF;NPNT;WDPCP;L1CAM;CSF1;ITGB1BP1
6604,GO:0022618,0.0065205497275073,0.996783323525413,23,194,ribonucleoprotein complex assembly,BP,GEMIN5;PPAN;RBM22;TGS1;SHQ1;GEMIN4;MDN1;NOP2;DDX28;RRP7BP;DDX3X;NUFIP1;MRTO4;LUC7L;LUC7L2;RPF2;HSP90AB1;GEMIN8;ATR;MRPS7;NCBP1;RC3H1;ZNHIT6
8746,GO:0034388,0.00664055337421812,0.999617994188012,3,6,Pwp2p-containing subcomplex of 90S preribosome,CC,WDR3;UTP18;WDR36
868,GO:0002200,0.00668206582537192,0.99791689134954,10,54,somatic diversification of immune receptors,BP,TFRC;EXO1;IL27RA;NBN;POLQ;THOC1;RIF1;MSH6;MSH3;ATAD5
13905,GO:0060523,0.00681749755251973,1,2,2,prostate epithelial cord elongation,BP,FGFR2;ESR1
6846,GO:0030307,0.00684455491334596,0.997045277028863,17,119,positive regulation of cell growth,BP,NRG1;FN1;EDN1;TGFB2;SFRP1;H3F3A;CXCL16;DDX3X;SRF;NEDD4L;ZFYVE27;L1CAM;ADAM17;NTN1;SHTN1;NCBP1;FGFR1OP
19523,GO:1990266,0.00690904528289754,0.998162402895724,8,44,neutrophil migration,BP,SAA1;EDN1;LGALS3;TGFB2;SYK;CCL20;CCL5;CD74
6602,GO:0022616,0.00696550334538175,0.998617348159257,6,25,DNA strand elongation,BP,NBN;NUCKS1;POLA1;RFC3;FEN1;GINS4
8485,GO:0033624,0.00701585279411946,1,2,2,negative regulation of integrin activation,BP,PTGER4;KIF14
17369,GO:1900034,0.00705670466432571,0.997485594333888,12,72,regulation of cellular response to heat,BP,CRYAB;BAG1;NUP50;NUP153;RPA1;NDC1;RANBP2;NUP160;NUP54;HSPA8;HSP90AB1;ATR
4231,GO:0009408,0.0070579515317066,0.996776627490783,19,140,response to heat,BP,CRYAB;GCLC;TP53;BAG1;NUP50;NUP153;RPA1;NDC1;RANBP2;NUP160;NUP54;HSPA8;HSP90AB1;HSF2;ATR;EIF2B5;EIF2B1;DAXX;CDKN1A
4504,GO:0010533,0.00706704341391778,0.999879995517264,2,3,regulation of activation of Janus kinase activity,BP,SOCS1;CCL5
2868,GO:0006361,0.00711253608010923,0.99831811224754,7,35,transcription initiation from RNA polymerase I promoter,BP,POLR1A;UBTF;RRN3;TAF1D;POLR2F;POLR1E;GTF2H3
1027,GO:0002526,0.00714082847749194,0.997731140364945,10,60,acute inflammatory response,BP,SAA1;C1R;FN1;PTGES;C3;B4GALT1;IL6ST;CLU;DNASE1;TNF
15496,GO:0071824,0.00715250303860612,0.996316049743295,25,237,protein-DNA complex subunit organization,BP,TP53;MCM2;H3F3A;RPA1;HELLS;TAF2;GRWD1;UBTF;SUPT16H;NAP1L1;RRN3;SET;SETD2;CENPF;TAF6L;ESR1;RAD51B;CENPN;DAXX;HIST1H4A;TAF1;SMARCC1;CTCF;GTF2H3;CENPO
717,GO:0001939,0.00716059962827152,0.999576372123164,3,6,female pronucleus,CC,AKAP8;RIF1;CCNA2
10394,GO:0043207,0.00724747966819518,0.995390923529862,51,524,response to external biotic stimulus,BP,PTGES;PML;MAP3K14;NLRC5;FGFR2;TRIM22;CYP1A1;DDX17;TRIM56;TRAF3;EDN1;GBP1;IFNGR1;AKAP8;IKBKE;IL27RA;IFIT3;SYK;FAM111A;CDK4;CD274;PTGER4;ARRDC1-AS1;ADM;CCL20;HSPB1;DDX3X;IL24;ODC1;BAIAP2;CLU;BIRC3;NFKBIB;SETD2;THBD;ABCC9;IFNAR1;ERAP1;SYT11;DDX21;IL12RB2;SERPINB9;HMGN2;ADAM17;POLR3B;TLR3;TNF;CCL5;IRF1;GBP6;IRAK3
13160,GO:0051707,0.00724747966819518,0.995390923529862,51,524,response to other organism,BP,PTGES;PML;MAP3K14;NLRC5;FGFR2;TRIM22;CYP1A1;DDX17;TRIM56;TRAF3;EDN1;GBP1;IFNGR1;AKAP8;IKBKE;IL27RA;IFIT3;SYK;FAM111A;CDK4;CD274;PTGER4;ARRDC1-AS1;ADM;CCL20;HSPB1;DDX3X;IL24;ODC1;BAIAP2;CLU;BIRC3;NFKBIB;SETD2;THBD;ABCC9;IFNAR1;ERAP1;SYT11;DDX21;IL12RB2;SERPINB9;HMGN2;ADAM17;POLR3B;TLR3;TNF;CCL5;IRF1;GBP6;IRAK3
3251,GO:0006913,0.00727544747607567,0.995855478753279,34,303,nucleocytoplasmic transport,BP,PML;TP53;RBM4;PTPN14;GEMIN5;CHP1;RBM22;SRSF2;NUP50;PHAX;NUP153;GEMIN4;LSG1;NDC1;CASC3;AKAP8L;THOC1;RAN;RANBP2;SET;ARNTL;NUP160;SDAD1;NUP54;SETD2;HSP90AB1;GEMIN8;NCBP1;UPF3B;TNF;SRSF7;CDKN1A;RBM8A;BUD13
2214,GO:0005102,0.00728085994653689,0.994892404970122,83,884,signaling receptor binding,MF,IL32;SAA1;NRG1;FN1;CYR61;C3;COL16A1;EPGN;S100P;CTGF;HLA-B;FBN1;TAP1;HSPG2;TRAF3;IRS1;SPG21;TP53;EDN1;PTPN14;LGALS3;PDPN;TGFB2;IL16;IL6ST;SLC9A3R1;INHBA;SYK;EMP2;HLA-F;SFRP1;WNT10A;DST;REEP1;IGFL3;TRAF1;OPHN1;ADM;CCL20;FRK;BTN2A1;WNT4;CXCL16;LCP1;RAN;IL24;ITGAV;SOCS1;ARNTL;CROT;TRIM37;NETO1;CDC42EP2;HIF1AN;NPNT;PDGFB;FZD1;CLU;MACC1;ENPP1;IL20;ERAP1;RIC3;PDCL3;HSPA8;HSP90AB1;NSF;TRAK2;ADAM17;CFLAR;CMTM3;RABEP2;TRAF2;TAP2;CSF1;ESR1;TNF;CCL5;CD74;DAXX;PANX1;PPARGC1B;ITGB1BP1
10310,GO:0043062,0.00743222171718339,0.995934290283032,30,242,extracellular structure organization,BP,FN1;CYP1B1;CYR61;COL16A1;COL5A3;CTGF;MMP9;FBN1;HSPG2;B4GALT1;CCDC80;COL27A1;ACSL3;PDPN;TGFB2;COL12A1;COL4A1;ADAMTS9;LCP1;ITGAV;COL5A2;NPNT;PDGFB;ANTXR1;TNC;MYH11;CFLAR;ABCA5;MFAP5;TNF
4187,GO:0009263,0.00743812225652652,0.999119457627283,4,13,deoxyribonucleotide biosynthetic process,BP,RRM2;RRM1;TYMS;TBPL1
7716,GO:0032200,0.00747745596480326,0.996471487508365,20,166,telomere organization,BP,PML;EXO1;DKC1;NBN;H3F3A;RPA1;POLA1;RFC3;FEN1;GNL3L;RIF1;APEX1;HSP90AB1;PRIM2;BRCA2;ATR;TELO2;POLE3;HNRNPU;HIST1H4A
483,GO:0001533,0.00754055105534992,0.997963683412108,8,44,cornified envelope,CC,SPRR3;KRT1;SPRR2A;KRT2;TCHH;HRNR;KRT10;RPTN
13718,GO:0060249,0.00757669342851294,0.995749114791206,32,288,anatomical structure homeostasis,BP,KRT1;PML;TFRC;CTGF;ACTG1;EXO1;DKC1;SLC22A5;SYK;NBN;RPA1;POLA1;RFC3;HSPB1;FEN1;GNL3L;SRF;RIF1;APEX1;HSP90AB1;PRIM2;BRCA2;ATR;AKR1B1;TELO2;POLE3;CSF1;WDR36;HNRNPU;HIST1H4A;PPARGC1B;MUC6
392,GO:0001047,0.00765935535297163,0.996656832064453,17,117,core promoter binding,MF,NLRC5;RUNX1;TP53;RELB;H3F3A;UBTF;RRN3;ARNTL;KANSL1L;CCAR1;MAZ;E2F8;CLOCK;ESR1;HNRNPU;TAF1;PSPC1
11679,GO:0046427,0.00770247106594049,0.997917006990147,8,43,positive regulation of JAK-STAT cascade,BP,CYP1B1;IL6ST;IL24;SOCS1;PARP14;IL20;AKR1B1;CCL5
1451,GO:0003678,0.00771320642907766,0.99773024909444,9,46,DNA helicase activity,MF,NBN;BRIP1;MCM5;MCM2;G3BP1;DDX3X;GINS4;MCM6;MCM4
12256,GO:0048513,0.00773335217662892,0.993952880899944,185,2137,animal organ development,BP,CRYAB;MAFB;SPRR3;KRT1;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;KRT13;TNS3;TENM3;PML;CYP1B1;JPH2;KRT2;TFRC;CYR61;KRT15;FOSL2;FGFR2;STAT5A;COL5A3;CTGF;MMP9;FBN1;HSPG2;RUNX1;CYP1A1;FAT4;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;KRTAP2-3;COL27A1;TUFT1;EDN1;HMGCS1;DOCK10;SIPA1L3;KBTBD8;ACSL3;PABPC4;MEGF11;LGALS3;PDPN;TGFB2;IRX2;CYLD;RAD1;SLC9A3R1;INHBA;IL7R;SYK;TJP2;ZFP42;RELB;LEPR;BRIP1;CDK4;SFRP1;KRT9;GPCPD1;WNT10A;MCM2;MIR17HG;H3F3A;ATP2B1;COL4A1;TCHH;HRNR;TPM1;ADAMTS9;PTGER4;OPHN1;ADM;IMMP2L;CD109;HERC6;MME;NEXN;WNT4;LCP1;PTPRM;KDM6A;RAN;CORO1C;SOCS1;ARNTL;ODC1;ARMC6;KRT24;LFNG;LUC7L;BAIAP2;WDR7;COL5A2;PHACTR4;SRF;NPNT;QDPR;PDGFB;SDK1;FZD1;IRX4;NFE2L1;RTKN2;SMYD2;ENPP1;FRAS1;IL20;SRD5A1;SETD2;GLIS2;ANLN;GLIPR2;JPH1;SLC11A2;CXCR5;TNC;CNTNAP2;UMPS;HSP90AB1;ZBTB24;MYH11;BRCA2;KRT10;WDPCP;FANCD2;E2F8;CENPF;ETV6;RAB3GAP1;BBS5;GPER1;RRM1;RPTN;ADAM17;SENP1;NTN1;PSME2;LILRB3;CFLAR;PSMB9;EIF2B5;EBP;AKR1B1;RBBP5;CITED2;MFAP5;CCNA2;TIMELESS;CSF1;AP3B1;CLOCK;KIF14;PURB;TLR3;ESR1;GJC1;TNF;ZFP36L2;RC3H1;TYMS;CD74;HNRNPU;RING1;PSMB10;DCTN5;PHF14;PHLPP2;HIST1H4A;TAF1;FTO;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;IRF1
1177,GO:0002821,0.00777840722385656,0.997685041005053,9,51,positive regulation of adaptive immune response,BP,TFRC;C3;IL27RA;IL6ST;RIF1;MSH6;TRAF2;TNF;ATAD5
3548,GO:0007584,0.00784381492872787,0.996374161010865,19,145,response to nutrient,BP,GCLC;CYP24A1;CYP1A1;TP53;HMGCS1;ACSL3;NQO1;SRSF2;BRIP1;SFRP1;ATP2B1;SETDB1;BAIAP2;SRF;GDAP1;TNC;TYMS;PANX1;TAF1
13997,GO:0060687,0.00784623630029527,0.999519707680361,3,6,regulation of branching involved in prostate gland morphogenesis,BP,FGFR2;SFRP1;ESR1
1460,GO:0003697,0.00793023680611005,0.996844774445466,14,96,single-stranded DNA binding,MF,NUCKS1;RPA1;TSN;APTX;LRPPRC;MCM6;PRIM2;BRCA2;MCM4;MSH3;PURB;RAD51B;HNRNPU;TREX1
12270,GO:0048535,0.00793355161991704,0.999064700063815,4,12,lymph node development,BP,PDPN;IL7R;CXCR5;RC3H1
11317,GO:0045620,0.0079748097445224,0.998370249232794,6,25,negative regulation of lymphocyte differentiation,BP,CYLD;INHBA;SFRP1;RC3H1;CD74;IRF1
326,GO:0000912,0.00800862737559129,0.999505998975473,3,6,assembly of actomyosin apparatus involved in cytokinesis,BP,KIF23;RTKN2;ANLN
327,GO:0000915,0.00800862737559129,0.999505998975473,3,6,actomyosin contractile ring assembly,BP,KIF23;RTKN2;ANLN
3226,GO:0006880,0.00803325343942931,0.999854059397618,2,3,intracellular sequestering of iron ion,BP,FTL;FTH1
16692,GO:0097577,0.00803325343942931,0.999854059397618,2,3,sequestering of iron ion,BP,FTL;FTH1
10113,GO:0042613,0.00808597524655657,0.999852593438626,2,3,MHC class II protein complex,CC,HLA-DOB;CD74
9802,GO:0040012,0.00815434112457428,0.994542979067403,63,620,regulation of locomotion,BP,IGFBP3;NRG1;HDAC9;FN1;PML;CYP1B1;AMOT;MTUS1;CYR61;STAT5A;STARD13;MMP9;TP53;DAPK3;EDN1;DOCK10;LGALS3;PDPN;TGFB2;IL16;SLC9A3R1;EMP2;SFRP1;CD274;TPM1;ULK4;ADAMTS9;PTGER4;CCL20;PLK2;NEXN;HSPB1;WNT4;CXCL16;PTPRM;SOD2;CORO1C;IL24;ITGAV;AJUBA;CDH13;SRF;PDGFB;ACKR3;GLIPR2;APEX1;SGK1;CCAR1;WDPCP;GPER1;ADAM17;NTN1;CBLL1;SHTN1;DPYSL3;CITED2;CSF1;KIF14;TNF;CCL5;CD74;FGFR1OP;ITGB1BP1
7717,GO:0032201,0.00820180191949573,0.998293867046523,6,27,telomere maintenance via semi-conservative replication,BP,RPA1;POLA1;RFC3;FEN1;PRIM2;POLE3
469,GO:0001510,0.00820700269286771,0.997333899786859,10,61,RNA methylation,BP,TGS1;THUMPD3;METTL1;NOP2;METTL16;TRMT5;THADA;TRMT1;TRMT61A;WDR4
12870,GO:0051169,0.00825684199676661,0.99525301513708,34,306,nuclear transport,BP,PML;TP53;RBM4;PTPN14;GEMIN5;CHP1;RBM22;SRSF2;NUP50;PHAX;NUP153;GEMIN4;LSG1;NDC1;CASC3;AKAP8L;THOC1;RAN;RANBP2;SET;ARNTL;NUP160;SDAD1;NUP54;SETD2;HSP90AB1;GEMIN8;NCBP1;UPF3B;TNF;SRSF7;CDKN1A;RBM8A;BUD13
16565,GO:0097300,0.00828927819185804,0.997981340113885,7,35,programmed necrotic cell death,BP,CYLD;TRPM7;BIRC3;CFLAR;TRAF2;TLR3;TNF
3803,GO:0008380,0.0084176282475266,0.994918760941103,40,392,RNA splicing,BP,DDX17;DDX47;RBM4;GEMIN5;LGALS3;RBM22;TGS1;SRSF2;SUGP2;HNRNPF;TARDBP;GEMIN4;TRA2A;ZMAT2;HNRNPA1L2;CASC3;AKAP8L;THOC1;RBMXL1;LUC7L;LUC7L2;USB1;EFTUD2;METTL16;TTF2;HSPA8;GEMIN8;SYNCRIP;CCAR1;POLR2F;NCBP1;UPF3B;HNRNPR;SRSF7;HNRNPU;PSPC1;HNRNPM;RBM8A;BUD13;DHX15
6656,GO:0030002,0.00851780941259685,0.999462322718607,3,6,cellular anion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
6856,GO:0030320,0.00851780941259685,0.999462322718607,3,6,cellular monovalent inorganic anion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
15193,GO:0071310,0.00855406072819128,0.993406047474442,156,1808,cellular response to organic substance,BP,IL32;SAA1;HDAC9;MAP2;KRT13;FN1;PML;CYP1B1;MAP3K14;GCLC;TFRC;CYR61;CYP24A1;COL16A1;NLRC5;FGFR2;STAT5A;TRIM22;CTGF;HLA-B;MMP9;FBN1;XAF1;RUNX1;CYP1A1;IL1R2;FAT4;ACTG1;MAT2A;DDX17;TRAF3;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;HMGCS1;PTPN14;IFNGR1;AKAP8;TGFB2;CYLD;IL27RA;IL16;IFIT3;IL6ST;HNRNPF;INHBA;IL7R;SYK;TJP2;LEPR;BRIP1;HLA-F;CDK4;SFRP1;NUCKS1;CD274;WNT10A;MCM2;MIR17HG;ATP2B1;COL4A1;AHR;KEAP1;TSN;PTGER4;TRAF1;CD109;CCL20;RRAGB;MME;GBP5;MYBL2;HSPB1;WNT4;LCP1;RAN;SOD2;IL24;SOCS1;PARP14;ARNTL;AKR1C2;ZC3H7B;CDC42EP2;BAIAP2;COL5A2;SRF;GDAP1;NPNT;PDGFB;FZD1;CLU;ENPP1;BIRC3;IL20;PIK3R3;NFKBIB;ZNF106;ACKR3;RIF1;SRD5A1;SRPRB;IFNAR1;APEX1;CXCR5;TNC;HSPA8;HSP90AB1;ZFYVE27;SYNCRIP;DGCR8;POLR2F;IL12RB2;GPER1;ADAM17;PSME2;CFLAR;PSMB9;HNRNPDL;DPYSL3;NCBP1;MYNN;AKR1B1;TRAF2;CITED2;NCL;CCNA2;TIMELESS;IFI30;CSF1;CLOCK;TLR3;ESR1;PARD3;EHD1;TNF;ZFP36L2;SRSF7;RC3H1;CCL5;CD74;HNRNPU;PSMB10;DAXX;TAF1;SMARCC1;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;IRF1;GBP6;IRAK3
12292,GO:0048584,0.0086387678583299,0.99349249387498,128,1447,positive regulation of response to stimulus,BP,IGFBP3;KRT1;SAA1;NRG1;C1R;TRIM16;PML;CYP1B1;JPH2;MAP3K14;TFRC;CYR61;C3;NLRC5;FGFR2;EPGN;TRIM22;CTGF;MMP9;RUNX1;ACTG1;TRAF3;IRS1;SPG21;MID1;TP53;DAPK3;EDN1;GBP1;C1QTNF1;CDKN2A;JRK;LGALS3;PDPN;TGFB2;CNTNAP1;CYLD;IKBKE;IL27RA;IL16;IL6ST;SLC9A3R1;INHBA;IL7R;SYK;EMP2;NAIP;RELB;SFRP1;NUCKS1;MIR17HG;PTGER4;DYNLL2;CCL20;PLK2;RRAGB;MUC16;UBQLN2;GBP5;BTN2A1;HSPB1;WNT4;ATP2C1;DDX3X;IL24;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;AKR1C2;LFNG;NETO1;BAIAP2;GADD45B;CDH13;NPNT;PDGFB;BRCC3;CLU;BIRC3;IL20;PIK3R3;EYA3;ACKR3;RIF1;THBD;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;GPER1;FAF1;ADAM17;MYO10;ATR;PSME2;MSH6;CFLAR;PSMB9;EIF2B5;CMTM3;AKR1B1;TRAF2;TELO2;CITED2;POLR3B;TIMELESS;CSF1;CLOCK;TLR3;ESR1;TNF;ATAD5;RC3H1;CCL5;CD74;PSMB10;EIF2B1;DAXX;TAF1;NRAS;PSPC1;MUC5B;ITGB1BP1;MUC6;IRF1;IRAK3
15428,GO:0071674,0.00865309385189123,0.998169761647637,6,28,mononuclear cell migration,BP,LGALS3;CCL20;PDGFB;CSF1;TNF;CCL5
2901,GO:0006409,0.00875830953902756,0.997868129065303,7,32,tRNA export from nucleus,BP,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
15278,GO:0071431,0.00875830953902756,0.997868129065303,7,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
19805,GO:2000181,0.00883006038528114,0.996933542258721,11,63,negative regulation of blood vessel morphogenesis,BP,PML;AMOT;STARD13;HSPG2;TGFB2;ADAMTS9;PLK2;WNT4;PTPRM;PGK1;ITGB1BP1
12914,GO:0051236,0.00894676895988594,0.995545915412089,22,176,establishment of RNA localization,BP,SRSF2;NUP50;PHAX;NUP153;NDC1;HNRNPA1L2;CASC3;AKAP8L;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;LRPPRC;SETD2;ATR;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
3545,GO:0007569,0.00894707623608021,0.996534923230939,13,86,cell aging,BP,PML;TP53;CDKN2A;NUAK1;PLK2;MME;ARNTL;SRF;BRCA2;CHEK1;ATR;RBL1;CDKN1A
7912,GO:0032479,0.00896371263930742,0.996243335448132,15,107,regulation of type I interferon production,BP,NLRC5;TRIM56;TRAF3;CYLD;IKBKE;SYK;RELB;DDX3X;SETD2;DTX4;POLR2F;POLR3B;TLR3;TREX1;IRF1
735,GO:0001961,0.00900720058883293,0.997786807582044,7,33,positive regulation of cytokine-mediated signaling pathway,BP,NLRC5;EDN1;PARP14;ADAM17;TRAF2;CSF1;CD74
19317,GO:1905517,0.00904360867411714,0.998425749384543,5,21,macrophage migration,BP,SAA1;MTUS1;LGALS3;CSF1;CCL5
7983,GO:0032591,0.00914542086301633,0.999407084614818,3,6,dendritic spine membrane,CC,SHISA9;ATP2B1;GPER1
12539,GO:0050663,0.00916238611732168,0.996150246115831,15,107,cytokine secretion,BP,SAA1;TRIM16;FN1;PML;IL1R2;GBP1;SYK;CD274;PTGER4;GBP5;ITGAV;SOCS1;SYT11;TNF;PANX1
257,GO:0000723,0.0091678495980133,0.995685470300778,19,153,telomere maintenance,BP,PML;EXO1;DKC1;NBN;RPA1;POLA1;RFC3;FEN1;GNL3L;RIF1;APEX1;HSP90AB1;PRIM2;BRCA2;ATR;TELO2;POLE3;HNRNPU;HIST1H4A
10624,GO:0043603,0.00919145093381077,0.993559304019074,77,907,cellular amide metabolic process,BP,PTGES;GCLC;CYR61;STAT5A;CLN6;G6PD;ENC1;DAPK3;PANK2;C9ORF3;ABCF1;KBTBD8;RBM4;GEMIN5;PABPC4;ACO1;CARS2;CDKAL1;NUP50;PUM3;NUP153;CDK4;MIR17HG;H3F3A;USP16;SLC5A6;DHFR;IMMP2L;NDC1;EIF5;CASC3;MRPL27;MME;HSPB1;RAN;RANBP2;DDX3X;MRTO4;AJUBA;FASTKD3;DND1;GATC;RARS;GDAP1;UGT8;EIF3J;CLU;NUP160;NUP54;LRPPRC;EFTUD2;METTL16;ERAP1;HSPA8;BACE2;DNPEP;SYNCRIP;POLR2F;RBMS3;EIF2B5;MRPS7;DPH2;NCBP1;UPF3B;HNRNPR;NCL;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;EIF2B1;HIST1H4A;RBM8A;GTF2H3;RPS12
8248,GO:0033010,0.0092219364035591,0.999400246970851,3,6,paranodal junction,CC,CNTNAP1;CNTNAP2;AKR1B1
12160,GO:0048247,0.00930773509092187,0.998368155697237,5,21,lymphocyte chemotaxis,BP,SAA1;CCL20;CXCL16;ADAM17;CCL5
15997,GO:0080135,0.00941411254404628,0.993850953215898,54,538,regulation of cellular response to stress,BP,CRYAB;PML;CTGF;MID1;TP53;EDN1;CDKN2A;TGFB2;BAG1;NUAK1;NUP50;SYK;NUP153;SFRP1;POLQ;DHFR;RPA1;ULK4;NDC1;PLK2;UBQLN2;WDR76;HSPB1;THOC1;RANBP2;SOD2;ARNTL;AJUBA;GADD45B;BRCC3;FZD1;CLU;NUP160;SMYD2;NUP54;EYA3;ACKR3;RIF1;SETD2;HSPA8;HSP90AB1;ARL6IP5;CHEK1;ATR;RFWD3;TRAF2;TIMELESS;RBL1;TLR3;TNF;CD74;DAXX;PHLPP1;USP1
13518,GO:0055062,0.00955465694899522,0.999370258582453,3,6,phosphate ion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
15826,GO:0072505,0.00955465694899522,0.999370258582453,3,6,divalent inorganic anion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
15827,GO:0072506,0.00955465694899522,0.999370258582453,3,6,trivalent inorganic anion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
7994,GO:0032606,0.00957852020674992,0.995952455966986,15,108,type I interferon production,BP,NLRC5;TRIM56;TRAF3;CYLD;IKBKE;SYK;RELB;DDX3X;SETD2;DTX4;POLR2F;POLR3B;TLR3;TREX1;IRF1
8835,GO:0034605,0.00964565462406553,0.995797020551343,16,113,cellular response to heat,BP,CRYAB;TP53;BAG1;NUP50;NUP153;RPA1;NDC1;RANBP2;NUP160;NUP54;HSPA8;HSP90AB1;HSF2;ATR;DAXX;CDKN1A
3180,GO:0006801,0.00974346132212152,0.997543757532646,7,36,superoxide metabolic process,BP,EDN1;NQO1;SYK;DHFR;IMMP2L;SOD2;TNF
11316,GO:0045619,0.00985681419716015,0.995968392948592,14,98,regulation of lymphocyte differentiation,BP,RUNX1;CYLD;INHBA;IL7R;SYK;SFRP1;MIR17HG;SOCS1;FANCD2;AP3B1;ZFP36L2;RC3H1;CD74;IRF1
4420,GO:0010212,0.00989080572590411,0.99542823621725,18,136,response to ionizing radiation,BP,CRYAB;PML;TP53;RAD1;SFRP1;NUCKS1;TOPBP1;BRCC3;EYA3;THBD;BRCA2;FANCD2;RRM1;ATR;RFWD3;CLOCK;RAD51B;CDKN1A
2869,GO:0006362,0.00989581625661847,0.997835047891509,6,29,transcription elongation from RNA polymerase I promoter,BP,POLR1A;UBTF;TAF1D;POLR2F;POLR1E;GTF2H3
14129,GO:0060964,0.00992900942611309,0.996063581598734,13,103,regulation of gene silencing by miRNA,BP,NUP50;NUP153;H3F3A;NDC1;RAN;RANBP2;AJUBA;DND1;NUP160;NUP54;POLR2F;ESR1;HIST1H4A
16313,GO:0090398,0.00994862740829944,0.996918197050206,9,51,cellular senescence,BP,PML;TP53;CDKN2A;NUAK1;PLK2;ARNTL;SRF;RBL1;CDKN1A
1050,GO:0002573,0.00999198851711153,0.995500413265979,17,123,myeloid leukocyte differentiation,BP,MAFB;TFRC;MMP9;FBN1;RUNX1;INHBA;TJP2;RELB;SFRP1;CD109;IL20;LILRB3;CSF1;TLR3;TNF;CD74;PPARGC1B
10207,GO:0042802,0.00999549934030933,0.992646062087806,103,1162,identical protein binding,MF,CRYAB;MAFB;FTL;NEFL;FN1;TENM3;PML;TFRC;FGFR2;UGT1A6;CBX5;S100P;MMP9;FBN1;TAP1;CLN6;ACTG1;G6PD;MAT2A;MID1;TP53;DAPK3;TPST1;GBP1;HMGCS1;ZBED1;NQO1;TGFB2;IFIT3;IL6ST;INHBA;NUP153;RELB;LEPR;ABCG2;SFRP1;VPS41;TARDBP;KEAP1;TPM1;TSN;TK1;TRAF1;DYNLL2;CASC3;HSCB;GBP5;HSPB1;LCP1;PTPRM;KDM6A;TOPBP1;SOD2;NUFIP1;ODC1;TRIM37;LUC7L;BAIAP2;CDH13;SRF;HIF1AN;QDPR;PDGFB;SDK1;ENPP1;TPM4;MCM6;GLIPR2;SYT11;HSP90AB1;DNPEP;BRCA2;DGCR8;DPYD;E2F8;MTMR2;CENPF;HSF2;MMAA;RRM1;RAD18;PSME2;CBLL1;UGT1A4;TRAF2;NCL;TIMELESS;CSF1;TLR3;ESR1;PARD3;EHD1;TNF;TYMS;CCL5;CD74;HNRNPU;FGFR1OP;EIF2B1;ZNHIT6;TREX1;GPX4;IRAK3
2252,GO:0005164,0.0100108914345996,0.998212775646581,5,21,tumor necrosis factor receptor binding,MF,TRAF3;TRAF1;TRIM37;TRAF2;TNF
12325,GO:0048660,0.0100342068189063,0.996053499787718,13,87,regulation of smooth muscle cell proliferation,BP,IGFBP3;FGFR2;MMP9;TP53;EDN1;TPM1;ABCC4;CDH13;PDGFB;GPER1;AKR1B1;TNF;CCL5
9841,GO:0042056,0.0100401149537106,0.998677015402703,4,14,chemoattractant activity,MF,SAA1;LGALS3;PDGFB;CCL5
2808,GO:0006268,0.0101604828715695,0.999246526766335,3,7,DNA unwinding involved in DNA replication,BP,MCM2;MCM6;MCM4
3663,GO:0008152,0.0101934300789489,0.991722551202966,620,8267,metabolic process,BP,CRYAB;IGFBP3;HEPHL1;MAFB;SPRR3;KRT1;SAA1;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;C1R;TRIM16;FN1;TENM3;PTGES;PML;CYP1B1;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;TRIM22;CBX5;FADS3;COL5A3;CTGF;UTP20;MMP9;FBN1;GNPTAB;VMP1;HSPG2;SLC7A2;RUNX1;CYP1A1;CLN6;IL1R2;B4GALT1;PBX1;G6PD;TSC22D3;FST;MAT2A;DDX17;SPON1;TRIM56;OVCH2;TFCP2L1;TRAF3;ENC1;IRS1;MID1;SLC16A9;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DDX47;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;LGALS3;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;COL12A1;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PUM3;GALNT18;CAMK1G;PHAX;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;GFOD1;RELB;NBN;LEPR;TRIO;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;LDHAL6B;CDK4;SFRP1;VPS41;POP1;RIPK4;GPCPD1;NUCKS1;HEATR1;ZDHHC6;WNT10A;MCM2;TARDBP;MIR17HG;GEMIN4;ABHD4;POLQ;TSR1;H3F3A;COL4A1;PUS3;USP16;AHR;APOL6;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;SLC5A6;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;ABCC4;TSN;DRAM1;ADAMTS9;SETDB1;PTGER4;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;MDN1;SLC1A3;EIF5;CASC3;CCL20;PLK2;RRAGB;ZNF512;MRPL27;MME;ZNF587;MUC16;UBQLN2;HSCB;FRK;DNTTIP2;BTN2A1;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;EXOG;PTPRM;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ZNF738;DDX3X;NAP1L1;NUFIP1;CPA4;IL24;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;TRPM7;AJUBA;FASTKD3;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;LFNG;ZC3H7B;PGK1;SNX5;TRIM37;FEN1;MCM3;LUC7L;CDCA5;HACD2;SRBD1;FRRS1;PPP4R4;GNL3L;ZNF586;YRDC;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;GANC;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;SGK494;FZD1;IRX4;UTY;NFE2L1;ANTXR1;ISG20L2;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;ACKR3;RIF1;METTL16;TYW1;MCM6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;RPF2;UBP1;UPK3B;TRMT5;TTF2;DTX4;METTL13;GLIPR2;DPY19L2P2;SEPHS2;NNT;WEE1;ZNF484;THADA;ERAP1;SLC11A2;BLOC1S2;APEX1;PDCL3;TNC;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;ANAPC7;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;KRT10;CCAR1;CYB561D2;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;STEAP4;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;ADAM17;SENP1;RBMS3;ATR;PSME2;UBAP2L;MSH6;HADHB;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;EBP;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;TPRA1;MSH3;TELO2;EDRF1;RBBP5;CYP20A1;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;IFI30;UQCRB;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;AZIN1;SYNPO2;ESR1;PARD3;RRP15;RNF19B;RAD51B;USP11;FEM1C;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;ZFP36L2;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;PHLPP1;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
2833,GO:0006302,0.010195642667703,0.994766748050887,23,194,double-strand break repair,BP,PML;NBN;BRIP1;NUCKS1;POLQ;RPA1;POLA1;FEN1;CDCA5;APTX;GINS4;MCM8;BRCC3;EYA3;RIF1;SETD2;HELQ;BRCA2;CHEK1;RFWD3;TIMELESS;RAD51B;HIST1H4A
6284,GO:0019885,0.0102134605819733,0.99924111711028,3,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,TAP1;ERAP1;TAP2
2226,GO:0005126,0.0102352277126618,0.995357206470561,17,136,cytokine receptor binding,MF,TRAF3;TGFB2;IL6ST;INHBA;TRAF1;CCL20;CXCL16;TRIM37;IL20;ERAP1;PDCL3;ADAM17;CFLAR;TRAF2;CSF1;TNF;CCL5
16513,GO:0097191,0.0102640016911947,0.994912366055586,21,171,extrinsic apoptotic signaling pathway,BP,PML;GCLC;DAPK3;DDX47;LGALS3;TGFB2;CYLD;INHBA;SFRP1;TRAF1;DDX3X;ITGAV;EYA3;BLOC1S2;GPER1;FAF1;CFLAR;TRAF2;TLR3;TNF;DAXX
4022,GO:0009051,0.0102891048425448,0.999786887791707,2,3,pentose-phosphate shunt, oxidative branch,BP,G6PD;PGD
12939,GO:0051270,0.0103038143956997,0.993042572772061,62,615,regulation of cellular component movement,BP,IGFBP3;NRG1;HDAC9;FN1;CYP1B1;AMOT;MTUS1;CYR61;STAT5A;STARD13;MMP9;B4GALT1;TP53;DAPK3;EDN1;DOCK10;LGALS3;PDPN;TGFB2;SLC9A3R1;EMP2;SFRP1;CD274;TPM1;ULK4;ADAMTS9;PTGER4;CCL20;PLK2;NEXN;HSPB1;WNT4;CXCL16;PTPRM;SOD2;CORO1C;IL24;ITGAV;AJUBA;CDH13;SRF;PDGFB;ACKR3;GLIPR2;APEX1;SGK1;CCAR1;WDPCP;GPER1;ADAM17;NTN1;CBLL1;SHTN1;DPYSL3;CITED2;CSF1;KIF14;TNF;CCL5;CD74;FGFR1OP;ITGB1BP1
12778,GO:0051028,0.0103191466919596,0.995210586588314,18,135,mRNA transport,BP,SRSF2;NUP50;NUP153;NDC1;HNRNPA1L2;CASC3;AKAP8L;THOC1;RANBP2;NUP160;NUP54;LRPPRC;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
12781,GO:0051031,0.0103712115254138,0.997380477559696,7,33,tRNA transport,BP,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
2533,GO:0005788,0.0104148692759461,0.994653237231648,23,185,endoplasmic reticulum lumen,CC,IGFBP3;FN1;CYR61;C3;COL16A1;COL5A3;FBN1;CLN6;SPON1;COL27A1;EDN1;PRSS23;COL12A1;P3H2;COL4A1;P4HA2;FOXRED2;WNT4;COL5A2;PDGFB;ERAP1;TNC;CSF1
12704,GO:0050900,0.0106702491193889,0.994253479378637,26,227,leukocyte migration,BP,SAA1;FN1;MTUS1;MMP9;B4GALT1;TP53;EDN1;LGALS3;TGFB2;IL16;SYK;PTGER4;CCL20;CXCL16;SIRPA;ITGAV;PDGFB;THBD;CXCR5;L1CAM;ADAM17;CSF1;TNF;CCL5;CD74;NRAS
465,GO:0001503,0.0106909721367724,0.994042432639999,29,242,ossification,BP,IGFBP3;CYR61;CYP24A1;FGFR2;CTGF;MMP9;RUNX1;FAT4;PBX1;TUFT1;TGFB2;IL6ST;SFRP1;PTGER4;WNT4;COL5A2;NPNT;KREMEN2;FZD1;ENPP1;TPM4;TNC;DDX21;SYNCRIP;CCDC47;CSF1;TNF;HNRNPU;PPARGC1B
10791,GO:0044238,0.0106924695616223,0.991238058459696,581,7698,primary metabolic process,BP,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;C1R;TRIM16;FN1;TENM3;PTGES;PML;CYP1B1;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;TRIM22;CBX5;FADS3;CTGF;UTP20;MMP9;FBN1;GNPTAB;HSPG2;SLC7A2;RUNX1;CYP1A1;CLN6;IL1R2;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;SPON1;TRIM56;OVCH2;TFCP2L1;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DDX47;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;LGALS3;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;GALNT18;CAMK1G;PHAX;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RELB;NBN;LEPR;TRIO;FAM111A;PARP15;BRIP1;MCM5;SHQ1;LSS;UTP15;LDHAL6B;CDK4;SFRP1;POP1;RIPK4;GPCPD1;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;MIR17HG;GEMIN4;ABHD4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;APOL6;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;TSN;ADAMTS9;SETDB1;PTGER4;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;HERC6;HNRNPA1L2;FOXRED2;MDN1;SLC1A3;EIF5;CASC3;CCL20;PLK2;ZNF512;MRPL27;MME;ZNF587;MUC16;UBQLN2;HSCB;FRK;DNTTIP2;BTN2A1;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;EXOG;PTPRM;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;RANBP2;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ZNF738;DDX3X;NAP1L1;NUFIP1;CPA4;IL24;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;TRPM7;AJUBA;FASTKD3;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;LFNG;ZC3H7B;PGK1;TRIM37;FEN1;MCM3;LUC7L;CDCA5;HACD2;SRBD1;PPP4R4;GNL3L;ZNF586;YRDC;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;GINS4;RRP1;RARS;COMMD4;PHACTR4;SRF;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;GANC;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;SGK494;FZD1;IRX4;UTY;NFE2L1;ANTXR1;ISG20L2;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;ACKR3;RIF1;METTL16;TYW1;MCM6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;DTX4;GLIPR2;DPY19L2P2;SEPHS2;NNT;WEE1;ZNF484;THADA;ERAP1;APEX1;PDCL3;TNC;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;ANAPC7;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;KRT10;CCAR1;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;ADAM17;SENP1;RBMS3;ATR;PSME2;MSH6;HADHB;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;EBP;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;TPRA1;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;UQCRB;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;RRP15;RNF19B;RAD51B;USP11;FEM1C;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;ZFP36L2;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
17108,GO:0099612,0.0107604797815219,0.999258199618198,3,6,protein localization to axon,BP,CNTNAP1;UGT8;CNTNAP2
16315,GO:0090400,0.0108011360602823,0.999180384455212,3,7,stress-induced premature senescence,BP,TP53;ARNTL;CDKN1A
8709,GO:0034340,0.0108841454080039,0.996059383454665,11,74,response to type I interferon,BP,NLRC5;HLA-B;XAF1;TRIM56;IKBKE;IFIT3;HLA-F;SETD2;IFNAR1;HSP90AB1;IRF1
1866,GO:0004527,0.0109516612974991,0.996050203627402,11,69,exonuclease activity,MF,EXO1;RAD1;POLQ;EXOG;FEN1;APTX;USB1;ISG20L2;ENPP1;APEX1;TREX1
4347,GO:0009897,0.0109653360159866,0.995292113454448,15,108,external side of plasma membrane,CC,NRG1;AMOT;TFRC;B4GALT1;IL6ST;IL7R;CD274;BTN2A1;ITGAV;CDH13;ANTXR1;CXCR5;IL12RB2;TNF;CD74
12324,GO:0048659,0.0109840941654171,0.995626093623788,13,88,smooth muscle cell proliferation,BP,IGFBP3;FGFR2;MMP9;TP53;EDN1;TPM1;ABCC4;CDH13;PDGFB;GPER1;AKR1B1;TNF;CCL5
8237,GO:0032991,0.0109981559179141,0.990990698955915,301,3841,protein-containing complex,CC,IGFBP3;MAFB;SAA1;FTL;FTH1;NEFL;HDAC9;MAP2;FN1;KIF23;AMOT;JPH2;GCLC;TFRC;C3;COL16A1;FGFR2;CBX5;COL5A3;HLA-B;UTP20;TAP1;HSPG2;MYO1B;ACTG1;PBX1;MAT2A;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;MID1;TP53;ABCF1;C1QTNF1;KBTBD8;RBM4;GEMIN5;PABPC4;STAG1;LGALS3;PPAN;CNTNAP1;RBM22;TGS1;PDLIM1;SRSF2;PPP1R3B;COL12A1;RAD1;IL6ST;HNRNPF;PDCD11;DKC1;INHBA;NUP50;CAMK1G;DNHD1;SYK;NUP153;ZFP42;RELB;NBN;LEPR;SHISA9;MCM5;ABCG2;LRRC8D;HLA-F;CDK4;VPS41;AP3M2;POP1;HLA-DOB;HEATR1;MCM2;GEMIN4;VPS8;TSR1;H3F3A;COL4A1;AHR;KEAP1;NAA15;RPA1;AP5M1;POLR1A;ZMAT2;METTL21A;PTPRB;METTL1;TAF2;POLA1;KCNS3;G3BP1;GRWD1;PARD3B;IMMP2L;ELMSAN1;NDC1;DYNLL2;HNRNPA1L2;MDN1;CASC3;RRAGB;MRPL27;RFC3;MYBL2;NOP58;HSPB1;LCP1;GTF3C6;KDM6A;DDX28;THOC1;RAN;RRP7BP;RANBP2;VCPKMT;ANAPC15;ORC4;SUPT16H;CORO1C;DDX3X;NUFIP1;KLHL21;ITGAV;SOCS1;SET;ARNTL;MRTO4;TAF1D;ABCF2;AJUBA;SMC2;KCNQ5;CGNL1;UTP14A;SNX5;TRIM37;MCM3;LUC7L;CDCA5;PPP4R4;GNL3L;NVL;GATC;CDH13;COL5A2;GINS4;RRP1;RARS;LUC7L2;NPNT;WDR3;MCM8;UTP18;BRCC3;EIF3J;FZD1;UTY;NFE2L1;CLU;NUP160;NAA50;PIK3R3;RRM2;NUP54;EYA3;EFTUD2;TPM4;KANSL1L;MCM6;KLHL9;RRP36;TIMM23B;ABCC9;TTF2;JPH1;SRPRB;TJP1;SLC11A2;BLOC1S2;APEX1;CNTNAP2;ORC1;HSPA8;TMEM199;HSP90AB1;EPHB6;MYH11;M6PR;PRIM2;ANAPC7;PXMP2;BRCA2;HPS5;GEMIN8;SYNCRIP;DGCR8;SKA2;E2F8;CENPF;GOSR1;POLR2F;FCF1;RAB3GAP1;CHEK1;SRFBP1;BBS5;FAF1;RRM1;RAD18;BMS1;MCM4;MYO10;PSME2;UBAP2L;MSH6;CFLAR;PSMB9;EIF2B5;NOL11;SDHD;TRMT61A;CBLL1;SHTN1;DPYSL3;TAF6L;MRPS7;NCBP1;UPF3B;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;MSH3;TELO2;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;TAP2;TIMELESS;ORC2;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;CLOCK;NSA2;KIF14;PURB;MPP5;SYNPO2;ESR1;CLCC1;GJC1;RRP15;RNF19B;RAD51B;CENPN;WDR4;PDSS1;RC3H1;CD74;WDR36;HNRNPU;RING1;MAK16;PSMB10;EIF2B1;DAXX;DCTN5;HIST1H4A;TAF1;TBPL1;ZNHIT6;SMARCC1;PPARGC1B;HNRNPM;CDKN1A;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;CENPO;GPX4;BUD13;COPS3;DHX15
7342,GO:0031347,0.0110984290676052,0.992939835320455,46,458,regulation of defense response,BP,KRT1;SAA1;C1R;C3;NLRC5;SLC7A2;IL1R2;TRAF3;IFNGR1;CYLD;IKBKE;IL6ST;SYK;RELB;PTGER4;MUC16;GBP5;SOCS1;PARP14;CHID1;CLU;BIRC3;IL20;IFNAR1;ERAP1;SYT11;HSP90AB1;FANCD2;SERPINB9;GPER1;PSME2;PSMB9;POLR3B;CLOCK;TLR3;ESR1;DNASE1;TNF;CCL5;PSMB10;NRAS;PSPC1;MUC5B;MUC6;IRF1;IRAK3
13774,GO:0060330,0.0111048221828906,0.997982496553313,5,20,regulation of response to interferon-gamma,BP,NLRC5;IFNGR1;SOCS1;PARP14;HSP90AB1
13778,GO:0060334,0.0111048221828906,0.997982496553313,5,20,regulation of interferon-gamma-mediated signaling pathway,BP,NLRC5;IFNGR1;SOCS1;PARP14;HSP90AB1
2378,GO:0005506,0.0111292867675132,0.995557739765446,13,89,iron ion binding,MF,FTL;FTH1;CYP1B1;CYP24A1;CYP1A1;SCD;P3H2;P4HA2;HIF1AN;TET3;SCD5;CYP20A1;FTO
12922,GO:0051249,0.0111586981580391,0.99381683115323,28,249,regulation of lymphocyte activation,BP,MAP3K14;TFRC;RUNX1;LGALS3;CYLD;IL27RA;IL6ST;INHBA;IL7R;SYK;SFRP1;CD274;MIR17HG;AHR;SIRPA;THOC1;SOCS1;RIF1;FANCD2;MSH6;AP3B1;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;CDKN1A;IRF1
3695,GO:0008202,0.0112645659798792,0.99416234699814,23,197,steroid metabolic process,BP,CYP1B1;CYP24A1;CYP1A1;CLN6;PBX1;G6PD;TFCP2L1;PANK2;SCD;HMGCS1;LEPR;LSS;ADM;WNT4;RAN;AKR1C2;NFE2L1;SRD5A1;EBP;AKR1B1;ESR1;ARV1;TNF
3069,GO:0006636,0.0112946611774558,0.997456575338756,6,29,unsaturated fatty acid biosynthetic process,BP,PTGES;FADS3;EDN1;SCD;SCD5;CD74
16673,GO:0097529,0.0114428269022745,0.995597812368434,12,86,myeloid leukocyte migration,BP,SAA1;MTUS1;EDN1;LGALS3;TGFB2;SYK;PTGER4;CCL20;PDGFB;CSF1;CCL5;CD74
9377,GO:0035886,0.0114551563472353,0.9984592134354,4,13,vascular smooth muscle cell differentiation,BP,ADM;SRF;PDGFB;GPER1
11404,GO:0045765,0.0114623521018279,0.994163149933067,22,174,regulation of angiogenesis,BP,KRT1;HDAC9;PML;CYP1B1;AMOT;C3;STARD13;HSPG2;RUNX1;TGFB2;EMP2;SFRP1;ADAMTS9;ADM;PLK2;HSPB1;PTPRM;PGK1;ERAP1;PDCL3;TLR3;ITGB1BP1
2870,GO:0006363,0.0114783482610561,0.99739501717361,6,30,termination of RNA polymerase I transcription,BP,POLR1A;UBTF;TAF1D;POLR2F;POLR1E;GTF2H3
4412,GO:0010165,0.0115099555156425,0.997032589137906,7,33,response to X-ray,BP,TP53;SFRP1;NUCKS1;BRCC3;THBD;BRCA2;CDKN1A
7653,GO:0032059,0.0115483911623581,0.999101287240245,3,7,bleb,CC,TPM1;ANLN;PANX1
3700,GO:0008209,0.0116594118702285,0.99842342555049,4,13,androgen metabolic process,BP,ADM;WNT4;SRD5A1;ESR1
7810,GO:0032354,0.0117768629480256,0.998438608232712,4,12,response to follicle-stimulating hormone,BP,GCLC;HMGCS1;INHBA;SRD5A1
15449,GO:0071704,0.0120224585540776,0.990143091167294,595,7911,organic substance metabolic process,BP,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;C1R;TRIM16;FN1;TENM3;PTGES;PML;CYP1B1;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;TRIM22;CBX5;FADS3;CTGF;UTP20;MMP9;FBN1;GNPTAB;HSPG2;SLC7A2;RUNX1;CYP1A1;CLN6;IL1R2;B4GALT1;PBX1;G6PD;TSC22D3;FST;MAT2A;DDX17;SPON1;TRIM56;OVCH2;TFCP2L1;TRAF3;ENC1;IRS1;MID1;SLC16A9;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DDX47;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;LGALS3;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PUM3;GALNT18;CAMK1G;PHAX;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RELB;NBN;LEPR;TRIO;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;LDHAL6B;CDK4;SFRP1;POP1;RIPK4;GPCPD1;NUCKS1;HEATR1;ZDHHC6;WNT10A;MCM2;TARDBP;MIR17HG;GEMIN4;ABHD4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;APOL6;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;SLC5A6;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;TSN;ADAMTS9;SETDB1;PTGER4;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;HERC6;HNRNPA1L2;FOXRED2;MDN1;SLC1A3;EIF5;CASC3;CCL20;PLK2;ZNF512;MRPL27;MME;ZNF587;MUC16;UBQLN2;HSCB;FRK;DNTTIP2;BTN2A1;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;EXOG;PTPRM;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ZNF738;DDX3X;NAP1L1;NUFIP1;CPA4;IL24;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;TRPM7;AJUBA;FASTKD3;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;LFNG;ZC3H7B;PGK1;TRIM37;FEN1;MCM3;LUC7L;CDCA5;HACD2;SRBD1;PPP4R4;GNL3L;ZNF586;YRDC;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;GANC;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;SGK494;FZD1;IRX4;UTY;NFE2L1;ANTXR1;ISG20L2;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;ACKR3;RIF1;METTL16;TYW1;MCM6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;RPF2;UBP1;UPK3B;TRMT5;TTF2;DTX4;GLIPR2;DPY19L2P2;SEPHS2;NNT;WEE1;ZNF484;THADA;ERAP1;SLC11A2;APEX1;PDCL3;TNC;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;ANAPC7;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;KRT10;CCAR1;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;ADAM17;SENP1;RBMS3;ATR;PSME2;UBAP2L;MSH6;HADHB;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;EBP;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;TPRA1;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;UQCRB;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;RRP15;RNF19B;RAD51B;USP11;FEM1C;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;ZFP36L2;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
13959,GO:0060603,0.0120759627418458,0.997297682564002,6,25,mammary gland duct morphogenesis,BP,PML;FGFR2;WNT4;NTN1;CSF1;ESR1
995,GO:0002449,0.0121557698102409,0.994384957116582,17,134,lymphocyte mediated immunity,BP,C1R;TFRC;C3;EXO1;IL27RA;IL7R;EMP2;NBN;THOC1;CLU;RIF1;SERPINB9;MSH6;TRAF2;TNF;ATAD5;CD74
1117,GO:0002703,0.0122695991473299,0.994830051825044,14,103,regulation of leukocyte mediated immunity,BP,TFRC;C3;IL27RA;IL7R;SYK;THOC1;RIF1;SERPINB9;MSH6;TRAF2;TLR3;DNASE1;TNF;ATAD5
15498,GO:0071826,0.0122814752720585,0.993576203992743,23,205,ribonucleoprotein complex subunit organization,BP,GEMIN5;PPAN;RBM22;TGS1;SHQ1;GEMIN4;MDN1;NOP2;DDX28;RRP7BP;DDX3X;NUFIP1;MRTO4;LUC7L;LUC7L2;RPF2;HSP90AB1;GEMIN8;ATR;MRPS7;NCBP1;RC3H1;ZNHIT6
2649,GO:0005984,0.0123525349415525,0.999013906287155,3,7,disaccharide metabolic process,BP,B4GALT1;MGAM;GANC
1270,GO:0003044,0.0123749492412599,0.997670002465727,5,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,EDN1;C9ORF3;TPM1;MME;SOD2
11021,GO:0044837,0.0124797426236778,0.998999874176087,3,7,actomyosin contractile ring organization,BP,KIF23;RTKN2;ANLN
1120,GO:0002706,0.0125304734546339,0.995369808501701,11,74,regulation of lymphocyte mediated immunity,BP,TFRC;C3;IL27RA;IL7R;THOC1;RIF1;SERPINB9;MSH6;TRAF2;TNF;ATAD5
11949,GO:0046979,0.0126371362540635,0.999707906073908,2,3,TAP2 binding,MF,TAP1;HLA-F
3674,GO:0008173,0.0126788169367676,0.995885873146236,9,55,RNA methyltransferase activity,MF,TGS1;THUMPD3;METTL1;NOP2;METTL16;TRMT5;TRMT1;TRMT61A;WDR4
13662,GO:0060147,0.0126923390376074,0.994798706290151,13,106,regulation of posttranscriptional gene silencing,BP,NUP50;NUP153;H3F3A;NDC1;RAN;RANBP2;AJUBA;DND1;NUP160;NUP54;POLR2F;ESR1;HIST1H4A
14131,GO:0060966,0.0126923390376074,0.994798706290151,13,106,regulation of gene silencing by RNA,BP,NUP50;NUP153;H3F3A;NDC1;RAN;RANBP2;AJUBA;DND1;NUP160;NUP54;POLR2F;ESR1;HIST1H4A
7430,GO:0031526,0.0127016840878371,0.997108420628224,6,26,brush border membrane,CC,B4GALT1;SLC9A3R1;SLC22A5;SLC5A6;SLC11A2;HSP90AB1
15154,GO:0071229,0.0127920631645332,0.99392385466051,18,136,cellular response to acid chemical,BP,KRT13;GCLC;COL16A1;FGFR2;EDN1;AKAP8;CDK4;SFRP1;COL4A1;PTGER4;RRAGB;SOCS1;AKR1C2;BAIAP2;COL5A2;PDGFB;TNC;TNF
12921,GO:0051248,0.0128342826821788,0.990799120973673,81,892,negative regulation of protein metabolic process,BP,CRYAB;IGFBP3;NRG1;PML;GCLC;C3;GPRC5A;MMP9;IL1R2;G6PD;ENC1;DAPK3;EDN1;GBP1;DUSP14;CDKN2A;RBM4;CHP1;SLC9A3R1;INHBA;NUP50;NUP153;NAIP;CDK4;SFRP1;TARDBP;MIR17HG;H3F3A;DHFR;OPHN1;CD109;NDC1;HSPB1;RAN;RANBP2;CORO1C;DDX3X;ITGAV;SOCS1;SET;PARP14;AJUBA;DND1;ZC3H7B;PPP4R4;GNL3L;GADD45B;SH3RF2;MDM4;CLU;NUP160;ENPP1;BIRC3;NUP54;METTL16;PDCL3;HSP90AB1;BACE2;SYNCRIP;DGCR8;POLR2F;SERPINB9;GPER1;SENP1;NCBP1;HNRNPR;NCL;AZIN1;ESR1;PARD3;TNF;ZFP36L2;RC3H1;TYMS;FGFR1OP;HIST1H4A;TAF1;SMARCC1;CDKN1A;ITGB1BP1;IRAK3
3676,GO:0008175,0.0128589487274879,0.997033920213465,6,28,tRNA methyltransferase activity,MF,THUMPD3;METTL1;TRMT5;TRMT1;TRMT61A;WDR4
20289,GO:2001212,0.0129146883763059,0.998951472562219,3,7,regulation of vasculogenesis,BP,EMP2;ADM;HIF1AN
7431,GO:0031527,0.012956239471345,0.998281304131431,4,11,filopodium membrane,CC,PDPN;ITGAV;ANTXR1;MYO10
8241,GO:0033002,0.0130025669508327,0.994125364385382,16,118,muscle cell proliferation,BP,IGFBP3;FGFR2;MMP9;TP53;EDN1;TGFB2;MIR17HG;TPM1;ABCC4;CDH13;PDGFB;GPER1;CFLAR;AKR1B1;TNF;CCL5
502,GO:0001558,0.0133829011629145,0.992165527905639,32,289,regulation of cell growth,BP,CRYAB;IGFBP3;NRG1;FN1;PML;CYR61;CTGF;G6PD;TP53;EDN1;CDKN2A;TGFB2;INHBA;SFRP1;H3F3A;TMEM97;CXCL16;DDX3X;SRF;ENPP1;NEDD4L;SGK1;ZFYVE27;L1CAM;ADAM17;NTN1;SHTN1;NCBP1;KIF14;WDR36;FGFR1OP;CDKN1A
15235,GO:0071371,0.0133963399127762,0.998111371261726,4,13,cellular response to gonadotropin stimulus,BP,GCLC;HMGCS1;INHBA;CCNA2
10028,GO:0042448,0.013410981689992,0.99882541331939,3,8,progesterone metabolic process,BP,ADM;AKR1C2;SRD5A1
3989,GO:0008853,0.0134883346574089,0.999677140467928,2,3,exodeoxyribonuclease III activity,MF,RAD1;TREX1
20304,GO:2001238,0.0135537206624181,0.995920555076771,8,46,positive regulation of extrinsic apoptotic signaling pathway,BP,PML;DAPK3;CYLD;INHBA;SFRP1;GPER1;FAF1;TRAF2
12533,GO:0050657,0.0135871033533784,0.993076827875072,21,173,nucleic acid transport,BP,SRSF2;NUP50;PHAX;NUP153;NDC1;HNRNPA1L2;CASC3;AKAP8L;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;LRPPRC;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
12534,GO:0050658,0.0135871033533784,0.993076827875072,21,173,RNA transport,BP,SRSF2;NUP50;PHAX;NUP153;NDC1;HNRNPA1L2;CASC3;AKAP8L;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;LRPPRC;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
14583,GO:0070098,0.0136458763402656,0.997346580097273,5,22,chemokine-mediated signaling pathway,BP,EDN1;CCL20;ACKR3;CXCR5;CCL5
1178,GO:0002822,0.0137507592347222,0.994849385485309,11,74,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TFRC;C3;IL27RA;IL7R;THOC1;RIF1;MSH6;TRAF2;TNF;ATAD5;RC3H1
16806,GO:0098609,0.0138979033037172,0.991040670260581,46,444,cell-cell adhesion,BP,TENM3;CYP1B1;MAP3K14;TFRC;CYR61;VMP1;FAT4;ACTG1;C1QTNF1;MEGF11;LGALS3;PDPN;TGFB2;CYLD;PDLIM1;PCDH7;IL6ST;IL7R;SYK;VEZT;CD274;CSRP1;HSPB1;WNT4;PTPRM;SIRPA;ATP2C1;ITGAV;SOCS1;AJUBA;BAIAP2;CDH13;SRF;NPNT;SDK1;PLEKHA7;MYO10;NTN1;CBLL1;CITED2;AP3B1;TNF;RC3H1;CCL5;CD74;IRF1
8918,GO:0034751,0.0139297821609833,0.9996607549556,2,3,aryl hydrocarbon receptor complex,CC,AHR;HSP90AB1
12592,GO:0050727,0.0139761046037597,0.992848581386308,21,180,regulation of inflammatory response,BP,KRT1;SAA1;C1R;C3;SLC7A2;IL1R2;IL6ST;PTGER4;GBP5;CHID1;CLU;BIRC3;IL20;FANCD2;GPER1;CLOCK;TLR3;ESR1;DNASE1;TNF;CCL5
13978,GO:0060664,0.0141097133197216,0.999653993308256,2,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,FGFR2;TNF
15246,GO:0071384,0.014162352018367,0.995711728643913,8,45,cellular response to corticosteroid stimulus,BP,EDN1;ATP2B1;RAN;SRD5A1;GPER1;CFLAR;ZFP36L2;HNRNPU
10208,GO:0042803,0.0142100108375278,0.990604617397473,51,530,protein homodimerization activity,MF,CRYAB;MAFB;TENM3;PML;TFRC;FGFR2;UGT1A6;CBX5;S100P;TAP1;CLN6;G6PD;MID1;DAPK3;TPST1;GBP1;HMGCS1;TGFB2;IL6ST;ABCG2;KEAP1;TPM1;DYNLL2;HSPB1;ODC1;TRIM37;CDH13;SRF;HIF1AN;QDPR;PDGFB;ENPP1;TPM4;GLIPR2;SYT11;HSP90AB1;DGCR8;DPYD;E2F8;MTMR2;CENPF;HSF2;MMAA;UGT1A4;TIMELESS;CSF1;TYMS;CCL5;FGFR1OP;TREX1;IRAK3
10389,GO:0043200,0.0143049517981585,0.994344767010285,12,81,response to amino acid,BP,GCLC;COL16A1;CTGF;TP53;EDN1;NAIP;COL4A1;RRAGB;SOCS1;BAIAP2;COL5A2;TNF
10625,GO:0043604,0.0143154841432714,0.990136916237695,62,734,amide biosynthetic process,BP,GCLC;CYR61;ENC1;DAPK3;ABCF1;KBTBD8;RBM4;GEMIN5;PABPC4;ACO1;CARS2;CDKAL1;NUP50;PUM3;NUP153;CDK4;MIR17HG;H3F3A;USP16;DHFR;NDC1;EIF5;CASC3;MRPL27;HSPB1;RAN;RANBP2;DDX3X;MRTO4;AJUBA;FASTKD3;DND1;GATC;RARS;UGT8;EIF3J;NUP160;NUP54;LRPPRC;EFTUD2;METTL16;SYNCRIP;POLR2F;RBMS3;EIF2B5;MRPS7;DPH2;NCBP1;UPF3B;HNRNPR;NCL;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;EIF2B1;HIST1H4A;RBM8A;GTF2H3;RPS12
150,GO:0000305,0.0143326462813585,0.997159170985554,5,23,response to oxygen radical,BP,TXNRD1;NQO1;DHFR;SOD2;TNF
6702,GO:0030098,0.0143704925305108,0.992275266661019,24,203,lymphocyte differentiation,BP,MAFB;HDAC9;RUNX1;DOCK10;CYLD;INHBA;IL7R;SYK;RELB;LEPR;SFRP1;MIR17HG;PTGER4;WNT4;SOCS1;LFNG;SRF;FANCD2;ADAM17;AP3B1;ZFP36L2;RC3H1;CD74;IRF1
5527,GO:0016494,0.0144054367581326,0.999642776751181,2,3,C-X-C chemokine receptor activity,MF,ACKR3;CXCR5
7860,GO:0032415,0.0144271116187708,0.999641949600021,2,3,regulation of sodium:proton antiporter activity,BP,CHP1;SLC9A3R1
11577,GO:0046104,0.0144731346464717,0.999640191004293,2,3,thymidine metabolic process,BP,TK1;DPYD
11587,GO:0046125,0.0144731346464717,0.999640191004293,2,3,pyrimidine deoxyribonucleoside metabolic process,BP,TK1;DPYD
14448,GO:0061740,0.0145355305590531,0.999637801846377,2,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,CLU;HSPA8
17450,GO:1900186,0.0145646394574109,0.999636685317624,2,3,negative regulation of clathrin-dependent endocytosis,BP,UBQLN2;SYT11
6598,GO:0022612,0.0145726712721496,0.99398611142673,13,86,gland morphogenesis,BP,PML;FGFR2;B4GALT1;TGFB2;SLC9A3R1;SFRP1;WNT4;TNC;NTN1;CFLAR;CSF1;ESR1;TNF
14823,GO:0070537,0.014593704572036,0.999635569237849,2,3,histone H2A K63-linked deubiquitination,BP,USP16;BRCC3
11082,GO:0045066,0.0146058089692216,0.99784697551037,4,14,regulatory T cell differentiation,BP,RUNX1;SOCS1;FANCD2;IRF1
11296,GO:0045589,0.0146058089692216,0.99784697551037,4,14,regulation of regulatory T cell differentiation,BP,RUNX1;SOCS1;FANCD2;IRF1
1180,GO:0002824,0.0146426281886904,0.995521970748949,8,47,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TFRC;C3;IL27RA;RIF1;MSH6;TRAF2;TNF;ATAD5
1011,GO:0002483,0.0146995775509787,0.998666931376515,3,8,antigen processing and presentation of endogenous peptide antigen,BP,TAP1;ERAP1;TAP2
1904,GO:0004586,0.0147386638515418,0.999629984580406,2,3,ornithine decarboxylase activity,MF,ODC1;AZIN1
8420,GO:0033387,0.0147386638515418,0.999629984580406,2,3,putrescine biosynthetic process from ornithine,BP,ODC1;AZIN1
7458,GO:0031589,0.0147827127597522,0.991727193657589,27,225,cell-substrate adhesion,BP,FN1;CYR61;COL16A1;COL5A3;CTGF;CCDC80;DAPK3;GBP1;CDKN2A;PDPN;EMP2;SFRP1;ADAMTS9;WNT4;CORO1C;ITGAV;TRPM7;AJUBA;CDH13;SRF;NPNT;ANTXR1;WDPCP;L1CAM;CSF1;KIF14;ITGB1BP1
2044,GO:0004784,0.0148476384058531,0.999475345839301,2,4,superoxide dismutase activity,MF,NQO1;SOD2
5639,GO:0016721,0.0148476384058531,0.999475345839301,2,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,NQO1;SOD2
3144,GO:0006740,0.0148804179873033,0.999624493964398,2,3,NADPH regeneration,BP,G6PD;NNT
19767,GO:2000106,0.0150557744876942,0.994964741710623,9,56,regulation of leukocyte apoptotic process,BP,TSC22D3;TP53;CDKN2A;LGALS3;CD274;MIR17HG;ADAM17;CCL5;CD74
9338,GO:0035809,0.0150610331706186,0.998621463145095,3,8,regulation of urine volume,BP,EDN1;ADM;AKR1B1
12574,GO:0050707,0.0151650275420354,0.993676518738818,13,94,regulation of cytokine secretion,BP,SAA1;TRIM16;FN1;PML;IL1R2;GBP1;SYK;CD274;PTGER4;SOCS1;SYT11;TNF;PANX1
14678,GO:0070265,0.0152635723578345,0.99574968144337,7,40,necrotic cell death,BP,CYLD;TRPM7;BIRC3;CFLAR;TRAF2;TLR3;TNF
7851,GO:0032404,0.0152652652364274,0.998595580513252,3,8,mismatch repair complex binding,MF,ATR;MSH6;TREX1
15258,GO:0071398,0.0152718537529049,0.995805157322497,7,35,cellular response to fatty acid,BP,EDN1;AKAP8;CDK4;SFRP1;PTGER4;AKR1C2;TNC
11287,GO:0045578,0.0153699727497915,0.999605309515769,2,3,negative regulation of B cell differentiation,BP,INHBA;SFRP1
10004,GO:0042405,0.0154392690036138,0.997778132165555,4,12,nuclear inclusion body,CC,NUP153;NBN;RANBP2;RAD18
12935,GO:0051262,0.0154497167680309,0.993255805261444,14,118,protein tetramerization,BP,TP53;USP16;TK1;GBP5;SOD2;TRPM7;NUP54;SYT11;MTMR2;RRM1;PDSS1;CCL5;CD74;HIST1H4A
4591,GO:0010693,0.0155378747776081,0.999598650979647,2,3,negative regulation of alkaline phosphatase activity,BP,TGFB2;TNF
4755,GO:0010927,0.0155864450684788,0.994134455444114,11,61,cellular component assembly involved in morphogenesis,BP,ACTG1;EDN1;CNTNAP1;TPM1;SRF;UGT8;MYH11;MTMR2;CFLAR;MPP5;TBPL1
8521,GO:0033693,0.0155918488196293,0.999596502012033,2,3,neurofilament bundle assembly,BP,NEFL;NEFM
12568,GO:0050701,0.01562996619183,0.996201507295699,6,30,interleukin-1 secretion,BP,SAA1;TRIM16;PML;IL1R2;GBP5;PANX1
10245,GO:0042940,0.01564055636321,0.999594559185512,2,3,D-amino acid transport,BP,SLC1A3;NFKBIE
9877,GO:0042127,0.0156527301324066,0.988437129331058,93,1035,regulation of cell proliferation,BP,IGFBP3;FTH1;NRG1;KRT4;FN1;TNS3;PTGES;PML;CYP1B1;TFRC;CYR61;FOSL2;FGFR2;STAT5A;EPGN;CTGF;UTP20;MMP9;B4GALT1;PBX1;IRS1;TP53;EDN1;CDKN2A;PTPN14;LGALS3;PDPN;TGFB2;IFIT3;P3H2;IL6ST;SLC9A3R1;NUAK1;INHBA;IL7R;SYK;EMP2;BRIP1;CDK4;SFRP1;CD274;MIR17HG;AHR;TPM1;ABCC4;ADM;CD109;FRK;RHOG;NOP2;PTPRM;SOD2;NAP1L1;IL24;ITGAV;ODC1;AKR1C2;CDH13;SRF;MDM4;PDGFB;RTKN2;SMYD2;PDCL3;TNC;SGK1;BRCA2;DGCR8;CCAR1;IL12RB2;GPER1;ADAM17;NTN1;CFLAR;AKR1B1;CCNA2;CSF1;KIF14;ESR1;TNF;ATAD5;RC3H1;CCL5;CD74;HNRNPU;FGFR1OP;PHF14;FTO;NRAS;CDKN1A;ITGB1BP1;IRF1;CTCF
16317,GO:0090403,0.0157597348698554,0.999589791291459,2,3,oxidative stress-induced premature senescence,BP,TP53;ARNTL
10219,GO:0042825,0.0157646229631115,0.999589595308523,2,3,TAP complex,CC,TAP1;TAP2
5553,GO:0016556,0.0158496448892612,0.997567993179535,4,15,mRNA modification,BP,DKC1;PUS3;METTL16;TRMT61A
7432,GO:0031528,0.0158659685955361,0.997601801931345,4,14,microvillus membrane,CC,S100P;PDPN;SLC9A3R1;ITGAV
14663,GO:0070234,0.0159238873411597,0.998445406644932,3,9,positive regulation of T cell apoptotic process,BP,TP53;CD274;CCL5
13863,GO:0060443,0.0159475221269349,0.995581165775792,7,35,mammary gland morphogenesis,BP,PML;FGFR2;B4GALT1;WNT4;NTN1;CSF1;ESR1
1383,GO:0003278,0.0159671693676962,0.999581444831867,2,3,apoptotic process involved in heart morphogenesis,BP,CYR61;TGFB2
2031,GO:0004768,0.0162970653440699,0.999568046625232,2,3,stearoyl-CoA 9-desaturase activity,MF,SCD;SCD5
5392,GO:0016215,0.0162970653440699,0.999568046625232,2,3,acyl-CoA desaturase activity,MF,SCD;SCD5
5640,GO:0016722,0.0163379397768443,0.997508344115351,4,14,oxidoreductase activity, oxidizing metal ions,MF,HEPHL1;FTH1;FRRS1;STEAP4
2021,GO:0004748,0.0164188535549739,0.999563062014232,2,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,RRM2;RRM1
2639,GO:0005971,0.0164188535549739,0.999563062014232,2,3,ribonucleoside-diphosphate reductase complex,CC,RRM2;RRM1
5646,GO:0016728,0.0164188535549739,0.999563062014232,2,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,RRM2;RRM1
14440,GO:0061731,0.0164188535549739,0.999563062014232,2,3,ribonucleoside-diphosphate reductase activity,MF,RRM2;RRM1
11407,GO:0045773,0.0164320297185774,0.995450612658092,7,33,positive regulation of axon extension,BP,NRG1;FN1;SRF;ZFYVE27;L1CAM;NTN1;SHTN1
631,GO:0001818,0.0164807187199233,0.991746067536663,19,160,negative regulation of cytokine production,BP,FN1;PML;NLRC5;IL1R2;TRAF3;GBP1;AKAP8;TGFB2;CYLD;IKBKE;INHBA;RELB;CD274;PTGER4;CHID1;SYT11;HSP90AB1;TNF;IRAK3
10892,GO:0044421,0.0164880737930657,0.986716420365568,198,2516,extracellular region part,CC,IL32;CRYAB;IGFBP3;SPRR3;KRT1;SAA1;FTL;FTH1;NRG1;KRT34;C1R;KRT13;FN1;KIF23;MTUS1;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;COL16A1;TXNRD1;FGFR2;UGT1A6;EPGN;COL5A3;S100P;CTGF;MMP9;FBN1;HSPG2;MYO1B;FAT4;B4GALT1;ACTG1;G6PD;SPON1;CCDC80;COL27A1;DYNC2H1;SVEP1;EDN1;DOCK10;SIPA1L3;TMEM106A;C1QTNF1;NQO1;COBLL1;LGALS3;CHP1;ACO1;TGFB2;PRSS23;TGS1;IL16;SRSF2;LRFN4;COL12A1;PGD;P3H2;IL6ST;SLC9A3R1;INHBA;SLC22A5;DNHD1;OLFML3;NAIP;SFRP1;KRT9;POP1;CD274;WNT10A;GEMIN4;DST;H3F3A;ATP2B1;COL4A1;HRNR;CSRP1;ADAMTS9;IGFL3;URM1;ADM;MGAM;CD109;CCL20;SLCO4C1;MME;MUC16;FRK;BTN2A1;HSPB1;RHOG;WNT4;CXCL16;LCP1;SIRPA;THOC1;RAN;SOD2;DDX3X;CPA4;IL24;ITGAV;QPCT;SMC2;KRT24;LFNG;PGK1;BAIAP2;CDH13;COL5A2;RARS;USB1;NPNT;QDPR;APMAP;PDGFB;CHID1;SDK1;TBC1D15;ANTXR1;CLU;NAA50;ENPP1;FRAS1;IL20;TPM4;THBD;UPK3B;GLIPR2;LRRN3;ERAP1;SLC11A2;TNC;HSPA8;GLIPR1L2;HSP90AB1;ARL6IP5;NSF;DNPEP;GREB1;LAIR1;MYH11;NEDD4L;NAV2;KRT10;MTMR2;PLEKHA7;L1CAM;STEAP4;FKBP5;RAB3GAP1;CHEK1;SERPINB9;HMGN2;RRM1;RPTN;NTN1;PSME2;HADHB;PSMB9;DNAJC9;CMTM3;HNRNPDL;DPYSL3;ESF1;TAF6L;AKR1B1;VPS36;MFAP5;NCL;CSF1;NAA16;MPHOSPH8;JMJD8;GLIPR1;IGFL1;MPP5;EHD1;DNASE1;TNF;SRSF7;CCL5;PLBD1;CD74;HIST1H4A;ZNHIT6;HIBCH;NRAS;MUC5B;HNRNPM;ITGB1BP1;NDUFB9;GBP6;GPX4;UFC1
2845,GO:0006323,0.0165007727478045,0.991880518842157,18,166,DNA packaging,BP,TP53;CDKN2A;AKAP8;MCM2;H3F3A;HELLS;GRWD1;AKAP8L;NAP1L1;SET;SMC2;CDCA5;GPER1;CENPN;DAXX;HIST1H4A;CTCF;CENPO
14051,GO:0060760,0.0165012953501742,0.995368342763628,7,37,positive regulation of response to cytokine stimulus,BP,NLRC5;EDN1;PARP14;ADAM17;TRAF2;CSF1;CD74
4760,GO:0010935,0.0165235436519461,0.998433124919024,3,8,regulation of macrophage cytokine production,BP,TGFB2;CD74;IRAK3
9429,GO:0035987,0.0165831088686917,0.995383899285753,7,34,endodermal cell differentiation,BP,FN1;MMP9;COL12A1;INHBA;ITGAV;COL5A2;SETD2
3940,GO:0008625,0.0166976589385277,0.993911966851164,10,66,extrinsic apoptotic signaling pathway via death domain receptors,BP,DDX47;LGALS3;SFRP1;DDX3X;BLOC1S2;FAF1;CFLAR;TRAF2;TNF;DAXX
7695,GO:0032142,0.0167536453863195,0.999549253507346,2,3,single guanine insertion binding,MF,MSH6;MSH3
1731,GO:0004322,0.0168065142007962,0.999547058777677,2,3,ferroxidase activity,MF,HEPHL1;FTH1
5642,GO:0016724,0.0168065142007962,0.999547058777677,2,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,HEPHL1;FTH1
258,GO:0000724,0.0169573767914127,0.992564208654154,14,101,double-strand break repair via homologous recombination,BP,NBN;NUCKS1;POLQ;RPA1;FEN1;GINS4;MCM8;RIF1;SETD2;HELQ;BRCA2;CHEK1;RFWD3;RAD51B
1308,GO:0003149,0.0169690078853527,0.998374403331072,3,8,membranous septum morphogenesis,BP,FGFR2;TGFB2;FZD1
1088,GO:0002673,0.0170501937333984,0.995758346484647,6,31,regulation of acute inflammatory response,BP,C1R;C3;IL6ST;CLU;DNASE1;TNF
8784,GO:0034455,0.0170629891177403,0.999536357283341,2,3,t-UTP complex,CC,HEATR1;NOL11
4619,GO:0010735,0.0170919684255296,0.999535142443286,2,3,positive regulation of transcription via serum response element binding,BP,MKL1;SRF
12631,GO:0050793,0.0171714057165883,0.986551637094684,145,1658,regulation of developmental process,BP,IGFBP3;MAFB;KRT1;NEFL;NRG1;HDAC9;TRIM16;MAP2;FN1;TENM3;PML;CYP1B1;AMOT;JPH2;TFRC;CYR61;C3;FGFR2;STAT5A;STARD13;CTGF;FBN1;HSPG2;RUNX1;FAT4;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;ENC1;DAPK3;EDN1;GBP1;RBM19;CDKN2A;RBM4;LGALS3;PDPN;TGFB2;CYLD;IL27RA;IL6ST;SLC9A3R1;NUAK1;INHBA;IL7R;PALM2;SYK;EMP2;TJP2;TRIO;CDK4;SFRP1;WNT10A;MIR17HG;H3F3A;KEAP1;TPM1;ULK4;ADAMTS9;ADM;CD109;PLK2;HSPB1;WNT4;PTPRM;THOC1;CORO1C;RRN3;ITGAV;SOCS1;ARNTL;LFNG;PGK1;LUC7L;CDC42EP2;BAIAP2;COL5A2;SRF;HIF1AN;NPNT;PDGFB;SDK1;FZD1;ENPP1;IL20;RIF1;FGD6;GLIPR2;LRRN3;ERAP1;PDCL3;HSP90AB1;NEDD4L;ZFYVE27;BRCA2;TRAK2;WDPCP;FANCD2;MTMR2;CENPF;L1CAM;GPER1;MYO10;SENP1;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;ABCA5;SHTN1;DPYSL3;RBBP5;CITED2;DDX56;CSF1;AP3B1;RBL1;CLOCK;KIF14;PURB;TLR3;ESR1;PARD3;EHD1;TNF;ATAD5;ZFP36L2;RC3H1;CD74;WDR36;HNRNPU;PSMB10;PHF14;HIST1H4A;PHLPP1;FTO;PPARGC1B;ITGB1BP1;IRF1;IRAK3
1476,GO:0003730,0.0172308688272102,0.994120361281955,9,54,mRNA 3'-UTR binding,MF,TP53;RBM4;GEMIN5;TARDBP;RBMS3;HNRNPR;ZFP36L2;RC3H1;HNRNPU
18069,GO:1902570,0.0173173884386506,0.998254405041864,3,9,protein localization to nucleolus,BP,POLR1A;RAN;RPF2
14657,GO:0070228,0.0173721795464025,0.995034857329148,7,40,regulation of lymphocyte apoptotic process,BP,TSC22D3;TP53;LGALS3;CD274;MIR17HG;CCL5;CD74
13553,GO:0055114,0.0173832995072196,0.987869124608311,63,718,oxidation-reduction process,BP,HEPHL1;FTH1;PTGES;CYP1B1;CYP24A1;TXNRD1;FADS3;CYP1A1;G6PD;IRS1;PANK2;SCD;NQO1;ACO1;PPP1R3B;PGD;P3H2;IL6ST;GFOD1;LEPR;LDHAL6B;DHFR;ABCC4;IMMP2L;P4HA2;FOXRED2;DOHH;KDM6A;SOD2;GPHN;FASTKD3;CROT;AKR1C2;PGK1;FRRS1;HIF1AN;QDPR;UTY;ENPP1;RRM2;TYW1;SRD5A1;NNT;BLOC1S2;APEX1;TET3;SCD5;DPYD;CYB561D2;STEAP4;RRM1;HADHB;SDHD;AKR1B1;CYP20A1;IFI30;UQCRB;FLAD1;FTO;HIBCH;PPARGC1B;NDUFB9;GPX4
234,GO:0000491,0.0174456137741977,0.998236514041929,3,9,small nucleolar ribonucleoprotein complex assembly,BP,SHQ1;NUFIP1;ZNHIT6
1472,GO:0003725,0.0174775023103822,0.993601732298175,10,63,double-stranded RNA binding,MF,TFRC;DDX3X;YRDC;APTX;HSP90AB1;DDX21;DGCR8;TLR3;HNRNPU;DHX15
4322,GO:0009812,0.0175311569720288,0.998224549298662,3,9,flavonoid metabolic process,BP,UGT1A6;CYP1A1;UGT1A4
8756,GO:0034399,0.0175427543799461,0.991788541768722,16,119,nuclear periphery,CC,MAP2;PML;ENC1;TP53;STAG1;AKAP8;NUP153;POLA1;AKAP8L;THOC1;NUFIP1;CENPF;TELO2;HNRNPU;PSPC1;HNRNPM
12681,GO:0050866,0.0177390080922281,0.992164742142801,14,104,negative regulation of cell activation,BP,GCLC;C1QTNF1;LGALS3;CYLD;INHBA;SFRP1;CD274;THOC1;PDGFB;THBD;GPER1;RC3H1;CD74;IRF1
10099,GO:0042590,0.017763733786791,0.993810020609216,9,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,HLA-B;TAP1;HLA-F;ITGAV;PSME2;PSMB9;TAP2;IFI30;PSMB10
15958,GO:0072741,0.0177977460282789,0.999505202771551,2,3,protein localization to cell division site,BP,RTKN2;ANLN
18290,GO:1903119,0.0177977460282789,0.999505202771551,2,3,protein localization to actin cytoskeleton,BP,RTKN2;ANLN
18887,GO:1904498,0.0177977460282789,0.999505202771551,2,3,protein localization to mitotic actomyosin contractile ring,BP,RTKN2;ANLN
19503,GO:1990179,0.0177977460282789,0.999505202771551,2,3,protein localization to actomyosin contractile ring,BP,RTKN2;ANLN
1490,GO:0003824,0.0179491463747065,0.985023586218424,342,4350,catalytic activity,MF,HEPHL1;FTH1;DTX2;NRG1;HDAC9;C1R;PTGES;CYP1B1;KIF23;MAP3K14;FAM46B;GCLC;C3;CYP24A1;TXNRD1;FGFR2;UGT1A6;STAT5A;TRIM22;FADS3;MMP9;GNPTAB;TAP1;MYO1B;CYP1A1;B4GALT1;G6PD;MAT2A;DDX17;TRIM56;OVCH2;TRAF3;PLD5;IRS1;DYNC2H1;MID1;DAPK3;PANK2;EXO1;TPST1;C9ORF3;SCD;ABHD16B;GBP1;HMGCS1;DDX47;ABCF1;DUSP14;KBTBD8;TMPPE;ACSL3;ZBED1;PTPN14;NQO1;PRUNE2;ACO1;ST6GALNAC5;PRSS23;CARS2;CYLD;IKBKE;PKMYT1;TGS1;CDKAL1;PPP1R3B;PGD;P3H2;RAD1;NUAK1;DKC1;GALNT18;CAMK1G;DNHD1;SYK;TJP2;NAIP;GFOD1;RAB32;NBN;TRIO;PARP15;BRIP1;MCM5;ABCG2;LSS;ARFRP1;LDHAL6B;CDK4;SFRP1;POP1;RIPK4;GPCPD1;ZDHHC6;MCM2;ABHD4;POLQ;TSR1;ATP2B1;PUS3;USP16;KEAP1;NAA15;UAP1L1;DHFR;POLR1A;THUMPD3;HELLS;METTL21A;PTPRB;METTL1;ULK4;POLA1;RCE1;ABCC4;TSN;ADAMTS9;SETDB1;TK1;LSG1;G3BP1;URM1;MGAM;IMMP2L;P4HA2;USP43;GGCX;HERC6;DYNLL2;FOXRED2;MDN1;EIF5;PLK2;RRAGB;MME;FRK;GBP5;RFC3;RHOG;NOP2;DOHH;SUV39H2;EXOG;PTPRM;KDM6A;DDX28;SETD4;RAN;HMGXB3;RANBP2;HS3ST1;VCPKMT;SOD2;ATP2C1;ZNF738;DDX3X;RAB26;CPA4;GPHN;KLHL21;RNF115;CDC25A;PARP14;PARP8;QPCT;ODC1;ABCF2;TRPM7;FASTKD3;CGNL1;CROT;AKR1C2;LFNG;PGK1;TRIM37;FEN1;MCM3;HACD2;FRRS1;GNL3L;YRDC;GATC;SH3RF2;APTX;GINS4;IBA57;RARS;GDAP1;MDM4;USB1;HIF1AN;QDPR;APMAP;GANC;MCM8;PDGFB;UGT8;BRCC3;CHID1;SGK494;UTY;ISG20L2;USP6;SMYD2;NAA50;ENPP1;BIRC3;PIK3R3;DDX10;MBOAT1;RRM2;LRPPRC;EYA3;EFTUD2;TRUB2;DDX24;KANSL1L;METTL16;TYW1;MCM6;SRD5A1;KLHL9;SETD2;ABCC9;TRMT5;TTF2;DTX4;METTL13;DPY19L2P2;SEPHS2;NNT;WEE1;ERAP1;BLOC1S2;APEX1;PDCL3;TET3;UMPS;HSPA8;DDX21;EPHB6;SMUG1;BACE2;SCD5;NSF;DNPEP;HELQ;MYH11;NEDD4L;SGK1;PRIM2;BRCA2;NAV2;TRMT1;DGCR8;DPYD;PPIP5K1;MTMR2;STEAP4;FKBP5;POLR2F;CHEK1;MMAA;RRM1;RAD18;BMS1;MCM4;ADAM17;MYO10;SENP1;ATR;MSH6;HADHB;CFLAR;DDX60L;NOL9;PSMB9;RFWD3;ABCA5;SDHD;TRMT61A;CBLL1;UGT1A4;DPYSL3;TAF6L;DPH2;EBP;AKR1B1;SPSB1;POLR1E;UBE2J2;TRAF2;MSH3;RBBP5;CYP20A1;POLR3B;CCNA2;GTF3C4;POLE3;DDX56;TAP2;IFI30;UQCRB;NAA16;MPHOSPH8;CLOCK;KIF14;AZIN1;ESR1;RNF19B;RAD51B;USP11;DNASE1;WDR4;CAPN12;PDSS1;RC3H1;TYMS;CCL5;PLBD1;RING1;FGFR1OP;PSMB10;FLAD1;METAP2;PHLPP2;TAF1;PHLPP1;FTO;HIBCH;NRAS;THTPA;ABCA11P;CDKN1A;USP1;TREX1;GTF2H3;NDUFB9;GBP6;GPX4;IRAK3;DHX15;UFC1
424,GO:0001129,0.0181229512449204,0.999491180945114,2,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,TAF2;TAF1
425,GO:0001132,0.0181229512449204,0.999491180945114,2,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,TAF2;TAF1
4552,GO:0010631,0.0181493311072476,0.990033727093307,24,202,epithelial cell migration,BP,HDAC9;CYP1B1;AMOT;KRT2;STAT5A;STARD13;S100P;MMP9;EDN1;TGFB2;EMP2;ADAMTS9;PLK2;HSPB1;PTPRM;CORO1C;CDH13;SRF;PDGFB;ANLN;GLIPR2;WDPCP;ADAM17;ITGB1BP1
16108,GO:0090068,0.0181518052194509,0.989887886309481,25,219,positive regulation of cell cycle process,BP,PML;KIF23;EPGN;CTGF;CYP1A1;PBX1;TP53;EDN1;CDK4;PLK2;WNT4;RANBP2;DDX3X;CDC25A;FEN1;CDCA5;MDM4;PDGFB;APEX1;CXCR5;E2F8;KIF14;RAD51B;HNRNPU;CDKN1A
14735,GO:0070371,0.0182688402380588,0.990247920889329,22,186,ERK1 and ERK2 cascade,BP,FN1;CYR61;FGFR2;CTGF;GBP1;SLC9A3R1;SYK;PTGER4;CCL20;ITGAV;NPNT;PDGFB;ACKR3;GLIPR2;EPHB6;GPER1;CFLAR;TNF;ZFP36L2;CCL5;CD74;ITGB1BP1
259,GO:0000725,0.0183146595734848,0.991885024681604,14,102,recombinational repair,BP,NBN;NUCKS1;POLQ;RPA1;FEN1;GINS4;MCM8;RIF1;SETD2;HELQ;BRCA2;CHEK1;RFWD3;RAD51B
14036,GO:0060737,0.0183594019892336,0.999480897082067,2,3,prostate gland morphogenetic growth,BP,FGFR2;ESR1
4860,GO:0014070,0.0184442438350541,0.98717930505446,61,636,response to organic cyclic compound,BP,CRYAB;NEFL;PTGES;CYP1B1;GCLC;CYP24A1;CTGF;RUNX1;CYP1A1;G6PD;DDX17;TP53;EDN1;HMGCS1;ACSL3;NQO1;TGFB2;SRSF2;INHBA;CDK4;SFRP1;ATP2B1;AHR;DHFR;TAF2;ABCC4;TSN;ADM;RAN;ARNTL;ZC3H7B;GDAP1;PDGFB;SDK1;CLU;EFTUD2;SRD5A1;THBD;APEX1;TNC;HSP90AB1;DDX21;DGCR8;GPER1;CFLAR;NCBP1;CCNA2;CLOCK;TLR3;ESR1;TNF;ZFP36L2;TYMS;CCL5;HNRNPU;DAXX;PANX1;TAF1;PPARGC1B;CDKN1A;IRAK3
12385,GO:0048754,0.0185211991315146,0.99153512525998,15,106,branching morphogenesis of an epithelial tube,BP,PML;FGFR2;FAT4;B4GALT1;PBX1;EDN1;COL4A1;WNT4;SRF;NPNT;TNC;TIMELESS;CSF1;ESR1;TNF
10409,GO:0043231,0.0185447878927776,0.984693693224477,619,8298,intracellular membrane-bounded organelle,CC,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;TRIM47;FTL;FTH1;DTX2;NRG1;HDAC9;KRT4;TRIM16;MAP2;KRT13;FN1;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;KRT2;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;CLN6;B4GALT1;ACTG1;PBX1;G6PD;TSC22D3;DDX17;SPON1;FAM69B;TFCP2L1;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;DOCK10;DDX47;ABCF1;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;ACO1;AKAP8;PPAN;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;IKBKE;PKMYT1;TGS1;CDKAL1;IL16;IFIT3;SRSF2;FOXD2;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;HNRNPF;BAG1;PDCD11;NUAK1;DKC1;NUP50;PUM3;GALNT18;CAMK1G;PHAX;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;NBN;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;VPS41;KRT9;AP3M2;POP1;HLA-DOB;NUCKS1;PITHD1;HEATR1;ZDHHC6;MCM2;TARDBP;GEMIN4;ABHD4;DST;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;COA7;KEAP1;NAA15;TRA2A;ZNF827;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;METTL1;TAF2;POLA1;RCE1;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;TMEM97;LSG1;G3BP1;GRWD1;ZNF584;PARD3B;IMMP2L;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;CASC3;SYNPO2L;RRAGB;ZNF512;MRPL27;SLCO4C1;ZNF587;MUC16;UBQLN2;HSCB;FRK;DNTTIP2;GBP5;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;EXOG;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARMC5;RRN3;RRP12;CDC25A;SOCS1;SET;PARP14;ARNTL;MRTO4;TAF1D;ABCF2;AJUBA;SMC2;FASTKD3;UTP14A;DND1;ZNF267;CROT;RBMXL1;LFNG;ZC3H7B;RBM12;TRIM37;FEN1;MCM3;LUC7L;CDCA5;HACD2;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;GATC;SH3RF2;APTX;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;QDPR;WDR3;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;TBC1D15;IRX4;UTY;NFE2L1;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;DDX10;MBOAT1;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;MCM6;FGD6;SRD5A1;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;TRMT5;TTF2;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;NNT;IFNAR1;WEE1;ZNF484;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;DGCR8;SS18L2;KRT10;CCAR1;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;ZNFX1;STEAP4;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;HADHB;CEP152;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;RABEP2;ESF1;TAF6L;MRPS7;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;MSH3;TELO2;EDRF1;RBBP5;FAM208B;CITED2;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;AZIN1;SYNPO2;ESR1;CLCC1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;FEM1C;CENPN;ARV1;DNASE1;WDR4;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;TYMS;STARD7;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;DAXX;ZSCAN31;DCTN5;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15
4190,GO:0009266,0.018555081761596,0.990240012832748,21,177,response to temperature stimulus,BP,CRYAB;GCLC;TP53;BAG1;NUP50;NUP153;ATP2B1;RPA1;ADM;NDC1;RANBP2;NUP160;NUP54;HSPA8;HSP90AB1;HSF2;ATR;EIF2B5;EIF2B1;DAXX;CDKN1A
11363,GO:0045672,0.0185584981465789,0.997012128211801,4,15,positive regulation of osteoclast differentiation,BP,IL20;CSF1;TNF;PPARGC1B
3260,GO:0006930,0.0185620453561465,0.998159415347862,3,8,substrate-dependent cell migration, cell extension,BP,OPHN1;NTN1;SHTN1
5541,GO:0016525,0.0185812774651409,0.993146610139902,10,61,negative regulation of angiogenesis,BP,PML;AMOT;STARD13;HSPG2;TGFB2;ADAMTS9;PLK2;PTPRM;PGK1;ITGB1BP1
13772,GO:0060326,0.0186111267566594,0.990957962561622,17,143,cell chemotaxis,BP,SAA1;MTUS1;EDN1;LGALS3;TGFB2;IL16;SYK;CCL20;HSPB1;RHOG;CXCL16;PDGFB;CXCR5;ADAM17;CSF1;CCL5;CD74
2411,GO:0005581,0.0186515138958577,0.994682309485358,7,34,collagen trimer,CC,COL16A1;COL5A3;COL27A1;C1QTNF1;COL12A1;COL4A1;COL5A2
12,GO:0000023,0.0186626026279239,0.999467601277378,2,3,maltose metabolic process,BP,MGAM;GANC
1882,GO:0004558,0.0186626026279239,0.999467601277378,2,3,alpha-1,4-glucosidase activity,MF,MGAM;GANC
7888,GO:0032450,0.0186626026279239,0.999467601277378,2,3,maltose alpha-glucosidase activity,MF,MGAM;GANC
2370,GO:0005488,0.0187022388590675,0.985482739390403,752,10146,binding,MF,IL32;CRYAB;IGFBP3;HEPHL1;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT4;C1R;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;FAM46B;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;SPACA6;TSC22D3;FST;MAT2A;DDX17;SPON1;FAM69B;TRIM56;OVCH2;TFCP2L1;KRTAP2-3;CCDC80;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;MID1;SLC16A9;TP53;DAPK3;TUFT1;SVEP1;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;ABCF1;C1QTNF1;DUSP14;RBM19;KBTBD8;TMPPE;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;COBLL1;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;CNTNAP1;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL16;IFIT3;SRSF2;FOXD2;PCDH7;LRFN4;PPP1R3B;SUGP2;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;ANKRD52;IL7R;NUP50;SLC22A5;PALM2;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;GFOD1;RAB32;RELB;NBN;LEPR;TRIO;SHISA9;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;UTP15;ARFRP1;LRRC8D;LDHAL6B;ANKRD36B;HLA-F;CDK4;SFRP1;VPS41;POP1;HLA-DOB;RIPK4;GPCPD1;NUCKS1;HEATR1;ZDHHC6;CD274;WNT10A;MCM2;TARDBP;MIR17HG;LAYN;GEMIN4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;APOL6;KEAP1;NAA15;TRA2A;TCHH;ZNF827;HRNR;DHFR;RPA1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;IGFL3;SETDB1;PTGER4;TK1;TMEM97;LSG1;G3BP1;GRWD1;ARRDC1-AS1;ZNF584;TMEM248;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;CD109;P4HA2;ZNF407;ELMSAN1;CADPS2;DYNLL2;HNRNPA1L2;FOXRED2;MDN1;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;ZNF512;MRPL27;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;CXCL16;NOP2;DOHH;SUV39H2;LCP1;EXOG;PTPRM;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;RAN;HMGXB3;UBTF;LENG8;RANBP2;VCPKMT;TOPBP1;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;CPA4;IL24;ARHGEF28;GPHN;KLHL21;RRN3;RNF115;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;QPCT;TAF1D;ODC1;ABCF2;SNX11;TRPM7;AJUBA;SMC2;FASTKD3;KCNQ5;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;LFNG;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;SRBD1;FRRS1;PPP4R4;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;FNDC3B;MDM4;LUC7L2;HIF1AN;NPNT;QDPR;WDR3;ZNF234;GANC;WDR43;MCM8;PDGFB;UTP18;BRCC3;CHID1;EIF3J;SGK494;SDK1;FZD1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;FRAS1;CWF19L2;CBWD5;ZNF316;IL20;PIK3R3;DDX10;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;KANSL1L;ACKR3;RIF1;METTL16;TYW1;MCM6;FGD6;SRD5A1;SETD2;RRP36;GLIS2;ANLN;RPF2;UBP1;TMEM51;THBD;ABCC9;TTF2;DTX4;METTL13;GLIPR2;SRPRB;SEPHS2;NNT;IFNAR1;WEE1;TJP1;ZNF484;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;CXCR5;TNC;CNTNAP2;ZNF57;TET3;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;BRCA2;HPS5;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;DGCR8;MAPK1IP1L;DPYD;LIMCH1;CCAR1;SKA2;CYB561D2;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;L1CAM;ZNFX1;STEAP4;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;LNX2;CHEK1;IL12RB2;SRFBP1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;DDX60L;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;CBLL1;UGT1A4;GPATCH4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;ZNF608;TAF6L;MRPS7;DPH2;EBP;CSRP2;NCBP1;MYNN;UPF3B;SPSB1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;TPRA1;MSH3;TELO2;RBBP5;CYP20A1;FAM208B;CITED2;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;IGFL1;KIF14;PURB;TLR3;MPP5;AZIN1;SYNPO2;ESR1;PARD3;NOP16;RNF19B;RAD51B;USP11;EHD1;KCNE4;FEM1C;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;C8ORF33;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;DCTN5;METAP2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;ZNHIT6;FTO;CCDC50;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;TREX1;ZNF471;IRF1;CTCF;SLC41A2;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GBP6;CENPO;GPX4;IRAK3;BUD13;TMEM234;COPS3;DHX15;UFC1
15002,GO:0070897,0.0187819759073067,0.994559313836783,7,39,DNA-templated transcriptional preinitiation complex assembly,BP,TP53;TAF2;UBTF;RRN3;TAF6L;ESR1;TAF1
8516,GO:0033688,0.0187891713046928,0.99700936814459,4,14,regulation of osteoblast proliferation,BP,CYR61;FGFR2;SFRP1;ITGAV
2794,GO:0006235,0.0188692373912273,0.999241712257724,2,4,dTTP biosynthetic process,BP,TYMS;TBPL1
4151,GO:0009212,0.0188692373912273,0.999241712257724,2,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,TYMS;TBPL1
11559,GO:0046075,0.0188692373912273,0.999241712257724,2,4,dTTP metabolic process,BP,TYMS;TBPL1
14919,GO:0070717,0.0188832621340513,0.996038274106973,5,21,poly-purine tract binding,MF,PABPC4;DDX3X;SYNCRIP;RBMS3;HNRNPU
1111,GO:0002697,0.0190986911537583,0.989590181469929,23,204,regulation of immune effector process,BP,C1R;TFRC;C3;TRAF3;LGALS3;TGFB2;IL27RA;IL7R;SYK;THOC1;CLU;BIRC3;RIF1;SERPINB9;MSH6;TRAF2;TLR3;DNASE1;TNF;ATAD5;RC3H1;CD74;IRAK3
15236,GO:0071372,0.0191091216700003,0.998083830541999,3,8,cellular response to follicle-stimulating hormone stimulus,BP,GCLC;HMGCS1;INHBA
9541,GO:0036265,0.0191188308485936,0.9992262177771,2,4,RNA (guanine-N7)-methylation,BP,METTL1;WDR4
3211,GO:0006855,0.0191511712575873,0.993857483497626,8,46,drug transmembrane transport,BP,SLC7A2;SLC4A11;SLC22A5;ABCG2;SLC1A3;ARL6IP5;EBP;SLC25A22
1097,GO:0002683,0.0191593015370831,0.988875484606529,28,265,negative regulation of immune system process,BP,MAFB;NLRC5;FBN1;TSC22D3;GBP1;LGALS3;TGFB2;CYLD;IL27RA;INHBA;IL7R;TJP2;SFRP1;HLA-DOB;CD274;PTGER4;THOC1;PARP14;SERPINB9;GPER1;LILRB3;TLR3;TNF;RC3H1;CD74;HIST1H4A;IRF1;IRAK3
4506,GO:0010543,0.0191844188758082,0.995928868336647,5,22,regulation of platelet activation,BP,C1QTNF1;PDPN;SYK;PDGFB;THBD
6748,GO:0030165,0.0191886137177931,0.99288590774159,10,61,PDZ domain binding,MF,SLC9A3R1;SLC22A5;SHISA9;ATP2B1;BAIAP2;FZD1;NSF;LNX2;ADAM17;KIF14
16150,GO:0090132,0.0192558085501321,0.989365805497021,24,203,epithelium migration,BP,HDAC9;CYP1B1;AMOT;KRT2;STAT5A;STARD13;S100P;MMP9;EDN1;TGFB2;EMP2;ADAMTS9;PLK2;HSPB1;PTPRM;CORO1C;CDH13;SRF;PDGFB;ANLN;GLIPR2;WDPCP;ADAM17;ITGB1BP1
11487,GO:0045927,0.0192821764432697,0.989830630329317,21,171,positive regulation of growth,BP,NRG1;FN1;FGFR2;TFCP2L1;EDN1;TGFB2;SFRP1;MIR17HG;H3F3A;CXCL16;DDX3X;SRF;NEDD4L;ZFYVE27;L1CAM;ADAM17;NTN1;SHTN1;NCBP1;CSF1;FGFR1OP
8891,GO:0034698,0.0192850472168733,0.995931773573641,5,21,response to gonadotropin,BP,GCLC;HMGCS1;INHBA;SRD5A1;CCNA2
12780,GO:0051030,0.019299854034625,0.999214909694533,2,4,snRNA transport,BP,PHAX;RAN
3387,GO:0007166,0.0193304884037005,0.984643923241745,160,1880,cell surface receptor signaling pathway,BP,IL32;IGFBP3;SAA1;DTX2;NRG1;FN1;PML;MAP3K14;GCLC;CYR61;GPRC5A;COL16A1;NLRC5;FGFR2;STAT5A;EPGN;TRIM22;CTGF;HLA-B;MMP9;FBN1;XAF1;RUNX1;IL1R2;FAT4;ACTG1;PBX1;FST;TRAF3;IRS1;SPG21;MID1;TP53;DAPK3;EDN1;GBP1;DDX47;JRK;LGALS3;IFNGR1;TGFB2;CYLD;IL27RA;IL16;IFIT3;IL6ST;HNRNPF;BAG1;SLC9A3R1;INHBA;IL7R;PALM2;SYK;EMP2;TJP2;NAIP;RELB;LEPR;TRIO;SHISA9;HLA-F;CDK4;SFRP1;NUCKS1;CD274;WNT10A;MIR17HG;DST;COL4A1;G3BP1;TRAF1;CD109;CCL20;MUC16;FRK;BTN2A1;HSPB1;WNT4;LCP1;KDM6A;SOD2;DDX3X;IL24;ARHGEF28;RNF115;ITGAV;SOCS1;PARP14;ARNTL;LFNG;NETO1;BAIAP2;CDH13;PHACTR4;HIF1AN;NPNT;PDGFB;KREMEN2;FZD1;ENPP1;BIRC3;IL20;PIK3R3;EYA3;ZNF106;ACKR3;GLIS2;DTX4;IFNAR1;BLOC1S2;CXCR5;HSPA8;HSP90AB1;EPHB6;ZFYVE27;WDPCP;FANCD2;MTMR2;POLR2F;RAB3GAP1;IL12RB2;GPER1;FAF1;ADAM17;MYO10;RBMS3;PSME2;LILRB3;CFLAR;PSMB9;EIF2B5;CMTM3;HNRNPDL;SHTN1;NCBP1;TRAF2;CITED2;IFI30;CSF1;TLR3;ESR1;PARD3;TNF;NEDD9;RC3H1;CCL5;CD74;PSMB10;EIF2B1;DAXX;PHF14;NRAS;SMARCC1;MUC5B;HNRNPM;CDKN1A;ITGB1BP1;MUC6;IRF1;IRAK3
7445,GO:0031570,0.0193455165487653,0.990151345191927,19,157,DNA integrity checkpoint,BP,PML;MAP3K14;TP53;RAD1;NBN;BRIP1;PLK2;WDR76;THOC1;TOPBP1;MDM4;BRCC3;E2F8;CHEK1;ATR;RFWD3;TIMELESS;CLOCK;CDKN1A
12431,GO:0048863,0.0194182492620238,0.989696516391385,21,201,stem cell differentiation,BP,NRG1;FGFR2;RUNX1;EDN1;KBTBD8;TGFB2;SFRP1;WNT10A;H3F3A;CORO1C;PHACTR4;SRF;FZD1;SETD2;PSME2;PSMB9;ESR1;ZFP36L2;HNRNPU;PSMB10;HIST1H4A
4536,GO:0010605,0.0194404167039837,0.984496172410163,166,2019,negative regulation of macromolecule metabolic process,BP,CRYAB;IGFBP3;NRG1;HDAC9;PML;GCLC;C3;GPRC5A;FGFR2;TRIM22;CBX5;CTGF;MMP9;IL1R2;G6PD;TSC22D3;FST;DDX17;TFCP2L1;ENC1;TP53;DAPK3;EDN1;GBP1;DUSP14;CDKN2A;RBM4;PABPC4;CHP1;TGFB2;IRX2;SRSF2;SLC9A3R1;DKC1;INHBA;NUP50;NUP153;NAIP;RELB;NBN;PARP15;BRIP1;SHQ1;CDK4;SFRP1;TARDBP;MIR17HG;POLQ;H3F3A;AHR;DHFR;GLIS3;HELLS;TSN;SETDB1;OPHN1;CD109;NDC1;CASC3;ZNF587;UBQLN2;FRK;HSPB1;WNT4;SUV39H2;THOC1;RAN;RANBP2;CORO1C;DDX3X;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;AJUBA;FASTKD3;DND1;ZC3H7B;TRIM37;PPP4R4;GNL3L;ZNF586;GADD45B;SH3RF2;SRF;MDM4;HIF1AN;PDGFB;FZD1;CLU;NUP160;SMYD2;ENPP1;BIRC3;NUP54;LRPPRC;RIF1;METTL16;GLIS2;UBP1;UPK3B;APEX1;PDCL3;HSPA8;HSP90AB1;BACE2;NEDD4L;BRCA2;SYNCRIP;DGCR8;CCAR1;E2F8;MTMR2;CENPF;ETV6;POLR2F;SERPINB9;GPER1;SENP1;RBMS3;ATR;PSME2;MSH6;PSMB9;ZNF12;ZNF608;NCBP1;UPF3B;MSH3;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;AZIN1;ESR1;PARD3;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;HNRNPU;RING1;FGFR1OP;PSMB10;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;IRF1;CTCF;RBM8A;RPS12;IRAK3
12917,GO:0051240,0.0194436647030255,0.985567406902346,90,981,positive regulation of multicellular organismal process,BP,SAA1;NEFL;NRG1;HDAC9;TRIM16;FN1;TENM3;CYP1B1;AMOT;TFRC;CYR61;C3;FGFR2;STAT5A;CTGF;MMP9;RUNX1;B4GALT1;FST;ENC1;EDN1;C1QTNF1;RBM19;PDPN;TGFB2;CYLD;IL27RA;IL6ST;INHBA;IL7R;SLC22A5;SYK;CD274;MIR17HG;TPM1;PTGER4;ADM;CCL20;PLK2;GBP5;HSPB1;WNT4;DDX3X;RRN3;SOCS1;ARNTL;BAIAP2;SRF;HIF1AN;NPNT;PDGFB;FZD1;CLU;BIRC3;IL20;RIF1;SETD2;THBD;GLIPR2;LRRN3;ERAP1;PDCL3;NEDD4L;ZFYVE27;L1CAM;POLR2F;IL12RB2;GPER1;ADAM17;NTN1;MSH6;CFLAR;SHTN1;DPYSL3;TRAF2;CITED2;POLR3B;DDX56;CSF1;AP3B1;TLR3;PARD3;TNF;ATAD5;CD74;PANX1;PPARGC1B;ITGB1BP1;IRF1;IRAK3
598,GO:0001763,0.0194983508631615,0.990302041250531,18,136,morphogenesis of a branching structure,BP,PML;FGFR2;FAT4;B4GALT1;PBX1;EDN1;SFRP1;COL4A1;ADM;WNT4;SRF;NPNT;SETD2;TNC;TIMELESS;CSF1;ESR1;TNF
11470,GO:0045910,0.0195394497822358,0.995864022493479,5,21,negative regulation of DNA recombination,BP,POLQ;THOC1;RIF1;MSH6;MSH3
19478,GO:1990111,0.0195910418760417,0.999196596372957,2,4,spermatoproteasome complex,CC,PSMB9;PSMB10
13068,GO:0051539,0.0196653165948875,0.994222986749678,7,41,4 iron, 4 sulfur cluster binding,MF,ACO1;CDKAL1;BRIP1;POLA1;TYW1;PRIM2;DPYD
14933,GO:0070757,0.0196920089005364,0.998002336296744,3,8,interleukin-35-mediated signaling pathway,BP,IL27RA;IL6ST;IL12RB2
4378,GO:0010002,0.019804199534261,0.997986538178582,3,8,cardioblast differentiation,BP,NRG1;TGFB2;SRF
14371,GO:0061572,0.0198407579826673,0.990833329848527,15,111,actin filament bundle organization,BP,CTGF;MYO1B;SFRP1;TPM1;PTGER4;SYNPO2L;WNT4;LCP1;BAIAP2;SRF;SHTN1;DPYSL3;SYNPO2;NEDD9;ITGB1BP1
12572,GO:0050705,0.0198618500742022,0.999179428724292,2,4,regulation of interleukin-1 alpha secretion,BP,IL1R2;PANX1
38,GO:0000077,0.0199417748372502,0.990024985977623,18,147,DNA damage checkpoint,BP,PML;MAP3K14;TP53;RAD1;NBN;BRIP1;PLK2;WDR76;THOC1;TOPBP1;MDM4;BRCC3;E2F8;CHEK1;ATR;RFWD3;CLOCK;CDKN1A
6148,GO:0019430,0.0199799044832538,0.996630039068376,4,17,removal of superoxide radicals,BP,NQO1;DHFR;SOD2;TNF
1206,GO:0002863,0.0200463484108848,0.999167657894751,2,4,positive regulation of inflammatory response to antigenic stimulus,BP,C3;TNF
8703,GO:0034330,0.0200509360911195,0.988751698531448,25,205,cell junction organization,BP,FN1;COL16A1;VMP1;RUNX1;ACTG1;DAPK3;TGFB2;CNTNAP1;SFRP1;OPHN1;WNT4;CORO1C;AJUBA;CDH13;SRF;UGT8;SDK1;TJP1;WDPCP;PLEKHA7;MPP5;PARD3;GJC1;TNF;ITGB1BP1
5524,GO:0016491,0.0200668781015199,0.986658401308178,47,529,oxidoreductase activity,MF,HEPHL1;FTH1;CYP1B1;CYP24A1;TXNRD1;FADS3;CYP1A1;G6PD;SCD;NQO1;PGD;P3H2;GFOD1;LDHAL6B;DHFR;ABCC4;P4HA2;FOXRED2;DOHH;KDM6A;SOD2;GPHN;AKR1C2;PGK1;FRRS1;HIF1AN;QDPR;UTY;RRM2;SRD5A1;NNT;BLOC1S2;APEX1;TET3;SCD5;DPYD;STEAP4;RRM1;HADHB;SDHD;AKR1B1;CYP20A1;IFI30;UQCRB;FTO;NDUFB9;GPX4
16148,GO:0090130,0.0200852318820363,0.988861979070181,24,204,tissue migration,BP,HDAC9;CYP1B1;AMOT;KRT2;STAT5A;STARD13;S100P;MMP9;EDN1;TGFB2;EMP2;ADAMTS9;PLK2;HSPB1;PTPRM;CORO1C;CDH13;SRF;PDGFB;ANLN;GLIPR2;WDPCP;ADAM17;ITGB1BP1
2831,GO:0006298,0.0202239930473635,0.994770275473697,6,31,mismatch repair,BP,EXO1;RPA1;SETD2;MSH6;MSH3;TREX1
3259,GO:0006929,0.020239987124944,0.995676207476039,5,21,substrate-dependent cell migration,BP,FN1;OPHN1;NTN1;SHTN1;ITGB1BP1
1172,GO:0002792,0.020286386956568,0.992354780279647,10,68,negative regulation of peptide secretion,BP,FN1;PML;IL1R2;IRS1;GBP1;SFRP1;PTGER4;SYT11;TNF;CD74
12820,GO:0051095,0.0203128087391994,0.997823162540323,3,9,regulation of helicase activity,BP,TP53;MSH6;MSH3
11042,GO:0044877,0.020392203065166,0.985625264567554,64,666,protein-containing complex binding,MF,CRYAB;NRG1;FN1;CYR61;COL16A1;SACS;CBX5;COL5A3;CTGF;MMP9;FBN1;MYO1B;FST;IRS1;C1QTNF1;GEMIN5;LGALS3;SYK;EMP2;RAB32;HLA-DOB;DST;H3F3A;NAA15;TPM1;NEXN;LCP1;SUPT16H;CORO1C;DDX3X;ITGAV;AJUBA;NVL;CDH13;NPNT;PDGFB;NFE2L1;ANTXR1;CLU;SMYD2;ENPP1;TPM4;SRPRB;HSPA8;HSP90AB1;NSF;MYH11;M6PR;CENPF;HMGN2;RAD18;ADAM17;MYO10;ATR;MSH6;SHTN1;NAA16;CD74;HNRNPU;PANX1;SMARCC1;CDKN1A;ITGB1BP1;TREX1
5518,GO:0016477,0.0204231319404007,0.9849861424931,83,884,cell migration,BP,IGFBP3;SAA1;NRG1;HDAC9;FN1;TNS3;PML;CYP1B1;AMOT;MTUS1;KRT2;CYR61;STAT5A;STARD13;S100P;CTGF;MMP9;B4GALT1;TP53;DAPK3;EDN1;DOCK10;LGALS3;PDPN;TGFB2;IL16;SLC9A3R1;SYK;EMP2;SFRP1;CD274;TPM1;ULK4;ADAMTS9;PTGER4;OPHN1;CCL20;PLK2;NEXN;FRK;HSPB1;RHOG;WNT4;CXCL16;LCP1;PTPRM;SIRPA;SOD2;CORO1C;IL24;ITGAV;AJUBA;CDH13;PHACTR4;SRF;PDGFB;ACKR3;SETD2;ANLN;THBD;GLIPR2;APEX1;CXCR5;SGK1;CCAR1;WDPCP;L1CAM;GPER1;ADAM17;NTN1;CBLL1;SHTN1;DPYSL3;CITED2;CSF1;KIF14;TNF;NEDD9;CCL5;CD74;FGFR1OP;NRAS;ITGB1BP1
4647,GO:0010767,0.0204406324781933,0.999387208666152,2,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,CHEK1;TAF1
4723,GO:0010883,0.020515633379568,0.994697563341618,6,30,regulation of lipid storage,BP,C3;IKBKE;ITGAV;EHD1;TNF;FTO
8702,GO:0034329,0.0205915291292391,0.988901397808376,22,175,cell junction assembly,BP,FN1;COL16A1;VMP1;RUNX1;ACTG1;DAPK3;CNTNAP1;SFRP1;OPHN1;WNT4;CORO1C;AJUBA;CDH13;SRF;UGT8;TJP1;WDPCP;MPP5;PARD3;GJC1;TNF;ITGB1BP1
12815,GO:0051090,0.0206371576145285,0.987486643141281,32,304,regulation of DNA binding transcription factor activity,BP,CYP1B1;NLRC5;TRIM22;TRAF3;EDN1;CDKN2A;CHP1;CYLD;SYK;RIPK4;KEAP1;TRAF1;TRIM37;SRF;FZD1;CLU;NFKBIB;GLIS2;SGK1;FANCD2;FAF1;CFLAR;NFKBIE;TAF6L;TRAF2;CLOCK;TLR3;ESR1;TNF;TAF1;PPARGC1B;IRAK3
5685,GO:0016796,0.0207500369523931,0.993219829584941,8,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,EXO1;RAD1;FEN1;APTX;USB1;ISG20L2;APEX1;TREX1
14661,GO:0070232,0.0209038729252914,0.995407120854057,5,24,regulation of T cell apoptotic process,BP,TSC22D3;TP53;LGALS3;CD274;CCL5
4672,GO:0010818,0.0212271213326301,0.99768618638281,3,9,T cell chemotaxis,BP,CXCL16;ADAM17;CCL5
5385,GO:0016202,0.0213381511000324,0.991072124986615,12,81,regulation of striated muscle tissue development,BP,NRG1;HDAC9;JPH2;FGFR2;G6PD;TSC22D3;DDX17;EDN1;MIR17HG;ARNTL;LUC7L;CENPF
17814,GO:1901861,0.0213381511000324,0.991072124986615,12,81,regulation of muscle tissue development,BP,NRG1;HDAC9;JPH2;FGFR2;G6PD;TSC22D3;DDX17;EDN1;MIR17HG;ARNTL;LUC7L;CENPF
14526,GO:0065004,0.0213692281547638,0.988531643779042,21,213,protein-DNA complex assembly,BP,TP53;MCM2;H3F3A;RPA1;HELLS;TAF2;GRWD1;UBTF;NAP1L1;RRN3;SET;CENPF;TAF6L;ESR1;RAD51B;CENPN;DAXX;HIST1H4A;TAF1;GTF2H3;CENPO
18031,GO:1902475,0.0215943067232425,0.994352849506218,6,30,L-alpha-amino acid transmembrane transport,BP,SLC7A2;SLC7A5P2;SLC1A3;ARL6IP5;SLC43A2;SLC25A22
12795,GO:0051051,0.0216883034987846,0.987276028279365,28,262,negative regulation of transport,BP,CRYAB;NRG1;FN1;PML;MMP9;IL1R2;IRS1;EDN1;GBP1;LGALS3;CHP1;SLC9A3R1;INHBA;NUP153;SFRP1;PTGER4;UBQLN2;ITGAV;YRDC;ENPP1;THADA;SYT11;ARL6IP5;NEDD4L;MTMR2;TNF;CD74;ITGB1BP1
6105,GO:0019322,0.021714386436835,0.999058526747386,2,4,pentose biosynthetic process,BP,G6PD;PGD
5630,GO:0016705,0.0218322139828261,0.990431974515028,13,95,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,CYP1B1;CYP24A1;CYP1A1;SCD;P3H2;P4HA2;DOHH;AKR1C2;HIF1AN;TET3;SCD5;CYP20A1;FTO
20227,GO:2001044,0.0220593995579415,0.997559414416655,3,9,regulation of integrin-mediated signaling pathway,BP,EMP2;PHACTR4;ITGB1BP1
10622,GO:0043601,0.0220916176273946,0.995075646901868,5,24,nuclear replisome,CC,RPA1;POLA1;MCM3;PRIM2;PURB
8131,GO:0032813,0.0221601838818396,0.994108861716702,6,33,tumor necrosis factor receptor superfamily binding,MF,TRAF3;TRAF1;TRIM37;CFLAR;TRAF2;TNF
12163,GO:0048254,0.0221678417485536,0.999028027109281,2,4,snoRNA localization,BP,NOP58;ZNHIT6
18551,GO:1903707,0.0222512042461395,0.990558653622867,12,94,negative regulation of hemopoiesis,BP,MAFB;FBN1;CYLD;INHBA;TJP2;SFRP1;LILRB3;TLR3;RC3H1;CD74;HIST1H4A;IRF1
8388,GO:0033280,0.0222678836100822,0.995087057632747,5,22,response to vitamin D,BP,CYP24A1;SFRP1;ATP2B1;GDAP1;TNC
12158,GO:0048245,0.0223591678573255,0.99901505312876,2,4,eosinophil chemotaxis,BP,LGALS3;CCL5
19429,GO:1905907,0.0225274943598461,0.999003587341739,2,4,negative regulation of amyloid fibril formation,BP,CRYAB;CLU
13937,GO:0060574,0.0225755526542814,0.999000304972322,2,4,intestinal epithelial cell maturation,BP,TYMS;CDKN1A
10621,GO:0043596,0.0228878821048809,0.993063454577669,7,41,nuclear replication fork,CC,RPA1;POLA1;MCM3;GINS4;PRIM2;TIMELESS;PURB
18243,GO:1903011,0.0229507702887086,0.999266862402098,2,3,negative regulation of bone development,BP,FBN1;TJP2
20287,GO:2001205,0.0229507702887086,0.999266862402098,2,3,negative regulation of osteoclast development,BP,FBN1;TJP2
13931,GO:0060562,0.0229852002153206,0.986769435272709,26,222,epithelial tube morphogenesis,BP,PML;FGFR2;STARD13;FAT4;B4GALT1;PBX1;EDN1;TGFB2;IRX2;SFRP1;COL4A1;ADM;WNT4;KDM6A;PHACTR4;SRF;NPNT;FZD1;SETD2;TNC;BBS5;NTN1;TIMELESS;CSF1;ESR1;TNF
2889,GO:0006397,0.023014742618132,0.984944823065905,42,440,mRNA processing,BP,DDX17;DDX47;RBM4;GEMIN5;LGALS3;RBM22;TGS1;SRSF2;SUGP2;HNRNPF;PDCD11;TARDBP;GEMIN4;TRA2A;ZMAT2;HNRNPA1L2;CASC3;AKAP8L;THOC1;RBMXL1;LUC7L;LUC7L2;EFTUD2;TRUB2;METTL16;TTF2;HSPA8;GEMIN8;SYNCRIP;CCAR1;POLR2F;NCBP1;UPF3B;HNRNPR;SRSF7;HNRNPU;PSPC1;HNRNPM;RBM8A;GTF2H3;BUD13;DHX15
2432,GO:0005614,0.0231311494306415,0.997502084920142,3,8,interstitial matrix,CC,CCDC80;TNC;NAV2
172,GO:0000377,0.0231731159572329,0.986041735367132,30,299,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,DDX17;RBM4;GEMIN5;RBM22;TGS1;SRSF2;HNRNPF;GEMIN4;TRA2A;ZMAT2;CASC3;LUC7L;LUC7L2;EFTUD2;METTL16;HSPA8;GEMIN8;SYNCRIP;CCAR1;POLR2F;NCBP1;UPF3B;HNRNPR;SRSF7;HNRNPU;PSPC1;HNRNPM;RBM8A;BUD13;DHX15
184,GO:0000398,0.0231731159572329,0.986041735367132,30,299,mRNA splicing, via spliceosome,BP,DDX17;RBM4;GEMIN5;RBM22;TGS1;SRSF2;HNRNPF;GEMIN4;TRA2A;ZMAT2;CASC3;LUC7L;LUC7L2;EFTUD2;METTL16;HSPA8;GEMIN8;SYNCRIP;CCAR1;POLR2F;NCBP1;UPF3B;HNRNPR;SRSF7;HNRNPU;PSPC1;HNRNPM;RBM8A;BUD13;DHX15
3543,GO:0007567,0.0232284102866397,0.99737807220013,3,9,parturition,BP,CYP1A1;EDN1;ARNTL
12312,GO:0048634,0.0232404707108519,0.990148056244528,12,82,regulation of muscle organ development,BP,NRG1;HDAC9;JPH2;FGFR2;G6PD;TSC22D3;DDX17;EDN1;MIR17HG;ARNTL;LUC7L;CENPF
14228,GO:0061138,0.0233408763576787,0.988407615161819,17,129,morphogenesis of a branching epithelium,BP,PML;FGFR2;FAT4;B4GALT1;PBX1;EDN1;SFRP1;COL4A1;ADM;WNT4;SRF;NPNT;TNC;TIMELESS;CSF1;ESR1;TNF
9552,GO:0036296,0.0233522055551209,0.994718405858391,5,24,response to increased oxygen levels,BP,CYP1A1;TP53;CDK4;TMEM199;CDKN1A
5470,GO:0016363,0.0233681792465463,0.989668057668552,13,94,nuclear matrix,CC,PML;ENC1;TP53;STAG1;AKAP8;POLA1;AKAP8L;THOC1;NUFIP1;CENPF;HNRNPU;PSPC1;HNRNPM
17774,GO:1901698,0.0234032996285243,0.983161939768515,69,738,response to nitrogen compound,BP,NEFL;HDAC9;TRIM16;GCLC;COL16A1;STAT5A;CTGF;FBN1;IRS1;TP53;EDN1;HMGCS1;NQO1;SYK;NAIP;BRIP1;CDK4;SFRP1;NUCKS1;COL4A1;AHR;DHFR;ABCC4;TSN;ADM;FOXRED2;RRAGB;UBQLN2;RANBP2;SOCS1;ZC3H7B;BAIAP2;CDH13;COL5A2;QDPR;SDK1;ENPP1;PIK3R3;EFTUD2;ZNF106;SRD5A1;THBD;APEX1;HSP90AB1;DDX21;DGCR8;CCDC47;GPER1;CFLAR;EIF2B5;NCBP1;AKR1B1;UBE2J2;TRAF2;CCNA2;TIMELESS;TLR3;ESR1;TNF;TYMS;EIF2B1;DAXX;PANX1;TAF1;SMARCC1;PPARGC1B;CDKN1A;IRAK3;DHX15
5429,GO:0016279,0.0234158804199356,0.992186040142224,8,47,protein-lysine N-methyltransferase activity,MF,METTL21A;SETDB1;SUV39H2;SETD4;VCPKMT;SMYD2;SETD2;RBBP5
1108,GO:0002694,0.0234587134782123,0.985870494357165,30,286,regulation of leukocyte activation,BP,MAP3K14;TFRC;SLC7A2;RUNX1;LGALS3;CYLD;IL27RA;IL6ST;INHBA;IL7R;SYK;SFRP1;CD274;MIR17HG;AHR;SIRPA;THOC1;SOCS1;RIF1;FANCD2;GPER1;MSH6;AP3B1;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;CDKN1A;IRF1
2576,GO:0005862,0.023557939192052,0.998932355931627,2,4,muscle thin filament tropomyosin,CC,TPM1;TPM4
13626,GO:0060076,0.0236645142083494,0.995954543246414,4,14,excitatory synapse,CC,FGFR2;NETO1;BAIAP2;SYT11
13906,GO:0060525,0.0239530161157601,0.997377808559022,3,8,prostate glandular acinus development,BP,FGFR2;SFRP1;ESR1
2426,GO:0005604,0.0240072087457408,0.990284378189618,11,67,basement membrane,CC,FN1;FBN1;HSPG2;CCDC80;P3H2;DST;COL4A1;NPNT;FRAS1;TNC;NTN1
14976,GO:0070852,0.0240126358125459,0.999213610548935,2,3,cell body fiber,CC,SACS;SRD5A1
6448,GO:0021761,0.0240308120032583,0.990718006190674,10,65,limbic system development,BP,NEFL;FGFR2;RAN;SRF;SRD5A1;CNTNAP2;RAB3GAP1;EIF2B5;KIF14;PHLPP2
2847,GO:0006333,0.0241661496627672,0.988120765364305,16,156,chromatin assembly or disassembly,BP,TP53;CDKN2A;MCM2;H3F3A;HELLS;GRWD1;SUV39H2;SUPT16H;NAP1L1;SET;CENPN;DAXX;HIST1H4A;SMARCC1;CTCF;CENPO
18550,GO:1903706,0.0242539474036208,0.985072982030143,32,330,regulation of hemopoiesis,BP,MAFB;FBN1;RUNX1;LGALS3;CYLD;INHBA;IL7R;SYK;TJP2;SFRP1;MIR17HG;H3F3A;SOCS1;IL20;FANCD2;SENP1;PSME2;LILRB3;PSMB9;RBBP5;CSF1;AP3B1;PURB;TLR3;TNF;ZFP36L2;RC3H1;CD74;PSMB10;HIST1H4A;PPARGC1B;IRF1
10125,GO:0042634,0.0242637067627898,0.994488885982948,5,23,regulation of hair cycle,BP,FST;TGFB2;ARNTL;CLOCK;TNF
3626,GO:0008088,0.0243255443924626,0.991809414533852,8,48,axo-dendritic transport,BP,NEFL;AP3M2;DST;HSPB1;BLOC1S2;HSPA8;TRAK2;AP3B1
2415,GO:0005588,0.0243431885191755,0.999196755203451,2,3,collagen type V trimer,CC,COL5A3;COL5A2
684,GO:0001891,0.0243670308645098,0.99567807118634,4,16,phagocytic cup,CC,LCP1;SNX5;SYT11;TNF
7372,GO:0031414,0.0244076028128135,0.997191361581605,3,9,N-terminal protein acetyltransferase complex,CC,NAA15;NAA50;NAA16
3319,GO:0007028,0.0244401759932272,0.997303313129294,3,8,cytoplasm organization,BP,TFCP2L1;RRN3;ETV6
19577,GO:1990481,0.0245543326249112,0.998861796126029,2,4,mRNA pseudouridine synthesis,BP,DKC1;PUS3
15511,GO:0071865,0.0247929573524401,0.998844655284493,2,4,regulation of apoptotic process in bone marrow,BP,FGFR2;PLK2
15512,GO:0071866,0.0247929573524401,0.998844655284493,2,4,negative regulation of apoptotic process in bone marrow,BP,FGFR2;PLK2
12571,GO:0050704,0.0248190792214727,0.994265768749582,5,25,regulation of interleukin-1 secretion,BP,SAA1;TRIM16;PML;IL1R2;PANX1
3969,GO:0008757,0.0248524684190274,0.987815277721754,16,132,S-adenosylmethionine-dependent methyltransferase activity,MF,THUMPD3;METTL21A;METTL1;SETDB1;NOP2;SUV39H2;SETD4;VCPKMT;SMYD2;METTL16;SETD2;TRMT5;TRMT1;TRMT61A;RBBP5;WDR4
632,GO:0001819,0.0248595471003155,0.985386438506636,27,256,positive regulation of cytokine production,BP,SAA1;TRIM16;CYP1B1;C3;RUNX1;IL27RA;IL6ST;SYK;CD274;PTGER4;CCL20;GBP5;HSPB1;DDX3X;CLU;BIRC3;SETD2;POLR2F;IL12RB2;ADAM17;TRAF2;POLR3B;TLR3;TNF;CD74;PANX1;IRF1
11433,GO:0045830,0.0249073617425097,0.995551963233405,4,16,positive regulation of isotype switching,BP,TFRC;RIF1;MSH6;ATAD5
11952,GO:0046983,0.0249332855104605,0.981818894476135,73,854,protein dimerization activity,MF,CRYAB;MAFB;NEFL;TENM3;PML;GCLC;TFRC;FGFR2;UGT1A6;CBX5;S100P;TAP1;CLN6;PBX1;G6PD;MID1;TP53;DAPK3;TPST1;GBP1;HMGCS1;ZBED1;SLC4A11;TGFB2;IL6ST;INHBA;ABCG2;H3F3A;AHR;KEAP1;TPM1;DYNLL2;RRAGB;HSPB1;RAN;ARNTL;ODC1;SMC2;SNX5;TRIM37;CDH13;SRF;HIF1AN;QDPR;PDGFB;ENPP1;TPM4;GLIPR2;SYT11;HSP90AB1;DGCR8;DPYD;E2F8;MTMR2;CENPF;HSF2;MMAA;UGT1A4;TAF6L;POLE3;TIMELESS;CSF1;CLOCK;PDSS1;TYMS;CCL5;FGFR1OP;DAXX;PANX1;HIST1H4A;TAF1;TREX1;IRAK3
19790,GO:2000147,0.0250086034668083,0.984362480830679,34,323,positive regulation of cell motility,BP,HDAC9;FN1;CYR61;STAT5A;MMP9;TP53;DAPK3;EDN1;LGALS3;PDPN;TGFB2;CD274;CCL20;PLK2;HSPB1;CXCL16;SOD2;ITGAV;CDH13;PDGFB;ACKR3;GLIPR2;CCAR1;GPER1;ADAM17;NTN1;CBLL1;SHTN1;CSF1;TNF;CCL5;CD74;FGFR1OP;ITGB1BP1
16268,GO:0090305,0.0252117726852351,0.985318486022003,26,248,nucleic acid phosphodiester bond hydrolysis,BP,UTP20;EXO1;RAD1;POP1;TSR1;RPA1;TSN;G3BP1;RFC3;EXOG;FEN1;APTX;USB1;ISG20L2;ENPP1;LRPPRC;RRP36;APEX1;DGCR8;FCF1;BMS1;NOL9;NCBP1;DNASE1;TREX1;GTF2H3
5891,GO:0018026,0.025334691905661,0.997041958847096,3,9,peptidyl-lysine monomethylation,BP,SETD4;SMYD2;SETD2
3744,GO:0008283,0.025345790244366,0.980349580912401,115,1333,cell proliferation,BP,IGFBP3;FTH1;NRG1;KRT4;FN1;TNS3;PTGES;PML;CYP1B1;KRT2;TFRC;CYR61;FOSL2;TXNRD1;FGFR2;STAT5A;EPGN;CTGF;UTP20;MMP9;RUNX1;CYP1A1;FAT4;B4GALT1;PBX1;IRS1;TP53;EDN1;CDKN2A;PTPN14;LGALS3;PDPN;TGFB2;IFIT3;P3H2;IL6ST;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;SYK;EMP2;NBN;BRIP1;CDK4;SFRP1;CD274;MIR17HG;AHR;TPM1;HELLS;POLA1;ABCC4;ADM;CD109;CDV3;FRK;RHOG;WNT4;NOP2;PTPRM;SOD2;NAP1L1;IL24;RRN3;CDC25A;ITGAV;ODC1;AKR1C2;CDH13;GINS4;SRF;MDM4;PDGFB;RTKN2;CLU;SMYD2;PDCL3;TNC;SGK1;BRCA2;DGCR8;CCAR1;E2F8;CENPF;ETV6;IL12RB2;GPER1;RRM1;ADAM17;NTN1;CFLAR;AKR1B1;CITED2;CCNA2;CSF1;KIF14;PURB;ESR1;TNF;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;HNRNPU;FGFR1OP;PHF14;FTO;NRAS;CDKN1A;ITGB1BP1;IRF1;CTCF
12326,GO:0048661,0.0253623704641556,0.990696058130045,9,58,positive regulation of smooth muscle cell proliferation,BP,FGFR2;MMP9;EDN1;ABCC4;CDH13;PDGFB;AKR1B1;TNF;CCL5
728,GO:0001954,0.0254869121962761,0.992156661275301,7,38,positive regulation of cell-matrix adhesion,BP,COL16A1;EMP2;SFRP1;WNT4;CDH13;CSF1;ITGB1BP1
41,GO:0000083,0.0255627975921177,0.994078980162381,5,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,DHFR;POLA1;RRM2;ORC1;TYMS
3221,GO:0006873,0.0255641776424061,0.98386243792401,35,343,cellular ion homeostasis,BP,SAA1;FTL;FTH1;PML;JPH2;TFRC;CLN6;TP53;EDN1;C1QTNF1;CHP1;SLC4A11;ACO1;SLC30A6;SLC9A3R1;ABCG2;GPCPD1;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;ENPP1;JPH1;THADA;SLC11A2;RIC3;TMEM199;NEDD4L;TMEM165;GPER1;SLC9A9;ESR1;CCL5
393,GO:0001054,0.0255959282650364,0.996826221574625,3,11,RNA polymerase I activity,MF,POLR1A;POLR2F;POLR1E
12702,GO:0050896,0.025615295212092,0.978316848762359,431,5546,response to stimulus,BP,IL32;CRYAB;IGFBP3;SPRR3;KRT1;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;C1R;TRIM16;MAP2;KRT13;FN1;TENM3;PTGES;PML;CYP1B1;AMOT;MTUS1;JPH2;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;CYP24A1;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;TRIM22;STARD13;CBX5;S100P;CTGF;HLA-B;MMP9;FBN1;TAP1;HSPG2;XAF1;SLC7A2;RUNX1;CYP1A1;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;G6PD;TSC22D3;FST;MAT2A;DDX17;TRIM56;TRAF3;IRS1;SPG21;MID1;TP53;DAPK3;TUFT1;EXO1;EDN1;TPST1;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;ABCF1;C1QTNF1;DUSP14;CDKN2A;RBM4;ACSL3;PTPN14;JRK;NQO1;PABPC4;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;TGFB2;CNTNAP1;RBM22;CYLD;IKBKE;PDLIM1;IL27RA;IL16;IFIT3;SRSF2;SLC30A6;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;NUAK1;INHBA;IL7R;NUP50;SLC22A5;PALM2;CAMK1G;SYK;EMP2;TJP2;NUP153;NAIP;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;FAM111A;BRIP1;ABCG2;ARFRP1;LRRC8D;HLA-F;CDK4;SFRP1;HLA-DOB;NUCKS1;PITHD1;CD274;WNT10A;MCM2;MIR17HG;DST;POLQ;H3F3A;ATP2B1;COL4A1;USP16;AHR;APOL6;KEAP1;SLC5A6;HRNR;DHFR;RPA1;TPM1;CSRP1;PTPRB;TAF2;ULK4;POLA1;ABCC4;TSN;SETDB1;PTGER4;G3BP1;ARRDC1-AS1;TRAF1;OPHN1;ADM;MGAM;IMMP2L;CD109;USP43;GGCX;NDC1;CADPS2;DYNLL2;FOXRED2;SLC1A3;CCL20;PLK2;RRAGB;SLCO4C1;MME;MUC16;UBQLN2;FRK;GBP5;BTN2A1;RFC3;MYBL2;WDR76;HSPB1;RHOG;WNT4;CXCL16;NOP2;SUV39H2;LCP1;PTPRM;SIRPA;KDM6A;THOC1;RAN;RANBP2;TOPBP1;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;RAB26;IL24;ARHGEF28;GPHN;RRN3;RNF115;CDC25A;ITGAV;SOCS1;PARP14;ARNTL;QPCT;ODC1;AJUBA;CGNL1;AKR1C2;LFNG;ZC3H7B;PGK1;NETO1;FEN1;CDC42EP2;CDCA5;BAIAP2;GADD45B;APTX;CDH13;COL5A2;GINS4;PHACTR4;SRF;GDAP1;MDM4;HIF1AN;NPNT;QDPR;MCM8;PDGFB;BRCC3;CHID1;KREMEN2;SDK1;FZD1;NFE2L1;ANTXR1;RTKN2;CLU;NUP160;SMYD2;MACC1;ENPP1;BIRC3;IL20;PIK3R3;COMMD9;NUP54;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;ACKR3;RIF1;FGD6;SRD5A1;SETD2;GLIS2;RPF2;THBD;ABCC9;DTX4;GLIPR2;JPH1;SRPRB;IFNAR1;TJP1;ERAP1;SLC11A2;BLOC1S2;APEX1;CXCR5;TNC;CNTNAP2;UMPS;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;HELQ;LAIR1;NEDD4L;SGK1;M6PR;ZFYVE27;PXMP2;BRCA2;HPS5;SYNCRIP;HCAR1;DGCR8;WDPCP;FANCD2;E2F8;MTMR2;CENPF;L1CAM;HSF2;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;SERPINB9;BBS5;GPER1;HMGN2;FAF1;RRM1;RAD18;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;EIF2B5;CMTM3;RFWD3;NFKBIE;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;EBP;NCBP1;MYNN;AKR1B1;UBE2J2;TRAF2;TPRA1;MSH3;TELO2;RBBP5;CITED2;POLR3B;NCL;CCNA2;TAP2;TIMELESS;IFI30;CSF1;AP3B1;RBL1;CLOCK;GLIPR1;KIF14;TLR3;ESR1;PARD3;RNF19B;RAD51B;EHD1;DNASE1;TNF;ATAD5;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;CCL5;CD74;WDR36;HNRNPU;PSMB10;EIF2B1;DAXX;METAP2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;PHLPP1;FTO;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;SLC25A22;TREX1;IRF1;GTF2H3;GBP6;GPX4;IRAK3;COPS3;IFI27L1;DHX15;UFC1
11417,GO:0045793,0.0257484940238794,0.996974544887098,3,9,positive regulation of cell size,BP,EDN1;CDK4;HSP90AB1
20302,GO:2001236,0.0257511748572038,0.987657690407862,15,121,regulation of extrinsic apoptotic signaling pathway,BP,PML;GCLC;DAPK3;LGALS3;CYLD;INHBA;SFRP1;TRAF1;ITGAV;EYA3;GPER1;FAF1;CFLAR;TRAF2;TNF
171,GO:0000375,0.0258412499250053,0.984287553922429,30,302,RNA splicing, via transesterification reactions,BP,DDX17;RBM4;GEMIN5;RBM22;TGS1;SRSF2;HNRNPF;GEMIN4;TRA2A;ZMAT2;CASC3;LUC7L;LUC7L2;EFTUD2;METTL16;HSPA8;GEMIN8;SYNCRIP;CCAR1;POLR2F;NCBP1;UPF3B;HNRNPR;SRSF7;HNRNPU;PSPC1;HNRNPM;RBM8A;BUD13;DHX15
6851,GO:0030314,0.0259207681867106,0.99911451811842,2,3,junctional membrane complex,CC,JPH2;JPH1
15646,GO:0072126,0.0259775425169753,0.998758193471778,2,4,positive regulation of glomerular mesangial cell proliferation,BP,PDGFB;CFLAR
8447,GO:0033559,0.0259902720935751,0.990371978128827,9,63,unsaturated fatty acid metabolic process,BP,PTGES;CYP1B1;FADS3;CYP1A1;EDN1;SCD;AKR1C2;SCD5;CD74
10790,GO:0044237,0.0260196881360345,0.978195762269068,589,7891,cellular metabolic process,BP,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;TRIM16;FN1;PTGES;PML;CYP1B1;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;TRIM22;CBX5;FADS3;CTGF;UTP20;MMP9;FBN1;GNPTAB;VMP1;HSPG2;SLC7A2;RUNX1;CYP1A1;CLN6;IL1R2;B4GALT1;PBX1;G6PD;TSC22D3;FST;MAT2A;DDX17;SPON1;TRIM56;TFCP2L1;TRAF3;ENC1;IRS1;MID1;SLC16A9;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DDX47;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;LGALS3;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PUM3;GALNT18;CAMK1G;PHAX;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RELB;NBN;LEPR;TRIO;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;UTP15;LDHAL6B;CDK4;SFRP1;VPS41;POP1;RIPK4;GPCPD1;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;MIR17HG;GEMIN4;ABHD4;POLQ;TSR1;H3F3A;PUS3;USP16;AHR;KEAP1;NAA15;UAP1L1;TRA2A;ZNF827;SLC5A6;DHFR;RPA1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;TSN;DRAM1;ADAMTS9;SETDB1;PTGER4;TK1;G3BP1;GRWD1;ZNF584;TRAF1;URM1;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;MDN1;SLC1A3;EIF5;CASC3;CCL20;PLK2;RRAGB;ZNF512;MRPL27;MME;ZNF587;MUC16;UBQLN2;HSCB;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;EXOG;PTPRM;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ZNF738;DDX3X;NAP1L1;NUFIP1;CPA4;IL24;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;TRPM7;AJUBA;FASTKD3;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;LFNG;ZC3H7B;PGK1;SNX5;TRIM37;FEN1;MCM3;LUC7L;CDCA5;HACD2;SRBD1;PPP4R4;GNL3L;ZNF586;YRDC;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;GANC;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;SGK494;FZD1;IRX4;UTY;NFE2L1;ANTXR1;ISG20L2;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;TRUB2;DDX24;VGLL3;ACKR3;RIF1;METTL16;TYW1;MCM6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;RPF2;UBP1;TRMT5;TTF2;DTX4;GLIPR2;DPY19L2P2;SEPHS2;NNT;WEE1;ZNF484;THADA;ERAP1;SLC11A2;APEX1;PDCL3;TNC;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;ANAPC7;BRCA2;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;KRT10;CCAR1;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;WDR75;BMS1;MCM4;ADAM17;SENP1;RBMS3;ATR;PSME2;MSH6;HADHB;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;POLE3;DDX56;TIMELESS;ORC2;UQCRB;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;KIF14;PURB;TLR3;AZIN1;SYNPO2;ESR1;PARD3;RRP15;RNF19B;RAD51B;USP11;FEM1C;ARV1;DNASE1;TNF;WDR4;ATAD5;PDSS1;ZFP36L2;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
5428,GO:0016278,0.0261563642363696,0.991070252751196,8,48,lysine N-methyltransferase activity,MF,METTL21A;SETDB1;SUV39H2;SETD4;VCPKMT;SMYD2;SETD2;RBBP5
10549,GO:0043487,0.0261755171028954,0.986751726984363,17,148,regulation of RNA stability,BP,PABPC4;DKC1;TARDBP;HSPB1;SET;FASTKD3;METTL16;APEX1;HSPA8;SYNCRIP;PSME2;PSMB9;HNRNPR;ZFP36L2;RC3H1;HNRNPU;PSMB10
9811,GO:0040029,0.0263040973537078,0.984127246792396,29,291,regulation of gene expression, epigenetic,BP,RBM4;NUP50;NUP153;MIR17HG;H3F3A;POLR1A;HELLS;TSN;SETDB1;NDC1;RAN;RANBP2;TAF1D;AJUBA;DND1;ZC3H7B;NUP160;NUP54;RIF1;DDX21;DGCR8;POLR2F;CHEK1;NCBP1;POLR1E;ESR1;HNRNPU;HIST1H4A;CTCF
12915,GO:0051238,0.0264719150473356,0.996674375186236,3,11,sequestering of metal ion,BP,FTL;FTH1;SLC30A6
16547,GO:0097242,0.0265531073918934,0.995293927543503,4,14,amyloid-beta clearance,BP,C3;MME;SRF;CLU
763,GO:0002002,0.0266015882269156,0.998711736199179,2,4,regulation of angiotensin levels in blood,BP,C9ORF3;MME
764,GO:0002003,0.0266015882269156,0.998711736199179,2,4,angiotensin maturation,BP,C9ORF3;MME
9313,GO:0035751,0.0266800359273388,0.996637995161177,3,11,regulation of lysosomal lumen pH,BP,CLN6;TMEM199;TMEM165
2412,GO:0005583,0.0267680210642581,0.99693901683299,3,8,fibrillar collagen trimer,CC,COL5A3;COL27A1;COL5A2
16820,GO:0098643,0.0267680210642581,0.99693901683299,3,8,banded collagen fibril,CC,COL5A3;COL27A1;COL5A2
9884,GO:0042136,0.026780434116599,0.990069276021731,9,59,neurotransmitter biosynthetic process,BP,CYP1B1;SLC7A2;EDN1;NQO1;SLC1A3;CLU;HSP90AB1;DPYD;TNF
12570,GO:0050703,0.0268266677110255,0.998493204916924,2,5,interleukin-1 alpha secretion,BP,IL1R2;PANX1
11491,GO:0045933,0.0268391675991869,0.993669476446799,5,25,positive regulation of muscle contraction,BP,CTGF;EDN1;SRF;NPNT;GPER1
5749,GO:0016893,0.0268780209671886,0.99248549241984,6,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,EXO1;POP1;FEN1;APEX1;DGCR8;DNASE1
4820,GO:0014012,0.0268863380190192,0.998690331612622,2,4,peripheral nervous system axon regeneration,BP,NEFL;TNC
8752,GO:0034394,0.0269043989648258,0.991585662363769,7,40,protein localization to cell surface,BP,NRG1;EMP2;RIC3;HSP90AB1;NEDD4L;TNF;ASTN2
10735,GO:0044062,0.02691316843425,0.99868830813966,2,4,regulation of excretion,BP,EDN1;SLC9A3R1
10100,GO:0042592,0.0269530556087527,0.979502516256807,96,1101,homeostatic process,BP,MAFB;KRT1;SAA1;FTL;FTH1;PML;JPH2;GCLC;TFRC;TXNRD1;CTGF;CLN6;ACTG1;G6PD;TSC22D3;IRS1;TP53;EXO1;EDN1;DOCK10;C1QTNF1;CHP1;SLC4A11;ACO1;CYLD;SLC30A6;SLC9A3R1;DKC1;INHBA;IL7R;SLC22A5;SYK;NBN;LEPR;ABCG2;GPCPD1;NUCKS1;MIR17HG;ABHD4;ATP2B1;HRNR;RPA1;POLA1;PTGER4;TMEM97;ADM;RFC3;HSPB1;SOD2;ATP2C1;RRN3;ITGAV;TRPM7;FEN1;GNL3L;SRF;NFE2L1;ENPP1;COMMD9;RIF1;JPH1;THADA;SLC11A2;APEX1;RIC3;TMEM199;HSP90AB1;NEDD4L;PRIM2;BRCA2;TMEM165;STEAP4;CCDC47;GPER1;RPTN;ADAM17;SENP1;ATR;UBAP2L;AKR1B1;TELO2;SLC9A9;POLE3;CSF1;ESR1;EHD1;TNF;RC3H1;CCL5;CD74;WDR36;HNRNPU;HIST1H4A;FTO;PPARGC1B;MUC6
15843,GO:0072527,0.0270997959048147,0.989867184541625,9,65,pyrimidine-containing compound metabolic process,BP,TK1;TET3;UMPS;SMUG1;DPYD;RRM1;TYMS;TBPL1;THTPA
4468,GO:0010460,0.0271483313452708,0.996638848826207,3,10,positive regulation of heart rate,BP,EDN1;TPM1;ADM
680,GO:0001887,0.0273246911406715,0.998657129554546,2,4,selenium compound metabolic process,BP,TXNRD1;SEPHS2
2776,GO:0006206,0.0274006003784757,0.994903602631937,4,17,pyrimidine nucleobase metabolic process,BP,UMPS;DPYD;RRM1;TYMS
1911,GO:0004596,0.0275056440293933,0.996577150429253,3,10,peptide alpha-N-acetyltransferase activity,MF,NAA15;NAA50;NAA16
4551,GO:0010629,0.0275164707306626,0.97850371298167,119,1429,negative regulation of gene expression,BP,CRYAB;NRG1;HDAC9;PML;GCLC;FGFR2;CBX5;CTGF;IL1R2;TSC22D3;FST;DDX17;TFCP2L1;ENC1;TP53;DAPK3;EDN1;CDKN2A;RBM4;PABPC4;TGFB2;IRX2;NUP50;NUP153;NAIP;RELB;PARP15;BRIP1;SHQ1;SFRP1;TARDBP;MIR17HG;H3F3A;AHR;DHFR;GLIS3;HELLS;TSN;SETDB1;NDC1;CASC3;ZNF587;FRK;HSPB1;WNT4;SUV39H2;RAN;RANBP2;DDX3X;SET;PARP14;ARNTL;MRTO4;AJUBA;FASTKD3;DND1;ZC3H7B;TRIM37;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;NUP160;SMYD2;BIRC3;NUP54;RIF1;METTL16;GLIS2;UBP1;UPK3B;APEX1;HSPA8;NEDD4L;SYNCRIP;DGCR8;E2F8;CENPF;ETV6;POLR2F;GPER1;RBMS3;PSME2;PSMB9;ZNF12;ZNF608;NCBP1;UPF3B;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;HNRNPU;RING1;PSMB10;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;CDKN1A;IRF1;CTCF;RBM8A;RPS12
3276,GO:0006956,0.0275406969784453,0.994869357703113,4,17,complement activation,BP,KRT1;C1R;C3;CLU
2851,GO:0006337,0.0275486231978012,0.994922737331105,4,16,nucleosome disassembly,BP,GRWD1;SUPT16H;SET;SMARCC1
1612,GO:0004032,0.0275839816114334,0.998426998913001,2,5,alditol:NADP+ 1-oxidoreductase activity,MF,AKR1C2;AKR1B1
15288,GO:0071450,0.0276008989560166,0.994763023484308,4,19,cellular response to oxygen radical,BP,NQO1;DHFR;SOD2;TNF
15289,GO:0071451,0.0276008989560166,0.994763023484308,4,19,cellular response to superoxide,BP,NQO1;DHFR;SOD2;TNF
4484,GO:0010499,0.027683105087889,0.994638681648072,4,22,proteasomal ubiquitin-independent protein catabolic process,BP,ENC1;KEAP1;PSMB9;PSMB10
3599,GO:0008033,0.0277018514158511,0.986945295503109,14,120,tRNA processing,BP,CDKAL1;POP1;PUS3;THUMPD3;METTL1;URM1;YRDC;TYW1;TRMT5;SEPHS2;THADA;TRMT1;TRMT61A;WDR4
13862,GO:0060442,0.0277721466227372,0.996638527648918,3,9,branching involved in prostate gland morphogenesis,BP,FGFR2;SFRP1;ESR1
7420,GO:0031503,0.0278628039852414,0.984023529340347,24,219,protein-containing complex localization,BP,DYNC2H1;SRSF2;NUP50;NUP153;NDC1;DYNLL2;CASC3;AKAP8L;THOC1;RAN;RANBP2;GPHN;KLHL21;NETO1;NUP160;SDAD1;NUP54;SETD2;ATR;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
9868,GO:0042108,0.0279856958819762,0.992147113030951,6,33,positive regulation of cytokine biosynthetic process,BP,SYK;CCL20;HSPB1;TLR3;TNF;IRF1
10218,GO:0042824,0.0280631368586366,0.998600513645485,2,4,MHC class I peptide loading complex,CC,TAP1;TAP2
5932,GO:0018206,0.0280730652080624,0.996478496784862,3,10,peptidyl-methionine modification,BP,NAA15;NAA16;METAP2
1867,GO:0004528,0.0282721256382809,0.998584335772426,2,4,phosphodiesterase I activity,MF,ENPP1;APEX1
6645,GO:0023029,0.0284274670487385,0.998572266688459,2,4,MHC class Ib protein binding,MF,TAP1;TAP2
19199,GO:1905209,0.0284616402628755,0.994700439427856,4,16,positive regulation of cardiocyte differentiation,BP,NRG1;EDN1;TGFB2;GPER1
14320,GO:0061428,0.0286321819222438,0.998556304333359,2,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,HIF1AN;CITED2
5672,GO:0016779,0.0286356242030483,0.986060041377273,15,127,nucleotidyltransferase activity,MF,FAM46B;DKC1;POLQ;UAP1L1;POLR1A;POLA1;GPHN;YRDC;APTX;PRIM2;POLR2F;POLR1E;POLR3B;POLE3;FLAD1
13000,GO:0051384,0.0286816298297838,0.98739048447063,12,91,response to glucocorticoid,BP,NEFL;EDN1;ATP2B1;ADM;SRD5A1;CFLAR;TNF;ZFP36L2;TYMS;HNRNPU;PPARGC1B;CDKN1A
13725,GO:0060261,0.0286850645765472,0.994587485649786,4,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,TP53;SRF;ESR1;TAF1
4277,GO:0009636,0.0286965441224331,0.982100117107606,32,325,response to toxic substance,BP,CRYAB;NEFL;HDAC9;CYP1B1;TXNRD1;FGFR2;CYP1A1;G6PD;TP53;EDN1;NQO1;BRIP1;CDK4;AHR;DHFR;SETDB1;RANBP2;SOD2;APTX;SRF;PDGFB;SRD5A1;APEX1;TNC;TIMELESS;TNF;TYMS;CCL5;DAXX;CDKN1A;GPX4;DHX15
8443,GO:0033554,0.0287134890978744,0.977229361838893,135,1621,cellular response to stress,BP,CRYAB;NEFL;PML;CYP1B1;MAP3K14;TXNRD1;CTGF;MMP9;G6PD;MID1;TP53;EXO1;EDN1;CDKN2A;RBM4;NQO1;TGFB2;IKBKE;RAD1;BAG1;NUAK1;NUP50;SYK;NUP153;RELB;NBN;BRIP1;SFRP1;NUCKS1;PITHD1;POLQ;USP16;DHFR;RPA1;TPM1;ULK4;POLA1;PTGER4;ADM;IMMP2L;USP43;NDC1;CADPS2;FOXRED2;PLK2;RRAGB;UBQLN2;RFC3;WDR76;HSPB1;WNT4;SUV39H2;THOC1;RANBP2;TOPBP1;SOD2;SUPT16H;DDX3X;ARNTL;AJUBA;PGK1;FEN1;CDCA5;GADD45B;APTX;GINS4;SRF;MDM4;HIF1AN;MCM8;BRCC3;FZD1;NFE2L1;CLU;NUP160;SMYD2;NUP54;EYA3;ACKR3;RIF1;SRD5A1;SETD2;SRPRB;APEX1;TNC;HSPA8;HSP90AB1;ARL6IP5;SMUG1;HELQ;SGK1;PXMP2;BRCA2;FANCD2;E2F8;HSF2;POLR2F;CCDC47;CHEK1;RAD18;ATR;PSME2;MSH6;CFLAR;PSMB9;EIF2B5;RFWD3;AKR1B1;UBE2J2;TRAF2;MSH3;RBBP5;CITED2;CCNA2;TIMELESS;RBL1;CLOCK;TLR3;RAD51B;TNF;ATAD5;CD74;PSMB10;DAXX;HIST1H4A;TAF1;PHLPP1;FTO;PPARGC1B;CDKN1A;USP1;TREX1;GTF2H3;COPS3;UFC1
13542,GO:0055093,0.0289692974466202,0.994516889210753,4,17,response to hyperoxia,BP,CYP1A1;TP53;CDK4;CDKN1A
1290,GO:0003096,0.0290007004140356,0.998527406039204,2,4,renal sodium ion transport,BP,SLC9A3R1;SGK1
16968,GO:0098930,0.0290213121254102,0.990757556741133,7,41,axonal transport,BP,NEFL;AP3M2;DST;HSPB1;BLOC1S2;TRAK2;AP3B1
5747,GO:0016891,0.0291208093717717,0.992916572526379,5,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,EXO1;POP1;FEN1;APEX1;DGCR8
412,GO:0001098,0.0291443604353985,0.99069087301677,7,42,basal transcription machinery binding,MF,TP53;AHR;NOP58;SMYD2;ESR1;HNRNPU;ZNHIT6
413,GO:0001099,0.0291443604353985,0.99069087301677,7,42,basal RNA polymerase II transcription machinery binding,MF,TP53;AHR;NOP58;SMYD2;ESR1;HNRNPU;ZNHIT6
283,GO:0000785,0.0292692980047787,0.980513882912959,42,457,chromatin,CC,PML;CBX5;ENC1;TP53;CDKN2A;STAG1;ZFP42;FAM111A;CDK4;NUCKS1;MCM2;H3F3A;HELLS;POLA1;PLK2;AKAP8L;SUV39H2;KDM6A;RAN;NUFIP1;CDCA5;APTX;SRF;UTY;RIF1;CENPF;CHEK1;HMGN2;MSH6;TELO2;CITED2;TIMELESS;ORC2;RBL1;MPHOSPH8;ESR1;RING1;DAXX;HIST1H4A;TAF1;SMARCC1;IRF1
2386,GO:0005520,0.0293326195476093,0.994486152410706,4,16,insulin-like growth factor binding,MF,IGFBP3;CYR61;CTGF;ITGAV
12259,GO:0048518,0.0293806644558301,0.975240648694213,311,3907,positive regulation of biological process,BP,IGFBP3;MAFB;KRT1;SAA1;NEFL;NRG1;HDAC9;C1R;TRIM16;FN1;TNS3;TENM3;PML;CYP1B1;KIF23;AMOT;JPH2;MAP3K14;GCLC;TFRC;CYR61;C3;MKL1;FOSL2;COL16A1;NLRC5;FGFR2;STAT5A;EPGN;TRIM22;CTGF;MMP9;RUNX1;CYP1A1;CLN6;B4GALT1;ACTG1;PBX1;G6PD;FST;DDX17;TFCP2L1;CCDC80;TRAF3;ENC1;IRS1;SPG21;MID1;TP53;DAPK3;EDN1;GBP1;C1QTNF1;RBM19;CDKN2A;RBM4;ACSL3;ZBED1;JRK;NQO1;STAG1;LGALS3;CHP1;PDPN;AKAP8;TGFB2;CNTNAP1;RBM22;CYLD;IKBKE;IL27RA;IL16;FOXD2;IL6ST;SLC9A3R1;DKC1;INHBA;IL7R;SLC22A5;SYK;EMP2;NAIP;RELB;NBN;TRIO;SHQ1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;CD274;WNT10A;TARDBP;MIR17HG;H3F3A;USP16;AHR;KEAP1;NAA15;DHFR;RPA1;POLR1A;TPM1;GLIS3;TAF2;ABCC4;ADAMTS9;SETDB1;PTGER4;TRAF1;ADM;CADPS2;DYNLL2;SLC1A3;CCL20;SYNPO2L;PLK2;RRAGB;MUC16;UBQLN2;GBP5;BTN2A1;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;CXCL16;NOP2;LCP1;SIRPA;KDM6A;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;NAP1L1;NUFIP1;IL24;RRN3;CDC25A;ITGAV;SOCS1;PARP14;ARNTL;TAF1D;ODC1;AJUBA;FASTKD3;DND1;AKR1C2;LFNG;TRIM37;NETO1;FEN1;CDC42EP2;CDCA5;GNL3L;BAIAP2;NVL;GADD45B;CDH13;SRF;MDM4;HIF1AN;NPNT;WDR43;PDGFB;BRCC3;FZD1;NFE2L1;ANTXR1;RTKN2;CLU;MACC1;BIRC3;IL20;PIK3R3;NFKBIB;EYA3;ACKR3;RIF1;METTL16;SETD2;GLIS2;ANLN;THBD;GLIPR2;LRRN3;ERAP1;APEX1;PDCL3;CXCR5;TNC;TET3;MYBL1;HSPA8;SYT11;HSP90AB1;DDX21;ARL6IP5;EPHB6;NSF;NEDD4L;SGK1;ZFYVE27;BRCA2;SYNCRIP;SS18L2;CCAR1;E2F8;MTMR2;ETV6;L1CAM;HSF2;POLR2F;RAB3GAP1;CHEK1;IL12RB2;SERPINB9;GPER1;FAF1;MLLT10;RAD18;WDR75;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;CFLAR;PSMB9;EIF2B5;CMTM3;NOL11;CBLL1;SHTN1;DPYSL3;NCBP1;UPF3B;AKR1B1;POLR1E;UBE2J2;TRAF2;TELO2;EDRF1;CITED2;POLR3B;HNRNPR;NCL;CCNA2;DDX56;TIMELESS;CSF1;AP3B1;RBL1;NAA16;CLOCK;KIF14;TLR3;AZIN1;SYNPO2;ESR1;PARD3;RNF19B;RAD51B;EHD1;TNF;ATAD5;ZFP36L2;RC3H1;STARD7;CCL5;CD74;HNRNPU;FGFR1OP;PSMB10;EIF2B1;DAXX;PANX1;HIST1H4A;TAF1;TBPL1;SPIB;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;MUC6;IRF1;CTCF;TSGA13;GTF2H3;IRAK3;IFI27L1
7615,GO:0031996,0.0293847807308311,0.996247308692487,3,10,thioesterase binding,MF,TRAF3;TRAF1;TRAF2
7103,GO:0030894,0.029416469453175,0.992856421934282,5,26,replisome,CC,RPA1;POLA1;MCM3;PRIM2;PURB
17822,GO:1901888,0.0295345939818666,0.988195808850492,10,65,regulation of cell junction assembly,BP,COL16A1;RUNX1;DAPK3;SFRP1;WNT4;CORO1C;TJP1;WDPCP;TNF;ITGB1BP1
15431,GO:0071677,0.0296146920295257,0.996112905562003,3,11,positive regulation of mononuclear cell migration,BP,LGALS3;TNF;CCL5
11022,GO:0044839,0.0296698398004181,0.982654634288005,25,239,cell cycle G2/M phase transition,BP,PBX1;TP53;AKAP8;PKMYT1;GPR132;NBN;CDK4;TAF2;AKAP8L;TOPBP1;CDC25A;AJUBA;BRCC3;WEE1;CENPF;CHEK1;PSME2;CEP152;PSMB9;CCNA2;KIF14;RAD51B;FGFR1OP;PSMB10;CDKN1A
5858,GO:0017153,0.0297294365687883,0.998469644531217,2,4,sodium:dicarboxylate symporter activity,MF,SLC1A3;SLC25A22
12620,GO:0050777,0.0299946847292722,0.98727096790737,11,83,negative regulation of immune response,BP,NLRC5;LGALS3;TGFB2;IL27RA;IL7R;THOC1;PARP14;SERPINB9;TNF;RC3H1;IRAK3
5118,GO:0015440,0.0300153811705217,0.998446757618639,2,4,peptide-transporting ATPase activity,MF,TAP1;TAP2
8362,GO:0033220,0.0300153811705217,0.998446757618639,2,4,amide-transporting ATPase activity,MF,TAP1;TAP2
9275,GO:0035690,0.0301086217903098,0.982185894610517,26,243,cellular response to drug,BP,CYP1B1;GCLC;TFRC;TP53;EDN1;NQO1;RBM22;CDK4;SFRP1;AHR;BAIAP2;QDPR;PDGFB;EFTUD2;SRD5A1;APEX1;UMPS;HSP90AB1;CFLAR;TRAF2;CCNA2;TIMELESS;TLR3;TNF;DAXX;TAF1
14525,GO:0065003,0.0301820387518775,0.976370955834994,117,1423,protein-containing complex assembly,BP,CRYAB;NEFL;NRG1;MAP2;FN1;PML;COL16A1;TRIM22;B4GALT1;MAT2A;TP53;GBP1;C1QTNF1;ACSL3;GEMIN5;COBLL1;CHP1;PPAN;RBM22;CYLD;IKBKE;TGS1;SLC9A3R1;DNHD1;NUP153;SHQ1;VPS41;MCM2;GEMIN4;POLQ;H3F3A;USP16;RPA1;HELLS;TAF2;KCNS3;PTGER4;TK1;GRWD1;TRAF1;IMMP2L;NDC1;CADPS2;MDN1;HSCB;GBP5;KANK4;RHOG;NOP2;LCP1;DDX28;UBTF;RRP7BP;SOD2;DDX3X;NAP1L1;NUFIP1;RRN3;SET;MRTO4;TRPM7;AJUBA;FASTKD3;LUC7L;CDC42EP2;BAIAP2;SRF;MDM4;LUC7L2;CLU;BIRC3;NUP54;ANLN;RPF2;KCTD3;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;MYH11;GEMIN8;MTMR2;CENPF;LNX2;FAF1;RRM1;ATR;NIFK;DPYSL3;TAF6L;MRPS7;NCBP1;TRAF2;RBBP5;UQCRB;KIF14;ESR1;PARD3;RAD51B;EHD1;CENPN;TNF;PDSS1;RC3H1;CCL5;CD74;DAXX;PANX1;HIST1H4A;TAF1;ZNHIT6;ITGB1BP1;GTF2H3;NDUFB9;CENPO;GPX4
15140,GO:0071211,0.0302717089086903,0.998426135319419,2,4,protein targeting to vacuole involved in autophagy,BP,CLU;HSPA8
4233,GO:0009410,0.0303504025482394,0.983723187342826,19,169,response to xenobiotic stimulus,BP,HDAC9;CYP1B1;GCLC;UGT1A6;STAT5A;CYP1A1;TP53;EDN1;NQO1;AHR;RANBP2;PDGFB;SDK1;EFTUD2;SRD5A1;HSP90AB1;CFLAR;UGT1A4;CCNA2
10588,GO:0043542,0.0304745936206411,0.984325616828975,17,140,endothelial cell migration,BP,HDAC9;CYP1B1;AMOT;STAT5A;STARD13;S100P;EDN1;EMP2;ADAMTS9;PLK2;HSPB1;PTPRM;CDH13;SRF;PDGFB;ADAM17;ITGB1BP1
11111,GO:0045109,0.0305361117606869,0.994186552471902,4,16,intermediate filament organization,BP,NEFL;KRT2;NEFM;KRT9
2346,GO:0005384,0.030761836661437,0.998386425506368,2,4,manganese ion transmembrane transporter activity,MF,ATP2C1;SLC11A2
7693,GO:0032138,0.0308098537658341,0.998382515645289,2,4,single base insertion or deletion binding,MF,MSH6;MSH3
1003,GO:0002474,0.0309743713580444,0.987350178357319,10,83,antigen processing and presentation of peptide antigen via MHC class I,BP,HLA-B;TAP1;HLA-F;ITGAV;ERAP1;PSME2;PSMB9;TAP2;IFI30;PSMB10
6980,GO:0030638,0.0309877168454107,0.998116879001799,2,5,polyketide metabolic process,BP,AKR1C2;AKR1B1
6984,GO:0030647,0.0309877168454107,0.998116879001799,2,5,aminoglycoside antibiotic metabolic process,BP,AKR1C2;AKR1B1
10948,GO:0044597,0.0309877168454107,0.998116879001799,2,5,daunorubicin metabolic process,BP,AKR1C2;AKR1B1
10949,GO:0044598,0.0309877168454107,0.998116879001799,2,5,doxorubicin metabolic process,BP,AKR1C2;AKR1B1
15124,GO:0071157,0.0310092128386903,0.993947291349657,4,18,negative regulation of cell cycle arrest,BP,CDK4;MDM4;HSP90AB1;GPER1
8068,GO:0032730,0.0310475838460897,0.998111243828764,2,5,positive regulation of interleukin-1 alpha production,BP,CCL20;PANX1
4510,GO:0010558,0.0311230981173705,0.976023323966653,101,1161,negative regulation of macromolecule biosynthetic process,BP,NRG1;HDAC9;PML;GCLC;FGFR2;TRIM22;CBX5;TSC22D3;FST;TFCP2L1;ENC1;TP53;DAPK3;EDN1;CDKN2A;RBM4;IRX2;SRSF2;INHBA;NUP50;NUP153;RELB;PARP15;SFRP1;MIR17HG;H3F3A;AHR;DHFR;GLIS3;HELLS;SETDB1;NDC1;ZNF587;FRK;WNT4;SUV39H2;RAN;RANBP2;DDX3X;ITGAV;SET;ARNTL;AJUBA;DND1;ZC3H7B;TRIM37;GNL3L;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;NUP160;SMYD2;ENPP1;NUP54;RIF1;METTL16;GLIS2;UBP1;APEX1;HSPA8;BACE2;NEDD4L;BRCA2;SYNCRIP;DGCR8;CCAR1;E2F8;CENPF;ETV6;POLR2F;ATR;ZNF12;ZNF608;NCBP1;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;ZFP36L2;RC3H1;TYMS;HNRNPU;RING1;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;IRF1;CTCF
6670,GO:0030023,0.0311658448629614,0.998820436547916,2,3,extracellular matrix constituent conferring elasticity,MF,FBN1;COL4A1
8831,GO:0034599,0.0311802325443764,0.98213024066916,23,219,cellular response to oxidative stress,BP,PML;CYP1B1;TXNRD1;MMP9;G6PD;TP53;NQO1;DHFR;TPM1;HSPB1;SOD2;ARNTL;FZD1;NFE2L1;APEX1;ARL6IP5;PXMP2;FANCD2;CFLAR;TRAF2;CCNA2;TNF;PPARGC1B
250,GO:0000710,0.0312120511752298,0.998349629658736,2,4,meiotic mismatch repair,BP,MSH6;MSH3
16593,GO:0097366,0.0312234529707927,0.992371677515447,5,24,response to bronchodilator,BP,HDAC9;RANBP2;CFLAR;TRAF2;CCNA2
8858,GO:0034645,0.0313401521761547,0.973524193040918,315,4041,cellular macromolecule biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;B4GALT1;PBX1;TSC22D3;FST;DDX17;SPON1;TFCP2L1;TRAF3;ENC1;IRS1;TP53;DAPK3;EXO1;EDN1;ABCF1;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;ZNF208;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL16;SRSF2;FOXD2;PPP1R3B;RAD1;DKC1;INHBA;NUP50;PUM3;GALNT18;PHAX;SYK;NUP153;ZFP42;RELB;NBN;FAM111A;PARP15;BRIP1;MCM5;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;GRWD1;ZNF584;TRAF1;CD109;USP43;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;ZNF512;MRPL27;ZNF587;MUC16;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;RRN3;CDC25A;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;DND1;ZNF267;LFNG;TRIM37;FEN1;MCM3;GNL3L;ZNF586;NVL;GATC;CDH13;GINS4;RARS;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;MCM8;PDGFB;EIF3J;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;VGLL3;RIF1;METTL16;MCM6;SETD2;GLIS2;UBP1;TTF2;DPY19L2P2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;BACE2;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;SYNCRIP;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;TMEM165;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;GPER1;FAF1;RRM1;MLLT10;WDR75;MCM4;SENP1;RBMS3;ATR;PSME2;CFLAR;NIFK;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;RAD51B;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;EIF2B1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3
3627,GO:0008089,0.0314569406157327,0.990900435974561,6,34,anterograde axonal transport,BP,NEFL;AP3M2;HSPB1;BLOC1S2;TRAK2;AP3B1
16551,GO:0097267,0.0314571960084581,0.998329465896667,2,4,omega-hydroxylase P450 pathway,BP,CYP1B1;CYP1A1
765,GO:0002009,0.0315786117164109,0.979116795687764,40,394,morphogenesis of an epithelium,BP,PML;CYR61;FGFR2;STARD13;FAT4;B4GALT1;PBX1;EDN1;PDPN;TGFB2;IRX2;SLC9A3R1;SFRP1;RIPK4;WNT10A;COL4A1;OPHN1;ADM;WNT4;KDM6A;AJUBA;PHACTR4;SRF;NPNT;FZD1;FRAS1;SETD2;TNC;BBS5;ADAM17;NTN1;PSME2;PSMB9;TIMELESS;CSF1;MPP5;ESR1;TNF;PSMB10;ASTN2
4759,GO:0010934,0.031639418026124,0.995839963416717,3,10,macrophage cytokine production,BP,TGFB2;CD74;IRAK3
19737,GO:2000045,0.031661437716361,0.983991348827919,16,135,regulation of G1/S transition of mitotic cell cycle,BP,PML;CYP1A1;TP53;CDKN2A;CDK4;PLK2;DDX3X;MDM4;APEX1;E2F8;ADAM17;PSME2;RFWD3;RBL1;KIF14;CDKN1A
4142,GO:0009202,0.0317235971084563,0.998047185852007,2,5,deoxyribonucleoside triphosphate biosynthetic process,BP,TYMS;TBPL1
10610,GO:0043570,0.0317319057123491,0.998306763362542,2,4,maintenance of DNA repeat elements,BP,MSH6;MSH3
18146,GO:1902806,0.0317989779180572,0.983534977892913,17,146,regulation of cell cycle G1/S phase transition,BP,PML;CYP1A1;TP53;CDKN2A;CDK4;PLK2;DDX3X;MDM4;APEX1;E2F8;ADAM17;PSME2;RFWD3;RBL1;KIF14;TAF1;CDKN1A
15155,GO:0071230,0.0318908722188523,0.988652123865214,8,50,cellular response to amino acid stimulus,BP,GCLC;COL16A1;COL4A1;RRAGB;SOCS1;BAIAP2;COL5A2;TNF
10126,GO:0042635,0.0319915424298522,0.995671581892687,3,11,positive regulation of hair cycle,BP,FST;TGFB2;TNF
13211,GO:0051798,0.0319915424298522,0.995671581892687,3,11,positive regulation of hair follicle development,BP,FST;TGFB2;TNF
16341,GO:0090521,0.0320477427482691,0.998280522687474,2,4,glomerular visceral epithelial cell migration,BP,ANLN;WDPCP
9139,GO:0035456,0.0321144465173854,0.993563659215404,4,20,response to interferon-beta,BP,XAF1;IKBKE;TLR3;IRF1
10550,GO:0043488,0.0321800386592114,0.983670062135058,16,141,regulation of mRNA stability,BP,PABPC4;TARDBP;HSPB1;SET;FASTKD3;METTL16;APEX1;HSPA8;SYNCRIP;PSME2;PSMB9;HNRNPR;ZFP36L2;RC3H1;HNRNPU;PSMB10
6870,GO:0030335,0.0323659930308735,0.979481012436389,33,317,positive regulation of cell migration,BP,HDAC9;FN1;CYR61;STAT5A;MMP9;TP53;DAPK3;EDN1;LGALS3;PDPN;TGFB2;CD274;CCL20;PLK2;HSPB1;CXCL16;SOD2;ITGAV;CDH13;PDGFB;ACKR3;GLIPR2;CCAR1;GPER1;ADAM17;CBLL1;SHTN1;CSF1;TNF;CCL5;CD74;FGFR1OP;ITGB1BP1
12669,GO:0050854,0.0324616545739646,0.990539774855184,6,34,regulation of antigen receptor-mediated signaling pathway,BP,RUNX1;GBP1;LGALS3;CYLD;CMTM3;RC3H1
8665,GO:0034212,0.0324767531088556,0.987520680116174,9,60,peptide N-acetyltransferase activity,MF,NAA15;NAA50;KANSL1L;BRCA2;TAF6L;GTF3C4;NAA16;CLOCK;TAF1
8376,GO:0033263,0.032479956549967,0.998244372522767,2,4,CORVET complex,CC,VPS41;VPS8
8000,GO:0032612,0.0325647239702969,0.988286748327224,8,55,interleukin-1 production,BP,SAA1;TRIM16;PML;IL1R2;CCL20;GBP5;HSPB1;PANX1
15470,GO:0071774,0.0325959790004806,0.984348332402897,14,111,response to fibroblast growth factor,BP,GCLC;FGFR2;CTGF;FAT4;HNRNPF;SFRP1;WNT4;TNC;POLR2F;NCBP1;ZFP36L2;CCL5;HNRNPM;ITGB1BP1
4028,GO:0009059,0.0326034900340653,0.972408153104494,320,4112,macromolecule biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;HSPG2;RUNX1;B4GALT1;PBX1;TSC22D3;FST;DDX17;SPON1;TFCP2L1;TRAF3;ENC1;IRS1;TP53;DAPK3;EXO1;EDN1;ABCF1;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;ZNF208;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL16;SRSF2;FOXD2;PPP1R3B;RAD1;DKC1;INHBA;NUP50;PUM3;GALNT18;PHAX;SYK;NUP153;ZFP42;RELB;NBN;FAM111A;PARP15;BRIP1;MCM5;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;GRWD1;ZNF584;TRAF1;CD109;USP43;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;CCL20;ZNF512;MRPL27;ZNF587;MUC16;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;HS3ST1;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;RRN3;CDC25A;ITGAV;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;DND1;ZNF267;LFNG;TRIM37;FEN1;MCM3;GNL3L;ZNF586;NVL;GATC;CDH13;GINS4;RARS;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;MCM8;PDGFB;EIF3J;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;VGLL3;RIF1;METTL16;MCM6;SETD2;GLIS2;UBP1;TTF2;DPY19L2P2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;BACE2;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;SYNCRIP;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;TMEM165;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;GPER1;FAF1;RRM1;MLLT10;WDR75;MCM4;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;RAD51B;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;EIF2B1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3
7337,GO:0031342,0.0326613371851181,0.995544709279514,3,11,negative regulation of cell killing,BP,IL7R;HSP90AB1;SERPINB9
11223,GO:0045341,0.0327542992607995,0.998221282933071,2,4,MHC class I biosynthetic process,BP,PML;NLRC5
11225,GO:0045343,0.0327542992607995,0.998221282933071,2,4,regulation of MHC class I biosynthetic process,BP,PML;NLRC5
11226,GO:0045345,0.0327542992607995,0.998221282933071,2,4,positive regulation of MHC class I biosynthetic process,BP,PML;NLRC5
14133,GO:0060968,0.0327763284984275,0.984165612386887,14,127,regulation of gene silencing,BP,NUP50;NUP153;H3F3A;SETDB1;NDC1;RAN;RANBP2;AJUBA;DND1;NUP160;NUP54;POLR2F;ESR1;HIST1H4A
11173,GO:0045216,0.0328030412139832,0.981703524007602,21,174,cell-cell junction organization,BP,COL16A1;RUNX1;DAPK3;TGFB2;CNTNAP1;SFRP1;WNT4;CORO1C;AJUBA;CDH13;SRF;UGT8;SDK1;TJP1;WDPCP;PLEKHA7;MPP5;PARD3;GJC1;TNF;ITGB1BP1
748,GO:0001976,0.032868592571899,0.998211630799959,2,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,SOD2;NAV2
13014,GO:0051412,0.0329914706838932,0.995589802455805,3,10,response to corticosterone,BP,NEFL;ATP2B1;CDKN1A
7996,GO:0032608,0.0332461433092017,0.989058600746771,7,43,interferon-beta production,BP,TRIM56;TRAF3;RELB;DDX3X;POLR3B;TLR3;IRF1
15464,GO:0071732,0.0334072942132985,0.99551199658336,3,10,cellular response to nitric oxide,BP,CFLAR;TRAF2;CCNA2
12918,GO:0051241,0.0334800778203774,0.975837065154932,62,677,negative regulation of multicellular organismal process,BP,MAFB;KRT1;NRG1;FN1;PML;AMOT;NLRC5;STARD13;FBN1;HSPG2;IL1R2;PBX1;G6PD;TSC22D3;TRAF3;EDN1;GBP1;C1QTNF1;AKAP8;TGFB2;CYLD;IKBKE;INHBA;TJP2;RELB;SFRP1;CD274;MIR17HG;ADAMTS9;PTGER4;ADM;PLK2;WNT4;PTPRM;THOC1;CORO1C;LFNG;PGK1;LUC7L;COL5A2;SRF;PDGFB;CHID1;KREMEN2;THBD;SYT11;HSP90AB1;BRCA2;TRAK2;MTMR2;NTN1;LILRB3;DPYSL3;TLR3;TNF;RC3H1;CD74;PHF14;HIST1H4A;ITGB1BP1;IRF1;IRAK3
3692,GO:0008199,0.0336732113312236,0.997858103545143,2,5,ferric iron binding,MF,FTL;FTH1
134,GO:0000280,0.0337398709147618,0.978534767438385,33,318,nuclear division,BP,KIF23;EPGN;DAPK3;EDN1;STAG1;AKAP8;PKMYT1;RAD1;NAIP;BRIP1;NDC1;AKAP8L;MYBL2;WNT4;RAN;RANBP2;ANAPC15;SMC2;CDCA5;PDGFB;NAA50;BIRC3;ANLN;MYBL1;BRCA2;FANCD2;CENPF;CHEK1;PSMC3IP;MSH3;KIF14;RAD51B;HNRNPU
7418,GO:0031498,0.0338291145607977,0.99327514312788,4,17,chromatin disassembly,BP,GRWD1;SUPT16H;SET;SMARCC1
1158,GO:0002763,0.033955281984721,0.989998360886517,6,34,positive regulation of myeloid leukocyte differentiation,BP,RUNX1;IL20;CSF1;TNF;CD74;PPARGC1B
7381,GO:0031428,0.0339622657488015,0.997829527015752,2,5,box C/D snoRNP complex,CC,NOP58;NOP56
7843,GO:0032392,0.0339921277795196,0.9853050226107,11,81,DNA geometric change,BP,TP53;NBN;BRIP1;MCM5;MCM2;G3BP1;DDX3X;GINS4;MCM6;MCM4;GTF2H3
2087,GO:0004844,0.0340071123107657,0.997825080933313,2,5,uracil DNA N-glycosylase activity,MF,APEX1;SMUG1
16664,GO:0097506,0.0340071123107657,0.997825080933313,2,5,deaminated base DNA N-glycosylase activity,MF,APEX1;SMUG1
883,GO:0002244,0.0340351571140247,0.982541010849416,16,158,hematopoietic progenitor cell differentiation,BP,RUNX1;FST;SIPA1L3;INHBA;SFRP1;H3F3A;HERC6;ARMC6;WDR7;SRF;ANLN;ZBTB24;PSME2;PSMB9;PSMB10;HIST1H4A
8117,GO:0032797,0.0340805956585643,0.995272312580485,3,11,SMN complex,CC,GEMIN5;GEMIN4;GEMIN8
989,GO:0002443,0.0341798503808197,0.976568600681602,46,503,leukocyte mediated immunity,BP,KRT1;FTL;FTH1;C1R;TFRC;C3;S100P;MMP9;B4GALT1;EXO1;LGALS3;IL27RA;IL7R;SYK;EMP2;NBN;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;THOC1;DDX3X;ITGAV;QPCT;CLU;COMMD9;RIF1;HSPA8;HSP90AB1;LAIR1;SERPINB9;ADAM17;MSH6;LILRB3;TRAF2;GLIPR1;TLR3;DNASE1;TNF;ATAD5;CD74;NRAS
15022,GO:0070934,0.0342702011456717,0.998091703636333,2,4,CRD-mediated mRNA stabilization,BP,SYNCRIP;HNRNPU
7937,GO:0032508,0.0343527620796315,0.985840482298014,10,71,DNA duplex unwinding,BP,NBN;BRIP1;MCM5;MCM2;G3BP1;DDX3X;GINS4;MCM6;MCM4;GTF2H3
8515,GO:0033687,0.0344441031815421,0.993113491910362,4,17,osteoblast proliferation,BP,CYR61;FGFR2;SFRP1;ITGAV
2490,GO:0005736,0.0346824928903364,0.995061174705847,3,12,DNA-directed RNA polymerase I complex,CC,POLR1A;POLR2F;POLR1E
740,GO:0001968,0.0347223524436283,0.993040030991852,4,17,fibronectin binding,MF,IGFBP3;CTGF;CCDC80;ITGAV
3782,GO:0008340,0.0347367201300159,0.995405975594407,3,9,determination of adult lifespan,BP,TFCP2L1;TP53;MSH6
11687,GO:0046449,0.0348731252522688,0.998039233828288,2,4,creatinine metabolic process,BP,STAT5A;MME
12803,GO:0051059,0.034895087391382,0.991090051126095,5,27,NF-kappaB binding,MF,CDKN2A;AKAP8;HIF1AN;APEX1;FAF1
13174,GO:0051726,0.0349554449020027,0.973384900480343,88,1003,regulation of cell cycle,BP,PML;KIF23;MAP3K14;FGFR2;EPGN;CBX5;CTGF;CYP1A1;PBX1;TP53;DAPK3;EDN1;CDKN2A;STAG1;TGFB2;CYLD;PKMYT1;RAD1;SLC9A3R1;INHBA;GPR132;NBN;BRIP1;CDK4;SFRP1;TARDBP;USP16;PLK2;RRAGB;MYBL2;WDR76;WNT4;THOC1;RANBP2;TOPBP1;ANAPC15;DDX3X;KLHL21;CDC25A;ARNTL;LFNG;TRIM37;FEN1;CDCA5;GADD45B;PHACTR4;MDM4;PDGFB;BRCC3;RRM2;KLHL9;SETD2;ANLN;WEE1;APEX1;CXCR5;HSPA8;HSP90AB1;BRCA2;E2F8;CENPF;CHEK1;GPER1;ADAM17;ATR;PSME2;CEP152;PSMB9;RFWD3;TPRA1;CITED2;CCNA2;TIMELESS;RBL1;CLOCK;KIF14;RAD51B;TNF;ATAD5;ZFP36L2;HNRNPU;RING1;FGFR1OP;PSMB10;TAF1;CDKN1A;IRF1;CTCF
15471,GO:0071782,0.0351965534762923,0.992848489464076,4,18,endoplasmic reticulum tubular network,CC,REEP1;ZFYVE27;RAB3GAP1;ARV1
12941,GO:0051272,0.0352337822807318,0.977339307695493,34,332,positive regulation of cellular component movement,BP,HDAC9;FN1;CYR61;STAT5A;MMP9;TP53;DAPK3;EDN1;LGALS3;PDPN;TGFB2;CD274;CCL20;PLK2;HSPB1;CXCL16;SOD2;ITGAV;CDH13;PDGFB;ACKR3;GLIPR2;CCAR1;GPER1;ADAM17;NTN1;CBLL1;SHTN1;CSF1;TNF;CCL5;CD74;FGFR1OP;ITGB1BP1
2489,GO:0005732,0.0354007661284481,0.992520967148419,4,24,small nucleolar ribonucleoprotein complex,CC,DKC1;POP1;NOP58;NOP56
14111,GO:0060916,0.0354040052442533,0.997992598528709,2,4,mesenchymal cell proliferation involved in lung development,BP,FGFR2;PHF14
149,GO:0000303,0.0354134687406784,0.992679392557472,4,20,response to superoxide,BP,NQO1;DHFR;SOD2;TNF
1040,GO:0002548,0.0355347137239198,0.992646347135328,4,20,monocyte chemotaxis,BP,LGALS3;CCL20;PDGFB;CCL5
11517,GO:0045987,0.0355814554505743,0.992745173277915,4,18,positive regulation of smooth muscle contraction,BP,EDN1;SRF;NPNT;GPER1
3225,GO:0006879,0.0357320877015531,0.987995263550733,7,46,cellular iron ion homeostasis,BP,FTL;FTH1;TFRC;ACO1;ABCG2;SLC11A2;TMEM199
18699,GO:1904018,0.0357905220763106,0.982599415203086,14,110,positive regulation of vasculature development,BP,HDAC9;CYP1B1;C3;RUNX1;ADM;PLK2;HSPB1;HIF1AN;PDGFB;ERAP1;PDCL3;GPER1;CFLAR;TLR3
3550,GO:0007586,0.0358180591961896,0.98802255045113,7,43,digestion,BP,ACO1;SLC22A5;TJP2;MGAM;AKR1C2;SGK1;MUC6
4665,GO:0010811,0.0358640275865687,0.984393909082197,11,78,positive regulation of cell-substrate adhesion,BP,FN1;CYR61;COL16A1;CCDC80;EMP2;SFRP1;WNT4;CDH13;NPNT;CSF1;ITGB1BP1
16662,GO:0097504,0.0358822034603622,0.994919694605796,3,11,Gemini of coiled bodies,CC,GEMIN5;GEMIN4;GEMIN8
16891,GO:0098801,0.0359001800693717,0.994916138195374,3,11,regulation of renal system process,BP,EDN1;EMP2;PDGFB
3708,GO:0008217,0.0360423397182602,0.984262319640402,11,82,regulation of blood pressure,BP,EDN1;C9ORF3;EMP2;TPM1;ADM;MME;SOD2;PDGFB;ERAP1;SGK1;NAV2
5931,GO:0018205,0.0360495265044307,0.9767636134166,34,337,peptidyl-lysine modification,BP,HDAC9;TRIM16;ZBED1;NUP50;NUP153;METTL21A;SETDB1;NDC1;DOHH;SUV39H2;KDM6A;SETD4;RANBP2;VCPKMT;CPA4;SET;GNL3L;NUP160;SMYD2;NAA50;NUP54;RIF1;SETD2;TET3;BRCA2;CHEK1;SENP1;TAF6L;RBBP5;GTF3C4;POLE3;CLOCK;TAF1;CTCF
3278,GO:0006958,0.036077810439094,0.994880956663129,3,11,complement activation, classical pathway,BP,C1R;C3;CLU
1594,GO:0004003,0.0361237444034434,0.989232811897993,6,33,ATP-dependent DNA helicase activity,MF,NBN;BRIP1;G3BP1;DDX3X;MCM6;MCM4
14125,GO:0060947,0.0361416207728811,0.997927130129043,2,4,cardiac vascular smooth muscle cell differentiation,BP,SRF;GPER1
14659,GO:0070230,0.0361803017176637,0.99476095332822,3,12,positive regulation of lymphocyte apoptotic process,BP,TP53;CD274;CCL5
6281,GO:0019882,0.0362265507156328,0.980494737605618,18,171,antigen processing and presentation,BP,KIF23;HLA-B;TAP1;RAB32;RELB;HLA-F;HLA-DOB;DYNLL2;ITGAV;ERAP1;PSME2;PSMB9;TAP2;IFI30;AP3B1;CD74;PSMB10;DCTN5
4197,GO:0009303,0.0362934550977781,0.990633880954927,5,27,rRNA transcription,BP,GTF3C6;NIFK;NOL11;NCL;GTF3C4
2891,GO:0006399,0.0364478498383039,0.979993955178426,19,183,tRNA metabolic process,BP,CARS2;CDKAL1;POP1;PUS3;THUMPD3;METTL1;URM1;GTF3C6;YRDC;GATC;RARS;TYW1;TRMT5;SEPHS2;THADA;TRMT1;TRMT61A;GTF3C4;WDR4
12859,GO:0051150,0.0366771477420851,0.99244899654438,4,18,regulation of smooth muscle cell differentiation,BP,FGFR2;SRF;PDGFB;GPER1
4371,GO:0009987,0.0367250576012278,0.971262403081474,770,10485,cellular process,BP,IL32;CRYAB;IGFBP3;MAFB;SPRR3;KRT1;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;SLC7A2;RUNX1;MYO1B;CYP1A1;ERVFRD-1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;SPACA6;TSC22D3;FST;MAT2A;DDX17;SPON1;TRIM56;TFCP2L1;KRTAP2-3;CCDC80;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;MID1;SLC16A9;TP53;DAPK3;TUFT1;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;COBLL1;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;CNTNAP1;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;IFIT3;SRSF2;FOXD2;PCDH7;LRFN4;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PALM2;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;POP1;HLA-DOB;RIPK4;GPCPD1;NUCKS1;PITHD1;HEATR1;ZDHHC6;CD274;WNT10A;MCM2;TARDBP;MIR17HG;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;KEAP1;NAA15;UAP1L1;TRA2A;TCHH;ZNF827;SLC5A6;HRNR;DHFR;RPA1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;PTGER4;TK1;TMEM97;G3BP1;GRWD1;ARRDC1-AS1;ZNF584;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;MDN1;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;KANK4;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;CXCL16;NOP2;DOHH;SUV39H2;LCP1;GPRIN1;EXOG;PTPRM;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;CPA4;IL24;ARHGEF28;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;SNX11;TRPM7;AJUBA;SMC2;ARMC6;FASTKD3;KCNQ5;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;KRT24;LFNG;ZC3H7B;PGK1;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;SRBD1;PPP4R4;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;GANC;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;SGK494;KREMEN2;SDK1;FZD1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;FRAS1;ZNF316;IL20;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;ACKR3;RIF1;METTL16;TYW1;MCM6;FGD6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;ABCC9;TRMT5;TTF2;DTX4;GLIPR2;JPH1;SRPRB;DPY19L2P2;SEPHS2;NNT;IFNAR1;WEE1;TJP1;LRRN3;ZNF484;THADA;KCTD3;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;CXCR5;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;GLIPR1L2;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;HPS5;GEMIN8;SYNCRIP;TRAK2;TRMT1;HCAR1;DGCR8;DPYD;SS18L2;LIMCH1;KRT10;CCAR1;SKA2;PPIP5K1;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;L1CAM;ZNFX1;STEAP4;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;LNX2;CHEK1;IL12RB2;SRFBP1;SERPINB9;SCFD2;BBS5;GPER1;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;ZNF608;TAF6L;MRPS7;DPH2;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;TPRA1;MSH3;TELO2;EDRF1;RBBP5;CITED2;MFAP5;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;MPP5;AZIN1;SYNPO2;ESR1;PARD3;GJC1;RRP15;RNF19B;RAD51B;USP11;EHD1;KCNE4;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;ATAD5;PDSS1;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;PHLPP1;ZNHIT6;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;TSGA13;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GBP6;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
289,GO:0000793,0.0367309474595649,0.979541659892029,20,175,condensed chromosome,CC,STAG1;AKAP8;RAD1;TOPBP1;SMC2;CDCA5;LRPPRC;RIF1;BRCA2;SKA2;FANCD2;CENPF;CHEK1;NIFK;ORC2;CENPN;HNRNPU;DCTN5;CTCF;CENPO
3625,GO:0008083,0.0367354262004478,0.985456744782714,9,68,growth factor activity,MF,NRG1;EPGN;CTGF;TGFB2;INHBA;PDGFB;MACC1;RABEP2;CSF1
8233,GO:0032986,0.0367400218246236,0.992431908883432,4,18,protein-DNA complex disassembly,BP,GRWD1;SUPT16H;SET;SMARCC1
8488,GO:0033628,0.0367640988939294,0.990479189159496,5,27,regulation of cell adhesion mediated by integrin,BP,CYP1B1;TGFB2;SYK;CCL5;ITGB1BP1
7664,GO:0032088,0.0368082232932107,0.985459952781527,9,65,negative regulation of NF-kappaB transcription factor activity,BP,CYP1B1;NLRC5;TRAF3;CDKN2A;CHP1;CYLD;TRIM37;FAF1;IRAK3
3320,GO:0007029,0.0368906336587838,0.987585281587964,7,43,endoplasmic reticulum organization,BP,VMP1;REEP1;ZFYVE27;CCDC47;RAB3GAP1;SHTN1;TRAM2
14827,GO:0070542,0.0369071236189882,0.986447343761345,8,52,response to fatty acid,BP,CTGF;EDN1;AKAP8;CDK4;SFRP1;PTGER4;AKR1C2;TNC
12537,GO:0050661,0.0370012241139447,0.988816925329127,6,36,NADP binding,MF,G6PD;DHFR;QDPR;SRD5A1;NNT;DPYD
13158,GO:0051704,0.0371438544771421,0.970363392420261,129,1585,multi-organism process,BP,FN1;PTGES;PML;MAP3K14;TFRC;COL16A1;NLRC5;FGFR2;TRIM22;CBX5;HLA-B;MMP9;VMP1;TAP1;CYP1A1;B4GALT1;SPACA6;DDX17;TRIM56;TFCP2L1;TRAF3;TP53;PANK2;EDN1;GBP1;IFNGR1;AKAP8;IKBKE;IL27RA;IL16;IFIT3;IL6ST;INHBA;NUP50;SLC22A5;SYK;EMP2;NUP153;LEPR;FAM111A;BRIP1;CDK4;NUCKS1;CD274;TARDBP;POLA1;PTGER4;ARRDC1-AS1;ADM;IMMP2L;NDC1;CCL20;SLCO4C1;HSPB1;WNT4;THOC1;RAN;RANBP2;DDX3X;IL24;ITGAV;SET;ARNTL;ODC1;DND1;ZC3H7B;BAIAP2;MCM8;CLU;NUP160;BIRC3;NUP54;NFKBIB;ACKR3;SETD2;UBP1;THBD;ABCC9;DPY19L2P2;IFNAR1;ERAP1;PDCL3;CNTNAP2;UMPS;MYBL1;HSPA8;GLIPR1L2;SYT11;HSP90AB1;DDX21;NEDD4L;BRCA2;SYNCRIP;FANCD2;ETV6;HSF2;POLR2F;IL12RB2;SERPINB9;HMGN2;ADAM17;UBAP2L;MSH6;CFLAR;PSMB9;DNAJC9;CBLL1;AKR1B1;POLR3B;CCNA2;TAP2;RBL1;CLOCK;TLR3;ESR1;TNF;TYMS;CCL5;CD74;PSMB10;DAXX;TAF1;TBPL1;IRF1;DIAPH3;RPS12;GBP6;GPX4;IRAK3
2420,GO:0005593,0.0371569477872344,0.997835743204407,2,4,FACIT collagen trimer,CC,COL16A1;COL12A1
1038,GO:0002544,0.0371727532382396,0.994559143200725,3,12,chronic inflammatory response,BP,PTGES;TNF;CCL5
12719,GO:0050918,0.0372796809129847,0.9887411433848,6,35,positive chemotaxis,BP,SAA1;LGALS3;IL16;CDH13;PDGFB;CCL5
12796,GO:0051052,0.0373344502484116,0.976038074971233,33,323,regulation of DNA metabolic process,BP,PML;TFRC;TP53;IL27RA;DKC1;IL7R;NBN;NUCKS1;POLQ;SETDB1;RFC3;THOC1;GNL3L;NVL;PDGFB;BRCC3;EYA3;RIF1;SETD2;HSP90AB1;BRCA2;E2F8;CHEK1;GPER1;ATR;MSH6;MSH3;TIMELESS;MPHOSPH8;ATAD5;HNRNPU;CDKN1A;USP1
5120,GO:0015459,0.0374918097211304,0.990325399588852,5,25,potassium channel regulator activity,MF,CHP1;KCNS3;ABCC9;NEDD4L;SGK1
12768,GO:0051017,0.0377098833866257,0.981533338101554,14,110,actin filament bundle assembly,BP,CTGF;MYO1B;SFRP1;TPM1;PTGER4;SYNPO2L;WNT4;LCP1;BAIAP2;SRF;DPYSL3;SYNPO2;NEDD9;ITGB1BP1
9862,GO:0042100,0.0377806112787606,0.98717498782016,7,45,B cell proliferation,BP,TFRC;IL7R;AHR;ATAD5;RC3H1;CD74;CDKN1A
12684,GO:0050869,0.0378340944700492,0.992205094998441,4,17,negative regulation of B cell activation,BP,INHBA;SFRP1;THOC1;RC3H1
148,GO:0000302,0.0378913316082688,0.979504340270899,18,167,response to reactive oxygen species,BP,CRYAB;CYP1B1;TXNRD1;MMP9;TP53;EDN1;NQO1;DHFR;TPM1;SOD2;APTX;APEX1;PXMP2;CFLAR;TRAF2;CCNA2;TNF;PPARGC1B
10581,GO:0043534,0.0379206721229213,0.983317019077906,11,81,blood vessel endothelial cell migration,BP,HDAC9;AMOT;STAT5A;STARD13;EMP2;PLK2;HSPB1;SRF;PDGFB;ADAM17;ITGB1BP1
6703,GO:0030099,0.0379271765923551,0.976359828244064,29,292,myeloid cell differentiation,BP,MAFB;PML;TFRC;MMP9;FBN1;RUNX1;G6PD;PABPC4;LGALS3;INHBA;TJP2;RELB;SFRP1;H3F3A;CD109;SRF;NFE2L1;IL20;SLC11A2;SENP1;LILRB3;RBBP5;CSF1;PURB;TLR3;TNF;CD74;HIST1H4A;PPARGC1B
7098,GO:0030888,0.0379742463560296,0.988480516370523,6,35,regulation of B cell proliferation,BP,TFRC;AHR;ATAD5;RC3H1;CD74;CDKN1A
804,GO:0002070,0.0380015237246636,0.994495341085612,3,11,epithelial cell maturation,BP,TFCP2L1;TYMS;CDKN1A
508,GO:0001570,0.0380506958051303,0.986003451786721,8,49,vasculogenesis,BP,AMOT;EMP2;ADM;ITGAV;HIF1AN;ACKR3;SETD2;GJC1
7743,GO:0032233,0.0382562010058043,0.987024264645883,7,43,positive regulation of actin filament bundle assembly,BP,CTGF;SFRP1;TPM1;SYNPO2L;WNT4;SYNPO2;ITGB1BP1
16561,GO:0097286,0.0388456145074796,0.994323512689644,3,11,iron ion import,BP,TFRC;SLC11A2;STEAP4
1008,GO:0002479,0.0389056680791154,0.985354052197656,8,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,HLA-B;TAP1;HLA-F;ITGAV;PSME2;PSMB9;TAP2;PSMB10
16821,GO:0098644,0.0389761386109848,0.992076367926681,4,15,complex of collagen trimers,CC,COL5A3;COL27A1;COL4A1;COL5A2
9687,GO:0038044,0.0389959615444884,0.997666514407876,2,4,transforming growth factor-beta secretion,BP,FN1;ITGAV
852,GO:0002175,0.0390147382867189,0.997664762137887,2,4,protein localization to paranode region of axon,BP,CNTNAP1;UGT8
14042,GO:0060745,0.0390250130043051,0.99766380308017,2,4,mammary gland branching involved in pregnancy,BP,WNT4;ESR1
5806,GO:0017056,0.039096682153364,0.989795031821341,5,25,structural constituent of nuclear pore,MF,NUP153;NDC1;NUP160;NUP54;UPF3B
8610,GO:0034112,0.0391179683409006,0.997296866959136,2,5,positive regulation of homotypic cell-cell adhesion,BP,PDPN;CCL5
3587,GO:0008009,0.0394739005733232,0.993910938699327,3,14,chemokine activity,MF,CCL20;CXCL16;CCL5
6251,GO:0019825,0.0395150335064282,0.99418611866034,3,11,oxygen binding,MF,CYP1B1;CYP1A1;HIF1AN
19443,GO:1905952,0.0396397607210765,0.983231442289475,10,73,regulation of lipid localization,BP,C3;EDN1;C1QTNF1;IKBKE;SYK;ITGAV;EHD1;ARV1;TNF;FTO
1090,GO:0002675,0.0396499865138304,0.994045601353849,3,12,positive regulation of acute inflammatory response,BP,C3;IL6ST;TNF
15261,GO:0071402,0.0397355259651287,0.991606447463736,4,18,cellular response to lipoprotein particle stimulus,BP,HMGCS1;SYK;CDH13;ADAM17
10405,GO:0043227,0.0398380601591794,0.966932491653496,681,9246,membrane-bounded organelle,CC,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NRG1;HDAC9;KRT34;KRT4;C1R;TRIM16;MAP2;KRT13;FN1;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;CLN6;FAT4;B4GALT1;ACTG1;PBX1;G6PD;TSC22D3;DDX17;SPON1;FAM69B;TFCP2L1;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;DOCK10;DDX47;ABCF1;TMEM106A;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;COBLL1;LGALS3;CHP1;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;IKBKE;PKMYT1;TGS1;CDKAL1;IL16;IFIT3;SRSF2;FOXD2;PCDH7;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;NUAK1;DKC1;IL7R;NUP50;SLC22A5;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;OLFML3;NAIP;ZFP42;RAB32;RELB;NBN;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;POP1;HLA-DOB;NUCKS1;PITHD1;HEATR1;ZDHHC6;CD274;MCM2;TARDBP;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;COA7;KEAP1;NAA15;TRA2A;ZNF827;SLC5A6;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;TMEM97;LSG1;G3BP1;GRWD1;ZNF584;URM1;PARD3B;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;CASC3;SYNPO2L;RRAGB;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;LCP1;EXOG;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARMC5;RRN3;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;QPCT;TAF1D;ABCF2;SNX11;AJUBA;SMC2;FASTKD3;UTP14A;DND1;ZNF267;CROT;RBMXL1;KRT24;LFNG;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;KREMEN2;SDK1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;DDX10;MBOAT1;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;MCM6;FGD6;SRD5A1;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;UPK3B;TRMT5;TTF2;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;NNT;IFNAR1;WEE1;ZNF484;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;GREB1;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;DGCR8;SS18L2;KRT10;CCAR1;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;ZNFX1;STEAP4;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;ANKRD13A;WDR75;BMS1;MCM4;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;RABEP2;DPYSL3;ESF1;TAF6L;MRPS7;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;MSH3;TELO2;EDRF1;RBBP5;FAM208B;CITED2;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;JMJD8;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;MPP5;AZIN1;SYNPO2;ESR1;CLCC1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;TYMS;STARD7;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;DAXX;ZSCAN31;DCTN5;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;ZNHIT6;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GBP6;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
4186,GO:0009262,0.0399224537292377,0.989279059197875,5,31,deoxyribonucleotide metabolic process,BP,RRM2;SMUG1;RRM1;TYMS;TBPL1
12837,GO:0051123,0.0399474503275075,0.989376767645884,5,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53;TAF2;TAF6L;ESR1;TAF1
567,GO:0001706,0.0400172977717299,0.986347181400517,7,41,endoderm formation,BP,FN1;MMP9;COL12A1;INHBA;ITGAV;COL5A2;SETD2
8159,GO:0032879,0.040037395418842,0.967632998989203,144,1693,regulation of localization,BP,CRYAB;IGFBP3;SAA1;NRG1;HDAC9;TRIM16;FN1;PML;CYP1B1;AMOT;MTUS1;JPH2;CYR61;C3;STAT5A;TRIM22;STARD13;MMP9;IL1R2;B4GALT1;G6PD;IRS1;TP53;DAPK3;EDN1;GBP1;DOCK10;C1QTNF1;RBM4;ACSL3;PTPN14;LGALS3;CHP1;PDPN;TGFB2;RBM22;CYLD;IKBKE;IL16;SLC30A6;SLC9A3R1;DKC1;INHBA;SYK;EMP2;NUP153;SHISA9;SHQ1;SFRP1;VPS41;CD274;POLR1A;TPM1;ULK4;REEP1;ADAMTS9;KCNS3;PTGER4;OPHN1;CADPS2;DYNLL2;CCL20;PLK2;UBQLN2;NEXN;AKAP8L;HSPB1;RHOG;WNT4;CXCL16;LCP1;PTPRM;SIRPA;SOD2;CORO1C;RAB26;IL24;ITGAV;SOCS1;ARNTL;AJUBA;KCNQ5;NETO1;CDCA5;GNL3L;YRDC;CDH13;SRF;PDGFB;TBC1D15;CLU;USP6;ENPP1;PIK3R3;NUP54;ACKR3;SETD2;GLIS2;GLIPR2;JPH1;THADA;APEX1;HSPA8;SYT11;HSP90AB1;ARL6IP5;NSF;NEDD4L;SGK1;CCAR1;WDPCP;MTMR2;GOSR1;RAB3GAP1;GPER1;WDR75;ADAM17;NTN1;CBLL1;SHTN1;DPYSL3;UBE2J2;TRAF2;CITED2;CSF1;CLOCK;KIF14;AZIN1;PARD3;EHD1;KCNE4;ARV1;TNF;STARD7;CCL5;CD74;HNRNPU;FGFR1OP;PANX1;FTO;CDKN1A;ITGB1BP1;ASTN2;TSGA13
265,GO:0000732,0.0400809188093618,0.989466573715872,5,25,strand displacement,BP,EXO1;NBN;BRIP1;BRCA2;RAD51B
6314,GO:0019956,0.0400836080371548,0.994068648807465,3,11,chemokine binding,MF,PDPN;ITGAV;ACKR3
14274,GO:0061304,0.0401410210730006,0.997558761328483,2,4,retinal blood vessel morphogenesis,BP,CYP1B1;COL4A1
13414,GO:0052696,0.0404507585796499,0.997152248583305,2,5,flavonoid glucuronidation,BP,UGT1A6;UGT1A4
13415,GO:0052697,0.0404507585796499,0.997152248583305,2,5,xenobiotic glucuronidation,BP,UGT1A6;UGT1A4
14529,GO:0065008,0.0404751769316527,0.966448486085743,195,2395,regulation of biological quality,BP,CRYAB;MAFB;KRT1;SAA1;FTL;FTH1;NEFL;NRG1;FN1;PML;CYP1B1;JPH2;GCLC;TFRC;C3;TXNRD1;STAT5A;CBX5;SLC16A2;CTGF;FBN1;SLC7A2;CYP1A1;CLN6;ACTG1;G6PD;TSC22D3;IRS1;TP53;DAPK3;PANK2;EXO1;EDN1;C9ORF3;DOCK10;C1QTNF1;NQO1;PABPC4;CHP1;SLC4A11;ACO1;PDPN;CNTNAP1;CYLD;IKBKE;SLC30A6;SLC9A3R1;DKC1;INHBA;IL7R;SLC22A5;PALM2;SYK;EMP2;TJP2;NBN;LEPR;SHISA9;ABCG2;LSS;CDK4;SFRP1;GPCPD1;NUCKS1;TARDBP;MIR17HG;ABHD4;H3F3A;ATP2B1;KEAP1;NAA15;HRNR;RPA1;TPM1;CSRP1;POLA1;KCNS3;PTGER4;TMEM97;ADM;GGCX;CADPS2;DYNLL2;SLC1A3;PLK2;MME;KANK4;RFC3;HSPB1;RHOG;WNT4;SOD2;ATP2C1;GPHN;RRN3;ITGAV;SET;ARNTL;TRPM7;FASTKD3;AKR1C2;NETO1;FEN1;CDC42EP2;GNL3L;YRDC;BAIAP2;GATC;APTX;SRF;MDM4;PDGFB;NFE2L1;CLU;ENPP1;COMMD9;RIF1;METTL16;FGD6;SRD5A1;THBD;JPH1;LRRN3;THADA;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;UMPS;HSPA8;SYT11;TMEM199;HSP90AB1;ARL6IP5;BACE2;NEDD4L;SGK1;PRIM2;ZFYVE27;BRCA2;HPS5;SYNCRIP;NAV2;DPYD;WDPCP;MTMR2;TMEM165;L1CAM;STEAP4;CCDC47;RAB3GAP1;GPER1;FAF1;RPTN;ADAM17;MYO10;SENP1;ATR;NTN1;PSME2;UBAP2L;PSMB9;NFKBIE;SHTN1;AKR1B1;TELO2;HNRNPR;SLC9A9;POLE3;CSF1;AP3B1;NAA16;CLOCK;ESR1;GJC1;RAD51B;EHD1;ARV1;TNF;ZFP36L2;RC3H1;CCL5;CD74;WDR36;HNRNPU;PSMB10;HIST1H4A;TAF1;FTO;PPARGC1B;CDKN1A;ITGB1BP1;MUC6;IRF1
9292,GO:0035722,0.04071221718392,0.987300151507695,6,40,interleukin-12-mediated signaling pathway,BP,HNRNPF;LCP1;SOD2;IL12RB2;PSME2;HNRNPDL
15220,GO:0071349,0.04071221718392,0.987300151507695,6,40,cellular response to interleukin-12,BP,HNRNPF;LCP1;SOD2;IL12RB2;PSME2;HNRNPDL
6802,GO:0030239,0.0407398762078452,0.987723464029866,6,28,myofibril assembly,BP,ACTG1;EDN1;TPM1;SRF;MYH11;CFLAR
12586,GO:0050719,0.0407574452598558,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
12588,GO:0050721,0.0407574452598558,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
12591,GO:0050726,0.0407574452598558,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
16672,GO:0097527,0.0407606389711263,0.997118224901473,2,5,necroptotic signaling pathway,BP,TLR3;TNF
10042,GO:0042481,0.0409740385103623,0.993883266639805,3,11,regulation of odontogenesis,BP,EDN1;WNT10A;CSF1
2456,GO:0005667,0.0410221816478717,0.974735141621649,27,260,transcription factor complex,CC,MAFB;HDAC9;PBX1;TP53;PDLIM1;ZFP42;CDK4;AHR;NAA15;TAF2;ELMSAN1;GTF3C6;ARNTL;TAF1D;AJUBA;EYA3;APEX1;E2F8;TAF6L;GTF3C4;RBL1;NAA16;CLOCK;HNRNPU;TAF1;TBPL1;GTF2H3
4248,GO:0009446,0.0410960658319634,0.997081227514721,2,5,putrescine biosynthetic process,BP,ODC1;AZIN1
3918,GO:0008584,0.0411290133284797,0.980878305800927,12,94,male gonad development,BP,HMGCS1;TGFB2;INHBA;ZFP42;BRIP1;SFRP1;WNT4;SRD5A1;RRM1;CITED2;TLR3;ESR1
9813,GO:0040031,0.0411688432595903,0.99682972915467,2,6,snRNA modification,BP,DKC1;METTL16
4287,GO:0009653,0.041187651329152,0.966589263868552,148,1704,anatomical structure morphogenesis,BP,CRYAB;MAFB;KRT1;NEFL;NRG1;HDAC9;MAP2;KRT13;FN1;TENM3;PML;CYP1B1;AMOT;CYR61;C3;TXNRD1;FGFR2;EPGN;STARD13;CTGF;MMP9;FBN1;HSPG2;RUNX1;ERVFRD-1;FAT4;B4GALT1;ACTG1;PBX1;TFCP2L1;COL27A1;DAPK3;TUFT1;PANK2;EDN1;GBP1;DOCK10;SIPA1L3;KBTBD8;PTPN14;MEGF11;PDPN;TGFB2;IRX2;CNTNAP1;FOXD2;LRFN4;COL12A1;SLC9A3R1;INHBA;IL7R;PALM2;SYK;EMP2;LEPR;ARFRP1;SFRP1;RIPK4;WNT10A;MIR17HG;COL4A1;NAA15;TPM1;PTPRB;ADAMTS9;OPHN1;ADM;CD109;SLC1A3;PLK2;HSPB1;RHOG;WNT4;PTPRM;KDM6A;CORO1C;ITGAV;AJUBA;LFNG;PGK1;CDC42EP2;BAIAP2;CDH13;COL5A2;PHACTR4;SRF;HIF1AN;NPNT;UGT8;SDK1;FZD1;IRX4;NFE2L1;ANTXR1;CLU;FRAS1;EYA3;ACKR3;FGD6;SETD2;UBP1;WEE1;ERAP1;SLC11A2;PDCL3;TNC;CNTNAP2;MYH11;NEDD4L;SGK1;ZFYVE27;TRAK2;WDPCP;FANCD2;E2F8;MTMR2;L1CAM;RAB3GAP1;BBS5;ADAM17;MYO10;NTN1;PSME2;CFLAR;PSMB9;SHTN1;CITED2;NCL;TIMELESS;CSF1;KIF14;TLR3;MPP5;ESR1;PARD3;GJC1;EHD1;TNF;RC3H1;WDR36;RING1;PSMB10;TBPL1;NRAS;SMARCC1;PPARGC1B;ITGB1BP1;ASTN2
9807,GO:0040017,0.0412106469922387,0.97296514247904,35,348,positive regulation of locomotion,BP,HDAC9;FN1;CYR61;STAT5A;MMP9;TP53;DAPK3;EDN1;LGALS3;PDPN;TGFB2;IL16;CD274;CCL20;PLK2;HSPB1;CXCL16;SOD2;ITGAV;CDH13;PDGFB;ACKR3;GLIPR2;CCAR1;GPER1;ADAM17;NTN1;CBLL1;SHTN1;CSF1;TNF;CCL5;CD74;FGFR1OP;ITGB1BP1
19510,GO:1990226,0.041211043328782,0.997068505263634,2,5,histone methyltransferase binding,MF,HSP90AB1;NOP56
1987,GO:0004704,0.0412419595410607,0.997065080881723,2,5,NF-kappaB-inducing kinase activity,MF,MAP3K14;IKBKE
13930,GO:0060561,0.0412519056834233,0.991180284654581,4,18,apoptotic process involved in morphogenesis,BP,CRYAB;CYR61;B4GALT1;TGFB2
16335,GO:0090501,0.0414877124868565,0.979320055940207,14,123,RNA phosphodiester bond hydrolysis,BP,UTP20;EXO1;POP1;TSR1;FEN1;USB1;ISG20L2;RRP36;APEX1;DGCR8;FCF1;BMS1;NOL9;NCBP1
12884,GO:0051186,0.0415111581481135,0.97206411011903,39,430,cofactor metabolic process,BP,PTGES;GCLC;STAT5A;CYP1A1;G6PD;MAT2A;PANK2;SCD;HMGCS1;ACSL3;PGD;NUP50;NUP153;SLC5A6;DHFR;NDC1;HSCB;RANBP2;GPHN;CROT;AKR1C2;PGK1;HACD2;IBA57;GDAP1;QDPR;NFE2L1;NUP160;NUP54;NNT;SLC11A2;SCD5;MMAA;UGT1A4;AKR1B1;PDSS1;TYMS;FLAD1;THTPA
10964,GO:0044666,0.0415667118165928,0.99375892560682,3,11,MLL3/4 complex,CC,KDM6A;UTY;RBBP5
8396,GO:0033299,0.0415675124236086,0.997028931493522,2,5,secretion of lysosomal enzymes,BP,GNPTAB;M6PR
7417,GO:0031497,0.0415838784175849,0.979759722954412,13,134,chromatin assembly,BP,TP53;CDKN2A;MCM2;H3F3A;HELLS;GRWD1;NAP1L1;SET;CENPN;DAXX;HIST1H4A;CTCF;CENPO
7758,GO:0032269,0.0415943099258146,0.968767827754918,74,853,negative regulation of cellular protein metabolic process,BP,CRYAB;IGFBP3;PML;GCLC;C3;GPRC5A;MMP9;IL1R2;G6PD;ENC1;DAPK3;EDN1;GBP1;DUSP14;CDKN2A;RBM4;CHP1;SLC9A3R1;NUP50;NUP153;NAIP;CDK4;SFRP1;TARDBP;MIR17HG;H3F3A;DHFR;OPHN1;CD109;NDC1;HSPB1;RAN;RANBP2;CORO1C;DDX3X;SOCS1;SET;PARP14;AJUBA;DND1;ZC3H7B;PPP4R4;GNL3L;GADD45B;SH3RF2;NUP160;ENPP1;BIRC3;NUP54;METTL16;PDCL3;HSP90AB1;SYNCRIP;DGCR8;POLR2F;SERPINB9;GPER1;SENP1;NCBP1;HNRNPR;NCL;ESR1;PARD3;TNF;ZFP36L2;RC3H1;TYMS;FGFR1OP;HIST1H4A;TAF1;SMARCC1;CDKN1A;ITGB1BP1;IRAK3
19748,GO:2000059,0.0417372581848243,0.986984159761666,6,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,PML;PDCL3;HSP90AB1;SENP1;TAF1;SMARCC1
12091,GO:0048024,0.0417924234912524,0.98311712979096,9,64,regulation of mRNA splicing, via spliceosome,BP,DDX17;RBM4;SRSF2;METTL16;HSPA8;NCBP1;SRSF7;HNRNPU;RBM8A
12291,GO:0048583,0.0418223258815725,0.965001644307553,221,2725,regulation of response to stimulus,BP,IL32;CRYAB;IGFBP3;KRT1;SAA1;NRG1;C1R;TRIM16;FN1;PML;CYP1B1;AMOT;MTUS1;JPH2;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;NLRC5;FGFR2;EPGN;TRIM22;STARD13;CTGF;HLA-B;MMP9;FBN1;SLC7A2;RUNX1;IL1R2;ACTG1;G6PD;FST;TRAF3;IRS1;SPG21;MID1;TP53;DAPK3;EXO1;EDN1;GBP1;SIPA1L3;C1QTNF1;DUSP14;CDKN2A;JRK;LGALS3;IFNGR1;CHP1;PDPN;TGFB2;CNTNAP1;CYLD;IKBKE;IL27RA;IL16;RAD1;IL6ST;BAG1;SLC9A3R1;NUAK1;INHBA;IL7R;NUP50;SYK;EMP2;NUP153;NAIP;RELB;NBN;TRIO;SHISA9;BRIP1;HLA-F;CDK4;SFRP1;NUCKS1;WNT10A;MIR17HG;POLQ;DHFR;RPA1;TAF2;ULK4;PTGER4;G3BP1;TRAF1;OPHN1;ADM;CD109;NDC1;DYNLL2;CCL20;PLK2;RRAGB;MUC16;UBQLN2;GBP5;BTN2A1;RFC3;WDR76;HSPB1;RHOG;WNT4;CXCL16;NOP2;THOC1;RANBP2;TOPBP1;SOD2;SUPT16H;ATP2C1;DDX3X;IL24;ARHGEF28;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;LFNG;NETO1;CDC42EP2;BAIAP2;GADD45B;CDH13;PHACTR4;MDM4;HIF1AN;NPNT;PDGFB;BRCC3;CHID1;KREMEN2;FZD1;CLU;NUP160;SMYD2;MACC1;ENPP1;BIRC3;IL20;PIK3R3;NUP54;EYA3;ACKR3;RIF1;FGD6;SETD2;GLIS2;RPF2;THBD;GLIPR2;JPH1;IFNAR1;ERAP1;HSPA8;SYT11;HSP90AB1;ARL6IP5;EPHB6;LAIR1;FANCD2;MTMR2;CHEK1;SERPINB9;GPER1;FAF1;ADAM17;MYO10;RBMS3;ATR;PSME2;MSH6;CFLAR;PSMB9;EIF2B5;CMTM3;RFWD3;RABEP2;AKR1B1;TRAF2;TELO2;CITED2;POLR3B;TIMELESS;CSF1;RBL1;CLOCK;KIF14;TLR3;ESR1;DNASE1;TNF;ATAD5;RC3H1;CCL5;CD74;PSMB10;EIF2B1;DAXX;METAP2;PHF14;PHLPP2;TAF1;PHLPP1;NRAS;PSPC1;MUC5B;ITGB1BP1;USP1;MUC6;IRF1;IRAK3
2875,GO:0006369,0.04195286273948,0.982968747374991,9,69,termination of RNA polymerase II transcription,BP,SRSF2;CASC3;THOC1;TTF2;MAZ;NCBP1;UPF3B;SRSF7;RBM8A
16167,GO:0090162,0.0420354481795571,0.988807270540804,5,25,establishment of epithelial cell polarity,BP,SIPA1L3;SLC9A3R1;OPHN1;MPP5;PARD3
2117,GO:0004904,0.0420767000921815,0.996972062171695,2,5,interferon receptor activity,MF,IFNGR1;IFNAR1
5282,GO:0015931,0.0422037323038799,0.975375010848868,22,207,nucleobase-containing compound transport,BP,SRSF2;NUP50;PHAX;NUP153;NDC1;HNRNPA1L2;SLC35A4;CASC3;AKAP8L;THOC1;RAN;RANBP2;NUP160;SDAD1;NUP54;LRPPRC;SETD2;NCBP1;UPF3B;SRSF7;RBM8A;BUD13
17123,GO:0099640,0.0423129467771948,1,1,1,axo-dendritic protein transport,BP,HSPB1
17124,GO:0099641,0.0423129467771948,1,1,1,anterograde axonal protein transport,BP,HSPB1
10043,GO:0042482,0.0423790606816966,0.996938103185843,2,5,positive regulation of odontogenesis,BP,EDN1;CSF1
5109,GO:0015399,0.0424265053009001,0.981841011822874,10,73,primary active transmembrane transporter activity,MF,TAP1;ABCG2;ATP2B1;ABCC4;ATP2C1;TIMM23B;ABCC9;ABCA5;TAP2;ABCA11P
5110,GO:0015405,0.0424265053009001,0.981841011822874,10,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,TAP1;ABCG2;ATP2B1;ABCC4;ATP2C1;TIMM23B;ABCC9;ABCA5;TAP2;ABCA11P
12873,GO:0051172,0.0424702688697404,0.965513969115477,147,1780,negative regulation of nitrogen compound metabolic process,BP,CRYAB;IGFBP3;NRG1;HDAC9;PML;GCLC;C3;GPRC5A;FGFR2;TRIM22;CBX5;MMP9;IL1R2;G6PD;TSC22D3;FST;TFCP2L1;ENC1;TP53;DAPK3;EDN1;GBP1;DUSP14;CDKN2A;RBM4;CHP1;IRX2;SRSF2;SLC9A3R1;DKC1;INHBA;NUP50;NUP153;NAIP;RELB;NBN;PARP15;SHQ1;CDK4;SFRP1;TARDBP;MIR17HG;POLQ;H3F3A;AHR;DHFR;GLIS3;HELLS;SETDB1;OPHN1;CD109;NDC1;ZNF587;FRK;HSPB1;WNT4;SUV39H2;THOC1;RAN;RANBP2;CORO1C;DDX3X;ITGAV;SOCS1;SET;PARP14;ARNTL;AJUBA;DND1;ZC3H7B;TRIM37;PPP4R4;GNL3L;ZNF586;GADD45B;SH3RF2;SRF;MDM4;HIF1AN;PDGFB;FZD1;CLU;NUP160;SMYD2;ENPP1;BIRC3;NUP54;LRPPRC;RIF1;METTL16;GLIS2;UBP1;APEX1;PDCL3;HSPA8;HSP90AB1;BACE2;NEDD4L;BRCA2;SYNCRIP;DGCR8;CCAR1;E2F8;CENPF;ETV6;POLR2F;SERPINB9;GPER1;SENP1;ATR;MSH6;ZNF12;ZNF608;NCBP1;MSH3;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;AZIN1;ESR1;PARD3;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;HNRNPU;RING1;FGFR1OP;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;IRF1;CTCF;IRAK3
4150,GO:0009211,0.0425418347186802,0.996663864156828,2,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,TYMS;TBPL1
8070,GO:0032732,0.0425665870254303,0.988481491946036,5,28,positive regulation of interleukin-1 production,BP,SAA1;TRIM16;CCL20;HSPB1;PANX1
11332,GO:0045637,0.0425773605182646,0.976205803474009,19,183,regulation of myeloid cell differentiation,BP,MAFB;FBN1;RUNX1;LGALS3;INHBA;TJP2;SFRP1;H3F3A;IL20;SENP1;LILRB3;RBBP5;CSF1;PURB;TLR3;TNF;CD74;HIST1H4A;PPARGC1B
4390,GO:0010041,0.0425947569725619,0.996913791688148,2,5,response to iron(III) ion,BP,CYP1A1;G6PD
17852,GO:1901987,0.0425968327744005,0.971776430430349,36,379,regulation of cell cycle phase transition,BP,PML;CYP1A1;PBX1;TP53;CDKN2A;GPR132;NBN;CDK4;PLK2;TOPBP1;ANAPC15;DDX3X;CDC25A;CDCA5;MDM4;BRCC3;ANLN;APEX1;E2F8;CENPF;CHEK1;ADAM17;PSME2;CEP152;PSMB9;RFWD3;TPRA1;RBL1;KIF14;RAD51B;ATAD5;ZFP36L2;FGFR1OP;PSMB10;TAF1;CDKN1A
8838,GO:0034614,0.042948895611779,0.978487721725273,14,123,cellular response to reactive oxygen species,BP,CYP1B1;MMP9;TP53;NQO1;DHFR;TPM1;SOD2;APEX1;PXMP2;CFLAR;TRAF2;CCNA2;TNF;PPARGC1B
8025,GO:0032652,0.0430031667263246,0.984916316134288,7,48,regulation of interleukin-1 production,BP,SAA1;TRIM16;PML;IL1R2;CCL20;HSPB1;PANX1
1122,GO:0002708,0.0430820891684025,0.984904725428535,7,47,positive regulation of lymphocyte mediated immunity,BP,TFRC;C3;RIF1;MSH6;TRAF2;TNF;ATAD5
8607,GO:0034109,0.0431232232188338,0.983625216998774,8,54,homotypic cell-cell adhesion,BP,ACTG1;C1QTNF1;MEGF11;PDPN;SYK;CSRP1;HSPB1;CCL5
4276,GO:0009635,0.0431325556516992,0.993300631944178,3,12,response to herbicide,BP,NEFL;CYP1A1;DAXX
4340,GO:0009890,0.0431449947918853,0.966133149978983,104,1219,negative regulation of biosynthetic process,BP,NRG1;HDAC9;PML;GCLC;FGFR2;TRIM22;CBX5;TSC22D3;FST;TFCP2L1;ENC1;TP53;DAPK3;EDN1;CDKN2A;RBM4;IRX2;SRSF2;INHBA;NUP50;NUP153;RELB;LEPR;PARP15;SFRP1;MIR17HG;H3F3A;AHR;DHFR;GLIS3;HELLS;SETDB1;NDC1;ZNF587;FRK;WNT4;SUV39H2;RAN;RANBP2;DDX3X;ITGAV;SET;ARNTL;AJUBA;DND1;ZC3H7B;TRIM37;GNL3L;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;NUP160;SMYD2;ENPP1;NUP54;RIF1;METTL16;GLIS2;UBP1;APEX1;HSPA8;BACE2;NEDD4L;BRCA2;SYNCRIP;DGCR8;CCAR1;E2F8;CENPF;ETV6;POLR2F;GPER1;ATR;CFLAR;ZNF12;ZNF608;NCBP1;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;ZFP36L2;RC3H1;TYMS;HNRNPU;RING1;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;IRF1;CTCF
19150,GO:1905063,0.0432005814126281,0.996845126145894,2,5,regulation of vascular smooth muscle cell differentiation,BP,PDGFB;GPER1
15429,GO:0071675,0.0432213744854712,0.990476492045701,4,20,regulation of mononuclear cell migration,BP,LGALS3;CSF1;TNF;CCL5
17714,GO:1901568,0.0432401150937982,0.979686202030625,12,100,fatty acid derivative metabolic process,BP,PTGES;CYP1B1;CYP1A1;EDN1;SCD;ACSL3;SYK;AKR1C2;HACD2;SCD5;CD74;GPX4
16780,GO:0098552,0.0433086229454212,0.973181260896119,27,263,side of membrane,CC,NRG1;AMOT;TFRC;HLA-B;B4GALT1;G6PD;TRAF3;CYLD;IL6ST;IL7R;SYK;HLA-F;CD274;ATP2B1;FRK;BTN2A1;ITGAV;SNX5;CDH13;ANTXR1;THADA;CXCR5;HSPA8;IL12RB2;TRAF2;TNF;CD74
2809,GO:0006269,0.0434350991805496,0.996818394499738,2,5,DNA replication, synthesis of RNA primer,BP,POLA1;PRIM2
11675,GO:0046415,0.0434756957992132,0.996813758540021,2,5,urate metabolic process,BP,SLC16A9;ABCG2
10424,GO:0043252,0.0435957832279968,0.993327558988288,3,11,sodium-independent organic anion transport,BP,SLC16A2;SLC22A5;SLCO4C1
11969,GO:0047066,0.0436022378852994,1,1,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,GPX4
16734,GO:0097707,0.0436022378852994,1,1,1,ferroptosis,BP,GPX4
17262,GO:0110075,0.0436022378852994,1,1,1,regulation of ferroptosis,BP,GPX4
17263,GO:0110076,0.0436022378852994,1,1,1,negative regulation of ferroptosis,BP,GPX4
15764,GO:0072331,0.0436802887926858,0.973461435788936,25,246,signal transduction by p53 class mediator,BP,PML;TP53;EXO1;RAD1;NUAK1;NBN;BRIP1;RPA1;TAF2;PLK2;RFC3;NOP2;TOPBP1;SUPT16H;RRN3;MDM4;SMYD2;RPF2;BRCA2;E2F8;CHEK1;ATR;CD74;TAF1;CDKN1A
12439,GO:0048872,0.0436823957123301,0.975559624629025,19,172,homeostasis of number of cells,BP,MAFB;G6PD;TSC22D3;DOCK10;CYLD;INHBA;IL7R;SLC22A5;MIR17HG;RRN3;SRF;NFE2L1;SLC11A2;ADAM17;SENP1;UBAP2L;CSF1;RC3H1;CD74
4664,GO:0010810,0.0437231741018635,0.976490738138693,17,140,regulation of cell-substrate adhesion,BP,FN1;CYR61;COL16A1;CCDC80;DAPK3;GBP1;CDKN2A;PDPN;EMP2;SFRP1;WNT4;CORO1C;CDH13;NPNT;WDPCP;CSF1;ITGB1BP1
11303,GO:0045599,0.0437611152516209,0.986262266373528,6,35,negative regulation of fat cell differentiation,BP,TRIO;ARNTL;ENPP1;GPER1;TNF;ZFP36L2
3284,GO:0006974,0.0439044296664721,0.967545546755717,65,740,cellular response to DNA damage stimulus,BP,PML;MAP3K14;TP53;EXO1;IKBKE;RAD1;NUAK1;NBN;BRIP1;NUCKS1;PITHD1;POLQ;USP16;RPA1;POLA1;IMMP2L;USP43;PLK2;RFC3;WDR76;THOC1;TOPBP1;SUPT16H;FEN1;CDCA5;APTX;GINS4;MDM4;MCM8;BRCC3;CLU;SMYD2;EYA3;ACKR3;RIF1;SETD2;APEX1;SMUG1;HELQ;SGK1;BRCA2;FANCD2;E2F8;POLR2F;CHEK1;RAD18;ATR;MSH6;RFWD3;MSH3;RBBP5;TIMELESS;CLOCK;RAD51B;TNF;ATAD5;CD74;HIST1H4A;TAF1;FTO;CDKN1A;USP1;TREX1;GTF2H3;COPS3
2811,GO:0006271,0.0440106724615956,0.990245664906453,4,20,DNA strand elongation involved in DNA replication,BP,POLA1;RFC3;FEN1;GINS4
10045,GO:0042487,0.0441892563698821,0.996731863012112,2,5,regulation of odontogenesis of dentin-containing tooth,BP,WNT10A;CSF1
2266,GO:0005179,0.0442540292343217,0.990174206290474,4,20,hormone activity,MF,FBN1;EDN1;INHBA;ADM
11102,GO:0045088,0.0443293804851182,0.97197545325067,29,291,regulation of innate immune response,BP,NLRC5;TRAF3;IFNGR1;CYLD;IKBKE;SYK;RELB;MUC16;GBP5;SOCS1;PARP14;BIRC3;IFNAR1;ERAP1;HSP90AB1;SERPINB9;PSME2;PSMB9;POLR3B;TLR3;ESR1;CCL5;PSMB10;NRAS;PSPC1;MUC5B;MUC6;IRF1;IRAK3
11750,GO:0046546,0.044410928864154,0.979096176876178,12,95,development of primary male sexual characteristics,BP,HMGCS1;TGFB2;INHBA;ZFP42;BRIP1;SFRP1;WNT4;SRD5A1;RRM1;CITED2;TLR3;ESR1
12595,GO:0050730,0.0444534878493582,0.975980707183556,17,152,regulation of peptidyl-tyrosine phosphorylation,BP,NRG1;GPRC5A;EPGN;TP53;IL6ST;SYK;SFRP1;IL24;SOCS1;PARP14;PDGFB;IL20;PDCL3;ADAM17;CCL5;CD74;FGFR1OP
8606,GO:0034105,0.0444595427818526,0.990183118981734,4,19,positive regulation of tissue remodeling,BP,TFRC;B4GALT1;SYK;PPARGC1B
7981,GO:0032589,0.0444746347192168,0.987971672454638,5,25,neuron projection membrane,CC,NRG1;SHISA9;ATP2B1;CNTNAP2;GPER1
5289,GO:0015939,0.044578740062295,0.996686835515023,2,5,pantothenate metabolic process,BP,PANK2;SLC5A6
12792,GO:0051048,0.0445812978470379,0.978247307426361,13,108,negative regulation of secretion,BP,NRG1;FN1;PML;IL1R2;IRS1;EDN1;GBP1;INHBA;SFRP1;PTGER4;SYT11;TNF;CD74
3660,GO:0008144,0.044676907756073,0.964573298867972,113,1266,drug binding,MF,CYP1B1;KIF23;MAP3K14;GCLC;NLRC5;FGFR2;TAP1;RUNX1;MYO1B;CYP1A1;ACTG1;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;HMGCS1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;TRIO;BRIP1;MCM5;ABCG2;CDK4;SFRP1;RIPK4;MCM2;POLQ;ATP2B1;DHFR;HELLS;ULK4;ABCC4;TK1;G3BP1;MDN1;PLK2;FRK;SUV39H2;DDX28;ORC4;ATP2C1;DDX3X;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;NVL;GATC;RARS;HIF1AN;MCM8;CHID1;SGK494;ENPP1;CBWD5;DDX10;DDX24;MCM6;ABCC9;TTF2;SEPHS2;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;PPIP5K1;FKBP5;CHEK1;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;TYMS;HNRNPU;FLAD1;TAF1;ABCA11P;IRAK3;DHX15
17885,GO:1902074,0.0447195608500195,0.992952485135786,3,12,response to salt,BP,NEFL;EDN1;DAXX
6764,GO:0030193,0.0448408797333927,0.984150301251673,7,47,regulation of blood coagulation,BP,KRT1;EDN1;C1QTNF1;PDPN;SYK;PDGFB;THBD
17379,GO:1900046,0.0448408797333927,0.984150301251673,7,47,regulation of hemostasis,BP,KRT1;EDN1;C1QTNF1;PDPN;SYK;PDGFB;THBD
7167,GO:0031032,0.0448662912036757,0.976357433661381,16,124,actomyosin structure organization,BP,KIF23;CTGF;ACTG1;EDN1;SFRP1;TPM1;PTGER4;WNT4;TRPM7;SRF;RTKN2;ANLN;MYH11;LIMCH1;CFLAR;ITGB1BP1
19720,GO:2000008,0.0450491460820084,0.987617722947629,5,28,regulation of protein localization to cell surface,BP,NRG1;HSP90AB1;NEDD4L;TNF;ASTN2
6757,GO:0030175,0.0451231353414124,0.980556222033552,10,68,filopodium,CC,MYO1B;B4GALT1;PDPN;SLC9A3R1;LCP1;ITGAV;BAIAP2;ANTXR1;MYO10;SHTN1
7853,GO:0032407,0.0455483922906786,0.996573739814243,2,5,MutSalpha complex binding,MF,ATR;TREX1
890,GO:0002253,0.0455742814355517,0.969827148656541,35,363,activation of immune response,BP,KRT1;C1R;C3;RUNX1;ACTG1;TRAF3;SPG21;GBP1;LGALS3;CYLD;IKBKE;SYK;RELB;MUC16;BTN2A1;BAIAP2;CLU;BIRC3;HSP90AB1;MYO10;PSME2;PSMB9;EIF2B5;CMTM3;TLR3;ESR1;RC3H1;PSMB10;EIF2B1;NRAS;PSPC1;MUC5B;MUC6;IRF1;IRAK3
5510,GO:0016458,0.0456047680939313,0.972765373806945,23,237,gene silencing,BP,DDX17;RBM4;NUP50;NUP153;MIR17HG;H3F3A;HELLS;TSN;SETDB1;NDC1;RAN;RANBP2;AJUBA;DND1;ZC3H7B;NUP160;NUP54;RIF1;DGCR8;POLR2F;NCBP1;ESR1;HIST1H4A
14899,GO:0070671,0.0456368849653999,0.985338209494788,6,41,response to interleukin-12,BP,HNRNPF;LCP1;SOD2;IL12RB2;PSME2;HNRNPDL
12576,GO:0050709,0.0457731915402162,0.981145146787734,9,67,negative regulation of protein secretion,BP,FN1;PML;IL1R2;IRS1;GBP1;SFRP1;PTGER4;SYT11;TNF
458,GO:0001306,0.0458707501979554,1,1,1,age-dependent response to oxidative stress,BP,SOD2
459,GO:0001315,0.0458707501979554,1,1,1,age-dependent response to reactive oxygen species,BP,SOD2
1277,GO:0003068,0.0458707501979554,1,1,1,regulation of systemic arterial blood pressure by acetylcholine,BP,SOD2
1278,GO:0003069,0.0458707501979554,1,1,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,SOD2
1279,GO:0003070,0.0458707501979554,1,1,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,SOD2
3546,GO:0007571,0.0458707501979554,1,1,1,age-dependent general metabolic decline,BP,SOD2
15463,GO:0071731,0.0458858855137167,0.99283033667569,3,11,response to nitric oxide,BP,CFLAR;TRAF2;CCNA2
13195,GO:0051781,0.0459129062184317,0.982323944111116,8,55,positive regulation of cell division,BP,KIF23;FGFR2;TGFB2;PDGFB;MACC1;CXCR5;KIF14;ITGB1BP1
3669,GO:0008168,0.0459224879053835,0.974132540676891,19,177,methyltransferase activity,MF,TGS1;THUMPD3;METTL21A;METTL1;SETDB1;NOP2;SUV39H2;SETD4;VCPKMT;SMYD2;METTL16;SETD2;TRMT5;METTL13;TRMT1;TRMT61A;RBBP5;WDR4;TYMS
11471,GO:0045911,0.0459837283720298,0.989734747952809,4,19,positive regulation of DNA recombination,BP,TFRC;RIF1;MSH6;ATAD5
14889,GO:0070661,0.0460360507626449,0.974985243415275,17,158,leukocyte proliferation,BP,TFRC;LGALS3;IL6ST;IL7R;SYK;CD274;AHR;HELLS;WNT4;CLU;CSF1;ATAD5;RC3H1;CCL5;CD74;CDKN1A;IRF1
16080,GO:0089718,0.0461102761444715,0.99278103574731,3,11,amino acid import across plasma membrane,BP,SLC7A2;SLC1A3;ARL6IP5
15251,GO:0071391,0.0463541693574454,0.992727333258111,3,11,cellular response to estrogen stimulus,BP,SFRP1;SERPINB9;ESR1
6861,GO:0030325,0.0464046923460847,0.992716193510102,3,11,adrenal gland development,BP,PBX1;WNT4;CITED2
8567,GO:0033993,0.04654502469063,0.96647148857808,54,592,response to lipid,BP,CRYAB;NEFL;TRIM16;KRT13;PTGES;CYP24A1;FGFR2;CTGF;RUNX1;CYP1A1;DDX17;TP53;EDN1;HMGCS1;NQO1;AKAP8;TGFB2;INHBA;CDK4;SFRP1;CD274;ATP2B1;AHR;PTGER4;ADM;CCL20;RAN;IL24;ARNTL;AKR1C2;GDAP1;CLU;NFKBIB;SRD5A1;THBD;IFNAR1;TNC;IL12RB2;GPER1;ADAM17;CFLAR;CCNA2;CLOCK;ESR1;TNF;ZFP36L2;TYMS;CCL5;HNRNPU;DAXX;TAF1;PPARGC1B;CDKN1A;IRAK3
8490,GO:0033630,0.0466102550828381,0.992530812316007,3,12,positive regulation of cell adhesion mediated by integrin,BP,TGFB2;SYK;CCL5
391,GO:0001046,0.046629708067391,0.979726080709952,10,72,core promoter sequence-specific DNA binding,MF,NLRC5;TP53;H3F3A;UBTF;RRN3;ARNTL;MAZ;CLOCK;ESR1;TAF1
12660,GO:0050839,0.0466512764350606,0.968517326785936,38,394,cell adhesion molecule binding,MF,NRG1;FN1;TENM3;CYR61;GPRC5A;COL16A1;S100P;CTGF;FBN1;MYO1B;COBLL1;PDLIM1;SYK;EMP2;TJP2;DST;EIF5;LCP1;PTPRM;RAN;DDX3X;ITGAV;SNX5;BAIAP2;CDH13;RARS;NPNT;ANLN;TJP1;HSPA8;HSP90AB1;ADAM17;SHTN1;NOP56;EHD1;ARGLU1;ITGB1BP1;DIAPH3
10691,GO:0043933,0.0467343719145018,0.962232275297185,133,1673,protein-containing complex subunit organization,BP,CRYAB;NEFL;NRG1;MAP2;FN1;PML;CYP1B1;COL16A1;TRIM22;COL5A3;B4GALT1;MAT2A;MID1;TP53;DAPK3;GBP1;C1QTNF1;ACSL3;GEMIN5;COBLL1;CHP1;PPAN;TGFB2;RBM22;CYLD;IKBKE;TGS1;COL12A1;SLC9A3R1;DNHD1;NUP153;SHQ1;VPS41;MCM2;GEMIN4;POLQ;H3F3A;USP16;RPA1;HELLS;TAF2;KCNS3;PTGER4;TK1;GRWD1;TRAF1;IMMP2L;NDC1;CADPS2;MDN1;MRPL27;HSCB;GBP5;KANK4;RHOG;NOP2;LCP1;DDX28;UBTF;RRP7BP;SOD2;SUPT16H;DDX3X;NAP1L1;NUFIP1;RRN3;SET;MRTO4;TRPM7;AJUBA;SMC2;FASTKD3;LUC7L;CDC42EP2;BAIAP2;COL5A2;SRF;MDM4;LUC7L2;FZD1;CLU;BIRC3;NUP54;SETD2;ANLN;RPF2;KCTD3;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;MYH11;GEMIN8;MTMR2;CENPF;LNX2;FAF1;RRM1;ATR;NIFK;ABCA5;DPYSL3;TAF6L;MRPS7;NCBP1;TRAF2;RBBP5;UQCRB;KIF14;ESR1;PARD3;RAD51B;EHD1;CENPN;TNF;PDSS1;RC3H1;CCL5;CD74;DAXX;PANX1;HIST1H4A;TAF1;ZNHIT6;SMARCC1;ITGB1BP1;CTCF;GTF2H3;NDUFB9;CENPO;GPX4;IRAK3
15136,GO:0071205,0.0468220269734679,0.996894529149632,2,4,protein localization to juxtaparanode region of axon,BP,CNTNAP1;CNTNAP2
17897,GO:1902107,0.0468638996374191,0.978584343104446,11,87,positive regulation of leukocyte differentiation,BP,RUNX1;CYLD;IL7R;SYK;SOCS1;IL20;CSF1;AP3B1;TNF;CD74;PPARGC1B
12663,GO:0050848,0.0469140694007999,0.983332197229418,7,44,regulation of calcium-mediated signaling,BP,NRG1;JPH2;GBP1;CHP1;SYK;CDH13;JPH1
3671,GO:0008170,0.0469312066628121,0.979513954836842,10,76,N-methyltransferase activity,MF,METTL21A;SETDB1;SUV39H2;SETD4;VCPKMT;SMYD2;METTL16;SETD2;TRMT1;RBBP5
32,GO:0000060,0.0470117009500009,0.98490887907901,6,37,protein import into nucleus, translocation,BP,RBM22;RAN;ARNTL;HSP90AB1;TNF;CDKN1A
19722,GO:2000010,0.0470443651508107,0.992432949149869,3,12,positive regulation of protein localization to cell surface,BP,NRG1;HSP90AB1;TNF
17716,GO:1901570,0.0471124689208949,0.981689173408686,8,59,fatty acid derivative biosynthetic process,BP,PTGES;EDN1;SCD;ACSL3;SYK;HACD2;SCD5;CD74
13199,GO:0051785,0.0474566057201916,0.983068121312092,7,45,positive regulation of nuclear division,BP,EPGN;EDN1;WNT4;RANBP2;CDCA5;PDGFB;HNRNPU
4761,GO:0010936,0.0475871464680498,0.996331351580921,2,5,negative regulation of macrophage cytokine production,BP,TGFB2;IRAK3
17776,GO:1901700,0.04780756583257,0.963009806881321,88,1020,response to oxygen-containing compound,BP,CRYAB;NEFL;HDAC9;TRIM16;KRT13;PTGES;CYP1B1;GCLC;CYP24A1;COL16A1;TXNRD1;FGFR2;STAT5A;CTGF;MMP9;FBN1;CYP1A1;G6PD;IRS1;TP53;EDN1;HMGCS1;NQO1;AKAP8;TGFB2;SRSF2;INHBA;NAIP;BRIP1;CDK4;SFRP1;NUCKS1;CD274;ATP2B1;COL4A1;AHR;DHFR;TPM1;SETDB1;PTGER4;ADM;CCL20;RRAGB;SOD2;IL24;SOCS1;AKR1C2;BAIAP2;APTX;COL5A2;SRF;GDAP1;QDPR;PDGFB;SDK1;CLU;ENPP1;PIK3R3;NFKBIB;EFTUD2;ZNF106;SRD5A1;THBD;IFNAR1;APEX1;TNC;HSP90AB1;PXMP2;IL12RB2;GPER1;ADAM17;CFLAR;EIF2B5;AKR1B1;TRAF2;CCNA2;TIMELESS;ESR1;TNF;TYMS;CCL5;EIF2B1;PANX1;TAF1;SMARCC1;PPARGC1B;CDKN1A;IRAK3
14736,GO:0070372,0.0478985057541055,0.972907668266047,19,172,regulation of ERK1 and ERK2 cascade,BP,FN1;CYR61;FGFR2;CTGF;GBP1;SLC9A3R1;SYK;CCL20;NPNT;PDGFB;ACKR3;GLIPR2;EPHB6;GPER1;CFLAR;TNF;CCL5;CD74;ITGB1BP1
10999,GO:0044786,0.0479945043066825,0.981314811692279,8,57,cell cycle DNA replication,BP,RPA1;POLA1;RFC3;FEN1;PRIM2;BRCA2;E2F8;POLE3
4563,GO:0010642,0.0481827116890292,0.992320868213244,3,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,SLC9A3R1;PDGFB;PHF14
12686,GO:0050871,0.0482095678819648,0.982660571055868,7,48,positive regulation of B cell activation,BP,TFRC;SYK;RIF1;MSH6;ATAD5;CD74;CDKN1A
6303,GO:0019915,0.0482739061939961,0.982683753538566,7,46,lipid storage,BP,C3;IKBKE;ITGAV;ENPP1;EHD1;TNF;FTO
15227,GO:0071356,0.0483371391623954,0.97210895768867,20,203,cellular response to tumor necrosis factor,BP,MAP3K14;TRAF3;EDN1;CYLD;SYK;TJP2;SFRP1;TRAF1;CCL20;NPNT;BIRC3;GPER1;ADAM17;PSME2;PSMB9;TRAF2;TNF;ZFP36L2;CCL5;PSMB10
18737,GO:1904115,0.0483692803706357,0.984364398003446,6,37,axon cytoplasm,CC,NEFL;AP3M2;DST;HSPB1;BLOC1S2;AP3B1
3577,GO:0007623,0.0484359079817754,0.974135964122843,16,135,circadian rhythm,BP,PML;TP53;RBM4;RELB;CDK4;AHR;SUV39H2;ARNTL;SRD5A1;HNRNPR;TIMELESS;CLOCK;TYMS;HNRNPU;PHLPP1;PSPC1
565,GO:0001704,0.0484962904941743,0.977803111274236,11,80,formation of primary germ layer,BP,FN1;TXNRD1;FGFR2;MMP9;COL12A1;INHBA;KDM6A;ITGAV;COL5A2;SRF;SETD2
4550,GO:0010628,0.0486279759693024,0.961169127886563,116,1367,positive regulation of gene expression,BP,MAFB;NRG1;TRIM16;FN1;PML;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;CTGF;RUNX1;PBX1;DDX17;TP53;EDN1;C1QTNF1;ZBED1;STAG1;TGFB2;RBM22;FOXD2;INHBA;IL7R;RELB;UTP15;CDK4;SFRP1;NUCKS1;HEATR1;WNT10A;TARDBP;H3F3A;USP16;AHR;NAA15;POLR1A;GLIS3;TAF2;AKAP8L;MYBL2;RHOG;WNT4;KDM6A;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;RRN3;ARNTL;TAF1D;FASTKD3;DND1;CDH13;SRF;NPNT;WDR43;PDGFB;FZD1;NFE2L1;CLU;MACC1;GLIS2;TNC;TET3;MYBL1;HSPA8;DDX21;BRCA2;SYNCRIP;SS18L2;E2F8;ETV6;HSF2;POLR2F;RAB3GAP1;CHEK1;SERPINB9;GPER1;MLLT10;WDR75;SENP1;RBMS3;UBAP2L;EIF2B5;NOL11;NCBP1;UPF3B;POLR1E;EDRF1;CITED2;NCL;CCNA2;CSF1;RBL1;NAA16;CLOCK;TLR3;ESR1;TNF;CCL5;CD74;HNRNPU;HIST1H4A;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
20291,GO:2001214,0.0486660166938226,0.996200587011031,2,5,positive regulation of vasculogenesis,BP,ADM;HIF1AN
3184,GO:0006809,0.0487222885912538,0.982487113780629,7,46,nitric oxide biosynthetic process,BP,CYP1B1;SLC7A2;EDN1;NQO1;CLU;HSP90AB1;TNF
4508,GO:0010556,0.0487408745138572,0.958631437761587,259,3252,regulation of macromolecule biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;TP53;DAPK3;EDN1;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;PPP1R3B;DKC1;INHBA;NUP50;PUM3;SYK;NUP153;ZFP42;RELB;NBN;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;MIR17HG;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;CCL20;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;ITGAV;SET;PARP14;ARNTL;TAF1D;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;TRIM37;GNL3L;ZNF586;NVL;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;BACE2;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;VPS36;TRAF2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
1091,GO:0002676,0.0487449495611075,0.995876178611316,2,6,regulation of chronic inflammatory response,BP,TNF;CCL5
5638,GO:0016717,0.0487662206223791,0.996188354701099,2,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,SCD;SCD5
4369,GO:0009982,0.048841786035066,0.991899864651736,3,13,pseudouridine synthase activity,MF,DKC1;PUS3;TRUB2
6829,GO:0030284,0.0488995402118037,0.996172056944036,2,5,estrogen receptor activity,MF,GPER1;ESR1
7278,GO:0031253,0.0489324861175295,0.970668593700925,23,205,cell projection membrane,CC,NRG1;S100P;B4GALT1;PDPN;SLC9A3R1;SLC22A5;SHISA9;ATP2B1;SLC5A6;TPM1;LCP1;ITGAV;ANTXR1;SLC11A2;CNTNAP2;HSP90AB1;BBS5;GPER1;ADAM17;MYO10;EHD1;PHLPP2;PHLPP1
19769,GO:2000108,0.0490240150189011,0.988676432103455,4,21,positive regulation of leukocyte apoptotic process,BP,TP53;CDKN2A;CD274;CCL5
7790,GO:0032310,0.0491436497483965,0.99582344684183,2,6,prostaglandin secretion,BP,EDN1;ABCC4
119,GO:0000247,0.0493135051584837,1,1,1,C-8 sterol isomerase activity,MF,EBP
2032,GO:0004769,0.0493135051584837,1,1,1,steroid delta-isomerase activity,MF,EBP
3437,GO:0007229,0.049344557838557,0.979497152644571,9,61,integrin-mediated signaling pathway,BP,COL16A1;CTGF;SYK;EMP2;DST;ITGAV;PHACTR4;NEDD9;ITGB1BP1
12932,GO:0051259,0.0493463282438363,0.967083740407145,35,380,protein complex oligomerization,BP,CRYAB;TRIM22;B4GALT1;MAT2A;TP53;GBP1;C1QTNF1;CHP1;IKBKE;POLQ;USP16;KCNS3;TK1;HSCB;GBP5;SOD2;NUFIP1;TRPM7;CLU;BIRC3;NUP54;KCTD3;SYT11;MTMR2;LNX2;RRM1;DPYSL3;TRAF2;EHD1;PDSS1;CCL5;CD74;PANX1;HIST1H4A;ZNHIT6
16615,GO:0097418,0.0493660262265568,0.996114825677388,2,5,neurofibrillary tangle,CC,NEFM;CLU
4270,GO:0009617,0.0501578613023827,0.9681555558586,28,297,response to bacterium,BP,PTGES;FGFR2;CYP1A1;EDN1;AKAP8;IL27RA;SYK;CDK4;CD274;PTGER4;ARRDC1-AS1;ADM;CCL20;IL24;BAIAP2;NFKBIB;THBD;IFNAR1;ERAP1;SYT11;IL12RB2;SERPINB9;ADAM17;TLR3;TNF;CCL5;GBP6;IRAK3
14038,GO:0060740,0.0501745793831503,0.988565991006887,4,18,prostate gland epithelium morphogenesis,BP,FGFR2;SFRP1;TNC;ESR1
12952,GO:0051290,0.0502357784054719,0.985276788394657,5,43,protein heterotetramerization,BP,NUP54;RRM1;PDSS1;CD74;HIST1H4A
10407,GO:0043229,0.0502498365755156,0.95802831520475,686,9301,intracellular organelle,CC,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;CLN6;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TSC22D3;DDX17;SPON1;FAM69B;TFCP2L1;KRTAP2-3;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;MID1;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;DOCK10;DDX47;SIPA1L3;ABCF1;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;PABPC4;STAG1;LGALS3;CHP1;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL16;IFIT3;SRSF2;FOXD2;PCDH7;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;HNRNPF;BAG1;SLC9A3R1;PDCD11;NUAK1;DKC1;IL7R;NUP50;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;NBN;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;VPS41;KRT9;AP3M2;POP1;HLA-DOB;NUCKS1;PITHD1;HEATR1;ZDHHC6;MCM2;TARDBP;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;COA7;KEAP1;NAA15;TRA2A;TCHH;ZNF827;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;TMEM97;LSG1;G3BP1;GRWD1;ZNF584;PARD3B;OPHN1;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;CASC3;SYNPO2L;PLK2;RRAGB;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;KANK4;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;LCP1;EXOG;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARMC5;GPHN;KLHL21;RRN3;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;QPCT;TAF1D;ABCF2;SNX11;AJUBA;SMC2;FASTKD3;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;KRT24;LFNG;ZC3H7B;RBM12;SNX5;TRIM37;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;ODF2L;KREMEN2;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;DDX10;MBOAT1;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;MCM6;FGD6;SRD5A1;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;ABCC9;TRMT5;TTF2;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;NNT;IFNAR1;WEE1;TJP1;ZNF484;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;DGCR8;SS18L2;KRT10;CCAR1;SKA2;PPIP5K1;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;ZNFX1;STEAP4;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;ANKRD13A;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;TAF6L;MRPS7;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;MSH3;TELO2;EDRF1;RBBP5;FAM208B;CITED2;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;AZIN1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;DAXX;ZSCAN31;DCTN5;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15
3554,GO:0007596,0.0502688235203807,0.970081669862528,22,214,blood coagulation,BP,KRT1;SAA1;CBX5;ACTG1;EDN1;C1QTNF1;PABPC4;PDPN;SYK;H3F3A;CSRP1;GGCX;HSPB1;RHOG;SRF;PDGFB;THBD;HPS5;AP3B1;RAD51B;EHD1;IRF1
3122,GO:0006702,0.050314844947605,0.99599743685863,2,5,androgen biosynthetic process,BP,WNT4;SRD5A1
4070,GO:0009120,0.0503766070305704,0.995658797922469,2,6,deoxyribonucleoside metabolic process,BP,TK1;DPYD
7009,GO:0030688,0.0504062425743421,0.99166209016102,3,12,preribosome, small subunit precursor,CC,UTP20;TSR1;RRP1
2399,GO:0005542,0.0505637877168716,0.995633594039062,2,6,folic acid binding,MF,DHFR;TYMS
10537,GO:0043462,0.050628781228342,0.981496956793679,7,52,regulation of ATPase activity,BP,TPM1;DYNLL2;HSCB;VCPKMT;THADA;DNAJC9;HNRNPU
11604,GO:0046165,0.0507237739088104,0.974743147993816,13,111,alcohol biosynthetic process,BP,G6PD;SCD;HMGCS1;LSS;DHFR;RAN;QDPR;PPIP5K1;GPER1;EBP;AKR1B1;ARV1;TNF
1237,GO:0002922,0.0507681244346545,0.995606017774975,2,6,positive regulation of humoral immune response,BP,C3;TNF
6840,GO:0030298,0.0510506480104782,1,1,1,receptor signaling protein tyrosine kinase activator activity,MF,CCL5
7529,GO:0031726,0.0510506480104782,1,1,1,CCR1 chemokine receptor binding,MF,CCL5
7530,GO:0031729,0.0510506480104782,1,1,1,CCR4 chemokine receptor binding,MF,CCL5
11858,GO:0046817,0.0510506480104782,1,1,1,chemokine receptor antagonist activity,MF,CCL5
11412,GO:0045780,0.0511466901581881,0.991647839665288,3,11,positive regulation of bone resorption,BP,TFRC;SYK;PPARGC1B
11878,GO:0046852,0.0511466901581881,0.991647839665288,3,11,positive regulation of bone remodeling,BP,TFRC;SYK;PPARGC1B
12942,GO:0051276,0.0512196034847384,0.960167377087089,89,1048,chromosome organization,BP,HDAC9;TRIM16;PML;KIF23;TP53;DAPK3;EXO1;CDKN2A;STAG1;AKAP8;DKC1;NBN;BRIP1;MCM5;NUCKS1;MCM2;H3F3A;USP16;RPA1;HELLS;POLA1;SETDB1;G3BP1;GRWD1;NDC1;DYNLL2;RFC3;AKAP8L;SUV39H2;KDM6A;RAN;UBTF;RANBP2;ANAPC15;SUPT16H;DDX3X;NAP1L1;CPA4;SET;SMC2;TRIM37;FEN1;CDCA5;GNL3L;GINS4;BRCC3;UTY;NUP160;SMYD2;NAA50;EYA3;RIF1;MCM6;SETD2;APEX1;TET3;HSP90AB1;PRIM2;BRCA2;SKA2;FANCD2;CENPF;CHEK1;GPER1;MCM4;ATR;MSH6;TAF6L;MSH3;TELO2;RBBP5;CCNA2;GTF3C4;POLE3;RBL1;CLOCK;KIF14;ESR1;CENPN;HNRNPU;RING1;DAXX;HIST1H4A;TAF1;SMARCC1;CTCF;GTF2H3;CENPO;COPS3
16249,GO:0090280,0.051221629702368,0.995884023966648,2,5,positive regulation of calcium ion import,BP,LGALS3;PDGFB
11276,GO:0045517,0.0512450649366476,1,1,1,interleukin-20 receptor binding,MF,IL20
11277,GO:0045518,0.0512450649366476,1,1,1,interleukin-22 receptor binding,MF,IL20
1115,GO:0002701,0.0513638219754522,0.988028079935079,4,20,negative regulation of production of molecular mediator of immune response,BP,TGFB2;THOC1;TNF;IRAK3
14183,GO:0061045,0.0514240087982781,0.981293087563454,7,46,negative regulation of wound healing,BP,KRT1;EDN1;C1QTNF1;CD109;WNT4;PDGFB;THBD
18177,GO:1902895,0.0514636091360821,0.98808039558174,4,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,TP53;TGFB2;SRF;PDGFB
5264,GO:0015893,0.0516106922553984,0.975074932518688,12,100,drug transport,BP,SLC7A2;EDN1;SLC4A11;INHBA;SLC22A5;ABCG2;SLC5A6;SLC1A3;ARL6IP5;NFKBIE;EBP;SLC25A22
18418,GO:1903409,0.0516245288009794,0.978249110374728,9,67,reactive oxygen species biosynthetic process,BP,CYP1B1;SLC7A2;CYP1A1;EDN1;NQO1;CLU;HSP90AB1;CFLAR;TNF
8374,GO:0033260,0.0517170646766838,0.981081191581216,7,49,nuclear DNA replication,BP,RPA1;POLA1;RFC3;FEN1;PRIM2;BRCA2;POLE3
4864,GO:0014701,0.0517309738565754,0.996368974715863,2,4,junctional sarcoplasmic reticulum membrane,CC,JPH2;JPH1
19773,GO:2000112,0.0519320882164673,0.955864835602865,255,3203,regulation of cellular macromolecule biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;TP53;DAPK3;EDN1;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;FOXD2;PPP1R3B;DKC1;INHBA;NUP50;PUM3;SYK;NUP153;ZFP42;RELB;NBN;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;MIR17HG;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;TRIM37;GNL3L;ZNF586;NVL;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;BACE2;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;VPS36;TRAF2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
3536,GO:0007530,0.052112628526033,0.991262181050519,3,12,sex determination,BP,WNT4;SRD5A1;CITED2
9716,GO:0038111,0.0522195928818162,0.987401141695177,4,26,interleukin-7-mediated signaling pathway,BP,STAT5A;IRS1;IL7R;SOCS1
16870,GO:0098760,0.0522195928818162,0.987401141695177,4,26,response to interleukin-7,BP,STAT5A;IRS1;IL7R;SOCS1
16871,GO:0098761,0.0522195928818162,0.987401141695177,4,26,cellular response to interleukin-7,BP,STAT5A;IRS1;IL7R;SOCS1
10858,GO:0044344,0.0523953498319093,0.97381143716137,13,108,cellular response to fibroblast growth factor stimulus,BP,GCLC;FGFR2;CTGF;FAT4;HNRNPF;SFRP1;WNT4;POLR2F;NCBP1;ZFP36L2;CCL5;HNRNPM;ITGB1BP1
4960,GO:0015030,0.0524005494120117,0.980725795052605,7,51,Cajal body,CC,TRIM22;TGS1;DKC1;PHAX;LSG1;NOP58;EFTUD2
6892,GO:0030397,0.0525069330490299,0.980810144917198,7,46,membrane disassembly,BP,NUP50;NUP153;NDC1;AKAP8L;RANBP2;NUP160;NUP54
12806,GO:0051081,0.0525069330490299,0.980810144917198,7,46,nuclear envelope disassembly,BP,NUP50;NUP153;NDC1;AKAP8L;RANBP2;NUP160;NUP54
4207,GO:0009314,0.0526494310440632,0.965161863711907,33,339,response to radiation,BP,CRYAB;KRT13;PML;TP53;HMGCS1;RBM4;RAD1;SFRP1;NUCKS1;SLC1A3;MME;TOPBP1;CDC25A;NETO1;FEN1;BRCC3;EYA3;THBD;BRCA2;FANCD2;CHEK1;RRM1;RAD18;ATR;MSH6;RFWD3;CLOCK;RAD51B;METAP2;TAF1;CDKN1A;USP1;COPS3
16873,GO:0098771,0.0527132124251758,0.964259874514221,37,387,inorganic ion homeostasis,BP,SAA1;FTL;FTH1;PML;JPH2;TFRC;CLN6;TP53;EDN1;C1QTNF1;CHP1;SLC4A11;ACO1;SLC30A6;SLC9A3R1;ABCG2;GPCPD1;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;ENPP1;JPH1;THADA;SLC11A2;RIC3;TMEM199;NEDD4L;TMEM165;STEAP4;CCDC47;GPER1;SLC9A9;ESR1;CCL5
1101,GO:0002687,0.0527193428913671,0.977616415429186,9,72,positive regulation of leukocyte migration,BP,TP53;EDN1;LGALS3;CCL20;ADAM17;CSF1;TNF;CCL5;CD74
11289,GO:0045580,0.0527306749780834,0.976475042568548,10,78,regulation of T cell differentiation,BP,RUNX1;CYLD;IL7R;SYK;SOCS1;FANCD2;AP3B1;RC3H1;CD74;IRF1
12369,GO:0048729,0.0527439907203952,0.963044276755633,44,450,tissue morphogenesis,BP,NRG1;PML;CYR61;TXNRD1;FGFR2;STARD13;FAT4;B4GALT1;PBX1;EDN1;PDPN;TGFB2;IRX2;SLC9A3R1;INHBA;SFRP1;RIPK4;WNT10A;COL4A1;TPM1;OPHN1;ADM;WNT4;KDM6A;AJUBA;PHACTR4;SRF;NPNT;FZD1;FRAS1;SETD2;TNC;BBS5;ADAM17;NTN1;PSME2;PSMB9;TIMELESS;CSF1;MPP5;ESR1;TNF;PSMB10;ASTN2
6423,GO:0021683,0.052748337083872,0.995690391488237,2,5,cerebellar granular layer morphogenesis,BP,OPHN1;KIF14
17364,GO:1900025,0.0528557678591879,0.991086230757039,3,12,negative regulation of substrate adhesion-dependent cell spreading,BP,GBP1;CORO1C;ITGB1BP1
17327,GO:0140101,0.0528840492413895,0.973450158376885,13,117,catalytic activity, acting on a tRNA,MF,CARS2;CDKAL1;POP1;THUMPD3;METTL1;GATC;RARS;TYW1;TRMT5;PDCL3;TRMT1;TRMT61A;WDR4
12649,GO:0050817,0.0529200640208152,0.968321474460899,22,215,coagulation,BP,KRT1;SAA1;CBX5;ACTG1;EDN1;C1QTNF1;PABPC4;PDPN;SYK;H3F3A;CSRP1;GGCX;HSPB1;RHOG;SRF;PDGFB;THBD;HPS5;AP3B1;RAD51B;EHD1;IRF1
19770,GO:2000109,0.0529690521980904,0.995304890173062,2,6,regulation of macrophage apoptotic process,BP,CDKN2A;CCL5
10528,GO:0043433,0.0530000312677236,0.972672333514613,14,120,negative regulation of DNA binding transcription factor activity,BP,CYP1B1;NLRC5;TRAF3;CDKN2A;CHP1;CYLD;KEAP1;TRIM37;GLIS2;FAF1;NFKBIE;ESR1;TAF1;IRAK3
9276,GO:0035691,0.0531410863885403,1,1,1,macrophage migration inhibitory factor signaling pathway,BP,CD74
9278,GO:0035693,0.0531410863885403,1,1,1,NOS2-CD74 complex,CC,CD74
10133,GO:0042658,0.0531410863885403,1,1,1,MHC class II protein binding, via antigen binding groove,MF,CD74
14749,GO:0070402,0.0533988530873228,0.990817476860431,3,13,NADPH binding,MF,DHFR;QDPR;SRD5A1
9608,GO:0036457,0.0534006420352114,0.996183183558928,2,4,keratohyalin granule,CC,HRNR;RPTN
15025,GO:0070937,0.0534186108310075,0.99560432300211,2,5,CRD-mediated mRNA stability complex,CC,SYNCRIP;HNRNPU
6596,GO:0022607,0.0535534476927044,0.955434584239839,178,2216,cellular component assembly,BP,CRYAB;NEFL;NRG1;MAP2;FN1;PML;KIF23;COL16A1;SACS;TRIM22;CTGF;VMP1;RUNX1;MYO1B;B4GALT1;ACTG1;NEFM;MAT2A;DYNC2H1;TP53;DAPK3;EXO1;EDN1;GBP1;C1QTNF1;CDKN2A;ACSL3;GEMIN5;STAG1;COBLL1;CHP1;PPAN;CNTNAP1;RBM22;CYLD;IKBKE;TGS1;SLC9A3R1;DNHD1;EMP2;NUP153;NAIP;RAB32;NBN;BRIP1;SHQ1;SFRP1;VPS41;MCM2;GEMIN4;POLQ;H3F3A;USP16;RPA1;TPM1;HELLS;TAF2;ABCC4;KCNS3;PTGER4;TK1;GRWD1;TRAF1;OPHN1;IMMP2L;NDC1;CADPS2;DYNLL2;MDN1;SYNPO2L;PLK2;UBQLN2;HSCB;GBP5;KANK4;MYBL2;RHOG;WNT4;NOP2;LCP1;DDX28;UBTF;RRP7BP;SOD2;CORO1C;DDX3X;NAP1L1;NUFIP1;RRN3;SET;MRTO4;TRPM7;AJUBA;FASTKD3;TRIM37;LUC7L;CDC42EP2;BAIAP2;CDH13;IBA57;SRF;MDM4;LUC7L2;UGT8;SDK1;FZD1;ANTXR1;RTKN2;CLU;BIRC3;NUP54;FGD6;ANLN;RPF2;TJP1;LRRN3;KCTD3;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;MYH11;ZFYVE27;TMEM138;GEMIN8;WDPCP;MTMR2;CENPF;RAB3GAP1;LNX2;BBS5;FAF1;RRM1;MYO10;ATR;NTN1;CEP152;CFLAR;NIFK;SHTN1;DPYSL3;TAF6L;MRPS7;NCBP1;VPS36;TRAF2;RBBP5;UQCRB;KIF14;MPP5;SYNPO2;ESR1;PARD3;GJC1;RAD51B;EHD1;CENPN;TNF;PDSS1;NEDD9;RC3H1;CCL5;CD74;HNRNPU;FGFR1OP;DAXX;PANX1;HIST1H4A;TAF1;TBPL1;ZNHIT6;ITGB1BP1;CTCF;GTF2H3;NDUFB9;CENPO;GPX4
6283,GO:0019884,0.053588896266605,0.97151781047303,15,144,antigen processing and presentation of exogenous antigen,BP,KIF23;HLA-B;TAP1;HLA-F;HLA-DOB;DYNLL2;ITGAV;PSME2;PSMB9;TAP2;IFI30;AP3B1;CD74;PSMB10;DCTN5
8836,GO:0034612,0.053692043931304,0.968181357795864,21,217,response to tumor necrosis factor,BP,MAP3K14;TRAF3;EDN1;CYLD;SYK;TJP2;SFRP1;TRAF1;CCL20;CXCL16;NPNT;BIRC3;GPER1;ADAM17;PSME2;PSMB9;TRAF2;TNF;ZFP36L2;CCL5;PSMB10
2269,GO:0005198,0.0537870523397476,0.962184894727204,44,509,structural molecule activity,MF,CRYAB;SPRR3;KRT1;NEFL;SPRR2A;KRT34;KRT4;MAP2;KRT13;KRT2;KRT15;COL5A3;FBN1;ACTG1;NEFM;COL27A1;TUFT1;COL12A1;SLC9A3R1;NUP153;KRT9;COL4A1;HRNR;TPM1;NDC1;MRPL27;NEXN;MRTO4;KRT24;COL5A2;NUP160;NUP54;TPM4;JPH1;MYH11;KRT10;RPTN;MRPS7;UPF3B;TELO2;MFAP5;ERVK13-1;MUC6;RPS12
4653,GO:0010793,0.0539169546418838,0.995539915647064,2,5,regulation of mRNA export from nucleus,BP,AKAP8L;SETD2
2407,GO:0005576,0.0539553037109281,0.954547213438592,212,2799,extracellular region,CC,IL32;CRYAB;IGFBP3;SPRR3;KRT1;SAA1;FTL;FTH1;NRG1;KRT34;C1R;KRT13;FN1;KIF23;MTUS1;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;COL16A1;TXNRD1;FGFR2;UGT1A6;EPGN;COL5A3;S100P;CTGF;MMP9;FBN1;HSPG2;MYO1B;IL1R2;FAT4;B4GALT1;ACTG1;G6PD;FST;SPON1;OVCH2;CCDC80;COL27A1;DYNC2H1;TUFT1;SVEP1;EDN1;GBP1;DOCK10;SIPA1L3;TMEM106A;C1QTNF1;NQO1;COBLL1;LGALS3;CHP1;ACO1;TGFB2;PRSS23;TGS1;IL16;SRSF2;LRFN4;COL12A1;PGD;P3H2;IL6ST;SLC9A3R1;INHBA;IL7R;SLC22A5;DNHD1;OLFML3;NAIP;GFOD1;LEPR;SFRP1;KRT9;POP1;CD274;WNT10A;GEMIN4;DST;H3F3A;ATP2B1;COL4A1;APOL6;HRNR;CSRP1;ADAMTS9;IGFL3;URM1;ADM;MGAM;CD109;CCL20;SLCO4C1;MME;MUC16;FRK;BTN2A1;HSPB1;RHOG;WNT4;CXCL16;LCP1;SIRPA;THOC1;RAN;SOD2;DDX3X;CPA4;IL24;ITGAV;QPCT;SMC2;KRT24;LFNG;PGK1;NETO1;BAIAP2;CDH13;COL5A2;RARS;USB1;NPNT;QDPR;APMAP;PDGFB;CHID1;SDK1;TBC1D15;ANTXR1;CLU;NAA50;ENPP1;FRAS1;IL20;COMMD9;TPM4;THBD;UPK3B;GLIPR2;LRRN3;ERAP1;SLC11A2;TNC;HSPA8;GLIPR1L2;HSP90AB1;ARL6IP5;EPHB6;NSF;DNPEP;GREB1;LAIR1;MYH11;NEDD4L;NAV2;KRT10;MTMR2;PLEKHA7;L1CAM;STEAP4;FKBP5;RAB3GAP1;CHEK1;SERPINB9;HMGN2;RRM1;RPTN;NTN1;PSME2;HADHB;PSMB9;DNAJC9;CMTM3;HNRNPDL;DPYSL3;ESF1;TAF6L;AKR1B1;VPS36;MFAP5;NCL;IFI30;CSF1;NAA16;MPHOSPH8;JMJD8;GLIPR1;IGFL1;MPP5;EHD1;DNASE1;TNF;SRSF7;CCL5;PLBD1;CD74;HIST1H4A;ZNHIT6;HIBCH;NRAS;MUC5B;HNRNPM;ITGB1BP1;MUC6;NDUFB9;GBP6;GPX4;UFC1
3165,GO:0006778,0.0539791472339776,0.984243792419748,5,31,porphyrin-containing compound metabolic process,BP,CYP1A1;IBA57;NFE2L1;SLC11A2;UGT1A4
2552,GO:0005826,0.0540970323042992,0.995516554854548,2,5,actomyosin contractile ring,CC,RTKN2;ANLN
6766,GO:0030195,0.054203963785649,0.984206842347643,5,30,negative regulation of blood coagulation,BP,KRT1;EDN1;C1QTNF1;PDGFB;THBD
17380,GO:1900047,0.054203963785649,0.984206842347643,5,30,negative regulation of hemostasis,BP,KRT1;EDN1;C1QTNF1;PDGFB;THBD
4724,GO:0010884,0.0543439526120031,0.990730654121531,3,12,positive regulation of lipid storage,BP,C3;IKBKE;EHD1
2568,GO:0005851,0.0544360542978319,0.995100041395148,2,6,eukaryotic translation initiation factor 2B complex,CC,EIF2B5;EIF2B1
1062,GO:0002587,0.0544814364352797,1,1,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,HLA-DOB
16686,GO:0097550,0.0550282751730884,0.995016415663029,2,6,transcriptional preinitiation complex,CC,ESR1;GTF2H3
1119,GO:0002705,0.0550419716677307,0.977898347790561,8,60,positive regulation of leukocyte mediated immunity,BP,TFRC;C3;SYK;RIF1;MSH6;TRAF2;TNF;ATAD5
2697,GO:0006061,0.0551652306503622,1,1,1,sorbitol biosynthetic process,BP,AKR1B1
5992,GO:0018931,0.0551652306503622,1,1,1,naphthalene metabolic process,BP,AKR1B1
6141,GO:0019406,0.0551652306503622,1,1,1,hexitol biosynthetic process,BP,AKR1B1
10670,GO:0043795,0.0551652306503622,1,1,1,glyceraldehyde oxidoreductase activity,MF,AKR1B1
16322,GO:0090420,0.0551652306503622,1,1,1,naphthalene-containing compound metabolic process,BP,AKR1B1
6272,GO:0019863,0.0552306416493181,1,1,1,IgE binding,MF,LGALS3
10520,GO:0043414,0.0552902466888786,0.965960190633996,24,234,macromolecule methylation,BP,TGS1;THUMPD3;METTL21A;METTL1;SETDB1;NOP2;SUV39H2;KDM6A;SETD4;VCPKMT;SMYD2;RIF1;METTL16;SETD2;TRMT5;THADA;TET3;HSPA8;TRMT1;TRMT61A;RBBP5;MPHOSPH8;WDR4;CTCF
8207,GO:0032946,0.0552947106726218,0.976293737304549,9,73,positive regulation of mononuclear cell proliferation,BP,TFRC;IL6ST;SYK;CD274;CSF1;ATAD5;CCL5;CD74;CDKN1A
15768,GO:0072338,0.0552998506882984,0.995359336797455,2,5,cellular lactam metabolic process,BP,STAT5A;MME
19774,GO:2000113,0.0556425901146297,0.956217237265961,95,1114,negative regulation of cellular macromolecule biosynthetic process,BP,NRG1;HDAC9;PML;GCLC;FGFR2;CBX5;TSC22D3;FST;TFCP2L1;ENC1;TP53;DAPK3;EDN1;CDKN2A;RBM4;IRX2;NUP50;NUP153;RELB;PARP15;SFRP1;MIR17HG;H3F3A;AHR;DHFR;GLIS3;HELLS;SETDB1;NDC1;ZNF587;FRK;WNT4;SUV39H2;RAN;RANBP2;DDX3X;SET;ARNTL;AJUBA;DND1;ZC3H7B;TRIM37;GNL3L;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;NUP160;SMYD2;ENPP1;NUP54;RIF1;METTL16;GLIS2;UBP1;HSPA8;BACE2;NEDD4L;BRCA2;SYNCRIP;DGCR8;E2F8;CENPF;ETV6;POLR2F;ATR;ZNF12;ZNF608;NCBP1;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;ZFP36L2;RC3H1;TYMS;HNRNPU;RING1;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;IRF1;CTCF
13186,GO:0051764,0.0556912514062659,0.990405066710579,3,12,actin crosslink formation,BP,LCP1;BAIAP2;DPYSL3
8899,GO:0034708,0.0557208859569857,0.973753252057641,11,90,methyltransferase complex,CC,HDAC9;CBX5;METTL1;KDM6A;TRIM37;UTY;TRMT61A;RBBP5;WDR4;TAF1;TEX10
2122,GO:0004910,0.0557918292867103,1,1,1,interleukin-1, Type II, blocking receptor activity,MF,IL1R2
8047,GO:0032690,0.0557918292867103,1,1,1,negative regulation of interleukin-1 alpha production,BP,IL1R2
12579,GO:0050712,0.0557918292867103,1,1,1,negative regulation of interleukin-1 alpha secretion,BP,IL1R2
16427,GO:0097036,0.0559198702906714,1,1,1,regulation of plasma membrane sterol distribution,BP,ARV1
803,GO:0002069,0.0559464179868515,0.994885716724813,2,6,columnar/cuboidal epithelial cell maturation,BP,TYMS;CDKN1A
18943,GO:1904627,0.05604735811521,1,1,1,response to phorbol 13-acetate 12-myristate,BP,CDK4
18944,GO:1904628,0.05604735811521,1,1,1,cellular response to phorbol 13-acetate 12-myristate,BP,CDK4
3157,GO:0006766,0.0560827316532504,0.973529193145872,11,92,vitamin metabolic process,BP,GCLC;CYP24A1;CYP1A1;PANK2;SLC5A6;DHFR;ENPP1;MMAA;TNF;FLAD1;THTPA
7520,GO:0031700,0.0561320416844644,1,1,1,adrenomedullin receptor binding,MF,ADM
7679,GO:0032103,0.0561953532037432,0.968660834655743,17,161,positive regulation of response to external stimulus,BP,C3;EDN1;IL16;IL6ST;PTGER4;GBP5;HSPB1;CDH13;PDGFB;THBD;ADAM17;CSF1;CLOCK;TLR3;TNF;CCL5;CD74
18974,GO:1904705,0.0562379379881782,0.983496323385403,5,29,regulation of vascular smooth muscle cell proliferation,BP,MMP9;TPM1;PDGFB;GPER1;TNF
19681,GO:1990874,0.0562379379881782,0.983496323385403,5,29,vascular smooth muscle cell proliferation,BP,MMP9;TPM1;PDGFB;GPER1;TNF
17913,GO:1902170,0.0562603966562734,0.990266488379119,3,12,cellular response to reactive nitrogen species,BP,CFLAR;TRAF2;CCNA2
8913,GO:0034728,0.0562800997767942,0.971319414270748,13,139,nucleosome organization,BP,MCM2;H3F3A;GRWD1;SUPT16H;NAP1L1;SET;SETD2;CENPN;DAXX;HIST1H4A;SMARCC1;CTCF;CENPO
225,GO:0000466,0.0562887742522487,0.986319709158052,4,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,UTP20;PDCD11;FCF1;NOL9
264,GO:0000731,0.0563485038656193,0.975841358314051,9,68,DNA synthesis involved in DNA repair,BP,EXO1;NBN;BRIP1;RPA1;POLA1;USP43;RFC3;BRCA2;RAD51B
726,GO:0001952,0.0564915982764125,0.973442085932021,11,82,regulation of cell-matrix adhesion,BP,COL16A1;DAPK3;CDKN2A;EMP2;SFRP1;WNT4;CORO1C;CDH13;WDPCP;CSF1;ITGB1BP1
2478,GO:0005697,0.0565503879309818,0.986235066390738,4,22,telomerase holoenzyme complex,CC,DKC1;GNL3L;NVL;HNRNPU
446,GO:0001205,0.0565584514166156,0.986391762914936,4,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,SRF;NFE2L1;SPIB;ARID3B
10322,GO:0043090,0.0565765009117332,0.990189256750296,3,12,amino acid import,BP,SLC7A2;SLC1A3;ARL6IP5
3557,GO:0007599,0.0565889896530744,0.965864715695475,22,217,hemostasis,BP,KRT1;SAA1;CBX5;ACTG1;EDN1;C1QTNF1;PABPC4;PDPN;SYK;H3F3A;CSRP1;GGCX;HSPB1;RHOG;SRF;PDGFB;THBD;HPS5;AP3B1;RAD51B;EHD1;IRF1
3694,GO:0008201,0.0566541799508269,0.9743996003622,10,78,heparin binding,MF,SAA1;FN1;CYR61;FGFR2;COL5A3;CTGF;FBN1;CCDC80;SFRP1;NAV2
3274,GO:0006954,0.0566981299812243,0.961967186196944,34,365,inflammatory response,BP,KRT1;SAA1;HDAC9;C1R;FN1;PTGES;C3;HSPG2;SLC7A2;IL1R2;B4GALT1;TPST1;ABCF1;IL6ST;SYK;NAIP;RELB;PTGER4;CCL20;GBP5;CHID1;NFE2L1;CLU;BIRC3;IL20;FANCD2;GPER1;CSF1;CLOCK;TLR3;ESR1;DNASE1;TNF;CCL5
2433,GO:0005615,0.0568658729795618,0.952461851872384,183,2406,extracellular space,CC,IL32;CRYAB;IGFBP3;SPRR3;KRT1;SAA1;FTL;FTH1;NRG1;KRT34;C1R;KRT13;FN1;MTUS1;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;TXNRD1;UGT1A6;EPGN;COL5A3;S100P;CTGF;MMP9;FBN1;HSPG2;MYO1B;FAT4;B4GALT1;ACTG1;G6PD;SPON1;CCDC80;DYNC2H1;SVEP1;EDN1;DOCK10;SIPA1L3;TMEM106A;C1QTNF1;NQO1;COBLL1;LGALS3;CHP1;ACO1;TGFB2;PRSS23;TGS1;IL16;SRSF2;LRFN4;COL12A1;PGD;IL6ST;SLC9A3R1;INHBA;SLC22A5;DNHD1;NAIP;SFRP1;KRT9;POP1;CD274;WNT10A;GEMIN4;DST;H3F3A;ATP2B1;COL4A1;HRNR;CSRP1;ADAMTS9;IGFL3;URM1;ADM;MGAM;CD109;CCL20;SLCO4C1;MME;MUC16;FRK;BTN2A1;HSPB1;RHOG;WNT4;CXCL16;LCP1;SIRPA;RAN;SOD2;DDX3X;CPA4;IL24;ITGAV;QPCT;SMC2;KRT24;PGK1;BAIAP2;CDH13;COL5A2;RARS;NPNT;QDPR;APMAP;PDGFB;CHID1;SDK1;TBC1D15;ANTXR1;CLU;NAA50;ENPP1;IL20;TPM4;THBD;UPK3B;GLIPR2;LRRN3;ERAP1;TNC;HSPA8;GLIPR1L2;HSP90AB1;ARL6IP5;NSF;DNPEP;GREB1;LAIR1;MYH11;NEDD4L;KRT10;MTMR2;PLEKHA7;STEAP4;FKBP5;RAB3GAP1;CHEK1;SERPINB9;HMGN2;RRM1;PSME2;HADHB;PSMB9;DNAJC9;CMTM3;HNRNPDL;DPYSL3;ESF1;TAF6L;AKR1B1;VPS36;MFAP5;NCL;CSF1;NAA16;MPHOSPH8;JMJD8;GLIPR1;IGFL1;MPP5;EHD1;DNASE1;TNF;SRSF7;CCL5;PLBD1;CD74;HIST1H4A;ZNHIT6;HIBCH;NRAS;MUC5B;HNRNPM;ITGB1BP1;NDUFB9;GBP6;GPX4;UFC1
15263,GO:0071404,0.0569091685157333,0.990107774588763,3,12,cellular response to low-density lipoprotein particle stimulus,BP,HMGCS1;SYK;CDH13
6258,GO:0019838,0.0569516058907151,0.973143476868358,11,85,growth factor binding,MF,IGFBP3;TRIM16;CYR61;FGFR2;CTGF;IL1R2;IL6ST;COL4A1;CD109;ITGAV;PDGFB
11951,GO:0046982,0.0569602482049791,0.962485245497818,31,353,protein heterodimerization activity,MF,MAFB;NEFL;TENM3;GCLC;UGT1A6;PBX1;MID1;TP53;TGFB2;INHBA;H3F3A;AHR;TPM1;DYNLL2;RRAGB;RAN;ARNTL;SMC2;SNX5;PDGFB;TPM4;UGT1A4;TAF6L;POLE3;TIMELESS;PDSS1;DAXX;PANX1;HIST1H4A;TAF1;IRAK3
19619,GO:1990668,0.0569803377887004,0.994737014799882,2,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,TAP1;TAP2
16732,GO:0097698,0.0570266465398946,1,1,1,telomere maintenance via base-excision repair,BP,APEX1
14517,GO:0061982,0.0570563948126005,0.975460811021221,9,69,meiosis I cell cycle process,BP,BRIP1;NDC1;MYBL1;BRCA2;FANCD2;MSH6;PSMC3IP;MSH3;RAD51B
545,GO:0001664,0.0571426044904693,0.97017019976421,14,125,G-protein coupled receptor binding,MF,SAA1;C3;EDN1;SLC9A3R1;SFRP1;WNT10A;REEP1;ADM;CCL20;WNT4;CXCL16;FZD1;HSPA8;CCL5
11290,GO:0045581,0.0571912701268297,0.986188650637409,4,20,negative regulation of T cell differentiation,BP,CYLD;RC3H1;CD74;IRF1
16594,GO:0097367,0.0573636959470935,0.953164761045422,136,1586,carbohydrate derivative binding,MF,SAA1;FN1;KIF23;MAP3K14;GCLC;CYR61;NLRC5;FGFR2;COL5A3;CTGF;FBN1;TAP1;RUNX1;MYO1B;ACTG1;FST;MAT2A;DDX17;CCDC80;DYNC2H1;TP53;DAPK3;PANK2;GBP1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;RAB32;TRIO;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;SFRP1;RIPK4;MCM2;LAYN;POLQ;TSR1;ATP2B1;HELLS;ULK4;POLA1;ABCC4;TK1;LSG1;G3BP1;MDN1;EIF5;PLK2;RRAGB;FRK;GBP5;RHOG;DDX28;RAN;ORC4;ATP2C1;DDX3X;RAB26;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;GNL3L;NVL;GATC;RARS;MCM8;CHID1;SGK494;ENPP1;CBWD5;DDX10;EFTUD2;DDX24;TYW1;MCM6;ABCC9;TTF2;SRPRB;SEPHS2;WEE1;TNC;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;PPIP5K1;CHEK1;MMAA;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;DPYSL3;UBE2J2;MSH3;POLR3B;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;HNRNPU;FLAD1;TAF1;NRAS;ABCA11P;GBP6;IRAK3;DHX15
16362,GO:0090599,0.0574620324799472,0.99507159017911,2,5,alpha-glucosidase activity,MF,MGAM;GANC
7411,GO:0031475,0.0576134734571999,1,1,1,myosin V complex,CC,DYNLL2
15528,GO:0071887,0.0578900535446424,0.974996996329978,9,71,leukocyte apoptotic process,BP,TSC22D3;TP53;CDKN2A;LGALS3;CD274;MIR17HG;ADAM17;CCL5;CD74
19276,GO:1905404,0.058010292529622,1,1,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
3116,GO:0006694,0.0580539051824088,0.969616291062384,14,126,steroid biosynthetic process,BP,PBX1;G6PD;TFCP2L1;SCD;HMGCS1;LSS;ADM;WNT4;RAN;SRD5A1;EBP;AKR1B1;ARV1;TNF
3112,GO:0006690,0.0581251184640306,0.976354603749445,8,62,icosanoid metabolic process,BP,PTGES;CYP1B1;CYP1A1;EDN1;SYK;AKR1C2;CD74;GPX4
16152,GO:0090136,0.0582096867538818,0.989787236514543,3,12,epithelial cell-cell adhesion,BP,CYP1B1;SRF;PLEKHA7
4767,GO:0010948,0.0582220462449901,0.962505759100968,28,295,negative regulation of cell cycle process,BP,PML;CBX5;TP53;RAD1;GPR132;NBN;CDK4;PLK2;TOPBP1;ANAPC15;TRIM37;MDM4;BRCC3;RRM2;HSP90AB1;E2F8;CENPF;CHEK1;GPER1;PSME2;PSMB9;RFWD3;TPRA1;RBL1;ZFP36L2;RING1;PSMB10;CDKN1A
15353,GO:0071557,0.0582302421957811,0.994967779484108,2,5,histone H3-K27 demethylation,BP,KDM6A;UTY
15354,GO:0071558,0.0582302421957811,0.994967779484108,2,5,histone demethylase activity (H3-K27 specific),MF,KDM6A;UTY
18662,GO:1903935,0.0582336279002147,0.994554613357174,2,6,response to sodium arsenite,BP,NEFL;DAXX
19922,GO:2000377,0.0583601724187389,0.970288493897602,13,114,regulation of reactive oxygen species metabolic process,BP,CRYAB;CYP1B1;G6PD;TP53;EDN1;SYK;DHFR;PDGFB;CLU;HSP90AB1;CFLAR;TNF;CDKN1A
5813,GO:0017065,0.0585740693157309,1,1,1,single-strand selective uracil DNA N-glycosylase activity,MF,SMUG1
13901,GO:0060512,0.0585826157848919,0.985837021313678,4,19,prostate gland morphogenesis,BP,FGFR2;SFRP1;TNC;ESR1
4660,GO:0010803,0.0587592572698154,0.977799129670903,7,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,CYLD;SYK;TRAF1;BIRC3;ADAM17;TRAF2;TNF
2053,GO:0004799,0.0588791630621263,1,1,1,thymidylate synthase activity,MF,TYMS
6032,GO:0019088,0.0588791630621263,1,1,1,immortalization of host cell by virus,BP,TYMS
6332,GO:0020021,0.0588791630621263,1,1,1,immortalization of host cell,BP,TYMS
9850,GO:0042083,0.0588791630621263,1,1,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,TYMS
12650,GO:0050818,0.0588870850734336,0.977793631853834,7,50,regulation of coagulation,BP,KRT1;EDN1;C1QTNF1;PDPN;SYK;PDGFB;THBD
6593,GO:0022603,0.0590927995065369,0.955539623318639,65,714,regulation of anatomical structure morphogenesis,BP,KRT1;NEFL;NRG1;HDAC9;MAP2;FN1;PML;CYP1B1;AMOT;C3;FGFR2;STARD13;HSPG2;RUNX1;B4GALT1;DAPK3;EDN1;GBP1;PDPN;TGFB2;SLC9A3R1;PALM2;EMP2;SFRP1;WNT10A;TPM1;ADAMTS9;ADM;PLK2;HSPB1;WNT4;PTPRM;CORO1C;LFNG;PGK1;CDC42EP2;BAIAP2;COL5A2;SRF;HIF1AN;FZD1;FGD6;ERAP1;PDCL3;NEDD4L;ZFYVE27;TRAK2;WDPCP;L1CAM;MYO10;NTN1;PSME2;CFLAR;PSMB9;SHTN1;CITED2;CSF1;TLR3;ESR1;EHD1;TNF;RC3H1;WDR36;PSMB10;ITGB1BP1
13249,GO:0051893,0.059142795678708,0.97786946302522,7,44,regulation of focal adhesion assembly,BP,COL16A1;DAPK3;SFRP1;WNT4;CORO1C;WDPCP;ITGB1BP1
16139,GO:0090109,0.059142795678708,0.97786946302522,7,44,regulation of cell-substrate junction assembly,BP,COL16A1;DAPK3;SFRP1;WNT4;CORO1C;WDPCP;ITGB1BP1
7494,GO:0031657,0.0591704888956839,0.989548401038603,3,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2A;CDK4;ADAM17
1874,GO:0004536,0.0591959238407901,0.975849267534795,8,61,deoxyribonuclease activity,MF,EXO1;RAD1;FEN1;APTX;APEX1;RAD51B;DNASE1;TREX1
2390,GO:0005524,0.0592223053064693,0.952865746523464,103,1149,ATP binding,MF,KIF23;MAP3K14;GCLC;NLRC5;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;TRIO;BRIP1;MCM5;ABCG2;CDK4;RIPK4;MCM2;POLQ;ATP2B1;HELLS;ULK4;ABCC4;TK1;G3BP1;MDN1;PLK2;FRK;DDX28;ORC4;ATP2C1;DDX3X;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;NVL;GATC;RARS;MCM8;SGK494;ENPP1;CBWD5;DDX10;DDX24;MCM6;ABCC9;TTF2;SEPHS2;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;PPIP5K1;CHEK1;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;HNRNPU;FLAD1;TAF1;ABCA11P;IRAK3;DHX15
12821,GO:0051096,0.0592819673531565,0.994400241989388,2,6,positive regulation of helicase activity,BP,MSH6;MSH3
19727,GO:2000018,0.0593446119537721,0.994390965722024,2,6,regulation of male gonad development,BP,WNT4;CITED2
1004,GO:0002475,0.0594197750610682,0.994379828072289,2,6,antigen processing and presentation via MHC class Ib,BP,TAP2;AP3B1
4426,GO:0010243,0.0597284421904675,0.955647590652886,59,653,response to organonitrogen compound,BP,NEFL;HDAC9;TRIM16;GCLC;COL16A1;STAT5A;CTGF;FBN1;IRS1;TP53;EDN1;HMGCS1;SYK;NAIP;BRIP1;CDK4;SFRP1;NUCKS1;COL4A1;AHR;DHFR;ABCC4;ADM;FOXRED2;RRAGB;UBQLN2;RANBP2;SOCS1;BAIAP2;CDH13;COL5A2;QDPR;SDK1;ENPP1;PIK3R3;EFTUD2;ZNF106;SRD5A1;THBD;APEX1;HSP90AB1;CCDC47;GPER1;CFLAR;EIF2B5;AKR1B1;UBE2J2;CCNA2;TIMELESS;TNF;TYMS;EIF2B1;PANX1;TAF1;SMARCC1;PPARGC1B;CDKN1A;IRAK3;DHX15
17782,GO:1901724,0.0598869217583921,0.994310418974797,2,6,positive regulation of cell proliferation involved in kidney development,BP,PDGFB;CFLAR
16495,GO:0097158,0.0599489418823431,1,1,1,pre-mRNA intronic pyrimidine-rich binding,MF,RBM4
1689,GO:0004155,0.0600919789359738,1,1,1,6,7-dihydropteridine reductase activity,MF,QDPR
1235,GO:0002920,0.0601063636043993,0.985070904998012,4,22,regulation of humoral immune response,BP,C1R;C3;CLU;TNF
9980,GO:0042359,0.0602004428883167,0.988988575453079,3,14,vitamin D metabolic process,BP,CYP24A1;CYP1A1;TNF
6585,GO:0022409,0.0602758897804207,0.966773357392494,16,146,positive regulation of cell-cell adhesion,BP,MAP3K14;TFRC;PDPN;CYLD;IL6ST;IL7R;SYK;CD274;SIRPA;SOCS1;MYO10;CITED2;AP3B1;TNF;CCL5;CD74
800,GO:0002066,0.0603146230838315,0.979360352246958,6,38,columnar/cuboidal epithelial cell development,BP,SLC9A3R1;ARNTL;WDPCP;CLOCK;TYMS;CDKN1A
1213,GO:0002876,0.0603571775904619,1,1,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,TNF
1240,GO:0002925,0.0603571775904619,1,1,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,TNF
14186,GO:0061048,0.0603571775904619,1,1,1,negative regulation of branching involved in lung morphogenesis,BP,TNF
15868,GO:0072564,0.0603571775904619,1,1,1,blood microparticle formation,BP,TNF
19125,GO:1904999,0.0603571775904619,1,1,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,TNF
19893,GO:2000332,0.0603571775904619,1,1,1,regulation of blood microparticle formation,BP,TNF
19894,GO:2000334,0.0603571775904619,1,1,1,positive regulation of blood microparticle formation,BP,TNF
12818,GO:0051093,0.0603822058468782,0.956001628788798,52,564,negative regulation of developmental process,BP,MAFB;NRG1;PML;AMOT;STARD13;FBN1;HSPG2;PBX1;G6PD;TSC22D3;GBP1;TGFB2;CYLD;INHBA;TJP2;TRIO;SFRP1;MIR17HG;ADAMTS9;PLK2;WNT4;PTPRM;THOC1;CORO1C;ITGAV;ARNTL;LFNG;PGK1;LUC7L;COL5A2;PDGFB;ENPP1;BRCA2;TRAK2;MTMR2;GPER1;NTN1;LILRB3;CFLAR;ABCA5;DPYSL3;RBL1;TLR3;TNF;ZFP36L2;RC3H1;CD74;HNRNPU;PHF14;HIST1H4A;ITGB1BP1;IRF1
10107,GO:0042605,0.0604480295194376,0.9889246217456,3,14,peptide antigen binding,MF,HLA-B;TAP1;HLA-F
4638,GO:0010758,0.0604544473569527,0.988922962438548,3,14,regulation of macrophage chemotaxis,BP,MTUS1;CSF1;CCL5
8281,GO:0033077,0.0604749053201132,0.977117603449834,7,48,T cell differentiation in thymus,BP,MAFB;IL7R;WNT4;SRF;ADAM17;ZFP36L2;CD74
3136,GO:0006729,0.0604937247079221,0.993919626225188,2,7,tetrahydrobiopterin biosynthetic process,BP,DHFR;QDPR
11599,GO:0046146,0.0604937247079221,0.993919626225188,2,7,tetrahydrobiopterin metabolic process,BP,DHFR;QDPR
77,GO:0000154,0.0605157218921453,0.981615909530588,5,34,rRNA modification,BP,DKC1;NOP58;NOP2;METTL16;NOP56
9870,GO:0042110,0.0606503652898827,0.961151145406386,27,273,T cell activation,BP,MAFB;MAP3K14;TFRC;RUNX1;LGALS3;CYLD;IL6ST;IL7R;SYK;RELB;LEPR;CD274;PTGER4;WNT4;LCP1;SIRPA;SOCS1;LFNG;SRF;FANCD2;ADAM17;AP3B1;ZFP36L2;RC3H1;CCL5;CD74;IRF1
766,GO:0002011,0.0606517878475651,0.977174536196097,7,44,morphogenesis of an epithelial sheet,BP,CYR61;PDPN;AJUBA;PHACTR4;SRF;ADAM17;MPP5
11390,GO:0045741,0.0608535901950294,0.994165767700475,2,6,positive regulation of epidermal growth factor-activated receptor activity,BP,EPGN;ADAM17
16191,GO:0090193,0.0609183836922526,0.994156022875926,2,6,positive regulation of glomerulus development,BP,PDGFB;CFLAR
17296,GO:0120111,0.0609186686606999,0.975044432911589,8,59,neuron projection cytoplasm,CC,NEFL;AP3M2;DST;HSPB1;BAIAP2;BLOC1S2;TRAK2;AP3B1
17019,GO:0099081,0.0610279004913123,0.95487872927086,57,602,supramolecular polymer,CC,CRYAB;KRT1;SAA1;NEFL;KRT34;KRT4;MAP2;KRT13;KIF23;AMOT;MTUS1;JPH2;KRT2;KRT15;COL5A3;FBN1;MYO1B;ACTG1;NEFM;KRTAP2-3;COL27A1;DYNC2H1;MID1;DAPK3;TCP11L1;CYLD;PDLIM1;KRT9;DST;COL4A1;KEAP1;TPM1;DYNLL2;SYNPO2L;NEXN;HSPB1;LCP1;KLHL21;KRT24;BAIAP2;COL5A2;NPNT;LRPPRC;TPM4;ABCC9;JPH1;SRPRB;MYH11;KRT10;SKA2;GPER1;SHTN1;DPYSL3;MFAP5;KIF14;SYNPO2;HNRNPU
8921,GO:0034754,0.0610731624823824,0.974878447331217,8,63,cellular hormone metabolic process,BP,CYP1B1;CYP1A1;ADM;WNT4;AKR1C2;SRD5A1;AKR1B1;ESR1
11348,GO:0045657,0.0611244006140099,0.994124997323247,2,6,positive regulation of monocyte differentiation,BP,CSF1;CD74
15320,GO:0071493,0.0615414330002128,0.994062002811671,2,6,cellular response to UV-B,BP,MME;CDKN1A
8204,GO:0032943,0.0616691379015866,0.965858012589334,16,152,mononuclear cell proliferation,BP,TFRC;LGALS3;IL6ST;IL7R;SYK;CD274;AHR;HELLS;WNT4;CSF1;ATAD5;RC3H1;CCL5;CD74;CDKN1A;IRF1
11876,GO:0046850,0.0616722187470689,0.981485097950557,5,28,regulation of bone remodeling,BP,TFRC;SYK;LEPR;SFRP1;PPARGC1B
3267,GO:0006940,0.0618342303617012,0.981299464716971,5,30,regulation of smooth muscle contraction,BP,DAPK3;EDN1;SRF;NPNT;GPER1
11075,GO:0045059,0.0618841854719179,0.994010037828359,2,6,positive thymic T cell selection,BP,SRF;CD74
1076,GO:0002639,0.061911527272218,0.984470348426181,4,22,positive regulation of immunoglobulin production,BP,TFRC;RIF1;MSH6;ATAD5
4673,GO:0010819,0.0619402065099152,0.994001528089749,2,6,regulation of T cell chemotaxis,BP,ADAM17;CCL5
4674,GO:0010820,0.0619402065099152,0.994001528089749,2,6,positive regulation of T cell chemotaxis,BP,ADAM17;CCL5
8906,GO:0034719,0.0620363115545507,0.988282422779701,3,16,SMN-Sm protein complex,CC,GEMIN5;GEMIN4;GEMIN8
8813,GO:0034511,0.0620629641447597,0.993982864849959,2,6,U3 snoRNA binding,MF,TSR1;BMS1
4283,GO:0009648,0.0620805947735899,0.984498518298861,4,21,photoperiodism,BP,PML;TP53;RBM4;CLOCK
7286,GO:0031265,0.0621670767347777,0.993967019019266,2,6,CD95 death-inducing signaling complex,CC,FAF1;CFLAR
528,GO:0001637,0.0621716712474423,0.993966319374321,2,6,G-protein coupled chemoattractant receptor activity,MF,ACKR3;CXCR5
2141,GO:0004950,0.0621716712474423,0.993966319374321,2,6,chemokine receptor activity,MF,ACKR3;CXCR5
6242,GO:0019798,0.0621717105323387,0.993966313391947,2,6,procollagen-proline dioxygenase activity,MF,P3H2;P4HA2
12372,GO:0048732,0.0623031369125152,0.959029362308003,30,297,gland development,BP,MAFB;NRG1;PML;FGFR2;STAT5A;CYP1A1;B4GALT1;PBX1;TFCP2L1;HMGCS1;TGFB2;SLC9A3R1;SFRP1;WNT10A;WNT4;SRF;QDPR;SRD5A1;TNC;UMPS;BRCA2;E2F8;NTN1;CFLAR;CITED2;CSF1;ESR1;TNF;TYMS;SMARCC1
1276,GO:0003065,0.0623961265723752,1,1,1,positive regulation of heart rate by epinephrine,BP,TPM1
12886,GO:0051188,0.0624154025933177,0.961039784635457,24,243,cofactor biosynthetic process,BP,GCLC;CYP1A1;MAT2A;PANK2;SCD;ACSL3;NUP50;NUP153;DHFR;NDC1;RANBP2;GPHN;PGK1;HACD2;IBA57;QDPR;NFE2L1;NUP160;NUP54;SLC11A2;SCD5;MMAA;PDSS1;FLAD1
8608,GO:0034110,0.0624376766443544,0.984379456972032,4,21,regulation of homotypic cell-cell adhesion,BP,C1QTNF1;PDPN;SYK;CCL5
3161,GO:0006772,0.0624725455094696,1,1,1,thiamine metabolic process,BP,THTPA
9979,GO:0042357,0.0624725455094696,1,1,1,thiamine diphosphate metabolic process,BP,THTPA
12487,GO:0050333,0.0624725455094696,1,1,1,thiamin-triphosphatase activity,MF,THTPA
4474,GO:0010468,0.0625396336833781,0.9463238553545,275,3510,regulation of gene expression,BP,CRYAB;MAFB;NRG1;HDAC9;C1R;TRIM16;FN1;PML;CYP1B1;GCLC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;IL1R2;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;TP53;DAPK3;EDN1;C1QTNF1;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;HNRNPF;DKC1;INHBA;IL7R;NUP50;PUM3;SYK;NUP153;NAIP;ZFP42;RELB;PARP15;BRIP1;SHQ1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;WNT10A;TARDBP;MIR17HG;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;POLR1A;GLIS3;HELLS;TAF2;POLA1;TSN;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;KDM6A;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;MRTO4;TAF1D;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;TRIM37;ZNF586;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;UTY;NFE2L1;CLU;NUP160;SMYD2;MACC1;BIRC3;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;METTL16;SETD2;GLIS2;UBP1;UPK3B;TTF2;ZNF484;APEX1;TNC;ZNF57;TET3;ORC1;MYBL1;HSPA8;DDX21;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;WDR75;SENP1;RBMS3;PSME2;UBAP2L;CFLAR;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3
6128,GO:0019373,0.06254800569957,0.993908907154936,2,6,epoxygenase P450 pathway,BP,CYP1B1;CYP1A1
2125,GO:0004917,0.0626240645875056,1,1,1,interleukin-7 receptor activity,MF,IL7R
2345,GO:0005381,0.0626938289217875,0.993886605372454,2,6,iron ion transmembrane transporter activity,MF,TFRC;SLC11A2
3441,GO:0007252,0.0627988283940692,0.988457862709062,3,13,I-kappaB phosphorylation,BP,IKBKE;TRAF2;TLR3
5454,GO:0016323,0.0629019969280453,0.965970984332632,15,125,basolateral plasma membrane,CC,TFRC;B4GALT1;MEGF11;SLC4A11;PDPN;NAIP;LEPR;DST;ATP2B1;ABCC4;SLCO4C1;PDGFB;ENPP1;TJP1;HSP90AB1
7148,GO:0030983,0.0630413731805016,0.988394798050116,3,13,mismatched DNA binding,MF,APTX;MSH6;MSH3
15792,GO:0072376,0.0630490097656271,0.984088668213754,4,22,protein activation cascade,BP,KRT1;C1R;C3;CLU
6678,GO:0030036,0.0630557959617582,0.954866282644062,46,472,actin cytoskeleton organization,BP,KIF23;AMOT;CTGF;MYO1B;ACTG1;DAPK3;EDN1;COBLL1;SLC9A3R1;PALM2;EMP2;SFRP1;TPM1;PTGER4;OPHN1;SYNPO2L;KANK4;RHOG;WNT4;LCP1;RAN;CORO1C;ATP2C1;TRPM7;CGNL1;CDC42EP2;BAIAP2;PHACTR4;SRF;ANTXR1;RTKN2;SDAD1;TPM4;FGD6;ANLN;MYH11;LIMCH1;CFLAR;SHTN1;DPYSL3;SYNPO2;TNF;NEDD9;PPARGC1B;ITGB1BP1;DIAPH3
10118,GO:0042626,0.0630684976853502,0.972411217497447,9,66,ATPase activity, coupled to transmembrane movement of substances,MF,TAP1;ABCG2;ATP2B1;ABCC4;ATP2C1;ABCC9;ABCA5;TAP2;ABCA11P
17018,GO:0099080,0.0630980971043715,0.953242174566163,57,603,supramolecular complex,CC,CRYAB;KRT1;SAA1;NEFL;KRT34;KRT4;MAP2;KRT13;KIF23;AMOT;MTUS1;JPH2;KRT2;KRT15;COL5A3;FBN1;MYO1B;ACTG1;NEFM;KRTAP2-3;COL27A1;DYNC2H1;MID1;DAPK3;TCP11L1;CYLD;PDLIM1;KRT9;DST;COL4A1;KEAP1;TPM1;DYNLL2;SYNPO2L;NEXN;HSPB1;LCP1;KLHL21;KRT24;BAIAP2;COL5A2;NPNT;LRPPRC;TPM4;ABCC9;JPH1;SRPRB;MYH11;KRT10;SKA2;GPER1;SHTN1;DPYSL3;MFAP5;KIF14;SYNPO2;HNRNPU
12819,GO:0051094,0.0632299613390375,0.951386472774162,74,831,positive regulation of developmental process,BP,IGFBP3;NEFL;NRG1;HDAC9;TRIM16;FN1;TENM3;CYP1B1;AMOT;TFRC;CYR61;C3;FGFR2;CTGF;RUNX1;B4GALT1;FST;ENC1;EDN1;RBM19;CDKN2A;RBM4;PDPN;TGFB2;CYLD;IL6ST;INHBA;IL7R;SYK;SFRP1;MIR17HG;ADAMTS9;ADM;PLK2;HSPB1;WNT4;CORO1C;RRN3;SOCS1;ARNTL;BAIAP2;SRF;HIF1AN;NPNT;PDGFB;FZD1;IL20;RIF1;GLIPR2;LRRN3;ERAP1;PDCL3;HSP90AB1;NEDD4L;ZFYVE27;L1CAM;GPER1;NTN1;MSH6;CFLAR;SHTN1;DPYSL3;CITED2;DDX56;CSF1;AP3B1;TLR3;PARD3;EHD1;TNF;ATAD5;CD74;PPARGC1B;IRAK3
5326,GO:0016049,0.0632958675383558,0.957163256218138,34,349,cell growth,BP,CRYAB;IGFBP3;NRG1;FN1;PML;CYR61;CTGF;HSPG2;G6PD;TP53;EDN1;CDKN2A;TGFB2;INHBA;SFRP1;H3F3A;TMEM97;NOP58;CXCL16;DDX3X;SRF;ENPP1;NEDD4L;SGK1;ZFYVE27;L1CAM;ADAM17;NTN1;SHTN1;NCBP1;KIF14;WDR36;FGFR1OP;CDKN1A
10355,GO:0043142,0.0633463985242327,0.98831533567984,3,13,single-stranded DNA-dependent ATPase activity,MF,POLQ;RFC3;RAD18
439,GO:0001179,0.0634407409440176,1,1,1,RNA polymerase I transcription factor binding,MF,POLR1E
64,GO:0000127,0.0635085246841542,0.993761438772724,2,6,transcription factor TFIIIC complex,CC,GTF3C6;GTF3C4
10201,GO:0042791,0.0635085246841542,0.993761438772724,2,6,5S class rRNA transcription by RNA polymerase III,BP,GTF3C6;GTF3C4
10204,GO:0042797,0.0635085246841542,0.993761438772724,2,6,tRNA transcription by RNA polymerase III,BP,GTF3C6;GTF3C4
7691,GO:0032135,0.0636079412357728,0.993746098797235,2,6,DNA insertion or deletion binding,MF,MSH6;MSH3
5878,GO:0017196,0.0636366820540371,0.993741661416873,2,6,N-terminal peptidyl-methionine acetylation,BP,NAA15;NAA16
6042,GO:0019135,0.0637952024097913,1,1,1,deoxyhypusine monooxygenase activity,MF,DOHH
950,GO:0002366,0.0641360327731987,0.954692882795479,42,471,leukocyte activation involved in immune response,BP,KRT1;FTL;FTH1;TFRC;C3;S100P;MMP9;B4GALT1;EXO1;DOCK10;LGALS3;IL27RA;SYK;RELB;NBN;HRNR;PTPRB;PTGER4;MGAM;SLCO4C1;MME;FRK;RHOG;LCP1;SIRPA;THOC1;DDX3X;ITGAV;QPCT;LFNG;COMMD9;RIF1;HSPA8;HSP90AB1;LAIR1;MSH6;LILRB3;GLIPR1;DNASE1;ATAD5;RC3H1;NRAS
3160,GO:0006771,0.0642273321578795,0.993650204129832,2,6,riboflavin metabolic process,BP,ENPP1;FLAD1
1508,GO:0003860,0.0643691578180196,1,1,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,HIBCH
14656,GO:0070227,0.0645625163950061,0.975080275068127,7,52,lymphocyte apoptotic process,BP,TSC22D3;TP53;LGALS3;CD274;MIR17HG;CCL5;CD74
10818,GO:0044295,0.0646277187854337,0.983742781210629,4,20,axonal growth cone,CC,TRAK2;L1CAM;SHTN1;PARD3
531,GO:0001649,0.0646279920348633,0.964082962182126,16,140,osteoblast differentiation,BP,IGFBP3;CYR61;CYP24A1;FGFR2;IL6ST;SFRP1;WNT4;NPNT;FZD1;TPM4;TNC;DDX21;SYNCRIP;CCDC47;TNF;HNRNPU
17788,GO:1901740,0.0647587354502106,1,1,1,negative regulation of myoblast fusion,BP,CFLAR
18666,GO:1903943,0.0647587354502106,1,1,1,regulation of hepatocyte apoptotic process,BP,CFLAR
18667,GO:1903944,0.0647587354502106,1,1,1,negative regulation of hepatocyte apoptotic process,BP,CFLAR
4592,GO:0010694,0.0647750882495099,0.994050372221051,2,5,positive regulation of alkaline phosphatase activity,BP,NPNT;PPARGC1B
1537,GO:0003919,0.0649143106543901,1,1,1,FMN adenylyltransferase activity,MF,FLAD1
3149,GO:0006747,0.0649143106543901,1,1,1,FAD biosynthetic process,BP,FLAD1
11684,GO:0046443,0.0649143106543901,1,1,1,FAD metabolic process,BP,FLAD1
15801,GO:0072388,0.0649143106543901,1,1,1,flavin adenine dinucleotide biosynthetic process,BP,FLAD1
472,GO:0001515,0.0649697449887519,1,1,1,opioid peptide activity,MF,CDC42EP2
11333,GO:0045638,0.065106494314846,0.972776632824434,8,67,negative regulation of myeloid cell differentiation,BP,MAFB;FBN1;INHBA;TJP2;SFRP1;LILRB3;TLR3;HIST1H4A
15466,GO:0071763,0.0651499267195101,0.993506338866537,2,6,nuclear membrane organization,BP,TARDBP;GPER1
12871,GO:0051170,0.0652411967672342,0.96442884300428,15,135,import into nucleus,BP,PML;GEMIN5;CHP1;RBM22;NUP50;NUP153;GEMIN4;RAN;RANBP2;ARNTL;NUP54;HSP90AB1;GEMIN8;TNF;CDKN1A
7861,GO:0032416,0.0652960765497249,1,1,1,negative regulation of sodium:proton antiporter activity,BP,SLC9A3R1
16562,GO:0097291,0.0652960765497249,1,1,1,renal phosphate ion absorption,BP,SLC9A3R1
3288,GO:0006979,0.0654382554772034,0.956692370412712,30,324,response to oxidative stress,BP,CRYAB;KRT1;PML;CYP1B1;GCLC;TXNRD1;MMP9;G6PD;TP53;EDN1;NQO1;PDLIM1;DHFR;TPM1;HSPB1;SOD2;ARNTL;APTX;FZD1;NFE2L1;APEX1;ARL6IP5;PXMP2;FANCD2;CFLAR;TRAF2;CCNA2;TNF;PPARGC1B;GPX4
8523,GO:0033699,0.0654961163926976,1,1,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,APTX
17295,GO:0120108,0.0654961163926976,1,1,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,APTX
19493,GO:1990165,0.0654961163926976,1,1,1,single-strand break-containing DNA binding,MF,APTX
11618,GO:0046209,0.0655659856613211,0.97469644187708,7,49,nitric oxide metabolic process,BP,CYP1B1;SLC7A2;EDN1;NQO1;CLU;HSP90AB1;TNF
17066,GO:0099522,0.0656463129616619,1,1,1,region of cytosol,CC,HSPA8
17067,GO:0099523,0.0656463129616619,1,1,1,presynaptic cytosol,CC,HSPA8
17068,GO:0099524,0.0656463129616619,1,1,1,postsynaptic cytosol,CC,HSPA8
19008,GO:1904764,0.0656463129616619,1,1,1,chaperone-mediated autophagy translocation complex disassembly,BP,HSPA8
19670,GO:1990832,0.0656463129616619,1,1,1,slow axonal transport,BP,HSPA8
19671,GO:1990833,0.0656463129616619,1,1,1,clathrin-uncoating ATPase activity,MF,HSPA8
13864,GO:0060444,0.0657492530068544,0.983364698473833,4,20,branching involved in mammary gland duct morphogenesis,BP,PML;WNT4;CSF1;ESR1
12651,GO:0050819,0.0659350461567005,0.979574816781359,5,32,negative regulation of coagulation,BP,KRT1;EDN1;C1QTNF1;PDGFB;THBD
3347,GO:0007076,0.065980413937916,0.983836068921831,4,16,mitotic chromosome condensation,BP,AKAP8;AKAP8L;SMC2;CDCA5
9079,GO:0035312,0.0660040959704123,0.993372050496239,2,6,5'-3' exodeoxyribonuclease activity,MF,EXO1;APTX
6657,GO:0030003,0.0660432866734872,0.955673429593827,32,335,cellular cation homeostasis,BP,SAA1;FTL;FTH1;PML;JPH2;TFRC;CLN6;TP53;EDN1;C1QTNF1;CHP1;SLC4A11;ACO1;SLC30A6;ABCG2;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;JPH1;THADA;SLC11A2;RIC3;TMEM199;NEDD4L;TMEM165;GPER1;SLC9A9;ESR1;CCL5
3816,GO:0008406,0.0661041738928564,0.963107557468207,16,145,gonad development,BP,HMGCS1;TGFB2;INHBA;ZFP42;BRIP1;SFRP1;IMMP2L;WNT4;LFNG;SRD5A1;BRCA2;RRM1;EIF2B5;CITED2;TLR3;ESR1
7191,GO:0031072,0.0661431769709813,0.966734600969566,12,102,heat shock protein binding,MF,SACS;GBP1;AHR;METTL21A;ARNTL;HSPA8;HSP90AB1;FKBP5;FAF1;DNAJC9;TELO2;DAXX
4247,GO:0009445,0.0662678332435115,0.992985638994317,2,7,putrescine metabolic process,BP,ODC1;AZIN1
4901,GO:0014826,0.0663465229293141,1,1,1,vein smooth muscle contraction,BP,EDN1
6763,GO:0030185,0.0663465229293141,1,1,1,nitric oxide transport,BP,EDN1
7453,GO:0031583,0.0663465229293141,1,1,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,EDN1
7524,GO:0031705,0.0663465229293141,1,1,1,bombesin receptor binding,MF,EDN1
7525,GO:0031707,0.0663465229293141,1,1,1,endothelin A receptor binding,MF,EDN1
7526,GO:0031708,0.0663465229293141,1,1,1,endothelin B receptor binding,MF,EDN1
9344,GO:0035815,0.0663465229293141,1,1,1,positive regulation of renal sodium excretion,BP,EDN1
9960,GO:0042313,0.0663465229293141,1,1,1,protein kinase C deactivation,BP,EDN1
10375,GO:0043179,0.0663465229293141,1,1,1,rhythmic excitation,BP,EDN1
6762,GO:0030183,0.0664267720572603,0.969107999220067,10,78,B cell differentiation,BP,HDAC9;DOCK10;CYLD;INHBA;SYK;SFRP1;MIR17HG;LFNG;ADAM17;ZFP36L2
7170,GO:0031038,0.066457123319723,1,1,1,myosin II filament organization,BP,DAPK3
10572,GO:0043519,0.066457123319723,1,1,1,regulation of myosin II filament organization,BP,DAPK3
14907,GO:0070685,0.0664936726528099,1,1,1,macropinocytic cup,CC,SNX5
12607,GO:0050764,0.0665261762344929,0.976573529348735,6,40,regulation of phagocytosis,BP,C3;SYK;SIRPA;ITGAV;SYT11;TNF
12071,GO:0048002,0.0665509863976961,0.963501997071727,15,149,antigen processing and presentation of peptide antigen,BP,KIF23;HLA-B;TAP1;HLA-F;HLA-DOB;DYNLL2;ITGAV;ERAP1;PSME2;PSMB9;TAP2;IFI30;CD74;PSMB10;DCTN5
3620,GO:0008076,0.0665962517219239,0.979491611661155,5,29,voltage-gated potassium channel complex,CC,CNTNAP1;KCNS3;KCNQ5;ABCC9;CNTNAP2
782,GO:0002037,0.0666229232429293,1,1,1,negative regulation of L-glutamate import across plasma membrane,BP,ARL6IP5
11086,GO:0045072,0.0667175562002891,0.993259081182938,2,6,regulation of interferon-gamma biosynthetic process,BP,INHBA;TLR3
12191,GO:0048297,0.0667248949994401,1,1,1,negative regulation of isotype switching to IgA isotypes,BP,THOC1
10732,GO:0044057,0.0668022951102518,0.95721142553247,26,252,regulation of system process,BP,NRG1;CTGF;G6PD;DAPK3;EDN1;C1QTNF1;TGFB2;IL6ST;SLC9A3R1;INHBA;SLC22A5;EMP2;MIR17HG;ATP2B1;TPM1;ADM;SRF;NPNT;PDGFB;ABCC9;SGK1;MTMR2;GPER1;PARD3;GJC1;FTO
16354,GO:0090560,0.066949768878814,1,1,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,DPH2
19197,GO:1905207,0.067000302685994,0.979331220341568,5,29,regulation of cardiocyte differentiation,BP,NRG1;G6PD;EDN1;TGFB2;GPER1
7323,GO:0031327,0.0670203119755133,0.946402815876529,101,1203,negative regulation of cellular biosynthetic process,BP,NRG1;HDAC9;PML;GCLC;FGFR2;TRIM22;CBX5;TSC22D3;FST;TFCP2L1;ENC1;TP53;DAPK3;EDN1;CDKN2A;RBM4;IRX2;SRSF2;INHBA;NUP50;NUP153;RELB;LEPR;PARP15;SFRP1;MIR17HG;H3F3A;AHR;DHFR;GLIS3;HELLS;SETDB1;NDC1;ZNF587;FRK;WNT4;SUV39H2;RAN;RANBP2;DDX3X;SET;ARNTL;AJUBA;DND1;ZC3H7B;TRIM37;GNL3L;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;NUP160;SMYD2;ENPP1;NUP54;RIF1;METTL16;GLIS2;UBP1;APEX1;HSPA8;BACE2;NEDD4L;BRCA2;SYNCRIP;DGCR8;CCAR1;E2F8;CENPF;ETV6;POLR2F;ATR;ZNF12;ZNF608;NCBP1;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;ZFP36L2;RC3H1;TYMS;HNRNPU;RING1;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;IRF1;CTCF
11112,GO:0045110,0.067026189534356,0.993209986441845,2,6,intermediate filament bundle assembly,BP,NEFL;NEFM
7766,GO:0032277,0.0670914019643163,1,1,1,negative regulation of gonadotropin secretion,BP,INHBA
10565,GO:0043509,0.0670914019643163,1,1,1,activin A complex,CC,INHBA
10566,GO:0043511,0.0670914019643163,1,1,1,inhibin complex,CC,INHBA
10567,GO:0043512,0.0670914019643163,1,1,1,inhibin A complex,CC,INHBA
11091,GO:0045077,0.0670914019643163,1,1,1,negative regulation of interferon-gamma biosynthetic process,BP,INHBA
11890,GO:0046882,0.0670914019643163,1,1,1,negative regulation of follicle-stimulating hormone secretion,BP,INHBA
12136,GO:0048180,0.0670914019643163,1,1,1,activin complex,CC,INHBA
13734,GO:0060278,0.0670914019643163,1,1,1,regulation of ovulation,BP,INHBA
13735,GO:0060279,0.0670914019643163,1,1,1,positive regulation of ovulation,BP,INHBA
19785,GO:2000142,0.0672068766758112,0.979183781947665,5,30,regulation of DNA-templated transcription, initiation,BP,TP53;RRN3;SRF;ESR1;TAF1
15256,GO:0071396,0.0672706571729289,0.953441535237304,37,389,cellular response to lipid,BP,KRT13;CYP24A1;FGFR2;RUNX1;DDX17;EDN1;HMGCS1;AKAP8;INHBA;CDK4;SFRP1;CD274;ATP2B1;AHR;PTGER4;CCL20;RAN;IL24;ARNTL;AKR1C2;GDAP1;CLU;NFKBIB;SRD5A1;TNC;GPER1;CFLAR;CCNA2;CLOCK;ESR1;TNF;ZFP36L2;CCL5;HNRNPU;DAXX;TAF1;PPARGC1B
15300,GO:0071466,0.0674366961353869,0.965915584044557,12,107,cellular response to xenobiotic stimulus,BP,CYP1B1;UGT1A6;STAT5A;CYP1A1;NQO1;AHR;PDGFB;SRD5A1;HSP90AB1;CFLAR;UGT1A4;CCNA2
6871,GO:0030336,0.0675432773275152,0.960784770419116,18,164,negative regulation of cell migration,BP,IGFBP3;NRG1;CYP1B1;STARD13;SLC9A3R1;SFRP1;TPM1;ADAMTS9;PTGER4;WNT4;PTPRM;CORO1C;IL24;SRF;APEX1;DPYSL3;CITED2;ITGB1BP1
12283,GO:0048561,0.0675607278935628,1,1,1,establishment of animal organ orientation,BP,IRX4
14816,GO:0070527,0.0675783143156731,0.976108002121365,6,40,platelet aggregation,BP,ACTG1;C1QTNF1;PDPN;SYK;CSRP1;HSPB1
3919,GO:0008585,0.0676742821013892,0.969917995672355,9,69,female gonad development,BP,INHBA;ZFP42;SFRP1;IMMP2L;WNT4;LFNG;BRCA2;EIF2B5;ESR1
11441,GO:0045840,0.0677051843390657,0.976096483784104,6,39,positive regulation of mitotic nuclear division,BP,EPGN;EDN1;RANBP2;CDCA5;PDGFB;HNRNPU
15244,GO:0071380,0.0677650199272548,0.987337324328321,3,12,cellular response to prostaglandin E stimulus,BP,AKAP8;SFRP1;PTGER4
9995,GO:0042382,0.0679636772294886,0.99306002535782,2,6,paraspeckles,CC,PSPC1;HNRNPM
9965,GO:0042325,0.0679755720335908,0.946274842628356,90,1044,regulation of phosphorylation,BP,IGFBP3;SAA1;NRG1;FN1;PML;MAP3K14;CYR61;C3;GPRC5A;NLRC5;FGFR2;EPGN;CTGF;MMP9;IRS1;MID1;TP53;EDN1;GBP1;C1QTNF1;DUSP14;CDKN2A;CHP1;AKAP8;TGFB2;PKMYT1;IL6ST;SLC9A3R1;INHBA;NUP50;SYK;EMP2;NUP153;NBN;CDK4;SFRP1;TARDBP;ULK4;CD109;NDC1;CCL20;AKAP8L;HSPB1;RANBP2;CORO1C;DDX3X;IL24;CDC25A;ITGAV;SOCS1;PARP14;AJUBA;GADD45B;NPNT;PDGFB;FZD1;CLU;NUP160;ENPP1;IL20;PIK3R3;NUP54;ACKR3;GLIPR2;PDCL3;HSP90AB1;ARL6IP5;EPHB6;GPER1;FAF1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;RBL1;KIF14;TLR3;PARD3;TNF;CCL5;CD74;HNRNPU;FGFR1OP;DAXX;PHLPP1;PPARGC1B;CDKN1A;ITGB1BP1;IRAK3
11366,GO:0045684,0.0679904193674657,0.978751728539405,5,32,positive regulation of epidermis development,BP,TRIM16;FST;TGFB2;IL20;TNF
2262,GO:0005174,0.0680953539245098,1,1,1,CD40 receptor binding,MF,TRAF2
5650,GO:0016741,0.0680982665650073,0.959717961650722,19,185,transferase activity, transferring one-carbon groups,MF,TGS1;THUMPD3;METTL21A;METTL1;SETDB1;NOP2;SUV39H2;SETD4;VCPKMT;SMYD2;METTL16;SETD2;TRMT5;METTL13;TRMT1;TRMT61A;RBBP5;WDR4;TYMS
14893,GO:0070665,0.0681557212443374,0.969522588655118,9,76,positive regulation of leukocyte proliferation,BP,TFRC;IL6ST;SYK;CD274;CSF1;ATAD5;CCL5;CD74;CDKN1A
786,GO:0002041,0.0681708861180741,1,1,1,intussusceptive angiogenesis,BP,CYR61
5796,GO:0017025,0.0684186040587897,0.982167147162319,4,23,TBP-class protein binding,MF,HNRNPF;AHR;ESR1;TAF1
2816,GO:0006281,0.0684957587658716,0.951156708365327,43,484,DNA repair,BP,PML;TP53;EXO1;RAD1;NBN;BRIP1;NUCKS1;POLQ;RPA1;POLA1;USP43;RFC3;TOPBP1;SUPT16H;FEN1;CDCA5;APTX;GINS4;MCM8;BRCC3;EYA3;RIF1;SETD2;APEX1;SMUG1;HELQ;BRCA2;FANCD2;POLR2F;CHEK1;RAD18;ATR;MSH6;RFWD3;MSH3;TIMELESS;RAD51B;HIST1H4A;FTO;USP1;TREX1;GTF2H3;COPS3
4616,GO:0010731,0.0685717691882267,1,1,1,protein glutathionylation,BP,G6PD
4617,GO:0010732,0.0685717691882267,1,1,1,regulation of protein glutathionylation,BP,G6PD
4618,GO:0010734,0.0685717691882267,1,1,1,negative regulation of protein glutathionylation,BP,G6PD
7100,GO:0030890,0.0686450620586095,0.982088219264604,4,23,positive regulation of B cell proliferation,BP,TFRC;ATAD5;CD74;CDKN1A
17603,GO:1901202,0.0686614993811417,1,1,1,negative regulation of extracellular matrix assembly,BP,ANTXR1
13278,GO:0051938,0.0686705581762517,0.992946125151295,2,6,L-glutamate import,BP,SLC1A3;ARL6IP5
16846,GO:0098712,0.0686705581762517,0.992946125151295,2,6,L-glutamate import across plasma membrane,BP,SLC1A3;ARL6IP5
17058,GO:0099512,0.0687551275398973,0.948880922337185,56,596,supramolecular fiber,CC,CRYAB;KRT1;SAA1;NEFL;KRT34;KRT4;MAP2;KRT13;KIF23;AMOT;MTUS1;JPH2;KRT2;KRT15;COL5A3;FBN1;MYO1B;ACTG1;NEFM;KRTAP2-3;COL27A1;DYNC2H1;MID1;DAPK3;TCP11L1;CYLD;PDLIM1;KRT9;DST;KEAP1;TPM1;DYNLL2;SYNPO2L;NEXN;HSPB1;LCP1;KLHL21;KRT24;BAIAP2;COL5A2;NPNT;LRPPRC;TPM4;ABCC9;JPH1;SRPRB;MYH11;KRT10;SKA2;GPER1;SHTN1;DPYSL3;MFAP5;KIF14;SYNPO2;HNRNPU
7532,GO:0031731,0.0687811839443499,0.998776247459367,1,2,CCR6 chemokine receptor binding,MF,CCL20
6491,GO:0021840,0.0688823317968711,1,1,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,NRG1
6492,GO:0021842,0.0688823317968711,1,1,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,NRG1
19885,GO:2000323,0.0689391717308396,0.992902657313554,2,6,negative regulation of glucocorticoid receptor signaling pathway,BP,ARNTL;CLOCK
16002,GO:0080163,0.0689751802900798,1,1,1,regulation of protein serine/threonine phosphatase activity,BP,PPP4R4
8229,GO:0032980,0.0691460555518272,1,1,1,keratinocyte activation,BP,KRT2
11809,GO:0046660,0.0691727276505525,0.967572387256984,10,79,female sex differentiation,BP,INHBA;ZFP42;SFRP1;IMMP2L;WNT4;LFNG;SRD5A1;BRCA2;EIF2B5;ESR1
13250,GO:0051894,0.0692100927912131,0.98218326109488,4,20,positive regulation of focal adhesion assembly,BP,COL16A1;SFRP1;WNT4;ITGB1BP1
1927,GO:0004618,0.0692173484463533,1,1,1,phosphoglycerate kinase activity,MF,PGK1
2247,GO:0005157,0.0692315073501922,1,1,1,macrophage colony-stimulating factor receptor binding,MF,CSF1
10046,GO:0042488,0.0692315073501922,1,1,1,positive regulation of odontogenesis of dentin-containing tooth,BP,CSF1
13962,GO:0060611,0.0692315073501922,1,1,1,mammary gland fat development,BP,CSF1
17940,GO:1902228,0.0692315073501922,1,1,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,CSF1
18681,GO:1903971,0.0692315073501922,1,1,1,positive regulation of response to macrophage colony-stimulating factor,BP,CSF1
18684,GO:1903974,0.0692315073501922,1,1,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,CSF1
18741,GO:1904124,0.0692315073501922,1,1,1,microglial cell migration,BP,CSF1
18742,GO:1904139,0.0692315073501922,1,1,1,regulation of microglial cell migration,BP,CSF1
18743,GO:1904141,0.0692315073501922,1,1,1,positive regulation of microglial cell migration,BP,CSF1
19620,GO:1990682,0.0692315073501922,1,1,1,CSF1-CSF1R complex,CC,CSF1
5589,GO:0016604,0.0693605370287169,0.948098285516566,58,652,nuclear body,CC,TRIM16;PML;TRIM22;CBX5;S100P;DDX17;TP53;DAPK3;EXO1;RBM4;GEMIN5;STAG1;IKBKE;TGS1;IL16;SRSF2;SUGP2;DKC1;PHAX;NBN;GEMIN4;RPA1;LSG1;PARD3B;CASC3;SYNPO2L;AKAP8L;NOP58;GTF3C6;THOC1;TOPBP1;DDX3X;ARNTL;LUC7L2;EFTUD2;RIF1;GLIS2;APEX1;SGK1;GEMIN8;FANCD2;RAD18;ATR;RFWD3;CBLL1;TELO2;TAP2;SURF2;HNRNPU;RING1;DAXX;FTO;PSPC1;HNRNPM;CDKN1A;ITGB1BP1;RBM8A;DHX15
5132,GO:0015578,0.0694126163026759,1,1,1,mannose transmembrane transporter activity,MF,M6PR
5190,GO:0015761,0.0694126163026759,1,1,1,mannose transmembrane transport,BP,M6PR
2629,GO:0005954,0.0695617005403023,1,1,1,calcium- and calmodulin-dependent protein kinase complex,CC,CAMK1G
14584,GO:0070099,0.0696440975755734,0.992788098244965,2,6,regulation of chemokine-mediated signaling pathway,BP,EDN1;CCL5
5625,GO:0016679,0.0698595032746633,0.992107190362843,2,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,CYP1A1;UQCRB
3120,GO:0006700,0.0699101846150028,0.986252174297654,3,15,C21-steroid hormone biosynthetic process,BP,ADM;WNT4;AKR1B1
838,GO:0002135,0.0700000947496719,1,1,1,CTP binding,MF,HSP90AB1
5827,GO:0017098,0.0700000947496719,1,1,1,sulfonylurea receptor binding,MF,HSP90AB1
17675,GO:1901388,0.0700000947496719,1,1,1,regulation of transforming growth factor beta activation,BP,HSP90AB1
17676,GO:1901389,0.0700000947496719,1,1,1,negative regulation of transforming growth factor beta activation,BP,HSP90AB1
18533,GO:1903659,0.0700000947496719,1,1,1,regulation of complement-dependent cytotoxicity,BP,HSP90AB1
18534,GO:1903660,0.0700000947496719,1,1,1,negative regulation of complement-dependent cytotoxicity,BP,HSP90AB1
19693,GO:1990913,0.0700000947496719,1,1,1,sperm head plasma membrane,CC,HSP90AB1
19694,GO:1990917,0.0700000947496719,1,1,1,ooplasm,CC,HSP90AB1
232,GO:0000480,0.0700109324400644,0.992728205244098,2,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,UTP20;FCF1
5581,GO:0016595,0.0700239187206571,0.992726081497882,2,6,glutamate binding,MF,GCLC;SLC1A3
11838,GO:0046717,0.070027252747534,0.972528210298873,7,50,acid secretion,BP,EDN1;SLC9A3R1;SYK;ABCC4;SLC1A3;SGK1;RAB3GAP1
238,GO:0000495,0.0702046253149008,1,1,1,box H/ACA snoRNA 3'-end processing,BP,DKC1
8564,GO:0033979,0.0702046253149008,1,1,1,box H/ACA snoRNA metabolic process,BP,DKC1
8942,GO:0034964,0.0702046253149008,1,1,1,box H/ACA snoRNA processing,BP,DKC1
10246,GO:0042942,0.0702255909915687,1,1,1,D-serine transport,BP,NFKBIE
398,GO:0001074,0.0702673012600841,1,1,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,TP53
404,GO:0001084,0.0702673012600841,1,1,1,transcription factor activity, TFIID-class binding,MF,TP53
8441,GO:0033552,0.0702673012600841,1,1,1,response to vitamin B3,BP,TP53
13167,GO:0051716,0.0702716773515714,0.938894988943472,362,4677,cellular response to stimulus,BP,IL32;CRYAB;IGFBP3;SAA1;DTX2;NEFL;NRG1;HDAC9;TRIM16;MAP2;KRT13;FN1;TENM3;PTGES;PML;CYP1B1;AMOT;MTUS1;JPH2;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;CYP24A1;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;TRIM22;STARD13;CTGF;HLA-B;MMP9;FBN1;XAF1;RUNX1;CYP1A1;IL1R2;FAT4;ACTG1;PBX1;G6PD;FST;MAT2A;DDX17;TRAF3;IRS1;SPG21;MID1;TP53;DAPK3;TUFT1;EXO1;EDN1;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;C1QTNF1;DUSP14;CDKN2A;RBM4;PTPN14;JRK;NQO1;LGALS3;IFNGR1;CHP1;PDPN;AKAP8;TGFB2;CNTNAP1;RBM22;CYLD;IKBKE;IL27RA;IL16;IFIT3;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;NUAK1;INHBA;IL7R;NUP50;PALM2;CAMK1G;SYK;EMP2;TJP2;NUP153;NAIP;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;BRIP1;ARFRP1;LRRC8D;HLA-F;CDK4;SFRP1;HLA-DOB;NUCKS1;PITHD1;CD274;WNT10A;MCM2;MIR17HG;DST;POLQ;ATP2B1;COL4A1;USP16;AHR;KEAP1;DHFR;RPA1;TPM1;TAF2;ULK4;POLA1;TSN;SETDB1;PTGER4;G3BP1;TRAF1;OPHN1;ADM;IMMP2L;CD109;USP43;NDC1;CADPS2;DYNLL2;FOXRED2;CCL20;PLK2;RRAGB;MME;MUC16;UBQLN2;FRK;GBP5;BTN2A1;RFC3;MYBL2;WDR76;HSPB1;RHOG;WNT4;CXCL16;NOP2;SUV39H2;LCP1;PTPRM;KDM6A;THOC1;RAN;RANBP2;TOPBP1;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;RAB26;IL24;ARHGEF28;RRN3;RNF115;CDC25A;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;LFNG;ZC3H7B;PGK1;NETO1;FEN1;CDC42EP2;CDCA5;BAIAP2;GADD45B;APTX;CDH13;COL5A2;GINS4;PHACTR4;SRF;GDAP1;MDM4;HIF1AN;NPNT;QDPR;MCM8;PDGFB;BRCC3;KREMEN2;FZD1;NFE2L1;ANTXR1;RTKN2;CLU;NUP160;SMYD2;MACC1;ENPP1;BIRC3;IL20;PIK3R3;NUP54;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;ACKR3;RIF1;FGD6;SRD5A1;SETD2;GLIS2;RPF2;THBD;ABCC9;DTX4;GLIPR2;JPH1;SRPRB;IFNAR1;TJP1;ERAP1;BLOC1S2;APEX1;CXCR5;TNC;UMPS;HSPA8;TMEM199;HSP90AB1;ARL6IP5;EPHB6;SMUG1;HELQ;SGK1;M6PR;ZFYVE27;PXMP2;BRCA2;SYNCRIP;HCAR1;DGCR8;WDPCP;FANCD2;E2F8;MTMR2;HSF2;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;SERPINB9;GPER1;FAF1;RAD18;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;EIF2B5;CMTM3;RFWD3;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;EBP;NCBP1;MYNN;AKR1B1;UBE2J2;TRAF2;TPRA1;MSH3;TELO2;RBBP5;CITED2;NCL;CCNA2;TIMELESS;IFI30;CSF1;RBL1;CLOCK;KIF14;TLR3;ESR1;PARD3;RAD51B;EHD1;TNF;ATAD5;ZFP36L2;NEDD9;SRSF7;RC3H1;CCL5;CD74;HNRNPU;PSMB10;EIF2B1;DAXX;METAP2;PHF14;PHLPP2;HIST1H4A;TAF1;PHLPP1;FTO;NRAS;SMARCC1;MUC5B;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;IRF1;GTF2H3;GBP6;GPX4;IRAK3;COPS3;IFI27L1;UFC1
7711,GO:0032185,0.0703247475514451,0.986451909401428,3,13,septin cytoskeleton organization,BP,RTKN2;ANLN;WDPCP
5216,GO:0015813,0.0703278037835987,0.986451074493195,3,13,L-glutamate transmembrane transport,BP,SLC1A3;ARL6IP5;SLC25A22
4272,GO:0009624,0.0703848886161125,1,1,1,response to nematode,BP,CYP1A1
4290,GO:0009692,0.0703848886161125,1,1,1,ethylene metabolic process,BP,CYP1A1
4291,GO:0009698,0.0703848886161125,1,1,1,phenylpropanoid metabolic process,BP,CYP1A1
4320,GO:0009804,0.0703848886161125,1,1,1,coumarin metabolic process,BP,CYP1A1
5634,GO:0016711,0.0703848886161125,1,1,1,flavonoid 3'-monooxygenase activity,MF,CYP1A1
6108,GO:0019341,0.0703848886161125,1,1,1,dibenzo-p-dioxin catabolic process,BP,CYP1A1
10532,GO:0043449,0.0703848886161125,1,1,1,cellular alkene metabolic process,BP,CYP1A1
3668,GO:0008160,0.070425504886728,1,1,1,protein tyrosine phosphatase activator activity,MF,IGFBP3
14794,GO:0070482,0.070454672900119,0.954147152383859,27,283,response to oxygen levels,BP,CRYAB;PML;CTGF;CYP1A1;TP53;EDN1;TGFB2;PDLIM1;BRIP1;CDK4;SFRP1;ADM;SUV39H2;AJUBA;PGK1;SRF;MDM4;HIF1AN;TMEM199;ADAM17;PSME2;CFLAR;PSMB9;CITED2;CCNA2;PSMB10;CDKN1A
11425,GO:0045815,0.0704827924333566,0.969850211066064,8,77,positive regulation of gene expression, epigenetic,BP,H3F3A;POLR1A;TAF1D;DDX21;POLR2F;CHEK1;POLR1E;HIST1H4A
20135,GO:2000772,0.0705036633978747,0.977794536167163,5,31,regulation of cellular senescence,BP,CDKN2A;NUAK1;PLK2;ARNTL;RBL1
9799,GO:0040008,0.0705471295906585,0.949818255333875,42,450,regulation of growth,BP,CRYAB;IGFBP3;NRG1;FN1;PML;CYR61;FGFR2;STAT5A;CTGF;G6PD;TFCP2L1;TP53;EDN1;CDKN2A;TGFB2;INHBA;CDK4;SFRP1;MIR17HG;H3F3A;TMEM97;CXCL16;DDX3X;SOCS1;SRF;ENPP1;NEDD4L;SGK1;ZFYVE27;L1CAM;ADAM17;NTN1;SHTN1;NCBP1;CSF1;KIF14;TNF;NEDD9;WDR36;FGFR1OP;FTO;CDKN1A
1906,GO:0004588,0.070658104885574,1,1,1,orotate phosphoribosyltransferase activity,MF,UMPS
1907,GO:0004590,0.070658104885574,1,1,1,orotidine-5'-phosphate decarboxylase activity,MF,UMPS
12169,GO:0048261,0.0707461461624556,0.986165266212903,3,14,negative regulation of receptor-mediated endocytosis,BP,UBQLN2;SYT11;MTMR2
9402,GO:0035931,0.07096784789067,1,1,1,mineralocorticoid secretion,BP,C1QTNF1
9403,GO:0035932,0.07096784789067,1,1,1,aldosterone secretion,BP,C1QTNF1
20185,GO:2000855,0.07096784789067,1,1,1,regulation of mineralocorticoid secretion,BP,C1QTNF1
20186,GO:2000857,0.07096784789067,1,1,1,positive regulation of mineralocorticoid secretion,BP,C1QTNF1
20187,GO:2000858,0.07096784789067,1,1,1,regulation of aldosterone secretion,BP,C1QTNF1
20188,GO:2000860,0.07096784789067,1,1,1,positive regulation of aldosterone secretion,BP,C1QTNF1
14491,GO:0061851,0.0709996241693636,1,1,1,leading edge of lamellipodium,CC,PDPN
18823,GO:1904328,0.0709996241693636,1,1,1,regulation of myofibroblast contraction,BP,PDPN
19648,GO:1990764,0.0709996241693636,1,1,1,myofibroblast contraction,BP,PDPN
399,GO:0001075,0.0710476763389411,0.992557910983786,2,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,TAF2;TAF1
6227,GO:0019774,0.0710694629196946,0.991511322210009,2,10,proteasome core complex, beta-subunit complex,CC,PSMB9;PSMB10
946,GO:0002357,0.0712335092191305,1,1,1,defense response to tumor cell,BP,RBMS3
235,GO:0000492,0.0713956850710732,0.992114325605305,2,7,box C/D snoRNP assembly,BP,NUFIP1;ZNHIT6
10766,GO:0044183,0.0714064142315475,0.977309692219149,5,33,protein binding involved in protein folding,MF,HSPB1;RIC3;PDCL3;HSPA8;CD74
15196,GO:0071314,0.0714105806571268,1,1,1,cellular response to cocaine,BP,CCNA2
1828,GO:0004478,0.0715150741033139,1,1,1,methionine adenosyltransferase activity,MF,MAT2A
894,GO:0002263,0.0715846393178743,0.948980465814266,42,474,cell activation involved in immune response,BP,KRT1;FTL;FTH1;TFRC;C3;S100P;MMP9;B4GALT1;EXO1;DOCK10;LGALS3;IL27RA;SYK;RELB;NBN;HRNR;PTPRB;PTGER4;MGAM;SLCO4C1;MME;FRK;RHOG;LCP1;SIRPA;THOC1;DDX3X;ITGAV;QPCT;LFNG;COMMD9;RIF1;HSPA8;HSP90AB1;LAIR1;MSH6;LILRB3;GLIPR1;DNASE1;ATAD5;RC3H1;NRAS
8727,GO:0034366,0.0716379448479793,1,1,1,spherical high-density lipoprotein particle,CC,CLU
14353,GO:0061517,0.0716379448479793,1,1,1,macrophage proliferation,BP,CLU
14354,GO:0061518,0.0716379448479793,1,1,1,microglial cell proliferation,BP,CLU
18158,GO:1902847,0.0716379448479793,1,1,1,regulation of neuronal signal transduction,BP,CLU
18234,GO:1902998,0.0716379448479793,1,1,1,positive regulation of neurofibrillary tangle assembly,BP,CLU
19420,GO:1905891,0.0716379448479793,1,1,1,regulation of cellular response to thapsigargin,BP,CLU
19421,GO:1905892,0.0716379448479793,1,1,1,negative regulation of cellular response to thapsigargin,BP,CLU
19422,GO:1905894,0.0716379448479793,1,1,1,regulation of cellular response to tunicamycin,BP,CLU
19423,GO:1905895,0.0716379448479793,1,1,1,negative regulation of cellular response to tunicamycin,BP,CLU
8205,GO:0032944,0.0716675009894878,0.962280207834193,13,119,regulation of mononuclear cell proliferation,BP,TFRC;LGALS3;IL6ST;SYK;CD274;AHR;CSF1;ATAD5;RC3H1;CCL5;CD74;CDKN1A;IRF1
6905,GO:0030449,0.0716923470242712,0.985902250363167,3,14,regulation of complement activation,BP,C1R;C3;CLU
19842,GO:2000257,0.0716923470242712,0.985902250363167,3,14,regulation of protein activation cascade,BP,C1R;C3;CLU
4958,GO:0015020,0.0717845271648301,0.985876543675045,3,14,glucuronosyltransferase activity,MF,UGT1A6;UGT8;UGT1A4
20208,GO:2001020,0.071791104323525,0.958646519272732,17,162,regulation of response to DNA damage stimulus,BP,PML;POLQ;WDR76;THOC1;BRCC3;CLU;SMYD2;EYA3;ACKR3;RIF1;SETD2;CHEK1;ATR;RFWD3;TIMELESS;CD74;USP1
15702,GO:0072209,0.0717953019733568,1,1,1,metanephric mesangial cell differentiation,BP,PDGFB
15725,GO:0072254,0.0717953019733568,1,1,1,metanephric glomerular mesangial cell differentiation,BP,PDGFB
15726,GO:0072255,0.0717953019733568,1,1,1,metanephric glomerular mesangial cell development,BP,PDGFB
17475,GO:1900241,0.0717953019733568,1,1,1,positive regulation of phenotypic switching,BP,PDGFB
19191,GO:1905176,0.0717953019733568,1,1,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
4507,GO:0010544,0.0717977194016997,0.985872863489161,3,14,negative regulation of platelet activation,BP,C1QTNF1;PDGFB;THBD
19525,GO:1990275,0.0718288529360638,1,1,1,preribosome binding,MF,NVL
8422,GO:0033391,0.071835976261382,0.992427414938335,2,6,chromatoid body,CC,ARNTL;CLOCK
5715,GO:0016843,0.0718694343029875,1,1,1,amine-lyase activity,MF,APMAP
5716,GO:0016844,0.0718694343029875,1,1,1,strictosidine synthase activity,MF,APMAP
5820,GO:0017082,0.0718694343029875,1,1,1,mineralocorticoid receptor activity,MF,GPER1
6817,GO:0030264,0.0718694343029875,1,1,1,nuclear fragmentation involved in apoptotic nuclear change,BP,GPER1
6907,GO:0030474,0.0718694343029875,1,1,1,spindle pole body duplication,BP,NDC1
6979,GO:0030629,0.0718694343029875,1,1,1,U6 snRNA 3'-end binding,MF,METTL16
8800,GO:0034477,0.0718694343029875,1,1,1,U6 snRNA 3'-end processing,BP,USB1
12960,GO:0051300,0.0718694343029875,1,1,1,spindle pole body organization,BP,NDC1
13478,GO:0052907,0.0718694343029875,1,1,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,METTL16
13773,GO:0060327,0.0718694343029875,1,1,1,cytoplasmic actin-based contraction involved in cell motility,BP,SHTN1
14244,GO:0061163,0.0718694343029875,1,1,1,endoplasmic reticulum polarization,BP,SHTN1
14372,GO:0061573,0.0718694343029875,1,1,1,actin filament bundle retrograde transport,BP,SHTN1
14874,GO:0070631,0.0718694343029875,1,1,1,spindle pole body localization,BP,NDC1
14875,GO:0070632,0.0718694343029875,1,1,1,establishment of spindle pole body localization,BP,NDC1
14886,GO:0070650,0.0718694343029875,1,1,1,actin filament bundle distribution,BP,SHTN1
14935,GO:0070762,0.0718694343029875,1,1,1,nuclear pore transmembrane ring,CC,NDC1
15474,GO:0071789,0.0718694343029875,1,1,1,spindle pole body localization to nuclear envelope,BP,NDC1
15475,GO:0071790,0.0718694343029875,1,1,1,establishment of spindle pole body localization to nuclear envelope,BP,NDC1
16682,GO:0097541,0.0718694343029875,1,1,1,axonemal basal plate,CC,WDPCP
17282,GO:0120048,0.0718694343029875,1,1,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,METTL16
17283,GO:0120049,0.0718694343029875,1,1,1,snRNA (adenine-N6)-methylation,BP,METTL16
19240,GO:1905319,0.0718694343029875,1,1,1,mesenchymal stem cell migration,BP,ACKR3
19241,GO:1905320,0.0718694343029875,1,1,1,regulation of mesenchymal stem cell migration,BP,ACKR3
19242,GO:1905322,0.0718694343029875,1,1,1,positive regulation of mesenchymal stem cell migration,BP,ACKR3
20107,GO:2000722,0.0718694343029875,1,1,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,GPER1
20108,GO:2000724,0.0718694343029875,1,1,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,GPER1
8144,GO:0032838,0.071871885140091,0.961220322657936,14,122,plasma membrane bounded cell projection cytoplasm,CC,NEFL;DYNC2H1;DNHD1;AP3M2;DST;HSPB1;BAIAP2;BLOC1S2;TRAK2;WDPCP;CENPF;BBS5;AKR1B1;AP3B1
3869,GO:0008489,0.0719098431372467,1,1,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,UGT8
11992,GO:0047263,0.0719098431372467,1,1,1,N-acylsphingosine galactosyltransferase activity,MF,UGT8
8518,GO:0033690,0.0720122526414888,0.99239811479233,2,6,positive regulation of osteoblast proliferation,BP,CYR61;ITGAV
12596,GO:0050731,0.0721404870496875,0.963158524362751,12,105,positive regulation of peptidyl-tyrosine phosphorylation,BP,NRG1;EPGN;TP53;IL6ST;SYK;IL24;PARP14;PDGFB;IL20;ADAM17;CCL5;CD74
4879,GO:0014739,0.0722271512075717,1,1,1,positive regulation of muscle hyperplasia,BP,MIR17HG
18335,GO:1903231,0.0722271512075717,1,1,1,mRNA binding involved in posttranscriptional gene silencing,MF,MIR17HG
6769,GO:0030199,0.0722406937969963,0.977300500445823,5,28,collagen fibril organization,BP,CYP1B1;COL5A3;TGFB2;COL12A1;COL5A2
6881,GO:0030368,0.072254871575733,0.992357716268552,2,6,interleukin-17 receptor activity,MF,IL27RA;IL6ST
1204,GO:0002861,0.0723109275891463,0.991667895715201,2,8,regulation of inflammatory response to antigenic stimulus,BP,C3;TNF
18467,GO:1903524,0.0723770345355587,0.976969023714826,5,32,positive regulation of blood circulation,BP,CTGF;EDN1;TGFB2;TPM1;ADM
3059,GO:0006622,0.0724799065532265,0.980932966419829,4,21,protein targeting to lysosome,BP,GNPTAB;CLU;HSPA8;AP3B1
8714,GO:0034346,0.0725368364934497,1,1,1,positive regulation of type III interferon production,BP,TLR3
1453,GO:0003682,0.0725482839325806,0.948501340865124,41,436,chromatin binding,MF,FOSL2;CBX5;TP53;SVEP1;EXO1;STAG1;RELB;BRIP1;MCM5;NUCKS1;POLQ;H3F3A;POLR1A;TAF2;POLA1;SETDB1;GRWD1;KDM6A;RAN;UBTF;SUPT16H;AJUBA;TRIM37;CDCA5;APTX;SRF;UTY;APEX1;ORC1;CENPF;GPER1;HMGN2;MSH6;CITED2;RBL1;CLOCK;ESR1;HNRNPU;RING1;SMARCC1;CTCF
16731,GO:0097696,0.0725957352862224,0.964143602485883,11,95,STAT cascade,BP,CYP1B1;STAT5A;IL6ST;IL7R;IL24;SOCS1;PARP14;IL20;IFNAR1;AKR1B1;CCL5
4431,GO:0010259,0.0726913227115169,0.980858423592454,4,21,multicellular organism aging,BP,TFCP2L1;TP53;EDN1;MSH6
6669,GO:0030021,0.0727178623144699,1,1,1,extracellular matrix structural constituent conferring compression resistance,MF,TUFT1
6875,GO:0030345,0.0727178623144699,1,1,1,structural constituent of tooth enamel,MF,TUFT1
8484,GO:0033623,0.0727185989175323,0.992280272015016,2,6,regulation of integrin activation,BP,PTGER4;KIF14
10967,GO:0044706,0.0727690013120047,0.959689497574784,15,136,multi-multicellular organism process,BP,COL16A1;MMP9;VMP1;CYP1A1;B4GALT1;TFCP2L1;EDN1;EMP2;ADM;WNT4;ARNTL;THBD;UMPS;AKR1B1;ESR1
10253,GO:0042976,0.0728032539832924,0.991868388840955,2,7,activation of Janus kinase activity,BP,SOCS1;CCL5
5057,GO:0015252,0.0728743622818741,1,1,1,proton channel activity,MF,SLC4A11
9137,GO:0035445,0.0728743622818741,1,1,1,borate transmembrane transport,BP,SLC4A11
11835,GO:0046713,0.0728743622818741,1,1,1,borate transport,BP,SLC4A11
11836,GO:0046715,0.0728743622818741,1,1,1,active borate transmembrane transporter activity,MF,SLC4A11
2781,GO:0006212,0.0729174504118167,1,1,1,uracil catabolic process,BP,DPYD
2783,GO:0006214,0.0729174504118167,1,1,1,thymidine catabolic process,BP,DPYD
5836,GO:0017113,0.0729174504118167,1,1,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,DPYD
6161,GO:0019483,0.0729174504118167,1,1,1,beta-alanine biosynthetic process,BP,DPYD
11588,GO:0046127,0.0729174504118167,1,1,1,pyrimidine deoxyribonucleoside catabolic process,BP,DPYD
4422,GO:0010224,0.072996087020302,0.985537301331191,3,14,response to UV-B,BP,TP53;MME;CDKN1A
1132,GO:0002718,0.073011840587433,0.973540485186325,6,43,regulation of cytokine production involved in immune response,BP,TGFB2;TRAF2;TLR3;TNF;CD74;IRAK3
978,GO:0002429,0.0730120706439737,0.954120635634299,23,234,immune response-activating cell surface receptor signaling pathway,BP,RUNX1;ACTG1;SPG21;GBP1;LGALS3;CYLD;SYK;RELB;MUC16;BTN2A1;BAIAP2;HSP90AB1;MYO10;PSME2;PSMB9;EIF2B5;CMTM3;RC3H1;PSMB10;EIF2B1;NRAS;MUC5B;MUC6
2862,GO:0006354,0.0730409849520981,0.961421306047326,13,121,DNA-templated transcription, elongation,BP,POLR1A;TAF2;THOC1;UBTF;SUPT16H;TAF1D;SETD2;POLR2F;NCBP1;POLR1E;HNRNPU;TAF1;GTF2H3
3868,GO:0008488,0.0731094064651566,1,1,1,gamma-glutamyl carboxylase activity,MF,GGCX
3813,GO:0008403,0.0731199814022111,1,1,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,CYP24A1
6873,GO:0030342,0.0731199814022111,1,1,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,CYP24A1
2128,GO:0004921,0.0732189506475278,1,1,1,interleukin-11 receptor activity,MF,IL6ST
6323,GO:0019970,0.0732189506475278,1,1,1,interleukin-11 binding,MF,IL6ST
9728,GO:0038154,0.0732189506475278,1,1,1,interleukin-11-mediated signaling pathway,BP,IL6ST
13262,GO:0051908,0.0732357199767794,1,1,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,EXO1
8808,GO:0034502,0.073396629238172,0.96678125950212,9,72,protein localization to chromosome,BP,DKC1;RPA1;CDCA5;GNL3L;SETD2;BRCA2;ATR;ESR1;CTCF
3850,GO:0008458,0.0734477011628545,1,1,1,carnitine O-octanoyltransferase activity,MF,CROT
5483,GO:0016414,0.0734477011628545,1,1,1,O-octanoyltransferase activity,MF,CROT
5484,GO:0016415,0.0734477011628545,1,1,1,octanoyltransferase activity,MF,CROT
4421,GO:0010216,0.0734615639526727,0.992155568559057,2,6,maintenance of DNA methylation,BP,HELLS;CTCF
14486,GO:0061845,0.0734641910309979,1,1,1,neuron projection branch point,CC,BAIAP2
14487,GO:0061846,0.0734641910309979,1,1,1,dendritic spine cytoplasm,CC,BAIAP2
13983,GO:0060669,0.0734712347427432,0.980478354385587,4,22,embryonic placenta morphogenesis,BP,CYR61;FGFR2;ADM;SETD2
19318,GO:1905521,0.0734979646235956,0.985241920300694,3,15,regulation of macrophage migration,BP,MTUS1;CSF1;CCL5
5643,GO:0016725,0.0735454458809777,0.992141441035808,2,6,oxidoreductase activity, acting on CH or CH2 groups,MF,RRM2;RRM1
9219,GO:0035598,0.0735627441209675,1,1,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,CDKAL1
14434,GO:0061712,0.0735627441209675,1,1,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,CDKAL1
4215,GO:0009372,0.073566836539622,1,1,1,quorum sensing,BP,SLC22A5
12441,GO:0048874,0.073566836539622,1,1,1,homeostasis of number of cells in a free-living population,BP,SLC22A5
13328,GO:0052097,0.073566836539622,1,1,1,interspecies quorum sensing,BP,SLC22A5
13329,GO:0052106,0.073566836539622,1,1,1,quorum sensing involved in interaction with host,BP,SLC22A5
14029,GO:0060730,0.073566836539622,1,1,1,regulation of intestinal epithelial structure maintenance,BP,SLC22A5
14030,GO:0060731,0.073566836539622,1,1,1,positive regulation of intestinal epithelial structure maintenance,BP,SLC22A5
14918,GO:0070715,0.073566836539622,1,1,1,sodium-dependent organic cation transport,BP,SLC22A5
8021,GO:0032648,0.0736478350733634,0.973336842120848,6,41,regulation of interferon-beta production,BP,TRAF3;RELB;DDX3X;POLR3B;TLR3;IRF1
3891,GO:0008523,0.07366270245064,1,1,1,sodium-dependent multivitamin transmembrane transporter activity,MF,SLC5A6
5253,GO:0015878,0.07366270245064,1,1,1,biotin transport,BP,SLC5A6
5260,GO:0015887,0.07366270245064,1,1,1,pantothenate transmembrane transport,BP,SLC5A6
12797,GO:0051053,0.0736850305096435,0.96116953516783,13,109,negative regulation of DNA metabolic process,BP,TP53;NBN;POLQ;THOC1;GNL3L;RIF1;BRCA2;GPER1;ATR;MSH6;MSH3;TIMELESS;HNRNPU
14652,GO:0070209,0.0738185748622343,1,1,1,ASTRA complex,CC,TELO2
18665,GO:1903939,0.0738185748622343,1,1,1,regulation of TORC2 signaling,BP,TELO2
18894,GO:1904515,0.0738185748622343,1,1,1,positive regulation of TORC2 signaling,BP,TELO2
6386,GO:0021571,0.073862861790531,1,1,1,rhombomere 5 development,BP,MAFB
6387,GO:0021572,0.073862861790531,1,1,1,rhombomere 6 development,BP,MAFB
9067,GO:0035283,0.073862861790531,1,1,1,central nervous system segmentation,BP,MAFB
9068,GO:0035284,0.073862861790531,1,1,1,brain segmentation,BP,MAFB
2978,GO:0006521,0.0739090642861043,0.972857556514704,6,51,regulation of cellular amino acid metabolic process,BP,NQO1;ODC1;PSME2;PSMB9;AZIN1;PSMB10
2146,GO:0004957,0.0740947911966825,1,1,1,prostaglandin E receptor activity,MF,PTGER4
15929,GO:0072682,0.0740947911966825,1,1,1,eosinophil extravasation,BP,PTGER4
19953,GO:2000417,0.0740947911966825,1,1,1,negative regulation of eosinophil migration,BP,PTGER4
19955,GO:2000419,0.0740947911966825,1,1,1,regulation of eosinophil extravasation,BP,PTGER4
19956,GO:2000420,0.0740947911966825,1,1,1,negative regulation of eosinophil extravasation,BP,PTGER4
18702,GO:1904021,0.0740987689339526,1,1,1,negative regulation of G-protein coupled receptor internalization,BP,UBQLN2
616,GO:0001782,0.0743001528099729,0.980182710970011,4,22,B cell homeostasis,BP,DOCK10;MIR17HG;RC3H1;CD74
1795,GO:0004421,0.0743836742469104,1,1,1,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS1
4281,GO:0009645,0.0743836742469104,1,1,1,response to low light intensity stimulus,BP,HMGCS1
4406,GO:0010142,0.0743836742469104,1,1,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,HMGCS1
11824,GO:0046690,0.0743836742469104,1,1,1,response to tellurium ion,BP,HMGCS1
18137,GO:1902767,0.0743836742469104,1,1,1,isoprenoid biosynthetic process via mevalonate,BP,HMGCS1
7905,GO:0032468,0.0744427229835729,1,1,1,Golgi calcium ion homeostasis,BP,ATP2C1
36,GO:0000075,0.0746406795272723,0.954089062945507,21,208,cell cycle checkpoint,BP,PML;MAP3K14;TP53;RAD1;NBN;BRIP1;PLK2;WDR76;THOC1;TOPBP1;ANAPC15;MDM4;BRCC3;E2F8;CENPF;CHEK1;ATR;RFWD3;TIMELESS;CLOCK;CDKN1A
11297,GO:0045590,0.0746743099920207,1,1,1,negative regulation of regulatory T cell differentiation,BP,IRF1
8896,GO:0034705,0.0746834875265104,0.976150588311747,5,30,potassium channel complex,CC,CNTNAP1;KCNS3;KCNQ5;ABCC9;CNTNAP2
9243,GO:0035625,0.0746978185683526,1,1,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,ADAM17
19813,GO:2000197,0.0747304028153878,0.99194082423511,2,6,regulation of ribonucleoprotein complex localization,BP,AKAP8L;SETD2
13466,GO:0052858,0.0747409050660398,1,1,1,peptidyl-lysine acetyltransferase activity,MF,NAA50
11110,GO:0045105,0.074780063651929,1,1,1,intermediate filament polymerization or depolymerization,BP,NEFL
18664,GO:1903937,0.074780063651929,1,1,1,response to acrylamide,BP,NEFL
19428,GO:1905906,0.0748200602716603,0.991510982203532,2,7,regulation of amyloid fibril formation,BP,CRYAB;CLU
17299,GO:0140009,0.0750502455752673,1,1,1,L-aspartate import across plasma membrane,BP,SLC1A3
12087,GO:0048020,0.0751201280213872,0.991153400030342,2,8,CCR chemokine receptor binding,MF,CCL20;CCL5
9540,GO:0036261,0.0752189346350092,1,1,1,7-methylguanosine cap hypermethylation,BP,TGS1
15128,GO:0071164,0.0752189346350092,1,1,1,RNA trimethylguanosine synthase activity,MF,TGS1
186,GO:0000403,0.0752622530847293,0.991850147436254,2,6,Y-form DNA binding,MF,RAD18;MSH3
8398,GO:0033301,0.0753093764277549,1,1,1,cell cycle comprising mitosis without cytokinesis,BP,E2F8
2315,GO:0005313,0.0753440442779186,0.991836167887606,2,6,L-glutamate transmembrane transporter activity,MF,SLC1A3;SLC25A22
5014,GO:0015172,0.0753440442779186,0.991836167887606,2,6,acidic amino acid transmembrane transporter activity,MF,SLC1A3;SLC25A22
13838,GO:0060412,0.0754090956099493,0.975925673641517,5,29,ventricular septum morphogenesis,BP,FGFR2;TGFB2;MIR17HG;FZD1;CITED2
3181,GO:0006805,0.0754324414166439,0.96746510462053,8,67,xenobiotic metabolic process,BP,CYP1B1;UGT1A6;STAT5A;CYP1A1;NQO1;AHR;HSP90AB1;UGT1A4
7553,GO:0031849,0.0754553074826351,1,1,1,olfactory receptor binding,MF,REEP1
5506,GO:0016446,0.0754620967434773,0.984839001987325,3,14,somatic hypermutation of immunoglobulin genes,BP,EXO1;POLQ;MSH6
6611,GO:0022804,0.0755905634110852,0.953473555919173,21,201,active transmembrane transporter activity,MF,SLC16A2;TAP1;SLC16A9;SLC7A5P2;SLC4A11;SLC22A5;ABCG2;ATP2B1;SLC5A6;ABCC4;SLC1A3;SLCO4C1;ATP2C1;TIMM23B;ABCC9;SLC11A2;ABCA5;SLC9A9;TAP2;ABCA11P;SLC25A22
9812,GO:0040030,0.0755939797129639,1,1,1,regulation of molecular function, epigenetic,BP,CTCF
10299,GO:0043035,0.0755939797129639,1,1,1,chromatin insulator sequence binding,MF,CTCF
16809,GO:0098625,0.0756297549212883,1,1,1,methylselenol reductase activity,MF,TXNRD1
16810,GO:0098626,0.0756297549212883,1,1,1,methylseleninic acid reductase activity,MF,TXNRD1
13544,GO:0055095,0.0757533972638902,1,1,1,lipoprotein particle mediated signaling,BP,CDH13
13545,GO:0055096,0.0757533972638902,1,1,1,low-density lipoprotein particle mediated signaling,BP,CDH13
9327,GO:0035790,0.0758014470111077,1,1,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,PHF14
20022,GO:2000583,0.0758014470111077,1,1,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,PHF14
20023,GO:2000584,0.0758014470111077,1,1,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,PHF14
4443,GO:0010332,0.0758197790812585,0.969702852107052,7,50,response to gamma radiation,BP,CRYAB;PML;TP53;BRCA2;FANCD2;ATR;CDKN1A
7586,GO:0031945,0.076035394675363,1,1,1,positive regulation of glucocorticoid metabolic process,BP,WNT4
7589,GO:0031948,0.076035394675363,1,1,1,positive regulation of glucocorticoid biosynthetic process,BP,WNT4
7802,GO:0032346,0.076035394675363,1,1,1,positive regulation of aldosterone metabolic process,BP,WNT4
7805,GO:0032349,0.076035394675363,1,1,1,positive regulation of aldosterone biosynthetic process,BP,WNT4
14044,GO:0060748,0.076035394675363,1,1,1,tertiary branching involved in mammary gland duct morphogenesis,BP,WNT4
14192,GO:0061054,0.076035394675363,1,1,1,dermatome development,BP,WNT4
14248,GO:0061183,0.076035394675363,1,1,1,regulation of dermatome development,BP,WNT4
14249,GO:0061184,0.076035394675363,1,1,1,positive regulation of dermatome development,BP,WNT4
14258,GO:0061205,0.076035394675363,1,1,1,paramesonephric duct development,BP,WNT4
14306,GO:0061369,0.076035394675363,1,1,1,negative regulation of testicular blood vessel morphogenesis,BP,WNT4
19728,GO:2000019,0.076035394675363,1,1,1,negative regulation of male gonad development,BP,WNT4
19752,GO:2000066,0.076035394675363,1,1,1,positive regulation of cortisol biosynthetic process,BP,WNT4
19823,GO:2000224,0.076035394675363,1,1,1,regulation of testosterone biosynthetic process,BP,WNT4
19824,GO:2000225,0.076035394675363,1,1,1,negative regulation of testosterone biosynthetic process,BP,WNT4
12248,GO:0048490,0.0760629537586376,0.984505964196807,3,15,anterograde synaptic vesicle transport,BP,AP3M2;BLOC1S2;AP3B1
17060,GO:0099514,0.0760629537586376,0.984505964196807,3,15,synaptic vesicle cytoskeletal transport,BP,AP3M2;BLOC1S2;AP3B1
17063,GO:0099517,0.0760629537586376,0.984505964196807,3,15,synaptic vesicle transport along microtubule,BP,AP3M2;BLOC1S2;AP3B1
8448,GO:0033560,0.0760964102005361,1,1,1,folate reductase activity,MF,DHFR
13234,GO:0051870,0.0760964102005361,1,1,1,methotrexate binding,MF,DHFR
11129,GO:0045137,0.0761585251209034,0.956627690542449,16,148,development of primary sexual characteristics,BP,HMGCS1;TGFB2;INHBA;ZFP42;BRIP1;SFRP1;IMMP2L;WNT4;LFNG;SRD5A1;BRCA2;RRM1;EIF2B5;CITED2;TLR3;ESR1
12437,GO:0048870,0.0762710788543389,0.939805363961233,84,956,cell motility,BP,IGFBP3;SAA1;NRG1;HDAC9;FN1;TNS3;PML;CYP1B1;AMOT;MTUS1;KRT2;CYR61;STAT5A;STARD13;S100P;CTGF;MMP9;B4GALT1;TP53;DAPK3;EDN1;DOCK10;LGALS3;PDPN;TGFB2;IL16;SLC9A3R1;SYK;EMP2;SFRP1;CD274;DST;TPM1;ULK4;ADAMTS9;PTGER4;OPHN1;CCL20;PLK2;NEXN;FRK;HSPB1;RHOG;WNT4;CXCL16;LCP1;PTPRM;SIRPA;SOD2;CORO1C;IL24;ITGAV;AJUBA;CDH13;PHACTR4;SRF;PDGFB;ACKR3;SETD2;ANLN;THBD;GLIPR2;APEX1;CXCR5;SGK1;CCAR1;WDPCP;L1CAM;GPER1;ADAM17;NTN1;CBLL1;SHTN1;DPYSL3;CITED2;CSF1;KIF14;TNF;NEDD9;CCL5;CD74;FGFR1OP;NRAS;ITGB1BP1
13147,GO:0051674,0.0762710788543389,0.939805363961233,84,956,localization of cell,BP,IGFBP3;SAA1;NRG1;HDAC9;FN1;TNS3;PML;CYP1B1;AMOT;MTUS1;KRT2;CYR61;STAT5A;STARD13;S100P;CTGF;MMP9;B4GALT1;TP53;DAPK3;EDN1;DOCK10;LGALS3;PDPN;TGFB2;IL16;SLC9A3R1;SYK;EMP2;SFRP1;CD274;DST;TPM1;ULK4;ADAMTS9;PTGER4;OPHN1;CCL20;PLK2;NEXN;FRK;HSPB1;RHOG;WNT4;CXCL16;LCP1;PTPRM;SIRPA;SOD2;CORO1C;IL24;ITGAV;AJUBA;CDH13;PHACTR4;SRF;PDGFB;ACKR3;SETD2;ANLN;THBD;GLIPR2;APEX1;CXCR5;SGK1;CCAR1;WDPCP;L1CAM;GPER1;ADAM17;NTN1;CBLL1;SHTN1;DPYSL3;CITED2;CSF1;KIF14;TNF;NEDD9;CCL5;CD74;FGFR1OP;NRAS;ITGB1BP1
1858,GO:0004518,0.0764341677765363,0.954811828384321,18,177,nuclease activity,MF,EXO1;RAD1;POP1;POLQ;TSN;G3BP1;EXOG;FEN1;APTX;USB1;ISG20L2;ENPP1;LRPPRC;APEX1;DGCR8;RAD51B;DNASE1;TREX1
15902,GO:0072616,0.0764406175795573,1,1,1,interleukin-18 secretion,BP,GBP5
2860,GO:0006352,0.0764674305065425,0.953387146384049,20,207,DNA-templated transcription, initiation,BP,CTGF;TP53;CDK4;POLR1A;TAF2;UBTF;RRN3;TAF1D;SRF;MAZ;POLR2F;TAF6L;POLR1E;GTF3C4;ESR1;HIST1H4A;TAF1;TBPL1;CDKN1A;GTF2H3
3623,GO:0008080,0.0765140264470895,0.965084121796012,9,72,N-acetyltransferase activity,MF,NAA15;NAA50;KANSL1L;BRCA2;TAF6L;GTF3C4;NAA16;CLOCK;TAF1
18135,GO:1902751,0.0765320018687995,0.979281264211352,4,23,positive regulation of cell cycle G2/M phase transition,BP,PBX1;CDK4;CDC25A;RAD51B
1012,GO:0002488,0.0765516719603444,1,1,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,TAP2
1013,GO:0002489,0.0765516719603444,1,1,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,TAP2
11940,GO:0046968,0.0765516719603444,1,1,1,peptide antigen transport,BP,TAP2
11950,GO:0046980,0.0765516719603444,1,1,1,tapasin binding,MF,TAP2
9266,GO:0035666,0.076846448625938,0.97907619306266,4,24,TRIF-dependent toll-like receptor signaling pathway,BP,TRAF3;IKBKE;BIRC3;TLR3
9222,GO:0035602,0.0768496673198776,1,1,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,FGFR2
9223,GO:0035603,0.0768496673198776,1,1,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,FGFR2
9224,GO:0035604,0.0768496673198776,1,1,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,FGFR2
13952,GO:0060595,0.0768496673198776,1,1,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,FGFR2
13965,GO:0060615,0.0768496673198776,1,1,1,mammary gland bud formation,BP,FGFR2
13975,GO:0060648,0.0768496673198776,1,1,1,mammary gland bud morphogenesis,BP,FGFR2
13981,GO:0060667,0.0768496673198776,1,1,1,branch elongation involved in salivary gland morphogenesis,BP,FGFR2
14110,GO:0060915,0.0768496673198776,1,1,1,mesenchymal cell differentiation involved in lung development,BP,FGFR2
7773,GO:0032288,0.0770133485582837,0.979440044569757,4,20,myelin assembly,BP,CNTNAP1;UGT8;MTMR2;MPP5
3715,GO:0008235,0.0770820350899573,0.975085062143676,5,31,metalloexopeptidase activity,MF,C9ORF3;CPA4;ERAP1;DNPEP;METAP2
4975,GO:0015086,0.0771762207165169,1,1,1,cadmium ion transmembrane transporter activity,MF,SLC11A2
4976,GO:0015087,0.0771762207165169,1,1,1,cobalt ion transmembrane transporter activity,MF,SLC11A2
4979,GO:0015094,0.0771762207165169,1,1,1,lead ion transmembrane transporter activity,MF,SLC11A2
5156,GO:0015692,0.0771762207165169,1,1,1,lead ion transport,BP,SLC11A2
14872,GO:0070627,0.0771762207165169,1,1,1,ferrous iron import,BP,SLC11A2
14956,GO:0070826,0.0771762207165169,1,1,1,paraferritin complex,CC,SLC11A2
3039,GO:0006591,0.0772950836014552,0.991064350602795,2,7,ornithine metabolic process,BP,ODC1;AZIN1
10114,GO:0042622,0.0773517628080698,0.991490121051987,2,6,photoreceptor outer segment membrane,CC,PHLPP2;PHLPP1
15467,GO:0071765,0.0773711610431577,1,1,1,nuclear inner membrane organization,BP,TARDBP
16623,GO:0097435,0.0773728089356767,0.94392754702715,45,470,supramolecular fiber organization,BP,CRYAB;NEFL;MAP2;CYP1B1;KRT2;COL5A3;CTGF;MYO1B;ACTG1;NEFM;MID1;EDN1;COBLL1;CHP1;TGFB2;COL12A1;PALM2;EMP2;SFRP1;KRT9;TPM1;PTGER4;SYNPO2L;KANK4;RHOG;WNT4;LCP1;CGNL1;CDC42EP2;BAIAP2;COL5A2;SRF;CLU;TPM4;HSPA8;HSP90AB1;MYH11;CFLAR;SHTN1;DPYSL3;MFAP5;SYNPO2;NEDD9;PPARGC1B;ITGB1BP1
537,GO:0001655,0.0773786020773331,0.951152132782464,23,215,urogenital system development,BP,FGFR2;FBN1;FAT4;PBX1;TGFB2;IRX2;SFRP1;COL4A1;MME;WNT4;ODC1;NPNT;PDGFB;FRAS1;SRD5A1;GLIS2;TNC;WDPCP;CENPF;CFLAR;AKR1B1;ESR1;SMARCC1
1099,GO:0002685,0.0775065729709181,0.961189334369373,11,101,regulation of leukocyte migration,BP,MTUS1;TP53;EDN1;LGALS3;PTGER4;CCL20;ADAM17;CSF1;TNF;CCL5;CD74
121,GO:0000250,0.0775572236748762,1,1,1,lanosterol synthase activity,MF,LSS
7444,GO:0031559,0.0775572236748762,1,1,1,oxidosqualene cyclase activity,MF,LSS
9672,GO:0038021,0.077577524777997,1,1,1,leptin receptor activity,MF,LEPR
5956,GO:0018315,0.0776001100486722,1,1,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,GPHN
9834,GO:0042040,0.0776001100486722,1,1,1,metal incorporation into metallo-molybdopterin complex,BP,GPHN
14383,GO:0061598,0.0776001100486722,1,1,1,molybdopterin adenylyltransferase activity,MF,GPHN
14384,GO:0061599,0.0776001100486722,1,1,1,molybdopterin molybdotransferase activity,MF,GPHN
15879,GO:0072579,0.0776001100486722,1,1,1,glycine receptor clustering,BP,GPHN
16469,GO:0097112,0.0776001100486722,1,1,1,gamma-aminobutyric acid receptor clustering,BP,GPHN
9169,GO:0035516,0.0777225842887711,1,1,1,oxidative DNA demethylase activity,MF,FTO
14726,GO:0070343,0.0777225842887711,1,1,1,white fat cell proliferation,BP,FTO
14730,GO:0070350,0.0777225842887711,1,1,1,regulation of white fat cell proliferation,BP,FTO
19701,GO:1990931,0.0777225842887711,1,1,1,RNA N6-methyladenosine dioxygenase activity,MF,FTO
11094,GO:0045080,0.0777796130347948,0.990975886136794,2,7,positive regulation of chemokine biosynthetic process,BP,TLR3;TNF
20313,GO:2001247,0.0778275891640526,1,1,1,positive regulation of phosphatidylcholine biosynthetic process,BP,ACSL3
1374,GO:0003257,0.0778321685078421,1,1,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,SRF
4620,GO:0010736,0.0778321685078421,1,1,1,serum response element binding,MF,SRF
17613,GO:1901228,0.0778321685078421,1,1,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,SRF
11749,GO:0046545,0.0778573410887639,0.96437157269815,9,71,development of primary female sexual characteristics,BP,INHBA;ZFP42;SFRP1;IMMP2L;WNT4;LFNG;BRCA2;EIF2B5;ESR1
12665,GO:0050850,0.0778722469975505,0.978793275839494,4,23,positive regulation of calcium-mediated signaling,BP,NRG1;JPH2;SYK;CDH13
5400,GO:0016234,0.0778807546282557,0.964433848413355,9,68,inclusion body,CC,NEFM;NUP153;NBN;RANBP2;TRIM37;CLU;URB2;HSP90AB1;RAD18
8249,GO:0033013,0.0779220759578927,0.971241918801112,6,44,tetrapyrrole metabolic process,BP,CYP1A1;IBA57;NFE2L1;SLC11A2;MMAA;UGT1A4
16739,GO:0097718,0.0779474391871973,0.974795242374861,5,30,disordered domain specific binding,MF,FN1;TP53;KEAP1;HSP90AB1;RRM1
12182,GO:0048285,0.0779600493670241,0.946220915016453,34,355,organelle fission,BP,KIF23;EPGN;DAPK3;EDN1;STAG1;AKAP8;PKMYT1;RAD1;NAIP;BRIP1;NDC1;AKAP8L;MYBL2;WNT4;RAN;RANBP2;ANAPC15;SMC2;CDCA5;GDAP1;PDGFB;NAA50;BIRC3;ANLN;MYBL1;BRCA2;FANCD2;CENPF;CHEK1;PSMC3IP;MSH3;KIF14;RAD51B;HNRNPU
3477,GO:0007339,0.0780623783276024,0.983780120787907,3,16,binding of sperm to zona pellucida,BP,B4GALT1;GLIPR1L2;UBAP2L
11502,GO:0045948,0.0780717726534463,0.9787203600448,4,23,positive regulation of translational initiation,BP,DDX3X;EIF2B5;TNF;CCL5
15981,GO:0075733,0.0780869640998636,0.968508311614747,7,52,intracellular transport of virus,BP,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
1133,GO:0002719,0.0781487919946874,0.983899194068406,3,15,negative regulation of cytokine production involved in immune response,BP,TGFB2;TNF;IRAK3
10806,GO:0044271,0.0781714776672025,0.932158715692321,300,3945,cellular nitrogen compound biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;SLC7A2;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;TP53;DAPK3;PANK2;EXO1;EDN1;ABCF1;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL16;SRSF2;FOXD2;DKC1;INHBA;NUP50;PUM3;PHAX;SYK;NUP153;ZFP42;RELB;NBN;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;UAP1L1;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;ZNF584;TRAF1;ADM;USP43;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;ZNF512;MRPL27;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;AJUBA;FASTKD3;DND1;ZNF267;PGK1;TRIM37;GNL3L;ZNF586;NVL;GATC;CDH13;IBA57;RARS;COMMD4;SRF;MDM4;HIF1AN;NPNT;QDPR;ZNF234;WDR43;PDGFB;UGT8;EIF3J;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;VGLL3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;ZNF484;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;SYNCRIP;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;WDR75;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;AZIN1;ESR1;RAD51B;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3
19243,GO:1905323,0.0783780761728606,0.991311088320571,2,6,telomerase holoenzyme complex assembly,BP,HSP90AB1;ATR
10857,GO:0044343,0.0785126838143155,1,1,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,SFRP1
10859,GO:0044345,0.0785126838143155,1,1,1,stromal-epithelial cell signaling involved in prostate gland development,BP,SFRP1
16229,GO:0090246,0.0785126838143155,1,1,1,convergent extension involved in somitogenesis,BP,SFRP1
19734,GO:2000040,0.0785126838143155,1,1,1,regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19735,GO:2000041,0.0785126838143155,1,1,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19745,GO:2000054,0.0785126838143155,1,1,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
19757,GO:2000079,0.0785126838143155,1,1,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
19758,GO:2000080,0.0785126838143155,1,1,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
16512,GO:0097190,0.078548045849762,0.943814640750139,41,469,apoptotic signaling pathway,BP,PML;CYP1B1;GCLC;MMP9;TP53;DAPK3;DDX47;LGALS3;TGFB2;CYLD;IKBKE;SLC9A3R1;INHBA;NBN;SFRP1;TRAF1;DYNLL2;HSPB1;WNT4;SOD2;DDX3X;RRN3;ITGAV;CLU;EYA3;ACKR3;BLOC1S2;ARL6IP5;BRCA2;GPER1;FAF1;SENP1;MSH6;CFLAR;TRAF2;TLR3;TNF;CD74;DAXX;CDKN1A;IFI27L1
5474,GO:0016404,0.0785530042854327,1,1,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,ABCC4
3763,GO:0008307,0.0786009241654726,0.975102621368157,5,24,structural constituent of muscle,MF,TPM1;NEXN;TPM4;JPH1;MYH11
9354,GO:0035853,0.0786076730086465,1,1,1,chromosome passenger complex localization to spindle midzone,BP,KLHL21
15855,GO:0072542,0.0788019548621235,0.990788129270215,2,7,protein phosphatase activator activity,MF,IGFBP3;PHACTR4
18409,GO:1903391,0.0788706708883661,0.968315895855412,7,47,regulation of adherens junction organization,BP,COL16A1;DAPK3;SFRP1;WNT4;CORO1C;WDPCP;ITGB1BP1
442,GO:0001190,0.0788815508281632,0.968310498971204,7,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,MKL1;KDM6A;ARNTL;UTY;NFE2L1;CITED2;CLOCK
13724,GO:0060260,0.0789228207596377,0.978408572757685,4,23,regulation of transcription initiation from RNA polymerase II promoter,BP,TP53;SRF;ESR1;TAF1
6322,GO:0019966,0.0789628929547549,0.990758436725725,2,7,interleukin-1 binding,MF,TRIM16;IL1R2
4596,GO:0010705,0.0790545876739994,1,1,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,BRIP1
437,GO:0001165,0.0790934192249602,1,1,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,UBTF
2606,GO:0005903,0.0791005160324094,0.965756582095152,8,59,brush border,CC,MYO1B;B4GALT1;SLC9A3R1;SLC22A5;SLC5A6;MME;SLC11A2;HSP90AB1
20106,GO:2000721,0.0791128573023794,1,1,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,NPNT
13108,GO:0051598,0.0791736964167788,1,1,1,meiotic recombination checkpoint,BP,RAD1
6951,GO:0030554,0.0792271403491709,0.935931755995483,104,1180,adenyl nucleotide binding,MF,KIF23;MAP3K14;GCLC;NLRC5;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;BAG1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;TRIO;BRIP1;MCM5;ABCG2;CDK4;RIPK4;MCM2;POLQ;ATP2B1;HELLS;ULK4;ABCC4;TK1;G3BP1;MDN1;PLK2;FRK;DDX28;ORC4;ATP2C1;DDX3X;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;NVL;GATC;RARS;MCM8;SGK494;ENPP1;CBWD5;DDX10;DDX24;MCM6;ABCC9;TTF2;SEPHS2;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;PPIP5K1;CHEK1;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;HNRNPU;FLAD1;TAF1;ABCA11P;IRAK3;DHX15
798,GO:0002064,0.0792790012839475,0.954642349030296,16,143,epithelial cell development,BP,KRT2;FOSL2;B4GALT1;TFCP2L1;SIPA1L3;SLC9A3R1;TJP2;ARNTL;PDGFB;TJP1;WDPCP;CLOCK;ESR1;TNF;TYMS;CDKN1A
1561,GO:0003957,0.0795392044120986,1,1,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,NNT
3965,GO:0008746,0.0795392044120986,1,1,1,NAD(P)+ transhydrogenase activity,MF,NNT
3967,GO:0008750,0.0795392044120986,1,1,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,NNT
5612,GO:0016652,0.0795392044120986,1,1,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,NNT
1385,GO:0003281,0.0795906527257015,0.967958338390259,7,47,ventricular septum development,BP,CYR61;FGFR2;TGFB2;MIR17HG;FZD1;CITED2;DCTN5
16777,GO:0098542,0.0796064939705811,0.948888781294345,24,262,defense response to other organism,BP,PML;MAP3K14;NLRC5;TRIM22;DDX17;TRIM56;TRAF3;GBP1;IL27RA;IFIT3;SYK;FAM111A;ARRDC1-AS1;CCL20;BIRC3;SETD2;ABCC9;SYT11;ADAM17;POLR3B;TLR3;TNF;IRF1;GBP6
9899,GO:0042168,0.0796092449743341,0.977974582880771,4,25,heme metabolic process,BP,IBA57;NFE2L1;SLC11A2;UGT1A4
5291,GO:0015949,0.0796206726999087,0.977817634240533,4,27,nucleobase-containing small molecule interconversion,BP,TXNRD1;RRM2;RRM1;TYMS
3742,GO:0008281,0.0796678949225098,1,1,1,sulfonylurea receptor activity,MF,ABCC9
2458,GO:0005669,0.0796880862899882,0.973739749897475,5,35,transcription factor TFIID complex,CC,TP53;TAF2;TAF6L;TAF1;GTF2H3
3330,GO:0007042,0.0797244632183488,0.990284845645476,2,8,lysosomal lumen acidification,BP,CLN6;TMEM199
17662,GO:1901362,0.0798141681394254,0.93094027500066,273,3521,organic cyclic compound biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;PANK2;EXO1;EDN1;SCD;HMGCS1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;DKC1;INHBA;NUP50;PHAX;SYK;NUP153;ZFP42;RELB;NBN;PARP15;BRIP1;LSS;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;UAP1L1;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;ZNF584;TRAF1;ADM;USP43;ZNF407;ELMSAN1;NDC1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;GPHN;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;PGK1;TRIM37;GNL3L;ZNF586;NVL;CDH13;IBA57;COMMD4;SRF;MDM4;HIF1AN;NPNT;QDPR;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SRD5A1;SETD2;GLIS2;UBP1;TTF2;ZNF484;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;WDR75;SENP1;ATR;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;EBP;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;RAD51B;ARV1;TNF;ZFP36L2;SRSF7;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;FLAD1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
6924,GO:0030511,0.0799915614720785,0.978120225356581,4,22,positive regulation of transforming growth factor beta receptor signaling pathway,BP,NPNT;HSP90AB1;ADAM17;CITED2
18617,GO:1903846,0.0799915614720785,0.978120225356581,4,22,positive regulation of cellular response to transforming growth factor beta stimulus,BP,NPNT;HSP90AB1;ADAM17;CITED2
18751,GO:1904170,0.0800874247030522,1,1,1,regulation of bleb assembly,BP,ANLN
18752,GO:1904172,0.0800874247030522,1,1,1,positive regulation of bleb assembly,BP,ANLN
15396,GO:0071622,0.0801724026922862,0.977685129520177,4,26,regulation of granulocyte chemotaxis,BP,EDN1;CSF1;CCL5;CD74
2112,GO:0004888,0.0801953147909338,0.945546101985107,31,321,transmembrane signaling receptor activity,MF,GPRC5A;FGFR2;IL1R2;IFNGR1;IL27RA;IL6ST;IL7R;GPR132;LEPR;SFRP1;HLA-DOB;PTPRB;PTGER4;PTPRM;FZD1;ANTXR1;ACKR3;THBD;ABCC9;IFNAR1;CXCR5;EPHB6;M6PR;HCAR1;IL12RB2;GPER1;LILRB3;EBP;TPRA1;TLR3;CD74
9881,GO:0042133,0.080365337632067,0.961179253480049,10,83,neurotransmitter metabolic process,BP,CYP1B1;SLC7A2;EDN1;NQO1;SLC1A3;CLU;SRD5A1;HSP90AB1;DPYD;TNF
17749,GO:1901654,0.0803977708915162,0.955818433950012,14,127,response to ketone,BP,NEFL;EDN1;AKAP8;TGFB2;CDK4;SFRP1;ATP2B1;AHR;PTGER4;SRD5A1;CFLAR;AKR1B1;TYMS;CDKN1A
4639,GO:0010759,0.0804052368928904,0.990490686591623,2,7,positive regulation of macrophage chemotaxis,BP,CSF1;CCL5
9161,GO:0035507,0.0804188957012398,0.990950807296075,2,6,regulation of myosin-light-chain-phosphatase activity,BP,NUAK1;TNF
15640,GO:0072110,0.0804288990295542,0.990486269468247,2,7,glomerular mesangial cell proliferation,BP,PDGFB;CFLAR
15644,GO:0072124,0.0804288990295542,0.990486269468247,2,7,regulation of glomerular mesangial cell proliferation,BP,PDGFB;CFLAR
10057,GO:0042509,0.0804968748687765,0.969998885470632,6,45,regulation of tyrosine phosphorylation of STAT protein,BP,IL6ST;IL24;SOCS1;PARP14;IL20;CCL5
10583,GO:0043536,0.0805171856431999,0.970170887844468,6,41,positive regulation of blood vessel endothelial cell migration,BP,HDAC9;STAT5A;PLK2;HSPB1;PDGFB;ADAM17
105,GO:0000217,0.0806462643338424,0.977773350643405,4,23,DNA secondary structure binding,MF,RAD18;MSH6;MSH3;RAD51B
14410,GO:0061646,0.0808906741666082,1,1,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,RAB3GAP1
6452,GO:0021766,0.0809538011273997,0.967151535536252,7,50,hippocampus development,BP,NEFL;RAN;SRF;SRD5A1;EIF2B5;KIF14;PHLPP2
11859,GO:0046822,0.081042853457149,0.959243255859303,11,92,regulation of nucleocytoplasmic transport,BP,TP53;RBM4;PTPN14;CHP1;RBM22;NUP153;AKAP8L;NUP54;SETD2;HSP90AB1;CDKN1A
18128,GO:1902742,0.0810618467295312,0.977726114169112,4,22,apoptotic process involved in development,BP,CRYAB;CYR61;B4GALT1;TGFB2
1007,GO:0002478,0.0811687647887963,0.955188272074571,14,141,antigen processing and presentation of exogenous peptide antigen,BP,KIF23;HLA-B;TAP1;HLA-F;HLA-DOB;DYNLL2;ITGAV;PSME2;PSMB9;TAP2;IFI30;CD74;PSMB10;DCTN5
11291,GO:0045582,0.0811973779451683,0.969756832600097,6,43,positive regulation of T cell differentiation,BP,CYLD;IL7R;SYK;SOCS1;AP3B1;CD74
882,GO:0002238,0.0813528467144983,1,1,1,response to molecule of fungal origin,BP,SYK
943,GO:0002351,0.0813528467144983,1,1,1,serotonin production involved in inflammatory response,BP,SYK
988,GO:0002442,0.0813528467144983,1,1,1,serotonin secretion involved in inflammatory response,BP,SYK
1043,GO:0002554,0.0813528467144983,1,1,1,serotonin secretion by platelet,BP,SYK
6249,GO:0019814,0.0813528467144983,1,1,1,immunoglobulin complex,CC,SYK
6250,GO:0019815,0.0813528467144983,1,1,1,B cell receptor complex,CC,SYK
8079,GO:0032752,0.0813528467144983,1,1,1,positive regulation of interleukin-3 production,BP,SYK
9914,GO:0042223,0.0813528467144983,1,1,1,interleukin-3 biosynthetic process,BP,SYK
11244,GO:0045399,0.0813528467144983,1,1,1,regulation of interleukin-3 biosynthetic process,BP,SYK
11245,GO:0045401,0.0813528467144983,1,1,1,positive regulation of interleukin-3 biosynthetic process,BP,SYK
11255,GO:0045423,0.0813528467144983,1,1,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,SYK
11256,GO:0045425,0.0813528467144983,1,1,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,SYK
15152,GO:0071226,0.0813528467144983,1,1,1,cellular response to molecule of fungal origin,BP,SYK
3511,GO:0007423,0.0813655576071004,0.94470652849415,31,311,sensory organ development,BP,CRYAB;MAFB;KRT13;TENM3;CYP1B1;FGFR2;FBN1;CYP1A1;FAT4;EDN1;SIPA1L3;MEGF11;TGFB2;SLC9A3R1;INHBA;CDK4;WNT10A;MCM2;ATP2B1;COL4A1;PTPRM;COL5A2;PHACTR4;SRF;SDK1;WDPCP;RAB3GAP1;RRM1;NTN1;CCNA2;RING1
19358,GO:1905634,0.0813759354828495,0.990779903095307,2,6,regulation of protein localization to chromatin,BP,CDCA5;SETD2
13524,GO:0055072,0.0814603794979381,0.964333915228753,8,65,iron ion homeostasis,BP,FTL;FTH1;TFRC;ACO1;ABCG2;SLC11A2;TMEM199;STEAP4
1489,GO:0003823,0.0816299292501818,0.977310628642659,4,24,antigen binding,MF,HLA-B;TAP1;IL7R;HLA-F
7966,GO:0032559,0.0816947521245675,0.933892481379218,103,1168,adenyl ribonucleotide binding,MF,KIF23;MAP3K14;GCLC;NLRC5;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;TRIO;BRIP1;MCM5;ABCG2;CDK4;RIPK4;MCM2;POLQ;ATP2B1;HELLS;ULK4;ABCC4;TK1;G3BP1;MDN1;PLK2;FRK;DDX28;ORC4;ATP2C1;DDX3X;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;NVL;GATC;RARS;MCM8;SGK494;ENPP1;CBWD5;DDX10;DDX24;MCM6;ABCC9;TTF2;SEPHS2;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;PPIP5K1;CHEK1;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;HNRNPU;FLAD1;TAF1;ABCA11P;IRAK3;DHX15
9859,GO:0042095,0.0817064165279218,0.990246614360231,2,7,interferon-gamma biosynthetic process,BP,INHBA;TLR3
14269,GO:0061299,0.0817130053047647,0.990719415030205,2,6,retina vasculature morphogenesis in camera-type eye,BP,CYP1B1;COL4A1
19899,GO:2000343,0.0817465112000175,0.989893597730882,2,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,TNF;CD74
6672,GO:0030029,0.0817774791173405,0.939663981304274,49,516,actin filament-based process,BP,KIF23;AMOT;CTGF;MYO1B;ACTG1;DAPK3;EDN1;COBLL1;PDPN;SLC9A3R1;PALM2;EMP2;SFRP1;TPM1;PTGER4;OPHN1;SYNPO2L;KANK4;RHOG;WNT4;LCP1;RAN;CORO1C;ATP2C1;TRPM7;CGNL1;CDC42EP2;BAIAP2;PHACTR4;SRF;ANTXR1;RTKN2;SDAD1;TPM4;FGD6;ANLN;MYH11;NEDD4L;LIMCH1;CFLAR;SHTN1;DPYSL3;SYNPO2;GJC1;TNF;NEDD9;PPARGC1B;ITGB1BP1;DIAPH3
622,GO:0001794,0.0818823207060846,1,1,1,type IIa hypersensitivity,BP,C3
623,GO:0001796,0.0818823207060846,1,1,1,regulation of type IIa hypersensitivity,BP,C3
624,GO:0001798,0.0818823207060846,1,1,1,positive regulation of type IIa hypersensitivity,BP,C3
742,GO:0001970,0.0818823207060846,1,1,1,positive regulation of activation of membrane attack complex,BP,C3
991,GO:0002445,0.0818823207060846,1,1,1,type II hypersensitivity,BP,C3
1225,GO:0002892,0.0818823207060846,1,1,1,regulation of type II hypersensitivity,BP,C3
1226,GO:0002894,0.0818823207060846,1,1,1,positive regulation of type II hypersensitivity,BP,C3
7527,GO:0031714,0.0818823207060846,1,1,1,C5a anaphylatoxin chemotactic receptor binding,MF,C3
7528,GO:0031715,0.0818823207060846,1,1,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,C3
1241,GO:0002930,0.0819609990744262,1,1,1,trabecular meshwork development,BP,CYP1B1
2397,GO:0005539,0.0820334293864497,0.957201431578897,12,105,glycosaminoglycan binding,MF,SAA1;FN1;CYR61;FGFR2;COL5A3;CTGF;FBN1;CCDC80;SFRP1;LAYN;NAV2;DPYSL3
2166,GO:0004998,0.0820424080180322,1,1,1,transferrin receptor activity,MF,TFRC
4977,GO:0015091,0.0820424080180322,1,1,1,ferric iron transmembrane transporter activity,MF,TFRC
8454,GO:0033570,0.0820424080180322,1,1,1,transferrin transmembrane transporter activity,MF,TFRC
15830,GO:0072510,0.0820424080180322,1,1,1,trivalent inorganic cation transmembrane transporter activity,MF,TFRC
11894,GO:0046886,0.0821458917381192,0.990163638988454,2,7,positive regulation of hormone biosynthetic process,BP,WNT4;TNF
11381,GO:0045726,0.0822055428547423,1,1,1,positive regulation of integrin biosynthetic process,BP,TGFB2
13247,GO:0051891,0.0822055428547423,1,1,1,positive regulation of cardioblast differentiation,BP,TGFB2
18548,GO:1903701,0.0822055428547423,1,1,1,substantia propria of cornea development,BP,TGFB2
3662,GO:0008150,0.0823296645459395,0.937837905555517,816,11232,biological_process,BP,IL32;CRYAB;IGFBP3;HEPHL1;MAFB;SPRR3;KRT1;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;C1R;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;SLC16A2;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;SLC7A2;RUNX1;MYO1B;CYP1A1;ERVFRD-1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;SPACA6;TSC22D3;FST;MAT2A;DDX17;SPON1;TRIM56;OVCH2;TFCP2L1;KRTAP2-3;CCDC80;TRAF3;COL27A1;ENC1;IRS1;VPS13B;DYNC2H1;SPG21;MID1;SLC16A9;TP53;DAPK3;TUFT1;SVEP1;PANK2;SLC7A5P2;EXO1;ANKRD36C;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;ABCF1;TMEM106A;C1QTNF1;DUSP14;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;COBLL1;MEGF11;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;CNTNAP1;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;IFIT3;SRSF2;FOXD2;PCDH7;LRFN4;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PALM2;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;OLFML3;NAIP;ZFP42;GFOD1;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;POP1;HLA-DOB;RIPK4;GPCPD1;NUCKS1;PITHD1;HEATR1;ZDHHC6;CD274;WNT10A;MCM2;TARDBP;MIR17HG;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;APOL6;KEAP1;NAA15;UAP1L1;TRA2A;TCHH;ZNF827;SLC5A6;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;IGFL3;KCNS3;SETDB1;PTGER4;TK1;TMEM97;LSG1;G3BP1;GRWD1;ARRDC1-AS1;ZNF584;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;CDV3;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;KANK4;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;CXCL16;NOP2;DOHH;SUV39H2;LCP1;GPRIN1;EXOG;PTPRM;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;CPA4;IL24;ARHGEF28;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;SNX11;TRPM7;AJUBA;SMC2;ARMC6;FASTKD3;KCNQ5;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;KRT24;LFNG;ZC3H7B;PGK1;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;SRBD1;FRRS1;PPP4R4;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;GANC;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;SGK494;KREMEN2;SDK1;FZD1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;FRAS1;ZNF316;IL20;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;ACKR3;RIF1;METTL16;TYW1;MCM6;FGD6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;TMEM51;THBD;UPK3B;ABCC9;TRMT5;TTF2;DTX4;METTL13;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;SEPHS2;NNT;IFNAR1;WEE1;TJP1;LRRN3;ZNF484;THADA;KCTD3;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;CXCR5;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;GLIPR1L2;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;HPS5;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;HCAR1;DGCR8;DPYD;SS18L2;TTC27;LIMCH1;KRT10;CCAR1;SKA2;CYB561D2;PPIP5K1;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;L1CAM;ZNFX1;STEAP4;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;LNX2;CHEK1;IL12RB2;SRFBP1;SERPINB9;SCFD2;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;ZNF608;TAF6L;MRPS7;DPH2;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;TPRA1;MSH3;TELO2;EDRF1;RBBP5;CYP20A1;CITED2;MFAP5;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;MPP5;AZIN1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;NOP16;RRP15;RNF19B;RAD51B;USP11;EHD1;KCNE4;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;DCTN5;METAP2;SLC43A2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;PHLPP1;ZNHIT6;FTO;CCDC50;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;SLC41A2;ASTN2;TSGA13;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GBP6;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
15247,GO:0071385,0.082334620876709,0.969269845206737,6,42,cellular response to glucocorticoid stimulus,BP,EDN1;ATP2B1;SRD5A1;CFLAR;ZFP36L2;HNRNPU
30,GO:0000055,0.0823446160659757,0.98977673183976,2,8,ribosomal large subunit export from nucleus,BP,RAN;SDAD1
4286,GO:0009651,0.0824172130072074,0.982634683728339,3,15,response to salt stress,BP,HSP90AB1;AKR1B1;TNF
17477,GO:1900243,0.0824721445883667,1,1,1,negative regulation of synaptic vesicle endocytosis,BP,SYT11
19179,GO:1905154,0.0824721445883667,1,1,1,negative regulation of membrane invagination,BP,SYT11
19181,GO:1905161,0.0824721445883667,1,1,1,protein localization to phagocytic vesicle,BP,SYT11
19182,GO:1905162,0.0824721445883667,1,1,1,regulation of phagosome maturation,BP,SYT11
19187,GO:1905169,0.0824721445883667,1,1,1,regulation of protein localization to phagocytic vesicle,BP,SYT11
19188,GO:1905171,0.0824721445883667,1,1,1,positive regulation of protein localization to phagocytic vesicle,BP,SYT11
19307,GO:1905468,0.0824721445883667,1,1,1,regulation of clathrin-coated pit assembly,BP,SYT11
19308,GO:1905469,0.0824721445883667,1,1,1,negative regulation of clathrin-coated pit assembly,BP,SYT11
11059,GO:0045026,0.0824765134552375,0.982461584216153,3,16,plasma membrane fusion,BP,ERVFRD-1;SPACA6;NSF
4160,GO:0009221,0.0825186415015136,0.989742631101017,2,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,TYMS;TBPL1
13477,GO:0052906,0.0826362835507676,1,1,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,TRMT5
8063,GO:0032722,0.0827934643240498,0.972468524643656,5,34,positive regulation of chemokine production,BP,DDX3X;ADAM17;TLR3;TNF;CD74
13413,GO:0052695,0.0828784856250026,0.990024717082058,2,7,cellular glucuronidation,BP,UGT1A6;UGT1A4
8250,GO:0033014,0.0829041055269567,0.976833711061571,4,24,tetrapyrrole biosynthetic process,BP,IBA57;NFE2L1;SLC11A2;MMAA
7495,GO:0031658,0.0829170810855482,0.990017377305042,2,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2A;CDK4
4284,GO:0009649,0.0830776923682968,0.976868553397725,4,23,entrainment of circadian clock,BP,PML;TP53;RBM4;PHLPP1
9312,GO:0035750,0.0830986535416636,1,1,1,protein localization to myelin sheath abaxonal region,BP,MPP5
15916,GO:0072666,0.0831749704233968,0.968978171361557,6,40,establishment of protein localization to vacuole,BP,GNPTAB;VPS41;CLU;HSPA8;VPS36;AP3B1
14203,GO:0061082,0.0831882717600847,0.982403028089999,3,15,myeloid leukocyte cytokine production,BP,TGFB2;CD74;IRAK3
10438,GO:0043273,0.0833119790217126,1,1,1,CTPase activity,MF,DDX3X
16666,GO:0097512,0.0834012424866386,0.998186691778515,1,2,cardiac myofibril,CC,CRYAB
8905,GO:0034718,0.0834241358239582,1,1,1,SMN-Gemin2 complex,CC,GEMIN5
4339,GO:0009889,0.0834962684111417,0.927720513278667,266,3397,regulation of biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;TP53;DAPK3;EDN1;SCD;HMGCS1;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;PPP1R3B;DKC1;INHBA;NUP50;PUM3;SYK;NUP153;ZFP42;RELB;NBN;LEPR;PARP15;BRIP1;LSS;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;MIR17HG;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;CCL20;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;ITGAV;SET;PARP14;ARNTL;TAF1D;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;TRIM37;GNL3L;ZNF586;NVL;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;BACE2;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;VPS36;TRAF2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
5729,GO:0016866,0.0836002483024609,0.976479909186957,4,25,intramolecular transferase activity,MF,DKC1;LSS;PUS3;TRUB2
10387,GO:0043198,0.0837675102315941,0.976721140153266,4,22,dendritic shaft,CC,MAP2;BAIAP2;NSF;GPER1
3223,GO:0006875,0.083778211378625,0.944494821237544,27,281,cellular metal ion homeostasis,BP,SAA1;FTL;FTH1;PML;JPH2;TFRC;EDN1;C1QTNF1;ACO1;SLC30A6;ABCG2;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;JPH1;THADA;SLC11A2;RIC3;TMEM199;NEDD4L;TMEM165;GPER1;ESR1;CCL5
19945,GO:2000406,0.083991744913622,0.982160591937527,3,15,positive regulation of T cell migration,BP,CCL20;ADAM17;CCL5
20234,GO:2001057,0.0839957814678467,0.965540326194474,7,52,reactive nitrogen species metabolic process,BP,CYP1B1;SLC7A2;EDN1;NQO1;CLU;HSP90AB1;TNF
14241,GO:0061157,0.0840501143106918,0.976738717693185,4,21,mRNA destabilization,BP,METTL16;HNRNPR;ZFP36L2;RC3H1
823,GO:0002093,0.0843281119107824,0.989747604846455,2,7,auditory receptor cell morphogenesis,BP,SLC9A3R1;WDPCP
15311,GO:0071479,0.0845861232228313,0.962720257085024,8,63,cellular response to ionizing radiation,BP,CRYAB;TP53;RAD1;SFRP1;NUCKS1;ATR;CLOCK;CDKN1A
11394,GO:0045745,0.0845922566465599,0.982164558698611,3,14,positive regulation of G-protein coupled receptor protein signaling pathway,BP,C3;UBQLN2;GPER1
2423,GO:0005597,0.0846198489582889,1,1,1,collagen type XVI trimer,CC,COL16A1
9904,GO:0042177,0.0846607909980493,0.956989019993813,11,98,negative regulation of protein catabolic process,BP,NRG1;PML;OPHN1;MDM4;PDCL3;HSP90AB1;SENP1;AZIN1;TAF1;SMARCC1;IRAK3
16626,GO:0097442,0.0847058351651818,1,1,1,CA3 pyramidal cell dendrite,CC,MAP2
2945,GO:0006474,0.0848363801682943,0.982091162346376,3,14,N-terminal protein amino acid acetylation,BP,NAA15;NAA50;NAA16
5892,GO:0018027,0.0849643291371542,0.982052655515809,3,14,peptidyl-lysine dimethylation,BP,SUV39H2;SMYD2;SETD2
16663,GO:0097505,0.0851304487012676,1,1,1,Rad6-Rad18 complex,CC,RAD18
18472,GO:1903531,0.0851548501173446,0.956709683890983,11,97,negative regulation of secretion by cell,BP,FN1;PML;IL1R2;IRS1;EDN1;GBP1;INHBA;SFRP1;PTGER4;SYT11;TNF
7751,GO:0032259,0.0853201507881531,0.943349026219426,27,285,methylation,BP,MAT2A;TGS1;THUMPD3;METTL21A;METTL1;SETDB1;NOP2;SUV39H2;KDM6A;SETD4;VCPKMT;SMYD2;RIF1;METTL16;SETD2;TRMT5;METTL13;THADA;TET3;HSPA8;TRMT1;TRMT61A;RBBP5;MPHOSPH8;WDR4;TYMS;CTCF
19754,GO:2000074,0.0853683383875961,0.989546943010166,2,7,regulation of type B pancreatic cell development,BP,ARNTL;CLOCK
16573,GO:0097327,0.0856323414971953,0.960007697540758,9,73,response to antineoplastic agent,BP,NEFL;EDN1;CDK4;DHFR;PDGFB;SRD5A1;CFLAR;TIMELESS;DAXX
4198,GO:0009304,0.0857320533760258,0.989476425650104,2,7,tRNA transcription,BP,GTF3C6;GTF3C4
19787,GO:2000144,0.0857438782244118,0.975864937742325,4,23,positive regulation of DNA-templated transcription, initiation,BP,TP53;SRF;ESR1;TAF1
2217,GO:0005109,0.0859475941953319,0.975787766086286,4,23,frizzled binding,MF,SFRP1;WNT10A;WNT4;FZD1
4482,GO:0010494,0.0859599667454741,0.967661967631253,6,40,cytoplasmic stress granule,CC,RBM4;PABPC4;G3BP1;CASC3;DDX3X;RC3H1
5337,GO:0016071,0.0859636004719494,0.934485481751691,59,738,mRNA metabolic process,BP,DDX17;TP53;DDX47;RBM4;GEMIN5;PABPC4;LGALS3;RBM22;TGS1;SRSF2;SUGP2;HNRNPF;PDCD11;DKC1;TARDBP;GEMIN4;PUS3;TRA2A;ZMAT2;HNRNPA1L2;CASC3;AKAP8L;HSPB1;THOC1;SET;MRTO4;FASTKD3;RBMXL1;LUC7L;SRF;LUC7L2;EFTUD2;TRUB2;METTL16;TTF2;APEX1;HSPA8;GEMIN8;SYNCRIP;CCAR1;POLR2F;PSME2;PSMB9;TRMT61A;NCBP1;UPF3B;HNRNPR;ZFP36L2;SRSF7;RC3H1;HNRNPU;PSMB10;PSPC1;HNRNPM;RBM8A;GTF2H3;RPS12;BUD13;DHX15
10984,GO:0044754,0.0860039329803441,0.989050488818084,2,8,autolysosome,CC,FTL;FTH1
17987,GO:1902337,0.0860982625581812,0.98940523869751,2,7,regulation of apoptotic process involved in morphogenesis,BP,B4GALT1;TGFB2
18998,GO:1904748,0.0860982625581812,0.98940523869751,2,7,regulation of apoptotic process involved in development,BP,B4GALT1;TGFB2
14891,GO:0070663,0.0861999098003134,0.953232043461612,13,123,regulation of leukocyte proliferation,BP,TFRC;LGALS3;IL6ST;SYK;CD274;AHR;CSF1;ATAD5;RC3H1;CCL5;CD74;CDKN1A;IRF1
9400,GO:0035929,0.0862302571374448,0.989379534711028,2,7,steroid hormone secretion,BP,C1QTNF1;INHBA
11489,GO:0045931,0.0865215024379822,0.953132450660539,13,115,positive regulation of mitotic cell cycle,BP,EPGN;CYP1A1;PBX1;EDN1;CDK4;RANBP2;DDX3X;CDCA5;PDGFB;APEX1;BRCA2;RAD51B;HNRNPU
5210,GO:0015807,0.0865536798369802,0.967270803120587,6,42,L-amino acid transport,BP,SLC7A2;SLC7A5P2;SLC1A3;ARL6IP5;SLC43A2;SLC25A22
14660,GO:0070231,0.0865702064464509,0.970769130919461,5,35,T cell apoptotic process,BP,TSC22D3;TP53;LGALS3;CD274;CCL5
12671,GO:0050856,0.0866721119293287,0.975407363214133,4,24,regulation of T cell receptor signaling pathway,BP,GBP1;LGALS3;CYLD;RC3H1
1787,GO:0004402,0.0867175790297908,0.964194610842417,7,51,histone acetyltransferase activity,MF,NAA50;KANSL1L;BRCA2;TAF6L;GTF3C4;CLOCK;TAF1
10158,GO:0042726,0.0868263360662151,0.989263155761451,2,7,flavin-containing compound metabolic process,BP,ENPP1;FLAD1
11810,GO:0046661,0.0869634778832074,0.954180617835095,12,105,male sex differentiation,BP,HMGCS1;TGFB2;INHBA;ZFP42;BRIP1;SFRP1;WNT4;SRD5A1;RRM1;CITED2;TLR3;ESR1
9252,GO:0035639,0.0870194631521395,0.928345604449889,120,1405,purine ribonucleoside triphosphate binding,MF,KIF23;MAP3K14;GCLC;NLRC5;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;GBP1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;RAB32;TRIO;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;RIPK4;MCM2;POLQ;TSR1;ATP2B1;HELLS;ULK4;ABCC4;TK1;LSG1;G3BP1;MDN1;EIF5;PLK2;RRAGB;FRK;GBP5;RHOG;DDX28;RAN;ORC4;ATP2C1;DDX3X;RAB26;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;GNL3L;NVL;GATC;RARS;MCM8;SGK494;ENPP1;CBWD5;DDX10;EFTUD2;DDX24;MCM6;ABCC9;TTF2;SRPRB;SEPHS2;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;PPIP5K1;CHEK1;MMAA;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;HNRNPU;FLAD1;TAF1;NRAS;ABCA11P;GBP6;IRAK3;DHX15
6320,GO:0019962,0.0870234257484712,1,1,1,type I interferon binding,MF,IFNAR1
178,GO:0000387,0.0873604799184115,0.970307595451014,5,37,spliceosomal snRNP assembly,BP,GEMIN5;RBM22;TGS1;GEMIN4;GEMIN8
10112,GO:0042612,0.0874319558299535,0.988470811376519,2,9,MHC class I protein complex,CC,HLA-B;HLA-F
1844,GO:0004497,0.0874795346467267,0.966777309488327,6,43,monooxygenase activity,MF,CYP1B1;CYP24A1;CYP1A1;DOHH;AKR1C2;CYP20A1
1861,GO:0004521,0.0878090382338204,0.966437913237135,6,47,endoribonuclease activity,MF,EXO1;POP1;TSN;FEN1;APEX1;DGCR8
17826,GO:1901895,0.0878464334267975,1,1,1,negative regulation of calcium-transporting ATPase activity,BP,THADA
8919,GO:0034752,0.0878517720315664,1,1,1,cytosolic aryl hydrocarbon receptor complex,CC,AHR
8920,GO:0034753,0.0878517720315664,1,1,1,nuclear aryl hydrocarbon receptor complex,CC,AHR
14738,GO:0070374,0.0879608282126735,0.952197988911227,13,117,positive regulation of ERK1 and ERK2 cascade,BP,FGFR2;CTGF;CCL20;NPNT;PDGFB;ACKR3;GLIPR2;EPHB6;GPER1;CFLAR;TNF;CCL5;CD74
4535,GO:0010604,0.0880459990272947,0.925260264023456,178,2220,positive regulation of macromolecule metabolic process,BP,IGFBP3;MAFB;SAA1;NRG1;TRIM16;FN1;PML;MAP3K14;GCLC;TFRC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;EPGN;CTGF;MMP9;RUNX1;CLN6;PBX1;DDX17;IRS1;MID1;TP53;EDN1;C1QTNF1;ZBED1;STAG1;CHP1;AKAP8;TGFB2;RBM22;FOXD2;IL6ST;DKC1;INHBA;IL7R;SYK;EMP2;RELB;NBN;UTP15;CDK4;SFRP1;NUCKS1;HEATR1;WNT10A;TARDBP;H3F3A;USP16;AHR;KEAP1;NAA15;POLR1A;GLIS3;TAF2;SETDB1;CCL20;PLK2;UBQLN2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;KDM6A;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;IL24;RRN3;ITGAV;SOCS1;PARP14;ARNTL;TAF1D;AJUBA;FASTKD3;DND1;NVL;GADD45B;CDH13;SRF;NPNT;WDR43;PDGFB;BRCC3;FZD1;NFE2L1;ANTXR1;CLU;MACC1;BIRC3;IL20;EYA3;ACKR3;RIF1;METTL16;GLIS2;GLIPR2;TNC;TET3;MYBL1;HSPA8;HSP90AB1;DDX21;ARL6IP5;EPHB6;NSF;NEDD4L;BRCA2;SYNCRIP;SS18L2;E2F8;ETV6;HSF2;POLR2F;RAB3GAP1;CHEK1;SERPINB9;GPER1;MLLT10;WDR75;ADAM17;SENP1;RBMS3;ATR;PSME2;UBAP2L;MSH6;CFLAR;EIF2B5;NOL11;NCBP1;UPF3B;POLR1E;TRAF2;TELO2;EDRF1;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;CSF1;RBL1;NAA16;CLOCK;KIF14;TLR3;ESR1;RNF19B;TNF;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;HNRNPU;DAXX;HIST1H4A;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;IRF1;CTCF;IFI27L1
19853,GO:2000278,0.0881197039158313,0.956666835880092,10,84,regulation of DNA biosynthetic process,BP,TP53;DKC1;RFC3;GNL3L;NVL;PDGFB;HSP90AB1;ATR;HNRNPU;CDKN1A
12193,GO:0048302,0.0881285565603881,0.989007195691271,2,7,regulation of isotype switching to IgG isotypes,BP,IL27RA;ATAD5
9513,GO:0036152,0.0881548258459573,0.980887566122958,3,15,phosphatidylethanolamine acyl-chain remodeling,BP,ABHD4;MBOAT1;PLBD1
12690,GO:0050878,0.0881878016929264,0.940342176492391,29,308,regulation of body fluid levels,BP,KRT1;SAA1;STAT5A;CBX5;ACTG1;EDN1;C1QTNF1;PABPC4;PDPN;SYK;EMP2;H3F3A;HRNR;CSRP1;ADM;GGCX;HSPB1;RHOG;SRF;PDGFB;THBD;UMPS;HPS5;RPTN;AKR1B1;AP3B1;RAD51B;EHD1;IRF1
17770,GO:1901681,0.0883041081859924,0.949622725327533,15,141,sulfur compound binding,MF,SAA1;FN1;PTGES;CYR61;FGFR2;COL5A3;CTGF;FBN1;FST;CCDC80;SFRP1;SUV39H2;ENPP1;NAV2;DPYSL3
2287,GO:0005243,0.088341362441766,0.988965144271689,2,7,gap junction channel activity,MF,GJC1;PANX1
1707,GO:0004197,0.0887006670170109,0.958228797987729,9,75,cysteine-type endopeptidase activity,MF,SFRP1;USP16;RCE1;USP6;SENP1;CFLAR;USP11;CAPN12;USP1
6799,GO:0030235,0.0887580956505048,0.988882614742688,2,7,nitric-oxide synthase regulator activity,MF,HSP90AB1;ESR1
19212,GO:1905255,0.0889286919493152,1,1,1,regulation of RNA binding transcription factor activity,BP,NUCKS1
19709,GO:1990968,0.0889286919493152,1,1,1,modulation by host of RNA binding by virus,BP,NUCKS1
19710,GO:1990969,0.0889286919493152,1,1,1,modulation by host of viral RNA-binding transcription factor activity,BP,NUCKS1
19884,GO:2000322,0.0890913310040011,0.988816448675957,2,7,regulation of glucocorticoid receptor signaling pathway,BP,ARNTL;CLOCK
3281,GO:0006970,0.0892729284592428,0.962802984562592,7,53,response to osmotic stress,BP,TSC22D3;RELB;DDX3X;HSP90AB1;AKR1B1;TLR3;TNF
1743,GO:0004339,0.0893065158289624,1,1,1,glucan 1,4-alpha-glucosidase activity,MF,MGAM
2647,GO:0005982,0.0893065158289624,1,1,1,starch metabolic process,BP,MGAM
2648,GO:0005983,0.0893065158289624,1,1,1,starch catabolic process,BP,MGAM
10794,GO:0044245,0.0893065158289624,1,1,1,polysaccharide digestion,BP,MGAM
285,GO:0000788,0.0893454235518568,0.97914797133268,3,31,nuclear nucleosome,CC,H3F3A;MPHOSPH8;HIST1H4A
16972,GO:0098939,0.0893650195266109,1,1,1,dendritic transport of mitochondrion,BP,TRAK2
16983,GO:0098972,0.0893650195266109,1,1,1,anterograde dendritic transport of mitochondrion,BP,TRAK2
4388,GO:0010039,0.0894186972195486,0.974352805858186,4,24,response to iron ion,BP,CYP1A1;G6PD;ACO1;SLC11A2
11047,GO:0045005,0.0895124610686671,0.96968351145087,5,32,DNA-dependent DNA replication maintenance of fidelity,BP,NUCKS1;THOC1;BRCA2;RFWD3;TIMELESS
3348,GO:0007077,0.0895585418106587,0.965829639439937,6,42,mitotic nuclear envelope disassembly,BP,NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54
14960,GO:0070830,0.0895684650548338,0.965879969485922,6,41,bicellular tight junction assembly,BP,RUNX1;SRF;TJP1;MPP5;PARD3;TNF
19000,GO:1904750,0.0900398427148156,1,1,1,negative regulation of protein localization to nucleolus,BP,POLR1A
4924,GO:0014866,0.0901382681711632,0.993663631994749,2,3,skeletal myofibril assembly,BP,MYH11;CFLAR
821,GO:0002091,0.0901969342789908,0.988595828503649,2,7,negative regulation of receptor internalization,BP,UBQLN2;MTMR2
4386,GO:0010035,0.0903441862171171,0.937494006972359,32,349,response to inorganic substance,BP,CRYAB;NEFL;PTGES;CYP1B1;GCLC;TXNRD1;MMP9;CYP1A1;G6PD;TP53;EDN1;HMGCS1;NQO1;ACO1;SLC30A6;CDK4;DHFR;SOD2;GPHN;APTX;QDPR;SLC11A2;APEX1;NEDD4L;CFLAR;EIF2B5;AKR1B1;TRAF2;CCNA2;TIMELESS;TNF;DAXX
10579,GO:0043532,0.0904166025620919,1,1,1,angiostatin binding,MF,AMOT
11815,GO:0046677,0.0904350793717992,0.943001911973184,21,219,response to antibiotic,BP,CRYAB;NEFL;CYP1B1;FGFR2;CYP1A1;G6PD;TP53;EDN1;NQO1;AHR;SETDB1;SLC1A3;APTX;PDGFB;CLU;SRD5A1;APEX1;TNC;TIMELESS;TYMS;DAXX
6421,GO:0021681,0.0905165301215388,0.988531740884378,2,7,cerebellar granular layer development,BP,OPHN1;KIF14
12722,GO:0050921,0.090529005379239,0.957142734935882,9,77,positive regulation of chemotaxis,BP,EDN1;IL16;HSPB1;CDH13;PDGFB;ADAM17;CSF1;CCL5;CD74
15696,GO:0072202,0.0907785158632401,0.980275059938512,3,14,cell differentiation involved in metanephros development,BP,FAT4;WNT4;PDGFB
10058,GO:0042531,0.0908824855869426,0.968805719428905,5,36,positive regulation of tyrosine phosphorylation of STAT protein,BP,IL6ST;IL24;PARP14;IL20;CCL5
5845,GO:0017130,0.0909016136569963,1,1,1,poly(C) RNA binding,MF,HNRNPU
16792,GO:0098577,0.0909016136569963,1,1,1,inactive sex chromosome,CC,HNRNPU
18172,GO:1902889,0.0909016136569963,1,1,1,protein localization to spindle microtubule,BP,HNRNPU
19526,GO:1990280,0.0909016136569963,1,1,1,RNA localization to chromatin,BP,HNRNPU
7320,GO:0031324,0.0909164788895344,0.923540129912513,152,1895,negative regulation of cellular metabolic process,BP,CRYAB;IGFBP3;NRG1;HDAC9;PML;GCLC;C3;GPRC5A;FGFR2;TRIM22;CBX5;MMP9;IL1R2;G6PD;TSC22D3;FST;TFCP2L1;ENC1;TP53;DAPK3;EDN1;GBP1;DUSP14;CDKN2A;RBM4;CHP1;TGFB2;IRX2;PKMYT1;SRSF2;SLC9A3R1;DKC1;INHBA;NUP50;NUP153;NAIP;RELB;NBN;LEPR;PARP15;SHQ1;CDK4;SFRP1;TARDBP;MIR17HG;POLQ;H3F3A;AHR;DHFR;GLIS3;HELLS;SETDB1;OPHN1;CD109;NDC1;ZNF587;UBQLN2;FRK;HSPB1;WNT4;SUV39H2;THOC1;RAN;RANBP2;CORO1C;DDX3X;ITGAV;SOCS1;SET;PARP14;ARNTL;AJUBA;DND1;ZC3H7B;TRIM37;PPP4R4;GNL3L;ZNF586;GADD45B;SH3RF2;SRF;MDM4;HIF1AN;PDGFB;FZD1;CLU;NUP160;SMYD2;ENPP1;BIRC3;NUP54;LRPPRC;RIF1;METTL16;GLIS2;UBP1;APEX1;PDCL3;HSPA8;HSP90AB1;BACE2;NEDD4L;BRCA2;SYNCRIP;DGCR8;CCAR1;E2F8;MTMR2;CENPF;ETV6;POLR2F;SERPINB9;GPER1;SENP1;ATR;MSH6;CFLAR;ZNF12;ZNF608;NCBP1;MSH3;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;PARD3;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;HNRNPU;RING1;FGFR1OP;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;IRF1;CTCF;IRAK3
13781,GO:0060337,0.0909664411609258,0.959094354809305,8,69,type I interferon signaling pathway,BP,NLRC5;HLA-B;XAF1;IFIT3;HLA-F;IFNAR1;HSP90AB1;IRF1
15228,GO:0071357,0.0909664411609258,0.959094354809305,8,69,cellular response to type I interferon,BP,NLRC5;HLA-B;XAF1;IFIT3;HLA-F;IFNAR1;HSP90AB1;IRF1
15529,GO:0071888,0.0912127444216794,0.987983739070437,2,8,macrophage apoptotic process,BP,CDKN2A;CCL5
8685,GO:0034250,0.091234736438627,0.9500442226394,13,123,positive regulation of cellular amide metabolic process,BP,CYR61;CDK4;USP16;DDX3X;FASTKD3;DND1;CLU;RBMS3;EIF2B5;UPF3B;ESR1;TNF;CCL5
4949,GO:0014912,0.0912650400330108,0.979918253790065,3,15,negative regulation of smooth muscle cell migration,BP,IGFBP3;TPM1;APEX1
1052,GO:0002577,0.0912852254383821,0.98796862422098,2,8,regulation of antigen processing and presentation,BP,HLA-DOB;CD74
478,GO:0001522,0.0913255415356228,0.979429442205897,3,18,pseudouridine synthesis,BP,DKC1;PUS3;TRUB2
9504,GO:0036138,0.0913648631100469,1,1,1,peptidyl-histidine hydroxylation,BP,HIF1AN
9505,GO:0036139,0.0913648631100469,1,1,1,peptidyl-histidine dioxygenase activity,MF,HIF1AN
9506,GO:0036140,0.0913648631100469,1,1,1,peptidyl-asparagine 3-dioxygenase activity,MF,HIF1AN
9929,GO:0042265,0.0913648631100469,1,1,1,peptidyl-asparagine hydroxylation,BP,HIF1AN
17146,GO:0102113,0.0913648631100469,1,1,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,HIF1AN
8883,GO:0034683,0.0915341437712366,1,1,1,integrin alphav-beta3 complex,CC,ITGAV
11372,GO:0045715,0.0915341437712366,1,1,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
12601,GO:0050748,0.0915341437712366,1,1,1,negative regulation of lipoprotein metabolic process,BP,ITGAV
13327,GO:0052066,0.0915341437712366,1,1,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,ITGAV
13337,GO:0052190,0.0915341437712366,1,1,1,modulation by symbiont of host phagocytosis,BP,ITGAV
13338,GO:0052191,0.0915341437712366,1,1,1,positive regulation by symbiont of host phagocytosis,BP,ITGAV
13348,GO:0052231,0.0915341437712366,1,1,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13364,GO:0052370,0.0915341437712366,1,1,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13381,GO:0052522,0.0915341437712366,1,1,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
19998,GO:2000536,0.0915341437712366,1,1,1,negative regulation of entry of bacterium into host cell,BP,ITGAV
9085,GO:0035329,0.091572430860536,0.965101298748462,6,38,hippo signaling,BP,AMOT;MAP3K14;FAT4;TJP2;AJUBA;TJP1
19666,GO:1990823,0.0915860810125949,0.956614374599307,9,74,response to leukemia inhibitory factor,BP,PML;TFRC;MAT2A;MYBL2;RIF1;MYNN;NCL;SRSF7;HNRNPU
19669,GO:1990830,0.0915860810125949,0.956614374599307,9,74,cellular response to leukemia inhibitory factor,BP,PML;TFRC;MAT2A;MYBL2;RIF1;MYNN;NCL;SRSF7;HNRNPU
15472,GO:0071786,0.0916111701600962,0.979809426719159,3,15,endoplasmic reticulum tubular network organization,BP,REEP1;ZFYVE27;RAB3GAP1
12052,GO:0047750,0.0917123933837309,0.997797491489254,1,2,cholestenol delta-isomerase activity,MF,EBP
18267,GO:1903051,0.0918717155811858,0.96138023557608,7,55,negative regulation of proteolysis involved in cellular protein catabolic process,BP,PML;OPHN1;PDCL3;HSP90AB1;SENP1;TAF1;SMARCC1
8667,GO:0034214,0.0919207059681796,0.988248505986779,2,7,protein hexamerization,BP,MAT2A;PANX1
428,GO:0001135,0.0919484878608287,0.988242874895345,2,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,MYBL2;MYBL1
17658,GO:1901350,0.0921603766377967,1,1,1,cell-cell signaling involved in cell-cell junction organization,BP,TJP1
6814,GO:0030261,0.092171157079606,0.968876014025143,5,28,chromosome condensation,BP,AKAP8;AKAP8L;SMC2;CDCA5;GPER1
4158,GO:0009219,0.0922672877510666,0.979126371005097,3,18,pyrimidine deoxyribonucleotide metabolic process,BP,SMUG1;TYMS;TBPL1
12856,GO:0051147,0.0923024229148582,0.952450391564946,11,94,regulation of muscle cell differentiation,BP,NRG1;HDAC9;FGFR2;G6PD;EDN1;RBM4;SRF;PDGFB;GPER1;CFLAR;EHD1
18411,GO:1903393,0.0923178299282303,0.973465426210001,4,22,positive regulation of adherens junction organization,BP,COL16A1;SFRP1;WNT4;ITGB1BP1
18348,GO:1903265,0.0923213919750864,0.987751738715534,2,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,ADAM17;TRAF2
15925,GO:0072678,0.0923272777029246,0.973118577514444,4,25,T cell migration,BP,CCL20;CXCL16;ADAM17;CCL5
12260,GO:0048519,0.0923692813145607,0.919577646210352,280,3642,negative regulation of biological process,BP,CRYAB;IGFBP3;MAFB;KRT1;SAA1;FTH1;NEFL;NRG1;HDAC9;KRT4;FN1;PTGES;PML;CYP1B1;AMOT;JPH2;MAP3K14;GCLC;CYR61;C3;GPRC5A;NLRC5;FGFR2;SACS;TRIM22;STARD13;CBX5;CTGF;UTP20;MMP9;FBN1;HSPG2;IL1R2;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;C1QTNF1;DUSP14;CDKN2A;RBM4;PTPN14;NQO1;PABPC4;LGALS3;CHP1;PDPN;AKAP8;TGFB2;IRX2;CYLD;IKBKE;PKMYT1;IL27RA;IFIT3;SRSF2;P3H2;RAD1;IL6ST;BAG1;SLC9A3R1;DKC1;INHBA;IL7R;NUP50;TJP2;NUP153;NAIP;RELB;GPR132;NBN;LEPR;TRIO;FAM111A;PARP15;BRIP1;SHQ1;CDK4;SFRP1;HLA-DOB;CD274;TARDBP;MIR17HG;POLQ;H3F3A;AHR;KEAP1;NAA15;DHFR;POLR1A;TPM1;GLIS3;HELLS;TSN;ADAMTS9;SETDB1;PTGER4;G3BP1;OPHN1;ADM;CD109;NDC1;CASC3;PLK2;RRAGB;ZNF587;UBQLN2;FRK;KANK4;WDR76;HSPB1;WNT4;SUV39H2;PTPRM;THOC1;RAN;RANBP2;TOPBP1;ANAPC15;SOD2;CORO1C;DDX3X;IL24;RRN3;RNF115;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;AJUBA;FASTKD3;CGNL1;DND1;LFNG;ZC3H7B;PGK1;TRIM37;LUC7L;PPP4R4;GNL3L;ZNF586;YRDC;GADD45B;SH3RF2;CDH13;COL5A2;PHACTR4;SRF;MDM4;HIF1AN;PDGFB;BRCC3;CHID1;KREMEN2;FZD1;ANTXR1;CLU;NUP160;SMYD2;ENPP1;BIRC3;RRM2;NUP54;LRPPRC;EYA3;ACKR3;RIF1;METTL16;GLIS2;UBP1;THBD;UPK3B;JPH1;THADA;APEX1;PDCL3;TNC;MYBL1;HSPA8;SYT11;HSP90AB1;ARL6IP5;EPHB6;BACE2;NEDD4L;BRCA2;SYNCRIP;TRAK2;DGCR8;CCAR1;E2F8;MTMR2;CENPF;ETV6;POLR2F;CHEK1;SERPINB9;GPER1;FAF1;RAD18;ADAM17;SENP1;RBMS3;ATR;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;ZNF12;RFWD3;ABCA5;NFKBIE;CBLL1;DPYSL3;ZNF608;NCBP1;UPF3B;AKR1B1;TRAF2;TPRA1;MSH3;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;CLOCK;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;DAXX;PHF14;PHLPP2;HIST1H4A;TAF1;PHLPP1;PSPC1;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;IRF1;CTCF;ASTN2;RBM8A;RPS12;GPX4;IRAK3
8604,GO:0034103,0.0924065597703689,0.964396384465354,6,43,regulation of tissue remodeling,BP,TFRC;B4GALT1;SYK;LEPR;SFRP1;PPARGC1B
6262,GO:0019843,0.0924092024822741,0.963877424795763,6,56,rRNA binding,MF,PPAN;DDX28;RPF2;NOL12;DDX21;MRPS7
16926,GO:0098868,0.0924697425589071,0.979747897379496,3,14,bone growth,BP,FGFR2;COL27A1;LEPR
5822,GO:0017085,0.0926940106122466,0.979467743829669,3,15,response to insecticide,BP,NEFL;CYP1A1;DAXX
1047,GO:0002566,0.0928019012980442,0.979433598082257,3,15,somatic diversification of immune receptors via somatic mutation,BP,EXO1;POLQ;MSH6
13703,GO:0060216,0.0928514264545198,0.979628302533583,3,14,definitive hemopoiesis,BP,SENP1;MFAP5;ZFP36L2
11945,GO:0046975,0.0929183602090924,0.98862205364866,2,6,histone methyltransferase activity (H3-K36 specific),MF,SMYD2;SETD2
19832,GO:2000241,0.0930264086557129,0.955716089256717,9,77,regulation of reproductive process,BP,FGFR2;B4GALT1;RAD1;INHBA;SFRP1;WNT4;LFNG;CITED2;ESR1
7413,GO:0031490,0.0931483625837619,0.953544550448773,10,92,chromatin DNA binding,MF,H3F3A;KDM6A;SRF;UTY;APEX1;HMGN2;CLOCK;HNRNPU;SMARCC1;CTCF
12569,GO:0050702,0.0932125485063041,0.972875905269718,4,24,interleukin-1 beta secretion,BP,TRIM16;PML;GBP5;PANX1
6425,GO:0021685,0.0934124839709237,1,1,1,cerebellar granular layer structural organization,BP,KIF14
12919,GO:0051246,0.0934333390245954,0.921038513797459,160,2022,regulation of protein metabolic process,BP,CRYAB;IGFBP3;SAA1;NRG1;C1R;FN1;PML;MAP3K14;GCLC;CYR61;C3;GPRC5A;FGFR2;EPGN;CTGF;MMP9;CLN6;IL1R2;G6PD;TRAF3;ENC1;MID1;TP53;DAPK3;EDN1;GBP1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;GEMIN5;CHP1;ACO1;AKAP8;TGFB2;PKMYT1;PPP1R3B;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;PUM3;SYK;EMP2;NUP153;NAIP;NBN;CDK4;SFRP1;TARDBP;MIR17HG;H3F3A;USP16;KEAP1;DHFR;ULK4;OPHN1;CD109;NDC1;EIF5;CASC3;CCL20;PLK2;UBQLN2;AKAP8L;HSPB1;RAN;RANBP2;CORO1C;DDX3X;IL24;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;ODC1;AJUBA;FASTKD3;DND1;ZC3H7B;PPP4R4;GNL3L;GADD45B;SH3RF2;PHACTR4;MDM4;NPNT;PDGFB;FZD1;ANTXR1;CLU;NUP160;ENPP1;BIRC3;IL20;NUP54;LRPPRC;ACKR3;RIF1;METTL16;GLIPR2;PDCL3;HSP90AB1;ARL6IP5;EPHB6;BACE2;NSF;NEDD4L;SYNCRIP;DGCR8;POLR2F;RAB3GAP1;CHEK1;SERPINB9;GPER1;FAF1;ADAM17;SENP1;RBMS3;PSME2;CFLAR;PSMB9;EIF2B5;DPH2;NCBP1;UPF3B;TRAF2;TELO2;HNRNPR;NCL;CSF1;KIF14;TLR3;AZIN1;ESR1;PARD3;RNF19B;TNF;ZFP36L2;RC3H1;TYMS;CCL5;CD74;FGFR1OP;DAXX;HIST1H4A;TAF1;PHLPP1;SMARCC1;CDKN1A;ITGB1BP1;IRF1;CTCF;RBM8A;IRAK3;IFI27L1
17857,GO:1901992,0.093485837121335,0.960537937070765,7,55,positive regulation of mitotic cell cycle phase transition,BP,CYP1A1;PBX1;CDK4;DDX3X;CDCA5;APEX1;RAD51B
11019,GO:0044829,0.0935437969537403,0.987917755089456,2,7,positive regulation by host of viral genome replication,BP,NUCKS1;HSPA8
16389,GO:0090673,0.0936387543618836,1,1,1,endothelial cell-matrix adhesion,BP,ADAMTS9
12240,GO:0048478,0.0936851752780908,0.987888775191585,2,7,replication fork protection,BP,BRCA2;TIMELESS
473,GO:0001516,0.0937148295049358,0.978799212480646,3,17,prostaglandin biosynthetic process,BP,PTGES;EDN1;CD74
11690,GO:0046457,0.0937148295049358,0.978799212480646,3,17,prostanoid biosynthetic process,BP,PTGES;EDN1;CD74
2591,GO:0005884,0.0939084403568148,0.955313443798473,9,73,actin filament,CC,AMOT;MYO1B;ACTG1;DAPK3;KEAP1;TPM1;LCP1;TPM4;DPYSL3
10837,GO:0044321,0.0939285131236899,0.979075946489241,3,15,response to leptin,BP,EDN1;LEPR;CCNA2
17854,GO:1901989,0.0942488262788351,0.957373982664135,8,66,positive regulation of cell cycle phase transition,BP,CYP1A1;PBX1;CDK4;DDX3X;CDC25A;CDCA5;APEX1;RAD51B
14535,GO:0070006,0.0942499898959061,0.978973525059973,3,15,metalloaminopeptidase activity,MF,C9ORF3;ERAP1;DNPEP
753,GO:0001990,0.0943204946872591,0.978765396965069,3,16,regulation of systemic arterial blood pressure by hormone,BP,EDN1;C9ORF3;MME
1061,GO:0002586,0.0944917472397019,0.997658472237156,1,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,HLA-DOB
5178,GO:0015732,0.0946279524054132,0.987263532530174,2,8,prostaglandin transport,BP,EDN1;ABCC4
14163,GO:0061013,0.0946905766732663,0.944257573551751,16,160,regulation of mRNA catabolic process,BP,PABPC4;TARDBP;HSPB1;SET;FASTKD3;METTL16;APEX1;HSPA8;SYNCRIP;PSME2;PSMB9;HNRNPR;ZFP36L2;RC3H1;HNRNPU;PSMB10
11689,GO:0046456,0.0947038689823501,0.97199268651421,4,27,icosanoid biosynthetic process,BP,PTGES;EDN1;SYK;CD74
9946,GO:0042287,0.0947328701722271,0.978632653776129,3,16,MHC protein binding,MF,TAP1;TAP2;CD74
1032,GO:0002537,0.0948206000777771,1,1,1,nitric oxide production involved in inflammatory response,BP,SLC7A2
14335,GO:0061459,0.0948206000777771,1,1,1,L-arginine transmembrane transporter activity,MF,SLC7A2
16700,GO:0097625,0.0948206000777771,1,1,1,low-affinity basic amino acid transmembrane transporter activity,MF,SLC7A2
16701,GO:0097626,0.0948206000777771,1,1,1,low-affinity L-arginine transmembrane transporter activity,MF,SLC7A2
16702,GO:0097627,0.0948206000777771,1,1,1,high-affinity L-ornithine transmembrane transporter activity,MF,SLC7A2
16711,GO:0097639,0.0948206000777771,1,1,1,L-lysine import across plasma membrane,BP,SLC7A2
16712,GO:0097640,0.0948206000777771,1,1,1,L-ornithine import across plasma membrane,BP,SLC7A2
15293,GO:0071456,0.0948610679213465,0.945195425224053,15,151,cellular response to hypoxia,BP,TP53;EDN1;BRIP1;SFRP1;SUV39H2;AJUBA;PGK1;MDM4;HIF1AN;PSME2;CFLAR;PSMB9;CITED2;CCNA2;PSMB10
10155,GO:0042720,0.0948632780688784,0.997639549969678,1,2,mitochondrial inner membrane peptidase complex,CC,IMMP2L
2384,GO:0005518,0.0948795271339291,0.963242952557141,6,42,collagen binding,MF,FN1;COL5A3;MMP9;C1QTNF1;PDGFB;ANTXR1
14649,GO:0070206,0.0949351894941174,0.967054007113716,5,35,protein trimerization,BP,TRIM22;C1QTNF1;NUP54;TRAF2;CD74
4505,GO:0010536,0.095014191886155,0.997631840984432,1,2,positive regulation of activation of Janus kinase activity,BP,CCL5
13866,GO:0060447,0.0950879895860322,1,1,1,bud outgrowth involved in lung branching,BP,TNC
14037,GO:0060739,0.0950879895860322,1,1,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,TNC
12622,GO:0050779,0.095112339068884,0.972375686923488,4,22,RNA destabilization,BP,METTL16;HNRNPR;ZFP36L2;RC3H1
400,GO:0001076,0.0951843430351956,0.944054584331866,16,147,transcription factor activity, RNA polymerase II transcription factor binding,MF,MKL1;TP53;ZFP42;PARP15;TAF2;MYBL2;KDM6A;ARNTL;SRF;UTY;NFE2L1;MYBL1;CITED2;CLOCK;TAF1;PPARGC1B
2304,GO:0005283,0.0952074752589179,0.987575010833764,2,7,amino acid:sodium symporter activity,MF,SLC1A3;SLC25A22
7624,GO:0032009,0.095242044188827,0.987567849231666,2,7,early phagosome,CC,SYK;SYT11
12578,GO:0050711,0.0953883243088732,0.98710096270527,2,8,negative regulation of interleukin-1 secretion,BP,PML;IL1R2
1009,GO:0002480,0.0954457079457538,0.986756307914149,2,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,HLA-B;HLA-F
19321,GO:1905524,0.0954625515659927,1,1,1,negative regulation of protein autoubiquitination,BP,TAF1
10518,GO:0043412,0.095535993209166,0.917057179088844,254,3243,macromolecule modification,BP,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;TRIM16;FN1;PML;MAP3K14;GCLC;KRT2;CYR61;C3;GPRC5A;FGFR2;STAT5A;EPGN;TRIM22;CTGF;MMP9;FBN1;B4GALT1;G6PD;SPON1;TRIM56;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;EDN1;TPST1;GBP1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;ZBED1;PTPN14;CHP1;AKAP8;TGFB2;ST6GALNAC5;PRSS23;CYLD;IKBKE;PKMYT1;TGS1;CDKAL1;PPP1R3B;P3H2;IL6ST;SLC9A3R1;NUAK1;DKC1;INHBA;NUP50;PUM3;GALNT18;CAMK1G;SYK;EMP2;NUP153;NAIP;NBN;TRIO;PARP15;CDK4;SFRP1;RIPK4;ZDHHC6;TARDBP;PUS3;USP16;KEAP1;NAA15;THUMPD3;HELLS;METTL21A;PTPRB;METTL1;ULK4;RCE1;SETDB1;PTGER4;URM1;CD109;P4HA2;USP43;GGCX;NDC1;HERC6;CCL20;PLK2;MUC16;FRK;AKAP8L;NOP58;HSPB1;NOP2;DOHH;SUV39H2;PTPRM;KDM6A;SETD4;RANBP2;VCPKMT;CORO1C;ZNF738;DDX3X;CPA4;IL24;GPHN;KLHL21;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;QPCT;TRPM7;AJUBA;FASTKD3;LFNG;TRIM37;PPP4R4;GNL3L;YRDC;GADD45B;SH3RF2;PHACTR4;MDM4;HIF1AN;NPNT;PDGFB;BRCC3;SGK494;FZD1;UTY;CLU;NUP160;USP6;SMYD2;NAA50;ENPP1;BIRC3;IL20;NUP54;LRPPRC;EYA3;TRUB2;ACKR3;RIF1;METTL16;KLHL9;SETD2;TRMT5;DTX4;GLIPR2;DPY19L2P2;SEPHS2;WEE1;THADA;APEX1;PDCL3;TNC;TET3;HSPA8;HSP90AB1;ARL6IP5;EPHB6;SMUG1;NEDD4L;SGK1;ANAPC7;BRCA2;TRAK2;TRMT1;KRT10;MTMR2;TMEM165;FKBP5;RAB3GAP1;CHEK1;IL12RB2;GPER1;FAF1;RAD18;ADAM17;SENP1;ATR;PSME2;CFLAR;PSMB9;RFWD3;TRMT61A;CBLL1;TAF6L;DPH2;SPSB1;UBE2J2;TRAF2;TELO2;RBBP5;CCNA2;GTF3C4;NOP56;POLE3;CSF1;NAA16;MPHOSPH8;CLOCK;KIF14;TLR3;ESR1;PARD3;RNF19B;USP11;FEM1C;TNF;WDR4;ZFP36L2;RC3H1;CCL5;CD74;RING1;FGFR1OP;PSMB10;DAXX;METAP2;PHLPP2;TAF1;PHLPP1;FTO;NRAS;MUC5B;CDKN1A;ITGB1BP1;USP1;MUC6;CTCF;GTF2H3;IRAK3;COPS3;UFC1
11109,GO:0045104,0.0955895449989751,0.966983556716846,5,32,intermediate filament cytoskeleton organization,BP,NEFL;KRT2;NEFM;KRT9;DST
17931,GO:1902216,0.0956012841153707,1,1,1,positive regulation of interleukin-4-mediated signaling pathway,BP,PARP14
19779,GO:2000121,0.0956103920999282,0.987053331916944,2,8,regulation of removal of superoxide radicals,BP,DHFR;TNF
7188,GO:0031065,0.0960014398622754,0.978412675497921,3,15,positive regulation of histone deacetylation,BP,TP53;AKAP8;AKAP8L
2943,GO:0006471,0.0961088326620556,0.971732852740336,4,24,protein ADP-ribosylation,BP,PUM3;PARP15;PARP14;PARP8
12817,GO:0051092,0.0961199924432404,0.948355669549266,12,113,positive regulation of NF-kappaB transcription factor activity,BP,TRIM22;RIPK4;TRAF1;TRIM37;CLU;NFKBIB;CFLAR;TRAF2;CLOCK;TLR3;TNF;IRAK3
4372,GO:0009988,0.0961280089427392,0.971423444975599,4,27,cell-cell recognition,BP,B4GALT1;LGALS3;GLIPR1L2;UBAP2L
16544,GO:0097238,0.0961808513666205,0.997571799496203,1,2,cellular response to methylglyoxal,BP,AKR1B1
12962,GO:0051302,0.0962222895363701,0.946938322765197,13,117,regulation of cell division,BP,KIF23;FGFR2;TGFB2;KLHL21;PDGFB;MACC1;KLHL9;SETD2;CXCR5;BRCA2;E2F8;KIF14;ITGB1BP1
5814,GO:0017069,0.096271109616603,0.966262083440651,5,38,snRNA binding,MF,GEMIN5;RBM22;METTL16;DDX21;HNRNPU
4342,GO:0009892,0.0964583613456136,0.918063263271781,169,2168,negative regulation of metabolic process,BP,CRYAB;IGFBP3;NRG1;HDAC9;PML;GCLC;C3;GPRC5A;FGFR2;TRIM22;CBX5;CTGF;MMP9;IL1R2;G6PD;TSC22D3;FST;DDX17;TFCP2L1;ENC1;TP53;DAPK3;EDN1;GBP1;DUSP14;CDKN2A;RBM4;PABPC4;CHP1;TGFB2;IRX2;PKMYT1;SRSF2;SLC9A3R1;DKC1;INHBA;NUP50;NUP153;NAIP;RELB;NBN;LEPR;PARP15;BRIP1;SHQ1;CDK4;SFRP1;TARDBP;MIR17HG;POLQ;H3F3A;AHR;DHFR;GLIS3;HELLS;TSN;SETDB1;OPHN1;CD109;NDC1;CASC3;ZNF587;UBQLN2;FRK;HSPB1;WNT4;SUV39H2;THOC1;RAN;RANBP2;CORO1C;DDX3X;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;AJUBA;FASTKD3;DND1;ZC3H7B;TRIM37;PPP4R4;GNL3L;ZNF586;GADD45B;SH3RF2;SRF;MDM4;HIF1AN;PDGFB;FZD1;CLU;NUP160;SMYD2;ENPP1;BIRC3;NUP54;LRPPRC;RIF1;METTL16;GLIS2;UBP1;UPK3B;APEX1;PDCL3;HSPA8;HSP90AB1;BACE2;NEDD4L;BRCA2;SYNCRIP;DGCR8;CCAR1;E2F8;MTMR2;CENPF;ETV6;POLR2F;SERPINB9;GPER1;SENP1;RBMS3;ATR;PSME2;MSH6;CFLAR;PSMB9;ZNF12;ZNF608;NCBP1;UPF3B;MSH3;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;AZIN1;ESR1;PARD3;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;HNRNPU;RING1;FGFR1OP;PSMB10;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;IRF1;CTCF;RBM8A;RPS12;IRAK3
17855,GO:1901990,0.0965099912820109,0.932771760235998,32,357,regulation of mitotic cell cycle phase transition,BP,PML;CYP1A1;PBX1;TP53;CDKN2A;GPR132;NBN;CDK4;PLK2;TOPBP1;ANAPC15;DDX3X;CDCA5;MDM4;ANLN;APEX1;E2F8;CENPF;ADAM17;PSME2;CEP152;PSMB9;RFWD3;TPRA1;RBL1;KIF14;RAD51B;ATAD5;ZFP36L2;FGFR1OP;PSMB10;CDKN1A
8022,GO:0032649,0.0966651318690778,0.962106205524086,6,47,regulation of interferon-gamma production,BP,IL27RA;INHBA;CD274;IL12RB2;TLR3;TNF
8594,GO:0034085,0.0967011816949842,0.987264085958118,2,7,establishment of sister chromatid cohesion,BP,CDCA5;NAA50
5355,GO:0016114,0.0967108530633633,0.986816284381101,2,8,terpenoid biosynthetic process,BP,CYP1A1;HMGCS1
8889,GO:0034695,0.0969316364309553,0.978335628690117,3,14,response to prostaglandin E,BP,AKAP8;SFRP1;PTGER4
3628,GO:0008090,0.097197982403942,0.987160005195348,2,7,retrograde axonal transport,BP,NEFL;DST
3448,GO:0007260,0.0972437441078131,0.961818997467766,6,47,tyrosine phosphorylation of STAT protein,BP,IL6ST;IL24;SOCS1;PARP14;IL20;CCL5
2590,GO:0005883,0.0972439582479711,0.987150356322998,2,7,neurofilament,CC,NEFL;NEFM
9233,GO:0035613,0.0973278476268033,0.977984749929679,3,15,RNA stem-loop binding,MF,DDX3X;METTL16;RC3H1
13812,GO:0060379,0.0973361421600589,0.987131001252072,2,7,cardiac muscle cell myoblast differentiation,BP,NRG1;SRF
8449,GO:0033561,0.0973873105422221,0.971345671148796,4,23,regulation of water loss via skin,BP,KRT1;HRNR;SRF;RPTN
3755,GO:0008296,0.0975172218695263,0.986641518941833,2,8,3'-5'-exodeoxyribonuclease activity,MF,APEX1;TREX1
8101,GO:0032780,0.0975378343970391,0.986637039743948,2,8,negative regulation of ATPase activity,BP,VCPKMT;THADA
7677,GO:0032101,0.0975779073480828,0.929514122923335,39,438,regulation of response to external stimulus,BP,KRT1;SAA1;C1R;MTUS1;C3;SLC7A2;IL1R2;TRAF3;EDN1;C1QTNF1;PDPN;IL16;IL6ST;SYK;PTGER4;CD109;GBP5;HSPB1;WNT4;CDH13;PDGFB;CHID1;CLU;BIRC3;IL20;THBD;SYT11;FANCD2;GPER1;ADAM17;CSF1;CLOCK;TLR3;ESR1;DNASE1;TNF;CCL5;CD74;METAP2
3746,GO:0008285,0.0975913530921191,0.928643034809466,42,472,negative regulation of cell proliferation,BP,IGFBP3;FTH1;KRT4;PTGES;PML;CYP1B1;FGFR2;UTP20;B4GALT1;TP53;CDKN2A;PTPN14;PDPN;TGFB2;IFIT3;P3H2;SLC9A3R1;INHBA;BRIP1;SFRP1;CD274;MIR17HG;TPM1;ADM;CD109;FRK;PTPRM;SOD2;IL24;CDH13;SRF;MDM4;SMYD2;BRCA2;GPER1;TNF;RC3H1;PHF14;CDKN1A;ITGB1BP1;IRF1;CTCF
3331,GO:0007043,0.097663919271199,0.951093514512274,10,81,cell-cell junction assembly,BP,RUNX1;CNTNAP1;CDH13;SRF;UGT8;TJP1;MPP5;PARD3;GJC1;TNF
11057,GO:0045023,0.0977281931983798,0.961840289179627,6,42,G0 to G1 transition,BP,CBX5;CTGF;MDM4;RRM2;CHEK1;RING1
19713,GO:2000001,0.0977738929009568,0.97764551033438,3,16,regulation of DNA damage checkpoint,BP,WDR76;THOC1;RFWD3
669,GO:0001871,0.0978294544752198,0.987027229964892,2,7,pattern binding,MF,GPCPD1;ENPP1
6807,GO:0030247,0.0978294544752198,0.987027229964892,2,7,polysaccharide binding,MF,GPCPD1;ENPP1
5911,GO:0018130,0.0979561260152039,0.914719883786412,265,3428,heterocycle biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;PANK2;EXO1;EDN1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;DKC1;INHBA;NUP50;PHAX;SYK;NUP153;ZFP42;RELB;NBN;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;UAP1L1;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;ZNF584;TRAF1;ADM;USP43;ZNF407;ELMSAN1;NDC1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;GPHN;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;PGK1;TRIM37;GNL3L;ZNF586;NVL;CDH13;IBA57;COMMD4;SRF;MDM4;HIF1AN;NPNT;QDPR;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;ZNF484;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;WDR75;SENP1;ATR;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;RAD51B;TNF;ZFP36L2;SRSF7;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;FLAD1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
7982,GO:0032590,0.0981587594168242,0.977715290652792,3,15,dendrite membrane,CC,SHISA9;ATP2B1;GPER1
1029,GO:0002532,0.0982362174305778,0.965557456075993,5,35,production of molecular mediator involved in inflammatory response,BP,SLC7A2;IL1R2;SYK;GBP5;CHID1
4756,GO:0010931,0.0983656293877804,1,1,1,macrophage tolerance induction,BP,IRAK3
4757,GO:0010932,0.0983656293877804,1,1,1,regulation of macrophage tolerance induction,BP,IRAK3
4758,GO:0010933,0.0983656293877804,1,1,1,positive regulation of macrophage tolerance induction,BP,IRAK3
18489,GO:1903556,0.0984664446741616,0.970576764836813,4,26,negative regulation of tumor necrosis factor superfamily cytokine production,BP,AKAP8;CD274;SYT11;IRAK3
16596,GO:0097371,0.0984754569131682,0.986890843722989,2,7,MDM2/MDM4 family protein binding,MF,TP53;RFWD3
3138,GO:0006732,0.0985008749278891,0.933539953674809,27,296,coenzyme metabolic process,BP,GCLC;G6PD;MAT2A;PANK2;SCD;HMGCS1;ACSL3;PGD;NUP50;NUP153;SLC5A6;DHFR;NDC1;RANBP2;GPHN;CROT;PGK1;HACD2;QDPR;NUP160;NUP54;NNT;SCD5;PDSS1;TYMS;FLAD1;THTPA
864,GO:0002192,0.0987114618908961,0.997438841635204,1,2,IRES-dependent translational initiation of linear mRNA,BP,RBM4
17250,GO:0110017,0.0987114618908961,0.997438841635204,1,2,cap-independent translational initiation of linear mRNA,BP,RBM4
12973,GO:0051321,0.0990164602763745,0.941401791707116,16,153,meiotic cell cycle,BP,EXO1;RAD1;ZFP42;NBN;BRIP1;NDC1;WNT4;SMC2;LFNG;MYBL1;BRCA2;FANCD2;MSH6;PSMC3IP;MSH3;RAD51B
7261,GO:0031223,0.0991138083365898,0.987391463200365,2,6,auditory behavior,BP,SLC1A3;CNTNAP2
13323,GO:0052047,0.0991340700152277,1,1,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,FN1
18783,GO:1904235,0.0991340700152277,1,1,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,FN1
18784,GO:1904237,0.0991340700152277,1,1,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,FN1
20284,GO:2001202,0.0991340700152277,1,1,1,negative regulation of transforming growth factor-beta secretion,BP,FN1
17853,GO:1901988,0.0991455642234447,0.937512570296052,20,215,negative regulation of cell cycle phase transition,BP,PML;TP53;GPR132;NBN;PLK2;TOPBP1;ANAPC15;MDM4;BRCC3;E2F8;CENPF;CHEK1;PSME2;PSMB9;RFWD3;TPRA1;RBL1;ZFP36L2;PSMB10;CDKN1A
20334,GO:2001288,0.099222239742401,1,1,1,positive regulation of caveolin-mediated endocytosis,BP,NEDD4L
9134,GO:0035441,0.0993933356987656,1,1,1,cell migration involved in vasculogenesis,BP,SETD2
8588,GO:0034061,0.0994762239163182,0.965064438181086,5,34,DNA polymerase activity,MF,DKC1;POLQ;POLA1;PRIM2;POLE3
11855,GO:0046794,0.0995362134354686,0.957346274319825,7,55,transport of virus,BP,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
14862,GO:0070601,0.0999158928667627,0.986116333039599,2,8,centromeric sister chromatid cohesion,BP,NAA50;CTCF
365,GO:0000983,0.0999168406465424,0.97714164282457,3,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,TAF2;SRF;TAF1
12924,GO:0051251,0.100078457152331,0.940610813891525,16,160,positive regulation of lymphocyte activation,BP,MAP3K14;TFRC;CYLD;IL6ST;IL7R;SYK;CD274;SIRPA;SOCS1;RIF1;MSH6;AP3B1;ATAD5;CCL5;CD74;CDKN1A
12134,GO:0048172,0.10024761863487,0.986513819629066,2,7,regulation of short-term neuronal synaptic plasticity,BP,SHISA9;RAB3GAP1
19789,GO:2000146,0.100338157734435,0.938513078321788,18,174,negative regulation of cell motility,BP,IGFBP3;NRG1;CYP1B1;STARD13;SLC9A3R1;SFRP1;TPM1;ADAMTS9;PTGER4;WNT4;PTPRM;CORO1C;IL24;SRF;APEX1;DPYSL3;CITED2;ITGB1BP1
11929,GO:0046949,0.100428180030298,0.96988822156112,4,25,fatty-acyl-CoA biosynthetic process,BP,SCD;ACSL3;HACD2;SCD5
4586,GO:0010669,0.10047856653235,0.976957354206527,3,15,epithelial structure maintenance,BP,SLC22A5;SRF;MUC6
12682,GO:0050867,0.100768314829294,0.938129089312812,18,184,positive regulation of cell activation,BP,MAP3K14;TFRC;CTGF;PDPN;CYLD;IL6ST;IL7R;SYK;CD274;SIRPA;SOCS1;RIF1;MSH6;AP3B1;ATAD5;CCL5;CD74;CDKN1A
7346,GO:0031365,0.100787163740352,0.969858531487405,4,24,N-terminal protein amino acid modification,BP,NAA15;NAA50;NAA16;METAP2
11803,GO:0046651,0.100805472685916,0.941225235371841,15,151,lymphocyte proliferation,BP,TFRC;LGALS3;IL6ST;IL7R;SYK;CD274;AHR;HELLS;WNT4;ATAD5;RC3H1;CCL5;CD74;CDKN1A;IRF1
7590,GO:0031952,0.10083884638941,0.964519935795571,5,33,regulation of protein autophosphorylation,BP,CHP1;SYK;NBN;PDGFB;ENPP1
18796,GO:1904263,0.101000480790263,0.985876259380702,2,8,positive regulation of TORC1 signaling,BP,RRAGB;TELO2
17762,GO:1901671,0.101147665216653,0.997307312465816,1,2,positive regulation of superoxide dismutase activity,BP,TNF
19041,GO:1904833,0.101147665216653,0.997307312465816,1,2,positive regulation of removal of superoxide radicals,BP,TNF
11817,GO:0046683,0.101184234550249,0.948882068672009,10,85,response to organophosphorus,BP,TRIM16;AHR;RFC3;SRD5A1;THBD;APEX1;TYMS;PANX1;TAF1;PPARGC1B
3158,GO:0006767,0.101312354992349,0.95344157480576,8,66,water-soluble vitamin metabolic process,BP,GCLC;PANK2;SLC5A6;DHFR;ENPP1;MMAA;FLAD1;THTPA
7322,GO:0031326,0.101491861077982,0.911583649683263,261,3347,regulation of cellular biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;TP53;DAPK3;EDN1;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;PPP1R3B;DKC1;INHBA;NUP50;PUM3;SYK;NUP153;ZFP42;RELB;NBN;LEPR;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;MIR17HG;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;CCL20;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;TRIM37;GNL3L;ZNF586;NVL;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;BACE2;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;VPS36;TRAF2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
16112,GO:0090073,0.1015111865826,0.985762654690741,2,8,positive regulation of protein homodimerization activity,BP,GNL3L;TRAF2
1288,GO:0003093,0.101547432249496,0.985754578364055,2,8,regulation of glomerular filtration,BP,EMP2;PDGFB
10188,GO:0042770,0.101609169748407,0.943402317946318,13,121,signal transduction in response to DNA damage,BP,PML;TP53;NBN;PLK2;MDM4;BRCC3;SMYD2;BRCA2;E2F8;CHEK1;ATR;CD74;CDKN1A
14442,GO:0061733,0.101671489304148,0.956293402867726,7,53,peptide-lysine-N-acetyltransferase activity,MF,NAA50;KANSL1L;BRCA2;TAF6L;GTF3C4;CLOCK;TAF1
14658,GO:0070229,0.102141829815016,0.969083703399022,4,26,negative regulation of lymphocyte apoptotic process,BP,TSC22D3;MIR17HG;CCL5;CD74
12636,GO:0050801,0.102288084694619,0.926131066494819,38,423,ion homeostasis,BP,SAA1;FTL;FTH1;PML;JPH2;GCLC;TFRC;CLN6;TP53;EDN1;C1QTNF1;CHP1;SLC4A11;ACO1;SLC30A6;SLC9A3R1;ABCG2;GPCPD1;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;ENPP1;JPH1;THADA;SLC11A2;RIC3;TMEM199;NEDD4L;TMEM165;STEAP4;CCDC47;GPER1;SLC9A9;ESR1;CCL5
11391,GO:0045742,0.102429457174416,0.969074319618195,4,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,EPGN;MMP9;GPER1;ADAM17
4407,GO:0010155,0.102444609084717,0.985184182747144,2,9,regulation of proton transport,BP,CHP1;SLC9A3R1
247,GO:0000703,0.102888182361977,0.997211213397109,1,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,SMUG1
9611,GO:0036461,0.102908992482305,0.997210053646748,1,2,BLOC-2 complex binding,MF,RAB32
16161,GO:0090154,0.102946543038782,0.985441449605329,2,8,positive regulation of sphingolipid biosynthetic process,BP,CYR61;TNF
19870,GO:2000304,0.102946543038782,0.985441449605329,2,8,positive regulation of ceramide biosynthetic process,BP,CYR61;TNF
13511,GO:0055029,0.103004890224186,0.942411311159676,13,127,nuclear DNA-directed RNA polymerase complex,CC,TP53;POLR1A;TAF2;POLA1;MCM3;PRIM2;POLR2F;TAF6L;POLR1E;POLR3B;TAF1;TBPL1;GTF2H3
14790,GO:0070475,0.103083540841076,0.985037237720931,2,9,rRNA base methylation,BP,NOP2;METTL16
175,GO:0000381,0.10322077436502,0.963342621071814,5,34,regulation of alternative mRNA splicing, via spliceosome,BP,DDX17;RBM4;SRSF2;HNRNPU;RBM8A
15264,GO:0071407,0.103287691788801,0.925049271387351,39,423,cellular response to organic cyclic compound,BP,CYP1B1;GCLC;CYP24A1;RUNX1;CYP1A1;DDX17;EDN1;HMGCS1;INHBA;CDK4;SFRP1;ATP2B1;AHR;TSN;RAN;ARNTL;ZC3H7B;GDAP1;PDGFB;CLU;SRD5A1;APEX1;TNC;HSP90AB1;DGCR8;GPER1;CFLAR;NCBP1;CCNA2;CLOCK;TLR3;ESR1;TNF;ZFP36L2;CCL5;HNRNPU;DAXX;TAF1;PPARGC1B
7118,GO:0030913,0.103380867105028,0.985836944276594,2,7,paranodal junction assembly,BP,CNTNAP1;UGT8
12905,GO:0051224,0.103458332818577,0.94540967433192,11,103,negative regulation of protein transport,BP,FN1;PML;IL1R2;IRS1;GBP1;CHP1;SFRP1;PTGER4;SYT11;TNF;ITGB1BP1
1151,GO:0002756,0.103517353536686,0.968519532186263,4,26,MyD88-independent toll-like receptor signaling pathway,BP,TRAF3;IKBKE;BIRC3;TLR3
3114,GO:0006692,0.103575082211076,0.968394723865734,4,27,prostanoid metabolic process,BP,PTGES;EDN1;AKR1C2;CD74
3115,GO:0006693,0.103575082211076,0.968394723865734,4,27,prostaglandin metabolic process,BP,PTGES;EDN1;AKR1C2;CD74
1435,GO:0003407,0.103581164906355,0.963439469621974,5,31,neural retina development,BP,MEGF11;TGFB2;ATP2B1;PTPRM;SDK1
3489,GO:0007369,0.10367161505759,0.940787212734372,14,123,gastrulation,BP,FN1;AMOT;TXNRD1;FGFR2;MMP9;COL12A1;INHBA;ARFRP1;SFRP1;KDM6A;ITGAV;COL5A2;SRF;SETD2
12271,GO:0048536,0.103687990624422,0.968679266149358,4,24,spleen development,BP,PBX1;ADAM17;CITED2;RC3H1
644,GO:0001832,0.103698933916746,0.975891527585717,3,15,blastocyst growth,BP,NBN;GINS4;BRCA2
15352,GO:0071556,0.103701935771039,0.975334473330406,3,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,HLA-B;HLA-F;CD74
16781,GO:0098553,0.103701935771039,0.975334473330406,3,18,lumenal side of endoplasmic reticulum membrane,CC,HLA-B;HLA-F;CD74
7447,GO:0031572,0.10386461394817,0.963126804322077,5,33,G2 DNA damage checkpoint,BP,MAP3K14;NBN;TOPBP1;BRCC3;CHEK1
19320,GO:1905523,0.103985961521763,0.985207088160073,2,8,positive regulation of macrophage migration,BP,CSF1;CCL5
13958,GO:0060602,0.104054635781063,0.975772836227506,3,15,branch elongation of an epithelium,BP,FGFR2;TNC;ESR1
17359,GO:1900016,0.104137051771867,0.985172898491191,2,8,negative regulation of cytokine production involved in inflammatory response,BP,IL1R2;CHID1
12205,GO:0048333,0.104152817201516,0.97574004111845,3,15,mesodermal cell differentiation,BP,FGFR2;INHBA;KDM6A
15103,GO:0071071,0.104374321820796,0.985119144662206,2,8,regulation of phospholipid biosynthetic process,BP,ACSL3;PDGFB
3364,GO:0007127,0.104431929799239,0.951649725980869,8,67,meiosis I,BP,BRIP1;NDC1;MYBL1;BRCA2;FANCD2;PSMC3IP;MSH3;RAD51B
8361,GO:0033218,0.104496963414895,0.934590285595898,19,197,amide binding,MF,CRYAB;PTGES;HLA-B;TAP1;C9ORF3;TGFB2;INHBA;NUP153;HLA-F;DHFR;MME;ITGAV;CLU;SRD5A1;ERAP1;HSP90AB1;BACE2;TYMS;CD74
8357,GO:0033209,0.104955676621631,0.940990629012727,13,139,tumor necrosis factor-mediated signaling pathway,BP,MAP3K14;TRAF3;CYLD;SYK;TJP2;TRAF1;BIRC3;ADAM17;PSME2;PSMB9;TRAF2;TNF;PSMB10
14165,GO:0061015,0.105220536449869,0.997079644394642,1,2,snRNA import into nucleus,BP,RAN
2610,GO:0005913,0.105244669196931,0.948697527135639,9,74,cell-cell adherens junction,CC,PDLIM1;PARD3B;PTPRM;BAIAP2;CDH13;TJP1;PLEKHA7;MPP5;PARD3
1431,GO:0003401,0.105346005224696,0.96813335940386,4,23,axis elongation,BP,FGFR2;SFRP1;TNC;ESR1
17750,GO:1901655,0.105383065317203,0.951213428451797,8,64,cellular response to ketone,BP,AKAP8;SFRP1;ATP2B1;AHR;PTGER4;SRD5A1;CFLAR;AKR1B1
14035,GO:0060736,0.105396481764562,0.985394603874317,2,7,prostate gland growth,BP,FGFR2;ESR1
8216,GO:0032963,0.105515238312647,0.948508607168538,9,75,collagen metabolic process,BP,COL5A3;CTGF;MMP9;COL12A1;P3H2;COL4A1;WNT4;COL5A2;TRAM2
10277,GO:0043008,0.105534350926762,0.984855234400328,2,8,ATP-dependent protein binding,MF,PLK2;HSP90AB1
11108,GO:0045103,0.105538310035464,0.962350285545794,5,33,intermediate filament-based process,BP,NEFL;KRT2;NEFM;KRT9;DST
12287,GO:0048566,0.105680943238114,0.975227731483371,3,15,embryonic digestive tract development,BP,FGFR2;TGFB2;TNF
17334,GO:0140131,0.105743134762383,0.984807540964602,2,8,positive regulation of lymphocyte chemotaxis,BP,ADAM17;CCL5
13115,GO:0051607,0.105779214206194,0.936706307851412,16,161,defense response to virus,BP,PML;MAP3K14;NLRC5;TRIM22;DDX17;TRIM56;TRAF3;GBP1;IFIT3;FAM111A;BIRC3;SETD2;ABCC9;POLR3B;TLR3;IRF1
3333,GO:0007045,0.10583694892806,0.951111482713723,8,60,cell-substrate adherens junction assembly,BP,COL16A1;DAPK3;SFRP1;WNT4;CORO1C;AJUBA;WDPCP;ITGB1BP1
12103,GO:0048041,0.10583694892806,0.951111482713723,8,60,focal adhesion assembly,BP,COL16A1;DAPK3;SFRP1;WNT4;CORO1C;AJUBA;WDPCP;ITGB1BP1
405,GO:0001085,0.106014165564965,0.94218741125607,12,106,RNA polymerase II transcription factor binding,MF,TP53;ZFP42;AHR;NOP58;SRF;BBS5;TAF6L;RBL1;ESR1;HNRNPU;TAF1;ZNHIT6
3300,GO:0006999,0.106103347077436,0.975085498478704,3,15,nuclear pore organization,BP,NUP153;NDC1;NUP54
2821,GO:0006286,0.106145164951954,0.997026597866561,1,2,base-excision repair, base-free sugar-phosphate removal,BP,APEX1
1457,GO:0003690,0.106151260626701,0.918927381497838,54,603,double-stranded DNA binding,MF,MAFB;FOSL2;NLRC5;RUNX1;PBX1;TFCP2L1;TP53;ZBED1;AKAP8;ZFP42;RELB;MCM5;NUCKS1;MCM2;TARDBP;H3F3A;AHR;GRWD1;MYBL2;SUV39H2;KDM6A;UBTF;ORC4;RRN3;ARNTL;FEN1;APTX;SRF;UTY;NFE2L1;MACC1;GLIS2;APEX1;MYBL1;MAZ;E2F8;ETV6;HSF2;MSH6;MSH3;ORC2;CLOCK;PURB;ESR1;RAD51B;HNRNPU;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;ARID3B;IRF1;CTCF
14247,GO:0061180,0.10626704278283,0.953823970677124,7,53,mammary gland epithelium development,BP,PML;FGFR2;WNT4;BRCA2;NTN1;CSF1;ESR1
12204,GO:0048332,0.106383408561762,0.957504394335884,6,42,mesoderm morphogenesis,BP,TXNRD1;FGFR2;INHBA;KDM6A;SRF;SETD2
2613,GO:0005921,0.106390382780593,0.974770882170892,3,16,gap junction,CC,TJP1;GJC1;PANX1
5887,GO:0018022,0.106435745171765,0.943704818669694,11,95,peptidyl-lysine methylation,BP,METTL21A;SETDB1;SUV39H2;KDM6A;SETD4;VCPKMT;SMYD2;RIF1;SETD2;TET3;RBBP5
2422,GO:0005595,0.106779103720951,1,1,1,collagen type XII trimer,CC,COL12A1
11140,GO:0045163,0.10689859658278,1,1,1,clustering of voltage-gated potassium channels,BP,CNTNAP2
9289,GO:0035718,0.10710187209244,0.996971179057058,1,2,macrophage migration inhibitory factor binding,MF,CD74
20181,GO:2000848,0.107173099983866,0.996967031404938,1,2,positive regulation of corticosteroid hormone secretion,BP,C1QTNF1
10740,GO:0044087,0.107259891631078,0.917050081866637,59,668,regulation of cellular component biogenesis,BP,CRYAB;MAP2;CYR61;COL16A1;SACS;CTGF;RUNX1;TP53;DAPK3;EDN1;STAG1;CYLD;SHQ1;UTP15;SFRP1;VPS41;HEATR1;RPA1;TPM1;PTGER4;SYNPO2L;PLK2;UBQLN2;GBP5;KANK4;RHOG;WNT4;LCP1;CORO1C;DDX3X;RRN3;AJUBA;TRIM37;CDC42EP2;BAIAP2;SRF;WDR43;ANTXR1;CLU;ANLN;TJP1;LRRN3;HSPA8;SYT11;WDPCP;RAB3GAP1;FAF1;WDR75;MYO10;ATR;DPYSL3;KIF14;SYNPO2;ESR1;TNF;HNRNPU;TAF1;ITGB1BP1;GTF2H3
14732,GO:0070365,0.10737447228791,0.984432848976783,2,8,hepatocyte differentiation,BP,CYP1A1;E2F8
2928,GO:0006446,0.107381945034643,0.94990857753155,8,69,regulation of translational initiation,BP,RBM4;EIF5;HSPB1;DDX3X;EIF2B5;NCBP1;TNF;CCL5
9692,GO:0038061,0.107422489307165,0.942789366040725,11,111,NIK/NF-kappaB signaling,BP,MAP3K14;IKBKE;RELB;BIRC3;PSME2;PSMB9;TRAF2;TLR3;TNF;RC3H1;PSMB10
754,GO:0001991,0.107843295072145,0.984324500493192,2,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,C9ORF3;MME
4814,GO:0014003,0.108014895532173,0.966654649760003,4,26,oligodendrocyte development,BP,CNTNAP1;CLU;EIF2B5;EIF2B1
12327,GO:0048662,0.108039985965719,0.966537741852989,4,27,negative regulation of smooth muscle cell proliferation,BP,IGFBP3;TP53;TPM1;GPER1
203,GO:0000428,0.108211004047767,0.938989289312193,13,128,DNA-directed RNA polymerase complex,CC,TP53;POLR1A;TAF2;POLA1;MCM3;PRIM2;POLR2F;TAF6L;POLR1E;POLR3B;TAF1;TBPL1;GTF2H3
10986,GO:0044766,0.108347653242947,0.949388651585318,8,68,multi-organism transport,BP,NUP50;NUP153;NDC1;THOC1;RAN;RANBP2;NUP160;NUP54
18073,GO:1902579,0.108347653242947,0.949388651585318,8,68,multi-organism localization,BP,NUP50;NUP153;NDC1;THOC1;RAN;RANBP2;NUP160;NUP54
4234,GO:0009411,0.108365423735466,0.93895924178285,13,123,response to UV,BP,PML;TP53;MME;CDC25A;FEN1;BRCA2;CHEK1;RAD18;ATR;MSH6;TAF1;CDKN1A;USP1
10582,GO:0043535,0.108483642725945,0.9494136084427,8,65,regulation of blood vessel endothelial cell migration,BP,HDAC9;STAT5A;STARD13;PLK2;HSPB1;PDGFB;ADAM17;ITGB1BP1
4104,GO:0009157,0.108506889342201,0.983767103157209,2,9,deoxyribonucleoside monophosphate biosynthetic process,BP,TK1;TYMS
12165,GO:0048256,0.108507776223811,0.984170424389715,2,8,flap endonuclease activity,MF,EXO1;FEN1
4305,GO:0009753,0.108672118807748,0.996879045083268,1,2,response to jasmonic acid,BP,AKR1C2
5982,GO:0018636,0.108672118807748,0.996879045083268,1,2,phenanthrene 9,10-monooxygenase activity,MF,AKR1C2
11963,GO:0047023,0.108672118807748,0.996879045083268,1,2,androsterone dehydrogenase activity,MF,AKR1C2
11970,GO:0047086,0.108672118807748,0.996879045083268,1,2,ketosteroid monooxygenase activity,MF,AKR1C2
11972,GO:0047115,0.108672118807748,0.996879045083268,1,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,AKR1C2
15255,GO:0071395,0.108672118807748,0.996879045083268,1,2,cellular response to jasmonic acid stimulus,BP,AKR1C2
9948,GO:0042289,0.108750891700399,0.9968743845779,1,2,MHC class II protein binding,MF,CD74
12232,GO:0048407,0.108968375842753,0.984597525853005,2,7,platelet-derived growth factor binding,MF,COL4A1;PDGFB
6567,GO:0022010,0.108990571474924,0.9840581022426,2,8,central nervous system myelination,BP,CNTNAP1;CLU
7776,GO:0032291,0.108990571474924,0.9840581022426,2,8,axon ensheathment in central nervous system,BP,CNTNAP1;CLU
6824,GO:0030278,0.109150816757552,0.938537787520453,13,117,regulation of ossification,BP,CYR61;FGFR2;PBX1;TGFB2;IL6ST;SFRP1;PTGER4;WNT4;NPNT;KREMEN2;ENPP1;CSF1;TNF
6468,GO:0021794,0.10919551223903,0.98454627122109,2,7,thalamus development,BP,SRD5A1;CNTNAP2
12816,GO:0051091,0.109203943234205,0.932213931895711,18,183,positive regulation of DNA binding transcription factor activity,BP,TRIM22;EDN1;RIPK4;TRAF1;TRIM37;SRF;FZD1;CLU;NFKBIB;CFLAR;TRAF2;CLOCK;TLR3;ESR1;TNF;TAF1;PPARGC1B;IRAK3
16439,GO:0097057,0.109222018533292,0.996846433999984,1,2,TRAF2-GSTP1 complex,CC,TRAF2
12546,GO:0050671,0.109320111410862,0.948708081469551,8,72,positive regulation of lymphocyte proliferation,BP,TFRC;IL6ST;SYK;CD274;ATAD5;CCL5;CD74;CDKN1A
13787,GO:0060343,0.10957902782826,0.973905013285748,3,15,trabecula formation,BP,SFRP1;SRF;PPARGC1B
15356,GO:0071560,0.109613923475976,0.933042067238139,17,163,cellular response to transforming growth factor beta stimulus,BP,PML;FGFR2;FBN1;EDN1;TGFB2;SFRP1;WNT10A;MIR17HG;CD109;WNT4;NPNT;HSP90AB1;ADAM17;CFLAR;CITED2;PARD3;ZFP36L2
1152,GO:0002757,0.110006397001811,0.923305754586205,30,331,immune response-activating signal transduction,BP,RUNX1;ACTG1;TRAF3;SPG21;GBP1;LGALS3;CYLD;IKBKE;SYK;RELB;MUC16;BTN2A1;BAIAP2;BIRC3;HSP90AB1;MYO10;PSME2;PSMB9;EIF2B5;CMTM3;TLR3;ESR1;RC3H1;PSMB10;EIF2B1;NRAS;MUC5B;MUC6;IRF1;IRAK3
6151,GO:0019438,0.11021101307736,0.903641422728968,264,3425,aromatic compound biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;PANK2;EXO1;EDN1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;DKC1;INHBA;NUP50;PHAX;SYK;NUP153;ZFP42;RELB;NBN;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;UAP1L1;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;ZNF584;TRAF1;ADM;USP43;ZNF407;ELMSAN1;NDC1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;PGK1;TRIM37;GNL3L;ZNF586;NVL;CDH13;IBA57;COMMD4;SRF;MDM4;HIF1AN;NPNT;QDPR;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;ZNF484;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;WDR75;SENP1;ATR;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;RAD51B;TNF;ZFP36L2;SRSF7;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;FLAD1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
4808,GO:0012501,0.110268904626968,0.908186831712112,118,1485,programmed cell death,BP,CRYAB;IGFBP3;SPRR3;KRT1;NEFL;SPRR2A;KRT34;KRT4;KRT13;PML;CYP1B1;MAP3K14;GCLC;KRT2;CYR61;KRT15;FGFR2;CTGF;MMP9;XAF1;B4GALT1;G6PD;TSC22D3;TRAF3;TP53;DAPK3;EDN1;DDX47;CDKN2A;NQO1;PRUNE2;LGALS3;PDPN;TGFB2;CYLD;IKBKE;IFIT3;IL6ST;BAG1;SLC9A3R1;INHBA;NAIP;NBN;TRIO;SHQ1;CDK4;SFRP1;KRT9;CD274;MCM2;TARDBP;MIR17HG;AHR;NAA15;TCHH;DRAM1;ARRDC1-AS1;TRAF1;ADM;DYNLL2;PLK2;MYBL2;HSPB1;WNT4;THOC1;SOD2;DDX3X;IL24;RRN3;ITGAV;SET;TRPM7;KRT24;GADD45B;MDM4;CLU;BIRC3;EYA3;ACKR3;BLOC1S2;APEX1;PDCL3;HSP90AB1;ARL6IP5;EPHB6;SGK1;BRCA2;KRT10;CCAR1;ETV6;CHEK1;SERPINB9;GPER1;FAF1;RPTN;ADAM17;SENP1;NTN1;MSH6;CFLAR;EIF2B5;AKR1B1;TRAF2;CITED2;NAA16;KIF14;TLR3;ESR1;DNASE1;TNF;CCL5;CD74;DAXX;PHLPP1;CDKN1A;IRF1;GPX4;IFI27L1
12186,GO:0048291,0.11035664555015,0.983738581576348,2,8,isotype switching to IgG isotypes,BP,IL27RA;ATAD5
18261,GO:1903039,0.110498077294806,0.937510155667057,13,126,positive regulation of leukocyte cell-cell adhesion,BP,MAP3K14;TFRC;CYLD;IL6ST;IL7R;SYK;CD274;SIRPA;SOCS1;AP3B1;TNF;CCL5;CD74
15312,GO:0071480,0.110559166950756,0.965586123409504,4,26,cellular response to gamma radiation,BP,CRYAB;TP53;ATR;CDKN1A
6806,GO:0030246,0.110576193992029,0.937503098125935,13,123,carbohydrate binding,MF,KRT1;G6PD;LGALS3;P3H2;GALNT18;GPCPD1;LAYN;MGAM;P4HA2;GANC;CHID1;ENPP1;M6PR
13543,GO:0055094,0.110580006085715,0.973332448593579,3,16,response to lipoprotein particle,BP,HMGCS1;SYK;CDH13
12599,GO:0050746,0.110645619145865,0.983670669300665,2,8,regulation of lipoprotein metabolic process,BP,ITGAV;RAB3GAP1
15350,GO:0071550,0.11065706847637,0.983252289766558,2,9,death-inducing signaling complex assembly,BP,TRAF2;TNF
2202,GO:0005080,0.110682612758793,0.959765725720524,5,35,protein kinase C binding,MF,HDAC9;IRS1;SRSF2;HSPB1;ITGAV
11909,GO:0046914,0.110710240172903,0.913460973690666,63,734,transition metal ion binding,MF,HEPHL1;TRIM47;FTL;FTH1;DTX2;TRIM16;PML;CYP1B1;CYP24A1;TRIM22;S100P;MMP9;XAF1;CYP1A1;B4GALT1;TRIM56;TRAF3;MID1;TP53;C9ORF3;SCD;RBM4;AKAP8;ZNF208;CYLD;P3H2;USP16;TCHH;HRNR;POLR1A;ZMAT2;CSRP1;ADAMTS9;SETDB1;TK1;TRAF1;P4HA2;ZNF407;MME;SUV39H2;SOD2;CPA4;QPCT;TRIM37;MDM4;HIF1AN;ENPP1;TTF2;DTX4;ERAP1;SLC11A2;TET3;SCD5;DNPEP;ZNFX1;RPTN;MYNN;TRAF2;CYP20A1;ESR1;SRSF7;FTO;CTCF
9913,GO:0042222,0.110735140413215,0.996755772505204,1,2,interleukin-1 biosynthetic process,BP,CCL20
11241,GO:0045360,0.110735140413215,0.996755772505204,1,2,regulation of interleukin-1 biosynthetic process,BP,CCL20
11242,GO:0045362,0.110735140413215,0.996755772505204,1,2,positive regulation of interleukin-1 biosynthetic process,BP,CCL20
13498,GO:0055013,0.110835286981063,0.955535747891475,6,38,cardiac muscle cell development,BP,G6PD;EDN1;NEXN;SRF;MYH11;HNRNPU
8974,GO:0035036,0.110873161041708,0.972696568825508,3,19,sperm-egg recognition,BP,B4GALT1;GLIPR1L2;UBAP2L
4625,GO:0010743,0.110907292593327,0.973218975704398,3,16,regulation of macrophage derived foam cell differentiation,BP,ITGAV;ABCA5;CSF1
20299,GO:2001233,0.110939585753812,0.924121855343111,27,307,regulation of apoptotic signaling pathway,BP,PML;GCLC;MMP9;TP53;DAPK3;LGALS3;CYLD;SLC9A3R1;INHBA;SFRP1;TRAF1;DYNLL2;HSPB1;WNT4;SOD2;DDX3X;RRN3;ITGAV;CLU;EYA3;ACKR3;GPER1;FAF1;CFLAR;TRAF2;TNF;CD74
1361,GO:0003229,0.110991739760616,0.959886378178992,5,32,ventricular cardiac muscle tissue development,BP,NRG1;FGFR2;TGFB2;TPM1;ADAMTS9
1116,GO:0002702,0.111088944516596,0.954746808013586,6,48,positive regulation of production of molecular mediator of immune response,BP,TFRC;RIF1;MSH6;TRAF2;ATAD5;CD74
16915,GO:0098840,0.11114477581447,0.996730994022947,1,2,protein transport along microtubule,BP,HSPB1
17032,GO:0099118,0.11114477581447,0.996730994022947,1,2,microtubule-based protein transport,BP,HSPB1
4495,GO:0010518,0.111314243990966,0.965387091177711,4,25,positive regulation of phospholipase activity,BP,CYR61;FGFR2;ESR1;CCL5
12583,GO:0050716,0.111377839605931,0.972853587574522,3,17,positive regulation of interleukin-1 secretion,BP,SAA1;TRIM16;PANX1
13487,GO:0055001,0.111442379935763,0.940699374653973,11,89,muscle cell development,BP,HDAC9;ACTG1;G6PD;EDN1;TPM1;ADM;NEXN;SRF;MYH11;CFLAR;HNRNPU
4519,GO:0010569,0.111472885417653,0.965320174638806,4,25,regulation of double-strand break repair via homologous recombination,BP,POLQ;RIF1;SETD2;CHEK1
7960,GO:0032553,0.111579890996789,0.906887456373244,121,1435,ribonucleotide binding,MF,KIF23;MAP3K14;GCLC;NLRC5;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;GBP1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;RAB32;TRIO;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;RIPK4;MCM2;POLQ;TSR1;ATP2B1;HELLS;ULK4;ABCC4;TK1;LSG1;G3BP1;MDN1;EIF5;PLK2;RRAGB;FRK;GBP5;RHOG;DDX28;RAN;ORC4;ATP2C1;DDX3X;RAB26;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;GNL3L;NVL;GATC;RARS;MCM8;SGK494;ENPP1;CBWD5;DDX10;EFTUD2;DDX24;TYW1;MCM6;ABCC9;TTF2;SRPRB;SEPHS2;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;PPIP5K1;CHEK1;MMAA;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;HNRNPU;FLAD1;TAF1;NRAS;ABCA11P;GBP6;IRAK3;DHX15
6494,GO:0021846,0.111735528929818,0.973432592932599,3,14,cell proliferation in forebrain,BP,FGFR2;RRM1;KIF14
19924,GO:2000379,0.111997787400942,0.950477218784755,7,58,positive regulation of reactive oxygen species metabolic process,BP,TP53;EDN1;PDGFB;CLU;HSP90AB1;TNF;CDKN1A
4365,GO:0009967,0.112031086257159,0.909076971558035,88,1067,positive regulation of signal transduction,BP,IGFBP3;SAA1;NRG1;TRIM16;PML;CYP1B1;JPH2;MAP3K14;CYR61;C3;NLRC5;FGFR2;EPGN;TRIM22;CTGF;MMP9;IRS1;MID1;TP53;DAPK3;EDN1;C1QTNF1;JRK;TGFB2;CNTNAP1;CYLD;IKBKE;IL6ST;SLC9A3R1;INHBA;IL7R;SYK;EMP2;NAIP;SFRP1;NUCKS1;DYNLL2;CCL20;PLK2;RRAGB;UBQLN2;WNT4;ATP2C1;DDX3X;IL24;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;AKR1C2;LFNG;NETO1;BAIAP2;GADD45B;CDH13;NPNT;PDGFB;BIRC3;IL20;ACKR3;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;GPER1;FAF1;ADAM17;ATR;PSME2;CFLAR;PSMB9;CMTM3;AKR1B1;TRAF2;TELO2;CITED2;CSF1;TLR3;ESR1;TNF;RC3H1;CCL5;CD74;PSMB10;DAXX;TAF1;ITGB1BP1
3230,GO:0006885,0.112092206701683,0.947204403181809,8,69,regulation of pH,BP,CLN6;TP53;EDN1;CHP1;SLC4A11;TMEM199;TMEM165;SLC9A9
1109,GO:0002695,0.112158572684171,0.942086025758949,10,89,negative regulation of leukocyte activation,BP,LGALS3;CYLD;INHBA;SFRP1;CD274;THOC1;GPER1;RC3H1;CD74;IRF1
11527,GO:0046007,0.112182196729384,0.983307669203887,2,8,negative regulation of activated T cell proliferation,BP,CD274;RC3H1
11115,GO:0045113,0.112308633343253,0.996660047313975,1,2,regulation of integrin biosynthetic process,BP,TGFB2
10444,GO:0043280,0.112312345557271,0.9397256424392,11,109,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PML;CYR61;CTGF;DDX3X;ARL6IP5;GPER1;SENP1;CFLAR;TRAF2;TNF;IFI27L1
10974,GO:0044725,0.112325407116922,1,1,1,chromatin reprogramming in the zygote,BP,TET3
10975,GO:0044727,0.112325407116922,1,1,1,DNA demethylation of male pronucleus,BP,TET3
7789,GO:0032309,0.112325992078346,0.972521016820897,3,17,icosanoid secretion,BP,EDN1;SYK;ABCC4
8959,GO:0035004,0.112352446889501,0.954521973832871,6,41,phosphatidylinositol 3-kinase activity,MF,NRG1;FGFR2;IRS1;PDGFB;PIK3R3;ESR1
16288,GO:0090330,0.112398451085798,0.972699965385106,3,16,regulation of platelet aggregation,BP,C1QTNF1;PDPN;SYK
1072,GO:0002635,0.11244569140878,1,1,1,negative regulation of germinal center formation,BP,RC3H1
7757,GO:0032268,0.112620018991279,0.904431456117512,150,1903,regulation of cellular protein metabolic process,BP,CRYAB;IGFBP3;SAA1;NRG1;FN1;PML;MAP3K14;GCLC;CYR61;C3;GPRC5A;FGFR2;EPGN;CTGF;MMP9;CLN6;IL1R2;G6PD;ENC1;MID1;TP53;DAPK3;EDN1;GBP1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;GEMIN5;CHP1;ACO1;AKAP8;TGFB2;PKMYT1;PPP1R3B;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;PUM3;SYK;EMP2;NUP153;NAIP;NBN;CDK4;SFRP1;TARDBP;MIR17HG;H3F3A;USP16;KEAP1;DHFR;ULK4;OPHN1;CD109;NDC1;EIF5;CASC3;CCL20;PLK2;UBQLN2;AKAP8L;HSPB1;RAN;RANBP2;CORO1C;DDX3X;IL24;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;AJUBA;FASTKD3;DND1;ZC3H7B;PPP4R4;GNL3L;GADD45B;SH3RF2;PHACTR4;NPNT;PDGFB;FZD1;ANTXR1;CLU;NUP160;ENPP1;BIRC3;IL20;NUP54;LRPPRC;ACKR3;RIF1;METTL16;GLIPR2;PDCL3;HSP90AB1;ARL6IP5;EPHB6;SYNCRIP;DGCR8;POLR2F;RAB3GAP1;CHEK1;SERPINB9;GPER1;FAF1;ADAM17;SENP1;RBMS3;PSME2;CFLAR;EIF2B5;DPH2;NCBP1;UPF3B;TRAF2;TELO2;HNRNPR;NCL;CSF1;KIF14;TLR3;ESR1;PARD3;RNF19B;TNF;ZFP36L2;RC3H1;TYMS;CCL5;CD74;FGFR1OP;DAXX;HIST1H4A;TAF1;PHLPP1;SMARCC1;CDKN1A;ITGB1BP1;CTCF;RBM8A;IRAK3;IFI27L1
19985,GO:2000501,0.112625370212569,0.996640599624612,1,2,regulation of natural killer cell chemotaxis,BP,CCL5
19986,GO:2000503,0.112625370212569,0.996640599624612,1,2,positive regulation of natural killer cell chemotaxis,BP,CCL5
13065,GO:0051536,0.112880049426165,0.949873283821473,7,61,iron-sulfur cluster binding,MF,ACO1;CDKAL1;BRIP1;POLA1;TYW1;PRIM2;DPYD
13069,GO:0051540,0.112880049426165,0.949873283821473,7,61,metal cluster binding,MF,ACO1;CDKAL1;BRIP1;POLA1;TYW1;PRIM2;DPYD
11087,GO:0045073,0.113335321628519,0.982602172611516,2,9,regulation of chemokine biosynthetic process,BP,TLR3;TNF
214,GO:0000447,0.113521948661702,0.982556505476,2,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,UTP20;FCF1
19942,GO:2000403,0.113697250869801,0.972037675138899,3,17,positive regulation of lymphocyte migration,BP,CCL20;ADAM17;CCL5
6866,GO:0030330,0.113919682546982,0.938851876134087,11,101,DNA damage response, signal transduction by p53 class mediator,BP,PML;TP53;NBN;PLK2;MDM4;SMYD2;BRCA2;E2F8;ATR;CD74;CDKN1A
11597,GO:0046136,0.114118155283816,0.996548134838079,1,2,positive regulation of vitamin metabolic process,BP,TNF
13926,GO:0060557,0.114118155283816,0.996548134838079,1,2,positive regulation of vitamin D biosynthetic process,BP,TNF
13928,GO:0060559,0.114118155283816,0.996548134838079,1,2,positive regulation of calcidiol 1-monooxygenase activity,BP,TNF
20286,GO:2001204,0.114167543560983,0.983407368884182,2,7,regulation of osteoclast development,BP,FBN1;TJP2
6655,GO:0030001,0.114250354042513,0.915651616024964,41,453,metal ion transport,BP,HEPHL1;FTL;FTH1;PML;JPH2;TFRC;CTGF;G6PD;LGALS3;CHP1;SLC4A11;IL16;SLC30A6;SLC9A3R1;SLC22A5;ATP2B1;SLC5A6;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;NETO1;PDGFB;COMMD9;ABCC9;JPH1;THADA;SLC11A2;NSF;NEDD4L;SGK1;TMEM165;STEAP4;GPER1;SLC9A9;KCNE4;CCL5;PANX1;SLC41A2
8463,GO:0033593,0.114444875824649,1,1,1,BRCA2-MAGE-D1 complex,CC,BRCA2
15761,GO:0072321,0.11450481909057,0.98197119971957,2,10,chaperone-mediated protein transport,BP,CLU;HSPA8
14392,GO:0061618,0.114766266416315,1,1,1,sublamina densa,CC,FRAS1
5817,GO:0017076,0.114767640391607,0.904086007328641,121,1438,purine nucleotide binding,MF,KIF23;MAP3K14;GCLC;NLRC5;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;GBP1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;BAG1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;RAB32;TRIO;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;RIPK4;MCM2;POLQ;TSR1;ATP2B1;HELLS;ULK4;ABCC4;TK1;LSG1;G3BP1;MDN1;EIF5;PLK2;RRAGB;FRK;GBP5;RHOG;DDX28;RAN;ORC4;ATP2C1;DDX3X;RAB26;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;GNL3L;NVL;GATC;RARS;MCM8;SGK494;ENPP1;CBWD5;DDX10;EFTUD2;DDX24;MCM6;ABCC9;TTF2;SRPRB;SEPHS2;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;PPIP5K1;CHEK1;MMAA;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;HNRNPU;FLAD1;TAF1;NRAS;ABCA11P;GBP6;IRAK3;DHX15
7962,GO:0032555,0.114942860931131,0.903996142101244,120,1424,purine ribonucleotide binding,MF,KIF23;MAP3K14;GCLC;NLRC5;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;GBP1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;RAB32;TRIO;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;RIPK4;MCM2;POLQ;TSR1;ATP2B1;HELLS;ULK4;ABCC4;TK1;LSG1;G3BP1;MDN1;EIF5;PLK2;RRAGB;FRK;GBP5;RHOG;DDX28;RAN;ORC4;ATP2C1;DDX3X;RAB26;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;GNL3L;NVL;GATC;RARS;MCM8;SGK494;ENPP1;CBWD5;DDX10;EFTUD2;DDX24;MCM6;ABCC9;TTF2;SRPRB;SEPHS2;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;PPIP5K1;CHEK1;MMAA;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;HNRNPU;FLAD1;TAF1;NRAS;ABCA11P;GBP6;IRAK3;DHX15
7091,GO:0030880,0.115189780105665,0.934341764811654,13,130,RNA polymerase complex,CC,TP53;POLR1A;TAF2;POLA1;MCM3;PRIM2;POLR2F;TAF6L;POLR1E;POLR3B;TAF1;TBPL1;GTF2H3
13533,GO:0055083,0.115233149921254,0.971946381452739,3,15,monovalent inorganic anion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
3717,GO:0008237,0.11527214207349,0.938031810132384,11,99,metallopeptidase activity,MF,MMP9;C9ORF3;RCE1;ADAMTS9;MME;CPA4;BRCC3;ERAP1;DNPEP;ADAM17;METAP2
381,GO:0001013,0.115313659441445,0.982558098063351,2,8,RNA polymerase I regulatory region DNA binding,MF,UBTF;RRN3
435,GO:0001163,0.115313659441445,0.982558098063351,2,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,UBTF;RRN3
436,GO:0001164,0.115313659441445,0.982558098063351,2,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,UBTF;RRN3
441,GO:0001188,0.115313659441445,0.982558098063351,2,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,UBTF;RRN3
11274,GO:0045505,0.115430161305126,0.96427218773488,4,21,dynein intermediate chain binding,MF,DYNC2H1;DNHD1;DYNLL2;RAN
18552,GO:1903708,0.115446613962127,0.935958963584187,12,113,positive regulation of hemopoiesis,BP,RUNX1;CYLD;INHBA;IL7R;SYK;SOCS1;IL20;CSF1;AP3B1;TNF;CD74;PPARGC1B
2536,GO:0005791,0.115680508906004,0.948281939106239,7,62,rough endoplasmic reticulum,CC,EDN1;CDKAL1;TMEM97;BAIAP2;SRPRB;CCDC47;TRAM2
11865,GO:0046831,0.115769633662118,0.971758102383605,3,15,regulation of RNA export from nucleus,BP,NUP153;AKAP8L;SETD2
15141,GO:0071214,0.115792664955196,0.923915869144814,22,230,cellular response to abiotic stimulus,BP,CRYAB;MAP3K14;GCLC;TP53;CHP1;RAD1;RELB;SFRP1;NUCKS1;PTGER4;MME;DDX3X;CDC25A;CHEK1;ATR;AKR1B1;CLOCK;TLR3;METAP2;TAF1;CDKN1A;IRF1
17208,GO:0104004,0.115792664955196,0.923915869144814,22,230,cellular response to environmental stimulus,BP,CRYAB;MAP3K14;GCLC;TP53;CHP1;RAD1;RELB;SFRP1;NUCKS1;PTGER4;MME;DDX3X;CDC25A;CHEK1;ATR;AKR1B1;CLOCK;TLR3;METAP2;TAF1;CDKN1A;IRF1
19075,GO:1904892,0.115797097211018,0.942175020914006,9,82,regulation of STAT cascade,BP,CYP1B1;IL6ST;IL7R;IL24;SOCS1;PARP14;IL20;AKR1B1;CCL5
11364,GO:0045682,0.115941260217362,0.94500736984087,8,68,regulation of epidermis development,BP,TRIM16;RUNX1;FST;TGFB2;KEAP1;CD109;IL20;TNF
9694,GO:0038063,0.115990628984398,0.982981689231937,2,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,SYK;COL4A1
3195,GO:0006825,0.116036913307492,0.971018888448159,3,18,copper ion transport,BP,HEPHL1;SLC11A2;STEAP4
13788,GO:0060346,0.116138705375962,0.982946924671779,2,7,bone trabecula formation,BP,SFRP1;PPARGC1B
7811,GO:0032355,0.116320610311317,0.94185836845413,9,82,response to estradiol,BP,CRYAB;CTGF;NQO1;SFRP1;SRD5A1;GPER1;CFLAR;CCNA2;ESR1
13939,GO:0060576,0.116323843417672,0.981865186967992,2,9,intestinal epithelial cell development,BP,TYMS;CDKN1A
4716,GO:0010876,0.116390851298621,0.923522017541943,22,223,lipid localization,BP,C3;EDN1;C1QTNF1;ACSL3;IKBKE;INHBA;SYK;ABCG2;APOL6;ABCC4;ITGAV;CROT;CLU;ENPP1;SPNS1;ABCA5;EHD1;ARV1;TNF;STARD7;FTO;ABCA11P
1147,GO:0002740,0.116454041391568,0.996400767422774,1,2,negative regulation of cytokine secretion involved in immune response,BP,TNF
1211,GO:0002874,0.116454041391568,0.996400767422774,1,2,regulation of chronic inflammatory response to antigenic stimulus,BP,TNF
15362,GO:0071568,0.116862328566696,0.99637467266811,1,2,UFM1 transferase activity,MF,UFC1
13530,GO:0055080,0.116900516637957,0.916107818808321,34,379,cation homeostasis,BP,SAA1;FTL;FTH1;PML;JPH2;TFRC;CLN6;TP53;EDN1;C1QTNF1;CHP1;SLC4A11;ACO1;SLC30A6;ABCG2;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;JPH1;THADA;SLC11A2;RIC3;TMEM199;NEDD4L;TMEM165;STEAP4;CCDC47;GPER1;SLC9A9;ESR1;CCL5
2457,GO:0005668,0.116901296393239,0.996372176883791,1,2,RNA polymerase transcription factor SL1 complex,CC,TAF1D
10913,GO:0044449,0.117114654511709,0.931836996240729,14,120,contractile fiber part,CC,CRYAB;JPH2;PDLIM1;DST;TPM1;SYNPO2L;NEXN;HSPB1;NPNT;TPM4;ABCC9;JPH1;MYH11;SYNPO2
7927,GO:0032496,0.117334915962235,0.925345512492631,19,204,response to lipopolysaccharide,BP,PTGES;FGFR2;CYP1A1;EDN1;AKAP8;CDK4;CD274;PTGER4;ADM;CCL20;IL24;NFKBIB;THBD;IFNAR1;IL12RB2;ADAM17;TNF;CCL5;IRAK3
3943,GO:0008630,0.11742760166623,0.938694986655914,10,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,PML;TP53;IKBKE;CLU;ACKR3;BRCA2;MSH6;TNF;CD74;CDKN1A
14836,GO:0070557,0.11747910899189,0.996335062260514,1,2,PCNA-p21 complex,CC,CDKN1A
5921,GO:0018193,0.117515889752412,0.905385678253603,79,945,peptidyl-amino acid modification,BP,NRG1;HDAC9;TRIM16;GPRC5A;FGFR2;STAT5A;EPGN;TP53;DAPK3;TPST1;ZBED1;ST6GALNAC5;IKBKE;P3H2;IL6ST;NUP50;GALNT18;CAMK1G;SYK;NUP153;SFRP1;ZDHHC6;NAA15;METTL21A;SETDB1;P4HA2;GGCX;NDC1;PLK2;FRK;DOHH;SUV39H2;KDM6A;SETD4;RANBP2;VCPKMT;CPA4;IL24;SOCS1;SET;PARP14;QPCT;GNL3L;HIF1AN;PDGFB;NUP160;SMYD2;NAA50;IL20;NUP54;RIF1;SETD2;DPY19L2P2;WEE1;PDCL3;TET3;SGK1;BRCA2;FKBP5;CHEK1;IL12RB2;ADAM17;SENP1;ATR;TAF6L;DPH2;RBBP5;GTF3C4;POLE3;NAA16;CLOCK;PARD3;TNF;CCL5;CD74;FGFR1OP;METAP2;TAF1;CTCF
9832,GO:0042035,0.117532938508983,0.947408558873794,7,58,regulation of cytokine biosynthetic process,BP,INHBA;SYK;CCL20;HSPB1;TLR3;TNF;IRF1
20300,GO:2001234,0.117544650672502,0.928492368351971,16,167,negative regulation of apoptotic signaling pathway,BP,GCLC;MMP9;LGALS3;HSPB1;WNT4;SOD2;DDX3X;RRN3;ITGAV;CLU;EYA3;ACKR3;CFLAR;TRAF2;TNF;CD74
8167,GO:0032890,0.118178138811854,0.962328845325213,4,26,regulation of organic acid transport,BP,EDN1;SYK;ARL6IP5;RAB3GAP1
687,GO:0001894,0.118232957292927,0.932400742785837,13,124,tissue homeostasis,BP,KRT1;TFRC;CTGF;ACTG1;SLC22A5;SYK;HSPB1;SRF;AKR1B1;CSF1;WDR36;PPARGC1B;MUC6
10025,GO:0042445,0.11827435400521,0.934021799310085,12,118,hormone metabolic process,BP,CYP1B1;CYP1A1;C9ORF3;ADM;MME;WNT4;AKR1C2;SRD5A1;BACE2;AKR1B1;ESR1;TNF
3273,GO:0006953,0.11827924728285,0.970209997151002,3,18,acute-phase response,BP,SAA1;FN1;TNF
3767,GO:0008311,0.118295462559184,0.99628228254779,1,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,APEX1
3279,GO:0006959,0.118306163241476,0.943194292931451,8,83,humoral immune response,BP,KRT1;C1R;C3;EXO1;CLU;HMGN2;TNF;PSMB10
4189,GO:0009265,0.118415506655247,0.980980254242303,2,10,2'-deoxyribonucleotide biosynthetic process,BP,TYMS;TBPL1
11666,GO:0046385,0.118415506655247,0.980980254242303,2,10,deoxyribose phosphate biosynthetic process,BP,TYMS;TBPL1
174,GO:0000380,0.118572368018749,0.950949947364001,6,46,alternative mRNA splicing, via spliceosome,BP,DDX17;RBM4;SRSF2;HNRNPU;HNRNPM;RBM8A
9911,GO:0042220,0.118650590712777,0.962253719482576,4,25,response to cocaine,BP,SDK1;EFTUD2;HSP90AB1;CCNA2
5523,GO:0016486,0.118665573020952,0.970263204598643,3,17,peptide hormone processing,BP,C9ORF3;MME;BACE2
7423,GO:0031508,0.118781097807554,0.996250694070669,1,2,pericentric heterochromatin assembly,BP,HELLS
10662,GO:0043691,0.118975637381137,0.981664951758807,2,8,reverse cholesterol transport,BP,CLU;ABCA5
7117,GO:0030911,0.119032799326578,0.981650868946862,2,8,TPR domain binding,MF,HSP90AB1;TRAK2
8102,GO:0032781,0.119036871832542,0.955306838644673,5,41,positive regulation of ATPase activity,BP,TPM1;DYNLL2;HSCB;DNAJC9;HNRNPU
19273,GO:1905397,0.119261447440975,0.996219309313503,1,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
19274,GO:1905402,0.119261447440975,0.996219309313503,1,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
14684,GO:0070274,0.119345556617899,0.996213799503607,1,2,RES complex,CC,BUD13
12923,GO:0051250,0.119396060924529,0.940076462093519,9,79,negative regulation of lymphocyte activation,BP,LGALS3;CYLD;INHBA;SFRP1;CD274;THOC1;RC3H1;CD74;IRF1
13124,GO:0051639,0.119595136301441,0.981512096959262,2,8,actin filament network formation,BP,COBLL1;LCP1
5937,GO:0018212,0.119654322545917,0.920301466492088,23,237,peptidyl-tyrosine modification,BP,NRG1;GPRC5A;FGFR2;STAT5A;EPGN;TP53;TPST1;IL6ST;SYK;SFRP1;FRK;IL24;SOCS1;PARP14;PDGFB;IL20;WEE1;PDCL3;IL12RB2;ADAM17;CCL5;CD74;FGFR1OP
1684,GO:0004146,0.119683895173691,0.996191592478962,1,2,dihydrofolate reductase activity,MF,DHFR
10447,GO:0043292,0.119703190845396,0.928587647902376,15,133,contractile fiber,CC,CRYAB;JPH2;ACTG1;PDLIM1;DST;TPM1;SYNPO2L;NEXN;HSPB1;NPNT;TPM4;ABCC9;JPH1;MYH11;SYNPO2
7784,GO:0032303,0.119717137106118,0.981013691235107,2,9,regulation of icosanoid secretion,BP,EDN1;SYK
19993,GO:2000520,0.119880419947246,0.99617866169396,1,2,regulation of immunological synapse formation,BP,LGALS3
19994,GO:2000521,0.119880419947246,0.99617866169396,1,2,negative regulation of immunological synapse formation,BP,LGALS3
20277,GO:2001188,0.119880419947246,0.99617866169396,1,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
20278,GO:2001189,0.119880419947246,0.99617866169396,1,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
8066,GO:0032728,0.120056925980385,0.961512559937386,4,26,positive regulation of interferon-beta production,BP,DDX3X;POLR3B;TLR3;IRF1
18928,GO:1904589,0.120061561983686,0.950163832604229,6,46,regulation of protein import,BP,CHP1;RBM22;NUP54;HSPA8;HSP90AB1;CDKN1A
224,GO:0000463,0.120097032419562,0.980547707031903,2,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,RPF2;NOL9
11299,GO:0045595,0.120214621933424,0.901225572619813,96,1157,regulation of cell differentiation,BP,IGFBP3;MAFB;NEFL;NRG1;HDAC9;TRIM16;MAP2;FN1;TENM3;CYR61;FGFR2;CTGF;FBN1;RUNX1;FAT4;PBX1;G6PD;DDX17;ENC1;EDN1;GBP1;RBM4;LGALS3;PDPN;TGFB2;CYLD;IL6ST;INHBA;IL7R;SYK;EMP2;TJP2;TRIO;SFRP1;MIR17HG;H3F3A;KEAP1;ULK4;ADAMTS9;ADM;CD109;PLK2;WNT4;CORO1C;RRN3;ITGAV;SOCS1;ARNTL;BAIAP2;COL5A2;SRF;HIF1AN;NPNT;PDGFB;SDK1;FZD1;ENPP1;IL20;GLIPR2;HSP90AB1;NEDD4L;ZFYVE27;TRAK2;FANCD2;L1CAM;GPER1;SENP1;NTN1;PSME2;LILRB3;CFLAR;PSMB9;ABCA5;SHTN1;DPYSL3;RBBP5;DDX56;CSF1;AP3B1;CLOCK;KIF14;PURB;TLR3;EHD1;TNF;ZFP36L2;RC3H1;CD74;WDR36;HNRNPU;PSMB10;HIST1H4A;FTO;PPARGC1B;ITGB1BP1;IRF1
11493,GO:0045935,0.120358208816618,0.900235106184565,106,1279,positive regulation of nucleobase-containing compound metabolic process,BP,MAFB;NRG1;TRIM16;PML;TFRC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;RUNX1;PBX1;DDX17;TP53;EDN1;ZBED1;STAG1;TGFB2;RBM22;FOXD2;DKC1;INHBA;RELB;NBN;UTP15;SFRP1;NUCKS1;HEATR1;USP16;AHR;NAA15;GLIS3;TAF2;SETDB1;ADM;RFC3;AKAP8L;MYBL2;RHOG;WNT4;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;RRN3;ARNTL;NVL;CDH13;SRF;NPNT;WDR43;PDGFB;BRCC3;FZD1;NFE2L1;MACC1;EYA3;RIF1;METTL16;GLIS2;TET3;MYBL1;HSPA8;HSP90AB1;BRCA2;SS18L2;E2F8;ETV6;HSF2;CHEK1;GPER1;MLLT10;WDR75;SENP1;ATR;MSH6;NOL11;NCBP1;EDRF1;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;RBL1;NAA16;CLOCK;TLR3;ESR1;TNF;ATAD5;ZFP36L2;RC3H1;CD74;HNRNPU;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
13488,GO:0055002,0.120361125796173,0.937235489781894,10,80,striated muscle cell development,BP,HDAC9;ACTG1;G6PD;EDN1;TPM1;NEXN;SRF;MYH11;CFLAR;HNRNPU
12804,GO:0051066,0.12088658196358,0.996112092835857,1,2,dihydrobiopterin metabolic process,BP,QDPR
1528,GO:0003899,0.120929880294917,0.954375126663779,5,41,DNA-directed 5'-3' RNA polymerase activity,MF,POLR1A;PRIM2;POLR2F;POLR1E;POLR3B
12153,GO:0048237,0.121110258904856,0.996097210795621,1,2,rough endoplasmic reticulum lumen,CC,EDN1
10835,GO:0044319,0.121192518457057,0.961149751974461,4,25,wound healing, spreading of cells,BP,CYR61;PDPN;AJUBA;ADAM17
16339,GO:0090505,0.121192518457057,0.961149751974461,4,25,epiboly involved in wound healing,BP,CYR61;PDPN;AJUBA;ADAM17
2696,GO:0006060,0.121213262953258,0.996090347363055,1,2,sorbitol metabolic process,BP,AKR1B1
11662,GO:0046370,0.121213262953258,0.996090347363055,1,2,fructose biosynthetic process,BP,AKR1B1
12545,GO:0050670,0.121330407179743,0.932009056354823,12,118,regulation of lymphocyte proliferation,BP,TFRC;LGALS3;IL6ST;SYK;CD274;AHR;ATAD5;RC3H1;CCL5;CD74;CDKN1A;IRF1
19772,GO:2000111,0.121422001974877,0.996076418800454,1,2,positive regulation of macrophage apoptotic process,BP,CDKN2A
11258,GO:0045429,0.121474609566879,0.960893234216553,4,26,positive regulation of nitric oxide biosynthetic process,BP,EDN1;CLU;HSP90AB1;TNF
18854,GO:1904407,0.121474609566879,0.960893234216553,4,26,positive regulation of nitric oxide metabolic process,BP,EDN1;CLU;HSP90AB1;TNF
2437,GO:0005635,0.121534807754815,0.912460162144019,34,375,nuclear envelope,CC,DTX2;PTGES;CBX5;ABCF1;NUP50;NUP153;BRIP1;CDK4;DST;POLA1;TMEM97;NDC1;CASC3;RAN;RANBP2;RRP12;WDR3;UTP18;NUP160;NUP54;LRPPRC;RIF1;DPY19L2P2;CENPF;GPER1;FAF1;RRM1;SENP1;CMTM3;EBP;DNASE1;DCTN5;PHLPP1;TREX1
15989,GO:0080090,0.121595399282311,0.892395509076955,345,4506,regulation of primary metabolic process,BP,CRYAB;IGFBP3;MAFB;SAA1;NRG1;HDAC9;C1R;TRIM16;FN1;PML;CYP1B1;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;TRIM22;CBX5;CTGF;MMP9;FBN1;RUNX1;CYP1A1;CLN6;IL1R2;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;PANK2;EDN1;SCD;GBP1;HMGCS1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CYLD;PKMYT1;TGS1;PDLIM1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;IL6ST;HNRNPF;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;SYK;EMP2;NUP153;NAIP;ZFP42;RELB;NBN;LEPR;PARP15;BRIP1;SHQ1;LSS;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;ULK4;POLA1;SETDB1;ZNF584;TRAF1;OPHN1;ADM;CD109;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;CCL20;PLK2;ZNF512;ZNF587;UBQLN2;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;CORO1C;ZNF738;DDX3X;NUFIP1;IL24;RRN3;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;TAF1D;ODC1;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;TRIM37;PPP4R4;GNL3L;ZNF586;NVL;GADD45B;SH3RF2;CDH13;COMMD4;PHACTR4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;BRCC3;FZD1;IRX4;NFE2L1;ANTXR1;CLU;NUP160;SMYD2;MACC1;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;ACKR3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;GLIPR2;ZNF484;APEX1;PDCL3;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;ARL6IP5;EPHB6;BACE2;ZBTB24;NSF;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;WDR75;ADAM17;SENP1;RBMS3;ATR;PSME2;MSH6;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;RNF19B;ARV1;TNF;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;USP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3;IFI27L1
8865,GO:0034654,0.121596474582762,0.89335010546679,260,3379,nucleobase-containing compound biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;PANK2;EXO1;EDN1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;DKC1;INHBA;NUP50;PHAX;SYK;NUP153;ZFP42;RELB;NBN;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;UAP1L1;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;ZNF584;TRAF1;ADM;USP43;ZNF407;ELMSAN1;NDC1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;PGK1;TRIM37;GNL3L;ZNF586;NVL;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;CHEK1;SRFBP1;GPER1;FAF1;RRM1;MLLT10;WDR75;SENP1;ATR;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;RAD51B;TNF;ZFP36L2;SRSF7;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;FLAD1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
11382,GO:0045727,0.121657455303857,0.933787051044803,11,106,positive regulation of translation,BP,CDK4;USP16;DDX3X;FASTKD3;DND1;RBMS3;EIF2B5;UPF3B;ESR1;TNF;CCL5
16281,GO:0090322,0.121931022223042,0.968699192070884,3,19,regulation of superoxide metabolic process,BP,SYK;DHFR;TNF
9549,GO:0036293,0.122011913583525,0.917699139584188,24,263,response to decreased oxygen levels,BP,CRYAB;PML;CTGF;CYP1A1;TP53;EDN1;TGFB2;PDLIM1;BRIP1;SFRP1;ADM;SUV39H2;AJUBA;PGK1;SRF;MDM4;HIF1AN;ADAM17;PSME2;CFLAR;PSMB9;CITED2;CCNA2;PSMB10
3170,GO:0006783,0.122090571559528,0.96881822436141,3,18,heme biosynthetic process,BP,IBA57;NFE2L1;SLC11A2
5706,GO:0016831,0.122338800737314,0.960276136968127,4,28,carboxy-lyase activity,MF,GGCX;ODC1;UMPS;AZIN1
4531,GO:0010594,0.122350680975849,0.931481551443313,12,110,regulation of endothelial cell migration,BP,HDAC9;STAT5A;STARD13;EDN1;EMP2;ADAMTS9;PLK2;HSPB1;PTPRM;PDGFB;ADAM17;ITGB1BP1
11771,GO:0046602,0.12248427009949,0.980792531778739,2,8,regulation of mitotic centrosome separation,BP,RANBP2;CHEK1
2731,GO:0006109,0.122521175049283,0.927987807009021,14,130,regulation of carbohydrate metabolic process,BP,IGFBP3;IRS1;C1QTNF1;PPP1R3B;NUP50;NUP153;LEPR;NDC1;RANBP2;PDGFB;NUP160;ENPP1;NUP54;GPER1
6104,GO:0019321,0.122601723531603,0.979896246274582,2,10,pentose metabolic process,BP,G6PD;PGD
9715,GO:0038110,0.122612858291887,0.980760249668908,2,8,interleukin-2-mediated signaling pathway,BP,STAT5A;SYK
16358,GO:0090576,0.122643111335101,0.980752651466439,2,8,RNA polymerase III transcription factor complex,CC,GTF3C6;GTF3C4
12254,GO:0048511,0.122756319756888,0.921544291531081,19,189,rhythmic process,BP,PML;TP53;RBM4;TGFB2;INHBA;RELB;CDK4;AHR;SUV39H2;ARNTL;SRD5A1;HNRNPR;TIMELESS;CLOCK;ESR1;TYMS;HNRNPU;PHLPP1;PSPC1
749,GO:0001977,0.122912354569748,0.980197698767443,2,9,renal system process involved in regulation of blood volume,BP,EMP2;PDGFB
13532,GO:0055082,0.123073363487018,0.909568152729541,38,432,cellular chemical homeostasis,BP,SAA1;FTL;FTH1;PML;JPH2;GCLC;TFRC;CLN6;TP53;EDN1;C1QTNF1;CHP1;SLC4A11;ACO1;SLC30A6;SLC9A3R1;ABCG2;GPCPD1;NUCKS1;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;SRF;ENPP1;JPH1;THADA;SLC11A2;RIC3;TMEM199;NEDD4L;TMEM165;GPER1;SLC9A9;ESR1;CCL5
10291,GO:0043027,0.123430997983881,0.968527349218696,3,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,NAIP;BIRC3;SERPINB9
548,GO:0001667,0.123881265448381,0.914983705102916,26,271,ameboidal-type cell migration,BP,HDAC9;PML;CYP1B1;AMOT;KRT2;STAT5A;STARD13;S100P;MMP9;EDN1;TGFB2;EMP2;ADAMTS9;PLK2;HSPB1;PTPRM;CORO1C;CDH13;PHACTR4;SRF;PDGFB;ANLN;GLIPR2;WDPCP;ADAM17;ITGB1BP1
14480,GO:0061827,0.123899123961196,0.995909107160162,1,2,sperm head,CC,HSP90AB1
5588,GO:0016603,0.123945376618081,0.995905947631941,1,2,glutaminyl-peptide cyclotransferase activity,MF,QPCT
5876,GO:0017186,0.123945376618081,0.995905947631941,1,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,QPCT
2900,GO:0006408,0.12395656033585,0.995905183474305,1,2,snRNA export from nucleus,BP,PHAX
8843,GO:0034622,0.123958280873909,0.90122029224772,69,885,cellular protein-containing complex assembly,BP,CRYAB;NEFL;NRG1;MAP2;TP53;GEMIN5;COBLL1;PPAN;RBM22;TGS1;DNHD1;NUP153;SHQ1;VPS41;MCM2;GEMIN4;H3F3A;RPA1;HELLS;TAF2;GRWD1;IMMP2L;NDC1;CADPS2;MDN1;GBP5;KANK4;RHOG;NOP2;DDX28;UBTF;RRP7BP;DDX3X;NAP1L1;NUFIP1;RRN3;SET;MRTO4;FASTKD3;LUC7L;CDC42EP2;BAIAP2;LUC7L2;CLU;ANLN;RPF2;TMEM199;HSP90AB1;MYH11;GEMIN8;CENPF;ATR;TAF6L;MRPS7;NCBP1;TRAF2;UQCRB;ESR1;RAD51B;CENPN;RC3H1;DAXX;HIST1H4A;TAF1;ZNHIT6;GTF2H3;NDUFB9;CENPO;GPX4
11341,GO:0045650,0.124013871658068,0.995901266328162,1,2,negative regulation of macrophage differentiation,BP,INHBA
11171,GO:0045213,0.12402503595251,0.995900503031884,1,2,neurotransmitter receptor metabolic process,BP,NRG1
4561,GO:0010640,0.12402760487271,0.968540548886364,3,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,SLC9A3R1;PDGFB;PHF14
1526,GO:0003887,0.12409868366428,0.959739271214855,4,26,DNA-directed DNA polymerase activity,MF,POLQ;POLA1;PRIM2;POLE3
1238,GO:0002923,0.124145641209753,0.995892252479634,1,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,TNF
10546,GO:0043484,0.124172480730883,0.932262555879007,11,101,regulation of RNA splicing,BP,DDX17;RBM4;RBM22;SRSF2;HNRNPF;METTL16;HSPA8;NCBP1;SRSF7;HNRNPU;RBM8A
8725,GO:0034364,0.124286667781363,0.979453189709012,2,10,high-density lipoprotein particle,CC,SAA1;CLU
7595,GO:0031958,0.124467768130886,0.968379272702233,3,16,corticosteroid receptor signaling pathway,BP,ARNTL;GPER1;CLOCK
16294,GO:0090342,0.124499322761733,0.95289806082913,5,37,regulation of cell aging,BP,CDKN2A;NUAK1;PLK2;ARNTL;RBL1
8262,GO:0033032,0.124700803873277,0.967852880502023,3,18,regulation of myeloid cell apoptotic process,BP,CDKN2A;ADAM17;CCL5
7305,GO:0031298,0.12470710526737,0.979733343670328,2,9,replication fork protection complex,CC,GINS4;TIMELESS
14590,GO:0070106,0.124724111424516,0.980227107072614,2,8,interleukin-27-mediated signaling pathway,BP,IL27RA;IL6ST
18257,GO:1903035,0.124849983300543,0.94333667135287,7,57,negative regulation of response to wounding,BP,KRT1;EDN1;C1QTNF1;CD109;WNT4;PDGFB;THBD
2295,GO:0005251,0.124855824702292,0.980193652113715,2,8,delayed rectifier potassium channel activity,MF,KCNS3;KCNQ5
1051,GO:0002576,0.125024966092442,0.936730029182291,9,76,platelet degranulation,BP,FN1;TGFB2;PCDH7;SYK;ABCC4;CD109;PDGFB;CHID1;CLU
3262,GO:0006933,0.12537518704587,0.99580763367214,1,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,ITGB1BP1
1859,GO:0004519,0.125474115699865,0.931271413730929,11,108,endonuclease activity,MF,EXO1;POP1;TSN;G3BP1;EXOG;FEN1;LRPPRC;APEX1;DGCR8;RAD51B;DNASE1
15374,GO:0071586,0.12555628898793,0.995795092065001,1,2,CAAX-box protein processing,BP,RCE1
15992,GO:0080120,0.12555628898793,0.995795092065001,1,2,CAAX-box protein maturation,BP,RCE1
4858,GO:0014068,0.125599264264521,0.952437092098576,5,36,positive regulation of phosphatidylinositol 3-kinase signaling,BP,NRG1;TGFB2;PDGFB;GPER1;CCL5
13508,GO:0055025,0.125629511024362,0.959200540687438,4,25,positive regulation of cardiac muscle tissue development,BP,NRG1;FGFR2;EDN1;MIR17HG
12774,GO:0051023,0.125710873100085,0.979075687424248,2,10,regulation of immunoglobulin secretion,BP,TRAF2;TNF
17597,GO:1901186,0.125989797742761,0.958773200740792,4,27,positive regulation of ERBB signaling pathway,BP,EPGN;MMP9;GPER1;ADAM17
17938,GO:1902226,0.126023537873899,0.995762641770997,1,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,CSF1
18679,GO:1903969,0.126023537873899,0.995762641770997,1,2,regulation of response to macrophage colony-stimulating factor,BP,CSF1
18682,GO:1903972,0.126023537873899,0.995762641770997,1,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,CSF1
17824,GO:1901890,0.126147869692633,0.958970993340586,4,25,positive regulation of cell junction assembly,BP,COL16A1;SFRP1;WNT4;ITGB1BP1
8103,GO:0032782,0.126164982513006,0.995752792171401,1,2,bile acid secretion,BP,SLC9A3R1
2949,GO:0006478,0.126197266338939,0.995750542349175,1,2,peptidyl-tyrosine sulfation,BP,TPST1
3860,GO:0008476,0.126197266338939,0.995750542349175,1,2,protein-tyrosine sulfotransferase activity,MF,TPST1
3944,GO:0008631,0.126358705686722,0.951816355555151,5,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PML;CYP1B1;HSPB1;SOD2;ARL6IP5
7344,GO:0031349,0.126445489624825,0.912267003936743,27,302,positive regulation of defense response,BP,C3;NLRC5;TRAF3;CYLD;IKBKE;IL6ST;SYK;RELB;PTGER4;MUC16;GBP5;BIRC3;PSME2;PSMB9;POLR3B;CLOCK;TLR3;ESR1;TNF;CCL5;PSMB10;NRAS;PSPC1;MUC5B;MUC6;IRF1;IRAK3
9923,GO:0042253,0.126449535030836,0.995732940086476,1,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,SYK
9065,GO:0035281,0.126453958758768,0.99573263106979,1,2,pre-miRNA export from nucleus,BP,RAN
10080,GO:0042565,0.126453958758768,0.99573263106979,1,2,RNA nuclear export complex,CC,RAN
7285,GO:0031264,0.12645868402694,0.979276003028819,2,9,death-inducing signaling complex,CC,FAF1;CFLAR
1112,GO:0002698,0.12655204540114,0.938651060740981,8,71,negative regulation of immune effector process,BP,LGALS3;TGFB2;IL7R;THOC1;SERPINB9;TNF;RC3H1;IRAK3
5323,GO:0016043,0.126626190024125,0.887736448594584,351,4601,cellular component organization,BP,CRYAB;IGFBP3;NEFL;NRG1;HDAC9;KRT4;TRIM16;MAP2;KRT13;FN1;TENM3;PML;CYP1B1;KIF23;AMOT;GCLC;KRT2;TFRC;CYR61;C3;KRT15;COL16A1;FGFR2;EPGN;SACS;TRIM22;COL5A3;CTGF;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;RUNX1;MYO1B;ERVFRD-1;CLN6;FAT4;B4GALT1;ACTG1;NEFM;G6PD;SPACA6;MAT2A;TFCP2L1;CCDC80;COL27A1;ENC1;DYNC2H1;MID1;TP53;DAPK3;PANK2;EXO1;EDN1;GBP1;DOCK10;SIPA1L3;C1QTNF1;CDKN2A;ACSL3;GEMIN5;STAG1;COBLL1;LGALS3;CHP1;PDPN;AKAP8;PPAN;TGFB2;CNTNAP1;RBM22;CYLD;IKBKE;PKMYT1;TGS1;LRFN4;COL12A1;RAD1;SLC9A3R1;DKC1;INHBA;IL7R;NUP50;PALM2;DNHD1;SYK;EMP2;NUP153;NAIP;RAB32;NBN;BRIP1;MCM5;SHQ1;CDK4;SFRP1;VPS41;KRT9;NUCKS1;MCM2;TARDBP;GEMIN4;DST;VPS8;POLQ;H3F3A;COL4A1;USP16;HRNR;DHFR;RPA1;TPM1;HELLS;TAF2;ULK4;POLA1;ABCC4;REEP1;ADAMTS9;KCNS3;SETDB1;PTGER4;TK1;TMEM97;G3BP1;GRWD1;TRAF1;PARD3B;OPHN1;ADM;IMMP2L;NDC1;CADPS2;DYNLL2;MDN1;SLC1A3;SYNPO2L;PLK2;MRPL27;UBQLN2;NEXN;HSCB;GBP5;KANK4;RFC3;AKAP8L;MYBL2;RHOG;WNT4;CXCL16;NOP2;SUV39H2;LCP1;GPRIN1;PTPRM;SIRPA;KDM6A;DDX28;RAN;UBTF;RRP7BP;RANBP2;ANAPC15;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;NAP1L1;NUFIP1;CPA4;GPHN;RRN3;ITGAV;SET;MRTO4;SNX11;TRPM7;AJUBA;SMC2;FASTKD3;CGNL1;SNX5;TRIM37;FEN1;LUC7L;CDC42EP2;CDCA5;GNL3L;BAIAP2;CDH13;COL5A2;GINS4;IBA57;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;NPNT;PDGFB;UGT8;BRCC3;SDK1;FZD1;TBC1D15;UTY;ANTXR1;RTKN2;CLU;NUP160;USP6;SDAD1;SMYD2;NAA50;ENPP1;BIRC3;NUP54;EYA3;TPM4;RIF1;MCM6;FGD6;SETD2;ANLN;TIMM23B;RPF2;WEE1;TJP1;LRRN3;KCTD3;SLC11A2;BLOC1S2;APEX1;TNC;CNTNAP2;TET3;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;MYH11;NEDD4L;SGK1;M6PR;PRIM2;ZFYVE27;TMEM138;BRCA2;HPS5;GEMIN8;TRAK2;LIMCH1;SKA2;WDPCP;FANCD2;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;L1CAM;CCDC47;RAB3GAP1;LNX2;CHEK1;BBS5;GPER1;FAF1;RRM1;WDR75;MCM4;ADAM17;MYO10;ATR;NTN1;MSH6;CEP152;CFLAR;PSMC3IP;NIFK;ABCA5;CBLL1;SHTN1;DPYSL3;TAF6L;MRPS7;NCBP1;UBE2J2;VPS36;TRAF2;MSH3;TELO2;RBBP5;MFAP5;CCNA2;GTF3C4;POLE3;DDX56;TAP2;UQCRB;AP3B1;RBL1;CLOCK;KIF14;MPP5;SYNPO2;ESR1;PARD3;GJC1;RAD51B;EHD1;CENPN;ARV1;TNF;PDSS1;NEDD9;RC3H1;STARD7;CCL5;CD74;WDR36;HNRNPU;RING1;FGFR1OP;DAXX;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;ZNHIT6;NRAS;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;CTCF;TSGA13;DIAPH3;GTF2H3;NDUFB9;CENPO;GPX4;IRAK3;COPS3
16581,GO:0097344,0.126773436866504,0.995710282471242,1,2,Rix1 complex,CC,TEX10
19099,GO:1904950,0.126903469815495,0.930359247270206,11,107,negative regulation of establishment of protein localization,BP,FN1;PML;IL1R2;IRS1;GBP1;CHP1;SFRP1;PTGER4;SYT11;TNF;ITGB1BP1
10265,GO:0042994,0.126908409567535,0.967028777122073,3,18,cytoplasmic sequestering of transcription factor,BP,KEAP1;FAF1;NFKBIE
5480,GO:0016410,0.126922987618755,0.935432385991827,9,80,N-acyltransferase activity,MF,NAA15;NAA50;KANSL1L;BRCA2;TAF6L;GTF3C4;NAA16;CLOCK;TAF1
15606,GO:0072061,0.127041409783816,0.995691488659486,1,2,inner medullary collecting duct development,BP,AKR1B1
2540,GO:0005796,0.127178384392316,0.942281759926534,7,52,Golgi lumen,CC,HSPG2;MUC16;WNT4;HS3ST1;PDGFB;MUC5B;MUC6
14213,GO:0061098,0.127248383596978,0.958211298574163,4,27,positive regulation of protein tyrosine kinase activity,BP,EPGN;PDGFB;ADAM17;CCL5
1243,GO:0002933,0.127262702075863,0.995675935559633,1,2,lipid hydroxylation,BP,CYP1A1
17135,GO:0101020,0.127262702075863,0.995675935559633,1,2,estrogen 16-alpha-hydroxylase activity,MF,CYP1A1
12685,GO:0050870,0.127314771956622,0.928037547367852,12,118,positive regulation of T cell activation,BP,MAP3K14;TFRC;CYLD;IL6ST;IL7R;SYK;CD274;SIRPA;SOCS1;AP3B1;CCL5;CD74
17300,GO:0140013,0.127370333289507,0.930138105135089,11,103,meiotic nuclear division,BP,RAD1;BRIP1;NDC1;WNT4;SMC2;MYBL1;BRCA2;FANCD2;PSMC3IP;MSH3;RAD51B
8618,GO:0034121,0.127402722636982,0.951539375064079,5,36,regulation of toll-like receptor signaling pathway,BP,BIRC3;TLR3;ESR1;IRF1;IRAK3
18919,GO:1904576,0.127462780710163,0.995661847595786,1,2,response to tunicamycin,BP,CLU
18920,GO:1904577,0.127462780710163,0.995661847595786,1,2,cellular response to tunicamycin,BP,CLU
19897,GO:2000341,0.127497384123412,0.978598266692538,2,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,TNF;CD74
17823,GO:1901889,0.127614084018647,0.967218409602775,3,16,negative regulation of cell junction assembly,BP,CORO1C;TNF;ITGB1BP1
16190,GO:0090192,0.127614538416442,0.978971964568678,2,9,regulation of glomerulus development,BP,PDGFB;CFLAR
9553,GO:0036297,0.127822863657144,0.945893210393878,6,48,interstrand cross-link repair,BP,NUCKS1;RPA1;FANCD2;ATR;RFWD3;USP1
1700,GO:0004175,0.127987869670074,0.915630649333762,21,230,endopeptidase activity,MF,C1R;C3;MMP9;OVCH2;PRSS23;SFRP1;USP16;RCE1;ADAMTS9;MME;USP6;ERAP1;BACE2;ADAM17;SENP1;CFLAR;PSMB9;USP11;CAPN12;PSMB10;USP1
14457,GO:0061757,0.128057625801523,0.995619818354073,1,2,leukocyte adhesion to arterial endothelial cell,BP,TNF
19123,GO:1904997,0.128057625801523,0.995619818354073,1,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,TNF
15355,GO:0071559,0.128206494915256,0.919844251374902,17,166,response to transforming growth factor beta,BP,PML;FGFR2;FBN1;EDN1;TGFB2;SFRP1;WNT10A;MIR17HG;CD109;WNT4;NPNT;HSP90AB1;ADAM17;CFLAR;CITED2;PARD3;ZFP36L2
7482,GO:0031641,0.128279283475733,0.957880559757465,4,26,regulation of myelination,BP,NRG1;MTMR2;KIF14;PARD3
14520,GO:0062012,0.128576117723312,0.908848230575369,30,336,regulation of small molecule metabolic process,BP,IGFBP3;IRS1;PANK2;SCD;HMGCS1;C1QTNF1;NQO1;PPP1R3B;NUP50;NUP153;LEPR;LSS;ADM;NDC1;WNT4;RAN;RANBP2;ODC1;PDGFB;NUP160;ENPP1;NUP54;GPER1;PSME2;PSMB9;AZIN1;ARV1;TNF;PSMB10;PPARGC1B
12316,GO:0048639,0.128580075501766,0.927455940459697,12,105,positive regulation of developmental growth,BP,NRG1;FN1;FGFR2;EDN1;MIR17HG;SRF;NEDD4L;ZFYVE27;L1CAM;NTN1;SHTN1;CSF1
6368,GO:0021546,0.128607103566178,0.995580801708599,1,2,rhombomere development,BP,MAFB
14643,GO:0070198,0.128708942226755,0.957688132272619,4,26,protein localization to chromosome, telomeric region,BP,DKC1;GNL3L;BRCA2;ATR
16499,GO:0097164,0.128966265875708,0.925015682052915,13,133,ammonium ion metabolic process,BP,ACSL3;TGFB2;SLC22A5;ABHD4;ODC1;CROT;AKR1C2;MBOAT1;SRD5A1;AKR1B1;AZIN1;STARD7;PLBD1
16790,GO:0098575,0.12900250822492,0.995552610597812,1,2,lumenal side of lysosomal membrane,CC,HSPA8
3447,GO:0007259,0.129308961060947,0.931180915461863,10,94,JAK-STAT cascade,BP,CYP1B1;STAT5A;IL6ST;IL24;SOCS1;PARP14;IL20;IFNAR1;AKR1B1;CCL5
3741,GO:0008278,0.12931596516739,0.979047368875048,2,8,cohesin complex,CC,STAG1;CDCA5
236,GO:0000493,0.12933759358395,0.995528644861041,1,2,box H/ACA snoRNP assembly,BP,SHQ1
6074,GO:0019220,0.129522651601489,0.892817311198398,99,1198,regulation of phosphate metabolic process,BP,IGFBP3;SAA1;NRG1;FN1;PML;MAP3K14;CYR61;C3;GPRC5A;NLRC5;FGFR2;EPGN;CTGF;MMP9;IRS1;MID1;TP53;EDN1;GBP1;C1QTNF1;DUSP14;CDKN2A;ACSL3;CHP1;AKAP8;TGFB2;PKMYT1;PPP1R3B;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;SYK;EMP2;NUP153;NBN;CDK4;SFRP1;TARDBP;ULK4;ADM;CD109;NDC1;CCL20;AKAP8L;HSPB1;RANBP2;CORO1C;DDX3X;IL24;CDC25A;ITGAV;SOCS1;SET;PARP14;AJUBA;PPP4R4;GADD45B;SH3RF2;PHACTR4;NPNT;PDGFB;FZD1;CLU;NUP160;ENPP1;IL20;PIK3R3;NUP54;ACKR3;GLIPR2;PDCL3;HSP90AB1;ARL6IP5;EPHB6;MTMR2;GPER1;FAF1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;RBL1;KIF14;TLR3;PARD3;TNF;CCL5;CD74;HNRNPU;FGFR1OP;DAXX;PHLPP1;PPARGC1B;CDKN1A;ITGB1BP1;IRAK3
9666,GO:0038001,0.129544609774472,0.995513804299174,1,2,paracrine signaling,BP,PDGFB
15733,GO:0072272,0.129661292466759,0.995505427943925,1,2,proximal/distal pattern formation involved in metanephric nephron development,BP,IRX2
2119,GO:0004906,0.129676766927629,0.99550431644253,1,2,interferon-gamma receptor activity,MF,IFNGR1
2066,GO:0004817,0.129733067102901,0.995500271263907,1,2,cysteine-tRNA ligase activity,MF,CARS2
2912,GO:0006423,0.129733067102901,0.995500271263907,1,2,cysteinyl-tRNA aminoacylation,BP,CARS2
4,GO:0000010,0.129801337515703,0.995495363405137,1,2,trans-hexaprenyltranstransferase activity,MF,PDSS1
12490,GO:0050347,0.129801337515703,0.995495363405137,1,2,trans-octaprenyltranstransferase activity,MF,PDSS1
9341,GO:0035812,0.129829627674498,0.995493328827128,1,2,renal sodium excretion,BP,EDN1
9342,GO:0035813,0.129829627674498,0.995493328827128,1,2,regulation of renal sodium excretion,BP,EDN1
3299,GO:0006998,0.129836936409728,0.933627489789927,9,80,nuclear envelope organization,BP,NUP50;NUP153;TARDBP;NDC1;AKAP8L;RANBP2;NUP160;NUP54;GPER1
9277,GO:0035692,0.129952410855359,0.995484492771151,1,2,macrophage migration inhibitory factor receptor complex,CC,CD74
17737,GO:1901623,0.130106740804606,0.978310359511668,2,9,regulation of lymphocyte chemotaxis,BP,ADAM17;CCL5
4419,GO:0010193,0.130122883008333,0.995472209406994,1,2,response to ozone,BP,EDN1
14719,GO:0070330,0.130154600661667,0.978297573395389,2,9,aromatase activity,MF,CYP1B1;CYP1A1
11921,GO:0046934,0.130158265816306,0.950353681568111,5,34,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,NRG1;FGFR2;IRS1;PDGFB;ESR1
10331,GO:0043111,0.130162812451466,0.995469329706573,1,2,replication fork arrest,BP,TIMELESS
12282,GO:0048560,0.130214010312985,0.995465635894607,1,2,establishment of anatomical structure orientation,BP,IRX4
9831,GO:0042033,0.130229753930027,0.977859740832697,2,10,chemokine biosynthetic process,BP,TLR3;TNF
12603,GO:0050755,0.130229753930027,0.977859740832697,2,10,chemokine metabolic process,BP,TLR3;TNF
9334,GO:0035801,0.130248240454708,0.995463165365621,1,2,adrenal cortex development,BP,CITED2
9335,GO:0035802,0.130248240454708,0.995463165365621,1,2,adrenal cortex formation,BP,CITED2
13193,GO:0051775,0.130281935293167,0.977845538968196,2,10,response to redox state,BP,ARNTL;CLOCK
799,GO:0002065,0.130357804552062,0.936486129677203,8,68,columnar/cuboidal epithelial cell differentiation,BP,FGFR2;SLC9A3R1;WNT4;ARNTL;WDPCP;CLOCK;TYMS;CDKN1A
440,GO:0001181,0.130428088457893,0.995450173145777,1,2,transcription factor activity, core RNA polymerase I binding,MF,RRN3
14990,GO:0070878,0.130597790677982,0.978713124670123,2,8,primary miRNA binding,MF,SRF;DGCR8
10852,GO:0044338,0.130631965612608,0.995435420964191,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,FZD1
16391,GO:0090677,0.130686229662225,0.995431490200353,1,2,reversible differentiation,BP,PDGFB
16392,GO:0090678,0.130686229662225,0.995431490200353,1,2,cell dedifferentiation involved in phenotypic switching,BP,PDGFB
19190,GO:1905174,0.130686229662225,0.995431490200353,1,2,regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
19702,GO:1990936,0.130686229662225,0.995431490200353,1,2,vascular smooth muscle cell dedifferentiation,BP,PDGFB
9305,GO:0035740,0.13073899242804,0.995427666446042,1,2,CD8-positive, alpha-beta T cell proliferation,BP,IRF1
20011,GO:2000564,0.13073899242804,0.995427666446042,1,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,IRF1
18054,GO:1902533,0.130750726223247,0.897989695071913,56,663,positive regulation of intracellular signal transduction,BP,IGFBP3;SAA1;NRG1;CYP1B1;JPH2;MAP3K14;FGFR2;EPGN;TRIM22;CTGF;IRS1;MID1;TP53;EDN1;C1QTNF1;TGFB2;IKBKE;IL6ST;SLC9A3R1;IL7R;SYK;CCL20;PLK2;RRAGB;ATP2C1;IL24;ITGAV;SOCS1;PARP14;AJUBA;AKR1C2;GADD45B;CDH13;NPNT;PDGFB;BIRC3;IL20;ACKR3;GLIPR2;ARL6IP5;EPHB6;GPER1;ATR;CFLAR;AKR1B1;TRAF2;TELO2;CSF1;TLR3;ESR1;TNF;RC3H1;CCL5;CD74;DAXX;ITGB1BP1
13252,GO:0051896,0.130774210083851,0.923946661862668,13,123,regulation of protein kinase B signaling,BP,NRG1;FGFR2;IRS1;C1QTNF1;SLC9A3R1;AKR1C2;PDGFB;GPER1;ESR1;TNF;PHLPP2;PHLPP1;ITGB1BP1
5746,GO:0016890,0.130915484552242,0.995414863469458,1,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,APEX1
7808,GO:0032352,0.13096700413385,0.978080070249577,2,9,positive regulation of hormone metabolic process,BP,WNT4;TNF
3117,GO:0006695,0.130982982349483,0.939736495249941,7,59,cholesterol biosynthetic process,BP,G6PD;SCD;HMGCS1;LSS;RAN;EBP;ARV1
734,GO:0001960,0.130983449267728,0.949490299501124,5,39,negative regulation of cytokine-mediated signaling pathway,BP,NLRC5;IL1R2;PARP14;CCL5;IRAK3
10403,GO:0043225,0.131109228185768,0.978579166811524,2,8,ATPase-coupled anion transmembrane transporter activity,MF,ABCC4;ABCC9
17037,GO:0099133,0.131109228185768,0.978579166811524,2,8,ATP hydrolysis coupled anion transmembrane transport,BP,ABCC4;ABCC9
4296,GO:0009725,0.131178105879507,0.897648215478092,56,652,response to hormone,BP,CRYAB;NEFL;HDAC9;TRIM16;GCLC;STAT5A;CTGF;FBN1;RUNX1;DDX17;IRS1;EDN1;HMGCS1;NQO1;AKAP8;TGFB2;INHBA;LEPR;BRIP1;CDK4;SFRP1;NUCKS1;H3F3A;ATP2B1;PTGER4;ADM;RAN;SOCS1;ARNTL;AKR1C2;BAIAP2;SRF;QDPR;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;TNC;GPER1;CFLAR;EIF2B5;AKR1B1;CCNA2;CLOCK;ESR1;TNF;ZFP36L2;TYMS;HNRNPU;EIF2B1;DAXX;TAF1;SMARCC1;PPARGC1B;CDKN1A
3060,GO:0006623,0.131220726842876,0.949820564288351,5,34,protein targeting to vacuole,BP,GNPTAB;VPS41;CLU;HSPA8;AP3B1
10159,GO:0042727,0.131240477527414,0.99539123779727,1,2,flavin-containing compound biosynthetic process,BP,FLAD1
6302,GO:0019912,0.131268706029661,0.995389182624757,1,2,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
7239,GO:0031133,0.13137379321002,0.995381527444532,1,2,regulation of axon diameter,BP,NEFL
3675,GO:0008174,0.131447074060628,0.977951130831619,2,9,mRNA methyltransferase activity,MF,METTL16;TRMT61A
5279,GO:0015926,0.131558055527816,0.978461327689812,2,8,glucosidase activity,MF,MGAM;GANC
4693,GO:0010842,0.131570081311513,0.966027413545554,3,15,retina layer formation,BP,MEGF11;PTPRM;SDK1
19528,GO:1990314,0.131753444070575,0.978409946801422,2,8,cellular response to insulin-like growth factor stimulus,BP,FBN1;CCNA2
6169,GO:0019520,0.131790986914533,0.995351069321901,1,2,aldonic acid metabolic process,BP,PGD
6170,GO:0019521,0.131790986914533,0.995351069321901,1,2,D-gluconate metabolic process,BP,PGD
5415,GO:0016256,0.131806948369576,0.995349901887631,1,2,N-glycan processing to lysosome,BP,GNPTAB
6591,GO:0022600,0.131845838743136,0.949308740256237,5,36,digestive system process,BP,ACO1;SLC22A5;TJP2;SGK1;MUC6
11334,GO:0045639,0.131916275029267,0.939246467930513,7,58,positive regulation of myeloid cell differentiation,BP,RUNX1;INHBA;IL20;CSF1;TNF;CD74;PPARGC1B
17467,GO:1900222,0.131922940387336,0.995341413408135,1,2,negative regulation of amyloid-beta clearance,BP,SRF
8890,GO:0034696,0.131973481776077,0.995337712110321,1,2,response to prostaglandin F,BP,EDN1
7304,GO:0031297,0.132002122914915,0.956204651384275,4,26,replication fork processing,BP,NUCKS1;THOC1;BRCA2;RFWD3
13920,GO:0060544,0.132143168861622,0.964849226497467,3,19,regulation of necroptotic process,BP,BIRC3;CFLAR;TRAF2
1218,GO:0002885,0.132293908591475,0.995314209576791,1,2,positive regulation of hypersensitivity,BP,C3
15954,GO:0072737,0.13249893833088,0.995299137853426,1,2,response to diamide,BP,DAXX
15955,GO:0072738,0.13249893833088,0.995299137853426,1,2,cellular response to diamide,BP,DAXX
1005,GO:0002476,0.132502730241419,0.995298858865589,1,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,TAP2
2515,GO:0005767,0.132622519626068,0.977204753855397,2,10,secondary lysosome,CC,FTL;FTH1
7090,GO:0030879,0.132688493867803,0.92674660550115,11,99,mammary gland development,BP,NRG1;PML;FGFR2;STAT5A;B4GALT1;WNT4;UMPS;BRCA2;NTN1;CSF1;ESR1
923,GO:0002315,0.132702299877265,0.978159722872594,2,8,marginal zone B cell differentiation,BP,DOCK10;LFNG
17992,GO:1902359,0.132757321809333,0.99528010708753,1,2,Notch signaling pathway involved in somitogenesis,BP,LFNG
17996,GO:1902366,0.132757321809333,0.99528010708753,1,2,regulation of Notch signaling pathway involved in somitogenesis,BP,LFNG
17997,GO:1902367,0.132757321809333,0.99528010708753,1,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,LFNG
19552,GO:1990410,0.132774166116414,0.995278865017236,1,2,adrenomedullin receptor signaling pathway,BP,ADM
2145,GO:0004955,0.13279415764628,0.995277390648401,1,2,prostaglandin receptor activity,MF,PTGER4
3174,GO:0006789,0.13280635057486,0.995276491302518,1,2,bilirubin conjugation,BP,UGT1A4
14148,GO:0060994,0.132856610416249,0.99527278318452,1,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,GLIS2
547,GO:0001666,0.132930640114187,0.910174646089646,23,255,response to hypoxia,BP,CRYAB;PML;CYP1A1;TP53;EDN1;TGFB2;PDLIM1;BRIP1;SFRP1;ADM;SUV39H2;AJUBA;PGK1;SRF;MDM4;HIF1AN;ADAM17;PSME2;CFLAR;PSMB9;CITED2;CCNA2;PSMB10
10168,GO:0042742,0.132963511994867,0.931301381403052,9,94,defense response to bacterium,BP,IL27RA;SYK;ARRDC1-AS1;CCL20;SYT11;ADAM17;TLR3;TNF;GBP6
5463,GO:0016339,0.132995443925914,0.964945111001583,3,17,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ATP2C1;AJUBA;CDH13
3010,GO:0006556,0.133002933872069,0.995261978697295,1,2,S-adenosylmethionine biosynthetic process,BP,MAT2A
12176,GO:0048269,0.133002933872069,0.995261978697295,1,2,methionine adenosyltransferase complex,CC,MAT2A
13210,GO:0051797,0.133029219353174,0.964707480996639,3,18,regulation of hair follicle development,BP,FST;TGFB2;TNF
12933,GO:0051260,0.133043046432483,0.912845403511962,20,215,protein homooligomerization,BP,CRYAB;B4GALT1;TP53;GBP1;C1QTNF1;IKBKE;POLQ;USP16;KCNS3;TK1;GBP5;SOD2;CLU;NUP54;KCTD3;SYT11;LNX2;DPYSL3;TRAF2;EHD1
17530,GO:1900673,0.13308463880017,0.99525593986222,1,2,olefin metabolic process,BP,CYP1A1
6910,GO:0030485,0.133110960466234,0.995253993540425,1,2,smooth muscle contractile fiber,CC,NPNT
7745,GO:0032239,0.133190379781799,0.96512654687505,3,16,regulation of nucleobase-containing compound transport,BP,NUP153;AKAP8L;SETD2
4024,GO:0009055,0.133221175820385,0.934148810371867,8,88,electron transfer activity,MF,TXNRD1;NQO1;P4HA2;QDPR;SRD5A1;SDHD;AKR1B1;UQCRB
9724,GO:0038129,0.133441597910393,0.995229508452638,1,2,ERBB3 signaling pathway,BP,NRG1
7189,GO:0031069,0.1334550835824,0.964769695919818,3,17,hair follicle morphogenesis,BP,FGFR2;TGFB2;WNT10A
2026,GO:0004756,0.133490087433142,0.995225911909562,1,2,selenide, water dikinase activity,MF,SEPHS2
5417,GO:0016260,0.133490087433142,0.995225911909562,1,2,selenocysteine biosynthetic process,BP,SEPHS2
5674,GO:0016781,0.133490087433142,0.995225911909562,1,2,phosphotransferase activity, paired acceptors,MF,SEPHS2
14718,GO:0070329,0.133490087433142,0.995225911909562,1,2,tRNA seleno-modification,BP,SEPHS2
4008,GO:0008967,0.13367101013646,0.995212479739594,1,2,phosphoglycolate phosphatase activity,MF,APTX
1510,GO:0003865,0.133803897418459,0.995202600927873,1,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,SRD5A1
8534,GO:0033765,0.133803897418459,0.995202600927873,1,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,SRD5A1
9269,GO:0035671,0.133803897418459,0.995202600927873,1,2,enone reductase activity,MF,SRD5A1
12053,GO:0047751,0.133803897418459,0.995202600927873,1,2,cholestenone 5-alpha-reductase activity,MF,SRD5A1
13857,GO:0060437,0.133860260062411,0.995198407636755,1,2,lung growth,BP,MIR17HG
11172,GO:0045214,0.133910009785122,0.956247539546795,4,21,sarcomere organization,BP,ACTG1;EDN1;TPM1;SRF
15639,GO:0072109,0.134013328300259,0.977256701947611,2,9,glomerular mesangium development,BP,PDGFB;CFLAR
1346,GO:0003206,0.134132372008989,0.931085535945065,9,76,cardiac chamber morphogenesis,BP,NRG1;CYR61;FGFR2;TGFB2;MIR17HG;TPM1;SRF;FZD1;CITED2
9217,GO:0035596,0.134289036734996,0.995166442869888,1,2,methylthiotransferase activity,MF,CDKAL1
9220,GO:0035600,0.134289036734996,0.995166442869888,1,2,tRNA methylthiolation,BP,CDKAL1
12509,GO:0050497,0.134289036734996,0.995166442869888,1,2,transferase activity, transferring alkylthio groups,MF,CDKAL1
1245,GO:0002940,0.134295367547603,0.995165970061809,1,2,tRNA N2-guanine methylation,BP,TRMT1
16478,GO:0097124,0.1343312348752,0.995163290890214,1,2,cyclin A2-CDK2 complex,CC,CCNA2
14019,GO:0060713,0.134403588322382,0.964178961960806,3,18,labyrinthine layer morphogenesis,BP,CYR61;FGFR2;ADM
14670,GO:0070252,0.134669987839266,0.938055598929863,7,51,actin-mediated cell contraction,BP,PDPN;EMP2;TPM1;TPM4;NEDD4L;SHTN1;GJC1
8589,GO:0034062,0.134700053292255,0.947311529046728,5,43,5'-3' RNA polymerase activity,MF,POLR1A;PRIM2;POLR2F;POLR1E;POLR3B
16753,GO:0097747,0.134700053292255,0.947311529046728,5,43,RNA polymerase activity,MF,POLR1A;PRIM2;POLR2F;POLR1E;POLR3B
11637,GO:0046325,0.134726421376697,0.97706219427706,2,9,negative regulation of glucose import,BP,ENPP1;TNF
20063,GO:2000650,0.134745775783145,0.977616867912167,2,8,negative regulation of sodium ion transmembrane transporter activity,BP,SLC9A3R1;NEDD4L
1179,GO:0002823,0.134765688078381,0.964039272600865,3,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL7R;THOC1;RC3H1
8621,GO:0034124,0.134797714033878,0.9951283737472,1,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,IRF1
7741,GO:0032231,0.134925553852014,0.933817284826552,8,66,regulation of actin filament bundle assembly,BP,CTGF;SFRP1;TPM1;PTGER4;SYNPO2L;WNT4;SYNPO2;ITGB1BP1
1363,GO:0003231,0.135073262068393,0.930533791891506,9,75,cardiac ventricle development,BP,NRG1;CYR61;FGFR2;TGFB2;MIR17HG;TPM1;FZD1;CITED2;DCTN5
19983,GO:2000490,0.135101858213926,0.995105535057333,1,2,negative regulation of hepatic stellate cell activation,BP,GCLC
16351,GO:0090557,0.135173510252552,0.977502554273301,2,8,establishment of endothelial intestinal barrier,BP,TJP2;TJP1
2778,GO:0006208,0.135246557049232,0.995094649218097,1,2,pyrimidine nucleobase catabolic process,BP,DPYD
2779,GO:0006210,0.135246557049232,0.995094649218097,1,2,thymine catabolic process,BP,DPYD
6269,GO:0019859,0.135246557049232,0.995094649218097,1,2,thymine metabolic process,BP,DPYD
1056,GO:0002581,0.135288783628979,0.995091470018623,1,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,HLA-DOB
9994,GO:0042379,0.135369080809269,0.963108658223997,3,22,chemokine receptor binding,MF,CCL20;CXCL16;CCL5
19066,GO:1904880,0.135403843175541,0.995082801672313,1,2,response to hydrogen sulfide,BP,NQO1
9906,GO:0042180,0.135432688688891,0.917186189701013,15,162,cellular ketone metabolic process,BP,IRS1;PANK2;NQO1;ADM;WNT4;ODC1;AKR1C2;SRD5A1;PSME2;PSMB9;AKR1B1;AZIN1;PDSS1;PSMB10;PPARGC1B
9550,GO:0036294,0.135478126523066,0.917201971682586,15,158,cellular response to decreased oxygen levels,BP,TP53;EDN1;BRIP1;SFRP1;SUV39H2;AJUBA;PGK1;MDM4;HIF1AN;PSME2;CFLAR;PSMB9;CITED2;CCNA2;PSMB10
2051,GO:0004797,0.13574281826187,0.995057216176942,1,2,thymidine kinase activity,MF,TK1
3365,GO:0007129,0.135798687377225,0.963639754416565,3,18,synapsis,BP,BRIP1;NDC1;FANCD2
15800,GO:0072387,0.135898186133702,0.995045465295728,1,2,flavin adenine dinucleotide metabolic process,BP,FLAD1
8491,GO:0033631,0.136053770486457,0.976698353146684,2,9,cell-cell adhesion mediated by integrin,BP,NPNT;CCL5
16566,GO:0097305,0.136077200521614,0.922250966362838,12,113,response to alcohol,BP,FGFR2;G6PD;TP53;HMGCS1;NQO1;AKAP8;INHBA;SFRP1;SETDB1;PTGER4;TNC;TYMS
5850,GO:0017143,0.136144544293024,0.99502680180563,1,2,insecticide metabolic process,BP,CYP1A1
16558,GO:0097278,0.136428934184561,0.995005210172059,1,2,complement-dependent cytotoxicity,BP,HSP90AB1
1554,GO:0003950,0.136484856428433,0.96360601558904,3,17,NAD+ ADP-ribosyltransferase activity,MF,PARP15;PARP14;PARP8
14685,GO:0070278,0.136540141839157,0.994996753302332,1,2,extracellular matrix constituent secretion,BP,CTGF
10639,GO:0043627,0.13655394024834,0.941062434000637,6,49,response to estrogen,BP,SFRP1;SRD5A1;SERPINB9;RBBP5;CITED2;ESR1
10554,GO:0043492,0.136652470000421,0.929506479710709,9,76,ATPase activity, coupled to movement of substances,MF,TAP1;ABCG2;ATP2B1;ABCC4;ATP2C1;ABCC9;ABCA5;TAP2;ABCA11P
1450,GO:0003677,0.136881368164621,0.882657152417872,152,1910,DNA binding,MF,MAFB;TRIM16;PML;FOSL2;NLRC5;STAT5A;RUNX1;PBX1;TFCP2L1;TP53;EXO1;ZBED1;ZNF397;JRK;AKAP8;IRX2;ZNF208;FOXD2;RAD1;PUM3;NUP153;ZFP42;RELB;NBN;BRIP1;MCM5;NUCKS1;MCM2;TARDBP;POLQ;H3F3A;AHR;ZNF827;RPA1;POLR1A;ZMAT2;GLIS3;TAF2;POLA1;TSN;SETDB1;G3BP1;GRWD1;ZNF584;ZNF407;ELMSAN1;ZNF512;ZNF587;RFC3;AKAP8L;MYBL2;WDR76;SUV39H2;GTF3C6;KDM6A;THOC1;HMGXB3;UBTF;TOPBP1;ORC4;ZNF738;DDX3X;NUFIP1;RRN3;SET;ARNTL;TAF1D;ZNF267;FEN1;MCM3;ZNF586;APTX;SRF;ZNF234;MCM8;IRX4;UTY;NFE2L1;MACC1;ZNF316;LRPPRC;ZNF670;KANSL1L;MCM6;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;SMUG1;ZBTB24;HELQ;PRIM2;ZBTB12;BRCA2;CCAR1;MAZ;ZNF33A;E2F8;ETV6;HSF2;POLR2F;HMGN2;MLLT10;RAD18;MCM4;ATR;MSH6;PSMC3IP;ZNF12;BAZ2B;HNRNPDL;TAF6L;MYNN;POLR1E;JRKL;MSH3;TELO2;RBBP5;POLR3B;NCL;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;ZNF286A;CLOCK;PURB;ESR1;RAD51B;TNF;ZFP36L2;HNRNPU;ZSCAN31;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;ARID3B;TREX1;ZNF471;IRF1;CTCF;GTF2H3;ZBTB9
5018,GO:0015179,0.136967135166561,0.946610462392921,5,37,L-amino acid transmembrane transporter activity,MF,SLC7A2;SLC7A5P2;SLC1A3;SLC43A2;SLC25A22
15237,GO:0071373,0.137097758244067,0.994954232823496,1,2,cellular response to luteinizing hormone stimulus,BP,CCNA2
3026,GO:0006573,0.137293813686516,0.97635634804664,2,9,valine metabolic process,BP,STAT5A;HIBCH
1573,GO:0003977,0.137358002840024,0.99493432182696,1,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,UAP1L1
6237,GO:0019785,0.137421072133567,0.994929490116638,1,2,ISG15-specific protease activity,MF,USP43
8067,GO:0032729,0.137484884618826,0.953305049146043,4,29,positive regulation of interferon-gamma production,BP,IL27RA;IL12RB2;TLR3;TNF
4027,GO:0009058,0.137562602481701,0.877558119652067,368,4937,biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PTGES;PML;CYP1B1;GCLC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FADS3;CTGF;FBN1;HSPG2;SLC7A2;RUNX1;CYP1A1;B4GALT1;PBX1;G6PD;TSC22D3;FST;MAT2A;DDX17;SPON1;TFCP2L1;TRAF3;ENC1;IRS1;TP53;DAPK3;PANK2;EXO1;EDN1;SCD;HMGCS1;ABCF1;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;ZNF208;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL16;SRSF2;FOXD2;PPP1R3B;PGD;RAD1;DKC1;INHBA;NUP50;PUM3;GALNT18;PHAX;SYK;NUP153;ZFP42;RELB;NBN;LEPR;FAM111A;PARP15;BRIP1;MCM5;LSS;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;UAP1L1;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;GRWD1;ZNF584;TRAF1;ADM;CD109;USP43;ZNF407;ELMSAN1;NDC1;SLC1A3;EIF5;CASC3;CCL20;ZNF512;MRPL27;ZNF587;MUC16;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;HS3ST1;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;GPHN;RRN3;CDC25A;ITGAV;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;AJUBA;FASTKD3;DND1;ZNF267;LFNG;PGK1;TRIM37;FEN1;MCM3;HACD2;GNL3L;ZNF586;NVL;GATC;CDH13;GINS4;IBA57;RARS;COMMD4;SRF;MDM4;HIF1AN;NPNT;QDPR;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;EIF3J;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;PIK3R3;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;VGLL3;RIF1;METTL16;MCM6;SRD5A1;SETD2;GLIS2;UBP1;TTF2;DPY19L2P2;SEPHS2;ZNF484;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;BACE2;SCD5;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;SYNCRIP;TRAK2;DPYD;SS18L2;CCAR1;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;WDR75;MCM4;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;EBP;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;AZIN1;ESR1;RAD51B;ARV1;TNF;PDSS1;ZFP36L2;SRSF7;RC3H1;TYMS;STARD7;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3
2118,GO:0004905,0.137611551217036,0.99491488254189,1,2,type I interferon receptor activity,MF,IFNAR1
17179,GO:0102521,0.137658307362672,0.994911293419511,1,2,tRNA-4-demethylwyosine synthase activity,MF,TYW1
6486,GO:0021826,0.137659067010767,0.994911235095706,1,2,substrate-independent telencephalic tangential migration,BP,NRG1
6489,GO:0021830,0.137659067010767,0.994911235095706,1,2,interneuron migration from the subpallium to the cortex,BP,NRG1
6493,GO:0021843,0.137659067010767,0.994911235095706,1,2,substrate-independent telencephalic tangential interneuron migration,BP,NRG1
13037,GO:0051453,0.137676939706277,0.935758477524562,7,61,regulation of intracellular pH,BP,CLN6;TP53;CHP1;SLC4A11;TMEM199;TMEM165;SLC9A9
9988,GO:0042369,0.137686964988492,0.994909092912183,1,2,vitamin D catabolic process,BP,CYP24A1
14586,GO:0070101,0.137734664704568,0.994905429100985,1,2,positive regulation of chemokine-mediated signaling pathway,BP,EDN1
11074,GO:0045058,0.137746206934285,0.953438042548811,4,27,T cell selection,BP,CYLD;SYK;SRF;CD74
5888,GO:0018023,0.137766531777347,0.946200184003116,5,37,peptidyl-lysine trimethylation,BP,SUV39H2;SETD4;VCPKMT;SETD2;TET3
4521,GO:0010572,0.137771835019219,0.994902573068223,1,2,positive regulation of platelet activation,BP,PDPN
17786,GO:1901731,0.137771835019219,0.994902573068223,1,2,positive regulation of platelet aggregation,BP,PDPN
5999,GO:0019002,0.137773355227349,0.994902456242571,1,2,GMP binding,MF,RAB26
1402,GO:0003333,0.137808251719035,0.940498650188386,6,47,amino acid transmembrane transport,BP,SLC7A2;SLC7A5P2;SLC1A3;ARL6IP5;SLC43A2;SLC25A22
4492,GO:0010512,0.137953236803374,0.994888622440681,1,2,negative regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
9325,GO:0035788,0.137953236803374,0.994888622440681,1,2,cell migration involved in metanephros development,BP,PDGFB
9326,GO:0035789,0.137953236803374,0.994888622440681,1,2,metanephric mesenchymal cell migration,BP,PDGFB
9329,GO:0035793,0.137953236803374,0.994888622440681,1,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
17473,GO:1900238,0.137953236803374,0.994888622440681,1,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
20027,GO:2000589,0.137953236803374,0.994888622440681,1,2,regulation of metanephric mesenchymal cell migration,BP,PDGFB
20028,GO:2000591,0.137953236803374,0.994888622440681,1,2,positive regulation of metanephric mesenchymal cell migration,BP,PDGFB
6378,GO:0021560,0.138064269565269,0.994880073381471,1,2,abducens nerve development,BP,MAFB
6397,GO:0021598,0.138064269565269,0.994880073381471,1,2,abducens nerve morphogenesis,BP,MAFB
6398,GO:0021599,0.138064269565269,0.994880073381471,1,2,abducens nerve formation,BP,MAFB
9119,GO:0035402,0.138178576279067,0.994871264202501,1,2,histone kinase activity (H3-T11 specific),MF,CHEK1
9124,GO:0035407,0.138178576279067,0.994871264202501,1,2,histone H3-T11 phosphorylation,BP,CHEK1
19450,GO:1990001,0.138328467124671,0.976652074573782,2,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,NAIP;BIRC3
12023,GO:0047496,0.138522822699112,0.945906587793792,5,36,vesicle transport along microtubule,BP,KIF23;AP3M2;BLOC1S2;TRAK2;AP3B1
17804,GO:1901838,0.138544365933833,0.976009397835333,2,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,NOL11;NCL
1814,GO:0004461,0.138572916132284,0.994840811321744,1,2,lactose synthase activity,MF,B4GALT1
4011,GO:0008988,0.138579194314468,0.994840325703845,1,2,rRNA (adenine-N6-)-methyltransferase activity,MF,METTL16
15985,GO:0080023,0.138579194314468,0.994840325703845,1,2,3R-hydroxyacyl-CoA dehydratase activity,MF,HACD2
13651,GO:0060126,0.138581323012856,0.994840161043263,1,2,somatotropin secreting cell differentiation,BP,WNT4
3194,GO:0006824,0.138714860806221,0.994829825873697,1,2,cobalt ion transport,BP,SLC11A2
16361,GO:0090596,0.138729778515686,0.915118308636261,15,142,sensory organ morphogenesis,BP,MAFB;KRT13;TENM3;FGFR2;FBN1;EDN1;MEGF11;SLC9A3R1;PTPRM;COL5A2;PHACTR4;SDK1;WDPCP;NTN1;RING1
10235,GO:0042904,0.13875644225779,0.994826605398393,1,2,9-cis-retinoic acid biosynthetic process,BP,CYP1A1
10236,GO:0042905,0.13875644225779,0.994826605398393,1,2,9-cis-retinoic acid metabolic process,BP,CYP1A1
18097,GO:1902653,0.139005394876613,0.935027516362717,7,60,secondary alcohol biosynthetic process,BP,G6PD;SCD;HMGCS1;LSS;RAN;EBP;ARV1
3539,GO:0007548,0.139071330510216,0.911932430212119,17,171,sex differentiation,BP,PBX1;HMGCS1;TGFB2;INHBA;ZFP42;BRIP1;SFRP1;IMMP2L;WNT4;LFNG;SRD5A1;BRCA2;RRM1;EIF2B5;CITED2;TLR3;ESR1
17301,GO:0140014,0.139081221532969,0.905588239381916,23,240,mitotic nuclear division,BP,KIF23;EPGN;DAPK3;EDN1;STAG1;AKAP8;PKMYT1;NAIP;AKAP8L;MYBL2;RAN;RANBP2;ANAPC15;SMC2;CDCA5;PDGFB;NAA50;BIRC3;ANLN;CENPF;CHEK1;KIF14;HNRNPU
13528,GO:0055077,0.13911588233783,0.994798721784094,1,2,gap junction hemi-channel activity,MF,PANX1
14310,GO:0061383,0.139199714769001,0.945768489905097,5,34,trabecula morphogenesis,BP,NRG1;TGFB2;SFRP1;SRF;PPARGC1B
694,GO:0001911,0.139250410289116,0.975350450629622,2,10,negative regulation of leukocyte mediated cytotoxicity,BP,IL7R;SERPINB9
11524,GO:0045994,0.139254533325317,0.994787944323487,1,2,positive regulation of translational initiation by iron,BP,TNF
15331,GO:0071505,0.139511141897283,0.994767966194601,1,2,response to mycophenolic acid,BP,PDGFB
15332,GO:0071506,0.139511141897283,0.994767966194601,1,2,cellular response to mycophenolic acid,BP,PDGFB
16591,GO:0097362,0.13952560742346,0.994766838761723,1,2,MCM8-MCM9 complex,CC,MCM8
8380,GO:0033269,0.139535690380649,0.994766052825722,1,2,internode region of axon,CC,PARD3
17787,GO:1901739,0.139662550959268,0.97523321148843,2,10,regulation of myoblast fusion,BP,CFLAR;EHD1
11477,GO:0045917,0.139698011902491,0.994753391596872,1,2,positive regulation of complement activation,BP,C3
19844,GO:2000259,0.139698011902491,0.994753391596872,1,2,positive regulation of protein activation cascade,BP,C3
1263,GO:0003014,0.139735937052998,0.934699124078446,7,58,renal system process,BP,EDN1;SLC9A3R1;EMP2;ADM;PDGFB;SGK1;AKR1B1
778,GO:0002031,0.139746061958042,0.975209428126621,2,10,G-protein coupled receptor internalization,BP,ADM;UBQLN2
13944,GO:0060584,0.139775573180597,0.994747335922269,1,2,regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
13945,GO:0060585,0.139775573180597,0.994747335922269,1,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
15806,GO:0072401,0.139847373398092,0.930577963978586,8,72,signal transduction involved in DNA integrity checkpoint,BP,PML;TP53;PLK2;MDM4;BRCC3;E2F8;CHEK1;CDKN1A
15810,GO:0072422,0.139847373398092,0.930577963978586,8,72,signal transduction involved in DNA damage checkpoint,BP,PML;TP53;PLK2;MDM4;BRCC3;E2F8;CHEK1;CDKN1A
11134,GO:0045145,0.139847382952118,0.994741725944598,1,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,EXO1
16275,GO:0090312,0.140071958875348,0.961971188761136,3,18,positive regulation of protein deacetylation,BP,TP53;AKAP8;AKAP8L
2243,GO:0005151,0.140109955991859,0.994721185522475,1,2,interleukin-1, Type II receptor binding,MF,ERAP1
8776,GO:0034446,0.140141486416582,0.930557978158194,8,68,substrate adhesion-dependent cell spreading,BP,FN1;GBP1;PDPN;CORO1C;ITGAV;ANTXR1;KIF14;ITGB1BP1
20158,GO:2000810,0.140141556681341,0.962184499403957,3,17,regulation of bicellular tight junction assembly,BP,RUNX1;TJP1;TNF
12375,GO:0048738,0.140161373076497,0.915837236255793,14,126,cardiac muscle tissue development,BP,NRG1;JPH2;FGFR2;G6PD;EDN1;TGFB2;MIR17HG;TPM1;ADAMTS9;NEXN;SRF;MYH11;GJC1;HNRNPU
10175,GO:0042752,0.140260800894926,0.930528294295156,8,67,regulation of circadian rhythm,BP,PML;TP53;RBM4;SUV39H2;ARNTL;TIMELESS;PHLPP1;PSPC1
10483,GO:0043366,0.140364724221141,0.994701214368037,1,2,beta selection,BP,SYK
10400,GO:0043220,0.140467763679455,0.975471770703871,2,9,Schmidt-Lanterman incisure,CC,AKR1B1;MPP5
16090,GO:0090031,0.140508000024811,0.994689965179512,1,2,positive regulation of steroid hormone biosynthetic process,BP,WNT4
1586,GO:0003994,0.140548076730837,0.994686816284992,1,2,aconitate hydratase activity,MF,ACO1
19065,GO:1904879,0.140556183907388,0.994686179167983,1,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
481,GO:0001527,0.140776816593251,0.975983229265732,2,8,microfibril,CC,FBN1;MFAP5
19128,GO:1905006,0.140780879631568,0.994668504652231,1,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFB2
16517,GO:0097195,0.141003946860935,0.994650926912097,1,2,pilomotor reflex,BP,NPNT
730,GO:0001956,0.141108290510345,0.975291655439296,2,9,positive regulation of neurotransmitter secretion,BP,RAB3GAP1;GPER1
9532,GO:0036228,0.141163223904393,0.99463835674699,1,2,protein localization to nuclear inner membrane,BP,NUP54
19151,GO:1905064,0.141333993626348,0.994624861891872,1,2,negative regulation of vascular smooth muscle cell differentiation,BP,PDGFB
18264,GO:1903046,0.141351420670423,0.918610413335738,12,116,meiotic cell cycle process,BP,RAD1;BRIP1;NDC1;WNT4;SMC2;MYBL1;BRCA2;FANCD2;MSH6;PSMC3IP;MSH3;RAD51B
11910,GO:0046915,0.141378256939971,0.951614924379611,4,28,transition metal ion transmembrane transporter activity,MF,TFRC;SLC30A6;ATP2C1;SLC11A2
7068,GO:0030850,0.141395497573201,0.944424646446635,5,36,prostate gland development,BP,FGFR2;SFRP1;TNC;ESR1;SMARCC1
14307,GO:0061370,0.141395769703285,0.99461997560877,1,2,testosterone biosynthetic process,BP,WNT4
4831,GO:0014033,0.141521402887508,0.933650276499697,7,58,neural crest cell differentiation,BP,NRG1;EDN1;KBTBD8;SFRP1;WNT10A;CORO1C;PHACTR4
16338,GO:0090504,0.141592772665326,0.951798832999923,4,26,epiboly,BP,CYR61;PDPN;AJUBA;ADAM17
15262,GO:0071403,0.141599037563949,0.994603880880116,1,2,cellular response to high density lipoprotein particle stimulus,BP,ADAM17
12594,GO:0050729,0.141638771600391,0.93329664642346,7,64,positive regulation of inflammatory response,BP,C3;IL6ST;PTGER4;GBP5;CLOCK;TLR3;TNF
14080,GO:0060838,0.141674403348594,0.994597906830822,1,2,lymphatic endothelial cell fate commitment,BP,PDPN
14179,GO:0061041,0.141738891404258,0.926118672812028,9,81,regulation of wound healing,BP,KRT1;EDN1;C1QTNF1;PDPN;SYK;CD109;WNT4;PDGFB;THBD
12149,GO:0048211,0.141766764398073,0.994590580745633,1,2,Golgi vesicle docking,BP,NSF
19491,GO:1990145,0.141836882491879,0.994585015394582,1,2,maintenance of translational fidelity,BP,CDKAL1
18701,GO:1904020,0.141987098796763,0.994573082160766,1,2,regulation of G-protein coupled receptor internalization,BP,UBQLN2
13059,GO:0051496,0.141995334498574,0.944015761068179,5,37,positive regulation of stress fiber assembly,BP,CTGF;SFRP1;TPM1;WNT4;ITGB1BP1
4770,GO:0010952,0.142087497031361,0.914079217749141,14,151,positive regulation of peptidase activity,BP,FN1;PML;CYR61;CTGF;DDX3X;ANTXR1;ARL6IP5;GPER1;SENP1;PSME2;CFLAR;TRAF2;TNF;IFI27L1
6716,GO:0030123,0.142126589265251,0.975004206531786,2,9,AP-3 adaptor complex,CC,VPS41;AP3B1
6160,GO:0019482,0.142188842030075,0.994557033296335,1,2,beta-alanine metabolic process,BP,DPYD
5705,GO:0016830,0.142215736243277,0.943559556164956,5,41,carbon-carbon lyase activity,MF,GGCX;ODC1;TYW1;UMPS;AZIN1
13520,GO:0055065,0.142276591572323,0.89863816997287,29,323,metal ion homeostasis,BP,SAA1;FTL;FTH1;PML;JPH2;TFRC;EDN1;C1QTNF1;ACO1;SLC30A6;ABCG2;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;JPH1;THADA;SLC11A2;RIC3;TMEM199;NEDD4L;TMEM165;STEAP4;CCDC47;GPER1;ESR1;CCL5
2609,GO:0005912,0.142433957483224,0.893452784663055,39,447,adherens junction,CC,TNS3;KIF23;HSPG2;ACTG1;CHP1;PDLIM1;TJP2;VEZT;LAYN;DST;CSRP1;G3BP1;PARD3B;MME;NEXN;HSPB1;RHOG;LCP1;PTPRM;CORO1C;ARMC5;ITGAV;AJUBA;BAIAP2;CDH13;FZD1;TPM4;TJP1;TNC;HSPA8;PLEKHA7;L1CAM;ADAM17;SENP1;CSRP2;MPP5;SYNPO2;PARD3;NEDD9
10485,GO:0043368,0.142467375970781,0.961024754609712,3,18,positive T cell selection,BP,CYLD;SRF;CD74
7862,GO:0032417,0.142468673864035,0.994534730044977,1,2,positive regulation of sodium:proton antiporter activity,BP,CHP1
4866,GO:0014706,0.142487866167889,0.903960928408307,22,219,striated muscle tissue development,BP,NRG1;HDAC9;JPH2;FGFR2;G6PD;TSC22D3;DDX17;EDN1;TGFB2;GPCPD1;MIR17HG;TPM1;ADAMTS9;NEXN;ARNTL;LUC7L;SRF;MYH11;CENPF;CFLAR;GJC1;HNRNPU
15319,GO:0071492,0.142507607137266,0.99453162306933,1,2,cellular response to UV-A,BP,MME
9919,GO:0042245,0.142517908272435,0.994530800852648,1,2,RNA repair,BP,FTO
6800,GO:0030237,0.142524930462754,0.994530240316737,1,2,female sex determination,BP,WNT4
1758,GO:0004357,0.142562451130082,0.994527244759504,1,2,glutamate-cysteine ligase activity,MF,GCLC
5832,GO:0017109,0.142562451130082,0.994527244759504,1,2,glutamate-cysteine ligase complex,CC,GCLC
16450,GO:0097069,0.142562451130082,0.994527244759504,1,2,cellular response to thyroxine stimulus,BP,GCLC
18847,GO:1904387,0.142562451130082,0.994527244759504,1,2,cellular response to L-phenylalanine derivative,BP,GCLC
10373,GO:0043177,0.14256361814535,0.919959265630295,11,109,organic acid binding,MF,GCLC;HMGCS1;P3H2;LAYN;DHFR;P4HA2;SLC1A3;AKR1C2;RARS;HIF1AN;TYMS
12609,GO:0050766,0.142636321174621,0.951024970478124,4,28,positive regulation of phagocytosis,BP,C3;SIRPA;ITGAV;TNF
2603,GO:0005900,0.142747281423561,0.994512475437353,1,2,oncostatin-M receptor complex,CC,IL6ST
7107,GO:0030898,0.142881112191528,0.975402215030152,2,8,actin-dependent ATPase activity,MF,MYO1B;MYO10
4752,GO:0010921,0.142888959115637,0.913755095973027,14,135,regulation of phosphatase activity,BP,IGFBP3;CHP1;TGFB2;PKMYT1;PPP1R3B;NUAK1;SET;PPP4R4;SH3RF2;PHACTR4;NPNT;HSP90AB1;TNF;PPARGC1B
1283,GO:0003081,0.142925337497247,0.97429711140336,2,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,C9ORF3;MME
7876,GO:0032432,0.143059222698656,0.937578322831432,6,47,actin filament bundle,CC,CRYAB;SIPA1L3;TPM1;LCP1;TPM4;SYNPO2
15829,GO:0072509,0.143266564247687,0.960707228120699,3,18,divalent inorganic cation transmembrane transporter activity,MF,SLC30A6;SLC11A2;SLC41A2
16238,GO:0090263,0.143335556006024,0.919399222944827,11,111,positive regulation of canonical Wnt signaling pathway,BP,FGFR2;DAPK3;JRK;NAIP;SFRP1;WNT4;DDX3X;ARNTL;PSME2;PSMB9;PSMB10
15769,GO:0072341,0.143451699057081,0.937098565459081,6,51,modified amino acid binding,MF,PTGES;JPH2;DHFR;ARRDC1-AS1;HSPA8;TYMS
17777,GO:1901701,0.143471714522371,0.886330826556246,60,713,cellular response to oxygen-containing compound,BP,HDAC9;KRT13;CYP1B1;GCLC;CYP24A1;COL16A1;FGFR2;STAT5A;MMP9;FBN1;IRS1;TP53;EDN1;HMGCS1;NQO1;AKAP8;INHBA;BRIP1;CDK4;SFRP1;NUCKS1;CD274;ATP2B1;COL4A1;AHR;DHFR;TPM1;PTGER4;CCL20;RRAGB;SOD2;IL24;SOCS1;AKR1C2;BAIAP2;COL5A2;SRF;GDAP1;PDGFB;CLU;ENPP1;PIK3R3;NFKBIB;ZNF106;SRD5A1;APEX1;TNC;PXMP2;GPER1;CFLAR;AKR1B1;TRAF2;CCNA2;TIMELESS;ESR1;TNF;CCL5;TAF1;SMARCC1;PPARGC1B
13654,GO:0060129,0.143501528350664,0.994451982517416,1,2,thyroid-stimulating hormone-secreting cell differentiation,BP,WNT4
9577,GO:0036363,0.143544809913774,0.994448500331492,1,2,transforming growth factor beta activation,BP,HSP90AB1
7197,GO:0031081,0.143574603483401,0.994446102626001,1,2,nuclear pore distribution,BP,NDC1
13142,GO:0051664,0.143574603483401,0.994446102626001,1,2,nuclear pore localization,BP,NDC1
84,GO:0000171,0.143696666489912,0.994436273485578,1,2,ribonuclease MRP activity,MF,POP1
4218,GO:0009383,0.143752420931209,0.994431780726782,1,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,NOP2
5091,GO:0015349,0.143842997799808,0.994424477757507,1,2,thyroid hormone transmembrane transporter activity,MF,SLC16A2
6213,GO:0019725,0.143855283787129,0.889697917354939,46,548,cellular homeostasis,BP,SAA1;FTL;FTH1;PML;JPH2;GCLC;TFRC;TXNRD1;CLN6;TP53;EDN1;C1QTNF1;CHP1;SLC4A11;ACO1;SLC30A6;SLC9A3R1;ABCG2;GPCPD1;NUCKS1;ATP2B1;RPA1;POLA1;PTGER4;ADM;RFC3;ATP2C1;ITGAV;TRPM7;FEN1;SRF;ENPP1;JPH1;THADA;SLC11A2;APEX1;RIC3;TMEM199;NEDD4L;PRIM2;TMEM165;GPER1;SLC9A9;POLE3;ESR1;CCL5
12147,GO:0048209,0.143861700038908,0.994422969201959,1,2,regulation of vesicle targeting, to, from or within Golgi,BP,GOSR1
787,GO:0002042,0.143878314801011,0.943035537279622,5,37,cell migration involved in sprouting angiogenesis,BP,HDAC9;STARD13;PLK2;SRF;ITGB1BP1
3710,GO:0008219,0.143886957315536,0.878093653609398,123,1571,cell death,BP,CRYAB;IGFBP3;SPRR3;KRT1;NEFL;SPRR2A;KRT34;KRT4;KRT13;PML;CYP1B1;MAP3K14;GCLC;KRT2;CYR61;KRT15;FOSL2;FGFR2;CTGF;MMP9;XAF1;B4GALT1;G6PD;TSC22D3;TRAF3;TP53;DAPK3;EDN1;DDX47;CDKN2A;NQO1;PRUNE2;LGALS3;CHP1;PDPN;TGFB2;CYLD;IKBKE;IFIT3;IL6ST;BAG1;SLC9A3R1;INHBA;EMP2;NAIP;NBN;TRIO;SHQ1;CDK4;SFRP1;KRT9;CD274;MCM2;TARDBP;MIR17HG;AHR;NAA15;TCHH;DRAM1;ARRDC1-AS1;TRAF1;ADM;DYNLL2;PLK2;MYBL2;HSPB1;WNT4;THOC1;SOD2;DDX3X;IL24;RRN3;ITGAV;SET;TRPM7;KRT24;GADD45B;MDM4;FZD1;CLU;BIRC3;EYA3;ACKR3;BLOC1S2;APEX1;PDCL3;HSP90AB1;ARL6IP5;EPHB6;SGK1;BRCA2;KRT10;CCAR1;ETV6;CHEK1;SERPINB9;GPER1;FAF1;RAD18;RPTN;ADAM17;SENP1;NTN1;MSH6;CFLAR;EIF2B5;AKR1B1;TRAF2;CITED2;NAA16;KIF14;TLR3;ESR1;DNASE1;TNF;CCL5;CD74;DAXX;PHLPP1;CDKN1A;IRF1;GPX4;IFI27L1
10254,GO:0042978,0.143955156260403,0.994415427553608,1,2,ornithine decarboxylase activator activity,MF,AZIN1
17963,GO:1902269,0.143955156260403,0.994415427553608,1,2,positive regulation of polyamine transmembrane transport,BP,AZIN1
2564,GO:0005846,0.144008962912795,0.994411083012908,1,2,nuclear cap binding complex,CC,NCBP1
165,GO:0000340,0.144055167878185,0.97445608903554,2,9,RNA 7-methylguanosine cap binding,MF,GEMIN5;NCBP1
3287,GO:0006978,0.144181488926093,0.960342636811396,3,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,TP53;BRCA2;CDKN1A
10915,GO:0044451,0.144212776273177,0.882170482051749,80,975,nucleoplasm part,CC,HDAC9;TRIM16;PML;TRIM22;CBX5;S100P;DDX17;TP53;DAPK3;EXO1;RBM4;GEMIN5;STAG1;IKBKE;TGS1;IL16;SRSF2;SUGP2;DKC1;PHAX;NBN;GEMIN4;RPA1;TAF2;LSG1;PARD3B;ELMSAN1;CASC3;SYNPO2L;AKAP8L;NOP58;GTF3C6;KDM6A;THOC1;TOPBP1;SUPT16H;DDX3X;NUFIP1;ARNTL;TRIM37;GINS4;LUC7L2;UTY;EFTUD2;KANSL1L;RIF1;GLIS2;TTF2;APEX1;SGK1;GEMIN8;FANCD2;POLR2F;RAD18;ATR;UBAP2L;RFWD3;CBLL1;TAF6L;TELO2;RBBP5;POLR3B;POLE3;TAP2;SURF2;HNRNPU;RING1;DAXX;TAF1;TBPL1;FTO;PSPC1;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;RBM8A;GTF2H3;TEX10;DHX15
8010,GO:0032632,0.144217003018119,0.994394267933141,1,2,interleukin-3 production,BP,SYK
8034,GO:0032672,0.144217003018119,0.994394267933141,1,2,regulation of interleukin-3 production,BP,SYK
5090,GO:0015347,0.144219161445466,0.974409256898346,2,9,sodium-independent organic anion transmembrane transporter activity,MF,SLC22A5;SLCO4C1
15323,GO:0071496,0.144407565618066,0.902347942739192,22,237,cellular response to external stimulus,BP,MAP3K14;GCLC;CYP24A1;TP53;BRIP1;SFRP1;ATP2B1;PTGER4;CADPS2;RRAGB;WNT4;BAIAP2;SRF;GDAP1;SRD5A1;TNC;HSPA8;CHEK1;TLR3;TAF1;CDKN1A;IRF1
6751,GO:0030168,0.144433802007979,0.918819082979594,11,104,platelet activation,BP,SAA1;ACTG1;C1QTNF1;PDPN;SYK;CSRP1;HSPB1;RHOG;SRF;PDGFB;THBD
15290,GO:0071453,0.144458640178152,0.909247792006287,16,172,cellular response to oxygen levels,BP,TP53;EDN1;BRIP1;SFRP1;SUV39H2;AJUBA;PGK1;MDM4;HIF1AN;TMEM199;PSME2;CFLAR;PSMB9;CITED2;CCNA2;PSMB10
10445,GO:0043281,0.14448276038898,0.90918522669999,16,176,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CRYAB;PML;CYR61;CTGF;MMP9;NAIP;DDX3X;BIRC3;ARL6IP5;SERPINB9;GPER1;SENP1;CFLAR;TRAF2;TNF;IFI27L1
16656,GO:0097498,0.144533209239584,0.994368657902814,1,2,endothelial tube lumen extension,BP,STARD13
2124,GO:0004915,0.14459017518264,0.994364037433885,1,2,interleukin-6 receptor activity,MF,IL6ST
6324,GO:0019981,0.14459017518264,0.994364037433885,1,2,interleukin-6 binding,MF,IL6ST
14591,GO:0070110,0.14459017518264,0.994364037433885,1,2,ciliary neurotrophic factor receptor complex,CC,IL6ST
14989,GO:0070877,0.144670824739193,0.994357492499428,1,2,microprocessor complex,CC,DGCR8
18284,GO:1903095,0.144670824739193,0.994357492499428,1,2,ribonuclease III complex,CC,DGCR8
7506,GO:0031673,0.144697372215389,1,1,1,H zone,CC,DST
11911,GO:0046916,0.144721594614552,0.927396979106892,8,77,cellular transition metal ion homeostasis,BP,FTL;FTH1;TFRC;ACO1;SLC30A6;ABCG2;SLC11A2;TMEM199
9888,GO:0042144,0.144810779794987,0.994346125011318,1,2,vacuole fusion, non-autophagic,BP,VPS41
16691,GO:0097576,0.144810779794987,0.994346125011318,1,2,vacuole fusion,BP,VPS41
13581,GO:0060024,0.144856699775289,0.994342392584064,1,2,rhythmic synaptic transmission,BP,EDN1
13032,GO:0051446,0.1450028108056,0.974184983892056,2,9,positive regulation of meiotic cell cycle,BP,WNT4;LFNG
15667,GO:0072162,0.14508492125455,0.994323822725236,1,2,metanephric mesenchymal cell differentiation,BP,WNT4
7696,GO:0032143,0.145224169729963,0.994312476229113,1,2,single thymine insertion binding,MF,MSH6
7782,GO:0032301,0.145224169729963,0.994312476229113,1,2,MutSalpha complex,CC,MSH6
248,GO:0000706,0.145248463897879,0.994310495392207,1,2,meiotic DNA double-strand break processing,BP,BRIP1
19695,GO:1990918,0.145248463897879,0.994310495392207,1,2,double-strand break repair involved in meiotic recombination,BP,BRIP1
5116,GO:0015433,0.145316276532741,0.99430496428163,1,2,peptide antigen-transporting ATPase activity,MF,TAP2
2348,GO:0005388,0.145575005987636,0.974650120955238,2,8,calcium-transporting ATPase activity,MF,ATP2B1;ATP2C1
3457,GO:0007271,0.145675710693753,0.973991768063761,2,9,synaptic transmission, cholinergic,BP,NQO1;RIC3
8678,GO:0034242,0.145676983710656,0.994275494477866,1,2,negative regulation of syncytium formation by plasma membrane fusion,BP,CFLAR
15505,GO:0071847,0.145864256178079,0.994260161848278,1,2,TNFSF11-mediated signaling pathway,BP,TJP2
3308,GO:0007010,0.14586819488297,0.88009653145383,85,984,cytoskeleton organization,BP,CRYAB;NEFL;KRT4;MAP2;KRT13;KIF23;AMOT;KRT2;KRT15;CTGF;MYO1B;ACTG1;NEFM;MID1;DAPK3;EDN1;SIPA1L3;STAG1;COBLL1;CHP1;CNTNAP1;CYLD;SLC9A3R1;PALM2;DNHD1;EMP2;NAIP;SFRP1;KRT9;DST;TPM1;ULK4;PTGER4;PARD3B;OPHN1;NDC1;SYNPO2L;PLK2;NEXN;KANK4;MYBL2;RHOG;WNT4;LCP1;RAN;RANBP2;CORO1C;ATP2C1;TRPM7;AJUBA;CGNL1;TRIM37;CDC42EP2;BAIAP2;PHACTR4;SRF;UGT8;ANTXR1;RTKN2;SDAD1;BIRC3;TPM4;FGD6;SETD2;ANLN;WEE1;MYH11;BRCA2;LIMCH1;SKA2;WDPCP;CHEK1;CEP152;CFLAR;SHTN1;DPYSL3;SYNPO2;PARD3;TNF;NEDD9;HNRNPU;FGFR1OP;PPARGC1B;ITGB1BP1;DIAPH3
14270,GO:0061300,0.146031666575961,0.994246436606947,1,2,cerebellum vasculature development,BP,IMMP2L
10573,GO:0043522,0.146111859308069,0.973369294557605,2,10,leucine zipper domain binding,MF,MKL1;DAPK3
14942,GO:0070777,0.146266511487467,0.994227152807853,1,2,D-aspartate transport,BP,SLC1A3
14944,GO:0070779,0.146266511487467,0.994227152807853,1,2,D-aspartate import across plasma membrane,BP,SLC1A3
15591,GO:0072034,0.146374549108711,0.994218269796401,1,2,renal vesicle induction,BP,WNT4
15983,GO:0080009,0.146464160678116,0.973265892541774,2,10,mRNA methylation,BP,METTL16;TRMT61A
1448,GO:0003674,0.146471989034191,0.88579867720347,819,11319,molecular_function,MF,IL32;CRYAB;IGFBP3;HEPHL1;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;C1R;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;FAM46B;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;SLC16A2;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;SLC7A2;RUNX1;MYO1B;CYP1A1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;SPACA6;TSC22D3;FST;MAT2A;DDX17;SPON1;FAM69B;TRIM56;OVCH2;TFCP2L1;KRTAP2-3;CCDC80;TRAF3;COL27A1;ENC1;PLD5;IRS1;DYNC2H1;SPG21;MID1;SLC16A9;TP53;DAPK3;TUFT1;SVEP1;PANK2;SLC7A5P2;EXO1;ANKRD36C;EDN1;TPST1;C9ORF3;SCD;ABHD16B;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;ABCF1;TMEM106A;C1QTNF1;DUSP14;RBM19;KBTBD8;TMPPE;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;COBLL1;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;CNTNAP1;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;IFIT3;SRSF2;FOXD2;PCDH7;LRFN4;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;ANKRD52;IL7R;NUP50;SLC22A5;PALM2;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;GFOD1;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;ANKRD36B;HLA-F;CDK4;SFRP1;VPS41;KRT9;POP1;HLA-DOB;RIPK4;GPCPD1;NUCKS1;HEATR1;ZDHHC6;CD274;WNT10A;MCM2;TARDBP;MIR17HG;LAYN;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;APOL6;KEAP1;NAA15;UAP1L1;TRA2A;TCHH;ZNF827;SLC5A6;HRNR;DHFR;RPA1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;IGFL3;KCNS3;SETDB1;PTGER4;TK1;TMEM97;LSG1;G3BP1;GRWD1;ARRDC1-AS1;ZNF584;TMEM248;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;CDV3;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;CXCL16;NOP2;DOHH;SUV39H2;LCP1;EXOG;PTPRM;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;LENG8;RANBP2;HS3ST1;VCPKMT;TOPBP1;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;CPA4;IL24;ARHGEF28;GPHN;KLHL21;RRN3;RNF115;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;ABCF2;SNX11;TRPM7;AJUBA;SMC2;FASTKD3;KCNQ5;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;KRT24;LFNG;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;SRBD1;FRRS1;PPP4R4;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;FNDC3B;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;GANC;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;SGK494;SDK1;FZD1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;FRAS1;CWF19L2;CBWD5;ZNF316;IL20;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;TYW1;MCM6;FGD6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;TMEM51;THBD;ABCC9;TRMT5;TTF2;DTX4;METTL13;GLIPR2;JPH1;SRPRB;DPY19L2P2;SEPHS2;NNT;IFNAR1;WEE1;TJP1;ZNF484;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;CXCR5;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;BRCA2;HPS5;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;HCAR1;DGCR8;MAPK1IP1L;DPYD;SS18L2;TTC27;LIMCH1;KRT10;CCAR1;SKA2;CYB561D2;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;L1CAM;ZNFX1;STEAP4;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;LNX2;CHEK1;IL12RB2;SRFBP1;SERPINB9;SCFD2;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;DDX60L;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;GPATCH4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;ZNF608;TAF6L;MRPS7;DPH2;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;TPRA1;MSH3;TELO2;RBBP5;CYP20A1;FAM208B;CITED2;MFAP5;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;NSA2;IGFL1;KIF14;PURB;TLR3;MPP5;AZIN1;ERVK13-1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;KCNE4;FEM1C;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;C8ORF33;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;DCTN5;METAP2;SLC43A2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;ZNHIT6;FTO;CCDC50;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;SLC41A2;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GBP6;CENPO;GPX4;IRAK3;BUD13;TMEM234;COPS3;DHX15;UFC1
3743,GO:0008282,0.146590575502594,0.994200485619034,1,2,inward rectifying potassium channel,CC,ABCC9
189,GO:0000406,0.146603198862268,0.994199445498098,1,2,double-strand/single-strand DNA junction binding,MF,MSH3
7707,GO:0032181,0.146603198862268,0.994199445498098,1,2,dinucleotide repeat insertion binding,MF,MSH3
7783,GO:0032302,0.146603198862268,0.994199445498098,1,2,MutSbeta complex,CC,MSH3
2651,GO:0005988,0.146623270648219,0.994197791444838,1,2,lactose metabolic process,BP,B4GALT1
2652,GO:0005989,0.146623270648219,0.994197791444838,1,2,lactose biosynthetic process,BP,B4GALT1
11653,GO:0046351,0.146623270648219,0.994197791444838,1,2,disaccharide biosynthetic process,BP,B4GALT1
4555,GO:0010634,0.146774085575763,0.917295380363588,11,102,positive regulation of epithelial cell migration,BP,HDAC9;STAT5A;MMP9;EDN1;TGFB2;PLK2;HSPB1;PDGFB;GLIPR2;ADAM17;ITGB1BP1
18960,GO:1904680,0.146948461725484,0.958620855304493,3,21,peptide transmembrane transporter activity,MF,TAP1;TIMM23B;TAP2
8162,GO:0032885,0.146980866219661,0.949436831827243,4,25,regulation of polysaccharide biosynthetic process,BP,IRS1;PPP1R3B;PDGFB;ENPP1
10041,GO:0042476,0.147018305389644,0.9228210385184,9,79,odontogenesis,BP,FGFR2;TUFT1;EDN1;TGFB2;INHBA;WNT10A;ADM;TNC;CSF1
1121,GO:0002707,0.147230840218641,0.958688124939716,3,20,negative regulation of lymphocyte mediated immunity,BP,IL7R;THOC1;SERPINB9
20236,GO:2001070,0.147243320241715,0.994146569301371,1,2,starch binding,MF,GPCPD1
15270,GO:0071421,0.147274958416148,0.994143949142548,1,2,manganese ion transmembrane transport,BP,SLC11A2
3535,GO:0007529,0.147381904752904,0.994135087533775,1,2,establishment of synaptic specificity at neuromuscular junction,BP,GPHN
13189,GO:0051767,0.147452411275373,0.972974963833595,2,10,nitric-oxide synthase biosynthetic process,BP,EDN1;CCL20
13190,GO:0051769,0.147452411275373,0.972974963833595,2,10,regulation of nitric-oxide synthase biosynthetic process,BP,EDN1;CCL20
11037,GO:0044868,0.147644650674389,0.994113285502025,1,2,modulation by host of viral molecular function,BP,NUCKS1
12696,GO:0050885,0.147677003805171,0.948938935525523,4,26,neuromuscular process controlling balance,BP,NEFL;CNTNAP1;NBN;SLC1A3
1077,GO:0002643,0.147759836894751,0.973389596927869,2,9,regulation of tolerance induction,BP,PHLPP1;IRAK3
11237,GO:0045356,0.14777638916952,0.994102337662047,1,2,positive regulation of interferon-alpha biosynthetic process,BP,TLR3
11884,GO:0046873,0.147805507982188,0.901916716067532,20,200,metal ion transmembrane transporter activity,MF,JPH2;TFRC;SLC4A11;SLC30A6;ATP2B1;SLC5A6;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;SLC11A2;SLC9A9;KCNE4;PANX1;SLC25A22;SLC41A2
10269,GO:0042998,0.14791421393346,0.994090872241506,1,2,positive regulation of Golgi to plasma membrane protein transport,BP,ACSL3
4553,GO:0010632,0.14795384606431,0.906885272826238,16,158,regulation of epithelial cell migration,BP,HDAC9;STAT5A;STARD13;MMP9;EDN1;TGFB2;EMP2;ADAMTS9;PLK2;HSPB1;PTPRM;CORO1C;PDGFB;GLIPR2;ADAM17;ITGB1BP1
13911,GO:0060532,0.148034684938345,0.994080840571523,1,2,bronchus cartilage development,BP,SRF
14231,GO:0061145,0.148034684938345,0.994080840571523,1,2,lung smooth muscle development,BP,SRF
14897,GO:0070669,0.148125580928954,0.973283339582044,2,9,response to interleukin-2,BP,STAT5A;SYK
15223,GO:0071352,0.148125580928954,0.973283339582044,2,9,cellular response to interleukin-2,BP,STAT5A;SYK
20311,GO:2001245,0.148140036523729,0.994072060345806,1,2,regulation of phosphatidylcholine biosynthetic process,BP,ACSL3
8850,GO:0034635,0.148195245535875,0.994067456293225,1,2,glutathione transport,BP,SLC9A3R1
10244,GO:0042939,0.148195245535875,0.994067456293225,1,2,tripeptide transport,BP,SLC9A3R1
7665,GO:0032089,0.148410271462334,0.994049506145008,1,2,NACHT domain binding,MF,TRIM16
677,GO:0001884,0.148567904913293,0.994036328393984,1,2,pyrimidine nucleoside binding,MF,HSP90AB1
837,GO:0002134,0.148567904913293,0.994036328393984,1,2,UTP binding,MF,HSP90AB1
7958,GO:0032551,0.148567904913293,0.994036328393984,1,2,pyrimidine ribonucleoside binding,MF,HSP90AB1
17978,GO:1902306,0.148581066158537,0.973150767513709,2,9,negative regulation of sodium ion transmembrane transport,BP,SLC9A3R1;NEDD4L
8880,GO:0034678,0.148630505473768,0.994031090765535,1,2,integrin alpha8-beta1 complex,CC,NPNT
4832,GO:0014034,0.148663449499069,0.99402833342264,1,2,neural crest cell fate commitment,BP,SFRP1
7596,GO:0031959,0.148696092622836,0.99402560058381,1,2,mineralocorticoid receptor signaling pathway,BP,GPER1
15457,GO:0071715,0.14879352253007,0.958256361004068,3,19,icosanoid transport,BP,EDN1;SYK;ABCC4
17717,GO:1901571,0.14879352253007,0.958256361004068,3,19,fatty acid derivative transport,BP,EDN1;SYK;ABCC4
4108,GO:0009162,0.148901875941912,0.972133811486153,2,11,deoxyribonucleoside monophosphate metabolic process,BP,TK1;TYMS
2056,GO:0004803,0.149283947996969,0.993976270091413,1,2,transposase activity,MF,ZBED1
7902,GO:0032465,0.149317477754406,0.924895558111704,8,68,regulation of cytokinesis,BP,KIF23;KLHL21;KLHL9;SETD2;CXCR5;BRCA2;E2F8;KIF14
3187,GO:0006812,0.149324650320292,0.884193170741704,49,578,cation transport,BP,HEPHL1;FTL;FTH1;PML;JPH2;TFRC;CTGF;MMP9;SLC7A2;G6PD;EDN1;LGALS3;CHP1;SLC4A11;IL16;SLC30A6;SLC9A3R1;SLC22A5;SYK;SHISA9;ATP2B1;SLC5A6;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;NETO1;PDGFB;COMMD9;ABCC9;JPH1;NNT;THADA;SLC11A2;NSF;NEDD4L;SGK1;TMEM165;STEAP4;GPER1;NFKBIE;SLC9A9;KCNE4;CCL5;PANX1;SLC25A22;SLC41A2
10150,GO:0042704,0.149365572962834,0.993969403058846,1,2,uterine wall breakdown,BP,TGFB2
3048,GO:0006606,0.149449986649835,0.913078934700563,12,115,protein import into nucleus,BP,PML;CHP1;RBM22;NUP50;NUP153;RAN;RANBP2;ARNTL;NUP54;HSP90AB1;TNF;CDKN1A
3464,GO:0007284,0.149677780830524,0.993943098151841,1,2,spermatogonial cell division,BP,BRIP1
2817,GO:0006282,0.149745739357421,0.920928853824812,9,83,regulation of DNA repair,BP,PML;POLQ;BRCC3;EYA3;RIF1;SETD2;CHEK1;TIMELESS;USP1
2353,GO:0005416,0.149765054682763,0.97280490065946,2,9,amino acid:cation symporter activity,MF,SLC1A3;SLC25A22
15382,GO:0071603,0.149831698074945,0.993930107086203,1,2,endothelial cell-cell adhesion,BP,CYP1B1
9696,GO:0038065,0.14988660212251,0.973427086657131,2,8,collagen-activated signaling pathway,BP,SYK;COL4A1
17856,GO:1901991,0.150071380589708,0.902328697105081,18,202,negative regulation of mitotic cell cycle phase transition,BP,PML;TP53;GPR132;NBN;PLK2;TOPBP1;ANAPC15;MDM4;E2F8;CENPF;PSME2;PSMB9;RFWD3;TPRA1;RBL1;ZFP36L2;PSMB10;CDKN1A
13910,GO:0060529,0.150107832676919,0.993906762679328,1,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,FGFR2
11463,GO:0045899,0.150162725480831,0.972170486664674,2,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53;ESR1
1382,GO:0003275,0.150328703600981,0.993888055269878,1,2,apoptotic process involved in outflow tract morphogenesis,BP,TGFB2
17954,GO:1902256,0.150328703600981,0.993888055269878,1,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,TGFB2
19667,GO:1990825,0.150406195572905,0.972097747289441,2,10,sequence-specific mRNA binding,MF,DHFR;TYMS
5370,GO:0016160,0.150526269444852,0.993871295400791,1,2,amylase activity,MF,MGAM
9872,GO:0042116,0.150530021974759,0.93943714885281,5,38,macrophage activation,BP,SLC7A2;SYK;CLU;TLR3;CD74
4978,GO:0015093,0.150660984752936,0.993859852977522,1,2,ferrous iron transmembrane transporter activity,MF,SLC11A2
5152,GO:0015684,0.150660984752936,0.993859852977522,1,2,ferrous iron transport,BP,SLC11A2
18627,GO:1903874,0.150660984752936,0.993859852977522,1,2,ferrous iron transmembrane transport,BP,SLC11A2
12011,GO:0047389,0.150723125729552,0.993854570955947,1,2,glycerophosphocholine phosphodiesterase activity,MF,GPCPD1
15923,GO:0072676,0.150746149512987,0.939056225650093,5,41,lymphocyte migration,BP,SAA1;CCL20;CXCL16;ADAM17;CCL5
17929,GO:1902214,0.150786052871305,0.993849219598348,1,2,regulation of interleukin-4-mediated signaling pathway,BP,PARP14
18360,GO:1903294,0.150839981927494,0.993844631431467,1,2,regulation of glutamate secretion, neurotransmission,BP,RAB3GAP1
18361,GO:1903296,0.150839981927494,0.993844631431467,1,2,positive regulation of glutamate secretion, neurotransmission,BP,RAB3GAP1
17297,GO:0120114,0.151068596309106,0.923372873797116,8,79,Sm-like protein family complex,CC,GEMIN5;TGS1;GEMIN4;ZMAT2;LUC7L;LUC7L2;EFTUD2;GEMIN8
8367,GO:0033238,0.151102214153505,0.932285892064575,6,60,regulation of cellular amine metabolic process,BP,NQO1;ODC1;PSME2;PSMB9;AZIN1;PSMB10
5635,GO:0016712,0.151274368070764,0.971837738024586,2,10,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,CYP1B1;CYP1A1
17998,GO:1902369,0.151286305728369,0.939035094461503,5,38,negative regulation of RNA catabolic process,BP,DKC1;TARDBP;LRPPRC;SYNCRIP;HNRNPU
15804,GO:0072395,0.151289727685667,0.923452349084697,8,73,signal transduction involved in cell cycle checkpoint,BP,PML;TP53;PLK2;MDM4;BRCC3;E2F8;CHEK1;CDKN1A
9953,GO:0042303,0.151410117848198,0.919960142246758,9,80,molting cycle,BP,FGFR2;FST;TGFB2;INHBA;WNT10A;CD109;ARNTL;CLOCK;TNF
10124,GO:0042633,0.151410117848198,0.919960142246758,9,80,hair cycle,BP,FGFR2;FST;TGFB2;INHBA;WNT10A;CD109;ARNTL;CLOCK;TNF
369,GO:0000990,0.151630919568216,0.972256157559636,2,9,transcription factor activity, core RNA polymerase binding,MF,TP53;RRN3
9691,GO:0038052,0.151643404243943,0.993776058052651,1,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,ESR1
6658,GO:0030004,0.151691982700848,0.923200416178321,8,73,cellular monovalent inorganic cation homeostasis,BP,CLN6;TP53;CHP1;SLC4A11;TMEM199;NEDD4L;TMEM165;SLC9A9
18015,GO:1902423,0.15171350506125,0.993770055271519,1,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,HNRNPU
18016,GO:1902425,0.15171350506125,0.993770055271519,1,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,HNRNPU
8254,GO:0033023,0.151736361049489,0.993768097418379,1,2,mast cell homeostasis,BP,ADAM17
8255,GO:0033024,0.151736361049489,0.993768097418379,1,2,mast cell apoptotic process,BP,ADAM17
8256,GO:0033025,0.151736361049489,0.993768097418379,1,2,regulation of mast cell apoptotic process,BP,ADAM17
10686,GO:0043922,0.151741657035021,0.971697380310551,2,10,negative regulation by host of viral transcription,BP,TARDBP;CCL5
14054,GO:0060763,0.151757214186824,0.993766310838865,1,2,mammary duct terminal end bud growth,BP,CSF1
6252,GO:0019826,0.151841687586726,0.993759070788529,1,2,oxygen sensor activity,MF,HIF1AN
19111,GO:1904975,0.15197804217158,0.99374737447483,1,2,response to bleomycin,BP,TIMELESS
19112,GO:1904976,0.15197804217158,0.99374737447483,1,2,cellular response to bleomycin,BP,TIMELESS
1176,GO:0002820,0.15206323990491,0.956916723304053,3,19,negative regulation of adaptive immune response,BP,IL7R;THOC1;RC3H1
552,GO:0001673,0.152076849911197,0.971596523492735,2,10,male germ cell nucleus,CC,RAN;TOPBP1
12615,GO:0050772,0.152105198406045,0.923251795884434,8,66,positive regulation of axonogenesis,BP,NEFL;NRG1;FN1;SRF;ZFYVE27;L1CAM;NTN1;SHTN1
19830,GO:2000233,0.152110165743389,0.993736029746859,1,2,negative regulation of rRNA processing,BP,SHQ1
14911,GO:0070697,0.152244087757009,0.993724519198687,1,2,activin receptor binding,MF,INHBA
14912,GO:0070699,0.152244087757009,0.993724519198687,1,2,type II activin receptor binding,MF,INHBA
12115,GO:0048103,0.15238456042313,0.957291223266524,3,17,somatic stem cell division,BP,FGFR2;TGFB2;ZFP36L2
4060,GO:0009108,0.152474555783701,0.900622576106961,18,193,coenzyme biosynthetic process,BP,MAT2A;PANK2;SCD;ACSL3;NUP50;NUP153;DHFR;NDC1;RANBP2;GPHN;PGK1;HACD2;QDPR;NUP160;NUP54;SCD5;PDSS1;FLAD1
19776,GO:2000116,0.152533528861792,0.901819609829711,17,191,regulation of cysteine-type endopeptidase activity,BP,CRYAB;PML;CYR61;CTGF;MMP9;NAIP;DDX3X;BIRC3;ARL6IP5;SERPINB9;GPER1;SENP1;CFLAR;PSMB9;TRAF2;TNF;IFI27L1
4786,GO:0010971,0.152594876759356,0.956697529929099,3,19,positive regulation of G2/M transition of mitotic cell cycle,BP,PBX1;CDK4;RAD51B
3739,GO:0008276,0.1527607270514,0.922570726963109,8,72,protein methyltransferase activity,MF,METTL21A;SETDB1;SUV39H2;SETD4;VCPKMT;SMYD2;SETD2;RBBP5
215,GO:0000448,0.153008887592471,0.993658564917103,1,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,NOL9
7997,GO:0032609,0.153100676747302,0.931495826548943,6,53,interferon-gamma production,BP,IL27RA;INHBA;CD274;IL12RB2;TLR3;TNF
3901,GO:0008537,0.153145998821917,0.991606692444321,1,3,proteasome activator complex,CC,PSME2
5600,GO:0016628,0.15314866013691,0.956062396379267,3,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,AKR1C2;SRD5A1;DPYD
83,GO:0000166,0.153173566177625,0.869107071811125,133,1629,nucleotide binding,MF,KIF23;MAP3K14;GCLC;NLRC5;TXNRD1;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;G6PD;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;GBP1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;BAG1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;RAB32;TRIO;PARP15;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;RIPK4;MCM2;POLQ;TSR1;ATP2B1;DHFR;HELLS;ULK4;POLA1;ABCC4;TK1;LSG1;G3BP1;FOXRED2;MDN1;EIF5;PLK2;RRAGB;FRK;GBP5;RHOG;DDX28;RAN;ORC4;ATP2C1;DDX3X;RAB26;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;GNL3L;NVL;GATC;RARS;QDPR;MCM8;SGK494;ENPP1;CBWD5;DDX10;EFTUD2;DDX24;TYW1;MCM6;SRD5A1;ABCC9;TTF2;SRPRB;SEPHS2;NNT;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;DPYD;PPIP5K1;CHEK1;MMAA;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;TYMS;HNRNPU;FLAD1;TAF1;NRAS;ABCA11P;GBP6;IRAK3;DHX15
5815,GO:0017070,0.153229919619205,0.970818181151101,2,11,U6 snRNA binding,MF,RBM22;METTL16
19935,GO:2000392,0.153330029982527,0.971752538347593,2,9,regulation of lamellipodium morphogenesis,BP,PDPN;CORO1C
13246,GO:0051890,0.153381451527615,0.993626300265727,1,2,regulation of cardioblast differentiation,BP,TGFB2
16101,GO:0090049,0.153387332102927,0.945896595929262,4,28,regulation of cell migration involved in sprouting angiogenesis,BP,HDAC9;STARD13;PLK2;ITGB1BP1
11862,GO:0046825,0.15339022901778,0.937817315716921,5,39,regulation of protein export from nucleus,BP,TP53;PTPN14;RBM22;AKAP8L;SETD2
9140,GO:0035457,0.153708982641577,0.971639707420771,2,9,cellular response to interferon-alpha,BP,IFIT3;IFNAR1
8157,GO:0032877,0.154050377262022,0.993568146784021,1,2,positive regulation of DNA endoreduplication,BP,E2F8
5997,GO:0018995,0.15428580309634,0.925876561063032,7,61,host,CC,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
10656,GO:0043657,0.15428580309634,0.925876561063032,7,61,host cell,CC,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
10779,GO:0044215,0.15428580309634,0.925876561063032,7,61,other organism,CC,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
10780,GO:0044216,0.15428580309634,0.925876561063032,7,61,other organism cell,CC,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
10781,GO:0044217,0.15428580309634,0.925876561063032,7,61,other organism part,CC,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
8885,GO:0034685,0.154292118446176,0.993547060211859,1,2,integrin alphav-beta6 complex,CC,ITGAV
17626,GO:1901265,0.154296976410773,0.868095429274989,133,1630,nucleoside phosphate binding,MF,KIF23;MAP3K14;GCLC;NLRC5;TXNRD1;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;G6PD;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;GBP1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;BAG1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;RAB32;TRIO;PARP15;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;RIPK4;MCM2;POLQ;TSR1;ATP2B1;DHFR;HELLS;ULK4;POLA1;ABCC4;TK1;LSG1;G3BP1;FOXRED2;MDN1;EIF5;PLK2;RRAGB;FRK;GBP5;RHOG;DDX28;RAN;ORC4;ATP2C1;DDX3X;RAB26;GPHN;ABCF2;TRPM7;SMC2;PGK1;MCM3;GNL3L;NVL;GATC;RARS;QDPR;MCM8;SGK494;ENPP1;CBWD5;DDX10;EFTUD2;DDX24;TYW1;MCM6;SRD5A1;ABCC9;TTF2;SRPRB;SEPHS2;NNT;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;DPYD;PPIP5K1;CHEK1;MMAA;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;TYMS;HNRNPU;FLAD1;TAF1;NRAS;ABCA11P;GBP6;IRAK3;DHX15
13507,GO:0055024,0.154330609012779,0.931193438786932,6,47,regulation of cardiac muscle tissue development,BP,NRG1;JPH2;FGFR2;G6PD;EDN1;MIR17HG
14352,GO:0061515,0.154523561385675,0.93100752636789,6,48,myeloid cell development,BP,FBN1;G6PD;PABPC4;TJP2;SRF;SLC11A2
20141,GO:2000779,0.154546982317113,0.930922116210429,6,49,regulation of double-strand break repair,BP,PML;POLQ;RIF1;SETD2;CHEK1;TIMELESS
10149,GO:0042701,0.154621270065871,0.993518288663614,1,2,progesterone secretion,BP,INHBA
5619,GO:0016668,0.154754054272856,0.970348974817343,2,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD1;PGK1
19698,GO:1990927,0.15481440330718,0.993501374239324,1,2,calcium ion regulated lysosome exocytosis,BP,SYT11
6319,GO:0019961,0.154883199161536,0.993495343372518,1,2,interferon binding,MF,IFNAR1
19205,GO:1905224,0.154902805040201,0.993493624100699,1,2,clathrin-coated pit assembly,BP,SYT11
13439,GO:0052813,0.154929065788269,0.937298813986717,5,36,phosphatidylinositol bisphosphate kinase activity,MF,NRG1;FGFR2;IRS1;PDGFB;ESR1
6495,GO:0021847,0.154933673020927,0.993490916735696,1,2,ventricular zone neuroblast division,BP,FGFR2
9227,GO:0035607,0.154933673020927,0.993490916735696,1,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,FGFR2
16717,GO:0097647,0.155036676927552,0.99139001012643,1,3,amylin receptor signaling pathway,BP,ADM
6667,GO:0030018,0.155252880162688,0.917904401593144,9,70,Z disc,CC,CRYAB;JPH2;PDLIM1;DST;SYNPO2L;NEXN;HSPB1;JPH1;SYNPO2
710,GO:0001932,0.1552646125329,0.872825212533509,78,943,regulation of protein phosphorylation,BP,IGFBP3;SAA1;NRG1;FN1;PML;MAP3K14;CYR61;C3;GPRC5A;FGFR2;EPGN;CTGF;MMP9;MID1;TP53;EDN1;GBP1;C1QTNF1;DUSP14;CDKN2A;CHP1;AKAP8;TGFB2;PKMYT1;IL6ST;SLC9A3R1;INHBA;SYK;EMP2;NBN;CDK4;SFRP1;TARDBP;ULK4;CD109;CCL20;AKAP8L;HSPB1;CORO1C;DDX3X;IL24;CDC25A;ITGAV;SOCS1;PARP14;AJUBA;GADD45B;NPNT;PDGFB;FZD1;CLU;ENPP1;IL20;ACKR3;GLIPR2;PDCL3;HSP90AB1;ARL6IP5;EPHB6;GPER1;FAF1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;KIF14;TLR3;PARD3;TNF;CCL5;CD74;FGFR1OP;DAXX;PHLPP1;CDKN1A;ITGB1BP1;IRAK3
10556,GO:0043496,0.155267970204419,0.955371627372369,3,20,regulation of protein homodimerization activity,BP,NRG1;GNL3L;TRAF2
7484,GO:0031643,0.155339777233184,0.971152033098246,2,9,positive regulation of myelination,BP,NRG1;PARD3
14966,GO:0070841,0.155364270065922,0.955793875594711,3,18,inclusion body assembly,BP,SACS;TRIM37;CLU
348,GO:0000961,0.155385846137183,0.99345118735203,1,2,negative regulation of mitochondrial RNA catabolic process,BP,LRPPRC
7845,GO:0032395,0.155431473800504,0.991344388343511,1,3,MHC class II receptor activity,MF,HLA-DOB
9346,GO:0035822,0.155485436357613,0.993442419357731,1,2,gene conversion,BP,NUCKS1
5662,GO:0016763,0.155631599006471,0.936522065121967,5,40,transferase activity, transferring pentosyl groups,MF,PARP15;PARP14;PARP8;PDCL3;UMPS
12875,GO:0051174,0.155727776103212,0.869697808442437,99,1211,regulation of phosphorus metabolic process,BP,IGFBP3;SAA1;NRG1;FN1;PML;MAP3K14;CYR61;C3;GPRC5A;NLRC5;FGFR2;EPGN;CTGF;MMP9;IRS1;MID1;TP53;EDN1;GBP1;C1QTNF1;DUSP14;CDKN2A;ACSL3;CHP1;AKAP8;TGFB2;PKMYT1;PPP1R3B;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;SYK;EMP2;NUP153;NBN;CDK4;SFRP1;TARDBP;ULK4;ADM;CD109;NDC1;CCL20;AKAP8L;HSPB1;RANBP2;CORO1C;DDX3X;IL24;CDC25A;ITGAV;SOCS1;SET;PARP14;AJUBA;PPP4R4;GADD45B;SH3RF2;PHACTR4;NPNT;PDGFB;FZD1;CLU;NUP160;ENPP1;IL20;PIK3R3;NUP54;ACKR3;GLIPR2;PDCL3;HSP90AB1;ARL6IP5;EPHB6;MTMR2;GPER1;FAF1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;RBL1;KIF14;TLR3;PARD3;TNF;CCL5;CD74;HNRNPU;FGFR1OP;DAXX;PHLPP1;PPARGC1B;CDKN1A;ITGB1BP1;IRAK3
7168,GO:0031033,0.155735939638415,0.975774118680211,2,5,myosin filament organization,BP,DAPK3;MYH11
18687,GO:1903977,0.155791543807512,0.993415429467696,1,2,positive regulation of glial cell migration,BP,CSF1
13687,GO:0060187,0.155956035838808,0.99340090106874,1,2,cell pole,CC,ASTN2
5235,GO:0015849,0.156016420584703,0.899414891389229,17,175,organic acid transport,BP,SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;EDN1;ACSL3;SLC9A3R1;SYK;SLC5A6;ABCC4;SLC1A3;CROT;ARL6IP5;RAB3GAP1;NFKBIE;SLC43A2;SLC25A22
11925,GO:0046942,0.156016420584703,0.899414891389229,17,175,carboxylic acid transport,BP,SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;EDN1;ACSL3;SLC9A3R1;SYK;SLC5A6;ABCC4;SLC1A3;CROT;ARL6IP5;RAB3GAP1;NFKBIE;SLC43A2;SLC25A22
8996,GO:0035097,0.156165926192253,0.920514326854578,8,70,histone methyltransferase complex,CC,HDAC9;CBX5;KDM6A;TRIM37;UTY;RBBP5;TAF1;TEX10
15483,GO:0071803,0.156277790413508,0.970320026792967,2,10,positive regulation of podosome assembly,BP,LCP1;TNF
10190,GO:0042772,0.15627981907067,0.955167699884931,3,19,DNA damage response, signal transduction resulting in transcription,BP,TP53;BRCA2;CDKN1A
6070,GO:0019216,0.15628803786737,0.891339895520508,24,260,regulation of lipid metabolic process,BP,CYR61;C3;TXNRD1;CTGF;CYP1A1;IRS1;PANK2;SCD;HMGCS1;ACSL3;TGS1;LSS;CDK4;WNT4;RAN;PDGFB;PIK3R3;MTMR2;GPER1;RBL1;GLIPR1;ARV1;TNF;PPARGC1B
10553,GO:0043491,0.156328314424707,0.902337556176728,15,150,protein kinase B signaling,BP,NRG1;FGFR2;IRS1;C1QTNF1;SLC9A3R1;AKR1C2;PDGFB;GPER1;ESR1;TNF;CCL5;PHLPP2;PHLPP1;CDKN1A;ITGB1BP1
11295,GO:0045588,0.156441342388503,0.993357935837662,1,2,positive regulation of gamma-delta T cell differentiation,BP,SYK
20228,GO:2001045,0.156527007981099,0.993350335914554,1,2,negative regulation of integrin-mediated signaling pathway,BP,PHACTR4
13984,GO:0060670,0.156537384416019,0.970240390182988,2,10,branching involved in labyrinthine layer morphogenesis,BP,FGFR2;ADM
6878,GO:0030350,0.156630040836256,0.993341188965883,1,2,iron-responsive element binding,MF,ACO1
14422,GO:0061684,0.156651369147314,0.970205394887996,2,10,chaperone-mediated autophagy,BP,CLU;HSPA8
15980,GO:0075732,0.156854543924417,0.99332123453886,1,2,viral penetration into host nucleus,BP,NUP153
18076,GO:1902594,0.156854543924417,0.99332123453886,1,2,multi-organism nuclear import,BP,NUP153
13750,GO:0060298,0.157001921145657,0.993308117582243,1,2,positive regulation of sarcomere organization,BP,EDN1
19943,GO:2000404,0.157039649021224,0.954628730997654,3,20,regulation of T cell migration,BP,CCL20;ADAM17;CCL5
10081,GO:0042567,0.157068059408834,0.993302226547843,1,2,insulin-like growth factor ternary complex,CC,IGFBP3
2305,GO:0005287,0.157082704564786,0.993300921700008,1,2,high-affinity basic amino acid transmembrane transporter activity,MF,SLC7A2
2306,GO:0005289,0.157082704564786,0.993300921700008,1,2,high-affinity arginine transmembrane transporter activity,MF,SLC7A2
2308,GO:0005292,0.157082704564786,0.993300921700008,1,2,high-affinity lysine transmembrane transporter activity,MF,SLC7A2
14400,GO:0061628,0.157124970497136,0.993297155131739,1,2,H3K27me3 modified histone binding,MF,TAF1
8060,GO:0032715,0.157243372302696,0.954764647311688,3,19,negative regulation of interleukin-6 production,BP,SYT11;TNF;IRAK3
3332,GO:0007044,0.157321293663446,0.916328412960893,9,75,cell-substrate junction assembly,BP,FN1;COL16A1;DAPK3;SFRP1;WNT4;CORO1C;AJUBA;WDPCP;ITGB1BP1
6066,GO:0019211,0.157378062340378,0.969981889043309,2,10,phosphatase activator activity,MF,IGFBP3;PHACTR4
9060,GO:0035272,0.15744520919757,0.935733827264767,5,38,exocrine system development,BP,FGFR2;TFCP2L1;TGFB2;RAB26;TNF
14582,GO:0070097,0.157462192139274,0.993267061996686,1,2,delta-catenin binding,MF,PLEKHA7
801,GO:0002067,0.157466906414381,0.943910417507867,4,28,glandular epithelial cell differentiation,BP,FGFR2;WNT4;ARNTL;CLOCK
9173,GO:0035520,0.157568032048173,0.970480152253363,2,9,monoubiquitinated protein deubiquitination,BP,USP16;USP1
2819,GO:0006284,0.157624268455763,0.935357210641621,5,41,base-excision repair,BP,TP53;POLQ;RPA1;APEX1;SMUG1
4481,GO:0010485,0.157637236328705,0.95484859001717,3,18,H4 histone acetyltransferase activity,MF,NAA50;KANSL1L;BRCA2
7613,GO:0031994,0.15766916959666,0.970449504822341,2,9,insulin-like growth factor I binding,MF,IGFBP3;ITGAV
19721,GO:2000009,0.157826332660365,0.969843673158495,2,10,negative regulation of protein localization to cell surface,BP,NEDD4L;ASTN2
1162,GO:0002768,0.157837814415382,0.890975745797603,23,257,immune response-regulating cell surface receptor signaling pathway,BP,RUNX1;ACTG1;SPG21;GBP1;LGALS3;CYLD;SYK;RELB;MUC16;BTN2A1;BAIAP2;HSP90AB1;MYO10;PSME2;PSMB9;EIF2B5;CMTM3;RC3H1;PSMB10;EIF2B1;NRAS;MUC5B;MUC6
4532,GO:0010595,0.157889613606256,0.919380948386513,8,71,positive regulation of endothelial cell migration,BP,HDAC9;STAT5A;EDN1;PLK2;HSPB1;PDGFB;ADAM17;ITGB1BP1
10279,GO:0043010,0.157941824756129,0.895388220477428,19,191,camera-type eye development,BP,CRYAB;TENM3;CYP1B1;FBN1;CYP1A1;MEGF11;TGFB2;INHBA;CDK4;ATP2B1;COL4A1;PTPRM;PHACTR4;SRF;SDK1;WDPCP;RAB3GAP1;RRM1;RING1
20270,GO:2001181,0.157962397340329,0.991048828622568,1,3,positive regulation of interleukin-10 secretion,BP,CD274
18938,GO:1904612,0.158384157720049,0.993184412162419,1,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,AHR
18939,GO:1904613,0.158384157720049,0.993184412162419,1,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,AHR
20309,GO:2001243,0.158647737250894,0.918586152138189,8,79,negative regulation of intrinsic apoptotic signaling pathway,BP,MMP9;HSPB1;SOD2;DDX3X;RRN3;CLU;ACKR3;CD74
8884,GO:0034684,0.158741511969085,0.993152229212273,1,2,integrin alphav-beta5 complex,CC,ITGAV
9365,GO:0035868,0.158897183429776,0.993138183755001,1,2,alphav-beta3 integrin-HMGB1 complex,CC,ITGAV
13815,GO:0060382,0.158939630647907,0.993134351232111,1,2,regulation of DNA strand elongation,BP,NUCKS1
5905,GO:0018108,0.158968766846169,0.891158422113941,22,234,peptidyl-tyrosine phosphorylation,BP,NRG1;GPRC5A;FGFR2;STAT5A;EPGN;TP53;IL6ST;SYK;SFRP1;FRK;IL24;SOCS1;PARP14;PDGFB;IL20;WEE1;PDCL3;IL12RB2;ADAM17;CCL5;CD74;FGFR1OP
881,GO:0002237,0.158988957278347,0.894366308133058,19,213,response to molecule of bacterial origin,BP,PTGES;FGFR2;CYP1A1;EDN1;AKAP8;CDK4;CD274;PTGER4;ADM;CCL20;IL24;NFKBIB;THBD;IFNAR1;IL12RB2;ADAM17;TNF;CCL5;IRAK3
14910,GO:0070696,0.159007570930488,0.969478206244058,2,10,transmembrane receptor protein serine/threonine kinase binding,MF,TGFB2;INHBA
8120,GO:0032800,0.159309450253629,0.953896197597922,3,19,receptor biosynthetic process,BP,EDN1;ITGAV;TNF
9928,GO:0042264,0.159485258903561,0.993084982993439,1,2,peptidyl-aspartic acid hydroxylation,BP,HIF1AN
9940,GO:0042277,0.159502450711644,0.898235486104007,16,171,peptide binding,MF,CRYAB;PTGES;HLA-B;TAP1;C9ORF3;TGFB2;INHBA;NUP153;HLA-F;MME;ITGAV;CLU;ERAP1;HSP90AB1;BACE2;CD74
2098,GO:0004861,0.159633369133057,0.968826268384794,2,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN2A;CDKN1A
361,GO:0000979,0.160028831246177,0.942505515424115,4,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,NLRC5;H3F3A;MAZ;TAF1
6430,GO:0021693,0.160236379465144,0.99301670614785,1,2,cerebellar Purkinje cell layer structural organization,BP,KIF14
6435,GO:0021698,0.160236379465144,0.99301670614785,1,2,cerebellar cortex structural organization,BP,KIF14
8541,GO:0033857,0.160352899130198,0.993006081712714,1,2,diphosphoinositol-pentakisphosphate kinase activity,MF,PPIP5K1
17145,GO:0102092,0.160352899130198,0.993006081712714,1,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,PPIP5K1
8450,GO:0033564,0.160484517006232,0.992994069998191,1,2,anterior/posterior axon guidance,BP,NTN1
18175,GO:1902893,0.160506113007679,0.942575337681857,4,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,TP53;TGFB2;SRF;PDGFB
3196,GO:0006826,0.160600163583842,0.933652682312904,5,42,iron ion transport,BP,FTL;FTH1;TFRC;SLC11A2;STEAP4
8191,GO:0032922,0.16062807471308,0.927640684602901,6,46,circadian regulation of gene expression,BP,PML;RELB;AHR;ARNTL;CLOCK;HNRNPU
15179,GO:0071280,0.160798243433627,0.968077348370942,2,12,cellular response to copper ion,BP,CYP1A1;DAXX
2106,GO:0004874,0.160947453166949,0.992951732115158,1,2,aryl hydrocarbon receptor activity,MF,AHR
4509,GO:0010557,0.160977188194205,0.864706307157209,102,1252,positive regulation of macromolecule biosynthetic process,BP,MAFB;NRG1;TRIM16;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;RUNX1;PBX1;DDX17;IRS1;TP53;EDN1;ZBED1;STAG1;CHP1;TGFB2;FOXD2;DKC1;INHBA;SYK;RELB;UTP15;CDK4;SFRP1;NUCKS1;HEATR1;USP16;AHR;NAA15;GLIS3;TAF2;CCL20;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;RRN3;ARNTL;FASTKD3;DND1;NVL;CDH13;SRF;NPNT;WDR43;PDGFB;FZD1;NFE2L1;MACC1;GLIS2;TET3;MYBL1;HSP90AB1;BRCA2;SS18L2;E2F8;ETV6;HSF2;RAB3GAP1;CHEK1;GPER1;MLLT10;WDR75;SENP1;RBMS3;ATR;EIF2B5;NOL11;UPF3B;EDRF1;CITED2;NCL;CCNA2;RBL1;NAA16;CLOCK;TLR3;ESR1;TNF;CCL5;CD74;HNRNPU;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
16760,GO:0098502,0.16103022195517,0.990683374456534,1,3,DNA dephosphorylation,BP,APEX1
17843,GO:1901976,0.161052994978247,0.941861887632017,4,30,regulation of cell cycle checkpoint,BP,WDR76;THOC1;ANAPC15;RFWD3
3586,GO:0007638,0.161094151951624,0.97013742425484,2,8,mechanosensory behavior,BP,SLC1A3;CNTNAP2
16028,GO:0086020,0.161311536218279,0.992918337010507,1,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,GJC1
16029,GO:0086021,0.161311536218279,0.992918337010507,1,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,GJC1
16047,GO:0086053,0.161311536218279,0.992918337010507,1,2,AV node cell to bundle of His cell communication by electrical coupling,BP,GJC1
16063,GO:0086077,0.161311536218279,0.992918337010507,1,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,GJC1
18975,GO:1904706,0.161441898095728,0.968253917718784,2,11,negative regulation of vascular smooth muscle cell proliferation,BP,TPM1;GPER1
3828,GO:0008426,0.161546733693442,0.990621066978066,1,3,protein kinase C inhibitor activity,MF,HSPB1
14615,GO:0070161,0.161583176104285,0.877190471000149,40,464,anchoring junction,CC,TNS3;KIF23;HSPG2;B4GALT1;ACTG1;CHP1;PDLIM1;TJP2;VEZT;LAYN;DST;CSRP1;G3BP1;PARD3B;MME;NEXN;HSPB1;RHOG;LCP1;PTPRM;CORO1C;ARMC5;ITGAV;AJUBA;BAIAP2;CDH13;FZD1;TPM4;TJP1;TNC;HSPA8;PLEKHA7;L1CAM;ADAM17;SENP1;CSRP2;MPP5;SYNPO2;PARD3;NEDD9
7439,GO:0031543,0.16159155224884,0.96867241023995,2,10,peptidyl-proline dioxygenase activity,MF,P3H2;P4HA2
10358,GO:0043153,0.161623689274328,0.952916634213212,3,19,entrainment of circadian clock by photoperiod,BP,PML;TP53;RBM4
10551,GO:0043489,0.161796910267485,0.941630083910576,4,29,RNA stabilization,BP,DKC1;TARDBP;SYNCRIP;HNRNPU
4627,GO:0010745,0.161931872854761,0.969145838209154,2,9,negative regulation of macrophage derived foam cell differentiation,BP,ITGAV;ABCA5
3635,GO:0008106,0.161957572758313,0.967705047765938,2,12,alcohol dehydrogenase (NADP+) activity,MF,AKR1C2;AKR1B1
12573,GO:0050706,0.162373175514169,0.952366748158576,3,20,regulation of interleukin-1 beta secretion,BP,TRIM16;PML;PANX1
17466,GO:1900221,0.162428624069835,0.968992399295978,2,9,regulation of amyloid-beta clearance,BP,SRF;CLU
17029,GO:0099106,0.162440701314207,0.926205687668763,6,51,ion channel regulator activity,MF,ANKRD36C;CHP1;KCNS3;ABCC9;NEDD4L;SGK1
12798,GO:0051054,0.162459545006636,0.894531557535323,17,181,positive regulation of DNA metabolic process,BP,PML;TFRC;DKC1;NBN;SETDB1;RFC3;NVL;PDGFB;BRCC3;EYA3;RIF1;HSP90AB1;E2F8;ATR;MSH6;TIMELESS;ATAD5
5563,GO:0016572,0.162539874090325,0.941261007373516,4,29,histone phosphorylation,BP,AKAP8;AKAP8L;CHEK1;CCNA2
6382,GO:0021564,0.16320691112941,0.992743092012911,1,2,vagus nerve development,BP,NAV2
11260,GO:0045445,0.16331798341247,0.925691896191115,6,51,myoblast differentiation,BP,IGFBP3;NRG1;DDX17;SRF;HIF1AN;TNF
19736,GO:2000042,0.163505654173081,0.968658635117517,2,9,negative regulation of double-strand break repair via homologous recombination,BP,POLQ;RIF1
8812,GO:0034508,0.163535195308887,0.9314774663198,5,50,centromere complex assembly,BP,HELLS;CENPF;CENPN;HIST1H4A;CENPO
951,GO:0002367,0.163627051937124,0.9253167490126,6,54,cytokine production involved in immune response,BP,TGFB2;TRAF2;TLR3;TNF;CD74;IRAK3
14751,GO:0070404,0.163701081266677,0.990358759583608,1,3,NADH binding,MF,QDPR
7429,GO:0031523,0.163802967582612,0.992687496885141,1,2,Myb complex,CC,MYBL2
14817,GO:0070528,0.164068378774563,0.951874076776776,3,19,protein kinase C signaling,BP,ULK4;PDGFB;PHLPP1
10478,GO:0043331,0.164083867906284,0.915350568729528,8,73,response to dsRNA,BP,TSN;ZC3H7B;DDX21;DGCR8;NCBP1;TLR3;ESR1;IRAK3
13837,GO:0060411,0.164179367176264,0.925487715187683,6,47,cardiac septum morphogenesis,BP,CYR61;FGFR2;TGFB2;MIR17HG;FZD1;CITED2
5663,GO:0016765,0.164212280634534,0.931291186314187,5,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,PTGES;MAT2A;GDAP1;DPH2;PDSS1
1748,GO:0004345,0.164358233154397,0.992635497574392,1,2,glucose-6-phosphate dehydrogenase activity,MF,G6PD
12597,GO:0050732,0.164379850903222,0.931758731766974,5,40,negative regulation of peptidyl-tyrosine phosphorylation,BP,GPRC5A;SFRP1;SOCS1;PARP14;FGFR1OP
5641,GO:0016723,0.164542929130432,0.967741435187509,2,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,FRRS1;STEAP4
9242,GO:0035624,0.164550410259488,0.992617453686156,1,2,receptor transactivation,BP,ADAM17
16520,GO:0097198,0.164606910547456,0.992612144167235,1,2,histone H3-K36 trimethylation,BP,SETD2
7900,GO:0032463,0.164632881484498,0.967233593737343,2,11,negative regulation of protein homooligomerization,BP,CRYAB;CLU
42,GO:0000086,0.164723288557538,0.888768678309443,20,225,G2/M transition of mitotic cell cycle,BP,PBX1;PKMYT1;GPR132;NBN;CDK4;TAF2;TOPBP1;CDC25A;AJUBA;WEE1;CENPF;PSME2;CEP152;PSMB9;CCNA2;KIF14;RAD51B;FGFR1OP;PSMB10;CDKN1A
13197,GO:0051783,0.164753496334213,0.896111586778642,15,154,regulation of nuclear division,BP,EPGN;DAPK3;EDN1;STAG1;PKMYT1;RAD1;WNT4;RANBP2;ANAPC15;CDCA5;PDGFB;ANLN;CENPF;CHEK1;HNRNPU
3342,GO:0007062,0.164811284812714,0.902254419290294,12,120,sister chromatid cohesion,BP,STAG1;DYNLL2;RANBP2;FEN1;CDCA5;NUP160;NAA50;SKA2;CENPF;CENPN;CTCF;CENPO
7654,GO:0032060,0.164864220093347,0.967639406191381,2,10,bleb assembly,BP,EMP2;ANLN
19477,GO:1990108,0.164881495430425,0.992586310775616,1,2,protein linear deubiquitination,BP,CYLD
5052,GO:0015238,0.165162836403605,0.919174599522826,7,62,drug transmembrane transporter activity,MF,SLC7A2;SLC4A11;SLC22A5;ABCG2;SLC1A3;EBP;SLC25A22
10540,GO:0043470,0.165234873944241,0.919300003724728,7,59,regulation of carbohydrate catabolic process,BP,PPP1R3B;NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54
19961,GO:2000427,0.165501644022665,0.992527784557469,1,2,positive regulation of apoptotic cell clearance,BP,C3
6981,GO:0030641,0.165567813914386,0.918820318679332,7,64,regulation of cellular pH,BP,CLN6;TP53;CHP1;SLC4A11;TMEM199;TMEM165;SLC9A9
6274,GO:0019865,0.165679428696927,0.990114426279958,1,3,immunoglobulin binding,MF,LGALS3
19267,GO:1905383,0.1656821584178,0.990114086858819,1,3,protein localization to presynapse,BP,HSPB1
13704,GO:0060218,0.165692710929091,0.913479425728406,8,100,hematopoietic stem cell differentiation,BP,RUNX1;SFRP1;H3F3A;SRF;PSME2;PSMB9;PSMB10;HIST1H4A
17761,GO:1901668,0.165755458948201,0.990104970102561,1,3,regulation of superoxide dismutase activity,BP,TNF
3936,GO:0008616,0.166168973602179,0.990053453825539,1,3,queuosine biosynthetic process,BP,PDCL3
11583,GO:0046116,0.166168973602179,0.990053453825539,1,3,queuosine metabolic process,BP,PDCL3
3290,GO:0006983,0.16619747778599,0.967214588952292,2,10,ER overload response,BP,TP53;CCDC47
4778,GO:0010961,0.16625456208718,0.992456389542478,1,2,cellular magnesium ion homeostasis,BP,TRPM7
4254,GO:0009452,0.166275233509969,0.938880299849113,4,33,7-methylguanosine RNA capping,BP,TGS1;POLR2F;NCBP1;GTF2H3
9539,GO:0036260,0.166275233509969,0.938880299849113,4,33,RNA capping,BP,TGS1;POLR2F;NCBP1;GTF2H3
20146,GO:2000790,0.166300423556744,0.992452028741781,1,2,regulation of mesenchymal cell proliferation involved in lung development,BP,PHF14
20147,GO:2000791,0.166300423556744,0.992452028741781,1,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,PHF14
7503,GO:0031669,0.166405478245036,0.893178746865747,16,166,cellular response to nutrient levels,BP,CYP24A1;TP53;BRIP1;SFRP1;ATP2B1;CADPS2;RRAGB;WNT4;BAIAP2;SRF;GDAP1;SRD5A1;TNC;HSPA8;TAF1;CDKN1A
13506,GO:0055023,0.166806669365144,0.950965030427805,3,18,positive regulation of cardiac muscle tissue growth,BP,FGFR2;EDN1;MIR17HG
8352,GO:0033197,0.166807780770264,0.9665305255186,2,11,response to vitamin E,BP,HMGCS1;SRSF2
12697,GO:0050886,0.166873738203423,0.930383393507625,5,40,endocrine process,BP,EDN1;C9ORF3;C1QTNF1;INHBA;MME
4828,GO:0014029,0.166903411942497,0.966988724732826,2,10,neural crest formation,BP,KBTBD8;SFRP1
7137,GO:0030956,0.166933747226939,0.989957794744229,1,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,GATC
12520,GO:0050567,0.166933747226939,0.989957794744229,1,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,GATC
14905,GO:0070681,0.166933747226939,0.989957794744229,1,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,GATC
11786,GO:0046628,0.167028576213936,0.967556537145427,2,9,positive regulation of insulin receptor signaling pathway,BP,IRS1;NUCKS1
17756,GO:1901661,0.167084206079447,0.949750433739589,3,23,quinone metabolic process,BP,AKR1C2;AKR1B1;PDSS1
305,GO:0000814,0.167093467457327,0.989937753976636,1,3,ESCRT II complex,CC,VPS36
12999,GO:0051383,0.167153578633308,0.950547011231566,3,19,kinetochore organization,BP,SMC2;CENPF;CENPN
11103,GO:0045089,0.167357012851971,0.884522926285581,22,246,positive regulation of innate immune response,BP,NLRC5;TRAF3;CYLD;IKBKE;SYK;RELB;MUC16;GBP5;BIRC3;PSME2;PSMB9;POLR3B;TLR3;ESR1;CCL5;PSMB10;NRAS;PSPC1;MUC5B;MUC6;IRF1;IRAK3
9853,GO:0042089,0.167479859543668,0.917635027897999,7,64,cytokine biosynthetic process,BP,INHBA;SYK;CCL20;HSPB1;TLR3;TNF;IRF1
13951,GO:0060594,0.1675342230133,0.99233419282258,1,2,mammary gland specification,BP,FGFR2
12438,GO:0048871,0.167898420109293,0.887674298337115,19,202,multicellular organismal homeostasis,BP,KRT1;TFRC;CTGF;ACTG1;SLC22A5;SYK;LEPR;HRNR;HSPB1;SRF;SLC11A2;RPTN;AKR1B1;CSF1;TNF;WDR36;FTO;PPARGC1B;MUC6
10189,GO:0042771,0.167995363220453,0.929491789791582,5,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,PML;TP53;BRCA2;CD74;CDKN1A
7914,GO:0032481,0.168113079742074,0.917293530411711,7,63,positive regulation of type I interferon production,BP,SYK;DDX3X;SETD2;POLR2F;POLR3B;TLR3;IRF1
10451,GO:0043297,0.168130843869966,0.923004691377227,6,49,apical junction assembly,BP,RUNX1;SRF;TJP1;MPP5;PARD3;TNF
11608,GO:0046173,0.168266424336416,0.929426720540819,5,42,polyol biosynthetic process,BP,DHFR;QDPR;PPIP5K1;GPER1;AKR1B1
8911,GO:0034724,0.16834866642515,0.928736822019395,5,51,DNA replication-independent nucleosome organization,BP,H3F3A;SUPT16H;CENPN;HIST1H4A;CENPO
7591,GO:0031953,0.168435300219872,0.966496378998516,2,10,negative regulation of protein autophosphorylation,BP,CHP1;ENPP1
6847,GO:0030308,0.16854647848971,0.899569423292115,12,122,negative regulation of cell growth,BP,CRYAB;PML;G6PD;TP53;CDKN2A;TGFB2;INHBA;SFRP1;DDX3X;ENPP1;NTN1;CDKN1A
12370,GO:0048730,0.168696708464642,0.949878513489201,3,19,epidermis morphogenesis,BP,FGFR2;TGFB2;WNT10A
13491,GO:0055006,0.168709973435413,0.923197082512932,6,43,cardiac cell development,BP,G6PD;EDN1;NEXN;SRF;MYH11;HNRNPU
2695,GO:0006059,0.168921080043224,0.989706890944124,1,3,hexitol metabolic process,BP,AKR1B1
6497,GO:0021854,0.169002929398242,0.965814644325207,2,11,hypothalamus development,BP,SRD5A1;RAB3GAP1
10363,GO:0043163,0.169253623322695,0.992168308585248,1,2,cell envelope organization,BP,HRNR
11182,GO:0045229,0.169253623322695,0.992168308585248,1,2,external encapsulating structure organization,BP,HRNR
5357,GO:0016125,0.169326698148192,0.901634340266969,11,110,sterol metabolic process,BP,CYP1B1;CLN6;G6PD;SCD;HMGCS1;LEPR;LSS;RAN;NFE2L1;EBP;ARV1
3795,GO:0008361,0.169379560968234,0.896871119572776,13,123,regulation of cell size,BP,NRG1;FN1;EDN1;SLC9A3R1;IL7R;CDK4;SRF;HSP90AB1;ZFYVE27;L1CAM;NTN1;SHTN1;WDR36
13521,GO:0055067,0.169407171050109,0.907939282195308,9,86,monovalent inorganic cation homeostasis,BP,CLN6;TP53;EDN1;CHP1;SLC4A11;TMEM199;NEDD4L;TMEM165;SLC9A9
689,GO:0001905,0.16942088801715,0.992152067229573,1,2,activation of membrane attack complex,BP,C3
741,GO:0001969,0.16942088801715,0.992152067229573,1,2,regulation of activation of membrane attack complex,BP,C3
10517,GO:0043410,0.169453509030594,0.876144025944619,30,337,positive regulation of MAPK cascade,BP,IGFBP3;SAA1;NRG1;MAP3K14;FGFR2;EPGN;CTGF;MID1;EDN1;C1QTNF1;TGFB2;SYK;CCL20;ITGAV;AJUBA;GADD45B;NPNT;PDGFB;ACKR3;GLIPR2;ARL6IP5;EPHB6;GPER1;CFLAR;TRAF2;TLR3;TNF;CCL5;CD74;DAXX
886,GO:0002249,0.169476795108754,0.992146634549757,1,2,lymphocyte anergy,BP,PHLPP1
1086,GO:0002667,0.169476795108754,0.992146634549757,1,2,regulation of T cell anergy,BP,PHLPP1
1210,GO:0002870,0.169476795108754,0.992146634549757,1,2,T cell anergy,BP,PHLPP1
1233,GO:0002911,0.169476795108754,0.992146634549757,1,2,regulation of lymphocyte anergy,BP,PHLPP1
15566,GO:0071962,0.169553764871172,0.989626307553022,1,3,mitotic sister chromatid cohesion, centromeric,BP,NAA50
7023,GO:0030730,0.169587213618719,0.966124158885675,2,10,sequestering of triglyceride,BP,ENPP1;TNF
6707,GO:0030104,0.169653559123493,0.9221831316401,6,48,water homeostasis,BP,KRT1;HRNR;SRF;NEDD4L;RPTN;AKR1B1
19412,GO:1905863,0.169753827951489,0.992119683896738,1,2,invadopodium organization,BP,PDPN
9167,GO:0035514,0.169769799760678,0.989598713555307,1,3,DNA demethylase activity,MF,FTO
6929,GO:0030516,0.169885828447435,0.911910046369393,8,67,regulation of axon extension,BP,NRG1;FN1;SRF;ZFYVE27;L1CAM;NTN1;SHTN1;WDR36
1209,GO:0002866,0.169965046829499,0.989573740502226,1,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,C3
14651,GO:0070208,0.169989349570048,0.965993812380683,2,10,protein heterotrimerization,BP,C1QTNF1;NUP54
2466,GO:0005681,0.170052659031152,0.890258336094226,16,181,spliceosomal complex,CC,LGALS3;RBM22;SRSF2;HNRNPF;HNRNPA1L2;LUC7L;LUC7L2;EFTUD2;TTF2;HSPA8;SYNCRIP;HNRNPR;HNRNPU;HNRNPM;RBM8A;DHX15
2723,GO:0006101,0.170172764313393,0.937018226039482,4,32,citrate metabolic process,BP,STAT5A;ACO1;NNT;SDHD
5464,GO:0016340,0.170273640234436,0.992068978096001,1,2,calcium-dependent cell-matrix adhesion,BP,TRPM7
12553,GO:0050682,0.17042775039637,0.992053910894442,1,2,AF-2 domain binding,MF,PPARGC1B
11318,GO:0045621,0.170639608374903,0.921230408296506,6,53,positive regulation of lymphocyte differentiation,BP,CYLD;IL7R;SYK;SOCS1;AP3B1;CD74
8161,GO:0032881,0.170681747010726,0.937498907749407,4,27,regulation of polysaccharide metabolic process,BP,IRS1;PPP1R3B;PDGFB;ENPP1
17719,GO:1901576,0.170799101109686,0.846766362225366,363,4894,organic substance biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PTGES;PML;CYP1B1;GCLC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FADS3;CTGF;FBN1;HSPG2;RUNX1;CYP1A1;B4GALT1;PBX1;G6PD;TSC22D3;FST;MAT2A;DDX17;SPON1;TFCP2L1;TRAF3;ENC1;IRS1;TP53;DAPK3;PANK2;EXO1;EDN1;SCD;HMGCS1;ABCF1;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;ZNF208;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL16;SRSF2;FOXD2;PPP1R3B;PGD;RAD1;DKC1;INHBA;NUP50;PUM3;GALNT18;PHAX;SYK;NUP153;ZFP42;RELB;NBN;LEPR;FAM111A;PARP15;BRIP1;MCM5;LSS;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;UAP1L1;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;GRWD1;ZNF584;TRAF1;ADM;CD109;USP43;ZNF407;ELMSAN1;NDC1;SLC1A3;EIF5;CASC3;CCL20;ZNF512;MRPL27;ZNF587;MUC16;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;HS3ST1;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;GPHN;RRN3;CDC25A;ITGAV;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;AJUBA;FASTKD3;DND1;ZNF267;LFNG;PGK1;TRIM37;FEN1;MCM3;HACD2;GNL3L;ZNF586;NVL;GATC;CDH13;GINS4;IBA57;RARS;COMMD4;SRF;MDM4;HIF1AN;NPNT;QDPR;ZNF234;WDR43;MCM8;PDGFB;UGT8;EIF3J;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;PIK3R3;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;VGLL3;RIF1;METTL16;MCM6;SRD5A1;SETD2;GLIS2;UBP1;TTF2;DPY19L2P2;SEPHS2;ZNF484;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;BACE2;SCD5;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;SYNCRIP;TRAK2;DPYD;SS18L2;CCAR1;PPIP5K1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;WDR75;MCM4;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;EBP;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;AZIN1;ESR1;RAD51B;ARV1;TNF;PDSS1;ZFP36L2;SRSF7;RC3H1;TYMS;STARD7;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3
13192,GO:0051771,0.170968986856946,0.989444817488482,1,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,EDN1
1059,GO:0002584,0.171116100272364,0.989425853243634,1,3,negative regulation of antigen processing and presentation of peptide antigen,BP,HLA-DOB
14195,GO:0061061,0.171251782621535,0.871684531535596,35,381,muscle structure development,BP,CRYAB;IGFBP3;NRG1;HDAC9;JPH2;MKL1;FGFR2;ACTG1;G6PD;TSC22D3;DDX17;EDN1;RBM4;TGFB2;GPCPD1;MIR17HG;TPM1;ADM;NEXN;WNT4;ARNTL;LUC7L;SRF;HIF1AN;NPNT;PDGFB;FZD1;JPH1;MYH11;CENPF;GPER1;CFLAR;EHD1;TNF;HNRNPU
18337,GO:1903233,0.171288581114974,0.991969459371301,1,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,RAB3GAP1
11161,GO:0045197,0.171303525636066,0.936853845732861,4,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,SLC9A3R1;PARD3B;OPHN1;PARD3
977,GO:0002428,0.171409129968921,0.989388023908304,1,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,TAP2
1268,GO:0003025,0.17142513490408,0.991956017732901,1,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,NAV2
8856,GO:0034643,0.171492616907349,0.948659284458528,3,19,establishment of mitochondrion localization, microtubule-mediated,BP,NEFL;LRPPRC;TRAK2
12024,GO:0047497,0.171492616907349,0.948659284458528,3,19,mitochondrion transport along microtubule,BP,NEFL;LRPPRC;TRAK2
1813,GO:0004459,0.171495702597999,0.989376833557117,1,3,L-lactate dehydrogenase activity,MF,LDHAL6B
6666,GO:0030017,0.171508225398902,0.897842789075261,12,107,sarcomere,CC,CRYAB;JPH2;PDLIM1;DST;TPM1;SYNPO2L;NEXN;HSPB1;TPM4;ABCC9;JPH1;SYNPO2
5631,GO:0016706,0.171508726091597,0.927909453467988,5,39,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,P3H2;P4HA2;HIF1AN;TET3;FTO
7965,GO:0032558,0.171749392082147,0.989344004787646,1,3,adenyl deoxyribonucleotide binding,MF,HSP90AB1
7969,GO:0032564,0.171749392082147,0.989344004787646,1,3,dATP binding,MF,HSP90AB1
17358,GO:1900015,0.171762517209134,0.948292341426304,3,20,regulation of cytokine production involved in inflammatory response,BP,IL1R2;GBP5;CHID1
9618,GO:0036473,0.171791248761633,0.914895879991354,7,65,cell death in response to oxidative stress,BP,PML;CYP1B1;TP53;HSPB1;SOD2;FZD1;ARL6IP5
1093,GO:0002678,0.171836838464901,0.98933267598963,1,3,positive regulation of chronic inflammatory response,BP,TNF
1055,GO:0002580,0.171883447183166,0.989326635091304,1,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,HLA-DOB
19486,GO:1990131,0.171998575940009,0.989311705421323,1,3,Gtr1-Gtr2 GTPase complex,CC,RRAGB
1280,GO:0003071,0.172090220410833,0.964797183308923,2,11,renal system process involved in regulation of systemic arterial blood pressure,BP,EMP2;PDGFB
9258,GO:0035651,0.1722148754164,0.989283625425883,1,3,AP-3 adaptor complex binding,MF,RAB32
8097,GO:0032774,0.172218276056838,0.847522998200227,230,2996,RNA biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EDN1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;INHBA;PHAX;SYK;ZFP42;RELB;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;TRIM37;ZNF586;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;SMYD2;MACC1;ZNF316;RRM2;COMMD9;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;DDX21;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;NCL;CCNA2;GTF3C4;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;SRSF7;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
5358,GO:0016126,0.172274303517228,0.914644829234519,7,64,sterol biosynthetic process,BP,G6PD;SCD;HMGCS1;LSS;RAN;EBP;ARV1
3166,GO:0006779,0.172364050423128,0.947802952100793,3,21,porphyrin-containing compound biosynthetic process,BP,IBA57;NFE2L1;SLC11A2
488,GO:0001540,0.172399025366212,0.927211364891255,5,41,amyloid-beta binding,MF,CRYAB;TGFB2;CLU;BACE2;CD74
11354,GO:0045663,0.172470550397399,0.9651849524146,2,10,positive regulation of myoblast differentiation,BP,IGFBP3;HIF1AN
18976,GO:1904707,0.172546638772542,0.94819697631719,3,19,positive regulation of vascular smooth muscle cell proliferation,BP,MMP9;PDGFB;TNF
210,GO:0000438,0.172596784292642,0.989233948125269,1,3,core TFIIH complex portion of holo TFIIH complex,CC,GTF2H3
10529,GO:0043434,0.172706874655845,0.875736932977988,27,299,response to peptide hormone,BP,NEFL;HDAC9;TRIM16;GCLC;STAT5A;CTGF;FBN1;IRS1;EDN1;BRIP1;CDK4;NUCKS1;ADM;SOCS1;BAIAP2;QDPR;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;GPER1;CFLAR;EIF2B5;CCNA2;EIF2B1;SMARCC1
20174,GO:2000833,0.172849302180152,0.989201032849742,1,3,positive regulation of steroid hormone secretion,BP,C1QTNF1
12318,GO:0048641,0.172948326133316,0.936015732909114,4,29,regulation of skeletal muscle tissue development,BP,HDAC9;TSC22D3;DDX17;ARNTL
12584,GO:0050717,0.172959343454935,0.989186672047257,1,3,positive regulation of interleukin-1 alpha secretion,BP,PANX1
20283,GO:2001201,0.17302092745356,0.991798019990943,1,2,regulation of transforming growth factor-beta secretion,BP,FN1
12953,GO:0051291,0.173026640711937,0.905069129695714,9,101,protein heterooligomerization,BP,MAT2A;C1QTNF1;BIRC3;NUP54;RRM1;TRAF2;PDSS1;CD74;HIST1H4A
18393,GO:1903363,0.173087735893442,0.914083168129829,7,65,negative regulation of cellular protein catabolic process,BP,PML;OPHN1;PDCL3;HSP90AB1;SENP1;TAF1;SMARCC1
12550,GO:0050679,0.173304135976402,0.896229993821492,12,120,positive regulation of epithelial cell proliferation,BP,FGFR2;STAT5A;EPGN;B4GALT1;SFRP1;CDH13;PDGFB;PDCL3;ADAM17;CFLAR;CCL5;NRAS
3042,GO:0006596,0.173363975843279,0.9639475518354,2,12,polyamine biosynthetic process,BP,ODC1;AZIN1
4646,GO:0010766,0.173395455968923,0.96488140703465,2,10,negative regulation of sodium ion transport,BP,SLC9A3R1;NEDD4L
2129,GO:0004923,0.17361562421817,0.991738707301984,1,2,leukemia inhibitory factor receptor activity,MF,IL6ST
1869,GO:0004530,0.173637689949126,0.991736502030491,1,2,deoxyribonuclease I activity,MF,DNASE1
8349,GO:0033189,0.173830737651479,0.964218100531087,2,11,response to vitamin A,BP,CYP1A1;TYMS
7999,GO:0032611,0.173868540579521,0.926292888146744,5,42,interleukin-1 beta production,BP,TRIM16;PML;GBP5;HSPB1;PANX1
2848,GO:0006334,0.174086372187831,0.904024528435885,9,116,nucleosome assembly,BP,MCM2;H3F3A;GRWD1;NAP1L1;SET;CENPN;DAXX;HIST1H4A;CENPO
10813,GO:0044283,0.17421493359843,0.864831215281475,44,542,small molecule biosynthetic process,BP,PTGES;FADS3;CYP1A1;G6PD;EDN1;SCD;HMGCS1;ACSL3;PGD;NUP50;SYK;NUP153;LEPR;LSS;DHFR;TK1;ADM;NDC1;SLC1A3;WNT4;RAN;RANBP2;PGK1;HACD2;QDPR;PDGFB;NUP160;ENPP1;NUP54;SEPHS2;PDCL3;UMPS;SMUG1;SCD5;DPYD;PPIP5K1;GPER1;MMAA;EBP;AKR1B1;ARV1;TNF;PDSS1;CD74
17973,GO:1902298,0.174436908515551,0.99165640896951,1,2,cell cycle DNA replication maintenance of fidelity,BP,BRCA2
19560,GO:1990426,0.174436908515551,0.99165640896951,1,2,mitotic recombination-dependent replication fork processing,BP,BRCA2
19581,GO:1990505,0.174436908515551,0.99165640896951,1,2,mitotic DNA replication maintenance of fidelity,BP,BRCA2
854,GO:0002177,0.174500076790528,0.988984508626835,1,3,manchette,CC,RAN
5446,GO:0016310,0.174539455447481,0.8499891014876,130,1649,phosphorylation,BP,CRYAB;IGFBP3;SAA1;NEFL;NRG1;FN1;PML;MAP3K14;CYR61;C3;GPRC5A;NLRC5;FGFR2;STAT5A;EPGN;CTGF;MMP9;GNPTAB;IRS1;MID1;TP53;DAPK3;PANK2;EDN1;GBP1;C1QTNF1;DUSP14;CDKN2A;CHP1;AKAP8;TGFB2;IKBKE;PKMYT1;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;CAMK1G;SYK;EMP2;NUP153;NBN;TRIO;CDK4;SFRP1;RIPK4;TARDBP;ULK4;PTGER4;TK1;CD109;NDC1;CCL20;PLK2;FRK;AKAP8L;HSPB1;HMGXB3;RANBP2;CORO1C;DDX3X;IL24;CDC25A;ITGAV;SOCS1;PARP14;TRPM7;AJUBA;FASTKD3;PGK1;GADD45B;NPNT;PDGFB;SGK494;FZD1;CLU;NUP160;ENPP1;IL20;PIK3R3;NUP54;ACKR3;GLIPR2;SEPHS2;WEE1;PDCL3;HSP90AB1;ARL6IP5;EPHB6;SGK1;PPIP5K1;CHEK1;IL12RB2;GPER1;FAF1;ADAM17;ATR;PSME2;CFLAR;NOL9;PSMB9;SDHD;TRAF2;TELO2;CCNA2;UQCRB;CSF1;RBL1;KIF14;TLR3;ESR1;PARD3;TNF;ZFP36L2;CCL5;CD74;HNRNPU;FGFR1OP;PSMB10;DAXX;TAF1;PHLPP1;NRAS;PPARGC1B;CDKN1A;ITGB1BP1;GTF2H3;NDUFB9;IRAK3
362,GO:0000980,0.17458810495202,0.919010716632043,6,51,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,ZFP42;H3F3A;NFE2L1;SPIB;SMARCC1;ARID3B
9428,GO:0035986,0.17473367983968,0.988953678871564,1,3,senescence-associated heterochromatin focus assembly,BP,CDKN2A
645,GO:0001833,0.174772728315014,0.964427357608733,2,10,inner cell mass cell proliferation,BP,GINS4;BRCA2
19747,GO:2000058,0.174785506537372,0.895061831060078,12,125,regulation of ubiquitin-dependent protein catabolic process,BP,PML;GCLC;KEAP1;PLK2;UBQLN2;CLU;PDCL3;HSP90AB1;SENP1;RNF19B;TAF1;SMARCC1
11797,GO:0046640,0.174814289408055,0.963889123756408,2,11,regulation of alpha-beta T cell proliferation,BP,SYK;IRF1
8596,GO:0034087,0.174815827951077,0.991618287245329,1,2,establishment of mitotic sister chromatid cohesion,BP,NAA50
5764,GO:0016925,0.174829552840422,0.904348537181293,9,85,protein sumoylation,BP,ZBED1;NUP50;NUP153;NDC1;RANBP2;GNL3L;NUP160;NUP54;SENP1
7668,GO:0032092,0.174865661796037,0.908383755304509,8,73,positive regulation of protein binding,BP,MMP9;PLK2;RAN;LFNG;GNL3L;HSP90AB1;TRAF2;TAF1
5930,GO:0018202,0.175049789650378,0.963810167492706,2,11,peptidyl-histidine modification,BP,HIF1AN;DPH2
12678,GO:0050863,0.175120036957563,0.884914201144202,17,186,regulation of T cell activation,BP,MAP3K14;TFRC;RUNX1;LGALS3;CYLD;IL6ST;IL7R;SYK;CD274;SIRPA;SOCS1;FANCD2;AP3B1;RC3H1;CCL5;CD74;IRF1
14052,GO:0060761,0.17513402703646,0.92548999304726,5,43,negative regulation of response to cytokine stimulus,BP,NLRC5;IL1R2;PARP14;CCL5;IRAK3
19035,GO:1904816,0.175306120359079,0.96372414550333,2,11,positive regulation of protein localization to chromosome, telomeric region,BP,DKC1;GNL3L
10515,GO:0043408,0.175390671950541,0.865168981195176,41,478,regulation of MAPK cascade,BP,IGFBP3;SAA1;NRG1;FN1;MAP3K14;CYR61;FGFR2;EPGN;CTGF;MID1;EDN1;GBP1;C1QTNF1;DUSP14;TGFB2;SLC9A3R1;INHBA;SYK;SFRP1;ULK4;CCL20;ITGAV;AJUBA;GADD45B;NPNT;PDGFB;ACKR3;GLIPR2;ARL6IP5;EPHB6;GPER1;CFLAR;TRAF2;TLR3;TNF;CCL5;CD74;DAXX;PHLPP1;ITGB1BP1;IRAK3
6823,GO:0030277,0.175589927599791,0.964156795228641,2,10,maintenance of gastrointestinal epithelium,BP,SLC22A5;MUC6
4648,GO:0010768,0.175640828423675,0.991534955865186,1,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,TAF1
16898,GO:0098813,0.175692245078956,0.876959329737449,23,253,nuclear chromosome segregation,BP,KIF23;STAG1;AKAP8;BRIP1;NDC1;DYNLL2;AKAP8L;RAN;RANBP2;ANAPC15;SMC2;FEN1;CDCA5;NUP160;NAA50;SKA2;FANCD2;CENPF;KIF14;CENPN;HNRNPU;CTCF;CENPO
4524,GO:0010575,0.175813041399392,0.946755019129023,3,19,positive regulation of vascular endothelial growth factor production,BP,CYP1B1;C3;IL6ST
18232,GO:1902996,0.175845792150195,0.991514182534193,1,2,regulation of neurofibrillary tangle assembly,BP,CLU
2322,GO:0005328,0.176008160513581,0.964017992322516,2,10,neurotransmitter:sodium symporter activity,MF,SLC1A3;SLC25A22
12832,GO:0051117,0.176038179465494,0.917930515385886,6,54,ATPase binding,MF,METTL21A;NOP58;VCPKMT;NUFIP1;ESR1;ZNHIT6
4461,GO:0010452,0.176098894678442,0.964646157208055,2,9,histone H3-K36 methylation,BP,SMYD2;SETD2
15248,GO:0071386,0.176152788691884,0.991483015577285,1,2,cellular response to corticosterone stimulus,BP,ATP2B1
723,GO:0001946,0.176168004493092,0.96462358026841,2,9,lymphangiogenesis,BP,PTPN14;PDPN
9867,GO:0042107,0.176230851441763,0.912105134505977,7,65,cytokine metabolic process,BP,INHBA;SYK;CCL20;HSPB1;TLR3;TNF;IRF1
15574,GO:0072001,0.176232269803867,0.88137611703787,19,192,renal system development,BP,FGFR2;FBN1;FAT4;PBX1;TGFB2;IRX2;SFRP1;COL4A1;MME;WNT4;ODC1;NPNT;PDGFB;FRAS1;GLIS2;WDPCP;CENPF;CFLAR;AKR1B1
14867,GO:0070613,0.176382934228086,0.917860059628803,6,52,regulation of protein processing,BP,C1R;C3;IL1R2;NAIP;CLU;BIRC3
15926,GO:0072679,0.176454439097269,0.98872513378516,1,3,thymocyte migration,BP,CCL20
11825,GO:0046695,0.176584290235844,0.988707783842231,1,3,SLIK (SAGA-like) complex,CC,TAF6L
12812,GO:0051087,0.176589467926372,0.907003048623217,8,79,chaperone binding,MF,FN1;SACS;TP53;PDPN;BAG1;HSCB;CDC25A;CLU
985,GO:0002439,0.176701925737707,0.988692053518439,1,3,chronic inflammatory response to antigenic stimulus,BP,TNF
12872,GO:0051171,0.176704563154994,0.841526285548362,333,4389,regulation of nitrogen compound metabolic process,BP,CRYAB;IGFBP3;MAFB;SAA1;NRG1;HDAC9;C1R;TRIM16;FN1;PML;CYP1B1;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;EPGN;TRIM22;CBX5;CTGF;MMP9;FBN1;RUNX1;CLN6;IL1R2;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;MID1;TP53;DAPK3;EDN1;GBP1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CYLD;PKMYT1;TGS1;PDLIM1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;IL6ST;HNRNPF;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;SYK;EMP2;NUP153;NAIP;ZFP42;RELB;NBN;PARP15;BRIP1;SHQ1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;ULK4;POLA1;SETDB1;ZNF584;TRAF1;OPHN1;ADM;CD109;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;CCL20;PLK2;ZNF512;ZNF587;UBQLN2;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;CORO1C;ZNF738;DDX3X;NUFIP1;IL24;RRN3;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;TAF1D;ODC1;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;TRIM37;PPP4R4;GNL3L;ZNF586;NVL;GADD45B;SH3RF2;CDH13;COMMD4;PHACTR4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;BRCC3;FZD1;IRX4;NFE2L1;ANTXR1;CLU;NUP160;SMYD2;MACC1;ENPP1;BIRC3;ZNF316;IL20;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;ACKR3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;GLIPR2;ZNF484;APEX1;PDCL3;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;ARL6IP5;EPHB6;BACE2;ZBTB24;NSF;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;WDR75;ADAM17;SENP1;RBMS3;ATR;PSME2;MSH6;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;RNF19B;TNF;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;USP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3;IFI27L1
6381,GO:0021563,0.176981095894889,0.991398609821239,1,2,glossopharyngeal nerve development,BP,NAV2
308,GO:0000819,0.177039640716647,0.879307658103052,20,216,sister chromatid segregation,BP,KIF23;STAG1;AKAP8;DYNLL2;AKAP8L;RAN;RANBP2;ANAPC15;SMC2;FEN1;CDCA5;NUP160;NAA50;SKA2;CENPF;KIF14;CENPN;HNRNPU;CTCF;CENPO
18921,GO:1904578,0.177190782620771,0.988626555158285,1,3,response to thapsigargin,BP,CLU
18922,GO:1904579,0.177190782620771,0.988626555158285,1,3,cellular response to thapsigargin,BP,CLU
15886,GO:0072589,0.177417245918595,0.987239658224672,1,4,box H/ACA scaRNP complex,CC,DKC1
13208,GO:0051795,0.177434239045749,0.988593859216202,1,3,positive regulation of timing of catagen,BP,TGFB2
7155,GO:0031005,0.177586737206832,0.963492069205203,2,10,filamin binding,MF,DPYSL3;SYNPO2
9967,GO:0042327,0.177710375120118,0.858173310667876,55,656,positive regulation of phosphorylation,BP,IGFBP3;SAA1;NRG1;MAP3K14;CYR61;C3;FGFR2;EPGN;CTGF;MMP9;IRS1;MID1;TP53;EDN1;C1QTNF1;TGFB2;IL6ST;INHBA;SYK;EMP2;NBN;CCL20;RANBP2;DDX3X;IL24;ITGAV;SOCS1;PARP14;AJUBA;GADD45B;NPNT;PDGFB;FZD1;CLU;IL20;ACKR3;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;GPER1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;KIF14;TLR3;TNF;CCL5;CD74;DAXX;PPARGC1B;CDKN1A;ITGB1BP1
13105,GO:0051595,0.177718483092118,0.988555620726108,1,3,response to methylglyoxal,BP,AKR1B1
2813,GO:0006273,0.17773568241734,0.962904573179787,2,11,lagging strand elongation,BP,POLA1;FEN1
17780,GO:1901722,0.17774060162985,0.962902905995879,2,11,regulation of cell proliferation involved in kidney development,BP,PDGFB;CFLAR
6589,GO:0022414,0.177834733422813,0.854843713040788,68,828,reproductive process,BP,CYR61;COL16A1;FGFR2;MMP9;VMP1;CYP1A1;B4GALT1;PBX1;SPACA6;TFCP2L1;PANK2;EXO1;EDN1;HMGCS1;TGFB2;RAD1;INHBA;EMP2;ZFP42;NBN;LEPR;BRIP1;SFRP1;ADM;IMMP2L;NDC1;SLCO4C1;WNT4;RAN;ARNTL;SMC2;DND1;LFNG;MCM8;PDGFB;ANTXR1;BIRC3;SRD5A1;SETD2;THBD;DPY19L2P2;TNC;UMPS;MYBL1;GLIPR1L2;HSP90AB1;BRCA2;FANCD2;E2F8;ETV6;HSF2;RRM1;UBAP2L;MSH6;PSMC3IP;EIF2B5;AKR1B1;MSH3;CITED2;CSF1;CLOCK;TLR3;ESR1;RAD51B;TBPL1;SMARCC1;DIAPH3;GPX4
19744,GO:2000053,0.177916123599613,0.991302777493171,1,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
4809,GO:0012505,0.177986148983836,0.84186992617111,242,3173,endomembrane system,CC,CRYAB;IGFBP3;SPRR3;KRT1;FTL;FTH1;DTX2;FN1;PTGES;PML;CYP1B1;MTUS1;JPH2;TFRC;CYR61;C3;COL16A1;FGFR2;UGT1A6;TRIM22;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;MYO1B;CYP1A1;CLN6;B4GALT1;SPON1;FAM69B;TRAF3;COL27A1;DYNC2H1;SPG21;TP53;EDN1;TPST1;SCD;GBP1;ABCF1;KBTBD8;ACSL3;LGALS3;CHP1;ACO1;AKAP8;TGFB2;ST6GALNAC5;PRSS23;IKBKE;PKMYT1;CDKAL1;PCDH7;COL12A1;SLC30A6;P3H2;SLC9A3R1;NUP50;PUM3;GALNT18;CAMK1G;EMP2;NUP153;RAB32;VEZT;BRIP1;LSS;UTP15;ARFRP1;LRRC8D;HLA-F;CDK4;VPS41;AP3M2;HLA-DOB;ZDHHC6;CD274;ABHD4;DST;VPS8;COL4A1;KEAP1;HRNR;AP5M1;PTPRB;POLA1;RCE1;ABCC4;REEP1;ADAMTS9;KCNS3;TMEM97;LSG1;PARD3B;MGAM;CD109;P4HA2;GGCX;NDC1;FOXRED2;SLC35A4;CASC3;RRAGB;SLCO4C1;MME;MUC16;FRK;GBP5;RHOG;WNT4;SIRPA;RAN;RANBP2;HS3ST1;ATP2C1;DDX3X;RAB26;RRP12;ITGAV;SET;QPCT;SNX11;AJUBA;LFNG;SNX5;CDC42EP2;HACD2;BAIAP2;WDR7;COL5A2;WDR3;APMAP;PDGFB;UTP18;CHID1;KREMEN2;TBC1D15;NFE2L1;ANTXR1;CLU;NUP160;USP6;MBOAT1;COMMD9;NUP54;LRPPRC;ACKR3;RIF1;FGD6;SRD5A1;GLIPR2;JPH1;SRPRB;DPY19L2P2;IFNAR1;THADA;ERAP1;SLC11A2;APEX1;RIC3;TNC;CNTNAP2;HSPA8;SYT11;TMEM199;HSP90AB1;ARL6IP5;BACE2;SCD5;NSF;LAIR1;NEDD4L;SGK1;M6PR;ZFYVE27;BRCA2;SYNCRIP;TRAK2;MTMR2;CENPF;GOSR1;TMEM165;STEAP4;CCDC47;RAB3GAP1;SERPINB9;GPER1;FAF1;RRM1;ANKRD13A;SENP1;ATR;MSH6;HADHB;LILRB3;CMTM3;ABCA5;NFKBIE;UGT1A4;RABEP2;DPYSL3;EBP;UBE2J2;VPS36;TRAF2;HNRNPR;SLC9A9;TAP2;CSF1;AP3B1;GLIPR1;TLR3;MPP5;ESR1;PARD3;CLCC1;GJC1;RNF19B;EHD1;ARV1;DNASE1;TNF;NEDD9;CD74;DCTN5;PANX1;TRAM2;PHLPP1;NRAS;MUC5B;MUC6;TREX1;ASTN2;RPS12
1251,GO:0002949,0.178026151222262,0.988514152338425,1,3,tRNA threonylcarbamoyladenosine modification,BP,YRDC
11688,GO:0046452,0.178102869379592,0.988503799293694,1,3,dihydrofolate metabolic process,BP,DHFR
11162,GO:0045198,0.178223336694145,0.963279072002021,2,10,establishment of epithelial cell apical/basal polarity,BP,SLC9A3R1;OPHN1
12376,GO:0048739,0.178266057136634,0.967473652628397,2,6,cardiac muscle fiber development,BP,NEXN;MYH11
14188,GO:0061050,0.178274635188426,0.963261885590652,2,10,regulation of cell growth involved in cardiac muscle cell development,BP,G6PD;EDN1
17732,GO:1901617,0.17830941040163,0.885950145054963,15,161,organic hydroxy compound biosynthetic process,BP,G6PD;SCD;HMGCS1;TGFB2;LSS;DHFR;WNT4;RAN;QDPR;PPIP5K1;GPER1;EBP;AKR1B1;ARV1;TNF
1001,GO:0002467,0.178384368857647,0.963225110437886,2,10,germinal center formation,BP,ADAM17;RC3H1
14694,GO:0070293,0.178427122887429,0.962669927412234,2,11,renal absorption,BP,SLC9A3R1;SGK1
7422,GO:0031507,0.178429331879498,0.963210037470557,2,10,heterochromatin assembly,BP,CDKN2A;HELLS
20233,GO:2001056,0.178559489125625,0.894938587556708,11,119,positive regulation of cysteine-type endopeptidase activity,BP,PML;CYR61;CTGF;DDX3X;ARL6IP5;GPER1;SENP1;CFLAR;TRAF2;TNF;IFI27L1
12582,GO:0050715,0.178709260280976,0.910537719198223,7,65,positive regulation of cytokine secretion,BP,SAA1;TRIM16;SYK;CD274;PTGER4;TNF;PANX1
18370,GO:1903311,0.178770973957588,0.875499181032833,22,251,regulation of mRNA metabolic process,BP,DDX17;RBM4;PABPC4;SRSF2;TARDBP;HSPB1;SET;FASTKD3;METTL16;APEX1;HSPA8;SYNCRIP;PSME2;PSMB9;NCBP1;HNRNPR;ZFP36L2;SRSF7;RC3H1;HNRNPU;PSMB10;RBM8A
9681,GO:0038033,0.178847692489051,0.988403021319479,1,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,HSPB1
5825,GO:0017091,0.178923195063896,0.944871218513413,3,21,AU-rich element binding,MF,DND1;RBMS3;ZFP36L2
6940,GO:0030540,0.178929779746363,0.963042096969805,2,10,female genitalia development,BP,SRD5A1;ESR1
12195,GO:0048305,0.178985920397914,0.96203273912959,2,12,immunoglobulin secretion,BP,TRAF2;TNF
489,GO:0001541,0.179019715508349,0.923377689576054,5,42,ovarian follicle development,BP,INHBA;IMMP2L;LFNG;EIF2B5;ESR1
7177,GO:0031053,0.179147986838341,0.9629687702955,2,10,primary miRNA processing,BP,DGCR8;NCBP1
5819,GO:0017081,0.179389678496856,0.962342244702977,2,11,chloride channel regulator activity,MF,SLC9A3R1;SGK1
3518,GO:0007492,0.179481919166158,0.910466043580132,7,58,endoderm development,BP,FN1;MMP9;COL12A1;INHBA;ITGAV;COL5A2;SETD2
6007,GO:0019045,0.179482748980787,0.991140898009996,1,2,latent virus replication,BP,NUCKS1
6008,GO:0019046,0.179482748980787,0.991140898009996,1,2,release from viral latency,BP,NUCKS1
14312,GO:0061386,0.179576006504605,0.991131209731095,1,2,closure of optic fissure,BP,PHACTR4
16710,GO:0097638,0.179613407382789,0.991127322609761,1,2,L-arginine import across plasma membrane,BP,SLC7A2
18557,GO:1903719,0.179679960116994,0.988289843224562,1,3,regulation of I-kappaB phosphorylation,BP,TRAF2
18558,GO:1903721,0.179679960116994,0.988289843224562,1,3,positive regulation of I-kappaB phosphorylation,BP,TRAF2
18259,GO:1903037,0.179696884772949,0.883085809846106,16,174,regulation of leukocyte cell-cell adhesion,BP,MAP3K14;TFRC;LGALS3;CYLD;IL6ST;IL7R;SYK;CD274;SIRPA;SOCS1;AP3B1;TNF;RC3H1;CCL5;CD74;IRF1
15870,GO:0072567,0.179849802262872,0.961734841925428,2,12,chemokine (C-X-C motif) ligand 2 production,BP,TNF;CD74
7179,GO:0031055,0.180039984152349,0.930939079656053,4,42,chromatin remodeling at centromere,BP,HELLS;CENPN;HIST1H4A;CENPO
9673,GO:0038023,0.18007546407404,0.86485661595161,34,386,signaling receptor activity,MF,GPRC5A;FGFR2;IL1R2;IFNGR1;IL27RA;IL6ST;IL7R;GPR132;LEPR;SFRP1;HLA-DOB;AHR;PTPRB;PTGER4;PTPRM;ITGAV;FZD1;ANTXR1;ACKR3;THBD;ABCC9;IFNAR1;CXCR5;EPHB6;M6PR;HCAR1;IL12RB2;GPER1;LILRB3;EBP;TPRA1;TLR3;ESR1;CD74
13637,GO:0060089,0.18007546407404,0.86485661595161,34,386,molecular transducer activity,MF,GPRC5A;FGFR2;IL1R2;IFNGR1;IL27RA;IL6ST;IL7R;GPR132;LEPR;SFRP1;HLA-DOB;AHR;PTPRB;PTGER4;PTPRM;ITGAV;FZD1;ANTXR1;ACKR3;THBD;ABCC9;IFNAR1;CXCR5;EPHB6;M6PR;HCAR1;IL12RB2;GPER1;LILRB3;EBP;TPRA1;TLR3;ESR1;CD74
14863,GO:0070602,0.180147212680908,0.988226039385016,1,3,regulation of centromeric sister chromatid cohesion,BP,CTCF
1630,GO:0004064,0.180151318670341,0.988225477867996,1,3,arylesterase activity,MF,APMAP
666,GO:0001867,0.180152352352384,0.988225336503889,1,3,complement activation, lectin pathway,BP,KRT1
19628,GO:1990723,0.18016136775908,0.991070264531814,1,2,cytoplasmic periphery of the nuclear pore complex,CC,RANBP2
3388,GO:0007167,0.180199550223978,0.854931625136555,59,694,enzyme linked receptor protein signaling pathway,BP,IGFBP3;NRG1;PML;CYR61;GPRC5A;FGFR2;STAT5A;EPGN;CTGF;MMP9;FBN1;FAT4;ACTG1;FST;IRS1;TGFB2;IL6ST;HNRNPF;SLC9A3R1;INHBA;PALM2;SYK;TRIO;CDK4;SFRP1;NUCKS1;MIR17HG;COL4A1;CD109;FRK;HSPB1;WNT4;ARHGEF28;RNF115;ITGAV;SOCS1;BAIAP2;CDH13;NPNT;PDGFB;FZD1;ENPP1;PIK3R3;ZNF106;HSP90AB1;EPHB6;ZFYVE27;POLR2F;GPER1;ADAM17;NCBP1;CITED2;CSF1;PARD3;NEDD9;PHF14;NRAS;SMARCC1;HNRNPM
9579,GO:0036369,0.180285688007347,0.991057291184612,1,2,transcription factor catabolic process,BP,TAF1
11584,GO:0046121,0.180292252981032,0.988206195440558,1,3,deoxyribonucleoside catabolic process,BP,DPYD
635,GO:0001822,0.180400977111144,0.879556975916541,18,182,kidney development,BP,FGFR2;FBN1;FAT4;PBX1;TGFB2;IRX2;SFRP1;MME;WNT4;ODC1;NPNT;PDGFB;FRAS1;GLIS2;WDPCP;CENPF;CFLAR;AKR1B1
2,GO:0000003,0.180554188783681,0.852453539480041,68,829,reproduction,BP,CYR61;COL16A1;FGFR2;MMP9;VMP1;CYP1A1;B4GALT1;PBX1;SPACA6;TFCP2L1;PANK2;EXO1;EDN1;HMGCS1;TGFB2;RAD1;INHBA;EMP2;ZFP42;NBN;LEPR;BRIP1;SFRP1;ADM;IMMP2L;NDC1;SLCO4C1;WNT4;RAN;ARNTL;SMC2;DND1;LFNG;MCM8;PDGFB;ANTXR1;BIRC3;SRD5A1;SETD2;THBD;DPY19L2P2;TNC;UMPS;MYBL1;GLIPR1L2;HSP90AB1;BRCA2;FANCD2;E2F8;ETV6;HSF2;RRM1;UBAP2L;MSH6;PSMC3IP;EIF2B5;AKR1B1;MSH3;CITED2;CSF1;CLOCK;TLR3;ESR1;RAD51B;TBPL1;SMARCC1;DIAPH3;GPX4
13558,GO:0055123,0.180651244990663,0.9006259310826,9,80,digestive system development,BP,FGFR2;CYP1A1;FAT4;TGFB2;SFRP1;WDPCP;TNF;TYMS;CDKN1A
9246,GO:0035631,0.180870426372818,0.961835810354552,2,11,CD40 receptor complex,CC,TRAF3;TRAF2
1559,GO:0003955,0.180900752248248,0.988122743441246,1,3,NAD(P)H dehydrogenase (quinone) activity,MF,NQO1
536,GO:0001654,0.181033387046189,0.875044997203942,21,219,eye development,BP,CRYAB;TENM3;CYP1B1;FBN1;CYP1A1;SIPA1L3;MEGF11;TGFB2;INHBA;CDK4;ATP2B1;COL4A1;PTPRM;COL5A2;PHACTR4;SRF;SDK1;WDPCP;RAB3GAP1;RRM1;RING1
11633,GO:0046321,0.181407940830651,0.962894139968231,2,9,positive regulation of fatty acid oxidation,BP,IRS1;PPARGC1B
2940,GO:0006468,0.181422702967085,0.845841266984012,107,1324,protein phosphorylation,BP,CRYAB;IGFBP3;SAA1;NEFL;NRG1;FN1;PML;MAP3K14;CYR61;C3;GPRC5A;FGFR2;STAT5A;EPGN;CTGF;MMP9;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;C1QTNF1;DUSP14;CDKN2A;CHP1;AKAP8;TGFB2;IKBKE;PKMYT1;IL6ST;SLC9A3R1;NUAK1;INHBA;CAMK1G;SYK;EMP2;NBN;TRIO;CDK4;SFRP1;RIPK4;TARDBP;ULK4;PTGER4;CD109;CCL20;PLK2;FRK;AKAP8L;HSPB1;CORO1C;DDX3X;IL24;CDC25A;ITGAV;SOCS1;PARP14;TRPM7;AJUBA;FASTKD3;GADD45B;NPNT;PDGFB;SGK494;FZD1;CLU;ENPP1;IL20;ACKR3;GLIPR2;WEE1;PDCL3;HSP90AB1;ARL6IP5;EPHB6;SGK1;CHEK1;IL12RB2;GPER1;FAF1;ADAM17;ATR;PSME2;CFLAR;PSMB9;TRAF2;TELO2;CCNA2;CSF1;KIF14;TLR3;PARD3;TNF;ZFP36L2;CCL5;CD74;FGFR1OP;PSMB10;DAXX;TAF1;PHLPP1;NRAS;CDKN1A;ITGB1BP1;GTF2H3;IRAK3
322,GO:0000900,0.181469315567485,0.962184925590678,2,10,translation repressor activity, mRNA regulatory element binding,MF,DHFR;TYMS
12672,GO:0050857,0.181598894665607,0.961585623239248,2,11,positive regulation of antigen receptor-mediated signaling pathway,BP,CYLD;CMTM3
2792,GO:0006231,0.181699180038001,0.988012755716573,1,3,dTMP biosynthetic process,BP,TYMS
11558,GO:0046073,0.181699180038001,0.988012755716573,1,3,dTMP metabolic process,BP,TYMS
10959,GO:0044615,0.181717371553921,0.962790924202779,2,9,nuclear pore nuclear basket,CC,NUP153;RANBP2
13562,GO:0060002,0.181747095010591,0.990904006578251,1,2,plus-end directed microfilament motor activity,MF,MYO10
722,GO:0001945,0.181779795373272,0.944384959251718,3,18,lymph vessel development,BP,PTPN14;PDPN;SYK
16515,GO:0097193,0.181841519628427,0.874172822285478,21,244,intrinsic apoptotic signaling pathway,BP,PML;CYP1B1;MMP9;TP53;CYLD;IKBKE;SLC9A3R1;NBN;HSPB1;SOD2;DDX3X;RRN3;CLU;ACKR3;ARL6IP5;BRCA2;MSH6;TRAF2;TNF;CD74;CDKN1A
846,GO:0002158,0.181893227099421,0.98798594092257,1,3,osteoclast proliferation,BP,CSF1
19578,GO:1990498,0.181998941717328,0.990877445289225,1,2,mitotic spindle microtubule,CC,HNRNPU
7746,GO:0032240,0.182000653679488,0.99087726458873,1,2,negative regulation of nucleobase-containing compound transport,BP,NUP153
11866,GO:0046832,0.182000653679488,0.99087726458873,1,2,negative regulation of RNA export from nucleus,BP,NUP153
7231,GO:0031120,0.182097613471373,0.986527336485567,1,4,snRNA pseudouridine synthesis,BP,DKC1
12954,GO:0051292,0.182194973997424,0.961938474486619,2,10,nuclear pore complex assembly,BP,NUP153;NDC1
13238,GO:0051879,0.182211841087463,0.930924916871354,4,31,Hsp90 protein binding,MF,GBP1;AHR;ARNTL;TELO2
18334,GO:1903225,0.182226687835701,0.990853388919876,1,2,negative regulation of endodermal cell differentiation,BP,COL5A2
10404,GO:0043226,0.182259699228146,0.840886584299086,711,9782,organelle,CC,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;KRT34;KRT4;C1R;TRIM16;MAP2;KRT13;FN1;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;CLN6;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TSC22D3;DDX17;SPON1;FAM69B;TFCP2L1;KRTAP2-3;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;MID1;TP53;DAPK3;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;DOCK10;DDX47;SIPA1L3;ABCF1;TMEM106A;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;COBLL1;LGALS3;CHP1;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL16;IFIT3;SRSF2;FOXD2;PCDH7;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;NUAK1;DKC1;IL7R;NUP50;SLC22A5;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;OLFML3;NAIP;ZFP42;RAB32;RELB;NBN;SHISA9;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;POP1;HLA-DOB;NUCKS1;PITHD1;HEATR1;ZDHHC6;CD274;MCM2;TARDBP;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;COA7;KEAP1;NAA15;TRA2A;TCHH;ZNF827;SLC5A6;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;TMEM97;LSG1;G3BP1;GRWD1;ZNF584;URM1;PARD3B;OPHN1;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;CASC3;SYNPO2L;PLK2;RRAGB;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;KANK4;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;NOP2;SUV39H2;LCP1;EXOG;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARMC5;GPHN;KLHL21;RRN3;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;QPCT;TAF1D;ABCF2;SNX11;AJUBA;SMC2;FASTKD3;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;KRT24;LFNG;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;ODF2L;KREMEN2;SDK1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;DDX10;MBOAT1;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;MCM6;FGD6;SRD5A1;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;UPK3B;ABCC9;TRMT5;TTF2;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;NNT;IFNAR1;WEE1;TJP1;ZNF484;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;GREB1;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;DGCR8;SS18L2;KRT10;CCAR1;SKA2;PPIP5K1;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;ZNFX1;STEAP4;FKBP5;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;ANKRD13A;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;ATR;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;TAF6L;MRPS7;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;MSH3;TELO2;EDRF1;RBBP5;FAM208B;CITED2;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;JMJD8;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;MPP5;AZIN1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;DAXX;ZSCAN31;DCTN5;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;ZNHIT6;FTO;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GBP6;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
339,GO:0000939,0.182283009415762,0.987931978991982,1,3,condensed chromosome inner kinetochore,CC,ORC2
3491,GO:0007379,0.182290626593072,0.961347417339899,2,11,segment specification,BP,MAFB;IRX2
8478,GO:0033612,0.182295192679018,0.961345842898779,2,11,receptor serine/threonine kinase binding,MF,TGFB2;INHBA
3188,GO:0006813,0.182354157655695,0.895750123006667,10,94,potassium ion transport,BP,CHP1;KCNS3;SLC1A3;KCNQ5;NETO1;ABCC9;NSF;NEDD4L;SLC9A9;KCNE4
4732,GO:0010893,0.1824335684151,0.961298116495664,2,11,positive regulation of steroid biosynthetic process,BP,WNT4;TNF
19771,GO:2000110,0.18249423749018,0.987902681041071,1,3,negative regulation of macrophage apoptotic process,BP,CCL5
19200,GO:1905214,0.182534431419912,0.96126331279399,2,11,regulation of RNA binding,BP,NUCKS1;NCBP1
3855,GO:0008467,0.182573039778078,0.987891740977127,1,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,HS3ST1
8154,GO:0032874,0.182710187267954,0.892271250416989,11,108,positive regulation of stress-activated MAPK cascade,BP,CTGF;MID1;EDN1;TGFB2;SYK;GADD45B;ARL6IP5;TRAF2;TLR3;TNF;DAXX
29,GO:0000054,0.182734815883796,0.960346805930191,2,13,ribosomal subunit export from nucleus,BP,RAN;SDAD1
8530,GO:0033750,0.182734815883796,0.960346805930191,2,13,ribosome localization,BP,RAN;SDAD1
13067,GO:0051538,0.182742090232898,0.987868253568782,1,3,3 iron, 4 sulfur cluster binding,MF,ACO1
9011,GO:0035145,0.182779627472469,0.943121194221358,3,21,exon-exon junction complex,CC,CASC3;UPF3B;RBM8A
3683,GO:0008187,0.183018683493847,0.943254652119245,3,20,poly-pyrimidine tract binding,MF,PABPC4;RBMS3;HNRNPU
270,GO:0000768,0.183092313278797,0.930771244098928,4,29,syncytium formation by plasma membrane fusion,BP,ERVFRD-1;CD109;CFLAR;EHD1
6919,GO:0030505,0.183178553862613,0.99075246579645,1,2,inorganic diphosphate transport,BP,ENPP1
8886,GO:0034686,0.183413112740217,0.99072750219954,1,2,integrin alphav-beta8 complex,CC,ITGAV
9363,GO:0035866,0.183413112740217,0.99072750219954,1,2,alphav-beta3 integrin-PKCalpha complex,CC,ITGAV
19563,GO:1990430,0.183413112740217,0.99072750219954,1,2,extracellular matrix protein binding,MF,ITGAV
688,GO:0001895,0.183442585182434,0.930139647740072,4,32,retina homeostasis,BP,KRT1;ACTG1;HSPB1;WDR36
2404,GO:0005547,0.183509257840783,0.930552917775741,4,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,JPH2;MYO1B;MYO10;PARD3
3758,GO:0008299,0.183587744959,0.942532088597343,3,22,isoprenoid biosynthetic process,BP,CYP1A1;HMGCS1;PDSS1
13495,GO:0055010,0.183638778669762,0.93065772021689,4,28,ventricular cardiac muscle tissue morphogenesis,BP,NRG1;FGFR2;TGFB2;TPM1
8539,GO:0033829,0.183681898233749,0.98773722482541,1,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,LFNG
15307,GO:0071475,0.183732061906995,0.987730209301166,1,3,cellular hyperosmotic salinity response,BP,AKR1B1
6583,GO:0022407,0.183952897735574,0.872593849393302,21,234,regulation of cell-cell adhesion,BP,MAP3K14;TFRC;C1QTNF1;LGALS3;PDPN;CYLD;IL6ST;IL7R;SYK;CD274;WNT4;SIRPA;SOCS1;MYO10;CITED2;AP3B1;TNF;RC3H1;CCL5;CD74;IRF1
1527,GO:0003896,0.183991070753139,0.987693951257368,1,3,DNA primase activity,MF,PRIM2
2264,GO:0005176,0.183991646592343,0.987693870581709,1,3,ErbB-2 class receptor binding,MF,NRG1
13915,GO:0060537,0.184042623959106,0.871538697398986,22,227,muscle tissue development,BP,NRG1;HDAC9;JPH2;FGFR2;G6PD;TSC22D3;DDX17;EDN1;TGFB2;GPCPD1;MIR17HG;TPM1;ADAMTS9;NEXN;ARNTL;LUC7L;SRF;MYH11;CENPF;CFLAR;GJC1;HNRNPU
4345,GO:0009895,0.184127280312704,0.875059463225556,19,208,negative regulation of catabolic process,BP,NRG1;PML;DKC1;LEPR;TARDBP;OPHN1;MDM4;LRPPRC;PDCL3;HSP90AB1;SYNCRIP;MTMR2;SENP1;AZIN1;TNF;HNRNPU;TAF1;SMARCC1;IRAK3
712,GO:0001934,0.184204859593817,0.853466059003829,52,622,positive regulation of protein phosphorylation,BP,IGFBP3;SAA1;NRG1;MAP3K14;CYR61;C3;FGFR2;EPGN;CTGF;MMP9;MID1;TP53;EDN1;C1QTNF1;TGFB2;IL6ST;INHBA;SYK;EMP2;NBN;CCL20;DDX3X;IL24;ITGAV;SOCS1;PARP14;AJUBA;GADD45B;NPNT;PDGFB;FZD1;CLU;IL20;ACKR3;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;GPER1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;KIF14;TLR3;TNF;CCL5;CD74;DAXX;CDKN1A;ITGB1BP1
909,GO:0002291,0.184517883894863,0.987620023089928,1,3,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
8456,GO:0033574,0.184588079391718,0.929535475978057,4,32,response to testosterone,BP,EDN1;CDK4;SRD5A1;CFLAR
5910,GO:0018126,0.184650718157709,0.942510511627846,3,20,protein hydroxylation,BP,P3H2;P4HA2;HIF1AN
13610,GO:0060057,0.184767680744866,0.987584884086716,1,3,apoptotic process involved in mammary gland involution,BP,B4GALT1
13611,GO:0060058,0.184767680744866,0.987584884086716,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,B4GALT1
17989,GO:1902339,0.184767680744866,0.987584884086716,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,B4GALT1
18463,GO:1903519,0.184767680744866,0.987584884086716,1,3,regulation of mammary gland involution,BP,B4GALT1
18464,GO:1903521,0.184767680744866,0.987584884086716,1,3,positive regulation of mammary gland involution,BP,B4GALT1
18997,GO:1904747,0.184767680744866,0.987584884086716,1,3,positive regulation of apoptotic process involved in development,BP,B4GALT1
10157,GO:0042723,0.18477953595733,0.987583215053902,1,3,thiamine-containing compound metabolic process,BP,THTPA
10143,GO:0042692,0.184830839671239,0.87333394656394,20,205,muscle cell differentiation,BP,NRG1;HDAC9;MKL1;FGFR2;ACTG1;G6PD;EDN1;RBM4;TPM1;ADM;NEXN;WNT4;SRF;NPNT;PDGFB;MYH11;GPER1;CFLAR;EHD1;HNRNPU
8586,GO:0034058,0.184849153708445,0.96103130559545,2,10,endosomal vesicle fusion,BP,VPS41;VPS8
14996,GO:0070888,0.184943977085028,0.942376431312542,3,20,E-box binding,MF,AHR;ARNTL;CLOCK
2063,GO:0004814,0.185109060759357,0.987536773794263,1,3,arginine-tRNA ligase activity,MF,RARS
2909,GO:0006420,0.185109060759357,0.987536773794263,1,3,arginyl-tRNA aminoacylation,BP,RARS
16480,GO:0097129,0.185123066578203,0.987534797792923,1,3,cyclin D2-CDK4 complex,CC,CDK4
15948,GO:0072717,0.18516696915418,0.987528602715724,1,3,cellular response to actinomycin D,BP,TP53
9439,GO:0036002,0.185176635712353,0.929224414952742,4,32,pre-mRNA binding,MF,RBM4;RBM22;SRSF2;HNRNPU
10059,GO:0042532,0.185531159493453,0.960223264572175,2,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,SOCS1;PARP14
286,GO:0000790,0.185966078495378,0.866578141122876,25,304,nuclear chromatin,CC,CBX5;ENC1;TP53;ZFP42;NUCKS1;H3F3A;KDM6A;NUFIP1;CDCA5;APTX;SRF;UTY;RIF1;MSH6;TELO2;CITED2;TIMELESS;MPHOSPH8;ESR1;RING1;DAXX;HIST1H4A;TAF1;SMARCC1;IRF1
9933,GO:0042270,0.186113259201412,0.98739466184405,1,3,protection from natural killer cell mediated cytotoxicity,BP,SERPINB9
13690,GO:0060193,0.186396582456487,0.928720015523033,4,31,positive regulation of lipase activity,BP,CYR61;FGFR2;ESR1;CCL5
17802,GO:1901836,0.186475157494265,0.959893236663002,2,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,NOL11;NCL
302,GO:0000811,0.186569086421027,0.987329862602111,1,3,GINS complex,CC,GINS4
9309,GO:0035747,0.186673144170806,0.987315044469245,1,3,natural killer cell chemotaxis,BP,CCL5
11529,GO:0046016,0.186699897826403,0.987311233134075,1,3,positive regulation of transcription by glucose,BP,SRF
1110,GO:0002696,0.18670140500593,0.877722995811894,16,177,positive regulation of leukocyte activation,BP,MAP3K14;TFRC;CYLD;IL6ST;IL7R;SYK;CD274;SIRPA;SOCS1;RIF1;MSH6;AP3B1;ATAD5;CCL5;CD74;CDKN1A
8546,GO:0033865,0.186739952136052,0.928263222762901,4,33,nucleoside bisphosphate metabolic process,BP,PANK2;TPST1;CROT;ENPP1
8552,GO:0033875,0.186739952136052,0.928263222762901,4,33,ribonucleoside bisphosphate metabolic process,BP,PANK2;TPST1;CROT;ENPP1
8573,GO:0034032,0.186739952136052,0.928263222762901,4,33,purine nucleoside bisphosphate metabolic process,BP,PANK2;TPST1;CROT;ENPP1
8706,GO:0034333,0.186833711129563,0.900713825371627,8,69,adherens junction assembly,BP,COL16A1;DAPK3;SFRP1;WNT4;CORO1C;AJUBA;WDPCP;ITGB1BP1
7955,GO:0032545,0.186849845627137,0.987289859893824,1,3,CURI complex,CC,RRP7BP
8785,GO:0034456,0.186849845627137,0.987289859893824,1,3,UTP-C complex,CC,RRP7BP
2699,GO:0006063,0.186895402198767,0.959268940862859,2,12,uronic acid metabolic process,BP,UGT1A6;UGT1A4
6187,GO:0019585,0.186895402198767,0.959268940862859,2,12,glucuronate metabolic process,BP,UGT1A6;UGT1A4
17747,GO:1901652,0.186923690939394,0.861804681908735,30,340,response to peptide,BP,NEFL;HDAC9;TRIM16;GCLC;STAT5A;CTGF;FBN1;IRS1;TP53;EDN1;BRIP1;CDK4;NUCKS1;ADM;SOCS1;BAIAP2;QDPR;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;GPER1;CFLAR;EIF2B5;AKR1B1;CCNA2;TIMELESS;EIF2B1;SMARCC1
7207,GO:0031091,0.186995035664319,0.911333421905939,6,53,platelet alpha granule,CC,FN1;TGFB2;PCDH7;CD109;PDGFB;CLU
12433,GO:0048865,0.187054646465729,0.987260636138574,1,3,stem cell fate commitment,BP,SFRP1
2600,GO:0005896,0.187360699121818,0.987216895774014,1,3,interleukin-6 receptor complex,CC,IL6ST
5477,GO:0016407,0.187377828688539,0.895727333817787,9,88,acetyltransferase activity,MF,NAA15;NAA50;KANSL1L;BRCA2;TAF6L;GTF3C4;NAA16;CLOCK;TAF1
777,GO:0002029,0.187402721533307,0.959088889343595,2,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,ADM;UBQLN2
6578,GO:0022401,0.187402721533307,0.959088889343595,2,12,negative adaptation of signaling pathway,BP,ADM;UBQLN2
15105,GO:0071073,0.187415563436312,0.987209045993634,1,3,positive regulation of phospholipid biosynthetic process,BP,ACSL3
4624,GO:0010742,0.187481892849861,0.941211422322297,3,20,macrophage derived foam cell differentiation,BP,ITGAV;ABCA5;CSF1
16115,GO:0090077,0.187481892849861,0.941211422322297,3,20,foam cell differentiation,BP,ITGAV;ABCA5;CSF1
9388,GO:0035909,0.187590930162865,0.941752632345546,3,18,aorta morphogenesis,BP,TGFB2;ADAMTS9;SRF
6648,GO:0023041,0.187601467581682,0.987182427866126,1,3,neuronal signal transduction,BP,CLU
15034,GO:0070948,0.187737841495366,0.987162882268349,1,3,regulation of neutrophil mediated cytotoxicity,BP,DNASE1
8258,GO:0033028,0.187879480569203,0.940550567834774,3,22,myeloid cell apoptotic process,BP,CDKN2A;ADAM17;CCL5
5889,GO:0018024,0.187937903703526,0.918465220046559,5,40,histone-lysine N-methyltransferase activity,MF,SETDB1;SUV39H2;SMYD2;SETD2;RBBP5
3670,GO:0008169,0.188317616944868,0.987079604278816,1,3,C-methyltransferase activity,MF,NOP2
19768,GO:2000107,0.188500203178013,0.927459767051136,4,32,negative regulation of leukocyte apoptotic process,BP,TSC22D3;MIR17HG;CCL5;CD74
18373,GO:1903317,0.188696043686051,0.910286608181706,6,53,regulation of protein maturation,BP,C1R;C3;IL1R2;NAIP;CLU;BIRC3
7281,GO:0031258,0.18871686052975,0.940922608534908,3,19,lamellipodium membrane,CC,PDPN;ITGAV;ANTXR1
15732,GO:0072268,0.188787806794397,0.987011849854483,1,3,pattern specification involved in metanephros development,BP,IRX2
785,GO:0002040,0.188791192910953,0.899253123673259,8,72,sprouting angiogenesis,BP,HDAC9;STARD13;ADAMTS9;PLK2;CDH13;SRF;E2F8;ITGB1BP1
13861,GO:0060441,0.188866795195711,0.940572181732359,3,20,epithelial tube branching involved in lung morphogenesis,BP,FGFR2;TNC;TNF
9596,GO:0036435,0.18895455305774,0.98698777495159,1,3,K48-linked polyubiquitin modification-dependent protein binding,MF,IKBKE
14268,GO:0061298,0.189262767986771,0.960236550526955,2,9,retina vasculature development in camera-type eye,BP,CYP1B1;COL4A1
1216,GO:0002883,0.18934388653822,0.986931467465429,1,3,regulation of hypersensitivity,BP,C3
15114,GO:0071109,0.189398733081921,0.990077818308583,1,2,superior temporal gyrus development,BP,CNTNAP2
11220,GO:0045337,0.189489079073687,0.986910434757007,1,3,farnesyl diphosphate biosynthetic process,BP,HMGCS1
12904,GO:0051223,0.189596538371678,0.853573899008939,40,475,regulation of protein transport,BP,SAA1;NRG1;TRIM16;FN1;PML;IL1R2;IRS1;TP53;GBP1;ACSL3;PTPN14;CHP1;TGFB2;RBM22;SYK;SFRP1;CD274;KCNS3;PTGER4;AKAP8L;LCP1;SOCS1;ARNTL;NUP54;SETD2;HSPA8;SYT11;HSP90AB1;GPER1;WDR75;UBE2J2;TRAF2;CLOCK;TNF;STARD7;CCL5;PANX1;CDKN1A;ITGB1BP1;TSGA13
5491,GO:0016422,0.189701579296464,0.986879618304345,1,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,METTL16
1572,GO:0003976,0.189842371039319,0.986859178977155,1,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,GNPTAB
20305,GO:2001239,0.190161715410689,0.926309447637527,4,34,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,DAPK3;INHBA;EYA3;TNF
14702,GO:0070304,0.19028132659967,0.886842212435749,11,109,positive regulation of stress-activated protein kinase signaling cascade,BP,CTGF;MID1;EDN1;TGFB2;SYK;GADD45B;ARL6IP5;TRAF2;TLR3;TNF;DAXX
2059,GO:0004809,0.1903337620864,0.986787704673737,1,3,tRNA (guanine-N2-)-methyltransferase activity,MF,TRMT1
11084,GO:0045070,0.190391194877662,0.926594974565197,4,31,positive regulation of viral genome replication,BP,NUCKS1;DDX3X;HSPA8;CCL5
1229,GO:0002903,0.190539658285206,0.957968139321024,2,12,negative regulation of B cell apoptotic process,BP,MIR17HG;CD74
16124,GO:0090087,0.19060838213456,0.852230884339168,41,489,regulation of peptide transport,BP,SAA1;NRG1;TRIM16;FN1;PML;IL1R2;IRS1;TP53;GBP1;ACSL3;PTPN14;CHP1;TGFB2;RBM22;SYK;SFRP1;CD274;KCNS3;PTGER4;AKAP8L;LCP1;SOCS1;ARNTL;NUP54;SETD2;HSPA8;SYT11;HSP90AB1;GPER1;WDR75;UBE2J2;TRAF2;CLOCK;TNF;STARD7;CCL5;CD74;PANX1;CDKN1A;ITGB1BP1;TSGA13
10768,GO:0044194,0.190620020429305,0.986745969310933,1,3,cytolytic granule,CC,RNF19B
7592,GO:0031954,0.190672610354532,0.939734939690019,3,20,positive regulation of protein autophosphorylation,BP,SYK;NBN;PDGFB
18079,GO:1902603,0.190886785199158,0.986707010901462,1,3,carnitine transmembrane transport,BP,SLC22A5
13137,GO:0051654,0.191003947177587,0.939580863564432,3,20,establishment of mitochondrion localization,BP,NEFL;LRPPRC;TRAK2
8069,GO:0032731,0.191004378049481,0.939324265120518,3,21,positive regulation of interleukin-1 beta production,BP,TRIM16;HSPB1;PANX1
1925,GO:0004616,0.191310097926357,0.986645061137792,1,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,PGD
7427,GO:0031515,0.191312937215775,0.98664464508686,1,3,tRNA (m1A) methyltransferase complex,CC,TRMT61A
892,GO:0002260,0.191434925562505,0.916122087632226,5,43,lymphocyte homeostasis,BP,TSC22D3;DOCK10;MIR17HG;RC3H1;CD74
3696,GO:0008203,0.191436714176176,0.889196017568201,10,100,cholesterol metabolic process,BP,CLN6;G6PD;SCD;HMGCS1;LEPR;LSS;RAN;NFE2L1;EBP;ARV1
15991,GO:0080111,0.19152224186315,0.939339566049979,3,20,DNA demethylation,BP,APEX1;TET3;FTO
18192,GO:1902930,0.191601971604978,0.908490755051361,6,53,regulation of alcohol biosynthetic process,BP,SCD;HMGCS1;LSS;RAN;GPER1;TNF
3137,GO:0006730,0.19161118784455,0.939040667505184,3,21,one-carbon metabolic process,BP,MAT2A;DHFR;TYMS
10072,GO:0042552,0.19174203125696,0.893017336957525,9,81,myelination,BP,NRG1;CNTNAP1;UGT8;CLU;MTMR2;EIF2B5;KIF14;MPP5;PARD3
2144,GO:0004954,0.191764074135481,0.986578447878289,1,3,prostanoid receptor activity,MF,PTGER4
9092,GO:0035337,0.191958185021568,0.925609213357043,4,32,fatty-acyl-CoA metabolic process,BP,SCD;ACSL3;HACD2;SCD5
10657,GO:0043666,0.191998139133785,0.892590908395573,9,87,regulation of phosphoprotein phosphatase activity,BP,IGFBP3;PPP1R3B;NUAK1;SET;PPP4R4;SH3RF2;PHACTR4;HSP90AB1;TNF
10272,GO:0043001,0.192113661920108,0.925830002543182,4,30,Golgi to plasma membrane protein transport,BP,ACSL3;ARFRP1;RAB26;NSF
3479,GO:0007341,0.192157741694217,0.986520536281755,1,3,penetration of zona pellucida,BP,B4GALT1
467,GO:0001505,0.192219012691395,0.873604889555899,16,170,regulation of neurotransmitter levels,BP,CYP1B1;SLC7A2;EDN1;NQO1;CADPS2;SLC1A3;CLU;SRD5A1;HSPA8;SYT11;HSP90AB1;ARL6IP5;DPYD;RAB3GAP1;GPER1;TNF
7694,GO:0032139,0.192442096335514,0.986478620141379,1,3,dinucleotide insertion or deletion binding,MF,MSH3
1485,GO:0003779,0.192463147688711,0.858955452524849,28,292,actin binding,MF,MKL1;MYO1B;ENC1;GBP1;COBLL1;DST;TPM1;OPHN1;SYNPO2L;NEXN;LCP1;CORO1C;KLHL21;TRPM7;AJUBA;PHACTR4;ANTXR1;TPM4;ANLN;MYH11;LIMCH1;MYO10;SHTN1;SYNPO2;DNASE1;HNRNPU;PANX1;DIAPH3
8108,GO:0032787,0.192594673251837,0.853690257162598,35,421,monocarboxylic acid metabolic process,BP,PTGES;CYP1B1;C3;UGT1A6;STAT5A;FADS3;CYP1A1;IRS1;PANK2;EDN1;SCD;ACSL3;PGD;NUP50;NUP153;LDHAL6B;SLC5A6;NDC1;SLC1A3;RANBP2;CROT;AKR1C2;PGK1;HACD2;NUP160;NUP54;SCD5;MMAA;HADHB;UGT1A4;ARV1;CD74;HIBCH;PPARGC1B;GPX4
19152,GO:1905065,0.192672781166191,0.986444562745354,1,3,positive regulation of vascular smooth muscle cell differentiation,BP,GPER1
577,GO:0001726,0.192807479319403,0.877317152290084,14,139,ruffle,CC,AMOT;PDPN;SLC9A3R1;LAYN;TPM1;LCP1;ITGAV;TRPM7;SNX5;BAIAP2;FGD6;ADAM17;MYO10;ITGB1BP1
9188,GO:0035552,0.192835012566143,0.986420583305074,1,3,oxidative single-stranded DNA demethylation,BP,FTO
10026,GO:0042446,0.192861795726948,0.915101488157191,5,45,hormone biosynthetic process,BP,ADM;WNT4;SRD5A1;AKR1B1;TNF
4337,GO:0009887,0.192883188028864,0.845023421571634,55,642,animal organ morphogenesis,BP,MAFB;NRG1;KRT13;TENM3;PML;CYR61;FGFR2;CTGF;FBN1;FAT4;B4GALT1;PBX1;COL27A1;TUFT1;EDN1;MEGF11;TGFB2;IRX2;SLC9A3R1;INHBA;SYK;SFRP1;WNT10A;MIR17HG;TPM1;ADM;WNT4;PTPRM;KDM6A;LFNG;COL5A2;PHACTR4;SRF;NPNT;SDK1;FZD1;IRX4;FRAS1;SETD2;TNC;WDPCP;FANCD2;BBS5;NTN1;PSME2;CFLAR;PSMB9;CITED2;CSF1;ESR1;TNF;RING1;PSMB10;SMARCC1;PPARGC1B
14446,GO:0061738,0.19291262745837,0.986409102790908,1,3,late endosomal microautophagy,BP,HSPA8
2602,GO:0005899,0.193079937526107,0.989666095497753,1,2,insulin receptor complex,CC,IRS1
16927,GO:0098869,0.193192454877931,0.906874701352087,6,63,cellular oxidant detoxification,BP,TXNRD1;NQO1;DHFR;SOD2;TNF;GPX4
8705,GO:0034332,0.193433914804616,0.88806497945114,10,92,adherens junction organization,BP,COL16A1;DAPK3;SFRP1;WNT4;CORO1C;AJUBA;CDH13;WDPCP;PLEKHA7;ITGB1BP1
9508,GO:0036146,0.193459303188714,0.986328089201533,1,3,cellular response to mycotoxin,BP,PDGFB
4526,GO:0010586,0.193527051134242,0.938142159928511,3,21,miRNA metabolic process,BP,DDX17;RAN;DGCR8
9141,GO:0035458,0.193642724275708,0.956846923671409,2,12,cellular response to interferon-beta,BP,TLR3;IRF1
15844,GO:0072528,0.193696189024328,0.924167639888968,4,36,pyrimidine-containing compound biosynthetic process,BP,TK1;UMPS;TYMS;TBPL1
18720,GO:1904047,0.193767469263047,0.986282304264646,1,3,S-adenosyl-L-methionine binding,MF,SUV39H2
5744,GO:0016888,0.193818128171692,0.957286852569355,2,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,FEN1;DNASE1
14317,GO:0061408,0.193837536722321,0.986271882421939,1,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,HSF2
12411,GO:0048821,0.194155645560481,0.937846330770103,3,21,erythrocyte development,BP,G6PD;SRF;SLC11A2
13722,GO:0060255,0.194210677503707,0.825047000654259,344,4573,regulation of macromolecule metabolic process,BP,CRYAB;IGFBP3;MAFB;SAA1;NRG1;HDAC9;C1R;TRIM16;FN1;PML;CYP1B1;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;EPGN;TRIM22;CBX5;CTGF;MMP9;FBN1;RUNX1;CLN6;IL1R2;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CYLD;PKMYT1;TGS1;PDLIM1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;IL6ST;HNRNPF;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;SYK;EMP2;NUP153;NAIP;ZFP42;RELB;NBN;PARP15;BRIP1;SHQ1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;WNT10A;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;POLR1A;GLIS3;HELLS;TAF2;ULK4;POLA1;TSN;SETDB1;ZNF584;TRAF1;OPHN1;CD109;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;CCL20;PLK2;ZNF512;ZNF587;UBQLN2;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;KDM6A;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;CORO1C;ZNF738;DDX3X;NUFIP1;IL24;RRN3;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;TRIM37;PPP4R4;GNL3L;ZNF586;NVL;GADD45B;SH3RF2;CDH13;COMMD4;PHACTR4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;BRCC3;FZD1;IRX4;UTY;NFE2L1;ANTXR1;CLU;NUP160;SMYD2;MACC1;ENPP1;BIRC3;ZNF316;IL20;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;ACKR3;RIF1;METTL16;SETD2;GLIS2;UBP1;UPK3B;TTF2;GLIPR2;ZNF484;APEX1;PDCL3;TNC;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;ARL6IP5;EPHB6;BACE2;ZBTB24;NSF;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;WDR75;ADAM17;SENP1;RBMS3;ATR;PSME2;UBAP2L;MSH6;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;RNF19B;TNF;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;USP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3;IFI27L1
7175,GO:0031050,0.194211867605969,0.914701490562293,5,41,dsRNA fragmentation,BP,TSN;ZC3H7B;DGCR8;NCBP1;ESR1
15014,GO:0070918,0.194211867605969,0.914701490562293,5,41,production of small RNA involved in gene silencing by RNA,BP,TSN;ZC3H7B;DGCR8;NCBP1;ESR1
12099,GO:0048037,0.194214268909237,0.856388860930035,29,355,cofactor binding,MF,PTGES;CYP1B1;GCLC;CYP24A1;TXNRD1;CYP1A1;G6PD;ACO1;CDKAL1;P3H2;PARP15;BRIP1;DHFR;POLA1;P4HA2;FOXRED2;SUV39H2;GPHN;HIF1AN;QDPR;TYW1;SRD5A1;NNT;PRIM2;DGCR8;DPYD;SDHD;CYP20A1;TYMS
11898,GO:0046890,0.194246646118777,0.880945165753229,12,126,regulation of lipid biosynthetic process,BP,CYR61;C3;SCD;HMGCS1;ACSL3;LSS;CDK4;WNT4;RAN;PDGFB;GPER1;TNF
5496,GO:0016429,0.194338532628961,0.986197237207029,1,3,tRNA (adenine-N1-)-methyltransferase activity,MF,TRMT61A
14514,GO:0061953,0.194338532628961,0.986197237207029,1,3,mRNA (adenine-N1-)-methyltransferase activity,MF,TRMT61A
5771,GO:0016942,0.194411829870404,0.986186297687317,1,3,insulin-like growth factor binding protein complex,CC,IGFBP3
9606,GO:0036454,0.194411829870404,0.986186297687317,1,3,growth factor complex,CC,IGFBP3
7192,GO:0031074,0.194606926146423,0.986157156551484,1,3,nucleocytoplasmic transport complex,CC,RAN
11340,GO:0045649,0.194636270472323,0.956992154136216,2,11,regulation of macrophage differentiation,BP,INHBA;CSF1
898,GO:0002274,0.194657691509305,0.851916554850284,35,430,myeloid leukocyte activation,BP,KRT1;FTL;FTH1;C3;S100P;MMP9;SLC7A2;B4GALT1;LGALS3;SYK;RELB;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;ITGAV;QPCT;CLU;COMMD9;HSPA8;HSP90AB1;LAIR1;LILRB3;CSF1;GLIPR1;TLR3;DNASE1;CCL5;CD74;NRAS
4873,GO:0014732,0.194694405437648,0.986144078961314,1,3,skeletal muscle atrophy,BP,CFLAR
5802,GO:0017049,0.19478362969674,0.937550281745188,3,21,GTP-Rho binding,MF,CDC42EP2;RTKN2;ANLN
6165,GO:0019511,0.194846769037882,0.956916192372971,2,11,peptidyl-proline hydroxylation,BP,P3H2;P4HA2
19438,GO:1905939,0.19489838490285,0.956389673823139,2,12,regulation of gonad development,BP,WNT4;CITED2
16975,GO:0098953,0.194986309486272,0.986100391956805,1,3,receptor diffusion trapping,BP,GPHN
16981,GO:0098970,0.194986309486272,0.986100391956805,1,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,GPHN
17115,GO:0099628,0.194986309486272,0.986100391956805,1,3,neurotransmitter receptor diffusion trapping,BP,GPHN
19003,GO:1904753,0.19500867222627,0.986097041974839,1,3,negative regulation of vascular associated smooth muscle cell migration,BP,TPM1
8494,GO:0033634,0.195154164508177,0.986075236086166,1,3,positive regulation of cell-cell adhesion mediated by integrin,BP,CCL5
12822,GO:0051097,0.195190705307239,0.986069756516696,1,3,negative regulation of helicase activity,BP,TP53
14709,GO:0070316,0.195225557645677,0.914106441228505,5,41,regulation of G0 to G1 transition,BP,CBX5;CTGF;RRM2;CHEK1;RING1
5668,GO:0016774,0.195355993530962,0.986044955454469,1,3,phosphotransferase activity, carboxyl group as acceptor,MF,PGK1
11465,GO:0045901,0.195356957559705,0.986044810733186,1,3,positive regulation of translational elongation,BP,USP16
1955,GO:0004656,0.195385829664484,0.986040476030889,1,3,procollagen-proline 4-dioxygenase activity,MF,P4HA2
14028,GO:0060729,0.195535841866368,0.986017942064412,1,3,intestinal epithelial structure maintenance,BP,SLC22A5
5535,GO:0016509,0.195594916309351,0.986009062745128,1,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,HADHB
18946,GO:1904636,0.195639667748879,0.986002334209277,1,3,response to ionomycin,BP,CDK4
18947,GO:1904637,0.195639667748879,0.986002334209277,1,3,cellular response to ionomycin,BP,CDK4
698,GO:0001915,0.195697618938139,0.985993618395069,1,3,negative regulation of T cell mediated cytotoxicity,BP,IL7R
2944,GO:0006473,0.1958309736365,0.872704215360403,15,162,protein acetylation,BP,TRIM16;NAA15;CPA4;SET;ARNTL;NAA50;BRCA2;CHEK1;TAF6L;GTF3C4;POLE3;NAA16;CLOCK;TAF1;CTCF
568,GO:0001707,0.19583543674372,0.913860542575527,5,40,mesoderm formation,BP,TXNRD1;FGFR2;INHBA;KDM6A;SRF
633,GO:0001820,0.195853103602615,0.985970218844885,1,3,serotonin secretion,BP,SYK
1289,GO:0003094,0.195933885069125,0.956522982199912,2,11,glomerular filtration,BP,EMP2;PDGFB
9727,GO:0038145,0.196015337065926,0.985945780683621,1,3,macrophage colony-stimulating factor signaling pathway,BP,CSF1
9153,GO:0035494,0.196169378924411,0.985922554767822,1,3,SNARE complex disassembly,BP,NSF
14288,GO:0061333,0.196222801946396,0.905950217880869,6,49,renal tubule morphogenesis,BP,FAT4;PBX1;IRX2;COL4A1;WNT4;NPNT
9189,GO:0035553,0.196235955395936,0.985912510045842,1,3,oxidative single-stranded RNA demethylation,BP,FTO
1068,GO:0002606,0.196273781450879,0.985906801281752,1,3,positive regulation of dendritic cell antigen processing and presentation,BP,CD74
10901,GO:0044432,0.196315735790683,0.836844263508186,76,965,endoplasmic reticulum part,CC,IGFBP3;FN1;PTGES;PML;CYP1B1;JPH2;CYR61;C3;COL16A1;UGT1A6;FADS3;COL5A3;HLA-B;FBN1;TAP1;CYP1A1;CLN6;SPON1;FAM69B;COL27A1;EDN1;SCD;ACSL3;PRSS23;PKMYT1;CDKAL1;COL12A1;P3H2;LSS;LRRC8D;HLA-F;ZDHHC6;ABHD4;DST;COL4A1;RCE1;REEP1;TMEM97;P4HA2;GGCX;FOXRED2;RHOG;WNT4;HACD2;COL5A2;PDGFB;NFE2L1;MBOAT1;SRD5A1;JPH1;SRPRB;THADA;ERAP1;RIC3;TNC;TMEM199;ARL6IP5;SCD5;SGK1;ZFYVE27;RAB3GAP1;GPER1;FAF1;UGT1A4;EBP;UBE2J2;TRAF2;TAP2;CSF1;TLR3;GJC1;RNF19B;ARV1;CD74;PANX1;TREX1
10836,GO:0044320,0.196370050954364,0.956364793772172,2,11,cellular response to leptin stimulus,BP,LEPR;CCNA2
15071,GO:0071006,0.196460658591616,0.985878578791798,1,3,U2-type catalytic step 1 spliceosome,CC,RBM22
9027,GO:0035198,0.19650418620204,0.936736570141964,3,21,miRNA binding,MF,RBM4;ZC3H7B;DDX21
4768,GO:0010950,0.196540370286119,0.879067736710621,12,135,positive regulation of endopeptidase activity,BP,PML;CYR61;CTGF;DDX3X;ARL6IP5;GPER1;SENP1;PSME2;CFLAR;TRAF2;TNF;IFI27L1
15,GO:0000028,0.196692861508846,0.953895032553863,2,18,ribosomal small subunit assembly,BP,RRP7BP;MRPS7
3104,GO:0006682,0.196705447585174,0.985841563251434,1,3,galactosylceramide biosynthetic process,BP,UGT8
6130,GO:0019375,0.196705447585174,0.985841563251434,1,3,galactolipid biosynthetic process,BP,UGT8
6073,GO:0019219,0.196754399578533,0.824219284921657,250,3265,regulation of nucleobase-containing compound metabolic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;TFRC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EDN1;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;PABPC4;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CYLD;TGS1;PDLIM1;IL27RA;IL16;SRSF2;FOXD2;HNRNPF;DKC1;INHBA;IL7R;NUP50;SYK;NUP153;ZFP42;RELB;NBN;PARP15;BRIP1;SHQ1;UTP15;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ADM;ZNF407;ELMSAN1;NDC1;ZNF512;ZNF587;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;FASTKD3;ZNF267;TRIM37;GNL3L;ZNF586;NVL;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;BRCC3;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ZNF316;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;ATR;PSME2;MSH6;CFLAR;PSMC3IP;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;VPS36;TRAF2;MSH3;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;USP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
20205,GO:2001014,0.196825344418382,0.95619940731379,2,11,regulation of skeletal muscle cell differentiation,BP,DDX17;ARNTL
20307,GO:2001241,0.196827961031623,0.955683036063614,2,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,DAPK3;INHBA
17508,GO:1900407,0.196829672733477,0.905018134131067,6,56,regulation of cellular response to oxidative stress,BP,TP53;DHFR;HSPB1;SOD2;FZD1;TNF
2617,GO:0005925,0.196868060591983,0.853481757685908,30,355,focal adhesion,CC,TNS3;KIF23;HSPG2;ACTG1;CHP1;PDLIM1;LAYN;DST;CSRP1;G3BP1;MME;NEXN;HSPB1;RHOG;LCP1;CORO1C;ARMC5;ITGAV;AJUBA;CDH13;FZD1;TPM4;TNC;HSPA8;L1CAM;ADAM17;SENP1;CSRP2;SYNPO2;NEDD9
14833,GO:0070552,0.196892363145782,0.985813263002217,1,3,BRISC complex,CC,BRCC3
7507,GO:0031674,0.196893822625329,0.889762436625328,9,75,I band,CC,CRYAB;JPH2;PDLIM1;DST;SYNPO2L;NEXN;HSPB1;JPH1;SYNPO2
6838,GO:0030296,0.196987071938133,0.95614059527397,2,11,protein tyrosine kinase activator activity,MF,NRG1;CCL5
8901,GO:0034711,0.197393265891519,0.98573726929216,1,3,inhibin binding,MF,INHBA
9128,GO:0035425,0.197472588602496,0.985725214420739,1,3,autocrine signaling,BP,FZD1
14105,GO:0060907,0.198134370651758,0.985624422659779,1,3,positive regulation of macrophage cytokine production,BP,CD74
19439,GO:1905940,0.198222247500912,0.985611009262075,1,3,negative regulation of gonad development,BP,WNT4
15776,GO:0072350,0.198346470838104,0.921875308710202,4,34,tricarboxylic acid metabolic process,BP,STAT5A;ACO1;NNT;SDHD
19982,GO:2000489,0.19834792771249,0.985591813612074,1,3,regulation of hepatic stellate cell activation,BP,GCLC
3270,GO:0006949,0.198480653144051,0.922394912854927,4,30,syncytium formation,BP,ERVFRD-1;CD109;CFLAR;EHD1
9396,GO:0035925,0.198494586049911,0.955590772731962,2,11,mRNA 3'-UTR AU-rich region binding,MF,RBMS3;ZFP36L2
11300,GO:0045596,0.198497644988145,0.848167995436343,36,421,negative regulation of cell differentiation,BP,MAFB;NRG1;FBN1;PBX1;G6PD;GBP1;TGFB2;CYLD;INHBA;TJP2;TRIO;SFRP1;PLK2;WNT4;CORO1C;ITGAV;ARNTL;COL5A2;PDGFB;ENPP1;TRAK2;GPER1;NTN1;LILRB3;CFLAR;ABCA5;DPYSL3;TLR3;TNF;ZFP36L2;RC3H1;CD74;HNRNPU;HIST1H4A;ITGB1BP1;IRF1
19097,GO:1904948,0.198527917842948,0.955578582927492,2,11,midbrain dopaminergic neuron differentiation,BP,SFRP1;FZD1
3162,GO:0006775,0.198627062348635,0.935061425872923,3,24,fat-soluble vitamin metabolic process,BP,CYP24A1;CYP1A1;TNF
12874,GO:0051173,0.198631440599352,0.825728357080372,164,2098,positive regulation of nitrogen compound metabolic process,BP,IGFBP3;MAFB;SAA1;NRG1;TRIM16;FN1;PML;MAP3K14;GCLC;TFRC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;EPGN;CTGF;MMP9;RUNX1;CLN6;PBX1;DDX17;MID1;TP53;EDN1;C1QTNF1;ACSL3;ZBED1;STAG1;CHP1;AKAP8;TGFB2;RBM22;FOXD2;IL6ST;DKC1;INHBA;SYK;EMP2;RELB;NBN;UTP15;CDK4;SFRP1;NUCKS1;HEATR1;USP16;AHR;KEAP1;NAA15;GLIS3;TAF2;SETDB1;ADM;CCL20;PLK2;UBQLN2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;IL24;RRN3;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;FASTKD3;DND1;NVL;GADD45B;CDH13;SRF;NPNT;WDR43;PDGFB;BRCC3;FZD1;NFE2L1;ANTXR1;CLU;MACC1;BIRC3;IL20;EYA3;ACKR3;RIF1;METTL16;GLIS2;GLIPR2;TET3;MYBL1;HSPA8;HSP90AB1;ARL6IP5;EPHB6;NSF;NEDD4L;BRCA2;SS18L2;E2F8;ETV6;HSF2;RAB3GAP1;CHEK1;GPER1;MLLT10;WDR75;ADAM17;SENP1;RBMS3;ATR;PSME2;MSH6;CFLAR;EIF2B5;NOL11;NCBP1;UPF3B;TRAF2;TELO2;EDRF1;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;CSF1;RBL1;NAA16;CLOCK;KIF14;TLR3;ESR1;RNF19B;TNF;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;HNRNPU;DAXX;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;IRF1;CTCF;IFI27L1
11077,GO:0045061,0.198720406457676,0.955508159802642,2,11,thymic T cell selection,BP,SRF;CD74
5170,GO:0015718,0.198758569196124,0.88790933236408,9,87,monocarboxylic acid transport,BP,SLC16A2;SLC16A9;EDN1;ACSL3;SLC9A3R1;SYK;SLC5A6;ABCC4;CROT
3012,GO:0006558,0.198765684674382,0.983818108916873,1,4,L-phenylalanine metabolic process,BP,QDPR
3013,GO:0006559,0.198765684674382,0.983818108916873,1,4,L-phenylalanine catabolic process,BP,QDPR
17935,GO:1902221,0.198765684674382,0.983818108916873,1,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,QDPR
17936,GO:1902222,0.198765684674382,0.983818108916873,1,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,QDPR
4878,GO:0014738,0.198901206776378,0.985507141016135,1,3,regulation of muscle hyperplasia,BP,MIR17HG
3370,GO:0007141,0.198967898155906,0.954893724331749,2,12,male meiosis I,BP,MYBL1;BRCA2
13839,GO:0060413,0.198977622788385,0.956050888987085,2,10,atrial septum morphogenesis,BP,CYR61;TGFB2
2189,GO:0005044,0.199046403724871,0.935527321640657,3,21,scavenger receptor activity,MF,CXCL16;ENPP1;ACKR3
11405,GO:0045766,0.199094708481214,0.88383831285641,10,98,positive regulation of angiogenesis,BP,HDAC9;CYP1B1;C3;RUNX1;ADM;PLK2;HSPB1;ERAP1;PDCL3;TLR3
7882,GO:0032438,0.199115335334716,0.935250114250512,3,22,melanosome organization,BP,RAB32;BLOC1S2;AP3B1
5567,GO:0016576,0.19912525059625,0.9854727759088,1,3,histone dephosphorylation,BP,EYA3
5988,GO:0018894,0.199156086806413,0.985468042557618,1,3,dibenzo-p-dioxin metabolic process,BP,CYP1A1
367,GO:0000988,0.199188920678725,0.843535454998667,44,522,transcription factor activity, protein binding,MF,NRG1;HDAC9;MKL1;TRIM22;DDX17;TFCP2L1;TP53;PTPN14;PDLIM1;SRSF2;ZFP42;RELB;PARP15;USP16;TAF2;MYBL2;WNT4;KDM6A;RAN;RRN3;ARNTL;AJUBA;SRF;UTY;NFE2L1;NFKBIB;UBP1;APEX1;MYBL1;SS18L2;CCAR1;E2F8;HSF2;PSMC3IP;TAF6L;CITED2;CLOCK;HNRNPU;DAXX;TAF1;TBPL1;SMARCC1;PPARGC1B;CTCF
1159,GO:0002764,0.199267829288203,0.851483449814455,30,355,immune response-regulating signaling pathway,BP,RUNX1;ACTG1;TRAF3;SPG21;GBP1;LGALS3;CYLD;IKBKE;SYK;RELB;MUC16;BTN2A1;BAIAP2;BIRC3;HSP90AB1;MYO10;PSME2;PSMB9;EIF2B5;CMTM3;TLR3;ESR1;RC3H1;PSMB10;EIF2B1;NRAS;MUC5B;MUC6;IRF1;IRAK3
19445,GO:1905954,0.199316253636104,0.911480304644647,5,43,positive regulation of lipid localization,BP,C3;EDN1;C1QTNF1;IKBKE;EHD1
7124,GO:0030934,0.199415201450517,0.988935627013411,1,2,anchoring collagen complex,CC,COL12A1
13607,GO:0060054,0.19941710064413,0.985427942876596,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,B4GALT1
11254,GO:0045416,0.199458854027221,0.985421522621595,1,3,positive regulation of interleukin-8 biosynthetic process,BP,TNF
6661,GO:0030010,0.19947031967153,0.880371593894299,11,104,establishment of cell polarity,BP,MAP2;AMOT;SIPA1L3;SLC9A3R1;PARD3B;OPHN1;WEE1;WDPCP;SHTN1;MPP5;PARD3
9809,GO:0040019,0.199546153722241,0.935559972822598,3,20,positive regulation of embryonic development,BP,AMOT;RBM19;WNT4
1890,GO:0004568,0.199715121530604,0.985382083144631,1,3,chitinase activity,MF,CHID1
2678,GO:0006030,0.199715121530604,0.985382083144631,1,3,chitin metabolic process,BP,CHID1
2679,GO:0006032,0.199715121530604,0.985382083144631,1,3,chitin catabolic process,BP,CHID1
3613,GO:0008061,0.199715121530604,0.985382083144631,1,3,chitin binding,MF,CHID1
1227,GO:0002901,0.19972967385769,0.983653089492976,1,4,mature B cell apoptotic process,BP,CD74
1231,GO:0002905,0.19972967385769,0.983653089492976,1,4,regulation of mature B cell apoptotic process,BP,CD74
1232,GO:0002906,0.19972967385769,0.983653089492976,1,4,negative regulation of mature B cell apoptotic process,BP,CD74
11098,GO:0045084,0.199796483267806,0.985369549290871,1,3,positive regulation of interleukin-12 biosynthetic process,BP,IRF1
4762,GO:0010939,0.199903731106852,0.934446193280538,3,24,regulation of necrotic cell death,BP,BIRC3;CFLAR;TRAF2
16548,GO:0097252,0.199977964568556,0.985341570537334,1,3,oligodendrocyte apoptotic process,BP,TP53
10853,GO:0044339,0.200056992070302,0.985329377731318,1,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,FZD1
15915,GO:0072665,0.200094926866773,0.90326828724578,6,52,protein localization to vacuole,BP,GNPTAB;VPS41;CLU;HSPA8;VPS36;AP3B1
2896,GO:0006404,0.200158679368591,0.985313680603315,1,3,RNA import into nucleus,BP,RAN
4237,GO:0009416,0.20020262650662,0.860972056406672,20,223,response to light stimulus,BP,PML;TP53;HMGCS1;RBM4;SLC1A3;MME;CDC25A;NETO1;FEN1;BRCA2;CHEK1;RAD18;ATR;MSH6;CLOCK;METAP2;TAF1;CDKN1A;USP1;COPS3
4202,GO:0009309,0.200231162060791,0.953982385811836,2,13,amine biosynthetic process,BP,ODC1;AZIN1
10001,GO:0042401,0.200231162060791,0.953982385811836,2,13,cellular biogenic amine biosynthetic process,BP,ODC1;AZIN1
11896,GO:0046888,0.200241169282929,0.921116693349414,4,32,negative regulation of hormone secretion,BP,IRS1;EDN1;INHBA;SFRP1
8848,GO:0034629,0.200283639485494,0.93468966191519,3,22,cellular protein-containing complex localization,BP,NDC1;RAN;KLHL21
2616,GO:0005924,0.200364865666886,0.850563411048034,30,356,cell-substrate adherens junction,CC,TNS3;KIF23;HSPG2;ACTG1;CHP1;PDLIM1;LAYN;DST;CSRP1;G3BP1;MME;NEXN;HSPB1;RHOG;LCP1;CORO1C;ARMC5;ITGAV;AJUBA;CDH13;FZD1;TPM4;TNC;HSPA8;L1CAM;ADAM17;SENP1;CSRP2;SYNPO2;NEDD9
3307,GO:0007009,0.200377142502925,0.896873592152296,7,60,plasma membrane organization,BP,FAT4;TGFB2;BAIAP2;CLU;SYT11;MPP5;ARV1
19056,GO:1904868,0.20040694737618,0.988818751318429,1,2,telomerase catalytic core complex assembly,BP,ATR
19068,GO:1904882,0.20040694737618,0.988818751318429,1,2,regulation of telomerase catalytic core complex assembly,BP,ATR
19069,GO:1904884,0.20040694737618,0.988818751318429,1,2,positive regulation of telomerase catalytic core complex assembly,BP,ATR
17825,GO:1901894,0.200436170738888,0.985270797987847,1,3,regulation of calcium-transporting ATPase activity,BP,THADA
6316,GO:0019958,0.200497242728888,0.985261350842943,1,3,C-X-C chemokine binding,MF,ACKR3
6241,GO:0019797,0.20049930719558,0.985261031434839,1,3,procollagen-proline 3-dioxygenase activity,MF,P3H2
16721,GO:0097659,0.200519451585836,0.821310622390161,228,2986,nucleic acid-templated transcription,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EDN1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;INHBA;PHAX;SYK;ZFP42;RELB;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;TRIM37;ZNF586;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;SMYD2;MACC1;ZNF316;RRM2;COMMD9;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;DDX21;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;NCL;CCNA2;GTF3C4;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;SRSF7;TYMS;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
15935,GO:0072697,0.20052682792153,0.954844951229158,2,11,protein localization to cell cortex,BP,RTKN2;ANLN
11114,GO:0045112,0.200780776908921,0.985217447460257,1,3,integrin biosynthetic process,BP,TGFB2
5155,GO:0015691,0.200850667231657,0.985206614318509,1,3,cadmium ion transport,BP,SLC11A2
14850,GO:0070574,0.200850667231657,0.985206614318509,1,3,cadmium ion transmembrane transport,BP,SLC11A2
11432,GO:0045829,0.200966806698359,0.985188602762987,1,3,negative regulation of isotype switching,BP,THOC1
16379,GO:0090661,0.201112590016288,0.98237451275848,1,5,box H/ACA telomerase RNP complex,CC,DKC1
6835,GO:0030292,0.201235100783413,0.98514694789062,1,3,protein tyrosine kinase inhibitor activity,MF,FGFR1OP
6289,GO:0019896,0.201239494702505,0.954582150833008,2,11,axonal transport of mitochondrion,BP,NEFL;TRAK2
10982,GO:0044752,0.201276847062131,0.985140460620714,1,3,response to human chorionic gonadotropin,BP,GCLC
13938,GO:0060575,0.201338690349355,0.954012345581449,2,12,intestinal epithelial cell differentiation,BP,TYMS;CDKN1A
13873,GO:0060456,0.201424230198637,0.985117545113367,1,3,positive regulation of digestive system process,BP,SLC22A5
4294,GO:0009719,0.201507212816284,0.830334908830662,87,1069,response to endogenous stimulus,BP,CRYAB;NEFL;HDAC9;TRIM16;PML;GCLC;CYR61;COL16A1;FGFR2;STAT5A;CTGF;FBN1;RUNX1;FAT4;DDX17;IRS1;TP53;EDN1;HMGCS1;NQO1;AKAP8;TGFB2;HNRNPF;INHBA;SYK;LEPR;BRIP1;CDK4;SFRP1;NUCKS1;WNT10A;MIR17HG;H3F3A;ATP2B1;COL4A1;AHR;PTGER4;ADM;CD109;RRAGB;WNT4;RAN;SOCS1;ARNTL;AKR1C2;BAIAP2;CDH13;COL5A2;SRF;NPNT;QDPR;FZD1;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;TNC;HSP90AB1;POLR2F;GPER1;ADAM17;CFLAR;EIF2B5;NCBP1;AKR1B1;CITED2;NCL;CCNA2;TIMELESS;CLOCK;ESR1;PARD3;EHD1;TNF;ZFP36L2;TYMS;CCL5;HNRNPU;EIF2B1;DAXX;TAF1;SMARCC1;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1
6078,GO:0019227,0.201628901823667,0.985085689854807,1,3,neuronal action potential propagation,BP,CNTNAP1
16928,GO:0098870,0.201628901823667,0.985085689854807,1,3,action potential propagation,BP,CNTNAP1
9955,GO:0042306,0.201696142267586,0.910169450815024,5,42,regulation of protein import into nucleus,BP,CHP1;RBM22;NUP54;HSP90AB1;CDKN1A
20058,GO:2000645,0.201757453259341,0.985065662743681,1,3,negative regulation of receptor catabolic process,BP,MTMR2
11784,GO:0046626,0.201777602693809,0.910120919026798,5,42,regulation of insulin receptor signaling pathway,BP,IRS1;CDK4;NUCKS1;SOCS1;ENPP1
15712,GO:0072223,0.201801609649572,0.985058780161412,1,3,metanephric glomerular mesangium development,BP,PDGFB
15719,GO:0072239,0.201801609649572,0.985058780161412,1,3,metanephric glomerulus vasculature development,BP,PDGFB
4341,GO:0009891,0.201922833515294,0.827385577942189,106,1326,positive regulation of biosynthetic process,BP,MAFB;NRG1;TRIM16;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;CTGF;RUNX1;PBX1;DDX17;IRS1;TP53;EDN1;ACSL3;ZBED1;STAG1;CHP1;TGFB2;FOXD2;DKC1;INHBA;SYK;RELB;UTP15;CDK4;SFRP1;NUCKS1;HEATR1;USP16;AHR;NAA15;GLIS3;TAF2;CCL20;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;RRN3;ARNTL;AJUBA;FASTKD3;DND1;NVL;CDH13;SRF;NPNT;WDR43;PDGFB;FZD1;NFE2L1;CLU;MACC1;GLIS2;TET3;MYBL1;HSP90AB1;BRCA2;SS18L2;E2F8;ETV6;HSF2;RAB3GAP1;CHEK1;GPER1;MLLT10;WDR75;SENP1;RBMS3;ATR;EIF2B5;NOL11;UPF3B;EDRF1;CITED2;NCL;CCNA2;RBL1;NAA16;CLOCK;TLR3;ESR1;TNF;CCL5;CD74;HNRNPU;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
11677,GO:0046425,0.201975865011875,0.889947024269378,8,81,regulation of JAK-STAT cascade,BP,CYP1B1;IL6ST;IL24;SOCS1;PARP14;IL20;AKR1B1;CCL5
18176,GO:1902894,0.201980947064224,0.954959406142377,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,SRF;PDGFB
3480,GO:0007342,0.202032710984015,0.983255119758052,1,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,SPACA6
288,GO:0000792,0.202246267519898,0.895262176900285,7,66,heterochromatin,CC,PML;CBX5;CDKN2A;HELLS;ORC2;MPHOSPH8;RING1
19952,GO:2000416,0.202254741166206,0.984988049937141,1,3,regulation of eosinophil migration,BP,PTGER4
8988,GO:0035088,0.202267210865359,0.920161174407538,4,31,establishment or maintenance of apical/basal cell polarity,BP,SLC9A3R1;PARD3B;OPHN1;PARD3
14265,GO:0061245,0.202267210865359,0.920161174407538,4,31,establishment or maintenance of bipolar cell polarity,BP,SLC9A3R1;PARD3B;OPHN1;PARD3
17375,GO:1900041,0.202400908077274,0.984965195021843,1,3,negative regulation of interleukin-2 secretion,BP,GBP1
13644,GO:0060117,0.202455693472312,0.954132164680166,2,11,auditory receptor cell development,BP,SLC9A3R1;WDPCP
18426,GO:1903428,0.202477721598771,0.919889249749936,4,32,positive regulation of reactive oxygen species biosynthetic process,BP,EDN1;CLU;HSP90AB1;TNF
2859,GO:0006351,0.202652070198682,0.819353431601676,227,2972,transcription, DNA-templated,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;CTGF;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EDN1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;INHBA;PHAX;SYK;ZFP42;RELB;PARP15;BRIP1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;CASC3;ZNF512;ZNF587;FRK;DNTTIP2;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;TRIM37;ZNF586;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;SMYD2;MACC1;ZNF316;RRM2;COMMD9;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;DDX21;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;POLR2F;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;PSME2;CFLAR;NIFK;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;NCL;CCNA2;GTF3C4;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;SRSF7;TYMS;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
8284,GO:0033080,0.202798919244434,0.984902863765119,1,3,immature T cell proliferation in thymus,BP,WNT4
5364,GO:0016137,0.202854569895429,0.952993705025041,2,13,glycoside metabolic process,BP,AKR1C2;AKR1B1
18880,GO:1904468,0.203030233901719,0.984866572736023,1,3,negative regulation of tumor necrosis factor secretion,BP,SYT11
713,GO:0001935,0.203059198507275,0.884867733172116,9,88,endothelial cell proliferation,BP,STAT5A;PTPRM;CDH13;PDGFB;PDCL3;ADAM17;TNF;NRAS;ITGB1BP1
7324,GO:0031328,0.203069306115299,0.826461338520838,105,1312,positive regulation of cellular biosynthetic process,BP,MAFB;NRG1;TRIM16;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;RUNX1;PBX1;DDX17;IRS1;TP53;EDN1;ACSL3;ZBED1;STAG1;CHP1;TGFB2;FOXD2;DKC1;INHBA;SYK;RELB;UTP15;CDK4;SFRP1;NUCKS1;HEATR1;USP16;AHR;NAA15;GLIS3;TAF2;CCL20;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;RRN3;ARNTL;AJUBA;FASTKD3;DND1;NVL;CDH13;SRF;NPNT;WDR43;PDGFB;FZD1;NFE2L1;CLU;MACC1;GLIS2;TET3;MYBL1;HSP90AB1;BRCA2;SS18L2;E2F8;ETV6;HSF2;RAB3GAP1;CHEK1;GPER1;MLLT10;WDR75;SENP1;RBMS3;ATR;EIF2B5;NOL11;UPF3B;EDRF1;CITED2;NCL;CCNA2;RBL1;NAA16;CLOCK;TLR3;ESR1;TNF;CCL5;CD74;HNRNPU;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
18133,GO:1902749,0.203155289188944,0.863170446059505,17,195,regulation of cell cycle G2/M phase transition,BP,PBX1;TP53;GPR132;NBN;CDK4;TOPBP1;CDC25A;BRCC3;CENPF;CHEK1;PSME2;CEP152;PSMB9;KIF14;RAD51B;FGFR1OP;PSMB10
7913,GO:0032480,0.203192858936221,0.909069934061525,5,44,negative regulation of type I interferon production,BP,NLRC5;TRAF3;CYLD;IKBKE;RELB
12093,GO:0048026,0.203225769749855,0.953305601588039,2,12,positive regulation of mRNA splicing, via spliceosome,BP,HSPA8;NCBP1
82,GO:0000165,0.203229442878613,0.837606313532255,50,609,MAPK cascade,BP,CRYAB;IGFBP3;SAA1;NEFL;NRG1;FN1;MAP3K14;CYR61;FGFR2;EPGN;CTGF;IRS1;MID1;EDN1;GBP1;C1QTNF1;DUSP14;TGFB2;SLC9A3R1;INHBA;SYK;SFRP1;ULK4;PTGER4;CCL20;ITGAV;AJUBA;GADD45B;NPNT;PDGFB;ACKR3;GLIPR2;ARL6IP5;EPHB6;GPER1;PSME2;CFLAR;PSMB9;TRAF2;TLR3;TNF;ZFP36L2;CCL5;CD74;PSMB10;DAXX;PHLPP1;NRAS;ITGB1BP1;IRAK3
13546,GO:0055100,0.203238807357822,0.984833808229079,1,3,adiponectin binding,MF,CDH13
5679,GO:0016787,0.203360734395584,0.822830391779542,141,1823,hydrolase activity,MF,HDAC9;C1R;KIF23;C3;MMP9;TAP1;MYO1B;DDX17;OVCH2;DYNC2H1;EXO1;C9ORF3;ABHD16B;GBP1;DDX47;ABCF1;DUSP14;TMPPE;PTPN14;PRUNE2;PRSS23;CYLD;PPP1R3B;RAD1;DNHD1;RAB32;NBN;BRIP1;MCM5;ABCG2;ARFRP1;SFRP1;POP1;GPCPD1;MCM2;ABHD4;POLQ;TSR1;ATP2B1;USP16;HELLS;PTPRB;RCE1;ABCC4;TSN;ADAMTS9;LSG1;G3BP1;MGAM;IMMP2L;USP43;DYNLL2;MDN1;EIF5;RRAGB;MME;GBP5;RFC3;RHOG;EXOG;PTPRM;DDX28;RAN;ATP2C1;DDX3X;RAB26;CPA4;CDC25A;ABCF2;CGNL1;FEN1;MCM3;GNL3L;APTX;GINS4;USB1;APMAP;GANC;MCM8;BRCC3;CHID1;ISG20L2;USP6;ENPP1;DDX10;LRPPRC;EYA3;EFTUD2;DDX24;MCM6;ABCC9;TTF2;ERAP1;APEX1;HSPA8;DDX21;SMUG1;BACE2;NSF;DNPEP;HELQ;MYH11;NAV2;DGCR8;MTMR2;MMAA;RAD18;BMS1;MCM4;ADAM17;MYO10;SENP1;MSH6;CFLAR;DDX60L;PSMB9;ABCA5;DPYSL3;MSH3;DDX56;TAP2;KIF14;RAD51B;USP11;DNASE1;CAPN12;CCL5;PLBD1;PSMB10;METAP2;PHLPP2;PHLPP1;HIBCH;NRAS;THTPA;ABCA11P;USP1;TREX1;GTF2H3;GBP6;DHX15
9386,GO:0035905,0.203560507753183,0.984783195853752,1,3,ascending aorta development,BP,TGFB2
9389,GO:0035910,0.203560507753183,0.984783195853752,1,3,ascending aorta morphogenesis,BP,TGFB2
13253,GO:0051897,0.203809617657968,0.884423940841081,9,86,positive regulation of protein kinase B signaling,BP,NRG1;FGFR2;IRS1;C1QTNF1;AKR1C2;PDGFB;ESR1;TNF;ITGB1BP1
7921,GO:0032488,0.203810329194292,0.953628723988653,2,11,Cdc42 protein signal transduction,BP,NTN1;SHTN1
7186,GO:0031063,0.203887401619802,0.933201785327406,3,21,regulation of histone deacetylation,BP,TP53;AKAP8;AKAP8L
1860,GO:0004520,0.204116503174316,0.908420133511198,5,45,endodeoxyribonuclease activity,MF,EXO1;FEN1;APEX1;RAD51B;DNASE1
19834,GO:2000243,0.20414783382017,0.918821075737367,4,33,positive regulation of reproductive process,BP,INHBA;WNT4;LFNG;CITED2
11219,GO:0045335,0.20431794348646,0.879881033410375,10,105,phagocytic vesicle,CC,HLA-B;TAP1;ACTG1;SYK;RAB32;HLA-F;ITGAV;CDC42EP2;SYT11;TAP2
6953,GO:0030574,0.204558228478481,0.908690226116772,5,40,collagen catabolic process,BP,COL5A3;MMP9;COL12A1;COL4A1;COL5A2
12276,GO:0048545,0.204624249843814,0.852546005906447,24,272,response to steroid hormone,BP,NEFL;CTGF;RUNX1;DDX17;EDN1;TGFB2;SFRP1;ATP2B1;ADM;RAN;ARNTL;SRD5A1;GPER1;CFLAR;CLOCK;ESR1;TNF;ZFP36L2;TYMS;HNRNPU;DAXX;TAF1;PPARGC1B;CDKN1A
4343,GO:0009893,0.204631288407538,0.819199009418364,183,2365,positive regulation of metabolic process,BP,IGFBP3;MAFB;SAA1;NRG1;TRIM16;FN1;PML;MAP3K14;GCLC;TFRC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;EPGN;TRIM22;CTGF;MMP9;RUNX1;CLN6;PBX1;DDX17;IRS1;MID1;TP53;EDN1;C1QTNF1;ACSL3;ZBED1;STAG1;CHP1;AKAP8;TGFB2;RBM22;FOXD2;IL6ST;DKC1;INHBA;IL7R;SYK;EMP2;RELB;NBN;UTP15;CDK4;SFRP1;NUCKS1;HEATR1;WNT10A;TARDBP;H3F3A;USP16;AHR;KEAP1;NAA15;DHFR;POLR1A;GLIS3;TAF2;SETDB1;ADM;CCL20;PLK2;UBQLN2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;KDM6A;THOC1;RAN;UBTF;RANBP2;SUPT16H;DDX3X;NUFIP1;IL24;RRN3;ITGAV;SOCS1;PARP14;ARNTL;TAF1D;AJUBA;FASTKD3;DND1;NVL;GADD45B;CDH13;SRF;NPNT;WDR43;PDGFB;BRCC3;FZD1;NFE2L1;ANTXR1;CLU;MACC1;BIRC3;IL20;EYA3;ACKR3;RIF1;METTL16;GLIS2;GLIPR2;TNC;TET3;MYBL1;HSPA8;HSP90AB1;DDX21;ARL6IP5;EPHB6;NSF;NEDD4L;BRCA2;SYNCRIP;SS18L2;E2F8;ETV6;HSF2;POLR2F;RAB3GAP1;CHEK1;SERPINB9;GPER1;MLLT10;WDR75;ADAM17;SENP1;RBMS3;ATR;PSME2;UBAP2L;MSH6;CFLAR;EIF2B5;NOL11;NCBP1;UPF3B;POLR1E;TRAF2;TELO2;EDRF1;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;CSF1;RBL1;NAA16;CLOCK;KIF14;TLR3;ESR1;RNF19B;TNF;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;HNRNPU;DAXX;HIST1H4A;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;IRF1;CTCF;IFI27L1
6152,GO:0019439,0.204642211748332,0.839579861990737,42,553,aromatic compound catabolic process,BP,CYP1A1;PABPC4;DKC1;NUP50;NUP153;POP1;TARDBP;NDC1;CASC3;HSPB1;EXOG;RANBP2;SET;MRTO4;FASTKD3;PGK1;FEN1;QDPR;NUP160;ENPP1;NUP54;LRPPRC;METTL16;APEX1;TET3;HSPA8;SMUG1;SYNCRIP;DPYD;PSME2;PSMB9;UGT1A4;NCBP1;UPF3B;HNRNPR;DNASE1;ZFP36L2;RC3H1;HNRNPU;PSMB10;RBM8A;RPS12
7692,GO:0032137,0.20464825130302,0.984611371783536,1,3,guanine/thymine mispair binding,MF,MSH6
1104,GO:0002690,0.204657593630012,0.907830739813026,5,48,positive regulation of leukocyte chemotaxis,BP,EDN1;ADAM17;CSF1;CCL5;CD74
142,GO:0000293,0.204863583351381,0.984577230372383,1,3,ferric-chelate reductase activity,MF,FRRS1
20020,GO:2000580,0.204937092080636,0.982745720847811,1,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,DYNLL2
20021,GO:2000582,0.204937092080636,0.982745720847811,1,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,DYNLL2
10476,GO:0043328,0.204959583850071,0.982741743217705,1,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,VPS36
5072,GO:0015293,0.204993681593513,0.888165076631793,8,75,symporter activity,MF,SLC16A2;SLC16A9;SLC4A11;SLC22A5;SLC5A6;SLC1A3;SLC11A2;SLC25A22
13288,GO:0051956,0.205149496977424,0.984531833288716,1,3,negative regulation of amino acid transport,BP,ARL6IP5
19849,GO:2000273,0.205214277346273,0.932305156844432,3,22,positive regulation of signaling receptor activity,BP,EPGN;ADAM17;TAF1
648,GO:0001836,0.205296494428562,0.907287559974965,5,50,release of cytochrome c from mitochondria,BP,MMP9;TP53;SOD2;CLU;GPER1
5499,GO:0016434,0.205301072989531,0.984507736206615,1,3,rRNA (cytosine) methyltransferase activity,MF,NOP2
4003,GO:0008940,0.205436584964931,0.984486175333745,1,3,nitrate reductase activity,MF,GPHN
10957,GO:0044613,0.205444468314982,0.952468777051411,2,12,nuclear pore central transport channel,CC,NUP153;NUP54
7964,GO:0032557,0.205475599802156,0.984479964727744,1,3,pyrimidine ribonucleotide binding,MF,HSP90AB1
10856,GO:0044342,0.205513559058975,0.952442616113133,2,12,type B pancreatic cell proliferation,BP,IGFBP3;SFRP1
411,GO:0001097,0.205712404539949,0.984442239225872,1,3,TFIIH-class transcription factor binding,MF,HNRNPU
10316,GO:0043073,0.20571681728334,0.952365617457306,2,12,germ cell nucleus,CC,RAN;TOPBP1
16094,GO:0090036,0.205761559342544,0.952899427639354,2,11,regulation of protein kinase C signaling,BP,ULK4;PHLPP1
4683,GO:0010829,0.205770226795918,0.952345375919536,2,12,negative regulation of glucose transmembrane transport,BP,ENPP1;TNF
7048,GO:0030816,0.205830459702224,0.952322543983058,2,12,positive regulation of cAMP metabolic process,BP,ADM;GPER1
17420,GO:1900127,0.206169585503629,0.984369261794109,1,3,positive regulation of hyaluronan biosynthetic process,BP,PDGFB
1058,GO:0002583,0.206196319313433,0.98252225102065,1,4,regulation of antigen processing and presentation of peptide antigen,BP,HLA-DOB
4240,GO:0009437,0.206407705811945,0.952103495105562,2,12,carnitine metabolic process,BP,SLC22A5;CROT
17748,GO:1901653,0.206448538489245,0.852202367719455,23,256,cellular response to peptide,BP,HDAC9;GCLC;STAT5A;FBN1;IRS1;TP53;EDN1;BRIP1;CDK4;NUCKS1;SOCS1;BAIAP2;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;GPER1;CFLAR;AKR1B1;CCNA2;TIMELESS;SMARCC1
8018,GO:0032642,0.206531660846578,0.90687411427551,5,46,regulation of chemokine production,BP,DDX3X;ADAM17;TLR3;TNF;CD74
6973,GO:0030622,0.206559688774491,0.984306841872318,1,3,U4atac snRNA binding,MF,GEMIN5
8215,GO:0032962,0.206623257466473,0.984296657254676,1,3,positive regulation of inositol trisphosphate biosynthetic process,BP,GPER1
8903,GO:0034714,0.206688675108875,0.984286172582485,1,3,type III transforming growth factor beta receptor binding,MF,TGFB2
4726,GO:0010886,0.206782853959114,0.984271071453108,1,3,positive regulation of cholesterol storage,BP,EHD1
15130,GO:0071168,0.206789374074282,0.931536895624154,3,22,protein localization to chromatin,BP,CDCA5;SETD2;ESR1
2929,GO:0006447,0.206871716680755,0.984256815362159,1,3,regulation of translational initiation by iron,BP,TNF
10800,GO:0044260,0.206897537556364,0.812704157659342,460,6228,cellular macromolecule metabolic process,BP,CRYAB;IGFBP3;MAFB;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;TRIM16;FN1;PML;CYP1B1;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;EPGN;TRIM22;CBX5;CTGF;MMP9;FBN1;GNPTAB;HSPG2;RUNX1;CLN6;IL1R2;B4GALT1;PBX1;G6PD;TSC22D3;FST;DDX17;SPON1;TRIM56;TFCP2L1;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;EXO1;EDN1;TPST1;GBP1;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;GEMIN5;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;P3H2;RAD1;IL6ST;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;GALNT18;CAMK1G;PHAX;SYK;EMP2;NUP153;NAIP;ZFP42;RELB;NBN;TRIO;FAM111A;PARP15;BRIP1;MCM5;UTP15;CDK4;SFRP1;POP1;RIPK4;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;RPA1;POLR1A;THUMPD3;GLIS3;HELLS;METTL21A;PTPRB;METTL1;TAF2;ULK4;POLA1;RCE1;TSN;ADAMTS9;SETDB1;PTGER4;TK1;GRWD1;ZNF584;TRAF1;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;HERC6;FOXRED2;EIF5;CASC3;CCL20;PLK2;ZNF512;MRPL27;ZNF587;MUC16;UBQLN2;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;EXOG;PTPRM;GTF3C6;KDM6A;THOC1;SETD4;RAN;UBTF;RANBP2;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ZNF738;DDX3X;NAP1L1;NUFIP1;CPA4;IL24;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;TRPM7;AJUBA;FASTKD3;DND1;ZNF267;LFNG;TRIM37;FEN1;MCM3;CDCA5;PPP4R4;GNL3L;ZNF586;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;GINS4;RARS;COMMD4;PHACTR4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;MCM8;PDGFB;BRCC3;EIF3J;SGK494;FZD1;IRX4;UTY;NFE2L1;ANTXR1;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;IL20;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;VGLL3;ACKR3;RIF1;METTL16;MCM6;KLHL9;SETD2;GLIS2;UBP1;TRMT5;TTF2;DTX4;GLIPR2;DPY19L2P2;WEE1;ZNF484;THADA;APEX1;PDCL3;TNC;ZNF57;TET3;ORC1;MYBL1;HSPA8;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;ZBTB24;NSF;HELQ;NEDD4L;SGK1;PRIM2;ZBTB12;ANAPC7;BRCA2;SYNCRIP;TRAK2;TRMT1;SS18L2;KRT10;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;FKBP5;HSF2;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;RRM1;MLLT10;RAD18;WDR75;MCM4;ADAM17;SENP1;RBMS3;ATR;PSME2;MSH6;CFLAR;PSMC3IP;NIFK;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;NFKBIE;TRMT61A;CBLL1;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;KIF14;PURB;TLR3;ESR1;PARD3;RNF19B;RAD51B;USP11;FEM1C;DNASE1;TNF;WDR4;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3;COPS3;IFI27L1;UFC1
17442,GO:1900165,0.207071602983141,0.984224721768609,1,3,negative regulation of interleukin-6 secretion,BP,SYT11
19603,GO:1990597,0.207078053269405,0.984223685511635,1,3,AIP1-IRE1 complex,CC,TRAF2
7446,GO:0031571,0.207176700436186,0.891883912462718,7,68,mitotic G1 DNA damage checkpoint,BP,PML;TP53;PLK2;MDM4;E2F8;RFWD3;CDKN1A
11015,GO:0044819,0.207176700436186,0.891883912462718,7,68,mitotic G1/S transition checkpoint,BP,PML;TP53;PLK2;MDM4;E2F8;RFWD3;CDKN1A
8998,GO:0035101,0.207226637774618,0.9841998045309,1,3,FACT complex,CC,SUPT16H
16449,GO:0097068,0.207419591134286,0.984168762531575,1,3,response to thyroxine,BP,GCLC
18846,GO:1904386,0.207419591134286,0.984168762531575,1,3,response to L-phenylalanine derivative,BP,GCLC
7977,GO:0032584,0.207652819453868,0.984131196034667,1,3,growth cone membrane,CC,ZFYVE27
16523,GO:0097201,0.207664672362324,0.951625023553112,2,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,HIF1AN;CITED2
6998,GO:0030673,0.207820717823196,0.952804262417533,2,10,axolemma,CC,NRG1;CNTNAP2
13113,GO:0051604,0.207866599510178,0.857733312555454,18,211,protein maturation,BP,C1R;C3;IL1R2;C9ORF3;NAIP;NAA15;RCE1;IMMP2L;MME;HSCB;DOHH;PGK1;CLU;NAA50;BIRC3;BACE2;NAA16;METAP2
16486,GO:0097149,0.207919214714744,0.984088226822428,1,3,centralspindlin complex,CC,KIF23
14169,GO:0061029,0.207959621785859,0.952072030156485,2,11,eyelid development in camera-type eye,BP,INHBA;SRF
3805,GO:0008384,0.207979869476884,0.984078434273893,1,3,IkappaB kinase activity,MF,IKBKE
14321,GO:0061430,0.208084889219294,0.952705746830801,2,10,bone trabecula morphogenesis,BP,SFRP1;PPARGC1B
5111,GO:0015410,0.208109096925423,0.984057559696807,1,3,manganese-transporting ATPase activity,MF,ATP2C1
4251,GO:0009449,0.208255837556418,0.984033837743426,1,3,gamma-aminobutyric acid biosynthetic process,BP,SLC1A3
11908,GO:0046912,0.208299210127689,0.984026822425045,1,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS1
3512,GO:0007431,0.208434842957324,0.916752056841863,4,31,salivary gland development,BP,FGFR2;TFCP2L1;TGFB2;TNF
8928,GO:0034763,0.208449432570483,0.891152281779137,7,66,negative regulation of transmembrane transport,BP,MMP9;SLC9A3R1;ENPP1;THADA;ARL6IP5;NEDD4L;TNF
12666,GO:0050851,0.208538017935497,0.864967324206681,14,162,antigen receptor-mediated signaling pathway,BP,RUNX1;SPG21;GBP1;LGALS3;CYLD;SYK;BTN2A1;PSME2;PSMB9;EIF2B5;CMTM3;RC3H1;PSMB10;EIF2B1
3041,GO:0006595,0.208588502099944,0.950402136857455,2,14,polyamine metabolic process,BP,ODC1;AZIN1
1102,GO:0002688,0.208673667399435,0.897186329617095,6,61,regulation of leukocyte chemotaxis,BP,MTUS1;EDN1;ADAM17;CSF1;CCL5;CD74
4610,GO:0010724,0.208691505543779,0.98396329267331,1,3,regulation of definitive erythrocyte differentiation,BP,SENP1
16287,GO:0090329,0.208758746870556,0.90582429918139,5,43,regulation of DNA-dependent DNA replication,BP,NBN;RFC3;BRCA2;E2F8;TIMELESS
1711,GO:0004298,0.208793575873355,0.949185365163054,2,18,threonine-type endopeptidase activity,MF,PSMB9;PSMB10
14533,GO:0070003,0.208793575873355,0.949185365163054,2,18,threonine-type peptidase activity,MF,PSMB9;PSMB10
10497,GO:0043383,0.208851632540607,0.983937320877825,1,3,negative T cell selection,BP,CD74
11076,GO:0045060,0.208851632540607,0.983937320877825,1,3,negative thymic T cell selection,BP,CD74
9836,GO:0042044,0.208953654087822,0.951132248342562,2,12,fluid transport,BP,EDN1;SLC4A11
20017,GO:2000573,0.209023288998244,0.897295603999714,6,56,positive regulation of DNA biosynthetic process,BP,DKC1;RFC3;NVL;PDGFB;HSP90AB1;ATR
6072,GO:0019218,0.209133950454244,0.88508545784135,8,80,regulation of steroid metabolic process,BP,PANK2;SCD;HMGCS1;LSS;WNT4;RAN;ARV1;TNF
10934,GO:0044539,0.209160370743932,0.98388717919933,1,3,long-chain fatty acid import,BP,ACSL3
15061,GO:0070989,0.209275806948787,0.95157362733569,2,11,oxidative demethylation,BP,TET3;FTO
14815,GO:0070525,0.209318008345422,0.950519689101462,2,13,tRNA threonylcarbamoyladenosine metabolic process,BP,YRDC;TRMT5
14376,GO:0061578,0.209352334890662,0.951544580076441,2,11,Lys63-specific deubiquitinase activity,MF,CYLD;BRCC3
11175,GO:0045218,0.209511304824936,0.983830079131277,1,3,zonula adherens maintenance,BP,PLEKHA7
9324,GO:0035787,0.209517232833084,0.983829113628365,1,3,cell migration involved in kidney development,BP,PDGFB
3458,GO:0007272,0.209574574164389,0.880504102524176,9,83,ensheathment of neurons,BP,NRG1;CNTNAP1;UGT8;CLU;MTMR2;EIF2B5;KIF14;MPP5;PARD3
3796,GO:0008366,0.209574574164389,0.880504102524176,9,83,axon ensheathment,BP,NRG1;CNTNAP1;UGT8;CLU;MTMR2;EIF2B5;KIF14;MPP5;PARD3
7380,GO:0031427,0.209585791009352,0.9838179451361,1,3,response to methotrexate,BP,DHFR
12473,GO:0050220,0.2096731636428,0.981896986485792,1,4,prostaglandin-E synthase activity,MF,PTGES
10398,GO:0043218,0.209692134339458,0.95084896322603,2,12,compact myelin,CC,AKR1B1;MPP5
19460,GO:1990034,0.209764915205455,0.983788744630713,1,3,calcium ion export across plasma membrane,BP,ATP2B1
6454,GO:0021769,0.209878843574926,0.983770157013271,1,3,orbitofrontal cortex development,BP,FGFR2
11444,GO:0045843,0.209931395574749,0.915754785770627,4,32,negative regulation of striated muscle tissue development,BP,G6PD;TSC22D3;MIR17HG;LUC7L
17815,GO:1901862,0.209931395574749,0.915754785770627,4,32,negative regulation of muscle tissue development,BP,G6PD;TSC22D3;MIR17HG;LUC7L
1702,GO:0004177,0.209968734132939,0.915581305670012,4,33,aminopeptidase activity,MF,C9ORF3;ERAP1;DNPEP;METAP2
11445,GO:0045844,0.210002028594953,0.905297300910331,5,41,positive regulation of striated muscle tissue development,BP,NRG1;FGFR2;EDN1;MIR17HG;ARNTL
12314,GO:0048636,0.210002028594953,0.905297300910331,5,41,positive regulation of muscle organ development,BP,NRG1;FGFR2;EDN1;MIR17HG;ARNTL
17816,GO:1901863,0.210002028594953,0.905297300910331,5,41,positive regulation of muscle tissue development,BP,NRG1;FGFR2;EDN1;MIR17HG;ARNTL
5517,GO:0016476,0.210018633292317,0.983747333899606,1,3,regulation of embryonic cell shape,BP,WDPCP
8712,GO:0034343,0.210030873946177,0.983745334550389,1,3,type III interferon production,BP,TLR3
8713,GO:0034344,0.210030873946177,0.983745334550389,1,3,regulation of type III interferon production,BP,TLR3
19606,GO:1990604,0.210270333395365,0.983706194519762,1,3,IRE1-TRAF2-ASK1 complex,CC,TRAF2
14695,GO:0070294,0.210339710914095,0.983694844878594,1,3,renal sodium ion absorption,BP,SGK1
19271,GO:1905394,0.210373916706557,0.983689247451093,1,3,retromer complex binding,MF,M6PR
714,GO:0001936,0.210433915279074,0.884330915336581,8,77,regulation of endothelial cell proliferation,BP,STAT5A;PTPRM;CDH13;PDGFB;PDCL3;ADAM17;TNF;NRAS
12813,GO:0051088,0.21049702222134,0.98366909365736,1,3,PMA-inducible membrane protein ectodomain proteolysis,BP,ADAM17
187,GO:0000404,0.210538404447736,0.98366231580264,1,3,heteroduplex DNA loop binding,MF,MSH3
7771,GO:0032286,0.210824965342423,0.983615338063499,1,3,central nervous system myelin maintenance,BP,CLU
17868,GO:1902022,0.210884365840415,0.983605590780913,1,3,L-lysine transport,BP,SLC7A2
18414,GO:1903401,0.210884365840415,0.983605590780913,1,3,L-lysine transmembrane transport,BP,SLC7A2
758,GO:0001996,0.210910297601508,0.983601334516369,1,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,TPM1
1400,GO:0003321,0.210910297601508,0.983601334516369,1,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,TPM1
3862,GO:0008479,0.210967706071943,0.98166107811271,1,4,queuine tRNA-ribosyltransferase activity,MF,PDCL3
6330,GO:0020016,0.211028247411859,0.983581967277704,1,3,ciliary pocket,CC,EHD1
6331,GO:0020018,0.211028247411859,0.983581967277704,1,3,ciliary pocket membrane,CC,EHD1
13270,GO:0051928,0.211137479497144,0.896015403122126,6,55,positive regulation of calcium ion transport,BP,JPH2;G6PD;LGALS3;PDGFB;GPER1;CCL5
15675,GO:0072174,0.211181152658278,0.983556841472285,1,3,metanephric tubule formation,BP,WNT4
17366,GO:1900027,0.211513585187373,0.928974121030297,3,23,regulation of ruffle assembly,BP,RHOG;CORO1C;WDPCP
7277,GO:0031252,0.211518586742202,0.843084914268321,28,303,cell leading edge,CC,NRG1;AMOT;PDPN;SLC9A3R1;SHISA9;LAYN;DST;ATP2B1;TPM1;LCP1;PTPRM;CORO1C;ITGAV;TRPM7;AJUBA;SNX5;BAIAP2;PHACTR4;ANTXR1;FGD6;CNTNAP2;GPER1;ADAM17;MYO10;SHTN1;DPYSL3;NEDD9;ITGB1BP1
3993,GO:0008889,0.211939454226559,0.983431919458443,1,3,glycerophosphodiester phosphodiesterase activity,MF,GPCPD1
7200,GO:0031084,0.211944360879414,0.983431109427625,1,3,BLOC-2 complex,CC,HPS5
2644,GO:0005979,0.212050539053652,0.929833231181718,3,19,regulation of glycogen biosynthetic process,BP,IRS1;PPP1R3B;ENPP1
4779,GO:0010962,0.212050539053652,0.929833231181718,3,19,regulation of glucan biosynthetic process,BP,IRS1;PPP1R3B;ENPP1
16577,GO:0097340,0.212057081492202,0.950513139616123,2,11,inhibition of cysteine-type endopeptidase activity,BP,NAIP;BIRC3
16578,GO:0097341,0.212057081492202,0.950513139616123,2,11,zymogen inhibition,BP,NAIP;BIRC3
14605,GO:0070138,0.212116292422969,0.983402711634834,1,3,ubiquitin-like protein-specific isopeptidase activity,MF,SENP1
14607,GO:0070140,0.212116292422969,0.983402711634834,1,3,SUMO-specific isopeptidase activity,MF,SENP1
10200,GO:0042790,0.212134877464834,0.949906903843879,2,12,nucleolar large rRNA transcription by RNA polymerase I,BP,NOL11;NCL
20308,GO:2001242,0.212310043272474,0.870348318588014,11,127,regulation of intrinsic apoptotic signaling pathway,BP,MMP9;TP53;CYLD;SLC9A3R1;HSPB1;SOD2;DDX3X;RRN3;CLU;ACKR3;CD74
6031,GO:0019087,0.21236906231239,0.983360912704989,1,3,transformation of host cell by virus,BP,TYMS
17775,GO:1901699,0.212381789351793,0.834646545846731,39,452,cellular response to nitrogen compound,BP,HDAC9;GCLC;COL16A1;STAT5A;FBN1;IRS1;TP53;EDN1;BRIP1;CDK4;SFRP1;NUCKS1;COL4A1;AHR;TSN;RRAGB;SOCS1;ZC3H7B;BAIAP2;COL5A2;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;DGCR8;GPER1;CFLAR;NCBP1;AKR1B1;TRAF2;CCNA2;TIMELESS;TLR3;ESR1;TNF;DAXX;TAF1;SMARCC1
10769,GO:0044205,0.212413635574796,0.98335353584387,1,3,'de novo' UMP biosynthetic process,BP,UMPS
17661,GO:1901361,0.212491258952841,0.832315596720394,43,569,organic cyclic compound catabolic process,BP,CYP24A1;CYP1A1;PABPC4;DKC1;NUP50;NUP153;POP1;TARDBP;NDC1;CASC3;HSPB1;EXOG;RANBP2;SET;MRTO4;FASTKD3;PGK1;FEN1;QDPR;NUP160;ENPP1;NUP54;LRPPRC;METTL16;APEX1;TET3;HSPA8;SMUG1;SYNCRIP;DPYD;PSME2;PSMB9;UGT1A4;NCBP1;UPF3B;HNRNPR;DNASE1;ZFP36L2;RC3H1;HNRNPU;PSMB10;RBM8A;RPS12
14967,GO:0070842,0.212542784341557,0.983332151489145,1,3,aggresome assembly,BP,TRIM37
5204,GO:0015800,0.212706398539168,0.914364066212938,4,31,acidic amino acid transport,BP,SLC1A3;ARL6IP5;RAB3GAP1;SLC25A22
3197,GO:0006828,0.212726713567759,0.983301670253384,1,3,manganese ion transport,BP,SLC11A2
10076,GO:0042559,0.212796949661448,0.948754068499565,2,14,pteridine-containing compound biosynthetic process,BP,DHFR;QDPR
9875,GO:0042119,0.212887524421772,0.840807816718852,29,358,neutrophil activation,BP,KRT1;FTL;FTH1;C3;S100P;MMP9;B4GALT1;LGALS3;SYK;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;ITGAV;QPCT;COMMD9;HSPA8;HSP90AB1;LAIR1;LILRB3;GLIPR1;DNASE1;CCL5;NRAS
3551,GO:0007588,0.213051229028762,0.928451498774547,3,22,excretion,BP,EDN1;SLC9A3R1;NEDD4L
9516,GO:0036156,0.213121298140523,0.987259054565407,1,2,inner dynein arm,CC,DNHD1
15812,GO:0072425,0.213170150806544,0.950085956981035,2,11,signal transduction involved in G2 DNA damage checkpoint,BP,BRCC3;CHEK1
5511,GO:0016459,0.213246565287618,0.90418803174908,5,35,myosin complex,CC,MYO1B;DYNLL2;CGNL1;MYH11;MYO10
7438,GO:0031536,0.213253421395068,0.981240420184995,1,4,positive regulation of exit from mitosis,BP,CDCA5
9521,GO:0036166,0.213376119782269,0.983193800947385,1,3,phenotypic switching,BP,PDGFB
17474,GO:1900239,0.213376119782269,0.983193800947385,1,3,regulation of phenotypic switching,BP,PDGFB
2460,GO:0005672,0.213381899880977,0.981216618633109,1,4,transcription factor TFIIA complex,CC,TBPL1
14787,GO:0070471,0.21338957860001,0.98319156128669,1,3,uterine smooth muscle contraction,BP,GPER1
14788,GO:0070472,0.21338957860001,0.98319156128669,1,3,regulation of uterine smooth muscle contraction,BP,GPER1
14789,GO:0070474,0.21338957860001,0.98319156128669,1,3,positive regulation of uterine smooth muscle contraction,BP,GPER1
1403,GO:0003334,0.213405773286414,0.94999532457392,2,11,keratinocyte development,BP,KRT2;FOSL2
2303,GO:0005280,0.213441495044441,0.983182920396085,1,3,amino acid:proton symporter activity,MF,SLC25A22
16725,GO:0097681,0.213535665163287,0.987206291548026,1,2,double-strand break repair via alternative nonhomologous end joining,BP,POLQ
6653,GO:0023058,0.213659692824215,0.948827388354891,2,13,adaptation of signaling pathway,BP,ADM;UBQLN2
14716,GO:0070327,0.213699475952092,0.983139945787481,1,3,thyroid hormone transport,BP,SLC16A2
8892,GO:0034699,0.213722844153742,0.983136050082286,1,3,response to luteinizing hormone,BP,CCNA2
12927,GO:0051254,0.213724875453544,0.818676130954054,91,1121,positive regulation of RNA metabolic process,BP,MAFB;NRG1;TRIM16;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;RUNX1;PBX1;DDX17;TP53;EDN1;ZBED1;STAG1;TGFB2;RBM22;FOXD2;INHBA;RELB;UTP15;SFRP1;NUCKS1;HEATR1;USP16;AHR;NAA15;GLIS3;TAF2;AKAP8L;MYBL2;RHOG;WNT4;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;RRN3;ARNTL;CDH13;SRF;NPNT;WDR43;PDGFB;FZD1;NFE2L1;MACC1;METTL16;GLIS2;TET3;MYBL1;HSPA8;BRCA2;SS18L2;E2F8;ETV6;HSF2;CHEK1;GPER1;MLLT10;WDR75;SENP1;NOL11;NCBP1;EDRF1;CITED2;HNRNPR;NCL;CCNA2;RBL1;NAA16;CLOCK;TLR3;ESR1;TNF;ZFP36L2;RC3H1;CD74;HNRNPU;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
14401,GO:0061629,0.213738134782406,0.98313350071535,1,3,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,TAF1
7336,GO:0031341,0.213926334812972,0.912942554717934,4,36,regulation of cell killing,BP,IL7R;HSP90AB1;SERPINB9;DNASE1
6839,GO:0030297,0.213933418843232,0.98310092263559,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,NRG1
9669,GO:0038007,0.214260608957999,0.98304626096793,1,3,netrin-activated signaling pathway,BP,SHTN1
7208,GO:0031092,0.214414104162641,0.949606666711503,2,11,platelet alpha granule membrane,CC,PCDH7;CD109
14425,GO:0061689,0.214491360359951,0.983007651597005,1,3,tricellular tight junction,CC,SIPA1L3
6424,GO:0021684,0.214645789479935,0.982981785153534,1,3,cerebellar granular layer formation,BP,OPHN1
6439,GO:0021707,0.214645789479935,0.982981785153534,1,3,cerebellar granule cell differentiation,BP,OPHN1
3298,GO:0006997,0.214652691358471,0.8658563161466,12,124,nucleus organization,BP,PML;NUP50;NUP153;TARDBP;NDC1;AKAP8L;RANBP2;RRN3;NUP160;NUP54;GPER1;TBPL1
3343,GO:0007063,0.214691196139806,0.927904449997148,3,21,regulation of sister chromatid cohesion,BP,FEN1;CDCA5;CTCF
8303,GO:0033127,0.21475217713143,0.948888991605637,2,12,regulation of histone phosphorylation,BP,AKAP8;AKAP8L
16798,GO:0098590,0.214778055716871,0.826153405635714,54,627,plasma membrane region,CC,CRYAB;NRG1;FN1;TFRC;S100P;B4GALT1;IRS1;SIPA1L3;MEGF11;SLC4A11;PDPN;SLC9A3R1;SLC22A5;EMP2;NAIP;LEPR;SHISA9;ABCG2;DST;ATP2B1;SLC5A6;TPM1;ABCC4;PARD3B;MGAM;CADPS2;SLCO4C1;LCP1;CORO1C;GPHN;ITGAV;NETO1;BAIAP2;CDH13;PDGFB;ANTXR1;ENPP1;THBD;TJP1;SLC11A2;CNTNAP2;SYT11;HSP90AB1;WDPCP;MTMR2;BBS5;GPER1;ADAM17;MYO10;PARD3;EHD1;KCNE4;PHLPP2;PHLPP1
12072,GO:0048003,0.214805897484986,0.982954944365579,1,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,AP3B1
12074,GO:0048007,0.214805897484986,0.982954944365579,1,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,AP3B1
5798,GO:0017038,0.214869430527742,0.857960474107622,15,167,protein import,BP,PML;CHP1;RBM22;NUP50;NUP153;RAN;RANBP2;ARNTL;CLU;NUP54;TIMM23B;HSPA8;HSP90AB1;TNF;CDKN1A
14336,GO:0061462,0.214874899698764,0.912975734159803,4,32,protein localization to lysosome,BP,GNPTAB;CLU;HSPA8;AP3B1
13093,GO:0051581,0.21499190276492,0.982923732513631,1,3,negative regulation of neurotransmitter uptake,BP,ARL6IP5
13949,GO:0060591,0.215096938474187,0.982906093369394,1,3,chondroblast differentiation,BP,CYR61
7878,GO:0032434,0.215202293501464,0.871985302147467,10,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,GCLC;KEAP1;PLK2;UBQLN2;CLU;HSP90AB1;SENP1;RNF19B;TAF1;SMARCC1
7756,GO:0032266,0.215280332685423,0.912914540718023,4,31,phosphatidylinositol-3-phosphate binding,MF,JPH2;BBS5;VPS36;PARD3
16776,GO:0098536,0.215866661288464,0.98277652033511,1,3,deuterosome,CC,CEP152
11772,GO:0046604,0.215942431458292,0.982763735896662,1,3,positive regulation of mitotic centrosome separation,BP,RANBP2
20166,GO:2000823,0.216107049638957,0.980707826843672,1,4,regulation of androgen receptor activity,BP,TAF1
20167,GO:2000825,0.216107049638957,0.980707826843672,1,4,positive regulation of androgen receptor activity,BP,TAF1
1381,GO:0003274,0.216155927914904,0.982727684927936,1,3,endocardial cushion fusion,BP,TGFB2
2732,GO:0006110,0.216309250688875,0.892931950730417,6,52,regulation of glycolytic process,BP,NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54
3266,GO:0006939,0.216310942148099,0.892760372872478,6,54,smooth muscle contraction,BP,DAPK3;EDN1;SRF;NPNT;MYH11;GPER1
8584,GO:0034056,0.216375566258634,0.982690553002388,1,3,estrogen response element binding,MF,ESR1
9712,GO:0038107,0.2164699023072,0.982674590953969,1,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,CITED2
17394,GO:1900094,0.2164699023072,0.982674590953969,1,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,CITED2
17441,GO:1900164,0.2164699023072,0.982674590953969,1,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,CITED2
2812,GO:0006272,0.216525427064417,0.982665192099677,1,3,leading strand elongation,BP,POLA1
2169,GO:0005001,0.216716971926467,0.94943791500567,2,10,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRB;PTPRM
6054,GO:0019198,0.216716971926467,0.94943791500567,2,10,transmembrane receptor protein phosphatase activity,MF,PTPRB;PTPRM
18488,GO:1903555,0.217024008285893,0.885227823189565,7,69,regulation of tumor necrosis factor superfamily cytokine production,BP,AKAP8;CD274;HSPB1;CLU;SYT11;TLR3;IRAK3
4171,GO:0009236,0.21703245865143,0.982579233674774,1,3,cobalamin biosynthetic process,BP,MMAA
1388,GO:0003289,0.217035264929478,0.982578757258822,1,3,atrial septum primum morphogenesis,BP,TGFB2
14138,GO:0060976,0.217088807923025,0.912073202929955,4,30,coronary vasculature development,BP,SRF;SETD2;GPER1;DCTN5
9798,GO:0040007,0.217127251654381,0.823705758470647,55,655,growth,BP,CRYAB;IGFBP3;NRG1;FN1;PML;CYR61;FGFR2;STAT5A;CTGF;HSPG2;G6PD;TFCP2L1;COL27A1;TP53;EDN1;CDKN2A;TGFB2;INHBA;NBN;LEPR;CDK4;SFRP1;MIR17HG;H3F3A;TMEM97;ADM;NOP58;CXCL16;KDM6A;DDX3X;SOCS1;GINS4;SRF;ENPP1;TNC;NEDD4L;SGK1;ZFYVE27;BRCA2;L1CAM;ADAM17;NTN1;CFLAR;SHTN1;NCBP1;CSF1;KIF14;ESR1;TNF;NEDD9;TYMS;WDR36;FGFR1OP;FTO;CDKN1A
15578,GO:0072007,0.21717839177268,0.982554449273887,1,3,mesangial cell differentiation,BP,PDGFB
15579,GO:0072008,0.21717839177268,0.982554449273887,1,3,glomerular mesangial cell differentiation,BP,PDGFB
15661,GO:0072143,0.21717839177268,0.982554449273887,1,3,mesangial cell development,BP,PDGFB
15662,GO:0072144,0.21717839177268,0.982554449273887,1,3,glomerular mesangial cell development,BP,PDGFB
18785,GO:1904238,0.21717839177268,0.982554449273887,1,3,pericyte cell differentiation,BP,PDGFB
17387,GO:1900078,0.217197242662345,0.926957292946482,3,20,positive regulation of cellular response to insulin stimulus,BP,IRS1;NUCKS1;PIK3R3
8623,GO:0034128,0.217441290073424,0.982509750593864,1,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TLR3
14343,GO:0061484,0.217448038832624,0.982508602311273,1,3,hematopoietic stem cell homeostasis,BP,UBAP2L
3261,GO:0006931,0.217520356234207,0.98249629506591,1,3,substrate-dependent cell migration, cell attachment to substrate,BP,FN1
10742,GO:0044089,0.217825245712244,0.833690713084744,33,383,positive regulation of cellular component biogenesis,BP,COL16A1;CTGF;TP53;EDN1;UTP15;SFRP1;HEATR1;RPA1;TPM1;SYNPO2L;GBP5;RHOG;WNT4;LCP1;AJUBA;CDC42EP2;BAIAP2;SRF;WDR43;CLU;ANLN;LRRN3;RAB3GAP1;FAF1;WDR75;ATR;DPYSL3;SYNPO2;ESR1;TNF;TAF1;ITGB1BP1;GTF2H3
10996,GO:0044783,0.218016379729372,0.884557050398075,7,69,G1 DNA damage checkpoint,BP,PML;TP53;PLK2;MDM4;E2F8;RFWD3;CDKN1A
12850,GO:0051138,0.218145061623136,0.982389779185361,1,3,positive regulation of NK T cell differentiation,BP,AP3B1
3277,GO:0006957,0.218193267741748,0.9823815447694,1,3,complement activation, alternative pathway,BP,C3
10187,GO:0042769,0.21827792254323,0.910338678306156,4,37,DNA damage response, detection of DNA damage,BP,RPA1;RFC3;RAD18;USP1
9358,GO:0035861,0.218381653216265,0.910986614220727,4,32,site of double-strand break,CC,NBN;RIF1;RAD18;RFWD3
16634,GO:0097454,0.218403867071881,0.982345545655015,1,3,Schwann cell microvillus,CC,AKR1B1
6665,GO:0030016,0.218798702495992,0.860197611353868,13,124,myofibril,CC,CRYAB;JPH2;ACTG1;PDLIM1;DST;TPM1;SYNPO2L;NEXN;HSPB1;TPM4;ABCC9;JPH1;SYNPO2
8169,GO:0032892,0.218894363453993,0.946754544562704,2,13,positive regulation of organic acid transport,BP,EDN1;RAB3GAP1
10733,GO:0044058,0.218991374551809,0.94722157727513,2,12,regulation of digestive system process,BP,SLC22A5;SGK1
19875,GO:2000312,0.219056964319963,0.982233646490658,1,3,regulation of kainate selective glutamate receptor activity,BP,NETO1
18422,GO:1903422,0.219141963402805,0.982219054031018,1,3,negative regulation of synaptic vesicle recycling,BP,SYT11
11431,GO:0045824,0.219161411977504,0.910231446681624,4,34,negative regulation of innate immune response,BP,NLRC5;PARP14;SERPINB9;IRAK3
125,GO:0000255,0.219280143869192,0.982195317221733,1,3,allantoin metabolic process,BP,STAT5A
12384,GO:0048753,0.219289628436633,0.925077365886083,3,23,pigment granule organization,BP,RAB32;BLOC1S2;AP3B1
3217,GO:0006865,0.219438987706468,0.878083332693811,8,77,amino acid transport,BP,SLC7A2;SLC7A5P2;SLC1A3;ARL6IP5;RAB3GAP1;NFKBIE;SLC43A2;SLC25A22
12670,GO:0050855,0.219667856920479,0.946953354102234,2,12,regulation of B cell receptor signaling pathway,BP,RUNX1;CMTM3
10797,GO:0044249,0.219788071734732,0.800873238075122,356,4831,cellular biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PTGES;PML;CYP1B1;GCLC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FADS3;CTGF;FBN1;SLC7A2;RUNX1;CYP1A1;B4GALT1;PBX1;TSC22D3;FST;MAT2A;DDX17;SPON1;TFCP2L1;TRAF3;ENC1;IRS1;TP53;DAPK3;PANK2;EXO1;EDN1;SCD;HMGCS1;ABCF1;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ST6GALNAC5;ZNF208;CARS2;CYLD;TGS1;PDLIM1;CDKAL1;IL16;SRSF2;FOXD2;PPP1R3B;RAD1;DKC1;INHBA;NUP50;PUM3;GALNT18;PHAX;SYK;NUP153;ZFP42;RELB;NBN;LEPR;FAM111A;PARP15;BRIP1;MCM5;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;ZDHHC6;MCM2;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;UAP1L1;ZNF827;DHFR;RPA1;POLR1A;GLIS3;HELLS;TAF2;POLA1;SETDB1;TK1;GRWD1;ZNF584;TRAF1;ADM;CD109;USP43;ZNF407;ELMSAN1;NDC1;SLC1A3;EIF5;CASC3;CCL20;ZNF512;MRPL27;ZNF587;MUC16;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;GTF3C6;THOC1;RAN;UBTF;RANBP2;TOPBP1;SOD2;ORC4;SUPT16H;ZNF738;DDX3X;NAP1L1;NUFIP1;GPHN;RRN3;CDC25A;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;AJUBA;FASTKD3;DND1;ZNF267;LFNG;PGK1;TRIM37;FEN1;MCM3;HACD2;GNL3L;ZNF586;NVL;GATC;CDH13;GINS4;IBA57;RARS;COMMD4;SRF;MDM4;HIF1AN;NPNT;QDPR;ZNF234;WDR43;MCM8;PDGFB;UGT8;EIF3J;FZD1;IRX4;NFE2L1;CLU;NUP160;SMYD2;MACC1;ENPP1;ZNF316;PIK3R3;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;EFTUD2;VGLL3;RIF1;METTL16;MCM6;SRD5A1;SETD2;GLIS2;UBP1;TTF2;DPY19L2P2;SEPHS2;ZNF484;SLC11A2;APEX1;PDCL3;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;SMUG1;BACE2;SCD5;ZBTB24;NEDD4L;SGK1;PRIM2;ZBTB12;BRCA2;SYNCRIP;TRAK2;DPYD;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;TMEM165;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;GPER1;FAF1;MMAA;RRM1;MLLT10;WDR75;MCM4;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMC3IP;NIFK;PSMB9;EIF2B5;ZNF12;RFWD3;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;MRPS7;DPH2;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;VPS36;TRAF2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;AZIN1;ESR1;RAD51B;TNF;PDSS1;ZFP36L2;SRSF7;RC3H1;TYMS;STARD7;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;MUC6;TREX1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3
5877,GO:0017187,0.220030801855334,0.979961992850155,1,4,peptidyl-glutamic acid carboxylation,BP,GGCX
5938,GO:0018214,0.220030801855334,0.979961992850155,1,4,protein carboxylation,BP,GGCX
16160,GO:0090153,0.220144078644089,0.946254431761909,2,13,regulation of sphingolipid biosynthetic process,BP,CYR61;TNF
19137,GO:1905038,0.220144078644089,0.946254431761909,2,13,regulation of membrane lipid metabolic process,BP,CYR61;TNF
19869,GO:2000303,0.220144078644089,0.946254431761909,2,13,regulation of ceramide biosynthetic process,BP,CYR61;TNF
2273,GO:0005212,0.220276686740826,0.979914731568911,1,4,structural constituent of eye lens,MF,CRYAB
18142,GO:1902775,0.220306459354693,0.982018461529758,1,3,mitochondrial large ribosomal subunit assembly,BP,DDX28
12940,GO:0051271,0.220378577606846,0.847954622112459,18,196,negative regulation of cellular component movement,BP,IGFBP3;NRG1;CYP1B1;STARD13;SLC9A3R1;SFRP1;TPM1;ADAMTS9;PTGER4;WNT4;PTPRM;CORO1C;IL24;SRF;APEX1;DPYSL3;CITED2;ITGB1BP1
2893,GO:0006401,0.220420056084436,0.837092548461472,26,346,RNA catabolic process,BP,PABPC4;DKC1;POP1;TARDBP;CASC3;HSPB1;SET;MRTO4;FASTKD3;FEN1;LRPPRC;METTL16;APEX1;HSPA8;SYNCRIP;PSME2;PSMB9;NCBP1;UPF3B;HNRNPR;ZFP36L2;RC3H1;HNRNPU;PSMB10;RBM8A;RPS12
13660,GO:0060142,0.220596092526932,0.946073046435546,2,13,regulation of syncytium formation by plasma membrane fusion,BP,CFLAR;EHD1
17033,GO:0099122,0.220746483216123,0.981942336841608,1,3,RNA polymerase II C-terminal domain binding,MF,HNRNPU
4221,GO:0009394,0.220828265804799,0.923482310627174,3,27,2'-deoxyribonucleotide metabolic process,BP,SMUG1;TYMS;TBPL1
11882,GO:0046870,0.220839277197028,0.981926260406195,1,3,cadmium ion binding,MF,SLC11A2
17876,GO:1902041,0.220953866118361,0.898153114458622,5,45,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,LGALS3;SFRP1;FAF1;CFLAR;TRAF2
14323,GO:0061436,0.221106377838742,0.924689218394967,3,21,establishment of skin barrier,BP,KRT1;HRNR;RPTN
15582,GO:0072012,0.221117110506296,0.946376746980714,2,12,glomerulus vasculature development,BP,PDGFB;CFLAR
11294,GO:0045586,0.221215521363016,0.981860994610247,1,3,regulation of gamma-delta T cell differentiation,BP,SYK
15767,GO:0072337,0.221326898487527,0.946293055751922,2,12,modified amino acid transport,BP,SLC9A3R1;SLC5A6
7556,GO:0031860,0.221389166487326,0.981830828602884,1,3,telomeric 3' overhang formation,BP,NBN
17251,GO:0110020,0.221505146069293,0.882572501635763,7,63,regulation of actomyosin structure organization,BP,CTGF;EDN1;SFRP1;TPM1;PTGER4;WNT4;ITGB1BP1
9803,GO:0040013,0.221548839409583,0.845364964955375,19,208,negative regulation of locomotion,BP,IGFBP3;NRG1;PML;CYP1B1;STARD13;SLC9A3R1;SFRP1;TPM1;ADAMTS9;PTGER4;WNT4;PTPRM;CORO1C;IL24;SRF;APEX1;DPYSL3;CITED2;ITGB1BP1
12396,GO:0048786,0.221561314665733,0.925115672897007,3,19,presynaptic active zone,CC,NUFIP1;SYT11;GPER1
7867,GO:0032422,0.22156515844565,0.981800226288159,1,3,purine-rich negative regulatory element binding,MF,PURB
16750,GO:0097742,0.221624825844975,0.981789844498987,1,3,de novo centriole assembly,BP,CEP152
16775,GO:0098535,0.221624825844975,0.981789844498987,1,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,CEP152
7765,GO:0032276,0.221763196427385,0.981765756055479,1,3,regulation of gonadotropin secretion,BP,INHBA
7767,GO:0032278,0.221763196427385,0.981765756055479,1,3,positive regulation of gonadotropin secretion,BP,INHBA
11888,GO:0046880,0.221763196427385,0.981765756055479,1,3,regulation of follicle-stimulating hormone secretion,BP,INHBA
11889,GO:0046881,0.221763196427385,0.981765756055479,1,3,positive regulation of follicle-stimulating hormone secretion,BP,INHBA
16887,GO:0098797,0.221950718120068,0.837214453779277,25,280,plasma membrane protein complex,CC,TFRC;HLA-B;HSPG2;TRAF3;IRS1;CNTNAP1;IL6ST;SYK;SHISA9;HLA-F;HLA-DOB;KCNS3;CORO1C;ITGAV;ABCF2;KCNQ5;CDH13;NPNT;ABCC9;CNTNAP2;FAF1;CFLAR;TRAF2;GJC1;CD74
15123,GO:0071156,0.221956130137509,0.871151292836739,9,96,regulation of cell cycle arrest,BP,PML;TP53;CDK4;PLK2;MDM4;HSP90AB1;E2F8;GPER1;CDKN1A
8587,GO:0034059,0.222022468275834,0.981720572369957,1,3,response to anoxia,BP,CTGF
7382,GO:0031429,0.222077357861973,0.978294563945695,1,5,box H/ACA snoRNP complex,CC,DKC1
8815,GO:0034513,0.222077357861973,0.978294563945695,1,5,box H/ACA snoRNA binding,MF,DKC1
18536,GO:1903671,0.222191747792023,0.924140126352694,3,21,negative regulation of sprouting angiogenesis,BP,STARD13;ADAMTS9;ITGB1BP1
357,GO:0000974,0.222193615808825,0.945429869619524,2,13,Prp19 complex,CC,RBM22;HSPA8
16061,GO:0086075,0.22247846412172,0.981640953473444,1,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,GJC1
6690,GO:0030055,0.222539980978668,0.831897273072213,30,360,cell-substrate junction,CC,TNS3;KIF23;HSPG2;ACTG1;CHP1;PDLIM1;LAYN;DST;CSRP1;G3BP1;MME;NEXN;HSPB1;RHOG;LCP1;CORO1C;ARMC5;ITGAV;AJUBA;CDH13;FZD1;TPM4;TNC;HSPA8;L1CAM;ADAM17;SENP1;CSRP2;SYNPO2;NEDD9
4947,GO:0014910,0.222650167779752,0.89755881346537,5,41,regulation of smooth muscle cell migration,BP,IGFBP3;TPM1;PDGFB;APEX1;CCL5
11801,GO:0046645,0.222792079003957,0.981586082501499,1,3,positive regulation of gamma-delta T cell activation,BP,SYK
1348,GO:0003208,0.222865589178199,0.897425449035092,5,41,cardiac ventricle morphogenesis,BP,NRG1;FGFR2;TGFB2;MIR17HG;TPM1
2300,GO:0005267,0.222954107951483,0.908207246473792,4,33,potassium channel activity,MF,KCNS3;KCNQ5;ABCC9;KCNE4
2741,GO:0006121,0.223442145278489,0.979300771537378,1,4,mitochondrial electron transport, succinate to ubiquinone,BP,SDHD
18398,GO:1903373,0.223635407191654,0.981438076468859,1,3,positive regulation of endoplasmic reticulum tubular network organization,BP,RAB3GAP1
9686,GO:0038042,0.223656226752592,0.979258877862937,1,4,dimeric G-protein coupled receptor signaling pathway,BP,ADM
16716,GO:0097646,0.223656226752592,0.979258877862937,1,4,calcitonin family receptor signaling pathway,BP,ADM
229,GO:0000472,0.223742670384275,0.981419203960795,1,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,UTP20
354,GO:0000967,0.223742670384275,0.981419203960795,1,3,rRNA 5'-end processing,BP,UTP20
5925,GO:0018197,0.223759320653801,0.981416273452704,1,3,peptidyl-aspartic acid modification,BP,HIF1AN
6614,GO:0022829,0.223874069731004,0.94474974072145,2,13,wide pore channel activity,MF,GJC1;PANX1
18096,GO:1902652,0.223903621591368,0.865685576072488,10,104,secondary alcohol metabolic process,BP,CLN6;G6PD;SCD;HMGCS1;LEPR;LSS;RAN;NFE2L1;EBP;ARV1
8778,GO:0034448,0.224023450645337,0.979186905935333,1,4,EGO complex,CC,RRAGB
9073,GO:0035303,0.22426999328906,0.850759883723276,15,159,regulation of dephosphorylation,BP,IGFBP3;CHP1;TGFB2;PKMYT1;PPP1R3B;NUAK1;SET;PPP4R4;SH3RF2;PHACTR4;NPNT;HSP90AB1;MTMR2;TNF;PPARGC1B
610,GO:0001776,0.224347160242948,0.887284849544808,6,57,leukocyte homeostasis,BP,TSC22D3;DOCK10;MIR17HG;ADAM17;RC3H1;CD74
1207,GO:0002864,0.224541005001674,0.979085235261027,1,4,regulation of acute inflammatory response to antigenic stimulus,BP,C3
15026,GO:0070938,0.22456127762494,0.945623093784534,2,11,contractile ring,CC,RTKN2;ANLN
11421,GO:0045806,0.224826863703495,0.906826680523079,4,35,negative regulation of endocytosis,BP,LGALS3;UBQLN2;SYT11;MTMR2
10596,GO:0043550,0.224866128180204,0.907269845498111,4,32,regulation of lipid kinase activity,BP,IRS1;PDGFB;PIK3R3;RBL1
11789,GO:0046632,0.224909393703281,0.887073250767548,6,55,alpha-beta T cell differentiation,BP,SYK;RELB;PTGER4;AP3B1;RC3H1;IRF1
9206,GO:0035582,0.224960432992038,0.981204189992635,1,3,sequestering of BMP in extracellular matrix,BP,FBN1
6038,GO:0019104,0.225042351469982,0.943443088692132,2,15,DNA N-glycosylase activity,MF,APEX1;SMUG1
20111,GO:2000727,0.225102325445394,0.944777236000573,2,12,positive regulation of cardiac muscle cell differentiation,BP,NRG1;EDN1
1221,GO:0002888,0.225246653417706,0.944191505538536,2,13,positive regulation of myeloid leukocyte mediated immunity,BP,C3;SYK
14993,GO:0070885,0.225252446777272,0.98115242450778,1,3,negative regulation of calcineurin-NFAT signaling cascade,BP,CHP1
17230,GO:0106057,0.225252446777272,0.98115242450778,1,3,negative regulation of calcineurin-mediated signaling,BP,CHP1
2227,GO:0005127,0.225284402461801,0.981146754856705,1,3,ciliary neurotrophic factor receptor binding,MF,IL6ST
17064,GO:0099518,0.225365305386779,0.89574922142621,5,42,vesicle cytoskeletal trafficking,BP,KIF23;AP3M2;BLOC1S2;TRAK2;AP3B1
11561,GO:0046078,0.225541073249868,0.97888799577187,1,4,dUMP metabolic process,BP,TYMS
14801,GO:0070492,0.225652569421898,0.97886594194073,1,4,oligosaccharide binding,MF,CHID1
10631,GO:0043618,0.225654535012051,0.868278685101954,9,102,regulation of transcription from RNA polymerase II promoter in response to stress,BP,TP53;HIF1AN;HSF2;CHEK1;PSME2;PSMB9;CITED2;PSMB10;TAF1
11922,GO:0046935,0.225698028038272,0.981073282167698,1,3,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R3
11828,GO:0046700,0.225753014045363,0.82177285702714,41,544,heterocycle catabolic process,BP,CYP1A1;PABPC4;DKC1;NUP50;NUP153;POP1;TARDBP;NDC1;CASC3;HSPB1;EXOG;RANBP2;SET;MRTO4;FASTKD3;PGK1;FEN1;NUP160;ENPP1;NUP54;LRPPRC;METTL16;APEX1;TET3;HSPA8;SMUG1;SYNCRIP;DPYD;PSME2;PSMB9;UGT1A4;NCBP1;UPF3B;HNRNPR;DNASE1;ZFP36L2;RC3H1;HNRNPU;PSMB10;RBM8A;RPS12
4064,GO:0009112,0.225819248463964,0.906251105558454,4,35,nucleobase metabolic process,BP,UMPS;DPYD;RRM1;TYMS
992,GO:0002446,0.225821833971885,0.829886683990086,29,361,neutrophil mediated immunity,BP,KRT1;FTL;FTH1;C3;S100P;MMP9;B4GALT1;LGALS3;SYK;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;ITGAV;QPCT;COMMD9;HSPA8;HSP90AB1;LAIR1;ADAM17;LILRB3;GLIPR1;DNASE1;NRAS
7369,GO:0031406,0.225865511728724,0.8641114757599,10,108,carboxylic acid binding,MF,GCLC;P3H2;LAYN;DHFR;P4HA2;SLC1A3;AKR1C2;RARS;HIF1AN;TYMS
12286,GO:0048565,0.22604236116363,0.873675086097121,8,73,digestive tract development,BP,FGFR2;CYP1A1;FAT4;TGFB2;SFRP1;TNF;TYMS;CDKN1A
11265,GO:0045471,0.226045184755604,0.879035348964735,7,70,response to ethanol,BP,FGFR2;G6PD;TP53;NQO1;SETDB1;TNC;TYMS
16237,GO:0090261,0.226079204111827,0.978781435585827,1,4,positive regulation of inclusion body assembly,BP,CLU
12313,GO:0048635,0.226166588979759,0.906351952635603,4,33,negative regulation of muscle organ development,BP,G6PD;TSC22D3;MIR17HG;LUC7L
19033,GO:1904814,0.226424295182951,0.943710611843054,2,13,regulation of protein localization to chromosome, telomeric region,BP,DKC1;GNL3L
9907,GO:0042181,0.226451374263671,0.920964554627939,3,25,ketone biosynthetic process,BP,ADM;WNT4;PDSS1
8977,GO:0035051,0.226478413817424,0.868496548480682,9,82,cardiocyte differentiation,BP,NRG1;G6PD;EDN1;TGFB2;NEXN;SRF;MYH11;GPER1;HNRNPU
1030,GO:0002534,0.226526749197215,0.921382237633457,3,23,cytokine production involved in inflammatory response,BP,IL1R2;GBP5;CHID1
6503,GO:0021869,0.226560716282262,0.980919526183426,1,3,forebrain ventricular zone progenitor cell division,BP,FGFR2
16525,GO:0097205,0.226587791048182,0.944175800473519,2,12,renal filtration,BP,EMP2;PDGFB
11790,GO:0046633,0.226610294413333,0.943634494467957,2,13,alpha-beta T cell proliferation,BP,SYK;IRF1
16084,GO:0090023,0.2266362374169,0.942783463848129,2,15,positive regulation of neutrophil chemotaxis,BP,EDN1;CD74
6286,GO:0019887,0.226712234479253,0.853619335014541,13,145,protein kinase regulator activity,MF,NRG1;CDKN2A;CHP1;CDK4;HSPB1;DDX3X;SOCS1;HSP90AB1;FAF1;CCL5;FGFR1OP;DAXX;CDKN1A
9427,GO:0035985,0.226732846932703,0.978651599717343,1,4,senescence-associated heterochromatin focus,CC,CDKN2A
6651,GO:0023056,0.226834334106032,0.806719984058737,91,1158,positive regulation of signaling,BP,IGFBP3;SAA1;NRG1;TRIM16;PML;CYP1B1;JPH2;MAP3K14;CYR61;C3;NLRC5;FGFR2;EPGN;TRIM22;CTGF;MMP9;IRS1;MID1;TP53;DAPK3;EDN1;C1QTNF1;JRK;TGFB2;CNTNAP1;CYLD;IKBKE;IL6ST;SLC9A3R1;INHBA;IL7R;SYK;EMP2;NAIP;SFRP1;NUCKS1;DYNLL2;SLC1A3;CCL20;PLK2;RRAGB;UBQLN2;WNT4;ATP2C1;DDX3X;IL24;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;AKR1C2;LFNG;NETO1;BAIAP2;GADD45B;CDH13;NPNT;PDGFB;BIRC3;IL20;ACKR3;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;NSF;RAB3GAP1;GPER1;FAF1;ADAM17;ATR;PSME2;CFLAR;PSMB9;CMTM3;AKR1B1;TRAF2;TELO2;CITED2;CSF1;TLR3;ESR1;TNF;RC3H1;CCL5;CD74;PSMB10;DAXX;TAF1;ITGB1BP1
19959,GO:2000425,0.227385782629013,0.980771822283276,1,3,regulation of apoptotic cell clearance,BP,C3
7920,GO:0032487,0.227422801625297,0.980765180133617,1,3,regulation of Rap protein signal transduction,BP,KIF14
11017,GO:0044827,0.227443387328502,0.94382809837957,2,12,modulation by host of viral genome replication,BP,NUCKS1;HSPA8
13998,GO:0060688,0.227456721308362,0.905446350745229,4,34,regulation of morphogenesis of a branching structure,BP,FGFR2;SFRP1;ESR1;TNF
8922,GO:0034755,0.227461441236084,0.94382075138662,2,12,iron ion transmembrane transport,BP,SLC11A2;STEAP4
12951,GO:0051289,0.227654995082848,0.885030977115583,6,58,protein homotetramerization,BP,TP53;USP16;TK1;GBP5;SOD2;SYT11
3286,GO:0006977,0.227749379464859,0.884895792098652,6,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,PML;TP53;PLK2;MDM4;E2F8;CDKN1A
4140,GO:0009200,0.2278133893016,0.942294176218412,2,15,deoxyribonucleoside triphosphate metabolic process,BP,TYMS;TBPL1
7485,GO:0031644,0.227880728128441,0.905356989847234,4,33,regulation of neurological system process,BP,NRG1;EDN1;MTMR2;PARD3
16491,GO:0097154,0.227903823653907,0.978417899313274,1,4,GABAergic neuron differentiation,BP,INHBA
10666,GO:0043734,0.228105222111088,0.978377561737389,1,4,DNA-N1-methyladenine dioxygenase activity,MF,FTO
16653,GO:0097493,0.22824638960552,0.951046326546882,2,6,structural molecule activity conferring elasticity,MF,FBN1;COL4A1
3933,GO:0008612,0.228692930468719,0.978259610938768,1,4,peptidyl-lysine modification to peptidyl-hypusine,BP,DOHH
6668,GO:0030020,0.22870351825168,0.980534593552149,1,3,extracellular matrix structural constituent conferring tensile strength,MF,COL12A1
17392,GO:1900086,0.228987167958286,0.980483315039201,1,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,SYK
4897,GO:0014821,0.229050817303089,0.978187609037388,1,4,phasic smooth muscle contraction,BP,EDN1
17942,GO:1902230,0.229076449525559,0.919398129417605,3,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,CLU;ACKR3;CD74
1018,GO:0002507,0.22913840431145,0.943136487585115,2,12,tolerance induction,BP,PHLPP1;IRAK3
14130,GO:0060965,0.22930482014597,0.943068386428242,2,12,negative regulation of gene silencing by miRNA,BP,DND1;ESR1
7501,GO:0031667,0.229309254848029,0.82888970169463,27,319,response to nutrient levels,BP,GCLC;CYP24A1;CYP1A1;G6PD;TP53;HMGCS1;ACSL3;NQO1;SRSF2;BRIP1;SFRP1;ATP2B1;SETDB1;ADM;CADPS2;RRAGB;WNT4;BAIAP2;SRF;GDAP1;SRD5A1;TNC;HSPA8;TYMS;PANX1;TAF1;CDKN1A
3396,GO:0007176,0.229341658769452,0.919927254747771,3,23,regulation of epidermal growth factor-activated receptor activity,BP,GPRC5A;EPGN;ADAM17
16227,GO:0090244,0.229384811335373,0.980411300992517,1,3,Wnt signaling pathway involved in somitogenesis,BP,SFRP1
368,GO:0000989,0.22964100426569,0.817529244633011,43,517,transcription factor activity, transcription factor binding,MF,NRG1;HDAC9;MKL1;TRIM22;DDX17;TFCP2L1;TP53;PTPN14;PDLIM1;SRSF2;ZFP42;RELB;PARP15;USP16;TAF2;MYBL2;WNT4;KDM6A;RAN;ARNTL;AJUBA;SRF;UTY;NFE2L1;NFKBIB;UBP1;APEX1;MYBL1;SS18L2;CCAR1;E2F8;HSF2;PSMC3IP;TAF6L;CITED2;CLOCK;HNRNPU;DAXX;TAF1;TBPL1;SMARCC1;PPARGC1B;CTCF
3817,GO:0008408,0.229646984931791,0.892622302651234,5,46,3'-5' exonuclease activity,MF,RAD1;USB1;ISG20L2;APEX1;TREX1
1811,GO:0004457,0.229734600405793,0.978049671809654,1,4,lactate dehydrogenase activity,MF,LDHAL6B
13845,GO:0060421,0.22980123154582,0.920249045909775,3,21,positive regulation of heart growth,BP,FGFR2;EDN1;MIR17HG
7021,GO:0030728,0.229832853933433,0.94285206717143,2,12,ovulation,BP,INHBA;IMMP2L
15257,GO:0071397,0.229903977198094,0.943472774103502,2,11,cellular response to cholesterol,BP,HMGCS1;INHBA
408,GO:0001093,0.229911572323168,0.980315673913192,1,3,TFIIB-class transcription factor binding,MF,ESR1
12700,GO:0050892,0.229920595711635,0.942816087314307,2,12,intestinal absorption,BP,ACO1;TJP2
7121,GO:0030916,0.229942376112756,0.98031007375665,1,3,otic vesicle formation,BP,FGFR2
15380,GO:0071600,0.229942376112756,0.98031007375665,1,3,otic vesicle morphogenesis,BP,FGFR2
16435,GO:0097051,0.229984205024744,0.980302467789384,1,3,establishment of protein localization to endoplasmic reticulum membrane,BP,RAB3GAP1
9533,GO:0036230,0.229989171554257,0.82634674816306,29,362,granulocyte activation,BP,KRT1;FTL;FTH1;C3;S100P;MMP9;B4GALT1;LGALS3;SYK;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;ITGAV;QPCT;COMMD9;HSPA8;HSP90AB1;LAIR1;LILRB3;GLIPR1;DNASE1;CCL5;NRAS
19449,GO:1990000,0.230014195587833,0.942233598823634,2,13,amyloid fibril formation,BP,CRYAB;CLU
1054,GO:0002579,0.230290445582784,0.977937185319722,1,4,positive regulation of antigen processing and presentation,BP,CD74
14212,GO:0061097,0.230391093400141,0.883295914948106,6,57,regulation of protein tyrosine kinase activity,BP,GPRC5A;EPGN;PDGFB;ADAM17;CCL5;FGFR1OP
9047,GO:0035255,0.230394752714908,0.919942509494063,3,21,ionotropic glutamate receptor binding,MF,OPHN1;NETO1;NSF
1373,GO:0003256,0.23045210899461,0.980217273814466,1,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,SRF
16857,GO:0098739,0.230515215224882,0.892406366771754,5,43,import across plasma membrane,BP,SLC7A2;SLC1A3;ARL6IP5;STEAP4;SLC9A9
10364,GO:0043167,0.230561949219547,0.790916665399797,336,4371,ion binding,MF,CRYAB;IGFBP3;HEPHL1;TRIM47;SAA1;FTL;FTH1;DTX2;HDAC9;C1R;TRIM16;FN1;PTGES;PML;CYP1B1;KIF23;JPH2;MAP3K14;GCLC;CYR61;CYP24A1;NLRC5;TXNRD1;FGFR2;TRIM22;COL5A3;S100P;CTGF;MMP9;FBN1;GNPTAB;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;FAT4;B4GALT1;ACTG1;FST;MAT2A;DDX17;SPON1;TRIM56;OVCH2;CCDC80;TRAF3;COL27A1;DYNC2H1;MID1;TP53;DAPK3;SVEP1;PANK2;EXO1;C9ORF3;SCD;GBP1;DDX47;ABCF1;TMPPE;RBM4;ACSL3;ZBED1;ZNF397;PRUNE2;CHP1;ACO1;AKAP8;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;PDLIM1;CDKAL1;PCDH7;P3H2;NUAK1;SLC22A5;GALNT18;CAMK1G;DNHD1;SYK;NUP153;NAIP;ZFP42;RAB32;TRIO;PARP15;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;SFRP1;VPS41;RIPK4;MCM2;LAYN;DST;VPS8;POLQ;TSR1;ATP2B1;USP16;TCHH;ZNF827;HRNR;DHFR;RPA1;POLR1A;ZMAT2;GLIS3;HELLS;CSRP1;ULK4;POLA1;ABCC4;ADAMTS9;SETDB1;TK1;LSG1;G3BP1;ARRDC1-AS1;ZNF584;TRAF1;PARD3B;OPHN1;P4HA2;ZNF407;CADPS2;FOXRED2;MDN1;SLC1A3;EIF5;PLK2;RRAGB;ZNF512;MME;ZNF587;HSCB;FRK;GBP5;AKAP8L;RHOG;DOHH;SUV39H2;LCP1;EXOG;KDM6A;DDX28;RAN;RANBP2;SOD2;ORC4;ATP2C1;DDX3X;RAB26;NUFIP1;CPA4;ARHGEF28;GPHN;RNF115;ITGAV;QPCT;ABCF2;SNX11;TRPM7;AJUBA;SMC2;ZNF267;AKR1C2;LFNG;ZC3H7B;PGK1;SNX5;TRIM37;FEN1;MCM3;FRRS1;GNL3L;ZNF586;NVL;GATC;SH3RF2;APTX;CDH13;COL5A2;RARS;MDM4;HIF1AN;NPNT;QDPR;ZNF234;MCM8;BRCC3;SGK494;UTY;ANTXR1;SMYD2;ENPP1;BIRC3;FRAS1;CBWD5;ZNF316;DDX10;RRM2;ZNF670;EYA3;EFTUD2;ZNF106;DDX24;TPM4;TYW1;MCM6;FGD6;SRD5A1;SETD2;GLIS2;THBD;ABCC9;TTF2;DTX4;SRPRB;SEPHS2;WEE1;ZNF484;ERAP1;SLC11A2;APEX1;ZNF57;TET3;ORC1;HSPA8;SYT11;HSP90AB1;DDX21;EPHB6;SCD5;ZBTB24;NSF;DNPEP;HELQ;MYH11;SGK1;PRIM2;ZBTB12;ZFYVE27;NAV2;TRMT1;DGCR8;DPYD;LIMCH1;CYB561D2;PPIP5K1;MAZ;ZNF33A;ZNFX1;STEAP4;CCDC47;LNX2;CHEK1;BBS5;MMAA;RRM1;MLLT10;RAD18;RPTN;BMS1;MCM4;ADAM17;MYO10;ATR;MSH6;DDX60L;NOL9;ZNF12;RFWD3;ABCA5;BAZ2B;SDHD;CBLL1;DPYSL3;ZNF608;CSRP2;MYNN;UBE2J2;VPS36;TRAF2;MSH3;CYP20A1;POLR3B;DDX56;TAP2;ZNF286A;KIF14;ESR1;PARD3;RNF19B;RAD51B;EHD1;CAPN12;ATAD5;PDSS1;ZFP36L2;SRSF7;RC3H1;TYMS;HNRNPU;RING1;FLAD1;ZSCAN31;METAP2;PHF14;PHLPP2;TAF1;YPEL4;PHLPP1;ZNHIT6;FTO;NRAS;THTPA;ABCA11P;CDKN1A;TREX1;ZNF471;CTCF;ASTN2;GTF2H3;ZBTB9;GBP6;IRAK3;DHX15
16969,GO:0098935,0.230594826790287,0.980191247212405,1,3,dendritic transport,BP,TRAK2
16971,GO:0098937,0.230594826790287,0.980191247212405,1,3,anterograde dendritic transport,BP,TRAK2
9257,GO:0035650,0.230705371397635,0.977853007391137,1,4,AP-1 adaptor complex binding,MF,RAB32
12388,GO:0048762,0.23075405690491,0.850676751817589,13,137,mesenchymal cell differentiation,BP,NRG1;FGFR2;DDX17;EDN1;KBTBD8;PDPN;TGFB2;SFRP1;WNT10A;WNT4;CORO1C;PHACTR4;GLIPR2
7781,GO:0032300,0.230964217504029,0.942387375076539,2,12,mismatch repair complex,CC,MSH6;MSH3
10759,GO:0044130,0.23110119765418,0.977772537389255,1,4,negative regulation of growth of symbiont in host,BP,TNF
10762,GO:0044146,0.23110119765418,0.977772537389255,1,4,negative regulation of growth of symbiont involved in interaction with host,BP,TNF
16580,GO:0097343,0.231194201040944,0.980081732695177,1,3,ripoptosome assembly,BP,CYLD
17555,GO:1901026,0.231194201040944,0.980081732695177,1,3,ripoptosome assembly involved in necroptotic process,BP,CYLD
19580,GO:1990504,0.231207431196213,0.980079311519267,1,3,dense core granule exocytosis,BP,CADPS2
14135,GO:0060971,0.231236749165068,0.980073945613641,1,3,embryonic heart tube left/right pattern formation,BP,CITED2
7219,GO:0031106,0.231548821251418,0.942146612095802,2,12,septin ring organization,BP,RTKN2;ANLN
13504,GO:0055021,0.231637482368832,0.90333545560026,4,32,regulation of cardiac muscle tissue growth,BP,FGFR2;G6PD;EDN1;MIR17HG
18242,GO:1903010,0.231657302703781,0.94275915105858,2,11,regulation of bone development,BP,FBN1;TJP2
14242,GO:0061158,0.231667181497793,0.94275511915261,2,11,3'-UTR-mediated mRNA destabilization,BP,ZFP36L2;RC3H1
18251,GO:1903026,0.231786146923371,0.976245180188394,1,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,TAF1
10350,GO:0043137,0.231855027027516,0.97761883561697,1,4,DNA replication, removal of RNA primer,BP,FEN1
15597,GO:0072047,0.232030637560608,0.977582944555979,1,4,proximal/distal pattern formation involved in nephron development,BP,IRX2
15618,GO:0072081,0.232030637560608,0.977582944555979,1,4,specification of nephron tubule identity,BP,IRX2
15619,GO:0072086,0.232030637560608,0.977582944555979,1,4,specification of loop of Henle identity,BP,IRX2
11331,GO:0045636,0.232103094688521,0.979915016042253,1,3,positive regulation of melanocyte differentiation,BP,ADAMTS9
14313,GO:0061387,0.232246344064067,0.869231452871066,8,74,regulation of extent of cell growth,BP,NRG1;FN1;SRF;ZFYVE27;L1CAM;NTN1;SHTN1;WDR36
4884,GO:0014744,0.232284515120202,0.979881644785665,1,3,positive regulation of muscle adaptation,BP,MIR17HG
576,GO:0001725,0.232366720722666,0.8912399804996,5,43,stress fiber,CC,SIPA1L3;TPM1;LCP1;TPM4;SYNPO2
16668,GO:0097517,0.232366720722666,0.8912399804996,5,43,contractile actin filament bundle,CC,SIPA1L3;TPM1;LCP1;TPM4;SYNPO2
7961,GO:0032554,0.232416251280945,0.977504020504529,1,4,purine deoxyribonucleotide binding,MF,HSP90AB1
16892,GO:0098802,0.232463612961864,0.86382679147512,9,89,plasma membrane receptor complex,CC,TFRC;TRAF3;IRS1;IL6ST;SYK;SHISA9;ITGAV;NPNT;TRAF2
13527,GO:0055076,0.23283986989647,0.863157712360518,9,99,transition metal ion homeostasis,BP,FTL;FTH1;TFRC;ACO1;SLC30A6;ABCG2;SLC11A2;TMEM199;STEAP4
17385,GO:1900076,0.232843223975559,0.881830175983273,6,55,regulation of cellular response to insulin stimulus,BP,IRS1;CDK4;NUCKS1;SOCS1;ENPP1;PIK3R3
19640,GO:1990748,0.232927285637283,0.880946936895781,6,67,cellular detoxification,BP,TXNRD1;NQO1;DHFR;SOD2;TNF;GPX4
11462,GO:0045898,0.232996552279901,0.940993880010269,2,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53;ESR1
9093,GO:0035338,0.233141700665613,0.94093325068363,2,13,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSL3;HACD2
6043,GO:0019136,0.23316702080602,0.977349914540659,1,4,deoxynucleoside kinase activity,MF,TK1
14954,GO:0070821,0.233171587337603,0.89061457986395,5,44,tertiary granule membrane,CC,PTPRB;MGAM;SIRPA;LAIR1;NRAS
6318,GO:0019960,0.233214192984219,0.979710146216353,1,3,C-X3-C chemokine binding,MF,ITGAV
15657,GO:0072137,0.233218549989633,0.984556553936463,1,2,condensed mesenchymal cell proliferation,BP,FAT4
17393,GO:1900087,0.233352681776965,0.917836900726919,3,23,positive regulation of G1/S transition of mitotic cell cycle,BP,CYP1A1;DDX3X;APEX1
12123,GO:0048147,0.233509114205982,0.917507068299732,3,24,negative regulation of fibroblast proliferation,BP,FTH1;TP53;SFRP1
3510,GO:0007422,0.233605530324343,0.88159461826765,6,52,peripheral nervous system development,BP,NRG1;RUNX1;CNTNAP1;UGT8;MPP5;PARD3
20329,GO:2001275,0.23397974712675,0.941807843691542,2,11,positive regulation of glucose import in response to insulin stimulus,BP,IRS1;PIK3R3
2408,GO:0005577,0.234005791439535,0.979563472736306,1,3,fibrinogen complex,CC,FN1
13671,GO:0060158,0.234273098244854,0.977121804072835,1,4,phospholipase C-activating dopamine receptor signaling pathway,BP,SLC9A3R1
6457,GO:0021773,0.234433424115007,0.979483989937327,1,3,striatal medium spiny neuron differentiation,BP,INHBA
4494,GO:0010517,0.234697571797093,0.901365875896766,4,33,regulation of phospholipase activity,BP,CYR61;FGFR2;ESR1;CCL5
3030,GO:0006577,0.234709973369337,0.94027643724241,2,13,amino-acid betaine metabolic process,BP,SLC22A5;CROT
17595,GO:1901184,0.234735386571388,0.867132950636533,8,80,regulation of ERBB signaling pathway,BP,NRG1;GPRC5A;EPGN;MMP9;RNF115;CDH13;GPER1;ADAM17
4389,GO:0010040,0.234754650118403,0.977022092065996,1,4,response to iron(II) ion,BP,ACO1
16133,GO:0090100,0.234797652086115,0.87325557726937,7,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CYR61;TGFB2;INHBA;NPNT;HSP90AB1;ADAM17;CITED2
4523,GO:0010574,0.235244216968753,0.916844154336006,3,23,regulation of vascular endothelial growth factor production,BP,CYP1B1;C3;IL6ST
15310,GO:0071478,0.235441998564232,0.846924449654732,13,142,cellular response to radiation,BP,CRYAB;TP53;RAD1;SFRP1;NUCKS1;MME;CDC25A;CHEK1;ATR;CLOCK;METAP2;TAF1;CDKN1A
6138,GO:0019401,0.235539043123268,0.976859152683574,1,4,alditol biosynthetic process,BP,AKR1B1
6793,GO:0030225,0.235550809448487,0.916682823354289,3,23,macrophage differentiation,BP,MMP9;INHBA;CSF1
2130,GO:0004924,0.23561985522998,0.979262560467807,1,3,oncostatin-M receptor activity,MF,IL6ST
9734,GO:0038165,0.23561985522998,0.979262560467807,1,3,oncostatin-M-mediated signaling pathway,BP,IL6ST
11528,GO:0046015,0.235913634304543,0.976781112575921,1,4,regulation of transcription by glucose,BP,SRF
15313,GO:0071481,0.235943422388119,0.940998116968341,2,11,cellular response to X-ray,BP,SFRP1;NUCKS1
7214,GO:0031100,0.236017696289257,0.879469429595521,6,58,animal organ regeneration,BP,CDK4;ADM;LCP1;CCNA2;TYMS;CDKN1A
4893,GO:0014812,0.236039805973142,0.879786905985583,6,54,muscle cell migration,BP,IGFBP3;TPM1;PDGFB;APEX1;CCL5;ITGB1BP1
18413,GO:1903400,0.236049248870526,0.9791820901291,1,3,L-arginine transmembrane transport,BP,SLC7A2
14646,GO:0070201,0.236078501745494,0.812363475933345,42,514,regulation of establishment of protein localization,BP,SAA1;NRG1;TRIM16;FN1;PML;IL1R2;IRS1;TP53;GBP1;ACSL3;PTPN14;CHP1;TGFB2;RBM22;DKC1;SYK;SFRP1;CD274;KCNS3;PTGER4;DYNLL2;AKAP8L;LCP1;SOCS1;ARNTL;NUP54;SETD2;HSPA8;SYT11;HSP90AB1;GPER1;WDR75;UBE2J2;TRAF2;CLOCK;TNF;STARD7;CCL5;PANX1;CDKN1A;ITGB1BP1;TSGA13
15168,GO:0071260,0.236175664030257,0.879363668232099,6,58,cellular response to mechanical stimulus,BP,MAP3K14;GCLC;PTGER4;CHEK1;TLR3;IRF1
3150,GO:0006749,0.236390359488654,0.899184577357915,4,42,glutathione metabolic process,BP,PTGES;GCLC;G6PD;GDAP1
1875,GO:0004540,0.2365212972717,0.865575003729402,8,86,ribonuclease activity,MF,EXO1;POP1;TSN;FEN1;USB1;ISG20L2;APEX1;DGCR8
546,GO:0001665,0.236673336606989,0.976622388641993,1,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC5
5649,GO:0016740,0.236897055471195,0.79135792433743,147,1890,transferase activity,MF,DTX2;NRG1;PTGES;MAP3K14;FAM46B;FGFR2;UGT1A6;STAT5A;TRIM22;GNPTAB;B4GALT1;MAT2A;TRIM56;TRAF3;IRS1;MID1;DAPK3;PANK2;TPST1;HMGCS1;KBTBD8;ZBED1;ST6GALNAC5;IKBKE;PKMYT1;TGS1;CDKAL1;NUAK1;DKC1;GALNT18;CAMK1G;SYK;TJP2;NAIP;TRIO;PARP15;CDK4;RIPK4;ZDHHC6;POLQ;KEAP1;NAA15;UAP1L1;POLR1A;THUMPD3;METTL21A;METTL1;ULK4;POLA1;SETDB1;TK1;URM1;HERC6;PLK2;FRK;NOP2;SUV39H2;SETD4;HMGXB3;RANBP2;HS3ST1;VCPKMT;ZNF738;GPHN;KLHL21;RNF115;PARP14;PARP8;QPCT;TRPM7;FASTKD3;CROT;LFNG;PGK1;TRIM37;YRDC;SH3RF2;APTX;IBA57;GDAP1;MDM4;PDGFB;UGT8;SGK494;SMYD2;NAA50;BIRC3;PIK3R3;MBOAT1;KANSL1L;METTL16;KLHL9;SETD2;TRMT5;DTX4;METTL13;DPY19L2P2;SEPHS2;WEE1;PDCL3;UMPS;EPHB6;NEDD4L;SGK1;PRIM2;BRCA2;TRMT1;PPIP5K1;POLR2F;CHEK1;RAD18;ATR;HADHB;NOL9;RFWD3;TRMT61A;CBLL1;UGT1A4;TAF6L;DPH2;SPSB1;POLR1E;UBE2J2;TRAF2;RBBP5;POLR3B;CCNA2;GTF3C4;POLE3;NAA16;MPHOSPH8;CLOCK;ESR1;RNF19B;WDR4;PDSS1;RC3H1;TYMS;CCL5;RING1;FGFR1OP;FLAD1;TAF1;CDKN1A;GTF2H3;IRAK3;UFC1
17059,GO:0099513,0.236919566925274,0.812784551442669,40,470,polymeric cytoskeletal fiber,CC,KRT1;SAA1;NEFL;KRT34;KRT4;MAP2;KRT13;KIF23;AMOT;MTUS1;KRT2;KRT15;MYO1B;ACTG1;NEFM;KRTAP2-3;DYNC2H1;MID1;DAPK3;TCP11L1;CYLD;KRT9;DST;KEAP1;TPM1;DYNLL2;LCP1;KLHL21;KRT24;BAIAP2;LRPPRC;TPM4;SRPRB;KRT10;SKA2;GPER1;SHTN1;DPYSL3;KIF14;HNRNPU
9059,GO:0035270,0.236969757992352,0.871682191230561,7,67,endocrine system development,BP,PBX1;WNT4;ARNTL;SRF;SRD5A1;CITED2;CLOCK
15029,GO:0070942,0.236973444199692,0.976559520444764,1,4,neutrophil mediated cytotoxicity,BP,DNASE1
14215,GO:0061101,0.23700989689126,0.976551877688548,1,4,neuroendocrine cell differentiation,BP,WNT4
17535,GO:1900744,0.237165399757151,0.915831283043887,3,23,regulation of p38MAPK cascade,BP,ULK4;GADD45B;PHLPP1
15503,GO:0071839,0.237256948438786,0.976500043480416,1,4,apoptotic process in bone marrow,BP,PLK2
2115,GO:0004897,0.237263301501037,0.978953619128759,1,3,ciliary neurotrophic factor receptor activity,MF,IL6ST
14593,GO:0070120,0.237263301501037,0.978953619128759,1,3,ciliary neurotrophic factor-mediated signaling pathway,BP,IL6ST
15006,GO:0070901,0.237398755280834,0.9764702618179,1,4,mitochondrial tRNA methylation,BP,TRMT5
3390,GO:0007169,0.237678403792953,0.811010449586735,42,500,transmembrane receptor protein tyrosine kinase signaling pathway,BP,IGFBP3;NRG1;GPRC5A;FGFR2;STAT5A;EPGN;CTGF;MMP9;FAT4;ACTG1;IRS1;HNRNPF;SLC9A3R1;SYK;CDK4;NUCKS1;COL4A1;FRK;HSPB1;WNT4;ARHGEF28;RNF115;ITGAV;SOCS1;BAIAP2;CDH13;PDGFB;ENPP1;PIK3R3;ZNF106;EPHB6;ZFYVE27;POLR2F;GPER1;ADAM17;NCBP1;CSF1;NEDD9;PHF14;NRAS;SMARCC1;HNRNPM
19731,GO:2000027,0.237701050158685,0.837701544687694,16,184,regulation of organ morphogenesis,BP,FGFR2;B4GALT1;EDN1;TGFB2;SFRP1;WNT10A;WNT4;FZD1;PSME2;CFLAR;PSMB9;CITED2;CSF1;ESR1;TNF;PSMB10
14883,GO:0070646,0.237768249438575,0.827534305389705,22,258,protein modification by small protein removal,BP,TRAF3;TP53;CYLD;USP16;KEAP1;RCE1;USP43;CDC25A;MDM4;BRCC3;USP6;BIRC3;SENP1;PSME2;PSMB9;TRAF2;CCNA2;ESR1;USP11;PSMB10;USP1;COPS3
8465,GO:0033596,0.237846520423071,0.978843363142202,1,3,TSC1-TSC2 complex,CC,NEFL
15828,GO:0072507,0.237943815962556,0.830345876705619,20,227,divalent inorganic cation homeostasis,BP,SAA1;PML;JPH2;EDN1;C1QTNF1;SLC30A6;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;JPH1;THADA;RIC3;TMEM165;CCDC47;GPER1;ESR1;CCL5
8857,GO:0034644,0.237955700215836,0.870868591664714,7,69,cellular response to UV,BP,TP53;MME;CDC25A;CHEK1;ATR;TAF1;CDKN1A
16129,GO:0090092,0.237967347566624,0.84507618767527,13,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CYR61;FBN1;FST;TGFB2;INHBA;SFRP1;MIR17HG;CD109;NPNT;FZD1;HSP90AB1;ADAM17;CITED2
1764,GO:0004364,0.238063358106394,0.936994662719971,2,18,glutathione transferase activity,MF,PTGES;GDAP1
10255,GO:0042979,0.238227399158644,0.97629581064239,1,4,ornithine decarboxylase regulator activity,MF,AZIN1
17961,GO:1902267,0.238227399158644,0.97629581064239,1,4,regulation of polyamine transmembrane transport,BP,AZIN1
10172,GO:0042747,0.238248963866526,0.976291261059776,1,4,circadian sleep/wake cycle, REM sleep,BP,SRD5A1
395,GO:0001056,0.238382324869207,0.937820245081641,2,15,RNA polymerase III activity,MF,POLR2F;POLR3B
4077,GO:0009129,0.238427128767208,0.938219745438319,2,14,pyrimidine nucleoside monophosphate metabolic process,BP,UMPS;TYMS
4078,GO:0009130,0.238427128767208,0.938219745438319,2,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,UMPS;TYMS
11004,GO:0044794,0.238622801395561,0.938623831402638,2,13,positive regulation by host of viral process,BP,NUCKS1;HSPA8
8192,GO:0032924,0.238680527234501,0.915308981249105,3,22,activin receptor signaling pathway,BP,FST;INHBA;CITED2
17712,GO:1901566,0.238710546099181,0.793002020165739,111,1533,organonitrogen compound biosynthetic process,BP,GCLC;CYR61;HSPG2;B4GALT1;SPON1;ENC1;DAPK3;PANK2;ABCF1;KBTBD8;RBM4;ACSL3;GEMIN5;PABPC4;CHP1;ACO1;TGFB2;ST6GALNAC5;CARS2;CDKAL1;INHBA;NUP50;PUM3;GALNT18;SYK;NUP153;CDK4;ZDHHC6;MIR17HG;H3F3A;USP16;DHFR;TK1;ADM;CD109;NDC1;SLC1A3;EIF5;CASC3;CCL20;MRPL27;MUC16;HSPB1;RAN;RANBP2;HS3ST1;DDX3X;GPHN;ITGAV;MRTO4;ODC1;AJUBA;FASTKD3;DND1;LFNG;PGK1;HACD2;GATC;IBA57;RARS;QDPR;PDGFB;UGT8;EIF3J;NFE2L1;NUP160;NUP54;LRPPRC;EFTUD2;METTL16;DPY19L2P2;SEPHS2;SLC11A2;PDCL3;TET3;UMPS;BACE2;SYNCRIP;TRAK2;DPYD;TMEM165;POLR2F;RAB3GAP1;GPER1;MMAA;RBMS3;EIF2B5;MRPS7;DPH2;NCBP1;UPF3B;HNRNPR;NCL;TLR3;AZIN1;ESR1;TNF;ZFP36L2;RC3H1;TYMS;STARD7;CCL5;FLAD1;EIF2B1;HIST1H4A;TBPL1;MUC5B;MUC6;RBM8A;GTF2H3;RPS12
15277,GO:0071428,0.238809606915934,0.937636310954201,2,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,RAN;SDAD1
7880,GO:0032436,0.238814291081715,0.870149555935322,7,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,GCLC;KEAP1;PLK2;UBQLN2;CLU;RNF19B;TAF1
3027,GO:0006574,0.239025279408435,0.976127152776195,1,4,valine catabolic process,BP,HIBCH
39,GO:0000079,0.239113678598827,0.869882852112442,7,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN2A;PKMYT1;CDK4;CDC25A;PDGFB;ADAM17;CDKN1A
13254,GO:0051898,0.239332832649423,0.898454178107384,4,34,negative regulation of protein kinase B signaling,BP,SLC9A3R1;GPER1;PHLPP2;PHLPP1
15481,GO:0071801,0.239348027061217,0.938315354090522,2,13,regulation of podosome assembly,BP,LCP1;TNF
13608,GO:0060055,0.239459835664019,0.938267735414919,2,13,angiogenesis involved in wound healing,BP,B4GALT1;SRF
4514,GO:0010562,0.239539595173326,0.803051306336495,57,701,positive regulation of phosphorus metabolic process,BP,IGFBP3;SAA1;NRG1;MAP3K14;CYR61;C3;FGFR2;EPGN;CTGF;MMP9;IRS1;MID1;TP53;EDN1;C1QTNF1;ACSL3;TGFB2;IL6ST;INHBA;SYK;EMP2;NBN;ADM;CCL20;RANBP2;DDX3X;IL24;ITGAV;SOCS1;PARP14;AJUBA;GADD45B;NPNT;PDGFB;FZD1;CLU;IL20;ACKR3;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;GPER1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;KIF14;TLR3;TNF;CCL5;CD74;DAXX;PPARGC1B;CDKN1A;ITGB1BP1
11495,GO:0045937,0.239539595173326,0.803051306336495,57,701,positive regulation of phosphate metabolic process,BP,IGFBP3;SAA1;NRG1;MAP3K14;CYR61;C3;FGFR2;EPGN;CTGF;MMP9;IRS1;MID1;TP53;EDN1;C1QTNF1;ACSL3;TGFB2;IL6ST;INHBA;SYK;EMP2;NBN;ADM;CCL20;RANBP2;DDX3X;IL24;ITGAV;SOCS1;PARP14;AJUBA;GADD45B;NPNT;PDGFB;FZD1;CLU;IL20;ACKR3;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;GPER1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;KIF14;TLR3;TNF;CCL5;CD74;DAXX;PPARGC1B;CDKN1A;ITGB1BP1
20245,GO:2001137,0.239647719871468,0.978500795054541,1,3,positive regulation of endocytic recycling,BP,EHD1
16198,GO:0090200,0.239686722261397,0.9135902406771,3,27,positive regulation of release of cytochrome c from mitochondria,BP,MMP9;TP53;GPER1
19060,GO:1904874,0.239753818612206,0.937229007963183,2,15,positive regulation of telomerase RNA localization to Cajal body,BP,DKC1;SHQ1
11497,GO:0045940,0.239918917565989,0.937580325426448,2,14,positive regulation of steroid metabolic process,BP,WNT4;TNF
10908,GO:0044444,0.240103542952406,0.781706939302663,522,7180,cytoplasmic part,CC,IL32;CRYAB;IGFBP3;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;NEFL;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TRIM16L;TNS3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;SACS;TRIM22;STARD13;FADS3;COL5A3;S100P;CTGF;HLA-B;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;CLN6;B4GALT1;ACTG1;NEFM;G6PD;TSC22D3;MAT2A;DDX17;SPON1;FAM69B;TRIM56;TFCP2L1;KRTAP2-3;TRAF3;COL27A1;IRS1;DYNC2H1;SPG21;MID1;TP53;PANK2;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;ABCF1;KBTBD8;CDKN2A;RBM4;ACSL3;ZNF397;GEMIN5;NQO1;PABPC4;STAG1;LGALS3;CHP1;ACO1;PDPN;AKAP8;TGFB2;ST6GALNAC5;PRSS23;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL16;IFIT3;SRSF2;PCDH7;PPP1R3B;COL12A1;SLC30A6;PGD;P3H2;HNRNPF;BAG1;SLC9A3R1;PDCD11;C15ORF39;INHBA;IL7R;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;RAB32;RELB;NBN;TRIO;VEZT;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;HLA-DOB;GPCPD1;HEATR1;ZDHHC6;GEMIN4;ABHD4;DST;VPS8;TSR1;COL4A1;PUS3;AHR;COA7;KEAP1;NAA15;UAP1L1;TCHH;HRNR;DHFR;AP5M1;THUMPD3;TPM1;PTPRB;METTL1;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;TK1;TMEM97;LSG1;G3BP1;GRWD1;TRAF1;URM1;PARD3B;OPHN1;MGAM;IMMP2L;CD109;P4HA2;GGCX;CADPS2;HERC6;DYNLL2;FOXRED2;SLC35A4;MDN1;EIF5;CASC3;SYNPO2L;PLK2;RRAGB;CDV3;MRPL27;SLCO4C1;MME;MUC16;UBQLN2;NEXN;HSCB;FRK;GBP5;KANK4;NOP58;HSPB1;RHOG;WNT4;DOHH;LCP1;EXOG;PTPRM;SIRPA;DDX28;THOC1;RAN;RANBP2;HS3ST1;VCPKMT;ANAPC15;SOD2;ORC4;ATP2C1;DDX3X;RAB26;NAP1L1;NUFIP1;ARHGEF28;ARMC5;KLHL21;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;QPCT;ODC1;ABCF2;SNX11;AJUBA;SMC2;ARMC6;FASTKD3;KCNQ5;UTP14A;CROT;AKR1C2;KRT24;LFNG;PGK1;SNX5;TRIM37;FEN1;MCM3;CDC42EP2;CDCA5;HACD2;PPP4R4;GNL3L;TTC1;YRDC;BAIAP2;WDR7;GATC;CDH13;COL5A2;IBA57;RARS;GDAP1;HIF1AN;NPNT;QDPR;APMAP;PDGFB;BRCC3;CHID1;EIF3J;KREMEN2;TBC1D15;NFE2L1;ANTXR1;RTKN2;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;PIK3R3;MBOAT1;RRM2;COMMD9;LRPPRC;NFKBIB;SPNS1;EFTUD2;ZNF106;TRUB2;TPM4;ACKR3;FGD6;SRD5A1;KLHL9;ANLN;TIMM23B;UBP1;THBD;ABCC9;TRMT5;TTF2;DTX4;GLIPR2;JPH1;SRPRB;SEPHS2;NNT;IFNAR1;TJP1;THADA;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;TNC;CNTNAP2;UMPS;ORC1;HSPA8;SYT11;TMEM199;HSP90AB1;ARL6IP5;EPHB6;BACE2;SCD5;NSF;DNPEP;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;HPS5;GEMIN8;SYNCRIP;TRAK2;TRMT1;DPYD;KRT10;CCAR1;SKA2;PPIP5K1;WDPCP;FANCD2;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;STEAP4;FKBP5;POLR2F;CCDC47;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;BBS5;GPER1;FAF1;MMAA;RRM1;MLLT10;RPTN;ANKRD13A;ADAM17;MYO10;ATR;PSME2;MSH6;HADHB;CEP152;LILRB3;CFLAR;PSMB9;DNAJC9;EIF2B5;ABCA5;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;MRPS7;DPH2;EBP;NCBP1;UPF3B;AKR1B1;SPSB1;UBE2J2;VPS36;TRAF2;TELO2;FAM208B;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;SLC9A9;TAP2;IFI30;UQCRB;CSF1;AP3B1;NAA16;MPHOSPH8;CLOCK;GLIPR1;KIF14;TLR3;AZIN1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;RNF19B;USP11;EHD1;FEM1C;CENPN;ARV1;TNF;WDR4;PDSS1;ZFP36L2;NEDD9;RC3H1;TYMS;STARD7;PLBD1;ARGLU1;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;DCTN5;METAP2;PHLPP2;PANX1;TRAM2;PHLPP1;CCDC50;HIBCH;NRAS;MUC5B;PPARGC1B;THTPA;CDKN1A;ITGB1BP1;MRFAP1;MUC6;SLC25A22;TREX1;IRF1;ASTN2;DIAPH3;RBM8A;NDUFB9;RPS12;CENPO;GPX4;COPS3;IFI27L1
13776,GO:0060332,0.240291168425674,0.978377663898603,1,3,positive regulation of response to interferon-gamma,BP,NLRC5
13779,GO:0060335,0.240291168425674,0.978377663898603,1,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,NLRC5
13598,GO:0060045,0.240340046358159,0.938473042781183,2,12,positive regulation of cardiac muscle cell proliferation,BP,FGFR2;MIR17HG
4491,GO:0010511,0.240403645552454,0.975834208555072,1,4,regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
8502,GO:0033668,0.240437210101965,0.975827050058526,1,4,negative regulation by symbiont of host apoptotic process,BP,SERPINB9
13321,GO:0052041,0.240437210101965,0.975827050058526,1,4,negative regulation by symbiont of host programmed cell death,BP,SERPINB9
13376,GO:0052490,0.240437210101965,0.975827050058526,1,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,SERPINB9
18535,GO:1903670,0.240511267259256,0.885942911537221,5,44,regulation of sprouting angiogenesis,BP,HDAC9;STARD13;ADAMTS9;PLK2;ITGB1BP1
16574,GO:0097329,0.240537809782003,0.938389260821056,2,12,response to antimetabolite,BP,DHFR;TIMELESS
18038,GO:1902498,0.240589461578405,0.978320447189894,1,3,regulation of protein autoubiquitination,BP,TAF1
19673,GO:1990837,0.241084887492086,0.806527989467429,45,531,sequence-specific double-stranded DNA binding,MF,MAFB;FOSL2;NLRC5;RUNX1;PBX1;TFCP2L1;TP53;ZBED1;ZFP42;RELB;MCM5;MCM2;H3F3A;AHR;GRWD1;MYBL2;SUV39H2;KDM6A;UBTF;ORC4;RRN3;ARNTL;SRF;UTY;NFE2L1;MACC1;GLIS2;MYBL1;MAZ;E2F8;ETV6;HSF2;ORC2;CLOCK;PURB;ESR1;HNRNPU;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;ARID3B;IRF1;CTCF
9864,GO:0042102,0.241158911728166,0.884906866852466,5,50,positive regulation of T cell proliferation,BP,TFRC;IL6ST;SYK;CD274;CCL5
5927,GO:0018199,0.241197821727124,0.975664510912945,1,4,peptidyl-glutamine modification,BP,QPCT
15073,GO:0071008,0.241317894975989,0.975638795894898,1,4,U2-type post-mRNA release spliceosomal complex,CC,DHX15
10128,GO:0042637,0.241350145712153,0.975631886442612,1,4,catagen,BP,TGFB2
13207,GO:0051794,0.241350145712153,0.975631886442612,1,4,regulation of timing of catagen,BP,TGFB2
9842,GO:0042058,0.241368326767336,0.868424079553386,7,70,regulation of epidermal growth factor receptor signaling pathway,BP,GPRC5A;EPGN;MMP9;RNF115;CDH13;GPER1;ADAM17
5143,GO:0015662,0.241447763159692,0.913840911612192,3,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,ATP2B1;ABCC4;ATP2C1
11451,GO:0045862,0.241858499492804,0.822714241349528,23,281,positive regulation of proteolysis,BP,FN1;PML;GCLC;CYR61;C3;CTGF;CLN6;KEAP1;PLK2;UBQLN2;DDX3X;ANTXR1;CLU;ARL6IP5;GPER1;SENP1;PSME2;CFLAR;TRAF2;RNF19B;TNF;TAF1;IFI27L1
13287,GO:0051955,0.241963534344018,0.937197191112243,2,13,regulation of amino acid transport,BP,ARL6IP5;RAB3GAP1
1053,GO:0002578,0.241965737036356,0.975499790003084,1,4,negative regulation of antigen processing and presentation,BP,HLA-DOB
8151,GO:0032870,0.242201770315474,0.808133896168221,40,476,cellular response to hormone stimulus,BP,HDAC9;GCLC;STAT5A;FBN1;RUNX1;DDX17;IRS1;EDN1;HMGCS1;AKAP8;INHBA;LEPR;BRIP1;CDK4;SFRP1;NUCKS1;ATP2B1;PTGER4;RAN;SOCS1;ARNTL;AKR1C2;BAIAP2;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;TNC;GPER1;CFLAR;CCNA2;CLOCK;ESR1;ZFP36L2;HNRNPU;DAXX;TAF1;SMARCC1;PPARGC1B
3257,GO:0006925,0.242223770592939,0.936586724134832,2,14,inflammatory cell apoptotic process,BP,CDKN2A;CCL5
16924,GO:0098858,0.242583997101486,0.844597824759586,12,123,actin-based cell projection,CC,S100P;MYO1B;B4GALT1;PDPN;SLC9A3R1;LCP1;ITGAV;BAIAP2;ANTXR1;MYO10;SHTN1;AKR1B1
6686,GO:0030048,0.242587003594714,0.862101382982513,8,70,actin filament-based movement,BP,MYO1B;PDPN;EMP2;TPM1;TPM4;NEDD4L;SHTN1;GJC1
9483,GO:0036094,0.242671406998337,0.78630177527362,143,1813,small molecule binding,MF,KIF23;MAP3K14;GCLC;NLRC5;TXNRD1;FGFR2;TAP1;RUNX1;MYO1B;ACTG1;G6PD;MAT2A;DDX17;DYNC2H1;TP53;DAPK3;PANK2;GBP1;HMGCS1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;P3H2;BAG1;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;RAB32;TRIO;PARP15;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;RIPK4;MCM2;LAYN;POLQ;TSR1;ATP2B1;DHFR;HELLS;ULK4;POLA1;ABCC4;TK1;LSG1;G3BP1;P4HA2;FOXRED2;MDN1;SLC1A3;EIF5;PLK2;RRAGB;FRK;GBP5;RHOG;DDX28;RAN;ORC4;ATP2C1;DDX3X;RAB26;GPHN;ABCF2;TRPM7;SMC2;AKR1C2;PGK1;MCM3;GNL3L;NVL;GATC;RARS;HIF1AN;QDPR;MCM8;SGK494;ENPP1;CBWD5;DDX10;EFTUD2;DDX24;TYW1;MCM6;SRD5A1;ABCC9;TTF2;SRPRB;SEPHS2;NNT;WEE1;ORC1;HSPA8;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;M6PR;NAV2;DPYD;PPIP5K1;CHEK1;MMAA;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;UBE2J2;MSH3;POLR3B;DDX56;TAP2;KIF14;RAD51B;EHD1;ATAD5;TYMS;HNRNPU;FLAD1;TAF1;NRAS;ABCA11P;ASTN2;GBP6;IRAK3;DHX15
11121,GO:0045124,0.242788157878583,0.913126390253377,3,22,regulation of bone resorption,BP,TFRC;SYK;PPARGC1B
8024,GO:0032651,0.242912239390146,0.896005287353236,4,36,regulation of interleukin-1 beta production,BP,TRIM16;PML;HSPB1;PANX1
3352,GO:0007088,0.243224553710201,0.840871295148119,13,141,regulation of mitotic nuclear division,BP,EPGN;DAPK3;EDN1;STAG1;PKMYT1;RANBP2;ANAPC15;CDCA5;PDGFB;ANLN;CENPF;CHEK1;HNRNPU
16058,GO:0086070,0.243271185348395,0.977802208845015,1,3,SA node cell to atrial cardiac muscle cell communication,BP,GJC1
7468,GO:0031620,0.243353477943722,0.975200528795488,1,4,regulation of fever generation,BP,TNF
7469,GO:0031622,0.243353477943722,0.975200528795488,1,4,positive regulation of fever generation,BP,TNF
11221,GO:0045338,0.243366015011097,0.975197815909258,1,4,farnesyl diphosphate metabolic process,BP,HMGCS1
10005,GO:0042406,0.243454347426115,0.975178696995827,1,4,extrinsic component of endoplasmic reticulum membrane,CC,PML
3110,GO:0006688,0.24357199652688,0.936505161180188,2,13,glycosphingolipid biosynthetic process,BP,ST6GALNAC5;UGT8
8427,GO:0033489,0.243718527882075,0.975121467585182,1,4,cholesterol biosynthetic process via desmosterol,BP,EBP
8428,GO:0033490,0.243718527882075,0.975121467585182,1,4,cholesterol biosynthetic process via lathosterol,BP,EBP
15947,GO:0072716,0.243741961182764,0.975116387649266,1,4,response to actinomycin D,BP,TP53
12432,GO:0048864,0.243929623593624,0.874221424225707,6,57,stem cell development,BP,NRG1;EDN1;KBTBD8;CORO1C;PHACTR4;SETD2
15398,GO:0071624,0.24420918641908,0.934914506758328,2,16,positive regulation of granulocyte chemotaxis,BP,EDN1;CD74
11230,GO:0045349,0.244220940129914,0.975012425380959,1,4,interferon-alpha biosynthetic process,BP,TLR3
11235,GO:0045354,0.244220940129914,0.975012425380959,1,4,regulation of interferon-alpha biosynthetic process,BP,TLR3
18194,GO:1902932,0.244275516834309,0.93620142487825,2,13,positive regulation of alcohol biosynthetic process,BP,GPER1;TNF
6016,GO:0019062,0.244288447585392,0.974997753292265,1,4,virion attachment to host cell,BP,HSP90AB1
10962,GO:0044650,0.244288447585392,0.974997753292265,1,4,adhesion of symbiont to host cell,BP,HSP90AB1
2787,GO:0006221,0.244378752517645,0.910871789929254,3,28,pyrimidine nucleotide biosynthetic process,BP,UMPS;TYMS;TBPL1
6931,GO:0030518,0.244447489117196,0.846502262379505,11,115,intracellular steroid hormone receptor signaling pathway,BP,RUNX1;DDX17;SFRP1;RAN;ARNTL;GPER1;CLOCK;ESR1;DAXX;TAF1;PPARGC1B
13251,GO:0051895,0.244546734560925,0.936680044963131,2,12,negative regulation of focal adhesion assembly,BP,CORO1C;ITGB1BP1
17607,GO:1901214,0.244568199683074,0.828247695707096,18,205,regulation of neuron death,BP,NEFL;GCLC;G6PD;TP53;NQO1;CHP1;TGFB2;NAIP;MYBL2;SOD2;SET;FZD1;CLU;HSP90AB1;TRAF2;KIF14;CCL5;DAXX
6621,GO:0022840,0.244726814843692,0.974902360484943,1,4,leak channel activity,MF,PANX1
6623,GO:0022842,0.244726814843692,0.974902360484943,1,4,narrow pore channel activity,MF,PANX1
14985,GO:0070873,0.244936176055356,0.912295406226034,3,21,regulation of glycogen metabolic process,BP,IRS1;PPP1R3B;ENPP1
7897,GO:0032460,0.245007176525583,0.935884860885912,2,13,negative regulation of protein oligomerization,BP,CRYAB;CLU
6358,GO:0021536,0.24506134220323,0.89519363516238,4,33,diencephalon development,BP,WNT4;SRD5A1;CNTNAP2;RAB3GAP1
18999,GO:1904749,0.245164285628053,0.974806958861994,1,4,regulation of protein localization to nucleolus,BP,POLR1A
7935,GO:0032506,0.245453938362108,0.911408842383127,3,23,cytokinetic process,BP,KIF23;RTKN2;ANLN
2786,GO:0006220,0.245492628638863,0.893808452345963,4,41,pyrimidine nucleotide metabolic process,BP,UMPS;SMUG1;TYMS;TBPL1
4941,GO:0014900,0.245541882666586,0.974724450338014,1,4,muscle hyperplasia,BP,MIR17HG
246,GO:0000702,0.245601835198655,0.973150262361656,1,5,oxidized base lesion DNA N-glycosylase activity,MF,SMUG1
9401,GO:0035930,0.245667700183093,0.9746969242741,1,4,corticosteroid hormone secretion,BP,C1QTNF1
20179,GO:2000846,0.245667700183093,0.9746969242741,1,4,regulation of corticosteroid hormone secretion,BP,C1QTNF1
22,GO:0000041,0.245725643318051,0.865130137453933,7,74,transition metal ion transport,BP,HEPHL1;FTL;FTH1;TFRC;SLC30A6;SLC11A2;STEAP4
8062,GO:0032720,0.245975081795252,0.910620681867683,3,25,negative regulation of tumor necrosis factor production,BP,AKAP8;SYT11;IRAK3
6334,GO:0020037,0.246092575780773,0.872593236713141,6,59,heme binding,MF,CYP1B1;CYP24A1;CYP1A1;DGCR8;SDHD;CYP20A1
18225,GO:1902988,0.246120871941742,0.977243897976461,1,3,neurofibrillary tangle assembly,BP,CLU
12675,GO:0050860,0.246131185625171,0.934886514312244,2,14,negative regulation of T cell receptor signaling pathway,BP,GBP1;LGALS3
4393,GO:0010044,0.246431805850202,0.974529392456355,1,4,response to aluminum ion,BP,QDPR
18271,GO:1903055,0.246461104092874,0.935856554984534,2,12,positive regulation of extracellular matrix organization,BP,PDPN;CFLAR
5410,GO:0016247,0.246924525575403,0.864457471126834,7,71,channel regulator activity,MF,ANKRD36C;CHP1;SLC9A3R1;KCNS3;ABCC9;NEDD4L;SGK1
4568,GO:0010647,0.247322818205894,0.78813023677579,90,1152,positive regulation of cell communication,BP,IGFBP3;SAA1;NRG1;TRIM16;PML;CYP1B1;JPH2;MAP3K14;CYR61;C3;NLRC5;FGFR2;EPGN;TRIM22;CTGF;MMP9;IRS1;MID1;TP53;DAPK3;EDN1;C1QTNF1;JRK;TGFB2;CNTNAP1;CYLD;IKBKE;IL6ST;SLC9A3R1;INHBA;IL7R;SYK;EMP2;NAIP;SFRP1;NUCKS1;DYNLL2;SLC1A3;CCL20;PLK2;RRAGB;UBQLN2;WNT4;ATP2C1;DDX3X;IL24;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;AKR1C2;LFNG;NETO1;BAIAP2;GADD45B;CDH13;NPNT;PDGFB;BIRC3;IL20;ACKR3;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;RAB3GAP1;GPER1;FAF1;ADAM17;ATR;PSME2;CFLAR;PSMB9;CMTM3;AKR1B1;TRAF2;TELO2;CITED2;CSF1;TLR3;ESR1;TNF;RC3H1;CCL5;CD74;PSMB10;DAXX;TAF1;ITGB1BP1
15239,GO:0071375,0.247395648892059,0.822560215664265,20,225,cellular response to peptide hormone stimulus,BP,HDAC9;GCLC;STAT5A;FBN1;IRS1;EDN1;BRIP1;CDK4;NUCKS1;SOCS1;BAIAP2;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;GPER1;CFLAR;CCNA2;SMARCC1
1357,GO:0003222,0.247419423631904,0.936167407543923,2,11,ventricular trabecula myocardium morphogenesis,BP,NRG1;TGFB2
16633,GO:0097452,0.247552422454775,0.974282567502568,1,4,GAIT complex,CC,SYNCRIP
9012,GO:0035148,0.247646688221511,0.844116040564026,11,113,tube formation,BP,FGFR2;TGFB2;IRX2;SFRP1;ADM;WNT4;KDM6A;PHACTR4;FZD1;SETD2;ITGB1BP1
4394,GO:0010046,0.24775378058429,0.974238074483176,1,4,response to mycotoxin,BP,PDGFB
20274,GO:2001185,0.247794051817559,0.974229170762191,1,4,regulation of CD8-positive, alpha-beta T cell activation,BP,IRF1
905,GO:0002283,0.247872639668904,0.811999211904936,28,352,neutrophil activation involved in immune response,BP,KRT1;FTL;FTH1;C3;S100P;MMP9;B4GALT1;LGALS3;SYK;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;ITGAV;QPCT;COMMD9;HSPA8;HSP90AB1;LAIR1;LILRB3;GLIPR1;DNASE1;NRAS
12408,GO:0048818,0.247881352347491,0.974209863197082,1,4,positive regulation of hair follicle maturation,BP,TGFB2
16791,GO:0098576,0.248200457508505,0.974139219857684,1,4,lumenal side of membrane,CC,HSPA8
1026,GO:0002524,0.248262383282895,0.974125498133659,1,4,hypersensitivity,BP,C3
16900,GO:0098815,0.248512481792284,0.909755390304409,3,23,modulation of excitatory postsynaptic potential,BP,NETO1;BAIAP2;MTMR2
15815,GO:0072431,0.248937476829913,0.87057685492201,6,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,PML;TP53;PLK2;MDM4;E2F8;CDKN1A
18007,GO:1902400,0.248937476829913,0.87057685492201,6,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,PML;TP53;PLK2;MDM4;E2F8;CDKN1A
14224,GO:0061133,0.248993980164197,0.972357834100326,1,5,endopeptidase activator activity,MF,PSME2
1552,GO:0003945,0.249273795322076,0.973900804600827,1,4,N-acetyllactosamine synthase activity,MF,B4GALT1
720,GO:0001942,0.249676510537776,0.862771562412472,7,67,hair follicle development,BP,FGFR2;FST;TGFB2;INHBA;WNT10A;CD109;TNF
16178,GO:0090179,0.249695016748794,0.934454735413093,2,12,planar cell polarity pathway involved in neural tube closure,BP,SFRP1;FZD1
1423,GO:0003365,0.249708761184507,0.976529741401463,1,3,establishment of cell polarity involved in ameboidal cell migration,BP,AMOT
8698,GO:0034312,0.249781035088264,0.932831905021524,2,15,diol biosynthetic process,BP,DHFR;QDPR
5455,GO:0016324,0.249911704119099,0.828043431133207,16,173,apical plasma membrane,CC,FN1;SIPA1L3;PDPN;SLC9A3R1;SLC22A5;EMP2;ABCG2;ATP2B1;PARD3B;MGAM;SLC11A2;HSP90AB1;WDPCP;ADAM17;PARD3;KCNE4
1909,GO:0004594,0.249955514302266,0.973748736323003,1,4,pantothenate kinase activity,MF,PANK2
19104,GO:1904956,0.250065264796108,0.973724208113188,1,4,regulation of midbrain dopaminergic neuron differentiation,BP,SFRP1
11346,GO:0045655,0.250202374734762,0.933617167583857,2,13,regulation of monocyte differentiation,BP,CSF1;CD74
16278,GO:0090315,0.25041801120562,0.97364528498314,1,4,negative regulation of protein targeting to membrane,BP,ITGB1BP1
11072,GO:0045055,0.250452746145207,0.800209456822289,41,514,regulated exocytosis,BP,KRT1;FTL;FTH1;FN1;C3;S100P;MMP9;B4GALT1;LGALS3;CHP1;TGFB2;PCDH7;SYK;VPS41;HRNR;PTPRB;ABCC4;MGAM;CD109;CADPS2;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;RAB26;ITGAV;QPCT;PDGFB;CHID1;CLU;COMMD9;HSPA8;SYT11;HSP90AB1;LAIR1;RAB3GAP1;LILRB3;GLIPR1;NRAS
10426,GO:0043255,0.25045751851496,0.87004773567085,6,54,regulation of carbohydrate biosynthetic process,BP,IRS1;PPP1R3B;LEPR;PDGFB;ENPP1;GPER1
18204,GO:1902949,0.250503671639511,0.973626099231401,1,4,positive regulation of tau-protein kinase activity,BP,CLU
6211,GO:0019722,0.250573430197125,0.85035831662729,9,92,calcium-mediated signaling,BP,NRG1;JPH2;EDN1;GBP1;CHP1;SYK;CCL20;CDH13;JPH1
12777,GO:0051026,0.250776958555367,0.973564837223124,1,4,chiasma assembly,BP,BRIP1
6765,GO:0030194,0.250911399255619,0.932779563240347,2,14,positive regulation of blood coagulation,BP,PDPN;THBD
17381,GO:1900048,0.250911399255619,0.932779563240347,2,14,positive regulation of hemostasis,BP,PDPN;THBD
11904,GO:0046903,0.25093603248937,0.787094730780157,78,999,secretion,BP,KRT1;SAA1;FTL;FTH1;NRG1;TRIM16;FN1;PML;C3;STAT5A;S100P;CTGF;MMP9;GNPTAB;VMP1;IL1R2;B4GALT1;IRS1;EDN1;GBP1;C1QTNF1;ACSL3;LGALS3;CHP1;TGFB2;PCDH7;SLC9A3R1;INHBA;SYK;SFRP1;VPS41;CD274;HRNR;PTPRB;ABCC4;KCNS3;PTGER4;ADM;MGAM;CD109;CADPS2;SLC1A3;SLCO4C1;MME;FRK;GBP5;RHOG;SIRPA;DDX3X;RAB26;ITGAV;SOCS1;ARNTL;QPCT;PDGFB;CHID1;CLU;COMMD9;UMPS;HSPA8;SYT11;HSP90AB1;NSF;LAIR1;SGK1;M6PR;RAB3GAP1;SCFD2;GPER1;LILRB3;TRAF2;CLOCK;GLIPR1;TNF;CCL5;CD74;PANX1;NRAS
955,GO:0002371,0.251000637242329,0.973514636009565,1,4,dendritic cell cytokine production,BP,TLR3
1141,GO:0002730,0.251000637242329,0.973514636009565,1,4,regulation of dendritic cell cytokine production,BP,TLR3
6220,GO:0019748,0.251099483994935,0.890895834713576,4,37,secondary metabolic process,BP,CYP1B1;CYP1A1;AKR1C2;AKR1B1
18078,GO:1902600,0.251198020617759,0.86085124004804,7,82,proton transmembrane transport,BP,CHP1;SLC4A11;SLC9A3R1;NNT;SLC11A2;SLC9A9;SLC25A22
15825,GO:0072503,0.251288566893941,0.820940728363115,19,217,cellular divalent inorganic cation homeostasis,BP,SAA1;PML;JPH2;EDN1;C1QTNF1;SLC30A6;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;TRPM7;JPH1;THADA;RIC3;TMEM165;GPER1;ESR1;CCL5
15473,GO:0071787,0.251470896221162,0.973408918167853,1,4,endoplasmic reticulum tubular network formation,BP,ZFYVE27
7944,GO:0032526,0.251504825292171,0.861214282525154,7,71,response to retinoic acid,BP,TRIM16;KRT13;PTGES;FGFR2;TP53;GDAP1;TNC
16385,GO:0090669,0.251845422989933,0.973324551402277,1,4,telomerase RNA stabilization,BP,DKC1
4935,GO:0014891,0.251950204136975,0.973300921118298,1,4,striated muscle atrophy,BP,CFLAR
3121,GO:0006701,0.252204653147969,0.973243488446372,1,4,progesterone biosynthetic process,BP,ADM
3297,GO:0006996,0.252253935873482,0.77257230039929,233,3096,organelle organization,BP,CRYAB;NEFL;NRG1;HDAC9;KRT4;TRIM16;MAP2;KRT13;PML;KIF23;AMOT;GCLC;KRT2;KRT15;EPGN;CTGF;MMP9;GNPTAB;VMP1;TAP1;MYO1B;CLN6;ACTG1;NEFM;DYNC2H1;MID1;TP53;DAPK3;PANK2;EXO1;EDN1;SIPA1L3;CDKN2A;STAG1;COBLL1;CHP1;AKAP8;PPAN;CNTNAP1;CYLD;PKMYT1;RAD1;SLC9A3R1;DKC1;NUP50;PALM2;DNHD1;EMP2;NUP153;NAIP;RAB32;NBN;BRIP1;MCM5;SFRP1;VPS41;KRT9;NUCKS1;MCM2;TARDBP;DST;VPS8;H3F3A;USP16;RPA1;TPM1;HELLS;ULK4;POLA1;ABCC4;REEP1;SETDB1;PTGER4;G3BP1;GRWD1;PARD3B;OPHN1;IMMP2L;NDC1;DYNLL2;MDN1;SYNPO2L;PLK2;UBQLN2;NEXN;KANK4;RFC3;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;LCP1;KDM6A;DDX28;RAN;UBTF;RRP7BP;RANBP2;ANAPC15;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;NAP1L1;CPA4;RRN3;SET;MRTO4;SNX11;TRPM7;AJUBA;SMC2;FASTKD3;CGNL1;SNX5;TRIM37;FEN1;CDC42EP2;CDCA5;GNL3L;BAIAP2;GINS4;PHACTR4;SRF;GDAP1;PDGFB;UGT8;BRCC3;TBC1D15;UTY;ANTXR1;RTKN2;CLU;NUP160;USP6;SDAD1;SMYD2;NAA50;BIRC3;NUP54;EYA3;TPM4;RIF1;MCM6;FGD6;SETD2;ANLN;TIMM23B;RPF2;WEE1;BLOC1S2;APEX1;TET3;MYBL1;SYT11;TMEM199;HSP90AB1;NSF;MYH11;PRIM2;ZFYVE27;TMEM138;BRCA2;HPS5;TRAK2;LIMCH1;SKA2;WDPCP;FANCD2;CENPF;GOSR1;TMEM165;CCDC47;RAB3GAP1;CHEK1;BBS5;GPER1;WDR75;MCM4;ATR;MSH6;CEP152;CFLAR;PSMC3IP;SHTN1;DPYSL3;TAF6L;MRPS7;UBE2J2;VPS36;MSH3;TELO2;RBBP5;CCNA2;GTF3C4;POLE3;TAP2;UQCRB;AP3B1;RBL1;CLOCK;KIF14;SYNPO2;ESR1;PARD3;RAD51B;EHD1;CENPN;TNF;NEDD9;RC3H1;STARD7;HNRNPU;RING1;FGFR1OP;DAXX;HIST1H4A;TAF1;TBPL1;TRAM2;SMARCC1;PPARGC1B;ITGB1BP1;CTCF;TSGA13;DIAPH3;GTF2H3;NDUFB9;CENPO;COPS3
5493,GO:0016426,0.252254922192435,0.973232133772949,1,4,tRNA (adenine) methyltransferase activity,MF,TRMT61A
14360,GO:0061535,0.252266044916805,0.976013050663349,1,3,glutamate secretion, neurotransmission,BP,RAB3GAP1
9166,GO:0035513,0.252713722588368,0.973128374949884,1,4,oxidative RNA demethylation,BP,FTO
9168,GO:0035515,0.252713722588368,0.973128374949884,1,4,oxidative RNA demethylase activity,MF,FTO
7992,GO:0032602,0.252756281119844,0.877270940441498,5,51,chemokine production,BP,DDX3X;ADAM17;TLR3;TNF;CD74
1353,GO:0003215,0.252763015703389,0.933112391988982,2,12,cardiac right ventricle morphogenesis,BP,TGFB2;MIR17HG
5045,GO:0015226,0.252819910906201,0.973104327856166,1,4,carnitine transmembrane transporter activity,MF,SLC22A5
5254,GO:0015879,0.252819910906201,0.973104327856166,1,4,carnitine transport,BP,SLC22A5
873,GO:0002220,0.25306755554408,0.848209433912821,9,99,innate immune response activating cell surface receptor signaling pathway,BP,SYK;RELB;MUC16;PSME2;PSMB9;PSMB10;NRAS;MUC5B;MUC6
875,GO:0002223,0.25306755554408,0.848209433912821,9,99,stimulatory C-type lectin receptor signaling pathway,BP,SYK;RELB;MUC16;PSME2;PSMB9;PSMB10;NRAS;MUC5B;MUC6
507,GO:0001569,0.253355529145991,0.907113548967404,3,23,branching involved in blood vessel morphogenesis,BP,EDN1;COL4A1;SRF
10419,GO:0043247,0.253378397798234,0.932213643582893,2,13,telomere maintenance in response to DNA damage,BP,RIF1;APEX1
12902,GO:0051220,0.253499646547741,0.906759288117695,3,24,cytoplasmic sequestering of protein,BP,KEAP1;FAF1;NFKBIE
1293,GO:0003100,0.253591627723593,0.972929201577851,1,4,regulation of systemic arterial blood pressure by endothelin,BP,EDN1
10801,GO:0044262,0.2536829110098,0.822779373214883,17,189,cellular carbohydrate metabolic process,BP,IGFBP3;GNPTAB;B4GALT1;IRS1;C1QTNF1;PPP1R3B;PGD;IL6ST;LEPR;MGAM;RANBP2;GANC;ENPP1;PPIP5K1;MTMR2;GPER1;AKR1B1
10929,GO:0044528,0.253696453345381,0.972905363814759,1,4,regulation of mitochondrial mRNA stability,BP,FASTKD3
1613,GO:0004033,0.253742619220385,0.93065976416749,2,16,aldo-keto reductase (NADP) activity,MF,AKR1C2;AKR1B1
4533,GO:0010596,0.253959608875272,0.889615833268196,4,34,negative regulation of endothelial cell migration,BP,STARD13;ADAMTS9;PTPRM;ITGB1BP1
5704,GO:0016829,0.253983466845995,0.838761046079132,11,129,lyase activity,MF,ACO1;POLQ;GGCX;ODC1;HACD2;APMAP;TYW1;APEX1;UMPS;HADHB;AZIN1
4641,GO:0010761,0.254107593824277,0.889703746354718,4,33,fibroblast migration,BP,PML;CORO1C;WDPCP;ITGB1BP1
4845,GO:0014049,0.254128434845435,0.972807004221139,1,4,positive regulation of glutamate secretion,BP,RAB3GAP1
19430,GO:1905908,0.254577959725434,0.972704435900757,1,4,positive regulation of amyloid fibril formation,BP,CLU
12626,GO:0050786,0.254795583771022,0.969070064254184,1,7,RAGE receptor binding,MF,S100P
20207,GO:2001016,0.254816633788919,0.972649888671784,1,4,positive regulation of skeletal muscle cell differentiation,BP,ARNTL
16467,GO:0097110,0.254889567139066,0.876496813618219,5,45,scaffold protein binding,MF,KRT15;DYNLL2;UBTF;BAIAP2;PANX1
10342,GO:0043125,0.255037367879043,0.972599386614274,1,4,ErbB-3 class receptor binding,MF,NRG1
4899,GO:0014824,0.255151503289505,0.972573252725163,1,4,artery smooth muscle contraction,BP,EDN1
455,GO:0001228,0.255195696458074,0.811659544165644,23,262,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,MAFB;FOSL2;RUNX1;PBX1;TP53;ZBED1;STAG1;FOXD2;NUCKS1;MYBL2;SRF;NFE2L1;MACC1;GLIS2;MYBL1;ETV6;HSF2;ESR1;TBPL1;SPIB;ARID3B;IRF1;CTCF
1127,GO:0002713,0.255219672861809,0.972557637027234,1,4,negative regulation of B cell mediated immunity,BP,THOC1
1223,GO:0002890,0.255219672861809,0.972557637027234,1,4,negative regulation of immunoglobulin mediated immune response,BP,THOC1
15676,GO:0072175,0.255312066574529,0.842238454104231,10,102,epithelial tube formation,BP,FGFR2;TGFB2;IRX2;SFRP1;ADM;WNT4;KDM6A;PHACTR4;FZD1;SETD2
10399,GO:0043219,0.255328220505814,0.972532761480308,1,4,lateral loop,CC,MPP5
7110,GO:0030901,0.255652356475864,0.866043244351893,6,59,midbrain development,BP,FGFR2;G6PD;RAD1;SFRP1;FZD1;TAF1
747,GO:0001975,0.255702643539695,0.931178258343023,2,13,response to amphetamine,BP,HDAC9;RANBP2
15666,GO:0072161,0.255974238413191,0.972384451326487,1,4,mesenchymal cell differentiation involved in kidney development,BP,WNT4
20203,GO:2001012,0.255974238413191,0.972384451326487,1,4,mesenchymal cell differentiation involved in renal system development,BP,WNT4
2127,GO:0004920,0.255974352087954,0.972384425189686,1,4,interleukin-10 receptor activity,MF,IFNAR1
17265,GO:0110096,0.256118273955639,0.970651244275171,1,5,cellular response to aldehyde,BP,AKR1B1
13525,GO:0055074,0.256192602010447,0.818720165458824,18,203,calcium ion homeostasis,BP,SAA1;PML;JPH2;EDN1;C1QTNF1;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;JPH1;THADA;RIC3;TMEM165;CCDC47;GPER1;ESR1;CCL5
14190,GO:0061052,0.256195507750977,0.972333549181922,1,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,G6PD
13512,GO:0055037,0.256330237853056,0.830484116581663,13,143,recycling endosome,CC,TFRC;HLA-B;HLA-F;RAN;USP6;ACKR3;SLC11A2;SYT11;ZFYVE27;GPER1;SLC9A9;EHD1;TNF
14665,GO:0070236,0.25638540148905,0.972289822519529,1,4,negative regulation of activation-induced cell death of T cells,BP,TSC22D3
1153,GO:0002758,0.256409444183043,0.820389719738285,17,199,innate immune response-activating signal transduction,BP,TRAF3;CYLD;IKBKE;SYK;RELB;MUC16;BIRC3;PSME2;PSMB9;TLR3;ESR1;PSMB10;NRAS;MUC5B;MUC6;IRF1;IRAK3
2555,GO:0005829,0.256629161401953,0.76667548705398,303,4102,cytosol,CC,IL32;CRYAB;SPRR3;KRT1;TRIM47;FTL;FTH1;NEFL;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;TRIM16L;TNS3;PML;KIF23;AMOT;MAP3K14;GCLC;KRT2;KRT15;MKL1;NLRC5;TXNRD1;STAT5A;TRIM22;STARD13;CTGF;XAF1;RUNX1;ACTG1;G6PD;TSC22D3;MAT2A;DDX17;TRIM56;KRTAP2-3;TRAF3;IRS1;SPG21;MID1;TP53;PANK2;C9ORF3;GBP1;HMGCS1;DOCK10;ABCF1;KBTBD8;CDKN2A;RBM4;ZNF397;GEMIN5;NQO1;PABPC4;STAG1;CHP1;ACO1;PDPN;CYLD;IKBKE;PKMYT1;TGS1;IL16;IFIT3;SRSF2;PGD;HNRNPF;BAG1;PDCD11;C15ORF39;PHAX;SYK;EMP2;TJP2;NUP153;RAB32;RELB;NBN;TRIO;VEZT;MCM5;SHQ1;ARFRP1;CDK4;SFRP1;KRT9;GPCPD1;GEMIN4;DST;TSR1;PUS3;AHR;KEAP1;NAA15;UAP1L1;TCHH;DHFR;AP5M1;THUMPD3;TPM1;METTL1;POLA1;RCE1;TSN;KCNS3;SETDB1;TK1;TMEM97;LSG1;G3BP1;GRWD1;TRAF1;URM1;OPHN1;P4HA2;HERC6;DYNLL2;MDN1;EIF5;CASC3;SYNPO2L;PLK2;RRAGB;CDV3;UBQLN2;HSCB;FRK;KANK4;NOP58;HSPB1;RHOG;DOHH;LCP1;DDX28;THOC1;RAN;RANBP2;VCPKMT;ANAPC15;ORC4;DDX3X;NUFIP1;ARHGEF28;ARMC5;KLHL21;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;MRTO4;ODC1;AJUBA;SMC2;ARMC6;UTP14A;AKR1C2;KRT24;PGK1;SNX5;TRIM37;CDC42EP2;CDCA5;PPP4R4;GNL3L;TTC1;BAIAP2;RARS;GDAP1;HIF1AN;QDPR;BRCC3;EIF3J;NFE2L1;CLU;NUP160;SMYD2;NAA50;BIRC3;PIK3R3;RRM2;COMMD9;NFKBIB;EFTUD2;ZNF106;TRUB2;TPM4;KLHL9;UBP1;TTF2;DTX4;SEPHS2;TJP1;THADA;ERAP1;BLOC1S2;PDCL3;UMPS;ORC1;HSPA8;HSP90AB1;EPHB6;NSF;DNPEP;MYH11;NEDD4L;SGK1;ZFYVE27;ANAPC7;BRCA2;HPS5;GEMIN8;DPYD;KRT10;SKA2;PPIP5K1;FANCD2;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;FKBP5;POLR2F;RAB3GAP1;CHEK1;SERPINB9;BBS5;FAF1;RRM1;MLLT10;RPTN;ADAM17;MYO10;PSME2;MSH6;CEP152;CFLAR;PSMB9;DNAJC9;EIF2B5;NFKBIE;CBLL1;HNRNPDL;RABEP2;DPYSL3;DPH2;NCBP1;UPF3B;AKR1B1;SPSB1;VPS36;TRAF2;TELO2;FAM208B;POLR3B;CCNA2;IFI30;NAA16;MPHOSPH8;CLOCK;KIF14;AZIN1;SYNPO2;ESR1;PARD3;RNF19B;USP11;FEM1C;CENPN;WDR4;ZFP36L2;NEDD9;TYMS;PLBD1;RING1;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;DCTN5;METAP2;PHLPP2;PHLPP1;CCDC50;THTPA;CDKN1A;ITGB1BP1;MRFAP1;TREX1;IRF1;DIAPH3;RBM8A;RPS12;CENPO;GPX4;COPS3
18562,GO:1903725,0.256633304497527,0.875231837114354,5,46,regulation of phospholipid metabolic process,BP,IRS1;ACSL3;PDGFB;PIK3R3;MTMR2
9302,GO:0035733,0.256642648307399,0.972230524106221,1,4,hepatic stellate cell activation,BP,GCLC
20062,GO:2000649,0.256736442445091,0.888090591526512,4,33,regulation of sodium ion transmembrane transporter activity,BP,CHP1;SLC9A3R1;NETO1;NEDD4L
20109,GO:2000725,0.256851605138885,0.905188453155564,3,23,regulation of cardiac muscle cell differentiation,BP,NRG1;G6PD;EDN1
7941,GO:0032515,0.25692115128735,0.887466391633651,4,36,negative regulation of phosphoprotein phosphatase activity,BP,SET;PPP4R4;SH3RF2;TNF
1294,GO:0003104,0.257008926462276,0.972145968703442,1,4,positive regulation of glomerular filtration,BP,PDGFB
16197,GO:0090199,0.257088527262174,0.886807824403546,4,40,regulation of release of cytochrome c from mitochondria,BP,MMP9;TP53;CLU;GPER1
10685,GO:0043921,0.257283620967502,0.904669103247102,3,24,modulation by host of viral transcription,BP,NUCKS1;TARDBP;CCL5
13356,GO:0052312,0.257283620967502,0.904669103247102,3,24,modulation of transcription in other organism involved in symbiotic interaction,BP,NUCKS1;TARDBP;CCL5
13375,GO:0052472,0.257283620967502,0.904669103247102,3,24,modulation by host of symbiont transcription,BP,NUCKS1;TARDBP;CCL5
6062,GO:0019207,0.25732846257985,0.826711896610571,14,161,kinase regulator activity,MF,NRG1;CDKN2A;CHP1;CDK4;HSPB1;DDX3X;SOCS1;PIK3R3;HSP90AB1;FAF1;CCL5;FGFR1OP;DAXX;CDKN1A
18564,GO:1903727,0.257385855031477,0.904612385973154,3,24,positive regulation of phospholipid metabolic process,BP,IRS1;ACSL3;PDGFB
690,GO:0001906,0.257408633857844,0.864262682966582,6,67,cell killing,BP,IL7R;EMP2;HSP90AB1;SERPINB9;HMGN2;DNASE1
6204,GO:0019692,0.257473030197535,0.903466494770465,3,29,deoxyribose phosphate metabolic process,BP,SMUG1;TYMS;TBPL1
16722,GO:0097676,0.25748782450794,0.97493804066512,1,3,histone H3-K36 dimethylation,BP,SETD2
14389,GO:0061614,0.257571035194372,0.887576785114104,4,33,pri-miRNA transcription by RNA polymerase II,BP,TP53;TGFB2;SRF;PDGFB
5416,GO:0016259,0.25759564549729,0.972010220713808,1,4,selenocysteine metabolic process,BP,SEPHS2
5608,GO:0016646,0.257643117626019,0.929762114137615,2,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,DHFR;QDPR
2451,GO:0005662,0.257762301394998,0.92970816010499,2,14,DNA replication factor A complex,CC,RPA1;PURB
5985,GO:0018812,0.257973292068804,0.97192264740006,1,4,3-hydroxyacyl-CoA dehydratase activity,MF,HACD2
17151,GO:0102158,0.257973292068804,0.97192264740006,1,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,HACD2
17163,GO:0102343,0.257973292068804,0.97192264740006,1,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,HACD2
17164,GO:0102344,0.257973292068804,0.97192264740006,1,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,HACD2
17165,GO:0102345,0.257973292068804,0.97192264740006,1,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,HACD2
16729,GO:0097694,0.258040166532026,0.974822754299045,1,3,establishment of RNA localization to telomere,BP,ATR
16730,GO:0097695,0.258040166532026,0.974822754299045,1,3,establishment of protein-containing complex localization to telomere,BP,ATR
7440,GO:0031544,0.258464158672828,0.971808587273636,1,4,peptidyl-proline 3-dioxygenase activity,MF,P3H2
7043,GO:0030811,0.258513890089264,0.864415637353236,6,55,regulation of nucleotide catabolic process,BP,NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54
11137,GO:0045159,0.25854407808713,0.971789991980373,1,4,myosin II binding,MF,SLC9A3R1
20322,GO:2001268,0.258671445701014,0.970025594521897,1,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,MMP9
15229,GO:0071359,0.25878054165842,0.863962621517139,6,58,cellular response to dsRNA,BP,TSN;ZC3H7B;DGCR8;NCBP1;TLR3;ESR1
18372,GO:1903313,0.258807273393859,0.864119737620122,6,56,positive regulation of mRNA metabolic process,BP,METTL16;HSPA8;NCBP1;HNRNPR;ZFP36L2;RC3H1
19512,GO:1990239,0.258887070578526,0.971710107007613,1,4,steroid hormone binding,MF,GPER1
1106,GO:0002692,0.258900496324474,0.971706977465252,1,4,negative regulation of cellular extravasation,BP,PTGER4
4804,GO:0010996,0.258978994480818,0.930355547419447,2,12,response to auditory stimulus,BP,SLC1A3;CNTNAP2
10073,GO:0042554,0.259201924986034,0.928581262857596,2,15,superoxide anion generation,BP,EDN1;SYK
15451,GO:0071706,0.259211444247456,0.855588078905809,7,73,tumor necrosis factor superfamily cytokine production,BP,AKAP8;CD274;HSPB1;CLU;SYT11;TLR3;IRAK3
3482,GO:0007346,0.25922861857241,0.789818119337518,46,577,regulation of mitotic cell cycle,BP,PML;MAP3K14;EPGN;CYP1A1;PBX1;TP53;DAPK3;EDN1;CDKN2A;STAG1;CYLD;PKMYT1;SLC9A3R1;GPR132;NBN;CDK4;PLK2;RANBP2;TOPBP1;ANAPC15;DDX3X;CDCA5;MDM4;PDGFB;ANLN;APEX1;BRCA2;E2F8;CENPF;CHEK1;ADAM17;PSME2;CEP152;PSMB9;RFWD3;TPRA1;RBL1;KIF14;RAD51B;TNF;ATAD5;ZFP36L2;HNRNPU;FGFR1OP;PSMB10;CDKN1A
12223,GO:0048386,0.25953199363069,0.971559553391505,1,4,positive regulation of retinoic acid receptor signaling pathway,BP,TRIM16
3614,GO:0008063,0.259621191040824,0.971538695054547,1,4,Toll signaling pathway,BP,TRAF3
5564,GO:0016573,0.259791667256171,0.830934690008515,12,131,histone acetylation,BP,TRIM16;CPA4;SET;NAA50;BRCA2;CHEK1;TAF6L;GTF3C4;POLE3;CLOCK;TAF1;CTCF
2330,GO:0005343,0.25982584394932,0.929324279802532,2,13,organic acid:sodium symporter activity,MF,SLC1A3;SLC25A22
340,GO:0000940,0.259877602148247,0.929300867016291,2,13,condensed chromosome outer kinetochore,CC,SKA2;CENPF
12844,GO:0051130,0.260044848131598,0.779935665630238,73,910,positive regulation of cellular component organization,BP,NEFL;NRG1;FN1;TENM3;PML;C3;COL16A1;EPGN;CTGF;MMP9;ENC1;TP53;EDN1;PDPN;AKAP8;TGFB2;DKC1;SYK;NBN;SFRP1;RPA1;TPM1;SETDB1;DYNLL2;SYNPO2L;GBP5;AKAP8L;RHOG;WNT4;LCP1;SIRPA;RANBP2;CORO1C;RRN3;ITGAV;AJUBA;FEN1;CDC42EP2;CDCA5;BAIAP2;SRF;PDGFB;FZD1;CLU;RIF1;ANLN;LRRN3;NEDD4L;ZFYVE27;L1CAM;RAB3GAP1;GPER1;FAF1;WDR75;ATR;NTN1;CFLAR;CBLL1;SHTN1;DPYSL3;UBE2J2;DDX56;SYNPO2;ESR1;EHD1;TNF;STARD7;HNRNPU;TAF1;PPARGC1B;ITGB1BP1;TSGA13;GTF2H3
8715,GO:0034349,0.260099943690467,0.929200251491088,2,13,glial cell apoptotic process,BP,TP53;TRAF2
13100,GO:0051589,0.260120228409056,0.929191068922294,2,13,negative regulation of neurotransmitter transport,BP,SYT11;ARL6IP5
3362,GO:0007100,0.260523484312806,0.929008410754892,2,13,mitotic centrosome separation,BP,RANBP2;CHEK1
13896,GO:0060501,0.26064410413241,0.971298871323274,1,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,FGFR2
1118,GO:0002704,0.260801787222299,0.902209130200655,3,26,negative regulation of leukocyte mediated immunity,BP,IL7R;THOC1;SERPINB9
12341,GO:0048678,0.260818524863951,0.87213444392361,5,49,response to axon injury,BP,NEFL;NAIP;DHFR;TNC;DPYSL3
13074,GO:0051546,0.260855585162998,0.928857824651772,2,13,keratinocyte migration,BP,KRT2;MMP9
11520,GO:0045990,0.260997960355459,0.97121564296715,1,4,carbon catabolite regulation of transcription,BP,SRF
11521,GO:0045991,0.260997960355459,0.97121564296715,1,4,carbon catabolite activation of transcription,BP,SRF
2646,GO:0005981,0.261073287663376,0.971197908015479,1,4,regulation of glycogen catabolic process,BP,PPP1R3B
11976,GO:0047134,0.261149011729051,0.969411337862754,1,5,protein-disulfide reductase activity,MF,PGK1
1170,GO:0002790,0.261284052778973,0.799594465804046,29,346,peptide secretion,BP,SAA1;TRIM16;FN1;PML;GNPTAB;IL1R2;IRS1;EDN1;GBP1;TGFB2;SYK;SFRP1;CD274;KCNS3;PTGER4;GBP5;RAB26;ITGAV;SOCS1;ARNTL;SYT11;M6PR;GPER1;TRAF2;CLOCK;TNF;CCL5;CD74;PANX1
15808,GO:0072413,0.261324526218327,0.861953599239968,6,61,signal transduction involved in mitotic cell cycle checkpoint,BP,PML;TP53;PLK2;MDM4;E2F8;CDKN1A
18008,GO:1902402,0.261324526218327,0.861953599239968,6,61,signal transduction involved in mitotic DNA damage checkpoint,BP,PML;TP53;PLK2;MDM4;E2F8;CDKN1A
18009,GO:1902403,0.261324526218327,0.861953599239968,6,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,PML;TP53;PLK2;MDM4;E2F8;CDKN1A
13749,GO:0060297,0.261441453671373,0.974106148672327,1,3,regulation of sarcomere organization,BP,EDN1
6603,GO:0022617,0.261550368208146,0.862216906617448,6,56,extracellular matrix disassembly,BP,FN1;MMP9;FBN1;HSPG2;PDPN;LCP1
18336,GO:1903232,0.261607531401389,0.9692968854069,1,5,melanosome assembly,BP,RAB32
7083,GO:0030866,0.261735422945193,0.884816238597182,4,34,cortical actin cytoskeleton organization,BP,KIF23;RTKN2;ANLN;TNF
1171,GO:0002791,0.261890695551203,0.805892769206204,23,271,regulation of peptide secretion,BP,SAA1;TRIM16;FN1;PML;IL1R2;IRS1;GBP1;TGFB2;SYK;SFRP1;CD274;KCNS3;PTGER4;SOCS1;ARNTL;SYT11;GPER1;TRAF2;CLOCK;TNF;CCL5;CD74;PANX1
4741,GO:0010906,0.261924146211927,0.854033251838155,7,67,regulation of glucose metabolic process,BP,IGFBP3;IRS1;C1QTNF1;PPP1R3B;LEPR;RANBP2;ENPP1
16103,GO:0090051,0.262000045955938,0.928337791280531,2,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,STARD13;ITGB1BP1
2249,GO:0005159,0.262074043740105,0.928304108881641,2,13,insulin-like growth factor receptor binding,MF,IRS1;SOCS1
20019,GO:2000576,0.262092571405238,0.969175549916089,1,5,positive regulation of microtubule motor activity,BP,DYNLL2
7787,GO:0032306,0.262200341507069,0.969148553853292,1,5,regulation of prostaglandin secretion,BP,EDN1
7788,GO:0032308,0.262200341507069,0.969148553853292,1,5,positive regulation of prostaglandin secretion,BP,EDN1
10569,GO:0043516,0.262375547516124,0.901565524565213,3,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,SMYD2;ATR;CD74
7700,GO:0032148,0.262558743014155,0.901725740994456,3,24,activation of protein kinase B activity,BP,NRG1;PDGFB;ITGB1BP1
756,GO:0001993,0.262751953920874,0.970801073463198,1,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,TPM1
10062,GO:0042535,0.262762822583591,0.970798494062923,1,4,positive regulation of tumor necrosis factor biosynthetic process,BP,HSPB1
14711,GO:0070318,0.262988129267882,0.970744994069847,1,4,positive regulation of G0 to G1 transition,BP,CTGF
2710,GO:0006082,0.263142004624156,0.779729801046466,63,829,organic acid metabolic process,BP,PTGES;CYP1B1;GCLC;C3;UGT1A6;STAT5A;FADS3;SLC7A2;CYP1A1;B4GALT1;IRS1;SLC16A9;PANK2;EDN1;TPST1;SCD;ACSL3;NQO1;PRUNE2;CHP1;ACO1;CARS2;PGD;NUP50;SYK;NUP153;ABCG2;LDHAL6B;SLC5A6;DHFR;NDC1;SLC1A3;RANBP2;ODC1;CROT;AKR1C2;PGK1;HACD2;GATC;RARS;QDPR;PDGFB;NUP160;ENPP1;NUP54;SEPHS2;NNT;SCD5;DPYD;MMAA;PSME2;HADHB;PSMB9;SDHD;UGT1A4;AZIN1;ARV1;TYMS;CD74;PSMB10;HIBCH;PPARGC1B;GPX4
15104,GO:0071072,0.263149850025,0.97070655847264,1,4,negative regulation of phospholipid biosynthetic process,BP,PDGFB
9174,GO:0035521,0.26328554311802,0.970674286627935,1,4,monoubiquitinated histone deubiquitination,BP,USP16
9175,GO:0035522,0.26328554311802,0.970674286627935,1,4,monoubiquitinated histone H2A deubiquitination,BP,USP16
18992,GO:1904738,0.263473721351033,0.928331065871453,2,12,vascular associated smooth muscle cell migration,BP,TPM1;PDGFB
19002,GO:1904752,0.263473721351033,0.928331065871453,2,12,regulation of vascular associated smooth muscle cell migration,BP,TPM1;PDGFB
9390,GO:0035912,0.263537173630879,0.970614387915248,1,4,dorsal aorta morphogenesis,BP,SRF
15797,GO:0072384,0.263737503738754,0.852655234652459,7,68,organelle transport along microtubule,BP,NEFL;KIF23;AP3M2;LRPPRC;BLOC1S2;TRAK2;AP3B1
9984,GO:0042363,0.263820932225336,0.970546757919974,1,4,fat-soluble vitamin catabolic process,BP,CYP24A1
11313,GO:0045616,0.263932736305722,0.883272128758148,4,35,regulation of keratinocyte differentiation,BP,TRIM16;RUNX1;CD109;IL20
9804,GO:0040014,0.264131517503741,0.870380592960962,5,45,regulation of multicellular organism growth,BP,FGFR2;STAT5A;CDK4;CSF1;FTO
3125,GO:0006705,0.264184598442802,0.970459953651827,1,4,mineralocorticoid biosynthetic process,BP,WNT4
3703,GO:0008212,0.264184598442802,0.970459953651827,1,4,mineralocorticoid metabolic process,BP,WNT4
7798,GO:0032341,0.264184598442802,0.970459953651827,1,4,aldosterone metabolic process,BP,WNT4
7799,GO:0032342,0.264184598442802,0.970459953651827,1,4,aldosterone biosynthetic process,BP,WNT4
7800,GO:0032344,0.264184598442802,0.970459953651827,1,4,regulation of aldosterone metabolic process,BP,WNT4
7803,GO:0032347,0.264184598442802,0.970459953651827,1,4,regulation of aldosterone biosynthetic process,BP,WNT4
8841,GO:0034618,0.264194792535057,0.970457518307076,1,4,arginine binding,MF,RARS
16502,GO:0097167,0.264269518746213,0.970439662901106,1,4,circadian regulation of translation,BP,RBM4
3367,GO:0007131,0.264270443274963,0.88289592207334,4,36,reciprocal meiotic recombination,BP,BRIP1;PSMC3IP;MSH3;RAD51B
9347,GO:0035825,0.264270443274963,0.88289592207334,4,36,homologous recombination,BP,BRIP1;PSMC3IP;MSH3;RAD51B
6680,GO:0030038,0.264599641605824,0.852032905199064,7,68,contractile actin filament bundle assembly,BP,CTGF;SFRP1;TPM1;PTGER4;WNT4;SRF;ITGB1BP1
10357,GO:0043149,0.264599641605824,0.852032905199064,7,68,stress fiber assembly,BP,CTGF;SFRP1;TPM1;PTGER4;WNT4;SRF;ITGB1BP1
12676,GO:0050861,0.264727419408573,0.970330115980136,1,4,positive regulation of B cell receptor signaling pathway,BP,CMTM3
2970,GO:0006509,0.264738609385822,0.882602664999728,4,36,membrane protein ectodomain proteolysis,BP,ERAP1;BACE2;ADAM17;TNF
14943,GO:0070778,0.264825270019608,0.970306676542373,1,4,L-aspartate transmembrane transport,BP,SLC1A3
1002,GO:0002468,0.264975282665434,0.970270721582876,1,4,dendritic cell antigen processing and presentation,BP,CD74
1066,GO:0002604,0.264975282665434,0.970270721582876,1,4,regulation of dendritic cell antigen processing and presentation,BP,CD74
4642,GO:0010762,0.265050329666578,0.900323578774638,3,24,regulation of fibroblast migration,BP,CORO1C;WDPCP;ITGB1BP1
7470,GO:0031623,0.265456487995106,0.859228623305871,6,59,receptor internalization,BP,TFRC;SYK;ADM;UBQLN2;ACKR3;MTMR2
11240,GO:0045359,0.265503064547476,0.970144026079179,1,4,positive regulation of interferon-beta biosynthetic process,BP,TLR3
2358,GO:0005452,0.265512600971798,0.926731112940066,2,13,inorganic anion exchanger activity,MF,SLC4A11;SLC22A5
9879,GO:0042129,0.265583620217778,0.844264111852769,8,88,regulation of T cell proliferation,BP,TFRC;LGALS3;IL6ST;SYK;CD274;RC3H1;CCL5;IRF1
781,GO:0002036,0.265877786546979,0.970053886679712,1,4,regulation of L-glutamate import across plasma membrane,BP,ARL6IP5
4775,GO:0010958,0.265877786546979,0.970053886679712,1,4,regulation of amino acid import across plasma membrane,BP,ARL6IP5
7074,GO:0030856,0.265877798587069,0.838764548394565,9,94,regulation of epithelial cell differentiation,BP,TRIM16;RUNX1;FAT4;KEAP1;CD109;ARNTL;IL20;CLOCK;TNF
13264,GO:0051918,0.266008738199829,0.970022349743147,1,4,negative regulation of fibrinolysis,BP,THBD
14595,GO:0070122,0.266309723500265,0.96994979208816,1,4,isopeptidase activity,MF,SENP1
2992,GO:0006537,0.266319490023979,0.9699474360261,1,4,glutamate biosynthetic process,BP,SLC1A3
8294,GO:0033093,0.26633626362679,0.96994338934075,1,4,Weibel-Palade body,CC,EDN1
7209,GO:0031093,0.2664318376483,0.881382892165605,4,37,platelet alpha granule lumen,CC,FN1;TGFB2;PDGFB;CLU
19904,GO:2000348,0.266523518992897,0.969898192299108,1,4,regulation of CD40 signaling pathway,BP,FANCD2
4017,GO:0009019,0.266583363169643,0.969883739799044,1,4,tRNA (guanine-N1-)-methyltransferase activity,MF,TRMT5
18169,GO:1902882,0.266754961039528,0.858079404188762,6,62,regulation of response to oxidative stress,BP,TP53;DHFR;HSPB1;SOD2;FZD1;TNF
5286,GO:0015936,0.266797457154513,0.925069878436362,2,15,coenzyme A metabolic process,BP,PANK2;CROT
11257,GO:0045428,0.266827574829759,0.881291075759686,4,36,regulation of nitric oxide biosynthetic process,BP,EDN1;CLU;HSP90AB1;TNF
13529,GO:0055078,0.266944697235292,0.926071465658913,2,13,sodium ion homeostasis,BP,EDN1;NEDD4L
18272,GO:1903059,0.267060609368102,0.969768342250967,1,4,regulation of protein lipidation,BP,RAB3GAP1
18273,GO:1903061,0.267060609368102,0.969768342250967,1,4,positive regulation of protein lipidation,BP,RAB3GAP1
16446,GO:0097065,0.26713119054229,0.969751254450145,1,4,anterior head development,BP,DDX10
8989,GO:0035089,0.267135755492847,0.925983259879167,2,13,establishment of apical/basal cell polarity,BP,SLC9A3R1;OPHN1
315,GO:0000827,0.267145991526447,0.969747670412905,1,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,PPIP5K1
316,GO:0000828,0.267145991526447,0.969747670412905,1,4,inositol hexakisphosphate kinase activity,MF,PPIP5K1
317,GO:0000829,0.267145991526447,0.969747670412905,1,4,inositol heptakisphosphate kinase activity,MF,PPIP5K1
318,GO:0000832,0.267145991526447,0.969747670412905,1,4,inositol hexakisphosphate 5-kinase activity,MF,PPIP5K1
13418,GO:0052723,0.267145991526447,0.969747670412905,1,4,inositol hexakisphosphate 1-kinase activity,MF,PPIP5K1
13419,GO:0052724,0.267145991526447,0.969747670412905,1,4,inositol hexakisphosphate 3-kinase activity,MF,PPIP5K1
12728,GO:0050927,0.267421319669665,0.925274120112083,2,14,positive regulation of positive chemotaxis,BP,IL16;CDH13
6868,GO:0030332,0.267568403976433,0.898898741280815,3,24,cyclin binding,MF,RBM4;CDK4;CDKN1A
862,GO:0002190,0.267607591950386,0.96777683817378,1,5,cap-independent translational initiation,BP,RBM4
4095,GO:0009148,0.267789492228844,0.923795575786574,2,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,TYMS;TBPL1
15232,GO:0071362,0.267820761998524,0.96958401847942,1,4,cellular response to ether,BP,CDK4
8309,GO:0033133,0.267869189539083,0.969572253989621,1,4,positive regulation of glucokinase activity,BP,RANBP2
14645,GO:0070200,0.267913971337313,0.925044709370093,2,14,establishment of protein localization to telomere,BP,DKC1;BRCA2
6445,GO:0021756,0.268029699191756,0.925569923953698,2,13,striatum development,BP,INHBA;CNTNAP2
7858,GO:0032413,0.268192986374326,0.880431071335748,4,36,negative regulation of ion transmembrane transporter activity,BP,MMP9;SLC9A3R1;THADA;NEDD4L
16402,GO:0090734,0.268245666011753,0.880565755949144,4,35,site of DNA damage,CC,NBN;RIF1;RAD18;RFWD3
16312,GO:0090394,0.268285763899792,0.969470948490336,1,4,negative regulation of excitatory postsynaptic potential,BP,MTMR2
8622,GO:0034127,0.268297879830121,0.969467999177559,1,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TLR3
8214,GO:0032960,0.268502397680233,0.96941819001331,1,4,regulation of inositol trisphosphate biosynthetic process,BP,GPER1
20114,GO:2000736,0.269009716278371,0.835427662003574,9,122,regulation of stem cell differentiation,BP,RUNX1;TGFB2;H3F3A;PSME2;PSMB9;ZFP36L2;HNRNPU;PSMB10;HIST1H4A
12236,GO:0048471,0.269048673482113,0.783179096318749,42,515,perinuclear region of cytoplasm,CC,SPRR3;PTGES;TFRC;CTGF;MYO1B;ACSL3;CYLD;SLC9A3R1;INHBA;CDK4;HRNR;CASC3;LCP1;PTPRM;RANBP2;SET;ODC1;TRIM37;MCM3;CDH13;HIF1AN;CLU;LRPPRC;ACKR3;SRD5A1;SLC11A2;APEX1;SYT11;M6PR;CCAR1;CENPF;SRFBP1;GPER1;FAF1;NFKBIE;SHTN1;AKR1B1;CSF1;FGFR1OP;CDKN1A;ITGB1BP1;MRFAP1
12585,GO:0050718,0.26922332828948,0.924433450230969,2,14,positive regulation of interleukin-1 beta secretion,BP,TRIM16;PANX1
19582,GO:1990511,0.269280340400429,0.969228302996449,1,4,piRNA biosynthetic process,BP,MYBL1
907,GO:0002286,0.26928477108324,0.866573806172645,5,48,T cell activation involved in immune response,BP,LGALS3;RELB;PTGER4;LCP1;RC3H1
12810,GO:0051085,0.269382918314258,0.897345565563273,3,26,chaperone cofactor-dependent protein refolding,BP,BAG1;HSPA8;CD74
12548,GO:0050673,0.269391161317573,0.800933061598514,22,257,epithelial cell proliferation,BP,IGFBP3;KRT4;KRT2;FGFR2;STAT5A;EPGN;B4GALT1;TGFB2;SFRP1;CD109;PTPRM;CDH13;PDGFB;PDCL3;BRCA2;ADAM17;CFLAR;ESR1;TNF;CCL5;NRAS;ITGB1BP1
9895,GO:0042162,0.269705065675515,0.879645141691864,4,35,telomeric DNA binding,MF,RPA1;APEX1;TELO2;NCL
12683,GO:0050868,0.269751325358703,0.856129049488951,6,60,negative regulation of T cell activation,BP,LGALS3;CYLD;CD274;RC3H1;CD74;IRF1
1391,GO:0003298,0.269847879711922,0.924726045021255,2,13,physiological muscle hypertrophy,BP,G6PD;EDN1
1394,GO:0003301,0.269847879711922,0.924726045021255,2,13,physiological cardiac muscle hypertrophy,BP,G6PD;EDN1
14187,GO:0061049,0.269847879711922,0.924726045021255,2,13,cell growth involved in cardiac muscle cell development,BP,G6PD;EDN1
9364,GO:0035867,0.269888292213429,0.972276429096965,1,3,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,ITGAV
6400,GO:0021603,0.26993848644789,0.96906713282132,1,4,cranial nerve formation,BP,MAFB
18709,GO:1904029,0.270019754651293,0.847647573045989,7,75,regulation of cyclin-dependent protein kinase activity,BP,CDKN2A;PKMYT1;CDK4;CDC25A;PDGFB;ADAM17;CDKN1A
3143,GO:0006739,0.270086150526946,0.896712074083208,3,27,NADP metabolic process,BP,G6PD;PGD;NNT
15641,GO:0072111,0.270099392441097,0.924023221574115,2,14,cell proliferation involved in kidney development,BP,PDGFB;CFLAR
11308,GO:0045604,0.270169200365552,0.865977510528226,5,48,regulation of epidermal cell differentiation,BP,TRIM16;RUNX1;KEAP1;CD109;IL20
7114,GO:0030905,0.270309521367694,0.968976059895558,1,4,retromer, tubulation complex,CC,SNX5
3666,GO:0008157,0.270358174487222,0.923901852043845,2,14,protein phosphatase 1 binding,MF,SH3RF2;PHACTR4
1442,GO:0003418,0.270381839593743,0.968958291107276,1,4,growth plate cartilage chondrocyte differentiation,BP,COL27A1
1446,GO:0003431,0.270381839593743,0.968958291107276,1,4,growth plate cartilage chondrocyte development,BP,COL27A1
6704,GO:0030100,0.270790765393958,0.81591887964129,14,157,regulation of endocytosis,BP,C3;LGALS3;SYK;OPHN1;UBQLN2;SIRPA;ITGAV;CDH13;CLU;SYT11;NEDD4L;MTMR2;CBLL1;TNF
20268,GO:2001179,0.270799220143465,0.966951263160442,1,5,regulation of interleukin-10 secretion,BP,CD274
12575,GO:0050708,0.27085604582138,0.799664120890888,22,259,regulation of protein secretion,BP,SAA1;TRIM16;FN1;PML;IL1R2;IRS1;GBP1;TGFB2;SYK;SFRP1;CD274;KCNS3;PTGER4;SOCS1;ARNTL;SYT11;GPER1;TRAF2;CLOCK;TNF;CCL5;PANX1
14537,GO:0070011,0.271048379700134,0.791020374533649,29,359,peptidase activity, acting on L-amino acid peptides,MF,C1R;C3;MMP9;OVCH2;C9ORF3;PRSS23;CYLD;SFRP1;USP16;RCE1;ADAMTS9;IMMP2L;USP43;MME;CPA4;BRCC3;USP6;ERAP1;BACE2;DNPEP;ADAM17;SENP1;CFLAR;PSMB9;USP11;CAPN12;PSMB10;METAP2;USP1
12397,GO:0048787,0.271104266663074,0.968780469621687,1,4,presynaptic active zone membrane,CC,SYT11
19903,GO:2000347,0.271164362630836,0.96876565117296,1,4,positive regulation of hepatocyte proliferation,BP,CFLAR
608,GO:0001774,0.271341605954074,0.92402954441203,2,13,microglial cell activation,BP,CLU;TLR3
19206,GO:1905232,0.271506178258731,0.968681289907803,1,4,cellular response to L-glutamate,BP,BAIAP2
5549,GO:0016538,0.271636575719203,0.895605626676164,3,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN2A;CDK4;CDKN1A
20209,GO:2001021,0.271697290764887,0.854596090031585,6,62,negative regulation of response to DNA damage stimulus,BP,POLQ;THOC1;CLU;ACKR3;RIF1;CD74
13177,GO:0051731,0.271714091346202,0.968629912618442,1,4,polynucleotide 5'-hydroxyl-kinase activity,MF,NOL9
16567,GO:0097306,0.271722459318208,0.865557858542755,5,43,cellular response to alcohol,BP,HMGCS1;AKAP8;INHBA;SFRP1;PTGER4
1274,GO:0003062,0.271728024448524,0.968626467895819,1,4,regulation of heart rate by chemical signal,BP,TPM1
2459,GO:0005671,0.271843690253351,0.923203451661254,2,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,UBAP2L;POLE3
7018,GO:0030705,0.271889945927895,0.815138059917566,14,152,cytoskeleton-dependent intracellular transport,BP,NEFL;KIF23;DYNC2H1;AP3M2;DST;DYNLL2;HSPB1;LRPPRC;BLOC1S2;HSPA8;TRAK2;MYO10;AP3B1;KIF14
15160,GO:0071243,0.272022607882967,0.922168816515372,2,16,cellular response to arsenic-containing substance,BP,DDX3X;DAXX
10539,GO:0043467,0.272039449284815,0.834119324267806,9,93,regulation of generation of precursor metabolites and energy,BP,IRS1;PPP1R3B;NUP50;NUP153;NDC1;RANBP2;NUP160;ENPP1;NUP54
15484,GO:0071804,0.272462026107246,0.839545911611508,8,80,cellular potassium ion transport,BP,KCNS3;SLC1A3;KCNQ5;NETO1;ABCC9;NEDD4L;SLC9A9;KCNE4
15485,GO:0071805,0.272462026107246,0.839545911611508,8,80,potassium ion transmembrane transport,BP,KCNS3;SLC1A3;KCNQ5;NETO1;ABCC9;NEDD4L;SLC9A9;KCNE4
16875,GO:0098773,0.272528987159245,0.84620372527532,7,69,skin epidermis development,BP,FGFR2;FST;TGFB2;INHBA;WNT10A;CD109;TNF
2293,GO:0005249,0.272602362456897,0.896026912995207,3,24,voltage-gated potassium channel activity,MF,KCNS3;KCNQ5;KCNE4
16925,GO:0098862,0.272651049846638,0.839291211693404,8,82,cluster of actin-based cell projections,CC,MYO1B;B4GALT1;SLC9A3R1;SLC22A5;SLC5A6;MME;SLC11A2;HSP90AB1
9020,GO:0035184,0.2726996491954,0.968385716567784,1,4,histone threonine kinase activity,MF,CHEK1
9122,GO:0035405,0.2726996491954,0.968385716567784,1,4,histone-threonine phosphorylation,BP,CHEK1
13664,GO:0060149,0.272801722137757,0.922751516112482,2,14,negative regulation of posttranscriptional gene silencing,BP,DND1;ESR1
14132,GO:0060967,0.272801722137757,0.922751516112482,2,14,negative regulation of gene silencing by RNA,BP,DND1;ESR1
2852,GO:0006338,0.273039130476816,0.816831411501408,13,155,chromatin remodeling,BP,CDKN2A;HELLS;SUV39H2;KDM6A;UBTF;CHEK1;TAF6L;ESR1;CENPN;DAXX;HIST1H4A;SMARCC1;CENPO
12699,GO:0050891,0.273165032055771,0.864313280928851,5,45,multicellular organismal water homeostasis,BP,KRT1;HRNR;SRF;RPTN;AKR1B1
4250,GO:0009448,0.273181291900537,0.968265983685386,1,4,gamma-aminobutyric acid metabolic process,BP,SLC1A3
13594,GO:0060041,0.273212181501307,0.839165957607555,8,77,retina development in camera-type eye,BP,CYP1B1;MEGF11;TGFB2;ATP2B1;COL4A1;PTPRM;SDK1;RRM1
16759,GO:0098501,0.273292012848425,0.966298185229234,1,5,polynucleotide dephosphorylation,BP,APEX1
7280,GO:0031256,0.273295643363128,0.824160288104827,11,113,leading edge membrane,CC,NRG1;PDPN;SHISA9;ATP2B1;TPM1;LCP1;ITGAV;ANTXR1;CNTNAP2;GPER1;ADAM17
12707,GO:0050905,0.273341084210877,0.864194165850877,5,45,neuromuscular process,BP,NEFL;NRG1;CNTNAP1;NBN;SLC1A3
13645,GO:0060119,0.273454429110881,0.895537732672054,3,24,inner ear receptor cell development,BP,FAT4;SLC9A3R1;WDPCP
16181,GO:0090183,0.273482970590612,0.877078979739484,4,36,regulation of kidney development,BP,FAT4;WNT4;PDGFB;CFLAR
9109,GO:0035372,0.273494683534421,0.923020498584017,2,13,protein localization to microtubule,BP,MID1;HNRNPU
716,GO:0001938,0.273509314334741,0.853558265554281,6,59,positive regulation of endothelial cell proliferation,BP,STAT5A;CDH13;PDGFB;PDCL3;ADAM17;NRAS
16976,GO:0098957,0.27351758801057,0.968182229339293,1,4,anterograde axonal transport of mitochondrion,BP,TRAK2
15885,GO:0072588,0.273775670653783,0.963288665517895,1,8,box H/ACA RNP complex,CC,DKC1
1440,GO:0003416,0.274006575224892,0.922779712652863,2,13,endochondral bone growth,BP,FGFR2;COL27A1
2560,GO:0005839,0.274086031045705,0.919861180509772,2,20,proteasome core complex,CC,PSMB9;PSMB10
6580,GO:0022404,0.2742611980502,0.844937551353683,7,69,molting cycle process,BP,FGFR2;FST;TGFB2;INHBA;WNT10A;CD109;TNF
6581,GO:0022405,0.2742611980502,0.844937551353683,7,69,hair cycle process,BP,FGFR2;FST;TGFB2;INHBA;WNT10A;CD109;TNF
1387,GO:0003284,0.274267995073173,0.967994885215735,1,4,septum primum development,BP,TGFB2
4205,GO:0009312,0.274314601389519,0.894509358067026,3,26,oligosaccharide biosynthetic process,BP,B4GALT1;ST6GALNAC5;GALNT18
12563,GO:0050693,0.274330746248041,0.967979190433854,1,4,LBD domain binding,MF,CITED2
7593,GO:0031956,0.274540819879023,0.967926616564518,1,4,medium-chain fatty acid-CoA ligase activity,MF,ACSL3
17168,GO:0102391,0.274540819879023,0.967926616564518,1,4,decanoate-CoA ligase activity,MF,ACSL3
6172,GO:0019530,0.274668123177327,0.967894733094704,1,4,taurine metabolic process,BP,STAT5A
6206,GO:0019694,0.274668123177327,0.967894733094704,1,4,alkanesulfonate metabolic process,BP,STAT5A
18410,GO:1903392,0.274725380765067,0.92244102261579,2,13,negative regulation of adherens junction organization,BP,CORO1C;ITGB1BP1
11302,GO:0045598,0.274756117383715,0.837657253207508,8,83,regulation of fat cell differentiation,BP,TRIO;SFRP1;ARNTL;ENPP1;GPER1;TNF;ZFP36L2;FTO
7919,GO:0032486,0.274756950968117,0.922426131824539,2,13,Rap protein signal transduction,BP,PLK2;KIF14
14340,GO:0061476,0.274785194083996,0.967865396341371,1,4,response to anticoagulant,BP,SFRP1
15329,GO:0071503,0.274785194083996,0.967865396341371,1,4,response to heparin,BP,SFRP1
15330,GO:0071504,0.274785194083996,0.967865396341371,1,4,cellular response to heparin,BP,SFRP1
15060,GO:0070988,0.275089236349616,0.852713259611638,6,56,demethylation,BP,CYP1A1;KDM6A;UTY;APEX1;TET3;FTO
10634,GO:0043621,0.275137340410646,0.863250345345065,5,43,protein self-association,MF,TP53;SLC9A3R1;VPS41;ZFYVE27;CCL5
820,GO:0002090,0.27513765590921,0.894289535553256,3,25,regulation of receptor internalization,BP,SYK;UBQLN2;MTMR2
18578,GO:1903763,0.275142162223204,0.967775849075945,1,4,gap junction channel activity involved in cell communication by electrical coupling,MF,GJC1
13505,GO:0055022,0.275234559845701,0.921598484191968,2,14,negative regulation of cardiac muscle tissue growth,BP,G6PD;MIR17HG
14223,GO:0061117,0.275234559845701,0.921598484191968,2,14,negative regulation of heart growth,BP,G6PD;MIR17HG
18269,GO:1903053,0.275268984486237,0.89479837111785,3,23,regulation of extracellular matrix organization,BP,PDPN;ANTXR1;CFLAR
10477,GO:0043330,0.275526989301506,0.893807531170874,3,26,response to exogenous dsRNA,BP,DDX21;TLR3;IRAK3
1305,GO:0003140,0.275557847927728,0.967671392266487,1,4,determination of left/right asymmetry in lateral mesoderm,BP,CITED2
20332,GO:2001286,0.275584392290476,0.967664715408157,1,4,regulation of caveolin-mediated endocytosis,BP,NEDD4L
6816,GO:0030263,0.275620183603581,0.96765571135958,1,4,apoptotic chromosome condensation,BP,GPER1
4785,GO:0010970,0.275641719026757,0.818345186188847,12,131,transport along microtubule,BP,NEFL;KIF23;DYNC2H1;AP3M2;DST;DYNLL2;HSPB1;LRPPRC;BLOC1S2;HSPA8;TRAK2;AP3B1
17030,GO:0099111,0.275641719026757,0.818345186188847,12,131,microtubule-based transport,BP,NEFL;KIF23;DYNC2H1;AP3M2;DST;DYNLL2;HSPB1;LRPPRC;BLOC1S2;HSPA8;TRAK2;AP3B1
12532,GO:0050656,0.27581730456351,0.967606095740381,1,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,ENPP1
14585,GO:0070100,0.275921474446871,0.967579858433138,1,4,negative regulation of chemokine-mediated signaling pathway,BP,CCL5
13946,GO:0060586,0.276051676672384,0.967547047230684,1,4,multicellular organismal iron ion homeostasis,BP,SLC11A2
11414,GO:0045786,0.276086738105309,0.77680919379688,42,535,negative regulation of cell cycle,BP,PML;MAP3K14;CBX5;TP53;CDKN2A;TGFB2;RAD1;SLC9A3R1;INHBA;GPR132;NBN;BRIP1;CDK4;PLK2;RRAGB;WDR76;THOC1;TOPBP1;ANAPC15;TRIM37;MDM4;BRCC3;RRM2;HSP90AB1;E2F8;CENPF;CHEK1;GPER1;ATR;PSME2;PSMB9;RFWD3;TPRA1;TIMELESS;RBL1;CLOCK;TNF;ZFP36L2;RING1;PSMB10;CDKN1A;IRF1
8707,GO:0034334,0.276098957795771,0.967535127591344,1,4,adherens junction maintenance,BP,PLEKHA7
872,GO:0002218,0.27616684655562,0.801928055272465,18,214,activation of innate immune response,BP,TRAF3;CYLD;IKBKE;SYK;RELB;MUC16;BIRC3;PSME2;PSMB9;TLR3;ESR1;PSMB10;NRAS;PSPC1;MUC5B;MUC6;IRF1;IRAK3
10991,GO:0044773,0.276250402784792,0.830630098920445,9,99,mitotic DNA damage checkpoint,BP,PML;TP53;NBN;PLK2;TOPBP1;MDM4;E2F8;RFWD3;CDKN1A
347,GO:0000960,0.276419269790574,0.967454310390875,1,4,regulation of mitochondrial RNA catabolic process,BP,LRPPRC
6287,GO:0019888,0.276459879975545,0.851216128216351,6,62,protein phosphatase regulator activity,MF,IGFBP3;PPP1R3B;SET;PPP4R4;SH3RF2;PHACTR4
17472,GO:1900227,0.276530390332058,0.967426246901779,1,4,positive regulation of NLRP3 inflammasome complex assembly,BP,GBP5
18052,GO:1902531,0.27667867386437,0.758921722861929,103,1313,regulation of intracellular signal transduction,BP,IGFBP3;SAA1;NRG1;FN1;PML;CYP1B1;AMOT;JPH2;MAP3K14;CYR61;FGFR2;EPGN;TRIM22;STARD13;CTGF;MMP9;IRS1;MID1;TP53;EXO1;EDN1;GBP1;SIPA1L3;C1QTNF1;DUSP14;CHP1;TGFB2;CYLD;IKBKE;RAD1;IL6ST;SLC9A3R1;NUAK1;INHBA;IL7R;SYK;NBN;TRIO;BRIP1;SFRP1;RPA1;TAF2;ULK4;OPHN1;CCL20;PLK2;RRAGB;RFC3;HSPB1;RHOG;NOP2;TOPBP1;SOD2;SUPT16H;ATP2C1;DDX3X;IL24;ARHGEF28;RRN3;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;GADD45B;CDH13;MDM4;NPNT;PDGFB;CLU;SMYD2;BIRC3;IL20;ACKR3;FGD6;RPF2;GLIPR2;JPH1;ARL6IP5;EPHB6;CHEK1;GPER1;ATR;CFLAR;AKR1B1;TRAF2;TELO2;CSF1;KIF14;TLR3;ESR1;TNF;RC3H1;CCL5;CD74;DAXX;PHLPP2;TAF1;PHLPP1;ITGB1BP1;IRAK3
4789,GO:0010976,0.276740000225462,0.803768467965363,17,186,positive regulation of neuron projection development,BP,NEFL;NRG1;FN1;TENM3;ENC1;RRN3;BAIAP2;SRF;FZD1;NEDD4L;ZFYVE27;L1CAM;NTN1;CFLAR;SHTN1;DPYSL3;DDX56
6568,GO:0022011,0.277016799296187,0.894501006229808,3,21,myelination in peripheral nervous system,BP,CNTNAP1;MPP5;PARD3
7777,GO:0032292,0.277016799296187,0.894501006229808,3,21,peripheral nervous system axon ensheathment,BP,CNTNAP1;MPP5;PARD3
12793,GO:0051049,0.277269765936667,0.760857140634692,88,1117,regulation of transport,BP,CRYAB;SAA1;NRG1;TRIM16;FN1;PML;JPH2;C3;MMP9;IL1R2;G6PD;IRS1;TP53;EDN1;GBP1;C1QTNF1;RBM4;ACSL3;PTPN14;LGALS3;CHP1;TGFB2;RBM22;IL16;SLC9A3R1;INHBA;SYK;NUP153;SHISA9;SFRP1;VPS41;CD274;REEP1;KCNS3;PTGER4;OPHN1;CADPS2;DYNLL2;UBQLN2;AKAP8L;LCP1;SIRPA;RAB26;ITGAV;SOCS1;ARNTL;KCNQ5;NETO1;YRDC;CDH13;PDGFB;TBC1D15;CLU;USP6;ENPP1;PIK3R3;NUP54;SETD2;JPH1;THADA;HSPA8;SYT11;HSP90AB1;ARL6IP5;NSF;NEDD4L;SGK1;MTMR2;GOSR1;RAB3GAP1;GPER1;WDR75;CBLL1;UBE2J2;TRAF2;CLOCK;AZIN1;EHD1;KCNE4;ARV1;TNF;STARD7;CCL5;CD74;PANX1;CDKN1A;ITGB1BP1;TSGA13
6994,GO:0030667,0.277326674664749,0.803109037600959,17,196,secretory granule membrane,CC,B4GALT1;LGALS3;PCDH7;PTPRB;ABCC4;MGAM;CD109;SLCO4C1;MME;RHOG;SIRPA;RAB26;ITGAV;LAIR1;LILRB3;GLIPR1;NRAS
10805,GO:0044270,0.277380097487553,0.776715857714933,40,544,cellular nitrogen compound catabolic process,BP,PABPC4;DKC1;NUP50;NUP153;POP1;TARDBP;NDC1;CASC3;HSPB1;EXOG;RANBP2;SET;MRTO4;FASTKD3;PGK1;FEN1;NUP160;ENPP1;NUP54;LRPPRC;METTL16;APEX1;TET3;HSPA8;SMUG1;SYNCRIP;DPYD;PSME2;PSMB9;UGT1A4;NCBP1;UPF3B;HNRNPR;DNASE1;ZFP36L2;RC3H1;HNRNPU;PSMB10;RBM8A;RPS12
19589,GO:1990564,0.277615386016059,0.965148226424936,1,5,protein polyufmylation,BP,UFC1
19602,GO:1990592,0.277615386016059,0.965148226424936,1,5,protein K69-linked ufmylation,BP,UFC1
16272,GO:0090309,0.277665212916072,0.967138852983398,1,4,positive regulation of methylation-dependent chromatin silencing,BP,SETDB1
3541,GO:0007565,0.27799249119434,0.820141440457975,11,122,female pregnancy,BP,COL16A1;MMP9;VMP1;TFCP2L1;EMP2;ADM;WNT4;THBD;UMPS;AKR1B1;ESR1
5709,GO:0016835,0.278033705336018,0.860121973437481,5,53,carbon-oxygen lyase activity,MF,ACO1;POLQ;HACD2;APEX1;HADHB
50,GO:0000104,0.278129757533657,0.965009944334113,1,5,succinate dehydrogenase activity,MF,SDHD
2501,GO:0005749,0.278129757533657,0.965009944334113,1,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,SDHD
3678,GO:0008177,0.278129757533657,0.965009944334113,1,5,succinate dehydrogenase (ubiquinone) activity,MF,SDHD
11191,GO:0045257,0.278129757533657,0.965009944334113,1,5,succinate dehydrogenase complex (ubiquinone),CC,SDHD
11196,GO:0045273,0.278129757533657,0.965009944334113,1,5,respiratory chain complex II,CC,SDHD
11200,GO:0045281,0.278129757533657,0.965009944334113,1,5,succinate dehydrogenase complex,CC,SDHD
11202,GO:0045283,0.278129757533657,0.965009944334113,1,5,fumarate reductase complex,CC,SDHD
10161,GO:0042730,0.278228897720539,0.919643001361564,2,15,fibrinolysis,BP,KRT1;THBD
15845,GO:0072529,0.278249858092559,0.891985049742135,3,27,pyrimidine-containing compound catabolic process,BP,TET3;SMUG1;DPYD
12657,GO:0050830,0.278250034765698,0.890720053092614,3,34,defense response to Gram-positive bacterium,BP,IL27RA;ADAM17;TNF
17918,GO:1902176,0.278252343841355,0.919175058006599,2,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,HSPB1;SOD2
19807,GO:2000191,0.278345346686188,0.920112885218765,2,14,regulation of fatty acid transport,BP,EDN1;SYK
3950,GO:0008649,0.278381356414672,0.919112521079985,2,16,rRNA methyltransferase activity,MF,NOP2;METTL16
17328,GO:0140102,0.278381356414672,0.919112521079985,2,16,catalytic activity, acting on a rRNA,MF,NOP2;METTL16
10633,GO:0043620,0.278641913046819,0.828483381494399,9,107,regulation of DNA-templated transcription in response to stress,BP,TP53;HIF1AN;HSF2;CHEK1;PSME2;PSMB9;CITED2;PSMB10;TAF1
7647,GO:0032052,0.278810709106895,0.964826398292523,1,5,bile acid binding,MF,AKR1C2
4522,GO:0010573,0.278830930103122,0.8921465241412,3,25,vascular endothelial growth factor production,BP,CYP1B1;C3;IL6ST
14324,GO:0061437,0.278858288058081,0.919866709046639,2,14,renal system vasculature development,BP,PDGFB;CFLAR
14327,GO:0061440,0.278858288058081,0.919866709046639,2,14,kidney vasculature development,BP,PDGFB;CFLAR
13766,GO:0060318,0.278965752609452,0.966807708813722,1,4,definitive erythrocyte differentiation,BP,SENP1
17869,GO:1902023,0.278976678850817,0.9668049186926,1,4,L-arginine transport,BP,SLC7A2
18270,GO:1903054,0.278994513884546,0.964776760903854,1,5,negative regulation of extracellular matrix organization,BP,ANTXR1
9207,GO:0035583,0.279112877210804,0.970195608086487,1,3,sequestering of TGFbeta in extracellular matrix,BP,FBN1
16111,GO:0090071,0.279244346125721,0.966736525210209,1,4,negative regulation of ribosome biogenesis,BP,SHQ1
4119,GO:0009176,0.279334947812866,0.964684719407849,1,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,TYMS
4120,GO:0009177,0.279334947812866,0.964684719407849,1,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,TYMS
6637,GO:0023014,0.279427693657472,0.769791414776611,50,627,signal transduction by protein phosphorylation,BP,CRYAB;IGFBP3;SAA1;NEFL;NRG1;FN1;MAP3K14;CYR61;FGFR2;EPGN;CTGF;IRS1;MID1;EDN1;GBP1;C1QTNF1;DUSP14;TGFB2;SLC9A3R1;INHBA;SYK;SFRP1;ULK4;PTGER4;CCL20;ITGAV;AJUBA;GADD45B;NPNT;PDGFB;ACKR3;GLIPR2;ARL6IP5;EPHB6;GPER1;PSME2;CFLAR;PSMB9;TRAF2;TLR3;TNF;ZFP36L2;CCL5;CD74;PSMB10;DAXX;PHLPP1;NRAS;ITGB1BP1;IRAK3
12640,GO:0050805,0.279585647604419,0.873172113317907,4,36,negative regulation of synaptic transmission,BP,PLK2;SRF;SYT11;MTMR2
1309,GO:0003150,0.279661159514656,0.966629861401114,1,4,muscular septum morphogenesis,BP,FZD1
11804,GO:0046653,0.279692730008549,0.91893571402459,2,15,tetrahydrofolate metabolic process,BP,DHFR;TYMS
3358,GO:0007096,0.280034712794532,0.9187700716408,2,15,regulation of exit from mitosis,BP,CDCA5;ANLN
12183,GO:0048286,0.280073084371933,0.892019591877067,3,23,lung alveolus development,BP,TNS3;FGFR2;PHF14
16176,GO:0090177,0.280105929979668,0.919884444445352,2,13,establishment of planar polarity involved in neural tube closure,BP,SFRP1;FZD1
16177,GO:0090178,0.280105929979668,0.919884444445352,2,13,regulation of establishment of planar polarity involved in neural tube closure,BP,SFRP1;FZD1
3911,GO:0008559,0.280112140232956,0.966514233086325,1,4,xenobiotic transmembrane transporting ATPase activity,MF,ABCG2
9163,GO:0035509,0.28029256657621,0.966467908662721,1,4,negative regulation of myosin-light-chain-phosphatase activity,BP,TNF
18384,GO:1903347,0.28029256657621,0.966467908662721,1,4,negative regulation of bicellular tight junction assembly,BP,TNF
3283,GO:0006972,0.280428678022145,0.919110893242373,2,14,hyperosmotic response,BP,AKR1B1;TLR3
14159,GO:0061005,0.280450163960861,0.872979590661425,4,34,cell differentiation involved in kidney development,BP,FAT4;WNT4;PDGFB;GLIS2
9385,GO:0035904,0.280490282639878,0.873153759358028,4,33,aorta development,BP,TGFB2;ADAMTS9;SRF;DCTN5
7518,GO:0031698,0.28053456193274,0.966405718622959,1,4,beta-2 adrenergic receptor binding,MF,SLC9A3R1
9926,GO:0042256,0.280544327441576,0.964356634783598,1,5,mature ribosome assembly,BP,DDX3X
14842,GO:0070566,0.280602704965068,0.891112508222487,3,25,adenylyltransferase activity,MF,GPHN;APTX;FLAD1
4728,GO:0010888,0.280681971046757,0.918988683465089,2,14,negative regulation of lipid storage,BP,ITGAV;TNF
9472,GO:0036066,0.280794099850343,0.918934556348525,2,14,protein O-linked fucosylation,BP,SPON1;LFNG
1345,GO:0003205,0.281091992801164,0.822305342980939,10,102,cardiac chamber development,BP,NRG1;CYR61;FGFR2;TGFB2;MIR17HG;TPM1;SRF;FZD1;CITED2;DCTN5
10894,GO:0044424,0.281155755390053,0.752752424773815,752,10404,intracellular part,CC,IL32;CRYAB;IGFBP3;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TRIM16L;TNS3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;CLN6;IL1R2;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TSC22D3;MAT2A;DDX17;SPON1;FAM69B;TRIM56;TFCP2L1;KRTAP2-3;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;MID1;TP53;DAPK3;TUFT1;SVEP1;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;ABCF1;DUSP14;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;LGALS3;CHP1;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL16;IFIT3;SRSF2;FOXD2;PCDH7;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;HNRNPF;BAG1;SLC9A3R1;PDCD11;C15ORF39;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;NBN;TRIO;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;POP1;HLA-DOB;RIPK4;GPCPD1;NUCKS1;PITHD1;HEATR1;ZDHHC6;MCM2;TARDBP;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;APOL6;COA7;KEAP1;NAA15;UAP1L1;TRA2A;TCHH;ZNF827;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;TK1;TMEM97;LSG1;G3BP1;GRWD1;ARRDC1-AS1;ZNF584;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;EIF5;CASC3;SYNPO2L;PLK2;RRAGB;CDV3;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;KANK4;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;LCP1;EXOG;PTPRM;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARHGEF28;ARMC5;GPHN;KLHL21;RRN3;RNF115;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;QPCT;TAF1D;ODC1;ABCF2;SNX11;AJUBA;SMC2;ARMC6;FASTKD3;KCNQ5;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;KRT24;LFNG;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;PPP4R4;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;ODF2L;KREMEN2;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;MCM6;FGD6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;ABCC9;TRMT5;TTF2;DTX4;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;SEPHS2;NNT;IFNAR1;WEE1;TJP1;ZNF484;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;HPS5;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;KRT10;CCAR1;SKA2;PPIP5K1;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;ZNFX1;STEAP4;FKBP5;IQCJ-SCHIP1;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;ANKRD13A;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;TAF6L;MRPS7;DPH2;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;MSH3;TELO2;EDRF1;RBBP5;FAM208B;CITED2;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;MPP5;AZIN1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;DCTN5;METAP2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;FTO;CCDC50;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
664,GO:0001865,0.281300670579095,0.966208400580531,1,4,NK T cell differentiation,BP,AP3B1
12849,GO:0051136,0.281300670579095,0.966208400580531,1,4,regulation of NK T cell differentiation,BP,AP3B1
9556,GO:0036303,0.281306625829489,0.920041687205547,2,12,lymph vessel morphogenesis,BP,PTPN14;PDPN
14311,GO:0061384,0.281373890942371,0.891262308734778,3,23,heart trabecula morphogenesis,BP,NRG1;TGFB2;SRF
8671,GO:0034227,0.281501813815929,0.964095653731302,1,5,tRNA thio-modification,BP,URM1
5013,GO:0015171,0.281756207069944,0.858088004179781,5,48,amino acid transmembrane transporter activity,MF,SLC7A2;SLC7A5P2;SLC1A3;SLC43A2;SLC25A22
13950,GO:0060592,0.281807930161402,0.966077385692691,1,4,mammary gland formation,BP,FGFR2
13382,GO:0052547,0.281983882755114,0.78988794770993,22,285,regulation of peptidase activity,BP,CRYAB;FN1;PML;CYR61;C3;CTGF;MMP9;NAIP;CD109;DDX3X;ANTXR1;BIRC3;ARL6IP5;SERPINB9;GPER1;SENP1;PSME2;CFLAR;PSMB9;TRAF2;TNF;IFI27L1
16669,GO:0097524,0.282095122600567,0.96600308040071,1,4,sperm plasma membrane,CC,HSP90AB1
7583,GO:0031941,0.282285835913697,0.889861850265659,3,26,filamentous actin,CC,ACTG1;TPM4;DPYSL3
12862,GO:0051153,0.282315274541204,0.847282735654773,6,59,regulation of striated muscle cell differentiation,BP,NRG1;HDAC9;G6PD;EDN1;CFLAR;EHD1
11800,GO:0046643,0.282476796537887,0.965904185146178,1,4,regulation of gamma-delta T cell activation,BP,SYK
12430,GO:0048861,0.282518970827936,0.965893247255874,1,4,leukemia inhibitory factor signaling pathway,BP,IL6ST
16844,GO:0098706,0.282663517709823,0.965855743745936,1,4,ferric iron import across plasma membrane,BP,STEAP4
273,GO:0000775,0.28279222441885,0.803286248796783,15,173,chromosome, centromeric region,CC,CBX5;STAG1;HELLS;SUV39H2;CDCA5;NUP160;SKA2;CENPF;ORC2;CENPN;HNRNPU;DAXX;DCTN5;CTCF;CENPO
8299,GO:0033120,0.282907933306038,0.889761394869976,3,25,positive regulation of RNA splicing,BP,RBM22;HSPA8;NCBP1
15336,GO:0071532,0.283149615664264,0.965729448833089,1,4,ankyrin repeat binding,MF,HIF1AN
4862,GO:0014074,0.283163815139985,0.825520021711446,9,94,response to purine-containing compound,BP,TP53;HMGCS1;AHR;SRD5A1;THBD;APEX1;PANX1;TAF1;PPARGC1B
12164,GO:0048255,0.283260776123207,0.88955401496297,3,25,mRNA stabilization,BP,TARDBP;SYNCRIP;HNRNPU
4974,GO:0015085,0.283391803160053,0.838529580415902,7,65,calcium ion transmembrane transporter activity,MF,JPH2;ATP2B1;ATP2C1;ITGAV;TRPM7;JPH1;PANX1
16521,GO:0097199,0.283538605188587,0.963536860968892,1,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,CFLAR
2486,GO:0005726,0.283541807552123,0.965627356333086,1,4,perichromatin fibrils,CC,NUFIP1
17390,GO:1900084,0.283543058921046,0.965627030306135,1,4,regulation of peptidyl-tyrosine autophosphorylation,BP,SYK
13842,GO:0060416,0.283597403169491,0.889646045210887,3,24,response to growth hormone,BP,TRIM16;STAT5A;SRD5A1
4753,GO:0010922,0.283666233032486,0.889922737013501,3,23,positive regulation of phosphatase activity,BP,NPNT;HSP90AB1;PPARGC1B
13373,GO:0052428,0.28371028246151,0.963489535527698,1,5,modulation by host of symbiont molecular function,BP,NUCKS1
9259,GO:0035655,0.2838694550644,0.963445625775075,1,5,interleukin-18-mediated signaling pathway,BP,PDGFB
15222,GO:0071351,0.2838694550644,0.963445625775075,1,5,cellular response to interleukin-18,BP,PDGFB
8128,GO:0032808,0.283908989536675,0.965531615722345,1,4,lacrimal gland development,BP,FGFR2
11892,GO:0046884,0.283984395324636,0.965511935111692,1,4,follicle-stimulating hormone secretion,BP,INHBA
7709,GO:0032183,0.284031787992853,0.917995274989847,2,13,SUMO binding,MF,PML;DAXX
2517,GO:0005769,0.284057898119678,0.788360891578175,22,259,early endosome,CC,PML;TFRC;HLA-B;MYO1B;RAB32;HLA-F;VPS41;VPS8;SNX5;KREMEN2;ACKR3;SLC11A2;CNTNAP2;TRAK2;MTMR2;TMEM165;STEAP4;GPER1;RABEP2;TLR3;EHD1;ASTN2
12652,GO:0050820,0.284163362689533,0.916758217148511,2,15,positive regulation of coagulation,BP,PDPN;THBD
7531,GO:0031730,0.284263916846001,0.96333667823907,1,5,CCR5 chemokine receptor binding,MF,CCL5
5968,GO:0018393,0.284346438017575,0.811261635404513,12,134,internal peptidyl-lysine acetylation,BP,TRIM16;CPA4;SET;NAA50;BRCA2;CHEK1;TAF6L;GTF3C4;POLE3;CLOCK;TAF1;CTCF
2722,GO:0006099,0.284443905234545,0.888116046947019,3,28,tricarboxylic acid cycle,BP,ACO1;NNT;SDHD
15245,GO:0071383,0.284525310803664,0.797111449447034,17,194,cellular response to steroid hormone stimulus,BP,RUNX1;DDX17;EDN1;SFRP1;ATP2B1;RAN;ARNTL;SRD5A1;GPER1;CFLAR;CLOCK;ESR1;ZFP36L2;HNRNPU;DAXX;TAF1;PPARGC1B
7433,GO:0031529,0.284614962506736,0.869591341640993,4,38,ruffle organization,BP,TPM1;RHOG;CORO1C;WDPCP
1864,GO:0004525,0.284732207432714,0.965316408759265,1,4,ribonuclease III activity,MF,DGCR8
7778,GO:0032296,0.284732207432714,0.965316408759265,1,4,double-stranded RNA-specific ribonuclease activity,MF,DGCR8
9165,GO:0035511,0.28480278718989,0.963187545772922,1,5,oxidative DNA demethylation,BP,FTO
18607,GO:1903826,0.284815983649304,0.965294464577754,1,4,arginine transmembrane transport,BP,SLC7A2
298,GO:0000803,0.284901513323658,0.888587679936955,3,25,sex chromosome,CC,HNRNPU;RING1;SMARCC1
13963,GO:0060612,0.28510785589626,0.888465917675543,3,25,adipose tissue development,BP,CDK4;CSF1;FTO
2455,GO:0005666,0.285259773762963,0.915331508548642,2,17,DNA-directed RNA polymerase III complex,CC,POLR2F;POLR3B
15274,GO:0071425,0.285274435326853,0.916758338164819,2,14,hematopoietic stem cell proliferation,BP,RUNX1;ETV6
12998,GO:0051382,0.285292811217599,0.916749358404275,2,14,kinetochore assembly,BP,CENPF;CENPN
18134,GO:1902750,0.285331461120186,0.828996436878972,8,97,negative regulation of cell cycle G2/M phase transition,BP,GPR132;NBN;TOPBP1;BRCC3;CHEK1;PSME2;PSMB9;PSMB10
990,GO:0002444,0.285408272370866,0.777368838343019,30,386,myeloid leukocyte mediated immunity,BP,KRT1;FTL;FTH1;C3;S100P;MMP9;B4GALT1;LGALS3;SYK;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;ITGAV;QPCT;COMMD9;HSPA8;HSP90AB1;LAIR1;SERPINB9;ADAM17;LILRB3;GLIPR1;DNASE1;NRAS
2748,GO:0006145,0.285639096812206,0.965078434414528,1,4,purine nucleobase catabolic process,BP,DPYD
14662,GO:0070233,0.285797052762551,0.91595595584527,2,15,negative regulation of T cell apoptotic process,BP,TSC22D3;CCL5
6222,GO:0019752,0.285928823777254,0.760937605444034,57,756,carboxylic acid metabolic process,BP,PTGES;CYP1B1;GCLC;C3;UGT1A6;STAT5A;FADS3;SLC7A2;CYP1A1;IRS1;PANK2;EDN1;SCD;ACSL3;NQO1;CHP1;ACO1;CARS2;PGD;NUP50;SYK;NUP153;LDHAL6B;SLC5A6;DHFR;NDC1;SLC1A3;RANBP2;ODC1;CROT;AKR1C2;PGK1;HACD2;GATC;RARS;QDPR;PDGFB;NUP160;NUP54;SEPHS2;NNT;SCD5;DPYD;MMAA;PSME2;HADHB;PSMB9;SDHD;UGT1A4;AZIN1;ARV1;TYMS;CD74;PSMB10;HIBCH;PPARGC1B;GPX4
2721,GO:0006098,0.286095011322836,0.915333662460072,2,16,pentose-phosphate shunt,BP,G6PD;PGD
8866,GO:0034655,0.28614176581669,0.770159597417807,38,518,nucleobase-containing compound catabolic process,BP,PABPC4;DKC1;NUP50;NUP153;POP1;TARDBP;NDC1;CASC3;HSPB1;EXOG;RANBP2;SET;MRTO4;FASTKD3;PGK1;FEN1;NUP160;ENPP1;NUP54;LRPPRC;METTL16;APEX1;HSPA8;SMUG1;SYNCRIP;DPYD;PSME2;PSMB9;NCBP1;UPF3B;HNRNPR;DNASE1;ZFP36L2;RC3H1;HNRNPU;PSMB10;RBM8A;RPS12
10576,GO:0043525,0.286516101228574,0.868352174189696,4,38,positive regulation of neuron apoptotic process,BP,TP53;NQO1;TGFB2;MYBL2
9457,GO:0036035,0.286566782055117,0.91676472644005,2,13,osteoclast development,BP,FBN1;TJP2
14046,GO:0060750,0.286626687157588,0.964818215994659,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,ESR1
10365,GO:0043168,0.28668618478377,0.743879370881077,157,2004,anion binding,MF,SAA1;FN1;PTGES;KIF23;JPH2;MAP3K14;GCLC;CYR61;NLRC5;TXNRD1;FGFR2;COL5A3;CTGF;FBN1;TAP1;RUNX1;MYO1B;ACTG1;FST;MAT2A;DDX17;CCDC80;DYNC2H1;TP53;DAPK3;PANK2;GBP1;DDX47;ABCF1;ACSL3;CARS2;IKBKE;PKMYT1;P3H2;NUAK1;SLC22A5;CAMK1G;DNHD1;SYK;NAIP;RAB32;TRIO;PARP15;BRIP1;MCM5;ABCG2;ARFRP1;CDK4;SFRP1;RIPK4;MCM2;LAYN;POLQ;TSR1;ATP2B1;DHFR;HELLS;ULK4;ABCC4;TK1;LSG1;G3BP1;ARRDC1-AS1;PARD3B;OPHN1;P4HA2;FOXRED2;MDN1;SLC1A3;EIF5;PLK2;RRAGB;FRK;GBP5;RHOG;DDX28;RAN;ORC4;ATP2C1;DDX3X;RAB26;GPHN;ABCF2;SNX11;TRPM7;SMC2;AKR1C2;PGK1;SNX5;MCM3;GNL3L;NVL;GATC;RARS;HIF1AN;QDPR;MCM8;SGK494;ENPP1;CBWD5;DDX10;EFTUD2;DDX24;TYW1;MCM6;SRD5A1;ABCC9;TTF2;SRPRB;SEPHS2;WEE1;ORC1;HSPA8;SYT11;HSP90AB1;DDX21;EPHB6;NSF;HELQ;MYH11;SGK1;NAV2;DPYD;PPIP5K1;CHEK1;BBS5;MMAA;RRM1;BMS1;MCM4;MYO10;ATR;MSH6;DDX60L;NOL9;ABCA5;DPYSL3;UBE2J2;VPS36;MSH3;DDX56;TAP2;KIF14;PARD3;RAD51B;EHD1;ATAD5;TYMS;HNRNPU;FLAD1;TAF1;NRAS;ABCA11P;ASTN2;GBP6;IRAK3;DHX15
12766,GO:0051015,0.286902783533949,0.809605392263997,12,121,actin filament binding,MF,MYO1B;TPM1;NEXN;LCP1;CORO1C;AJUBA;ANTXR1;TPM4;MYH11;MYO10;SHTN1;PANX1
8748,GO:0034390,0.286932653734146,0.915946234482519,2,14,smooth muscle cell apoptotic process,BP,EDN1;CDKN2A
8749,GO:0034391,0.286932653734146,0.915946234482519,2,14,regulation of smooth muscle cell apoptotic process,BP,EDN1;CDKN2A
10378,GO:0043184,0.286954648270868,0.962588554533241,1,5,vascular endothelial growth factor receptor 2 binding,MF,PDCL3
20143,GO:2000781,0.287032585672073,0.915897178256807,2,14,positive regulation of double-strand break repair,BP,RIF1;TIMELESS
14638,GO:0070192,0.287127816127894,0.868284956887327,4,36,chromosome organization involved in meiotic cell cycle,BP,BRIP1;NDC1;SMC2;FANCD2
13049,GO:0051480,0.287294416994786,0.805531532816502,13,143,regulation of cytosolic calcium ion concentration,BP,SAA1;PML;JPH2;EDN1;C1QTNF1;ATP2B1;PTGER4;ADM;ITGAV;JPH1;RIC3;GPER1;ESR1
18333,GO:1903224,0.287340799708364,0.964629361308569,1,4,regulation of endodermal cell differentiation,BP,COL5A2
12264,GO:0048523,0.287498569071788,0.738633370036764,247,3293,negative regulation of cellular process,BP,CRYAB;IGFBP3;MAFB;FTH1;NEFL;NRG1;HDAC9;KRT4;FN1;PTGES;PML;CYP1B1;JPH2;MAP3K14;GCLC;CYR61;C3;GPRC5A;NLRC5;FGFR2;SACS;TRIM22;STARD13;CBX5;CTGF;UTP20;MMP9;FBN1;IL1R2;B4GALT1;PBX1;G6PD;TSC22D3;FST;TFCP2L1;ENC1;IRS1;MID1;TP53;DAPK3;EDN1;GBP1;C1QTNF1;DUSP14;CDKN2A;RBM4;PTPN14;NQO1;LGALS3;CHP1;PDPN;TGFB2;IRX2;CYLD;PKMYT1;IFIT3;SRSF2;P3H2;RAD1;IL6ST;BAG1;SLC9A3R1;DKC1;INHBA;NUP50;TJP2;NUP153;NAIP;RELB;GPR132;NBN;LEPR;TRIO;PARP15;BRIP1;SHQ1;CDK4;SFRP1;CD274;TARDBP;MIR17HG;POLQ;H3F3A;AHR;NAA15;DHFR;TPM1;GLIS3;HELLS;ADAMTS9;SETDB1;PTGER4;G3BP1;OPHN1;ADM;CD109;NDC1;PLK2;RRAGB;ZNF587;UBQLN2;FRK;KANK4;WDR76;HSPB1;WNT4;SUV39H2;PTPRM;THOC1;RAN;RANBP2;TOPBP1;ANAPC15;SOD2;CORO1C;DDX3X;IL24;RRN3;RNF115;ITGAV;SOCS1;SET;PARP14;ARNTL;AJUBA;CGNL1;DND1;LFNG;ZC3H7B;TRIM37;PPP4R4;GNL3L;ZNF586;GADD45B;SH3RF2;CDH13;COL5A2;PHACTR4;SRF;MDM4;HIF1AN;PDGFB;BRCC3;KREMEN2;FZD1;ANTXR1;CLU;NUP160;SMYD2;ENPP1;BIRC3;RRM2;NUP54;LRPPRC;EYA3;ACKR3;RIF1;METTL16;GLIS2;UBP1;THBD;JPH1;APEX1;PDCL3;TNC;MYBL1;HSPA8;SYT11;HSP90AB1;EPHB6;BACE2;NEDD4L;BRCA2;SYNCRIP;TRAK2;DGCR8;CCAR1;E2F8;MTMR2;CENPF;ETV6;POLR2F;CHEK1;SERPINB9;GPER1;RAD18;ADAM17;SENP1;RBMS3;ATR;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;ZNF12;RFWD3;ABCA5;CBLL1;DPYSL3;ZNF608;NCBP1;AKR1B1;TRAF2;TPRA1;MSH3;CITED2;HNRNPR;NCL;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;CLOCK;KIF14;PURB;TLR3;ESR1;PARD3;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;DAXX;PHF14;PHLPP2;HIST1H4A;TAF1;PHLPP1;PSPC1;SMARCC1;PPARGC1B;CDKN1A;ITGB1BP1;IRF1;CTCF;GPX4;IRAK3
8049,GO:0032692,0.287544520968172,0.91461481708047,2,16,negative regulation of interleukin-1 production,BP,PML;IL1R2
8238,GO:0032993,0.287564289156608,0.81153659587738,11,163,protein-DNA complex,CC,H3F3A;RPA1;POLA1;MCM3;GINS4;PRIM2;MPHOSPH8;PURB;ESR1;HIST1H4A;GTF2H3
12443,GO:0048878,0.287699131862661,0.761821084836952,51,645,chemical homeostasis,BP,KRT1;SAA1;FTL;FTH1;PML;JPH2;GCLC;TFRC;CLN6;IRS1;TP53;EDN1;C1QTNF1;CHP1;SLC4A11;ACO1;SLC30A6;SLC9A3R1;LEPR;ABCG2;GPCPD1;NUCKS1;ABHD4;ATP2B1;HRNR;PTGER4;TMEM97;ADM;SOD2;ATP2C1;ITGAV;TRPM7;SRF;ENPP1;COMMD9;JPH1;THADA;SLC11A2;RIC3;TMEM199;NEDD4L;TMEM165;STEAP4;CCDC47;GPER1;RPTN;AKR1B1;SLC9A9;ESR1;EHD1;CCL5
14653,GO:0070212,0.28778469042434,0.964511675556043,1,4,protein poly-ADP-ribosylation,BP,PARP15
8453,GO:0033567,0.287816378460312,0.962347127227129,1,5,DNA replication, Okazaki fragment processing,BP,FEN1
1310,GO:0003151,0.287939329853093,0.854068467340652,5,46,outflow tract morphogenesis,BP,FGFR2;TGFB2;MIR17HG;FZD1;CITED2
16179,GO:0090181,0.287943311551567,0.853700150069887,5,49,regulation of cholesterol metabolic process,BP,SCD;HMGCS1;LSS;RAN;ARV1
20071,GO:2000660,0.287968494934017,0.962304416801871,1,5,negative regulation of interleukin-1-mediated signaling pathway,BP,IL1R2
7343,GO:0031348,0.288035671237419,0.816373831254122,10,114,negative regulation of defense response,BP,KRT1;SAA1;NLRC5;IL1R2;PTGER4;PARP14;CHID1;SERPINB9;GPER1;IRAK3
2834,GO:0006303,0.288051748949492,0.842517896409677,6,67,double-strand break repair via nonhomologous end joining,BP,NBN;POLQ;POLA1;BRCC3;RIF1;HIST1H4A
16248,GO:0090279,0.288113170918028,0.915365886984579,2,14,regulation of calcium ion import,BP,LGALS3;PDGFB
5208,GO:0015804,0.288115196505326,0.886413708328524,3,26,neutral amino acid transport,BP,SLC7A5P2;NFKBIE;SLC43A2
14338,GO:0061470,0.288120423123488,0.964422515113485,1,4,T follicular helper cell differentiation,BP,RC3H1
7347,GO:0031369,0.288170206558243,0.88613056876322,3,27,translation initiation factor binding,MF,DDX3X;SYT11;EIF2B5
15234,GO:0071364,0.288361589402757,0.867479331142505,4,36,cellular response to epidermal growth factor stimulus,BP,BAIAP2;CFLAR;NCL;ZFP36L2
2780,GO:0006211,0.288839456588684,0.967906530875813,1,3,5-methylcytosine catabolic process,BP,TET3
6267,GO:0019857,0.288839456588684,0.967906530875813,1,3,5-methylcytosine metabolic process,BP,TET3
14292,GO:0061343,0.288871589814967,0.964222559998756,1,4,cell adhesion involved in heart morphogenesis,BP,TGFB2
16120,GO:0090083,0.288969339798409,0.914943847655171,2,14,regulation of inclusion body assembly,BP,SACS;CLU
3905,GO:0008543,0.288998429533951,0.826754474131877,8,85,fibroblast growth factor receptor signaling pathway,BP,FGFR2;CTGF;FAT4;HNRNPF;WNT4;POLR2F;NCBP1;HNRNPM
7879,GO:0032435,0.289284193976443,0.885465600221511,3,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,HSP90AB1;SENP1;SMARCC1
10617,GO:0043586,0.28933922174351,0.914761220968649,2,14,tongue development,BP,KRT13;WNT10A
12959,GO:0051299,0.289404502797567,0.914728970265745,2,14,centrosome separation,BP,RANBP2;CHEK1
5708,GO:0016833,0.289564096866414,0.961854735707266,1,5,oxo-acid-lyase activity,MF,TYW1
18615,GO:1903844,0.289692596853993,0.826391847531813,8,82,regulation of cellular response to transforming growth factor beta stimulus,BP,FBN1;MIR17HG;CD109;NPNT;HSP90AB1;ADAM17;CFLAR;CITED2
75,GO:0000152,0.289744266818339,0.865938383951094,4,40,nuclear ubiquitin ligase complex,CC,ANAPC15;BRCC3;ANAPC7;RING1
538,GO:0001656,0.289994100097057,0.842037080409163,6,56,metanephros development,BP,FBN1;FAT4;IRX2;WNT4;PDGFB;FRAS1
9180,GO:0035529,0.290037870275516,0.961720624098939,1,5,NADH pyrophosphatase activity,MF,ENPP1
4946,GO:0014909,0.290361293705112,0.852387540001258,5,46,smooth muscle cell migration,BP,IGFBP3;TPM1;PDGFB;APEX1;CCL5
10574,GO:0043523,0.29046559186018,0.806222565312133,12,137,regulation of neuron apoptotic process,BP,NEFL;GCLC;G6PD;TP53;NQO1;TGFB2;NAIP;MYBL2;SOD2;SET;HSP90AB1;KIF14
34,GO:0000064,0.290591710569596,0.96376223574732,1,4,L-ornithine transmembrane transporter activity,MF,SLC7A2
18074,GO:1902581,0.290618039358402,0.961556026265446,1,5,multi-organism cellular localization,BP,NUP153
18075,GO:1902583,0.290618039358402,0.961556026265446,1,5,multi-organism intracellular transport,BP,NUP153
18645,GO:1903902,0.29074862937669,0.851528258856177,5,51,positive regulation of viral life cycle,BP,NUCKS1;DDX3X;HSPA8;CCL5;CD74
11301,GO:0045597,0.290762889140562,0.759998887285785,49,601,positive regulation of cell differentiation,BP,IGFBP3;NEFL;NRG1;TRIM16;FN1;TENM3;CYR61;CTGF;RUNX1;ENC1;EDN1;RBM4;PDPN;TGFB2;CYLD;IL6ST;INHBA;IL7R;SYK;SFRP1;ADAMTS9;ADM;WNT4;RRN3;SOCS1;ARNTL;BAIAP2;SRF;HIF1AN;NPNT;FZD1;IL20;GLIPR2;HSP90AB1;NEDD4L;ZFYVE27;L1CAM;GPER1;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;CSF1;AP3B1;EHD1;TNF;CD74;PPARGC1B
57,GO:0000120,0.291102866838837,0.96141816588972,1,5,RNA polymerase I transcription factor complex,CC,TAF1D
4601,GO:0010714,0.291147195921198,0.913304089945382,2,15,positive regulation of collagen metabolic process,BP,CTGF;WNT4
8220,GO:0032967,0.291147195921198,0.913304089945382,2,15,positive regulation of collagen biosynthetic process,BP,CTGF;WNT4
261,GO:0000727,0.291265334253192,0.961371904880741,1,5,double-strand break repair via break-induced replication,BP,GINS4
3938,GO:0008622,0.291272131812072,0.961369968647186,1,5,epsilon DNA polymerase complex,CC,POLE3
17612,GO:1901224,0.291418652902032,0.865137695692497,4,38,positive regulation of NIK/NF-kappaB signaling,BP,TRAF2;TLR3;TNF;RC3H1
2605,GO:0005902,0.291532339923845,0.851202217877052,5,49,microvillus,CC,S100P;PDPN;SLC9A3R1;ITGAV;AKR1B1
20001,GO:2000542,0.291556412867812,0.96350258018038,1,4,negative regulation of gastrulation,BP,COL5A2
8979,GO:0035061,0.291866870791429,0.963418790365544,1,4,interchromatin granule,CC,SRSF2
13560,GO:0055131,0.29188348689422,0.961195600350406,1,5,C3HC4-type RING finger domain binding,MF,HSPA8
7502,GO:0031668,0.29194068350175,0.793102965842544,16,187,cellular response to extracellular stimulus,BP,CYP24A1;TP53;BRIP1;SFRP1;ATP2B1;CADPS2;RRAGB;WNT4;BAIAP2;SRF;GDAP1;SRD5A1;TNC;HSPA8;TAF1;CDKN1A
6572,GO:0022028,0.292096561762959,0.963356727263462,1,4,tangential migration from the subventricular zone to the olfactory bulb,BP,SRF
921,GO:0002313,0.292219252166447,0.912768182882266,2,15,mature B cell differentiation involved in immune response,BP,DOCK10;LFNG
14614,GO:0070160,0.29231711646622,0.818552692807894,9,91,occluding junction,CC,AMOT;SIPA1L3;TJP2;CDK4;PARD3B;CGNL1;TJP1;MPP5;PARD3
14604,GO:0070137,0.292405416582035,0.96327317789027,1,4,ubiquitin-like protein-specific endopeptidase activity,MF,SENP1
14606,GO:0070139,0.292405416582035,0.96327317789027,1,4,SUMO-specific endopeptidase activity,MF,SENP1
7898,GO:0032461,0.292818743021351,0.91197583002132,2,16,positive regulation of protein oligomerization,BP,TP53;CLU
3383,GO:0007162,0.293001983757368,0.794876798749193,15,169,negative regulation of cell adhesion,BP,CYP1B1;GBP1;C1QTNF1;CDKN2A;LGALS3;CYLD;CD274;CORO1C;CDH13;TNC;CBLL1;RC3H1;CD74;ITGB1BP1;IRF1
7904,GO:0032467,0.293028308729802,0.883752584005606,3,25,positive regulation of cytokinesis,BP,KIF23;CXCR5;KIF14
8750,GO:0034392,0.293094193239695,0.963086457715881,1,4,negative regulation of smooth muscle cell apoptotic process,BP,EDN1
10465,GO:0043313,0.293094964027831,0.963086248456111,1,4,regulation of neutrophil degranulation,BP,SYK
18064,GO:1902563,0.293094964027831,0.963086248456111,1,4,regulation of neutrophil activation,BP,SYK
13599,GO:0060046,0.293103272644127,0.960846346528213,1,5,regulation of acrosome reaction,BP,B4GALT1
12580,GO:0050713,0.293297409713378,0.960790594185271,1,5,negative regulation of interleukin-1 beta secretion,BP,PML
16447,GO:0097066,0.293299763633941,0.912226517786626,2,15,response to thyroid hormone,BP,GCLC;AKR1B1
7952,GO:0032541,0.293318095989156,0.960784650800457,1,5,cortical endoplasmic reticulum,CC,ARV1
18663,GO:1903936,0.293350087014059,0.960775458420519,1,5,cellular response to sodium arsenite,BP,DAXX
16128,GO:0090091,0.293517811592229,0.962971346817641,1,4,positive regulation of extracellular matrix disassembly,BP,PDPN
15322,GO:0071495,0.29352069083308,0.749113238433172,73,910,cellular response to endogenous stimulus,BP,HDAC9;PML;GCLC;CYR61;COL16A1;FGFR2;STAT5A;CTGF;FBN1;RUNX1;FAT4;DDX17;IRS1;TP53;EDN1;HMGCS1;AKAP8;TGFB2;HNRNPF;INHBA;LEPR;BRIP1;CDK4;SFRP1;NUCKS1;WNT10A;MIR17HG;ATP2B1;COL4A1;AHR;PTGER4;CD109;RRAGB;WNT4;RAN;SOCS1;ARNTL;AKR1C2;BAIAP2;COL5A2;NPNT;FZD1;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;TNC;HSP90AB1;POLR2F;GPER1;ADAM17;CFLAR;NCBP1;AKR1B1;CITED2;NCL;CCNA2;TIMELESS;CLOCK;ESR1;PARD3;EHD1;TNF;ZFP36L2;CCL5;HNRNPU;DAXX;TAF1;SMARCC1;PPARGC1B;HNRNPM;ITGB1BP1
12925,GO:0051252,0.293521029652831,0.73354641984354,228,3021,regulation of RNA metabolic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EDN1;CDKN2A;RBM4;ZBED1;ZNF397;PTPN14;PABPC4;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;HNRNPF;DKC1;INHBA;SYK;ZFP42;RELB;PARP15;BRIP1;SHQ1;UTP15;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;ZNF512;ZNF587;FRK;DNTTIP2;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;FASTKD3;ZNF267;TRIM37;ZNF586;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;SMYD2;MACC1;ZNF316;RRM2;COMMD9;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;PSME2;CFLAR;PSMC3IP;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;NCBP1;MYNN;VPS36;TRAF2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3
7283,GO:0031261,0.293590593569617,0.960706310934349,1,5,DNA replication preinitiation complex,CC,GINS4
839,GO:0002138,0.293618667559398,0.960698234873303,1,5,retinoic acid biosynthetic process,BP,CYP1A1
5353,GO:0016102,0.293618667559398,0.960698234873303,1,5,diterpenoid biosynthetic process,BP,CYP1A1
10757,GO:0044126,0.293901726175744,0.960616753807899,1,5,regulation of growth of symbiont in host,BP,TNF
10760,GO:0044144,0.293901726175744,0.960616753807899,1,5,modulation of growth of symbiont involved in interaction with host,BP,TNF
20292,GO:2001222,0.294048938695229,0.883774738327783,3,23,regulation of neuron migration,BP,NRG1;ULK4;SHTN1
4587,GO:0010675,0.294067643050162,0.823038004731052,8,82,regulation of cellular carbohydrate metabolic process,BP,IGFBP3;IRS1;C1QTNF1;PPP1R3B;LEPR;RANBP2;ENPP1;GPER1
9496,GO:0036123,0.294195122616111,0.960532194263768,1,5,histone H3-K9 dimethylation,BP,SUV39H2
2569,GO:0005852,0.294333949906184,0.910776386721713,2,17,eukaryotic translation initiation factor 3 complex,CC,DDX3X;EIF3J
3380,GO:0007159,0.29437947315338,0.790965698746195,16,192,leukocyte cell-cell adhesion,BP,MAP3K14;TFRC;LGALS3;CYLD;IL6ST;IL7R;SYK;CD274;SIRPA;SOCS1;AP3B1;TNF;RC3H1;CCL5;CD74;IRF1
5594,GO:0016616,0.294521299586699,0.829039188483519,7,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,G6PD;PGD;LDHAL6B;ABCC4;AKR1C2;HADHB;AKR1B1
5222,GO:0015822,0.294529024928879,0.962695727529693,1,4,ornithine transport,BP,SLC7A2
18389,GO:1903352,0.294529024928879,0.962695727529693,1,4,L-ornithine transmembrane transport,BP,SLC7A2
11461,GO:0045893,0.294559607693332,0.745582962664553,84,1059,positive regulation of transcription, DNA-templated,BP,MAFB;NRG1;TRIM16;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;RUNX1;PBX1;DDX17;TP53;EDN1;ZBED1;STAG1;TGFB2;FOXD2;INHBA;RELB;UTP15;SFRP1;NUCKS1;HEATR1;USP16;AHR;NAA15;GLIS3;TAF2;AKAP8L;MYBL2;RHOG;WNT4;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;RRN3;ARNTL;CDH13;SRF;NPNT;WDR43;PDGFB;FZD1;NFE2L1;MACC1;GLIS2;TET3;MYBL1;BRCA2;SS18L2;E2F8;ETV6;HSF2;CHEK1;GPER1;MLLT10;WDR75;SENP1;NOL11;EDRF1;CITED2;NCL;CCNA2;RBL1;NAA16;CLOCK;TLR3;ESR1;TNF;CD74;HNRNPU;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
18454,GO:1903508,0.294559607693332,0.745582962664553,84,1059,positive regulation of nucleic acid-templated transcription,BP,MAFB;NRG1;TRIM16;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;RUNX1;PBX1;DDX17;TP53;EDN1;ZBED1;STAG1;TGFB2;FOXD2;INHBA;RELB;UTP15;SFRP1;NUCKS1;HEATR1;USP16;AHR;NAA15;GLIS3;TAF2;AKAP8L;MYBL2;RHOG;WNT4;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;RRN3;ARNTL;CDH13;SRF;NPNT;WDR43;PDGFB;FZD1;NFE2L1;MACC1;GLIS2;TET3;MYBL1;BRCA2;SS18L2;E2F8;ETV6;HSF2;CHEK1;GPER1;MLLT10;WDR75;SENP1;NOL11;EDRF1;CITED2;NCL;CCNA2;RBL1;NAA16;CLOCK;TLR3;ESR1;TNF;CD74;HNRNPU;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
4711,GO:0010871,0.294671612647516,0.962656768099386,1,4,negative regulation of receptor biosynthetic process,BP,ITGAV
15303,GO:0071470,0.294719434541379,0.882456816565704,3,26,cellular response to osmotic stress,BP,RELB;DDX3X;AKR1B1
2143,GO:0004953,0.294789242424996,0.960360643278809,1,5,icosanoid receptor activity,MF,PTGER4
11422,GO:0045807,0.2948774156479,0.822244311320142,8,85,positive regulation of endocytosis,BP,C3;SYK;SIRPA;ITGAV;CLU;NEDD4L;CBLL1;TNF
20136,GO:2000773,0.294889576934569,0.911999208684684,2,14,negative regulation of cellular senescence,BP,PLK2;RBL1
19729,GO:2000020,0.295650706234715,0.960111134978902,1,5,positive regulation of male gonad development,BP,CITED2
9726,GO:0038132,0.295702224032253,0.962374471476214,1,4,neuregulin binding,MF,ITGAV
10412,GO:0043235,0.295752316845762,0.7878015029431,17,185,receptor complex,CC,TFRC;FGFR2;TRAF3;IRS1;IL6ST;SYK;LEPR;SHISA9;ABCG2;AHR;PTPRB;ITGAV;NPNT;HSP90AB1;EPHB6;TRAF2;CD74
13492,GO:0055007,0.295975063668931,0.829150326646512,7,65,cardiac muscle cell differentiation,BP,NRG1;G6PD;EDN1;NEXN;SRF;MYH11;HNRNPU
10397,GO:0043217,0.296051727582068,0.912876093634489,2,12,myelin maintenance,BP,CLU;MPP5
9080,GO:0035313,0.296291232265712,0.911966344941656,2,13,wound healing, spreading of epidermal cells,BP,AJUBA;ADAM17
8973,GO:0035035,0.296375905645405,0.881737346741515,3,25,histone acetyltransferase binding,MF,TP53;KANSL1L;CITED2
16182,GO:0090184,0.296408958830267,0.881176608695796,3,27,positive regulation of kidney development,BP,WNT4;PDGFB;CFLAR
1113,GO:0002699,0.296410515091853,0.814794768897774,9,103,positive regulation of immune effector process,BP,TFRC;C3;SYK;RIF1;MSH6;TRAF2;TNF;ATAD5;CD74
17881,GO:1902047,0.296486531084873,0.959868189089555,1,5,polyamine transmembrane transport,BP,AZIN1
3340,GO:0007059,0.296669875998692,0.773177010798266,25,301,chromosome segregation,BP,KIF23;STAG1;AKAP8;BRIP1;NDC1;DYNLL2;AKAP8L;RAN;RANBP2;ANAPC15;DDX3X;SMC2;FEN1;CDCA5;NUP160;NAA50;SKA2;FANCD2;CENPF;RAD18;KIF14;CENPN;HNRNPU;CTCF;CENPO
8697,GO:0034311,0.297014729529884,0.909409824436096,2,17,diol metabolic process,BP,DHFR;QDPR
3417,GO:0007204,0.297061711076378,0.800992028742133,12,132,positive regulation of cytosolic calcium ion concentration,BP,SAA1;PML;JPH2;EDN1;C1QTNF1;PTGER4;ADM;ITGAV;JPH1;RIC3;GPER1;ESR1
1401,GO:0003323,0.297068000766499,0.910904103838016,2,14,type B pancreatic cell development,BP,ARNTL;CLOCK
14184,GO:0061046,0.297424131281661,0.959594646977074,1,5,regulation of branching involved in lung morphogenesis,BP,TNF
12896,GO:0051205,0.297499258385161,0.860660895699094,4,41,protein insertion into membrane,BP,TP53;REEP1;DYNLL2;TRAM2
5616,GO:0016661,0.297519745154018,0.959566691625456,1,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,GPHN
7454,GO:0031584,0.297588690054018,0.959546526755466,1,5,activation of phospholipase D activity,BP,CCL5
18105,GO:1902680,0.297601211182019,0.742746106286059,84,1060,positive regulation of RNA biosynthetic process,BP,MAFB;NRG1;TRIM16;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;RUNX1;PBX1;DDX17;TP53;EDN1;ZBED1;STAG1;TGFB2;FOXD2;INHBA;RELB;UTP15;SFRP1;NUCKS1;HEATR1;USP16;AHR;NAA15;GLIS3;TAF2;AKAP8L;MYBL2;RHOG;WNT4;THOC1;RAN;UBTF;SUPT16H;DDX3X;NUFIP1;RRN3;ARNTL;CDH13;SRF;NPNT;WDR43;PDGFB;FZD1;NFE2L1;MACC1;GLIS2;TET3;MYBL1;BRCA2;SS18L2;E2F8;ETV6;HSF2;CHEK1;GPER1;MLLT10;WDR75;SENP1;NOL11;EDRF1;CITED2;NCL;CCNA2;RBL1;NAA16;CLOCK;TLR3;ESR1;TNF;CD74;HNRNPU;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
8469,GO:0033600,0.297628923213652,0.961843414857013,1,4,negative regulation of mammary gland epithelial cell proliferation,BP,BRCA2
4364,GO:0009966,0.297643177733057,0.73295912731841,164,2150,regulation of signal transduction,BP,IL32;IGFBP3;SAA1;NRG1;TRIM16;FN1;PML;CYP1B1;AMOT;JPH2;MAP3K14;GCLC;CYR61;C3;GPRC5A;NLRC5;FGFR2;EPGN;TRIM22;STARD13;CTGF;MMP9;FBN1;RUNX1;IL1R2;FST;IRS1;MID1;TP53;DAPK3;EXO1;EDN1;GBP1;SIPA1L3;C1QTNF1;DUSP14;JRK;LGALS3;IFNGR1;CHP1;TGFB2;CNTNAP1;CYLD;IKBKE;IL16;RAD1;IL6ST;SLC9A3R1;NUAK1;INHBA;IL7R;SYK;EMP2;NAIP;NBN;TRIO;SHISA9;BRIP1;CDK4;SFRP1;NUCKS1;WNT10A;MIR17HG;RPA1;TAF2;ULK4;G3BP1;TRAF1;OPHN1;ADM;CD109;DYNLL2;CCL20;PLK2;RRAGB;UBQLN2;RFC3;HSPB1;RHOG;WNT4;CXCL16;NOP2;TOPBP1;SOD2;SUPT16H;ATP2C1;DDX3X;IL24;ARHGEF28;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;LFNG;NETO1;CDC42EP2;BAIAP2;GADD45B;CDH13;PHACTR4;MDM4;HIF1AN;NPNT;PDGFB;KREMEN2;FZD1;CLU;SMYD2;MACC1;ENPP1;BIRC3;IL20;EYA3;ACKR3;FGD6;GLIS2;RPF2;GLIPR2;JPH1;IFNAR1;HSP90AB1;ARL6IP5;EPHB6;FANCD2;MTMR2;CHEK1;GPER1;FAF1;ADAM17;RBMS3;ATR;PSME2;CFLAR;PSMB9;CMTM3;RABEP2;AKR1B1;TRAF2;TELO2;CITED2;CSF1;CLOCK;KIF14;TLR3;ESR1;TNF;RC3H1;CCL5;CD74;PSMB10;DAXX;METAP2;PHF14;PHLPP2;TAF1;PHLPP1;ITGB1BP1;IRF1;IRAK3
12315,GO:0048638,0.297749712960902,0.78389197829527,18,199,regulation of developmental growth,BP,NRG1;FN1;FGFR2;STAT5A;G6PD;EDN1;CDK4;SFRP1;MIR17HG;SRF;NEDD4L;ZFYVE27;L1CAM;NTN1;SHTN1;CSF1;WDR36;FTO
10883,GO:0044406,0.297814620569109,0.959480406349834,1,5,adhesion of symbiont to host,BP,HSP90AB1
18397,GO:1903371,0.29787723243258,0.9617746588897,1,4,regulation of endoplasmic reticulum tubular network organization,BP,RAB3GAP1
1432,GO:0003402,0.29790858432479,0.961765972547415,1,4,planar cell polarity pathway involved in axis elongation,BP,SFRP1
13616,GO:0060065,0.298368293581019,0.910925403328882,2,13,uterus development,BP,TGFB2;ESR1
14200,GO:0061077,0.298433611624476,0.834937493050109,6,67,chaperone-mediated protein folding,BP,BAG1;HSPB1;CLU;HSPA8;FKBP5;CD74
19940,GO:2000401,0.298574292566137,0.879860768576589,3,27,regulation of lymphocyte migration,BP,CCL20;ADAM17;CCL5
12727,GO:0050926,0.298966715274924,0.909360448333924,2,15,regulation of positive chemotaxis,BP,IL16;CDH13
13869,GO:0060452,0.299102370304616,0.95910234432881,1,5,positive regulation of cardiac muscle contraction,BP,CTGF
9801,GO:0040011,0.299313659820112,0.740351100345734,88,1101,locomotion,BP,IGFBP3;SAA1;NEFL;NRG1;HDAC9;FN1;TNS3;PML;CYP1B1;AMOT;MTUS1;KRT2;CYR61;STAT5A;STARD13;S100P;CTGF;MMP9;CLN6;B4GALT1;TP53;DAPK3;EDN1;DOCK10;LGALS3;PDPN;TGFB2;IL16;SLC9A3R1;SYK;EMP2;SFRP1;CD274;DST;TPM1;ULK4;ADAMTS9;PTGER4;OPHN1;CCL20;PLK2;NEXN;FRK;HSPB1;RHOG;WNT4;CXCL16;LCP1;PTPRM;SIRPA;SOD2;CORO1C;IL24;ITGAV;AJUBA;CDH13;PHACTR4;SRF;PDGFB;SPNS1;ACKR3;SETD2;ANLN;THBD;GLIPR2;APEX1;CXCR5;SGK1;CCAR1;WDPCP;L1CAM;GPER1;ADAM17;NTN1;CMTM3;CBLL1;SHTN1;DPYSL3;CITED2;CSF1;KIF14;TNF;NEDD9;CCL5;CD74;FGFR1OP;NRAS;ITGB1BP1
15703,GO:0072210,0.299375696582398,0.879919811328854,3,25,metanephric nephron development,BP,IRX2;WNT4;PDGFB
10065,GO:0042538,0.299473097494831,0.958993128700432,1,5,hyperosmotic salinity response,BP,AKR1B1
1720,GO:0004309,0.299643576515414,0.961283487653558,1,4,exopolyphosphatase activity,MF,PRUNE2
3179,GO:0006798,0.299643576515414,0.961283487653558,1,4,polyphosphate catabolic process,BP,PRUNE2
12673,GO:0050858,0.299664919348985,0.908495512712299,2,16,negative regulation of antigen receptor-mediated signaling pathway,BP,GBP1;LGALS3
3680,GO:0008180,0.299687186088935,0.879182241752047,3,27,COP9 signalosome,CC,AMOT;HSP90AB1;COPS3
3470,GO:0007296,0.299781248861961,0.961245051632154,1,4,vitellogenesis,BP,ETV6
2086,GO:0004843,0.299876745379726,0.825804704778765,7,70,thiol-dependent ubiquitin-specific protease activity,MF,CYLD;USP16;USP43;BRCC3;USP6;USP11;USP1
13927,GO:0060558,0.299880331977731,0.958872963977885,1,5,regulation of calcidiol 1-monooxygenase activity,BP,TNF
4480,GO:0010484,0.299961753337419,0.961194623933125,1,4,H3 histone acetyltransferase activity,MF,BRCA2
3172,GO:0006787,0.300059630233925,0.957270692089222,1,6,porphyrin-containing compound catabolic process,BP,UGT1A4
8251,GO:0033015,0.300059630233925,0.957270692089222,1,6,tetrapyrrole catabolic process,BP,UGT1A4
9898,GO:0042167,0.300059630233925,0.957270692089222,1,6,heme catabolic process,BP,UGT1A4
11601,GO:0046149,0.300059630233925,0.957270692089222,1,6,pigment catabolic process,BP,UGT1A4
12190,GO:0048296,0.300073569198481,0.95881587337048,1,5,regulation of isotype switching to IgA isotypes,BP,THOC1
13841,GO:0060415,0.300077121574363,0.846182106161118,5,42,muscle tissue morphogenesis,BP,NRG1;FGFR2;TGFB2;TPM1;FZD1
13870,GO:0060453,0.300088583191539,0.95881143567213,1,5,regulation of gastric acid secretion,BP,SGK1
12600,GO:0050747,0.300098437121253,0.958808522987684,1,5,positive regulation of lipoprotein metabolic process,BP,RAB3GAP1
9164,GO:0035510,0.300119107242099,0.879181868950175,3,26,DNA dealkylation,BP,APEX1;TET3;FTO
9562,GO:0036315,0.300358738173096,0.909922559727789,2,13,cellular response to sterol,BP,HMGCS1;INHBA
10018,GO:0042428,0.300608624886128,0.961013593547861,1,4,serotonin metabolic process,BP,SRD5A1
5933,GO:0018208,0.300714228179866,0.858373293733252,4,42,peptidyl-proline modification,BP,P3H2;P4HA2;RANBP2;FKBP5
10239,GO:0042921,0.30087339993565,0.908976127525626,2,14,glucocorticoid receptor signaling pathway,BP,ARNTL;CLOCK
9345,GO:0035821,0.301088813015598,0.817085654367481,8,92,modification of morphology or physiology of other organism,BP,NUCKS1;TARDBP;ITGAV;HSPA8;SERPINB9;HMGN2;TYMS;CCL5
7487,GO:0031646,0.301091086692,0.908865261440475,2,14,positive regulation of neurological system process,BP,NRG1;PARD3
20172,GO:2000831,0.301166617997594,0.958492076896463,1,5,regulation of steroid hormone secretion,BP,C1QTNF1
13055,GO:0051492,0.301299966437857,0.833489533800292,6,59,regulation of stress fiber assembly,BP,CTGF;SFRP1;TPM1;PTGER4;WNT4;ITGB1BP1
16222,GO:0090237,0.301358924438757,0.95843495769387,1,5,regulation of arachidonic acid secretion,BP,SYK
10958,GO:0044614,0.301522421165797,0.96075702719737,1,4,nuclear pore cytoplasmic filaments,CC,RANBP2
2717,GO:0006091,0.301623277432331,0.76609087874203,27,365,generation of precursor metabolites and energy,BP,TXNRD1;IRS1;PANK2;ACO1;PPP1R3B;IL6ST;NUP50;NUP153;LEPR;IMMP2L;P4HA2;NDC1;RANBP2;FASTKD3;CROT;PGK1;QDPR;NUP160;ENPP1;NUP54;SRD5A1;NNT;SDHD;AKR1B1;UQCRB;THTPA;NDUFB9
7105,GO:0030896,0.301705949597197,0.958331768611552,1,5,checkpoint clamp complex,CC,RAD1
13844,GO:0060420,0.301793833277082,0.858596437022786,4,36,regulation of heart growth,BP,FGFR2;G6PD;EDN1;MIR17HG
13332,GO:0052150,0.301796151946453,0.958304922391467,1,5,modulation by symbiont of host apoptotic process,BP,SERPINB9
612,GO:0001778,0.301834195969767,0.960669266110327,1,4,plasma membrane repair,BP,SYT11
13501,GO:0055017,0.301906824513513,0.844155232061445,5,47,cardiac muscle tissue growth,BP,FGFR2;G6PD;EDN1;TGFB2;MIR17HG
4772,GO:0010955,0.302018095026791,0.878021615345361,3,26,negative regulation of protein processing,BP,IL1R2;NAIP;BIRC3
18374,GO:1903318,0.302018095026791,0.878021615345361,3,26,negative regulation of protein maturation,BP,IL1R2;NAIP;BIRC3
7274,GO:0031248,0.302183592559202,0.816433983884789,8,88,protein acetyltransferase complex,CC,NAA15;TAF2;NAA50;KANSL1L;UBAP2L;TAF6L;POLE3;NAA16
18035,GO:1902493,0.302183592559202,0.816433983884789,8,88,acetyltransferase complex,CC,NAA15;TAF2;NAA50;KANSL1L;UBAP2L;TAF6L;POLE3;NAA16
6124,GO:0019369,0.302327749551431,0.877566219623518,3,27,arachidonic acid metabolic process,BP,PTGES;CYP1B1;CYP1A1
16102,GO:0090050,0.302476965793716,0.907563871574888,2,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,HDAC9;PLK2
2191,GO:0005047,0.302596227105364,0.958066363956485,1,5,signal recognition particle binding,MF,SRPRB
7889,GO:0032451,0.302604638850006,0.858246122758756,4,35,demethylase activity,MF,CYP1A1;KDM6A;UTY;FTO
8492,GO:0033632,0.302811342215564,0.958002088606387,1,5,regulation of cell-cell adhesion mediated by integrin,BP,CCL5
6956,GO:0030578,0.30281808950729,0.960391562360267,1,4,PML body organization,BP,PML
11385,GO:0045736,0.302900634875144,0.877480890839368,3,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN2A;CDK4;CDKN1A
3222,GO:0006874,0.303149685655964,0.781299242449277,17,197,cellular calcium ion homeostasis,BP,SAA1;PML;JPH2;EDN1;C1QTNF1;ATP2B1;PTGER4;ADM;ATP2C1;ITGAV;JPH1;THADA;RIC3;TMEM165;GPER1;ESR1;CCL5
7899,GO:0032462,0.303284717335248,0.906176408855469,2,17,regulation of protein homooligomerization,BP,CRYAB;CLU
15416,GO:0071651,0.30357191546396,0.960178024725237,1,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,DDX3X
16622,GO:0097433,0.30374024734832,0.957723881175523,1,5,dense body,CC,ACTG1
7072,GO:0030854,0.303837442286974,0.957694709732324,1,5,positive regulation of granulocyte differentiation,BP,RUNX1
8721,GO:0034358,0.304025571877586,0.906246393755892,2,16,plasma lipoprotein particle,CC,SAA1;CLU
19654,GO:1990777,0.304025571877586,0.906246393755892,2,16,lipoprotein particle,CC,SAA1;CLU
15509,GO:0071863,0.304089997624177,0.957618854920765,1,5,regulation of cell proliferation in bone marrow,BP,FGFR2
15510,GO:0071864,0.304089997624177,0.957618854920765,1,5,positive regulation of cell proliferation in bone marrow,BP,FGFR2
1415,GO:0003348,0.304158851358594,0.960011298870941,1,4,cardiac endothelial cell differentiation,BP,NRG1
14127,GO:0060956,0.304158851358594,0.960011298870941,1,4,endocardial cell differentiation,BP,NRG1
8283,GO:0033079,0.30416940794001,0.95759498781223,1,5,immature T cell proliferation,BP,WNT4
14664,GO:0070235,0.304223521034812,0.957578719428586,1,5,regulation of activation-induced cell death of T cells,BP,TSC22D3
1219,GO:0002886,0.30429485532712,0.876356792045905,3,27,regulation of myeloid leukocyte mediated immunity,BP,C3;SYK;DNASE1
16082,GO:0090009,0.304295617385261,0.959972390572318,1,4,primitive streak formation,BP,SRF
10231,GO:0042887,0.304495771377069,0.875755265046426,3,29,amide transmembrane transporter activity,MF,TAP1;TIMM23B;TAP2
10036,GO:0042471,0.304725323410252,0.83086838719962,6,60,ear morphogenesis,BP,MAFB;FGFR2;EDN1;SLC9A3R1;WDPCP;NTN1
12234,GO:0048468,0.304897320748148,0.732224999644475,105,1300,cell development,BP,NEFL;NRG1;HDAC9;MAP2;FN1;TENM3;KRT2;FOSL2;FGFR2;FBN1;RUNX1;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TFCP2L1;COL27A1;ENC1;PANK2;EDN1;GBP1;DOCK10;SIPA1L3;KBTBD8;PABPC4;PDPN;TGFB2;CNTNAP1;LRFN4;IL6ST;SLC9A3R1;INHBA;TJP2;BRIP1;SFRP1;DHFR;TPM1;ULK4;OPHN1;ADM;SLC1A3;PLK2;NEXN;RHOG;WNT4;GPRIN1;PTPRM;RAN;CORO1C;RRN3;ITGAV;ARNTL;DND1;BAIAP2;PHACTR4;SRF;PDGFB;UGT8;SDK1;FZD1;ANTXR1;CLU;SETD2;DPY19L2P2;WEE1;TJP1;SLC11A2;BLOC1S2;TNC;CNTNAP2;MYH11;NEDD4L;SGK1;ZFYVE27;BRCA2;TRAK2;WDPCP;MTMR2;L1CAM;GPER1;NTN1;CFLAR;EIF2B5;SHTN1;DPYSL3;DDX56;CSF1;CLOCK;KIF14;MPP5;ESR1;PARD3;GJC1;EHD1;TNF;TYMS;WDR36;HNRNPU;EIF2B1;TBPL1;NRAS;CDKN1A;ITGB1BP1
5522,GO:0016485,0.304940891142117,0.790687417598102,13,155,protein processing,BP,C1R;C3;IL1R2;C9ORF3;NAIP;RCE1;IMMP2L;MME;PGK1;CLU;BIRC3;BACE2;METAP2
10936,GO:0044545,0.304984913588446,0.957349433168179,1,5,NSL complex,CC,KANSL1L
448,GO:0001221,0.305001158186519,0.856445121154282,4,36,transcription cofactor binding,MF,TP53;AHR;BAIAP2;ESR1
10503,GO:0043394,0.305079761743413,0.877098230589839,3,23,proteoglycan binding,MF,COL5A3;FST;TNC
19625,GO:1990712,0.305155284251423,0.95729802948143,1,5,HFE-transferrin receptor complex,CC,TFRC
10314,GO:0043068,0.305184078080891,0.753861522873547,37,474,positive regulation of programmed cell death,BP,IGFBP3;PML;CYP1B1;CYR61;CTGF;MMP9;B4GALT1;TP53;DAPK3;CDKN2A;NQO1;TGFB2;CYLD;SLC9A3R1;INHBA;TRIO;SHQ1;CDK4;SFRP1;CD274;ADM;DYNLL2;MYBL2;DDX3X;GADD45B;ARL6IP5;GPER1;FAF1;SENP1;CFLAR;EIF2B5;TRAF2;TLR3;TNF;CCL5;CDKN1A;IFI27L1
19714,GO:2000002,0.305239579940233,0.957272582777216,1,5,negative regulation of DNA damage checkpoint,BP,THOC1
15314,GO:0071482,0.30536957155734,0.81400787168497,8,87,cellular response to light stimulus,BP,TP53;MME;CDC25A;CHEK1;ATR;METAP2;TAF1;CDKN1A
4569,GO:0010648,0.305429347093056,0.737998330553507,73,942,negative regulation of cell communication,BP,IGFBP3;NRG1;GCLC;GPRC5A;NLRC5;FGFR2;MMP9;FBN1;IL1R2;FST;IRS1;EDN1;GBP1;DUSP14;LGALS3;CHP1;TGFB2;CYLD;SLC9A3R1;INHBA;SFRP1;MIR17HG;G3BP1;ADM;CD109;PLK2;UBQLN2;HSPB1;WNT4;SOD2;DDX3X;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;LFNG;PHACTR4;SRF;HIF1AN;PDGFB;KREMEN2;FZD1;CLU;ENPP1;EYA3;ACKR3;GLIS2;SYT11;EPHB6;MTMR2;GPER1;ADAM17;RBMS3;PSME2;CFLAR;PSMB9;TRAF2;CLOCK;TLR3;ESR1;TNF;CCL5;CD74;PSMB10;PHF14;PHLPP2;PHLPP1;ITGB1BP1;IRAK3
13636,GO:0060088,0.305446399507399,0.957210112001412,1,5,auditory receptor cell stereocilium organization,BP,SLC9A3R1
14669,GO:0070245,0.305551065055324,0.95717847712488,1,5,positive regulation of thymocyte apoptotic process,BP,TP53
2120,GO:0004908,0.305703575677929,0.957132356921297,1,5,interleukin-1 receptor activity,MF,IL1R2
5570,GO:0016579,0.305752384020238,0.77283866636992,20,243,protein deubiquitination,BP,TRAF3;TP53;CYLD;USP16;KEAP1;RCE1;USP43;CDC25A;MDM4;BRCC3;USP6;BIRC3;PSME2;PSMB9;TRAF2;CCNA2;ESR1;USP11;PSMB10;USP1
11919,GO:0046931,0.305788598697095,0.905854010983316,2,15,pore complex assembly,BP,NUP153;NDC1
4765,GO:0010942,0.30581880093723,0.75187689700071,39,500,positive regulation of cell death,BP,IGFBP3;PML;CYP1B1;CYR61;CTGF;MMP9;B4GALT1;TP53;DAPK3;CDKN2A;NQO1;TGFB2;CYLD;SLC9A3R1;INHBA;TRIO;SHQ1;CDK4;SFRP1;CD274;ADM;DYNLL2;MYBL2;DDX3X;GADD45B;CLU;ARL6IP5;GPER1;FAF1;SENP1;CFLAR;EIF2B5;TRAF2;TLR3;TNF;CCL5;DAXX;CDKN1A;IFI27L1
16228,GO:0090245,0.305934199748182,0.959504516260339,1,4,axis elongation involved in somitogenesis,BP,SFRP1
12899,GO:0051213,0.306182051227124,0.820797613313184,7,73,dioxygenase activity,MF,P3H2;P4HA2;KDM6A;HIF1AN;UTY;TET3;FTO
9078,GO:0035308,0.306338497441087,0.855023089520287,4,39,negative regulation of protein dephosphorylation,BP,SET;PPP4R4;SH3RF2;TNF
11706,GO:0046476,0.30649275110758,0.956893244752581,1,5,glycosylceramide biosynthetic process,BP,UGT8
10075,GO:0042558,0.306504155996618,0.874742885901641,3,28,pteridine-containing compound metabolic process,BP,DHFR;QDPR;TYMS
6837,GO:0030295,0.306994652700882,0.84005131161476,5,51,protein kinase activator activity,MF,NRG1;DDX3X;CCL5;DAXX;CDKN1A
5374,GO:0016176,0.307252052751409,0.959125917545341,1,4,superoxide-generating NADPH oxidase activator activity,MF,PDGFB
20262,GO:2001169,0.307282872469347,0.828973386354837,6,60,regulation of ATP biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54
11315,GO:0045618,0.30733462718601,0.905050794171227,2,15,positive regulation of keratinocyte differentiation,BP,TRIM16;IL20
8318,GO:0033144,0.307578383468009,0.874598921646498,3,26,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,SFRP1;ARNTL;CLOCK
14710,GO:0070317,0.307582897547767,0.854520256570936,4,37,negative regulation of G0 to G1 transition,BP,CBX5;RRM2;CHEK1;RING1
13647,GO:0060122,0.307648806325477,0.904887179676868,2,15,inner ear receptor cell stereocilium organization,BP,FAT4;SLC9A3R1
3066,GO:0006631,0.307824795587533,0.769214310658214,21,262,fatty acid metabolic process,BP,PTGES;CYP1B1;C3;STAT5A;FADS3;CYP1A1;IRS1;PANK2;EDN1;SCD;ACSL3;CROT;AKR1C2;HACD2;SCD5;MMAA;HADHB;CD74;HIBCH;PPARGC1B;GPX4
20303,GO:2001237,0.308111942769881,0.819120940309125,7,76,negative regulation of extrinsic apoptotic signaling pathway,BP,GCLC;LGALS3;ITGAV;EYA3;CFLAR;TRAF2;TNF
11860,GO:0046823,0.308132808489602,0.904104913444103,2,16,negative regulation of nucleocytoplasmic transport,BP,CHP1;NUP153
14256,GO:0061200,0.308149403323754,0.956388781959811,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,HSPA8
14257,GO:0061202,0.308149403323754,0.956388781959811,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,HSPA8
2545,GO:0005811,0.308239892903897,0.827995755437184,6,63,lipid droplet,CC,STARD13;ACSL3;LSS;SET;RAB3GAP1;EHD1
37,GO:0000076,0.308394391015406,0.903967767453295,2,16,DNA replication checkpoint,BP,TOPBP1;TIMELESS
2950,GO:0006479,0.308632400307205,0.787760643943023,13,149,protein methylation,BP,METTL21A;SETDB1;SUV39H2;KDM6A;SETD4;VCPKMT;SMYD2;RIF1;SETD2;TET3;HSPA8;RBBP5;CTCF
3704,GO:0008213,0.308632400307205,0.787760643943023,13,149,protein alkylation,BP,METTL21A;SETDB1;SUV39H2;KDM6A;SETD4;VCPKMT;SMYD2;RIF1;SETD2;TET3;HSPA8;RBBP5;CTCF
4844,GO:0014048,0.308668563940411,0.956229991686414,1,5,regulation of glutamate secretion,BP,RAB3GAP1
12263,GO:0048522,0.30884826987105,0.717722306463507,263,3491,positive regulation of cellular process,BP,IGFBP3;MAFB;SAA1;NEFL;NRG1;HDAC9;TRIM16;FN1;TNS3;TENM3;PML;CYP1B1;KIF23;JPH2;MAP3K14;GCLC;TFRC;CYR61;C3;MKL1;FOSL2;COL16A1;NLRC5;FGFR2;STAT5A;EPGN;TRIM22;CTGF;MMP9;RUNX1;CYP1A1;CLN6;B4GALT1;PBX1;DDX17;ENC1;IRS1;MID1;TP53;DAPK3;EDN1;C1QTNF1;CDKN2A;RBM4;ACSL3;ZBED1;JRK;NQO1;STAG1;LGALS3;CHP1;PDPN;AKAP8;TGFB2;CNTNAP1;RBM22;CYLD;IKBKE;FOXD2;IL6ST;SLC9A3R1;DKC1;INHBA;IL7R;SYK;EMP2;NAIP;RELB;NBN;TRIO;SHQ1;UTP15;CDK4;SFRP1;NUCKS1;HEATR1;CD274;MIR17HG;H3F3A;USP16;AHR;KEAP1;NAA15;RPA1;TPM1;GLIS3;TAF2;ABCC4;ADAMTS9;SETDB1;PTGER4;ADM;CADPS2;DYNLL2;SLC1A3;CCL20;SYNPO2L;PLK2;RRAGB;UBQLN2;GBP5;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;CXCL16;NOP2;LCP1;SIRPA;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;NAP1L1;NUFIP1;IL24;RRN3;CDC25A;ITGAV;SOCS1;PARP14;ARNTL;ODC1;AJUBA;FASTKD3;DND1;AKR1C2;LFNG;NETO1;FEN1;CDC42EP2;CDCA5;BAIAP2;NVL;GADD45B;CDH13;SRF;MDM4;HIF1AN;NPNT;WDR43;PDGFB;BRCC3;FZD1;NFE2L1;ANTXR1;RTKN2;CLU;MACC1;BIRC3;IL20;PIK3R3;EYA3;ACKR3;RIF1;METTL16;GLIS2;ANLN;GLIPR2;LRRN3;APEX1;PDCL3;CXCR5;TNC;TET3;MYBL1;HSPA8;HSP90AB1;ARL6IP5;EPHB6;NSF;NEDD4L;ZFYVE27;BRCA2;SS18L2;CCAR1;E2F8;MTMR2;ETV6;L1CAM;HSF2;RAB3GAP1;CHEK1;IL12RB2;GPER1;FAF1;MLLT10;RAD18;WDR75;ADAM17;SENP1;RBMS3;ATR;NTN1;PSME2;MSH6;CFLAR;PSMB9;EIF2B5;CMTM3;NOL11;CBLL1;SHTN1;DPYSL3;NCBP1;UPF3B;AKR1B1;UBE2J2;TRAF2;TELO2;EDRF1;CITED2;HNRNPR;NCL;CCNA2;DDX56;TIMELESS;CSF1;AP3B1;RBL1;NAA16;CLOCK;KIF14;TLR3;SYNPO2;ESR1;PARD3;RNF19B;RAD51B;EHD1;TNF;ATAD5;ZFP36L2;RC3H1;STARD7;CCL5;CD74;HNRNPU;FGFR1OP;PSMB10;DAXX;PANX1;TAF1;TBPL1;SPIB;NRAS;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;IRF1;CTCF;TSGA13;GTF2H3;IFI27L1
12554,GO:0050684,0.308988006205203,0.80496818455082,9,100,regulation of mRNA processing,BP,DDX17;RBM4;SRSF2;METTL16;HSPA8;NCBP1;SRSF7;HNRNPU;RBM8A
12116,GO:0048104,0.309058016128281,0.958603746324325,1,4,establishment of body hair or bristle planar orientation,BP,ASTN2
12117,GO:0048105,0.309058016128281,0.958603746324325,1,4,establishment of body hair planar orientation,BP,ASTN2
11069,GO:0045048,0.309182716474895,0.956072402477682,1,5,protein insertion into ER membrane,BP,TRAM2
9415,GO:0035965,0.309221035232698,0.956060644483984,1,5,cardiolipin acyl-chain remodeling,BP,HADHB
16865,GO:0098754,0.309224914531051,0.82641689858973,6,75,detoxification,BP,TXNRD1;NQO1;DHFR;SOD2;TNF;GPX4
3522,GO:0007498,0.309662018486763,0.818209229754403,7,72,mesoderm development,BP,TXNRD1;FGFR2;INHBA;KDM6A;SRF;SETD2;CITED2
14822,GO:0070536,0.309829001201961,0.873500058206265,3,25,protein K63-linked deubiquitination,BP,CYLD;USP16;BRCC3
7816,GO:0032364,0.310073290342477,0.955798659478869,1,5,oxygen homeostasis,BP,SOD2
15773,GO:0072347,0.310081801075868,0.852651120408668,4,38,response to anesthetic,BP,SDK1;EFTUD2;HSP90AB1;CCNA2
15143,GO:0071216,0.31030214247149,0.793872425841035,11,129,cellular response to biotic stimulus,BP,TP53;AKAP8;SYK;CDK4;CD274;CCL20;IL24;NFKBIB;CCDC47;TNF;CCL5
10890,GO:0044419,0.31034877932837,0.74006005065098,53,727,interspecies interaction between organisms,BP,FN1;PML;TFRC;TRIM22;CBX5;HLA-B;TAP1;TP53;IL16;IL6ST;NUP50;SLC22A5;SYK;NUP153;FAM111A;NUCKS1;TARDBP;POLA1;NDC1;THOC1;RAN;RANBP2;DDX3X;ITGAV;SET;ZC3H7B;NUP160;NUP54;ACKR3;UBP1;PDCL3;HSPA8;HSP90AB1;NEDD4L;SYNCRIP;POLR2F;SERPINB9;HMGN2;MSH6;CFLAR;PSMB9;CBLL1;CCNA2;TAP2;RBL1;TNF;TYMS;CCL5;CD74;PSMB10;DAXX;TAF1;RPS12
5343,GO:0016078,0.310503065366162,0.95400562002324,1,6,tRNA catabolic process,BP,POP1
4262,GO:0009597,0.310570679913987,0.955645342083259,1,5,detection of virus,BP,TLR3
16083,GO:0090022,0.310845838053343,0.901792019292273,2,18,regulation of neutrophil chemotaxis,BP,EDN1;CD74
12101,GO:0048039,0.310897733765463,0.953879496878104,1,6,ubiquinone binding,MF,SDHD
4671,GO:0010817,0.310966695014129,0.763343907726085,23,282,regulation of hormone levels,BP,CYP1B1;SLC16A2;CYP1A1;IRS1;EDN1;C9ORF3;C1QTNF1;INHBA;SFRP1;KCNS3;ADM;MME;WNT4;ARNTL;AKR1C2;SRD5A1;BACE2;GPER1;AKR1B1;CLOCK;ESR1;TNF;CCL5
14991,GO:0070883,0.311469279054136,0.955367570589766,1,5,pre-miRNA binding,MF,RAN
4554,GO:0010633,0.311495382678646,0.837059529392815,5,49,negative regulation of epithelial cell migration,BP,STARD13;ADAMTS9;PTPRM;CORO1C;ITGB1BP1
15851,GO:0072537,0.311760408532578,0.955277361191001,1,5,fibroblast activation,BP,GCLC
9442,GO:0036005,0.311770349303377,0.955274279070399,1,5,response to macrophage colony-stimulating factor,BP,CSF1
9443,GO:0036006,0.311770349303377,0.955274279070399,1,5,cellular response to macrophage colony-stimulating factor stimulus,BP,CSF1
10464,GO:0043312,0.311828048077473,0.757132788197992,27,351,neutrophil degranulation,BP,KRT1;FTL;FTH1;C3;S100P;MMP9;B4GALT1;LGALS3;SYK;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;ITGAV;QPCT;COMMD9;HSPA8;HSP90AB1;LAIR1;LILRB3;GLIPR1;NRAS
460,GO:0001325,0.311890351373492,0.902665501655335,2,15,formation of extrachromosomal circular DNA,BP,EXO1;NBN
16376,GO:0090656,0.311890351373492,0.902665501655335,2,15,t-circle formation,BP,EXO1;NBN
16404,GO:0090737,0.311890351373492,0.902665501655335,2,15,telomere maintenance via telomere trimming,BP,EXO1;NBN
3594,GO:0008022,0.311910209576047,0.781795437396259,14,161,protein C-terminus binding,MF,NEFL;FN1;CTGF;HSPG2;TP53;DAPK3;TJP2;DST;TOPBP1;BAIAP2;BRCA2;CENPF;VPS36;NCL
11147,GO:0045177,0.31192459603343,0.769558088760838,19,218,apical part of cell,CC,FN1;MYO1B;FAT4;SIPA1L3;PDPN;SLC9A3R1;SLC22A5;EMP2;ABCG2;ATP2B1;PARD3B;MGAM;TJP1;SLC11A2;HSP90AB1;WDPCP;ADAM17;PARD3;KCNE4
5611,GO:0016651,0.312048939600106,0.823876384472943,6,83,oxidoreductase activity, acting on NAD(P)H,MF,TXNRD1;NQO1;AKR1C2;PGK1;NNT;NDUFB9
9677,GO:0038027,0.312082851791348,0.95772045495509,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ITGAV
5119,GO:0015450,0.312158348189337,0.952284886439796,1,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,TIMM23B
8152,GO:0032872,0.312311647501667,0.781457193877362,14,161,regulation of stress-activated MAPK cascade,BP,CTGF;MID1;EDN1;TGFB2;SYK;SFRP1;ULK4;GADD45B;ARL6IP5;TRAF2;TLR3;TNF;DAXX;PHLPP1
18090,GO:1902624,0.312366739859041,0.900981566602626,2,18,positive regulation of neutrophil migration,BP,EDN1;CD74
13309,GO:0051984,0.312399917711653,0.87160027018606,3,26,positive regulation of chromosome segregation,BP,FEN1;RAD18;HNRNPU
9922,GO:0042249,0.312419501510426,0.903009445652131,2,14,establishment of planar polarity of embryonic epithelium,BP,SFRP1;FZD1
7215,GO:0031102,0.312548438991372,0.850971300719677,4,38,neuron projection regeneration,BP,NEFL;DHFR;ADM;TNC
8400,GO:0033313,0.312622156085996,0.955009718076134,1,5,meiotic cell cycle checkpoint,BP,RAD1
12302,GO:0048608,0.312625586276005,0.759134064614316,25,300,reproductive structure development,BP,CYR61;FGFR2;HMGCS1;TGFB2;INHBA;ZFP42;BRIP1;SFRP1;ADM;IMMP2L;WNT4;LFNG;PDGFB;SRD5A1;SETD2;TNC;HSP90AB1;BRCA2;E2F8;RRM1;EIF2B5;CITED2;TLR3;ESR1;SMARCC1
15763,GO:0072330,0.312905350041904,0.772834449573441,17,204,monocarboxylic acid biosynthetic process,BP,PTGES;FADS3;CYP1A1;EDN1;SCD;ACSL3;NUP50;NUP153;NDC1;SLC1A3;RANBP2;PGK1;HACD2;NUP160;NUP54;SCD5;CD74
20301,GO:2001235,0.313017428492946,0.787366615720542,12,150,positive regulation of apoptotic signaling pathway,BP,PML;MMP9;TP53;DAPK3;CYLD;SLC9A3R1;INHBA;SFRP1;DYNLL2;GPER1;FAF1;TRAF2
185,GO:0000400,0.313093063962922,0.901488783762967,2,16,four-way junction DNA binding,MF,MSH6;RAD51B
6556,GO:0021984,0.313099938528453,0.9548609264923,1,5,adenohypophysis development,BP,WNT4
16617,GO:0097422,0.313112415302156,0.954857037124354,1,5,tubular endosome,CC,SNX5
16270,GO:0090307,0.313232206072852,0.824446757786982,6,61,mitotic spindle assembly,BP,KIF23;STAG1;NAIP;MYBL2;BIRC3;HNRNPU
9837,GO:0042045,0.313294694735607,0.954800193129069,1,5,epithelial fluid transport,BP,EDN1
11393,GO:0045744,0.313818170208031,0.870177184828288,3,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,ADM;UBQLN2;CCL5
18346,GO:1903251,0.313829552588844,0.954633156513921,1,5,multi-ciliated epithelial cell differentiation,BP,CEP152
11767,GO:0046598,0.313831796427683,0.952935578206448,1,6,positive regulation of viral entry into host cell,BP,CD74
8331,GO:0033162,0.313857823406684,0.952927155359584,1,6,melanosome membrane,CC,RAB32
11051,GO:0045009,0.313857823406684,0.952927155359584,1,6,chitosome,CC,RAB32
16405,GO:0090741,0.313857823406684,0.952927155359584,1,6,pigment granule membrane,CC,RAB32
6936,GO:0030532,0.31387869719003,0.82331645632148,6,69,small nuclear ribonucleoprotein complex,CC,TGS1;GEMIN4;ZMAT2;LUC7L;LUC7L2;EFTUD2
10491,GO:0043374,0.314364973821267,0.954465584022537,1,5,CD8-positive, alpha-beta T cell differentiation,BP,IRF1
17448,GO:1900181,0.314684466879592,0.901188917832609,2,15,negative regulation of protein localization to nucleus,BP,CHP1;POLR1A
9873,GO:0042117,0.314746960499198,0.954345812136926,1,5,monocyte activation,BP,CSF1
7204,GO:0031088,0.314763763525524,0.954340539334975,1,5,platelet dense granule membrane,CC,ABCC4
2946,GO:0006475,0.314806519421563,0.786195019395193,12,138,internal protein amino acid acetylation,BP,TRIM16;CPA4;SET;NAA50;BRCA2;CHEK1;TAF6L;GTF3C4;POLE3;CLOCK;TAF1;CTCF
3003,GO:0006549,0.314822680941853,0.954322048199877,1,5,isoleucine metabolic process,BP,STAT5A
8360,GO:0033216,0.314842368121462,0.954315868436986,1,5,ferric iron import,BP,STEAP4
9311,GO:0035749,0.315283281303001,0.954177338932227,1,5,myelin sheath adaxonal region,CC,MPP5
11785,GO:0046627,0.315302405748913,0.869501432148915,3,27,negative regulation of insulin receptor signaling pathway,BP,IRS1;SOCS1;ENPP1
12194,GO:0048304,0.315473746461654,0.954117421405351,1,5,positive regulation of isotype switching to IgG isotypes,BP,ATAD5
18424,GO:1903426,0.315484454461554,0.833830376777637,5,52,regulation of reactive oxygen species biosynthetic process,BP,EDN1;CLU;HSP90AB1;CFLAR;TNF
4856,GO:0014066,0.315490671020573,0.822663142427764,6,62,regulation of phosphatidylinositol 3-kinase signaling,BP,NRG1;TGFB2;SLC9A3R1;PDGFB;GPER1;CCL5
16878,GO:0098781,0.315501406950508,0.805707044890842,8,94,ncRNA transcription,BP,PHAX;GTF3C6;POLR2F;NIFK;NOL11;NCBP1;NCL;GTF3C4
2104,GO:0004869,0.315511253600027,0.868870800613088,3,29,cysteine-type endopeptidase inhibitor activity,MF,NAIP;BIRC3;SERPINB9
6652,GO:0023057,0.315585514355768,0.728521154359757,73,945,negative regulation of signaling,BP,IGFBP3;NRG1;GCLC;GPRC5A;NLRC5;FGFR2;MMP9;FBN1;IL1R2;FST;IRS1;EDN1;GBP1;DUSP14;LGALS3;CHP1;TGFB2;CYLD;SLC9A3R1;INHBA;SFRP1;MIR17HG;G3BP1;ADM;CD109;PLK2;UBQLN2;HSPB1;WNT4;SOD2;DDX3X;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;LFNG;PHACTR4;SRF;HIF1AN;PDGFB;KREMEN2;FZD1;CLU;ENPP1;EYA3;ACKR3;GLIS2;SYT11;EPHB6;MTMR2;GPER1;ADAM17;RBMS3;PSME2;CFLAR;PSMB9;TRAF2;CLOCK;TLR3;ESR1;TNF;CCL5;CD74;PSMB10;PHF14;PHLPP2;PHLPP1;ITGB1BP1;IRAK3
11132,GO:0045143,0.315854775972982,0.869153504230807,3,27,homologous chromosome segregation,BP,BRIP1;NDC1;FANCD2
13311,GO:0051987,0.315855987319501,0.953997036164392,1,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,HNRNPU
9840,GO:0042054,0.315921758264773,0.833744050246456,5,50,histone methyltransferase activity,MF,SETDB1;SUV39H2;SMYD2;SETD2;RBBP5
11492,GO:0045934,0.31593805588695,0.725538610682578,84,1096,negative regulation of nucleobase-containing compound metabolic process,BP,NRG1;HDAC9;PML;GCLC;FGFR2;TRIM22;CBX5;TSC22D3;FST;TFCP2L1;TP53;EDN1;CDKN2A;IRX2;SRSF2;DKC1;RELB;NBN;PARP15;SHQ1;SFRP1;TARDBP;POLQ;H3F3A;AHR;GLIS3;HELLS;SETDB1;ZNF587;FRK;WNT4;SUV39H2;THOC1;SET;ARNTL;AJUBA;TRIM37;GNL3L;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;SMYD2;LRPPRC;RIF1;GLIS2;UBP1;APEX1;HSPA8;NEDD4L;BRCA2;SYNCRIP;CCAR1;E2F8;CENPF;ETV6;GPER1;ATR;MSH6;ZNF12;ZNF608;MSH3;CITED2;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;SRSF7;HNRNPU;RING1;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;IRF1;CTCF
10938,GO:0044547,0.315982272333015,0.953957222727125,1,5,DNA topoisomerase binding,MF,NCL
7959,GO:0032552,0.31599779528229,0.952231619460264,1,6,deoxyribonucleotide binding,MF,HSP90AB1
8292,GO:0033089,0.316036292412145,0.95394018586392,1,5,positive regulation of T cell differentiation in thymus,BP,IL7R
9339,GO:0035810,0.316272266972315,0.95386572100771,1,5,positive regulation of urine volume,BP,EDN1
13887,GO:0060484,0.316478997628176,0.953800426717774,1,5,lung-associated mesenchyme development,BP,FGFR2
4228,GO:0009404,0.316481667957434,0.899199912088871,2,17,toxin metabolic process,BP,CYP1B1;CYP1A1
13285,GO:0051953,0.316929488165303,0.953657955885998,1,5,negative regulation of amine transport,BP,ARL6IP5
11486,GO:0045926,0.317176511053523,0.777235999198197,14,166,negative regulation of growth,BP,CRYAB;PML;G6PD;TP53;CDKN2A;TGFB2;INHBA;SFRP1;MIR17HG;DDX3X;ENPP1;NTN1;TNF;CDKN1A
2298,GO:0005261,0.317203416884041,0.793319291221573,10,105,cation channel activity,MF,JPH2;SLC4A11;KCNS3;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;KCNE4;PANX1
10037,GO:0042472,0.317211868874902,0.833061170601381,5,48,inner ear morphogenesis,BP,MAFB;FGFR2;SLC9A3R1;WDPCP;NTN1
19742,GO:2000051,0.31721793865269,0.956195847271585,1,4,negative regulation of non-canonical Wnt signaling pathway,BP,SFRP1
3064,GO:0006627,0.317240794002686,0.951824893168234,1,6,protein processing involved in protein targeting to mitochondrion,BP,IMMP2L
9702,GO:0038089,0.317360682441397,0.953521347545016,1,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,HSPB1
14608,GO:0070141,0.317364617732462,0.953520099708151,1,5,response to UV-A,BP,MME
2856,GO:0006346,0.31753092168357,0.899673994496076,2,15,methylation-dependent chromatin silencing,BP,HELLS;SETDB1
9387,GO:0035907,0.317722761940475,0.953406454204173,1,5,dorsal aorta development,BP,SRF
12293,GO:0048585,0.317884981284203,0.723496207487574,85,1109,negative regulation of response to stimulus,BP,IGFBP3;KRT1;SAA1;NRG1;GCLC;GPRC5A;NLRC5;FGFR2;MMP9;FBN1;IL1R2;FST;IRS1;EDN1;GBP1;C1QTNF1;DUSP14;LGALS3;CHP1;TGFB2;CYLD;IL27RA;SLC9A3R1;IL7R;SFRP1;MIR17HG;POLQ;PTGER4;G3BP1;ADM;CD109;PLK2;UBQLN2;HSPB1;WNT4;THOC1;SOD2;DDX3X;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;LFNG;PHACTR4;HIF1AN;PDGFB;CHID1;KREMEN2;FZD1;CLU;ENPP1;EYA3;ACKR3;RIF1;GLIS2;THBD;ARL6IP5;EPHB6;MTMR2;SERPINB9;GPER1;ADAM17;RBMS3;PSME2;CFLAR;PSMB9;TRAF2;RBL1;CLOCK;TLR3;ESR1;TNF;RC3H1;CCL5;CD74;PSMB10;PHF14;PHLPP2;PHLPP1;ITGB1BP1;IRAK3
2046,GO:0004791,0.318116667353899,0.951537089526984,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD1
380,GO:0001012,0.318346172313581,0.742818854927469,36,438,RNA polymerase II regulatory region DNA binding,MF,MAFB;FOSL2;NLRC5;RUNX1;PBX1;TFCP2L1;TP53;ZBED1;ZFP42;RELB;H3F3A;AHR;MYBL2;KDM6A;ARNTL;SRF;UTY;NFE2L1;MACC1;GLIS2;MYBL1;MAZ;E2F8;ETV6;HSF2;RBL1;CLOCK;PURB;ESR1;TAF1;TBPL1;SPIB;SMARCC1;ARID3B;IRF1;CTCF
10595,GO:0043549,0.318515203261072,0.733578482454438,51,643,regulation of kinase activity,BP,SAA1;NRG1;MAP3K14;CYR61;GPRC5A;NLRC5;FGFR2;EPGN;IRS1;EDN1;DUSP14;CDKN2A;CHP1;TGFB2;PKMYT1;SLC9A3R1;SYK;EMP2;NBN;CDK4;SFRP1;HSPB1;RANBP2;CORO1C;DDX3X;CDC25A;SOCS1;AJUBA;GADD45B;PDGFB;CLU;PIK3R3;HSP90AB1;EPHB6;FAF1;ADAM17;TRAF2;TELO2;CSF1;RBL1;KIF14;TLR3;TNF;CCL5;CD74;HNRNPU;FGFR1OP;DAXX;CDKN1A;ITGB1BP1;IRAK3
540,GO:0001658,0.318518704531146,0.847250246837396,4,36,branching involved in ureteric bud morphogenesis,BP,FAT4;PBX1;WNT4;NPNT
15921,GO:0072674,0.318653879026375,0.95576383230655,1,4,multinuclear osteoclast differentiation,BP,CD109
15922,GO:0072675,0.318653879026375,0.95576383230655,1,4,osteoclast fusion,BP,CD109
2932,GO:0006450,0.31881588833444,0.897510589737109,2,18,regulation of translational fidelity,BP,YRDC;GATC
20293,GO:2001223,0.318849023838902,0.95304801359082,1,5,negative regulation of neuron migration,BP,NRG1
8317,GO:0033143,0.319096346102515,0.819860503274705,6,63,regulation of intracellular steroid hormone receptor signaling pathway,BP,RUNX1;SFRP1;ARNTL;CLOCK;ESR1;TAF1
4919,GO:0014855,0.31917620419511,0.846605286743374,4,37,striated muscle cell proliferation,BP,FGFR2;TGFB2;MIR17HG;CFLAR
4855,GO:0014065,0.319259474211364,0.803210767403821,8,85,phosphatidylinositol 3-kinase signaling,BP,NRG1;IRS1;EDN1;TGFB2;SLC9A3R1;PDGFB;GPER1;CCL5
2850,GO:0006336,0.319277837057577,0.844766528597563,4,50,DNA replication-independent nucleosome assembly,BP,H3F3A;CENPN;HIST1H4A;CENPO
3985,GO:0008823,0.319330702765139,0.952894225358324,1,5,cupric reductase activity,MF,STEAP4
13465,GO:0052851,0.319330702765139,0.952894225358324,1,5,ferric-chelate reductase (NADPH) activity,MF,STEAP4
3248,GO:0006909,0.319418101268176,0.778650911941232,13,152,phagocytosis,BP,C3;ACTG1;SYK;LEPR;RHOG;SIRPA;CORO1C;ITGAV;BAIAP2;SYT11;HSP90AB1;MYO10;TNF
85,GO:0000172,0.319539213770041,0.951067525639275,1,6,ribonuclease MRP complex,CC,POP1
1447,GO:0003433,0.319565060446219,0.952819294306495,1,5,chondrocyte development involved in endochondral bone morphogenesis,BP,COL27A1
11388,GO:0045739,0.319716053538839,0.845715918133892,4,40,positive regulation of DNA repair,BP,BRCC3;EYA3;RIF1;TIMELESS
12845,GO:0051131,0.319716897593126,0.897454142269962,2,17,chaperone-mediated protein complex assembly,BP,CLU;HSP90AB1
18591,GO:1903789,0.319918387821479,0.952706193387351,1,5,regulation of amino acid transmembrane transport,BP,ARL6IP5
18260,GO:1903038,0.320080294957038,0.819031303292271,6,64,negative regulation of leukocyte cell-cell adhesion,BP,LGALS3;CYLD;CD274;RC3H1;CD74;IRF1
13031,GO:0051445,0.320125778256865,0.866450629158722,3,27,regulation of meiotic cell cycle,BP,RAD1;WNT4;LFNG
13744,GO:0060292,0.320177621616956,0.898255698107527,2,15,long term synaptic depression,BP,PLK2;SRF
14700,GO:0070302,0.320322043265448,0.774660744880024,14,162,regulation of stress-activated protein kinase signaling cascade,BP,CTGF;MID1;EDN1;TGFB2;SYK;SFRP1;ULK4;GADD45B;ARL6IP5;TRAF2;TLR3;TNF;DAXX;PHLPP1
12242,GO:0048484,0.320369268434185,0.952561635233951,1,5,enteric nervous system development,BP,PHACTR4
18366,GO:1903301,0.320505263792485,0.952517982663209,1,5,positive regulation of hexokinase activity,BP,RANBP2
13156,GO:0051702,0.32055803079985,0.830032077267188,5,53,interaction with symbiont,BP,FN1;NUCKS1;TARDBP;HSPA8;CCL5
8378,GO:0033267,0.320622955959699,0.758232399346171,21,244,axon part,CC,NEFL;NRG1;CNTNAP1;AP3M2;DST;OPHN1;HSPB1;GPRIN1;BLOC1S2;CNTNAP2;HSPA8;SYT11;ZFYVE27;TRAK2;L1CAM;GPER1;SHTN1;DPYSL3;HNRNPR;AP3B1;PARD3
9810,GO:0040020,0.320659600801928,0.897434886329786,2,16,regulation of meiotic nuclear division,BP,RAD1;WNT4
17609,GO:1901216,0.320676454243467,0.818580483807185,6,64,positive regulation of neuron death,BP,TP53;NQO1;TGFB2;MYBL2;CLU;DAXX
9682,GO:0038034,0.320987787652521,0.82961246129061,5,54,signal transduction in absence of ligand,BP,DAPK3;INHBA;ITGAV;EYA3;TNF
16514,GO:0097192,0.320987787652521,0.82961246129061,5,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,DAPK3;INHBA;ITGAV;EYA3;TNF
10873,GO:0044381,0.32099475245997,0.898463723714232,2,14,glucose import in response to insulin stimulus,BP,IRS1;PIK3R3
20327,GO:2001273,0.32099475245997,0.898463723714232,2,14,regulation of glucose import in response to insulin stimulus,BP,IRS1;PIK3R3
6821,GO:0030275,0.321083172710152,0.897205690150772,2,16,LRR domain binding,MF,MKL1;DAPK3
3647,GO:0008121,0.321202056080497,0.949254227152202,1,7,ubiquinol-cytochrome-c reductase activity,MF,UQCRB
5626,GO:0016681,0.321202056080497,0.949254227152202,1,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,UQCRB
10267,GO:0042996,0.321266836400245,0.952273094138183,1,5,regulation of Golgi to plasma membrane protein transport,BP,ACSL3
8046,GO:0032689,0.321321422402174,0.896583122019865,2,17,negative regulation of interferon-gamma production,BP,INHBA;CD274
12790,GO:0051046,0.32154288873827,0.74148897234701,34,425,regulation of secretion,BP,SAA1;NRG1;TRIM16;FN1;PML;IL1R2;IRS1;EDN1;GBP1;C1QTNF1;ACSL3;TGFB2;SLC9A3R1;INHBA;SYK;SFRP1;CD274;KCNS3;PTGER4;CADPS2;RAB26;SOCS1;ARNTL;SYT11;NSF;SGK1;RAB3GAP1;GPER1;TRAF2;CLOCK;TNF;CCL5;CD74;PANX1
15615,GO:0072078,0.321575198652266,0.830026227384762,5,47,nephron tubule morphogenesis,BP,FAT4;PBX1;IRX2;WNT4;NPNT
20229,GO:2001046,0.321619791202008,0.952159348996619,1,5,positive regulation of integrin-mediated signaling pathway,BP,EMP2
1228,GO:0002902,0.322000705581604,0.896213331848769,2,17,regulation of B cell apoptotic process,BP,MIR17HG;CD74
10096,GO:0042587,0.322248218535837,0.951956435793054,1,5,glycogen granule,CC,PPP1R3B
2578,GO:0005865,0.322490049260257,0.89931593558749,2,12,striated muscle thin filament,CC,TPM1;TPM4
8862,GO:0034650,0.322643534278801,0.951828534147942,1,5,cortisol metabolic process,BP,WNT4
8863,GO:0034651,0.322643534278801,0.951828534147942,1,5,cortisol biosynthetic process,BP,WNT4
19750,GO:2000064,0.322643534278801,0.951828534147942,1,5,regulation of cortisol biosynthetic process,BP,WNT4
6463,GO:0021781,0.322657565467717,0.951823990791652,1,5,glial cell fate commitment,BP,NRG1
1021,GO:0002517,0.322675453812493,0.951818198108278,1,5,T cell tolerance induction,BP,PHLPP1
1084,GO:0002664,0.322675453812493,0.951818198108278,1,5,regulation of T cell tolerance induction,BP,PHLPP1
12598,GO:0050733,0.322801279628536,0.951777441095776,1,5,RS domain binding,MF,LUC7L
6037,GO:0019103,0.322870586628535,0.949957539187612,1,6,pyrimidine nucleotide binding,MF,HSP90AB1
3549,GO:0007585,0.322913376622058,0.84366343389257,4,39,respiratory gaseous exchange,BP,MAFB;EDN1;KDM6A;FTO
11092,GO:0045078,0.322979393110655,0.951719712718853,1,5,positive regulation of interferon-gamma biosynthetic process,BP,TLR3
15920,GO:0072673,0.323103703316916,0.896676808648037,2,15,lamellipodium morphogenesis,BP,PDPN;CORO1C
3718,GO:0008238,0.323155519726577,0.8167020576131,6,64,exopeptidase activity,MF,C9ORF3;MME;CPA4;ERAP1;DNPEP;METAP2
15898,GO:0072608,0.323172699987979,0.949856158400821,1,6,interleukin-10 secretion,BP,CD274
9104,GO:0035360,0.323236251135352,0.951636391121936,1,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,CITED2
1542,GO:0003924,0.323495713118982,0.761261682971454,18,228,GTPase activity,MF,GBP1;RAB32;ARFRP1;TSR1;LSG1;EIF5;RRAGB;GBP5;RHOG;RAN;DDX3X;RAB26;GNL3L;EFTUD2;MMAA;BMS1;NRAS;GBP6
15559,GO:0071944,0.323661411005584,0.704890774783903,223,2904,cell periphery,CC,CRYAB;SPRR3;KRT1;NRG1;SPRR2A;TRIM16;FN1;TRIM16L;TENM3;AMOT;MTUS1;JPH2;KRT2;TFRC;C3;GPRC5A;CYP24A1;FGFR2;EPGN;S100P;SLC16A2;CTGF;HLA-B;UTP20;VMP1;HSPG2;SLC7A2;MYO1B;ERVFRD-1;IL1R2;FAT4;B4GALT1;ACTG1;G6PD;TRAF3;IRS1;DYNC2H1;SLC16A9;SLC7A5P2;EXO1;GBP1;SIPA1L3;C1QTNF1;ZNF397;MEGF11;LGALS3;IFNGR1;CHP1;SLC4A11;PDPN;CNTNAP1;CYLD;IL27RA;IL16;PCDH7;LRFN4;IL6ST;HNRNPF;SLC9A3R1;IL7R;SLC22A5;PALM2;CAMK1G;SYK;EMP2;TJP2;NAIP;GPR132;LEPR;SHISA9;VEZT;ABCG2;LRRC8D;HLA-F;SFRP1;HLA-DOB;CD274;DST;ATP2B1;TCHH;SLC5A6;HRNR;TPM1;PTPRB;RCE1;ABCC4;KCNS3;SETDB1;PTGER4;TMEM97;G3BP1;PARD3B;MGAM;CD109;NDC1;CADPS2;DYNLL2;SLC1A3;EIF5;CDV3;SLCO4C1;MME;MUC16;UBQLN2;FRK;BTN2A1;HSPB1;RHOG;WNT4;CXCL16;LCP1;GPRIN1;PTPRM;SIRPA;CORO1C;RAB26;ARHGEF28;GPHN;ITGAV;ABCF2;TRPM7;AJUBA;KCNQ5;SNX5;NETO1;CDC42EP2;BAIAP2;CDH13;NPNT;PDGFB;UGT8;KREMEN2;SDK1;FZD1;ANTXR1;RTKN2;CLU;USP6;ENPP1;FRAS1;TPM4;ACKR3;RIF1;ANLN;THBD;UPK3B;ABCC9;JPH1;IFNAR1;TJP1;KCTD3;ERAP1;SLC11A2;CXCR5;CNTNAP2;ORC1;HSPA8;SYT11;HSP90AB1;ARL6IP5;EPHB6;BACE2;NSF;LAIR1;NEDD4L;SGK1;M6PR;ZFYVE27;TRAK2;HCAR1;KRT10;PPIP5K1;WDPCP;MTMR2;L1CAM;STEAP4;IL12RB2;BBS5;GPER1;FAF1;RPTN;ANKRD13A;ADAM17;MYO10;LILRB3;CFLAR;DNAJC9;EBP;TRAF2;NCL;SLC9A9;CSF1;MPHOSPH8;GLIPR1;KIF14;TLR3;MPP5;ERVK13-1;ESR1;PARD3;GJC1;EHD1;KCNE4;ARV1;TNF;SURF2;NEDD9;CD74;FLAD1;EIF2B1;METAP2;SLC43A2;PHLPP2;PANX1;PHLPP1;NRAS;MUC5B;HNRNPM;ITGB1BP1;MUC6;SLC41A2;ASTN2;IRAK3
15363,GO:0071569,0.323771236028654,0.949654952482713,1,6,protein ufmylation,BP,UFC1
4200,GO:0009306,0.324031857578125,0.746391152477128,27,331,protein secretion,BP,SAA1;TRIM16;FN1;PML;GNPTAB;IL1R2;IRS1;GBP1;TGFB2;SYK;SFRP1;CD274;KCNS3;PTGER4;GBP5;RAB26;ITGAV;SOCS1;ARNTL;SYT11;M6PR;GPER1;TRAF2;CLOCK;TNF;CCL5;PANX1
1398,GO:0003309,0.324187623128832,0.896089030823985,2,15,type B pancreatic cell differentiation,BP,ARNTL;CLOCK
9854,GO:0042090,0.324295753935833,0.951291810318457,1,5,interleukin-12 biosynthetic process,BP,IRF1
11089,GO:0045075,0.324295753935833,0.951291810318457,1,5,regulation of interleukin-12 biosynthetic process,BP,IRF1
6671,GO:0030027,0.324399827596223,0.771367612003973,14,155,lamellipodium,CC,AMOT;PDPN;PTPRM;CORO1C;ITGAV;AJUBA;PHACTR4;ANTXR1;FGD6;MYO10;SHTN1;DPYSL3;NEDD9;ITGB1BP1
14819,GO:0070531,0.324420210317335,0.951251239297501,1,5,BRCA1-A complex,CC,BRCC3
15069,GO:0071004,0.324552817895386,0.894818474045137,2,17,U2-type prespliceosome,CC,LUC7L;LUC7L2
9903,GO:0042176,0.324617273597354,0.749747623643611,24,301,regulation of protein catabolic process,BP,NRG1;PML;GCLC;KEAP1;OPHN1;PLK2;UBQLN2;ARNTL;ODC1;MDM4;CLU;PDCL3;HSP90AB1;NSF;NEDD4L;FAF1;SENP1;PSME2;AZIN1;RNF19B;TNF;TAF1;SMARCC1;IRAK3
16864,GO:0098751,0.324921669483421,0.863994586738892,3,25,bone cell development,BP,FBN1;TJP2;SRF
3440,GO:0007250,0.324994849743452,0.895077717406541,2,16,activation of NF-kappaB-inducing kinase activity,BP,TRAF2;TLR3
11905,GO:0046906,0.325352308360649,0.814947819921091,6,65,tetrapyrrole binding,MF,CYP1B1;CYP24A1;CYP1A1;DGCR8;SDHD;CYP20A1
466,GO:0001504,0.325472089698606,0.894816693078216,2,16,neurotransmitter uptake,BP,SLC1A3;ARL6IP5
18256,GO:1903034,0.325509270390749,0.791646877282389,9,101,regulation of response to wounding,BP,KRT1;EDN1;C1QTNF1;PDPN;SYK;CD109;WNT4;PDGFB;THBD
784,GO:0002039,0.32573218547026,0.815015315109447,6,61,p53 binding,MF,TP53;NUAK1;SMYD2;RFWD3;DAXX;TAF1
5602,GO:0016635,0.325818859308338,0.948963052497295,1,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,SDHD
6367,GO:0021545,0.325877840436369,0.863066578177182,3,26,cranial nerve development,BP,MAFB;SLC1A3;NAV2
8462,GO:0033592,0.325880654014115,0.950773672868192,1,5,RNA strand annealing activity,MF,DDX3X
11330,GO:0045634,0.325957674979319,0.950748411026479,1,5,regulation of melanocyte differentiation,BP,ADAMTS9
10882,GO:0044403,0.326079207581803,0.725961462261513,52,715,symbiont process,BP,FN1;PML;TFRC;TRIM22;CBX5;HLA-B;TAP1;TP53;IL16;IL6ST;NUP50;SLC22A5;SYK;NUP153;FAM111A;NUCKS1;TARDBP;POLA1;NDC1;THOC1;RAN;RANBP2;DDX3X;ITGAV;SET;ZC3H7B;NUP160;NUP54;ACKR3;UBP1;PDCL3;HSPA8;HSP90AB1;NEDD4L;SYNCRIP;POLR2F;SERPINB9;MSH6;CFLAR;PSMB9;CBLL1;CCNA2;TAP2;RBL1;TNF;TYMS;CCL5;CD74;PSMB10;DAXX;TAF1;RPS12
10597,GO:0043551,0.326166104636121,0.862881623164633,3,26,regulation of phosphatidylinositol 3-kinase activity,BP,IRS1;PDGFB;PIK3R3
3382,GO:0007161,0.326185932394554,0.953456704963307,1,4,calcium-independent cell-matrix adhesion,BP,FN1
2452,GO:0005663,0.326198901209714,0.94883402692239,1,6,DNA replication factor C complex,CC,RFC3
10092,GO:0042583,0.326286305043841,0.950640539223608,1,5,chromaffin granule,CC,CLU
2948,GO:0006477,0.326292010033801,0.950638665353841,1,5,protein sulfation,BP,TPST1
10049,GO:0042492,0.326425244032963,0.950594891223045,1,5,gamma-delta T cell differentiation,BP,SYK
19122,GO:1904996,0.326521356206448,0.950563299339593,1,5,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,TNF
5395,GO:0016229,0.326765001916644,0.8927579837735,2,19,steroid dehydrogenase activity,MF,AKR1C2;SRD5A1
2553,GO:0005827,0.326843800796121,0.950457225730128,1,5,polar microtubule,CC,KLHL21
7236,GO:0031126,0.326881389217594,0.947295358557538,1,7,snoRNA 3'-end processing,BP,DKC1
6240,GO:0019789,0.326948251221934,0.89400737887603,2,16,SUMO transferase activity,MF,ZBED1;RANBP2
3316,GO:0007021,0.327102697828646,0.947218150149286,1,7,tubulin complex assembly,BP,CRYAB
12644,GO:0050810,0.327467914718901,0.813334942189735,6,65,regulation of steroid biosynthetic process,BP,SCD;HMGCS1;LSS;WNT4;RAN;TNF
14334,GO:0061458,0.327519338007729,0.745862796917713,25,303,reproductive system development,BP,CYR61;FGFR2;HMGCS1;TGFB2;INHBA;ZFP42;BRIP1;SFRP1;ADM;IMMP2L;WNT4;LFNG;PDGFB;SRD5A1;SETD2;TNC;HSP90AB1;BRCA2;E2F8;RRM1;EIF2B5;CITED2;TLR3;ESR1;SMARCC1
11791,GO:0046634,0.327618186867649,0.840214995400806,4,40,regulation of alpha-beta T cell activation,BP,SYK;AP3B1;RC3H1;IRF1
13595,GO:0060042,0.32763270874953,0.862604370741879,3,24,retina morphogenesis in camera-type eye,BP,MEGF11;PTPRM;SDK1
9622,GO:0036477,0.327760836618016,0.731996703928067,39,477,somatodendritic compartment,CC,CRYAB;NRG1;MAP2;SACS;ENC1;DOCK10;NQO1;TGFB2;IL6ST;PHAX;NAIP;SHISA9;ATP2B1;OPHN1;SLC1A3;CASC3;PLK2;MME;GPHN;BAIAP2;CLU;SRD5A1;RIC3;CNTNAP2;HSPA8;SYT11;NSF;ZFYVE27;TRAK2;MTMR2;L1CAM;GPER1;RRM1;MYO10;SHTN1;HNRNPR;PARD3;ASTN2;RBM8A
1386,GO:0003283,0.327762842270322,0.894806854930197,2,14,atrial septum development,BP,CYR61;TGFB2
67,GO:0000138,0.327816198890254,0.948282815177838,1,6,Golgi trans cisterna,CC,B4GALT1
7321,GO:0031325,0.327932534891913,0.703928621294856,166,2181,positive regulation of cellular metabolic process,BP,IGFBP3;MAFB;SAA1;NRG1;TRIM16;FN1;PML;MAP3K14;GCLC;TFRC;CYR61;C3;MKL1;FOSL2;NLRC5;FGFR2;EPGN;TRIM22;CTGF;MMP9;RUNX1;CLN6;PBX1;DDX17;IRS1;MID1;TP53;EDN1;C1QTNF1;ACSL3;ZBED1;STAG1;CHP1;AKAP8;TGFB2;RBM22;FOXD2;IL6ST;DKC1;INHBA;SYK;EMP2;RELB;NBN;UTP15;CDK4;SFRP1;NUCKS1;HEATR1;USP16;AHR;KEAP1;NAA15;GLIS3;TAF2;SETDB1;ADM;CCL20;PLK2;UBQLN2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;THOC1;RAN;UBTF;RANBP2;SUPT16H;DDX3X;NUFIP1;IL24;RRN3;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;FASTKD3;DND1;NVL;GADD45B;CDH13;SRF;NPNT;WDR43;PDGFB;BRCC3;FZD1;NFE2L1;ANTXR1;CLU;MACC1;BIRC3;IL20;EYA3;ACKR3;RIF1;METTL16;GLIS2;GLIPR2;TET3;MYBL1;HSPA8;HSP90AB1;ARL6IP5;EPHB6;NSF;BRCA2;SS18L2;E2F8;ETV6;HSF2;RAB3GAP1;CHEK1;GPER1;MLLT10;WDR75;ADAM17;SENP1;RBMS3;ATR;PSME2;MSH6;CFLAR;EIF2B5;NOL11;NCBP1;UPF3B;TRAF2;TELO2;EDRF1;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;CSF1;RBL1;NAA16;CLOCK;KIF14;TLR3;ESR1;RNF19B;TNF;ATAD5;ZFP36L2;RC3H1;CCL5;CD74;HNRNPU;DAXX;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;IRF1;CTCF;IFI27L1
17417,GO:1900122,0.3279337456656,0.948242617722881,1,6,positive regulation of receptor binding,BP,MMP9
11944,GO:0046974,0.327975534125304,0.950083864629436,1,5,histone methyltransferase activity (H3-K9 specific),MF,SUV39H2
167,GO:0000347,0.328053034789703,0.948201805735293,1,6,THO complex,CC,THOC1
213,GO:0000445,0.328053034789703,0.948201805735293,1,6,THO complex part of transcription export complex,CC,THOC1
14164,GO:0061014,0.328300068557926,0.840467956982696,4,36,positive regulation of mRNA catabolic process,BP,METTL16;HNRNPR;ZFP36L2;RC3H1
7086,GO:0030870,0.328424446593349,0.94993531071438,1,5,Mre11 complex,CC,NBN
10752,GO:0044110,0.329091017672371,0.94784588837571,1,6,growth involved in symbiotic interaction,BP,TNF
10755,GO:0044116,0.329091017672371,0.94784588837571,1,6,growth of symbiont involved in interaction with host,BP,TNF
10756,GO:0044117,0.329091017672371,0.94784588837571,1,6,growth of symbiont in host,BP,TNF
8040,GO:0032680,0.329118057512689,0.811991029340907,6,66,regulation of tumor necrosis factor production,BP,AKAP8;HSPB1;CLU;SYT11;TLR3;IRAK3
3492,GO:0007386,0.329182931181077,0.949683722963784,1,5,compartment pattern specification,BP,LFNG
12290,GO:0048570,0.329243540095235,0.949663587086246,1,5,notochord morphogenesis,BP,KDM6A
12913,GO:0051235,0.32930991097266,0.754357615183217,19,221,maintenance of location,BP,FTL;FTH1;PML;JPH2;C3;FBN1;IKBKE;SLC30A6;KEAP1;ITGAV;ENPP1;JPH1;GPER1;FAF1;NFKBIE;EHD1;TNF;HNRNPU;FTO
14078,GO:0060836,0.329341310683542,0.95246954267157,1,4,lymphatic endothelial cell differentiation,BP,PDPN
3402,GO:0007185,0.329354504484539,0.952465389218748,1,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,TRIO
12593,GO:0050728,0.32944154344957,0.811663121405429,6,67,negative regulation of inflammatory response,BP,KRT1;SAA1;IL1R2;PTGER4;CHID1;GPER1
693,GO:0001910,0.329479363149606,0.859691235912126,3,30,regulation of leukocyte mediated cytotoxicity,BP,IL7R;SERPINB9;DNASE1
4235,GO:0009414,0.329738304783578,0.94762321457371,1,6,response to water deprivation,BP,AKR1B1
6592,GO:0022602,0.329812396595412,0.860533282846525,3,26,ovulation cycle process,BP,TGFB2;INHBA;ESR1
13091,GO:0051575,0.32982302582395,0.949470827166643,1,5,5'-deoxyribose-5-phosphate lyase activity,MF,POLQ
2174,GO:0005007,0.329823508288207,0.949470666499172,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR2
1078,GO:0002645,0.329862030534865,0.949457837071269,1,5,positive regulation of tolerance induction,BP,IRAK3
8931,GO:0034766,0.329868105147426,0.823421717371266,5,51,negative regulation of ion transmembrane transport,BP,MMP9;SLC9A3R1;THADA;ARL6IP5;NEDD4L
7839,GO:0032387,0.329911830275458,0.838293182665932,4,42,negative regulation of intracellular transport,BP,CRYAB;CHP1;NUP153;ITGB1BP1
904,GO:0002281,0.330011549906233,0.949408023052316,1,5,macrophage activation involved in immune response,BP,SYK
5969,GO:0018394,0.330262405767689,0.773205748503396,12,140,peptidyl-lysine acetylation,BP,TRIM16;CPA4;SET;NAA50;BRCA2;CHEK1;TAF6L;GTF3C4;POLE3;CLOCK;TAF1;CTCF
17485,GO:1900262,0.330722024735191,0.947283738575312,1,6,regulation of DNA-directed DNA polymerase activity,BP,RFC3
17486,GO:1900264,0.330722024735191,0.947283738575312,1,6,positive regulation of DNA-directed DNA polymerase activity,BP,RFC3
9321,GO:0035771,0.330799772934269,0.949144939958063,1,5,interleukin-4-mediated signaling pathway,BP,PARP14
17878,GO:1902043,0.331109520118286,0.892298390916892,2,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP1;FAF1
7901,GO:0032464,0.331518081819009,0.947008081596336,1,6,positive regulation of protein homooligomerization,BP,CLU
7077,GO:0030859,0.331666481575165,0.891990588591179,2,15,polarized epithelial cell differentiation,BP,SLC9A3R1;OPHN1
13973,GO:0060638,0.331706143709335,0.94884142875556,1,5,mesenchymal-epithelial cell signaling,BP,TNC
344,GO:0000957,0.331715337529456,0.948838344619084,1,5,mitochondrial RNA catabolic process,BP,LRPPRC
17952,GO:1902254,0.331754476138091,0.890378572619014,2,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,RRN3;CD74
16134,GO:0090101,0.331762778804428,0.800979469605597,7,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FBN1;FST;SFRP1;MIR17HG;CD109;FZD1;ADAM17
2469,GO:0005684,0.331947339086943,0.821142638536801,5,58,U2-type spliceosomal complex,CC,RBM22;LUC7L;LUC7L2;EFTUD2;DHX15
14513,GO:0061951,0.331952621398357,0.837337579437237,4,39,establishment of protein localization to plasma membrane,BP,ACSL3;ARFRP1;RAB26;NSF
10872,GO:0044380,0.332143271012176,0.822266726926364,5,47,protein localization to cytoskeleton,BP,MID1;KLHL21;RTKN2;ANLN;HNRNPU
14992,GO:0070884,0.332254150188865,0.891665364245876,2,15,regulation of calcineurin-NFAT signaling cascade,BP,NRG1;CHP1
17229,GO:0106056,0.332254150188865,0.891665364245876,2,15,regulation of calcineurin-mediated signaling,BP,NRG1;CHP1
11203,GO:0045292,0.332340193664947,0.890508164235239,2,17,mRNA cis splicing, via spliceosome,BP,RBM22;NCBP1
10441,GO:0043277,0.33234219925418,0.858595787856731,3,27,apoptotic cell clearance,BP,C3;RHOG;ITGAV
3730,GO:0008266,0.332366633012733,0.891011626847617,2,16,poly(U) RNA binding,MF,PABPC4;RBMS3
9861,GO:0042098,0.332448513628735,0.785698676145293,9,108,T cell proliferation,BP,TFRC;LGALS3;IL6ST;SYK;CD274;WNT4;RC3H1;CCL5;IRF1
12386,GO:0048755,0.332460952891333,0.948587857259018,1,5,branching morphogenesis of a nerve,BP,FGFR2
619,GO:0001786,0.332756098066282,0.858326446608602,3,27,phosphatidylserine binding,MF,JPH2;ARRDC1-AS1;HSPA8
19059,GO:1904872,0.333318604864449,0.889501107902838,2,18,regulation of telomerase RNA localization to Cajal body,BP,DKC1;SHQ1
658,GO:0001846,0.33338166264267,0.94635946112141,1,6,opsonin binding,MF,ITGAV
3263,GO:0006935,0.333473868289003,0.73557521040893,29,357,chemotaxis,BP,SAA1;NRG1;AMOT;MTUS1;CYR61;EDN1;LGALS3;TGFB2;IL16;SYK;OPHN1;CCL20;HSPB1;RHOG;CXCL16;PTPRM;ITGAV;CDH13;PDGFB;ACKR3;CXCR5;L1CAM;ADAM17;NTN1;CMTM3;CSF1;CCL5;CD74;NRAS
9969,GO:0042330,0.333473868289003,0.73557521040893,29,357,taxis,BP,SAA1;NRG1;AMOT;MTUS1;CYR61;EDN1;LGALS3;TGFB2;IL16;SYK;OPHN1;CCL20;HSPB1;RHOG;CXCL16;PTPRM;ITGAV;CDH13;PDGFB;ACKR3;CXCR5;L1CAM;ADAM17;NTN1;CMTM3;CSF1;CCL5;CD74;NRAS
15198,GO:0071316,0.333514075321526,0.946313198358589,1,6,cellular response to nicotine,BP,TNF
13585,GO:0060028,0.333588959308738,0.948207534302971,1,5,convergent extension involved in axis elongation,BP,SFRP1
1581,GO:0003988,0.333652621467198,0.946264767572008,1,6,acetyl-CoA C-acyltransferase activity,MF,HADHB
11582,GO:0046113,0.333680562616197,0.9481765763486,1,5,nucleobase catabolic process,BP,DPYD
8738,GO:0034379,0.333682929227845,0.946254169639375,1,6,very-low-density lipoprotein particle assembly,BP,ACSL3
19665,GO:1990822,0.333712712730118,0.948165708412563,1,5,basic amino acid transmembrane transport,BP,SLC7A2
11298,GO:0045591,0.333975883875086,0.946151666750434,1,6,positive regulation of regulatory T cell differentiation,BP,SOCS1
9074,GO:0035304,0.334003901404393,0.78468497503502,9,102,regulation of protein dephosphorylation,BP,IGFBP3;PPP1R3B;NUAK1;SET;PPP4R4;SH3RF2;PHACTR4;HSP90AB1;TNF
5020,GO:0015181,0.33403048347622,0.948058217699201,1,5,arginine transmembrane transporter activity,MF,SLC7A2
5027,GO:0015189,0.33403048347622,0.948058217699201,1,5,L-lysine transmembrane transporter activity,MF,SLC7A2
10854,GO:0044340,0.334413188387184,0.947928587493294,1,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,SFRP1
11499,GO:0045944,0.334464151100929,0.713952245899624,63,793,positive regulation of transcription by RNA polymerase II,BP,MAFB;NRG1;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;RUNX1;PBX1;DDX17;TP53;EDN1;ZBED1;STAG1;TGFB2;FOXD2;INHBA;RELB;NUCKS1;USP16;AHR;GLIS3;TAF2;AKAP8L;MYBL2;SUPT16H;DDX3X;NUFIP1;ARNTL;CDH13;SRF;NPNT;PDGFB;NFE2L1;MACC1;GLIS2;TET3;MYBL1;SS18L2;E2F8;ETV6;HSF2;GPER1;MLLT10;SENP1;CITED2;NCL;RBL1;CLOCK;TLR3;ESR1;TNF;HNRNPU;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ITGB1BP1;IRF1;CTCF
5498,GO:0016433,0.334599865720817,0.945932956804336,1,6,rRNA (adenine) methyltransferase activity,MF,METTL16
11780,GO:0046622,0.334649190956486,0.857392978029809,3,26,positive regulation of organ growth,BP,FGFR2;EDN1;MIR17HG
18202,GO:1902947,0.334653367698757,0.947847136247392,1,5,regulation of tau-protein kinase activity,BP,CLU
14047,GO:0060751,0.334709366307402,0.947828134808311,1,5,branch elongation involved in mammary gland duct branching,BP,ESR1
15758,GO:0072318,0.335037193792247,0.94771681440232,1,5,clathrin coat disassembly,BP,HSPA8
11352,GO:0045661,0.335058393542156,0.856545628741121,3,28,regulation of myoblast differentiation,BP,IGFBP3;HIF1AN;TNF
9025,GO:0035196,0.33526282242846,0.835179282402708,4,38,production of miRNAs involved in gene silencing by miRNA,BP,ZC3H7B;DGCR8;NCBP1;ESR1
3067,GO:0006633,0.335307700038992,0.789949238227695,8,93,fatty acid biosynthetic process,BP,PTGES;FADS3;EDN1;SCD;ACSL3;HACD2;SCD5;CD74
9090,GO:0035335,0.335347379204256,0.798005790814857,7,75,peptidyl-tyrosine dephosphorylation,BP,DUSP14;PTPN14;PTPRB;PTPRM;CDC25A;EYA3;MTMR2
17363,GO:1900024,0.335527163274104,0.83463873536684,4,40,regulation of substrate adhesion-dependent cell spreading,BP,GBP1;PDPN;CORO1C;ITGB1BP1
9697,GO:0038066,0.335770501063833,0.8560789966496,3,28,p38MAPK cascade,BP,ULK4;GADD45B;PHLPP1
4517,GO:0010565,0.335773892410284,0.777351615054768,10,123,regulation of cellular ketone metabolic process,BP,IRS1;PANK2;NQO1;WNT4;ODC1;PSME2;PSMB9;AZIN1;PSMB10;PPARGC1B
14747,GO:0070391,0.33610281241829,0.945404021645575,1,6,response to lipoteichoic acid,BP,CCL20
15149,GO:0071223,0.33610281241829,0.945404021645575,1,6,cellular response to lipoteichoic acid,BP,CCL20
829,GO:0002102,0.336322929395851,0.856299590074996,3,26,podosome,CC,LCP1;TPM4;TJP1
10531,GO:0043436,0.336323374485032,0.71279957962384,61,822,oxoacid metabolic process,BP,PTGES;CYP1B1;GCLC;C3;UGT1A6;STAT5A;FADS3;SLC7A2;CYP1A1;B4GALT1;IRS1;PANK2;EDN1;TPST1;SCD;ACSL3;NQO1;PRUNE2;CHP1;ACO1;CARS2;PGD;NUP50;SYK;NUP153;LDHAL6B;SLC5A6;DHFR;NDC1;SLC1A3;RANBP2;ODC1;CROT;AKR1C2;PGK1;HACD2;GATC;RARS;QDPR;PDGFB;NUP160;ENPP1;NUP54;SEPHS2;NNT;SCD5;DPYD;MMAA;PSME2;HADHB;PSMB9;SDHD;UGT1A4;AZIN1;ARV1;TYMS;CD74;PSMB10;HIBCH;PPARGC1B;GPX4
3258,GO:0006928,0.336350419291761,0.703095715468991,101,1270,movement of cell or subcellular component,BP,IGFBP3;SAA1;NEFL;NRG1;HDAC9;FN1;TNS3;PML;CYP1B1;KIF23;AMOT;MTUS1;KRT2;CYR61;STAT5A;STARD13;S100P;CTGF;MMP9;MYO1B;B4GALT1;DYNC2H1;TP53;DAPK3;EDN1;DOCK10;LGALS3;PDPN;TGFB2;IL16;SLC9A3R1;DNHD1;SYK;EMP2;SFRP1;AP3M2;CD274;DST;TPM1;ULK4;ADAMTS9;PTGER4;OPHN1;DYNLL2;CCL20;PLK2;NEXN;FRK;HSPB1;RHOG;WNT4;CXCL16;LCP1;PTPRM;SIRPA;SOD2;CORO1C;IL24;ITGAV;AJUBA;CDH13;PHACTR4;SRF;PDGFB;LRPPRC;TPM4;ACKR3;SETD2;ANLN;THBD;GLIPR2;BLOC1S2;APEX1;CXCR5;HSPA8;MYH11;NEDD4L;SGK1;TRAK2;CCAR1;WDPCP;L1CAM;GPER1;ADAM17;MYO10;NTN1;CBLL1;SHTN1;DPYSL3;CITED2;CSF1;AP3B1;KIF14;GJC1;TNF;NEDD9;CCL5;CD74;FGFR1OP;NRAS;ITGB1BP1
9083,GO:0035326,0.336397597409563,0.797175311507793,7,75,enhancer binding,MF,ZFP42;H3F3A;AHR;NFE2L1;SPIB;SMARCC1;ARID3B
7405,GO:0031463,0.336684352349308,0.818360127265654,5,51,Cul3-RING ubiquitin ligase complex,CC,ENC1;KBTBD8;KEAP1;KLHL21;KLHL9
15077,GO:0071013,0.336689108481174,0.788686083250986,8,96,catalytic step 2 spliceosome,CC,RBM22;HNRNPF;EFTUD2;SYNCRIP;HNRNPR;HNRNPU;HNRNPM;RBM8A
4094,GO:0009147,0.336706647693985,0.886802244951477,2,20,pyrimidine nucleoside triphosphate metabolic process,BP,TYMS;TBPL1
13877,GO:0060462,0.336714152388466,0.947145174855858,1,5,lung lobe development,BP,FGFR2
13878,GO:0060463,0.336714152388466,0.947145174855858,1,5,lung lobe morphogenesis,BP,FGFR2
10527,GO:0043426,0.336757162079988,0.94713046541751,1,5,MRF binding,MF,TSC22D3
14958,GO:0070828,0.336779643740983,0.889145328450062,2,15,heterochromatin organization,BP,CDKN2A;HELLS
12105,GO:0048050,0.336895847482608,0.945123705030704,1,6,post-embryonic eye morphogenesis,BP,FBN1
13848,GO:0060425,0.337109727095667,0.833687206415192,4,39,lung morphogenesis,BP,FGFR2;SRF;TNC;TNF
15549,GO:0071922,0.337178495389787,0.946986240179069,1,5,regulation of cohesin loading,BP,CDCA5
1332,GO:0003181,0.337366295209489,0.889512841057829,2,14,atrioventricular valve morphogenesis,BP,CYR61;TGFB2
4754,GO:0010923,0.33759810921615,0.796224740160575,7,75,negative regulation of phosphatase activity,BP,CHP1;TGFB2;PKMYT1;SET;PPP4R4;SH3RF2;TNF
19129,GO:1905007,0.337636207329916,0.946829298836653,1,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFB2
12961,GO:0051301,0.337653980853011,0.722128068629804,40,508,cell division,BP,KIF23;FGFR2;STAG1;TGFB2;NAIP;BRIP1;CDK4;USP16;HELLS;PARD3B;RAN;ANAPC15;KLHL21;CDC25A;SMC2;CDCA5;PDGFB;BRCC3;RTKN2;MACC1;BIRC3;KLHL9;SETD2;ANLN;WEE1;CXCR5;ANAPC7;BRCA2;SKA2;E2F8;CENPF;TPRA1;CCNA2;TIMELESS;KIF14;PARD3;ZFP36L2;NEDD9;HNRNPU;ITGB1BP1
18729,GO:1904063,0.337969625899843,0.832902399974439,4,40,negative regulation of cation transmembrane transport,BP,MMP9;SLC9A3R1;THADA;NEDD4L
10992,GO:0044774,0.338097870731907,0.781195584269194,9,105,mitotic DNA integrity checkpoint,BP,PML;TP53;NBN;PLK2;TOPBP1;MDM4;E2F8;RFWD3;CDKN1A
8202,GO:0032940,0.338304146420974,0.707745139933082,71,934,secretion by cell,BP,KRT1;SAA1;FTL;FTH1;TRIM16;FN1;PML;C3;S100P;CTGF;MMP9;GNPTAB;VMP1;IL1R2;B4GALT1;IRS1;EDN1;GBP1;C1QTNF1;LGALS3;CHP1;TGFB2;PCDH7;INHBA;SYK;SFRP1;VPS41;CD274;HRNR;PTPRB;ABCC4;KCNS3;PTGER4;ADM;MGAM;CD109;CADPS2;SLC1A3;SLCO4C1;MME;FRK;GBP5;RHOG;SIRPA;DDX3X;RAB26;ITGAV;SOCS1;ARNTL;QPCT;PDGFB;CHID1;CLU;COMMD9;HSPA8;SYT11;HSP90AB1;NSF;LAIR1;M6PR;RAB3GAP1;SCFD2;GPER1;LILRB3;TRAF2;CLOCK;GLIPR1;TNF;CCL5;PANX1;NRAS
17386,GO:1900077,0.33832475368163,0.854400097920729,3,28,negative regulation of cellular response to insulin stimulus,BP,IRS1;SOCS1;ENPP1
95,GO:0000185,0.338339780334136,0.887663329202075,2,16,activation of MAPKKK activity,BP,GADD45B;TNF
6834,GO:0030291,0.338344957219643,0.853882112885007,3,30,protein serine/threonine kinase inhibitor activity,MF,CDKN2A;HSPB1;CDKN1A
3914,GO:0008569,0.338351586527968,0.891886889209924,2,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,DYNC2H1;DNHD1
12734,GO:0050942,0.338547601053336,0.946515980097699,1,5,positive regulation of pigment cell differentiation,BP,ADAMTS9
431,GO:0001158,0.338576602187166,0.804882073137915,6,64,enhancer sequence-specific DNA binding,MF,ZFP42;H3F3A;NFE2L1;SPIB;SMARCC1;ARID3B
1071,GO:0002634,0.338628370748922,0.946488160533691,1,5,regulation of germinal center formation,BP,RC3H1
5851,GO:0017144,0.338745503910556,0.721648275929448,39,537,drug metabolic process,BP,CYP1B1;STAT5A;SLC7A2;CYP1A1;MAT2A;EDN1;NQO1;ACO1;TGFB2;NUP50;NUP153;SLC5A6;DHFR;ADM;NDC1;WNT4;RANBP2;AKR1C2;PGK1;QDPR;CHID1;CLU;NUP160;ENPP1;NUP54;SRD5A1;NNT;HSPA8;HSP90AB1;DPYD;MMAA;SDHD;AKR1B1;UQCRB;TNF;TYMS;FLAD1;THTPA;NDUFB9
14854,GO:0070579,0.3388168663197,0.94943091426107,1,4,methylcytosine dioxygenase activity,MF,TET3
10931,GO:0044531,0.338930840071184,0.944400517104457,1,6,modulation of programmed cell death in other organism,BP,SERPINB9
10932,GO:0044532,0.338930840071184,0.944400517104457,1,6,modulation of apoptotic process in other organism,BP,SERPINB9
13320,GO:0052040,0.338930840071184,0.944400517104457,1,6,modulation by symbiont of host programmed cell death,BP,SERPINB9
13349,GO:0052248,0.338930840071184,0.944400517104457,1,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,SERPINB9
13374,GO:0052433,0.338930840071184,0.944400517104457,1,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,SERPINB9
20221,GO:2001034,0.339084697241906,0.946330826735177,1,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,RIF1
13218,GO:0051817,0.339265123538364,0.79469324180265,7,78,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,NUCKS1;TARDBP;ITGAV;HSPA8;SERPINB9;TYMS;CCL5
18710,GO:1904030,0.339681996559831,0.853504716506532,3,28,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN2A;CDK4;CDKN1A
13775,GO:0060331,0.339885894745023,0.944059187503124,1,6,negative regulation of response to interferon-gamma,BP,PARP14
13780,GO:0060336,0.339885894745023,0.944059187503124,1,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,PARP14
8794,GO:0034471,0.339970837273997,0.885311397394838,2,19,ncRNA 5'-end processing,BP,UTP20;POP1
2521,GO:0005774,0.3401251050216,0.731817867960671,27,342,vacuolar membrane,CC,VMP1;B4GALT1;VPS41;HLA-DOB;AP5M1;DRAM1;RRAGB;SLCO4C1;ENPP1;SPNS1;THBD;SLC11A2;BLOC1S2;HSPA8;TMEM199;HSP90AB1;NSF;MFSD12;M6PR;TMEM138;MTMR2;TMEM165;ABCA5;AP3B1;GLIPR1;TLR3;CD74
14202,GO:0061081,0.340168999513464,0.943957771057278,1,6,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,CD74
3740,GO:0008277,0.340653926114707,0.793522742876414,7,79,regulation of G-protein coupled receptor protein signaling pathway,BP,C3;EDN1;ADM;UBQLN2;GPER1;CCL5;METAP2
13579,GO:0060022,0.340693927527375,0.945773805345503,1,5,hard palate development,BP,FZD1
11435,GO:0045834,0.340866836730759,0.793487728103593,7,77,positive regulation of lipid metabolic process,BP,CYR61;IRS1;ACSL3;WNT4;PDGFB;TNF;PPARGC1B
8072,GO:0032735,0.340929569757535,0.885184155513344,2,18,positive regulation of interleukin-12 production,BP,TLR3;IRF1
6306,GO:0019932,0.340998079196098,0.756970599591854,14,162,second-messenger-mediated signaling,BP,NRG1;JPH2;EDN1;GBP1;CHP1;SLC9A3R1;SYK;AHR;PTGER4;ADM;CCL20;CDH13;JPH1;GPER1
19937,GO:2000394,0.341013786826233,0.945662682476977,1,5,positive regulation of lamellipodium morphogenesis,BP,CORO1C
14023,GO:0060718,0.341097536588031,0.945633564544002,1,5,chorionic trophoblast cell differentiation,BP,E2F8
12378,GO:0048742,0.341106814407531,0.945630338282981,1,5,regulation of skeletal muscle fiber development,BP,HDAC9
4062,GO:0009110,0.341232387314205,0.88548627242122,2,17,vitamin biosynthetic process,BP,MMAA;TNF
4840,GO:0014044,0.341411507549111,0.853653883472431,3,24,Schwann cell development,BP,CNTNAP1;MPP5;PARD3
495,GO:0001547,0.3414664706106,0.945505184219817,1,5,antral ovarian follicle growth,BP,ESR1
15706,GO:0072215,0.341579569922523,0.885827075454749,2,16,regulation of metanephros development,BP,FAT4;PDGFB
2930,GO:0006448,0.341664756049461,0.885239361284418,2,17,regulation of translational elongation,BP,USP16;DPH2
13101,GO:0051590,0.341984477039448,0.88505661631706,2,17,positive regulation of neurotransmitter transport,BP,RAB3GAP1;GPER1
5394,GO:0016226,0.3421804480178,0.883661884899639,2,20,iron-sulfur cluster assembly,BP,HSCB;IBA57
7246,GO:0031163,0.3421804480178,0.883661884899639,2,20,metallo-sulfur cluster assembly,BP,HSCB;IBA57
7198,GO:0031082,0.34242410989943,0.88432722005395,2,18,BLOC complex,CC,BLOC1S2;HPS5
15059,GO:0070987,0.342911586579389,0.884047055335809,2,18,error-free translesion synthesis,BP,RPA1;RFC3
17886,GO:1902075,0.342941099123272,0.942958987086918,1,6,cellular response to salt,BP,DAXX
19854,GO:2000279,0.342968422975982,0.851614015623563,3,27,negative regulation of DNA biosynthetic process,BP,TP53;GNL3L;HNRNPU
4373,GO:0009991,0.343072652620952,0.729150192262167,27,342,response to extracellular stimulus,BP,GCLC;CYP24A1;CYP1A1;G6PD;TP53;HMGCS1;ACSL3;NQO1;SRSF2;BRIP1;SFRP1;ATP2B1;SETDB1;ADM;CADPS2;RRAGB;WNT4;BAIAP2;SRF;GDAP1;SRD5A1;TNC;HSPA8;TYMS;PANX1;TAF1;CDKN1A
12880,GO:0051181,0.343103098467295,0.850724424293567,3,30,cofactor transport,BP,SLC9A3R1;ABCG2;SLC5A6
3406,GO:0007189,0.343462390788171,0.829335472759861,4,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,SLC9A3R1;PTGER4;ADM;GPER1
498,GO:0001553,0.343477149659141,0.944802354884418,1,5,luteinization,BP,INHBA
6279,GO:0019871,0.343526137887208,0.944785164386723,1,5,sodium channel inhibitor activity,MF,NEDD4L
4204,GO:0009311,0.34353651044285,0.812868752574513,5,54,oligosaccharide metabolic process,BP,B4GALT1;ST6GALNAC5;GALNT18;MGAM;GANC
5328,GO:0016051,0.343857021200101,0.757741236255962,13,157,carbohydrate biosynthetic process,BP,B4GALT1;G6PD;IRS1;ST6GALNAC5;PPP1R3B;PGD;GALNT18;LEPR;PGK1;PDGFB;ENPP1;GPER1;AKR1B1
650,GO:0001838,0.344044714384322,0.776576971304216,9,99,embryonic epithelial tube formation,BP,TGFB2;IRX2;SFRP1;ADM;WNT4;KDM6A;PHACTR4;FZD1;SETD2
6500,GO:0021859,0.344047353744905,0.944602067202425,1,5,pyramidal neuron differentiation,BP,FGFR2
6501,GO:0021860,0.344047353744905,0.944602067202425,1,5,pyramidal neuron development,BP,FGFR2
9951,GO:0042297,0.344127592748649,0.947678636514597,1,4,vocal learning,BP,CNTNAP2
16802,GO:0098596,0.344127592748649,0.947678636514597,1,4,imitative learning,BP,CNTNAP2
16804,GO:0098598,0.344127592748649,0.947678636514597,1,4,learned vocalization behavior or vocal learning,BP,CNTNAP2
17941,GO:1902229,0.344263292903056,0.849300132781076,3,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,CLU;ACKR3;CD74
15135,GO:0071204,0.344410453402688,0.942425348100127,1,6,histone pre-mRNA 3'end processing complex,CC,SYNCRIP
5233,GO:0015846,0.344458693927923,0.94240777829662,1,6,polyamine transport,BP,AZIN1
164,GO:0000339,0.344609678003012,0.88355086436236,2,17,RNA cap binding,MF,GEMIN5;NCBP1
3747,GO:0008286,0.344667747234528,0.775964360177898,9,101,insulin receptor signaling pathway,BP,IRS1;CDK4;NUCKS1;SOCS1;BAIAP2;ENPP1;PIK3R3;ZNF106;SMARCC1
20248,GO:2001141,0.344753870885022,0.685001844603578,213,2845,regulation of RNA biosynthetic process,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EDN1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;INHBA;SYK;ZFP42;RELB;PARP15;BRIP1;UTP15;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;ZNF512;ZNF587;FRK;DNTTIP2;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;TRIM37;ZNF586;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;SMYD2;MACC1;ZNF316;RRM2;COMMD9;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;PSME2;CFLAR;PSMC3IP;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;MYNN;VPS36;TRAF2;EDRF1;RBBP5;CITED2;NCL;CCNA2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;GTF2H3;ZBTB9;IRAK3
19704,GO:1990939,0.345140687812634,0.828996702867276,4,34,ATP-dependent microtubule motor activity,MF,DYNC2H1;DNHD1;DYNLL2;KIF14
14974,GO:0070849,0.345380636067371,0.827770094830519,4,39,response to epidermal growth factor,BP,BAIAP2;CFLAR;NCL;ZFP36L2
9376,GO:0035883,0.345415456053139,0.883634578341639,2,16,enteroendocrine cell differentiation,BP,ARNTL;CLOCK
8094,GO:0032770,0.345497907689002,0.882555225421605,2,18,positive regulation of monooxygenase activity,BP,DHFR;TNF
11375,GO:0045719,0.345499239907266,0.944090135718369,1,5,negative regulation of glycogen biosynthetic process,BP,ENPP1
14986,GO:0070874,0.345499239907266,0.944090135718369,1,5,negative regulation of glycogen metabolic process,BP,ENPP1
4201,GO:0009308,0.345515836734693,0.788957831690567,7,91,amine metabolic process,BP,CYP1A1;NQO1;ODC1;PSME2;PSMB9;AZIN1;PSMB10
13383,GO:0052548,0.345561506090051,0.737562458158612,20,268,regulation of endopeptidase activity,BP,CRYAB;PML;CYR61;C3;CTGF;MMP9;NAIP;CD109;DDX3X;BIRC3;ARL6IP5;SERPINB9;GPER1;SENP1;PSME2;CFLAR;PSMB9;TRAF2;TNF;IFI27L1
12499,GO:0050431,0.34568212521418,0.884107312130883,2,15,transforming growth factor beta binding,MF,CD109;ITGAV
8264,GO:0033034,0.34574131388664,0.941939467883303,1,6,positive regulation of myeloid cell apoptotic process,BP,CDKN2A
14243,GO:0061162,0.345964036660968,0.883946023232682,2,15,establishment of monopolar cell polarity,BP,SLC9A3R1;OPHN1
14290,GO:0061339,0.345964036660968,0.883946023232682,2,15,establishment or maintenance of monopolar cell polarity,BP,SLC9A3R1;OPHN1
2876,GO:0006370,0.345993689798038,0.848342110183866,3,32,7-methylguanosine mRNA capping,BP,POLR2F;NCBP1;GTF2H3
14632,GO:0070182,0.346050350301452,0.882235387442046,2,18,DNA polymerase binding,MF,HSP90AB1;FANCD2
3310,GO:0007015,0.346138434078896,0.730653451539071,24,284,actin filament organization,BP,CTGF;MYO1B;COBLL1;PALM2;EMP2;SFRP1;TPM1;PTGER4;SYNPO2L;KANK4;RHOG;WNT4;LCP1;CGNL1;CDC42EP2;BAIAP2;SRF;TPM4;SHTN1;DPYSL3;SYNPO2;NEDD9;PPARGC1B;ITGB1BP1
17559,GO:1901031,0.346185598044481,0.848663843313132,3,30,regulation of response to reactive oxygen species,BP,TP53;DHFR;TNF
17566,GO:1901072,0.346254543463834,0.941751448140588,1,6,glucosamine-containing compound catabolic process,BP,CHID1
13925,GO:0060556,0.346338279144269,0.941720737719448,1,6,regulation of vitamin D biosynthetic process,BP,TNF
7903,GO:0032466,0.346524105165693,0.941652550972444,1,6,negative regulation of cytokinesis,BP,E2F8
7896,GO:0032459,0.346546361560263,0.848421914014809,3,30,regulation of protein oligomerization,BP,CRYAB;TP53;CLU
2443,GO:0005642,0.346934689063953,0.943581244624946,1,5,annulate lamellae,CC,RANBP2
2004,GO:0004725,0.347018576205955,0.788646324916589,7,76,protein tyrosine phosphatase activity,MF,DUSP14;PTPN14;PTPRB;PTPRM;CDC25A;EYA3;MTMR2
17374,GO:1900040,0.347066159858323,0.943534498796096,1,5,regulation of interleukin-2 secretion,BP,GBP1
6278,GO:0019870,0.347115083222884,0.943517097693677,1,5,potassium channel inhibitor activity,MF,NEDD4L
1330,GO:0003179,0.347274849560474,0.849401785267535,3,25,heart valve morphogenesis,BP,CYR61;TGFB2;ADAMTS9
3513,GO:0007435,0.347344376968713,0.848698385215963,3,27,salivary gland morphogenesis,BP,FGFR2;TGFB2;TNF
4606,GO:0010719,0.347825762772612,0.881204691212175,2,18,negative regulation of epithelial to mesenchymal transition,BP,TGFB2;SFRP1
2444,GO:0005643,0.348004843871244,0.787855669744856,7,76,nuclear pore,CC,NUP50;NUP153;NDC1;RAN;RANBP2;NUP160;NUP54
19749,GO:2000060,0.348005386236169,0.787581117461666,7,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,GCLC;KEAP1;PLK2;UBQLN2;CLU;RNF19B;TAF1
1467,GO:0003714,0.348369139150004,0.74737254356864,15,179,transcription corepressor activity,MF,HDAC9;TRIM22;TFCP2L1;SRSF2;RELB;WNT4;AJUBA;UBP1;APEX1;CCAR1;E2F8;CITED2;HNRNPU;DAXX;CTCF
15218,GO:0071347,0.34845161000241,0.76656091222608,10,129,cellular response to interleukin-1,BP,IL1R2;EDN1;SFRP1;CCL20;PSME2;PSMB9;RC3H1;CCL5;PSMB10;IRAK3
11231,GO:0045350,0.348473404001189,0.940934428062112,1,6,interferon-beta biosynthetic process,BP,TLR3
11238,GO:0045357,0.348473404001189,0.940934428062112,1,6,regulation of interferon-beta biosynthetic process,BP,TLR3
20025,GO:2000587,0.348506850560696,0.943020734715654,1,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
19969,GO:2000463,0.348579088869025,0.881811288603122,2,16,positive regulation of excitatory postsynaptic potential,BP,NETO1;BAIAP2
2719,GO:0006096,0.348692447081773,0.787303914667781,7,76,glycolytic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
3155,GO:0006757,0.348692447081773,0.787303914667781,7,76,ATP generation from ADP,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
8217,GO:0032964,0.349120179419658,0.846943772708296,3,29,collagen biosynthetic process,BP,CTGF;WNT4;TRAM2
14601,GO:0070129,0.34921086976751,0.880397596311945,2,18,regulation of mitochondrial translation,BP,FASTKD3;LRPPRC
11488,GO:0045930,0.349212868848712,0.732500084770482,21,275,negative regulation of mitotic cell cycle,BP,PML;TP53;SLC9A3R1;GPR132;NBN;PLK2;TOPBP1;ANAPC15;MDM4;E2F8;CENPF;CHEK1;PSME2;PSMB9;RFWD3;TPRA1;RBL1;TNF;ZFP36L2;PSMB10;CDKN1A
14953,GO:0070820,0.349218245337961,0.771878589617836,9,108,tertiary granule,CC,FTH1;MMP9;LGALS3;PTPRB;MGAM;SIRPA;QPCT;LAIR1;NRAS
5573,GO:0016584,0.349335557851995,0.939121224711148,1,7,nucleosome positioning,BP,CTCF
19781,GO:2000134,0.349355775150878,0.778531106919012,8,93,negative regulation of G1/S transition of mitotic cell cycle,BP,PML;TP53;PLK2;MDM4;E2F8;RFWD3;RBL1;CDKN1A
14147,GO:0060993,0.349486002388517,0.7967745399341,6,60,kidney morphogenesis,BP,FAT4;PBX1;IRX2;WNT4;NPNT;FRAS1
11701,GO:0046470,0.349598637386785,0.808059122901657,5,56,phosphatidylcholine metabolic process,BP,ACSL3;ABHD4;MBOAT1;STARD7;PLBD1
13303,GO:0051972,0.34960379872173,0.824207059156571,4,42,regulation of telomerase activity,BP,TP53;DKC1;NVL;HSP90AB1
12321,GO:0048644,0.349656161559916,0.809469045593869,5,45,muscle organ morphogenesis,BP,NRG1;FGFR2;TGFB2;TPM1;FZD1
13888,GO:0060485,0.349695089136659,0.749416529114627,14,163,mesenchyme development,BP,NRG1;FGFR2;DDX17;EDN1;KBTBD8;PDPN;TGFB2;SFRP1;WNT10A;WNT4;CORO1C;PHACTR4;GLIPR2;CITED2
18711,GO:1904031,0.34972400561512,0.846284027030812,3,30,positive regulation of cyclin-dependent protein kinase activity,BP,PDGFB;ADAM17;CDKN1A
4383,GO:0010032,0.349812403477779,0.942552765537403,1,5,meiotic chromosome condensation,BP,SMC2
3178,GO:0006797,0.349838884736031,0.942543249839485,1,5,polyphosphate metabolic process,BP,PRUNE2
11282,GO:0045545,0.350233624192403,0.942401293869789,1,5,syndecan binding,MF,TNC
8593,GO:0034080,0.35029665927337,0.844087648360579,3,40,CENP-A containing nucleosome assembly,BP,CENPN;HIST1H4A;CENPO
14406,GO:0061641,0.35029665927337,0.844087648360579,3,40,CENP-A containing chromatin organization,BP,CENPN;HIST1H4A;CENPO
14516,GO:0061980,0.35033836652176,0.846395646377353,3,28,regulatory RNA binding,MF,RBM4;ZC3H7B;DDX21
18141,GO:1902774,0.350383432025493,0.940225712885233,1,6,late endosome to lysosome transport,BP,VPS41
4971,GO:0015078,0.350415991621064,0.794790853631494,6,75,proton transmembrane transporter activity,MF,SLC4A11;ATP2C1;NNT;SLC11A2;SLC9A9;SLC25A22
3630,GO:0008092,0.350466789474109,0.702119431053281,55,671,cytoskeletal protein binding,MF,CRYAB;MAP2;KIF23;MTUS1;KRT2;MKL1;MYO1B;B4GALT1;NEFM;ENC1;MID1;GBP1;COBLL1;CHP1;SLC9A3R1;VEZT;VPS41;DST;TPM1;REEP1;OPHN1;DYNLL2;SYNPO2L;NEXN;LCP1;CORO1C;KLHL21;TRPM7;AJUBA;SNX5;BAIAP2;CDH13;PHACTR4;ANTXR1;CLU;LRPPRC;TPM4;SETD2;ANLN;BLOC1S2;SYT11;MYH11;BRCA2;TRAK2;LIMCH1;SKA2;MYO10;SHTN1;DPYSL3;KIF14;SYNPO2;DNASE1;HNRNPU;PANX1;DIAPH3
31,GO:0000056,0.350633283878278,0.938627494458574,1,7,ribosomal small subunit export from nucleus,BP,RAN
2528,GO:0005783,0.350855631273869,0.68970934495648,98,1325,endoplasmic reticulum,CC,IGFBP3;FN1;PTGES;PML;CYP1B1;JPH2;CYR61;C3;COL16A1;UGT1A6;FADS3;COL5A3;HLA-B;FBN1;VMP1;TAP1;CYP1A1;CLN6;SPON1;FAM69B;COL27A1;TP53;EDN1;SCD;ACSL3;CHP1;ACO1;PRSS23;PKMYT1;CDKAL1;COL12A1;P3H2;PUM3;RAB32;LSS;UTP15;LRRC8D;HLA-F;ZDHHC6;ABHD4;DST;COL4A1;KEAP1;RCE1;REEP1;ADAMTS9;TMEM97;LSG1;P4HA2;GGCX;FOXRED2;RHOG;WNT4;SET;HACD2;BAIAP2;COL5A2;APMAP;PDGFB;NFE2L1;CLU;MBOAT1;SRD5A1;JPH1;SRPRB;THADA;ERAP1;APEX1;RIC3;TNC;TMEM199;ARL6IP5;BACE2;SCD5;SGK1;ZFYVE27;SYNCRIP;CCDC47;RAB3GAP1;GPER1;FAF1;HADHB;UGT1A4;EBP;UBE2J2;TRAF2;HNRNPR;TAP2;CSF1;TLR3;CLCC1;GJC1;RNF19B;ARV1;CD74;PANX1;TRAM2;TREX1
15671,GO:0072170,0.350967620014607,0.881065388378257,2,15,metanephric tubule development,BP,FAT4;WNT4
587,GO:0001739,0.351006529419695,0.939993426540441,1,6,sex chromatin,CC,RING1
6624,GO:0022843,0.351125174572326,0.823614924811489,4,39,voltage-gated cation channel activity,MF,KCNS3;ITGAV;KCNQ5;KCNE4
9585,GO:0036379,0.3511597558257,0.882550921330976,2,13,myofilament,CC,TPM1;TPM4
3408,GO:0007191,0.351165187571106,0.939934194392452,1,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,SLC9A3R1
10067,GO:0042541,0.351241480873456,0.939905699306503,1,6,hemoglobin biosynthetic process,BP,INHBA
1075,GO:0002638,0.351660071852794,0.941886572373558,1,5,negative regulation of immunoglobulin production,BP,THOC1
15508,GO:0071855,0.35170544602231,0.938217799569454,1,7,neuropeptide receptor binding,MF,EDN1
12185,GO:0048290,0.351763075860109,0.939710671557658,1,6,isotype switching to IgA isotypes,BP,THOC1
13762,GO:0060314,0.351786490958195,0.879386545279317,2,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH2;JPH1
2382,GO:0005515,0.351906494377031,0.676087060540422,603,8319,protein binding,MF,IL32;CRYAB;IGFBP3;MAFB;SPRR3;KRT1;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT4;C1R;TRIM16;MAP2;KRT13;FN1;TNS3;TENM3;PML;KIF23;AMOT;MTUS1;JPH2;MAP3K14;FAM46B;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;RUNX1;MYO1B;CYP1A1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;SPACA6;TSC22D3;FST;MAT2A;DDX17;SPON1;FAM69B;KRTAP2-3;CCDC80;TRAF3;ENC1;IRS1;DYNC2H1;SPG21;MID1;SLC16A9;TP53;DAPK3;TUFT1;PANK2;EXO1;EDN1;TPST1;GBP1;HMGCS1;DOCK10;DDX47;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;COBLL1;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;TGFB2;CNTNAP1;RBM22;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL16;IFIT3;SRSF2;LRFN4;PPP1R3B;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;NUAK1;DKC1;INHBA;ANKRD52;IL7R;NUP50;SLC22A5;PALM2;PUM3;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;GFOD1;RAB32;RELB;NBN;LEPR;TRIO;SHISA9;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;UTP15;ARFRP1;LRRC8D;LDHAL6B;ANKRD36B;HLA-F;CDK4;SFRP1;VPS41;POP1;RIPK4;NUCKS1;HEATR1;ZDHHC6;CD274;WNT10A;MCM2;TARDBP;GEMIN4;DST;VPS8;POLQ;H3F3A;ATP2B1;COL4A1;USP16;AHR;KEAP1;NAA15;ZNF827;RPA1;POLR1A;TPM1;ZMAT2;HELLS;METTL21A;PTPRB;METTL1;TAF2;POLA1;TSN;REEP1;DRAM1;IGFL3;SETDB1;PTGER4;TK1;TMEM97;G3BP1;GRWD1;TMEM248;TRAF1;URM1;PARD3B;OPHN1;ADM;CD109;ELMSAN1;DYNLL2;FOXRED2;MDN1;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;MRPL27;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;GBP5;BTN2A1;RFC3;AKAP8L;MYBL2;NOP58;HSPB1;RHOG;WNT4;CXCL16;NOP2;DOHH;SUV39H2;LCP1;PTPRM;SIRPA;GTF3C6;KDM6A;THOC1;RAN;UBTF;LENG8;RANBP2;VCPKMT;TOPBP1;SOD2;ORC4;SUPT16H;CORO1C;DDX3X;RAB26;NAP1L1;NUFIP1;IL24;ARHGEF28;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;SNX11;TRPM7;AJUBA;SMC2;FASTKD3;KCNQ5;CGNL1;UTP14A;CROT;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;PPP4R4;GNL3L;TTC1;BAIAP2;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;RARS;COMMD4;PHACTR4;SRF;MDM4;LUC7L2;HIF1AN;NPNT;QDPR;WDR43;MCM8;PDGFB;BRCC3;CHID1;EIF3J;SDK1;FZD1;TBC1D15;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;CWF19L2;IL20;PIK3R3;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;DDX24;TPM4;KANSL1L;ACKR3;RIF1;MCM6;FGD6;SETD2;GLIS2;ANLN;TMEM51;THBD;ABCC9;TTF2;METTL13;GLIPR2;IFNAR1;WEE1;TJP1;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;CXCR5;TNC;CNTNAP2;TET3;ORC1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;NEDD4L;SGK1;M6PR;ZFYVE27;ANAPC7;PXMP2;BRCA2;HPS5;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;DGCR8;MAPK1IP1L;DPYD;LIMCH1;CCAR1;SKA2;MAZ;FANCD2;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;L1CAM;FKBP5;HSF2;CCDC47;RAB3GAP1;LNX2;CHEK1;IL12RB2;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;MCM4;ADAM17;MYO10;SENP1;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;CMTM3;RFWD3;NOL11;BAZ2B;NFKBIE;CBLL1;UGT1A4;GPATCH4;HNRNPDL;SHTN1;RABEP2;DPYSL3;TAF6L;DPH2;EBP;CSRP2;NCBP1;UPF3B;SPSB1;POLR1E;UBE2J2;VPS36;TRAF2;TPRA1;MSH3;TELO2;RBBP5;FAM208B;CITED2;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;CLOCK;IGFL1;KIF14;PURB;TLR3;MPP5;AZIN1;SYNPO2;ESR1;PARD3;RNF19B;RAD51B;USP11;EHD1;KCNE4;FEM1C;DNASE1;TNF;WDR4;PDSS1;ZFP36L2;NEDD9;SRSF7;TYMS;C8ORF33;CCL5;ARGLU1;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;DCTN5;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;PHLPP1;ZNHIT6;CCDC50;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MRFAP1;TREX1;IRF1;CTCF;SLC41A2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;ZBTB9;CENPO;GPX4;IRAK3;BUD13;TMEM234;COPS3;DHX15;UFC1
12857,GO:0051148,0.351956731660245,0.845599629855108,3,27,negative regulation of muscle cell differentiation,BP,G6PD;PDGFB;CFLAR
5266,GO:0015908,0.351978369982956,0.806700559586342,5,52,fatty acid transport,BP,EDN1;ACSL3;SYK;ABCC4;CROT
6756,GO:0030174,0.352087567097038,0.939589152633986,1,6,regulation of DNA-dependent DNA replication initiation,BP,NBN
11252,GO:0045414,0.352203439643437,0.939545724204261,1,6,regulation of interleukin-8 biosynthetic process,BP,TNF
15621,GO:0072088,0.352238153340579,0.80689685822892,5,49,nephron epithelium morphogenesis,BP,FAT4;PBX1;IRX2;WNT4;NPNT
10663,GO:0043696,0.352458658424613,0.941597214927856,1,5,dedifferentiation,BP,PDGFB
10664,GO:0043697,0.352458658424613,0.941597214927856,1,5,cell dedifferentiation,BP,PDGFB
13692,GO:0060198,0.352477840467912,0.93944280618813,1,6,clathrin-sculpted vesicle,CC,HSPA8
16818,GO:0098641,0.352514691329638,0.878018617105749,2,19,cadherin binding involved in cell-cell adhesion,MF,PDLIM1;BAIAP2
5070,GO:0015291,0.35262081427065,0.758614343802432,11,126,secondary active transmembrane transporter activity,MF,SLC16A2;SLC16A9;SLC7A5P2;SLC4A11;SLC22A5;SLC5A6;SLC1A3;SLCO4C1;SLC11A2;SLC9A9;SLC25A22
19917,GO:2000369,0.35269794922343,0.880061289305522,2,15,regulation of clathrin-dependent endocytosis,BP,UBQLN2;SYT11
15267,GO:0071417,0.352781177250332,0.71587889316107,31,379,cellular response to organonitrogen compound,BP,HDAC9;GCLC;COL16A1;STAT5A;FBN1;IRS1;TP53;EDN1;BRIP1;CDK4;SFRP1;NUCKS1;COL4A1;AHR;RRAGB;SOCS1;BAIAP2;COL5A2;ENPP1;PIK3R3;ZNF106;SRD5A1;APEX1;GPER1;CFLAR;AKR1B1;CCNA2;TIMELESS;TNF;TAF1;SMARCC1
4896,GO:0014820,0.352824760512231,0.939312539756,1,6,tonic smooth muscle contraction,BP,EDN1
3164,GO:0006777,0.35298823414098,0.939251098657519,1,6,Mo-molybdopterin cofactor biosynthetic process,BP,GPHN
6210,GO:0019720,0.35298823414098,0.939251098657519,1,6,Mo-molybdopterin cofactor metabolic process,BP,GPHN
1486,GO:0003785,0.353080959446023,0.878128618394348,2,18,actin monomer binding,MF,MKL1;COBLL1
10362,GO:0043162,0.353147731689595,0.878089290956992,2,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,RNF115;VPS36
18791,GO:1904251,0.35328251992792,0.939140398953219,1,6,regulation of bile acid metabolic process,BP,PANK2
10580,GO:0043533,0.353310382046352,0.941287657428639,1,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ASTN2
12503,GO:0050435,0.353317817405855,0.84438289141054,3,28,amyloid-beta metabolic process,BP,MME;CLU;BACE2
2874,GO:0006368,0.353446798496787,0.774970225364738,8,97,transcription elongation from RNA polymerase II promoter,BP,TAF2;SUPT16H;SETD2;POLR2F;NCBP1;HNRNPU;TAF1;GTF2H3
8065,GO:0032727,0.353479029551229,0.878960413458016,2,16,positive regulation of interferon-alpha production,BP,SETD2;TLR3
10260,GO:0042985,0.353496482446294,0.93905983867827,1,6,negative regulation of amyloid precursor protein biosynthetic process,BP,BACE2
4344,GO:0009894,0.353685992959675,0.697313215613091,59,770,regulation of catabolic process,BP,NRG1;PML;GCLC;TRIM22;IRS1;DAPK3;PABPC4;PPP1R3B;DKC1;NUP50;NUP153;LEPR;CDK4;TARDBP;KEAP1;DRAM1;OPHN1;NDC1;PLK2;RRAGB;UBQLN2;HSPB1;RANBP2;SET;ARNTL;ODC1;FASTKD3;SNX5;MDM4;CLU;NUP160;NUP54;LRPPRC;METTL16;APEX1;PDCL3;HSPA8;HSP90AB1;NSF;NEDD4L;SYNCRIP;MTMR2;RAB3GAP1;FAF1;WDR75;SENP1;PSME2;PSMB9;HNRNPR;AZIN1;RNF19B;TNF;ZFP36L2;RC3H1;HNRNPU;PSMB10;TAF1;SMARCC1;IRAK3
12413,GO:0048839,0.353894525563759,0.768402872401297,9,99,inner ear development,BP,MAFB;FGFR2;FAT4;TGFB2;SLC9A3R1;MCM2;WDPCP;NTN1;CCNA2
562,GO:0001696,0.354037468087334,0.938855866081779,1,6,gastric acid secretion,BP,SGK1
12668,GO:0050853,0.354346201205158,0.843409060501447,3,29,B cell receptor signaling pathway,BP,RUNX1;SYK;CMTM3
17844,GO:1901977,0.354434306178218,0.938705984705809,1,6,negative regulation of cell cycle checkpoint,BP,THOC1
15076,GO:0071012,0.354450949128948,0.938699694073209,1,6,catalytic step 1 spliceosome,CC,RBM22
5852,GO:0017145,0.354489281516552,0.843886972818636,3,27,stem cell division,BP,FGFR2;TGFB2;ZFP36L2
10311,GO:0043065,0.354760230185065,0.709284982114757,36,471,positive regulation of apoptotic process,BP,IGFBP3;PML;CYP1B1;CYR61;CTGF;MMP9;B4GALT1;TP53;DAPK3;CDKN2A;NQO1;TGFB2;CYLD;SLC9A3R1;INHBA;TRIO;SHQ1;CDK4;SFRP1;CD274;ADM;DYNLL2;MYBL2;DDX3X;GADD45B;ARL6IP5;GPER1;FAF1;SENP1;CFLAR;EIF2B5;TRAF2;TLR3;TNF;CCL5;IFI27L1
16116,GO:0090079,0.35486598098822,0.877578125026354,2,17,translation regulator activity, nucleic acid binding,MF,DHFR;TYMS
13232,GO:0051865,0.35488033917021,0.804483495262607,5,52,protein autoubiquitination,BP,RNF115;TRIM37;RAD18;TRAF2;TAF1
19221,GO:1905276,0.354918305406775,0.878116789911918,2,16,regulation of epithelial tube formation,BP,SFRP1;FZD1
10963,GO:0044665,0.355115157102203,0.84288611037415,3,29,MLL1/2 complex,CC,RBBP5;TAF1;TEX10
15213,GO:0071339,0.355115157102203,0.84288611037415,3,29,MLL1 complex,CC,RBBP5;TAF1;TEX10
3794,GO:0008360,0.3553198827295,0.756423356144438,11,123,regulation of cell shape,BP,FN1;DAPK3;PDPN;SLC9A3R1;PALM2;TPM1;CDC42EP2;BAIAP2;FGD6;WDPCP;MYO10
11875,GO:0046849,0.355604329592319,0.80392900660229,5,52,bone remodeling,BP,TFRC;SYK;LEPR;SFRP1;PPARGC1B
12551,GO:0050680,0.355783207374489,0.77359420529275,8,87,negative regulation of epithelial cell proliferation,BP,KRT4;FGFR2;TGFB2;SFRP1;CD109;PTPRM;BRCA2;TNF
8307,GO:0033131,0.355913051468757,0.938145553347486,1,6,regulation of glucokinase activity,BP,RANBP2
11525,GO:0045995,0.355982146145587,0.773492749760967,8,86,regulation of embryonic development,BP,AMOT;RBM19;SFRP1;WNT4;LFNG;COL5A2;FZD1;WDPCP
12926,GO:0051253,0.356151734013164,0.689751452272864,75,991,negative regulation of RNA metabolic process,BP,NRG1;HDAC9;PML;GCLC;FGFR2;TRIM22;CBX5;TSC22D3;FST;TFCP2L1;TP53;EDN1;CDKN2A;IRX2;SRSF2;DKC1;RELB;PARP15;SHQ1;SFRP1;TARDBP;H3F3A;AHR;GLIS3;HELLS;SETDB1;ZNF587;FRK;WNT4;SUV39H2;SET;ARNTL;AJUBA;TRIM37;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;SMYD2;LRPPRC;RIF1;GLIS2;UBP1;APEX1;HSPA8;NEDD4L;SYNCRIP;CCAR1;E2F8;CENPF;ETV6;ZNF12;ZNF608;CITED2;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;SRSF7;HNRNPU;RING1;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;IRF1;CTCF
14426,GO:0061695,0.356521674974473,0.729998768521137,19,239,transferase complex, transferring phosphorus-containing groups,CC,IRS1;TP53;CDK4;POLR1A;TAF2;POLA1;MCM3;PIK3R3;PRIM2;POLR2F;TAF6L;POLR1E;POLR3B;CCNA2;POLE3;TAF1;TBPL1;CDKN1A;GTF2H3
3132,GO:0006721,0.356539759009769,0.802971761725353,5,54,terpenoid metabolic process,BP,CYP1B1;HSPG2;CYP1A1;HMGCS1;SRD5A1
8239,GO:0032994,0.356547405096583,0.876078879350883,2,18,protein-lipid complex,CC,SAA1;CLU
18685,GO:1903975,0.356561898849067,0.937898686058968,1,6,regulation of glial cell migration,BP,CSF1
8504,GO:0033674,0.356578659826646,0.71035769949597,33,413,positive regulation of kinase activity,BP,SAA1;NRG1;MAP3K14;CYR61;FGFR2;EPGN;IRS1;EDN1;TGFB2;SYK;EMP2;NBN;RANBP2;DDX3X;SOCS1;AJUBA;GADD45B;PDGFB;CLU;HSP90AB1;EPHB6;ADAM17;TRAF2;TELO2;CSF1;KIF14;TLR3;TNF;CCL5;CD74;DAXX;CDKN1A;ITGB1BP1
3265,GO:0006937,0.356619349205112,0.780698861162716,7,79,regulation of muscle contraction,BP,CTGF;DAPK3;EDN1;TPM1;SRF;NPNT;GPER1
16519,GO:0097197,0.356787195634569,0.937812830144677,1,6,tetraspanin-enriched microdomain,CC,PDPN
16386,GO:0090670,0.356949605383699,0.875388732876634,2,19,RNA localization to Cajal body,BP,DKC1;SHQ1
16387,GO:0090671,0.356949605383699,0.875388732876634,2,19,telomerase RNA localization to Cajal body,BP,DKC1;SHQ1
16388,GO:0090672,0.356949605383699,0.875388732876634,2,19,telomerase RNA localization,BP,DKC1;SHQ1
16393,GO:0090685,0.356949605383699,0.875388732876634,2,19,RNA localization to nucleus,BP,DKC1;SHQ1
6366,GO:0021544,0.357201215665656,0.876772863524412,2,16,subpallium development,BP,INHBA;CNTNAP2
9519,GO:0036159,0.357270505035163,0.939835480811664,1,5,inner dynein arm assembly,BP,DNHD1
11358,GO:0045667,0.357323501119841,0.780341177275083,7,76,regulation of osteoblast differentiation,BP,CYR61;FGFR2;IL6ST;SFRP1;WNT4;NPNT;TNF
10698,GO:0043966,0.357456043496663,0.80215434844332,5,55,histone H3 acetylation,BP,TRIM16;BRCA2;CHEK1;TAF6L;POLE3
1307,GO:0003148,0.357884697460305,0.876369116571412,2,16,outflow tract septum morphogenesis,BP,FGFR2;TGFB2
11279,GO:0045540,0.357896817105086,0.8183098752919,4,41,regulation of cholesterol biosynthetic process,BP,SCD;HMGCS1;LSS;RAN
10290,GO:0043025,0.357944173868408,0.723108382353231,22,268,neuronal cell body,CC,CRYAB;MAP2;ENC1;NQO1;TGFB2;IL6ST;PHAX;NAIP;ATP2B1;SLC1A3;BAIAP2;SRD5A1;RIC3;CNTNAP2;TRAK2;L1CAM;RRM1;MYO10;SHTN1;PARD3;ASTN2;RBM8A
10332,GO:0043112,0.358080910459048,0.75381381757424,11,130,receptor metabolic process,BP,NRG1;TFRC;EDN1;SYK;ADM;UBQLN2;ITGAV;ACKR3;NSF;MTMR2;TNF
14287,GO:0061326,0.358092903273771,0.789887738648698,6,61,renal tubule development,BP,FAT4;PBX1;IRX2;COL4A1;WNT4;NPNT
3442,GO:0007253,0.35829713064323,0.935663361891598,1,7,cytoplasmic sequestering of NF-kappaB,BP,FAF1
8674,GO:0034237,0.358622544948365,0.876592346680123,2,15,protein kinase A regulatory subunit binding,MF,AKAP8;AKAP8L
655,GO:0001843,0.358901088744394,0.77913656715032,7,75,neural tube closure,BP,TGFB2;SFRP1;ADM;KDM6A;PHACTR4;FZD1;SETD2
13961,GO:0060606,0.358901088744394,0.77913656715032,7,75,tube closure,BP,TGFB2;SFRP1;ADM;KDM6A;PHACTR4;FZD1;SETD2
12750,GO:0050994,0.359051012153671,0.840478925423692,3,28,regulation of lipid catabolic process,BP,IRS1;CDK4;TNF
8576,GO:0034035,0.359347538529194,0.874411093536489,2,18,purine ribonucleoside bisphosphate metabolic process,BP,TPST1;ENPP1
12497,GO:0050427,0.359347538529194,0.874411093536489,2,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,TPST1;ENPP1
3103,GO:0006681,0.359493038602392,0.93677615513384,1,6,galactosylceramide metabolic process,BP,UGT8
6129,GO:0019374,0.359493038602392,0.93677615513384,1,6,galactolipid metabolic process,BP,UGT8
16571,GO:0097322,0.359691667441557,0.936699652190427,1,6,7SK snRNA binding,MF,DDX21
5138,GO:0015643,0.359736016198188,0.936682563485895,1,6,toxic substance binding,MF,PHAX
12549,GO:0050678,0.359750206131916,0.729437220587161,18,219,regulation of epithelial cell proliferation,BP,KRT4;FGFR2;STAT5A;EPGN;B4GALT1;TGFB2;SFRP1;CD109;PTPRM;CDH13;PDGFB;PDCL3;BRCA2;ADAM17;CFLAR;TNF;CCL5;NRAS
770,GO:0002020,0.359818319070487,0.7701421078429,8,89,protease binding,MF,FN1;TP53;ITGAV;BRCA2;SERPINB9;CFLAR;TNF;PANX1
3756,GO:0008297,0.359839875122297,0.936642533216001,1,6,single-stranded DNA exodeoxyribonuclease activity,MF,EXO1
10608,GO:0043568,0.360304843683465,0.938708377333961,1,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP3
2654,GO:0005996,0.360338968401402,0.733872214929219,16,198,monosaccharide metabolic process,BP,IGFBP3;GCLC;UGT1A6;B4GALT1;G6PD;IRS1;C1QTNF1;PPP1R3B;PGD;LEPR;RANBP2;PGK1;ENPP1;UGT1A4;AKR1B1;TNF
7496,GO:0031659,0.360352850194014,0.938690444418365,1,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,ADAM17
6992,GO:0030665,0.360473428052236,0.787428677935865,6,67,clathrin-coated vesicle membrane,CC,TFRC;IL7R;HSPA8;M6PR;AP3B1;CD74
6125,GO:0019370,0.360478874837897,0.934804307144456,1,7,leukotriene biosynthetic process,BP,SYK
4644,GO:0010764,0.360520276627077,0.936379912545966,1,6,negative regulation of fibroblast migration,BP,ITGB1BP1
14528,GO:0065007,0.360651885816693,0.667012272307859,581,7914,biological regulation,BP,IL32;CRYAB;IGFBP3;MAFB;KRT1;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;KRT4;C1R;TRIM16;MAP2;FN1;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;SLC16A2;CTGF;HLA-B;UTP20;MMP9;FBN1;HSPG2;XAF1;SLC7A2;RUNX1;CYP1A1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;G6PD;TSC22D3;FST;DDX17;TRIM56;TFCP2L1;CCDC80;TRAF3;ENC1;IRS1;SPG21;MID1;TP53;DAPK3;TUFT1;PANK2;EXO1;ANKRD36C;EDN1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;C1QTNF1;DUSP14;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;TGFB2;IRX2;CNTNAP1;ZNF208;RBM22;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;IL27RA;IL16;IFIT3;SRSF2;FOXD2;PPP1R3B;SLC30A6;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PALM2;PUM3;CAMK1G;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;FAM111A;PARP15;BRIP1;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;HLA-F;CDK4;SFRP1;VPS41;HLA-DOB;RIPK4;GPCPD1;NUCKS1;HEATR1;CD274;WNT10A;TARDBP;MIR17HG;ABHD4;DST;POLQ;H3F3A;ATP2B1;COL4A1;USP16;AHR;KEAP1;NAA15;ZNF827;HRNR;DHFR;RPA1;POLR1A;TPM1;GLIS3;HELLS;CSRP1;TAF2;ULK4;POLA1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;PTGER4;TMEM97;G3BP1;ZNF584;TRAF1;OPHN1;ADM;CD109;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;DYNLL2;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;ZNF512;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;KANK4;RFC3;AKAP8L;MYBL2;WDR76;HSPB1;RHOG;WNT4;CXCL16;NOP2;SUV39H2;LCP1;PTPRM;SIRPA;KDM6A;THOC1;RAN;UBTF;RANBP2;VCPKMT;TOPBP1;ANAPC15;SOD2;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;IL24;ARHGEF28;GPHN;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;TRPM7;AJUBA;FASTKD3;KCNQ5;CGNL1;DND1;ZNF267;AKR1C2;LFNG;ZC3H7B;PGK1;SNX5;TRIM37;NETO1;FEN1;LUC7L;CDC42EP2;CDCA5;PPP4R4;GNL3L;ZNF586;YRDC;BAIAP2;NVL;GADD45B;GATC;SH3RF2;APTX;CDH13;COL5A2;COMMD4;PHACTR4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;BRCC3;CHID1;KREMEN2;SDK1;FZD1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CLU;NUP160;USP6;SMYD2;MACC1;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;ZNF106;VGLL3;ACKR3;RIF1;METTL16;FGD6;SRD5A1;KLHL9;SETD2;GLIS2;ANLN;RPF2;UBP1;THBD;UPK3B;ABCC9;TTF2;DTX4;GLIPR2;JPH1;SRPRB;IFNAR1;WEE1;TJP1;LRRN3;ZNF484;THADA;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;CXCR5;TNC;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;BACE2;ZBTB24;NSF;LAIR1;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;BRCA2;HPS5;SYNCRIP;NAV2;TRAK2;HCAR1;DGCR8;DPYD;SS18L2;CCAR1;SKA2;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;GOSR1;ETV6;TMEM165;L1CAM;ZNFX1;STEAP4;HSF2;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;RAD18;RPTN;WDR75;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;CEP152;LILRB3;CFLAR;PSMC3IP;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;NFKBIE;CBLL1;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;ZNF608;TAF6L;DPH2;EBP;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;UBE2J2;VPS36;TRAF2;TPRA1;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;GTF3C4;SLC9A9;POLE3;DDX56;TIMELESS;ORC2;IFI30;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;KIF14;PURB;TLR3;AZIN1;SYNPO2;ESR1;PARD3;GJC1;RNF19B;RAD51B;EHD1;KCNE4;ARV1;DNASE1;TNF;ATAD5;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;FGFR1OP;PSMB10;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;ASTN2;TSGA13;RBM8A;GTF2H3;RPS12;ZBTB9;GPX4;IRAK3;COPS3;IFI27L1
12613,GO:0050770,0.360797961301153,0.751814620057221,11,121,regulation of axonogenesis,BP,NEFL;NRG1;MAP2;FN1;SRF;ZFYVE27;TRAK2;L1CAM;NTN1;SHTN1;WDR36
2470,GO:0005685,0.360840732095674,0.87264865815859,2,20,U1 snRNP,CC,LUC7L;LUC7L2
14081,GO:0060839,0.360892100353911,0.936236121991494,1,6,endothelial cell fate commitment,BP,PDPN
13289,GO:0051957,0.36098660733546,0.936199543602307,1,6,positive regulation of amino acid transport,BP,RAB3GAP1
16579,GO:0097342,0.361049214508388,0.936175304946111,1,6,ripoptosome,CC,CFLAR
7483,GO:0031642,0.361093971560367,0.936157973672423,1,6,negative regulation of myelination,BP,MTMR2
9171,GO:0035518,0.361101282958211,0.873876665082447,2,17,histone H2A monoubiquitination,BP,TRIM37;RING1
12602,GO:0050750,0.361199631691944,0.873817854519913,2,17,low-density lipoprotein particle receptor binding,MF,HSPG2;CLU
3713,GO:0008233,0.361262260292841,0.710108722019166,29,376,peptidase activity,MF,C1R;C3;MMP9;OVCH2;C9ORF3;PRSS23;CYLD;SFRP1;USP16;RCE1;ADAMTS9;IMMP2L;USP43;MME;CPA4;BRCC3;USP6;ERAP1;BACE2;DNPEP;ADAM17;SENP1;CFLAR;PSMB9;USP11;CAPN12;PSMB10;METAP2;USP1
13868,GO:0060449,0.361454110132426,0.936018414786481,1,6,bud elongation involved in lung branching,BP,FGFR2
17796,GO:1901799,0.361464648915876,0.815352035655751,4,43,negative regulation of proteasomal protein catabolic process,BP,OPHN1;HSP90AB1;SENP1;SMARCC1
7229,GO:0031118,0.361480368549057,0.93321480148811,1,8,rRNA pseudouridine synthesis,BP,DKC1
7472,GO:0031625,0.361629932891666,0.721412273356787,21,268,ubiquitin protein ligase binding,MF,PML;ACTG1;TRAF3;MID1;TP53;IKBKE;TRAF1;CASC3;TRIM37;CLU;LRPPRC;HSPA8;SYT11;FAF1;RAD18;UBE2J2;TRAF2;MPHOSPH8;DAXX;CCDC50;CDKN1A
13929,GO:0060560,0.361650846225191,0.739164604383536,14,156,developmental growth involved in morphogenesis,BP,NRG1;FN1;FGFR2;SFRP1;SRF;TNC;NEDD4L;ZFYVE27;L1CAM;NTN1;SHTN1;CSF1;ESR1;WDR36
12373,GO:0048733,0.361699294054459,0.938186193860622,1,5,sebaceous gland development,BP,WNT10A
10589,GO:0043543,0.361843865289546,0.732538741835227,16,198,protein acylation,BP,TRIM16;ZDHHC6;NAA15;CPA4;SET;ARNTL;NAA50;BRCA2;CHEK1;TAF6L;GTF3C4;POLE3;NAA16;CLOCK;TAF1;CTCF
18266,GO:1903050,0.362034996955856,0.738363948474082,14,175,regulation of proteolysis involved in cellular protein catabolic process,BP,PML;GCLC;KEAP1;OPHN1;PLK2;UBQLN2;CLU;PDCL3;HSP90AB1;SENP1;PSME2;RNF19B;TAF1;SMARCC1
13291,GO:0051959,0.362053257548052,0.840235090081368,3,23,dynein light intermediate chain binding,MF,DYNC2H1;DNHD1;DYNLL2
14016,GO:0060710,0.362240595535596,0.93571300647337,1,6,chorio-allantoic fusion,BP,CYR61
10356,GO:0043144,0.36232282472283,0.932874472337755,1,8,snoRNA processing,BP,DKC1
5831,GO:0017108,0.362489238539282,0.935616272259561,1,6,5'-flap endonuclease activity,MF,FEN1
682,GO:0001889,0.362553566395935,0.760950580159622,9,103,liver development,BP,CYP1A1;HMGCS1;WNT4;QDPR;SRD5A1;E2F8;CFLAR;CITED2;TYMS
14421,GO:0061676,0.362619979320062,0.935565372821588,1,6,importin-alpha family protein binding,MF,RAN
17752,GO:1901657,0.362773386691434,0.760253412279872,9,115,glycosyl compound metabolic process,BP,TJP2;TK1;RAN;GPHN;AKR1C2;PDCL3;UMPS;DPYD;AKR1B1
2447,GO:0005655,0.362795940717262,0.93268289512924,1,8,nucleolar ribonuclease P complex,CC,POP1
5140,GO:0015651,0.36304656106743,0.935399130395743,1,6,quaternary ammonium group transmembrane transporter activity,MF,SLC22A5
7230,GO:0031119,0.363172763538541,0.933734217934768,1,7,tRNA pseudouridine synthesis,BP,PUS3
727,GO:0001953,0.363185385566499,0.837945647129265,3,27,negative regulation of cell-matrix adhesion,BP,CDKN2A;CORO1C;ITGB1BP1
13263,GO:0051917,0.363387378257804,0.935266126804727,1,6,regulation of fibrinolysis,BP,THBD
11768,GO:0046599,0.363825774190646,0.872242548724442,2,17,regulation of centriole replication,BP,PLK2;TRIM37
13754,GO:0060304,0.364097574121432,0.937281867989238,1,5,regulation of phosphatidylinositol dephosphorylation,BP,MTMR2
6647,GO:0023035,0.364141666807207,0.934971183723174,1,6,CD40 signaling pathway,BP,FANCD2
5476,GO:0016406,0.364241301373556,0.934932164400661,1,6,carnitine O-acyltransferase activity,MF,CROT
15950,GO:0072719,0.364315345992708,0.934903157641411,1,6,cellular response to cisplatin,BP,TIMELESS
8006,GO:0032621,0.364457573401042,0.934847418747035,1,6,interleukin-18 production,BP,GBP5
7649,GO:0032055,0.364471527069827,0.934841948767076,1,6,negative regulation of translation in response to stress,BP,RBM4
7908,GO:0032471,0.364483618335189,0.933209746510808,1,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,THADA
13843,GO:0060419,0.364594811477761,0.797128164729263,5,51,heart growth,BP,FGFR2;G6PD;EDN1;TGFB2;MIR17HG
6759,GO:0030177,0.364675193844291,0.747956787851259,11,136,positive regulation of Wnt signaling pathway,BP,FGFR2;DAPK3;JRK;NAIP;SFRP1;WNT4;DDX3X;ARNTL;PSME2;PSMB9;PSMB10
14418,GO:0061668,0.36475073840337,0.934732437237074,1,6,mitochondrial ribosome assembly,BP,DDX28
2593,GO:0005886,0.364905716218759,0.665387813952304,216,2831,plasma membrane,CC,CRYAB;SPRR3;KRT1;NRG1;SPRR2A;TRIM16;FN1;TRIM16L;TENM3;AMOT;MTUS1;JPH2;KRT2;TFRC;C3;GPRC5A;CYP24A1;FGFR2;EPGN;S100P;SLC16A2;CTGF;HLA-B;UTP20;VMP1;HSPG2;SLC7A2;MYO1B;ERVFRD-1;IL1R2;FAT4;B4GALT1;ACTG1;G6PD;TRAF3;IRS1;DYNC2H1;SLC16A9;SLC7A5P2;EXO1;GBP1;SIPA1L3;C1QTNF1;ZNF397;MEGF11;LGALS3;IFNGR1;CHP1;SLC4A11;PDPN;CNTNAP1;CYLD;IL27RA;IL16;PCDH7;LRFN4;IL6ST;HNRNPF;SLC9A3R1;IL7R;SLC22A5;PALM2;CAMK1G;SYK;EMP2;TJP2;NAIP;GPR132;LEPR;SHISA9;VEZT;ABCG2;LRRC8D;HLA-F;SFRP1;HLA-DOB;CD274;DST;ATP2B1;TCHH;SLC5A6;HRNR;TPM1;PTPRB;RCE1;ABCC4;KCNS3;SETDB1;PTGER4;TMEM97;G3BP1;PARD3B;MGAM;CD109;NDC1;CADPS2;DYNLL2;SLC1A3;EIF5;CDV3;SLCO4C1;MME;MUC16;UBQLN2;FRK;BTN2A1;HSPB1;RHOG;WNT4;CXCL16;LCP1;GPRIN1;PTPRM;SIRPA;CORO1C;RAB26;ARHGEF28;GPHN;ITGAV;ABCF2;TRPM7;AJUBA;KCNQ5;SNX5;NETO1;CDC42EP2;BAIAP2;CDH13;NPNT;PDGFB;UGT8;KREMEN2;SDK1;FZD1;ANTXR1;USP6;ENPP1;FRAS1;ACKR3;RIF1;THBD;UPK3B;ABCC9;JPH1;IFNAR1;TJP1;KCTD3;ERAP1;SLC11A2;CXCR5;CNTNAP2;ORC1;HSPA8;SYT11;HSP90AB1;ARL6IP5;EPHB6;BACE2;NSF;LAIR1;NEDD4L;SGK1;M6PR;ZFYVE27;TRAK2;HCAR1;KRT10;PPIP5K1;WDPCP;MTMR2;L1CAM;STEAP4;IL12RB2;BBS5;GPER1;FAF1;RPTN;ANKRD13A;ADAM17;MYO10;LILRB3;CFLAR;DNAJC9;EBP;TRAF2;SLC9A9;CSF1;MPHOSPH8;GLIPR1;KIF14;TLR3;MPP5;ERVK13-1;ESR1;PARD3;GJC1;EHD1;KCNE4;TNF;SURF2;NEDD9;CD74;FLAD1;EIF2B1;METAP2;SLC43A2;PHLPP2;PANX1;PHLPP1;NRAS;MUC5B;HNRNPM;ITGB1BP1;MUC6;SLC41A2;IRAK3
13619,GO:0060068,0.365580138552126,0.934406481823358,1,6,vagina development,BP,ESR1
8027,GO:0032655,0.365722402609421,0.835081654311311,3,31,regulation of interleukin-12 production,BP,TLR3;IRF1;IRAK3
5901,GO:0018103,0.365793336371845,0.93432253745354,1,6,protein C-linked glycosylation,BP,DPY19L2P2
5936,GO:0018211,0.365793336371845,0.93432253745354,1,6,peptidyl-tryptophan modification,BP,DPY19L2P2
5957,GO:0018317,0.365793336371845,0.93432253745354,1,6,protein C-linked glycosylation via tryptophan,BP,DPY19L2P2
5973,GO:0018406,0.365793336371845,0.93432253745354,1,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,DPY19L2P2
5687,GO:0016799,0.365952272356886,0.869548274233571,2,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,APEX1;SMUG1
1384,GO:0003279,0.366077379747329,0.77344657603104,7,73,cardiac septum development,BP,CYR61;FGFR2;TGFB2;MIR17HG;FZD1;CITED2;DCTN5
2344,GO:0005375,0.366190408527316,0.934166022856526,1,6,copper ion transmembrane transporter activity,MF,SLC11A2
9130,GO:0035434,0.366190408527316,0.934166022856526,1,6,copper ion transmembrane transport,BP,SLC11A2
4469,GO:0010463,0.366202957121888,0.835862045530057,3,27,mesenchymal cell proliferation,BP,FGFR2;FAT4;PHF14
8016,GO:0032640,0.366316470332756,0.782591375378833,6,69,tumor necrosis factor production,BP,AKAP8;HSPB1;CLU;SYT11;TLR3;IRAK3
6860,GO:0030324,0.366373913620611,0.75204595152321,10,111,lung development,BP,TNS3;FGFR2;CTGF;PDPN;MIR17HG;SRF;TNC;TIMELESS;TNF;PHF14
16550,GO:0097264,0.366617573965469,0.93399739675394,1,6,self proteolysis,BP,TENM3
7925,GO:0032494,0.366674830117638,0.933974774874478,1,6,response to peptidoglycan,BP,IRAK3
7441,GO:0031545,0.366734607499089,0.933951151894844,1,6,peptidyl-proline 4-dioxygenase activity,MF,P4HA2
9939,GO:0042276,0.366790912048447,0.869456179281777,2,19,error-prone translesion synthesis,BP,RPA1;RFC3
11893,GO:0046885,0.366897525185531,0.870387875436185,2,17,regulation of hormone biosynthetic process,BP,WNT4;TNF
11437,GO:0045836,0.366920031816551,0.933877843170924,1,6,positive regulation of meiotic nuclear division,BP,WNT4
3202,GO:0006837,0.367032973359456,0.933833167070461,1,6,serotonin transport,BP,SYK
15302,GO:0071468,0.367635452687065,0.933594539206767,1,6,cellular response to acidic pH,BP,CHP1
12858,GO:0051149,0.367798600342909,0.794143406465904,5,55,positive regulation of muscle cell differentiation,BP,NRG1;EDN1;RBM4;GPER1;EHD1
15589,GO:0072028,0.367863254613885,0.794725702525853,5,50,nephron morphogenesis,BP,FAT4;PBX1;IRX2;WNT4;NPNT
15440,GO:0071692,0.367865665615909,0.935845018915628,1,5,protein localization to extracellular region,BP,FBN1
15441,GO:0071694,0.367865665615909,0.935845018915628,1,5,maintenance of protein location in extracellular region,BP,FBN1
14002,GO:0060693,0.367923189198098,0.933480391532089,1,6,regulation of branching involved in salivary gland morphogenesis,BP,TNF
4709,GO:0010869,0.367953126508605,0.869747511473192,2,17,regulation of receptor biosynthetic process,BP,EDN1;ITGAV
3391,GO:0007171,0.36797926673043,0.933458131359246,1,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,NRG1
325,GO:0000910,0.368021371296413,0.740868948987446,12,140,cytokinesis,BP,KIF23;NAIP;KLHL21;RTKN2;BIRC3;KLHL9;SETD2;ANLN;CXCR5;BRCA2;E2F8;KIF14
5212,GO:0015809,0.368251185075679,0.933350128980072,1,6,arginine transport,BP,SLC7A2
10827,GO:0044306,0.368333270075194,0.771141375535023,7,79,neuron projection terminus,CC,OPHN1;MME;BAIAP2;HSPA8;SYT11;GPER1;HNRNPR
16452,GO:0097084,0.368389822758026,0.933295023423786,1,6,vascular smooth muscle cell development,BP,ADM
3415,GO:0007200,0.368510920355044,0.8331376730931,3,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,EDN1;SLC9A3R1;ESR1
2530,GO:0005785,0.368536505409579,0.931572534860671,1,7,signal recognition particle receptor complex,CC,SRPRB
6297,GO:0019904,0.368605141035064,0.690726441866045,44,562,protein domain specific binding,MF,NEFL;TRIM16;FN1;MKL1;IRS1;TP53;DAPK3;ACSL3;CNTNAP1;SLC9A3R1;SLC22A5;SYK;TJP2;SHISA9;ATP2B1;KEAP1;SIRPA;RAN;LUC7L;BAIAP2;HIF1AN;FZD1;NFE2L1;ZNF106;HSPA8;HSP90AB1;NSF;TRAK2;ETV6;L1CAM;LNX2;CHEK1;FAF1;RRM1;ADAM17;DPYSL3;CITED2;CCNA2;KIF14;MPP5;SRSF7;HIST1H4A;PPARGC1B;HNRNPM
5560,GO:0016569,0.368704122992036,0.70015683665058,32,396,covalent chromatin modification,BP,HDAC9;TRIM16;TP53;AKAP8;USP16;HELLS;SETDB1;AKAP8L;SUV39H2;KDM6A;CPA4;SET;TRIM37;BRCC3;UTY;SMYD2;NAA50;EYA3;RIF1;SETD2;TET3;BRCA2;CHEK1;TAF6L;RBBP5;CCNA2;GTF3C4;POLE3;CLOCK;RING1;TAF1;CTCF
359,GO:0000977,0.368730611440658,0.697310228394247,35,435,RNA polymerase II regulatory region sequence-specific DNA binding,MF,MAFB;FOSL2;NLRC5;RUNX1;PBX1;TFCP2L1;TP53;ZBED1;ZFP42;RELB;H3F3A;AHR;MYBL2;KDM6A;ARNTL;SRF;UTY;NFE2L1;MACC1;GLIS2;MYBL1;MAZ;E2F8;ETV6;HSF2;CLOCK;PURB;ESR1;TAF1;TBPL1;SPIB;SMARCC1;ARID3B;IRF1;CTCF
11436,GO:0045835,0.368898608836461,0.933092557179028,1,6,negative regulation of meiotic nuclear division,BP,RAD1
15404,GO:0071635,0.369120187951715,0.933004266750966,1,6,negative regulation of transforming growth factor beta production,BP,HSP90AB1
4830,GO:0014032,0.369190857515934,0.793173514225978,5,54,neural crest cell development,BP,NRG1;EDN1;KBTBD8;CORO1C;PHACTR4
4972,GO:0015079,0.369205935124478,0.79328344635864,5,53,potassium ion transmembrane transporter activity,MF,KCNS3;KCNQ5;ABCC9;SLC9A9;KCNE4
7376,GO:0031418,0.369352329574273,0.868363865925998,2,18,L-ascorbic acid binding,MF,P3H2;P4HA2
6972,GO:0030621,0.369451501552849,0.932872120949002,1,6,U4 snRNA binding,MF,GEMIN5
11788,GO:0046631,0.369657743679743,0.780076330362967,6,67,alpha-beta T cell activation,BP,SYK;RELB;PTGER4;AP3B1;RC3H1;IRF1
10443,GO:0043279,0.369668246202276,0.780157326430601,6,66,response to alkaloid,BP,TP53;SDK1;EFTUD2;HSP90AB1;CCNA2;DHX15
2403,GO:0005546,0.369811852289007,0.809133193605534,4,43,phosphatidylinositol-4,5-bisphosphate binding,MF,JPH2;MYO1B;ARRDC1-AS1;PARD3
605,GO:0001771,0.369891915762284,0.932696217516404,1,6,immunological synapse formation,BP,LGALS3
18148,GO:1902808,0.369951723794162,0.832381726603408,3,30,positive regulation of cell cycle G1/S phase transition,BP,CYP1A1;DDX3X;APEX1
5229,GO:0015838,0.370244417119527,0.93255522739606,1,6,amino-acid betaine transport,BP,SLC22A5
4366,GO:0009968,0.370304500503095,0.678386312973032,68,894,negative regulation of signal transduction,BP,IGFBP3;NRG1;GCLC;GPRC5A;NLRC5;FGFR2;MMP9;FBN1;IL1R2;FST;IRS1;GBP1;DUSP14;LGALS3;CHP1;TGFB2;CYLD;SLC9A3R1;SFRP1;MIR17HG;G3BP1;ADM;CD109;UBQLN2;HSPB1;WNT4;SOD2;DDX3X;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;LFNG;PHACTR4;HIF1AN;PDGFB;KREMEN2;FZD1;CLU;ENPP1;EYA3;ACKR3;GLIS2;EPHB6;MTMR2;GPER1;ADAM17;RBMS3;PSME2;CFLAR;PSMB9;TRAF2;CLOCK;TLR3;ESR1;TNF;CCL5;CD74;PSMB10;PHF14;PHLPP2;PHLPP1;ITGB1BP1;IRAK3
7614,GO:0031995,0.370352290779892,0.932512045658125,1,6,insulin-like growth factor II binding,MF,IGFBP3
7820,GO:0032368,0.370483631210916,0.792162859076972,5,54,regulation of lipid transport,BP,EDN1;C1QTNF1;SYK;ITGAV;ARV1
2218,GO:0005112,0.370659299458197,0.869396412304311,2,15,Notch binding,MF,HIF1AN;ADAM17
3361,GO:0007099,0.370689766493016,0.83213620665141,3,29,centriole replication,BP,PLK2;TRIM37;CEP152
1265,GO:0003016,0.371272162276179,0.867724022747519,2,17,respiratory system process,BP,KDM6A;FTO
4889,GO:0014807,0.371280271379227,0.932139888773979,1,6,regulation of somitogenesis,BP,LFNG
8943,GO:0034968,0.371396538027745,0.760503584519661,8,89,histone lysine methylation,BP,SETDB1;SUV39H2;KDM6A;SMYD2;RIF1;SETD2;TET3;RBBP5
18452,GO:1903506,0.37169034828117,0.658978103790603,212,2843,regulation of nucleic acid-templated transcription,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EDN1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;SRSF2;FOXD2;INHBA;SYK;ZFP42;RELB;PARP15;BRIP1;UTP15;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;ZNF512;ZNF587;FRK;DNTTIP2;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;TRIM37;ZNF586;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;SMYD2;MACC1;ZNF316;RRM2;COMMD9;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;PSME2;CFLAR;PSMC3IP;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;MYNN;VPS36;TRAF2;EDRF1;RBBP5;CITED2;NCL;CCNA2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;TYMS;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;GTF2H3;ZBTB9;IRAK3
6927,GO:0030514,0.372236090353781,0.831662246460746,3,27,negative regulation of BMP signaling pathway,BP,FBN1;SFRP1;FZD1
10229,GO:0042866,0.372314624030448,0.767936062178408,7,78,pyruvate biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
10212,GO:0042813,0.372350737077139,0.86767301167428,2,16,Wnt-activated receptor activity,MF,SFRP1;FZD1
12449,GO:0048934,0.372353784545346,0.93170782994255,1,6,peripheral nervous system neuron differentiation,BP,RUNX1
12450,GO:0048935,0.372353784545346,0.93170782994255,1,6,peripheral nervous system neuron development,BP,RUNX1
5847,GO:0017134,0.37248259675978,0.866443379507261,2,18,fibroblast growth factor binding,MF,FGFR2;ITGAV
19846,GO:2000270,0.372643939137719,0.931590767325161,1,6,negative regulation of fibroblast apoptotic process,BP,SFRP1
11782,GO:0046624,0.372788093767238,0.931532563355551,1,6,sphingolipid transporter activity,MF,SPNS1
12721,GO:0050920,0.373306256897483,0.745694618510976,10,121,regulation of chemotaxis,BP,MTUS1;EDN1;IL16;HSPB1;CDH13;PDGFB;ADAM17;CSF1;CCL5;CD74
6555,GO:0021983,0.373507059661238,0.866352886598511,2,17,pituitary gland development,BP,WNT4;SRD5A1
14031,GO:0060732,0.373577620634215,0.931213254270835,1,6,positive regulation of inositol phosphate biosynthetic process,BP,GPER1
18183,GO:1902905,0.3735970882065,0.735852647011287,12,145,positive regulation of supramolecular fiber organization,BP,CTGF;EDN1;SFRP1;TPM1;SYNPO2L;RHOG;WNT4;CDC42EP2;BAIAP2;CLU;SYNPO2;ITGB1BP1
15480,GO:0071800,0.373673850057393,0.866250280569066,2,17,podosome assembly,BP,LCP1;TNF
7855,GO:0032410,0.373700232963547,0.806374573819568,4,42,negative regulation of transporter activity,BP,MMP9;SLC9A3R1;THADA;NEDD4L
4681,GO:0010827,0.373701131423333,0.789891273114589,5,52,regulation of glucose transmembrane transport,BP,C3;IRS1;ENPP1;PIK3R3;TNF
7587,GO:0031946,0.373773055540586,0.9311340760662,1,6,regulation of glucocorticoid biosynthetic process,BP,WNT4
1713,GO:0004301,0.373903406123419,0.929367865026493,1,7,epoxide hydrolase activity,MF,C9ORF3
2491,GO:0005737,0.374617318985481,0.654057434564741,603,8373,cytoplasm,CC,IL32;CRYAB;IGFBP3;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TRIM16L;TNS3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;SACS;TRIM22;STARD13;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;CLN6;IL1R2;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TSC22D3;MAT2A;DDX17;SPON1;FAM69B;TRIM56;TFCP2L1;KRTAP2-3;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;MID1;TP53;DAPK3;TUFT1;SVEP1;PANK2;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;ABCF1;DUSP14;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;LGALS3;CHP1;ACO1;PDPN;AKAP8;TGFB2;ST6GALNAC5;PRSS23;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL16;IFIT3;SRSF2;PCDH7;PPP1R3B;COL12A1;SLC30A6;PGD;P3H2;HNRNPF;BAG1;SLC9A3R1;PDCD11;C15ORF39;NUAK1;DKC1;INHBA;IL7R;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;NBN;TRIO;VEZT;FAM111A;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;HLA-DOB;RIPK4;GPCPD1;NUCKS1;HEATR1;ZDHHC6;MCM2;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;COL4A1;PUS3;USP16;AHR;APOL6;COA7;KEAP1;NAA15;UAP1L1;TCHH;HRNR;DHFR;AP5M1;THUMPD3;TPM1;METTL21A;PTPRB;METTL1;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;TK1;TMEM97;LSG1;G3BP1;GRWD1;ARRDC1-AS1;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;EIF5;CASC3;SYNPO2L;PLK2;RRAGB;CDV3;MRPL27;SLCO4C1;MME;MUC16;UBQLN2;NEXN;HSCB;FRK;GBP5;KANK4;AKAP8L;NOP58;HSPB1;RHOG;WNT4;DOHH;LCP1;EXOG;PTPRM;SIRPA;DDX28;THOC1;RAN;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;CORO1C;ATP2C1;DDX3X;RAB26;NAP1L1;NUFIP1;ARHGEF28;ARMC5;GPHN;KLHL21;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;QPCT;ODC1;ABCF2;SNX11;AJUBA;SMC2;ARMC6;FASTKD3;KCNQ5;UTP14A;DND1;CROT;AKR1C2;KRT24;LFNG;PGK1;SNX5;TRIM37;FEN1;MCM3;CDC42EP2;CDCA5;HACD2;PPP4R4;GNL3L;TTC1;YRDC;BAIAP2;GADD45B;WDR7;GATC;APTX;CDH13;COL5A2;GINS4;IBA57;RARS;COMMD4;PHACTR4;SRF;GDAP1;HIF1AN;NPNT;QDPR;APMAP;PDGFB;BRCC3;CHID1;EIF3J;KREMEN2;TBC1D15;NFE2L1;ANTXR1;RTKN2;CEP95;CLU;NUP160;USP6;SMYD2;MACC1;NAA50;ENPP1;BIRC3;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;LRPPRC;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;ACKR3;RIF1;FGD6;SRD5A1;KLHL9;GLIS2;ANLN;TIMM23B;UBP1;THBD;ABCC9;TRMT5;TTF2;DTX4;GLIPR2;JPH1;SRPRB;SEPHS2;NNT;IFNAR1;WEE1;TJP1;THADA;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;TNC;CNTNAP2;TET3;UMPS;ORC1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;BACE2;SCD5;NSF;DNPEP;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;HPS5;GEMIN8;SYNCRIP;TRAK2;TRMT1;DGCR8;DPYD;KRT10;CCAR1;SKA2;PPIP5K1;WDPCP;FANCD2;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;STEAP4;FKBP5;IQCJ-SCHIP1;HSF2;POLR2F;CCDC47;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;ANKRD13A;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;NIFK;PSMB9;DNAJC9;EIF2B5;CMTM3;RFWD3;ABCA5;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;MRPS7;DPH2;EBP;NCBP1;UPF3B;AKR1B1;SPSB1;UBE2J2;VPS36;TRAF2;TELO2;FAM208B;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;DDX56;TAP2;IFI30;UQCRB;CSF1;AP3B1;NAA16;MPHOSPH8;CLOCK;GLIPR1;KIF14;TLR3;MPP5;AZIN1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;RNF19B;USP11;EHD1;FEM1C;CENPN;ARV1;TNF;WDR4;CAPN12;PDSS1;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;DCTN5;METAP2;PHLPP2;PANX1;TBPL1;TRAM2;SPIB;PHLPP1;CCDC50;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;THTPA;HNRNPM;CDKN1A;ITGB1BP1;MRFAP1;MUC6;SLC25A22;TREX1;IRF1;ASTN2;DIAPH3;RBM8A;NDUFB9;TEX10;RPS12;CENPO;GPX4;IRAK3;COPS3;IFI27L1;DHX15;UFC1
18147,GO:1902807,0.374753286873128,0.757291333716211,8,96,negative regulation of cell cycle G1/S phase transition,BP,PML;TP53;PLK2;MDM4;E2F8;RFWD3;RBL1;CDKN1A
3589,GO:0008015,0.374912422651476,0.70958849129875,21,251,blood circulation,BP,GCLC;CTGF;EDN1;C9ORF3;TGFB2;EMP2;ATP2B1;TPM1;ADM;IMMP2L;MME;SOD2;PDGFB;ABCC9;ERAP1;NEDD4L;SGK1;NAV2;GPER1;GJC1;ITGB1BP1
17977,GO:1902305,0.375025800001346,0.805732646258285,4,40,regulation of sodium ion transmembrane transport,BP,CHP1;SLC9A3R1;NETO1;NEDD4L
15342,GO:0071542,0.375104367517023,0.86536866735987,2,17,dopaminergic neuron differentiation,BP,SFRP1;FZD1
1183,GO:0002827,0.375205904482941,0.928826473504582,1,7,positive regulation of T-helper 1 type immune response,BP,IL27RA
19676,GO:1990845,0.375340150561002,0.930497198208289,1,6,adaptive thermogenesis,BP,THADA
2594,GO:0005887,0.375380688276666,0.677271194742124,58,736,integral component of plasma membrane,CC,NRG1;TENM3;TFRC;GPRC5A;FGFR2;EPGN;SLC16A2;SLC7A2;TRAF3;IRS1;SLC16A9;SLC7A5P2;C1QTNF1;IFNGR1;SLC4A11;PDPN;CNTNAP1;IL27RA;PCDH7;IL6ST;SLC22A5;SHISA9;LRRC8D;ATP2B1;SLC5A6;PTPRB;RCE1;ABCC4;KCNS3;SLC1A3;SLCO4C1;MME;BTN2A1;PTPRM;ITGAV;KCNQ5;NPNT;ENPP1;THBD;ABCC9;IFNAR1;SLC11A2;CXCR5;CNTNAP2;SYT11;EPHB6;M6PR;STEAP4;IL12RB2;GPER1;ADAM17;LILRB3;EBP;TRAF2;TLR3;TNF;SLC43A2;HNRNPM
10819,GO:0044297,0.375620662349287,0.702189085236201,25,312,cell body,CC,CRYAB;NRG1;MAP2;ENC1;NQO1;TGFB2;IL6ST;PHAX;NAIP;ATP2B1;SLC1A3;BAIAP2;SRD5A1;RIC3;CNTNAP2;SYT11;TRAK2;L1CAM;RRM1;MYO10;SHTN1;DPYSL3;PARD3;ASTN2;RBM8A
10578,GO:0043531,0.375636157980053,0.828658944896165,3,29,ADP binding,MF,GCLC;TAP1;MSH6
11174,GO:0045217,0.37565919600009,0.930367102476971,1,6,cell-cell junction maintenance,BP,PLEKHA7
15765,GO:0072332,0.376012006319733,0.774527252727223,6,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PML;TP53;RRN3;BRCA2;CD74;CDKN1A
2275,GO:0005216,0.376074655311539,0.729882821548662,13,150,ion channel activity,MF,JPH2;SLC4A11;LRRC8D;KCNS3;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;CLCC1;GJC1;KCNE4;PANX1
11794,GO:0046637,0.376217071890763,0.827972408517081,3,30,regulation of alpha-beta T cell differentiation,BP,SYK;AP3B1;RC3H1
8212,GO:0032958,0.376440790771714,0.864542471108846,2,17,inositol phosphate biosynthetic process,BP,PPIP5K1;GPER1
12809,GO:0051084,0.376456288943433,0.827545527428012,3,31,'de novo' posttranslational protein folding,BP,BAG1;HSPA8;CD74
618,GO:0001784,0.376543220494893,0.828636184037307,3,27,phosphotyrosine residue binding,MF,IRS1;SYK;PIK3R3
17873,GO:1902036,0.376762583942789,0.772594561767395,6,95,regulation of hematopoietic stem cell differentiation,BP,RUNX1;H3F3A;PSME2;PSMB9;PSMB10;HIST1H4A
9138,GO:0035455,0.376832283802626,0.863264760392125,2,19,response to interferon-alpha,BP,IFIT3;IFNAR1
13782,GO:0060338,0.377001899851865,0.827693461143155,3,29,regulation of type I interferon-mediated signaling pathway,BP,NLRC5;IFNAR1;HSP90AB1
4626,GO:0010744,0.377233423795754,0.927978770278303,1,7,positive regulation of macrophage derived foam cell differentiation,BP,CSF1
8213,GO:0032959,0.377287637838873,0.92970079022032,1,6,inositol trisphosphate biosynthetic process,BP,GPER1
1255,GO:0003006,0.377309087600659,0.691138512201121,33,415,developmental process involved in reproduction,BP,CYR61;FGFR2;B4GALT1;PBX1;PANK2;HMGCS1;TGFB2;INHBA;ZFP42;BRIP1;SFRP1;ADM;IMMP2L;WNT4;RAN;DND1;LFNG;PDGFB;SRD5A1;SETD2;DPY19L2P2;TNC;HSP90AB1;BRCA2;E2F8;RRM1;EIF2B5;CITED2;CSF1;TLR3;ESR1;TBPL1;SMARCC1
11519,GO:0045989,0.377346659173141,0.927931248534353,1,7,positive regulation of striated muscle contraction,BP,CTGF
539,GO:0001657,0.377367111621664,0.774224458415108,6,63,ureteric bud development,BP,FGFR2;FAT4;PBX1;SFRP1;WNT4;NPNT
14332,GO:0061448,0.377397442307584,0.732709787860735,12,139,connective tissue development,BP,CYR61;CTGF;RUNX1;COL27A1;EDN1;CDK4;SRF;PDGFB;CFLAR;CSF1;TYMS;FTO
260,GO:0000726,0.377610453611835,0.773078036397825,6,74,non-recombinational repair,BP,NBN;POLQ;POLA1;BRCC3;RIF1;HIST1H4A
14835,GO:0070555,0.377649681938329,0.736448102659135,11,145,response to interleukin-1,BP,GCLC;IL1R2;EDN1;SFRP1;CCL20;PSME2;PSMB9;RC3H1;CCL5;PSMB10;IRAK3
16413,GO:0097011,0.377774308555346,0.927751605675908,1,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,ZFP36L2
16414,GO:0097012,0.377774308555346,0.927751605675908,1,7,response to granulocyte macrophage colony-stimulating factor,BP,ZFP36L2
10592,GO:0043546,0.377780429102847,0.929498398095304,1,6,molybdopterin cofactor binding,MF,GPHN
13268,GO:0051924,0.377822381860505,0.741919729516569,10,118,regulation of calcium ion transport,BP,PML;JPH2;G6PD;LGALS3;IL16;PDGFB;JPH1;THADA;GPER1;CCL5
696,GO:0001913,0.378014020785536,0.862088538836372,2,20,T cell mediated cytotoxicity,BP,IL7R;EMP2
4649,GO:0010769,0.378244586416457,0.715437452907624,17,199,regulation of cell morphogenesis involved in differentiation,BP,NEFL;NRG1;MAP2;FN1;GBP1;PDPN;CORO1C;BAIAP2;SRF;NEDD4L;ZFYVE27;TRAK2;L1CAM;NTN1;SHTN1;WDR36;ITGB1BP1
9704,GO:0038092,0.378268440754669,0.929297622298602,1,6,nodal signaling pathway,BP,CITED2
11798,GO:0046641,0.378308781900107,0.92752671041256,1,7,positive regulation of alpha-beta T cell proliferation,BP,SYK
390,GO:0001042,0.378496177468128,0.929203809620184,1,6,RNA polymerase I core binding,MF,RRN3
14209,GO:0061088,0.378596490004854,0.929162463529622,1,6,regulation of sequestering of zinc ion,BP,SLC30A6
802,GO:0002068,0.378694214743982,0.863143736448264,2,17,glandular epithelial cell development,BP,ARNTL;CLOCK
6013,GO:0019058,0.3788531088748,0.707724627540107,20,256,viral life cycle,BP,PML;TFRC;NUP50;NUP153;FAM111A;NUCKS1;NDC1;RAN;RANBP2;DDX3X;ITGAV;NUP160;NUP54;UBP1;HSPA8;HSP90AB1;NEDD4L;TNF;CCL5;CD74
70,GO:0000146,0.379005715407061,0.865112074280676,2,14,microfilament motor activity,MF,MYO1B;MYO10
6986,GO:0030656,0.379121013648595,0.927184133517469,1,7,regulation of vitamin metabolic process,BP,TNF
16423,GO:0097027,0.379275609683044,0.927118818854387,1,7,ubiquitin-protein transferase activator activity,MF,RING1
11371,GO:0045714,0.379386172349509,0.928836467958352,1,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
14398,GO:0061626,0.379469868470679,0.928801863559165,1,6,pharyngeal arch artery morphogenesis,BP,TGFB2
7330,GO:0031334,0.379548642972924,0.71672272587657,16,199,positive regulation of protein complex assembly,BP,TP53;RPA1;GBP5;RHOG;LCP1;AJUBA;CDC42EP2;BAIAP2;SRF;CLU;FAF1;ATR;ESR1;TNF;TAF1;GTF2H3
12296,GO:0048592,0.379554025215411,0.753835805170822,8,86,eye morphogenesis,BP,TENM3;FBN1;MEGF11;PTPRM;COL5A2;PHACTR4;SDK1;RING1
8306,GO:0033130,0.37957273605455,0.928759318719377,1,6,acetylcholine receptor binding,MF,RIC3
10848,GO:0044332,0.379599464104658,0.931243962271877,1,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
14975,GO:0070851,0.379645575262365,0.761585034496553,7,82,growth factor receptor binding,MF,EPGN;IL6ST;SLC9A3R1;PDGFB;ERAP1;PDCL3;ADAM17
15759,GO:0072319,0.379734799974409,0.928692259756471,1,6,vesicle uncoating,BP,HSPA8
16845,GO:0098711,0.37977160474305,0.928677025323753,1,6,iron ion import across plasma membrane,BP,STEAP4
14158,GO:0061004,0.379782081822632,0.926904594090192,1,7,pattern specification involved in kidney development,BP,IRX2
15598,GO:0072048,0.379782081822632,0.926904594090192,1,7,renal system pattern specification,BP,IRX2
19127,GO:1905005,0.379924936164971,0.928613536339152,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFB2
14725,GO:0070341,0.379960241712073,0.928598912748732,1,6,fat cell proliferation,BP,FTO
14727,GO:0070344,0.379960241712073,0.928598912748732,1,6,regulation of fat cell proliferation,BP,FTO
19997,GO:2000535,0.380045548633293,0.928563571059269,1,6,regulation of entry of bacterium into host cell,BP,ITGAV
6190,GO:0019626,0.380065886734217,0.926784386067362,1,7,short-chain fatty acid catabolic process,BP,MMAA
3177,GO:0006796,0.380298029925363,0.653140951420307,170,2292,phosphate-containing compound metabolic process,BP,CRYAB;IGFBP3;SAA1;NEFL;NRG1;FN1;PML;MAP3K14;CYR61;C3;GPRC5A;NLRC5;FGFR2;STAT5A;EPGN;CTGF;MMP9;GNPTAB;G6PD;IRS1;MID1;TP53;DAPK3;PANK2;EDN1;TPST1;GBP1;HMGCS1;C1QTNF1;DUSP14;CDKN2A;ACSL3;PTPN14;CHP1;AKAP8;TGFB2;IKBKE;PKMYT1;PPP1R3B;PGD;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;CAMK1G;SYK;EMP2;TJP2;NUP153;NBN;TRIO;CDK4;SFRP1;RIPK4;GPCPD1;TARDBP;ABHD4;PTPRB;ULK4;PTGER4;TK1;ADM;CD109;NDC1;CCL20;PLK2;FRK;AKAP8L;HSPB1;PTPRM;RAN;HMGXB3;RANBP2;CORO1C;DDX3X;IL24;GPHN;CDC25A;ITGAV;SOCS1;SET;PARP14;TRPM7;AJUBA;FASTKD3;CROT;PGK1;PPP4R4;GADD45B;SH3RF2;APTX;PHACTR4;NPNT;PDGFB;SGK494;FZD1;CLU;NUP160;ENPP1;IL20;PIK3R3;MBOAT1;RRM2;NUP54;EYA3;ACKR3;GLIPR2;SEPHS2;NNT;WEE1;APEX1;PDCL3;UMPS;HSPA8;HSP90AB1;ARL6IP5;EPHB6;SMUG1;SGK1;PPIP5K1;MTMR2;CHEK1;IL12RB2;GPER1;FAF1;RRM1;ADAM17;ATR;PSME2;HADHB;CFLAR;NOL9;PSMB9;SDHD;TRAF2;TELO2;CCNA2;UQCRB;CSF1;RBL1;KIF14;TLR3;ESR1;PARD3;TNF;ZFP36L2;TYMS;STARD7;CCL5;PLBD1;CD74;HNRNPU;FGFR1OP;PSMB10;FLAD1;DAXX;PHLPP2;TAF1;TBPL1;PHLPP1;NRAS;PPARGC1B;THTPA;CDKN1A;ITGB1BP1;GTF2H3;NDUFB9;GPX4;IRAK3
15878,GO:0072578,0.380371832271654,0.928428297748972,1,6,neurotransmitter-gated ion channel clustering,BP,GPHN
19919,GO:2000371,0.380371988141851,0.92842823309003,1,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,HNRNPU
19920,GO:2000373,0.380371988141851,0.92842823309003,1,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,HNRNPU
3326,GO:0007035,0.380411225555732,0.86102404957119,2,19,vacuolar acidification,BP,CLN6;TMEM199
6456,GO:0021772,0.380414660440144,0.862699746686587,2,16,olfactory bulb development,BP,SRF;KIF14
4042,GO:0009074,0.380879512201994,0.925114216849663,1,8,aromatic amino acid family catabolic process,BP,QDPR
10359,GO:0043154,0.381156636632769,0.770414919759572,6,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CRYAB;MMP9;NAIP;DDX3X;BIRC3;SERPINB9
2611,GO:0005915,0.381394532060784,0.928003294012907,1,6,zonula adherens,CC,PLEKHA7
20321,GO:2001267,0.381640687865029,0.85980588533994,2,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,MMP9;TRAF2
15157,GO:0071236,0.381694623503972,0.744453591673188,9,108,cellular response to antibiotic,BP,CYP1B1;TP53;NQO1;AHR;PDGFB;CLU;APEX1;TIMELESS;DAXX
17561,GO:1901033,0.381842777204425,0.926029057613732,1,7,positive regulation of response to reactive oxygen species,BP,TNF
13629,GO:0060079,0.381857632835295,0.8001887653935,4,42,excitatory postsynaptic potential,BP,NETO1;BAIAP2;MTMR2;RAB3GAP1
8328,GO:0033158,0.381979775454449,0.861091636440066,2,17,regulation of protein import into nucleus, translocation,BP,HSP90AB1;CDKN1A
5442,GO:0016303,0.382292499279096,0.824914196512245,3,26,1-phosphatidylinositol-3-kinase activity,MF,FGFR2;IRS1;PIK3R3
9679,GO:0038030,0.382296019397908,0.927627397689522,1,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,WNT4
7619,GO:0032000,0.382365247587206,0.930131176542944,1,5,positive regulation of fatty acid beta-oxidation,BP,IRS1
18824,GO:1904338,0.382674388067593,0.927469274351366,1,6,regulation of dopaminergic neuron differentiation,BP,SFRP1
10386,GO:0043197,0.382695144273054,0.743883435801995,9,102,dendritic spine,CC,CRYAB;DOCK10;SHISA9;ATP2B1;OPHN1;BAIAP2;SYT11;MTMR2;GPER1
4684,GO:0010830,0.382702255788091,0.82335672096748,3,30,regulation of myotube differentiation,BP,HDAC9;CFLAR;EHD1
8278,GO:0033063,0.382926122412209,0.925566245716472,1,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,RAD51B
10922,GO:0044459,0.382994310369313,0.656524850678796,113,1455,plasma membrane part,CC,CRYAB;NRG1;FN1;TENM3;AMOT;TFRC;GPRC5A;FGFR2;EPGN;S100P;SLC16A2;HLA-B;HSPG2;SLC7A2;B4GALT1;G6PD;TRAF3;IRS1;SLC16A9;SLC7A5P2;SIPA1L3;C1QTNF1;MEGF11;LGALS3;IFNGR1;SLC4A11;PDPN;CNTNAP1;CYLD;IL27RA;PCDH7;IL6ST;SLC9A3R1;IL7R;SLC22A5;SYK;EMP2;NAIP;LEPR;SHISA9;ABCG2;LRRC8D;HLA-F;HLA-DOB;CD274;DST;ATP2B1;SLC5A6;TPM1;PTPRB;RCE1;ABCC4;KCNS3;PARD3B;MGAM;CADPS2;SLC1A3;SLCO4C1;MME;FRK;BTN2A1;LCP1;PTPRM;CORO1C;RAB26;GPHN;ITGAV;ABCF2;KCNQ5;SNX5;NETO1;BAIAP2;CDH13;NPNT;PDGFB;ANTXR1;ENPP1;THBD;ABCC9;IFNAR1;TJP1;SLC11A2;CXCR5;CNTNAP2;SYT11;HSP90AB1;EPHB6;M6PR;ZFYVE27;WDPCP;MTMR2;STEAP4;IL12RB2;BBS5;GPER1;FAF1;ADAM17;MYO10;LILRB3;CFLAR;EBP;TRAF2;TLR3;PARD3;GJC1;EHD1;KCNE4;TNF;CD74;SLC43A2;PHLPP2;PHLPP1;HNRNPM
13668,GO:0060155,0.382998768031071,0.92553514863837,1,7,platelet dense granule organization,BP,BLOC1S2
8064,GO:0032725,0.383182152643834,0.925456613101698,1,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,SYK
6077,GO:0019226,0.383269978703122,0.823863753771078,3,27,transmission of nerve impulse,BP,CNTNAP1;CNTNAP2;GPER1
17418,GO:1900125,0.383436101346291,0.927150313206067,1,6,regulation of hyaluronan biosynthetic process,BP,PDGFB
2541,GO:0005797,0.383536707490959,0.925304630987136,1,7,Golgi medial cisterna,CC,GOSR1
20149,GO:2000794,0.383851312578067,0.926976089264631,1,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,FGFR2
1483,GO:0003774,0.384178295544473,0.743057227207794,9,94,motor activity,MF,KIF23;MYO1B;DYNC2H1;DNHD1;DYNLL2;CGNL1;MYH11;MYO10;KIF14
1670,GO:0004128,0.384229118895318,0.925007284754429,1,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,NQO1
5607,GO:0016645,0.384276672137459,0.858583814420258,2,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,DHFR;QDPR
15713,GO:0072224,0.384438199020422,0.926729398931444,1,6,metanephric glomerulus development,BP,PDGFB
5654,GO:0016746,0.384539895658748,0.715144909395374,15,189,transferase activity, transferring acyl groups,MF,HMGCS1;ZDHHC6;NAA15;QPCT;CROT;NAA50;MBOAT1;KANSL1L;BRCA2;HADHB;TAF6L;GTF3C4;NAA16;CLOCK;TAF1
10598,GO:0043552,0.384652967752659,0.85941086592708,2,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,IRS1;PDGFB
5675,GO:0016782,0.384724960462151,0.797361904801626,4,46,transferase activity, transferring sulfur-containing groups,MF,TPST1;CDKAL1;URM1;HS3ST1
6970,GO:0030619,0.384772369313097,0.924773493222749,1,7,U1 snRNA binding,MF,GEMIN5
15548,GO:0071921,0.384836848315738,0.926561543582213,1,6,cohesin loading,BP,CDCA5
5074,GO:0015295,0.385103328803912,0.858561784257799,2,18,solute:proton symporter activity,MF,SLC11A2;SLC25A22
9987,GO:0042368,0.385222450610246,0.924579464059944,1,7,vitamin D biosynthetic process,BP,TNF
15695,GO:0072201,0.385288787523853,0.926370967793503,1,6,negative regulation of mesenchymal cell proliferation,BP,PHF14
19440,GO:1905941,0.385394660657748,0.924505144625537,1,7,positive regulation of gonad development,BP,CITED2
13609,GO:0060056,0.385395297784958,0.924504869582917,1,7,mammary gland involution,BP,B4GALT1
2518,GO:0005770,0.385523608251385,0.71424177671447,15,190,late endosome,CC,VPS41;AP5M1;CHID1;IFNAR1;SLC11A2;HSPA8;NEDD4L;M6PR;TMEM165;ANKRD13A;ABCA5;VPS36;SLC9A9;CD74;ASTN2
8002,GO:0032615,0.385599414318868,0.820765231693555,3,32,interleukin-12 production,BP,TLR3;IRF1;IRAK3
15821,GO:0072497,0.385685979910052,0.926203230127665,1,6,mesenchymal stem cell differentiation,BP,FZD1
3176,GO:0006793,0.385781864490727,0.647455299496421,175,2364,phosphorus metabolic process,BP,CRYAB;IGFBP3;SAA1;NEFL;NRG1;FN1;PML;MAP3K14;CYR61;C3;GPRC5A;NLRC5;FGFR2;STAT5A;EPGN;CTGF;MMP9;GNPTAB;G6PD;IRS1;MID1;TP53;DAPK3;PANK2;EDN1;TPST1;SCD;GBP1;HMGCS1;C1QTNF1;DUSP14;CDKN2A;ACSL3;PTPN14;PRUNE2;CHP1;AKAP8;TGFB2;IKBKE;PKMYT1;PPP1R3B;PGD;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;CAMK1G;SYK;EMP2;TJP2;NUP153;NBN;TRIO;CDK4;SFRP1;RIPK4;GPCPD1;TARDBP;ABHD4;UAP1L1;PTPRB;ULK4;PTGER4;TK1;ADM;CD109;NDC1;CCL20;PLK2;FRK;AKAP8L;HSPB1;PTPRM;RAN;HMGXB3;RANBP2;CORO1C;DDX3X;IL24;GPHN;CDC25A;ITGAV;SOCS1;SET;PARP14;TRPM7;AJUBA;FASTKD3;CROT;PGK1;HACD2;PPP4R4;GADD45B;SH3RF2;APTX;PHACTR4;NPNT;PDGFB;SGK494;FZD1;CLU;NUP160;ENPP1;IL20;PIK3R3;MBOAT1;RRM2;NUP54;EYA3;ACKR3;GLIPR2;SEPHS2;NNT;WEE1;APEX1;PDCL3;UMPS;HSPA8;HSP90AB1;ARL6IP5;EPHB6;SMUG1;SCD5;SGK1;PPIP5K1;MTMR2;CHEK1;IL12RB2;GPER1;FAF1;RRM1;ADAM17;ATR;PSME2;HADHB;CFLAR;NOL9;PSMB9;SDHD;TRAF2;TELO2;CCNA2;UQCRB;CSF1;RBL1;KIF14;TLR3;ESR1;PARD3;TNF;ZFP36L2;TYMS;STARD7;CCL5;PLBD1;CD74;HNRNPU;FGFR1OP;PSMB10;FLAD1;DAXX;PHLPP2;TAF1;TBPL1;PHLPP1;NRAS;PPARGC1B;THTPA;CDKN1A;ITGB1BP1;GTF2H3;NDUFB9;GPX4;IRAK3
16641,GO:0097472,0.385831151662366,0.820845810840956,3,31,cyclin-dependent protein kinase activity,MF,CDK4;CCNA2;CDKN1A
10614,GO:0043583,0.385984333084239,0.734972420222982,10,115,ear development,BP,MAFB;FGFR2;FAT4;EDN1;TGFB2;SLC9A3R1;MCM2;WDPCP;NTN1;CCNA2
13077,GO:0051549,0.385997246444579,0.926071617548561,1,6,positive regulation of keratinocyte migration,BP,MMP9
14404,GO:0061635,0.386087500689185,0.924205692804201,1,7,regulation of protein complex stability,BP,HSPA8
14764,GO:0070424,0.386125553426681,0.926017324124468,1,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,BIRC3
12990,GO:0051353,0.386459743177529,0.820144483224786,3,32,positive regulation of oxidoreductase activity,BP,EDN1;DHFR;TNF
8951,GO:0034983,0.38648443269266,0.925865334784291,1,6,peptidyl-lysine deacetylation,BP,HDAC9
2271,GO:0005200,0.3865436286916,0.755962135038157,7,80,structural constituent of cytoskeleton,MF,NEFL;KRT2;KRT15;ACTG1;NEFM;KRT9;TPM1
2414,GO:0005587,0.387130153335572,0.928188455228126,1,5,collagen type IV trimer,CC,COL4A1
2406,GO:0005575,0.387250515643998,0.690713970272959,841,11709,cellular_component,CC,IL32;CRYAB;IGFBP3;HEPHL1;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;C1R;TRIM16;MAP2;KRT13;FN1;TRIM16L;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;SLC16A2;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;SLC7A2;RUNX1;MYO1B;CYP1A1;ERVFRD-1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;SPACA6;TSC22D3;FST;MAT2A;DDX17;SPON1;FAM69B;TRIM56;OVCH2;TFCP2L1;KRTAP2-3;CCDC80;TRAF3;COL27A1;ENC1;PLD5;IRS1;DYNC2H1;SPG21;MID1;SLC16A9;TP53;DAPK3;TUFT1;SVEP1;PANK2;SLC7A5P2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;ABCF1;TMEM106A;C1QTNF1;DUSP14;RBM19;KBTBD8;TMPPE;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;COBLL1;MEGF11;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;CNTNAP1;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;IFIT3;SRSF2;FOXD2;PCDH7;LRFN4;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;C15ORF39;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PALM2;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;OLFML3;NAIP;ZFP42;GFOD1;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;POP1;HLA-DOB;RIPK4;GPCPD1;NUCKS1;PITHD1;HEATR1;ZDHHC6;CD274;WNT10A;MCM2;TARDBP;LAYN;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;APOL6;COA7;KEAP1;NAA15;UAP1L1;TRA2A;TCHH;ZNF827;SLC5A6;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;IGFL3;KCNS3;SETDB1;PTGER4;TK1;TMEM97;LSG1;G3BP1;GRWD1;ARRDC1-AS1;ZNF584;TMEM248;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;CDV3;ZNF512;MRPL27;SLCO4C1;MME;TMEM212;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;KANK4;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;CXCL16;NOP2;DOHH;SUV39H2;LCP1;GPRIN1;EXOG;PTPRM;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;CPA4;IL24;ARHGEF28;ARMC5;GPHN;KLHL21;RRN3;RNF115;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;ABCF2;SNX11;TRPM7;AJUBA;SMC2;ARMC6;FASTKD3;KCNQ5;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;KRT24;LFNG;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;FRRS1;PPP4R4;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;FNDC3B;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;ODF2L;KREMEN2;SDK1;FZD1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;FRAS1;ZNF316;IL20;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;KANSL1L;ACKR3;FAM173B;RIF1;METTL16;MCM6;FGD6;SRD5A1;TMEM14EP;KLHL9;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;TMEM51;THBD;UPK3B;ABCC9;TRMT5;TTF2;DTX4;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;SEPHS2;NNT;IFNAR1;WEE1;TJP1;LRRN3;ZNF484;THADA;NOL12;KCTD3;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;CXCR5;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;GLIPR1L2;SYT11;ERVMER34-1;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;LYSMD4;GREB1;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;HPS5;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;HCAR1;DGCR8;DPYD;SS18L2;TTC27;KRT10;CCAR1;SKA2;CYB561D2;PPIP5K1;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;L1CAM;ZNFX1;STEAP4;FKBP5;IQCJ-SCHIP1;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;SCFD2;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;ANKRD13A;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;ARIH2OS;TAF6L;MRPS7;DPH2;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;TPRA1;MSH3;TELO2;EDRF1;RBBP5;CYP20A1;FAM208B;CITED2;MFAP5;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;JMJD8;CLOCK;GLIPR1;NSA2;IGFL1;KIF14;PURB;TLR3;MPP5;AZIN1;ERVK13-1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;NOP16;RRP15;RNF19B;RAD51B;USP11;EHD1;KCNE4;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;DCTN5;METAP2;SLC43A2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;SMIM7;YPEL4;PHLPP1;ZNHIT6;FTO;CCDC50;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;SLC41A2;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;GBP6;CENPO;GPX4;IRAK3;BUD13;TMEM234;COPS3;IFI27L1;DHX15;UFC1
16055,GO:0086067,0.387359604281248,0.925493894435496,1,6,AV node cell to bundle of His cell communication,BP,GJC1
6028,GO:0019083,0.387452658709979,0.727245368534907,11,171,viral transcription,BP,NUP50;NUP153;NUCKS1;TARDBP;NDC1;RANBP2;NUP160;NUP54;POLR2F;CCL5;RPS12
11642,GO:0046330,0.387546107864961,0.746683077907949,8,92,positive regulation of JNK cascade,BP,CTGF;EDN1;SYK;GADD45B;TRAF2;TLR3;TNF;DAXX
8276,GO:0033059,0.387651605877136,0.795414069559689,4,44,cellular pigmentation,BP,RAB32;BLOC1S2;BBS5;AP3B1
20070,GO:2000659,0.387938733981167,0.92340204719197,1,7,regulation of interleukin-1-mediated signaling pathway,BP,IL1R2
8961,GO:0035014,0.387961842337456,0.925237636416615,1,6,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R3
11640,GO:0046328,0.388172399951802,0.727711756286043,11,130,regulation of JNK cascade,BP,CTGF;EDN1;SYK;SFRP1;ULK4;GADD45B;TRAF2;TLR3;TNF;DAXX;PHLPP1
15233,GO:0071363,0.388333579118002,0.678085365810277,36,454,cellular response to growth factor stimulus,BP,PML;GCLC;CYR61;FGFR2;CTGF;FBN1;FAT4;EDN1;TGFB2;HNRNPF;SFRP1;WNT10A;MIR17HG;CD109;HSPB1;WNT4;BAIAP2;NPNT;PDGFB;FZD1;SRD5A1;HSP90AB1;ZFYVE27;POLR2F;ADAM17;CFLAR;NCBP1;CITED2;NCL;CCNA2;PARD3;EHD1;ZFP36L2;CCL5;HNRNPM;ITGB1BP1
14160,GO:0061008,0.388379475552573,0.738842275456175,9,105,hepaticobiliary system development,BP,CYP1A1;HMGCS1;WNT4;QDPR;SRD5A1;E2F8;CFLAR;CITED2;TYMS
5458,GO:0016331,0.388832966569084,0.732492131315948,10,115,morphogenesis of embryonic epithelium,BP,FGFR2;TGFB2;IRX2;SFRP1;ADM;WNT4;KDM6A;PHACTR4;FZD1;SETD2
5388,GO:0016209,0.388876093396993,0.793285261603295,4,53,antioxidant activity,MF,TXNRD1;NQO1;SOD2;GPX4
16774,GO:0098534,0.389215059388897,0.81866832639572,3,30,centriole assembly,BP,PLK2;TRIM37;CEP152
11207,GO:0045296,0.389234187748848,0.692657351702087,23,298,cadherin binding,MF,GPRC5A;S100P;MYO1B;COBLL1;PDLIM1;TJP2;EIF5;PTPRM;RAN;DDX3X;SNX5;BAIAP2;CDH13;RARS;ANLN;TJP1;HSPA8;HSP90AB1;SHTN1;NOP56;EHD1;ARGLU1;DIAPH3
15403,GO:0071634,0.389438798932916,0.856376718747981,2,17,regulation of transforming growth factor beta production,BP,TGFB2;HSP90AB1
20115,GO:2000737,0.389473626711625,0.856354520345117,2,17,negative regulation of stem cell differentiation,BP,ZFP36L2;HNRNPU
10867,GO:0044359,0.389502208334516,0.922719314875721,1,7,modulation of molecular function in other organism,BP,NUCKS1
13344,GO:0052205,0.389502208334516,0.922719314875721,1,7,modulation of molecular function in other organism involved in symbiotic interaction,BP,NUCKS1
1325,GO:0003171,0.389810074863578,0.856790766973089,2,16,atrioventricular valve development,BP,CYR61;TGFB2
13764,GO:0060316,0.389943274315655,0.922526046640017,1,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH2
16325,GO:0090435,0.390044062811349,0.92248184155314,1,7,protein localization to nuclear envelope,BP,NUP54
13534,GO:0055085,0.39008153717738,0.660171836028588,66,875,transmembrane transport,BP,JPH2;C3;SLC16A2;MMP9;TAP1;SLC7A2;G6PD;TSC22D3;IRS1;SLC16A9;SLC7A5P2;ABCF1;CHP1;SLC4A11;SLC30A6;SLC9A3R1;SLC22A5;SHISA9;ABCG2;LRRC8D;ATP2B1;SLC5A6;ABCC4;KCNS3;SLC35A4;SLC1A3;SLCO4C1;ATP2C1;ITGAV;TRPM7;KCNQ5;NETO1;CLU;ENPP1;PIK3R3;SPNS1;TIMM23B;ABCC9;JPH1;NNT;THADA;SLC11A2;HSPA8;ARL6IP5;NEDD4L;SGK1;M6PR;STEAP4;GPER1;PSME2;PSMB9;ABCA5;EBP;SLC9A9;TAP2;AZIN1;CLCC1;GJC1;KCNE4;TNF;PSMB10;SLC43A2;PANX1;ABCA11P;SLC25A22;SLC41A2
2097,GO:0004860,0.390088442286096,0.763078951197903,6,71,protein kinase inhibitor activity,MF,CDKN2A;CHP1;HSPB1;SOCS1;FGFR1OP;CDKN1A
6076,GO:0019222,0.390107229859416,0.637086572848585,360,4909,regulation of metabolic process,BP,CRYAB;IGFBP3;MAFB;SAA1;NRG1;HDAC9;C1R;TRIM16;FN1;PML;CYP1B1;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;MKL1;FOSL2;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;TRIM22;CBX5;CTGF;MMP9;FBN1;RUNX1;CYP1A1;CLN6;IL1R2;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;PANK2;EDN1;SCD;GBP1;HMGCS1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CYLD;PKMYT1;TGS1;PDLIM1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;IL6ST;HNRNPF;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;SYK;EMP2;NUP153;NAIP;ZFP42;RELB;NBN;LEPR;PARP15;BRIP1;SHQ1;LSS;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;WNT10A;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;POLR1A;GLIS3;HELLS;TAF2;ULK4;POLA1;TSN;DRAM1;SETDB1;ZNF584;TRAF1;OPHN1;ADM;CD109;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;CCL20;PLK2;RRAGB;ZNF512;ZNF587;UBQLN2;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;KDM6A;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;CORO1C;ZNF738;DDX3X;NUFIP1;IL24;RRN3;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;SNX5;TRIM37;PPP4R4;GNL3L;ZNF586;NVL;GADD45B;SH3RF2;CDH13;COMMD4;PHACTR4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;BRCC3;FZD1;IRX4;UTY;NFE2L1;ANTXR1;CLU;NUP160;SMYD2;MACC1;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;ACKR3;RIF1;METTL16;SETD2;GLIS2;UBP1;UPK3B;TTF2;GLIPR2;ZNF484;APEX1;PDCL3;TNC;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;DDX21;ARL6IP5;EPHB6;BACE2;ZBTB24;NSF;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;WDR75;ADAM17;SENP1;RBMS3;ATR;PSME2;UBAP2L;MSH6;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;POLR1E;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;RNF19B;ARV1;TNF;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;USP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;RPS12;ZBTB9;IRAK3;IFI27L1
9111,GO:0035374,0.390122888300382,0.92431367700134,1,6,chondroitin sulfate binding,MF,DPYSL3
1184,GO:0002828,0.390305303549953,0.854277498995493,2,20,regulation of type 2 immune response,BP,IL27RA;CD74
19146,GO:1905050,0.390307865800743,0.922366067029186,1,7,positive regulation of metallopeptidase activity,BP,ANTXR1
12285,GO:0048563,0.390470733102063,0.922294537494371,1,7,post-embryonic animal organ morphogenesis,BP,FBN1
10305,GO:0043045,0.39047236006221,0.924163609896307,1,6,DNA methylation involved in embryo development,BP,TET3
17701,GO:1901538,0.39047236006221,0.924163609896307,1,6,changes to DNA methylation involved in embryo development,BP,TET3
11805,GO:0046654,0.390639401161885,0.922220418155175,1,7,tetrahydrofolate biosynthetic process,BP,DHFR
10785,GO:0044224,0.390710155272418,0.924061394352416,1,6,juxtaparanode region of axon,CC,CNTNAP2
11531,GO:0046031,0.390883656775333,0.752316258944023,7,80,ADP metabolic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
6203,GO:0019682,0.390962525255724,0.853853844675532,2,20,glyceraldehyde-3-phosphate metabolic process,BP,G6PD;PGD
9091,GO:0035336,0.390988325516256,0.854296875481064,2,19,long-chain fatty-acyl-CoA metabolic process,BP,ACSL3;HACD2
7943,GO:0032525,0.3911939981427,0.923853156754711,1,6,somite rostral/caudal axis specification,BP,KDM6A
7213,GO:0031099,0.391222763928355,0.730119912576817,10,122,regeneration,BP,NEFL;CDK4;DHFR;ADM;LCP1;TNC;CFLAR;CCNA2;TYMS;CDKN1A
8517,GO:0033689,0.391424326946946,0.923753905026947,1,6,negative regulation of osteoblast proliferation,BP,SFRP1
11450,GO:0045861,0.391614340773396,0.705609796061984,16,212,negative regulation of proteolysis,BP,CRYAB;PML;C3;MMP9;IL1R2;NAIP;OPHN1;CD109;DDX3X;BIRC3;PDCL3;HSP90AB1;SERPINB9;SENP1;TAF1;SMARCC1
5766,GO:0016929,0.391792703128464,0.92359500290805,1,6,SUMO-specific protease activity,MF,SENP1
7792,GO:0032324,0.391881824595068,0.921673125171349,1,7,molybdopterin cofactor biosynthetic process,BP,GPHN
10591,GO:0043545,0.391881824595068,0.921673125171349,1,7,molybdopterin cofactor metabolic process,BP,GPHN
12887,GO:0051189,0.391881824595068,0.921673125171349,1,7,prosthetic group metabolic process,BP,GPHN
2894,GO:0006402,0.391936034523515,0.691533565394652,22,322,mRNA catabolic process,BP,PABPC4;TARDBP;CASC3;HSPB1;SET;MRTO4;FASTKD3;METTL16;APEX1;HSPA8;SYNCRIP;PSME2;PSMB9;NCBP1;UPF3B;HNRNPR;ZFP36L2;RC3H1;HNRNPU;PSMB10;RBM8A;RPS12
8372,GO:0033256,0.392026978246412,0.921609032145676,1,7,I-kappaB/NF-kappaB complex,CC,RELB
634,GO:0001821,0.392050429371438,0.920194703836073,1,8,histamine secretion,BP,EDN1
14964,GO:0070838,0.39208721510727,0.695780533943307,20,245,divalent metal ion transport,BP,PML;JPH2;CTGF;G6PD;LGALS3;IL16;SLC30A6;ATP2B1;ATP2C1;ITGAV;TRPM7;PDGFB;JPH1;THADA;SLC11A2;TMEM165;GPER1;CCL5;PANX1;SLC41A2
542,GO:0001660,0.392348857173548,0.921466791827347,1,7,fever generation,BP,TNF
15891,GO:0072594,0.392607040066318,0.677491399964879,32,462,establishment of protein localization to organelle,BP,NRG1;PML;GNPTAB;TP53;CHP1;RBM22;DKC1;NUP50;NUP153;VPS41;IMMP2L;DYNLL2;RAN;RANBP2;ARNTL;GDAP1;CLU;NUP54;TIMM23B;HSPA8;HSP90AB1;BRCA2;RAB3GAP1;WDR75;UBE2J2;VPS36;AP3B1;TNF;STARD7;CDKN1A;TSGA13;RPS12
11897,GO:0046889,0.392664038246447,0.791538060064814,4,44,positive regulation of lipid biosynthetic process,BP,CYR61;ACSL3;WNT4;TNF
16204,GO:0090207,0.392919026181556,0.853051903701759,2,19,regulation of triglyceride metabolic process,BP,C3;PANK2
6126,GO:0019371,0.39311056799666,0.921129562153036,1,7,cyclooxygenase pathway,BP,PTGES
11873,GO:0046847,0.393345210498765,0.791725906388162,4,40,filopodium assembly,BP,SRF;FGD6;MYO10;DPYSL3
7670,GO:0032094,0.393374035011092,0.853275549699851,2,18,response to food,BP,CYP1A1;G6PD
10237,GO:0042908,0.393651662715711,0.922790042463105,1,6,xenobiotic transport,BP,ABCG2
10238,GO:0042910,0.393651662715711,0.922790042463105,1,6,xenobiotic transmembrane transporter activity,MF,ABCG2
12974,GO:0051336,0.39389150002633,0.655853503538881,68,900,regulation of hydrolase activity,BP,CRYAB;IGFBP3;FN1;PML;AMOT;CYR61;C3;FGFR2;STARD13;CTGF;MMP9;TP53;DOCK10;SIPA1L3;CHP1;TGFB2;PKMYT1;PPP1R3B;NUAK1;NAIP;LEPR;SFRP1;TPM1;OPHN1;CD109;DYNLL2;CCL20;HSCB;RHOG;WNT4;RANBP2;VCPKMT;CORO1C;DDX3X;SET;AJUBA;CDC42EP2;PPP4R4;SH3RF2;PHACTR4;NPNT;TBC1D15;ANTXR1;USP6;BIRC3;FGD6;THADA;HSP90AB1;ARL6IP5;RAB3GAP1;SERPINB9;GPER1;SENP1;PSME2;MSH6;CFLAR;PSMB9;DNAJC9;RABEP2;TRAF2;MSH3;ESR1;TNF;CCL5;HNRNPU;PPARGC1B;ITGB1BP1;IFI27L1
6787,GO:0030218,0.394055393468679,0.749569596347947,7,81,erythrocyte differentiation,BP,MAFB;G6PD;INHBA;SRF;NFE2L1;SLC11A2;SENP1
2938,GO:0006464,0.394085293786006,0.6363658728786,230,3084,cellular protein modification process,BP,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;TRIM16;FN1;PML;MAP3K14;GCLC;KRT2;CYR61;C3;GPRC5A;FGFR2;STAT5A;EPGN;TRIM22;CTGF;MMP9;FBN1;B4GALT1;G6PD;SPON1;TRIM56;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;EDN1;TPST1;GBP1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;ZBED1;PTPN14;CHP1;AKAP8;TGFB2;ST6GALNAC5;PRSS23;CYLD;IKBKE;PKMYT1;PPP1R3B;P3H2;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;PUM3;GALNT18;CAMK1G;SYK;EMP2;NUP153;NAIP;NBN;TRIO;PARP15;CDK4;SFRP1;RIPK4;ZDHHC6;TARDBP;USP16;KEAP1;NAA15;METTL21A;PTPRB;ULK4;RCE1;SETDB1;PTGER4;CD109;P4HA2;USP43;GGCX;NDC1;HERC6;CCL20;PLK2;MUC16;FRK;AKAP8L;HSPB1;DOHH;SUV39H2;PTPRM;KDM6A;SETD4;RANBP2;VCPKMT;CORO1C;ZNF738;DDX3X;CPA4;IL24;GPHN;KLHL21;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;QPCT;TRPM7;AJUBA;FASTKD3;LFNG;TRIM37;PPP4R4;GNL3L;GADD45B;SH3RF2;PHACTR4;MDM4;HIF1AN;NPNT;PDGFB;BRCC3;SGK494;FZD1;UTY;CLU;NUP160;USP6;SMYD2;NAA50;ENPP1;BIRC3;IL20;NUP54;EYA3;ACKR3;RIF1;KLHL9;SETD2;DTX4;GLIPR2;DPY19L2P2;WEE1;PDCL3;TNC;TET3;HSPA8;HSP90AB1;ARL6IP5;EPHB6;NEDD4L;SGK1;ANAPC7;BRCA2;TRAK2;KRT10;MTMR2;TMEM165;FKBP5;RAB3GAP1;CHEK1;IL12RB2;GPER1;FAF1;RAD18;ADAM17;SENP1;ATR;PSME2;CFLAR;PSMB9;RFWD3;CBLL1;TAF6L;DPH2;SPSB1;UBE2J2;TRAF2;TELO2;RBBP5;CCNA2;GTF3C4;POLE3;CSF1;NAA16;MPHOSPH8;CLOCK;KIF14;TLR3;ESR1;PARD3;RNF19B;USP11;FEM1C;TNF;ZFP36L2;RC3H1;CCL5;CD74;RING1;FGFR1OP;PSMB10;DAXX;METAP2;PHLPP2;TAF1;PHLPP1;NRAS;MUC5B;CDKN1A;ITGB1BP1;USP1;MUC6;CTCF;GTF2H3;IRAK3;COPS3;UFC1
9525,GO:0036211,0.394085293786006,0.6363658728786,230,3084,protein modification process,BP,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;TRIM16;FN1;PML;MAP3K14;GCLC;KRT2;CYR61;C3;GPRC5A;FGFR2;STAT5A;EPGN;TRIM22;CTGF;MMP9;FBN1;B4GALT1;G6PD;SPON1;TRIM56;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;EDN1;TPST1;GBP1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;ZBED1;PTPN14;CHP1;AKAP8;TGFB2;ST6GALNAC5;PRSS23;CYLD;IKBKE;PKMYT1;PPP1R3B;P3H2;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;PUM3;GALNT18;CAMK1G;SYK;EMP2;NUP153;NAIP;NBN;TRIO;PARP15;CDK4;SFRP1;RIPK4;ZDHHC6;TARDBP;USP16;KEAP1;NAA15;METTL21A;PTPRB;ULK4;RCE1;SETDB1;PTGER4;CD109;P4HA2;USP43;GGCX;NDC1;HERC6;CCL20;PLK2;MUC16;FRK;AKAP8L;HSPB1;DOHH;SUV39H2;PTPRM;KDM6A;SETD4;RANBP2;VCPKMT;CORO1C;ZNF738;DDX3X;CPA4;IL24;GPHN;KLHL21;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;QPCT;TRPM7;AJUBA;FASTKD3;LFNG;TRIM37;PPP4R4;GNL3L;GADD45B;SH3RF2;PHACTR4;MDM4;HIF1AN;NPNT;PDGFB;BRCC3;SGK494;FZD1;UTY;CLU;NUP160;USP6;SMYD2;NAA50;ENPP1;BIRC3;IL20;NUP54;EYA3;ACKR3;RIF1;KLHL9;SETD2;DTX4;GLIPR2;DPY19L2P2;WEE1;PDCL3;TNC;TET3;HSPA8;HSP90AB1;ARL6IP5;EPHB6;NEDD4L;SGK1;ANAPC7;BRCA2;TRAK2;KRT10;MTMR2;TMEM165;FKBP5;RAB3GAP1;CHEK1;IL12RB2;GPER1;FAF1;RAD18;ADAM17;SENP1;ATR;PSME2;CFLAR;PSMB9;RFWD3;CBLL1;TAF6L;DPH2;SPSB1;UBE2J2;TRAF2;TELO2;RBBP5;CCNA2;GTF3C4;POLE3;CSF1;NAA16;MPHOSPH8;CLOCK;KIF14;TLR3;ESR1;PARD3;RNF19B;USP11;FEM1C;TNF;ZFP36L2;RC3H1;CCL5;CD74;RING1;FGFR1OP;PSMB10;DAXX;METAP2;PHLPP2;TAF1;PHLPP1;NRAS;MUC5B;CDKN1A;ITGB1BP1;USP1;MUC6;CTCF;GTF2H3;IRAK3;COPS3;UFC1
6921,GO:0030507,0.394237696645913,0.853963122780846,2,16,spectrin binding,MF,GBP1;MYO10
4029,GO:0009060,0.394450420255755,0.771713698018833,5,68,aerobic respiration,BP,PANK2;ACO1;NNT;SDHD;UQCRB
18088,GO:1902622,0.394631595428755,0.851058100237954,2,21,regulation of neutrophil migration,BP,EDN1;CD74
16001,GO:0080154,0.394706648202609,0.920420081060765,1,7,regulation of fertilization,BP,B4GALT1
3946,GO:0008637,0.394870795428134,0.739746289752941,8,105,apoptotic mitochondrial changes,BP,GCLC;MMP9;TP53;DYNLL2;SOD2;CLU;BLOC1S2;GPER1
2846,GO:0006325,0.394875429118671,0.662889795920613,49,660,chromatin organization,BP,HDAC9;TRIM16;TP53;DAPK3;CDKN2A;AKAP8;NUCKS1;MCM2;H3F3A;USP16;HELLS;SETDB1;GRWD1;AKAP8L;SUV39H2;KDM6A;UBTF;SUPT16H;NAP1L1;CPA4;SET;TRIM37;BRCC3;UTY;SMYD2;NAA50;EYA3;RIF1;SETD2;TET3;BRCA2;CHEK1;TAF6L;RBBP5;CCNA2;GTF3C4;POLE3;RBL1;CLOCK;ESR1;CENPN;HNRNPU;RING1;DAXX;HIST1H4A;TAF1;SMARCC1;CTCF;CENPO
9115,GO:0035384,0.394991780022764,0.789895021289224,4,43,thioester biosynthetic process,BP,SCD;ACSL3;HACD2;SCD5
15392,GO:0071616,0.394991780022764,0.789895021289224,4,43,acyl-CoA biosynthetic process,BP,SCD;ACSL3;HACD2;SCD5
13052,GO:0051489,0.394996634860373,0.814754100545377,3,29,regulation of filopodium assembly,BP,SRF;MYO10;DPYSL3
16507,GO:0097178,0.395068872991547,0.813881544008946,3,32,ruffle assembly,BP,RHOG;CORO1C;WDPCP
6635,GO:0022900,0.39513852829391,0.731664049539618,9,142,electron transport chain,BP,TXNRD1;IMMP2L;P4HA2;QDPR;SRD5A1;SDHD;AKR1B1;UQCRB;NDUFB9
15379,GO:0071599,0.395654154733535,0.921917157204309,1,6,otic vesicle development,BP,FGFR2
1998,GO:0004716,0.395803224522771,0.921851937690739,1,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,SYK
12677,GO:0050862,0.395856121566439,0.919906724653277,1,7,positive regulation of T cell receptor signaling pathway,BP,CYLD
1262,GO:0003013,0.396056549314755,0.690194192238856,21,253,circulatory system process,BP,GCLC;CTGF;EDN1;C9ORF3;TGFB2;EMP2;ATP2B1;TPM1;ADM;IMMP2L;MME;SOD2;PDGFB;ABCC9;ERAP1;NEDD4L;SGK1;NAV2;GPER1;GJC1;ITGB1BP1
18276,GO:1903071,0.396070666227453,0.919810685875339,1,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,UBQLN2
17755,GO:1901660,0.396111251841294,0.92171706712493,1,6,calcium ion export,BP,ATP2B1
7248,GO:0031167,0.396643153155386,0.849744165124595,2,21,rRNA methylation,BP,NOP2;METTL16
7082,GO:0030865,0.396918845207869,0.788568956404062,4,42,cortical cytoskeleton organization,BP,KIF23;RTKN2;ANLN;TNF
353,GO:0000966,0.397032289458501,0.849489320032857,2,21,RNA 5'-end processing,BP,UTP20;POP1
2465,GO:0005680,0.397159897585842,0.849405702651856,2,21,anaphase-promoting complex,CC,ANAPC15;ANAPC7
18606,GO:1903825,0.397217398104281,0.747038379829728,7,79,organic acid transmembrane transport,BP,SLC7A2;SLC7A5P2;SLC5A6;SLC1A3;ARL6IP5;SLC43A2;SLC25A22
19138,GO:1905039,0.397217398104281,0.747038379829728,7,79,carboxylic acid transmembrane transport,BP,SLC7A2;SLC7A5P2;SLC5A6;SLC1A3;ARL6IP5;SLC43A2;SLC25A22
5561,GO:0016570,0.397249854178191,0.674559137171022,31,388,histone modification,BP,HDAC9;TRIM16;TP53;AKAP8;USP16;SETDB1;AKAP8L;SUV39H2;KDM6A;CPA4;SET;TRIM37;BRCC3;UTY;SMYD2;NAA50;EYA3;RIF1;SETD2;TET3;BRCA2;CHEK1;TAF6L;RBBP5;CCNA2;GTF3C4;POLE3;CLOCK;RING1;TAF1;CTCF
13493,GO:0055008,0.397481546713177,0.789407441189761,4,36,cardiac muscle tissue morphogenesis,BP,NRG1;FGFR2;TGFB2;TPM1
19178,GO:1905153,0.397481960394131,0.921115171706184,1,6,regulation of membrane invagination,BP,SYT11
9458,GO:0036037,0.397537328196595,0.919152268355261,1,7,CD8-positive, alpha-beta T cell activation,BP,IRF1
366,GO:0000987,0.397616817407963,0.683414864611112,24,297,proximal promoter sequence-specific DNA binding,MF,MAFB;FOSL2;PBX1;TP53;ZBED1;ZFP42;AHR;MYBL2;KDM6A;UBTF;ARNTL;SRF;UTY;MYBL1;E2F8;ETV6;HSF2;CLOCK;ESR1;TBPL1;SMARCC1;ARID3B;IRF1;CTCF
7838,GO:0032386,0.397650699479301,0.68173961338479,25,320,regulation of intracellular transport,BP,CRYAB;NRG1;TP53;RBM4;PTPN14;CHP1;RBM22;SYK;NUP153;REEP1;AKAP8L;LCP1;NUP54;SETD2;HSP90AB1;MTMR2;RAB3GAP1;WDR75;UBE2J2;EHD1;ARV1;STARD7;CDKN1A;ITGB1BP1;TSGA13
10382,GO:0043190,0.397787690501452,0.920980536571596,1,6,ATP-binding cassette (ABC) transporter complex,CC,ABCF2
10909,GO:0044445,0.397796276167725,0.709396397379022,13,203,cytosolic part,CC,NEFL;GEMIN5;AHR;DDX3X;NUFIP1;MRTO4;RRM2;BLOC1S2;HSPA8;HPS5;RRM1;CFLAR;RPS12
5083,GO:0015318,0.397815954656766,0.673956933519048,31,398,inorganic molecular entity transmembrane transporter activity,MF,JPH2;TFRC;SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;SLC4A11;SLC30A6;SLC22A5;LRRC8D;ATP2B1;SLC5A6;ABCC4;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;NNT;SLC11A2;SLC9A9;CLCC1;GJC1;KCNE4;SLC43A2;PANX1;SLC25A22;SLC41A2
2863,GO:0006355,0.397957542345698,0.633507738856541,210,2826,regulation of transcription, DNA-templated,BP,MAFB;NRG1;HDAC9;TRIM16;PML;CYP1B1;GCLC;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;TRIM22;CBX5;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;TP53;DAPK3;EDN1;CDKN2A;ZBED1;ZNF397;PTPN14;STAG1;CHP1;AKAP8;TGFB2;IRX2;ZNF208;CYLD;TGS1;PDLIM1;IL16;FOXD2;INHBA;SYK;ZFP42;RELB;PARP15;BRIP1;UTP15;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;POLA1;SETDB1;ZNF584;TRAF1;ZNF407;ELMSAN1;ZNF512;ZNF587;FRK;DNTTIP2;AKAP8L;MYBL2;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;SOD2;SUPT16H;ZNF738;DDX3X;NUFIP1;RRN3;SET;PARP14;ARNTL;TAF1D;AJUBA;ZNF267;TRIM37;ZNF586;CDH13;COMMD4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;FZD1;IRX4;NFE2L1;CLU;SMYD2;MACC1;ZNF316;RRM2;COMMD9;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;ZNF484;APEX1;ZNF57;TET3;ORC1;MYBL1;HSPA8;ZBTB24;NEDD4L;SGK1;ZBTB12;BRCA2;TRAK2;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;CENPF;ETV6;ZNFX1;HSF2;CHEK1;SRFBP1;GPER1;FAF1;MLLT10;WDR75;SENP1;PSME2;CFLAR;PSMB9;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;MYNN;VPS36;TRAF2;EDRF1;RBBP5;CITED2;NCL;CCNA2;TIMELESS;ORC2;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;TYMS;ARGLU1;CD74;HNRNPU;RING1;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;ZNF471;IRF1;CTCF;GTF2H3;ZBTB9;IRAK3
13148,GO:0051683,0.397966415934931,0.918959019892507,1,7,establishment of Golgi localization,BP,SLC9A3R1
9249,GO:0035635,0.398021244830631,0.850262844793885,2,18,entry of bacterium into host cell,BP,ITGAV;CBLL1
13988,GO:0060675,0.398565155271871,0.78766480295439,4,40,ureteric bud morphogenesis,BP,FAT4;PBX1;WNT4;NPNT
15672,GO:0072171,0.398565155271871,0.78766480295439,4,40,mesonephric tubule morphogenesis,BP,FAT4;PBX1;WNT4;NPNT
6629,GO:0022857,0.398640486808632,0.664359785636015,41,535,transmembrane transporter activity,MF,JPH2;TFRC;SLC16A2;TAP1;SLC7A2;SLC16A9;SLC7A5P2;SLC4A11;SLC30A6;SLC22A5;ABCG2;LRRC8D;ATP2B1;SLC5A6;ABCC4;KCNS3;SLC35A4;SLC1A3;SLCO4C1;ATP2C1;ITGAV;TRPM7;KCNQ5;TIMM23B;ABCC9;JPH1;NNT;SLC11A2;M6PR;ABCA5;EBP;SLC9A9;TAP2;CLCC1;GJC1;KCNE4;SLC43A2;PANX1;ABCA11P;SLC25A22;SLC41A2
2777,GO:0006207,0.398831437795897,0.920519838554613,1,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,UMPS
6266,GO:0019856,0.398831437795897,0.920519838554613,1,6,pyrimidine nucleobase biosynthetic process,BP,UMPS
6619,GO:0022838,0.398947494501736,0.709442525646081,13,153,substrate-specific channel activity,MF,JPH2;SLC4A11;LRRC8D;KCNS3;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;CLCC1;GJC1;KCNE4;PANX1
6064,GO:0019209,0.399119773881195,0.76896367128769,5,57,kinase activator activity,MF,NRG1;DDX3X;CCL5;DAXX;CDKN1A
17476,GO:1900242,0.399206676129706,0.920353811372786,1,6,regulation of synaptic vesicle endocytosis,BP,SYT11
7486,GO:0031645,0.399253394633583,0.91837771228504,1,7,negative regulation of neurological system process,BP,MTMR2
14189,GO:0061051,0.399372114336073,0.92028054443819,1,6,positive regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
11822,GO:0046688,0.399457264668287,0.847510206850967,2,22,response to copper ion,BP,CYP1A1;DAXX
2782,GO:0006213,0.399474306681038,0.809758822407827,3,36,pyrimidine nucleoside metabolic process,BP,TK1;UMPS;DPYD
12131,GO:0048168,0.399674921376227,0.811026834690533,3,30,regulation of neuronal synaptic plasticity,BP,SHISA9;NETO1;RAB3GAP1
15831,GO:0072511,0.399854013305871,0.688622921677005,20,246,divalent inorganic cation transport,BP,PML;JPH2;CTGF;G6PD;LGALS3;IL16;SLC30A6;ATP2B1;ATP2C1;ITGAV;TRPM7;PDGFB;JPH1;THADA;SLC11A2;TMEM165;GPER1;CCL5;PANX1;SLC41A2
9013,GO:0035150,0.399900819676531,0.755015098176769,6,70,regulation of tube size,BP,GCLC;EDN1;ADM;SOD2;GPER1;ITGB1BP1
12692,GO:0050880,0.399900819676531,0.755015098176769,6,70,regulation of blood vessel size,BP,GCLC;EDN1;ADM;SOD2;GPER1;ITGB1BP1
19120,GO:1904994,0.40006812350557,0.918008399669453,1,7,regulation of leukocyte adhesion to vascular endothelial cell,BP,TNF
938,GO:0002335,0.400270752029193,0.848262910840318,2,19,mature B cell differentiation,BP,DOCK10;LFNG
13204,GO:0051791,0.400324668587531,0.91789189803668,1,7,medium-chain fatty acid metabolic process,BP,CROT
6373,GO:0021554,0.400355166300258,0.919844331625242,1,6,optic nerve development,BP,NAV2
2873,GO:0006367,0.40046073643827,0.711889976755253,12,152,transcription initiation from RNA polymerase II promoter,BP,CTGF;TP53;CDK4;TAF2;SRF;MAZ;POLR2F;TAF6L;ESR1;TAF1;CDKN1A;GTF2H3
8176,GO:0032906,0.40052661862394,0.91976810291719,1,6,transforming growth factor beta2 production,BP,TGFB2
8179,GO:0032909,0.40052661862394,0.91976810291719,1,6,regulation of transforming growth factor beta2 production,BP,TGFB2
14800,GO:0070491,0.400564693828093,0.767904708210492,5,56,repressing transcription factor binding,MF,HDAC9;CBX5;ZFP42;ARNTL;BBS5
6712,GO:0030119,0.400584672281989,0.785523942715869,4,43,AP-type membrane coat adaptor complex,CC,VPS41;AP3M2;AP5M1;AP3B1
15306,GO:0071474,0.400676919992826,0.917731769686805,1,7,cellular hyperosmotic response,BP,AKR1B1
17951,GO:1902253,0.400766323355798,0.846645032687679,2,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,RRN3;CD74
10292,GO:0043028,0.400924659729282,0.809568208712204,3,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,NAIP;BIRC3;SERPINB9
11659,GO:0046364,0.400939519665147,0.767154709181408,5,60,monosaccharide biosynthetic process,BP,G6PD;PGD;LEPR;PGK1;AKR1B1
15668,GO:0072163,0.401083858154458,0.754596130767479,6,64,mesonephric epithelium development,BP,FGFR2;FAT4;PBX1;SFRP1;WNT4;NPNT
15669,GO:0072164,0.401083858154458,0.754596130767479,6,64,mesonephric tubule development,BP,FGFR2;FAT4;PBX1;SFRP1;WNT4;NPNT
675,GO:0001882,0.401153213623452,0.683284009955988,22,293,nucleoside binding,MF,GBP1;RAB32;ARFRP1;TSR1;POLA1;LSG1;EIF5;RRAGB;GBP5;RHOG;RAN;RAB26;GNL3L;EFTUD2;SRPRB;HSP90AB1;MMAA;BMS1;POLR3B;EHD1;NRAS;GBP6
7951,GO:0032536,0.401305844338458,0.917445395284307,1,7,regulation of cell projection size,BP,NEFL
4026,GO:0009057,0.401408665447282,0.644565323608147,82,1128,macromolecule catabolic process,BP,NRG1;PML;GCLC;HSPG2;CLN6;ENC1;TP53;PABPC4;CHP1;CYLD;PPP1R3B;DKC1;POP1;TARDBP;USP16;KEAP1;ADAMTS9;OPHN1;MGAM;USP43;FOXRED2;CASC3;PLK2;UBQLN2;HSPB1;EXOG;RANBP2;ANAPC15;RNF115;SET;ARNTL;MRTO4;ODC1;FASTKD3;FEN1;MDM4;CHID1;CLU;USP6;LRPPRC;METTL16;APEX1;PDCL3;HSPA8;TMEM199;HSP90AB1;BACE2;NSF;NEDD4L;ANAPC7;SYNCRIP;MTMR2;CCDC47;FAF1;SENP1;PSME2;PSMB9;NCBP1;UPF3B;SPSB1;UBE2J2;VPS36;TRAF2;HNRNPR;CLOCK;KIF14;AZIN1;RNF19B;USP11;DNASE1;TNF;ZFP36L2;RC3H1;HNRNPU;PSMB10;TAF1;SMARCC1;USP1;RBM8A;RPS12;IRAK3;COPS3
15819,GO:0072488,0.401424926181184,0.91739110400932,1,7,ammonium transmembrane transport,BP,SLC22A5
13605,GO:0060052,0.401492055280243,0.917360489177884,1,7,neurofilament cytoskeleton organization,BP,NEFL
9075,GO:0035305,0.401582279670843,0.743255231825283,7,80,negative regulation of dephosphorylation,BP,CHP1;TGFB2;PKMYT1;SET;PPP4R4;SH3RF2;TNF
5614,GO:0016655,0.40182945885114,0.806160313826564,3,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,NQO1;AKR1C2;NDUFB9
10176,GO:0042753,0.402122018420228,0.919056644366878,1,6,positive regulation of circadian rhythm,BP,ARNTL
4688,GO:0010835,0.402132946551759,0.917067855351995,1,7,regulation of protein ADP-ribosylation,BP,PUM3
4686,GO:0010832,0.402210214825456,0.919017201160564,1,6,negative regulation of myotube differentiation,BP,CFLAR
18364,GO:1903299,0.402225915764358,0.917025352604765,1,7,regulation of hexokinase activity,BP,RANBP2
3359,GO:0007097,0.402452352005178,0.848643442335177,2,16,nuclear migration,BP,SLC9A3R1;NTN1
9753,GO:0038203,0.402520304579952,0.916890678877316,1,7,TORC2 signaling,BP,TELO2
9957,GO:0042308,0.402624878110536,0.916842807550124,1,7,negative regulation of protein import into nucleus,BP,CHP1
18929,GO:1904590,0.402624878110536,0.916842807550124,1,7,negative regulation of protein import,BP,CHP1
15348,GO:0071548,0.402633683225806,0.808301178831668,3,32,response to dexamethasone,BP,EDN1;SRD5A1;CFLAR
3301,GO:0007000,0.402714312946814,0.916801852973512,1,7,nucleolus organization,BP,RRN3
11000,GO:0044788,0.403012676148449,0.846457095164278,2,19,modulation by host of viral process,BP,NUCKS1;HSPA8
7829,GO:0032377,0.403182189596797,0.916587398554052,1,7,regulation of intracellular lipid transport,BP,ARV1
7832,GO:0032380,0.403182189596797,0.916587398554052,1,7,regulation of intracellular sterol transport,BP,ARV1
7835,GO:0032383,0.403182189596797,0.916587398554052,1,7,regulation of intracellular cholesterol transport,BP,ARV1
9916,GO:0042228,0.403208432323739,0.916575360007435,1,7,interleukin-8 biosynthetic process,BP,TNF
12094,GO:0048027,0.403936961777192,0.844539365495821,2,22,mRNA 5'-UTR binding,MF,DDX3X;NCL
12124,GO:0048148,0.403988643999958,0.916216960561639,1,7,behavioral response to cocaine,BP,SDK1
4318,GO:0009798,0.404025059236988,0.765330250419398,5,54,axis specification,BP,SFRP1;KDM6A;SRF;IRX4;CITED2
7940,GO:0032511,0.404084557095954,0.914681182092944,1,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,VPS36
7319,GO:0031323,0.404487181065377,0.623264364189914,340,4613,regulation of cellular metabolic process,BP,CRYAB;IGFBP3;MAFB;SAA1;NRG1;HDAC9;TRIM16;FN1;PML;CYP1B1;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;EPGN;TRIM22;CBX5;CTGF;MMP9;FBN1;RUNX1;CLN6;IL1R2;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;PANK2;EDN1;GBP1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;GEMIN5;NQO1;PABPC4;STAG1;CHP1;ACO1;AKAP8;TGFB2;IRX2;ZNF208;RBM22;CYLD;PKMYT1;TGS1;PDLIM1;IL27RA;IL16;SRSF2;FOXD2;PPP1R3B;IL6ST;HNRNPF;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;SYK;EMP2;NUP153;NAIP;ZFP42;RELB;NBN;LEPR;PARP15;BRIP1;SHQ1;UTP15;CDK4;SFRP1;RIPK4;NUCKS1;HEATR1;TARDBP;MIR17HG;POLQ;H3F3A;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;GLIS3;HELLS;TAF2;ULK4;POLA1;DRAM1;SETDB1;ZNF584;TRAF1;OPHN1;ADM;CD109;ZNF407;ELMSAN1;NDC1;EIF5;CASC3;CCL20;PLK2;RRAGB;ZNF512;ZNF587;UBQLN2;FRK;DNTTIP2;RFC3;AKAP8L;MYBL2;HSPB1;RHOG;WNT4;NOP2;SUV39H2;THOC1;RAN;UBTF;RANBP2;SOD2;SUPT16H;CORO1C;ZNF738;DDX3X;NUFIP1;IL24;RRN3;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;TAF1D;ODC1;AJUBA;FASTKD3;DND1;ZNF267;ZC3H7B;SNX5;TRIM37;PPP4R4;GNL3L;ZNF586;NVL;GADD45B;SH3RF2;CDH13;COMMD4;PHACTR4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;BRCC3;FZD1;IRX4;NFE2L1;ANTXR1;CLU;NUP160;SMYD2;MACC1;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;EYA3;VGLL3;ACKR3;RIF1;METTL16;SETD2;GLIS2;UBP1;TTF2;GLIPR2;ZNF484;APEX1;PDCL3;ZNF57;TET3;ORC1;MYBL1;HSPA8;HSP90AB1;ARL6IP5;EPHB6;BACE2;ZBTB24;NSF;NEDD4L;SGK1;ZBTB12;BRCA2;SYNCRIP;TRAK2;DGCR8;SS18L2;CCAR1;MAZ;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;ETV6;ZNFX1;HSF2;POLR2F;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;WDR75;ADAM17;SENP1;RBMS3;ATR;PSME2;MSH6;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;NOL11;BAZ2B;NFKBIE;HNRNPDL;ESF1;ZNF608;TAF6L;DPH2;NCBP1;MYNN;UPF3B;VPS36;TRAF2;MSH3;TELO2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;TIMELESS;ORC2;CSF1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;KIF14;PURB;TLR3;AZIN1;ESR1;PARD3;RNF19B;TNF;ATAD5;ZFP36L2;SRSF7;RC3H1;TYMS;CCL5;ARGLU1;CD74;HNRNPU;RING1;FGFR1OP;PSMB10;DAXX;ZSCAN31;PHF14;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;PSPC1;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;USP1;ZNF471;IRF1;CTCF;RBM8A;GTF2H3;ZBTB9;IRAK3;IFI27L1
12167,GO:0048259,0.404604367861585,0.764605786707071,5,56,regulation of receptor-mediated endocytosis,BP,SYK;UBQLN2;CLU;SYT11;MTMR2
13865,GO:0060445,0.405252375298891,0.846120882855846,2,17,branching involved in salivary gland morphogenesis,BP,FGFR2;TNF
3400,GO:0007182,0.405255809657012,0.917647891830101,1,6,common-partner SMAD protein phosphorylation,BP,PML
6996,GO:0030670,0.405289494306571,0.76339375542009,5,62,phagocytic vesicle membrane,CC,HLA-B;TAP1;RAB32;HLA-F;TAP2
6507,GO:0021873,0.405366955037675,0.917597653125808,1,6,forebrain neuroblast division,BP,FGFR2
16210,GO:0090218,0.405452653937013,0.845381342180003,2,18,positive regulation of lipid kinase activity,BP,IRS1;PDGFB
4934,GO:0014889,0.405456130281924,0.91554029754883,1,7,muscle atrophy,BP,CFLAR
7564,GO:0031901,0.405503935332582,0.723796382957459,9,108,early endosome membrane,CC,PML;HLA-B;HLA-F;SNX5;KREMEN2;MTMR2;TMEM165;STEAP4;EHD1
11360,GO:0045669,0.405730109373771,0.781650993761158,4,42,positive regulation of osteoblast differentiation,BP,CYR61;IL6ST;WNT4;NPNT
4829,GO:0014031,0.405829494928075,0.76360192335927,5,56,mesenchymal cell development,BP,NRG1;EDN1;KBTBD8;CORO1C;PHACTR4
17017,GO:0099078,0.406008998655953,0.913778590368081,1,8,BORC complex,CC,BLOC1S2
2960,GO:0006493,0.406422153546697,0.730511218654213,8,91,protein O-linked glycosylation,BP,SPON1;GALNT18;MUC16;LFNG;TET3;TRAK2;MUC5B;MUC6
2615,GO:0005923,0.406705399701387,0.730393250885643,8,89,bicellular tight junction,CC,AMOT;TJP2;CDK4;PARD3B;CGNL1;TJP1;MPP5;PARD3
3254,GO:0006919,0.406947096581279,0.748553627881734,6,77,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PML;SENP1;CFLAR;TRAF2;TNF;IFI27L1
6559,GO:0021988,0.407313569699684,0.844757872665138,2,17,olfactory lobe development,BP,SRF;KIF14
5719,GO:0016853,0.407390285270075,0.721592487987933,9,121,isomerase activity,MF,PTGES;HMGCS1;DKC1;LSS;PUS3;RANBP2;TRUB2;FKBP5;EBP
5125,GO:0015491,0.407399860542749,0.84408922304875,2,18,cation:cation antiporter activity,MF,SLC22A5;SLC9A9
11376,GO:0045721,0.407566659320796,0.914561266355121,1,7,negative regulation of gluconeogenesis,BP,LEPR
6859,GO:0030323,0.407701807061008,0.715902074098224,10,115,respiratory tube development,BP,TNS3;FGFR2;CTGF;PDPN;MIR17HG;SRF;TNC;TIMELESS;TNF;PHF14
15254,GO:0071394,0.407854500374865,0.914427205523988,1,7,cellular response to testosterone stimulus,BP,SRD5A1
1474,GO:0003727,0.408061256330518,0.748082033631406,6,71,single-stranded RNA binding,MF,PABPC4;HNRNPF;DDX3X;SYNCRIP;RBMS3;HNRNPU
4082,GO:0009135,0.408204455315603,0.7287811052358,8,94,purine nucleoside diphosphate metabolic process,BP,NUP50;TJP2;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
4121,GO:0009179,0.408204455315603,0.7287811052358,8,94,purine ribonucleoside diphosphate metabolic process,BP,NUP50;TJP2;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
14845,GO:0070569,0.408227284521817,0.914253390781722,1,7,uridylyltransferase activity,MF,UAP1L1
10340,GO:0043123,0.408275851577806,0.709518065040918,11,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,MAP3K14;TRIM22;IKBKE;PLK2;ATP2C1;AJUBA;BIRC3;CFLAR;TRAF2;TNF;CD74
6752,GO:0030169,0.408400101478075,0.916219343984879,1,6,low-density lipoprotein particle binding,MF,CDH13
10830,GO:0044309,0.408513611193512,0.721350084783949,9,104,neuron spine,CC,CRYAB;DOCK10;SHISA9;ATP2B1;OPHN1;BAIAP2;SYT11;MTMR2;GPER1
12319,GO:0048642,0.408643849789129,0.914058906076672,1,7,negative regulation of skeletal muscle tissue development,BP,TSC22D3
14504,GO:0061900,0.40867339929201,0.843855322611605,2,17,glial cell activation,BP,CLU;TLR3
13191,GO:0051770,0.408704266249495,0.914030676532981,1,7,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
450,GO:0001223,0.408857003284754,0.843733257170942,2,17,transcription coactivator binding,MF,AHR;ESR1
9082,GO:0035325,0.408943170074444,0.912391212819641,1,8,Toll-like receptor binding,MF,SYK
1324,GO:0003170,0.409006010554039,0.804725447649295,3,28,heart valve development,BP,CYR61;TGFB2;ADAMTS9
15700,GO:0072207,0.409130246633973,0.843551507204056,2,17,metanephric epithelium development,BP,FAT4;WNT4
14227,GO:0061136,0.409142005394302,0.704041836595542,12,154,regulation of proteasomal protein catabolic process,BP,GCLC;KEAP1;OPHN1;PLK2;UBQLN2;CLU;HSP90AB1;SENP1;PSME2;RNF19B;TAF1;SMARCC1
17131,GO:0101002,0.40922732317616,0.7085156657531,11,146,ficolin-1-rich granule,CC,KRT1;FTH1;MMP9;LGALS3;MGAM;SIRPA;DDX3X;QPCT;COMMD9;HSPA8;HSP90AB1
9863,GO:0042101,0.409355464255272,0.913726042759961,1,7,T cell receptor complex,CC,SYK
8489,GO:0033629,0.409358753831178,0.913724502195284,1,7,negative regulation of cell adhesion mediated by integrin,BP,CYP1B1
11050,GO:0045008,0.409366514110631,0.912189919965144,1,8,depyrimidination,BP,SMUG1
18616,GO:1903845,0.409488355831949,0.760718780545723,5,55,negative regulation of cellular response to transforming growth factor beta stimulus,BP,FBN1;MIR17HG;CD109;ADAM17;CFLAR
9510,GO:0036149,0.409528736060423,0.913644873665925,1,7,phosphatidylinositol acyl-chain remodeling,BP,PLBD1
12911,GO:0051233,0.410123940154679,0.802970336639134,3,31,spindle midzone,CC,RIF1;KIF14;HNRNPU
14714,GO:0070325,0.410225169995429,0.84220474289891,2,18,lipoprotein particle receptor binding,MF,HSPG2;CLU
11670,GO:0046394,0.410404985976349,0.674746990384889,22,287,carboxylic acid biosynthetic process,BP,PTGES;FADS3;CYP1A1;EDN1;SCD;ACSL3;NUP50;SYK;NUP153;DHFR;NDC1;SLC1A3;RANBP2;PGK1;HACD2;PDGFB;NUP160;NUP54;SEPHS2;SCD5;DPYD;CD74
8150,GO:0032869,0.410675445625658,0.698720132704474,13,158,cellular response to insulin stimulus,BP,HDAC9;GCLC;IRS1;CDK4;NUCKS1;SOCS1;BAIAP2;ENPP1;PIK3R3;ZNF106;SRD5A1;CFLAR;SMARCC1
3232,GO:0006887,0.410962108359109,0.649900362973409,45,602,exocytosis,BP,KRT1;FTL;FTH1;FN1;C3;S100P;MMP9;VMP1;B4GALT1;LGALS3;CHP1;TGFB2;PCDH7;SYK;VPS41;HRNR;PTPRB;ABCC4;MGAM;CD109;CADPS2;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;RAB26;ITGAV;QPCT;PDGFB;CHID1;CLU;COMMD9;HSPA8;SYT11;HSP90AB1;NSF;LAIR1;RAB3GAP1;SCFD2;LILRB3;GLIPR1;CCL5;NRAS
5055,GO:0015248,0.411095132039092,0.840578349443653,2,20,sterol transporter activity,MF,ABCG2;ARV1
9674,GO:0038024,0.411168616911671,0.777336678216502,4,42,cargo receptor activity,MF,TFRC;CXCL16;ENPP1;ACKR3
7870,GO:0032426,0.411176645142091,0.912870561911974,1,7,stereocilium tip,CC,SLC9A3R1
15305,GO:0071472,0.411193239391153,0.912862743035453,1,7,cellular response to salt stress,BP,AKR1B1
14973,GO:0070848,0.411409198689805,0.65540526853333,37,471,response to growth factor,BP,PML;GCLC;CYR61;FGFR2;CTGF;FBN1;FAT4;EDN1;TGFB2;HNRNPF;SFRP1;WNT10A;MIR17HG;CD109;HSPB1;WNT4;BAIAP2;NPNT;PDGFB;FZD1;SRD5A1;TNC;HSP90AB1;ZFYVE27;POLR2F;ADAM17;CFLAR;NCBP1;CITED2;NCL;CCNA2;PARD3;EHD1;ZFP36L2;CCL5;HNRNPM;ITGB1BP1
1484,GO:0003777,0.41158187185747,0.726654990781787,8,82,microtubule motor activity,MF,KIF23;MYO1B;DYNC2H1;DNHD1;DYNLL2;MYH11;MYO10;KIF14
3131,GO:0006720,0.411660320140704,0.744874637273402,6,73,isoprenoid metabolic process,BP,CYP1B1;HSPG2;CYP1A1;HMGCS1;SRD5A1;PDSS1
14682,GO:0070269,0.411815363554526,0.911019965370001,1,8,pyroptosis,BP,ARRDC1-AS1
649,GO:0001837,0.412015506419498,0.725459414953416,8,94,epithelial to mesenchymal transition,BP,FGFR2;DDX17;KBTBD8;PDPN;TGFB2;SFRP1;WNT4;GLIPR2
5794,GO:0017022,0.412073699623966,0.776258408531289,4,44,myosin binding,MF,SLC9A3R1;VEZT;TRPM7;TRAK2
8194,GO:0032926,0.412246542907252,0.912365562741153,1,7,negative regulation of activin receptor signaling pathway,BP,FST
636,GO:0001823,0.412636750300541,0.744779593311297,6,65,mesonephros development,BP,FGFR2;FAT4;PBX1;SFRP1;WNT4;NPNT
7599,GO:0031965,0.412833431528041,0.676536237506137,20,251,nuclear membrane,CC,DTX2;NUP50;NUP153;BRIP1;CDK4;TMEM97;NDC1;CASC3;RANBP2;RRP12;WDR3;UTP18;NUP54;LRPPRC;RIF1;DPY19L2P2;SENP1;CMTM3;DCTN5;PHLPP1
8358,GO:0033210,0.412954330220536,0.912030493160758,1,7,leptin-mediated signaling pathway,BP,LEPR
18104,GO:1902679,0.413020703878977,0.637099499776202,69,925,negative regulation of RNA biosynthetic process,BP,NRG1;HDAC9;PML;GCLC;FGFR2;TRIM22;CBX5;TSC22D3;FST;TFCP2L1;TP53;EDN1;CDKN2A;IRX2;SRSF2;RELB;PARP15;SFRP1;H3F3A;AHR;GLIS3;HELLS;SETDB1;ZNF587;FRK;WNT4;SUV39H2;SET;ARNTL;AJUBA;TRIM37;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;SMYD2;RIF1;GLIS2;UBP1;APEX1;HSPA8;NEDD4L;CCAR1;E2F8;CENPF;ETV6;ZNF12;ZNF608;CITED2;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;HNRNPU;RING1;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;IRF1;CTCF
18453,GO:1903507,0.413020703878977,0.637099499776202,69,925,negative regulation of nucleic acid-templated transcription,BP,NRG1;HDAC9;PML;GCLC;FGFR2;TRIM22;CBX5;TSC22D3;FST;TFCP2L1;TP53;EDN1;CDKN2A;IRX2;SRSF2;RELB;PARP15;SFRP1;H3F3A;AHR;GLIS3;HELLS;SETDB1;ZNF587;FRK;WNT4;SUV39H2;SET;ARNTL;AJUBA;TRIM37;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;SMYD2;RIF1;GLIS2;UBP1;APEX1;HSPA8;NEDD4L;CCAR1;E2F8;CENPF;ETV6;ZNF12;ZNF608;CITED2;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;HNRNPU;RING1;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;IRF1;CTCF
541,GO:0001659,0.413140101330707,0.839197396963038,2,20,temperature homeostasis,BP,TNF;FTO
12339,GO:0048675,0.413177455427615,0.724892882091476,8,87,axon extension,BP,NRG1;FN1;SRF;ZFYVE27;L1CAM;NTN1;SHTN1;WDR36
6464,GO:0021782,0.413295211708958,0.744021202606161,6,67,glial cell development,BP,CNTNAP1;CLU;EIF2B5;MPP5;PARD3;EIF2B1
2484,GO:0005721,0.413450791056246,0.840039215482493,2,18,pericentric heterochromatin,CC,CBX5;HELLS
14337,GO:0061469,0.413639228843421,0.911705508195267,1,7,regulation of type B pancreatic cell proliferation,BP,SFRP1
899,GO:0002275,0.413791060213653,0.662290764026296,28,382,myeloid cell activation involved in immune response,BP,KRT1;FTL;FTH1;C3;S100P;MMP9;B4GALT1;LGALS3;SYK;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;ITGAV;QPCT;COMMD9;HSPA8;HSP90AB1;LAIR1;LILRB3;GLIPR1;DNASE1;NRAS
8735,GO:0034375,0.413819233237372,0.91005551679051,1,8,high-density lipoprotein particle remodeling,BP,ABCA5
10874,GO:0044387,0.413990659660233,0.911538466905605,1,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,CORO1C
12881,GO:0051182,0.41420389079894,0.91143701938544,1,7,coenzyme transport,BP,SLC5A6
1712,GO:0004300,0.414237174168836,0.909853558365115,1,8,enoyl-CoA hydratase activity,MF,HADHB
9205,GO:0035581,0.41429449254606,0.913500339576804,1,6,sequestering of extracellular ligand from receptor,BP,FBN1
10903,GO:0044437,0.414320680604486,0.655224393114094,34,452,vacuolar part,CC,FTL;C3;VMP1;HSPG2;B4GALT1;VPS41;HLA-DOB;HRNR;AP5M1;DRAM1;RRAGB;SLCO4C1;FRK;CHID1;ENPP1;SPNS1;THBD;SLC11A2;BLOC1S2;HSPA8;TMEM199;HSP90AB1;NSF;MFSD12;M6PR;TMEM138;MTMR2;TMEM165;ABCA5;IFI30;AP3B1;GLIPR1;TLR3;CD74
12112,GO:0048087,0.414383006969304,0.91135174705371,1,7,positive regulation of developmental pigmentation,BP,ADAMTS9
10313,GO:0043067,0.414410548163899,0.632016853481394,82,1113,regulation of programmed cell death,BP,CRYAB;IGFBP3;NEFL;PML;CYP1B1;MAP3K14;GCLC;CYR61;FGFR2;CTGF;MMP9;B4GALT1;G6PD;TSC22D3;TRAF3;TP53;DAPK3;EDN1;CDKN2A;NQO1;LGALS3;PDPN;TGFB2;CYLD;IFIT3;IL6ST;BAG1;SLC9A3R1;INHBA;NAIP;TRIO;SHQ1;CDK4;SFRP1;CD274;TARDBP;MIR17HG;NAA15;TRAF1;ADM;DYNLL2;PLK2;MYBL2;HSPB1;WNT4;SOD2;DDX3X;RRN3;ITGAV;SET;GADD45B;MDM4;CLU;BIRC3;EYA3;ACKR3;APEX1;HSP90AB1;ARL6IP5;EPHB6;SGK1;SERPINB9;GPER1;FAF1;ADAM17;SENP1;CFLAR;EIF2B5;AKR1B1;TRAF2;CITED2;NAA16;KIF14;TLR3;ESR1;TNF;CCL5;CD74;PHLPP1;CDKN1A;GPX4;IFI27L1
16543,GO:0097237,0.414727910622497,0.698787302803007,12,162,cellular response to toxic substance,BP,CYP1B1;TXNRD1;TP53;NQO1;DHFR;SOD2;PDGFB;APEX1;TIMELESS;TNF;DAXX;GPX4
11410,GO:0045778,0.414924955373361,0.756225610761582,5,55,positive regulation of ossification,BP,CYR61;TGFB2;IL6ST;WNT4;NPNT
10825,GO:0044304,0.414958348013947,0.774708002600006,4,40,main axon,CC,NRG1;CNTNAP1;CNTNAP2;PARD3
8353,GO:0033198,0.415025621320963,0.838418392652393,2,19,response to ATP,BP,PANX1;TAF1
19511,GO:1990234,0.415212093261893,0.641387694027761,53,711,transferase complex,CC,HDAC9;CBX5;MAT2A;ENC1;IRS1;TP53;KBTBD8;CDK4;KEAP1;NAA15;POLR1A;METTL1;TAF2;POLA1;KDM6A;ANAPC15;KLHL21;TRIM37;MCM3;BRCC3;UTY;NAA50;PIK3R3;KANSL1L;KLHL9;HSPA8;PRIM2;ANAPC7;POLR2F;RAD18;UBAP2L;TRMT61A;CBLL1;TAF6L;SPSB1;POLR1E;UBE2J2;TRAF2;RBBP5;POLR3B;CCNA2;POLE3;NAA16;MPHOSPH8;RNF19B;WDR4;PDSS1;RING1;TAF1;TBPL1;CDKN1A;GTF2H3;TEX10
3186,GO:0006811,0.415284063201252,0.636306128176954,65,862,ion transport,BP,HEPHL1;FTL;FTH1;PML;JPH2;TFRC;SLC16A2;CTGF;MMP9;SLC7A2;G6PD;TSC22D3;SLC16A9;SLC7A5P2;EDN1;ACSL3;LGALS3;CHP1;SLC4A11;IL16;SLC30A6;SLC9A3R1;SLC22A5;SYK;SHISA9;LRRC8D;ATP2B1;SLC5A6;ABCC4;KCNS3;SLC1A3;SLCO4C1;ATP2C1;ITGAV;TRPM7;KCNQ5;CROT;NETO1;PDGFB;ENPP1;COMMD9;ABCC9;JPH1;NNT;THADA;SLC11A2;ARL6IP5;NSF;NEDD4L;SGK1;TMEM165;STEAP4;RAB3GAP1;GPER1;NFKBIE;SLC9A9;CLCC1;GJC1;KCNE4;STARD7;CCL5;SLC43A2;PANX1;SLC25A22;SLC41A2
12095,GO:0048029,0.415475864232562,0.773208740849543,4,46,monosaccharide binding,MF,G6PD;P3H2;P4HA2;M6PR
7687,GO:0032119,0.415498901515145,0.909242171152742,1,8,sequestering of zinc ion,BP,SLC30A6
983,GO:0002437,0.415587516971777,0.837086008603662,2,21,inflammatory response to antigenic stimulus,BP,C3;TNF
16489,GO:0097152,0.415668254572428,0.910738388599211,1,7,mesenchymal cell apoptotic process,BP,ETV6
7807,GO:0032351,0.415796953360611,0.910676825768731,1,7,negative regulation of hormone metabolic process,BP,WNT4
7809,GO:0032353,0.415796953360611,0.910676825768731,1,7,negative regulation of hormone biosynthetic process,BP,WNT4
11468,GO:0045906,0.416108994088586,0.912652490405133,1,6,negative regulation of vasoconstriction,BP,ADM
18516,GO:1903608,0.416320526719082,0.910426104973304,1,7,protein localization to cytoplasmic stress granule,BP,DDX3X
15590,GO:0072033,0.416540407455122,0.912450151765471,1,6,renal vesicle formation,BP,WNT4
5330,GO:0016053,0.416848305901086,0.668717176464387,22,288,organic acid biosynthetic process,BP,PTGES;FADS3;CYP1A1;EDN1;SCD;ACSL3;NUP50;SYK;NUP153;DHFR;NDC1;SLC1A3;RANBP2;PGK1;HACD2;PDGFB;NUP160;NUP54;SEPHS2;SCD5;DPYD;CD74
2857,GO:0006348,0.416993025334255,0.908514878336955,1,8,chromatin silencing at telomere,BP,RIF1
9183,GO:0035542,0.417063608336795,0.91006952336304,1,7,regulation of SNARE complex assembly,BP,VPS41
5789,GO:0017015,0.417101592140585,0.729925135907813,7,80,regulation of transforming growth factor beta receptor signaling pathway,BP,FBN1;MIR17HG;CD109;NPNT;HSP90AB1;ADAM17;CITED2
14920,GO:0070723,0.417118630594393,0.838190466580093,2,17,response to cholesterol,BP,HMGCS1;INHBA
8271,GO:0033045,0.417277864817211,0.740357281193884,6,70,regulation of sister chromatid segregation,BP,ANAPC15;FEN1;CDCA5;CENPF;HNRNPU;CTCF
160,GO:0000323,0.417294324729646,0.648064512727122,39,519,lytic vacuole,CC,FTL;FTH1;C3;HSPG2;B4GALT1;VPS41;HLA-DOB;HRNR;AP5M1;DRAM1;TMEM97;RRAGB;SLCO4C1;FRK;CHID1;USP6;ENPP1;SPNS1;IFNAR1;SLC11A2;BLOC1S2;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;MFSD12;M6PR;TMEM165;ABCA5;AKR1B1;VPS36;IFI30;AP3B1;GLIPR1;TLR3;RNF19B;PLBD1;CD74
2512,GO:0005764,0.417294324729646,0.648064512727122,39,519,lysosome,CC,FTL;FTH1;C3;HSPG2;B4GALT1;VPS41;HLA-DOB;HRNR;AP5M1;DRAM1;TMEM97;RRAGB;SLCO4C1;FRK;CHID1;USP6;ENPP1;SPNS1;IFNAR1;SLC11A2;BLOC1S2;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;MFSD12;M6PR;TMEM165;ABCA5;AKR1B1;VPS36;IFI30;AP3B1;GLIPR1;TLR3;RNF19B;PLBD1;CD74
16089,GO:0090030,0.417489009340402,0.909864992291052,1,7,regulation of steroid hormone biosynthetic process,BP,WNT4
3761,GO:0008305,0.417512405924452,0.837923819277191,2,17,integrin complex,CC,ITGAV;NPNT
16816,GO:0098636,0.417512405924452,0.837923819277191,2,17,protein complex involved in cell adhesion,CC,ITGAV;NPNT
10009,GO:0042415,0.417595745478276,0.909813628877635,1,7,norepinephrine metabolic process,BP,AKR1B1
5168,GO:0015711,0.417675016100615,0.669954967522379,21,266,organic anion transport,BP,SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;EDN1;ACSL3;SLC4A11;SLC9A3R1;SLC22A5;SYK;SLC5A6;ABCC4;SLC1A3;SLCO4C1;CROT;ARL6IP5;RAB3GAP1;NFKBIE;STARD7;SLC43A2;SLC25A22
4279,GO:0009642,0.417961975730168,0.909637254432629,1,7,response to light intensity,BP,HMGCS1
15436,GO:0071682,0.41797692981124,0.908033988770073,1,8,endocytic vesicle lumen,CC,SAA1
15383,GO:0071604,0.418008330526109,0.836953894212056,2,18,transforming growth factor beta production,BP,TGFB2;HSP90AB1
20018,GO:2000574,0.4180613612587,0.907992649894033,1,8,regulation of microtubule motor activity,BP,DYNLL2
10335,GO:0043116,0.418392240021139,0.909429769076373,1,7,negative regulation of vascular permeability,BP,ADM
4749,GO:0010917,0.418435894039619,0.907809134925689,1,8,negative regulation of mitochondrial membrane potential,BP,ARL6IP5
11438,GO:0045837,0.418435894039619,0.907809134925689,1,8,negative regulation of membrane potential,BP,ARL6IP5
16087,GO:0090026,0.418598672936736,0.907729305540961,1,8,positive regulation of monocyte chemotaxis,BP,CCL5
9806,GO:0040016,0.418671860080645,0.909294770589754,1,7,embryonic cleavage,BP,TPRA1
17447,GO:1900180,0.418691164381178,0.728258764203908,7,84,regulation of protein localization to nucleus,BP,CHP1;RBM22;POLR1A;NUP54;GLIS2;HSP90AB1;CDKN1A
11370,GO:0045713,0.418748727533819,0.90925763774201,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
5592,GO:0016614,0.418803340989187,0.727607541405444,7,93,oxidoreductase activity, acting on CH-OH group of donors,MF,G6PD;PGD;LDHAL6B;ABCC4;AKR1C2;HADHB;AKR1B1
13304,GO:0051973,0.419075029554421,0.795667090829683,3,33,positive regulation of telomerase activity,BP,DKC1;NVL;HSP90AB1
984,GO:0002438,0.419151987841986,0.907457632092347,1,8,acute inflammatory response to antigenic stimulus,BP,C3
10911,GO:0044447,0.419308422955864,0.837425738013857,2,16,axoneme part,CC,DNHD1;WDPCP
12733,GO:0050932,0.419405356733246,0.908940052005352,1,7,regulation of pigment cell differentiation,BP,ADAMTS9
8265,GO:0033036,0.419479668937358,0.615184557074523,167,2268,macromolecule localization,BP,SAA1;NRG1;TRIM16;FN1;PML;AMOT;TFRC;C3;TRIM22;FBN1;GNPTAB;TAP1;IL1R2;IRS1;VPS13B;MID1;TP53;EDN1;GBP1;C1QTNF1;ACSL3;PTPN14;CHP1;AKAP8;TGFB2;CNTNAP1;RBM22;CYLD;IKBKE;SRSF2;SLC9A3R1;DKC1;INHBA;NUP50;PHAX;SYK;EMP2;NUP153;RAB32;SHQ1;ABCG2;ARFRP1;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;VPS8;APOL6;KEAP1;RPA1;AP5M1;POLR1A;ABCC4;REEP1;ADAMTS9;KCNS3;PTGER4;LSG1;IMMP2L;NDC1;CADPS2;DYNLL2;HNRNPA1L2;CASC3;RRAGB;GBP5;AKAP8L;NOP58;HSPB1;RHOG;WNT4;LCP1;THOC1;RAN;RANBP2;CORO1C;DDX3X;RAB26;GPHN;KLHL21;ITGAV;SOCS1;ARNTL;SNX11;AJUBA;CROT;SNX5;CDCA5;GNL3L;BAIAP2;GDAP1;NPNT;UGT8;TBC1D15;RTKN2;CLU;NUP160;USP6;SDAD1;ENPP1;FRAS1;NUP54;LRPPRC;SPNS1;SETD2;GLIS2;ANLN;TIMM23B;RPF2;RIC3;CNTNAP2;HSPA8;SYT11;HSP90AB1;NSF;NEDD4L;M6PR;ZFYVE27;BRCA2;TRAK2;WDPCP;CENPF;GOSR1;RAB3GAP1;SCFD2;BBS5;GPER1;FAF1;WDR75;ATR;ABCA5;NFKBIE;RABEP2;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;TAP2;AP3B1;CLOCK;KIF14;MPP5;ESR1;PARD3;EHD1;ARV1;TNF;SRSF7;STARD7;CCL5;CD74;HNRNPU;PANX1;TRAM2;ZNHIT6;FTO;ABCA11P;CDKN1A;ITGB1BP1;CTCF;ASTN2;TSGA13;RBM8A;RPS12;BUD13
2276,GO:0005217,0.419527973561057,0.837276925085529,2,16,intracellular ligand-gated ion channel activity,MF,JPH2;JPH1
5066,GO:0015278,0.419527973561057,0.837276925085529,2,16,calcium-release channel activity,MF,JPH2;JPH1
17763,GO:1901673,0.419731533423671,0.835212579440097,2,19,regulation of mitotic spindle assembly,BP,STAG1;HNRNPU
4825,GO:0014020,0.41979098311954,0.727592665736309,7,80,primary neural tube formation,BP,TGFB2;SFRP1;ADM;KDM6A;PHACTR4;FZD1;SETD2
1124,GO:0002710,0.419884399650743,0.907097264588864,1,8,negative regulation of T cell mediated immunity,BP,IL7R
7786,GO:0032305,0.420177376858996,0.906952869127536,1,8,positive regulation of icosanoid secretion,BP,EDN1
19809,GO:2000193,0.420177376858996,0.906952869127536,1,8,positive regulation of fatty acid transport,BP,EDN1
806,GO:0002072,0.420237133005259,0.910704396313699,1,6,optic cup morphogenesis involved in camera-type eye development,BP,PHACTR4
6934,GO:0030522,0.420455161735135,0.674035592443029,18,225,intracellular receptor signaling pathway,BP,TRIM16;PML;CYP24A1;RUNX1;DDX17;CYLD;SFRP1;AHR;RAN;ARNTL;BIRC3;GPER1;CITED2;CLOCK;ESR1;DAXX;TAF1;PPARGC1B
11879,GO:0046854,0.420545301307148,0.737951074023507,6,66,phosphatidylinositol phosphorylation,BP,NRG1;FGFR2;IRS1;PDGFB;PIK3R3;ESR1
11266,GO:0045472,0.420625609912461,0.908348036668512,1,7,response to ether,BP,CDK4
17509,GO:1900408,0.420799765861645,0.794106736596963,3,34,negative regulation of cellular response to oxidative stress,BP,HSPB1;SOD2;FZD1
18322,GO:1903202,0.420799765861645,0.794106736596963,3,34,negative regulation of oxidative stress-induced cell death,BP,HSPB1;SOD2;FZD1
7033,GO:0030801,0.420841855620084,0.833942146323299,2,20,positive regulation of cyclic nucleotide metabolic process,BP,ADM;GPER1
16233,GO:0090257,0.421069272396728,0.703759953215901,10,120,regulation of muscle system process,BP,CTGF;G6PD;DAPK3;EDN1;IL6ST;MIR17HG;TPM1;SRF;NPNT;GPER1
11851,GO:0046784,0.421210795224198,0.906442435956696,1,8,viral mRNA export from host cell nucleus,BP,THOC1
11504,GO:0045953,0.421381766908974,0.906357821939793,1,8,negative regulation of natural killer cell mediated cytotoxicity,BP,SERPINB9
4438,GO:0010288,0.421557592366655,0.83344939252869,2,20,response to lead ion,BP,CDK4;QDPR
12399,GO:0048791,0.421580998554766,0.834514250749294,2,18,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT11;RAB3GAP1
6687,GO:0030049,0.421588027176615,0.836706828848469,2,15,muscle filament sliding,BP,TPM1;TPM4
8384,GO:0033275,0.421588027176615,0.836706828848469,2,15,actin-myosin filament sliding,BP,TPM1;TPM4
6804,GO:0030241,0.4216457097671,0.942691648263782,1,2,skeletal muscle myosin thick filament assembly,BP,MYH11
16296,GO:0090344,0.42177443147608,0.833810884145826,2,19,negative regulation of cell aging,BP,PLK2;RBL1
5857,GO:0017151,0.421815549423808,0.90776843595934,1,7,DEAD/H-box RNA helicase binding,MF,AKAP8L
18593,GO:1903793,0.421908802546486,0.832747085673055,2,21,positive regulation of anion transport,BP,EDN1;RAB3GAP1
1329,GO:0003177,0.421975701621784,0.909875944534641,1,6,pulmonary valve development,BP,TGFB2
1334,GO:0003184,0.421975701621784,0.909875944534641,1,6,pulmonary valve morphogenesis,BP,TGFB2
2549,GO:0005816,0.422331222760351,0.907516555299916,1,7,spindle pole body,CC,NDC1
4751,GO:0010919,0.422447970327547,0.9074594707424,1,7,regulation of inositol phosphate biosynthetic process,BP,GPER1
16620,GO:0097428,0.422450226886191,0.903563351003507,1,10,protein maturation by iron-sulfur cluster transfer,BP,HSCB
16803,GO:0098597,0.422488113108922,0.912730835698688,1,5,observational learning,BP,CNTNAP2
9102,GO:0035358,0.422531922187955,0.907418408373551,1,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,CITED2
4063,GO:0009111,0.422550453883147,0.905778170228992,1,8,vitamin catabolic process,BP,CYP24A1
11483,GO:0045923,0.422587609664464,0.833823521596897,2,18,positive regulation of fatty acid metabolic process,BP,IRS1;PPARGC1B
10256,GO:0042981,0.422661489521172,0.624265737006682,81,1101,regulation of apoptotic process,BP,CRYAB;IGFBP3;NEFL;PML;CYP1B1;MAP3K14;GCLC;CYR61;FGFR2;CTGF;MMP9;B4GALT1;G6PD;TSC22D3;TRAF3;TP53;DAPK3;EDN1;CDKN2A;NQO1;LGALS3;PDPN;TGFB2;CYLD;IFIT3;IL6ST;BAG1;SLC9A3R1;INHBA;NAIP;TRIO;SHQ1;CDK4;SFRP1;CD274;TARDBP;MIR17HG;NAA15;TRAF1;ADM;DYNLL2;PLK2;MYBL2;HSPB1;WNT4;SOD2;DDX3X;RRN3;ITGAV;SET;GADD45B;MDM4;CLU;BIRC3;EYA3;ACKR3;APEX1;HSP90AB1;ARL6IP5;EPHB6;SGK1;SERPINB9;GPER1;FAF1;ADAM17;SENP1;CFLAR;EIF2B5;AKR1B1;TRAF2;CITED2;NAA16;KIF14;TLR3;ESR1;TNF;CCL5;CD74;PHLPP1;CDKN1A;IFI27L1
6065,GO:0019210,0.422804670065204,0.735374199267615,6,73,kinase inhibitor activity,MF,CDKN2A;CHP1;HSPB1;SOCS1;FGFR1OP;CDKN1A
12865,GO:0051156,0.422910544895547,0.832054153143081,2,21,glucose 6-phosphate metabolic process,BP,G6PD;PGD
11632,GO:0046320,0.423065111329496,0.834139817423873,2,17,regulation of fatty acid oxidation,BP,IRS1;PPARGC1B
1478,GO:0003743,0.423234191231965,0.766497777921381,4,49,translation initiation factor activity,MF,EIF5;EIF3J;EIF2B5;EIF2B1
2708,GO:0006073,0.423663961124545,0.748937753484163,5,55,cellular glucan metabolic process,BP,IRS1;PPP1R3B;IL6ST;MGAM;ENPP1
10730,GO:0044042,0.423663961124545,0.748937753484163,5,55,glucan metabolic process,BP,IRS1;PPP1R3B;IL6ST;MGAM;ENPP1
1349,GO:0003209,0.423876977602441,0.833582797263705,2,17,cardiac atrium morphogenesis,BP,CYR61;TGFB2
3256,GO:0006924,0.424117369199087,0.904997525632594,1,8,activation-induced cell death of T cells,BP,TSC22D3
3028,GO:0006575,0.424183763560219,0.70043501971935,10,134,cellular modified amino acid metabolic process,BP,PTGES;GCLC;STAT5A;G6PD;PANK2;SLC5A6;DHFR;GDAP1;MBOAT1;TYMS
5050,GO:0015232,0.424224300382905,0.90658822112328,1,7,heme transporter activity,MF,ABCG2
5259,GO:0015886,0.424224300382905,0.90658822112328,1,7,heme transport,BP,ABCG2
11916,GO:0046928,0.424309718320479,0.792185158892586,3,31,regulation of neurotransmitter secretion,BP,SYT11;RAB3GAP1;GPER1
11083,GO:0045069,0.424431121407654,0.7338163026415,6,75,regulation of viral genome replication,BP,FAM111A;NUCKS1;DDX3X;HSPA8;TNF;CCL5
19901,GO:2000345,0.424603071077284,0.906401786180645,1,7,regulation of hepatocyte proliferation,BP,CFLAR
8032,GO:0032663,0.424626742171054,0.791664409330072,3,32,regulation of interleukin-2 production,BP,RUNX1;GBP1;TRAF2
4387,GO:0010038,0.424836111199951,0.672438900830295,17,219,response to metal ion,BP,PTGES;GCLC;MMP9;CYP1A1;G6PD;TP53;EDN1;NQO1;ACO1;SLC30A6;CDK4;GPHN;QDPR;SLC11A2;NEDD4L;EIF2B5;DAXX
12297,GO:0048593,0.424929524636745,0.734195632279449,6,66,camera-type eye morphogenesis,BP,TENM3;MEGF11;PTPRM;PHACTR4;SDK1;RING1
10023,GO:0042440,0.424979256604122,0.765219959338323,4,48,pigment metabolic process,BP,IBA57;NFE2L1;SLC11A2;UGT1A4
3285,GO:0006975,0.425081894642644,0.906165773334528,1,7,DNA damage induced protein phosphorylation,BP,CHEK1
290,GO:0000794,0.425345232469209,0.733838564988073,6,66,condensed nuclear chromosome,CC,RAD1;TOPBP1;LRPPRC;BRCA2;CHEK1;NIFK
73,GO:0000150,0.425349253082599,0.904380990989352,1,8,recombinase activity,MF,RAD51B
9046,GO:0035254,0.425360849287328,0.791672637943691,3,30,glutamate receptor binding,MF,OPHN1;NETO1;NSF
5420,GO:0016264,0.4254958100305,0.905961455855319,1,7,gap junction assembly,BP,GJC1
8981,GO:0035064,0.425576421608517,0.74720329505162,5,56,methylated histone binding,MF,CBX5;MSH6;RBBP5;MPHOSPH8;TAF1
17306,GO:0140034,0.425576421608517,0.74720329505162,5,56,methylation-dependent protein binding,MF,CBX5;MSH6;RBBP5;MPHOSPH8;TAF1
10130,GO:0042641,0.425582336605328,0.747460992104303,5,54,actomyosin,CC,SIPA1L3;TPM1;LCP1;TPM4;SYNPO2
15727,GO:0072257,0.425757465755693,0.90805737938945,1,6,metanephric nephron tubule epithelial cell differentiation,BP,FAT4
15751,GO:0072307,0.425757465755693,0.90805737938945,1,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,FAT4
2579,GO:0005868,0.426111910714673,0.83029643457656,2,20,cytoplasmic dynein complex,CC,DYNC2H1;DYNLL2
13783,GO:0060339,0.426113087071514,0.905656240961936,1,7,negative regulation of type I interferon-mediated signaling pathway,BP,NLRC5
7355,GO:0031390,0.426182446151211,0.903962590787601,1,8,Ctf18 RFC-like complex,CC,RFC3
2702,GO:0006066,0.42622876222893,0.668514562156799,18,234,alcohol metabolic process,BP,CYP1B1;CLN6;G6PD;SCD;HMGCS1;LEPR;LSS;DHFR;RAN;QDPR;NFE2L1;PPIP5K1;MTMR2;GPER1;EBP;AKR1B1;ARV1;TNF
10652,GO:0043652,0.426303563901758,0.903901675361581,1,8,engulfment of apoptotic cell,BP,RHOG
12731,GO:0050930,0.426489738033916,0.903807993469572,1,8,induction of positive chemotaxis,BP,IL16
7026,GO:0030742,0.426526772986495,0.8300077184172,2,20,GTP-dependent protein binding,MF,RAB32;AP3B1
2220,GO:0005114,0.426650585601269,0.905389971318998,1,7,type II transforming growth factor beta receptor binding,MF,TGFB2
9848,GO:0042074,0.426744522097328,0.907578988941407,1,6,cell migration involved in gastrulation,BP,AMOT
16914,GO:0098839,0.426870192512867,0.905281046512459,1,7,postsynaptic density membrane,CC,NETO1
17119,GO:0099634,0.426870192512867,0.905281046512459,1,7,postsynaptic specialization membrane,CC,NETO1
19765,GO:2000104,0.426916003588301,0.830256161943294,2,19,negative regulation of DNA-dependent DNA replication,BP,BRCA2;TIMELESS
14901,GO:0070673,0.427105831183644,0.903497574392764,1,8,response to interleukin-18,BP,PDGFB
11232,GO:0045351,0.427209120678542,0.903445471104785,1,8,type I interferon biosynthetic process,BP,TLR3
2260,GO:0005172,0.427222423768542,0.903438759227989,1,8,vascular endothelial growth factor receptor binding,MF,PDCL3
10555,GO:0043495,0.427293248035211,0.90507099133828,1,7,protein membrane anchor,MF,NUP153
249,GO:0000707,0.427298800247521,0.903400219031899,1,8,meiotic DNA recombinase assembly,BP,RAD51B
4127,GO:0009185,0.427317856741173,0.711876828355075,8,96,ribonucleoside diphosphate metabolic process,BP,NUP50;TJP2;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
2434,GO:0005622,0.42736352939723,0.613874200185699,757,10528,intracellular,CC,IL32;CRYAB;IGFBP3;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TRIM16L;TNS3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;RUNX1;MYO1B;CYP1A1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TSC22D3;MAT2A;DDX17;SPON1;FAM69B;TRIM56;TFCP2L1;KRTAP2-3;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;MID1;TP53;DAPK3;TUFT1;SVEP1;PANK2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;ABCF1;DUSP14;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;LGALS3;CHP1;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL16;IFIT3;SRSF2;FOXD2;PCDH7;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;HNRNPF;BAG1;SLC9A3R1;PDCD11;C15ORF39;NUAK1;DKC1;INHBA;IL7R;NUP50;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;NBN;TRIO;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;POP1;HLA-DOB;RIPK4;GPCPD1;NUCKS1;PITHD1;HEATR1;ZDHHC6;MCM2;TARDBP;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;APOL6;COA7;KEAP1;NAA15;UAP1L1;TRA2A;TCHH;ZNF827;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;PTGER4;TK1;TMEM97;LSG1;G3BP1;GRWD1;ARRDC1-AS1;ZNF584;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;CDV3;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;KANK4;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;NOP2;DOHH;SUV39H2;LCP1;EXOG;PTPRM;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARHGEF28;ARMC5;GPHN;KLHL21;RRN3;RNF115;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;ABCF2;SNX11;AJUBA;SMC2;ARMC6;FASTKD3;KCNQ5;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;KRT24;LFNG;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;PPP4R4;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;ODF2L;KREMEN2;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;ZNF316;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;MCM6;FGD6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;ABCC9;TRMT5;TTF2;DTX4;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;SEPHS2;NNT;IFNAR1;WEE1;TJP1;ZNF484;THADA;NOL12;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;HPS5;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;DGCR8;DPYD;SS18L2;KRT10;CCAR1;SKA2;PPIP5K1;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;ZNFX1;STEAP4;FKBP5;IQCJ-SCHIP1;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;SRFBP1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;ANKRD13A;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;TAF6L;MRPS7;DPH2;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;MSH3;TELO2;EDRF1;RBBP5;FAM208B;CITED2;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;MPP5;AZIN1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;DCTN5;METAP2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;FTO;CCDC50;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
7493,GO:0031652,0.427506982474356,0.903295120085834,1,8,positive regulation of heat generation,BP,TNF
3045,GO:0006600,0.42751573789337,0.903290698432088,1,8,creatine metabolic process,BP,STAT5A
2483,GO:0005720,0.427887751518683,0.788883515093796,3,33,nuclear heterochromatin,CC,CBX5;MPHOSPH8;RING1
17580,GO:1901099,0.428231367833686,0.827923806775134,2,22,negative regulation of signal transduction in absence of ligand,BP,EYA3;TNF
20306,GO:2001240,0.428231367833686,0.827923806775134,2,22,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA3;TNF
8704,GO:0034331,0.428264835875989,0.904587481481265,1,7,cell junction maintenance,BP,PLEKHA7
13912,GO:0060534,0.428479681358748,0.904480357068169,1,7,trachea cartilage development,BP,SRF
7993,GO:0032604,0.428545994108701,0.902769522408372,1,8,granulocyte macrophage colony-stimulating factor production,BP,SYK
8019,GO:0032645,0.428545994108701,0.902769522408372,1,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,SYK
5765,GO:0016926,0.428629176308165,0.904405772955434,1,7,protein desumoylation,BP,SENP1
10393,GO:0043204,0.42893883872936,0.744124709616976,5,58,perikaryon,CC,CRYAB;NAIP;CNTNAP2;SHTN1;ASTN2
1456,GO:0003689,0.428994464424193,0.90254211058411,1,8,DNA clamp loader activity,MF,RFC3
8335,GO:0033170,0.428994464424193,0.90254211058411,1,8,protein-DNA loading ATPase activity,MF,RFC3
5599,GO:0016627,0.429080432971084,0.761724828368656,4,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,AKR1C2;SRD5A1;DPYD;SDHD
4745,GO:0010911,0.429125908846638,0.90415768874815,1,7,regulation of isomerase activity,BP,HNRNPU
4746,GO:0010912,0.429125908846638,0.90415768874815,1,7,positive regulation of isomerase activity,BP,HNRNPU
8263,GO:0033033,0.429192486959847,0.90244159152427,1,8,negative regulation of myeloid cell apoptotic process,BP,CCL5
12861,GO:0051152,0.429678461584539,0.902194630700793,1,8,positive regulation of smooth muscle cell differentiation,BP,GPER1
360,GO:0000978,0.429688506043089,0.654981818270578,23,290,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MAFB;FOSL2;PBX1;TP53;ZBED1;ZFP42;AHR;MYBL2;KDM6A;ARNTL;SRF;UTY;MYBL1;E2F8;ETV6;HSF2;CLOCK;ESR1;TBPL1;SMARCC1;ARID3B;IRF1;CTCF
4909,GO:0014841,0.429698004430392,0.903871468718209,1,7,skeletal muscle satellite cell proliferation,BP,CFLAR
4910,GO:0014842,0.429698004430392,0.903871468718209,1,7,regulation of skeletal muscle satellite cell proliferation,BP,CFLAR
4920,GO:0014856,0.429698004430392,0.903871468718209,1,7,skeletal muscle cell proliferation,BP,CFLAR
4921,GO:0014857,0.429698004430392,0.903871468718209,1,7,regulation of skeletal muscle cell proliferation,BP,CFLAR
8716,GO:0034350,0.429757001237396,0.903841922259961,1,7,regulation of glial cell apoptotic process,BP,TRAF2
8717,GO:0034351,0.429757001237396,0.903841922259961,1,7,negative regulation of glial cell apoptotic process,BP,TRAF2
5513,GO:0016461,0.430005258117166,0.903717529519046,1,7,unconventional myosin complex,CC,DYNLL2
6943,GO:0030546,0.430075440299659,0.903682345510568,1,7,receptor activator activity,MF,NRG1
11344,GO:0045653,0.430251287526429,0.895734363240153,1,17,negative regulation of megakaryocyte differentiation,BP,HIST1H4A
15414,GO:0071649,0.430280037549809,0.903579730223922,1,7,regulation of chemokine (C-C motif) ligand 5 production,BP,DDX3X
16819,GO:0098642,0.430352241997283,0.905817221455046,1,6,network-forming collagen trimer,CC,COL4A1
16822,GO:0098645,0.430352241997283,0.905817221455046,1,6,collagen network,CC,COL4A1
16826,GO:0098651,0.430352241997283,0.905817221455046,1,6,basement membrane collagen trimer,CC,COL4A1
3685,GO:0008190,0.430634592469176,0.903401742464568,1,7,eukaryotic initiation factor 4E binding,MF,DDX3X
14022,GO:0060717,0.430679106859232,0.903379381615488,1,7,chorion development,BP,E2F8
11310,GO:0045606,0.430701124161111,0.827088604508916,2,20,positive regulation of epidermal cell differentiation,BP,TRIM16;IL20
18563,GO:1903726,0.43071181922108,0.901668210990406,1,8,negative regulation of phospholipid metabolic process,BP,PDGFB
7234,GO:0031124,0.430730832694823,0.717474197910764,7,88,mRNA 3'-end processing,BP,SRSF2;CASC3;THOC1;NCBP1;UPF3B;SRSF7;RBM8A
12362,GO:0048709,0.430760148467242,0.742584040106375,5,58,oligodendrocyte differentiation,BP,NRG1;CNTNAP1;CLU;EIF2B5;EIF2B1
12864,GO:0051155,0.430816415664436,0.786607060297285,3,33,positive regulation of striated muscle cell differentiation,BP,NRG1;EDN1;EHD1
12860,GO:0051151,0.430816529076206,0.903310330105979,1,7,negative regulation of smooth muscle cell differentiation,BP,PDGFB
5105,GO:0015386,0.430926497744264,0.903255051177892,1,7,potassium:proton antiporter activity,MF,SLC9A9
6633,GO:0022890,0.431273062691747,0.657158996175064,21,269,inorganic cation transmembrane transporter activity,MF,JPH2;TFRC;SLC4A11;SLC30A6;ATP2B1;SLC5A6;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;NNT;SLC11A2;SLC9A9;KCNE4;PANX1;SLC25A22;SLC41A2
982,GO:0002433,0.431390801689859,0.742049742565879,5,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,ACTG1;SYK;BAIAP2;HSP90AB1;MYO10
9708,GO:0038096,0.431390801689859,0.742049742565879,5,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,ACTG1;SYK;BAIAP2;HSP90AB1;MYO10
7906,GO:0032469,0.431672775135166,0.826405457514087,2,20,endoplasmic reticulum calcium ion homeostasis,BP,PML;THADA
7759,GO:0032270,0.431818825637716,0.615631759658895,80,1081,positive regulation of cellular protein metabolic process,BP,IGFBP3;SAA1;NRG1;FN1;PML;MAP3K14;GCLC;CYR61;C3;FGFR2;EPGN;CTGF;MMP9;CLN6;MID1;TP53;EDN1;C1QTNF1;CHP1;AKAP8;TGFB2;IL6ST;INHBA;SYK;EMP2;NBN;CDK4;USP16;KEAP1;CCL20;PLK2;UBQLN2;AKAP8L;DDX3X;IL24;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;FASTKD3;DND1;GADD45B;NPNT;PDGFB;FZD1;ANTXR1;CLU;BIRC3;IL20;ACKR3;RIF1;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;RAB3GAP1;GPER1;ADAM17;SENP1;RBMS3;PSME2;CFLAR;EIF2B5;UPF3B;TRAF2;TELO2;CSF1;KIF14;TLR3;ESR1;RNF19B;TNF;CCL5;CD74;DAXX;TAF1;CDKN1A;ITGB1BP1;IFI27L1
11522,GO:0045992,0.431924541885861,0.82675618941304,2,19,negative regulation of embryonic development,BP,LFNG;COL5A2
3809,GO:0008395,0.431940382624759,0.901040057755477,1,8,steroid hydroxylase activity,MF,CYP1A1
8614,GO:0034116,0.43211367062092,0.900951256633674,1,8,positive regulation of heterotypic cell-cell adhesion,BP,TNF
10450,GO:0043296,0.432184877012483,0.700354670022489,9,103,apical junction complex,CC,AMOT;TJP2;CDK4;PARD3B;CGNL1;TJP1;PLEKHA7;MPP5;PARD3
5633,GO:0016709,0.432298332917984,0.825964905578331,2,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,CYP1A1;AKR1C2
19775,GO:2000114,0.432308164630462,0.827077143108769,2,18,regulation of establishment of cell polarity,BP,WDPCP;SHTN1
18989,GO:1904724,0.432441183061753,0.784235164220011,3,38,tertiary granule lumen,CC,FTH1;MMP9;QPCT
7212,GO:0031098,0.43259638899294,0.662624082734181,18,230,stress-activated protein kinase signaling cascade,BP,CRYAB;MAP3K14;CTGF;MID1;EDN1;TGFB2;SYK;SFRP1;ULK4;PTGER4;GADD45B;ARL6IP5;AKR1B1;TRAF2;TLR3;TNF;DAXX;PHLPP1
3190,GO:0006816,0.432744873707501,0.665209918675336,17,211,calcium ion transport,BP,PML;JPH2;CTGF;G6PD;LGALS3;IL16;ATP2B1;ATP2C1;ITGAV;TRPM7;PDGFB;JPH1;THADA;TMEM165;GPER1;CCL5;PANX1
1438,GO:0003413,0.432773560239588,0.902323619377288,1,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,COL27A1
19847,GO:2000271,0.432810767442034,0.902304799283197,1,7,positive regulation of fibroblast apoptotic process,BP,SFRP1
18568,GO:1903749,0.432887252488251,0.715390645480833,7,91,positive regulation of establishment of protein localization to mitochondrion,BP,NRG1;TP53;DYNLL2;WDR75;UBE2J2;STARD7;TSGA13
685,GO:0001892,0.433190086339437,0.726675853228724,6,70,embryonic placenta development,BP,CYR61;FGFR2;ADM;PDGFB;SETD2;E2F8
13584,GO:0060027,0.433307835091445,0.902053155709197,1,7,convergent extension involved in gastrulation,BP,SFRP1
13305,GO:0051974,0.433320893946781,0.900331238918619,1,8,negative regulation of telomerase activity,BP,TP53
10010,GO:0042416,0.433426818304116,0.900276722082496,1,8,dopamine biosynthetic process,BP,TGFB2
2882,GO:0006384,0.433767810208959,0.901819929603819,1,7,transcription initiation from RNA polymerase III promoter,BP,GTF3C4
19032,GO:1904813,0.433775671420189,0.705466526952188,8,109,ficolin-1-rich granule lumen,CC,KRT1;FTH1;MMP9;DDX3X;QPCT;COMMD9;HSPA8;HSP90AB1
7584,GO:0031943,0.43384704505473,0.900060257820285,1,8,regulation of glucocorticoid metabolic process,BP,WNT4
9438,GO:0035999,0.434116555399195,0.899921275387569,1,8,tetrahydrofolate interconversion,BP,TYMS
3633,GO:0008097,0.434339694781257,0.897413091594012,1,10,5S rRNA binding,MF,RPF2
8218,GO:0032965,0.434463302360797,0.823956558892424,2,21,regulation of collagen biosynthetic process,BP,CTGF;WNT4
7216,GO:0031103,0.434503050133593,0.783991640166105,3,32,axon regeneration,BP,NEFL;DHFR;TNC
17999,GO:1902373,0.434523382562577,0.783975714172341,3,32,negative regulation of mRNA catabolic process,BP,TARDBP;SYNCRIP;HNRNPU
5727,GO:0016863,0.435190722731331,0.89696380447917,1,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,EBP
3357,GO:0007095,0.435323568187848,0.824359916105893,2,19,mitotic G2 DNA damage checkpoint,BP,NBN;TOPBP1
13104,GO:0051593,0.435539198737326,0.899185640614322,1,8,response to folic acid,BP,TYMS
9890,GO:0042148,0.435585398331376,0.899161694847947,1,8,strand invasion,BP,RAD51B
3542,GO:0007566,0.435738955271188,0.782270220769446,3,35,embryo implantation,BP,MMP9;VMP1;EMP2
6882,GO:0030371,0.435770246469914,0.82404374495817,2,19,translation repressor activity,MF,DHFR;TYMS
1462,GO:0003705,0.435793625341435,0.73842993459264,5,57,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,SRF;NFE2L1;VGLL3;SPIB;ARID3B
8424,GO:0033483,0.4358141251789,0.899043090830744,1,8,gas homeostasis,BP,SOD2
3714,GO:0008234,0.435946788539734,0.679754487579702,12,150,cysteine-type peptidase activity,MF,CYLD;SFRP1;USP16;RCE1;USP43;BRCC3;USP6;SENP1;CFLAR;USP11;CAPN12;USP1
15674,GO:0072173,0.435986194513787,0.900690237276285,1,7,metanephric tubule morphogenesis,BP,WNT4
1468,GO:0003720,0.436349136917889,0.89876532558616,1,8,telomerase activity,MF,DKC1
1566,GO:0003964,0.436349136917889,0.89876532558616,1,8,RNA-directed DNA polymerase activity,MF,DKC1
3534,GO:0007528,0.436388773520915,0.783431485741947,3,29,neuromuscular junction development,BP,COL4A1;GPHN;TNC
13688,GO:0060191,0.436477728868101,0.756088810582195,4,46,regulation of lipase activity,BP,CYR61;FGFR2;ESR1;CCL5
7794,GO:0032329,0.436583093585031,0.898643710986545,1,8,serine transport,BP,NFKBIE
3253,GO:0006915,0.436696300348609,0.606063707817722,102,1397,apoptotic process,BP,CRYAB;IGFBP3;NEFL;PML;CYP1B1;MAP3K14;GCLC;CYR61;FGFR2;CTGF;MMP9;XAF1;B4GALT1;G6PD;TSC22D3;TRAF3;TP53;DAPK3;EDN1;DDX47;CDKN2A;NQO1;PRUNE2;LGALS3;PDPN;TGFB2;CYLD;IKBKE;IFIT3;IL6ST;BAG1;SLC9A3R1;INHBA;NAIP;NBN;TRIO;SHQ1;CDK4;SFRP1;CD274;MCM2;TARDBP;MIR17HG;AHR;NAA15;DRAM1;TRAF1;ADM;DYNLL2;PLK2;MYBL2;HSPB1;WNT4;THOC1;SOD2;DDX3X;IL24;RRN3;ITGAV;SET;GADD45B;MDM4;CLU;BIRC3;EYA3;ACKR3;BLOC1S2;APEX1;PDCL3;HSP90AB1;ARL6IP5;EPHB6;SGK1;BRCA2;CCAR1;ETV6;CHEK1;SERPINB9;GPER1;FAF1;ADAM17;SENP1;NTN1;MSH6;CFLAR;EIF2B5;AKR1B1;TRAF2;CITED2;NAA16;KIF14;TLR3;ESR1;DNASE1;TNF;CCL5;CD74;DAXX;PHLPP1;CDKN1A;IRF1;IFI27L1
13591,GO:0060038,0.436738339898871,0.782523320292344,3,31,cardiac muscle cell proliferation,BP,FGFR2;TGFB2;MIR17HG
7726,GO:0032211,0.43689422398929,0.82324685700882,2,19,negative regulation of telomere maintenance via telomerase,BP,GNL3L;HNRNPU
11636,GO:0046324,0.437019577817834,0.756168944014983,4,43,regulation of glucose import,BP,IRS1;ENPP1;PIK3R3;TNF
1185,GO:0002829,0.437239229033222,0.898302153684013,1,8,negative regulation of type 2 immune response,BP,IL27RA
7415,GO:0031492,0.437348570374688,0.779676405023067,3,42,nucleosomal DNA binding,MF,H3F3A;HMGN2;SMARCC1
14563,GO:0070064,0.437492365090613,0.82282201887081,2,19,proline-rich region binding,MF,CYLD;BAIAP2
17589,GO:1901160,0.437553275894925,0.899887327810836,1,7,primary amino compound metabolic process,BP,SRD5A1
4682,GO:0010828,0.437556218435479,0.782187078379166,3,30,positive regulation of glucose transmembrane transport,BP,C3;IRS1;PIK3R3
3529,GO:0007517,0.437594424463332,0.655753683076941,19,228,muscle organ development,BP,CRYAB;NRG1;HDAC9;JPH2;FGFR2;G6PD;TSC22D3;DDX17;EDN1;TGFB2;GPCPD1;MIR17HG;TPM1;ARNTL;LUC7L;FZD1;JPH1;CENPF;CFLAR
15201,GO:0071320,0.437666255910974,0.782100614175265,3,30,cellular response to cAMP,BP,AHR;SRD5A1;APEX1
11795,GO:0046638,0.437678736850881,0.821667806507915,2,21,positive regulation of alpha-beta T cell differentiation,BP,SYK;AP3B1
7575,GO:0031931,0.437722603744631,0.899800328140901,1,7,TORC1 complex,CC,TELO2
2826,GO:0006293,0.437995328818498,0.821441627459324,2,21,nucleotide-excision repair, preincision complex stabilization,BP,RPA1;GTF2H3
2828,GO:0006295,0.437995328818498,0.821441627459324,2,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,RPA1;GTF2H3
7362,GO:0031399,0.438048828965017,0.606116704744827,95,1266,regulation of protein modification process,BP,IGFBP3;SAA1;NRG1;FN1;PML;MAP3K14;GCLC;CYR61;C3;GPRC5A;FGFR2;EPGN;CTGF;MMP9;G6PD;MID1;TP53;EDN1;GBP1;C1QTNF1;DUSP14;CDKN2A;CHP1;AKAP8;TGFB2;PKMYT1;PPP1R3B;IL6ST;SLC9A3R1;NUAK1;INHBA;PUM3;SYK;EMP2;NBN;CDK4;SFRP1;TARDBP;ULK4;CD109;CCL20;AKAP8L;HSPB1;CORO1C;DDX3X;IL24;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;AJUBA;PPP4R4;GNL3L;GADD45B;SH3RF2;PHACTR4;NPNT;PDGFB;FZD1;CLU;ENPP1;BIRC3;IL20;ACKR3;RIF1;GLIPR2;PDCL3;HSP90AB1;ARL6IP5;EPHB6;RAB3GAP1;CHEK1;GPER1;FAF1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;KIF14;TLR3;PARD3;TNF;CCL5;CD74;FGFR1OP;DAXX;TAF1;PHLPP1;CDKN1A;ITGB1BP1;CTCF;IRAK3
8247,GO:0033008,0.438077270886875,0.897864857717517,1,8,positive regulation of mast cell activation involved in immune response,BP,SYK
10459,GO:0043306,0.438077270886875,0.897864857717517,1,8,positive regulation of mast cell degranulation,BP,SYK
9208,GO:0035584,0.438142361372557,0.895396055806757,1,10,calcium-mediated signaling using intracellular calcium source,BP,CCL20
4843,GO:0014047,0.438516106212977,0.822093661891905,2,19,glutamate secretion,BP,SLC1A3;RAB3GAP1
8415,GO:0033365,0.438563287925729,0.619260417364062,52,731,protein localization to organelle,BP,NRG1;PML;GNPTAB;MID1;TP53;CHP1;RBM22;DKC1;NUP50;NUP153;ARFRP1;VPS41;RPA1;POLR1A;IMMP2L;DYNLL2;RAN;RANBP2;DDX3X;KLHL21;ARNTL;CDCA5;GNL3L;GDAP1;RTKN2;CLU;NUP54;SETD2;GLIS2;ANLN;TIMM23B;RPF2;HSPA8;SYT11;HSP90AB1;BRCA2;RAB3GAP1;WDR75;ATR;UBE2J2;VPS36;AP3B1;ESR1;EHD1;TNF;STARD7;HNRNPU;TRAM2;CDKN1A;CTCF;TSGA13;RPS12
15074,GO:0071010,0.43864849317668,0.820535081661629,2,22,prespliceosome,CC,LUC7L;LUC7L2
12892,GO:0051196,0.439073848854092,0.721648607920348,6,69,regulation of coenzyme metabolic process,BP,NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54
8160,GO:0032880,0.439181179947511,0.618781584368204,52,690,regulation of protein localization,BP,SAA1;NRG1;TRIM16;FN1;PML;TRIM22;IL1R2;IRS1;TP53;GBP1;ACSL3;PTPN14;CHP1;TGFB2;RBM22;CYLD;DKC1;SYK;SFRP1;CD274;POLR1A;KCNS3;PTGER4;DYNLL2;AKAP8L;RHOG;LCP1;SOCS1;ARNTL;CDCA5;GNL3L;NUP54;SETD2;GLIS2;HSPA8;SYT11;HSP90AB1;NEDD4L;WDPCP;GPER1;WDR75;UBE2J2;TRAF2;CLOCK;TNF;STARD7;CCL5;PANX1;CDKN1A;ITGB1BP1;ASTN2;TSGA13
5135,GO:0015629,0.439243460929293,0.638414573133113,28,347,actin cytoskeleton,CC,CRYAB;AMOT;MYO1B;ACTG1;DAPK3;SIPA1L3;SLC9A3R1;KEAP1;TPM1;OPHN1;NDC1;DYNLL2;SYNPO2L;LCP1;TOPBP1;CORO1C;KLHL21;CGNL1;BAIAP2;RTKN2;TPM4;ANLN;TJP1;MYH11;ADAM17;MYO10;DPYSL3;SYNPO2
9430,GO:0035988,0.439441026669009,0.898914726389525,1,7,chondrocyte proliferation,BP,CTGF
10562,GO:0043506,0.439454300946337,0.721221563847205,6,70,regulation of JUN kinase activity,BP,EDN1;SYK;SFRP1;TRAF2;TNF;DAXX
7763,GO:0032274,0.439587400994743,0.898839064986619,1,7,gonadotropin secretion,BP,INHBA
5710,GO:0016836,0.439629556862518,0.778975434260962,3,36,hydro-lyase activity,MF,ACO1;HACD2;HADHB
2299,GO:0005262,0.439998756239794,0.735379865306025,5,53,calcium channel activity,MF,JPH2;ITGAV;TRPM7;JPH1;PANX1
16476,GO:0097120,0.44003008917006,0.820472040096796,2,20,receptor localization to synapse,BP,GPHN;NETO1
7113,GO:0030904,0.440182934373982,0.820362561180592,2,20,retromer complex,CC,SNX5;M6PR
6897,GO:0030424,0.440280683776988,0.636123004207629,29,362,axon,CC,CRYAB;NEFL;NRG1;TENM3;SACS;NEFM;TGFB2;CNTNAP1;AP3M2;DST;OPHN1;MME;HSPB1;GPRIN1;BLOC1S2;CNTNAP2;HSPA8;SYT11;ZFYVE27;TRAK2;MTMR2;L1CAM;IQCJ-SCHIP1;GPER1;SHTN1;DPYSL3;HNRNPR;AP3B1;PARD3
8077,GO:0032743,0.440460493364192,0.820163664310541,2,20,positive regulation of interleukin-2 production,BP,RUNX1;TRAF2
13090,GO:0051574,0.440871860831889,0.898173596072961,1,7,positive regulation of histone H3-K9 methylation,BP,RIF1
6933,GO:0030521,0.441253424408543,0.733639026129054,5,58,androgen receptor signaling pathway,BP,DDX17;SFRP1;RAN;DAXX;TAF1
12221,GO:0048384,0.441352886226099,0.8190337662107,2,21,retinoic acid receptor signaling pathway,BP,TRIM16;PML
19202,GO:1905216,0.441491332258249,0.896071215257434,1,8,positive regulation of RNA binding,BP,NCBP1
14913,GO:0070700,0.441766689428701,0.895925697404329,1,8,BMP receptor binding,MF,TGFB2
5147,GO:0015672,0.441785327190831,0.651458156543651,19,250,monovalent inorganic cation transport,BP,CHP1;SLC4A11;SLC9A3R1;SLC22A5;SLC5A6;KCNS3;SLC1A3;KCNQ5;NETO1;COMMD9;ABCC9;NNT;SLC11A2;NSF;NEDD4L;SGK1;SLC9A9;KCNE4;SLC25A22
6333,GO:0020027,0.441832695996615,0.895890795972582,1,8,hemoglobin metabolic process,BP,INHBA
16274,GO:0090311,0.441880029712757,0.778178174602526,3,32,regulation of protein deacetylation,BP,TP53;AKAP8;AKAP8L
18672,GO:1903955,0.442460816824431,0.732045589659538,5,63,positive regulation of protein targeting to mitochondrion,BP,NRG1;WDR75;UBE2J2;STARD7;TSGA13
6063,GO:0019208,0.442484370592163,0.718300081594287,6,73,phosphatase regulator activity,MF,IGFBP3;PPP1R3B;SET;PPP4R4;SH3RF2;PHACTR4
5098,GO:0015370,0.442751702350856,0.777776748955586,3,31,solute:sodium symporter activity,MF,SLC5A6;SLC1A3;SLC25A22
8170,GO:0032897,0.442908067392458,0.81791278802792,2,21,negative regulation of viral transcription,BP,TARDBP;CCL5
10734,GO:0044060,0.442965306261118,0.818363545245149,2,20,regulation of endocrine process,BP,C1QTNF1;INHBA
5305,GO:0016004,0.443160740052298,0.895187021967282,1,8,phospholipase activator activity,MF,CCL5
13708,GO:0060229,0.443160740052298,0.895187021967282,1,8,lipase activator activity,MF,CCL5
13116,GO:0051608,0.443454767014419,0.893642393187248,1,9,histamine transport,BP,EDN1
6711,GO:0030118,0.443525734820446,0.750399235789292,4,45,clathrin coat,CC,VPS41;AP3M2;KCNQ5;AP3B1
8401,GO:0033314,0.443539946733205,0.894985521272786,1,8,mitotic DNA replication checkpoint,BP,TOPBP1
10876,GO:0044389,0.443616802615099,0.645339372707755,21,281,ubiquitin-like protein ligase binding,MF,PML;ACTG1;TRAF3;MID1;TP53;IKBKE;TRAF1;CASC3;TRIM37;CLU;LRPPRC;HSPA8;SYT11;FAF1;RAD18;UBE2J2;TRAF2;MPHOSPH8;DAXX;CCDC50;CDKN1A
3657,GO:0008140,0.443746314018747,0.894875760832372,1,8,cAMP response element binding protein binding,MF,DAPK3
1506,GO:0003857,0.443814159748448,0.893449013202446,1,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,HADHB
9706,GO:0038094,0.443841347834277,0.73129527999028,5,59,Fc-gamma receptor signaling pathway,BP,ACTG1;SYK;BAIAP2;HSP90AB1;MYO10
6285,GO:0019886,0.443898710244833,0.716973454008291,6,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,KIF23;HLA-DOB;DYNLL2;IFI30;CD74;DCTN5
20137,GO:2000774,0.443982083659456,0.893358582175032,1,9,positive regulation of cellular senescence,BP,CDKN2A
16256,GO:0090288,0.444321937208389,0.696733676210547,8,95,negative regulation of cellular response to growth factor stimulus,BP,FBN1;SFRP1;MIR17HG;CD109;WNT4;FZD1;ADAM17;CFLAR
3220,GO:0006869,0.444347767138332,0.657197946484538,16,199,lipid transport,BP,EDN1;C1QTNF1;ACSL3;INHBA;SYK;ABCG2;APOL6;ABCC4;ITGAV;CROT;CLU;SPNS1;ABCA5;ARV1;STARD7;ABCA11P
7233,GO:0031123,0.444654976114695,0.688312732312858,9,119,RNA 3'-end processing,BP,SRSF2;DKC1;CASC3;THOC1;USB1;NCBP1;UPF3B;SRSF7;RBM8A
12863,GO:0051154,0.444729714272557,0.817639465894122,2,19,negative regulation of striated muscle cell differentiation,BP,G6PD;CFLAR
2442,GO:0005641,0.444765914388211,0.89613929913625,1,7,nuclear envelope lumen,CC,PTGES
2832,GO:0006301,0.445024110458522,0.748506823851586,4,49,postreplication repair,BP,RPA1;USP43;RFC3;RAD18
1709,GO:0004222,0.445093322506148,0.73033639329175,5,58,metalloendopeptidase activity,MF,MMP9;RCE1;ADAMTS9;MME;ADAM17
10060,GO:0042533,0.445137747221081,0.894133817844973,1,8,tumor necrosis factor biosynthetic process,BP,HSPB1
10061,GO:0042534,0.445137747221081,0.894133817844973,1,8,regulation of tumor necrosis factor biosynthetic process,BP,HSPB1
7084,GO:0030867,0.445179443929894,0.814699148633613,2,25,rough endoplasmic reticulum membrane,CC,TMEM97;SRPRB
18045,GO:1902514,0.44526990779571,0.895874151622246,1,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
12975,GO:0051338,0.445329929132527,0.61132097632377,55,733,regulation of transferase activity,BP,SAA1;NRG1;MAP3K14;CYR61;GPRC5A;NLRC5;FGFR2;EPGN;IRS1;TP53;EDN1;DUSP14;CDKN2A;CHP1;TGFB2;PKMYT1;SLC9A3R1;DKC1;SYK;EMP2;NBN;CDK4;SFRP1;RFC3;HSPB1;RANBP2;CORO1C;DDX3X;CDC25A;SOCS1;AJUBA;NVL;GADD45B;PDGFB;CLU;PIK3R3;HSP90AB1;EPHB6;FAF1;ADAM17;TRAF2;TELO2;CSF1;RBL1;KIF14;TLR3;TNF;CCL5;CD74;HNRNPU;FGFR1OP;DAXX;CDKN1A;ITGB1BP1;IRAK3
13035,GO:0051451,0.445684923982061,0.893841151727934,1,8,myoblast migration,BP,ITGB1BP1
12555,GO:0050685,0.44593840253335,0.815718144197023,2,21,positive regulation of mRNA processing,BP,HSPA8;NCBP1
3124,GO:0006704,0.446147769140788,0.893593194704443,1,8,glucocorticoid biosynthetic process,BP,WNT4
13918,GO:0060541,0.446205388522478,0.675404975644344,11,131,respiratory system development,BP,TNS3;FGFR2;CTGF;PDPN;MIR17HG;SRF;TNC;WDPCP;TIMELESS;TNF;PHF14
13643,GO:0060113,0.446334219114112,0.77463371642698,3,32,inner ear receptor cell differentiation,BP,FAT4;SLC9A3R1;WDPCP
2107,GO:0004879,0.446337976737364,0.774630715324403,3,32,nuclear receptor activity,MF,AHR;GPER1;ESR1
16771,GO:0098531,0.446337976737364,0.774630715324403,3,32,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,AHR;GPER1;ESR1
8129,GO:0032809,0.44638431051838,0.895286356201366,1,7,neuronal cell body membrane,CC,ATP2B1
10820,GO:0044298,0.44638431051838,0.895286356201366,1,7,cell body membrane,CC,ATP2B1
14075,GO:0060828,0.446445991385966,0.658145190915887,15,198,regulation of canonical Wnt signaling pathway,BP,FGFR2;DAPK3;JRK;CYLD;NAIP;SFRP1;G3BP1;WNT4;DDX3X;ARNTL;KREMEN2;RBMS3;PSME2;PSMB9;PSMB10
12300,GO:0048598,0.446497308092621,0.62891833918447,30,378,embryonic morphogenesis,BP,MAFB;FN1;AMOT;CYR61;TXNRD1;FGFR2;MMP9;FBN1;PBX1;EDN1;TGFB2;IRX2;COL12A1;SLC9A3R1;INHBA;ARFRP1;SFRP1;ADM;WNT4;KDM6A;ITGAV;COL5A2;PHACTR4;SRF;FZD1;FRAS1;SETD2;WDPCP;BBS5;NTN1
358,GO:0000976,0.446503886576504,0.620111928520129,39,498,transcription regulatory region sequence-specific DNA binding,MF,MAFB;FOSL2;NLRC5;RUNX1;PBX1;TFCP2L1;TP53;ZBED1;ZFP42;RELB;H3F3A;AHR;MYBL2;SUV39H2;KDM6A;UBTF;RRN3;ARNTL;SRF;UTY;NFE2L1;MACC1;GLIS2;MYBL1;MAZ;E2F8;ETV6;HSF2;CLOCK;PURB;ESR1;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;ARID3B;IRF1;CTCF
5583,GO:0016597,0.446505680638386,0.773965294480803,3,34,amino acid binding,MF,GCLC;SLC1A3;RARS
10435,GO:0043269,0.446629246250358,0.638815605800758,23,298,regulation of ion transport,BP,PML;JPH2;MMP9;G6PD;EDN1;LGALS3;CHP1;IL16;SLC9A3R1;SYK;SHISA9;KCNS3;KCNQ5;NETO1;PDGFB;JPH1;THADA;ARL6IP5;NEDD4L;RAB3GAP1;GPER1;KCNE4;CCL5
8583,GO:0034046,0.446770291370659,0.895082281961537,1,7,poly(G) binding,MF,HNRNPU
13932,GO:0060563,0.446794406072989,0.77399162451534,3,33,neuroepithelial cell differentiation,BP,SLC9A3R1;WNT4;WDPCP
13198,GO:0051784,0.447045560549163,0.747116647979188,4,47,negative regulation of nuclear division,BP,RAD1;ANAPC15;CENPF;CHEK1
737,GO:0001964,0.447061327543469,0.894928240471657,1,7,startle response,BP,NRG1
11877,GO:0046851,0.447079237340523,0.893093080918544,1,8,negative regulation of bone remodeling,BP,SFRP1
20142,GO:2000780,0.447112975504661,0.81591575066404,2,19,negative regulation of double-strand break repair,BP,POLQ;RIF1
2105,GO:0004871,0.447121274093775,0.611105596331458,52,680,signal transducer activity,MF,NRG1;JPH2;MAP3K14;GPRC5A;FGFR2;STAT5A;IL1R2;FST;TRAF3;IRS1;IFNGR1;IKBKE;IL27RA;IL6ST;BAG1;IL7R;SYK;GPR132;LEPR;SFRP1;HLA-DOB;AHR;PTPRB;PTGER4;PLK2;RHOG;PTPRM;ATP2C1;ITGAV;FZD1;ANTXR1;NFKBIB;ACKR3;THBD;ABCC9;JPH1;IFNAR1;CXCR5;EPHB6;M6PR;HCAR1;IL12RB2;GPER1;LILRB3;CFLAR;EBP;TRAF2;TPRA1;TLR3;ESR1;CD74;DAXX
292,GO:0000796,0.447208553065018,0.894850261607439,1,7,condensin complex,CC,SMC2
13854,GO:0060433,0.447558793059909,0.892835026939274,1,8,bronchus development,BP,SRF
19777,GO:2000117,0.447804999525644,0.713290554943798,6,77,negative regulation of cysteine-type endopeptidase activity,BP,CRYAB;MMP9;NAIP;DDX3X;BIRC3;SERPINB9
267,GO:0000737,0.448133182553283,0.814120048346711,2,21,DNA catabolic process, endonucleolytic,BP,EXOG;DNASE1
1997,GO:0004715,0.448136620920153,0.773192069890748,3,32,non-membrane spanning protein tyrosine kinase activity,MF,SYK;FRK;WEE1
4518,GO:0010566,0.448261040171913,0.892456432756012,1,8,regulation of ketone biosynthetic process,BP,WNT4
11338,GO:0045647,0.448615225564675,0.892265165617293,1,8,negative regulation of erythrocyte differentiation,BP,MAFB
4195,GO:0009299,0.448728541096079,0.814186131385328,2,20,mRNA transcription,BP,TP53;SRF
2829,GO:0006296,0.448999781839231,0.771276841718931,3,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,RPA1;RFC3;GTF2H3
3189,GO:0006814,0.449403627733304,0.678013160398108,10,120,sodium ion transport,BP,CHP1;SLC4A11;SLC9A3R1;SLC22A5;SLC5A6;NETO1;COMMD9;NEDD4L;SGK1;SLC9A9
11595,GO:0046134,0.449434050021358,0.811924943720367,2,24,pyrimidine nucleoside biosynthetic process,BP,TK1;UMPS
10746,GO:0044093,0.449438100245471,0.595161498379775,94,1259,positive regulation of molecular function,BP,SAA1;NRG1;FN1;PML;JPH2;MAP3K14;CYR61;FGFR2;EPGN;TRIM22;STARD13;CTGF;MMP9;IRS1;EDN1;DOCK10;SIPA1L3;CHP1;TGFB2;DKC1;SYK;EMP2;NBN;SFRP1;RIPK4;DHFR;TPM1;TRAF1;OPHN1;DYNLL2;CCL20;PLK2;HSCB;RFC3;RHOG;WNT4;RAN;RANBP2;CORO1C;DDX3X;SOCS1;AJUBA;LFNG;TRIM37;CDC42EP2;CDCA5;GNL3L;NVL;GADD45B;PHACTR4;SRF;NPNT;PDGFB;FZD1;TBC1D15;ANTXR1;CLU;USP6;NFKBIB;HSP90AB1;ARL6IP5;EPHB6;SGK1;RAB3GAP1;GPER1;ADAM17;SENP1;PSME2;MSH6;CFLAR;DNAJC9;RABEP2;NCBP1;TRAF2;MSH3;TELO2;GTF3C4;CSF1;CLOCK;KIF14;TLR3;AZIN1;ESR1;TNF;CCL5;CD74;HNRNPU;DAXX;TAF1;PPARGC1B;CDKN1A;ITGB1BP1;IRAK3;IFI27L1
11272,GO:0045503,0.449515170876855,0.817193966695915,2,15,dynein light chain binding,MF,DYNC2H1;DNHD1
12929,GO:0051256,0.450112123487955,0.891454441844024,1,8,mitotic spindle midzone assembly,BP,KIF23
3241,GO:0006898,0.450234917077581,0.66212190859754,13,165,receptor-mediated endocytosis,BP,SAA1;TFRC;HSPG2;SYK;ADM;UBQLN2;CXCL16;CLU;ENPP1;ACKR3;SYT11;M6PR;MTMR2
12799,GO:0051055,0.45023941714655,0.770724313946785,3,35,negative regulation of lipid biosynthetic process,BP,WNT4;PDGFB;GPER1
7003,GO:0030681,0.450387771625355,0.88873318321214,1,10,multimeric ribonuclease P complex,CC,POP1
13131,GO:0051647,0.450440249157319,0.814119808372497,2,18,nucleus localization,BP,SLC9A3R1;NTN1
8729,GO:0034368,0.450501677531491,0.88981028581164,1,9,protein-lipid complex remodeling,BP,ABCA5
8730,GO:0034369,0.450501677531491,0.88981028581164,1,9,plasma lipoprotein particle remodeling,BP,ABCA5
8809,GO:0034504,0.450627275144383,0.651167010112113,16,205,protein localization to nucleus,BP,PML;CHP1;RBM22;NUP50;NUP153;POLR1A;RAN;RANBP2;ARNTL;NUP54;GLIS2;RPF2;HSP90AB1;TNF;HNRNPU;CDKN1A
10048,GO:0042491,0.450969355415073,0.812548448072,2,20,inner ear auditory receptor cell differentiation,BP,SLC9A3R1;WDPCP
12196,GO:0048306,0.450973256880443,0.769480049132682,3,38,calcium-dependent protein binding,MF,S100P;CHP1;RBM22
10749,GO:0044106,0.451052002386179,0.709793407160551,6,86,cellular amine metabolic process,BP,NQO1;ODC1;PSME2;PSMB9;AZIN1;PSMB10
1495,GO:0003831,0.451066976682808,0.890935285409694,1,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT1
3665,GO:0008156,0.452099141902917,0.769729637837832,3,33,negative regulation of DNA replication,BP,BRCA2;ATR;TIMELESS
18321,GO:1903201,0.452181687296807,0.74247646605645,4,49,regulation of oxidative stress-induced cell death,BP,TP53;HSPB1;SOD2;FZD1
6127,GO:0019372,0.452226648673297,0.888859219560261,1,9,lipoxygenase pathway,BP,GPX4
296,GO:0000800,0.452329745964487,0.89211495758545,1,7,lateral element,CC,BRCA2
10542,GO:0043473,0.452363679532012,0.709584869512558,6,73,pigmentation,BP,RAB32;ADAMTS9;BLOC1S2;HPS5;BBS5;AP3B1
7611,GO:0031987,0.452519954706942,0.892012506075398,1,7,locomotion involved in locomotory behavior,BP,CLN6
11864,GO:0046827,0.452653671959754,0.811312505627676,2,20,positive regulation of protein export from nucleus,BP,TP53;RBM22
18250,GO:1903025,0.452712689622971,0.888590308906075,1,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,TAF1
6728,GO:0030136,0.45275600844394,0.674754641843698,10,124,clathrin-coated vesicle,CC,TFRC;SPG21;EDN1;IL7R;VPS41;HSPA8;M6PR;AP3B1;CD74;ASTN2
13011,GO:0051403,0.453275373637708,0.648627999300831,16,207,stress-activated MAPK cascade,BP,CRYAB;CTGF;MID1;EDN1;TGFB2;SYK;SFRP1;ULK4;PTGER4;GADD45B;ARL6IP5;TRAF2;TLR3;TNF;DAXX;PHLPP1
7315,GO:0031313,0.453431923607868,0.889642709002018,1,8,extrinsic component of endosome membrane,CC,SNX5
10085,GO:0042574,0.453458467993256,0.889628146317443,1,8,retinal metabolic process,BP,CYP1B1
5206,GO:0015802,0.453479449775539,0.889616634509638,1,8,basic amino acid transport,BP,SLC7A2
5077,GO:0015298,0.45350150696966,0.810688749784691,2,20,solute:cation antiporter activity,MF,SLC22A5;SLC9A9
9320,GO:0035770,0.45364310395467,0.658828620465371,13,169,ribonucleoprotein granule,CC,RBM4;PABPC4;G3BP1;CASC3;DDX28;DDX3X;SOCS1;ARNTL;AJUBA;NCL;CLOCK;RC3H1;HNRNPU
13789,GO:0060347,0.453750167915392,0.889468034856373,1,8,heart trabecula formation,BP,SRF
6263,GO:0019852,0.453959093544325,0.887898838999382,1,9,L-ascorbic acid metabolic process,BP,GCLC
8155,GO:0032875,0.454201103764703,0.891104308541777,1,7,regulation of DNA endoreduplication,BP,E2F8
7956,GO:0032549,0.454297717367937,0.635099747586429,21,287,ribonucleoside binding,MF,GBP1;RAB32;ARFRP1;TSR1;LSG1;EIF5;RRAGB;GBP5;RHOG;RAN;RAB26;GNL3L;EFTUD2;SRPRB;HSP90AB1;MMAA;BMS1;POLR3B;EHD1;NRAS;GBP6
10650,GO:0043650,0.454393900922601,0.889114175550922,1,8,dicarboxylic acid biosynthetic process,BP,SLC1A3
9575,GO:0036353,0.454633030081653,0.888982544050877,1,8,histone H2A-K119 monoubiquitination,BP,TRIM37
10361,GO:0043161,0.454636597928138,0.624695634132267,27,371,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,PML;GCLC;TP53;KEAP1;FOXRED2;PLK2;UBQLN2;ANAPC15;RNF115;ARNTL;CLU;HSP90AB1;NEDD4L;ANAPC7;CCDC47;FAF1;SENP1;PSME2;PSMB9;SPSB1;UBE2J2;CLOCK;KIF14;RNF19B;PSMB10;TAF1;SMARCC1
6,GO:0000012,0.454642611545915,0.888977267757425,1,8,single strand break repair,BP,APTX
617,GO:0001783,0.454745787283822,0.80879987022167,2,22,B cell apoptotic process,BP,MIR17HG;CD74
11024,GO:0044848,0.454775975059523,0.88890381103998,1,8,biological phase,BP,TGFB2
11026,GO:0044851,0.454775975059523,0.88890381103998,1,8,hair cycle phase,BP,TGFB2
12409,GO:0048819,0.454775975059523,0.88890381103998,1,8,regulation of hair follicle maturation,BP,TGFB2
10738,GO:0044070,0.454920724156635,0.74046497213298,4,47,regulation of anion transport,BP,EDN1;SYK;ARL6IP5;RAB3GAP1
2756,GO:0006165,0.455383906477046,0.695576061465722,7,87,nucleoside diphosphate phosphorylation,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
10618,GO:0043587,0.455632706234165,0.888431188627735,1,8,tongue morphogenesis,BP,KRT13
9055,GO:0035265,0.455654225160399,0.686589549183404,8,93,organ growth,BP,FGFR2;G6PD;COL27A1;EDN1;TGFB2;LEPR;MIR17HG;ESR1
20024,GO:2000586,0.455771197930414,0.890251737361768,1,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
12281,GO:0048557,0.455919738646117,0.890170859821566,1,7,embryonic digestive tract morphogenesis,BP,FGFR2
4589,GO:0010677,0.455928845947718,0.808896938581623,2,20,negative regulation of cellular carbohydrate metabolic process,BP,LEPR;ENPP1
15882,GO:0072584,0.455982037604704,0.888238112206854,1,8,caveolin-mediated endocytosis,BP,NEDD4L
17610,GO:1901222,0.456150645031945,0.739259669917478,4,48,regulation of NIK/NF-kappaB signaling,BP,TRAF2;TLR3;TNF;RC3H1
637,GO:0001824,0.45616131101464,0.739250592539848,4,48,blastocyst development,BP,NBN;GINS4;SRF;BRCA2
2830,GO:0006297,0.45625970906264,0.807254592154964,2,23,nucleotide-excision repair, DNA gap filling,BP,RPA1;RFC3
2881,GO:0006383,0.456322908998681,0.738813354510646,4,50,transcription by RNA polymerase III,BP,GTF3C6;POLR2F;POLR3B;GTF3C4
15067,GO:0070997,0.456436108275416,0.640037394318373,18,235,neuron death,BP,NEFL;GCLC;G6PD;TP53;NQO1;CHP1;TGFB2;NAIP;MYBL2;SOD2;SET;FZD1;CLU;HSP90AB1;TRAF2;KIF14;CCL5;DAXX
8823,GO:0034587,0.456595564361663,0.887898501756804,1,8,piRNA metabolic process,BP,MYBL1
14546,GO:0070034,0.456677431707747,0.80782964032628,2,21,telomerase RNA binding,MF,DKC1;HNRNPU
15125,GO:0071158,0.456779334130649,0.705325134677286,6,77,positive regulation of cell cycle arrest,BP,PML;TP53;PLK2;MDM4;E2F8;CDKN1A
7326,GO:0031330,0.456779338551422,0.652011568365248,14,181,negative regulation of cellular catabolic process,BP,PML;DKC1;LEPR;TARDBP;OPHN1;LRPPRC;PDCL3;HSP90AB1;SYNCRIP;MTMR2;SENP1;HNRNPU;TAF1;SMARCC1
10563,GO:0043507,0.456817432276123,0.720282337827944,5,57,positive regulation of JUN kinase activity,BP,EDN1;SYK;TRAF2;TNF;DAXX
14057,GO:0060766,0.456864520299858,0.887749418298845,1,8,negative regulation of androgen receptor signaling pathway,BP,SFRP1
6586,GO:0022410,0.45690189097942,0.886255518157635,1,9,circadian sleep/wake cycle process,BP,SRD5A1
12637,GO:0050802,0.45690189097942,0.886255518157635,1,9,circadian sleep/wake cycle, sleep,BP,SRD5A1
4223,GO:0009396,0.456917642612828,0.886246681398489,1,9,folic acid-containing compound biosynthetic process,BP,DHFR
12016,GO:0047429,0.45709600568349,0.886146588325222,1,9,nucleoside-triphosphate diphosphatase activity,MF,ENPP1
3212,GO:0006857,0.457184440015476,0.887571921690348,1,8,oligopeptide transport,BP,SLC9A3R1
15176,GO:0071276,0.457274413260358,0.806112077802771,2,24,cellular response to cadmium ion,BP,MMP9;DAXX
2814,GO:0006275,0.457424277061111,0.684609793371358,8,99,regulation of DNA replication,BP,NBN;NUCKS1;RFC3;PDGFB;BRCA2;E2F8;ATR;TIMELESS
3418,GO:0007205,0.457596847738478,0.807660481935154,2,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,EDN1;PARD3
15005,GO:0070900,0.457998968368218,0.885639011866793,1,9,mitochondrial tRNA modification,BP,TRMT5
17545,GO:1900864,0.457998968368218,0.885639011866793,1,9,mitochondrial RNA modification,BP,TRMT5
2499,GO:0005746,0.458018180880323,0.73520084401083,4,72,mitochondrial respiratory chain,CC,NNT;SDHD;UQCRB;NDUFB9
13228,GO:0051851,0.45810200974002,0.737443074261657,4,49,modification by host of symbiont morphology or physiology,BP,NUCKS1;TARDBP;HSPA8;CCL5
17917,GO:1902175,0.45820786444266,0.805801003589128,2,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,HSPB1;SOD2
2396,GO:0005537,0.458541423833184,0.886817065085377,1,8,mannose binding,MF,M6PR
10019,GO:0042430,0.458821616682851,0.886660800996609,1,8,indole-containing compound metabolic process,BP,SRD5A1
6746,GO:0030162,0.45890665615807,0.609523477779554,37,520,regulation of proteolysis,BP,CRYAB;C1R;FN1;PML;GCLC;CYR61;C3;CTGF;MMP9;CLN6;IL1R2;TRAF3;NAIP;KEAP1;OPHN1;CD109;PLK2;UBQLN2;DDX3X;ANTXR1;CLU;BIRC3;PDCL3;HSP90AB1;ARL6IP5;SERPINB9;GPER1;SENP1;PSME2;CFLAR;PSMB9;TRAF2;RNF19B;TNF;TAF1;SMARCC1;IFI27L1
564,GO:0001702,0.459013066978858,0.807822074305037,2,18,gastrulation with mouth forming second,BP,AMOT;SRF
5162,GO:0015698,0.45903791480105,0.692413001103565,7,85,inorganic anion transport,BP,SLC4A11;LRRC8D;ABCC4;SLC1A3;ENPP1;ABCC9;CLCC1
17606,GO:1901213,0.459334755388331,0.886374267317941,1,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,SRF
2131,GO:0004930,0.459435367129208,0.668226573837025,10,133,G-protein coupled receptor activity,MF,GPRC5A;GPR132;SFRP1;PTGER4;FZD1;ACKR3;CXCR5;HCAR1;GPER1;TPRA1
1441,GO:0003417,0.459455773881102,0.886306624276995,1,8,growth plate cartilage development,BP,COL27A1
16757,GO:0097755,0.459576009220613,0.76314441576082,3,35,positive regulation of blood vessel diameter,BP,ADM;SOD2;GPER1
18170,GO:1902883,0.460181205522291,0.762413698940439,3,36,negative regulation of response to oxidative stress,BP,HSPB1;SOD2;FZD1
12083,GO:0048016,0.460548229134523,0.763451919485124,3,31,inositol phosphate-mediated signaling,BP,NRG1;EDN1;CHP1
11205,GO:0045294,0.460782754520108,0.885563231003213,1,8,alpha-catenin binding,MF,AJUBA
8603,GO:0034101,0.460824091934922,0.690586181261968,7,88,erythrocyte homeostasis,BP,MAFB;G6PD;INHBA;SRF;NFE2L1;SLC11A2;SENP1
5865,GO:0017162,0.460877741355812,0.885509899807501,1,8,aryl hydrocarbon receptor binding,MF,ARNTL
2314,GO:0005310,0.460904872947214,0.805195806640626,2,20,dicarboxylic acid transmembrane transporter activity,MF,SLC1A3;SLC25A22
5780,GO:0016999,0.461080545768897,0.689865237148122,7,96,antibiotic metabolic process,BP,STAT5A;CYP1A1;ACO1;AKR1C2;NNT;SDHD;AKR1B1
8927,GO:0034762,0.461084004490969,0.628854044245683,21,267,regulation of transmembrane transport,BP,JPH2;C3;MMP9;G6PD;IRS1;CHP1;SLC9A3R1;SHISA9;KCNS3;KCNQ5;NETO1;ENPP1;PIK3R3;JPH1;THADA;ARL6IP5;NEDD4L;GPER1;AZIN1;KCNE4;TNF
715,GO:0001937,0.461091829926211,0.805056015266562,2,20,negative regulation of endothelial cell proliferation,BP,PTPRM;TNF
11434,GO:0045833,0.461227199276638,0.734769419252795,4,49,negative regulation of lipid metabolic process,BP,WNT4;PDGFB;GPER1;TNF
10889,GO:0044417,0.461250086710843,0.883799613977805,1,9,translocation of molecules into host,BP,THOC1
13227,GO:0051836,0.461250086710843,0.883799613977805,1,9,translocation of molecules into other organism involved in symbiotic interaction,BP,THOC1
15282,GO:0071439,0.461323272562226,0.885259541316907,1,8,clathrin complex,CC,VPS41
17863,GO:1902004,0.461899309808186,0.884935331042471,1,8,positive regulation of amyloid-beta formation,BP,CLU
19565,GO:1990440,0.461965981018648,0.883392075631181,1,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,TP53
4777,GO:0010960,0.462111561284566,0.886765671105305,1,7,magnesium ion homeostasis,BP,TRPM7
15796,GO:0072383,0.462316581942809,0.886651783704934,1,7,plus-end-directed vesicle transport along microtubule,BP,KIF23
11651,GO:0046348,0.462349380029354,0.883173444714709,1,9,amino sugar catabolic process,BP,CHID1
3139,GO:0006733,0.462396242939696,0.659901621740313,11,144,oxidoreduction coenzyme metabolic process,BP,G6PD;PGD;NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54;NNT;PDSS1
17797,GO:1901800,0.462518523442854,0.688916337870357,7,90,positive regulation of proteasomal protein catabolic process,BP,GCLC;KEAP1;PLK2;UBQLN2;CLU;RNF19B;TAF1
5655,GO:0016747,0.46252116380269,0.650432838066409,13,171,transferase activity, transferring acyl groups other than amino-acyl groups,MF,ZDHHC6;NAA15;CROT;NAA50;MBOAT1;KANSL1L;BRCA2;HADHB;TAF6L;GTF3C4;NAA16;CLOCK;TAF1
7144,GO:0030971,0.462650101650439,0.734212420637718,4,45,receptor tyrosine kinase binding,MF,NRG1;IRS1;TP53;PTPN14
9985,GO:0042364,0.462827272275525,0.884411821283764,1,8,water-soluble vitamin biosynthetic process,BP,MMAA
13897,GO:0060502,0.462879634129154,0.884382236223714,1,8,epithelial cell proliferation involved in lung morphogenesis,BP,FGFR2
17789,GO:1901741,0.463133444148725,0.882725526436317,1,9,positive regulation of myoblast fusion,BP,EHD1
4109,GO:0009163,0.463146111828555,0.759154035157418,3,40,nucleoside biosynthetic process,BP,TK1;PDCL3;UMPS
5161,GO:0015697,0.46316501870618,0.884220905764973,1,8,quaternary ammonium group transport,BP,SLC22A5
876,GO:0002224,0.463174686930328,0.688319547500146,7,90,toll-like receptor signaling pathway,BP,TRAF3;IKBKE;BIRC3;TLR3;ESR1;IRF1;IRAK3
3949,GO:0008645,0.463428539781429,0.699892429233746,6,71,hexose transmembrane transport,BP,C3;IRS1;ENPP1;PIK3R3;M6PR;TNF
12381,GO:0048747,0.463967739140408,0.761708112087752,3,28,muscle fiber development,BP,HDAC9;NEXN;MYH11
16277,GO:0090314,0.464036306163368,0.801848952025826,2,22,positive regulation of protein targeting to membrane,BP,CHP1;ITGB1BP1
908,GO:0002287,0.464071716130301,0.759705849657153,3,34,alpha-beta T cell activation involved in immune response,BP,RELB;PTGER4;RC3H1
911,GO:0002293,0.464071716130301,0.759705849657153,3,34,alpha-beta T cell differentiation involved in immune response,BP,RELB;PTGER4;RC3H1
912,GO:0002294,0.464071716130301,0.759705849657153,3,34,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,RELB;PTGER4;RC3H1
9857,GO:0042093,0.464071716130301,0.759705849657153,3,34,T-helper cell differentiation,BP,RELB;PTGER4;RC3H1
6895,GO:0030422,0.464314120326173,0.882048975115298,1,9,production of siRNA involved in RNA interference,BP,TSN
6628,GO:0022853,0.464365483606103,0.759211418987621,3,35,active ion transmembrane transporter activity,MF,ATP2B1;ABCC4;ATP2C1
10117,GO:0042625,0.464365483606103,0.759211418987621,3,35,ATPase coupled ion transmembrane transporter activity,MF,ATP2B1;ABCC4;ATP2C1
12113,GO:0048096,0.46447081072769,0.883480899108048,1,8,chromatin-mediated maintenance of transcription,BP,CHEK1
16858,GO:0098742,0.46454922824623,0.670659926086265,9,106,cell-cell adhesion via plasma-membrane adhesion molecules,BP,TENM3;FAT4;TGFB2;PCDH7;PTPRM;ATP2C1;AJUBA;CDH13;SDK1
10035,GO:0042470,0.46467135868303,0.686831439025675,7,92,melanosome,CC,TFRC;RAB32;RAN;NAP1L1;HSPA8;HSP90AB1;MYH11
12394,GO:0048770,0.46467135868303,0.686831439025675,7,92,pigment granule,CC,TFRC;RAB32;RAN;NAP1L1;HSPA8;HSP90AB1;MYH11
15387,GO:0071609,0.464827591224759,0.883278184329625,1,8,chemokine (C-C motif) ligand 5 production,BP,DDX3X
8802,GO:0034483,0.464849119083537,0.883265945473838,1,8,heparan sulfate sulfotransferase activity,MF,HS3ST1
17093,GO:0099568,0.464923100516459,0.615039580869369,27,340,cytoplasmic region,CC,NEFL;FGFR2;CTGF;DYNC2H1;DNHD1;AP3M2;DST;PARD3B;HSPB1;BAIAP2;RTKN2;TPM4;ANLN;BLOC1S2;TRAK2;WDPCP;CENPF;BBS5;MYO10;AKR1B1;TRAF2;NCL;AP3B1;PARD3;ARV1;NEDD9;ASTN2
5016,GO:0015174,0.464979177844076,0.883191988083936,1,8,basic amino acid transmembrane transporter activity,MF,SLC7A2
3200,GO:0006835,0.465206712409183,0.731837386730091,4,46,dicarboxylic acid transport,BP,SLC1A3;ARL6IP5;RAB3GAP1;SLC25A22
9042,GO:0035250,0.465549672803999,0.800704220396807,2,22,UDP-galactosyltransferase activity,MF,B4GALT1;UGT8
15148,GO:0071222,0.465578801778502,0.676757641096625,8,106,cellular response to lipopolysaccharide,BP,AKAP8;CDK4;CD274;CCL20;IL24;NFKBIB;TNF;CCL5
3526,GO:0007507,0.465742692657908,0.611658046123762,29,356,heart development,BP,NRG1;HDAC9;JPH2;CYR61;FGFR2;FBN1;FAT4;G6PD;EDN1;TGFB2;MIR17HG;TPM1;ADAMTS9;ADM;NEXN;KDM6A;SRF;PDGFB;FZD1;IRX4;SMYD2;SETD2;MYH11;BBS5;GPER1;CITED2;GJC1;HNRNPU;DCTN5
5569,GO:0016578,0.465804311425138,0.800987977011554,2,21,histone deubiquitination,BP,USP16;BRCC3
9983,GO:0042362,0.465831314630339,0.881175952941112,1,9,fat-soluble vitamin biosynthetic process,BP,TNF
600,GO:0001765,0.465853374032623,0.881163229301104,1,9,membrane raft assembly,BP,EMP2
15078,GO:0071014,0.466013253815679,0.881070986309049,1,9,post-mRNA release spliceosomal complex,CC,DHX15
3237,GO:0006893,0.466151141415582,0.731023633588945,4,46,Golgi to plasma membrane transport,BP,ACSL3;ARFRP1;RAB26;NSF
11138,GO:0045161,0.466363747384736,0.884388591416569,1,7,neuronal ion channel clustering,BP,CNTNAP2
1014,GO:0002495,0.466621200508506,0.696578955921679,6,76,antigen processing and presentation of peptide antigen via MHC class II,BP,KIF23;HLA-DOB;DYNLL2;IFI30;CD74;DCTN5
9143,GO:0035461,0.466817958182186,0.882143169437804,1,8,vitamin transmembrane transport,BP,SLC5A6
1130,GO:0002716,0.4668396027011,0.880593495215869,1,9,negative regulation of natural killer cell mediated immunity,BP,SERPINB9
10736,GO:0044065,0.466848977530494,0.882125424966219,1,8,regulation of respiratory system process,BP,FTO
3156,GO:0006760,0.467057427540353,0.799560241507304,2,22,folic acid-containing compound metabolic process,BP,DHFR;TYMS
7428,GO:0031519,0.467061313796265,0.730067351467809,4,47,PcG protein complex,CC,ZFP42;TRIM37;UBAP2L;RING1
13531,GO:0055081,0.467080283727595,0.757781251448685,3,32,anion homeostasis,BP,SLC9A3R1;GPCPD1;ENPP1
19051,GO:1904851,0.46713450518705,0.880422795670649,1,9,positive regulation of establishment of protein localization to telomere,BP,DKC1
7364,GO:0031401,0.467242238961845,0.588095435499626,59,791,positive regulation of protein modification process,BP,IGFBP3;SAA1;NRG1;MAP3K14;CYR61;C3;FGFR2;EPGN;CTGF;MMP9;MID1;TP53;EDN1;C1QTNF1;CHP1;AKAP8;TGFB2;IL6ST;INHBA;SYK;EMP2;NBN;CCL20;AKAP8L;DDX3X;IL24;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;GADD45B;NPNT;PDGFB;FZD1;CLU;BIRC3;IL20;ACKR3;RIF1;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;RAB3GAP1;GPER1;ADAM17;CFLAR;TRAF2;TELO2;CSF1;KIF14;TLR3;TNF;CCL5;CD74;DAXX;CDKN1A;ITGB1BP1
3378,GO:0007157,0.467433109274233,0.799753609996253,2,21,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,TENM3;FAT4
16290,GO:0090335,0.467663565860009,0.881658832125057,1,8,regulation of brown fat cell differentiation,BP,FTO
6118,GO:0019362,0.468001247628369,0.660393595467713,10,129,pyridine nucleotide metabolic process,BP,G6PD;PGD;NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54;NNT
11719,GO:0046496,0.468001247628369,0.660393595467713,10,129,nicotinamide nucleotide metabolic process,BP,G6PD;PGD;NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54;NNT
10924,GO:0044464,0.468081542984723,0.583760171910046,798,11099,cell part,CC,IL32;CRYAB;IGFBP3;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TRIM16L;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;SLC16A2;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;SLC7A2;RUNX1;MYO1B;CYP1A1;ERVFRD-1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TSC22D3;MAT2A;DDX17;SPON1;FAM69B;TRIM56;TFCP2L1;KRTAP2-3;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;MID1;SLC16A9;TP53;DAPK3;TUFT1;SVEP1;PANK2;SLC7A5P2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;ABCF1;C1QTNF1;DUSP14;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;MEGF11;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;CNTNAP1;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;IFIT3;SRSF2;FOXD2;PCDH7;LRFN4;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;C15ORF39;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PALM2;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;POP1;HLA-DOB;RIPK4;GPCPD1;NUCKS1;PITHD1;HEATR1;ZDHHC6;CD274;MCM2;TARDBP;LAYN;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;APOL6;COA7;KEAP1;NAA15;UAP1L1;TRA2A;TCHH;ZNF827;SLC5A6;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;PTGER4;TK1;TMEM97;LSG1;G3BP1;GRWD1;ARRDC1-AS1;ZNF584;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;CDV3;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;KANK4;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;CXCL16;NOP2;DOHH;SUV39H2;LCP1;GPRIN1;EXOG;PTPRM;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARHGEF28;ARMC5;GPHN;KLHL21;RRN3;RNF115;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;ABCF2;SNX11;TRPM7;AJUBA;SMC2;ARMC6;FASTKD3;KCNQ5;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;KRT24;LFNG;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;PPP4R4;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;ODF2L;KREMEN2;SDK1;FZD1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;FRAS1;ZNF316;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;MCM6;FGD6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;UPK3B;ABCC9;TRMT5;TTF2;DTX4;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;SEPHS2;NNT;IFNAR1;WEE1;TJP1;ZNF484;THADA;NOL12;KCTD3;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;CXCR5;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;HPS5;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;HCAR1;DGCR8;DPYD;SS18L2;KRT10;CCAR1;SKA2;PPIP5K1;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;L1CAM;ZNFX1;STEAP4;FKBP5;IQCJ-SCHIP1;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;ANKRD13A;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;TAF6L;MRPS7;DPH2;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;MSH3;TELO2;EDRF1;RBBP5;FAM208B;CITED2;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;MPP5;AZIN1;ERVK13-1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;KCNE4;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;DCTN5;METAP2;SLC43A2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;FTO;CCDC50;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;SLC41A2;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
11769,GO:0046600,0.468211810778099,0.881344135696203,1,8,negative regulation of centriole replication,BP,TRIM37
10843,GO:0044327,0.468248145061759,0.881323260667604,1,8,dendritic spine head,CC,GPER1
8277,GO:0033061,0.468484137840431,0.879639596670813,1,9,DNA recombinase mediator complex,CC,RAD51B
6296,GO:0019903,0.468601455867976,0.674347623331475,8,99,protein phosphatase binding,MF,TRAF3;TP53;SH3RF2;PHACTR4;ANAPC7;TRAF2;AP3B1;PARD3
14318,GO:0061418,0.468673220568341,0.708367080574922,5,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,HIF1AN;PSME2;PSMB9;CITED2;PSMB10
11745,GO:0046540,0.468701518055588,0.797472642414316,2,24,U4/U6 x U5 tri-snRNP complex,CC,ZMAT2;EFTUD2
14168,GO:0061028,0.46907724951979,0.755839421899799,3,33,establishment of endothelial barrier,BP,TJP2;TJP1;TNF
6842,GO:0030301,0.469244763163987,0.72801458013636,4,48,cholesterol transport,BP,ABCG2;CLU;ABCA5;ARV1
13603,GO:0060050,0.469292890047524,0.880722020525172,1,8,positive regulation of protein glycosylation,BP,CHP1
5562,GO:0016571,0.469454425031861,0.665847668727699,9,111,histone methylation,BP,SETDB1;SUV39H2;KDM6A;SMYD2;RIF1;SETD2;TET3;RBBP5;CTCF
5811,GO:0017062,0.469602828830343,0.878987938881369,1,9,respiratory chain complex III assembly,BP,UQCRB
8819,GO:0034551,0.469602828830343,0.878987938881369,1,9,mitochondrial respiratory chain complex III assembly,BP,UQCRB
7040,GO:0030808,0.470106504793391,0.68226198471863,7,86,regulation of nucleotide biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54;GPER1
17499,GO:1900371,0.470106504793391,0.68226198471863,7,86,regulation of purine nucleotide biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54;GPER1
10280,GO:0043011,0.47018650057305,0.878647046830619,1,9,myeloid dendritic cell differentiation,BP,RELB
10452,GO:0043299,0.470259673537447,0.609546853320256,27,378,leukocyte degranulation,BP,KRT1;FTL;FTH1;C3;S100P;MMP9;B4GALT1;LGALS3;SYK;HRNR;PTPRB;MGAM;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;ITGAV;QPCT;COMMD9;HSPA8;HSP90AB1;LAIR1;LILRB3;GLIPR1;NRAS
4959,GO:0015026,0.470658727985657,0.797831246440374,2,20,coreceptor activity,MF,ITGAV;ACKR3
16494,GO:0097157,0.470887847948777,0.879800381737408,1,8,pre-mRNA intronic binding,MF,RBM4
4666,GO:0010812,0.470902116823168,0.727094414140038,4,45,negative regulation of cell-substrate adhesion,BP,GBP1;CDKN2A;CORO1C;ITGB1BP1
17104,GO:0099604,0.47097205103735,0.79884990128553,2,18,ligand-gated calcium channel activity,MF,JPH2;JPH1
15438,GO:0071688,0.471087343068441,0.904315893880583,1,3,striated muscle myosin thick filament assembly,BP,MYH11
10804,GO:0044267,0.471119992811954,0.558761227764617,281,3921,cellular protein metabolic process,BP,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;TRIM16;FN1;PML;MAP3K14;GCLC;KRT2;CYR61;C3;GPRC5A;FGFR2;STAT5A;EPGN;TRIM22;CTGF;MMP9;FBN1;HSPG2;CLN6;IL1R2;B4GALT1;G6PD;SPON1;TRIM56;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;EDN1;TPST1;GBP1;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ZBED1;PTPN14;GEMIN5;PABPC4;CHP1;ACO1;AKAP8;TGFB2;ST6GALNAC5;PRSS23;CARS2;CYLD;IKBKE;PKMYT1;CDKAL1;PPP1R3B;P3H2;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;PUM3;GALNT18;CAMK1G;SYK;EMP2;NUP153;NAIP;NBN;TRIO;PARP15;CDK4;SFRP1;RIPK4;ZDHHC6;TARDBP;MIR17HG;H3F3A;USP16;KEAP1;NAA15;DHFR;METTL21A;PTPRB;ULK4;RCE1;SETDB1;PTGER4;OPHN1;IMMP2L;CD109;P4HA2;USP43;GGCX;NDC1;HERC6;FOXRED2;EIF5;CASC3;CCL20;PLK2;MRPL27;MUC16;UBQLN2;FRK;AKAP8L;HSPB1;DOHH;SUV39H2;PTPRM;KDM6A;SETD4;RAN;RANBP2;VCPKMT;ANAPC15;CORO1C;ZNF738;DDX3X;CPA4;IL24;GPHN;KLHL21;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TRPM7;AJUBA;FASTKD3;DND1;LFNG;TRIM37;PPP4R4;GNL3L;GADD45B;GATC;SH3RF2;RARS;PHACTR4;MDM4;HIF1AN;NPNT;PDGFB;BRCC3;EIF3J;SGK494;FZD1;UTY;ANTXR1;CLU;NUP160;USP6;SMYD2;NAA50;ENPP1;BIRC3;IL20;NUP54;LRPPRC;EYA3;EFTUD2;ACKR3;RIF1;METTL16;KLHL9;SETD2;DTX4;GLIPR2;DPY19L2P2;WEE1;PDCL3;TNC;TET3;HSPA8;TMEM199;HSP90AB1;ARL6IP5;EPHB6;NEDD4L;SGK1;ANAPC7;BRCA2;SYNCRIP;TRAK2;KRT10;MTMR2;TMEM165;FKBP5;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;SERPINB9;GPER1;FAF1;RAD18;ADAM17;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMB9;EIF2B5;RFWD3;CBLL1;TAF6L;MRPS7;DPH2;NCBP1;UPF3B;SPSB1;UBE2J2;VPS36;TRAF2;TELO2;RBBP5;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;CSF1;NAA16;MPHOSPH8;CLOCK;KIF14;TLR3;ESR1;PARD3;RNF19B;USP11;FEM1C;TNF;ZFP36L2;RC3H1;TYMS;CCL5;CD74;RING1;FGFR1OP;PSMB10;EIF2B1;DAXX;METAP2;PHLPP2;HIST1H4A;TAF1;PHLPP1;NRAS;SMARCC1;MUC5B;CDKN1A;ITGB1BP1;USP1;MUC6;CTCF;RBM8A;GTF2H3;RPS12;IRAK3;COPS3;IFI27L1;UFC1
19101,GO:1904953,0.471150932725782,0.879647922399817,1,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,FZD1
14226,GO:0061135,0.47129912982193,0.691820908183021,6,83,endopeptidase regulator activity,MF,C3;NAIP;CD109;BIRC3;SERPINB9;PSME2
4360,GO:0009954,0.471349627481253,0.796768812593264,2,21,proximal/distal pattern formation,BP,PBX1;IRX2
5352,GO:0016101,0.471513642136972,0.726045416364765,4,48,diterpenoid metabolic process,BP,CYP1B1;HSPG2;CYP1A1;SRD5A1
2788,GO:0006222,0.471562534716853,0.87784094962654,1,9,UMP biosynthetic process,BP,UMPS
4117,GO:0009173,0.471562534716853,0.87784094962654,1,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,UMPS
4118,GO:0009174,0.471562534716853,0.87784094962654,1,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,UMPS
11543,GO:0046049,0.471562534716853,0.87784094962654,1,9,UMP metabolic process,BP,UMPS
5318,GO:0016032,0.471632896321887,0.58976968339751,47,680,viral process,BP,PML;TFRC;TRIM22;CBX5;HLA-B;TAP1;TP53;IL16;IL6ST;NUP50;SYK;NUP153;FAM111A;NUCKS1;TARDBP;POLA1;NDC1;RAN;RANBP2;DDX3X;ITGAV;SET;ZC3H7B;NUP160;NUP54;ACKR3;UBP1;PDCL3;HSPA8;HSP90AB1;NEDD4L;SYNCRIP;POLR2F;MSH6;CFLAR;PSMB9;CCNA2;TAP2;RBL1;TNF;TYMS;CCL5;CD74;PSMB10;DAXX;TAF1;RPS12
7491,GO:0031650,0.471694536714386,0.877763441791261,1,9,regulation of heat generation,BP,TNF
5104,GO:0015385,0.471851107085234,0.879241562655798,1,8,sodium:proton antiporter activity,MF,SLC9A9
16221,GO:0090235,0.471877513509755,0.881258928267911,1,7,regulation of metaphase plate congression,BP,HNRNPU
20056,GO:2000643,0.471969784235254,0.879172598961345,1,8,positive regulation of early endosome to late endosome transport,BP,MTMR2
9905,GO:0042178,0.472232960530603,0.876195611018824,1,10,xenobiotic catabolic process,BP,CYP1A1
10371,GO:0043175,0.472274997844799,0.75264957427851,3,35,RNA polymerase core enzyme binding,MF,RRN3;SMYD2;HNRNPU
10541,GO:0043471,0.472286331652233,0.877415569795494,1,9,regulation of cellular carbohydrate catabolic process,BP,PPP1R3B
11449,GO:0045860,0.472312223858831,0.606354191799447,28,370,positive regulation of protein kinase activity,BP,SAA1;NRG1;MAP3K14;CYR61;EPGN;EDN1;TGFB2;SYK;EMP2;DDX3X;SOCS1;AJUBA;GADD45B;PDGFB;CLU;HSP90AB1;ADAM17;TRAF2;TELO2;CSF1;KIF14;TLR3;TNF;CCL5;CD74;DAXX;CDKN1A;ITGB1BP1
4178,GO:0009251,0.472399400544335,0.796501581215599,2,20,glucan catabolic process,BP,PPP1R3B;MGAM
434,GO:0001162,0.472811133597554,0.878682963071773,1,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,HSF2
13620,GO:0060070,0.472811234467072,0.624284306756128,18,241,canonical Wnt signaling pathway,BP,FGFR2;DAPK3;JRK;CYLD;NAIP;SFRP1;WNT10A;G3BP1;WNT4;KDM6A;DDX3X;ARNTL;KREMEN2;FZD1;RBMS3;PSME2;PSMB9;PSMB10
2248,GO:0005158,0.472838316125707,0.797429915705122,2,18,insulin receptor binding,MF,IRS1;ENPP1
6433,GO:0021696,0.473028766876353,0.7966171043312,2,19,cerebellar cortex morphogenesis,BP,OPHN1;KIF14
2820,GO:0006285,0.473033022540956,0.875720208116169,1,10,base-excision repair, AP site formation,BP,SMUG1
17322,GO:0140078,0.473035044159445,0.87571900538291,1,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,APEX1
17323,GO:0140080,0.473035044159445,0.87571900538291,1,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,APEX1
14101,GO:0060900,0.47308646795522,0.880565514911319,1,7,embryonic camera-type eye formation,BP,PHACTR4
18274,GO:1903069,0.47311426002945,0.876927830052831,1,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,UBQLN2
2198,GO:0005068,0.473390686835372,0.880390615886712,1,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,IRS1
1407,GO:0003338,0.473442197022816,0.795702765521749,2,20,metanephros morphogenesis,BP,WNT4;FRAS1
8211,GO:0032957,0.473500139893111,0.878281038076576,1,8,inositol trisphosphate metabolic process,BP,GPER1
3576,GO:0007622,0.473833169607375,0.794376073374961,2,22,rhythmic behavior,BP,TP53;SRD5A1
12255,GO:0048512,0.473833169607375,0.794376073374961,2,22,circadian behavior,BP,TP53;SRD5A1
3201,GO:0006836,0.47403311496436,0.654817888941683,10,127,neurotransmitter transport,BP,EDN1;SYK;CADPS2;SLC1A3;HSPA8;SYT11;ARL6IP5;RAB3GAP1;GPER1;SLC25A22
18626,GO:1903867,0.474300716919306,0.87781295607562,1,8,extraembryonic membrane development,BP,E2F8
7580,GO:0031937,0.474418707532327,0.877743871570121,1,8,positive regulation of chromatin silencing,BP,SETDB1
7264,GO:0031226,0.474506209387798,0.58100653316861,59,773,intrinsic component of plasma membrane,CC,NRG1;TENM3;TFRC;GPRC5A;FGFR2;EPGN;SLC16A2;SLC7A2;TRAF3;IRS1;SLC16A9;SLC7A5P2;C1QTNF1;IFNGR1;SLC4A11;PDPN;CNTNAP1;IL27RA;PCDH7;IL6ST;SLC22A5;SHISA9;LRRC8D;ATP2B1;SLC5A6;PTPRB;RCE1;ABCC4;KCNS3;SLC1A3;SLCO4C1;MME;BTN2A1;PTPRM;RAB26;ITGAV;KCNQ5;NPNT;ENPP1;THBD;ABCC9;IFNAR1;SLC11A2;CXCR5;CNTNAP2;SYT11;EPHB6;M6PR;STEAP4;IL12RB2;GPER1;ADAM17;LILRB3;EBP;TRAF2;TLR3;TNF;SLC43A2;HNRNPM
12667,GO:0050852,0.474512710738275,0.653862130321408,10,141,T cell receptor signaling pathway,BP,GBP1;LGALS3;CYLD;BTN2A1;PSME2;PSMB9;EIF2B5;RC3H1;PSMB10;EIF2B1
5659,GO:0016755,0.474539021984652,0.876085583366957,1,9,transferase activity, transferring amino-acyl groups,MF,QPCT
10630,GO:0043616,0.474625320021305,0.751217278455805,3,33,keratinocyte proliferation,BP,KRT2;CD109;CDH13
13099,GO:0051588,0.474659451110671,0.723305010367868,4,48,regulation of neurotransmitter transport,BP,SYT11;ARL6IP5;RAB3GAP1;GPER1
13012,GO:0051409,0.47483812098721,0.875908303402704,1,9,response to nitrosative stress,BP,GCLC
4089,GO:0009142,0.474868356236089,0.660384658388778,9,120,nucleoside triphosphate biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54;TYMS;TBPL1
1704,GO:0004181,0.475080617214996,0.877355852162528,1,8,metallocarboxypeptidase activity,MF,CPA4
12213,GO:0048368,0.475081457718095,0.877355358952237,1,8,lateral mesoderm development,BP,CITED2
14519,GO:0062009,0.475719146436902,0.876980788838964,1,8,secondary palate development,BP,FZD1
9852,GO:0042088,0.47617568719319,0.792120880422608,2,23,T-helper 1 type immune response,BP,IL27RA;RELB
443,GO:0001191,0.476396041510297,0.749197566410263,3,35,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,ZFP42;PARP15;CITED2
17092,GO:0099565,0.476409450057491,0.721942022639651,4,47,chemical synaptic transmission, postsynaptic,BP,NETO1;BAIAP2;MTMR2;RAB3GAP1
13678,GO:0060170,0.476507896855847,0.722212691668401,4,45,ciliary membrane,CC,BBS5;EHD1;PHLPP2;PHLPP1
5010,GO:0015165,0.476511226063819,0.8749136303903,1,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,SLC35A4
10258,GO:0042983,0.476636400572886,0.874839008190736,1,9,amyloid precursor protein biosynthetic process,BP,BACE2
10259,GO:0042984,0.476636400572886,0.874839008190736,1,9,regulation of amyloid precursor protein biosynthetic process,BP,BACE2
13723,GO:0060259,0.47667577013449,0.876417501004209,1,8,regulation of feeding behavior,BP,LEPR
13092,GO:0051580,0.476718559841113,0.874790013794857,1,9,regulation of neurotransmitter uptake,BP,ARL6IP5
6939,GO:0030539,0.477081271722224,0.876178229592379,1,8,male genitalia development,BP,SRD5A1
10047,GO:0042490,0.477177529688816,0.748800445981724,3,34,mechanoreceptor differentiation,BP,FAT4;SLC9A3R1;WDPCP
3228,GO:0006883,0.477203469022463,0.876106067036426,1,8,cellular sodium ion homeostasis,BP,NEDD4L
4787,GO:0010972,0.477281933508211,0.686110405312973,6,87,negative regulation of G2/M transition of mitotic cell cycle,BP,GPR132;NBN;TOPBP1;PSME2;PSMB9;PSMB10
10557,GO:0043497,0.477747805383377,0.874175194892396,1,9,regulation of protein heterodimerization activity,BP,NRG1
12661,GO:0050840,0.478057836490454,0.748059690412234,3,34,extracellular matrix binding,MF,CYR61;LGALS3;ITGAV
14056,GO:0060765,0.478202893791452,0.790995068883094,2,22,regulation of androgen receptor signaling pathway,BP,SFRP1;TAF1
9947,GO:0042288,0.478429394335412,0.873766982420525,1,9,MHC class I protein binding,MF,TAP1
16830,GO:0098657,0.478513067048767,0.589701227091555,38,501,import into cell,BP,SAA1;TFRC;C3;HSPG2;SLC7A2;ACTG1;LGALS3;SYK;LEPR;OPHN1;ADM;SLC1A3;UBQLN2;RHOG;CXCL16;SIRPA;CORO1C;ITGAV;SNX11;SNX5;BAIAP2;CDH13;CLU;ENPP1;ACKR3;SYT11;HSP90AB1;ARL6IP5;NEDD4L;M6PR;MTMR2;STEAP4;MYO10;CBLL1;RABEP2;SLC9A9;EHD1;TNF
3532,GO:0007520,0.478517403237732,0.791244766312434,2,21,myoblast fusion,BP,CFLAR;EHD1
15518,GO:0071872,0.47873192859986,0.875201157519158,1,8,cellular response to epinephrine stimulus,BP,SRD5A1
275,GO:0000777,0.479032940052968,0.673645879440374,7,92,condensed chromosome kinetochore,CC,SKA2;CENPF;ORC2;CENPN;HNRNPU;DCTN5;CENPO
211,GO:0000439,0.47921240314421,0.873296978106493,1,9,core TFIIH complex,CC,GTF2H3
15499,GO:0071827,0.479227201059681,0.790198228065291,2,22,plasma lipoprotein particle organization,BP,ACSL3;ABCA5
20243,GO:2001135,0.479252924084851,0.874891736140777,1,8,regulation of endocytic recycling,BP,EHD1
11917,GO:0046929,0.47927486360212,0.874878695320407,1,8,negative regulation of neurotransmitter secretion,BP,SYT11
11891,GO:0046883,0.479320470186748,0.643993427856243,11,143,regulation of hormone secretion,BP,IRS1;EDN1;C1QTNF1;INHBA;SFRP1;KCNS3;ARNTL;GPER1;CLOCK;TNF;CCL5
11128,GO:0045136,0.479842550515751,0.872917912845389,1,9,development of secondary sexual characteristics,BP,B4GALT1
5188,GO:0015749,0.479855824024569,0.684913976374455,6,72,monosaccharide transmembrane transport,BP,C3;IRS1;ENPP1;PIK3R3;M6PR;TNF
13041,GO:0051457,0.479858116139512,0.789706604610425,2,22,maintenance of protein location in nucleus,BP,PML;HNRNPU
13267,GO:0051923,0.479952460316583,0.872851721907872,1,9,sulfation,BP,TPST1
8994,GO:0035094,0.480080819806883,0.790029259297762,2,21,response to nicotine,BP,EDN1;TNF
692,GO:0001909,0.480185454742328,0.717723022791728,4,53,leukocyte mediated cytotoxicity,BP,IL7R;EMP2;SERPINB9;DNASE1
10558,GO:0043500,0.480383465019552,0.698989991773619,5,60,muscle adaptation,BP,G6PD;EDN1;IL6ST;MIR17HG;CFLAR
8145,GO:0032839,0.480458771262161,0.789237982660713,2,22,dendrite cytoplasm,CC,BAIAP2;TRAK2
19675,GO:1990841,0.48047783861647,0.746296703182159,3,33,promoter-specific chromatin binding,MF,SETDB1;RBL1;HNRNPU
8791,GO:0034464,0.480540028499188,0.872497494341575,1,9,BBSome,CC,BBS5
18609,GO:1903828,0.480693107500336,0.683708363525131,6,77,negative regulation of cellular protein localization,BP,GBP1;CHP1;POLR1A;NEDD4L;ITGB1BP1;ASTN2
10315,GO:0043069,0.480730787316101,0.58157265830291,46,632,negative regulation of programmed cell death,BP,CRYAB;NEFL;GCLC;CYR61;FGFR2;MMP9;TSC22D3;TP53;EDN1;NQO1;LGALS3;PDPN;IFIT3;IL6ST;BAG1;NAIP;SFRP1;MIR17HG;NAA15;PLK2;HSPB1;WNT4;SOD2;DDX3X;RRN3;ITGAV;SET;MDM4;CLU;BIRC3;EYA3;ACKR3;HSP90AB1;EPHB6;SERPINB9;CFLAR;AKR1B1;TRAF2;CITED2;NAA16;KIF14;TNF;CCL5;CD74;CDKN1A;GPX4
9561,GO:0036314,0.480896762517255,0.790553897374493,2,19,response to sterol,BP,HMGCS1;INHBA
14039,GO:0060742,0.480992077946386,0.873855260708378,1,8,epithelial cell differentiation involved in prostate gland development,BP,FGFR2
2241,GO:0005149,0.481086861862234,0.872167254024562,1,9,interleukin-1 receptor binding,MF,ERAP1
8327,GO:0033157,0.481090437090403,0.621997143102915,16,212,regulation of intracellular protein transport,BP,NRG1;TP53;PTPN14;CHP1;RBM22;AKAP8L;LCP1;NUP54;SETD2;HSP90AB1;WDR75;UBE2J2;STARD7;CDKN1A;ITGB1BP1;TSGA13
8950,GO:0034982,0.481126466871296,0.870845181785926,1,10,mitochondrial protein processing,BP,IMMP2L
12608,GO:0050765,0.481205229265979,0.872095697811865,1,9,negative regulation of phagocytosis,BP,SYT11
6235,GO:0019783,0.481450213771174,0.662535500600949,8,97,ubiquitin-like protein-specific protease activity,MF,CYLD;USP16;USP43;BRCC3;USP6;SENP1;USP11;USP1
364,GO:0000982,0.481587550551953,0.609037897629644,21,270,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MAFB;FOSL2;PBX1;TP53;ZBED1;ZFP42;NUCKS1;MYBL2;ARNTL;SRF;GLIS2;MYBL1;E2F8;ETV6;RBL1;CLOCK;ESR1;TBPL1;ARID3B;IRF1;CTCF
9856,GO:0042092,0.481605774717522,0.787474560718859,2,24,type 2 immune response,BP,IL27RA;CD74
8231,GO:0032982,0.481702704144573,0.875547714475213,1,7,myosin filament,CC,MYH11
1017,GO:0002504,0.481877517160438,0.682622826403966,6,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,KIF23;HLA-DOB;DYNLL2;IFI30;CD74;DCTN5
5339,GO:0016073,0.482047536793295,0.681942596073722,6,84,snRNA metabolic process,BP,DKC1;PHAX;USB1;METTL16;POLR2F;NCBP1
2734,GO:0006112,0.482074638111414,0.697589132265326,5,59,energy reserve metabolic process,BP,IRS1;PPP1R3B;IL6ST;LEPR;ENPP1
7242,GO:0031145,0.482107091293379,0.695843447963726,5,77,anaphase-promoting complex-dependent catabolic process,BP,ANAPC15;ANAPC7;PSME2;PSMB9;PSMB10
12645,GO:0050811,0.482141752423808,0.871528634341872,1,9,GABA receptor binding,MF,TRAK2
5873,GO:0017182,0.482178056689434,0.871506619576612,1,9,peptidyl-diphthamide metabolic process,BP,DPH2
5874,GO:0017183,0.482178056689434,0.871506619576612,1,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,DPH2
18018,GO:1902430,0.48225616337125,0.87309843861861,1,8,negative regulation of amyloid-beta formation,BP,CLU
18503,GO:1903578,0.482271755650273,0.682518078170399,6,74,regulation of ATP metabolic process,BP,NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54
19908,GO:2000353,0.482410553009542,0.873005803128165,1,8,positive regulation of endothelial cell apoptotic process,BP,GPER1
8020,GO:0032647,0.482780014332649,0.787921726961262,2,21,regulation of interferon-alpha production,BP,SETD2;TLR3
554,GO:0001675,0.482945140032638,0.872684706994367,1,8,acrosome assembly,BP,TBPL1
7813,GO:0032357,0.483358051742822,0.870789749525415,1,9,oxidized purine DNA binding,MF,MSH6
10776,GO:0044212,0.483417652004559,0.578438168560212,47,610,transcription regulatory region DNA binding,MF,MAFB;FOSL2;NLRC5;RUNX1;PBX1;TFCP2L1;TP53;ZBED1;ZFP42;RELB;H3F3A;AHR;TAF2;ELMSAN1;MYBL2;SUV39H2;KDM6A;UBTF;RRN3;ARNTL;SRF;UTY;NFE2L1;MACC1;KANSL1L;GLIS2;MYBL1;CCAR1;MAZ;E2F8;ETV6;HSF2;RBBP5;RBL1;CLOCK;PURB;ESR1;TNF;HNRNPU;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;ARID3B;IRF1;CTCF
1312,GO:0003157,0.483518251930041,0.872339888043608,1,8,endocardium development,BP,NRG1
10719,GO:0044003,0.483568220290106,0.743399095854605,3,34,modification by symbiont of host morphology or physiology,BP,ITGAV;SERPINB9;TYMS
8168,GO:0032891,0.483629948780958,0.872272614116238,1,8,negative regulation of organic acid transport,BP,ARL6IP5
2502,GO:0005750,0.483681802801501,0.868212481039129,1,11,mitochondrial respiratory chain complex III,CC,UQCRB
11198,GO:0045275,0.483681802801501,0.868212481039129,1,11,respiratory chain complex III,CC,UQCRB
849,GO:0002162,0.483712427699571,0.874358024822071,1,7,dystroglycan binding,MF,MAP2
12982,GO:0051345,0.483897988799892,0.581236888116495,42,562,positive regulation of hydrolase activity,BP,FN1;PML;CYR61;FGFR2;STARD13;CTGF;DOCK10;SIPA1L3;SFRP1;TPM1;OPHN1;DYNLL2;CCL20;HSCB;RHOG;WNT4;RANBP2;CORO1C;DDX3X;CDC42EP2;NPNT;TBC1D15;ANTXR1;USP6;HSP90AB1;ARL6IP5;RAB3GAP1;GPER1;SENP1;PSME2;MSH6;CFLAR;DNAJC9;RABEP2;TRAF2;MSH3;ESR1;TNF;CCL5;HNRNPU;PPARGC1B;IFI27L1
6932,GO:0030520,0.484323105230856,0.714981793708293,4,47,intracellular estrogen receptor signaling pathway,BP,RUNX1;DDX17;ESR1;PPARGC1B
6691,GO:0030056,0.484460417471248,0.876795529688179,1,6,hemidesmosome,CC,DST
8158,GO:0032878,0.484471200168898,0.787150625407782,2,20,regulation of establishment or maintenance of cell polarity,BP,WDPCP;SHTN1
17767,GO:1901678,0.484579311251408,0.870045096672046,1,9,iron coordination entity transport,BP,ABCG2
16295,GO:0090343,0.484587907137718,0.868723304096519,1,10,positive regulation of cell aging,BP,CDKN2A
14375,GO:0061577,0.484640026307137,0.87166321119204,1,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
7051,GO:0030819,0.48472784461674,0.869954341051962,1,9,positive regulation of cAMP biosynthetic process,BP,GPER1
5060,GO:0015267,0.48477510940086,0.629460367835502,13,164,channel activity,MF,JPH2;SLC4A11;LRRC8D;KCNS3;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;CLCC1;GJC1;KCNE4;PANX1
6610,GO:0022803,0.48477510940086,0.629460367835502,13,164,passive transmembrane transporter activity,MF,JPH2;SLC4A11;LRRC8D;KCNS3;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;CLCC1;GJC1;KCNE4;PANX1
163,GO:0000338,0.484784595349829,0.868602063964767,1,10,protein deneddylation,BP,COPS3
2687,GO:0006048,0.484814102784637,0.869901617506102,1,9,UDP-N-acetylglucosamine biosynthetic process,BP,UAP1L1
8512,GO:0033683,0.484867594115081,0.741113307564306,3,39,nucleotide-excision repair, DNA incision,BP,RPA1;RFC3;GTF2H3
19311,GO:1905476,0.484903038627059,0.78575307788025,2,22,negative regulation of protein localization to membrane,BP,GBP1;ITGB1BP1
10123,GO:0042632,0.484911525022224,0.74174298993649,3,36,cholesterol homeostasis,BP,TMEM97;COMMD9;EHD1
13541,GO:0055092,0.484911525022224,0.74174298993649,3,36,sterol homeostasis,BP,TMEM97;COMMD9;EHD1
10421,GO:0043249,0.48502348360493,0.869773580292158,1,9,erythrocyte maturation,BP,G6PD
12695,GO:0050884,0.485263967882218,0.871285833297136,1,8,neuromuscular process controlling posture,BP,CNTNAP1
12920,GO:0051247,0.485286945866557,0.562076887703489,84,1151,positive regulation of protein metabolic process,BP,IGFBP3;SAA1;NRG1;FN1;PML;MAP3K14;GCLC;CYR61;C3;FGFR2;EPGN;CTGF;MMP9;CLN6;MID1;TP53;EDN1;C1QTNF1;CHP1;AKAP8;TGFB2;IL6ST;INHBA;SYK;EMP2;NBN;CDK4;USP16;KEAP1;CCL20;PLK2;UBQLN2;AKAP8L;HSPB1;DDX3X;IL24;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;FASTKD3;DND1;GADD45B;NPNT;PDGFB;FZD1;ANTXR1;CLU;BIRC3;IL20;ACKR3;RIF1;GLIPR2;HSP90AB1;ARL6IP5;EPHB6;NSF;NEDD4L;RAB3GAP1;GPER1;ADAM17;SENP1;RBMS3;PSME2;CFLAR;EIF2B5;UPF3B;TRAF2;TELO2;CSF1;KIF14;TLR3;ESR1;RNF19B;TNF;CCL5;CD74;DAXX;TAF1;CDKN1A;ITGB1BP1;IRF1;IFI27L1
1458,GO:0003691,0.485373163367609,0.869559568134853,1,9,double-stranded telomeric DNA binding,MF,APEX1
11387,GO:0045738,0.485466118471407,0.785813072637514,2,21,negative regulation of DNA repair,BP,POLQ;RIF1
2520,GO:0005773,0.485581442064579,0.578124377174334,44,601,vacuole,CC,FTL;FTH1;C3;VMP1;HSPG2;B4GALT1;VPS41;HLA-DOB;HRNR;AP5M1;DRAM1;TMEM97;RRAGB;SLCO4C1;UBQLN2;FRK;CHID1;USP6;ENPP1;SPNS1;THBD;IFNAR1;SLC11A2;BLOC1S2;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;MFSD12;M6PR;TMEM138;MTMR2;TMEM165;ABCA5;AKR1B1;VPS36;IFI30;AP3B1;GLIPR1;TLR3;RNF19B;PLBD1;CD74
5421,GO:0016266,0.485650971196376,0.71436436367095,4,44,O-glycan processing,BP,GALNT18;MUC16;MUC5B;MUC6
14644,GO:0070199,0.485753443782718,0.784624366611365,2,23,establishment of protein localization to chromosome,BP,DKC1;BRCA2
5148,GO:0015677,0.48611875052996,0.870767668994965,1,8,copper ion import,BP,STEAP4
13509,GO:0055026,0.486127255237173,0.785292324816002,2,21,negative regulation of cardiac muscle tissue development,BP,G6PD;MIR17HG
17695,GO:1901532,0.486595811706971,0.676699690828692,6,103,regulation of hematopoietic progenitor cell differentiation,BP,RUNX1;H3F3A;PSME2;PSMB9;PSMB10;HIST1H4A
16535,GO:0097225,0.486817743452052,0.867344580609351,1,10,sperm midpiece,CC,SLC9A3R1
6061,GO:0019206,0.487235149104807,0.867085461724164,1,10,nucleoside kinase activity,MF,TK1
15944,GO:0072711,0.487243661995349,0.870083694027119,1,8,cellular response to hydroxyurea,BP,TIMELESS
19835,GO:2000249,0.487286519283612,0.783411067584733,2,23,regulation of actin cytoskeleton reorganization,BP,DAPK3;BAIAP2
16271,GO:0090308,0.4873322521408,0.870029729350736,1,8,regulation of methylation-dependent chromatin silencing,BP,SETDB1
2838,GO:0006307,0.487586965609335,0.866866805759019,1,10,DNA dealkylation involved in DNA repair,BP,FTO
3908,GO:0008553,0.487644916113502,0.868163659931303,1,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,ATP2C1
7290,GO:0031272,0.487663177710189,0.868152399855117,1,9,regulation of pseudopodium assembly,BP,CDC42EP2
7291,GO:0031274,0.487663177710189,0.868152399855117,1,9,positive regulation of pseudopodium assembly,BP,CDC42EP2
12984,GO:0051347,0.487802741800294,0.582315363806423,36,481,positive regulation of transferase activity,BP,SAA1;NRG1;MAP3K14;CYR61;FGFR2;EPGN;IRS1;EDN1;TGFB2;DKC1;SYK;EMP2;NBN;RFC3;RANBP2;DDX3X;SOCS1;AJUBA;NVL;GADD45B;PDGFB;CLU;HSP90AB1;EPHB6;ADAM17;TRAF2;TELO2;CSF1;KIF14;TLR3;TNF;CCL5;CD74;DAXX;CDKN1A;ITGB1BP1
152,GO:0000307,0.487862644208447,0.738984841411173,3,37,cyclin-dependent protein kinase holoenzyme complex,CC,CDK4;CCNA2;CDKN1A
10312,GO:0043066,0.488022903510282,0.575034981412568,45,619,negative regulation of apoptotic process,BP,CRYAB;NEFL;GCLC;CYR61;FGFR2;MMP9;TSC22D3;TP53;EDN1;NQO1;LGALS3;PDPN;IFIT3;IL6ST;BAG1;NAIP;SFRP1;MIR17HG;NAA15;PLK2;HSPB1;WNT4;SOD2;DDX3X;RRN3;ITGAV;SET;MDM4;CLU;BIRC3;EYA3;ACKR3;HSP90AB1;EPHB6;SERPINB9;CFLAR;AKR1B1;TRAF2;CITED2;NAA16;KIF14;TNF;CCL5;CD74;CDKN1A
2640,GO:0005975,0.488101287478074,0.584930252055099,33,448,carbohydrate metabolic process,BP,IGFBP3;GCLC;UGT1A6;GNPTAB;B4GALT1;G6PD;IRS1;C1QTNF1;ST6GALNAC5;PPP1R3B;PGD;IL6ST;NUP50;GALNT18;NUP153;LEPR;LDHAL6B;MGAM;NDC1;RANBP2;PGK1;GANC;PDGFB;CHID1;NUP160;ENPP1;NUP54;PPIP5K1;MTMR2;GPER1;UGT1A4;AKR1B1;TNF
19923,GO:2000378,0.488121499744724,0.738762962205124,3,37,negative regulation of reactive oxygen species metabolic process,BP,CRYAB;G6PD;CFLAR
4111,GO:0009165,0.488401771642593,0.611832291176725,17,234,nucleotide biosynthetic process,BP,PANK2;NUP50;NUP153;TK1;ADM;NDC1;RANBP2;PGK1;NUP160;RRM2;NUP54;UMPS;GPER1;RRM1;TYMS;FLAD1;TBPL1
3386,GO:0007165,0.488452966826855,0.541845865085311,271,3680,signal transduction,BP,IL32;CRYAB;IGFBP3;SAA1;DTX2;NEFL;NRG1;TRIM16;FN1;TENM3;PTGES;PML;CYP1B1;AMOT;JPH2;MAP3K14;GCLC;CYR61;C3;GPRC5A;CYP24A1;COL16A1;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;TRIM22;STARD13;CTGF;HLA-B;MMP9;FBN1;XAF1;RUNX1;IL1R2;FAT4;ACTG1;PBX1;FST;DDX17;TRAF3;IRS1;SPG21;MID1;TP53;DAPK3;TUFT1;EXO1;EDN1;GBP1;DOCK10;DDX47;SIPA1L3;C1QTNF1;DUSP14;CDKN2A;JRK;LGALS3;IFNGR1;CHP1;PDPN;AKAP8;TGFB2;CNTNAP1;CYLD;IKBKE;IL27RA;IL16;IFIT3;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;NUAK1;INHBA;IL7R;PALM2;CAMK1G;SYK;EMP2;TJP2;NAIP;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;BRIP1;ARFRP1;LRRC8D;HLA-F;CDK4;SFRP1;HLA-DOB;NUCKS1;CD274;WNT10A;MIR17HG;DST;COL4A1;AHR;RPA1;TAF2;ULK4;SETDB1;PTGER4;G3BP1;TRAF1;OPHN1;ADM;CD109;DYNLL2;CCL20;PLK2;RRAGB;MUC16;UBQLN2;FRK;BTN2A1;RFC3;HSPB1;RHOG;WNT4;CXCL16;NOP2;LCP1;PTPRM;KDM6A;THOC1;RAN;TOPBP1;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;RAB26;IL24;ARHGEF28;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;LFNG;NETO1;CDC42EP2;BAIAP2;GADD45B;CDH13;PHACTR4;MDM4;HIF1AN;NPNT;PDGFB;BRCC3;KREMEN2;FZD1;ANTXR1;RTKN2;CLU;SMYD2;MACC1;ENPP1;BIRC3;IL20;PIK3R3;NFKBIB;SPNS1;EYA3;ZNF106;ACKR3;FGD6;GLIS2;RPF2;THBD;ABCC9;DTX4;GLIPR2;JPH1;SRPRB;IFNAR1;TJP1;ERAP1;BLOC1S2;CXCR5;HSPA8;HSP90AB1;ARL6IP5;EPHB6;SGK1;M6PR;ZFYVE27;BRCA2;HCAR1;WDPCP;FANCD2;E2F8;MTMR2;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;GPER1;FAF1;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;EIF2B5;CMTM3;HNRNPDL;SHTN1;RABEP2;EBP;NCBP1;AKR1B1;TRAF2;TPRA1;TELO2;CITED2;CCNA2;IFI30;CSF1;CLOCK;KIF14;TLR3;ESR1;PARD3;TNF;ZFP36L2;NEDD9;RC3H1;CCL5;CD74;PSMB10;EIF2B1;DAXX;METAP2;PHF14;PHLPP2;TAF1;PHLPP1;NRAS;SMARCC1;MUC5B;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;MUC6;IRF1;IRAK3;COPS3;IFI27L1
396,GO:0001067,0.4885915110773,0.573335513397749,47,611,regulatory region nucleic acid binding,MF,MAFB;FOSL2;NLRC5;RUNX1;PBX1;TFCP2L1;TP53;ZBED1;ZFP42;RELB;H3F3A;AHR;TAF2;ELMSAN1;MYBL2;SUV39H2;KDM6A;UBTF;RRN3;ARNTL;SRF;UTY;NFE2L1;MACC1;KANSL1L;GLIS2;MYBL1;CCAR1;MAZ;E2F8;ETV6;HSF2;RBBP5;RBL1;CLOCK;PURB;ESR1;TNF;HNRNPU;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;ARID3B;IRF1;CTCF
11126,GO:0045132,0.488670903470503,0.710791920720266,4,49,meiotic chromosome segregation,BP,BRIP1;NDC1;SMC2;FANCD2
1427,GO:0003376,0.488793195557601,0.867454419586624,1,9,sphingosine-1-phosphate signaling pathway,BP,SPNS1
16340,GO:0090520,0.488793195557601,0.867454419586624,1,9,sphingolipid mediated signaling pathway,BP,SPNS1
4834,GO:0014037,0.488820357997388,0.739828707084758,3,31,Schwann cell differentiation,BP,CNTNAP1;MPP5;PARD3
2435,GO:0005623,0.488827948790419,0.563391402534735,798,11105,cell,CC,IL32;CRYAB;IGFBP3;MAFB;SPRR3;KRT1;TRIM47;SAA1;FTL;FTH1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;KRT34;KRT4;TRIM16;MAP2;KRT13;FN1;TRIM16L;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;KRT2;TFRC;CYR61;C3;GPRC5A;KRT15;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;UGT1A6;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;FADS3;COL5A3;S100P;SLC16A2;CTGF;HLA-B;UTP20;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;XAF1;SLC7A2;RUNX1;MYO1B;CYP1A1;ERVFRD-1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;NEFM;G6PD;TSC22D3;MAT2A;DDX17;SPON1;FAM69B;TRIM56;TFCP2L1;KRTAP2-3;TRAF3;COL27A1;ENC1;IRS1;DYNC2H1;SPG21;MID1;SLC16A9;TP53;DAPK3;TUFT1;SVEP1;PANK2;SLC7A5P2;EXO1;EDN1;TPST1;C9ORF3;SCD;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;ABCF1;C1QTNF1;DUSP14;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;TCP11L1;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;PRUNE2;MEGF11;LGALS3;IFNGR1;CHP1;SLC4A11;ACO1;PDPN;AKAP8;PPAN;TGFB2;IRX2;ST6GALNAC5;CNTNAP1;PRSS23;ZNF208;RBM22;CARS2;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;CDKAL1;IL27RA;IL16;IFIT3;SRSF2;FOXD2;PCDH7;LRFN4;PPP1R3B;COL12A1;SLC30A6;SUGP2;PGD;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;PDCD11;C15ORF39;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PALM2;PUM3;GALNT18;CAMK1G;PHAX;DNHD1;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;VEZT;FAM111A;PARP15;BRIP1;MCM5;SHQ1;ABCG2;LSS;UTP15;ARFRP1;LRRC8D;LDHAL6B;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;POP1;HLA-DOB;RIPK4;GPCPD1;NUCKS1;PITHD1;HEATR1;ZDHHC6;CD274;MCM2;TARDBP;LAYN;GEMIN4;ABHD4;DST;VPS8;POLQ;TSR1;H3F3A;ATP2B1;COL4A1;PUS3;USP16;AHR;APOL6;COA7;KEAP1;NAA15;UAP1L1;TRA2A;TCHH;ZNF827;SLC5A6;HRNR;DHFR;RPA1;AP5M1;POLR1A;THUMPD3;TPM1;ZMAT2;GLIS3;HELLS;CSRP1;METTL21A;PTPRB;METTL1;TAF2;POLA1;RCE1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;PTGER4;TK1;TMEM97;LSG1;G3BP1;GRWD1;ARRDC1-AS1;ZNF584;TRAF1;URM1;PARD3B;OPHN1;ADM;MGAM;IMMP2L;CD109;P4HA2;USP43;ZNF407;ELMSAN1;GGCX;NDC1;CADPS2;HERC6;DYNLL2;HNRNPA1L2;FOXRED2;SLC35A4;MDN1;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;CDV3;ZNF512;MRPL27;SLCO4C1;MME;ZNF587;MUC16;UBQLN2;NEXN;HSCB;FRK;DNTTIP2;GBP5;BTN2A1;KANK4;RFC3;AKAP8L;MYBL2;WDR76;NOP58;HSPB1;RHOG;WNT4;CXCL16;NOP2;DOHH;SUV39H2;LCP1;GPRIN1;EXOG;PTPRM;SIRPA;GTF3C6;KDM6A;DDX28;THOC1;SETD4;RAN;HMGXB3;UBTF;RRP7BP;RANBP2;HS3ST1;VCPKMT;TOPBP1;ANAPC15;SOD2;ORC4;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;ARHGEF28;ARMC5;GPHN;KLHL21;RRN3;RNF115;RRP12;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;TAF1D;ODC1;ABCF2;SNX11;TRPM7;AJUBA;SMC2;ARMC6;FASTKD3;KCNQ5;CGNL1;UTP14A;DND1;ZNF267;CROT;RBMXL1;AKR1C2;KRT24;LFNG;ZC3H7B;RBM12;PGK1;SNX5;TRIM37;NETO1;FEN1;MCM3;LUC7L;CDC42EP2;CDCA5;HACD2;PPP4R4;GNL3L;ZNF586;TTC1;YRDC;BAIAP2;NVL;GADD45B;WDR7;GATC;SH3RF2;APTX;CDH13;COL5A2;GINS4;IBA57;RRP1;RARS;COMMD4;PHACTR4;SRF;GDAP1;MDM4;LUC7L2;USB1;HIF1AN;NPNT;QDPR;WDR3;ZNF234;APMAP;WDR43;MCM8;PDGFB;UGT8;UTP18;BRCC3;CHID1;EIF3J;ODF2L;KREMEN2;SDK1;FZD1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CEP95;ISG20L2;CLU;NUP160;USP6;SDAD1;SMYD2;MACC1;NAA50;ENPP1;BIRC3;FRAS1;ZNF316;PIK3R3;DDX10;MBOAT1;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;EFTUD2;ZNF106;TRUB2;DDX24;TPM4;VGLL3;KANSL1L;ACKR3;RIF1;METTL16;MCM6;FGD6;SRD5A1;KLHL9;SETD2;RRP36;GLIS2;ANLN;TIMM23B;RPF2;UBP1;THBD;UPK3B;ABCC9;TRMT5;TTF2;DTX4;URB2;GLIPR2;JPH1;SRPRB;DPY19L2P2;SEPHS2;NNT;IFNAR1;WEE1;TJP1;ZNF484;THADA;NOL12;KCTD3;ERAP1;SLC11A2;BLOC1S2;APEX1;RIC3;PDCL3;CXCR5;TNC;CNTNAP2;ZNF57;TET3;UMPS;ORC1;MYBL1;HSPA8;SYT11;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;SMUG1;BACE2;SCD5;ZBTB24;NSF;DNPEP;HELQ;LAIR1;MYH11;MFSD12;NEDD4L;SGK1;M6PR;PRIM2;ZBTB12;ZFYVE27;ANAPC7;PXMP2;TMEM138;BRCA2;HPS5;GEMIN8;SYNCRIP;NAV2;TRAK2;TRMT1;HCAR1;DGCR8;DPYD;SS18L2;KRT10;CCAR1;SKA2;PPIP5K1;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;PLEKHA7;GOSR1;ETV6;TMEM165;L1CAM;ZNFX1;STEAP4;FKBP5;IQCJ-SCHIP1;HSF2;POLR2F;CCDC47;FCF1;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;BBS5;GPER1;HMGN2;FAF1;MMAA;RRM1;MLLT10;RAD18;RPTN;ANKRD13A;WDR75;BMS1;MCM4;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;HADHB;CEP152;LILRB3;CFLAR;PSMC3IP;NIFK;NOL9;PSMB9;DNAJC9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;SDHD;NFKBIE;TRMT61A;CBLL1;UGT1A4;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;TAF6L;MRPS7;DPH2;EBP;CSRP2;NCBP1;MYNN;UPF3B;AKR1B1;SPSB1;POLR1E;UBE2J2;VPS36;JRKL;TRAF2;MSH3;TELO2;EDRF1;RBBP5;FAM208B;CITED2;POLR3B;LRRC75A-AS1;HNRNPR;NCL;CCNA2;GTF3C4;NOP56;SLC9A9;POLE3;DDX56;TAP2;TIMELESS;ORC2;IFI30;UQCRB;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;NSA2;KIF14;PURB;TLR3;MPP5;AZIN1;ERVK13-1;SYNPO2;ESR1;PARD3;CLCC1;GJC1;NOP16;RNF19B;RAD51B;USP11;EHD1;KCNE4;FEM1C;CENPN;ARV1;DNASE1;TNF;WDR4;CAPN12;ATAD5;PDSS1;SURF2;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;PLBD1;ARGLU1;CD74;WDR36;HNRNPU;RING1;MAK16;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;ZSCAN31;DCTN5;METAP2;SLC43A2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;TRAM2;SPIB;YPEL4;PHLPP1;FTO;CCDC50;HIBCH;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;THTPA;HNRNPM;ABCA11P;CDKN1A;ITGB1BP1;USP1;MRFAP1;MUC6;SLC25A22;TREX1;ZNF471;IRF1;CTCF;SLC41A2;ASTN2;DIAPH3;RBM8A;GTF2H3;NDUFB9;TEX10;RPS12;ZBTB9;CENPO;GPX4;IRAK3;BUD13;COPS3;IFI27L1;DHX15;UFC1
980,GO:0002431,0.489063395426482,0.690892895468307,5,62,Fc receptor mediated stimulatory signaling pathway,BP,ACTG1;SYK;BAIAP2;HSP90AB1;MYO10
1865,GO:0004526,0.48910463620561,0.864828919300995,1,11,ribonuclease P activity,MF,POP1
18474,GO:1903533,0.489141376034083,0.664065000199356,7,95,regulation of protein targeting,BP,NRG1;CHP1;WDR75;UBE2J2;STARD7;ITGB1BP1;TSGA13
18598,GO:1903799,0.489176492217358,0.868903000825637,1,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,ESR1
15045,GO:0070970,0.489410271389602,0.868759722892829,1,8,interleukin-2 secretion,BP,GBP1
4453,GO:0010389,0.489774149525143,0.624247108509248,13,180,regulation of G2/M transition of mitotic cell cycle,BP,PBX1;GPR132;NBN;CDK4;TOPBP1;CENPF;PSME2;CEP152;PSMB9;KIF14;RAD51B;FGFR1OP;PSMB10
4764,GO:0010941,0.490145105399789,0.556755069075352,86,1190,regulation of cell death,BP,CRYAB;IGFBP3;NEFL;PML;CYP1B1;MAP3K14;GCLC;CYR61;FGFR2;CTGF;MMP9;B4GALT1;G6PD;TSC22D3;TRAF3;TP53;DAPK3;EDN1;CDKN2A;NQO1;LGALS3;CHP1;PDPN;TGFB2;CYLD;IFIT3;IL6ST;BAG1;SLC9A3R1;INHBA;NAIP;TRIO;SHQ1;CDK4;SFRP1;CD274;TARDBP;MIR17HG;NAA15;TRAF1;ADM;DYNLL2;PLK2;MYBL2;HSPB1;WNT4;SOD2;DDX3X;RRN3;ITGAV;SET;GADD45B;MDM4;FZD1;CLU;BIRC3;EYA3;ACKR3;APEX1;HSP90AB1;ARL6IP5;EPHB6;SGK1;SERPINB9;GPER1;FAF1;RAD18;ADAM17;SENP1;CFLAR;EIF2B5;AKR1B1;TRAF2;CITED2;NAA16;KIF14;TLR3;ESR1;TNF;CCL5;CD74;DAXX;PHLPP1;CDKN1A;GPX4;IFI27L1
13785,GO:0060341,0.49015661153042,0.572339038103765,46,618,regulation of cellular localization,BP,CRYAB;NRG1;PML;JPH2;TP53;GBP1;RBM4;ACSL3;PTPN14;CHP1;RBM22;CYLD;DKC1;SYK;NUP153;POLR1A;REEP1;DYNLL2;AKAP8L;RHOG;LCP1;CDCA5;GNL3L;NUP54;SETD2;GLIS2;JPH1;SYT11;HSP90AB1;NEDD4L;MTMR2;GOSR1;RAB3GAP1;GPER1;WDR75;UBE2J2;PARD3;EHD1;ARV1;TNF;STARD7;HNRNPU;CDKN1A;ITGB1BP1;ASTN2;TSGA13
8728,GO:0034367,0.490370070538211,0.865128887094529,1,10,protein-containing complex remodeling,BP,ABCA5
17360,GO:1900017,0.49044596603947,0.866429241552804,1,9,positive regulation of cytokine production involved in inflammatory response,BP,GBP5
9817,GO:0040036,0.490480812619412,0.781335370919315,2,22,regulation of fibroblast growth factor receptor signaling pathway,BP,FGFR2;WNT4
13578,GO:0060021,0.490686287605901,0.690043509183729,5,57,roof of mouth development,BP,TGFB2;INHBA;FZD1;FRAS1;WDPCP
15774,GO:0072348,0.490707688347848,0.781154639904565,2,22,sulfur compound transport,BP,SLC9A3R1;SLC5A6
13075,GO:0051547,0.490856932221782,0.867870830638548,1,8,regulation of keratinocyte migration,BP,MMP9
5818,GO:0017080,0.49090948657623,0.780993817258131,2,22,sodium channel regulator activity,MF,NEDD4L;SGK1
2903,GO:0006413,0.490917892956258,0.631851843810554,11,185,translational initiation,BP,RBM4;EIF5;HSPB1;DDX3X;EIF3J;EIF2B5;NCBP1;TNF;CCL5;EIF2B1;RPS12
14154,GO:0061000,0.491237516463932,0.867636333453578,1,8,negative regulation of dendritic spine development,BP,PLK2
2279,GO:0005225,0.491353122140571,0.867565049313964,1,8,volume-sensitive anion channel activity,MF,LRRC8D
8751,GO:0034393,0.491700502473801,0.865647653083452,1,9,positive regulation of smooth muscle cell apoptotic process,BP,CDKN2A
12162,GO:0048251,0.491768568243304,0.867308672739557,1,8,elastic fiber assembly,BP,MYH11
8851,GO:0034637,0.491919036362115,0.688405561351469,5,61,cellular carbohydrate biosynthetic process,BP,B4GALT1;IRS1;PPP1R3B;ENPP1;AKR1B1
8413,GO:0033363,0.49194705452152,0.780678547168711,2,21,secretory granule organization,BP,BLOC1S2;TBPL1
7722,GO:0032206,0.492012684548408,0.707810453631263,4,49,positive regulation of telomere maintenance,BP,PML;DKC1;NBN;ATR
11787,GO:0046629,0.492056138052078,0.865425549398543,1,9,gamma-delta T cell activation,BP,SYK
266,GO:0000733,0.492164301512935,0.86535795119807,1,9,DNA strand renaturation,BP,TP53
7467,GO:0031618,0.49239810488405,0.866919562255969,1,8,nuclear pericentric heterochromatin,CC,CBX5
16289,GO:0090331,0.492400409506473,0.865210315676269,1,9,negative regulation of platelet aggregation,BP,C1QTNF1
10449,GO:0043295,0.492449770419599,0.862714045607817,1,11,glutathione binding,MF,PTGES
17540,GO:1900750,0.492449770419599,0.862714045607817,1,11,oligopeptide binding,MF,PTGES
8962,GO:0035019,0.492556768921503,0.707166267006109,4,50,somatic stem cell population maintenance,BP,PBX1;SFRP1;POLR2F;ZFP36L2
5287,GO:0015937,0.492615855790334,0.863715839809226,1,10,coenzyme A biosynthetic process,BP,PANK2
7070,GO:0030852,0.49262791698054,0.865067958411379,1,9,regulation of granulocyte differentiation,BP,RUNX1
2398,GO:0005540,0.492714126657684,0.865013989276516,1,9,hyaluronic acid binding,MF,LAYN
2991,GO:0006536,0.4927403025993,0.779064749463898,2,23,glutamate metabolic process,BP,GCLC;SLC1A3
9613,GO:0036464,0.492920035554712,0.62584973671961,12,160,cytoplasmic ribonucleoprotein granule,CC,RBM4;PABPC4;G3BP1;CASC3;DDX3X;SOCS1;ARNTL;AJUBA;NCL;CLOCK;RC3H1;HNRNPU
5585,GO:0016600,0.493009758012928,0.866540793464543,1,8,flotillin complex,CC,CORO1C
5843,GO:0017127,0.493013363995658,0.863464732170513,1,10,cholesterol transporter activity,MF,ABCG2
13922,GO:0060546,0.493185016667853,0.86471895403235,1,9,negative regulation of necroptotic process,BP,BIRC3
1286,GO:0003085,0.493232883557579,0.86468893965685,1,9,negative regulation of systemic arterial blood pressure,BP,SOD2
17371,GO:1900037,0.493369441142543,0.863239541907445,1,10,regulation of cellular response to hypoxia,BP,AJUBA
9827,GO:0042023,0.49345369134007,0.866265445870535,1,8,DNA endoreduplication,BP,E2F8
8050,GO:0032693,0.49354491417355,0.86312848063405,1,10,negative regulation of interleukin-10 production,BP,CD274
5690,GO:0016803,0.493917155852151,0.862892685710913,1,10,ether hydrolase activity,MF,C9ORF3
394,GO:0001055,0.493926032529088,0.861773949397831,1,11,RNA polymerase II activity,MF,POLR2F
19836,GO:2000251,0.494240839480766,0.862687435353819,1,10,positive regulation of actin cytoskeleton reorganization,BP,BAIAP2
9440,GO:0036003,0.494248452193303,0.777854520488459,2,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,TP53;HSF2
8503,GO:0033673,0.494302442348362,0.609143936575878,16,216,negative regulation of kinase activity,BP,GPRC5A;DUSP14;CDKN2A;CHP1;CDK4;SFRP1;HSPB1;CORO1C;SOCS1;AJUBA;GADD45B;HNRNPU;FGFR1OP;CDKN1A;ITGB1BP1;IRAK3
13201,GO:0051787,0.494650604739183,0.777531197799698,2,23,misfolded protein binding,MF,CLU;HSPA8
10056,GO:0042501,0.494800702329941,0.862331950794669,1,10,serine phosphorylation of STAT protein,BP,IL24
5854,GO:0017147,0.495130609768172,0.778131977378377,2,21,Wnt-protein binding,MF,SFRP1;FZD1
18608,GO:1903827,0.495204430801064,0.580177270556807,31,417,regulation of cellular protein localization,BP,NRG1;TP53;GBP1;ACSL3;PTPN14;CHP1;RBM22;CYLD;DKC1;POLR1A;DYNLL2;AKAP8L;RHOG;LCP1;CDCA5;GNL3L;NUP54;SETD2;GLIS2;SYT11;HSP90AB1;NEDD4L;GPER1;WDR75;UBE2J2;TNF;STARD7;CDKN1A;ITGB1BP1;ASTN2;TSGA13
2329,GO:0005342,0.495443409914931,0.658473312230847,7,90,organic acid transmembrane transporter activity,MF,SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;SLC1A3;SLC43A2;SLC25A22
11926,GO:0046943,0.495443409914931,0.658473312230847,7,90,carboxylic acid transmembrane transporter activity,MF,SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;SLC1A3;SLC43A2;SLC25A22
13628,GO:0060078,0.495624161003931,0.704738477354629,4,48,regulation of postsynaptic membrane potential,BP,NETO1;BAIAP2;MTMR2;RAB3GAP1
12086,GO:0048019,0.495913922852441,0.861623335835201,1,10,receptor antagonist activity,MF,CCL5
8619,GO:0034122,0.496233869022107,0.777245695979951,2,21,negative regulation of toll-like receptor signaling pathway,BP,TLR3;IRAK3
4067,GO:0009116,0.49643441600216,0.656994057043806,7,99,nucleoside metabolic process,BP,TJP2;TK1;RAN;GPHN;PDCL3;UMPS;DPYD
4162,GO:0009223,0.49666385983388,0.860019447288489,1,11,pyrimidine deoxyribonucleotide catabolic process,BP,SMUG1
13058,GO:0051495,0.496706961118398,0.62225949162583,12,158,positive regulation of cytoskeleton organization,BP,CTGF;EDN1;SFRP1;TPM1;SYNPO2L;RHOG;WNT4;RANBP2;CDC42EP2;BAIAP2;SYNPO2;ITGB1BP1
5340,GO:0016074,0.496882359431875,0.858943942184653,1,12,snoRNA metabolic process,BP,DKC1
132,GO:0000272,0.496936110103387,0.776680551735281,2,21,polysaccharide catabolic process,BP,PPP1R3B;MGAM
10795,GO:0044247,0.496936110103387,0.776680551735281,2,21,cellular polysaccharide catabolic process,BP,PPP1R3B;MGAM
17514,GO:1900449,0.497383940854927,0.776319738036366,2,21,regulation of glutamate receptor signaling pathway,BP,SHISA9;NETO1
4599,GO:0010712,0.497385098193017,0.774894144970083,2,24,regulation of collagen metabolic process,BP,CTGF;WNT4
13010,GO:0051402,0.497403884710844,0.621528890587878,12,160,neuron apoptotic process,BP,NEFL;GCLC;G6PD;TP53;NQO1;TGFB2;NAIP;MYBL2;SOD2;SET;HSP90AB1;KIF14
11473,GO:0045913,0.497469219805418,0.703433683575325,4,46,positive regulation of carbohydrate metabolic process,BP,IRS1;RANBP2;PDGFB;GPER1
3469,GO:0007292,0.497599488970216,0.668251727484161,6,75,female gamete generation,BP,INHBA;IMMP2L;WNT4;MCM8;BRCA2;ETV6
2391,GO:0005525,0.497656347349165,0.595226149141557,20,280,GTP binding,MF,GBP1;RAB32;ARFRP1;TSR1;LSG1;EIF5;RRAGB;GBP5;RHOG;RAN;RAB26;GNL3L;EFTUD2;SRPRB;HSP90AB1;MMAA;BMS1;EHD1;NRAS;GBP6
20057,GO:2000644,0.497742890652275,0.861841493338169,1,9,regulation of receptor catabolic process,BP,MTMR2
3476,GO:0007338,0.498036526838806,0.701803414288915,4,53,single fertilization,BP,B4GALT1;SPACA6;GLIPR1L2;UBAP2L
16828,GO:0098655,0.498096518707796,0.577334999624757,31,416,cation transmembrane transport,BP,JPH2;MMP9;SLC7A2;G6PD;CHP1;SLC4A11;SLC30A6;SLC9A3R1;SLC22A5;SHISA9;ATP2B1;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;NETO1;ABCC9;JPH1;NNT;THADA;SLC11A2;NEDD4L;STEAP4;GPER1;SLC9A9;KCNE4;PANX1;SLC25A22;SLC41A2
11494,GO:0045936,0.498131711360478,0.575081557373423,33,444,negative regulation of phosphate metabolic process,BP,IGFBP3;GPRC5A;GBP1;DUSP14;CDKN2A;CHP1;TGFB2;PKMYT1;SLC9A3R1;INHBA;CDK4;SFRP1;TARDBP;CD109;HSPB1;CORO1C;SOCS1;SET;PARP14;AJUBA;PPP4R4;GADD45B;SH3RF2;PDGFB;ENPP1;GPER1;PARD3;TNF;HNRNPU;FGFR1OP;CDKN1A;ITGB1BP1;IRAK3
2519,GO:0005771,0.498318512819496,0.773740830589372,2,25,multivesicular body,CC,NEDD4L;CD74
10548,GO:0043486,0.498408025429474,0.727901200817575,3,48,histone exchange,BP,CENPN;HIST1H4A;CENPO
11460,GO:0045892,0.498523156893094,0.554763063107872,65,892,negative regulation of transcription, DNA-templated,BP,NRG1;HDAC9;PML;GCLC;FGFR2;CBX5;TSC22D3;FST;TFCP2L1;TP53;EDN1;CDKN2A;IRX2;RELB;PARP15;SFRP1;H3F3A;AHR;GLIS3;HELLS;SETDB1;ZNF587;FRK;WNT4;SUV39H2;SET;ARNTL;AJUBA;TRIM37;ZNF586;SRF;MDM4;HIF1AN;PDGFB;FZD1;SMYD2;RIF1;GLIS2;UBP1;HSPA8;NEDD4L;E2F8;CENPF;ETV6;ZNF12;ZNF608;CITED2;TIMELESS;ORC2;RBL1;MPHOSPH8;CLOCK;PURB;ESR1;TNF;HNRNPU;RING1;DAXX;PHF14;HIST1H4A;TAF1;PSPC1;PPARGC1B;IRF1;CTCF
1820,GO:0004467,0.498561745487582,0.861320344114485,1,9,long-chain fatty acid-CoA ligase activity,MF,ACSL3
18565,GO:1903729,0.498588242126395,0.861303459265059,1,9,regulation of plasma membrane organization,BP,TGFB2
13102,GO:0051591,0.498694598221925,0.682190458900365,5,61,response to cAMP,BP,AHR;SRD5A1;THBD;APEX1;PPARGC1B
13681,GO:0060174,0.498828479040545,0.862902253072243,1,8,limb bud formation,BP,FGFR2
8602,GO:0034098,0.499291997476853,0.860854502860107,1,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,FAF1
18221,GO:1902969,0.500011534259842,0.860394497463212,1,9,mitotic DNA replication,BP,BRCA2
7395,GO:0031442,0.500025596890436,0.860385497224253,1,9,positive regulation of mRNA 3'-end processing,BP,NCBP1
2395,GO:0005536,0.500271275683381,0.860228198742361,1,9,glucose binding,MF,G6PD
15874,GO:0072574,0.500340846050783,0.86018363450966,1,9,hepatocyte proliferation,BP,CFLAR
15875,GO:0072575,0.500340846050783,0.86018363450966,1,9,epithelial cell proliferation involved in liver morphogenesis,BP,CFLAR
5181,GO:0015740,0.500463048678892,0.860105333473386,1,9,C4-dicarboxylate transport,BP,SLC1A3
3653,GO:0008135,0.500510706778507,0.665038236760558,6,81,translation factor activity, RNA binding,MF,ABCF1;EIF5;EIF3J;EIF2B5;EIF2B1;GTF2H3
17754,GO:1901659,0.500548380744485,0.726969717133022,3,42,glycosyl compound biosynthetic process,BP,TK1;PDCL3;UMPS
3049,GO:0006607,0.500555975716937,0.774334489839843,2,20,NLS-bearing protein import into nucleus,BP,RANBP2;NUP54
5666,GO:0016772,0.500665404241835,0.55514391098606,59,777,transferase activity, transferring phosphorus-containing groups,MF,NRG1;MAP3K14;FAM46B;FGFR2;STAT5A;GNPTAB;IRS1;DAPK3;PANK2;IKBKE;PKMYT1;NUAK1;DKC1;CAMK1G;SYK;TJP2;TRIO;CDK4;RIPK4;POLQ;UAP1L1;POLR1A;ULK4;POLA1;TK1;PLK2;FRK;HMGXB3;GPHN;TRPM7;FASTKD3;PGK1;YRDC;APTX;PDGFB;SGK494;PIK3R3;SEPHS2;WEE1;EPHB6;SGK1;PRIM2;PPIP5K1;POLR2F;CHEK1;ATR;NOL9;POLR1E;POLR3B;CCNA2;POLE3;ESR1;CCL5;FGFR1OP;FLAD1;TAF1;CDKN1A;GTF2H3;IRAK3
93,GO:0000183,0.500865121359467,0.768282263298083,2,39,chromatin silencing at rDNA,BP,H3F3A;HIST1H4A
10368,GO:0043171,0.501146460079104,0.772272847087003,2,23,peptide catabolic process,BP,C9ORF3;ERAP1
3302,GO:0007004,0.50118040808354,0.679551553742862,5,64,telomere maintenance via telomerase,BP,DKC1;GNL3L;HSP90AB1;ATR;HNRNPU
17703,GO:1901550,0.501213791468669,0.859623666935498,1,9,regulation of endothelial cell development,BP,TNF
18297,GO:1903140,0.501213791468669,0.859623666935498,1,9,regulation of establishment of endothelial barrier,BP,TNF
7995,GO:0032607,0.501245088623873,0.772670118516468,2,22,interferon-alpha production,BP,SETD2;TLR3
2513,GO:0005765,0.501393319812557,0.58751405354564,22,298,lysosomal membrane,CC,B4GALT1;VPS41;HLA-DOB;AP5M1;DRAM1;RRAGB;SLCO4C1;ENPP1;SPNS1;SLC11A2;BLOC1S2;HSPA8;HSP90AB1;NSF;MFSD12;M6PR;TMEM165;ABCA5;AP3B1;GLIPR1;TLR3;CD74
16921,GO:0098852,0.501393319812557,0.58751405354564,22,298,lytic vacuole membrane,CC,B4GALT1;VPS41;HLA-DOB;AP5M1;DRAM1;RRAGB;SLCO4C1;ENPP1;SPNS1;SLC11A2;BLOC1S2;HSPA8;HSP90AB1;NSF;MFSD12;M6PR;TMEM165;ABCA5;AP3B1;GLIPR1;TLR3;CD74
4072,GO:0009124,0.501602612841413,0.628255664596385,10,136,nucleoside monophosphate biosynthetic process,BP,NUP50;NUP153;TK1;NDC1;RANBP2;PGK1;NUP160;NUP54;UMPS;TYMS
15949,GO:0072718,0.501951450385459,0.859149338296161,1,9,response to cisplatin,BP,TIMELESS
7806,GO:0032350,0.502038601271213,0.771545377594651,2,23,regulation of hormone metabolic process,BP,WNT4;TNF
4650,GO:0010770,0.502322628153937,0.634810581409428,9,111,positive regulation of cell morphogenesis involved in differentiation,BP,NEFL;NRG1;FN1;BAIAP2;SRF;ZFYVE27;L1CAM;NTN1;SHTN1
7211,GO:0031095,0.502336333342552,0.862978453416433,1,7,platelet dense tubular network membrane,CC,EHD1
4045,GO:0009081,0.502416810811372,0.771236591241879,2,23,branched-chain amino acid metabolic process,BP,STAT5A;HIBCH
4559,GO:0010638,0.502451718158077,0.566051518325592,38,515,positive regulation of organelle organization,BP,NRG1;PML;EPGN;CTGF;MMP9;TP53;EDN1;AKAP8;DKC1;NBN;SFRP1;TPM1;SETDB1;DYNLL2;SYNPO2L;AKAP8L;RHOG;WNT4;LCP1;RANBP2;FEN1;CDC42EP2;CDCA5;BAIAP2;PDGFB;RIF1;RAB3GAP1;GPER1;WDR75;ATR;UBE2J2;SYNPO2;TNF;STARD7;HNRNPU;PPARGC1B;ITGB1BP1;TSGA13
18820,GO:1904321,0.502618856096277,0.860497470800622,1,8,response to forskolin,BP,AHR
18821,GO:1904322,0.502618856096277,0.860497470800622,1,8,cellular response to forskolin,BP,AHR
2729,GO:0006107,0.502766418097414,0.857209030601335,1,10,oxaloacetate metabolic process,BP,STAT5A
18831,GO:1904354,0.502772594192888,0.860399352346735,1,8,negative regulation of telomere capping,BP,NBN
4515,GO:0010563,0.503107231735939,0.570160569589329,33,445,negative regulation of phosphorus metabolic process,BP,IGFBP3;GPRC5A;GBP1;DUSP14;CDKN2A;CHP1;TGFB2;PKMYT1;SLC9A3R1;INHBA;CDK4;SFRP1;TARDBP;CD109;HSPB1;CORO1C;SOCS1;SET;PARP14;AJUBA;PPP4R4;GADD45B;SH3RF2;PDGFB;ENPP1;GPER1;PARD3;TNF;HNRNPU;FGFR1OP;CDKN1A;ITGB1BP1;IRAK3
1181,GO:0002825,0.50343505135376,0.856773447398799,1,10,regulation of T-helper 1 type immune response,BP,IL27RA
3772,GO:0008324,0.503499012990035,0.583603805338568,23,308,cation transmembrane transporter activity,MF,JPH2;TFRC;SLC7A2;SLC4A11;SLC30A6;SLC22A5;ATP2B1;SLC5A6;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;NNT;SLC11A2;SLC9A9;KCNE4;PANX1;SLC25A22;SLC41A2
893,GO:0002262,0.503599480595052,0.641104429693259,8,106,myeloid cell homeostasis,BP,MAFB;G6PD;INHBA;SRF;NFE2L1;SLC11A2;ADAM17;SENP1
2843,GO:0006312,0.503709982343692,0.770659743432253,2,22,mitotic recombination,BP,BRCA2;RAD51B
8758,GO:0034404,0.503966492730109,0.61501157032952,12,166,nucleobase-containing small molecule biosynthetic process,BP,NUP50;NUP153;TK1;NDC1;RANBP2;PGK1;NUP160;ENPP1;NUP54;PDCL3;UMPS;SMUG1
14994,GO:0070886,0.504143047383501,0.857733905280262,1,9,positive regulation of calcineurin-NFAT signaling cascade,BP,NRG1
17231,GO:0106058,0.504143047383501,0.857733905280262,1,9,positive regulation of calcineurin-mediated signaling,BP,NRG1
4542,GO:0010613,0.504198059937081,0.770789932745771,2,21,positive regulation of cardiac muscle hypertrophy,BP,EDN1;IL6ST
4882,GO:0014742,0.504198059937081,0.770789932745771,2,21,positive regulation of muscle hypertrophy,BP,EDN1;IL6ST
17730,GO:1901615,0.504247773258576,0.581038865863166,24,328,organic hydroxy compound metabolic process,BP,CYP1B1;CYP24A1;CYP1A1;CLN6;G6PD;PANK2;SCD;HMGCS1;TGFB2;LEPR;LSS;DHFR;WNT4;RAN;QDPR;NFE2L1;SRD5A1;PPIP5K1;MTMR2;GPER1;EBP;AKR1B1;ARV1;TNF
17794,GO:1901797,0.504289489654481,0.768861774194123,2,25,negative regulation of signal transduction by p53 class mediator,BP,RRN3;CD74
20216,GO:2001028,0.504294264109113,0.857635900000817,1,9,positive regulation of endothelial cell chemotaxis,BP,HSPB1
9293,GO:0035723,0.504697725296148,0.857374195338589,1,9,interleukin-15-mediated signaling pathway,BP,STAT5A
15221,GO:0071350,0.504697725296148,0.857374195338589,1,9,cellular response to interleukin-15,BP,STAT5A
10177,GO:0042754,0.504808985773454,0.857301970821272,1,9,negative regulation of circadian rhythm,BP,SUV39H2
12235,GO:0048469,0.504817050583693,0.649551870096457,7,91,cell maturation,BP,G6PD;TFCP2L1;CNTNAP2;BRCA2;KIF14;TYMS;CDKN1A
12653,GO:0050821,0.504819847119335,0.625191933375923,10,135,protein stabilization,BP,CRYAB;CHP1;NAA15;MDM4;CLU;HSP90AB1;TELO2;NAA16;TAF1;CDKN1A
262,GO:0000729,0.505180223737386,0.76945594031179,2,22,DNA double-strand break processing,BP,NBN;BRIP1
4857,GO:0014067,0.50538053936939,0.856930569223518,1,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,SLC9A3R1
17882,GO:1902065,0.50554251062352,0.856825203210229,1,9,response to L-glutamate,BP,BAIAP2
14648,GO:0070203,0.505560028214893,0.855383350672984,1,10,regulation of establishment of protein localization to telomere,BP,DKC1
8668,GO:0034219,0.505908400504784,0.660557097821724,6,74,carbohydrate transmembrane transport,BP,C3;IRS1;ENPP1;PIK3R3;M6PR;TNF
14565,GO:0070070,0.50592144478887,0.858379694168752,1,8,proton-transporting V-type ATPase complex assembly,BP,TMEM199
14567,GO:0070072,0.50592144478887,0.858379694168752,1,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,TMEM199
13308,GO:0051983,0.506003753251207,0.648561004532107,7,89,regulation of chromosome segregation,BP,ANAPC15;FEN1;CDCA5;CENPF;RAD18;HNRNPU;CTCF
11814,GO:0046676,0.506061247558424,0.768249286024921,2,23,negative regulation of insulin secretion,BP,IRS1;SFRP1
16247,GO:0090278,0.506061247558424,0.768249286024921,2,23,negative regulation of peptide hormone secretion,BP,IRS1;SFRP1
263,GO:0000730,0.506134007863372,0.85500635970528,1,10,DNA recombinase assembly,BP,RAD51B
11045,GO:0045003,0.506134007863372,0.85500635970528,1,10,double-strand break repair via synthesis-dependent strand annealing,BP,RAD51B
16403,GO:0090735,0.506134007863372,0.85500635970528,1,10,DNA repair complex assembly,BP,RAD51B
11337,GO:0045646,0.5062204466309,0.723267980087188,3,36,regulation of erythrocyte differentiation,BP,MAFB;INHBA;SENP1
18330,GO:1903214,0.50622084875472,0.674463733319086,5,68,regulation of protein targeting to mitochondrion,BP,NRG1;WDR75;UBE2J2;STARD7;TSGA13
11343,GO:0045652,0.506711938661344,0.692480873018333,4,66,regulation of megakaryocyte differentiation,BP,RUNX1;H3F3A;RBBP5;HIST1H4A
19690,GO:1990909,0.506856409462472,0.857776327105091,1,8,Wnt signalosome,CC,FZD1
7980,GO:0032588,0.507073083763384,0.673976611718476,5,65,trans-Golgi network membrane,CC,MYO1B;ARFRP1;M6PR;TMEM165;CD74
15442,GO:0071695,0.507266776223748,0.637995018915844,8,99,anatomical structure maturation,BP,FAT4;G6PD;TFCP2L1;TGFB2;CNTNAP2;BRCA2;TYMS;CDKN1A
17631,GO:1901293,0.50732622119013,0.593326781334731,17,237,nucleoside phosphate biosynthetic process,BP,PANK2;NUP50;NUP153;TK1;ADM;NDC1;RANBP2;PGK1;NUP160;RRM2;NUP54;UMPS;GPER1;RRM1;TYMS;FLAD1;TBPL1
13130,GO:0051646,0.507434715789581,0.722457685753517,3,35,mitochondrion localization,BP,NEFL;LRPPRC;TRAK2
14737,GO:0070373,0.50745035048295,0.69369906346194,4,50,negative regulation of ERK1 and ERK2 cascade,BP,GBP1;SLC9A3R1;GPER1;ITGB1BP1
9087,GO:0035331,0.507464903951477,0.857382733583192,1,8,negative regulation of hippo signaling,BP,AJUBA
8381,GO:0033270,0.507491353301236,0.857365609019211,1,8,paranode region of axon,CC,CNTNAP1
8411,GO:0033344,0.507606008490713,0.767462106445308,2,22,cholesterol efflux,BP,ABCG2;ABCA5
10937,GO:0044546,0.507914728710074,0.855276169864857,1,9,NLRP3 inflammasome complex assembly,BP,GBP5
17470,GO:1900225,0.507914728710074,0.855276169864857,1,9,regulation of NLRP3 inflammasome complex assembly,BP,GBP5
6788,GO:0030219,0.508110347386804,0.671786397580169,5,79,megakaryocyte differentiation,BP,RUNX1;H3F3A;SRF;RBBP5;HIST1H4A
15799,GO:0072386,0.508185913139284,0.856915431936176,1,8,plus-end-directed organelle transport along microtubule,BP,KIF23
11977,GO:0047144,0.50832671361598,0.855006029173891,1,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT1
9256,GO:0035646,0.508390479311813,0.853518054177313,1,10,endosome to melanosome transport,BP,RAB32
10547,GO:0043485,0.508390479311813,0.853518054177313,1,10,endosome to pigment granule transport,BP,RAB32
12387,GO:0048757,0.508390479311813,0.853518054177313,1,10,pigment granule maturation,BP,RAB32
14838,GO:0070561,0.508477741526701,0.854906916241611,1,9,vitamin D receptor signaling pathway,BP,CYP24A1
18624,GO:1903861,0.509006673396419,0.856382249679184,1,8,positive regulation of dendrite extension,BP,NEDD4L
3429,GO:0007219,0.509172082007481,0.621216986566727,10,129,Notch signaling pathway,BP,DTX2;FAT4;PBX1;TGFB2;IL6ST;LFNG;HIF1AN;DTX4;ADAM17;ITGB1BP1
19759,GO:2000095,0.50922831791012,0.854413683973612,1,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,SFRP1
11723,GO:0046500,0.509307796373729,0.852910160223116,1,10,S-adenosylmethionine metabolic process,BP,MAT2A
910,GO:0002292,0.509404913070258,0.720453276202836,3,36,T cell differentiation involved in immune response,BP,RELB;PTGER4;RC3H1
3733,GO:0008270,0.509575885693628,0.555130687824162,43,575,zinc ion binding,MF,TRIM47;DTX2;TRIM16;PML;TRIM22;MMP9;XAF1;TRIM56;TRAF3;MID1;TP53;C9ORF3;RBM4;AKAP8;ZNF208;CYLD;USP16;POLR1A;ZMAT2;CSRP1;ADAMTS9;SETDB1;TK1;TRAF1;ZNF407;MME;SUV39H2;CPA4;QPCT;TRIM37;MDM4;HIF1AN;ENPP1;TTF2;DTX4;ERAP1;DNPEP;ZNFX1;MYNN;TRAF2;ESR1;SRSF7;CTCF
13627,GO:0060077,0.510086686023038,0.853848264365682,1,9,inhibitory synapse,CC,SYT11
6914,GO:0030497,0.510228040429242,0.852298661940733,1,10,fatty acid elongation,BP,HACD2
10183,GO:0042761,0.510228040429242,0.852298661940733,1,10,very long-chain fatty acid biosynthetic process,BP,HACD2
4041,GO:0009072,0.510281865644126,0.851076792992024,1,11,aromatic amino acid family metabolic process,BP,QDPR
15707,GO:0072216,0.510314685750615,0.852241000489532,1,10,positive regulation of metanephros development,BP,PDGFB
4710,GO:0010870,0.510499904196988,0.852117690076941,1,10,positive regulation of receptor biosynthetic process,BP,EDN1
15596,GO:0072044,0.510523479706158,0.855393448173011,1,8,collecting duct development,BP,AKR1B1
11263,GO:0045453,0.5106665815753,0.719334201736318,3,36,bone resorption,BP,TFRC;SYK;PPARGC1B
2357,GO:0005451,0.510754467093165,0.853407386871473,1,9,monovalent cation:proton antiporter activity,MF,SLC9A9
19312,GO:1905477,0.510817105869265,0.643708920566861,7,93,positive regulation of protein localization to membrane,BP,TP53;ACSL3;CHP1;DYNLL2;RHOG;GPER1;ITGB1BP1
35,GO:0000070,0.510838445718206,0.613757301230536,11,142,mitotic sister chromatid segregation,BP,KIF23;AKAP8;AKAP8L;RAN;ANAPC15;SMC2;CDCA5;NAA50;CENPF;KIF14;HNRNPU
7169,GO:0031034,0.510889699796619,0.872243107273454,1,4,myosin filament assembly,BP,MYH11
1137,GO:0002726,0.510915357611254,0.851840852844401,1,10,positive regulation of T cell cytokine production,BP,TRAF2
12541,GO:0050665,0.510999925057992,0.851784459583746,1,10,hydrogen peroxide biosynthetic process,BP,CYP1A1
14134,GO:0060969,0.511441671963204,0.764289926994678,2,22,negative regulation of gene silencing,BP,DND1;ESR1
3443,GO:0007254,0.511465661894257,0.607940625125116,12,158,JNK cascade,BP,CTGF;EDN1;SYK;SFRP1;ULK4;PTGER4;GADD45B;TRAF2;TLR3;TNF;DAXX;PHLPP1
11342,GO:0045651,0.511928338977723,0.852630255462487,1,9,positive regulation of macrophage differentiation,BP,CSF1
7699,GO:0032147,0.511930708033222,0.586262007282103,18,238,activation of protein kinase activity,BP,SAA1;NRG1;MAP3K14;EPGN;TGFB2;SYK;EMP2;SOCS1;GADD45B;PDGFB;TRAF2;KIF14;TLR3;TNF;CCL5;CD74;DAXX;ITGB1BP1
16329,GO:0090481,0.512130786960275,0.851028992367612,1,10,pyrimidine nucleotide-sugar transmembrane transport,BP,SLC35A4
6325,GO:0019985,0.512338722985384,0.717140940628842,3,39,translesion synthesis,BP,RPA1;USP43;RFC3
3328,GO:0007040,0.512714515468384,0.6887174883425,4,51,lysosome organization,BP,GNPTAB;CLN6;TMEM199;TMEM165
16003,GO:0080171,0.512714515468384,0.6887174883425,4,51,lytic vacuole organization,BP,GNPTAB;CLN6;TMEM199;TMEM165
9298,GO:0035729,0.512716856605922,0.852106712812448,1,9,cellular response to hepatocyte growth factor stimulus,BP,GCLC
12751,GO:0050995,0.512723899388789,0.850631753686807,1,10,negative regulation of lipid catabolic process,BP,TNF
4293,GO:0009713,0.512772462556249,0.850599197473281,1,10,catechol-containing compound biosynthetic process,BP,TGFB2
10015,GO:0042423,0.512772462556249,0.850599197473281,1,10,catecholamine biosynthetic process,BP,TGFB2
10526,GO:0043425,0.513020750040781,0.762977017922289,2,22,bHLH transcription factor binding,MF,TSC22D3;ARNTL
19515,GO:1990253,0.513088067587969,0.851859819248949,1,9,cellular response to leucine starvation,BP,RRAGB
3369,GO:0007140,0.51311002452086,0.762410316104187,2,23,male meiotic nuclear division,BP,MYBL1;BRCA2
14045,GO:0060749,0.513270528063779,0.850265029618059,1,10,mammary gland alveolus development,BP,ESR1
14309,GO:0061377,0.513270528063779,0.850265029618059,1,10,mammary gland lobule development,BP,ESR1
10220,GO:0042826,0.513316711605373,0.641517765376108,7,90,histone deacetylase binding,MF,HDAC9;CBX5;TP53;AKAP8;AKAP8L;SRF;HSP90AB1
3931,GO:0008610,0.513648654060357,0.555762676593444,37,511,lipid biosynthetic process,BP,PTGES;CYR61;C3;FGFR2;FADS3;CYP1A1;PBX1;G6PD;TFCP2L1;IRS1;EDN1;SCD;HMGCS1;ACSL3;ST6GALNAC5;LSS;CDK4;ADM;WNT4;RAN;AJUBA;HACD2;PDGFB;UGT8;PIK3R3;MBOAT1;SRD5A1;SCD5;MTMR2;GPER1;EBP;AKR1B1;ARV1;TNF;PDSS1;STARD7;CD74
700,GO:0001917,0.513711669757382,0.762401275886426,2,22,photoreceptor inner segment,CC,PHLPP2;PHLPP1
11775,GO:0046607,0.513900136972664,0.851318759273964,1,9,positive regulation of centrosome cycle,BP,RANBP2
5712,GO:0016840,0.513913761284229,0.848630229127941,1,11,carbon-nitrogen lyase activity,MF,APMAP
653,GO:0001841,0.514012101747924,0.641065738632848,7,87,neural tube formation,BP,TGFB2;SFRP1;ADM;KDM6A;PHACTR4;FZD1;SETD2
274,GO:0000776,0.514098746675632,0.622990678323438,9,121,kinetochore,CC,CBX5;NUP160;SKA2;CENPF;ORC2;CENPN;HNRNPU;DCTN5;CENPO
12634,GO:0050796,0.514245350347818,0.630890447762936,8,106,regulation of insulin secretion,BP,IRS1;SFRP1;KCNS3;ARNTL;GPER1;CLOCK;TNF;CCL5
15517,GO:0071871,0.514327712770356,0.851033352292482,1,9,response to epinephrine,BP,SRD5A1
10976,GO:0044728,0.51433780796549,0.667524697711945,5,62,DNA methylation or demethylation,BP,APEX1;TET3;MPHOSPH8;FTO;CTCF
8196,GO:0032928,0.514401349201078,0.848299773714089,1,11,regulation of superoxide anion generation,BP,SYK
16522,GO:0097200,0.51445402186813,0.848264047177461,1,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CFLAR
12247,GO:0048489,0.514712737848355,0.652048711731613,6,76,synaptic vesicle transport,BP,AP3M2;CADPS2;BLOC1S2;SYT11;RAB3GAP1;AP3B1
16645,GO:0097480,0.514712737848355,0.652048711731613,6,76,establishment of synaptic vesicle localization,BP,AP3M2;CADPS2;BLOC1S2;SYT11;RAB3GAP1;AP3B1
11773,GO:0046605,0.514740949463426,0.68700742264428,4,50,regulation of centrosome cycle,BP,PLK2;RANBP2;TRIM37;CHEK1
11320,GO:0045623,0.514910700015087,0.850643624057384,1,9,negative regulation of T-helper cell differentiation,BP,RC3H1
8107,GO:0032786,0.515151589514586,0.760252168776968,2,24,positive regulation of DNA-templated transcription, elongation,BP,THOC1;SUPT16H
13596,GO:0060043,0.515208800229337,0.761151033978585,2,22,regulation of cardiac muscle cell proliferation,BP,FGFR2;MIR17HG
16874,GO:0098772,0.515332089529698,0.532697005132572,82,1130,molecular function regulator,MF,IL32;IGFBP3;SAA1;NEFL;NRG1;FN1;C3;FGFR2;EPGN;STARD13;CTGF;FBN1;IRS1;ANKRD36C;EDN1;DOCK10;SIPA1L3;CDKN2A;LGALS3;CHP1;TGFB2;IL16;PPP1R3B;BAG1;SLC9A3R1;INHBA;NAIP;TRIO;CDK4;WNT10A;KCNS3;OPHN1;ADM;CD109;CCL20;HSCB;HSPB1;WNT4;CXCL16;RANBP2;DDX3X;IL24;ARHGEF28;SOCS1;SET;CDC42EP2;PPP4R4;SH3RF2;PHACTR4;PDGFB;BRCC3;TBC1D15;USP6;MACC1;BIRC3;IL20;PIK3R3;FGD6;ABCC9;HSP90AB1;NEDD4L;SGK1;RAB3GAP1;SERPINB9;FAF1;PSME2;CFLAR;EIF2B5;CMTM3;RABEP2;GTF3C4;CSF1;AZIN1;ESR1;TNF;CCL5;RING1;FGFR1OP;EIF2B1;DAXX;CDKN1A;ITGB1BP1
7436,GO:0031532,0.515616871495677,0.651101520475962,6,77,actin cytoskeleton reorganization,BP,DAPK3;RHOG;ATP2C1;BAIAP2;ANTXR1;NEDD9
19175,GO:1905146,0.515680151434804,0.850128211046733,1,9,lysosomal protein catabolic process,BP,TMEM199
14530,GO:0065009,0.51573161594867,0.520182920859688,164,2250,regulation of molecular function,BP,IL32;CRYAB;IGFBP3;SAA1;NEFL;NRG1;FN1;PML;CYP1B1;AMOT;JPH2;MAP3K14;CYR61;C3;GPRC5A;NLRC5;FGFR2;EPGN;TRIM22;STARD13;CTGF;MMP9;FBN1;TRAF3;IRS1;TP53;ANKRD36C;EDN1;DOCK10;SIPA1L3;DUSP14;CDKN2A;NQO1;CHP1;TGFB2;CYLD;PKMYT1;IL16;PPP1R3B;BAG1;SLC9A3R1;NUAK1;DKC1;INHBA;SYK;EMP2;NAIP;NBN;LEPR;TRIO;SHISA9;CDK4;SFRP1;RIPK4;NUCKS1;WNT10A;KEAP1;DHFR;TPM1;KCNS3;TRAF1;OPHN1;ADM;CD109;DYNLL2;CCL20;PLK2;HSCB;RFC3;HSPB1;RHOG;WNT4;CXCL16;RAN;RANBP2;VCPKMT;CORO1C;DDX3X;IL24;ARHGEF28;CDC25A;SOCS1;SET;AJUBA;LFNG;TRIM37;NETO1;CDC42EP2;CDCA5;PPP4R4;GNL3L;NVL;GADD45B;SH3RF2;PHACTR4;SRF;NPNT;PDGFB;BRCC3;FZD1;TBC1D15;ANTXR1;CLU;USP6;MACC1;BIRC3;IL20;PIK3R3;NFKBIB;FGD6;GLIS2;ABCC9;JPH1;THADA;HSP90AB1;ARL6IP5;EPHB6;NEDD4L;SGK1;FANCD2;RAB3GAP1;SERPINB9;GPER1;FAF1;ADAM17;SENP1;PSME2;MSH6;CFLAR;PSMB9;DNAJC9;EIF2B5;CMTM3;NFKBIE;RABEP2;TAF6L;NCBP1;TRAF2;MSH3;TELO2;HNRNPR;GTF3C4;CSF1;RBL1;CLOCK;KIF14;TLR3;AZIN1;ESR1;TNF;CCL5;CD74;HNRNPU;RING1;FGFR1OP;EIF2B1;DAXX;TAF1;PPARGC1B;CDKN1A;ITGB1BP1;CTCF;IRAK3;IFI27L1
9066,GO:0035282,0.515750451266104,0.666445787153553,5,60,segmentation,BP,MAFB;IRX2;SFRP1;KDM6A;LFNG
10326,GO:0043097,0.515860182557033,0.847308231759958,1,11,pyrimidine nucleoside salvage,BP,TK1
5315,GO:0016021,0.515964732877073,0.51765879822536,196,2707,integral component of membrane,CC,HEPHL1;NRG1;TENM3;PTGES;JPH2;TFRC;GPRC5A;FGFR2;UGT1A6;EPGN;FADS3;SLC16A2;HLA-B;GNPTAB;VMP1;TAP1;SLC7A2;ERVFRD-1;CLN6;IL1R2;FAT4;B4GALT1;SPACA6;FAM69B;TRAF3;PLD5;IRS1;SLC16A9;SLC7A5P2;TPST1;SCD;TMEM106A;C1QTNF1;TMPPE;ACSL3;MEGF11;IFNGR1;SLC4A11;PDPN;ST6GALNAC5;CNTNAP1;CDKAL1;IL27RA;PCDH7;LRFN4;SLC30A6;IL6ST;IL7R;SLC22A5;GALNT18;EMP2;GPR132;LEPR;SHISA9;VEZT;ABCG2;LRRC8D;HLA-F;SFRP1;HLA-DOB;ZDHHC6;CD274;LAYN;DST;ATP2B1;SLC5A6;PTPRB;RCE1;ABCC4;REEP1;DRAM1;KCNS3;PTGER4;TMEM97;TMEM248;MGAM;IMMP2L;GGCX;NDC1;SLC35A4;SLC1A3;SLCO4C1;MME;TMEM212;MUC16;BTN2A1;CXCL16;PTPRM;SIRPA;HS3ST1;ATP2C1;RRP12;ITGAV;ABCF2;TRPM7;KCNQ5;LFNG;NETO1;HACD2;FRRS1;GDAP1;FNDC3B;NPNT;APMAP;UGT8;KREMEN2;SDK1;FZD1;NFE2L1;ANTXR1;ENPP1;FRAS1;MBOAT1;SPNS1;ACKR3;FAM173B;SRD5A1;TMEM14EP;TIMM23B;TMEM51;THBD;UPK3B;ABCC9;JPH1;SRPRB;DPY19L2P2;NNT;IFNAR1;LRRN3;ERAP1;SLC11A2;RIC3;CXCR5;CNTNAP2;GLIPR1L2;SYT11;ERVMER34-1;TMEM199;ARL6IP5;EPHB6;BACE2;SCD5;LYSMD4;GREB1;LAIR1;MFSD12;M6PR;ZFYVE27;PXMP2;TMEM138;HCAR1;CYB561D2;GOSR1;TMEM165;L1CAM;STEAP4;CCDC47;IL12RB2;GPER1;ADAM17;LILRB3;CMTM3;ABCA5;SDHD;UGT1A4;ARIH2OS;EBP;UBE2J2;TRAF2;TPRA1;CYP20A1;SLC9A9;TAP2;CSF1;GLIPR1;TLR3;ERVK13-1;ESR1;CLCC1;GJC1;RNF19B;KCNE4;ARV1;TNF;CD74;SLC43A2;PANX1;TRAM2;SMIM7;HNRNPM;ABCA11P;SLC25A22;SLC41A2;ASTN2;TMEM234;IFI27L1
3439,GO:0007249,0.515967558087154,0.591143274259265,15,207,I-kappaB kinase/NF-kappaB signaling,BP,MAP3K14;TRIM22;IKBKE;RELB;PLK2;HSPB1;ATP2C1;AJUBA;BIRC3;CFLAR;TRAF2;TLR3;ESR1;TNF;CD74
3693,GO:0008200,0.516511074805603,0.759110596832242,2,24,ion channel inhibitor activity,MF,ANKRD36C;NEDD4L
3377,GO:0007156,0.516616030150332,0.651150525558107,6,67,homophilic cell adhesion via plasma membrane adhesion molecules,BP,TENM3;FAT4;PCDH7;PTPRM;CDH13;SDK1
2716,GO:0006090,0.516647391138762,0.628680730683181,8,104,pyruvate metabolic process,BP,NUP50;NUP153;LDHAL6B;NDC1;RANBP2;PGK1;NUP160;NUP54
3601,GO:0008037,0.516787428021742,0.665103895293728,5,63,cell recognition,BP,B4GALT1;LGALS3;CNTNAP2;GLIPR1L2;UBAP2L
6025,GO:0019080,0.516924484021509,0.606667067700571,11,185,viral gene expression,BP,NUP50;NUP153;NUCKS1;TARDBP;NDC1;RANBP2;NUP160;NUP54;POLR2F;CCL5;RPS12
4863,GO:0014075,0.517105953729492,0.759064147053793,2,23,response to amine,BP,HDAC9;RANBP2
18537,GO:1903672,0.517108958619916,0.759061620897718,2,23,positive regulation of sprouting angiogenesis,BP,HDAC9;PLK2
14683,GO:0070273,0.517195728189914,0.758988668912001,2,23,phosphatidylinositol-4-phosphate binding,MF,JPH2;ARRDC1-AS1
14017,GO:0060711,0.517243717581154,0.713213003456644,3,37,labyrinthine layer development,BP,CYR61;FGFR2;ADM
12628,GO:0050789,0.517505610412464,0.511671006685004,547,7519,regulation of biological process,BP,IL32;CRYAB;IGFBP3;MAFB;KRT1;SAA1;FTH1;DTX2;NEFL;NRG1;HDAC9;KRT4;C1R;TRIM16;MAP2;FN1;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;CTGF;HLA-B;UTP20;MMP9;FBN1;HSPG2;XAF1;SLC7A2;RUNX1;CYP1A1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;G6PD;TSC22D3;FST;DDX17;TRIM56;TFCP2L1;CCDC80;TRAF3;ENC1;IRS1;SPG21;MID1;TP53;DAPK3;TUFT1;PANK2;EXO1;EDN1;SCD;GBP1;HMGCS1;DOCK10;DDX47;SIPA1L3;C1QTNF1;DUSP14;RBM19;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;LGALS3;IFNGR1;CHP1;ACO1;PDPN;AKAP8;TGFB2;IRX2;CNTNAP1;ZNF208;RBM22;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;IL27RA;IL16;IFIT3;SRSF2;FOXD2;PPP1R3B;SLC30A6;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;NUP50;SLC22A5;PALM2;PUM3;CAMK1G;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;FAM111A;PARP15;BRIP1;SHQ1;LSS;UTP15;ARFRP1;LRRC8D;HLA-F;CDK4;SFRP1;VPS41;HLA-DOB;RIPK4;NUCKS1;HEATR1;CD274;WNT10A;TARDBP;MIR17HG;DST;POLQ;H3F3A;ATP2B1;COL4A1;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;RPA1;POLR1A;TPM1;GLIS3;HELLS;TAF2;ULK4;POLA1;ABCC4;TSN;REEP1;DRAM1;ADAMTS9;KCNS3;SETDB1;PTGER4;TMEM97;G3BP1;ZNF584;TRAF1;OPHN1;ADM;CD109;ZNF407;ELMSAN1;NDC1;CADPS2;DYNLL2;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;ZNF512;ZNF587;MUC16;UBQLN2;NEXN;FRK;DNTTIP2;GBP5;BTN2A1;KANK4;RFC3;AKAP8L;MYBL2;WDR76;HSPB1;RHOG;WNT4;CXCL16;NOP2;SUV39H2;LCP1;PTPRM;SIRPA;KDM6A;THOC1;RAN;UBTF;RANBP2;TOPBP1;ANAPC15;SOD2;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;IL24;ARHGEF28;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;MRTO4;TAF1D;ODC1;AJUBA;FASTKD3;KCNQ5;CGNL1;DND1;ZNF267;AKR1C2;LFNG;ZC3H7B;PGK1;SNX5;TRIM37;NETO1;FEN1;LUC7L;CDC42EP2;CDCA5;PPP4R4;GNL3L;ZNF586;YRDC;BAIAP2;NVL;GADD45B;SH3RF2;CDH13;COL5A2;COMMD4;PHACTR4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;BRCC3;CHID1;KREMEN2;SDK1;FZD1;TBC1D15;IRX4;UTY;NFE2L1;ANTXR1;RTKN2;CLU;NUP160;USP6;SMYD2;MACC1;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;ZNF106;VGLL3;ACKR3;RIF1;METTL16;FGD6;KLHL9;SETD2;GLIS2;ANLN;RPF2;UBP1;THBD;UPK3B;ABCC9;TTF2;DTX4;GLIPR2;JPH1;SRPRB;IFNAR1;WEE1;TJP1;LRRN3;ZNF484;THADA;ERAP1;BLOC1S2;APEX1;PDCL3;CXCR5;TNC;ZNF57;TET3;ORC1;MYBL1;HSPA8;SYT11;HSP90AB1;DDX21;ARL6IP5;EPHB6;BACE2;ZBTB24;NSF;LAIR1;NEDD4L;SGK1;M6PR;ZBTB12;ZFYVE27;BRCA2;SYNCRIP;TRAK2;HCAR1;DGCR8;SS18L2;CCAR1;SKA2;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;GOSR1;ETV6;L1CAM;ZNFX1;HSF2;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;RAD18;WDR75;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;UBAP2L;MSH6;CEP152;LILRB3;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;NFKBIE;CBLL1;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;ZNF608;TAF6L;DPH2;EBP;NCBP1;MYNN;UPF3B;AKR1B1;POLR1E;UBE2J2;VPS36;TRAF2;TPRA1;MSH3;TELO2;EDRF1;RBBP5;CITED2;POLR3B;HNRNPR;NCL;CCNA2;DDX56;TIMELESS;ORC2;IFI30;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;GLIPR1;KIF14;PURB;TLR3;AZIN1;SYNPO2;ESR1;PARD3;GJC1;RNF19B;RAD51B;EHD1;KCNE4;ARV1;DNASE1;TNF;ATAD5;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;FGFR1OP;PSMB10;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;TREX1;ZNF471;IRF1;CTCF;ASTN2;TSGA13;RBM8A;GTF2H3;RPS12;ZBTB9;GPX4;IRAK3;COPS3;IFI27L1
11923,GO:0046939,0.517570237924611,0.637237378353997,7,93,nucleotide phosphorylation,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
9471,GO:0036065,0.517574830270662,0.758669791277947,2,23,fucosylation,BP,SPON1;LFNG
7957,GO:0032550,0.517586150464826,0.575568543331648,20,283,purine ribonucleoside binding,MF,GBP1;RAB32;ARFRP1;TSR1;LSG1;EIF5;RRAGB;GBP5;RHOG;RAN;RAB26;GNL3L;EFTUD2;SRPRB;HSP90AB1;MMAA;BMS1;EHD1;NRAS;GBP6
3398,GO:0007179,0.51774834066915,0.612925305556543,10,128,transforming growth factor beta receptor signaling pathway,BP,PML;FBN1;TGFB2;MIR17HG;CD109;NPNT;HSP90AB1;ADAM17;CITED2;PARD3
7812,GO:0032356,0.517750364354355,0.847237149871348,1,10,oxidized DNA binding,MF,MSH6
14167,GO:0061025,0.517977696584465,0.596889722531891,13,177,membrane fusion,BP,TAP1;ERVFRD-1;SPACA6;CHP1;VPS41;VPS8;GDAP1;TBC1D15;USP6;SYT11;NSF;GOSR1;TAP2
5676,GO:0016783,0.518368822554024,0.844578310322627,1,12,sulfurtransferase activity,MF,URM1
241,GO:0000502,0.518418002935553,0.681961335239083,4,63,proteasome complex,CC,HSPB1;PSME2;PSMB9;PSMB10
15612,GO:0072075,0.518433771392097,0.848274052186587,1,9,metanephric mesenchyme development,BP,WNT4
4725,GO:0010885,0.518452163464978,0.848261616915414,1,9,regulation of cholesterol storage,BP,EHD1
8365,GO:0033234,0.518473011643046,0.846744957645461,1,10,negative regulation of protein sumoylation,BP,GNL3L
10436,GO:0043270,0.518882814221887,0.618346332677287,9,121,positive regulation of ion transport,BP,JPH2;G6PD;EDN1;LGALS3;CHP1;PDGFB;RAB3GAP1;GPER1;CCL5
4676,GO:0010822,0.518952581778425,0.611295685019512,10,140,positive regulation of mitochondrion organization,BP,NRG1;MMP9;TP53;DYNLL2;GPER1;WDR75;UBE2J2;STARD7;PPARGC1B;TSGA13
4573,GO:0010656,0.519239492463817,0.75726677257234,2,23,negative regulation of muscle cell apoptotic process,BP,EDN1;CFLAR
15158,GO:0071241,0.519248038791141,0.618035150379216,9,120,cellular response to inorganic substance,BP,MMP9;CYP1A1;EDN1;NQO1;CFLAR;TRAF2;CCNA2;TIMELESS;DAXX
15608,GO:0072070,0.519264052211072,0.847712006705114,1,9,loop of Henle development,BP,IRX2
15840,GO:0072524,0.51940079237359,0.611074650143244,10,134,pyridine-containing compound metabolic process,BP,G6PD;PGD;NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54;NNT
15021,GO:0070933,0.519409528346293,0.847613386694774,1,9,histone H4 deacetylation,BP,HDAC9
559,GO:0001682,0.519764872781175,0.843613103359383,1,12,tRNA 5'-leader removal,BP,POP1
6365,GO:0021543,0.519779130991791,0.617850884313401,9,113,pallium development,BP,NEFL;FAT4;RAN;SRF;SRD5A1;CNTNAP2;EIF2B5;KIF14;PHLPP2
10294,GO:0043030,0.51988682202667,0.756719951037427,2,23,regulation of macrophage activation,BP,SLC7A2;CD74
16848,GO:0098719,0.520207672663327,0.847071559390825,1,9,sodium ion import across plasma membrane,BP,SLC9A9
6612,GO:0022821,0.520290080208126,0.847015543434148,1,9,potassium ion antiporter activity,MF,SLC9A9
3884,GO:0008514,0.520535749937416,0.610003817887492,10,133,organic anion transmembrane transporter activity,MF,SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;SLC4A11;SLC22A5;SLC1A3;SLCO4C1;SLC43A2;SLC25A22
1134,GO:0002720,0.520584125393392,0.755252430984728,2,25,positive regulation of cytokine production involved in immune response,BP,TRAF2;CD74
1146,GO:0002739,0.520649654070615,0.845256105335264,1,10,regulation of cytokine secretion involved in immune response,BP,TNF
17132,GO:0101003,0.520741479495456,0.71006491879688,3,37,ficolin-1-rich granule membrane,CC,LGALS3;MGAM;SIRPA
16763,GO:0098505,0.520830068339503,0.845132270701708,1,10,G-rich strand telomeric DNA binding,MF,RPA1
13923,GO:0060547,0.520919808735219,0.845070649250295,1,10,negative regulation of necrotic cell death,BP,BIRC3
10575,GO:0043524,0.520983614865482,0.633949613555992,7,93,negative regulation of neuron apoptotic process,BP,NEFL;GCLC;NAIP;SOD2;SET;HSP90AB1;KIF14
2614,GO:0005922,0.520986518933944,0.845024831245331,1,10,connexin complex,CC,GJC1
8244,GO:0033005,0.52101962353364,0.845002090952554,1,10,positive regulation of mast cell activation,BP,SYK
10640,GO:0043628,0.521033016439288,0.754127929367639,2,27,ncRNA 3'-end processing,BP,DKC1;USB1
6954,GO:0030575,0.521180290110072,0.84640955873201,1,9,nuclear body organization,BP,PML
13425,GO:0052742,0.521485357894872,0.710504490459279,3,33,phosphatidylinositol kinase activity,MF,FGFR2;IRS1;PIK3R3
13054,GO:0051491,0.521489847942782,0.755865547211753,2,22,positive regulation of filopodium assembly,BP,SRF;DPYSL3
10584,GO:0043537,0.521575371667903,0.755290310787762,2,23,negative regulation of blood vessel endothelial cell migration,BP,STARD13;ITGB1BP1
18566,GO:1903747,0.521587745340967,0.633002736357736,7,99,regulation of establishment of protein localization to mitochondrion,BP,NRG1;TP53;DYNLL2;WDR75;UBE2J2;STARD7;TSGA13
10286,GO:0043021,0.521684546225161,0.623485630430507,8,110,ribonucleoprotein complex binding,MF,CBX5;GEMIN5;NAA15;DDX3X;NVL;SRPRB;NAA16;HNRNPU
20315,GO:2001252,0.521700190962754,0.603008859715989,11,146,positive regulation of chromosome organization,BP,PML;TP53;AKAP8;DKC1;NBN;SETDB1;AKAP8L;FEN1;RIF1;ATR;HNRNPU
17211,GO:0106003,0.521732170633502,0.84603308072552,1,9,amyloid-beta complex,CC,CLU
941,GO:0002347,0.521816993137557,0.844453690007446,1,10,response to tumor cell,BP,RBMS3
7341,GO:0031346,0.521868955929924,0.571670871939324,20,257,positive regulation of cell projection organization,BP,NEFL;NRG1;FN1;TENM3;ENC1;CORO1C;RRN3;CDC42EP2;BAIAP2;SRF;FZD1;ANLN;NEDD4L;ZFYVE27;L1CAM;NTN1;CFLAR;SHTN1;DPYSL3;DDX56
18643,GO:1903900,0.522420163480106,0.622673372496069,8,112,regulation of viral life cycle,BP,PML;FAM111A;NUCKS1;DDX3X;HSPA8;TNF;CCL5;CD74
11779,GO:0046621,0.52246599685635,0.755038259968145,2,22,negative regulation of organ growth,BP,G6PD;MIR17HG
4090,GO:0009143,0.522535434765045,0.842716536101839,1,11,nucleoside triphosphate catabolic process,BP,ENPP1
415,GO:0001102,0.522833286117599,0.708428110728071,3,36,RNA polymerase II activating transcription factor binding,MF,SRF;TAF6L;RBL1
2100,GO:0004864,0.522889358322984,0.753713990007642,2,24,protein phosphatase inhibitor activity,MF,SET;SH3RF2
7720,GO:0032204,0.522893585441964,0.644238132887667,6,76,regulation of telomere maintenance,BP,PML;DKC1;NBN;GNL3L;ATR;HNRNPU
9966,GO:0042326,0.522915294355247,0.559333113989397,26,354,negative regulation of phosphorylation,BP,IGFBP3;GPRC5A;GBP1;DUSP14;CDKN2A;CHP1;SLC9A3R1;INHBA;CDK4;SFRP1;TARDBP;CD109;HSPB1;CORO1C;SOCS1;PARP14;AJUBA;GADD45B;ENPP1;GPER1;PARD3;HNRNPU;FGFR1OP;CDKN1A;ITGB1BP1;IRAK3
10425,GO:0043254,0.522920700099106,0.560906813324204,25,339,regulation of protein complex assembly,BP,CRYAB;MAP2;TP53;VPS41;RPA1;PTGER4;GBP5;KANK4;RHOG;LCP1;DDX3X;RRN3;AJUBA;CDC42EP2;BAIAP2;SRF;CLU;HSPA8;FAF1;ATR;KIF14;ESR1;TNF;TAF1;GTF2H3
15145,GO:0071219,0.523173540391261,0.621989214540401,8,111,cellular response to molecule of bacterial origin,BP,AKAP8;CDK4;CD274;CCL20;IL24;NFKBIB;TNF;CCL5
11120,GO:0045123,0.523217243375925,0.753895656395236,2,23,cellular extravasation,BP,PTGER4;TNF
17062,GO:0099516,0.523408728570523,0.707907123692766,3,36,ion antiporter activity,MF,SLC4A11;SLC22A5;SLC9A9
25,GO:0000049,0.523651429219751,0.67813916545214,4,54,tRNA binding,MF,METTL1;YRDC;RARS;TRMT1
3570,GO:0007616,0.523938212151199,0.753787560593927,2,22,long-term memory,BP,SRF;SGK1
1186,GO:0002830,0.523958883255919,0.841725703316254,1,11,positive regulation of type 2 immune response,BP,CD74
15943,GO:0072710,0.52412248887214,0.844395368535685,1,9,response to hydroxyurea,BP,TIMELESS
5740,GO:0016884,0.524293351766747,0.842742321941623,1,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,GATC
13784,GO:0060340,0.524303415888391,0.844270936579099,1,9,positive regulation of type I interferon-mediated signaling pathway,BP,NLRC5
15617,GO:0072080,0.524395891774933,0.658277853601437,5,60,nephron tubule development,BP,FAT4;PBX1;IRX2;WNT4;NPNT
2818,GO:0006283,0.524829572051544,0.65648913283229,5,73,transcription-coupled nucleotide-excision repair,BP,RPA1;RFC3;POLR2F;GTF2H3;COPS3
10039,GO:0042474,0.52509488536117,0.8409319874538,1,11,middle ear morphogenesis,BP,EDN1
1313,GO:0003158,0.525315292477796,0.642003687639888,6,75,endothelium development,BP,NRG1;STARD13;PDPN;TJP2;TJP1;TNF
6307,GO:0019933,0.525433106459089,0.657040496402434,5,62,cAMP-mediated signaling,BP,SLC9A3R1;AHR;PTGER4;ADM;GPER1
3344,GO:0007064,0.525482862042391,0.752471444877542,2,22,mitotic sister chromatid cohesion,BP,CDCA5;NAA50
8680,GO:0034244,0.525601967883421,0.841832919518356,1,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,HNRNPU
3770,GO:0008320,0.525856921809432,0.838474973482278,1,13,protein transmembrane transporter activity,MF,TIMM23B
6732,GO:0030141,0.525891324971739,0.542601248137536,38,541,secretory granule,CC,KRT1;FTL;FTH1;FN1;C3;S100P;MMP9;B4GALT1;EDN1;LGALS3;TGFB2;PCDH7;VEZT;HRNR;PTPRB;ABCC4;MGAM;CD109;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;RAB26;ITGAV;QPCT;BAIAP2;PDGFB;CLU;COMMD9;HSPA8;HSP90AB1;LAIR1;BRCA2;LILRB3;GLIPR1;NRAS
4236,GO:0009415,0.526148146646763,0.841452326648275,1,10,response to water,BP,AKR1B1
9610,GO:0036459,0.526270978945808,0.629253836196959,7,87,thiol-dependent ubiquitinyl hydrolase activity,MF,CYLD;USP16;USP43;BRCC3;USP6;USP11;USP1
17133,GO:0101005,0.526270978945808,0.629253836196959,7,87,ubiquitinyl hydrolase activity,MF,CYLD;USP16;USP43;BRCC3;USP6;USP11;USP1
12928,GO:0051255,0.526276989920365,0.841362456054135,1,10,spindle midzone assembly,BP,KIF23
7462,GO:0031593,0.526379391359184,0.70495424846611,3,37,polyubiquitin modification-dependent protein binding,MF,IKBKE;BRCC3;RAD18
10171,GO:0042745,0.52639697077212,0.840018979716634,1,11,circadian sleep/wake cycle,BP,SRD5A1
11396,GO:0045747,0.526442985979543,0.705423539101745,3,35,positive regulation of Notch signaling pathway,BP,TGFB2;LFNG;ITGB1BP1
20210,GO:2001022,0.526472259284323,0.655490459287549,5,67,positive regulation of response to DNA damage stimulus,BP,BRCC3;EYA3;RIF1;ATR;TIMELESS
15497,GO:0071825,0.5265151700317,0.750616132104397,2,24,protein-lipid complex subunit organization,BP,ACSL3;ABCA5
510,GO:0001573,0.526617618409094,0.841124697634663,1,10,ganglioside metabolic process,BP,CLN6
8085,GO:0032760,0.526656336161304,0.704460187119475,3,38,positive regulation of tumor necrosis factor production,BP,HSPB1;CLU;TLR3
3192,GO:0006820,0.526944663949469,0.556924171018666,25,336,anion transport,BP,SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;EDN1;ACSL3;SLC4A11;SLC9A3R1;SLC22A5;SYK;LRRC8D;SLC5A6;ABCC4;SLC1A3;SLCO4C1;CROT;ENPP1;ABCC9;ARL6IP5;RAB3GAP1;NFKBIE;CLCC1;STARD7;SLC43A2;SLC25A22
11288,GO:0045579,0.52714048119441,0.840759277373244,1,10,positive regulation of B cell differentiation,BP,SYK
11214,GO:0045324,0.527161673774293,0.839481156138987,1,11,late endosome to vacuole transport,BP,VPS36
18430,GO:1903432,0.527252128975788,0.749983799372639,2,24,regulation of TORC1 signaling,BP,RRAGB;TELO2
12983,GO:0051346,0.527288950554294,0.565956411704373,20,281,negative regulation of hydrolase activity,BP,CRYAB;AMOT;C3;MMP9;TP53;CHP1;TGFB2;PKMYT1;NAIP;LEPR;CD109;VCPKMT;DDX3X;SET;PPP4R4;SH3RF2;BIRC3;THADA;SERPINB9;TNF
642,GO:0001829,0.527550611382533,0.840472251761607,1,10,trophectodermal cell differentiation,BP,SRF
6831,GO:0030286,0.527617736859417,0.704642841674248,3,34,dynein complex,CC,DYNC2H1;DNHD1;DYNLL2
13284,GO:0051952,0.528000652177984,0.748913231985624,2,25,regulation of amine transport,BP,ARL6IP5;RAB3GAP1
4970,GO:0015077,0.528111011463186,0.591366399470336,12,166,monovalent inorganic cation transmembrane transporter activity,MF,SLC4A11;SLC5A6;KCNS3;SLC1A3;ATP2C1;KCNQ5;ABCC9;NNT;SLC11A2;SLC9A9;KCNE4;SLC25A22
15577,GO:0072006,0.528711268129861,0.626961232008613,7,86,nephron development,BP,FAT4;PBX1;IRX2;WNT4;NPNT;PDGFB;CFLAR
1316,GO:0003161,0.528836159246374,0.841131809780506,1,9,cardiac conduction system development,BP,NRG1
17550,GO:1901017,0.529167440429751,0.840900736162478,1,9,negative regulation of potassium ion transmembrane transporter activity,BP,NEDD4L
17669,GO:1901380,0.529167440429751,0.840900736162478,1,9,negative regulation of potassium ion transmembrane transport,BP,NEDD4L
8007,GO:0032623,0.529219304050567,0.702119788789131,3,38,interleukin-2 production,BP,RUNX1;GBP1;TRAF2
2392,GO:0005527,0.529321132344354,0.836899245609099,1,12,macrolide binding,MF,FKBP5
2393,GO:0005528,0.529321132344354,0.836899245609099,1,12,FK506 binding,MF,FKBP5
14013,GO:0060707,0.52934159629166,0.839214798058771,1,10,trophoblast giant cell differentiation,BP,E2F8
10620,GO:0043589,0.529472254754736,0.840687924630937,1,9,skin morphogenesis,BP,SRF
8048,GO:0032691,0.529530311191869,0.837807624242402,1,11,negative regulation of interleukin-1 beta production,BP,PML
10803,GO:0044265,0.529547053887411,0.522988379367053,67,960,cellular macromolecule catabolic process,BP,PML;GCLC;CLN6;ENC1;TP53;PABPC4;CYLD;DKC1;POP1;TARDBP;USP16;KEAP1;ADAMTS9;OPHN1;USP43;FOXRED2;CASC3;PLK2;UBQLN2;HSPB1;EXOG;RANBP2;ANAPC15;RNF115;SET;ARNTL;MRTO4;FASTKD3;FEN1;CLU;USP6;LRPPRC;METTL16;APEX1;PDCL3;HSPA8;TMEM199;HSP90AB1;NEDD4L;ANAPC7;SYNCRIP;CCDC47;FAF1;SENP1;PSME2;PSMB9;NCBP1;UPF3B;SPSB1;UBE2J2;VPS36;HNRNPR;CLOCK;KIF14;RNF19B;USP11;DNASE1;ZFP36L2;RC3H1;HNRNPU;PSMB10;TAF1;SMARCC1;USP1;RBM8A;RPS12;COPS3
14143,GO:0060986,0.529670574760055,0.748370458915624,2,23,endocrine hormone secretion,BP,C1QTNF1;INHBA
676,GO:0001883,0.529739030074871,0.563465586438655,20,285,purine nucleoside binding,MF,GBP1;RAB32;ARFRP1;TSR1;LSG1;EIF5;RRAGB;GBP5;RHOG;RAN;RAB26;GNL3L;EFTUD2;SRPRB;HSP90AB1;MMAA;BMS1;EHD1;NRAS;GBP6
4983,GO:0015103,0.529856598986367,0.637446331144289,6,77,inorganic anion transmembrane transporter activity,MF,SLC4A11;SLC22A5;LRRC8D;ABCC4;ABCC9;CLCC1
12855,GO:0051146,0.530134253821135,0.589851903064065,12,150,striated muscle cell differentiation,BP,NRG1;HDAC9;ACTG1;G6PD;EDN1;TPM1;NEXN;SRF;MYH11;CFLAR;EHD1;HNRNPU
6792,GO:0030224,0.530575947989194,0.747120557894711,2,24,monocyte differentiation,BP,CSF1;CD74
18294,GO:1903131,0.530575947989194,0.747120557894711,2,24,mononuclear cell differentiation,BP,CSF1;CD74
11792,GO:0046635,0.530705814506896,0.746578155877445,2,25,positive regulation of alpha-beta T cell activation,BP,SYK;AP3B1
2971,GO:0006511,0.530804439537168,0.538617980796874,37,514,ubiquitin-dependent protein catabolic process,BP,PML;GCLC;TP53;CYLD;USP16;KEAP1;USP43;FOXRED2;PLK2;UBQLN2;RANBP2;ANAPC15;RNF115;ARNTL;CLU;USP6;PDCL3;HSP90AB1;NEDD4L;ANAPC7;CCDC47;FAF1;SENP1;PSME2;PSMB9;SPSB1;UBE2J2;VPS36;CLOCK;KIF14;RNF19B;USP11;PSMB10;TAF1;SMARCC1;USP1;COPS3
7721,GO:0032205,0.530853888287328,0.701397652570501,3,35,negative regulation of telomere maintenance,BP,NBN;GNL3L;HNRNPU
18037,GO:1902495,0.530933666002369,0.606890632815232,9,114,transmembrane transporter complex,CC,CNTNAP1;SHISA9;LRRC8D;KCNS3;ABCF2;KCNQ5;ABCC9;CNTNAP2;CLCC1
4416,GO:0010181,0.531000650814532,0.838044074260931,1,10,FMN binding,MF,TYW1
16135,GO:0090102,0.531009874743086,0.747215037109554,2,23,cochlea development,BP,MCM2;CCNA2
18532,GO:1903651,0.53127655690678,0.839424306942025,1,9,positive regulation of cytoplasmic transport,BP,MTMR2
13051,GO:0051482,0.531341466349066,0.836520147285208,1,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,EDN1
12732,GO:0050931,0.531999050665783,0.74635973075356,2,23,pigment cell differentiation,BP,RAB32;ADAMTS9
4470,GO:0010464,0.532016113699109,0.746344962467231,2,23,regulation of mesenchymal cell proliferation,BP,FGFR2;PHF14
18229,GO:1902993,0.532054367880067,0.837297555010423,1,10,positive regulation of amyloid precursor protein catabolic process,BP,CLU
1150,GO:0002755,0.532154613474731,0.745754143960034,2,24,MyD88-dependent toll-like receptor signaling pathway,BP,IRF1;IRAK3
2620,GO:0005930,0.532411587435192,0.65037483323656,5,62,axoneme,CC,DYNC2H1;DNHD1;WDPCP;CENPF;BBS5
3880,GO:0008509,0.532537706349469,0.578506101975205,14,188,anion transmembrane transporter activity,MF,SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;SLC4A11;SLC22A5;LRRC8D;ABCC4;SLC1A3;SLCO4C1;ABCC9;CLCC1;SLC43A2;SLC25A22
5516,GO:0016471,0.532629084548045,0.83560068852318,1,11,vacuolar proton-transporting V-type ATPase complex,CC,TMEM199
4588,GO:0010676,0.532699823094842,0.699704584076601,3,35,positive regulation of cellular carbohydrate metabolic process,BP,IRS1;RANBP2;GPER1
5139,GO:0015645,0.532763220758602,0.83679406361249,1,10,fatty acid ligase activity,MF,ACSL3
5017,GO:0015175,0.532775181811031,0.745215861032689,2,24,neutral amino acid transmembrane transporter activity,MF,SLC7A5P2;SLC43A2
2797,GO:0006244,0.532956544691789,0.834295657345124,1,12,pyrimidine nucleotide catabolic process,BP,SMUG1
2835,GO:0006304,0.533045711526103,0.634105106523787,6,80,DNA modification,BP,APEX1;TET3;SMUG1;MPHOSPH8;FTO;CTCF
788,GO:0002043,0.53305134159661,0.836589115796354,1,10,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,ITGB1BP1
19263,GO:1905369,0.533061341248741,0.668114524966332,4,64,endopeptidase complex,CC,HSPB1;PSME2;PSMB9;PSMB10
11612,GO:0046184,0.533075859654205,0.836571667500081,1,10,aldehyde biosynthetic process,BP,WNT4
8893,GO:0034702,0.533123162770924,0.612812181858683,8,101,ion channel complex,CC,CNTNAP1;SHISA9;LRRC8D;KCNS3;KCNQ5;ABCC9;CNTNAP2;CLCC1
13033,GO:0051447,0.533406209353352,0.836336451931849,1,10,negative regulation of meiotic cell cycle,BP,RAD1
5076,GO:0015297,0.533623189472469,0.669206808916857,4,51,antiporter activity,MF,SLC7A5P2;SLC4A11;SLC22A5;SLC9A9
10737,GO:0044068,0.533722249859959,0.744393118098374,2,24,modulation by symbiont of host cellular process,BP,ITGAV;SERPINB9
14341,GO:0061478,0.533821174877757,0.837630801071351,1,9,response to platelet aggregation inhibitor,BP,AHR
272,GO:0000774,0.533836101843188,0.83473564799168,1,11,adenyl-nucleotide exchange factor activity,MF,BAG1
11526,GO:0046006,0.533878857028688,0.743424834293328,2,26,regulation of activated T cell proliferation,BP,CD274;RC3H1
13957,GO:0060601,0.534958940972492,0.836824535263911,1,9,lateral sprouting from an epithelium,BP,FGFR2
16490,GO:0097153,0.535016234943771,0.832808313391291,1,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,CFLAR
15349,GO:0071549,0.535302496044401,0.742582084755623,2,25,cellular response to dexamethasone stimulus,BP,SRD5A1;CFLAR
14603,GO:0070131,0.53533118978992,0.833659932084739,1,11,positive regulation of mitochondrial translation,BP,FASTKD3
11472,GO:0045912,0.535390916008006,0.74341435584125,2,23,negative regulation of carbohydrate metabolic process,BP,LEPR;ENPP1
1915,GO:0004602,0.535494667777724,0.830099278351569,1,15,glutathione peroxidase activity,MF,GPX4
2815,GO:0006278,0.535505929991234,0.646939697601602,5,66,RNA-dependent DNA biosynthetic process,BP,DKC1;GNL3L;HSP90AB1;ATR;HNRNPU
2522,GO:0005775,0.535567026830885,0.601781988452699,9,126,vacuolar lumen,CC,FTL;C3;HSPG2;HRNR;FRK;CHID1;HSPA8;IFI30;CD74
10084,GO:0042573,0.53566938245884,0.83341595294013,1,11,retinoic acid metabolic process,BP,CYP1A1
10339,GO:0043122,0.535796857756184,0.579166937099942,13,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,MAP3K14;TRIM22;IKBKE;PLK2;HSPB1;ATP2C1;AJUBA;BIRC3;CFLAR;TRAF2;ESR1;TNF;CD74
7196,GO:0031080,0.536430222002652,0.834172717355711,1,10,nuclear pore outer ring,CC,NUP160
12945,GO:0051281,0.536541437610066,0.741935032278815,2,24,positive regulation of release of sequestered calcium ion into cytosol,BP,JPH2;GPER1
1362,GO:0003230,0.536545253795252,0.743502176429537,2,21,cardiac atrium development,BP,CYR61;TGFB2
15616,GO:0072079,0.53661317963774,0.832733807986372,1,11,nephron tubule formation,BP,IRX2
6060,GO:0019205,0.536815894579037,0.694463730781543,3,41,nucleobase-containing compound kinase activity,MF,TJP2;TK1;NOL9
6024,GO:0019079,0.536854788920709,0.618261780323937,7,97,viral genome replication,BP,FAM111A;NUCKS1;DDX3X;UBP1;HSPA8;TNF;CCL5
11539,GO:0046039,0.536865511577073,0.740443096710435,2,27,GTP metabolic process,BP,RAN;GPHN
6521,GO:0021895,0.537076500748351,0.833707812196335,1,10,cerebral cortex neuron differentiation,BP,OPHN1
16086,GO:0090025,0.537167325758557,0.832332417038587,1,11,regulation of monocyte chemotaxis,BP,CCL5
12889,GO:0051193,0.537235547711675,0.630286840228471,6,77,regulation of cofactor metabolic process,BP,NUP50;NUP153;NDC1;RANBP2;NUP160;NUP54
12985,GO:0051348,0.537306520091125,0.563590669354229,17,239,negative regulation of transferase activity,BP,GPRC5A;TP53;DUSP14;CDKN2A;CHP1;CDK4;SFRP1;HSPB1;CORO1C;SOCS1;AJUBA;GADD45B;HNRNPU;FGFR1OP;CDKN1A;ITGB1BP1;IRAK3
2972,GO:0006513,0.537371046451977,0.645251064148604,5,65,protein monoubiquitination,BP,KBTBD8;TRIM37;NEDD4L;RAD18;RING1
16127,GO:0090090,0.537458688218468,0.599754041317615,9,130,negative regulation of canonical Wnt signaling pathway,BP,CYLD;SFRP1;G3BP1;WNT4;KREMEN2;RBMS3;PSME2;PSMB9;PSMB10
11,GO:0000022,0.537512582674317,0.833393618261045,1,10,mitotic spindle elongation,BP,KIF23
16448,GO:0097067,0.537900929054318,0.833113481054051,1,10,cellular response to thyroid hormone stimulus,BP,GCLC
7725,GO:0032210,0.537919611168176,0.665129541617927,4,51,regulation of telomere maintenance via telomerase,BP,DKC1;GNL3L;ATR;HNRNPU
10658,GO:0043679,0.538179585008192,0.644359986916537,5,66,axon terminus,CC,OPHN1;HSPA8;SYT11;GPER1;HNRNPR
2709,GO:0006081,0.538277289511971,0.664065204281279,4,56,cellular aldehyde metabolic process,BP,CYP1B1;G6PD;PGD;WNT4
3915,GO:0008574,0.538358087876479,0.740821775879953,2,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,DYNLL2;KIF14
13597,GO:0060044,0.538566226732759,0.832632825117065,1,10,negative regulation of cardiac muscle cell proliferation,BP,MIR17HG
9328,GO:0035791,0.538572919559448,0.8342456278545,1,9,platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
20037,GO:2000615,0.538605864876836,0.832604158430063,1,10,regulation of histone H3-K9 acetylation,BP,CHEK1
5006,GO:0015149,0.538704207071178,0.832533022110376,1,10,hexose transmembrane transporter activity,MF,M6PR
11259,GO:0045444,0.538757539809705,0.586090990386698,11,148,fat cell differentiation,BP,TRIO;SFRP1;SOCS1;ARNTL;ENPP1;ERAP1;STEAP4;GPER1;TNF;ZFP36L2;FTO
12705,GO:0050901,0.538861821060477,0.832418968721908,1,10,leukocyte tethering or rolling,BP,TNF
9481,GO:0036092,0.53957472914674,0.693965420307491,3,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGFR2;IRS1;PIK3R3
12623,GO:0050780,0.539575012422867,0.831902230868053,1,10,dopamine receptor binding,MF,SLC9A3R1
10484,GO:0043367,0.539728063685341,0.69242529528108,3,38,CD4-positive, alpha-beta T cell differentiation,BP,RELB;PTGER4;RC3H1
4429,GO:0010256,0.539862370540434,0.54098608541085,27,357,endomembrane system organization,BP,VMP1;FAT4;DYNC2H1;TGFB2;NUP50;NUP153;TARDBP;REEP1;NDC1;AKAP8L;RANBP2;BAIAP2;CLU;NUP160;NUP54;BLOC1S2;SYT11;ZFYVE27;CCDC47;RAB3GAP1;GPER1;SHTN1;VPS36;MPP5;ARV1;TBPL1;TRAM2
11456,GO:0045876,0.539870290764913,0.831687974661554,1,10,positive regulation of sister chromatid cohesion,BP,FEN1
7210,GO:0031094,0.540011321711536,0.835257392357206,1,8,platelet dense tubular network,CC,EHD1
15681,GO:0072182,0.540145631864894,0.833114806584352,1,9,regulation of nephron tubule epithelial cell differentiation,BP,FAT4
5411,GO:0016248,0.540274168423584,0.738219716098298,2,25,channel inhibitor activity,MF,ANKRD36C;NEDD4L
14411,GO:0061647,0.540274805223818,0.692427168058267,3,36,histone H3-K9 modification,BP,SUV39H2;RIF1;CHEK1
3329,GO:0007041,0.540395714323222,0.615242060011347,7,90,lysosomal transport,BP,GNPTAB;VPS41;CLU;HSPA8;M6PR;TRAK2;AP3B1
18862,GO:1904427,0.540584531761503,0.691628179744198,3,38,positive regulation of calcium ion transmembrane transport,BP,JPH2;G6PD;GPER1
4336,GO:0009886,0.540898276728171,0.830940622072265,1,10,post-embryonic animal morphogenesis,BP,FBN1
14647,GO:0070202,0.541123096664358,0.82944825133698,1,11,regulation of establishment of protein localization to chromosome,BP,DKC1
8252,GO:0033017,0.541164995956703,0.739461942366059,2,21,sarcoplasmic reticulum membrane,CC,JPH2;JPH1
3063,GO:0006626,0.541231010723406,0.60382303576547,8,121,protein targeting to mitochondrion,BP,NRG1;IMMP2L;GDAP1;TIMM23B;WDR75;UBE2J2;STARD7;TSGA13
4577,GO:0010660,0.541393325551908,0.69087445932204,3,38,regulation of muscle cell apoptotic process,BP,EDN1;CDKN2A;CFLAR
16996,GO:0099003,0.541430589832763,0.614223662401106,7,90,vesicle-mediated transport in synapse,BP,AP3M2;OPHN1;CADPS2;BLOC1S2;SYT11;RAB3GAP1;AP3B1
14785,GO:0070469,0.541527893363837,0.658904941519061,4,78,respiratory chain,CC,NNT;SDHD;UQCRB;NDUFB9
2643,GO:0005978,0.541596068007433,0.69119719750908,3,36,glycogen biosynthetic process,BP,IRS1;PPP1R3B;ENPP1
4177,GO:0009250,0.541596068007433,0.69119719750908,3,36,glucan biosynthetic process,BP,IRS1;PPP1R3B;ENPP1
16671,GO:0097526,0.541626243077853,0.735576491192185,2,29,spliceosomal tri-snRNP complex,CC,ZMAT2;EFTUD2
11820,GO:0046686,0.541766420443028,0.689281779736631,3,44,response to cadmium ion,BP,GCLC;MMP9;DAXX
6662,GO:0030011,0.542222012098338,0.831613850501425,1,9,maintenance of cell polarity,BP,DST
11600,GO:0046148,0.542229763238458,0.689635248849577,3,40,pigment biosynthetic process,BP,IBA57;NFE2L1;SLC11A2
3355,GO:0007093,0.542468745455244,0.58220267858004,11,154,mitotic cell cycle checkpoint,BP,PML;TP53;NBN;PLK2;TOPBP1;ANAPC15;MDM4;E2F8;CENPF;RFWD3;CDKN1A
13935,GO:0060572,0.542548352800954,0.829736322651817,1,10,morphogenesis of an epithelial bud,BP,FGFR2
4513,GO:0010561,0.542823856732335,0.828198013437797,1,11,negative regulation of glycoprotein biosynthetic process,BP,BACE2
968,GO:0002407,0.543032285110814,0.828044372408042,1,11,dendritic cell chemotaxis,BP,CCL5
3568,GO:0007613,0.543488726377076,0.639557116119179,5,63,memory,BP,PLK2;NETO1;FEN1;SRF;SGK1
19743,GO:2000052,0.543518829462617,0.82902532220075,1,10,positive regulation of non-canonical Wnt signaling pathway,BP,SFRP1
4193,GO:0009295,0.543577810869441,0.688374139731181,3,40,nucleoid,CC,DDX28;LRPPRC;HADHB
10132,GO:0042645,0.543577810869441,0.688374139731181,3,40,mitochondrial nucleoid,CC,DDX28;LRPPRC;HADHB
12082,GO:0048015,0.544046392896509,0.60186289871983,8,104,phosphatidylinositol-mediated signaling,BP,NRG1;IRS1;EDN1;TGFB2;SLC9A3R1;PDGFB;GPER1;CCL5
15836,GO:0072520,0.544598500090661,0.828231963273411,1,10,seminiferous tubule development,BP,BRIP1
3954,GO:0008655,0.544669917502767,0.825717713191693,1,12,pyrimidine-containing compound salvage,BP,TK1
11871,GO:0046838,0.544733263767988,0.828132762032797,1,10,phosphorylated carbohydrate dephosphorylation,BP,MTMR2
11880,GO:0046855,0.544733263767988,0.828132762032797,1,10,inositol phosphate dephosphorylation,BP,MTMR2
2658,GO:0006000,0.545061132487696,0.826543972530519,1,11,fructose metabolic process,BP,AKR1B1
4776,GO:0010959,0.545120724407386,0.565937945716652,14,188,regulation of metal ion transport,BP,PML;JPH2;G6PD;LGALS3;CHP1;IL16;SLC9A3R1;NETO1;PDGFB;JPH1;THADA;NEDD4L;GPER1;CCL5
1314,GO:0003159,0.545206127177261,0.826436406445731,1,11,morphogenesis of an endothelium,BP,STARD13
14238,GO:0061154,0.545206127177261,0.826436406445731,1,11,endothelial tube morphogenesis,BP,STARD13
331,GO:0000921,0.545346415596538,0.827680922774589,1,10,septin ring assembly,BP,ANLN
14900,GO:0070672,0.545427532388854,0.827621086520125,1,10,response to interleukin-15,BP,STAT5A
427,GO:0001134,0.545617762176986,0.734415196057056,2,23,transcription factor activity, transcription factor recruiting,MF,MYBL2;MYBL1
16342,GO:0090527,0.545657035893051,0.829110705049122,1,9,actin filament reorganization,BP,NEDD9
15876,GO:0072576,0.545711644707319,0.827411398358055,1,10,liver morphogenesis,BP,CFLAR
14403,GO:0061631,0.545740333600816,0.732964940165813,2,26,ubiquitin conjugating enzyme activity,MF,UBE2J2;TAF1
1878,GO:0004551,0.545804096567267,0.824871602812112,1,12,nucleotide diphosphatase activity,MF,ENPP1
6067,GO:0019212,0.545806307205918,0.733315929107029,2,25,phosphatase inhibitor activity,MF,SET;SH3RF2
16782,GO:0098554,0.54581705998685,0.823917079901584,1,13,cytoplasmic side of endoplasmic reticulum membrane,CC,THADA
7968,GO:0032561,0.54600106856547,0.54714220138669,20,287,guanyl ribonucleotide binding,MF,GBP1;RAB32;ARFRP1;TSR1;LSG1;EIF5;RRAGB;GBP5;RHOG;RAN;RAB26;GNL3L;EFTUD2;SRPRB;HSP90AB1;MMAA;BMS1;EHD1;NRAS;GBP6
2666,GO:0006012,0.546222767961652,0.825680930504515,1,11,galactose metabolic process,BP,B4GALT1
17710,GO:1901564,0.546257900613522,0.48236714468234,346,4911,organonitrogen compound metabolic process,BP,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;C1R;TRIM16;FN1;TENM3;PTGES;PML;MAP3K14;GCLC;KRT2;CYR61;C3;GPRC5A;FGFR2;STAT5A;EPGN;TRIM22;CTGF;MMP9;FBN1;GNPTAB;HSPG2;SLC7A2;CYP1A1;CLN6;IL1R2;B4GALT1;G6PD;SPON1;TRIM56;OVCH2;TRAF3;ENC1;IRS1;MID1;SLC16A9;TP53;DAPK3;PANK2;EDN1;TPST1;C9ORF3;GBP1;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;PTPN14;GEMIN5;NQO1;PABPC4;CHP1;ACO1;AKAP8;TGFB2;ST6GALNAC5;PRSS23;CARS2;CYLD;IKBKE;PKMYT1;CDKAL1;PPP1R3B;PGD;P3H2;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;SLC22A5;PUM3;GALNT18;CAMK1G;SYK;EMP2;TJP2;NUP153;NAIP;NBN;TRIO;PARP15;ABCG2;CDK4;SFRP1;RIPK4;ZDHHC6;TARDBP;MIR17HG;ABHD4;H3F3A;USP16;APOL6;KEAP1;NAA15;SLC5A6;DHFR;METTL21A;PTPRB;ULK4;RCE1;ADAMTS9;SETDB1;PTGER4;TK1;OPHN1;ADM;IMMP2L;CD109;P4HA2;USP43;GGCX;NDC1;HERC6;FOXRED2;SLC1A3;EIF5;CASC3;CCL20;PLK2;MRPL27;MME;MUC16;UBQLN2;HSCB;FRK;AKAP8L;HSPB1;DOHH;SUV39H2;PTPRM;KDM6A;SETD4;RAN;RANBP2;HS3ST1;VCPKMT;ANAPC15;CORO1C;ZNF738;DDX3X;CPA4;IL24;GPHN;KLHL21;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;ODC1;TRPM7;AJUBA;FASTKD3;DND1;CROT;LFNG;PGK1;TRIM37;HACD2;PPP4R4;GNL3L;GADD45B;GATC;SH3RF2;IBA57;RARS;PHACTR4;GDAP1;MDM4;HIF1AN;NPNT;QDPR;PDGFB;UGT8;BRCC3;CHID1;EIF3J;SGK494;FZD1;UTY;NFE2L1;ANTXR1;CLU;NUP160;USP6;SMYD2;NAA50;ENPP1;BIRC3;IL20;MBOAT1;NUP54;LRPPRC;EYA3;EFTUD2;ACKR3;RIF1;METTL16;SRD5A1;KLHL9;SETD2;DTX4;GLIPR2;DPY19L2P2;SEPHS2;NNT;WEE1;ERAP1;SLC11A2;PDCL3;TNC;TET3;UMPS;HSPA8;TMEM199;HSP90AB1;ARL6IP5;EPHB6;SMUG1;BACE2;NSF;DNPEP;NEDD4L;SGK1;ANAPC7;BRCA2;SYNCRIP;TRAK2;DPYD;KRT10;MTMR2;TMEM165;FKBP5;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;SERPINB9;GPER1;FAF1;MMAA;RRM1;RAD18;ADAM17;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMB9;EIF2B5;RFWD3;SDHD;CBLL1;UGT1A4;TAF6L;MRPS7;DPH2;NCBP1;UPF3B;AKR1B1;SPSB1;UBE2J2;VPS36;TRAF2;TELO2;RBBP5;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;UQCRB;CSF1;NAA16;MPHOSPH8;CLOCK;KIF14;TLR3;AZIN1;ESR1;PARD3;RNF19B;USP11;FEM1C;ARV1;TNF;CAPN12;ZFP36L2;RC3H1;TYMS;STARD7;CCL5;PLBD1;CD74;RING1;FGFR1OP;PSMB10;FLAD1;EIF2B1;DAXX;METAP2;PHLPP2;HIST1H4A;TAF1;TBPL1;PHLPP1;HIBCH;NRAS;SMARCC1;MUC5B;THTPA;CDKN1A;ITGB1BP1;USP1;MUC6;IRF1;CTCF;RBM8A;GTF2H3;NDUFB9;RPS12;IRAK3;COPS3;IFI27L1;UFC1
14214,GO:0061099,0.546398636106781,0.732787760024786,2,25,negative regulation of protein tyrosine kinase activity,BP,GPRC5A;FGFR1OP
16415,GO:0097014,0.546509624191892,0.636615308892544,5,63,ciliary plasm,CC,DYNC2H1;DNHD1;WDPCP;CENPF;BBS5
7001,GO:0030677,0.54668026570202,0.823268384511992,1,13,ribonuclease P complex,CC,POP1
6465,GO:0021783,0.546726801701105,0.826660750806686,1,10,preganglionic parasympathetic fiber development,BP,NAV2
6649,GO:0023051,0.547219563082552,0.487936854911691,172,2353,regulation of signaling,BP,IL32;IGFBP3;SAA1;NRG1;TRIM16;FN1;PML;CYP1B1;AMOT;JPH2;MAP3K14;GCLC;CYR61;C3;GPRC5A;NLRC5;FGFR2;EPGN;TRIM22;STARD13;CTGF;MMP9;FBN1;RUNX1;IL1R2;FST;IRS1;MID1;TP53;DAPK3;EXO1;EDN1;GBP1;SIPA1L3;C1QTNF1;DUSP14;JRK;LGALS3;IFNGR1;CHP1;TGFB2;CNTNAP1;CYLD;IKBKE;IL16;RAD1;IL6ST;SLC9A3R1;NUAK1;INHBA;IL7R;SYK;EMP2;NAIP;NBN;TRIO;SHISA9;BRIP1;CDK4;SFRP1;NUCKS1;WNT10A;MIR17HG;ATP2B1;RPA1;TAF2;ULK4;KCNS3;G3BP1;TRAF1;OPHN1;ADM;CD109;DYNLL2;SLC1A3;CCL20;PLK2;RRAGB;UBQLN2;RFC3;HSPB1;RHOG;WNT4;CXCL16;NOP2;TOPBP1;SOD2;SUPT16H;ATP2C1;DDX3X;IL24;ARHGEF28;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;LFNG;NETO1;CDC42EP2;BAIAP2;GADD45B;CDH13;PHACTR4;SRF;MDM4;HIF1AN;NPNT;PDGFB;KREMEN2;FZD1;CLU;SMYD2;MACC1;ENPP1;BIRC3;IL20;EYA3;ACKR3;FGD6;GLIS2;RPF2;ABCC9;GLIPR2;JPH1;IFNAR1;SYT11;HSP90AB1;ARL6IP5;EPHB6;NSF;FANCD2;MTMR2;RAB3GAP1;CHEK1;GPER1;FAF1;ADAM17;RBMS3;ATR;PSME2;CFLAR;PSMB9;CMTM3;RABEP2;AKR1B1;TRAF2;TELO2;CITED2;CSF1;CLOCK;KIF14;TLR3;ESR1;TNF;RC3H1;CCL5;CD74;PSMB10;DAXX;METAP2;PHF14;PHLPP2;TAF1;PHLPP1;ITGB1BP1;IRF1;IRAK3
9127,GO:0035418,0.547519663191745,0.732721808018622,2,23,protein localization to synapse,BP,HSPB1;BAIAP2
4948,GO:0014911,0.547579137184308,0.733203430467186,2,22,positive regulation of smooth muscle cell migration,BP,PDGFB;CCL5
11210,GO:0045309,0.54799417308291,0.685205221064496,3,36,protein phosphorylated amino acid binding,MF,IRS1;SYK;PIK3R3
6429,GO:0021692,0.548225362114508,0.82932929761143,1,8,cerebellar Purkinje cell layer morphogenesis,BP,KIF14
20116,GO:2000738,0.54881899200039,0.825106711806377,1,10,positive regulation of stem cell differentiation,BP,TGFB2
401,GO:0001077,0.54883509903305,0.566354430472655,13,172,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MAFB;PBX1;ZBED1;NUCKS1;MYBL2;SRF;GLIS2;MYBL1;ETV6;ESR1;TBPL1;ARID3B;IRF1
12222,GO:0048385,0.548910098376317,0.823673223387924,1,11,regulation of retinoic acid receptor signaling pathway,BP,TRIM16
10715,GO:0043995,0.549036960289325,0.82494426625192,1,10,histone acetyltransferase activity (H4-K5 specific),MF,KANSL1L
10716,GO:0043996,0.549036960289325,0.82494426625192,1,10,histone acetyltransferase activity (H4-K8 specific),MF,KANSL1L
11943,GO:0046972,0.549036960289325,0.82494426625192,1,10,histone acetyltransferase activity (H4-K16 specific),MF,KANSL1L
4079,GO:0009132,0.549104401893783,0.596511280292042,8,110,nucleoside diphosphate metabolic process,BP,NUP50;TJP2;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
8894,GO:0034703,0.549203108832264,0.618643834884363,6,76,cation channel complex,CC,CNTNAP1;SHISA9;KCNS3;KCNQ5;ABCC9;CNTNAP2
2251,GO:0005161,0.5492604895549,0.824777569639598,1,10,platelet-derived growth factor receptor binding,MF,PDGFB
4441,GO:0010314,0.54955039684807,0.824561210818613,1,10,phosphatidylinositol-5-phosphate binding,MF,JPH2
2328,GO:0005338,0.549790937480234,0.823011748638659,1,11,nucleotide-sugar transmembrane transporter activity,MF,SLC35A4
13924,GO:0060548,0.550043948987076,0.510591825198588,49,689,negative regulation of cell death,BP,CRYAB;NEFL;GCLC;CYR61;FGFR2;CTGF;MMP9;TSC22D3;TP53;EDN1;NQO1;LGALS3;PDPN;IFIT3;IL6ST;BAG1;NAIP;SFRP1;MIR17HG;NAA15;PLK2;HSPB1;WNT4;SOD2;DDX3X;RRN3;ITGAV;SET;MDM4;FZD1;CLU;BIRC3;EYA3;ACKR3;HSP90AB1;EPHB6;SERPINB9;RAD18;CFLAR;AKR1B1;TRAF2;CITED2;NAA16;KIF14;TNF;CCL5;CD74;CDKN1A;GPX4
12126,GO:0048156,0.55023627065081,0.822676680568935,1,11,tau protein binding,MF,CLU
7708,GO:0032182,0.550277309781885,0.61707116120576,6,82,ubiquitin-like protein binding,MF,PML;USP16;HSPB1;FAF1;VPS36;DAXX
10607,GO:0043567,0.550510039697379,0.823843728237154,1,10,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP3
2727,GO:0006105,0.550551167048956,0.822439492870784,1,11,succinate metabolic process,BP,STAT5A
4351,GO:0009914,0.550742064692043,0.564330916208975,13,176,hormone transport,BP,SLC16A2;IRS1;EDN1;C1QTNF1;INHBA;SFRP1;KCNS3;ADM;ARNTL;GPER1;CLOCK;TNF;CCL5
11783,GO:0046625,0.550844826185823,0.822218107282927,1,11,sphingolipid binding,MF,TRAF2
10488,GO:0043371,0.55090526914615,0.823547652311681,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,RC3H1
3397,GO:0007178,0.551031607516578,0.553080450486118,16,211,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,PML;CYR61;FBN1;FST;TGFB2;INHBA;PALM2;SFRP1;MIR17HG;CD109;NPNT;FZD1;HSP90AB1;ADAM17;CITED2;PARD3
16255,GO:0090287,0.55107844170117,0.564098018225034,13,172,regulation of cellular response to growth factor stimulus,BP,CYR61;FGFR2;FBN1;SFRP1;MIR17HG;CD109;WNT4;NPNT;FZD1;HSP90AB1;ADAM17;CFLAR;CITED2
4651,GO:0010771,0.551078971898384,0.63202579272752,5,64,negative regulation of cell morphogenesis involved in differentiation,BP,GBP1;CORO1C;TRAK2;NTN1;ITGB1BP1
12402,GO:0048806,0.551335839430556,0.72984434795691,2,22,genitalia development,BP,SRD5A1;ESR1
589,GO:0001741,0.551549480970619,0.821686112006951,1,11,XY body,CC,SMARCC1
13828,GO:0060397,0.551579450363521,0.823041824237707,1,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,STAT5A
2321,GO:0005326,0.551756164274014,0.728434534232827,2,24,neurotransmitter transporter activity,MF,SLC1A3;SLC25A22
4466,GO:0010458,0.551787526735928,0.727539301979642,2,26,exit from mitosis,BP,CDCA5;ANLN
8679,GO:0034243,0.551798818451971,0.727944517976428,2,25,regulation of transcription elongation from RNA polymerase II promoter,BP,SUPT16H;HNRNPU
12268,GO:0048532,0.551912949840068,0.822791239354212,1,10,anatomical structure arrangement,BP,KIF14
3337,GO:0007052,0.55201813844036,0.59387308039676,8,105,mitotic spindle organization,BP,KIF23;STAG1;NAIP;PLK2;MYBL2;RAN;BIRC3;HNRNPU
2588,GO:0005881,0.552083107416649,0.651361754290102,4,52,cytoplasmic microtubule,CC,SAA1;MID1;CYLD;SRPRB
433,GO:0001161,0.552394400263256,0.822429060142531,1,10,intronic transcription regulatory region sequence-specific DNA binding,MF,HSF2
10777,GO:0044213,0.552394400263256,0.822429060142531,1,10,intronic transcription regulatory region DNA binding,MF,HSF2
17911,GO:1902166,0.552471305480501,0.818874593803598,1,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CD74
5998,GO:0019001,0.55274998383083,0.54031966293647,20,288,guanyl nucleotide binding,MF,GBP1;RAB32;ARFRP1;TSR1;LSG1;EIF5;RRAGB;GBP5;RHOG;RAN;RAB26;GNL3L;EFTUD2;SRPRB;HSP90AB1;MMAA;BMS1;EHD1;NRAS;GBP6
8297,GO:0033116,0.552882945396994,0.650142264667299,4,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,VMP1;TAP1;TMEM199;TAP2
4460,GO:0010447,0.55290939527956,0.820656351593266,1,11,response to acidic pH,BP,CHP1
8105,GO:0032784,0.552971295047578,0.679512887075514,3,40,regulation of DNA-templated transcription, elongation,BP,THOC1;SUPT16H;HNRNPU
12842,GO:0051128,0.553099395030369,0.485653760255294,134,1809,regulation of cellular component organization,BP,CRYAB;IGFBP3;NEFL;NRG1;MAP2;FN1;TENM3;PML;CYR61;C3;COL16A1;EPGN;SACS;CTGF;MMP9;RUNX1;G6PD;ENC1;MID1;TP53;DAPK3;EDN1;GBP1;CDKN2A;STAG1;LGALS3;PDPN;AKAP8;TGFB2;CYLD;PKMYT1;RAD1;SLC9A3R1;DKC1;INHBA;PALM2;SYK;NBN;SFRP1;VPS41;H3F3A;RPA1;TPM1;ULK4;SETDB1;PTGER4;TMEM97;OPHN1;DYNLL2;SYNPO2L;PLK2;UBQLN2;NEXN;GBP5;KANK4;AKAP8L;RHOG;WNT4;CXCL16;LCP1;SIRPA;RANBP2;ANAPC15;CORO1C;DDX3X;RRN3;ITGAV;SET;AJUBA;TRIM37;FEN1;CDC42EP2;CDCA5;GNL3L;BAIAP2;CDH13;SRF;PDGFB;SDK1;FZD1;TBC1D15;ANTXR1;CLU;USP6;ENPP1;RIF1;FGD6;ANLN;TJP1;LRRN3;HSPA8;SYT11;NEDD4L;SGK1;ZFYVE27;TRAK2;SKA2;WDPCP;MTMR2;CENPF;L1CAM;RAB3GAP1;CHEK1;GPER1;FAF1;WDR75;ADAM17;MYO10;ATR;NTN1;CFLAR;CBLL1;SHTN1;DPYSL3;NCBP1;UBE2J2;DDX56;KIF14;SYNPO2;ESR1;EHD1;TNF;STARD7;WDR36;HNRNPU;FGFR1OP;TAF1;PPARGC1B;CDKN1A;ITGB1BP1;CTCF;TSGA13;GTF2H3;IRAK3
3652,GO:0008134,0.55339061827141,0.515909790602676,37,506,transcription factor binding,MF,MAFB;HDAC9;CBX5;TSC22D3;TP53;DAPK3;CDKN2A;AKAP8;HNRNPF;PDCD11;ZFP42;NBN;NUCKS1;AHR;KEAP1;ELMSAN1;NOP58;RAN;DDX3X;ARNTL;BAIAP2;SRF;HIF1AN;APEX1;CENPF;BBS5;FAF1;TAF6L;POLR1E;RBL1;PURB;ESR1;HNRNPU;DAXX;TAF1;ZNHIT6;PPARGC1B
12273,GO:0048538,0.553611218566373,0.679626469641349,3,37,thymus development,BP,MAFB;PBX1;SRF
6781,GO:0030212,0.553710488300308,0.726217858334468,2,25,hyaluronan metabolic process,BP,CHP1;PDGFB
18471,GO:1903530,0.553769561757508,0.524100443865334,29,399,regulation of secretion by cell,BP,SAA1;TRIM16;FN1;PML;IL1R2;IRS1;EDN1;GBP1;C1QTNF1;TGFB2;INHBA;SYK;SFRP1;CD274;KCNS3;PTGER4;CADPS2;RAB26;SOCS1;ARNTL;SYT11;NSF;RAB3GAP1;GPER1;TRAF2;CLOCK;TNF;CCL5;PANX1
11013,GO:0044815,0.553896822738087,0.646180515720689,4,91,DNA packaging complex,CC,H3F3A;SMC2;MPHOSPH8;HIST1H4A
3698,GO:0008206,0.554162500653655,0.725391064422345,2,26,bile acid metabolic process,BP,PANK2;ARV1
12364,GO:0048711,0.554394636540202,0.819527068720162,1,11,positive regulation of astrocyte differentiation,BP,IL6ST
19238,GO:1905314,0.554529453998925,0.822528161913861,1,9,semi-lunar valve development,BP,TGFB2
3801,GO:0008378,0.554562015215488,0.725028723502655,2,26,galactosyltransferase activity,MF,B4GALT1;UGT8
12969,GO:0051310,0.554577186103341,0.648636244029911,4,54,metaphase plate congression,BP,CDCA5;CENPF;KIF14;HNRNPU
3034,GO:0006584,0.554673037103314,0.724927982310517,2,26,catecholamine metabolic process,BP,TGFB2;AKR1B1
4292,GO:0009712,0.554673037103314,0.724927982310517,2,26,catechol-containing compound metabolic process,BP,TGFB2;AKR1B1
14667,GO:0070243,0.554756506145616,0.819251193140492,1,11,regulation of thymocyte apoptotic process,BP,TP53
3598,GO:0008028,0.554840648915597,0.724775850602992,2,26,monocarboxylic acid transmembrane transporter activity,MF,SLC16A2;SLC16A9
2989,GO:0006534,0.554852915778485,0.819177645585233,1,11,cysteine metabolic process,BP,GCLC
3895,GO:0008528,0.554855224588367,0.724376620182281,2,27,G-protein coupled peptide receptor activity,MF,ACKR3;CXCR5
3154,GO:0006754,0.555074823446529,0.600294026632535,7,96,ATP biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
2942,GO:0006470,0.555083603126711,0.543045774272865,18,246,protein dephosphorylation,BP,IGFBP3;DUSP14;PTPN14;PPP1R3B;NUAK1;PTPRB;PTPRM;CDC25A;SET;PPP4R4;SH3RF2;PHACTR4;EYA3;HSP90AB1;MTMR2;TNF;PHLPP2;PHLPP1
18228,GO:1902992,0.555225616824552,0.82028899393977,1,10,negative regulation of amyloid precursor protein catabolic process,BP,CLU
16276,GO:0090313,0.555419438527273,0.724250138115992,2,26,regulation of protein targeting to membrane,BP,CHP1;ITGB1BP1
12993,GO:0051371,0.555547947673357,0.835882181016834,1,5,muscle alpha-actinin binding,MF,SYNPO2
2563,GO:0005845,0.555624286646764,0.818588457653725,1,11,mRNA cap binding complex,CC,NCBP1
16398,GO:0090723,0.555929051816944,0.818355311219052,1,11,growth cone part,CC,ZFYVE27
13298,GO:0051966,0.55601936119945,0.724579778525229,2,24,regulation of synaptic transmission, glutamatergic,BP,OPHN1;RAB3GAP1
19489,GO:1990138,0.556174560210227,0.581907289987425,9,112,neuron projection extension,BP,NRG1;FN1;SRF;NEDD4L;ZFYVE27;L1CAM;NTN1;SHTN1;WDR36
16560,GO:0097284,0.55681577085926,0.817675803447389,1,11,hepatocyte apoptotic process,BP,CFLAR
10121,GO:0042629,0.557020810734471,0.817518430898961,1,11,mast cell granule,CC,AKR1B1
6176,GO:0019538,0.557496650982722,0.471909214958639,299,4213,protein metabolic process,BP,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;DTX2;NEFL;NRG1;HDAC9;SPRR2A;C1R;TRIM16;FN1;TENM3;PML;MAP3K14;GCLC;KRT2;CYR61;C3;GPRC5A;FGFR2;STAT5A;EPGN;TRIM22;CTGF;MMP9;FBN1;GNPTAB;HSPG2;CLN6;IL1R2;B4GALT1;G6PD;SPON1;TRIM56;OVCH2;TRAF3;ENC1;IRS1;MID1;TP53;DAPK3;EDN1;TPST1;C9ORF3;GBP1;ABCF1;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ZBED1;PTPN14;GEMIN5;PABPC4;CHP1;ACO1;AKAP8;TGFB2;ST6GALNAC5;PRSS23;CARS2;CYLD;IKBKE;PKMYT1;CDKAL1;PPP1R3B;P3H2;IL6ST;SLC9A3R1;NUAK1;INHBA;NUP50;PUM3;GALNT18;CAMK1G;SYK;EMP2;NUP153;NAIP;NBN;TRIO;PARP15;CDK4;SFRP1;RIPK4;ZDHHC6;TARDBP;MIR17HG;H3F3A;USP16;APOL6;KEAP1;NAA15;DHFR;METTL21A;PTPRB;ULK4;RCE1;ADAMTS9;SETDB1;PTGER4;OPHN1;IMMP2L;CD109;P4HA2;USP43;GGCX;NDC1;HERC6;FOXRED2;EIF5;CASC3;CCL20;PLK2;MRPL27;MME;MUC16;UBQLN2;HSCB;FRK;AKAP8L;HSPB1;DOHH;SUV39H2;PTPRM;KDM6A;SETD4;RAN;RANBP2;VCPKMT;ANAPC15;CORO1C;ZNF738;DDX3X;CPA4;IL24;GPHN;KLHL21;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;PARP8;ARNTL;MRTO4;QPCT;ODC1;TRPM7;AJUBA;FASTKD3;DND1;LFNG;PGK1;TRIM37;PPP4R4;GNL3L;GADD45B;GATC;SH3RF2;RARS;PHACTR4;MDM4;HIF1AN;NPNT;PDGFB;BRCC3;EIF3J;SGK494;FZD1;UTY;ANTXR1;CLU;NUP160;USP6;SMYD2;NAA50;ENPP1;BIRC3;IL20;NUP54;LRPPRC;EYA3;EFTUD2;ACKR3;RIF1;METTL16;KLHL9;SETD2;DTX4;GLIPR2;DPY19L2P2;WEE1;ERAP1;PDCL3;TNC;TET3;HSPA8;TMEM199;HSP90AB1;ARL6IP5;EPHB6;BACE2;NSF;DNPEP;NEDD4L;SGK1;ANAPC7;BRCA2;SYNCRIP;TRAK2;KRT10;MTMR2;TMEM165;FKBP5;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;SERPINB9;GPER1;FAF1;RAD18;ADAM17;SENP1;RBMS3;ATR;PSME2;CFLAR;PSMB9;EIF2B5;RFWD3;CBLL1;TAF6L;MRPS7;DPH2;NCBP1;UPF3B;SPSB1;UBE2J2;VPS36;TRAF2;TELO2;RBBP5;HNRNPR;NCL;CCNA2;GTF3C4;POLE3;CSF1;NAA16;MPHOSPH8;CLOCK;KIF14;TLR3;AZIN1;ESR1;PARD3;RNF19B;USP11;FEM1C;TNF;CAPN12;ZFP36L2;RC3H1;TYMS;CCL5;CD74;RING1;FGFR1OP;PSMB10;EIF2B1;DAXX;METAP2;PHLPP2;HIST1H4A;TAF1;PHLPP1;NRAS;SMARCC1;MUC5B;CDKN1A;ITGB1BP1;USP1;MUC6;IRF1;CTCF;RBM8A;GTF2H3;RPS12;IRAK3;COPS3;IFI27L1;UFC1
11868,GO:0046834,0.557703844150578,0.610216844613896,6,76,lipid phosphorylation,BP,NRG1;FGFR2;IRS1;PDGFB;PIK3R3;ESR1
8235,GO:0032989,0.5577534385559,0.498372792008458,58,751,cellular component morphogenesis,BP,NEFL;NRG1;MAP2;FN1;TENM3;FGFR2;ACTG1;TFCP2L1;DAPK3;PANK2;EDN1;GBP1;DOCK10;SIPA1L3;PDPN;TGFB2;CNTNAP1;LRFN4;SLC9A3R1;IL7R;PALM2;TPM1;OPHN1;SLC1A3;RHOG;PTPRM;CORO1C;ITGAV;CDC42EP2;BAIAP2;CDH13;SRF;UGT8;ANTXR1;CLU;FGD6;WEE1;SLC11A2;CNTNAP2;MYH11;NEDD4L;SGK1;ZFYVE27;TRAK2;WDPCP;MTMR2;L1CAM;MYO10;NTN1;CFLAR;SHTN1;KIF14;MPP5;PARD3;WDR36;TBPL1;NRAS;ITGB1BP1
10282,GO:0043015,0.557894959635918,0.722416041992397,2,25,gamma-tubulin binding,MF,BLOC1S2;BRCA2
16644,GO:0097479,0.558221169496665,0.609432868798266,6,79,synaptic vesicle localization,BP,AP3M2;CADPS2;BLOC1S2;SYT11;RAB3GAP1;AP3B1
7772,GO:0032287,0.558291685109629,0.821867321880238,1,8,peripheral nervous system myelin maintenance,BP,MPP5
8929,GO:0034764,0.558374100029923,0.587505333983154,8,105,positive regulation of transmembrane transport,BP,JPH2;C3;G6PD;IRS1;CHP1;PIK3R3;GPER1;AZIN1
12076,GO:0048009,0.558472754647491,0.723394939880212,2,22,insulin-like growth factor receptor signaling pathway,BP,IGFBP3;IRS1
6005,GO:0019042,0.558506841973917,0.816375090678549,1,11,viral latency,BP,NUCKS1
3113,GO:0006691,0.558697615187113,0.815056167819241,1,12,leukotriene metabolic process,BP,SYK
8051,GO:0032695,0.558962856145621,0.816023256030599,1,11,negative regulation of interleukin-12 production,BP,IRAK3
10221,GO:0042827,0.559254041193131,0.815798352700264,1,11,platelet dense granule,CC,ABCC4
6990,GO:0030662,0.560112184300365,0.577239777217562,9,127,coated vesicle membrane,CC,TFRC;HLA-B;IL7R;HLA-F;HSPA8;TMEM199;M6PR;AP3B1;CD74
12824,GO:0051099,0.560209467353847,0.570306054908376,10,140,positive regulation of binding,BP,MMP9;PLK2;RAN;LFNG;CDCA5;GNL3L;HSP90AB1;NCBP1;TRAF2;TAF1
2497,GO:0005744,0.560431328554746,0.812714872745051,1,13,mitochondrial inner membrane presequence translocase complex,CC,TIMM23B
14413,GO:0061650,0.560903697229812,0.718848464640252,2,27,ubiquitin-like protein conjugating enzyme activity,MF,UBE2J2;TAF1
4483,GO:0010498,0.561211710086098,0.51643011335397,29,416,proteasomal protein catabolic process,BP,PML;GCLC;ENC1;TP53;KEAP1;OPHN1;FOXRED2;PLK2;UBQLN2;ANAPC15;RNF115;ARNTL;CLU;HSP90AB1;NEDD4L;ANAPC7;CCDC47;FAF1;SENP1;PSME2;PSMB9;SPSB1;UBE2J2;CLOCK;KIF14;RNF19B;PSMB10;TAF1;SMARCC1
17877,GO:1902042,0.561246670759347,0.718533064083221,2,27,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,CFLAR;TRAF2
14783,GO:0070461,0.561265897011938,0.718906818872348,2,26,SAGA-type complex,CC,TAF2;TAF6L
17414,GO:1900119,0.56128042188907,0.81304589253912,1,12,positive regulation of execution phase of apoptosis,BP,TP53
8106,GO:0032785,0.561372187462381,0.814156677265107,1,11,negative regulation of DNA-templated transcription, elongation,BP,HNRNPU
3509,GO:0007420,0.561705434357002,0.510442167381299,34,448,brain development,BP,MAFB;NEFL;NRG1;FGFR2;HSPG2;FAT4;G6PD;HMGCS1;ACSL3;RAD1;INHBA;SFRP1;H3F3A;ATP2B1;COL4A1;OPHN1;IMMP2L;WNT4;RAN;BAIAP2;SRF;FZD1;SRD5A1;SETD2;CNTNAP2;BRCA2;FANCD2;CENPF;RAB3GAP1;RRM1;EIF2B5;KIF14;PHLPP2;TAF1
81,GO:0000164,0.561710451609841,0.813893578155245,1,11,protein phosphatase type 1 complex,CC,PPP1R3B
18490,GO:1903557,0.561756291992318,0.671108104243927,3,40,positive regulation of tumor necrosis factor superfamily cytokine production,BP,HSPB1;CLU;TLR3
8083,GO:0032757,0.561773797334463,0.718047909555675,2,27,positive regulation of interleukin-8 production,BP,TLR3;TNF
7770,GO:0032281,0.561841854112877,0.813791305389065,1,11,AMPA glutamate receptor complex,CC,SHISA9
10307,GO:0043047,0.561926777058299,0.813725187905381,1,11,single-stranded telomeric DNA binding,MF,RPA1
6631,GO:0022884,0.56201036921665,0.810622864819535,1,14,macromolecule transmembrane transporter activity,MF,TIMM23B
6355,GO:0021533,0.562202145346375,0.816697308773028,1,9,cell differentiation in hindbrain,BP,OPHN1
19004,GO:1904754,0.562250252109963,0.816660339516161,1,9,positive regulation of vascular associated smooth muscle cell migration,BP,PDGFB
19509,GO:1990204,0.562415530589064,0.618777699469596,5,88,oxidoreductase complex,CC,RRM2;RRM1;SDHD;UQCRB;NDUFB9
2641,GO:0005976,0.562468155113133,0.605189941165294,6,79,polysaccharide metabolic process,BP,IRS1;PPP1R3B;IL6ST;MGAM;PDGFB;ENPP1
2663,GO:0006006,0.5625539654248,0.568043890769731,10,137,glucose metabolic process,BP,IGFBP3;G6PD;IRS1;C1QTNF1;PPP1R3B;LEPR;RANBP2;PGK1;ENPP1;TNF
8336,GO:0033173,0.562916130981157,0.718276109174477,2,24,calcineurin-NFAT signaling cascade,BP,NRG1;CHP1
12244,GO:0048486,0.563052835549632,0.812846959258042,1,11,parasympathetic nervous system development,BP,NAV2
2250,GO:0005160,0.563160978737109,0.717587755305174,2,25,transforming growth factor beta receptor binding,MF,TGFB2;INHBA
11652,GO:0046349,0.563229821775135,0.812708666839947,1,11,amino sugar biosynthetic process,BP,UAP1L1
19535,GO:1990380,0.56351595603339,0.815685814595353,1,9,Lys48-specific deubiquitinase activity,MF,CYLD
8609,GO:0034111,0.563761883041724,0.812292504681489,1,11,negative regulation of homotypic cell-cell adhesion,BP,C1QTNF1
18674,GO:1903960,0.564017637319819,0.813530610816002,1,10,negative regulation of anion transmembrane transport,BP,ARL6IP5
19333,GO:1905564,0.564182690747183,0.81340208928352,1,10,positive regulation of vascular endothelial cell proliferation,BP,ADAM17
12901,GO:0051219,0.56435097704008,0.618902004925559,5,64,phosphoprotein binding,MF,IRS1;MID1;SYK;APTX;PIK3R3
15663,GO:0072148,0.564535362271658,0.811686378119673,1,11,epithelial cell fate commitment,BP,PDPN
15072,GO:0071007,0.564618183510626,0.714717630766813,2,29,U2-type catalytic step 2 spliceosome,CC,RBM22;EFTUD2
4268,GO:0009612,0.565115114549564,0.565642708549058,10,132,response to mechanical stimulus,BP,MAP3K14;GCLC;EDN1;PTGER4;SLC1A3;TNC;CNTNAP2;CHEK1;TLR3;IRF1
9902,GO:0042175,0.565558566196838,0.490705956563209,57,813,nuclear outer membrane-endoplasmic reticulum membrane network,CC,PTGES;PML;CYP1B1;JPH2;UGT1A6;FADS3;HLA-B;TAP1;CYP1A1;CLN6;FAM69B;SCD;ACSL3;PKMYT1;CDKAL1;LSS;LRRC8D;HLA-F;ZDHHC6;ABHD4;DST;RCE1;REEP1;TMEM97;GGCX;RHOG;RANBP2;HACD2;NFE2L1;MBOAT1;LRPPRC;SRD5A1;JPH1;SRPRB;THADA;ERAP1;RIC3;TMEM199;ARL6IP5;SCD5;SGK1;ZFYVE27;RAB3GAP1;GPER1;FAF1;UGT1A4;EBP;UBE2J2;TRAF2;TAP2;TLR3;GJC1;RNF19B;ARV1;CD74;PANX1;TREX1
7289,GO:0031269,0.565636462840347,0.810821191644744,1,11,pseudopodium assembly,BP,CDC42EP2
2742,GO:0006122,0.565646506629478,0.808602531598436,1,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,UQCRB
9294,GO:0035725,0.565826788605241,0.60199869788213,6,77,sodium ion transmembrane transport,BP,CHP1;SLC4A11;SLC9A3R1;NETO1;NEDD4L;SLC9A9
17302,GO:0140029,0.56595585631852,0.637187636256383,4,56,exocytic process,BP,SYK;CADPS2;RAB26;SCFD2
4540,GO:0010611,0.566058197493589,0.667687696831732,3,37,regulation of cardiac muscle hypertrophy,BP,G6PD;EDN1;IL6ST
4883,GO:0014743,0.566058197493589,0.667687696831732,3,37,regulation of muscle hypertrophy,BP,G6PD;EDN1;IL6ST
16372,GO:0090646,0.566059429858949,0.80928681750237,1,12,mitochondrial tRNA processing,BP,TRMT5
14820,GO:0070534,0.566329359792155,0.666687492841913,3,40,protein K63-linked ubiquitination,BP,TRIM56;RNF115;TRAF2
1530,GO:0003906,0.566422092532054,0.807985712362507,1,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,APEX1
857,GO:0002182,0.566506129542549,0.810135919591101,1,11,cytoplasmic translational elongation,BP,DPH2
17481,GO:1900247,0.566506129542549,0.810135919591101,1,11,regulation of cytoplasmic translational elongation,BP,DPH2
20219,GO:2001032,0.566547406228861,0.810103352263493,1,11,regulation of double-strand break repair via nonhomologous end joining,BP,RIF1
4567,GO:0010646,0.56657025778163,0.468633006255077,169,2320,regulation of cell communication,BP,IL32;IGFBP3;SAA1;NRG1;TRIM16;FN1;PML;CYP1B1;AMOT;JPH2;MAP3K14;GCLC;CYR61;C3;GPRC5A;NLRC5;FGFR2;EPGN;TRIM22;STARD13;CTGF;MMP9;FBN1;RUNX1;IL1R2;FST;IRS1;MID1;TP53;DAPK3;EXO1;EDN1;GBP1;SIPA1L3;C1QTNF1;DUSP14;JRK;LGALS3;IFNGR1;CHP1;TGFB2;CNTNAP1;CYLD;IKBKE;IL16;RAD1;IL6ST;SLC9A3R1;NUAK1;INHBA;IL7R;SYK;EMP2;NAIP;NBN;TRIO;SHISA9;BRIP1;CDK4;SFRP1;NUCKS1;WNT10A;MIR17HG;RPA1;TAF2;ULK4;KCNS3;G3BP1;TRAF1;OPHN1;ADM;CD109;DYNLL2;SLC1A3;CCL20;PLK2;RRAGB;UBQLN2;RFC3;HSPB1;RHOG;WNT4;CXCL16;NOP2;TOPBP1;SOD2;SUPT16H;ATP2C1;DDX3X;IL24;ARHGEF28;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;LFNG;NETO1;CDC42EP2;BAIAP2;GADD45B;CDH13;PHACTR4;SRF;MDM4;HIF1AN;NPNT;PDGFB;KREMEN2;FZD1;CLU;SMYD2;MACC1;ENPP1;BIRC3;IL20;EYA3;ACKR3;FGD6;GLIS2;RPF2;GLIPR2;JPH1;IFNAR1;SYT11;HSP90AB1;ARL6IP5;EPHB6;FANCD2;MTMR2;RAB3GAP1;CHEK1;GPER1;FAF1;ADAM17;RBMS3;ATR;PSME2;CFLAR;PSMB9;CMTM3;RABEP2;AKR1B1;TRAF2;TELO2;CITED2;CSF1;CLOCK;KIF14;TLR3;ESR1;TNF;RC3H1;CCL5;CD74;PSMB10;DAXX;METAP2;PHF14;PHLPP2;TAF1;PHLPP1;ITGB1BP1;IRF1;IRAK3
10502,GO:0043393,0.566833816755771,0.552441685663697,12,169,regulation of protein binding,BP,NRG1;MMP9;CYLD;PLK2;RAN;LFNG;GNL3L;PDGFB;HSP90AB1;TRAF2;TAF1;ITGB1BP1
346,GO:0000959,0.566926390182556,0.665887110233854,3,41,mitochondrial RNA metabolic process,BP,LRPPRC;TRMT5;PPARGC1B
6310,GO:0019941,0.566970327364936,0.502042031820537,37,522,modification-dependent protein catabolic process,BP,PML;GCLC;TP53;CYLD;USP16;KEAP1;USP43;FOXRED2;PLK2;UBQLN2;RANBP2;ANAPC15;RNF115;ARNTL;CLU;USP6;PDCL3;HSP90AB1;NEDD4L;ANAPC7;CCDC47;FAF1;SENP1;PSME2;PSMB9;SPSB1;UBE2J2;VPS36;CLOCK;KIF14;RNF19B;USP11;PSMB10;TAF1;SMARCC1;USP1;COPS3
3757,GO:0008298,0.567003830485923,0.808537870540918,1,12,intracellular mRNA localization,BP,CASC3
6782,GO:0030213,0.567102179472501,0.809665261616196,1,11,hyaluronan biosynthetic process,BP,PDGFB
10486,GO:0043369,0.567112092429205,0.809657427263318,1,11,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,CYLD
7099,GO:0030889,0.567155355594925,0.811076887724101,1,10,negative regulation of B cell proliferation,BP,RC3H1
16121,GO:0090084,0.567196795689799,0.811044332698387,1,10,negative regulation of inclusion body assembly,BP,SACS
4704,GO:0010862,0.567285890551544,0.713771333815332,2,25,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,TGFB2;INHBA
10902,GO:0044433,0.567443757903187,0.482444107602862,74,1043,cytoplasmic vesicle part,CC,KRT1;SAA1;FTL;FTH1;FN1;PML;TFRC;C3;GPRC5A;S100P;HLA-B;MMP9;TAP1;MYO1B;B4GALT1;SPG21;LGALS3;TGFB2;IKBKE;PCDH7;IL7R;RAB32;HLA-F;VPS41;AP3M2;HLA-DOB;VPS8;HRNR;AP5M1;PTPRB;ABCC4;MGAM;CD109;CADPS2;RRAGB;SLCO4C1;MME;FRK;RHOG;WNT4;SIRPA;DDX3X;RAB26;ITGAV;QPCT;SNX5;PDGFB;KREMEN2;ANTXR1;CLU;COMMD9;SLC11A2;HSPA8;SYT11;TMEM199;HSP90AB1;LAIR1;M6PR;ZFYVE27;MTMR2;TMEM165;STEAP4;GPER1;LILRB3;ABCA5;VPS36;SLC9A9;TAP2;AP3B1;GLIPR1;TLR3;EHD1;CD74;NRAS
19874,GO:2000311,0.567534508077145,0.810778883603874,1,10,regulation of AMPA receptor activity,BP,SHISA9
11730,GO:0046513,0.567587904999723,0.665244221754008,3,41,ceramide biosynthetic process,BP,CYR61;UGT8;TNF
11148,GO:0045178,0.567854342898723,0.666221076943534,3,36,basal part of cell,CC,EDN1;DST;SLC11A2
15023,GO:0070935,0.567979899369164,0.808970723293781,1,11,3'-UTR-mediated mRNA stabilization,BP,TARDBP
14750,GO:0070403,0.568470311172835,0.807370879743484,1,12,NAD+ binding,MF,PARP15
826,GO:0002098,0.568529092296364,0.807324001114775,1,12,tRNA wobble uridine modification,BP,URM1
10921,GO:0044458,0.568671069788879,0.807210739948135,1,12,motile cilium assembly,BP,BBS5
3250,GO:0006911,0.568721499375677,0.712435957135888,2,25,phagocytosis, engulfment,BP,C3;RHOG
2187,GO:0005041,0.569049064760304,0.811383468534231,1,9,low-density lipoprotein particle receptor activity,MF,CXCL16
10146,GO:0042698,0.569201561157762,0.664128696625742,3,39,ovulation cycle,BP,TGFB2;INHBA;ESR1
3403,GO:0007186,0.569331099798189,0.51096868810991,27,377,G-protein coupled receptor signaling pathway,BP,SAA1;C3;GPRC5A;EDN1;SLC9A3R1;GPR132;TRIO;SFRP1;PTGER4;ADM;CCL20;UBQLN2;RHOG;CXCL16;AKR1C2;FZD1;SPNS1;ACKR3;CXCR5;HCAR1;GPER1;ADAM17;TPRA1;ESR1;PARD3;CCL5;METAP2
12909,GO:0051231,0.569376367510743,0.807862093084173,1,11,spindle elongation,BP,KIF23
8620,GO:0034123,0.569402086242036,0.806626851082538,1,12,positive regulation of toll-like receptor signaling pathway,BP,TLR3
14876,GO:0070633,0.5694590220976,0.807796335997253,1,11,transepithelial transport,BP,EDN1
2170,GO:0005003,0.569528996467575,0.807740654674776,1,11,ephrin receptor activity,MF,EPHB6
2172,GO:0005005,0.569528996467575,0.807740654674776,1,11,transmembrane-ephrin receptor activity,MF,EPHB6
16834,GO:0098662,0.569529742519669,0.510790458677493,27,374,inorganic cation transmembrane transport,BP,JPH2;G6PD;CHP1;SLC4A11;SLC30A6;SLC9A3R1;ATP2B1;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;NETO1;ABCC9;JPH1;NNT;THADA;SLC11A2;NEDD4L;STEAP4;GPER1;SLC9A9;KCNE4;PANX1;SLC25A22;SLC41A2
1257,GO:0003008,0.570034889326584,0.484955969738529,60,804,system process,BP,CRYAB;NEFL;NRG1;CYP1B1;GCLC;CTGF;CLN6;G6PD;DAPK3;EDN1;C9ORF3;C1QTNF1;ACO1;TGFB2;CNTNAP1;IL6ST;SLC9A3R1;INHBA;SLC22A5;EMP2;TJP2;NBN;MIR17HG;ATP2B1;TPM1;ADM;IMMP2L;SLC1A3;PLK2;MME;KDM6A;SOD2;NETO1;FEN1;SRF;NPNT;PDGFB;EYA3;TPM4;ABCC9;ERAP1;SLC11A2;CNTNAP2;MYH11;NEDD4L;SGK1;NAV2;MTMR2;BBS5;GPER1;CFLAR;AKR1B1;PARD3;GJC1;WDR36;FTO;CCDC50;ITGB1BP1;MUC6;NDUFB9
17533,GO:1900739,0.570163135339592,0.709890719731025,2,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;DYNLL2
17534,GO:1900740,0.570163135339592,0.709890719731025,2,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;DYNLL2
19444,GO:1905953,0.570191427578706,0.711064824619446,2,25,negative regulation of lipid localization,BP,ITGAV;TNF
11380,GO:0045725,0.570374208393668,0.810342831748755,1,9,positive regulation of glycogen biosynthetic process,BP,IRS1
16563,GO:0097296,0.570451233085201,0.80578672741684,1,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TRAF2
195,GO:0000413,0.570509479613536,0.708903716012578,2,30,protein peptidyl-prolyl isomerization,BP,RANBP2;FKBP5
1481,GO:0003755,0.570509479613536,0.708903716012578,2,30,peptidyl-prolyl cis-trans isomerase activity,MF,RANBP2;FKBP5
3478,GO:0007340,0.570936384609332,0.805397381758547,1,12,acrosome reaction,BP,B4GALT1
7262,GO:0031224,0.570962122103565,0.462132983861983,199,2772,intrinsic component of membrane,CC,HEPHL1;NRG1;TENM3;PTGES;JPH2;TFRC;GPRC5A;FGFR2;UGT1A6;EPGN;FADS3;SLC16A2;HLA-B;GNPTAB;VMP1;TAP1;SLC7A2;ERVFRD-1;CLN6;IL1R2;FAT4;B4GALT1;SPACA6;FAM69B;TRAF3;PLD5;IRS1;SLC16A9;SLC7A5P2;TPST1;SCD;TMEM106A;C1QTNF1;TMPPE;ACSL3;MEGF11;IFNGR1;SLC4A11;PDPN;ST6GALNAC5;CNTNAP1;CDKAL1;IL27RA;PCDH7;LRFN4;SLC30A6;IL6ST;IL7R;SLC22A5;GALNT18;EMP2;GPR132;LEPR;SHISA9;VEZT;ABCG2;LRRC8D;HLA-F;SFRP1;HLA-DOB;ZDHHC6;CD274;LAYN;DST;ATP2B1;SLC5A6;PTPRB;RCE1;ABCC4;REEP1;DRAM1;KCNS3;PTGER4;TMEM97;TMEM248;MGAM;IMMP2L;CD109;GGCX;NDC1;SLC35A4;SLC1A3;SLCO4C1;MME;TMEM212;MUC16;BTN2A1;CXCL16;PTPRM;SIRPA;HS3ST1;ATP2C1;RAB26;RRP12;ITGAV;ABCF2;TRPM7;KCNQ5;LFNG;NETO1;HACD2;FRRS1;CDH13;GDAP1;FNDC3B;NPNT;APMAP;UGT8;KREMEN2;SDK1;FZD1;NFE2L1;ANTXR1;ENPP1;FRAS1;MBOAT1;SPNS1;ACKR3;FAM173B;SRD5A1;TMEM14EP;TIMM23B;TMEM51;THBD;UPK3B;ABCC9;JPH1;SRPRB;DPY19L2P2;NNT;IFNAR1;LRRN3;ERAP1;SLC11A2;RIC3;CXCR5;CNTNAP2;GLIPR1L2;SYT11;ERVMER34-1;TMEM199;ARL6IP5;EPHB6;BACE2;SCD5;LYSMD4;GREB1;LAIR1;MFSD12;M6PR;ZFYVE27;PXMP2;TMEM138;HCAR1;CYB561D2;GOSR1;TMEM165;L1CAM;STEAP4;CCDC47;IL12RB2;GPER1;ADAM17;LILRB3;CMTM3;ABCA5;SDHD;UGT1A4;ARIH2OS;EBP;UBE2J2;TRAF2;TPRA1;CYP20A1;SLC9A9;TAP2;CSF1;GLIPR1;TLR3;ERVK13-1;ESR1;CLCC1;GJC1;RNF19B;KCNE4;ARV1;TNF;CD74;SLC43A2;PANX1;TRAM2;SMIM7;HNRNPM;ABCA11P;SLC25A22;SLC41A2;ASTN2;TMEM234;IFI27L1
4810,GO:0012506,0.570995143874454,0.497119493460439,38,525,vesicle membrane,CC,TFRC;GPRC5A;HLA-B;TAP1;B4GALT1;LGALS3;PCDH7;IL7R;RAB32;HLA-F;AP3M2;SLC5A6;PTPRB;ABCC4;MGAM;CD109;CADPS2;SLCO4C1;MME;RHOG;WNT4;SIRPA;RAB26;ITGAV;SNX5;HSPA8;SYT11;TMEM199;LAIR1;M6PR;GPER1;LILRB3;TRAF2;TAP2;AP3B1;GLIPR1;CD74;NRAS
14152,GO:0060998,0.571127064227947,0.632813906232914,4,51,regulation of dendritic spine development,BP,NRG1;PLK2;BAIAP2;SDK1
6577,GO:0022400,0.571233888515909,0.806380552093652,1,11,regulation of rhodopsin mediated signaling pathway,BP,METAP2
18879,GO:1904467,0.571726761015713,0.807462128711464,1,10,regulation of tumor necrosis factor secretion,BP,SYT11
8467,GO:0033598,0.571948041076061,0.709421174666036,2,25,mammary gland epithelial cell proliferation,BP,BRCA2;ESR1
5829,GO:0017101,0.571997718076026,0.80454375439058,1,12,aminoacyl-tRNA synthetase multienzyme complex,CC,RARS
4969,GO:0015075,0.572008545477903,0.501928693311932,32,444,ion transmembrane transporter activity,MF,JPH2;TFRC;SLC16A2;SLC7A2;SLC16A9;SLC7A5P2;SLC4A11;SLC30A6;SLC22A5;LRRC8D;ATP2B1;SLC5A6;ABCC4;KCNS3;SLC1A3;SLCO4C1;ATP2C1;ITGAV;TRPM7;KCNQ5;ABCC9;JPH1;NNT;SLC11A2;SLC9A9;CLCC1;GJC1;KCNE4;SLC43A2;PANX1;SLC25A22;SLC41A2
17510,GO:1900409,0.572185096805627,0.804392777554259,1,12,positive regulation of cellular response to oxidative stress,BP,TNF
18171,GO:1902884,0.572185096805627,0.804392777554259,1,12,positive regulation of response to oxidative stress,BP,TNF
1256,GO:0003007,0.572336395649625,0.54737736890658,12,151,heart morphogenesis,BP,NRG1;CYR61;FGFR2;FAT4;TGFB2;MIR17HG;TPM1;KDM6A;SRF;FZD1;BBS5;CITED2
2670,GO:0006020,0.572381306692781,0.806940659652113,1,10,inositol metabolic process,BP,PPIP5K1
16880,GO:0098789,0.572464510362403,0.805394671715822,1,11,pre-mRNA cleavage required for polyadenylation,BP,NCBP1
18268,GO:1903052,0.57274041206704,0.582312068031617,7,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,GCLC;KEAP1;PLK2;UBQLN2;CLU;RNF19B;TAF1
13661,GO:0060143,0.572922580648595,0.80379777948695,1,12,positive regulation of syncytium formation by plasma membrane fusion,BP,EHD1
9601,GO:0036445,0.573018840711628,0.806431800042718,1,10,neuronal stem cell division,BP,FGFR2
13516,GO:0055057,0.573018840711628,0.806431800042718,1,10,neuroblast division,BP,FGFR2
16681,GO:0097539,0.573503162254185,0.806044606510642,1,10,ciliary transition fiber,CC,CENPF
16604,GO:0097386,0.573641093440041,0.804448830751133,1,11,glial cell projection,CC,AKR1B1
3631,GO:0008093,0.573733500269173,0.804374411073931,1,11,cytoskeletal adaptor activity,MF,BAIAP2
2827,GO:0006294,0.574029473970569,0.705910468583426,2,29,nucleotide-excision repair, preincision complex assembly,BP,RPA1;GTF2H3
11596,GO:0046135,0.574091740200036,0.801812146839319,1,13,pyrimidine nucleoside catabolic process,BP,DPYD
16894,GO:0098805,0.574096156746595,0.472443206442731,86,1197,whole membrane,CC,PML;TFRC;CYP24A1;HLA-B;VMP1;TAP1;MYO1B;B4GALT1;IRS1;SPG21;DAPK3;ACSL3;LGALS3;PDPN;IKBKE;PCDH7;SLC9A3R1;IL7R;EMP2;RAB32;HLA-F;VPS41;HLA-DOB;ATP2B1;AP5M1;PTPRB;ABCC4;DRAM1;MGAM;CD109;RRAGB;SLCO4C1;MME;RHOG;WNT4;SIRPA;RANBP2;CORO1C;DDX3X;RAB26;ITGAV;PGK1;SNX5;TTC1;CDH13;GDAP1;KREMEN2;ANTXR1;ENPP1;BIRC3;LRPPRC;SPNS1;THBD;SLC11A2;BLOC1S2;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;LAIR1;MFSD12;M6PR;ZFYVE27;PXMP2;TMEM138;MTMR2;TMEM165;STEAP4;ADAM17;HADHB;LILRB3;CFLAR;ABCA5;VPS36;TRAF2;SLC9A9;TAP2;AP3B1;GLIPR1;TLR3;EHD1;TNF;STARD7;CD74;NRAS
10697,GO:0043954,0.574199508767117,0.707780324109999,2,24,cellular component maintenance,BP,MTMR2;PLEKHA7
10570,GO:0043517,0.574517387791643,0.803742316770617,1,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,ATR
16022,GO:0086014,0.574832978081277,0.804978704515537,1,10,atrial cardiac muscle cell action potential,BP,GJC1
16032,GO:0086026,0.574832978081277,0.804978704515537,1,10,atrial cardiac muscle cell to AV node cell signaling,BP,GJC1
16054,GO:0086066,0.574832978081277,0.804978704515537,1,10,atrial cardiac muscle cell to AV node cell communication,BP,GJC1
18063,GO:1902562,0.575212287142686,0.657786836828973,3,41,H4 histone acetyltransferase complex,CC,KANSL1L;UBAP2L;POLE3
13286,GO:0051954,0.575468841565997,0.801733824037225,1,12,positive regulation of amine transport,BP,RAB3GAP1
7199,GO:0031083,0.575627477984673,0.800559705553787,1,13,BLOC-1 complex,CC,BLOC1S2
12752,GO:0050996,0.575937519550457,0.804090270271388,1,10,positive regulation of lipid catabolic process,BP,IRS1
3393,GO:0007173,0.576150434649986,0.569271617121797,8,109,epidermal growth factor receptor signaling pathway,BP,GPRC5A;EPGN;MMP9;RNF115;CDH13;GPER1;ADAM17;NRAS
12137,GO:0048185,0.576187180837049,0.802391131715882,1,11,activin binding,MF,FST
2877,GO:0006376,0.576190077404959,0.704991177964338,2,26,mRNA splice site selection,BP,LUC7L;LUC7L2
10571,GO:0043518,0.576206136443052,0.801133383081401,1,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,CD74
5791,GO:0017017,0.576346508298392,0.801018923499214,1,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP14
3634,GO:0008104,0.576367779233884,0.460645299313424,147,2059,protein localization,BP,SAA1;NRG1;TRIM16;FN1;PML;AMOT;TFRC;TRIM22;FBN1;GNPTAB;TAP1;IL1R2;IRS1;VPS13B;MID1;TP53;GBP1;ACSL3;PTPN14;CHP1;AKAP8;TGFB2;CNTNAP1;RBM22;CYLD;SRSF2;SLC9A3R1;DKC1;NUP50;PHAX;SYK;EMP2;NUP153;RAB32;ARFRP1;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;VPS8;KEAP1;RPA1;AP5M1;POLR1A;REEP1;ADAMTS9;KCNS3;PTGER4;LSG1;IMMP2L;NDC1;CADPS2;DYNLL2;CASC3;RRAGB;GBP5;AKAP8L;HSPB1;RHOG;WNT4;LCP1;THOC1;RAN;RANBP2;CORO1C;DDX3X;RAB26;GPHN;KLHL21;ITGAV;SOCS1;ARNTL;SNX11;AJUBA;SNX5;CDCA5;GNL3L;BAIAP2;GDAP1;NPNT;UGT8;TBC1D15;RTKN2;CLU;NUP160;USP6;SDAD1;FRAS1;NUP54;SETD2;GLIS2;ANLN;TIMM23B;RPF2;RIC3;CNTNAP2;HSPA8;SYT11;HSP90AB1;NSF;NEDD4L;M6PR;ZFYVE27;BRCA2;TRAK2;WDPCP;CENPF;GOSR1;RAB3GAP1;SCFD2;BBS5;GPER1;FAF1;WDR75;ATR;NFKBIE;RABEP2;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;TAP2;AP3B1;CLOCK;KIF14;MPP5;ESR1;PARD3;EHD1;TNF;SRSF7;STARD7;CCL5;CD74;HNRNPU;PANX1;TRAM2;CDKN1A;ITGB1BP1;CTCF;ASTN2;TSGA13;RBM8A;RPS12;BUD13
2573,GO:0005858,0.576566726193429,0.807748210820588,1,8,axonemal dynein complex,CC,DNHD1
17273,GO:0120032,0.576596878458181,0.56065645945248,9,123,regulation of plasma membrane bounded cell projection assembly,BP,CYLD;RHOG;CORO1C;CDC42EP2;SRF;ANLN;WDPCP;MYO10;DPYSL3
17410,GO:1900115,0.576628374268905,0.802033042370339,1,11,extracellular regulation of signal transduction,BP,FBN1
17411,GO:1900116,0.576628374268905,0.802033042370339,1,11,extracellular negative regulation of signal transduction,BP,FBN1
12084,GO:0048017,0.576683173718549,0.568835786021803,8,107,inositol lipid-mediated signaling,BP,NRG1;IRS1;EDN1;TGFB2;SLC9A3R1;PDGFB;GPER1;CCL5
7112,GO:0030903,0.576750436068319,0.801933892598752,1,11,notochord development,BP,KDM6A
535,GO:0001653,0.576787554460442,0.703646814600132,2,28,peptide receptor activity,MF,ACKR3;CXCR5
13256,GO:0051900,0.576976171739097,0.799455286604044,1,13,regulation of mitochondrial depolarization,BP,GCLC
7360,GO:0031397,0.577166776312139,0.625749226004893,4,58,negative regulation of protein ubiquitination,BP,GCLC;CHP1;GNL3L;TAF1
12788,GO:0051044,0.577407165173129,0.800152579757484,1,12,positive regulation of membrane protein ectodomain proteolysis,BP,TNF
4285,GO:0009650,0.577478861003432,0.800093924147991,1,12,UV protection,BP,FEN1
15665,GO:0072160,0.577543863557705,0.802793176572355,1,10,nephron tubule epithelial cell differentiation,BP,FAT4
7119,GO:0030914,0.577894222539338,0.799753873814902,1,12,STAGA complex,CC,TAF6L
18622,GO:1903859,0.577947526360986,0.802466285259601,1,10,regulation of dendrite extension,BP,NEDD4L
8435,GO:0033522,0.578005900436469,0.703710034408153,2,25,histone H2A ubiquitination,BP,TRIM37;RING1
10564,GO:0043508,0.578148506724182,0.79954549650773,1,12,negative regulation of JUN kinase activity,BP,SFRP1
8482,GO:0033619,0.578150291431166,0.625169710250916,4,55,membrane protein proteolysis,BP,ERAP1;BACE2;ADAM17;TNF
12100,GO:0048038,0.578187745539019,0.797559396642076,1,14,quinone binding,MF,SDHD
13697,GO:0060205,0.578281023479786,0.528064454233924,15,230,cytoplasmic vesicle lumen,CC,SAA1;FTL;FN1;C3;S100P;TGFB2;HRNR;FRK;DDX3X;QPCT;PDGFB;CLU;COMMD9;HSPA8;HSP90AB1
2761,GO:0006171,0.578359095346013,0.703374994513462,2,25,cAMP biosynthetic process,BP,ADM;GPER1
12241,GO:0048483,0.578497330845439,0.703722015025255,2,24,autonomic nervous system development,BP,PHACTR4;NAV2
12266,GO:0048525,0.578513303227284,0.603715182090885,5,73,negative regulation of viral process,BP,PML;FAM111A;TARDBP;TNF;CCL5
18060,GO:1902555,0.579035726164182,0.701160477838195,2,29,endoribonuclease complex,CC,POP1;DGCR8
19254,GO:1905348,0.579035726164182,0.701160477838195,2,29,endonuclease complex,CC,POP1;DGCR8
10391,GO:0043202,0.579135811010609,0.603273096332313,5,71,lysosomal lumen,CC,HSPG2;CHID1;HSPA8;IFI30;CD74
6214,GO:0019730,0.579145665166044,0.698575927021187,2,39,antimicrobial humoral response,BP,CLU;HMGN2
3465,GO:0007286,0.579266610189814,0.603341677710968,5,69,spermatid development,BP,PANK2;BRIP1;RAN;DPY19L2P2;TBPL1
10319,GO:0043085,0.57959182532947,0.470116855765982,74,1024,positive regulation of catalytic activity,BP,SAA1;NRG1;FN1;PML;MAP3K14;CYR61;FGFR2;EPGN;STARD13;CTGF;IRS1;EDN1;DOCK10;SIPA1L3;TGFB2;DKC1;SYK;EMP2;NBN;SFRP1;DHFR;TPM1;OPHN1;DYNLL2;CCL20;HSCB;RFC3;RHOG;WNT4;RANBP2;CORO1C;DDX3X;SOCS1;AJUBA;CDC42EP2;NVL;GADD45B;PHACTR4;NPNT;PDGFB;TBC1D15;ANTXR1;CLU;USP6;HSP90AB1;ARL6IP5;EPHB6;RAB3GAP1;GPER1;ADAM17;SENP1;PSME2;MSH6;CFLAR;DNAJC9;RABEP2;TRAF2;MSH3;TELO2;GTF3C4;CSF1;KIF14;TLR3;AZIN1;ESR1;TNF;CCL5;CD74;HNRNPU;DAXX;PPARGC1B;CDKN1A;ITGB1BP1;IFI27L1
16740,GO:0097720,0.579708060740542,0.702093269891464,2,25,calcineurin-mediated signaling,BP,NRG1;CHP1
14521,GO:0062013,0.579904765691129,0.57518977862819,7,96,positive regulation of small molecule metabolic process,BP,IRS1;ADM;WNT4;PDGFB;GPER1;TNF;PPARGC1B
697,GO:0001914,0.58022713829983,0.796775677189955,1,13,regulation of T cell mediated cytotoxicity,BP,IL7R
5194,GO:0015780,0.580429518677465,0.797669521792241,1,12,nucleotide-sugar transmembrane transport,BP,SLC35A4
12664,GO:0050849,0.580434653465867,0.79766528502705,1,12,negative regulation of calcium-mediated signaling,BP,CHP1
12418,GO:0048844,0.58046312463004,0.653860562537397,3,36,artery morphogenesis,BP,TGFB2;ADAMTS9;SRF
4605,GO:0010718,0.580602574270022,0.653176121556873,3,38,positive regulation of epithelial to mesenchymal transition,BP,PDPN;TGFB2;GLIPR2
18281,GO:1903078,0.580681594420652,0.652846660953251,3,39,positive regulation of protein localization to plasma membrane,BP,ACSL3;RHOG;GPER1
8605,GO:0034104,0.580808694746697,0.797356493218696,1,12,negative regulation of tissue remodeling,BP,SFRP1
13602,GO:0060049,0.580903746873775,0.798539504441478,1,11,regulation of protein glycosylation,BP,CHP1
5005,GO:0015145,0.581010575621482,0.798451663949228,1,11,monosaccharide transmembrane transporter activity,MF,M6PR
17102,GO:0099601,0.581027888875884,0.700836003927813,2,25,regulation of neurotransmitter receptor activity,BP,SHISA9;NETO1
3240,GO:0006897,0.581394646327759,0.491259921908262,33,454,endocytosis,BP,SAA1;TFRC;C3;HSPG2;ACTG1;LGALS3;SYK;LEPR;OPHN1;ADM;UBQLN2;RHOG;CXCL16;SIRPA;CORO1C;ITGAV;SNX11;SNX5;BAIAP2;CDH13;CLU;ENPP1;ACKR3;SYT11;HSP90AB1;NEDD4L;M6PR;MTMR2;MYO10;CBLL1;RABEP2;EHD1;TNF
12294,GO:0048588,0.58162667773841,0.542890599484338,11,143,developmental cell growth,BP,NRG1;FN1;G6PD;EDN1;SRF;NEDD4L;ZFYVE27;L1CAM;NTN1;SHTN1;WDR36
61,GO:0000124,0.581784366958812,0.795483344516367,1,13,SAGA complex,CC,TAF6L
12104,GO:0048048,0.581940535873474,0.701547665526839,2,22,embryonic eye morphogenesis,BP,FBN1;PHACTR4
12769,GO:0051018,0.581942391724666,0.652112920608897,3,37,protein kinase A binding,MF,AKAP8;PALM2;AKAP8L
8898,GO:0034707,0.582569090146326,0.795898767620105,1,12,chloride channel complex,CC,CLCC1
7481,GO:0031640,0.582614194590902,0.792401765687686,1,16,killing of cells of other organism,BP,HMGN2
10869,GO:0044364,0.582614194590902,0.792401765687686,1,16,disruption of cells of other organism,BP,HMGN2
16347,GO:0090543,0.582689127529844,0.698805358660972,2,26,Flemming body,CC,KIF23;KIF14
4502,GO:0010528,0.582715104520159,0.795777529700146,1,12,regulation of transposition,BP,MYBL1
4503,GO:0010529,0.582715104520159,0.795777529700146,1,12,negative regulation of transposition,BP,MYBL1
9076,GO:0035306,0.582910024425505,0.650633295570029,3,39,positive regulation of dephosphorylation,BP,NPNT;HSP90AB1;PPARGC1B
7163,GO:0031018,0.582936182329202,0.698568682743649,2,26,endocrine pancreas development,BP,ARNTL;CLOCK
1372,GO:0003254,0.583183259799978,0.69792209466535,2,27,regulation of membrane depolarization,BP,GCLC;NEDD4L
3948,GO:0008643,0.583262290531872,0.571812073089847,7,95,carbohydrate transport,BP,C3;IRS1;SLC35A4;ENPP1;PIK3R3;M6PR;TNF
6584,GO:0022408,0.583374758264782,0.571444385739169,7,99,negative regulation of cell-cell adhesion,BP,C1QTNF1;LGALS3;CYLD;CD274;RC3H1;CD74;IRF1
15614,GO:0072077,0.583451184765495,0.796437546636888,1,11,renal vesicle morphogenesis,BP,WNT4
15620,GO:0072087,0.583451184765495,0.796437546636888,1,11,renal vesicle development,BP,WNT4
7565,GO:0031902,0.583549292282707,0.57097846060577,7,104,late endosome membrane,CC,VPS41;AP5M1;SLC11A2;TMEM165;ABCA5;VPS36;SLC9A9
3467,GO:0007289,0.583616242275677,0.796300825485781,1,11,spermatid nucleus differentiation,BP,TBPL1
5577,GO:0016591,0.583673742783176,0.570905526363845,7,103,DNA-directed RNA polymerase II, holoenzyme,CC,TP53;TAF2;POLR2F;TAF6L;TAF1;TBPL1;GTF2H3
1710,GO:0004252,0.584038463072618,0.59799935121823,5,74,serine-type endopeptidase activity,MF,C1R;C3;MMP9;OVCH2;PRSS23
5347,GO:0016082,0.584163817803895,0.795846793970358,1,11,synaptic vesicle priming,BP,CADPS2
3159,GO:0006768,0.584375300087553,0.79567124989547,1,11,biotin metabolic process,BP,SLC5A6
4788,GO:0010975,0.584396979783418,0.500411375834569,24,319,regulation of neuron projection development,BP,NEFL;NRG1;MAP2;FN1;TENM3;ENC1;SFRP1;ULK4;PLK2;RRN3;BAIAP2;SRF;SDK1;FZD1;NEDD4L;ZFYVE27;TRAK2;L1CAM;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;WDR36
4718,GO:0010878,0.584467376794463,0.795594787131432,1,11,cholesterol storage,BP,EHD1
5273,GO:0015918,0.58495406282671,0.618300428583314,4,55,sterol transport,BP,ABCG2;CLU;ABCA5;ARV1
7480,GO:0031639,0.585133609487737,0.7937620683457,1,12,plasminogen activation,BP,PGK1
7195,GO:0031078,0.585203189573234,0.794983028027514,1,11,histone deacetylase activity (H3-K14 specific),MF,HDAC9
7639,GO:0032041,0.585203189573234,0.794983028027514,1,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,HDAC9
18392,GO:1903362,0.5854070794965,0.524627944198667,14,202,regulation of cellular protein catabolic process,BP,PML;GCLC;KEAP1;OPHN1;PLK2;UBQLN2;CLU;PDCL3;HSP90AB1;SENP1;PSME2;RNF19B;TAF1;SMARCC1
3350,GO:0007080,0.585505844010836,0.647156392166634,3,43,mitotic metaphase plate congression,BP,CDCA5;KIF14;HNRNPU
7608,GO:0031983,0.585508144497357,0.520605221764321,15,231,vesicle lumen,CC,SAA1;FTL;FN1;C3;S100P;TGFB2;HRNR;FRK;DDX3X;QPCT;PDGFB;CLU;COMMD9;HSPA8;HSP90AB1
12754,GO:0050998,0.585514629764082,0.794723707825401,1,11,nitric-oxide synthase binding,MF,CD74
9081,GO:0035315,0.585630203195257,0.695980529639754,2,26,hair cell differentiation,BP,SLC9A3R1;WDPCP
5591,GO:0016607,0.585873343656406,0.498670082901231,24,341,nuclear speck,CC,TRIM22;DDX17;RBM4;IL16;SRSF2;CASC3;SYNPO2L;AKAP8L;THOC1;DDX3X;LUC7L2;EFTUD2;GLIS2;APEX1;SGK1;CBLL1;TAP2;SURF2;HNRNPU;RING1;FTO;PSPC1;RBM8A;DHX15
5723,GO:0016859,0.58595348382843,0.69388424996109,2,31,cis-trans isomerase activity,MF,RANBP2;FKBP5
6925,GO:0030512,0.586003129090754,0.617538270181065,4,53,negative regulation of transforming growth factor beta receptor signaling pathway,BP,FBN1;MIR17HG;CD109;ADAM17
17056,GO:0099503,0.58609235368699,0.478381664444854,42,611,secretory vesicle,CC,KRT1;FTL;FTH1;FN1;C3;S100P;MMP9;B4GALT1;EDN1;LGALS3;TGFB2;PCDH7;VEZT;HRNR;PTPRB;ABCC4;MGAM;CD109;SLCO4C1;MME;FRK;RHOG;SIRPA;DDX3X;RAB26;ITGAV;QPCT;BAIAP2;WDR7;PDGFB;CLU;COMMD9;HSPA8;SYT11;HSP90AB1;LAIR1;BRCA2;MTMR2;LILRB3;DPYSL3;GLIPR1;NRAS
7288,GO:0031268,0.586271884449609,0.792808679787047,1,12,pseudopodium organization,BP,CDC42EP2
3562,GO:0007605,0.586505230846773,0.595961759836273,5,69,sensory perception of sound,BP,SLC9A3R1;SLC1A3;NAV2;CCDC50;NDUFB9
2463,GO:0005675,0.586661666018195,0.791398572683175,1,13,holo TFIIH complex,CC,GTF2H3
8149,GO:0032868,0.58670340620122,0.523482937232691,14,193,response to insulin,BP,HDAC9;GCLC;IRS1;CDK4;NUCKS1;ADM;SOCS1;BAIAP2;ENPP1;PIK3R3;ZNF106;SRD5A1;CFLAR;SMARCC1
10559,GO:0043501,0.58693761713797,0.793535924874727,1,11,skeletal muscle adaptation,BP,CFLAR
12508,GO:0050482,0.587088675686254,0.792122654108663,1,12,arachidonic acid secretion,BP,SYK
18676,GO:1903963,0.587088675686254,0.792122654108663,1,12,arachidonate transport,BP,SYK
7601,GO:0031967,0.58716208670144,0.465633057022827,64,972,organelle envelope,CC,DTX2;PTGES;CYP24A1;STARD13;CBX5;PANK2;ABCF1;ACSL3;LGALS3;IKBKE;NUP50;NUP153;RAB32;BRIP1;ABCG2;CDK4;DST;COA7;POLA1;REEP1;TMEM97;IMMP2L;NDC1;CASC3;MRPL27;EXOG;RAN;RANBP2;SOD2;DDX3X;RRP12;ABCF2;GDAP1;WDR3;UTP18;CLU;NUP160;NUP54;LRPPRC;SPNS1;RIF1;TIMM23B;DPY19L2P2;NNT;SLC11A2;CENPF;GPER1;FAF1;RRM1;SENP1;HADHB;CMTM3;SDHD;MRPS7;EBP;UQCRB;DNASE1;TYMS;STARD7;DCTN5;PHLPP1;SLC25A22;TREX1;NDUFB9
7605,GO:0031975,0.58716208670144,0.465633057022827,64,972,envelope,CC,DTX2;PTGES;CYP24A1;STARD13;CBX5;PANK2;ABCF1;ACSL3;LGALS3;IKBKE;NUP50;NUP153;RAB32;BRIP1;ABCG2;CDK4;DST;COA7;POLA1;REEP1;TMEM97;IMMP2L;NDC1;CASC3;MRPL27;EXOG;RAN;RANBP2;SOD2;DDX3X;RRP12;ABCF2;GDAP1;WDR3;UTP18;CLU;NUP160;NUP54;LRPPRC;SPNS1;RIF1;TIMM23B;DPY19L2P2;NNT;SLC11A2;CENPF;GPER1;FAF1;RRM1;SENP1;HADHB;CMTM3;SDHD;MRPS7;EBP;UQCRB;DNASE1;TYMS;STARD7;DCTN5;PHLPP1;SLC25A22;TREX1;NDUFB9
8817,GO:0034518,0.587590194024889,0.791700637485661,1,12,RNA cap binding complex,CC,NCBP1
6898,GO:0030425,0.587593071007466,0.49235365586801,27,364,dendrite,CC,CRYAB;NRG1;MAP2;SACS;DOCK10;NQO1;IL6ST;SHISA9;ATP2B1;OPHN1;CASC3;PLK2;MME;GPHN;BAIAP2;CLU;CNTNAP2;HSPA8;SYT11;NSF;ZFYVE27;TRAK2;MTMR2;L1CAM;GPER1;HNRNPR;RBM8A
16629,GO:0097447,0.587593071007466,0.49235365586801,27,364,dendritic tree,CC,CRYAB;NRG1;MAP2;SACS;DOCK10;NQO1;IL6ST;SHISA9;ATP2B1;OPHN1;CASC3;PLK2;MME;GPHN;BAIAP2;CLU;CNTNAP2;HSPA8;SYT11;NSF;ZFYVE27;TRAK2;MTMR2;L1CAM;GPER1;HNRNPR;RBM8A
1780,GO:0004385,0.587624995233999,0.792960434386621,1,11,guanylate kinase activity,MF,TJP2
12538,GO:0050662,0.587700995749699,0.518508668225141,15,221,coenzyme binding,MF,GCLC;TXNRD1;G6PD;P3H2;PARP15;DHFR;P4HA2;FOXRED2;SUV39H2;GPHN;QDPR;TYW1;SRD5A1;NNT;DPYD
11635,GO:0046323,0.588163275674992,0.615502877915137,4,52,glucose import,BP,IRS1;ENPP1;PIK3R3;TNF
4499,GO:0010522,0.588310119091342,0.615037780434215,4,54,regulation of calcium ion transport into cytosol,BP,PML;JPH2;JPH1;GPER1
14146,GO:0060992,0.588352263185502,0.792350318072135,1,11,response to fungicide,BP,SRD5A1
16670,GO:0097525,0.588732595569868,0.613557173350879,4,62,spliceosomal snRNP complex,CC,ZMAT2;LUC7L;LUC7L2;EFTUD2
18248,GO:1903019,0.588930127554549,0.789479393604087,1,13,negative regulation of glycoprotein metabolic process,BP,BACE2
17849,GO:1901983,0.588963801130482,0.613941489352865,4,57,regulation of protein acetylation,BP,SET;ARNTL;CHEK1;CTCF
18159,GO:1902850,0.589076427737984,0.547855458814704,9,122,microtubule cytoskeleton organization involved in mitosis,BP,KIF23;STAG1;NAIP;PLK2;MYBL2;RAN;BIRC3;SETD2;HNRNPU
8330,GO:0033160,0.589271049193194,0.793140546855331,1,10,positive regulation of protein import into nucleus, translocation,BP,HSP90AB1
11085,GO:0045071,0.589323760989307,0.642941169906998,3,45,negative regulation of viral genome replication,BP,FAM111A;TNF;CCL5
6609,GO:0022627,0.589516450333349,0.687861857529245,2,43,cytosolic small ribosomal subunit,CC,DDX3X;RPS12
9297,GO:0035728,0.589825371744659,0.79111062254572,1,11,response to hepatocyte growth factor,BP,GCLC
6608,GO:0022626,0.589889018671458,0.58984384259913,5,110,cytosolic ribosome,CC,GEMIN5;DDX3X;NUFIP1;MRTO4;RPS12
4898,GO:0014823,0.590244603765408,0.643052588531429,3,40,response to activity,BP,GCLC;EDN1;SRD5A1
372,GO:0000993,0.590645738943431,0.690710325961009,2,27,RNA polymerase II core binding,MF,SMYD2;HNRNPU
3148,GO:0006744,0.590668627963454,0.787063453817817,1,14,ubiquinone biosynthetic process,BP,PDSS1
17758,GO:1901663,0.590668627963454,0.787063453817817,1,14,quinone biosynthetic process,BP,PDSS1
2388,GO:0005522,0.590688827907608,0.79195146182336,1,10,profilin binding,MF,ACTG1
16010,GO:0086002,0.590860460942538,0.691858531546755,2,24,cardiac muscle cell action potential involved in contraction,BP,NEDD4L;GJC1
4021,GO:0009048,0.590968569495745,0.79171627352971,1,10,dosage compensation by inactivation of X chromosome,BP,HNRNPU
9999,GO:0042393,0.591095265102039,0.5274318034913,12,172,histone binding,MF,CBX5;MCM2;USP16;GRWD1;SUPT16H;SET;MSH6;RBBP5;MPHOSPH8;DAXX;HIST1H4A;TAF1
957,GO:0002374,0.591103996884747,0.788726926038671,1,12,cytokine secretion involved in immune response,BP,TNF
14139,GO:0060977,0.591344521575893,0.7913999012426,1,10,coronary vasculature morphogenesis,BP,SETD2
12288,GO:0048568,0.591428593711793,0.500975078876687,20,271,embryonic organ development,BP,MAFB;CYR61;FGFR2;FBN1;PBX1;EDN1;TGFB2;SLC9A3R1;ADM;KDM6A;PHACTR4;SRF;PDGFB;SETD2;WDPCP;E2F8;BBS5;NTN1;CITED2;TNF
16171,GO:0090169,0.591704810686023,0.690546857048896,2,25,regulation of spindle assembly,BP,STAG1;HNRNPU
10439,GO:0043274,0.591775261243183,0.789461668620985,1,11,phospholipase binding,MF,NEFL
17136,GO:0101023,0.591835415765974,0.789410652232572,1,11,vascular endothelial cell proliferation,BP,ADAM17
19331,GO:1905562,0.591835415765974,0.789410652232572,1,11,regulation of vascular endothelial cell proliferation,BP,ADAM17
5073,GO:0015294,0.59190001922973,0.611527686325969,4,53,solute:cation symporter activity,MF,SLC5A6;SLC1A3;SLC11A2;SLC25A22
15230,GO:0071360,0.592165786117188,0.787822486154678,1,12,cellular response to exogenous dsRNA,BP,TLR3
11448,GO:0045859,0.592237888042883,0.472171441636892,42,585,regulation of protein kinase activity,BP,SAA1;NRG1;MAP3K14;CYR61;GPRC5A;EPGN;EDN1;DUSP14;CDKN2A;CHP1;TGFB2;PKMYT1;SLC9A3R1;SYK;EMP2;CDK4;SFRP1;HSPB1;CORO1C;DDX3X;CDC25A;SOCS1;AJUBA;GADD45B;PDGFB;CLU;HSP90AB1;FAF1;ADAM17;TRAF2;TELO2;CSF1;KIF14;TLR3;TNF;CCL5;CD74;FGFR1OP;DAXX;CDKN1A;ITGB1BP1;IRAK3
19262,GO:1905368,0.592541126781816,0.588406468116873,5,85,peptidase complex,CC,HSPB1;PSME2;PSMB9;TAF6L;PSMB10
1267,GO:0003018,0.592564549926389,0.574139296766387,6,84,vascular process in circulatory system,BP,GCLC;EDN1;ADM;SOD2;GPER1;ITGB1BP1
11386,GO:0045737,0.592575838633873,0.688441740033491,2,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,PDGFB;ADAM17
2574,GO:0005859,0.592599657068686,0.797905190082988,1,7,muscle myosin complex,CC,MYH11
19656,GO:1990782,0.592631687233544,0.610778600195736,4,53,protein tyrosine kinase binding,MF,NRG1;IRS1;TP53;PTPN14
16683,GO:0097542,0.592681275618929,0.640365031129867,3,41,ciliary tip,CC,DYNC2H1;CYLD;DYNLL2
11014,GO:0044818,0.592969071604004,0.688861681442152,2,26,mitotic G2/M transition checkpoint,BP,NBN;TOPBP1
6309,GO:0019935,0.593073326785452,0.589427287675388,5,67,cyclic-nucleotide-mediated signaling,BP,SLC9A3R1;AHR;PTGER4;ADM;GPER1
13564,GO:0060004,0.593581238591596,0.787926224646825,1,11,reflex,BP,NPNT
6117,GO:0019359,0.593730711887206,0.560873497158221,7,97,nicotinamide nucleotide biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
6119,GO:0019363,0.593730711887206,0.560873497158221,7,97,pyridine nucleotide biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
5543,GO:0016529,0.593883612439376,0.640148485672666,3,37,sarcoplasmic reticulum,CC,JPH2;P3H2;JPH1
11261,GO:0045446,0.593904296988108,0.588683359777356,5,66,endothelial cell differentiation,BP,NRG1;PDPN;TJP2;TJP1;TNF
10789,GO:0044233,0.59402682037698,0.786230652180792,1,12,ER-mitochondrion membrane contact site,CC,RAB32
20110,GO:2000726,0.59419165083922,0.787405463219939,1,11,negative regulation of cardiac muscle cell differentiation,BP,G6PD
10384,GO:0043195,0.594286043714458,0.638740829695876,3,41,terminal bouton,CC,OPHN1;HSPA8;SYT11
11440,GO:0045839,0.594368987535705,0.638437787474102,3,42,negative regulation of mitotic nuclear division,BP,ANAPC15;CENPF;CHEK1
18951,GO:1904659,0.594383181122923,0.588074785334566,5,67,glucose transmembrane transport,BP,C3;IRS1;ENPP1;PIK3R3;TNF
4088,GO:0009141,0.594607546317576,0.50772642388505,16,257,nucleoside triphosphate metabolic process,BP,NUP50;NUP153;NDC1;RAN;RANBP2;GPHN;PGK1;NUP160;ENPP1;NUP54;HSPA8;SDHD;UQCRB;TYMS;TBPL1;NDUFB9
17848,GO:1901981,0.594675938096954,0.55012124551894,8,110,phosphatidylinositol phosphate binding,MF,JPH2;MYO1B;ARRDC1-AS1;SNX11;BBS5;MYO10;VPS36;PARD3
12756,GO:0051000,0.594692374526577,0.785659326873725,1,12,positive regulation of nitric-oxide synthase activity,BP,DHFR
4068,GO:0009117,0.594816870043476,0.479380262279246,31,474,nucleotide metabolic process,BP,G6PD;PANK2;TPST1;PGD;NUP50;TJP2;NUP153;TK1;ADM;NDC1;RAN;RANBP2;GPHN;CROT;PGK1;NUP160;ENPP1;RRM2;NUP54;NNT;UMPS;HSPA8;SMUG1;GPER1;RRM1;SDHD;UQCRB;TYMS;FLAD1;TBPL1;NDUFB9
3559,GO:0007601,0.594993532766111,0.57178246431231,6,82,visual perception,BP,CYP1B1;CLN6;EYA3;BBS5;GJC1;WDR36
12736,GO:0050953,0.594993532766111,0.57178246431231,6,82,sensory perception of light stimulus,BP,CYP1B1;CLN6;EYA3;BBS5;GJC1;WDR36
11796,GO:0046639,0.595056008858397,0.786666502858757,1,11,negative regulation of alpha-beta T cell differentiation,BP,RC3H1
12109,GO:0048070,0.595096110787277,0.785312225233901,1,12,regulation of developmental pigmentation,BP,ADAMTS9
1342,GO:0003198,0.595103416098693,0.786625920643928,1,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFB2
4680,GO:0010826,0.595126147683893,0.785286385905317,1,12,negative regulation of centrosome duplication,BP,TRIM37
3335,GO:0007050,0.595277688229246,0.51076415590526,15,215,cell cycle arrest,BP,PML;TP53;CDKN2A;TGFB2;INHBA;NBN;CDK4;PLK2;RRAGB;MDM4;HSP90AB1;E2F8;GPER1;CDKN1A;IRF1
20094,GO:2000696,0.595295747239118,0.786461222429335,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,FAT4
16280,GO:0090317,0.595325857958127,0.685385246215034,2,29,negative regulation of intracellular protein transport,BP,CHP1;ITGB1BP1
11691,GO:0046459,0.595457464050718,0.783887817684571,1,13,short-chain fatty acid metabolic process,BP,MMAA
15017,GO:0070925,0.595656625436914,0.465943897204825,46,636,organelle assembly,BP,KIF23;ACTG1;DYNC2H1;EDN1;STAG1;PPAN;CYLD;DNHD1;NAIP;RAB32;TPM1;ABCC4;DYNLL2;MDN1;PLK2;UBQLN2;MYBL2;NOP2;LCP1;DDX28;RRP7BP;DDX3X;MRTO4;TRIM37;SRF;BIRC3;ANLN;RPF2;MYH11;TMEM138;WDPCP;CENPF;RAB3GAP1;BBS5;CEP152;CFLAR;MRPS7;VPS36;SYNPO2;EHD1;CENPN;TNF;RC3H1;HNRNPU;FGFR1OP;TBPL1
11837,GO:0046716,0.595713069035193,0.784781042932561,1,12,muscle cell cellular homeostasis,BP,SRF
6825,GO:0030279,0.595730328017694,0.637506526273375,3,40,negative regulation of ossification,BP,SFRP1;KREMEN2;TNF
19531,GO:1990351,0.595860473494371,0.540812374914691,9,122,transporter complex,CC,CNTNAP1;SHISA9;LRRC8D;KCNS3;ABCF2;KCNQ5;ABCC9;CNTNAP2;CLCC1
17007,GO:0099054,0.59591755686109,0.785928133002509,1,11,presynapse assembly,BP,FZD1
13537,GO:0055088,0.596028361425065,0.586051350808,5,70,lipid homeostasis,BP,ABHD4;TMEM97;COMMD9;THADA;EHD1
13240,GO:0051881,0.596063078355348,0.635600869467431,3,48,regulation of mitochondrial membrane potential,BP,GCLC;PANK2;ARL6IP5
4501,GO:0010524,0.596578356570367,0.684902838031841,2,27,positive regulation of calcium ion transport into cytosol,BP,JPH2;GPER1
13894,GO:0060491,0.596813353104566,0.539685798032379,9,125,regulation of cell projection assembly,BP,CYLD;RHOG;CORO1C;CDC42EP2;SRF;ANLN;WDPCP;MYO10;DPYSL3
464,GO:0001502,0.597014334370928,0.784985541313554,1,11,cartilage condensation,BP,CTGF
16859,GO:0098743,0.597014334370928,0.784985541313554,1,11,cell aggregation,BP,CTGF
166,GO:0000346,0.597062447426868,0.782497031332003,1,13,transcription export complex,CC,THOC1
4574,GO:0010657,0.597309650209429,0.635669605172986,3,41,muscle cell apoptotic process,BP,EDN1;CDKN2A;CFLAR
13583,GO:0060026,0.597576757524679,0.784501041480841,1,11,convergent extension,BP,SFRP1
10293,GO:0043029,0.597921282722111,0.683188564735135,2,28,T cell homeostasis,BP,TSC22D3;RC3H1
5613,GO:0016653,0.598040002411723,0.782769237311572,1,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NQO1
4602,GO:0010715,0.598351751713827,0.783832150324327,1,11,regulation of extracellular matrix disassembly,BP,PDPN
4584,GO:0010667,0.598462314529154,0.782402691572829,1,12,negative regulation of cardiac muscle cell apoptotic process,BP,CFLAR
11007,GO:0044798,0.598476738157376,0.524960755190806,11,157,nuclear transcription factor complex,CC,PBX1;TP53;TAF2;GTF3C6;TAF1D;TAF6L;GTF3C4;HNRNPU;TAF1;TBPL1;GTF2H3
17910,GO:1902165,0.59851195493821,0.779446216288081,1,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CD74
10560,GO:0043502,0.598524038097197,0.604882025436779,4,52,regulation of muscle adaptation,BP,G6PD;EDN1;IL6ST;MIR17HG
8781,GO:0034452,0.598645865861354,0.785187732879835,1,10,dynactin binding,MF,SNX5
3126,GO:0006706,0.598957796626906,0.780846479801323,1,13,steroid catabolic process,BP,CYP24A1
11359,GO:0045668,0.599013843871884,0.682922204572025,2,26,negative regulation of osteoblast differentiation,BP,SFRP1;TNF
6392,GO:0021587,0.599039961242074,0.683852631444136,2,24,cerebellum morphogenesis,BP,OPHN1;KIF14
16890,GO:0098800,0.599447462225985,0.580428150311626,5,99,inner mitochondrial membrane protein complex,CC,IMMP2L;TIMM23B;SDHD;UQCRB;NDUFB9
6795,GO:0030228,0.599591707349354,0.784373461125529,1,10,lipoprotein particle receptor activity,MF,CXCL16
5478,GO:0016408,0.599755426504214,0.780149220279886,1,13,C-acyltransferase activity,MF,HADHB
5434,GO:0016289,0.599882473307229,0.779073985241032,1,14,CoA hydrolase activity,MF,HIBCH
3624,GO:0008081,0.599935718971786,0.602807637209879,4,56,phosphoric diester hydrolase activity,MF,GPCPD1;ENPP1;APEX1;CCL5
9203,GO:0035579,0.600008697826077,0.602877246547475,4,55,specific granule membrane,CC,PTPRB;SLCO4C1;ITGAV;LAIR1
4985,GO:0015106,0.600011196008664,0.78239492686923,1,11,bicarbonate transmembrane transporter activity,MF,SLC4A11
5688,GO:0016801,0.600104280508186,0.779843769970793,1,13,hydrolase activity, acting on ether bonds,MF,C9ORF3
14484,GO:0061842,0.600197805554811,0.682709114809968,2,24,microtubule organizing center localization,BP,NDC1;RANBP2
4442,GO:0010324,0.600313100128994,0.632383707795286,3,42,membrane invagination,BP,C3;RHOG;SYT11
20145,GO:2000786,0.600367391527459,0.782085544862269,1,11,positive regulation of autophagosome assembly,BP,RAB3GAP1
10509,GO:0043401,0.600621301904461,0.522911228655526,11,151,steroid hormone mediated signaling pathway,BP,RUNX1;DDX17;SFRP1;RAN;ARNTL;GPER1;CLOCK;ESR1;DAXX;TAF1;PPARGC1B
17276,GO:0120035,0.600845923185863,0.472354331157149,32,432,regulation of plasma membrane bounded cell projection organization,BP,NEFL;NRG1;MAP2;FN1;TENM3;ENC1;PDPN;CYLD;SFRP1;ULK4;PLK2;RHOG;CORO1C;RRN3;CDC42EP2;BAIAP2;SRF;SDK1;FZD1;ANLN;NEDD4L;ZFYVE27;TRAK2;WDPCP;L1CAM;MYO10;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;WDR36
15907,GO:0072655,0.601180755848539,0.527596220395049,10,158,establishment of protein localization to mitochondrion,BP,NRG1;TP53;IMMP2L;DYNLL2;GDAP1;TIMM23B;WDR75;UBE2J2;STARD7;TSGA13
3384,GO:0007163,0.601193361051904,0.517291146113753,12,159,establishment or maintenance of cell polarity,BP,MAP2;AMOT;SIPA1L3;SLC9A3R1;DST;PARD3B;OPHN1;WEE1;WDPCP;SHTN1;MPP5;PARD3
656,GO:0001844,0.601205550254348,0.679229938935611,2,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;DYNLL2
3590,GO:0008016,0.601209681137359,0.543359539986845,8,109,regulation of heart contraction,BP,CTGF;EDN1;TGFB2;ATP2B1;TPM1;ADM;ABCC9;GJC1
15610,GO:0072073,0.601256097906569,0.553369634839703,7,92,kidney epithelium development,BP,FGFR2;FAT4;PBX1;IRX2;SFRP1;WNT4;NPNT
3702,GO:0008211,0.601465793817418,0.778648767007179,1,13,glucocorticoid metabolic process,BP,WNT4
3029,GO:0006576,0.602029610749688,0.678409056099274,2,30,cellular biogenic amine metabolic process,BP,ODC1;AZIN1
7325,GO:0031329,0.602122690568183,0.457421056262515,49,692,regulation of cellular catabolic process,BP,PML;GCLC;TRIM22;IRS1;DAPK3;PABPC4;PPP1R3B;DKC1;NUP50;NUP153;LEPR;TARDBP;KEAP1;DRAM1;OPHN1;NDC1;PLK2;RRAGB;UBQLN2;HSPB1;RANBP2;SET;FASTKD3;SNX5;CLU;NUP160;NUP54;LRPPRC;METTL16;APEX1;PDCL3;HSPA8;HSP90AB1;SYNCRIP;MTMR2;RAB3GAP1;WDR75;SENP1;PSME2;PSMB9;HNRNPR;RNF19B;TNF;ZFP36L2;RC3H1;HNRNPU;PSMB10;TAF1;SMARCC1
2102,GO:0004866,0.602300693567705,0.578795100535087,5,78,endopeptidase inhibitor activity,MF,C3;NAIP;CD109;BIRC3;SERPINB9
6893,GO:0030414,0.602300693567705,0.578795100535087,5,78,peptidase inhibitor activity,MF,C3;NAIP;CD109;BIRC3;SERPINB9
10966,GO:0044703,0.602353199886307,0.464033065016144,39,549,multi-organism reproductive process,BP,COL16A1;MMP9;VMP1;CYP1A1;B4GALT1;SPACA6;TFCP2L1;PANK2;EDN1;INHBA;EMP2;LEPR;BRIP1;ADM;IMMP2L;NDC1;SLCO4C1;WNT4;RAN;ARNTL;DND1;MCM8;BIRC3;THBD;DPY19L2P2;UMPS;MYBL1;GLIPR1L2;BRCA2;FANCD2;ETV6;HSF2;UBAP2L;AKR1B1;CLOCK;ESR1;TBPL1;DIAPH3;GPX4
15345,GO:0071545,0.602511562385822,0.778865776244911,1,12,inositol phosphate catabolic process,BP,MTMR2
8055,GO:0032703,0.602619799478186,0.778770675595079,1,12,negative regulation of interleukin-2 production,BP,GBP1
10811,GO:0044281,0.603014535117622,0.439495610203633,102,1504,small molecule metabolic process,BP,IGFBP3;PTGES;CYP1B1;GCLC;C3;CYP24A1;TXNRD1;UGT1A6;STAT5A;FADS3;SLC7A2;CYP1A1;CLN6;B4GALT1;G6PD;MAT2A;IRS1;SLC16A9;PANK2;EDN1;TPST1;SCD;HMGCS1;C1QTNF1;ACSL3;NQO1;PRUNE2;CHP1;ACO1;CARS2;PPP1R3B;PGD;NUP50;SYK;TJP2;NUP153;LEPR;ABCG2;LSS;LDHAL6B;UAP1L1;SLC5A6;DHFR;TK1;ADM;NDC1;SLC1A3;MME;WNT4;RAN;RANBP2;GPHN;ODC1;CROT;AKR1C2;PGK1;HACD2;GATC;RARS;QDPR;PDGFB;NFE2L1;NUP160;ENPP1;RRM2;NUP54;SRD5A1;SEPHS2;NNT;PDCL3;UMPS;HSPA8;SMUG1;SCD5;DPYD;PPIP5K1;MTMR2;GPER1;MMAA;RRM1;PSME2;HADHB;PSMB9;SDHD;UGT1A4;EBP;AKR1B1;UQCRB;AZIN1;ARV1;TNF;PDSS1;TYMS;CD74;PSMB10;FLAD1;TBPL1;HIBCH;PPARGC1B;THTPA;NDUFB9;GPX4
10351,GO:0043138,0.603122900367016,0.778328251496413,1,12,3'-5' DNA helicase activity,MF,GINS4
14987,GO:0070875,0.603125695041223,0.781311520606336,1,10,positive regulation of glycogen metabolic process,BP,IRS1
11079,GO:0045063,0.603161127247057,0.778294609194855,1,12,T-helper 1 cell differentiation,BP,RELB
19652,GO:1990774,0.60350980210437,0.779342504691867,1,11,tumor necrosis factor secretion,BP,SYT11
7490,GO:0031649,0.603655673044254,0.776717032201225,1,13,heat generation,BP,TNF
4771,GO:0010954,0.603938813284073,0.777609399645511,1,12,positive regulation of protein processing,BP,C3
16893,GO:0098803,0.604164132193124,0.62518094746778,3,66,respiratory chain complex,CC,SDHD;UQCRB;NDUFB9
2209,GO:0005092,0.604243008641022,0.776196895632329,1,13,GDP-dissociation inhibitor activity,MF,ITGB1BP1
11850,GO:0046782,0.604640419307968,0.597390803325618,4,60,regulation of viral transcription,BP,NUCKS1;TARDBP;POLR2F;CCL5
10544,GO:0043476,0.604877027854641,0.776780737781345,1,12,pigment accumulation,BP,RAB32
10545,GO:0043482,0.604877027854641,0.776780737781345,1,12,cellular pigment accumulation,BP,RAB32
17630,GO:1901292,0.605263881450348,0.530635170987932,9,130,nucleoside phosphate catabolic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;ENPP1;NUP54;SMUG1
2680,GO:0006040,0.605278681102946,0.675869490680914,2,28,amino sugar metabolic process,BP,UAP1L1;CHID1
10702,GO:0043970,0.605551476054454,0.776183680303168,1,12,histone H3-K9 acetylation,BP,CHEK1
9818,GO:0040037,0.605578143744051,0.776160049182788,1,12,negative regulation of fibroblast growth factor receptor signaling pathway,BP,WNT4
8439,GO:0033540,0.605669846963419,0.774929704909893,1,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,CROT
4191,GO:0009267,0.605710847005162,0.538380864978128,8,114,cellular response to starvation,BP,TP53;SFRP1;CADPS2;RRAGB;WNT4;SRD5A1;HSPA8;CDKN1A
3327,GO:0007039,0.605757512368604,0.776001058314051,1,12,protein catabolic process in the vacuole,BP,TMEM199
16832,GO:0098660,0.60580012880918,0.47067593113119,29,407,inorganic ion transmembrane transport,BP,JPH2;G6PD;CHP1;SLC4A11;SLC30A6;SLC9A3R1;ATP2B1;ABCC4;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;NETO1;ABCC9;JPH1;NNT;THADA;SLC11A2;NEDD4L;STEAP4;GPER1;SLC9A9;CLCC1;KCNE4;PANX1;SLC25A22;SLC41A2
5228,GO:0015837,0.605902632777648,0.674876059870752,2,29,amine transport,BP,ARL6IP5;RAB3GAP1
14225,GO:0061134,0.606109479419664,0.547263212579927,7,109,peptidase regulator activity,MF,FN1;C3;NAIP;CD109;BIRC3;SERPINB9;PSME2
9900,GO:0042169,0.606114575758579,0.676320625380349,2,25,SH2 domain binding,MF,IRS1;SYK
9511,GO:0036150,0.606232354802009,0.77557977154465,1,12,phosphatidylserine acyl-chain remodeling,BP,MBOAT1
5447,GO:0016311,0.606282052475417,0.474377493511695,26,362,dephosphorylation,BP,IGFBP3;DUSP14;PTPN14;CHP1;TGFB2;PKMYT1;PPP1R3B;NUAK1;PTPRB;PTPRM;CDC25A;SET;PPP4R4;SH3RF2;APTX;PHACTR4;NPNT;EYA3;APEX1;HSP90AB1;MTMR2;TNF;PHLPP2;PHLPP1;PPARGC1B;THTPA
6221,GO:0019751,0.60657954088086,0.559368981947559,6,86,polyol metabolic process,BP,DHFR;QDPR;PPIP5K1;MTMR2;GPER1;AKR1B1
10408,GO:0043230,0.606601927394062,0.43083600551392,137,2047,extracellular organelle,CC,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;FTL;FTH1;KRT34;C1R;KRT13;FN1;KRT2;TFRC;C3;GPRC5A;KRT15;TXNRD1;UGT1A6;COL5A3;S100P;MMP9;FBN1;HSPG2;MYO1B;FAT4;B4GALT1;ACTG1;G6PD;DYNC2H1;DOCK10;TMEM106A;NQO1;COBLL1;LGALS3;CHP1;ACO1;PRSS23;SRSF2;COL12A1;PGD;IL6ST;SLC9A3R1;SLC22A5;DNHD1;OLFML3;NAIP;SFRP1;KRT9;CD274;GEMIN4;DST;H3F3A;ATP2B1;HRNR;CSRP1;URM1;MGAM;SLCO4C1;MME;MUC16;FRK;BTN2A1;HSPB1;RHOG;WNT4;LCP1;SIRPA;RAN;SOD2;DDX3X;ITGAV;QPCT;SMC2;KRT24;LFNG;PGK1;BAIAP2;CDH13;RARS;NPNT;QDPR;APMAP;CHID1;SDK1;TBC1D15;ANTXR1;CLU;NAA50;TPM4;UPK3B;GLIPR2;ERAP1;SLC11A2;HSPA8;HSP90AB1;ARL6IP5;NSF;GREB1;LAIR1;MYH11;NEDD4L;KRT10;MTMR2;PLEKHA7;STEAP4;FKBP5;RAB3GAP1;SERPINB9;RRM1;PSME2;HADHB;PSMB9;HNRNPDL;TAF6L;AKR1B1;VPS36;NCL;CSF1;NAA16;MPHOSPH8;JMJD8;MPP5;EHD1;DNASE1;SRSF7;CD74;HIST1H4A;ZNHIT6;HIBCH;NRAS;MUC5B;HNRNPM;ITGB1BP1;NDUFB9;GBP6;GPX4;UFC1
18491,GO:1903561,0.606601927394062,0.43083600551392,137,2047,extracellular vesicle,CC,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;FTL;FTH1;KRT34;C1R;KRT13;FN1;KRT2;TFRC;C3;GPRC5A;KRT15;TXNRD1;UGT1A6;COL5A3;S100P;MMP9;FBN1;HSPG2;MYO1B;FAT4;B4GALT1;ACTG1;G6PD;DYNC2H1;DOCK10;TMEM106A;NQO1;COBLL1;LGALS3;CHP1;ACO1;PRSS23;SRSF2;COL12A1;PGD;IL6ST;SLC9A3R1;SLC22A5;DNHD1;OLFML3;NAIP;SFRP1;KRT9;CD274;GEMIN4;DST;H3F3A;ATP2B1;HRNR;CSRP1;URM1;MGAM;SLCO4C1;MME;MUC16;FRK;BTN2A1;HSPB1;RHOG;WNT4;LCP1;SIRPA;RAN;SOD2;DDX3X;ITGAV;QPCT;SMC2;KRT24;LFNG;PGK1;BAIAP2;CDH13;RARS;NPNT;QDPR;APMAP;CHID1;SDK1;TBC1D15;ANTXR1;CLU;NAA50;TPM4;UPK3B;GLIPR2;ERAP1;SLC11A2;HSPA8;HSP90AB1;ARL6IP5;NSF;GREB1;LAIR1;MYH11;NEDD4L;KRT10;MTMR2;PLEKHA7;STEAP4;FKBP5;RAB3GAP1;SERPINB9;RRM1;PSME2;HADHB;PSMB9;HNRNPDL;TAF6L;AKR1B1;VPS36;NCL;CSF1;NAA16;MPHOSPH8;JMJD8;MPP5;EHD1;DNASE1;SRSF7;CD74;HIST1H4A;ZNHIT6;HIBCH;NRAS;MUC5B;HNRNPM;ITGB1BP1;NDUFB9;GBP6;GPX4;UFC1
20064,GO:2000651,0.606829922841633,0.776417580958619,1,11,positive regulation of sodium ion transmembrane transporter activity,BP,CHP1
9451,GO:0036020,0.606874222466054,0.775009395928009,1,12,endolysosome membrane,CC,TLR3
8319,GO:0033145,0.606883880821093,0.77384747825479,1,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,TAF1
6923,GO:0030510,0.60708199514822,0.595997256735909,4,52,regulation of BMP signaling pathway,BP,CYR61;FBN1;SFRP1;FZD1
10644,GO:0043632,0.607271181632984,0.460591177284533,37,531,modification-dependent macromolecule catabolic process,BP,PML;GCLC;TP53;CYLD;USP16;KEAP1;USP43;FOXRED2;PLK2;UBQLN2;RANBP2;ANAPC15;RNF115;ARNTL;CLU;USP6;PDCL3;HSP90AB1;NEDD4L;ANAPC7;CCDC47;FAF1;SENP1;PSME2;PSMB9;SPSB1;UBE2J2;VPS36;CLOCK;KIF14;RNF19B;USP11;PSMB10;TAF1;SMARCC1;USP1;COPS3
15358,GO:0071564,0.607415487657091,0.774527610670158,1,12,npBAF complex,CC,SMARCC1
16624,GO:0097440,0.607470712915896,0.775849878630494,1,11,apical dendrite,CC,CLU
607,GO:0001773,0.607649571286919,0.772175834412039,1,14,myeloid dendritic cell activation,BP,RELB
2534,GO:0005789,0.607826767021265,0.448331306928517,55,798,endoplasmic reticulum membrane,CC,PTGES;PML;CYP1B1;JPH2;UGT1A6;FADS3;HLA-B;TAP1;CYP1A1;CLN6;FAM69B;SCD;ACSL3;PKMYT1;CDKAL1;LSS;LRRC8D;HLA-F;ZDHHC6;ABHD4;DST;RCE1;REEP1;TMEM97;GGCX;RHOG;HACD2;NFE2L1;MBOAT1;SRD5A1;JPH1;SRPRB;THADA;ERAP1;RIC3;TMEM199;ARL6IP5;SCD5;SGK1;ZFYVE27;RAB3GAP1;GPER1;FAF1;UGT1A4;EBP;UBE2J2;TRAF2;TAP2;TLR3;GJC1;RNF19B;ARV1;CD74;PANX1;TREX1
3082,GO:0006656,0.607859328472873,0.672908402720641,2,29,phosphatidylcholine biosynthetic process,BP,ACSL3;STARD7
6747,GO:0030163,0.60788865218716,0.449803403999429,52,742,protein catabolic process,BP,NRG1;PML;GCLC;CLN6;ENC1;TP53;CYLD;USP16;KEAP1;ADAMTS9;OPHN1;USP43;FOXRED2;PLK2;UBQLN2;RANBP2;ANAPC15;RNF115;ARNTL;ODC1;MDM4;CLU;USP6;PDCL3;HSPA8;TMEM199;HSP90AB1;BACE2;NSF;NEDD4L;ANAPC7;CCDC47;FAF1;SENP1;PSME2;PSMB9;SPSB1;UBE2J2;VPS36;TRAF2;CLOCK;KIF14;AZIN1;RNF19B;USP11;TNF;PSMB10;TAF1;SMARCC1;USP1;IRAK3;COPS3
16007,GO:0085029,0.608069040851661,0.674360436092001,2,25,extracellular matrix assembly,BP,ANTXR1;MYH11
15058,GO:0070986,0.608177989737261,0.773847645541314,1,12,left/right axis specification,BP,CITED2
8999,GO:0035102,0.608182036010746,0.773844033335876,1,12,PRC1 complex,CC,RING1
2642,GO:0005977,0.608246378209197,0.59445763542132,4,54,glycogen metabolic process,BP,IRS1;PPP1R3B;IL6ST;ENPP1
6509,GO:0021879,0.608346243000597,0.673185425848149,2,27,forebrain neuron differentiation,BP,FGFR2;INHBA
5078,GO:0015299,0.608542630324818,0.773521955849388,1,12,solute:proton antiporter activity,MF,SLC9A9
11153,GO:0045184,0.608601548011555,0.432440332807363,110,1583,establishment of protein localization,BP,SAA1;NRG1;TRIM16;FN1;PML;TFRC;GNPTAB;TAP1;IL1R2;IRS1;VPS13B;TP53;GBP1;ACSL3;PTPN14;CHP1;AKAP8;TGFB2;RBM22;SRSF2;DKC1;NUP50;PHAX;SYK;NUP153;RAB32;ARFRP1;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;VPS8;AP5M1;REEP1;ADAMTS9;KCNS3;PTGER4;LSG1;IMMP2L;NDC1;CADPS2;DYNLL2;CASC3;GBP5;AKAP8L;HSPB1;LCP1;THOC1;RAN;RANBP2;CORO1C;RAB26;ITGAV;SOCS1;ARNTL;SNX11;SNX5;GDAP1;NPNT;TBC1D15;CLU;NUP160;USP6;SDAD1;FRAS1;NUP54;SETD2;TIMM23B;HSPA8;SYT11;HSP90AB1;NSF;M6PR;BRCA2;TRAK2;WDPCP;CENPF;GOSR1;RAB3GAP1;SCFD2;BBS5;GPER1;WDR75;RABEP2;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;TAP2;AP3B1;CLOCK;KIF14;PARD3;EHD1;TNF;SRSF7;STARD7;CCL5;CD74;PANX1;TRAM2;CDKN1A;ITGB1BP1;ASTN2;TSGA13;RBM8A;RPS12;BUD13
10504,GO:0043395,0.608692854923631,0.776424858860012,1,10,heparan sulfate proteoglycan binding,MF,FST
8440,GO:0033549,0.608973638503203,0.771975889097772,1,13,MAP kinase phosphatase activity,MF,DUSP14
16797,GO:0098589,0.60905097133977,0.496518049054921,15,208,membrane region,CC,IRS1;DAPK3;PDPN;SLC9A3R1;EMP2;ATP2B1;RANBP2;CORO1C;PGK1;CDH13;BIRC3;ADAM17;CFLAR;TRAF2;TNF
8045,GO:0032688,0.609091327920356,0.771870157344859,1,13,negative regulation of interferon-beta production,BP,RELB
3175,GO:0006790,0.609169702684179,0.486985555643691,18,273,sulfur compound metabolic process,BP,PTGES;GCLC;STAT5A;B4GALT1;G6PD;MAT2A;TPST1;SCD;HMGCS1;ACSL3;SLC5A6;HSCB;HACD2;IBA57;GDAP1;ENPP1;SCD5;THTPA
3151,GO:0006750,0.609226841697445,0.77075648101742,1,14,glutathione biosynthetic process,BP,GCLC
15611,GO:0072074,0.609427788913453,0.772729948743337,1,12,kidney mesenchyme development,BP,WNT4
13709,GO:0060231,0.609432847886481,0.771563137956631,1,13,mesenchymal to epithelial transition,BP,WNT4
17511,GO:1900424,0.609678945943153,0.771341717214325,1,13,regulation of defense response to bacterium,BP,SYT11
3313,GO:0007018,0.609807688314348,0.489534654129318,17,228,microtubule-based movement,BP,NEFL;KIF23;MYO1B;DYNC2H1;DNHD1;AP3M2;DST;DYNLL2;HSPB1;LRPPRC;BLOC1S2;HSPA8;MYH11;TRAK2;MYO10;AP3B1;KIF14
15200,GO:0071318,0.609916350573518,0.772291950475209,1,12,cellular response to ATP,BP,TAF1
9291,GO:0035721,0.609941674496118,0.772269230906214,1,12,intraciliary retrograde transport,BP,DYNC2H1
10165,GO:0042734,0.609955135732165,0.623151407477649,3,39,presynaptic membrane,CC,CADPS2;SYT11;GPER1
994,GO:0002448,0.610499627974193,0.670612667613047,2,28,mast cell mediated immunity,BP,SYK;SERPINB9
1952,GO:0004653,0.610516140882924,0.771753405481067,1,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT18
5944,GO:0018243,0.610516140882924,0.771753405481067,1,12,protein O-linked glycosylation via threonine,BP,GALNT18
10437,GO:0043271,0.611240986612368,0.570049098637746,5,71,negative regulation of ion transport,BP,MMP9;SLC9A3R1;THADA;ARL6IP5;NEDD4L
4357,GO:0009950,0.611314482936735,0.772422728959645,1,11,dorsal/ventral axis specification,BP,SFRP1
11832,GO:0046710,0.611398883492716,0.77095913453195,1,12,GDP metabolic process,BP,TJP2
13312,GO:0051988,0.611703115280692,0.770684933413006,1,12,regulation of attachment of spindle microtubules to kinetochore,BP,HNRNPU
10078,GO:0042562,0.611737375388607,0.620376711828691,3,43,hormone binding,MF,INHBA;CDH13;GPER1
19655,GO:1990778,0.611811831594155,0.493598312273638,15,209,protein localization to cell periphery,BP,GBP1;ACSL3;SLC9A3R1;EMP2;ARFRP1;RHOG;WNT4;RAB26;RTKN2;ANLN;NSF;ZFYVE27;GPER1;MPP5;TNF
19991,GO:2000515,0.611837857001897,0.770563416498722,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,RC3H1
8071,GO:0032733,0.611978325394995,0.768265328341899,1,14,positive regulation of interleukin-10 production,BP,CD274
12138,GO:0048188,0.61203628584709,0.770384378839484,1,12,Set1C/COMPASS complex,CC,RBBP5
8795,GO:0034472,0.612469258622336,0.767818811088279,1,14,snRNA 3'-end processing,BP,USB1
6899,GO:0030426,0.612513168130252,0.523342179811962,9,122,growth cone,CC,NEFL;GPRIN1;ZFYVE27;TRAK2;L1CAM;SHTN1;DPYSL3;HNRNPR;PARD3
7505,GO:0031672,0.612552686102477,0.673758343125163,2,19,A band,CC,CRYAB;DST
14018,GO:0060712,0.61274386800635,0.769745124300723,1,12,spongiotrophoblast layer development,BP,ADM
3661,GO:0008146,0.613076029572852,0.667999064507792,2,28,sulfotransferase activity,MF,TPST1;HS3ST1
11409,GO:0045777,0.613464784368007,0.767916034990672,1,13,positive regulation of blood pressure,BP,TPM1
15301,GO:0071467,0.613534018451388,0.767853045648855,1,13,cellular response to pH,BP,CHP1
7260,GO:0031214,0.613792778181883,0.567670361994984,5,68,biomineral tissue development,BP,FGFR2;TUFT1;WNT4;ENPP1;ITGB1BP1
19833,GO:2000242,0.614007533929614,0.666329862043733,2,30,negative regulation of reproductive process,BP,RAD1;WNT4
14689,GO:0070286,0.614129278564966,0.769889164421555,1,11,axonemal dynein complex assembly,BP,DNHD1
3716,GO:0008236,0.61446365299431,0.550624689845456,6,92,serine-type peptidase activity,MF,C1R;C3;MMP9;OVCH2;PRSS23;IMMP2L
9551,GO:0036295,0.614906155373987,0.766602127966388,1,13,cellular response to increased oxygen levels,BP,TMEM199
4973,GO:0015081,0.615057956456346,0.56644352372677,5,67,sodium ion transmembrane transporter activity,MF,SLC4A11;SLC5A6;SLC1A3;SLC9A9;SLC25A22
463,GO:0001501,0.615133733482224,0.470233750477702,23,309,skeletal system development,BP,CYR61;FGFR2;CTGF;MMP9;FBN1;RUNX1;FAT4;PBX1;COL27A1;EDN1;TGFB2;COL12A1;TJP2;SFRP1;PTGER4;COL5A2;SRF;SRD5A1;SETD2;EBP;TYMS;PPARGC1B;USP1
10455,GO:0043302,0.615538327757651,0.766024170794323,1,13,positive regulation of leukocyte degranulation,BP,SYK
4706,GO:0010866,0.615858829394662,0.765730761052822,1,13,regulation of triglyceride biosynthetic process,BP,C3
2941,GO:0006469,0.615979244365018,0.492675415426179,14,204,negative regulation of protein kinase activity,BP,GPRC5A;DUSP14;CDKN2A;CHP1;CDK4;SFRP1;HSPB1;CORO1C;SOCS1;GADD45B;FGFR1OP;CDKN1A;ITGB1BP1;IRAK3
7414,GO:0031491,0.616015219062855,0.584766685745548,4,66,nucleosome binding,MF,H3F3A;SUPT16H;HMGN2;SMARCC1
17562,GO:1901068,0.616202740640647,0.615122924204253,3,46,guanosine-containing compound metabolic process,BP,TJP2;RAN;GPHN
16920,GO:0098847,0.616524786940518,0.765120246861517,1,13,sequence-specific single stranded DNA binding,MF,RPA1
7109,GO:0030900,0.616566303568279,0.482416326115567,17,229,forebrain development,BP,NEFL;NRG1;FGFR2;FAT4;INHBA;OPHN1;WNT4;RAN;SRF;SRD5A1;SETD2;CNTNAP2;RAB3GAP1;RRM1;EIF2B5;KIF14;PHLPP2
18834,GO:1904357,0.616853639949935,0.664984705932719,2,26,negative regulation of telomere maintenance via telomere lengthening,BP,GNL3L;HNRNPU
5628,GO:0016701,0.61704796052631,0.763624486790198,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,P4HA2
5629,GO:0016702,0.61704796052631,0.763624486790198,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,P4HA2
277,GO:0000779,0.617152196467297,0.53585141796764,7,104,condensed chromosome, centromeric region,CC,SKA2;CENPF;ORC2;CENPN;HNRNPU;DCTN5;CENPO
19766,GO:2000105,0.617279596937593,0.765616817234759,1,12,positive regulation of DNA-dependent DNA replication,BP,E2F8
3153,GO:0006753,0.617660770380476,0.455630978919811,31,479,nucleoside phosphate metabolic process,BP,G6PD;PANK2;TPST1;PGD;NUP50;TJP2;NUP153;TK1;ADM;NDC1;RAN;RANBP2;GPHN;CROT;PGK1;NUP160;ENPP1;RRM2;NUP54;NNT;UMPS;HSPA8;SMUG1;GPER1;RRM1;SDHD;UQCRB;TYMS;FLAD1;TBPL1;NDUFB9
13129,GO:0051645,0.617848055431032,0.765095670412301,1,12,Golgi localization,BP,SLC9A3R1
18036,GO:1902494,0.617864696071036,0.428051753166903,84,1227,catalytic complex,CC,HDAC9;GCLC;CBX5;MAT2A;ENC1;IRS1;DYNC2H1;TP53;KBTBD8;RBM22;PPP1R3B;HNRNPF;DKC1;DNHD1;CDK4;POP1;KEAP1;NAA15;POLR1A;METTL1;TAF2;POLA1;ELMSAN1;DYNLL2;HSPB1;KDM6A;ANAPC15;KLHL21;ABCF2;TRIM37;MCM3;PPP4R4;BRCC3;UTY;NAA50;PIK3R3;RRM2;EFTUD2;KANSL1L;KLHL9;HSPA8;PRIM2;ANAPC7;SYNCRIP;DGCR8;POLR2F;RRM1;RAD18;PSME2;UBAP2L;CFLAR;PSMB9;SDHD;TRMT61A;CBLL1;TAF6L;SPSB1;POLR1E;UBE2J2;TRAF2;RBBP5;POLR3B;HNRNPR;CCNA2;POLE3;UQCRB;NAA16;MPHOSPH8;RNF19B;WDR4;PDSS1;HNRNPU;RING1;PSMB10;DAXX;TAF1;TBPL1;SMARCC1;HNRNPM;CDKN1A;RBM8A;GTF2H3;NDUFB9;TEX10
17602,GO:1901201,0.618219311723951,0.766171455949973,1,11,regulation of extracellular matrix assembly,BP,ANTXR1
2686,GO:0006047,0.618260820499824,0.763523336338963,1,13,UDP-N-acetylglucosamine metabolic process,BP,UAP1L1
6902,GO:0030431,0.61854257956877,0.762243587656268,1,14,sleep,BP,SRD5A1
12284,GO:0048562,0.618670676828004,0.4987487698618,12,164,embryonic organ morphogenesis,BP,MAFB;FGFR2;FBN1;EDN1;SLC9A3R1;KDM6A;PHACTR4;SRF;SETD2;WDPCP;BBS5;NTN1
6988,GO:0030659,0.618989942781497,0.449350201500235,36,508,cytoplasmic vesicle membrane,CC,TFRC;GPRC5A;HLA-B;TAP1;B4GALT1;LGALS3;PCDH7;IL7R;RAB32;HLA-F;AP3M2;PTPRB;ABCC4;MGAM;CD109;CADPS2;SLCO4C1;MME;RHOG;WNT4;SIRPA;RAB26;ITGAV;SNX5;HSPA8;SYT11;TMEM199;LAIR1;M6PR;GPER1;LILRB3;TAP2;AP3B1;GLIPR1;CD74;NRAS
4170,GO:0009235,0.618994724834943,0.762845888138454,1,13,cobalamin metabolic process,BP,MMAA
7971,GO:0032570,0.619112861468791,0.661447222649926,2,29,response to progesterone,BP,TGFB2;TYMS
13398,GO:0052629,0.619165457229023,0.765305266741473,1,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,MTMR2
4511,GO:0010559,0.619326793481067,0.661603957961104,2,28,regulation of glycoprotein biosynthetic process,BP,CHP1;BACE2
18181,GO:1902903,0.61959837169187,0.476334352838142,18,251,regulation of supramolecular fiber organization,BP,CRYAB;MAP2;CTGF;MID1;EDN1;SFRP1;TPM1;PTGER4;SYNPO2L;KANK4;RHOG;WNT4;CDC42EP2;BAIAP2;CLU;HSPA8;SYNPO2;ITGB1BP1
15488,GO:0071813,0.620083468886061,0.763038148756837,1,12,lipoprotein particle binding,MF,CDH13
15489,GO:0071814,0.620083468886061,0.763038148756837,1,12,protein-lipid complex binding,MF,CDH13
17353,GO:0150034,0.620173509094639,0.492526726727172,13,180,distal axon,CC,NEFL;OPHN1;GPRIN1;HSPA8;SYT11;ZFYVE27;TRAK2;L1CAM;GPER1;SHTN1;DPYSL3;HNRNPR;PARD3
9722,GO:0038127,0.620518277812255,0.514671902259725,9,126,ERBB signaling pathway,BP,NRG1;GPRC5A;EPGN;MMP9;RNF115;CDH13;GPER1;ADAM17;NRAS
6783,GO:0030214,0.620803242819629,0.761170486828387,1,13,hyaluronan catabolic process,BP,CHP1
16239,GO:0090266,0.620905122624847,0.761075851106135,1,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,ANAPC15
18451,GO:1903504,0.620905122624847,0.761075851106135,1,13,regulation of mitotic spindle checkpoint,BP,ANAPC15
13083,GO:0051567,0.62114123864024,0.660580871989765,2,26,histone H3-K9 methylation,BP,SUV39H2;RIF1
4462,GO:0010453,0.621299347135277,0.760709401001554,1,13,regulation of cell fate commitment,BP,FGFR2
12629,GO:0050790,0.621551776193871,0.41840600769591,115,1617,regulation of catalytic activity,BP,CRYAB;IGFBP3;SAA1;NRG1;FN1;PML;AMOT;MAP3K14;CYR61;C3;GPRC5A;NLRC5;FGFR2;EPGN;STARD13;CTGF;MMP9;IRS1;TP53;EDN1;DOCK10;SIPA1L3;DUSP14;CDKN2A;NQO1;CHP1;TGFB2;PKMYT1;PPP1R3B;BAG1;SLC9A3R1;NUAK1;DKC1;SYK;EMP2;NAIP;NBN;LEPR;CDK4;SFRP1;DHFR;TPM1;OPHN1;CD109;DYNLL2;CCL20;HSCB;RFC3;HSPB1;RHOG;WNT4;RANBP2;VCPKMT;CORO1C;DDX3X;CDC25A;SOCS1;SET;AJUBA;CDC42EP2;PPP4R4;NVL;GADD45B;SH3RF2;PHACTR4;NPNT;PDGFB;BRCC3;TBC1D15;ANTXR1;CLU;USP6;BIRC3;PIK3R3;FGD6;THADA;HSP90AB1;ARL6IP5;EPHB6;SGK1;RAB3GAP1;SERPINB9;GPER1;FAF1;ADAM17;SENP1;PSME2;MSH6;CFLAR;PSMB9;DNAJC9;RABEP2;TRAF2;MSH3;TELO2;HNRNPR;GTF3C4;CSF1;RBL1;KIF14;TLR3;AZIN1;ESR1;TNF;CCL5;CD74;HNRNPU;RING1;FGFR1OP;DAXX;PPARGC1B;CDKN1A;ITGB1BP1;IRAK3;IFI27L1
12635,GO:0050798,0.621989950362809,0.658124495766135,2,30,activated T cell proliferation,BP,CD274;RC3H1
11774,GO:0046606,0.622164569124576,0.759903705078839,1,13,negative regulation of centrosome cycle,BP,TRIM37
10847,GO:0044331,0.622190655660901,0.759879382675006,1,13,cell-cell adhesion mediated by cadherin,BP,CDH13
16905,GO:0098827,0.622861662636518,0.432760328581477,55,802,endoplasmic reticulum subcompartment,CC,PTGES;PML;CYP1B1;JPH2;UGT1A6;FADS3;HLA-B;TAP1;CYP1A1;CLN6;FAM69B;SCD;ACSL3;PKMYT1;CDKAL1;LSS;LRRC8D;HLA-F;ZDHHC6;ABHD4;DST;RCE1;REEP1;TMEM97;GGCX;RHOG;HACD2;NFE2L1;MBOAT1;SRD5A1;JPH1;SRPRB;THADA;ERAP1;RIC3;TMEM199;ARL6IP5;SCD5;SGK1;ZFYVE27;RAB3GAP1;GPER1;FAF1;UGT1A4;EBP;UBE2J2;TRAF2;TAP2;TLR3;GJC1;RNF19B;ARV1;CD74;PANX1;TREX1
3147,GO:0006743,0.622935904563742,0.757258396658721,1,15,ubiquinone metabolic process,BP,PDSS1
4963,GO:0015036,0.623351041200203,0.655514272919791,2,34,disulfide oxidoreductase activity,MF,TXNRD1;PGK1
14566,GO:0070071,0.623523168614075,0.759846620194435,1,12,proton-transporting two-sector ATPase complex assembly,BP,TMEM199
479,GO:0001523,0.623551749502783,0.607954673478231,3,43,retinoid metabolic process,BP,CYP1B1;HSPG2;CYP1A1
12295,GO:0048589,0.624179898832748,0.45041564582708,30,398,developmental growth,BP,NRG1;FN1;FGFR2;STAT5A;G6PD;COL27A1;EDN1;TGFB2;NBN;LEPR;CDK4;SFRP1;MIR17HG;ADM;KDM6A;GINS4;SRF;TNC;NEDD4L;ZFYVE27;BRCA2;L1CAM;NTN1;CFLAR;SHTN1;CSF1;ESR1;TYMS;WDR36;FTO
10743,GO:0044090,0.624310086690548,0.759112096193008,1,12,positive regulation of vacuole organization,BP,RAB3GAP1
15399,GO:0071625,0.624324420627186,0.760541068667243,1,11,vocalization behavior,BP,CNTNAP2
9086,GO:0035330,0.624422862391447,0.760449478551523,1,11,regulation of hippo signaling,BP,AJUBA
10040,GO:0042475,0.624478722224369,0.577134594099578,4,55,odontogenesis of dentin-containing tooth,BP,WNT10A;ADM;TNC;CSF1
20214,GO:2001026,0.624605903578092,0.75883555144413,1,12,regulation of endothelial cell chemotaxis,BP,HSPB1
3068,GO:0006635,0.624702225595119,0.576078617589735,4,61,fatty acid beta-oxidation,BP,IRS1;CROT;HADHB;HIBCH
14191,GO:0061053,0.624722503524926,0.577356925214422,4,52,somite development,BP,SFRP1;WNT4;KDM6A;LFNG
2839,GO:0006308,0.62552379507715,0.654806292013863,2,29,DNA catabolic process,BP,EXOG;DNASE1
711,GO:0001933,0.62560785528323,0.459008830819475,23,330,negative regulation of protein phosphorylation,BP,IGFBP3;GPRC5A;GBP1;DUSP14;CDKN2A;CHP1;SLC9A3R1;CDK4;SFRP1;TARDBP;CD109;HSPB1;CORO1C;SOCS1;PARP14;GADD45B;ENPP1;GPER1;PARD3;FGFR1OP;CDKN1A;ITGB1BP1;IRAK3
19144,GO:1905048,0.626105731573455,0.756208678443269,1,13,regulation of metallopeptidase activity,BP,ANTXR1
5618,GO:0016667,0.626130016818001,0.603944765431764,3,50,oxidoreductase activity, acting on a sulfur group of donors,MF,TXNRD1;PGK1;IFI30
586,GO:0001738,0.626207157527977,0.516302221253012,8,121,morphogenesis of a polarized epithelium,BP,SLC9A3R1;SFRP1;OPHN1;FZD1;PSME2;PSMB9;PSMB10;ASTN2
10606,GO:0043565,0.626279205344863,0.429342454383493,55,752,sequence-specific DNA binding,MF,MAFB;FOSL2;NLRC5;RUNX1;PBX1;TFCP2L1;TP53;ZBED1;IRX2;FOXD2;ZFP42;RELB;MCM5;MCM2;H3F3A;AHR;RPA1;TAF2;TSN;GRWD1;MYBL2;SUV39H2;KDM6A;UBTF;ORC4;RRN3;ARNTL;SRF;IRX4;UTY;NFE2L1;MACC1;GLIS2;UBP1;APEX1;MYBL1;MAZ;E2F8;ETV6;HSF2;TELO2;NCL;ORC2;CLOCK;PURB;ESR1;HNRNPU;TAF1;TBPL1;SPIB;PSPC1;SMARCC1;ARID3B;IRF1;CTCF
6827,GO:0030282,0.626398797307017,0.575078541096988,4,55,bone mineralization,BP,FGFR2;TUFT1;WNT4;ENPP1
4039,GO:0009070,0.626467602215359,0.754823625544166,1,14,serine family amino acid biosynthetic process,BP,SEPHS2
1105,GO:0002691,0.626804015572208,0.755549704114066,1,13,regulation of cellular extravasation,BP,PTGER4
15359,GO:0071565,0.626923551222211,0.756660855971004,1,12,nBAF complex,CC,SMARCC1
4146,GO:0009206,0.626947387595734,0.525329942041561,7,105,purine ribonucleoside triphosphate biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
16199,GO:0090201,0.626969325622708,0.754348278572034,1,14,negative regulation of release of cytochrome c from mitochondria,BP,CLU
14568,GO:0070076,0.62700865696199,0.654976999474987,2,25,histone lysine demethylation,BP,KDM6A;UTY
4903,GO:0014829,0.627192433992923,0.756407632129909,1,12,vascular smooth muscle contraction,BP,EDN1
11357,GO:0045666,0.627218042157649,0.471108765005334,17,232,positive regulation of neuron differentiation,BP,NEFL;NRG1;FN1;TENM3;ENC1;RRN3;BAIAP2;SRF;FZD1;NEDD4L;ZFYVE27;L1CAM;NTN1;CFLAR;SHTN1;DPYSL3;DDX56
12258,GO:0048515,0.62724388848981,0.552807372885305,5,73,spermatid differentiation,BP,PANK2;BRIP1;RAN;DPY19L2P2;TBPL1
9355,GO:0035855,0.62750897205021,0.756109280952053,1,12,megakaryocyte development,BP,SRF
17031,GO:0099116,0.627546039031357,0.752107830931585,1,16,tRNA 5'-end processing,BP,POP1
2885,GO:0006390,0.627551228415379,0.754843114342764,1,13,mitochondrial transcription,BP,PPARGC1B
7854,GO:0032409,0.627801405907978,0.50001104026439,10,140,regulation of transporter activity,BP,JPH2;MMP9;CHP1;SLC9A3R1;SHISA9;NETO1;JPH1;THADA;NEDD4L;SGK1
15841,GO:0072525,0.627825946162516,0.524674959007441,7,100,pyridine-containing compound biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
7513,GO:0031690,0.627898907751596,0.754513828227718,1,13,adrenergic receptor binding,MF,SLC9A3R1
16813,GO:0098632,0.627900968605305,0.652322927818754,2,29,cell-cell adhesion mediator activity,MF,PDLIM1;BAIAP2
12971,GO:0051315,0.627916035146239,0.754497598561462,1,13,attachment of mitotic spindle microtubules to kinetochore,BP,HNRNPU
7576,GO:0031932,0.627949639461113,0.75446575332608,1,13,TORC2 complex,CC,TELO2
8533,GO:0033764,0.62795534984368,0.751716917839376,1,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,AKR1C2
18644,GO:1903901,0.62817485753139,0.572231863521877,4,62,negative regulation of viral life cycle,BP,PML;FAM111A;TNF;CCL5
10689,GO:0043931,0.628227446503529,0.758650378542507,1,10,ossification involved in bone maturation,BP,FAT4
6588,GO:0022412,0.628362565177532,0.483676072992189,13,186,cellular process involved in reproduction in multicellular organism,BP,SPACA6;PANK2;INHBA;BRIP1;SFRP1;WNT4;RAN;DND1;DPY19L2P2;MYBL1;BRCA2;ETV6;TBPL1
14856,GO:0070585,0.628468030850087,0.498627528240258,10,161,protein localization to mitochondrion,BP,NRG1;TP53;IMMP2L;DYNLL2;GDAP1;TIMM23B;WDR75;UBE2J2;STARD7;TSGA13
6101,GO:0019318,0.628546581418428,0.487968383031231,12,174,hexose metabolic process,BP,IGFBP3;B4GALT1;G6PD;IRS1;C1QTNF1;PPP1R3B;LEPR;RANBP2;PGK1;ENPP1;AKR1B1;TNF
6758,GO:0030176,0.629117295967982,0.513092391430593,8,123,integral component of endoplasmic reticulum membrane,CC,HLA-B;TAP1;HLA-F;RCE1;HACD2;ZFYVE27;TAP2;CD74
6594,GO:0022604,0.629447919466458,0.451750084874396,25,339,regulation of cell morphogenesis,BP,NEFL;NRG1;MAP2;FN1;DAPK3;GBP1;PDPN;SLC9A3R1;PALM2;TPM1;CORO1C;CDC42EP2;BAIAP2;SRF;FGD6;NEDD4L;ZFYVE27;TRAK2;WDPCP;L1CAM;MYO10;NTN1;SHTN1;WDR36;ITGB1BP1
10985,GO:0044764,0.629497836170404,0.650648326524032,2,29,multi-organism cellular process,BP,SLC22A5;BIRC3
56,GO:0000118,0.629742381434621,0.57148540068157,4,55,histone deacetylase complex,CC,HDAC9;CBX5;ELMSAN1;TAF6L
5456,GO:0016327,0.629878013695988,0.752633249852211,1,13,apicolateral plasma membrane,CC,THBD
7243,GO:0031146,0.630005891556362,0.569423637582587,4,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSME2;PSMB9;KIF14;PSMB10
10396,GO:0043209,0.630041967731525,0.503980364127909,9,139,myelin sheath,CC,CRYAB;NEFL;ACTG1;CNTNAP1;SRD5A1;HSPA8;NSF;AKR1B1;MPP5
1135,GO:0002724,0.630435350531267,0.751046050606936,1,14,regulation of T cell cytokine production,BP,TRAF2
5333,GO:0016056,0.63044462438558,0.752092908299402,1,13,rhodopsin mediated signaling pathway,BP,METAP2
16245,GO:0090276,0.630515871725136,0.511857828980704,8,117,regulation of peptide hormone secretion,BP,IRS1;SFRP1;KCNS3;ARNTL;GPER1;CLOCK;TNF;CCL5
13550,GO:0055106,0.63056386945448,0.749215073542839,1,16,ubiquitin-protein transferase regulator activity,MF,RING1
10320,GO:0043086,0.630665775430539,0.436158394213304,37,542,negative regulation of catalytic activity,BP,CRYAB;AMOT;C3;GPRC5A;MMP9;TP53;DUSP14;CDKN2A;NQO1;CHP1;TGFB2;PKMYT1;NAIP;LEPR;CDK4;SFRP1;CD109;HSPB1;VCPKMT;CORO1C;DDX3X;SOCS1;SET;AJUBA;PPP4R4;GADD45B;SH3RF2;BIRC3;THADA;SERPINB9;HNRNPR;TNF;HNRNPU;FGFR1OP;CDKN1A;ITGB1BP1;IRAK3
8935,GO:0034774,0.630876194129974,0.476534889733097,14,222,secretory granule lumen,CC,FTL;FN1;C3;S100P;TGFB2;HRNR;FRK;DDX3X;QPCT;PDGFB;CLU;COMMD9;HSPA8;HSP90AB1
8612,GO:0034114,0.631047473857794,0.750459496940497,1,14,regulation of heterotypic cell-cell adhesion,BP,TNF
13241,GO:0051882,0.631054339895927,0.749539481346115,1,15,mitochondrial depolarization,BP,GCLC
8930,GO:0034765,0.631283045026872,0.472969105515542,15,210,regulation of ion transmembrane transport,BP,JPH2;MMP9;G6PD;CHP1;SLC9A3R1;SHISA9;KCNS3;KCNQ5;NETO1;JPH1;THADA;ARL6IP5;NEDD4L;GPER1;KCNE4
10304,GO:0043044,0.631416339464935,0.567993799579286,4,69,ATP-dependent chromatin remodeling,BP,CENPN;HIST1H4A;SMARCC1;CENPO
12641,GO:0050806,0.631441610694318,0.532956791906995,6,85,positive regulation of synaptic transmission,BP,SLC1A3;PLK2;NETO1;BAIAP2;RAB3GAP1;GPER1
594,GO:0001756,0.631726955428773,0.600170423148921,3,39,somitogenesis,BP,SFRP1;KDM6A;LFNG
16697,GO:0097617,0.631867187111353,0.750732479805925,1,13,annealing activity,MF,DDX3X
5299,GO:0015980,0.631871329140401,0.479323575200469,13,216,energy derivation by oxidation of organic compounds,BP,IRS1;PANK2;ACO1;PPP1R3B;IL6ST;LEPR;IMMP2L;FASTKD3;ENPP1;NNT;SDHD;UQCRB;NDUFB9
3591,GO:0008017,0.632303835982486,0.468804093424944,16,213,microtubule binding,MF,CRYAB;MAP2;KIF23;MTUS1;MYO1B;NEFM;MID1;CHP1;VPS41;DST;REEP1;LRPPRC;MYH11;SKA2;MYO10;KIF14
6137,GO:0019400,0.632480439892598,0.749082425740726,1,14,alditol metabolic process,BP,AKR1B1
11638,GO:0046326,0.632494119466648,0.648742368303386,2,26,positive regulation of glucose import,BP,IRS1;PIK3R3
12277,GO:0048546,0.632674923458993,0.649038451866964,2,25,digestive tract morphogenesis,BP,FGFR2;SFRP1
7617,GO:0031998,0.632727252564392,0.752630026239396,1,11,regulation of fatty acid beta-oxidation,BP,IRS1
7046,GO:0030814,0.632740655081162,0.647617573572512,2,28,regulation of cAMP metabolic process,BP,ADM;GPER1
4449,GO:0010369,0.632765812986343,0.749870281184225,1,13,chromocenter,CC,CBX5
17608,GO:1901215,0.632989925185022,0.501110949414031,9,131,negative regulation of neuron death,BP,NEFL;GCLC;NAIP;SOD2;SET;FZD1;HSP90AB1;TRAF2;KIF14
10899,GO:0044430,0.633027579570595,0.411781967764551,87,1189,cytoskeletal part,CC,CRYAB;KRT1;SAA1;NEFL;KRT34;KRT4;MAP2;KRT13;KIF23;AMOT;MTUS1;KRT2;KRT15;NLRC5;TAP1;MYO1B;ACTG1;NEFM;KRTAP2-3;DYNC2H1;MID1;DAPK3;SIPA1L3;KBTBD8;TCP11L1;STAG1;CYLD;PHAX;DNHD1;RELB;KRT9;DST;KEAP1;TPM1;NDC1;DYNLL2;PLK2;HSPB1;LCP1;RAN;RANBP2;TOPBP1;KLHL21;TAF1D;AJUBA;CGNL1;KRT24;MCM3;BAIAP2;BRCC3;ODF2L;RTKN2;CEP95;LRPPRC;EYA3;TPM4;RIF1;ANLN;SRPRB;TJP1;BLOC1S2;APEX1;MYH11;BRCA2;KRT10;SKA2;WDPCP;CENPF;PLEKHA7;CHEK1;BBS5;GPER1;RAD18;MYO10;CEP152;ZNF12;SHTN1;DPYSL3;UPF3B;ORC2;KIF14;SYNPO2;NEDD9;HNRNPU;FGFR1OP;DCTN5;ITGB1BP1
6723,GO:0030131,0.633075150491146,0.647264152115929,2,28,clathrin adaptor complex,CC,AP3M2;AP3B1
18610,GO:1903829,0.633676226017854,0.456494477413919,20,287,positive regulation of cellular protein localization,BP,NRG1;TP53;ACSL3;CHP1;RBM22;CYLD;DKC1;DYNLL2;RHOG;GNL3L;GLIS2;SYT11;HSP90AB1;GPER1;WDR75;UBE2J2;TNF;STARD7;ITGB1BP1;TSGA13
7857,GO:0032412,0.633769533879278,0.500479753706157,9,126,regulation of ion transmembrane transporter activity,BP,JPH2;MMP9;CHP1;SLC9A3R1;SHISA9;NETO1;JPH1;THADA;NEDD4L
3452,GO:0007266,0.633813181533215,0.487815629972761,11,149,Rho protein signal transduction,BP,PDPN;TRIO;OPHN1;RHOG;ARHGEF28;CDC42EP2;CDH13;PHACTR4;FGD6;NTN1;SHTN1
12301,GO:0048599,0.634158638981898,0.646117788225795,2,28,oocyte development,BP,WNT4;BRCA2
14082,GO:0060840,0.634270830450737,0.567080349621573,4,52,artery development,BP,TGFB2;ADAMTS9;SRF;DCTN5
7314,GO:0031312,0.634277433287247,0.645605124792391,2,29,extrinsic component of organelle membrane,CC,PML;SNX5
87,GO:0000175,0.634553654578408,0.644952063424729,2,30,3'-5'-exoribonuclease activity,MF,USB1;ISG20L2
5160,GO:0015696,0.634666326915435,0.595458413248399,3,46,ammonium transport,BP,EDN1;SLC22A5;SYK
7890,GO:0032452,0.634740167843832,0.646857669175771,2,25,histone demethylase activity,MF,KDM6A;UTY
16266,GO:0090303,0.634744147928746,0.645110171317764,2,29,positive regulation of wound healing,BP,PDPN;THBD
5285,GO:0015935,0.634896325344676,0.592478532416629,3,68,small ribosomal subunit,CC,DDX3X;MRPS7;RPS12
18809,GO:1904294,0.635098709668458,0.747621704092059,1,13,positive regulation of ERAD pathway,BP,UBQLN2
6080,GO:0019229,0.635154178936405,0.645062356712721,2,28,regulation of vasoconstriction,BP,EDN1;ADM
416,GO:0001103,0.635351327981467,0.644465585152524,2,29,RNA polymerase II repressing transcription factor binding,MF,ZFP42;BBS5
7479,GO:0031638,0.635605254780812,0.643498344602882,2,31,zymogen activation,BP,C1R;PGK1
10032,GO:0042455,0.635657971652072,0.6425552334799,2,34,ribonucleoside biosynthetic process,BP,PDCL3;UMPS
2936,GO:0006458,0.635718574196118,0.594320576558675,3,46,'de novo' protein folding,BP,BAG1;HSPA8;CD74
4687,GO:0010833,0.635813184976967,0.543447998480021,5,74,telomere maintenance via telomere lengthening,BP,DKC1;GNL3L;HSP90AB1;ATR;HNRNPU
18375,GO:1903319,0.635861215950586,0.746883536519005,1,13,positive regulation of protein maturation,BP,C3
15450,GO:0071705,0.636022334247349,0.403033975466548,118,1703,nitrogen compound transport,BP,SAA1;NRG1;TRIM16;FN1;PML;TFRC;GNPTAB;TAP1;SLC7A2;IL1R2;IRS1;VPS13B;TP53;SLC7A5P2;EDN1;GBP1;ACSL3;PTPN14;CHP1;AKAP8;TGFB2;RBM22;SRSF2;SLC9A3R1;NUP50;SLC22A5;PHAX;SYK;NUP153;RAB32;ABCG2;ARFRP1;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;VPS8;SLC5A6;AP5M1;ADAMTS9;KCNS3;PTGER4;LSG1;IMMP2L;NDC1;CADPS2;HNRNPA1L2;SLC35A4;SLC1A3;CASC3;GBP5;AKAP8L;HSPB1;LCP1;THOC1;RAN;RANBP2;RAB26;ITGAV;SOCS1;ARNTL;SNX11;SNX5;GDAP1;TBC1D15;CLU;NUP160;USP6;SDAD1;FRAS1;NUP54;LRPPRC;SETD2;TIMM23B;HSPA8;SYT11;HSP90AB1;ARL6IP5;NSF;M6PR;TRAK2;CENPF;GOSR1;RAB3GAP1;SCFD2;BBS5;GPER1;WDR75;NFKBIE;RABEP2;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;TAP2;AP3B1;CLOCK;AZIN1;PARD3;EHD1;TNF;SRSF7;STARD7;CCL5;CD74;SLC43A2;PANX1;TRAM2;CDKN1A;ITGB1BP1;SLC25A22;ASTN2;TSGA13;RBM8A;RPS12;BUD13
14456,GO:0061756,0.636081901899532,0.746669597641795,1,13,leukocyte adhesion to vascular endothelial cell,BP,TNF
4092,GO:0009145,0.636202608425721,0.51528956050414,7,106,purine nucleoside triphosphate biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
12895,GO:0051204,0.636876976044506,0.641828223242272,2,32,protein insertion into mitochondrial membrane,BP,TP53;DYNLL2
10289,GO:0043024,0.636941025864591,0.744760053489964,1,14,ribosomal small subunit binding,MF,DDX3X
14157,GO:0061003,0.637277243761395,0.746769418254606,1,12,positive regulation of dendritic spine morphogenesis,BP,BAIAP2
7339,GO:0031344,0.637338476997962,0.434188925295083,32,439,regulation of cell projection organization,BP,NEFL;NRG1;MAP2;FN1;TENM3;ENC1;PDPN;CYLD;SFRP1;ULK4;PLK2;RHOG;CORO1C;RRN3;CDC42EP2;BAIAP2;SRF;SDK1;FZD1;ANLN;NEDD4L;ZFYVE27;TRAK2;WDPCP;L1CAM;MYO10;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;WDR36
18845,GO:1904385,0.637351607098655,0.744359455594672,1,14,cellular response to angiotensin,BP,BRIP1
6388,GO:0021575,0.637408467005152,0.643536493834958,2,26,hindbrain morphogenesis,BP,OPHN1;KIF14
15280,GO:0071437,0.637554102912022,0.745238985833899,1,13,invadopodium,CC,PDPN
2526,GO:0005779,0.63803680070524,0.742758247320146,1,15,integral component of peroxisomal membrane,CC,PXMP2
7268,GO:0031231,0.63803680070524,0.742758247320146,1,15,intrinsic component of peroxisomal membrane,CC,PXMP2
9956,GO:0042307,0.638329306886413,0.642102157465999,2,27,positive regulation of protein import into nucleus,BP,RBM22;HSP90AB1
5943,GO:0018242,0.638537483975022,0.744280061873332,1,13,protein O-linked glycosylation via serine,BP,GALNT18
15507,GO:0071850,0.638598366461778,0.743140164768042,1,14,mitotic cell cycle arrest,BP,CDKN1A
9062,GO:0035278,0.638598418600352,0.745486207795489,1,12,miRNA mediated inhibition of translation,BP,RBM4
9815,GO:0040033,0.638598418600352,0.745486207795489,1,12,negative regulation of translation, ncRNA-mediated,BP,RBM4
11511,GO:0045974,0.638598418600352,0.745486207795489,1,12,regulation of translation, ncRNA-mediated,BP,RBM4
4038,GO:0009069,0.638714982362461,0.640179954316626,2,31,serine family amino acid metabolic process,BP,GCLC;SEPHS2
12737,GO:0050954,0.638996954781426,0.540077120409283,5,73,sensory perception of mechanical stimulus,BP,SLC9A3R1;SLC1A3;NAV2;CCDC50;NDUFB9
17523,GO:1900542,0.639003140696599,0.502784531499279,8,115,regulation of purine nucleotide metabolic process,BP,NUP50;NUP153;ADM;NDC1;RANBP2;NUP160;NUP54;GPER1
20088,GO:2000678,0.639197085185366,0.742553111422556,1,14,negative regulation of transcription regulatory region DNA binding,BP,TAF1
10802,GO:0044264,0.639227361683283,0.540025714224184,5,71,cellular polysaccharide metabolic process,BP,IRS1;PPP1R3B;IL6ST;MGAM;ENPP1
15911,GO:0072659,0.639501380663082,0.471774156561601,13,185,protein localization to plasma membrane,BP,GBP1;ACSL3;SLC9A3R1;EMP2;ARFRP1;RHOG;WNT4;RAB26;NSF;ZFYVE27;GPER1;MPP5;TNF
2001,GO:0004721,0.639668964551408,0.487068328849379,10,145,phosphoprotein phosphatase activity,MF,DUSP14;PTPN14;PPP1R3B;PTPRB;PTPRM;CDC25A;EYA3;MTMR2;PHLPP2;PHLPP1
11887,GO:0046879,0.639863059706873,0.475857695596806,12,173,hormone secretion,BP,IRS1;EDN1;C1QTNF1;INHBA;SFRP1;KCNS3;ADM;ARNTL;GPER1;CLOCK;TNF;CCL5
3792,GO:0008356,0.639985091737458,0.742863595080906,1,13,asymmetric cell division,BP,PARD3
3356,GO:0007094,0.640094795402905,0.63940375877273,2,29,mitotic spindle assembly checkpoint,BP,ANAPC15;CENPF
15132,GO:0071173,0.640094795402905,0.63940375877273,2,29,spindle assembly checkpoint,BP,ANAPC15;CENPF
15133,GO:0071174,0.640094795402905,0.63940375877273,2,29,mitotic spindle checkpoint,BP,ANAPC15;CENPF
3099,GO:0006677,0.640603993918096,0.741169706239856,1,14,glycosylceramide metabolic process,BP,UGT8
1876,GO:0004549,0.640744533065074,0.739273638785772,1,16,tRNA-specific ribonuclease activity,MF,POP1
8385,GO:0033276,0.640770430256621,0.741005686854715,1,14,transcription factor TFTC complex,CC,TAF2
9352,GO:0035850,0.640779727037392,0.639481246194547,2,27,epithelial cell differentiation involved in kidney development,BP,FAT4;PDGFB
1465,GO:0003712,0.641009618057133,0.430205018182543,32,457,transcription cofactor activity,MF,NRG1;HDAC9;MKL1;TRIM22;DDX17;TFCP2L1;PTPN14;PDLIM1;SRSF2;RELB;USP16;WNT4;RAN;AJUBA;NFE2L1;NFKBIB;UBP1;APEX1;SS18L2;CCAR1;E2F8;HSF2;PSMC3IP;TAF6L;CITED2;HNRNPU;DAXX;TAF1;TBPL1;SMARCC1;PPARGC1B;CTCF
704,GO:0001921,0.641085498073348,0.741782973550574,1,13,positive regulation of receptor recycling,BP,NSF
4811,GO:0012507,0.641339463488059,0.588210634425539,3,46,ER to Golgi transport vesicle membrane,CC,HLA-B;HLA-F;CD74
12380,GO:0048745,0.64148797440234,0.742662861148846,1,12,smooth muscle tissue development,BP,SRF
10745,GO:0044092,0.641636815830116,0.414685145063328,52,755,negative regulation of molecular function,BP,CRYAB;CYP1B1;AMOT;C3;GPRC5A;NLRC5;MMP9;TRAF3;TP53;DUSP14;CDKN2A;NQO1;CHP1;TGFB2;CYLD;PKMYT1;SLC9A3R1;NAIP;LEPR;CDK4;SFRP1;KEAP1;CD109;HSPB1;VCPKMT;CORO1C;DDX3X;SOCS1;SET;AJUBA;TRIM37;PPP4R4;GNL3L;GADD45B;SH3RF2;PDGFB;BIRC3;GLIS2;THADA;NEDD4L;SERPINB9;FAF1;NFKBIE;HNRNPR;ESR1;TNF;HNRNPU;FGFR1OP;TAF1;CDKN1A;ITGB1BP1;IRAK3
6449,GO:0021762,0.64188806398854,0.636773366545412,2,31,substantia nigra development,BP,G6PD;RAD1
4356,GO:0009948,0.642667820350209,0.637030726302668,2,28,anterior/posterior axis specification,BP,KDM6A;SRF
3235,GO:0006891,0.642753916665312,0.636180738108395,2,30,intra-Golgi vesicle-mediated transport,BP,NSF;GOSR1
3540,GO:0007549,0.643028715346651,0.741147930896511,1,12,dosage compensation,BP,HNRNPU
18833,GO:1904356,0.6433803984978,0.556221581406824,4,58,regulation of telomere maintenance via telomere lengthening,BP,DKC1;GNL3L;ATR;HNRNPU
7643,GO:0032048,0.643395805883063,0.738408219294708,1,14,cardiolipin metabolic process,BP,HADHB
2824,GO:0006289,0.64389258502088,0.506565387055781,7,113,nucleotide-excision repair,BP,TP53;RPA1;RFC3;BRCA2;POLR2F;GTF2H3;COPS3
7877,GO:0032433,0.643968106030237,0.74022101938302,1,12,filopodium tip,CC,MYO10
8747,GO:0034389,0.644030964058201,0.737776916203792,1,14,lipid particle organization,BP,RAB3GAP1
13793,GO:0060351,0.64419079149873,0.738715303279783,1,13,cartilage development involved in endochondral bone morphogenesis,BP,COL27A1
5781,GO:0017000,0.644647603041511,0.737162936005235,1,14,antibiotic biosynthetic process,BP,CYP1A1
1980,GO:0004693,0.644698644584293,0.634080094602362,2,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDK4;CDKN1A
4423,GO:0010225,0.644700305642759,0.73820938222083,1,13,response to UV-C,BP,BRCA2
9152,GO:0035493,0.645265992626736,0.7365461383211,1,14,SNARE complex assembly,BP,VPS41
16773,GO:0098533,0.645999840939727,0.736915701545464,1,13,ATPase dependent transmembrane transport complex,CC,ABCF2
776,GO:0002028,0.646256019777967,0.553200076230928,4,57,regulation of sodium ion transport,BP,CHP1;SLC9A3R1;NETO1;NEDD4L
16582,GO:0097345,0.646350008138157,0.582188887144459,3,49,mitochondrial outer membrane permeabilization,BP,TP53;DYNLL2;BLOC1S2
9286,GO:0035710,0.646444600471252,0.582807421345627,3,45,CD4-positive, alpha-beta T cell activation,BP,RELB;PTGER4;RC3H1
6944,GO:0030547,0.646467134585087,0.734391329453622,1,15,receptor inhibitor activity,MF,CCL5
4145,GO:0009205,0.646488257433413,0.459607380080751,14,233,purine ribonucleoside triphosphate metabolic process,BP,NUP50;NUP153;NDC1;RAN;RANBP2;GPHN;PGK1;NUP160;ENPP1;NUP54;HSPA8;SDHD;UQCRB;NDUFB9
10370,GO:0043174,0.646614689676732,0.733410900400623,1,16,nucleoside salvage,BP,TK1
14150,GO:0060996,0.646627307498913,0.532020572177437,5,70,dendritic spine development,BP,NRG1;DOCK10;PLK2;BAIAP2;SDK1
11353,GO:0045662,0.646637684017475,0.735174127616411,1,14,negative regulation of myoblast differentiation,BP,TNF
13535,GO:0055086,0.646675929820431,0.420981236534744,35,544,nucleobase-containing small molecule metabolic process,BP,TXNRD1;G6PD;PANK2;TPST1;PGD;NUP50;TJP2;NUP153;UAP1L1;TK1;ADM;NDC1;RAN;RANBP2;GPHN;CROT;PGK1;NUP160;ENPP1;RRM2;NUP54;NNT;PDCL3;UMPS;HSPA8;SMUG1;DPYD;GPER1;RRM1;SDHD;UQCRB;TYMS;FLAD1;TBPL1;NDUFB9
15538,GO:0071900,0.646774996077974,0.430214404788022,27,391,regulation of protein serine/threonine kinase activity,BP,SAA1;NRG1;MAP3K14;EPGN;EDN1;DUSP14;CDKN2A;PKMYT1;SYK;CDK4;SFRP1;HSPB1;DDX3X;CDC25A;AJUBA;GADD45B;PDGFB;HSP90AB1;ADAM17;TRAF2;TELO2;TLR3;TNF;CD74;DAXX;CDKN1A;IRAK3
1706,GO:0004190,0.646825804477524,0.734985548559405,1,14,aspartic-type endopeptidase activity,MF,BACE2
14532,GO:0070001,0.646825804477524,0.734985548559405,1,14,aspartic-type peptidase activity,MF,BACE2
1261,GO:0003012,0.646948516492805,0.452935506257609,16,223,muscle system process,BP,CRYAB;CTGF;G6PD;DAPK3;EDN1;IL6ST;MIR17HG;TPM1;SRF;NPNT;TPM4;MYH11;NEDD4L;GPER1;CFLAR;GJC1
10000,GO:0042398,0.647058839030241,0.63055591520454,2,33,cellular modified amino acid biosynthetic process,BP,GCLC;DHFR
11119,GO:0045121,0.647346840652151,0.459276520307977,14,200,membrane raft,CC,IRS1;DAPK3;PDPN;SLC9A3R1;EMP2;ATP2B1;CORO1C;PGK1;CDH13;BIRC3;ADAM17;CFLAR;TRAF2;TNF
2223,GO:0005123,0.647488922379525,0.734320014370343,1,14,death receptor binding,MF,CFLAR
97,GO:0000187,0.647991290288522,0.502542756911902,7,104,activation of MAPK activity,BP,SAA1;NRG1;EPGN;SYK;TNF;CD74;DAXX
15188,GO:0071300,0.647997423573265,0.581299138517716,3,44,cellular response to retinoic acid,BP,KRT13;FGFR2;TNC
4454,GO:0010390,0.64823338599249,0.630609859599337,2,29,histone monoubiquitination,BP,TRIM37;RING1
13271,GO:0051930,0.648400928442646,0.733402646191996,1,14,regulation of sensory perception of pain,BP,EDN1
13272,GO:0051931,0.648400928442646,0.733402646191996,1,14,regulation of sensory perception,BP,EDN1
19245,GO:1905331,0.648522110893708,0.734391164164474,1,13,negative regulation of morphogenesis of an epithelium,BP,TNF
17036,GO:0099132,0.648539968166035,0.629907465942872,2,30,ATP hydrolysis coupled cation transmembrane transport,BP,ATP2B1;ATP2C1
9395,GO:0035924,0.648544569357962,0.63027085571724,2,29,cellular response to vascular endothelial growth factor stimulus,BP,HSPB1;ITGB1BP1
5869,GO:0017171,0.64870798778567,0.513426014525683,6,95,serine hydrolase activity,MF,C1R;C3;MMP9;OVCH2;PRSS23;IMMP2L
11758,GO:0046579,0.648751885715633,0.630440884081394,2,28,positive regulation of Ras protein signal transduction,BP,NRG1;CSF1
16217,GO:0090231,0.64883875698454,0.732961402904749,1,14,regulation of spindle checkpoint,BP,ANAPC15
17042,GO:0099172,0.649047445868244,0.733863083019338,1,13,presynapse organization,BP,FZD1
18728,GO:1904062,0.649196435581694,0.470900916524711,11,158,regulation of cation transmembrane transport,BP,JPH2;MMP9;G6PD;CHP1;SLC9A3R1;SHISA9;NETO1;JPH1;THADA;NEDD4L;GPER1
19455,GO:1990023,0.650063435460601,0.732839548981378,1,13,mitotic spindle midzone,CC,HNRNPU
7623,GO:0032008,0.650533355515369,0.627729867670593,2,30,positive regulation of TOR signaling,BP,RRAGB;TELO2
4048,GO:0009084,0.650647841638738,0.731132408831847,1,14,glutamine family amino acid biosynthetic process,BP,SLC1A3
14485,GO:0061844,0.650708293281055,0.725454350522513,1,23,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,HMGN2
6434,GO:0021697,0.650876541130946,0.733327822308173,1,12,cerebellar cortex formation,BP,OPHN1
6295,GO:0019902,0.650983449955374,0.474881915773648,10,142,phosphatase binding,MF,TRAF3;TP53;SLC9A3R1;SYK;SH3RF2;PHACTR4;ANAPC7;TRAF2;AP3B1;PARD3
12075,GO:0048008,0.651225034994824,0.57840257558822,3,41,platelet-derived growth factor receptor signaling pathway,BP,SLC9A3R1;PDGFB;PHF14
2608,GO:0005911,0.651349293597219,0.433689515505251,22,301,cell-cell junction,CC,AMOT;B4GALT1;SIPA1L3;CNTNAP1;PDLIM1;TJP2;CDK4;PARD3B;PTPRM;AJUBA;CGNL1;BAIAP2;CDH13;TJP1;CNTNAP2;PLEKHA7;ADAM17;AKR1B1;MPP5;PARD3;GJC1;PANX1
2675,GO:0006026,0.651399424048421,0.577537127886372,3,44,aminoglycan catabolic process,BP,HSPG2;CHP1;CHID1
3070,GO:0006637,0.651703559033149,0.525651624499704,5,78,acyl-CoA metabolic process,BP,SCD;HMGCS1;ACSL3;HACD2;SCD5
9114,GO:0035383,0.651703559033149,0.525651624499704,5,78,thioester metabolic process,BP,SCD;HMGCS1;ACSL3;HACD2;SCD5
775,GO:0002027,0.651889089078723,0.576993978990859,3,44,regulation of heart rate,BP,EDN1;TPM1;ADM
19198,GO:1905208,0.651960421898848,0.730920567160333,1,13,negative regulation of cardiocyte differentiation,BP,G6PD
5536,GO:0016514,0.652123236136056,0.730755383594947,1,13,SWI/SNF complex,CC,SMARCC1
15580,GO:0072009,0.652164551267098,0.526012709842721,5,69,nephron epithelium development,BP,FAT4;PBX1;IRX2;WNT4;NPNT
17303,GO:0140030,0.652438727537931,0.488164238647805,8,114,modification-dependent protein binding,MF,CBX5;IKBKE;BRCC3;RAD18;MSH6;RBBP5;MPHOSPH8;TAF1
4375,GO:0009994,0.652475961163824,0.625970278014265,2,29,oocyte differentiation,BP,WNT4;BRCA2
5151,GO:0015682,0.652781603366023,0.624594218914108,2,32,ferric iron transport,BP,TFRC;STEAP4
15832,GO:0072512,0.652781603366023,0.624594218914108,2,32,trivalent inorganic cation transport,BP,TFRC;STEAP4
5670,GO:0016776,0.652824399971643,0.624547125931732,2,32,phosphotransferase activity, phosphate group as acceptor,MF,TJP2;PPIP5K1
18421,GO:1903421,0.652987260658238,0.729877507795386,1,13,regulation of synaptic vesicle recycling,BP,SYT11
9201,GO:0035577,0.65324213010981,0.574907184832775,3,47,azurophil granule membrane,CC,B4GALT1;SLCO4C1;GLIPR1
4915,GO:0014850,0.653388552251282,0.728343652876162,1,14,response to muscle activity,BP,SRD5A1
20323,GO:2001269,0.653434858726568,0.727324433850396,1,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TRAF2
12265,GO:0048524,0.653701525895522,0.507911348542244,6,95,positive regulation of viral process,BP,NUCKS1;DDX3X;HSPA8;POLR2F;CCL5;CD74
3445,GO:0007257,0.654094587301953,0.624589351809119,2,28,activation of JUN kinase activity,BP,SYK;DAXX
131,GO:0000271,0.654159565506866,0.544303114300846,4,58,polysaccharide biosynthetic process,BP,IRS1;PPP1R3B;PDGFB;ENPP1
284,GO:0000786,0.6543298749705,0.570003014025971,3,84,nucleosome,CC,H3F3A;MPHOSPH8;HIST1H4A
16923,GO:0098857,0.654895679525724,0.451082258253958,14,201,membrane microdomain,CC,IRS1;DAPK3;PDPN;SLC9A3R1;EMP2;ATP2B1;CORO1C;PGK1;CDH13;BIRC3;ADAM17;CFLAR;TRAF2;TNF
10287,GO:0043022,0.654918044939321,0.573040024645677,3,47,ribosome binding,MF,GEMIN5;NAA15;NAA16
12794,GO:0051050,0.65493952983276,0.406063289059283,43,612,positive regulation of transport,BP,SAA1;NRG1;TRIM16;JPH2;C3;G6PD;IRS1;TP53;EDN1;C1QTNF1;ACSL3;LGALS3;CHP1;TGFB2;RBM22;INHBA;SYK;CD274;PTGER4;CADPS2;DYNLL2;SIRPA;ITGAV;PDGFB;CLU;PIK3R3;HSP90AB1;NEDD4L;SGK1;MTMR2;RAB3GAP1;GPER1;WDR75;CBLL1;UBE2J2;AZIN1;EHD1;TNF;STARD7;CCL5;PANX1;ITGB1BP1;TSGA13
9780,GO:0039535,0.654963722196011,0.727861251159237,1,13,regulation of RIG-I signaling pathway,BP,BIRC3
3564,GO:0007608,0.655208406531868,0.726479915273389,1,14,sensory perception of smell,BP,NAV2
5475,GO:0016405,0.655282035545612,0.726404308578248,1,14,CoA-ligase activity,MF,ACSL3
6735,GO:0030148,0.655398181432165,0.521634613890359,5,77,sphingolipid biosynthetic process,BP,CYR61;ST6GALNAC5;HACD2;UGT8;TNF
13196,GO:0051782,0.655624408531943,0.726052532361344,1,14,negative regulation of cell division,BP,E2F8
3395,GO:0007175,0.655689476040277,0.725985639220545,1,14,negative regulation of epidermal growth factor-activated receptor activity,BP,GPRC5A
17901,GO:1902115,0.655875063445256,0.469494377830846,10,143,regulation of organelle assembly,BP,EDN1;STAG1;CYLD;PLK2;UBQLN2;LCP1;TRIM37;RAB3GAP1;TNF;HNRNPU
10433,GO:0043267,0.65600886772053,0.726790481571222,1,13,negative regulation of potassium ion transport,BP,NEDD4L
11778,GO:0046620,0.656086357366805,0.542296094601525,4,57,regulation of organ growth,BP,FGFR2;G6PD;EDN1;MIR17HG
10612,GO:0043576,0.65621483704534,0.726579087423135,1,13,regulation of respiratory gaseous exchange,BP,FTO
16444,GO:0097062,0.656402082622828,0.726386802854722,1,13,dendritic spine maintenance,BP,MTMR2
2939,GO:0006465,0.656886493034323,0.722916293485647,1,16,signal peptide processing,BP,IMMP2L
5531,GO:0016504,0.656971714895055,0.619964848306452,2,32,peptidase activator activity,MF,FN1;PSME2
16306,GO:0090382,0.656983287325202,0.61964687880411,2,33,phagosome maturation,BP,RAB32;SYT11
12289,GO:0048569,0.657073179526499,0.724560191116945,1,14,post-embryonic animal organ development,BP,FBN1
15051,GO:0070977,0.657162427950659,0.72851918871562,1,11,bone maturation,BP,FAT4
4733,GO:0010894,0.657218923781355,0.723427900046265,1,15,negative regulation of steroid biosynthetic process,BP,WNT4
6634,GO:0022898,0.657300029827785,0.474725678745821,9,129,regulation of transmembrane transporter activity,BP,JPH2;MMP9;CHP1;SLC9A3R1;SHISA9;NETO1;JPH1;THADA;NEDD4L
5785,GO:0017004,0.657445500401783,0.618846938900659,2,34,cytochrome complex assembly,BP,FASTKD3;UQCRB
8982,GO:0035065,0.657524356413034,0.570313025837957,3,46,regulation of histone acetylation,BP,SET;CHEK1;CTCF
11705,GO:0046475,0.657562113053673,0.723072446787664,1,15,glycerophospholipid catabolic process,BP,GPCPD1
3923,GO:0008593,0.657668298899423,0.519378717732934,5,74,regulation of Notch signaling pathway,BP,TGFB2;IL6ST;LFNG;HIF1AN;ITGB1BP1
1123,GO:0002709,0.657988881465013,0.618529762553267,2,33,regulation of T cell mediated immunity,BP,IL7R;TRAF2
3264,GO:0006936,0.658351502994387,0.455901748384426,12,169,muscle contraction,BP,CRYAB;CTGF;DAPK3;EDN1;TPM1;SRF;NPNT;TPM4;MYH11;NEDD4L;GPER1;GJC1
8669,GO:0034220,0.658445826947717,0.403770759938743,41,583,ion transmembrane transport,BP,JPH2;MMP9;SLC7A2;G6PD;TSC22D3;SLC7A5P2;CHP1;SLC4A11;SLC30A6;SLC9A3R1;SLC22A5;SHISA9;LRRC8D;ATP2B1;SLC5A6;ABCC4;KCNS3;SLC1A3;ATP2C1;ITGAV;TRPM7;KCNQ5;NETO1;ABCC9;JPH1;NNT;THADA;SLC11A2;ARL6IP5;NEDD4L;SGK1;STEAP4;GPER1;SLC9A9;CLCC1;GJC1;KCNE4;SLC43A2;PANX1;SLC25A22;SLC41A2
13300,GO:0051968,0.658745977936982,0.723971158721364,1,13,positive regulation of synaptic transmission, glutamatergic,BP,RAB3GAP1
18592,GO:1903792,0.65882034044217,0.723894256334791,1,13,negative regulation of anion transport,BP,ARL6IP5
12245,GO:0048487,0.658847161033494,0.617880551280846,2,32,beta-tubulin binding,MF,LRPPRC;SYT11
11442,GO:0045841,0.659068119956078,0.618310368620492,2,30,negative regulation of mitotic metaphase/anaphase transition,BP,ANAPC15;CENPF
17891,GO:1902100,0.659068119956078,0.618310368620492,2,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,ANAPC15;CENPF
13513,GO:0055038,0.659118877704606,0.538119607111783,4,63,recycling endosome membrane,CC,HLA-B;HLA-F;ZFYVE27;EHD1
16879,GO:0098787,0.659296088166975,0.722258492136228,1,14,mRNA cleavage involved in mRNA processing,BP,NCBP1
7265,GO:0031227,0.659588060969643,0.479735009107414,8,126,intrinsic component of endoplasmic reticulum membrane,CC,HLA-B;TAP1;HLA-F;RCE1;HACD2;ZFYVE27;TAP2;CD74
13768,GO:0060322,0.659771738960427,0.407407965307253,35,481,head development,BP,MAFB;NEFL;NRG1;FGFR2;HSPG2;FAT4;G6PD;HMGCS1;ACSL3;RAD1;INHBA;SFRP1;H3F3A;ATP2B1;COL4A1;OPHN1;IMMP2L;WNT4;RAN;BAIAP2;SRF;FZD1;DDX10;SRD5A1;SETD2;CNTNAP2;BRCA2;FANCD2;CENPF;RAB3GAP1;RRM1;EIF2B5;KIF14;PHLPP2;TAF1
6359,GO:0021537,0.659780456006819,0.45936975324279,11,157,telencephalon development,BP,NEFL;NRG1;FAT4;INHBA;RAN;SRF;SRD5A1;CNTNAP2;EIF2B5;KIF14;PHLPP2
3405,GO:0007188,0.660332764229822,0.516496988438215,5,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,EDN1;SLC9A3R1;PTGER4;ADM;GPER1
678,GO:0001885,0.66063258982956,0.567224230573758,3,44,endothelial cell development,BP,TJP2;TJP1;TNF
8285,GO:0033081,0.660739190870412,0.719765414920166,1,15,regulation of T cell differentiation in thymus,BP,IL7R
13968,GO:0060627,0.660824495448441,0.419800119991622,24,345,regulation of vesicle-mediated transport,BP,C3;ACSL3;LGALS3;SYK;VPS41;OPHN1;CADPS2;UBQLN2;SIRPA;RAB26;ITGAV;CDH13;TBC1D15;CLU;USP6;SYT11;NSF;NEDD4L;MTMR2;GOSR1;RAB3GAP1;CBLL1;EHD1;TNF
2858,GO:0006349,0.660878488572793,0.72175934788941,1,13,regulation of gene expression by genetic imprinting,BP,CTCF
8837,GO:0034613,0.661260011884114,0.379547874315797,101,1462,cellular protein localization,BP,NRG1;PML;AMOT;GNPTAB;MID1;TP53;GBP1;ACSL3;PTPN14;CHP1;CNTNAP1;RBM22;CYLD;SRSF2;SLC9A3R1;DKC1;NUP50;EMP2;NUP153;RAB32;ARFRP1;VPS41;AP3M2;ZDHHC6;RPA1;POLR1A;REEP1;IMMP2L;NDC1;DYNLL2;CASC3;RRAGB;AKAP8L;HSPB1;RHOG;WNT4;LCP1;THOC1;RAN;RANBP2;DDX3X;RAB26;GPHN;KLHL21;ARNTL;SNX11;AJUBA;SNX5;CDCA5;GNL3L;GDAP1;UGT8;TBC1D15;RTKN2;CLU;NUP160;USP6;SDAD1;NUP54;SETD2;GLIS2;ANLN;TIMM23B;RPF2;RIC3;CNTNAP2;HSPA8;SYT11;HSP90AB1;NSF;NEDD4L;ZFYVE27;BRCA2;TRAK2;RAB3GAP1;GPER1;WDR75;ATR;NCBP1;UPF3B;UBE2J2;VPS36;AP3B1;MPP5;ESR1;PARD3;EHD1;TNF;SRSF7;STARD7;CD74;HNRNPU;TRAM2;CDKN1A;ITGB1BP1;CTCF;ASTN2;TSGA13;RBM8A;RPS12;BUD13
1466,GO:0003713,0.661336340464804,0.431593847919377,18,261,transcription coactivator activity,MF,MKL1;DDX17;PDLIM1;USP16;RAN;NFKBIB;APEX1;SS18L2;CCAR1;HSF2;PSMC3IP;TAF6L;CITED2;DAXX;TAF1;TBPL1;SMARCC1;PPARGC1B
6900,GO:0030427,0.661337841142865,0.470400133950775,9,126,site of polarized growth,CC,NEFL;GPRIN1;ZFYVE27;TRAK2;L1CAM;SHTN1;DPYSL3;HNRNPR;PARD3
6730,GO:0030139,0.661419491730383,0.443821082524166,14,209,endocytic vesicle,CC,SAA1;AMOT;HLA-B;TAP1;ACTG1;SYK;RAB32;HLA-F;WNT4;ITGAV;CDC42EP2;SYT11;TAP2;CD74
16411,GO:0097009,0.661656803065568,0.719798174193618,1,14,energy homeostasis,BP,LEPR
8984,GO:0035067,0.661784412596865,0.719664710837119,1,14,negative regulation of histone acetylation,BP,SET
5465,GO:0016342,0.661929397667963,0.720664416455643,1,13,catenin complex,CC,CDH13
19845,GO:2000269,0.662349200342215,0.719073434245755,1,14,regulation of fibroblast apoptotic process,BP,SFRP1
18371,GO:1903312,0.663097976689783,0.533886849041139,4,61,negative regulation of mRNA metabolic process,BP,TARDBP;SYNCRIP;SRSF7;HNRNPU
555,GO:0001676,0.663275180685107,0.533443186150937,4,63,long-chain fatty acid metabolic process,BP,PTGES;CYP1B1;CYP1A1;ACSL3
3797,GO:0008373,0.663379706617549,0.717992152420289,1,14,sialyltransferase activity,MF,ST6GALNAC5
16661,GO:0097503,0.663379706617549,0.717992152420289,1,14,sialylation,BP,ST6GALNAC5
9016,GO:0035173,0.663454212392379,0.717913852938864,1,14,histone kinase activity,MF,CHEK1
2935,GO:0006457,0.664124309436554,0.444526079728379,13,210,protein folding,BP,CRYAB;SACS;BAG1;HSPB1;RANBP2;TTC1;CLU;RIC3;PDCL3;HSPA8;HSP90AB1;FKBP5;CD74
17415,GO:1900120,0.664184993119515,0.715272713698238,1,16,regulation of receptor binding,BP,MMP9
6051,GO:0019184,0.664518527236254,0.71491963305427,1,16,nonribosomal peptide biosynthetic process,BP,GCLC
12833,GO:0051119,0.664663637218561,0.71664052774512,1,14,sugar transmembrane transporter activity,MF,M6PR
11117,GO:0045117,0.664902802714385,0.714512424682074,1,16,azole transport,BP,EDN1
7821,GO:0032369,0.664935276738995,0.716353934361617,1,14,negative regulation of lipid transport,BP,ITGAV
17096,GO:0099572,0.665270669605875,0.453524404253281,11,151,postsynaptic specialization,CC,CRYAB;MAP2;SHISA9;GPHN;NETO1;BAIAP2;SYT11;NSF;DGCR8;MTMR2;GPER1
15622,GO:0072089,0.66529547048373,0.511023189693876,5,72,stem cell proliferation,BP,FGFR2;RUNX1;DGCR8;ETV6;HNRNPU
12107,GO:0048066,0.665360218339598,0.611264919269546,2,30,developmental pigmentation,BP,RAB32;ADAMTS9
17553,GO:1901020,0.665435069876279,0.713947661862889,1,16,negative regulation of calcium ion transmembrane transporter activity,BP,THADA
8590,GO:0034063,0.66562799261156,0.716784743398264,1,13,stress granule assembly,BP,DDX3X
10199,GO:0042789,0.665721639111919,0.715523035131243,1,14,mRNA transcription by RNA polymerase II,BP,SRF
6136,GO:0019395,0.666090402774024,0.50948260017283,5,79,fatty acid oxidation,BP,IRS1;CROT;HADHB;HIBCH;PPARGC1B
11395,GO:0045746,0.666146943058298,0.609694967869044,2,32,negative regulation of Notch signaling pathway,BP,LFNG;HIF1AN
4069,GO:0009119,0.66630166581753,0.50892691980338,5,83,ribonucleoside metabolic process,BP,TJP2;RAN;GPHN;PDCL3;UMPS
2454,GO:0005665,0.666412983832303,0.712135996722065,1,17,DNA-directed RNA polymerase II, core complex,CC,POLR2F
18597,GO:1903798,0.666630863069467,0.714559999717387,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,ESR1
13489,GO:0055003,0.666748310964796,0.726009154065354,1,8,cardiac myofibril assembly,BP,SRF
5137,GO:0015631,0.666798757504984,0.421110406626912,20,276,tubulin binding,MF,CRYAB;MAP2;KIF23;MTUS1;MYO1B;NEFM;MID1;CHP1;VPS41;DST;REEP1;LRPPRC;SETD2;BLOC1S2;SYT11;MYH11;BRCA2;SKA2;MYO10;KIF14
15540,GO:0071902,0.667300310673129,0.42508053628741,18,264,positive regulation of protein serine/threonine kinase activity,BP,SAA1;NRG1;MAP3K14;EPGN;EDN1;SYK;DDX3X;AJUBA;GADD45B;PDGFB;HSP90AB1;ADAM17;TRAF2;TELO2;TLR3;TNF;CD74;DAXX
16330,GO:0090482,0.667531317908098,0.713603797446909,1,14,vitamin transmembrane transporter activity,MF,SLC5A6
13084,GO:0051568,0.667759432174982,0.558953262898762,3,45,histone H3-K4 methylation,BP,KDM6A;TET3;RBBP5
2836,GO:0006305,0.66792263028788,0.558974119011187,3,44,DNA alkylation,BP,TET3;MPHOSPH8;CTCF
2837,GO:0006306,0.66792263028788,0.558974119011187,3,44,DNA methylation,BP,TET3;MPHOSPH8;CTCF
7036,GO:0030804,0.668033524136146,0.712059293667248,1,15,positive regulation of cyclic nucleotide biosynthetic process,BP,GPER1
19402,GO:1905819,0.66805243109509,0.607869891527289,2,31,negative regulation of chromosome separation,BP,ANAPC15;CENPF
20161,GO:2000816,0.66805243109509,0.607869891527289,2,31,negative regulation of mitotic sister chromatid separation,BP,ANAPC15;CENPF
13656,GO:0060135,0.668281747069797,0.558565223181472,3,44,maternal process involved in female pregnancy,BP,WNT4;AKR1B1;ESR1
874,GO:0002221,0.668418603969658,0.47008842613004,8,122,pattern recognition receptor signaling pathway,BP,TRAF3;CYLD;IKBKE;BIRC3;TLR3;ESR1;IRF1;IRAK3
4232,GO:0009409,0.668639027409334,0.607204838472649,2,31,response to cold,BP,ATP2B1;ADM
5329,GO:0016052,0.668662187880722,0.461951686357497,9,134,carbohydrate catabolic process,BP,PPP1R3B;NUP50;NUP153;MGAM;NDC1;RANBP2;PGK1;NUP160;NUP54
12320,GO:0048643,0.668674001508002,0.712386841516797,1,14,positive regulation of skeletal muscle tissue development,BP,ARNTL
6079,GO:0019228,0.66885460008675,0.713366623589203,1,13,neuronal action potential,BP,GPER1
4543,GO:0010614,0.669094785505657,0.711937710415834,1,14,negative regulation of cardiac muscle hypertrophy,BP,G6PD
4881,GO:0014741,0.669094785505657,0.711937710415834,1,14,negative regulation of muscle hypertrophy,BP,G6PD
4512,GO:0010560,0.669342270706425,0.711673301684574,1,14,positive regulation of glycoprotein biosynthetic process,BP,CHP1
4692,GO:0010839,0.669359515102855,0.712828888856852,1,13,negative regulation of keratinocyte proliferation,BP,CD109
2974,GO:0006516,0.669370578486668,0.710629405587636,1,15,glycoprotein catabolic process,BP,ADAMTS9
1800,GO:0004435,0.669624779685791,0.711371246611961,1,14,phosphatidylinositol phospholipase C activity,MF,CCL5
9568,GO:0036336,0.669870860746887,0.710092992318082,1,15,dendritic cell migration,BP,CCL5
5568,GO:0016577,0.66992957362065,0.607323275085352,2,27,histone demethylation,BP,KDM6A;UTY
13600,GO:0060047,0.669995467417164,0.460751827843868,9,127,heart contraction,BP,CTGF;EDN1;TGFB2;ATP2B1;TPM1;ADM;ABCC9;NEDD4L;GJC1
2387,GO:0005521,0.670023867058977,0.710944133530535,1,14,lamin binding,MF,AKAP8L
5409,GO:0016246,0.67016748758053,0.709774582983371,1,15,RNA interference,BP,TSN
17922,GO:1902187,0.670321663630653,0.710625108276805,1,14,negative regulation of viral release from host cell,BP,PML
17536,GO:1900745,0.670339162824168,0.709590178458891,1,15,positive regulation of p38MAPK cascade,BP,GADD45B
7714,GO:0032196,0.670530146182235,0.709384928582998,1,15,transposition,BP,MYBL1
948,GO:0002360,0.67074635267373,0.710169677035937,1,14,T cell lineage commitment,BP,CYLD
4424,GO:0010226,0.6711001102449,0.709789891411196,1,14,response to lithium ion,BP,EIF2B5
1995,GO:0004713,0.671161926237572,0.467500859792171,8,112,protein tyrosine kinase activity,MF,NRG1;FGFR2;STAT5A;SYK;FRK;WEE1;EPHB6;FGFR1OP
1708,GO:0004198,0.671165070906075,0.707813695807084,1,16,calcium-dependent cysteine-type endopeptidase activity,MF,CAPN12
8611,GO:0034113,0.671274666287679,0.604562721943075,2,30,heterotypic cell-cell adhesion,BP,ITGAV;TNF
5816,GO:0017075,0.671381684338831,0.709487326813172,1,14,syntaxin-1 binding,MF,NSF
6855,GO:0030318,0.671478645671363,0.710563545997238,1,13,melanocyte differentiation,BP,ADAMTS9
6789,GO:0030220,0.671560237837159,0.709295337005464,1,14,platelet formation,BP,SRF
16106,GO:0090066,0.672015708249549,0.409456718609012,23,329,regulation of anatomical structure size,BP,NEFL;NRG1;FN1;GCLC;EDN1;SLC9A3R1;IL7R;CDK4;ADM;KANK4;RHOG;SOD2;CDC42EP2;BAIAP2;SRF;HSP90AB1;ZFYVE27;L1CAM;GPER1;NTN1;SHTN1;WDR36;ITGB1BP1
8221,GO:0032968,0.672754030707547,0.706986708971473,1,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,SUPT16H
14763,GO:0070423,0.672916947010863,0.602331545515631,2,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,CYLD;BIRC3
11144,GO:0045171,0.673086879539765,0.552295077332579,3,48,intercellular bridge,CC,KIF23;THOC1;USB1
8532,GO:0033762,0.673146326810826,0.602425507154877,2,30,response to glucagon,BP,QDPR;CCNA2
3246,GO:0006906,0.673346756065541,0.464617566852979,8,121,vesicle fusion,BP,TAP1;VPS41;VPS8;TBC1D15;USP6;SYT11;GOSR1;TAP2
774,GO:0002026,0.673599885355514,0.707095264151786,1,14,regulation of the force of heart contraction,BP,ADM
12331,GO:0048666,0.67370356926321,0.381047177583903,52,709,neuron development,BP,NEFL;NRG1;MAP2;FN1;TENM3;FGFR2;RUNX1;FAT4;NEFM;ENC1;DOCK10;TGFB2;CNTNAP1;LRFN4;SLC9A3R1;SFRP1;DHFR;ULK4;OPHN1;ADM;SLC1A3;PLK2;RHOG;GPRIN1;PTPRM;RRN3;BAIAP2;SRF;UGT8;SDK1;FZD1;WEE1;SLC11A2;BLOC1S2;TNC;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;WDPCP;MTMR2;L1CAM;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;PARD3;EHD1;WDR36;NRAS
17900,GO:1902110,0.674075482056836,0.550659374750037,3,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TP53;DYNLL2;BLOC1S2
6417,GO:0021675,0.67408402666863,0.552143924114584,3,43,nerve development,BP,MAFB;SLC1A3;NAV2
17795,GO:1901798,0.674148462613207,0.704580362189277,1,16,positive regulation of signal transduction by p53 class mediator,BP,ATR
15015,GO:0070920,0.67423572128664,0.705380436063463,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,ESR1
14951,GO:0070816,0.674339895198886,0.705267248395923,1,15,phosphorylation of RNA polymerase II C-terminal domain,BP,GTF2H3
256,GO:0000722,0.674426184600983,0.706200328952755,1,14,telomere maintenance via recombination,BP,BRCA2
7154,GO:0031000,0.674430126750782,0.707385494295647,1,13,response to caffeine,BP,TP53
9544,GO:0036270,0.674430126750782,0.707385494295647,1,13,response to diuretic,BP,TP53
10346,GO:0043130,0.674601338950833,0.520333154808035,4,65,ubiquitin binding,MF,USP16;HSPB1;FAF1;VPS36
9723,GO:0038128,0.674751863790297,0.600228675807323,2,31,ERBB2 signaling pathway,BP,NRG1;NRAS
10725,GO:0044030,0.674789290891602,0.705806394461118,1,14,regulation of DNA methylation,BP,MPHOSPH8
7840,GO:0032388,0.675014458751509,0.432862348106926,13,194,positive regulation of intracellular transport,BP,NRG1;TP53;CHP1;RBM22;SYK;HSP90AB1;MTMR2;WDR75;UBE2J2;EHD1;STARD7;ITGB1BP1;TSGA13
9014,GO:0035162,0.675345315342887,0.705202371961141,1,14,embryonic hemopoiesis,BP,PBX1
17552,GO:1901019,0.675443994857559,0.550152833158139,3,45,regulation of calcium ion transmembrane transporter activity,BP,JPH2;JPH1;THADA
8774,GO:0034440,0.675706229964438,0.498488843671944,5,80,lipid oxidation,BP,IRS1;CROT;HADHB;HIBCH;PPARGC1B
10333,GO:0043113,0.676043239817515,0.599102011045367,2,30,receptor clustering,BP,GPHN;ITGB1BP1
7979,GO:0032587,0.676473416513658,0.498242513329455,5,73,ruffle membrane,CC,PDPN;TPM1;LCP1;ITGAV;ADAM17
15877,GO:0072577,0.676571458761691,0.598877835688213,2,29,endothelial cell apoptotic process,BP,GPER1;TNF
13858,GO:0060438,0.676897113944314,0.702478223892776,1,15,trachea development,BP,SRF
3789,GO:0008353,0.677033721188274,0.701427255365125,1,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,GTF2H3
3595,GO:0008023,0.677038371942102,0.54811444891125,3,46,transcription elongation factor complex,CC,SUPT16H;NUFIP1;TTF2
350,GO:0000963,0.677160667246997,0.701287930568449,1,16,mitochondrial RNA processing,BP,TRMT5
6238,GO:0019787,0.677356705371189,0.396151984459004,28,400,ubiquitin-like protein transferase activity,MF,TRIM56;TRAF3;KBTBD8;ZBED1;NAIP;KEAP1;HERC6;RANBP2;ZNF738;KLHL21;RNF115;TRIM37;MDM4;BIRC3;KLHL9;DTX4;NEDD4L;RAD18;RFWD3;CBLL1;SPSB1;UBE2J2;TRAF2;MPHOSPH8;RNF19B;RC3H1;TAF1;UFC1
10086,GO:0042575,0.677679095698491,0.700718427559646,1,16,DNA polymerase complex,CC,POLE3
12720,GO:0050919,0.677824589933238,0.597846668734008,2,28,negative chemotaxis,BP,NRG1;ITGAV
5928,GO:0018200,0.678005009019737,0.700359976380129,1,16,peptidyl-glutamic acid modification,BP,GGCX
3375,GO:0007154,0.678129818021968,0.349164418703986,286,3967,cell communication,BP,IL32;CRYAB;IGFBP3;SAA1;DTX2;NEFL;NRG1;TRIM16;FN1;TENM3;PTGES;PML;CYP1B1;AMOT;JPH2;MAP3K14;GCLC;CYR61;C3;GPRC5A;CYP24A1;COL16A1;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;TRIM22;STARD13;CTGF;HLA-B;MMP9;FBN1;XAF1;RUNX1;IL1R2;FAT4;ACTG1;PBX1;FST;DDX17;TRAF3;IRS1;SPG21;MID1;TP53;DAPK3;TUFT1;EXO1;EDN1;GBP1;DOCK10;DDX47;SIPA1L3;C1QTNF1;DUSP14;CDKN2A;JRK;NQO1;LGALS3;IFNGR1;CHP1;PDPN;AKAP8;TGFB2;CNTNAP1;CYLD;IKBKE;IL27RA;IL16;IFIT3;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;NUAK1;INHBA;IL7R;PALM2;CAMK1G;SYK;EMP2;TJP2;NAIP;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;BRIP1;ARFRP1;LRRC8D;HLA-F;CDK4;SFRP1;HLA-DOB;NUCKS1;CD274;WNT10A;MIR17HG;DST;ATP2B1;COL4A1;AHR;RPA1;TAF2;ULK4;KCNS3;SETDB1;PTGER4;G3BP1;TRAF1;OPHN1;ADM;CD109;CADPS2;DYNLL2;SLC1A3;CCL20;PLK2;RRAGB;MUC16;UBQLN2;FRK;BTN2A1;RFC3;HSPB1;RHOG;WNT4;CXCL16;NOP2;LCP1;PTPRM;KDM6A;THOC1;RAN;TOPBP1;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;RAB26;IL24;ARHGEF28;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;LFNG;NETO1;CDC42EP2;BAIAP2;GADD45B;CDH13;PHACTR4;SRF;GDAP1;MDM4;HIF1AN;NPNT;PDGFB;BRCC3;KREMEN2;FZD1;ANTXR1;RTKN2;CLU;SMYD2;MACC1;ENPP1;BIRC3;FRAS1;IL20;PIK3R3;NFKBIB;SPNS1;EYA3;ZNF106;ACKR3;FGD6;SRD5A1;GLIS2;RPF2;THBD;ABCC9;DTX4;GLIPR2;JPH1;SRPRB;IFNAR1;TJP1;ERAP1;BLOC1S2;RIC3;CXCR5;TNC;CNTNAP2;HSPA8;SYT11;HSP90AB1;ARL6IP5;EPHB6;SGK1;M6PR;ZFYVE27;BRCA2;HCAR1;WDPCP;FANCD2;E2F8;MTMR2;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;GPER1;FAF1;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;EIF2B5;CMTM3;HNRNPDL;SHTN1;RABEP2;EBP;NCBP1;AKR1B1;TRAF2;TPRA1;TELO2;CITED2;CCNA2;IFI30;CSF1;CLOCK;KIF14;TLR3;ESR1;PARD3;GJC1;TNF;ZFP36L2;NEDD9;RC3H1;CCL5;CD74;PSMB10;EIF2B1;DAXX;METAP2;PHF14;PHLPP2;PANX1;TAF1;PHLPP1;NRAS;SMARCC1;MUC5B;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;MUC6;IRF1;IRAK3;COPS3;IFI27L1
16833,GO:0098661,0.678328061621473,0.546821884541428,3,45,inorganic anion transmembrane transport,BP,SLC4A11;SLC1A3;CLCC1
15486,GO:0071806,0.678831447542616,0.544722217129171,3,54,protein transmembrane transport,BP,CLU;TIMM23B;HSPA8
4659,GO:0010801,0.678835468900367,0.700350598333005,1,15,negative regulation of peptidyl-threonine phosphorylation,BP,PARD3
9101,GO:0035357,0.678850676838835,0.70137227646378,1,14,peroxisome proliferator activated receptor signaling pathway,BP,CITED2
7488,GO:0031647,0.678852029100731,0.424583854907118,14,214,regulation of protein stability,BP,CRYAB;CHP1;LSS;NAA15;GNL3L;APTX;MDM4;CLU;HSPA8;HSP90AB1;TELO2;NAA16;TAF1;CDKN1A
17271,GO:0120025,0.678892089982984,0.362898280456016,92,1264,plasma membrane bounded cell projection,CC,CRYAB;NEFL;NRG1;MAP2;TENM3;AMOT;SACS;S100P;MYO1B;B4GALT1;NEFM;DYNC2H1;DOCK10;NQO1;PDPN;TGFB2;CNTNAP1;CYLD;IL6ST;SLC9A3R1;SLC22A5;CAMK1G;DNHD1;NAIP;SHISA9;AP3M2;LAYN;DST;ATP2B1;SLC5A6;TPM1;OPHN1;DYNLL2;SLC1A3;CASC3;PLK2;MME;HSPB1;LCP1;GPRIN1;PTPRM;RAN;CORO1C;GPHN;ITGAV;TRPM7;AJUBA;SNX5;BAIAP2;CDH13;PHACTR4;QDPR;ANTXR1;CLU;FGD6;SRD5A1;GLIS2;ANLN;SLC11A2;BLOC1S2;RIC3;CNTNAP2;HSPA8;SYT11;HSP90AB1;EPHB6;NSF;ZFYVE27;TMEM138;TRAK2;WDPCP;MTMR2;CENPF;L1CAM;IQCJ-SCHIP1;BBS5;GPER1;ADAM17;MYO10;SHTN1;DPYSL3;AKR1B1;HNRNPR;AP3B1;PARD3;EHD1;NEDD9;PHLPP2;PANX1;PHLPP1;ITGB1BP1;RBM8A
18247,GO:1903018,0.678917095551489,0.595090993975775,2,32,regulation of glycoprotein metabolic process,BP,CHP1;BACE2
18427,GO:1903429,0.679470084891291,0.699651459339,1,15,regulation of cell maturation,BP,KIF14
7822,GO:0032370,0.679604788842563,0.594294096674184,2,32,positive regulation of lipid transport,BP,EDN1;C1QTNF1
3455,GO:0007269,0.679613825683272,0.494455232712219,5,75,neurotransmitter secretion,BP,CADPS2;HSPA8;SYT11;RAB3GAP1;GPER1
17125,GO:0099643,0.679613825683272,0.494455232712219,5,75,signal release from synapse,BP,CADPS2;HSPA8;SYT11;RAB3GAP1;GPER1
6993,GO:0030666,0.67962442793458,0.466833398089292,7,112,endocytic vesicle membrane,CC,HLA-B;TAP1;RAB32;HLA-F;WNT4;TAP2;CD74
135,GO:0000281,0.679638911181288,0.515144698097844,4,60,mitotic cytokinesis,BP,KIF23;RTKN2;ANLN;BRCA2
2746,GO:0006140,0.679650881816335,0.457568400753315,8,120,regulation of nucleotide metabolic process,BP,NUP50;NUP153;ADM;NDC1;RANBP2;NUP160;NUP54;GPER1
9752,GO:0038202,0.679942309704308,0.594238958163149,2,31,TORC1 signaling,BP,RRAGB;TELO2
2347,GO:0005385,0.680144119247643,0.698907508500158,1,15,zinc ion transmembrane transporter activity,MF,SLC30A6
15365,GO:0071577,0.680144119247643,0.698907508500158,1,15,zinc ion transmembrane transport,BP,SLC30A6
18838,GO:1904377,0.68020500717112,0.544645791301534,3,45,positive regulation of protein localization to cell periphery,BP,ACSL3;RHOG;GPER1
6737,GO:0030150,0.680278235911071,0.696342362742211,1,18,protein import into mitochondrial matrix,BP,TIMM23B
2289,GO:0005245,0.680570124776263,0.699479480254255,1,14,voltage-gated calcium channel activity,MF,ITGAV
4188,GO:0009264,0.680665306867975,0.695912005636773,1,18,deoxyribonucleotide catabolic process,BP,SMUG1
11496,GO:0045939,0.680796269636301,0.697276412442446,1,16,negative regulation of steroid metabolic process,BP,WNT4
2274,GO:0005215,0.680879020117562,0.375990379308058,47,680,transporter activity,MF,JPH2;TFRC;SLC16A2;TAP1;SLC7A2;SLC16A9;SLC7A5P2;CHP1;SLC4A11;SLC30A6;SLC22A5;ABCG2;LRRC8D;ATP2B1;SLC5A6;ABCC4;KCNS3;SLC35A4;SLC1A3;SLCO4C1;ATP2C1;ITGAV;ABCF2;TRPM7;KCNQ5;SPNS1;TIMM23B;ABCC9;JPH1;NNT;SLC11A2;M6PR;ABCA5;EBP;SLC9A9;TAP2;CLCC1;GJC1;KCNE4;ARV1;STARD7;SLC43A2;PANX1;ABCA11P;ITGB1BP1;SLC25A22;SLC41A2
825,GO:0002097,0.680977252214891,0.697075631136586,1,16,tRNA wobble base modification,BP,URM1
60,GO:0000123,0.681019045453295,0.492487084286206,5,79,histone acetyltransferase complex,CC,TAF2;KANSL1L;UBAP2L;TAF6L;POLE3
3430,GO:0007220,0.681086353238679,0.697865139682338,1,15,Notch receptor processing,BP,ADAM17
18324,GO:1903204,0.681399456563282,0.697518141314336,1,15,negative regulation of oxidative stress-induced neuron death,BP,FZD1
9497,GO:0036124,0.68197214295062,0.697929216001791,1,14,histone H3-K9 trimethylation,BP,SUV39H2
8547,GO:0033866,0.68213717221595,0.695786363263348,1,16,nucleoside bisphosphate biosynthetic process,BP,PANK2
8571,GO:0034030,0.68213717221595,0.695786363263348,1,16,ribonucleoside bisphosphate biosynthetic process,BP,PANK2
8574,GO:0034033,0.68213717221595,0.695786363263348,1,16,purine nucleoside bisphosphate biosynthetic process,BP,PANK2
7298,GO:0031290,0.682277531825271,0.697590710780216,1,14,retinal ganglion cell axon guidance,BP,PTPRM
4581,GO:0010664,0.682449848654138,0.696351772611528,1,15,negative regulation of striated muscle cell apoptotic process,BP,CFLAR
4578,GO:0010661,0.682513226999786,0.696281284616436,1,15,positive regulation of muscle cell apoptotic process,BP,CDKN2A
12246,GO:0048488,0.682645151690322,0.591843586159696,2,29,synaptic vesicle endocytosis,BP,OPHN1;SYT11
2516,GO:0005768,0.68335290168407,0.373352659605949,47,680,endosome,CC,PML;TFRC;HLA-B;MYO1B;TRAF3;SPG21;IKBKE;RAB32;HLA-F;VPS41;HLA-DOB;VPS8;AP5M1;RRAGB;RAN;RAB26;SNX11;SNX5;CHID1;KREMEN2;ANTXR1;USP6;ACKR3;IFNAR1;SLC11A2;CNTNAP2;HSPA8;SYT11;BACE2;NEDD4L;M6PR;ZFYVE27;TRAK2;MTMR2;TMEM165;STEAP4;GPER1;ANKRD13A;ABCA5;RABEP2;VPS36;SLC9A9;TLR3;EHD1;TNF;CD74;ASTN2
7089,GO:0030878,0.683477865467707,0.695206859686004,1,15,thyroid gland development,BP,SRF
4141,GO:0009201,0.683964539108869,0.46194845351134,7,111,ribonucleoside triphosphate biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
3325,GO:0007034,0.68415850050263,0.452514346340078,8,119,vacuolar transport,BP,GNPTAB;VPS41;CLU;HSPA8;M6PR;TRAK2;VPS36;AP3B1
13934,GO:0060571,0.684190100132321,0.694411663877643,1,15,morphogenesis of an epithelial fold,BP,FGFR2
2379,GO:0005507,0.684444392041739,0.587496316125394,2,36,copper ion binding,MF,HEPHL1;TP53
18930,GO:1904591,0.684558839432493,0.589221647925434,2,30,positive regulation of protein import,BP,RBM22;HSP90AB1
14587,GO:0070102,0.684561061649386,0.695050156345432,1,14,interleukin-6-mediated signaling pathway,BP,IL6ST
17436,GO:1900151,0.684650109194195,0.694950749077327,1,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L2
17438,GO:1900153,0.684650109194195,0.694950749077327,1,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L2
4159,GO:0009220,0.684743830053157,0.691348562611653,1,18,pyrimidine ribonucleotide biosynthetic process,BP,UMPS
11593,GO:0046132,0.684743830053157,0.691348562611653,1,18,pyrimidine ribonucleoside biosynthetic process,BP,UMPS
12958,GO:0051298,0.684781340193612,0.509058995578761,4,61,centrosome duplication,BP,PLK2;TRIM37;BRCA2;CEP152
11154,GO:0045185,0.685066179196242,0.472962294967738,6,89,maintenance of protein location,BP,PML;FBN1;KEAP1;FAF1;NFKBIE;HNRNPU
12377,GO:0048741,0.685760810857068,0.693708695896868,1,14,skeletal muscle fiber development,BP,HDAC9
15448,GO:0071702,0.685873279616944,0.349307518044379,134,1934,organic substance transport,BP,SAA1;NRG1;TRIM16;FN1;PML;TFRC;C3;SLC16A2;GNPTAB;TAP1;SLC7A2;IL1R2;IRS1;VPS13B;SLC16A9;TP53;SLC7A5P2;EDN1;GBP1;C1QTNF1;ACSL3;PTPN14;CHP1;SLC4A11;AKAP8;TGFB2;RBM22;SRSF2;SLC9A3R1;INHBA;NUP50;SLC22A5;PHAX;SYK;NUP153;RAB32;ABCG2;ARFRP1;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;VPS8;APOL6;SLC5A6;AP5M1;ABCC4;ADAMTS9;KCNS3;PTGER4;LSG1;IMMP2L;NDC1;CADPS2;HNRNPA1L2;SLC35A4;SLC1A3;CASC3;SLCO4C1;GBP5;AKAP8L;HSPB1;LCP1;THOC1;RAN;RANBP2;RAB26;ITGAV;SOCS1;ARNTL;SNX11;CROT;SNX5;GDAP1;TBC1D15;CLU;NUP160;USP6;SDAD1;ENPP1;FRAS1;PIK3R3;NUP54;LRPPRC;SPNS1;SETD2;TIMM23B;HSPA8;SYT11;HSP90AB1;ARL6IP5;NSF;M6PR;TRAK2;CENPF;GOSR1;RAB3GAP1;SCFD2;BBS5;GPER1;WDR75;ABCA5;NFKBIE;RABEP2;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;TAP2;AP3B1;CLOCK;AZIN1;PARD3;EHD1;ARV1;TNF;SRSF7;STARD7;CCL5;CD74;SLC43A2;PANX1;TRAM2;ABCA11P;CDKN1A;ITGB1BP1;SLC25A22;ASTN2;TSGA13;RBM8A;RPS12;BUD13
17903,GO:1902117,0.686342722677012,0.507506806040383,4,59,positive regulation of organelle assembly,BP,EDN1;LCP1;RAB3GAP1;TNF
5752,GO:0016896,0.686502252658665,0.586241175742132,2,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,USB1;ISG20L2
4139,GO:0009199,0.686807676931723,0.415357415501761,14,239,ribonucleoside triphosphate metabolic process,BP,NUP50;NUP153;NDC1;RAN;RANBP2;GPHN;PGK1;NUP160;ENPP1;NUP54;HSPA8;SDHD;UQCRB;NDUFB9
11668,GO:0046390,0.686979019752623,0.423793310771562,12,187,ribose phosphate biosynthetic process,BP,G6PD;PANK2;NUP50;NUP153;ADM;NDC1;RANBP2;PGK1;NUP160;NUP54;UMPS;GPER1
18306,GO:1903169,0.6870139451205,0.485835781231292,5,76,regulation of calcium ion transmembrane transport,BP,JPH2;G6PD;JPH1;THADA;GPER1
822,GO:0002092,0.687299608523235,0.690920941931233,1,15,positive regulation of receptor internalization,BP,SYK
16011,GO:0086003,0.687307360276893,0.586386262058083,2,29,cardiac muscle cell contraction,BP,NEDD4L;GJC1
7069,GO:0030851,0.687545720896801,0.68971812407102,1,16,granulocyte differentiation,BP,RUNX1
1100,GO:0002686,0.687601032050628,0.688841610165838,1,17,negative regulation of leukocyte migration,BP,PTGER4
17979,GO:1902307,0.687642180807805,0.691595791623288,1,14,positive regulation of sodium ion transmembrane transport,BP,CHP1
4091,GO:0009144,0.687706050467844,0.414343766561915,14,240,purine nucleoside triphosphate metabolic process,BP,NUP50;NUP153;NDC1;RAN;RANBP2;GPHN;PGK1;NUP160;ENPP1;NUP54;HSPA8;SDHD;UQCRB;NDUFB9
5993,GO:0018958,0.687755562782153,0.535432530295676,3,47,phenol-containing compound metabolic process,BP,TGFB2;SRD5A1;AKR1B1
7449,GO:0031577,0.687815031052026,0.584695987711195,2,32,spindle checkpoint,BP,ANAPC15;CENPF
11678,GO:0046426,0.687815875736139,0.584694992191492,2,32,negative regulation of JAK-STAT cascade,BP,SOCS1;PARP14
19076,GO:1904893,0.687815875736139,0.584694992191492,2,32,negative regulation of STAT cascade,BP,SOCS1;PARP14
9369,GO:0035872,0.6882185231573,0.584220253656642,2,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,CYLD;BIRC3
4306,GO:0009755,0.688319211825823,0.427527539063232,11,162,hormone-mediated signaling pathway,BP,RUNX1;DDX17;SFRP1;RAN;ARNTL;GPER1;CLOCK;ESR1;DAXX;TAF1;PPARGC1B
7329,GO:0031333,0.688347114572119,0.468913536784782,6,93,negative regulation of protein complex assembly,BP,CRYAB;PTGER4;KANK4;DDX3X;CLU;KIF14
3701,GO:0008210,0.688374347236958,0.687964629753221,1,17,estrogen metabolic process,BP,CYP1B1
12950,GO:0051287,0.688574047225864,0.533625571511893,3,52,NAD binding,MF,PARP15;QDPR;NNT
6544,GO:0021953,0.68867662975024,0.468811096305655,6,89,central nervous system neuron differentiation,BP,MAP2;FGFR2;INHBA;SFRP1;OPHN1;FZD1
14922,GO:0070727,0.688690048153431,0.350849460874402,101,1472,cellular macromolecule localization,BP,NRG1;PML;AMOT;GNPTAB;MID1;TP53;GBP1;ACSL3;PTPN14;CHP1;CNTNAP1;RBM22;CYLD;SRSF2;SLC9A3R1;DKC1;NUP50;EMP2;NUP153;RAB32;ARFRP1;VPS41;AP3M2;ZDHHC6;RPA1;POLR1A;REEP1;IMMP2L;NDC1;DYNLL2;CASC3;RRAGB;AKAP8L;HSPB1;RHOG;WNT4;LCP1;THOC1;RAN;RANBP2;DDX3X;RAB26;GPHN;KLHL21;ARNTL;SNX11;AJUBA;SNX5;CDCA5;GNL3L;GDAP1;UGT8;TBC1D15;RTKN2;CLU;NUP160;USP6;SDAD1;NUP54;SETD2;GLIS2;ANLN;TIMM23B;RPF2;RIC3;CNTNAP2;HSPA8;SYT11;HSP90AB1;NSF;NEDD4L;ZFYVE27;BRCA2;TRAK2;RAB3GAP1;GPER1;WDR75;ATR;NCBP1;UPF3B;UBE2J2;VPS36;AP3B1;MPP5;ESR1;PARD3;EHD1;TNF;SRSF7;STARD7;CD74;HNRNPU;TRAM2;CDKN1A;ITGB1BP1;CTCF;ASTN2;TSGA13;RBM8A;RPS12;BUD13
7942,GO:0032516,0.688714250136398,0.690386675599947,1,14,positive regulation of phosphoprotein phosphatase activity,BP,HSP90AB1
17860,GO:1901998,0.688869059218582,0.583133550402919,2,33,toxin transport,BP,CD274;ANTXR1
14561,GO:0070062,0.689489043212898,0.345474494521954,134,2038,extracellular exosome,CC,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;FTL;FTH1;KRT34;C1R;KRT13;FN1;KRT2;TFRC;C3;GPRC5A;KRT15;TXNRD1;UGT1A6;COL5A3;S100P;MMP9;FBN1;HSPG2;MYO1B;FAT4;B4GALT1;ACTG1;G6PD;DYNC2H1;DOCK10;TMEM106A;NQO1;COBLL1;LGALS3;CHP1;ACO1;PRSS23;SRSF2;COL12A1;PGD;IL6ST;SLC9A3R1;SLC22A5;DNHD1;NAIP;SFRP1;KRT9;CD274;GEMIN4;DST;H3F3A;ATP2B1;HRNR;CSRP1;URM1;MGAM;SLCO4C1;MME;MUC16;FRK;BTN2A1;HSPB1;RHOG;WNT4;LCP1;SIRPA;RAN;SOD2;DDX3X;ITGAV;QPCT;SMC2;KRT24;PGK1;BAIAP2;CDH13;RARS;NPNT;QDPR;APMAP;CHID1;SDK1;TBC1D15;ANTXR1;CLU;NAA50;TPM4;UPK3B;GLIPR2;ERAP1;HSPA8;HSP90AB1;ARL6IP5;NSF;GREB1;LAIR1;MYH11;NEDD4L;KRT10;MTMR2;PLEKHA7;STEAP4;FKBP5;RAB3GAP1;SERPINB9;RRM1;PSME2;HADHB;PSMB9;HNRNPDL;TAF6L;AKR1B1;VPS36;NCL;CSF1;NAA16;MPHOSPH8;JMJD8;MPP5;EHD1;DNASE1;SRSF7;CD74;HIST1H4A;ZNHIT6;HIBCH;NRAS;MUC5B;HNRNPM;ITGB1BP1;NDUFB9;GBP6;GPX4;UFC1
7106,GO:0030897,0.689530973213641,0.689463047109476,1,14,HOPS complex,CC,VPS41
3247,GO:0006907,0.689974296215631,0.686962720725276,1,16,pinocytosis,BP,SNX5
4705,GO:0010863,0.690082685186169,0.68777022897151,1,15,positive regulation of phospholipase C activity,BP,ESR1
9932,GO:0042269,0.69010093777649,0.686818511100456,1,16,regulation of natural killer cell mediated cytotoxicity,BP,SERPINB9
12198,GO:0048311,0.690787322785007,0.688038009747972,1,14,mitochondrion distribution,BP,TRAK2
12021,GO:0047485,0.690911890165827,0.465763085153035,6,96,protein N-terminus binding,MF,TP53;NBN;APTX;DAXX;SMARCC1;GTF2H3
3507,GO:0007417,0.691103316230561,0.36828014817335,42,587,central nervous system development,BP,MAFB;NEFL;NRG1;MAP2;FGFR2;HSPG2;FAT4;G6PD;HMGCS1;ACSL3;CNTNAP1;RAD1;IL6ST;INHBA;SFRP1;H3F3A;ATP2B1;COL4A1;OPHN1;IMMP2L;WNT4;RAN;BAIAP2;SRF;UGT8;FZD1;CLU;SRD5A1;SETD2;CNTNAP2;BRCA2;NAV2;FANCD2;CENPF;RAB3GAP1;RRM1;EIF2B5;JRKL;KIF14;EIF2B1;PHLPP2;TAF1
6650,GO:0023052,0.691543561820561,0.335341286868518,284,3942,signaling,BP,IL32;CRYAB;IGFBP3;SAA1;DTX2;NEFL;NRG1;TRIM16;FN1;TENM3;PTGES;PML;CYP1B1;AMOT;JPH2;MAP3K14;GCLC;CYR61;C3;GPRC5A;CYP24A1;COL16A1;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;TRIM22;STARD13;CTGF;HLA-B;MMP9;FBN1;XAF1;RUNX1;IL1R2;FAT4;ACTG1;PBX1;FST;DDX17;TRAF3;IRS1;SPG21;MID1;TP53;DAPK3;TUFT1;EXO1;EDN1;GBP1;DOCK10;DDX47;SIPA1L3;C1QTNF1;DUSP14;CDKN2A;JRK;NQO1;LGALS3;IFNGR1;CHP1;PDPN;AKAP8;TGFB2;CNTNAP1;CYLD;IKBKE;IL27RA;IL16;IFIT3;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;NUAK1;INHBA;IL7R;PALM2;CAMK1G;SYK;EMP2;TJP2;NAIP;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;BRIP1;ARFRP1;LRRC8D;HLA-F;CDK4;SFRP1;HLA-DOB;NUCKS1;CD274;WNT10A;MIR17HG;DST;ATP2B1;COL4A1;AHR;RPA1;TAF2;ULK4;KCNS3;SETDB1;PTGER4;G3BP1;TRAF1;OPHN1;ADM;CD109;CADPS2;DYNLL2;SLC1A3;CCL20;PLK2;RRAGB;MUC16;UBQLN2;FRK;BTN2A1;RFC3;HSPB1;RHOG;WNT4;CXCL16;NOP2;LCP1;PTPRM;KDM6A;THOC1;RAN;TOPBP1;SOD2;SUPT16H;CORO1C;ATP2C1;DDX3X;RAB26;IL24;ARHGEF28;RRN3;RNF115;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;LFNG;NETO1;CDC42EP2;BAIAP2;GADD45B;CDH13;PHACTR4;SRF;MDM4;HIF1AN;NPNT;PDGFB;BRCC3;KREMEN2;FZD1;ANTXR1;RTKN2;CLU;SMYD2;MACC1;ENPP1;BIRC3;IL20;PIK3R3;NFKBIB;SPNS1;EYA3;ZNF106;ACKR3;FGD6;GLIS2;RPF2;THBD;ABCC9;DTX4;GLIPR2;JPH1;SRPRB;IFNAR1;TJP1;ERAP1;BLOC1S2;RIC3;CXCR5;TNC;CNTNAP2;HSPA8;SYT11;HSP90AB1;ARL6IP5;EPHB6;NSF;SGK1;M6PR;ZFYVE27;BRCA2;HCAR1;WDPCP;FANCD2;E2F8;MTMR2;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;GPER1;FAF1;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;MSH6;LILRB3;CFLAR;PSMB9;EIF2B5;CMTM3;HNRNPDL;SHTN1;RABEP2;EBP;NCBP1;AKR1B1;TRAF2;TPRA1;TELO2;CITED2;CCNA2;IFI30;CSF1;CLOCK;KIF14;TLR3;ESR1;PARD3;GJC1;TNF;ZFP36L2;NEDD9;RC3H1;CCL5;CD74;PSMB10;EIF2B1;DAXX;METAP2;PHF14;PHLPP2;PANX1;TAF1;PHLPP1;NRAS;SMARCC1;MUC5B;PPARGC1B;HNRNPM;CDKN1A;ITGB1BP1;MUC6;IRF1;IRAK3;COPS3;IFI27L1
2872,GO:0006366,0.6919177429777,0.344045336370297,125,1761,transcription by RNA polymerase II,BP,MAFB;NRG1;HDAC9;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;CBX5;CTGF;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TP53;EDN1;ZBED1;STAG1;TGFB2;IRX2;SRSF2;FOXD2;INHBA;PHAX;RELB;PARP15;BRIP1;CDK4;SFRP1;NUCKS1;TARDBP;USP16;AHR;GLIS3;TAF2;ELMSAN1;CASC3;FRK;AKAP8L;MYBL2;NOP2;SUV39H2;THOC1;UBTF;SOD2;SUPT16H;DDX3X;NUFIP1;ARNTL;AJUBA;ZNF267;TRIM37;CDH13;SRF;MDM4;HIF1AN;NPNT;PDGFB;FZD1;IRX4;NFE2L1;SMYD2;MACC1;VGLL3;RIF1;SETD2;GLIS2;UBP1;TTF2;TET3;MYBL1;DDX21;ZBTB24;NEDD4L;TRAK2;SS18L2;MAZ;E2F8;ETV6;ZNFX1;HSF2;POLR2F;CHEK1;GPER1;MLLT10;SENP1;PSME2;PSMB9;ZNF12;ZNF608;TAF6L;NCBP1;UPF3B;CITED2;NCL;TIMELESS;ORC2;RBL1;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;SRSF7;HNRNPU;PSMB10;PHF14;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;IRF1;CTCF;RBM8A;GTF2H3
12943,GO:0051279,0.691975982319418,0.530645869514965,3,46,regulation of release of sequestered calcium ion into cytosol,BP,JPH2;JPH1;GPER1
9572,GO:0036344,0.69217150859997,0.685388919544065,1,15,platelet morphogenesis,BP,SRF
18377,GO:1903321,0.692541756571133,0.499291566010267,4,67,negative regulation of protein modification by small protein conjugation or removal,BP,GCLC;CHP1;GNL3L;TAF1
1379,GO:0003272,0.692690158850419,0.685869858427743,1,14,endocardial cushion formation,BP,TGFB2
11319,GO:0045622,0.693018153125051,0.68348211091355,1,16,regulation of T-helper cell differentiation,BP,RC3H1
14021,GO:0060716,0.693026396308079,0.68347264371966,1,16,labyrinthine layer blood vessel development,BP,CYR61
14666,GO:0070242,0.693073551449408,0.683418482326697,1,16,thymocyte apoptotic process,BP,TP53
17596,GO:1901185,0.693138389732699,0.528715752115521,3,49,negative regulation of ERBB signaling pathway,BP,NRG1;GPRC5A;RNF115
1264,GO:0003015,0.693228040783784,0.434504021114358,9,129,heart process,BP,CTGF;EDN1;TGFB2;ATP2B1;TPM1;ADM;ABCC9;NEDD4L;GJC1
1933,GO:0004629,0.693650903371092,0.683693721268747,1,15,phospholipase C activity,MF,CCL5
4112,GO:0009166,0.693884290825427,0.441169211845949,8,125,nucleotide catabolic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54;SMUG1
4398,GO:0010092,0.694387436882623,0.681906436174137,1,16,specification of animal organ identity,BP,FGFR2
1931,GO:0004622,0.694547957552708,0.681721315225736,1,16,lysophospholipase activity,MF,PLBD1
17558,GO:1901030,0.694639303637686,0.575691799485703,2,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TP53;DYNLL2
5738,GO:0016881,0.694790614361265,0.681441308788604,1,16,acid-amino acid ligase activity,MF,GCLC
2725,GO:0006103,0.694854470610125,0.681367591439204,1,16,2-oxoglutarate metabolic process,BP,STAT5A
3531,GO:0007519,0.695217354066317,0.461104552297056,6,91,skeletal muscle tissue development,BP,HDAC9;TSC22D3;DDX17;GPCPD1;ARNTL;CFLAR
19310,GO:1905475,0.695303394075231,0.439501877261061,8,126,regulation of protein localization to membrane,BP,TP53;GBP1;ACSL3;CHP1;DYNLL2;RHOG;GPER1;ITGB1BP1
4103,GO:0009156,0.695494558480673,0.439242089989491,8,127,ribonucleoside monophosphate biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54;UMPS
8736,GO:0034377,0.695545481970178,0.680569005761647,1,16,plasma lipoprotein particle assembly,BP,ACSL3
10301,GO:0043039,0.695570574690175,0.525337356657554,3,52,tRNA aminoacylation,BP,CARS2;GATC;RARS
16831,GO:0098659,0.695922189209852,0.575406990928144,2,31,inorganic cation import across plasma membrane,BP,STEAP4;SLC9A9
17099,GO:0099587,0.695922189209852,0.575406990928144,2,31,inorganic ion import across plasma membrane,BP,STEAP4;SLC9A9
4962,GO:0015035,0.696354587666886,0.676815621484944,1,20,protein disulfide oxidoreductase activity,MF,TXNRD1
16424,GO:0097028,0.696359933843501,0.678794468875383,1,17,dendritic cell differentiation,BP,RELB
8037,GO:0032675,0.696432657949912,0.49492312186391,4,65,regulation of interleukin-6 production,BP,SYT11;TLR3;TNF;IRAK3
11534,GO:0046034,0.696582641341731,0.412588324597253,12,208,ATP metabolic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;ENPP1;NUP54;HSPA8;SDHD;UQCRB;NDUFB9
19653,GO:1990776,0.697052869637536,0.67882145083985,1,16,response to angiotensin,BP,BRIP1
19244,GO:1905330,0.697267831414141,0.429341119689483,9,144,regulation of morphogenesis of an epithelium,BP,FGFR2;SFRP1;WNT4;FZD1;PSME2;PSMB9;ESR1;TNF;PSMB10
10682,GO:0043903,0.697651234742495,0.416556685302378,11,179,regulation of symbiosis, encompassing mutualism through parasitism,BP,PML;FAM111A;NUCKS1;TARDBP;DDX3X;ITGAV;HSPA8;POLR2F;TNF;CCL5;CD74
14153,GO:0060999,0.697665613795504,0.573683832465851,2,30,positive regulation of dendritic spine development,BP,NRG1;BAIAP2
10275,GO:0043005,0.698189090673691,0.353960117520572,54,757,neuron projection,CC,CRYAB;NEFL;NRG1;MAP2;TENM3;SACS;NEFM;DOCK10;NQO1;TGFB2;CNTNAP1;IL6ST;SLC9A3R1;CAMK1G;NAIP;SHISA9;AP3M2;DST;ATP2B1;OPHN1;SLC1A3;CASC3;PLK2;MME;HSPB1;GPRIN1;GPHN;BAIAP2;CDH13;QDPR;CLU;SRD5A1;BLOC1S2;RIC3;CNTNAP2;HSPA8;SYT11;EPHB6;NSF;ZFYVE27;TRAK2;MTMR2;L1CAM;IQCJ-SCHIP1;GPER1;MYO10;SHTN1;DPYSL3;HNRNPR;AP3B1;PARD3;PHLPP2;PHLPP1;RBM8A
3561,GO:0007603,0.698823626868381,0.676758881533421,1,16,phototransduction, visible light,BP,METAP2
514,GO:0001578,0.69942075308021,0.52198256050127,3,45,microtubule bundle formation,BP,MAP2;CHP1;DNHD1
11217,GO:0045333,0.699462601812034,0.433767923356407,8,155,cellular respiration,BP,PANK2;ACO1;IMMP2L;FASTKD3;NNT;SDHD;UQCRB;NDUFB9
15715,GO:0072234,0.699729115535619,0.677745348758402,1,14,metanephric nephron tubule development,BP,FAT4
17549,GO:1901016,0.699907388818024,0.570985222537672,2,30,regulation of potassium ion transmembrane transporter activity,BP,NETO1;NEDD4L
5542,GO:0016528,0.699991465563007,0.521733154167366,3,43,sarcoplasm,CC,JPH2;P3H2;JPH1
13948,GO:0060590,0.700082519041404,0.569147436294712,2,35,ATPase regulator activity,MF,BAG1;HSCB
18108,GO:1902686,0.700127377503969,0.519738222809647,3,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,TP53;DYNLL2;BLOC1S2
9190,GO:0035556,0.700522928322311,0.33320351783282,142,1987,intracellular signal transduction,BP,CRYAB;IGFBP3;SAA1;NEFL;NRG1;FN1;PML;CYP1B1;AMOT;JPH2;MAP3K14;CYR61;NLRC5;FGFR2;STAT5A;EPGN;TRIM22;STARD13;CTGF;MMP9;FAT4;IRS1;MID1;TP53;DAPK3;TUFT1;EXO1;EDN1;GBP1;DOCK10;SIPA1L3;C1QTNF1;DUSP14;CDKN2A;CHP1;PDPN;TGFB2;CYLD;IKBKE;RAD1;IL6ST;SLC9A3R1;NUAK1;INHBA;IL7R;CAMK1G;SYK;TJP2;RAB32;RELB;NBN;TRIO;BRIP1;SFRP1;AHR;RPA1;TAF2;ULK4;SETDB1;PTGER4;G3BP1;OPHN1;ADM;CCL20;PLK2;RRAGB;RFC3;HSPB1;RHOG;NOP2;LCP1;TOPBP1;SOD2;SUPT16H;ATP2C1;DDX3X;RAB26;IL24;ARHGEF28;RRN3;ITGAV;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;AKR1C2;CDC42EP2;GADD45B;CDH13;PHACTR4;MDM4;NPNT;PDGFB;BRCC3;CLU;SMYD2;BIRC3;IL20;ACKR3;FGD6;RPF2;GLIPR2;JPH1;IFNAR1;TJP1;ARL6IP5;EPHB6;SGK1;BRCA2;E2F8;CHEK1;GPER1;ATR;NTN1;PSME2;MSH6;CFLAR;PSMB9;SHTN1;AKR1B1;TRAF2;TELO2;CCNA2;CSF1;KIF14;TLR3;ESR1;TNF;ZFP36L2;RC3H1;CCL5;CD74;PSMB10;DAXX;PHLPP2;TAF1;PHLPP1;NRAS;CDKN1A;ITGB1BP1;IRAK3
6399,GO:0021602,0.700588605192874,0.675647104475079,1,15,cranial nerve morphogenesis,BP,MAFB
12807,GO:0051082,0.700760198563921,0.453972067393348,6,102,unfolded protein binding,MF,CRYAB;SHQ1;MDN1;TTC1;HSPA8;HSP90AB1
6676,GO:0030033,0.700843851581728,0.675347982257526,1,15,microvillus assembly,BP,SLC9A3R1
1801,GO:0004438,0.701058984191254,0.67619175557521,1,14,phosphatidylinositol-3-phosphatase activity,MF,MTMR2
13427,GO:0052744,0.701058984191254,0.67619175557521,1,14,phosphatidylinositol monophosphate phosphatase activity,MF,MTMR2
2953,GO:0006482,0.701116477656562,0.569920768203617,2,29,protein demethylation,BP,KDM6A;UTY
3705,GO:0008214,0.701116477656562,0.569920768203617,2,29,protein dealkylation,BP,KDM6A;UTY
4604,GO:0010717,0.701598838030679,0.489150083340709,4,62,regulation of epithelial to mesenchymal transition,BP,PDPN;TGFB2;SFRP1;GLIPR2
11793,GO:0046636,0.701684236777857,0.674361580109078,1,15,negative regulation of alpha-beta T cell activation,BP,RC3H1
16027,GO:0086019,0.70205159923797,0.673929636300035,1,15,cell-cell signaling involved in cardiac conduction,BP,GJC1
12630,GO:0050792,0.702149428448424,0.417060417026291,10,164,regulation of viral process,BP,PML;FAM111A;NUCKS1;TARDBP;DDX3X;HSPA8;POLR2F;TNF;CCL5;CD74
10102,GO:0042594,0.702297890646171,0.423749098712438,9,139,response to starvation,BP,TP53;SFRP1;ADM;CADPS2;RRAGB;WNT4;SRD5A1;HSPA8;CDKN1A
12900,GO:0051216,0.702555304508547,0.440924346319445,7,104,cartilage development,BP,CYR61;CTGF;RUNX1;COL27A1;EDN1;SRF;TYMS
7727,GO:0032212,0.702627377939174,0.566654147712116,2,33,positive regulation of telomere maintenance via telomerase,BP,DKC1;ATR
5227,GO:0015833,0.702999016258725,0.335440260152883,103,1519,peptide transport,BP,SAA1;NRG1;TRIM16;FN1;PML;TFRC;GNPTAB;TAP1;IL1R2;IRS1;VPS13B;TP53;EDN1;GBP1;ACSL3;PTPN14;CHP1;AKAP8;TGFB2;RBM22;SRSF2;SLC9A3R1;NUP50;PHAX;SYK;NUP153;RAB32;ARFRP1;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;VPS8;AP5M1;ADAMTS9;KCNS3;PTGER4;LSG1;IMMP2L;NDC1;CADPS2;CASC3;GBP5;AKAP8L;HSPB1;LCP1;THOC1;RAN;RANBP2;RAB26;ITGAV;SOCS1;ARNTL;SNX11;SNX5;GDAP1;TBC1D15;CLU;NUP160;USP6;SDAD1;FRAS1;NUP54;SETD2;TIMM23B;HSPA8;SYT11;HSP90AB1;NSF;M6PR;TRAK2;CENPF;GOSR1;SCFD2;BBS5;GPER1;WDR75;RABEP2;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;TAP2;AP3B1;CLOCK;PARD3;EHD1;TNF;SRSF7;STARD7;CCL5;CD74;PANX1;TRAM2;CDKN1A;ITGB1BP1;ASTN2;TSGA13;RBM8A;RPS12;BUD13
10230,GO:0042886,0.703137194270566,0.335132855089993,104,1533,amide transport,BP,SAA1;NRG1;TRIM16;FN1;PML;TFRC;GNPTAB;TAP1;IL1R2;IRS1;VPS13B;TP53;EDN1;GBP1;ACSL3;PTPN14;CHP1;AKAP8;TGFB2;RBM22;SRSF2;SLC9A3R1;NUP50;PHAX;SYK;NUP153;RAB32;ARFRP1;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;VPS8;SLC5A6;AP5M1;ADAMTS9;KCNS3;PTGER4;LSG1;IMMP2L;NDC1;CADPS2;CASC3;GBP5;AKAP8L;HSPB1;LCP1;THOC1;RAN;RANBP2;RAB26;ITGAV;SOCS1;ARNTL;SNX11;SNX5;GDAP1;TBC1D15;CLU;NUP160;USP6;SDAD1;FRAS1;NUP54;SETD2;TIMM23B;HSPA8;SYT11;HSP90AB1;NSF;M6PR;TRAK2;CENPF;GOSR1;SCFD2;BBS5;GPER1;WDR75;RABEP2;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;TAP2;AP3B1;CLOCK;PARD3;EHD1;TNF;SRSF7;STARD7;CCL5;CD74;PANX1;TRAM2;CDKN1A;ITGB1BP1;ASTN2;TSGA13;RBM8A;RPS12;BUD13
3098,GO:0006672,0.703317358724182,0.486635477111729,4,66,ceramide metabolic process,BP,CYR61;CLN6;UGT8;TNF
16052,GO:0086064,0.703642570637095,0.67109232060128,1,16,cell communication by electrical coupling involved in cardiac conduction,BP,GJC1
3691,GO:0008198,0.703718963567076,0.670156162239384,1,17,ferrous iron binding,MF,FTO
6437,GO:0021700,0.703883174259227,0.415516924005944,10,149,developmental maturation,BP,FAT4;G6PD;TFCP2L1;TGFB2;RAB32;CNTNAP2;BRCA2;KIF14;TYMS;CDKN1A
17217,GO:0106018,0.703987349195098,0.672749593293192,1,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,MTMR2
11667,GO:0046386,0.70414308883779,0.668232734172686,1,19,deoxyribose phosphate catabolic process,BP,SMUG1
9450,GO:0036019,0.704471156405147,0.670110042376998,1,16,endolysosome,CC,TLR3
2977,GO:0006520,0.704753772023867,0.386054575456961,17,278,cellular amino acid metabolic process,BP,GCLC;STAT5A;SLC7A2;NQO1;CARS2;SLC1A3;ODC1;GATC;RARS;QDPR;SEPHS2;DPYD;PSME2;PSMB9;AZIN1;PSMB10;HIBCH
10206,GO:0042800,0.704798797203253,0.66972098003052,1,16,histone methyltransferase activity (H3-K4 specific),MF,RBBP5
5800,GO:0017046,0.705106210489963,0.670320222621605,1,15,peptide hormone binding,MF,INHBA
13797,GO:0060359,0.705148425475616,0.484558212434515,4,65,response to ammonium ion,BP,SDK1;EFTUD2;HSP90AB1;CCNA2
4071,GO:0009123,0.705315428508522,0.388130480438711,16,271,nucleoside monophosphate metabolic process,BP,NUP50;TJP2;NUP153;TK1;NDC1;RANBP2;PGK1;NUP160;ENPP1;NUP54;UMPS;HSPA8;SDHD;UQCRB;TYMS;NDUFB9
16004,GO:0080182,0.705353136246673,0.669061882891365,1,16,histone H3-K4 trimethylation,BP,TET3
13739,GO:0060284,0.705420942331093,0.353548103993663,41,571,regulation of cell development,BP,NEFL;NRG1;HDAC9;MAP2;FN1;TENM3;FBN1;PBX1;G6PD;ENC1;EDN1;GBP1;PDPN;IL6ST;TJP2;SFRP1;ULK4;PLK2;CORO1C;RRN3;ARNTL;BAIAP2;SRF;SDK1;FZD1;NEDD4L;ZFYVE27;TRAK2;L1CAM;GPER1;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;CSF1;CLOCK;KIF14;TNF;WDR36;ITGB1BP1
3141,GO:0006735,0.705768751702664,0.667717336209593,1,17,NADH regeneration,BP,PGK1
14394,GO:0061621,0.705768751702664,0.667717336209593,1,17,canonical glycolysis,BP,PGK1
14435,GO:0061718,0.705768751702664,0.667717336209593,1,17,glucose catabolic process to pyruvate,BP,PGK1
4348,GO:0009898,0.706074547032058,0.427296210352454,8,121,cytoplasmic side of plasma membrane,CC,G6PD;TRAF3;CYLD;SYK;ATP2B1;FRK;SNX5;TRAF2
4255,GO:0009566,0.706265297877789,0.482897726230527,4,68,fertilization,BP,B4GALT1;SPACA6;GLIPR1L2;UBAP2L
5848,GO:0017136,0.706285178155308,0.667951324634006,1,16,NAD-dependent histone deacetylase activity,MF,HDAC9
9774,GO:0039529,0.706563893902765,0.668586510421656,1,15,RIG-I signaling pathway,BP,BIRC3
17012,GO:0099072,0.706760462607483,0.667383855640987,1,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,GPHN
18032,GO:1902476,0.706855115911387,0.561824224923573,2,32,chloride transmembrane transport,BP,SLC1A3;CLCC1
12903,GO:0051222,0.707229497080905,0.37644256711534,20,300,positive regulation of protein transport,BP,SAA1;NRG1;TRIM16;TP53;ACSL3;CHP1;TGFB2;RBM22;SYK;CD274;PTGER4;HSP90AB1;GPER1;WDR75;UBE2J2;TNF;STARD7;PANX1;ITGB1BP1;TSGA13
7249,GO:0031175,0.707242887677725,0.347833062101314,47,649,neuron projection development,BP,NEFL;NRG1;MAP2;FN1;TENM3;FGFR2;FAT4;NEFM;ENC1;DOCK10;CNTNAP1;LRFN4;SLC9A3R1;SFRP1;DHFR;ULK4;OPHN1;ADM;PLK2;RHOG;GPRIN1;PTPRM;RRN3;BAIAP2;SRF;UGT8;SDK1;FZD1;WEE1;SLC11A2;BLOC1S2;TNC;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;L1CAM;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;PARD3;EHD1;WDR36;NRAS
9041,GO:0035249,0.707259572429142,0.56167671990516,2,31,synaptic transmission, glutamatergic,BP,OPHN1;RAB3GAP1
14564,GO:0070069,0.707302573711549,0.662351686395514,1,23,cytochrome complex,CC,UQCRB
3553,GO:0007595,0.707996260403144,0.560425469079219,2,32,lactation,BP,STAT5A;UMPS
6699,GO:0030073,0.708383476150228,0.424486268485093,8,124,insulin secretion,BP,IRS1;SFRP1;KCNS3;ARNTL;GPER1;CLOCK;TNF;CCL5
12168,GO:0048260,0.708730014249425,0.55919785701442,2,33,positive regulation of receptor-mediated endocytosis,BP,SYK;CLU
3404,GO:0007187,0.70880386377937,0.460079829708147,5,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,EDN1;SLC9A3R1;PTGER4;ADM;GPER1
9202,GO:0035578,0.709099988574183,0.479391841996659,4,69,azurophil granule lumen,CC,FTL;C3;HRNR;FRK
10300,GO:0043038,0.709158072011373,0.508817835091045,3,53,amino acid activation,BP,CARS2;GATC;RARS
16279,GO:0090316,0.709178264079006,0.409226363254549,10,156,positive regulation of intracellular protein transport,BP,NRG1;TP53;CHP1;RBM22;HSP90AB1;WDR75;UBE2J2;STARD7;ITGB1BP1;TSGA13
11680,GO:0046434,0.70919553307136,0.403578789200731,11,172,organophosphate catabolic process,BP,NUP50;NUP153;GPCPD1;NDC1;RANBP2;PGK1;NUP160;ENPP1;NUP54;SMUG1;MTMR2
20126,GO:2000756,0.709415530474882,0.508976268804221,3,50,regulation of peptidyl-lysine acetylation,BP,SET;CHEK1;CTCF
12761,GO:0051010,0.70981367142592,0.667109526273847,1,13,microtubule plus-end binding,MF,DST
6991,GO:0030663,0.710085902980379,0.661772872437315,1,18,COPI-coated vesicle membrane,CC,TMEM199
6432,GO:0021695,0.710230703159308,0.558026282167531,2,31,cerebellar cortex development,BP,OPHN1;KIF14
10266,GO:0042995,0.710253345326565,0.32925336595907,95,1314,cell projection,CC,CRYAB;NEFL;NRG1;MAP2;TENM3;AMOT;SACS;S100P;MYO1B;B4GALT1;NEFM;DYNC2H1;DOCK10;NQO1;PDPN;TGFB2;CNTNAP1;CYLD;IL6ST;SLC9A3R1;SLC22A5;CAMK1G;DNHD1;NAIP;SHISA9;AP3M2;LAYN;DST;ATP2B1;SLC5A6;TPM1;OPHN1;DYNLL2;SLC1A3;CASC3;PLK2;MME;HSPB1;LCP1;GPRIN1;PTPRM;RAN;CORO1C;GPHN;ITGAV;TRPM7;AJUBA;SNX5;BAIAP2;CDH13;PHACTR4;QDPR;ANTXR1;CLU;FGD6;SRD5A1;GLIS2;ANLN;TJP1;SLC11A2;BLOC1S2;RIC3;CNTNAP2;HSPA8;SYT11;HSP90AB1;EPHB6;NSF;ZFYVE27;TMEM138;TRAK2;WDPCP;MTMR2;CENPF;L1CAM;IQCJ-SCHIP1;BBS5;GPER1;RRM1;ADAM17;MYO10;SHTN1;DPYSL3;AKR1B1;HNRNPR;AP3B1;PARD3;EHD1;NEDD9;FGFR1OP;PHLPP2;PANX1;PHLPP1;ITGB1BP1;RBM8A
17898,GO:1902108,0.710549431126659,0.506975519129649,3,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TP53;DYNLL2;BLOC1S2
6255,GO:0019829,0.710557616248949,0.556639761840195,2,34,cation-transporting ATPase activity,MF,ATP2B1;ATP2C1
12689,GO:0050877,0.710643368627756,0.359841889660964,28,407,nervous system process,BP,NEFL;NRG1;CYP1B1;CLN6;EDN1;CNTNAP1;SLC9A3R1;NBN;SLC1A3;PLK2;MME;SOD2;NETO1;FEN1;SRF;EYA3;SLC11A2;CNTNAP2;SGK1;NAV2;MTMR2;BBS5;GPER1;PARD3;GJC1;WDR36;CCDC50;NDUFB9
12410,GO:0048820,0.711568650401215,0.662577972108362,1,15,hair follicle maturation,BP,TGFB2
9751,GO:0038201,0.712049598622915,0.661015913160735,1,16,TOR complex,CC,TELO2
14809,GO:0070509,0.71231221612451,0.555105894245118,2,32,calcium ion import,BP,LGALS3;PDGFB
20294,GO:2001224,0.712315242029473,0.66279903627695,1,14,positive regulation of neuron migration,BP,SHTN1
18249,GO:1903020,0.712399195332612,0.660591561678835,1,16,positive regulation of glycoprotein metabolic process,BP,CHP1
9959,GO:0042311,0.712701045714217,0.658596615514544,1,18,vasodilation,BP,SOD2
11848,GO:0046777,0.712877375909618,0.394836804083862,12,173,protein autophosphorylation,BP,FGFR2;DAPK3;CHP1;SYK;NBN;FRK;TRPM7;PDGFB;ENPP1;ATR;TAF1;IRAK3
5660,GO:0016757,0.713177929494981,0.38980750985325,13,206,transferase activity, transferring glycosyl groups,MF,UGT1A6;B4GALT1;ST6GALNAC5;GALNT18;PARP15;PARP14;PARP8;LFNG;UGT8;DPY19L2P2;PDCL3;UMPS;UGT1A4
4769,GO:0010951,0.713187584951778,0.418430620344978,8,136,negative regulation of endopeptidase activity,BP,CRYAB;C3;MMP9;NAIP;CD109;DDX3X;BIRC3;SERPINB9
7678,GO:0032102,0.713245407473487,0.394059068491007,12,188,negative regulation of response to external stimulus,BP,KRT1;SAA1;IL1R2;EDN1;C1QTNF1;PTGER4;CD109;WNT4;PDGFB;CHID1;THBD;GPER1
8193,GO:0032925,0.713269489479966,0.65953329901678,1,16,regulation of activin receptor signaling pathway,BP,FST
7607,GO:0031982,0.713280687115199,0.315326940592697,208,3059,vesicle,CC,CRYAB;IGFBP3;SPRR3;KRT1;SAA1;FTL;FTH1;KRT34;C1R;KRT13;FN1;PML;AMOT;KRT2;TFRC;C3;GPRC5A;KRT15;TXNRD1;FGFR2;UGT1A6;COL5A3;S100P;HLA-B;MMP9;FBN1;TAP1;HSPG2;MYO1B;FAT4;B4GALT1;ACTG1;G6PD;TRAF3;DYNC2H1;SPG21;EDN1;DOCK10;TMEM106A;NQO1;COBLL1;LGALS3;CHP1;ACO1;PDPN;TGFB2;PRSS23;IKBKE;SRSF2;PCDH7;COL12A1;PGD;IL6ST;SLC9A3R1;IL7R;SLC22A5;DNHD1;SYK;EMP2;OLFML3;NAIP;RAB32;VEZT;HLA-F;SFRP1;VPS41;KRT9;AP3M2;HLA-DOB;CD274;GEMIN4;DST;VPS8;H3F3A;ATP2B1;SLC5A6;HRNR;AP5M1;CSRP1;PTPRB;ABCC4;URM1;MGAM;CD109;CADPS2;RRAGB;SLCO4C1;MME;MUC16;UBQLN2;FRK;GBP5;BTN2A1;HSPB1;RHOG;WNT4;LCP1;SIRPA;RAN;SOD2;CORO1C;DDX3X;RAB26;NAP1L1;ITGAV;SOCS1;QPCT;SNX11;SMC2;KRT24;LFNG;PGK1;SNX5;CDC42EP2;BAIAP2;WDR7;CDH13;RARS;NPNT;QDPR;APMAP;PDGFB;CHID1;KREMEN2;SDK1;TBC1D15;ANTXR1;CLU;USP6;NAA50;COMMD9;SPNS1;TPM4;ACKR3;UPK3B;GLIPR2;IFNAR1;ERAP1;SLC11A2;CNTNAP2;HSPA8;SYT11;TMEM199;HSP90AB1;ARL6IP5;BACE2;NSF;GREB1;LAIR1;MYH11;NEDD4L;M6PR;ZFYVE27;BRCA2;TRAK2;KRT10;MTMR2;PLEKHA7;GOSR1;TMEM165;STEAP4;FKBP5;RAB3GAP1;SERPINB9;GPER1;RRM1;ANKRD13A;PSME2;HADHB;LILRB3;PSMB9;ABCA5;HNRNPDL;RABEP2;DPYSL3;TAF6L;EBP;AKR1B1;VPS36;TRAF2;NCL;SLC9A9;TAP2;CSF1;AP3B1;NAA16;MPHOSPH8;JMJD8;GLIPR1;TLR3;MPP5;EHD1;DNASE1;TNF;SRSF7;CD74;HIST1H4A;ZNHIT6;HIBCH;NRAS;MUC5B;HNRNPM;ITGB1BP1;ASTN2;NDUFB9;GBP6;GPX4;UFC1
7363,GO:0031400,0.713460127312157,0.353227034092652,31,462,negative regulation of protein modification process,BP,IGFBP3;GCLC;GPRC5A;G6PD;GBP1;DUSP14;CDKN2A;CHP1;SLC9A3R1;CDK4;SFRP1;TARDBP;CD109;HSPB1;CORO1C;SOCS1;SET;PARP14;PPP4R4;GNL3L;GADD45B;SH3RF2;ENPP1;GPER1;PARD3;TNF;FGFR1OP;TAF1;CDKN1A;ITGB1BP1;IRAK3
8628,GO:0034138,0.713480112017076,0.658412106852527,1,17,toll-like receptor 3 signaling pathway,BP,TLR3
6709,GO:0030111,0.713616422263005,0.376338685602418,17,260,regulation of Wnt signaling pathway,BP,FGFR2;RUNX1;DAPK3;JRK;CYLD;NAIP;SFRP1;G3BP1;WNT4;DDX3X;ARNTL;KREMEN2;RBMS3;PSME2;PSMB9;ESR1;PSMB10
2288,GO:0005244,0.714083471819611,0.47403141307741,4,63,voltage-gated ion channel activity,MF,KCNS3;ITGAV;KCNQ5;KCNE4
6615,GO:0022832,0.714083471819611,0.47403141307741,4,63,voltage-gated channel activity,MF,KCNS3;ITGAV;KCNQ5;KCNE4
7302,GO:0031295,0.714126271145274,0.552219267511052,2,34,T cell costimulation,BP,MAP3K14;CD274
14136,GO:0060972,0.714164724702646,0.658441913796055,1,16,left/right pattern formation,BP,CITED2
7388,GO:0031435,0.714250511839929,0.658337181172736,1,16,mitogen-activated protein kinase kinase kinase binding,MF,TRAF2
3779,GO:0008333,0.714370100989716,0.503264472733613,3,48,endosome to lysosome transport,BP,VPS41;M6PR;TRAK2
14807,GO:0070507,0.714442677754101,0.403404901540001,10,148,regulation of microtubule cytoskeleton organization,BP,MAP2;MID1;STAG1;CYLD;PLK2;RANBP2;TRIM37;SKA2;CHEK1;HNRNPU
1871,GO:0004532,0.714666134847084,0.551547749325038,2,34,exoribonuclease activity,MF,USB1;ISG20L2
19100,GO:1904951,0.714863062171884,0.364043061127248,22,332,positive regulation of establishment of protein localization,BP,SAA1;NRG1;TRIM16;TP53;ACSL3;CHP1;TGFB2;RBM22;DKC1;SYK;CD274;PTGER4;DYNLL2;HSP90AB1;GPER1;WDR75;UBE2J2;TNF;STARD7;PANX1;ITGB1BP1;TSGA13
19072,GO:1904888,0.714952956857639,0.502930254250414,3,46,cranial skeletal system development,BP,FGFR2;TGFB2;SETD2
12882,GO:0051184,0.715353090421797,0.656988777814263,1,16,cofactor transmembrane transporter activity,MF,ABCG2
10513,GO:0043406,0.715543525301814,0.387286965975877,13,197,positive regulation of MAP kinase activity,BP,SAA1;NRG1;MAP3K14;EPGN;EDN1;SYK;AJUBA;GADD45B;PDGFB;TRAF2;TNF;CD74;DAXX
16786,GO:0098562,0.7155780808431,0.408363965534914,9,140,cytoplasmic side of membrane,CC,G6PD;TRAF3;CYLD;SYK;ATP2B1;FRK;SNX5;THADA;TRAF2
18279,GO:1903076,0.715907015217016,0.471584458339079,4,65,regulation of protein localization to plasma membrane,BP,GBP1;ACSL3;RHOG;GPER1
2525,GO:0005778,0.716020197713826,0.500720023396473,3,51,peroxisomal membrane,CC,ACSL3;TTC1;PXMP2
7566,GO:0031903,0.716020197713826,0.500720023396473,3,51,microbody membrane,CC,ACSL3;TTC1;PXMP2
11264,GO:0045454,0.716053058933558,0.499818657549447,3,57,cell redox homeostasis,BP,GCLC;TXNRD1;APEX1
14873,GO:0070628,0.716252817649124,0.654244121778443,1,18,proteasome binding,MF,SACS
11765,GO:0046596,0.716277798498913,0.653525190716384,1,19,regulation of viral entry into host cell,BP,CD74
593,GO:0001755,0.716371098076994,0.549731260707607,2,33,neural crest cell migration,BP,CORO1C;PHACTR4
16173,GO:0090174,0.716645992532196,0.414760863154676,8,126,organelle membrane fusion,BP,TAP1;VPS41;VPS8;TBC1D15;USP6;SYT11;GOSR1;TAP2
10661,GO:0043687,0.717069446115481,0.365291773148549,20,317,post-translational protein modification,BP,IGFBP3;FN1;CYR61;C3;FBN1;KBTBD8;PRSS23;KEAP1;CD109;KLHL21;KLHL9;TNC;PSME2;PSMB9;SPSB1;RBBP5;CSF1;FEM1C;PSMB10;COPS3
9071,GO:0035296,0.717120818080868,0.469996643481712,4,66,regulation of tube diameter,BP,EDN1;ADM;SOD2;GPER1
16752,GO:0097746,0.717120818080868,0.469996643481712,4,66,regulation of blood vessel diameter,BP,EDN1;ADM;SOD2;GPER1
5686,GO:0016798,0.717173281661097,0.449507352670409,5,85,hydrolase activity, acting on glycosyl bonds,MF,MGAM;GANC;CHID1;APEX1;SMUG1
12639,GO:0050804,0.71756561990045,0.389220678817407,12,183,modulation of chemical synaptic transmission,BP,EDN1;SHISA9;OPHN1;SLC1A3;PLK2;NETO1;BAIAP2;SRF;SYT11;MTMR2;RAB3GAP1;GPER1
17046,GO:0099177,0.71756561990045,0.389220678817407,12,183,regulation of trans-synaptic signaling,BP,EDN1;SHISA9;OPHN1;SLC1A3;PLK2;NETO1;BAIAP2;SRF;SYT11;MTMR2;RAB3GAP1;GPER1
12322,GO:0048645,0.717763596275807,0.547389457111903,2,35,animal organ formation,BP,FGFR2;CITED2
12130,GO:0048167,0.717766690402339,0.434440895672579,6,93,regulation of synaptic plasticity,BP,SHISA9;PLK2;NETO1;BAIAP2;SRF;RAB3GAP1
16013,GO:0086005,0.717990594952598,0.654738747385388,1,15,ventricular cardiac muscle cell action potential,BP,NEDD4L
13824,GO:0060393,0.718025532834085,0.54735251057399,2,34,regulation of pathway-restricted SMAD protein phosphorylation,BP,TGFB2;INHBA
18258,GO:1903036,0.718055546576342,0.547314899787681,2,34,positive regulation of response to wounding,BP,PDPN;THBD
20054,GO:2000641,0.718098900335579,0.652738328056771,1,17,regulation of early endosome to late endosome transport,BP,MTMR2
3655,GO:0008138,0.718100036854205,0.546967849756495,2,35,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP14;MTMR2
8997,GO:0035098,0.718148415995863,0.653550766064899,1,16,ESC/E(Z) complex,CC,TRIM37
8976,GO:0035050,0.718522520059748,0.498333417363578,3,47,embryonic heart tube development,BP,SRF;BBS5;CITED2
10687,GO:0043923,0.718644397435614,0.652937820289171,1,16,positive regulation by host of viral transcription,BP,NUCKS1
13036,GO:0051452,0.718680946054954,0.545705214944758,2,37,intracellular pH reduction,BP,CLN6;TMEM199
14650,GO:0070207,0.718746010335006,0.651161982853103,1,18,protein homotrimerization,BP,TRAF2
8320,GO:0033146,0.719780555780748,0.545459571302963,2,33,regulation of intracellular estrogen receptor signaling pathway,BP,RUNX1;ESR1
6904,GO:0030433,0.720054761478512,0.466204428441319,4,68,ubiquitin-dependent ERAD pathway,BP,FOXRED2;UBQLN2;CCDC47;UBE2J2
19043,GO:1904837,0.720092089480557,0.543022843887499,2,41,beta-catenin-TCF complex assembly,BP,RBBP5;HIST1H4A
12963,GO:0051303,0.720315758153132,0.46609797102488,4,66,establishment of chromosome localization,BP,CDCA5;CENPF;KIF14;HNRNPU
6512,GO:0021884,0.72037835253133,0.650787970578624,1,16,forebrain neuron development,BP,FGFR2
19217,GO:1905269,0.720567712214437,0.445800839503558,5,80,positive regulation of chromatin organization,BP,TP53;AKAP8;SETDB1;AKAP8L;RIF1
17074,GO:0099531,0.720596383229978,0.445766186529242,5,80,presynaptic process involved in chemical synaptic transmission,BP,CADPS2;HSPA8;SYT11;RAB3GAP1;GPER1
17565,GO:1901071,0.72079362808167,0.649392720086339,1,17,glucosamine-containing compound metabolic process,BP,CHID1
3900,GO:0008536,0.720820139088412,0.544481876485171,2,32,Ran GTPase binding,MF,NUP50;RANBP2
2584,GO:0005875,0.721258981548316,0.409643725777299,8,119,microtubule associated complex,CC,MAP2;KIF23;DYNC2H1;MID1;DNHD1;DYNLL2;SHTN1;KIF14
2959,GO:0006491,0.721472346563853,0.649425965129907,1,16,N-glycan processing,BP,GNPTAB
11141,GO:0045165,0.721502729767161,0.409266500931424,8,121,cell fate commitment,BP,NRG1;PML;FGFR2;PDPN;CYLD;SFRP1;WNT10A;WNT4
11501,GO:0045947,0.72175788225267,0.648189163397572,1,17,negative regulation of translational initiation,BP,RBM4
14390,GO:0061615,0.721761981255672,0.647403610590058,1,18,glycolytic process through fructose-6-phosphate,BP,PGK1
14393,GO:0061620,0.721761981255672,0.647403610590058,1,18,glycolytic process through glucose-6-phosphate,BP,PGK1
16410,GO:0097006,0.72188828165827,0.49329681459808,3,52,regulation of plasma lipoprotein particle levels,BP,ACSL3;ABCA5;EHD1
13155,GO:0051701,0.721903896394927,0.394391136094229,10,160,interaction with host,BP,PML;TFRC;SLC22A5;NUP153;THOC1;ITGAV;SERPINB9;CBLL1;TYMS;CD74
1703,GO:0004180,0.721934659419135,0.647968147229647,1,17,carboxypeptidase activity,MF,CPA4
11806,GO:0046655,0.722230431177525,0.647598102569075,1,17,folic acid metabolic process,BP,DHFR
2301,GO:0005272,0.722483276569506,0.649166453587912,1,15,sodium channel activity,MF,SLC4A11
501,GO:0001556,0.722672894059922,0.64704393335946,1,17,oocyte maturation,BP,BRCA2
20127,GO:2000757,0.722815321876318,0.646865395097017,1,17,negative regulation of peptidyl-lysine acetylation,BP,SET
18425,GO:1903427,0.723059686601275,0.645776284718331,1,18,negative regulation of reactive oxygen species biosynthetic process,BP,CFLAR
16353,GO:0090559,0.723120601843596,0.462151700511645,4,71,regulation of membrane permeability,BP,TP53;TJP2;DYNLL2;BLOC1S2
17862,GO:1902003,0.723157809081231,0.647319041670857,1,16,regulation of amyloid-beta formation,BP,CLU
9330,GO:0035794,0.723419384053305,0.49094997749638,3,55,positive regulation of mitochondrial membrane permeability,BP,TP53;DYNLL2;BLOC1S2
19378,GO:1905710,0.723419384053305,0.49094997749638,3,55,positive regulation of membrane permeability,BP,TP53;DYNLL2;BLOC1S2
2849,GO:0006335,0.723534983764726,0.639420786092283,1,32,DNA replication-dependent nucleosome assembly,BP,HIST1H4A
8910,GO:0034723,0.723534983764726,0.639420786092283,1,32,DNA replication-dependent nucleosome organization,BP,HIST1H4A
3689,GO:0008194,0.723564701281822,0.427132657873286,6,99,UDP-glycosyltransferase activity,MF,UGT1A6;B4GALT1;GALNT18;LFNG;UGT8;UGT1A4
3785,GO:0008347,0.723664119526542,0.540557465457468,2,33,glial cell migration,BP,TGFB2;CSF1
9776,GO:0039531,0.72390974288671,0.646375722199737,1,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,BIRC3
2290,GO:0005246,0.724046522549143,0.644534661730207,1,18,calcium channel regulator activity,MF,SGK1
7301,GO:0031294,0.724567589836046,0.538806585922487,2,35,lymphocyte costimulation,BP,MAP3K14;CD274
9384,GO:0035902,0.724638474862474,0.644573431762557,1,17,response to immobilization stress,BP,CYP1A1
12355,GO:0048701,0.725348979871438,0.538750746797712,2,32,embryonic cranial skeleton morphogenesis,BP,FGFR2;SETD2
15721,GO:0072243,0.725468706446489,0.645422784220118,1,15,metanephric nephron epithelium development,BP,FAT4
14805,GO:0070498,0.725775955835143,0.43850900267062,5,94,interleukin-1-mediated signaling pathway,BP,IL1R2;PSME2;PSMB9;PSMB10;IRAK3
15454,GO:0071711,0.725888209633565,0.644894096899372,1,15,basement membrane organization,BP,COL4A1
16337,GO:0090503,0.726181439168734,0.536753205658074,2,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,USB1;ISG20L2
13827,GO:0060396,0.726221449021432,0.643462567892836,1,16,growth hormone receptor signaling pathway,BP,STAT5A
4472,GO:0010466,0.726246269963963,0.403010186927179,8,138,negative regulation of peptidase activity,BP,CRYAB;C3;MMP9;NAIP;CD109;DDX3X;BIRC3;SERPINB9
8274,GO:0033048,0.726696484158134,0.536390237077875,2,34,negative regulation of mitotic sister chromatid segregation,BP,ANAPC15;CENPF
17002,GO:0099024,0.726987712128685,0.536018656066825,2,34,plasma membrane invagination,BP,C3;RHOG
5673,GO:0016780,0.726991456170381,0.640808044112201,1,18,phosphotransferase activity, for other substituted phosphate groups,MF,GNPTAB
8296,GO:0033108,0.727071139237756,0.455942915002239,4,89,mitochondrial respiratory chain complex assembly,BP,IMMP2L;FASTKD3;UQCRB;NDUFB9
7076,GO:0030858,0.727456952605404,0.535125483424189,2,35,positive regulation of epithelial cell differentiation,BP,TRIM16;IL20
8337,GO:0033176,0.727515586743373,0.638803416059584,1,20,proton-transporting V-type ATPase complex,CC,TMEM199
12791,GO:0051047,0.727522493417525,0.366359395024129,15,232,positive regulation of secretion,BP,SAA1;TRIM16;EDN1;C1QTNF1;ACSL3;TGFB2;INHBA;SYK;CD274;PTGER4;CADPS2;RAB3GAP1;GPER1;TNF;PANX1
6867,GO:0030331,0.727587435327131,0.535565331416199,2,33,estrogen receptor binding,MF,ESR1;PPARGC1B
3065,GO:0006629,0.727699064662994,0.317592476726778,66,977,lipid metabolic process,BP,NRG1;PTGES;CYP1B1;CYR61;C3;CYP24A1;TXNRD1;FGFR2;STAT5A;FADS3;CTGF;HSPG2;CYP1A1;CLN6;PBX1;G6PD;TFCP2L1;IRS1;PANK2;EDN1;C9ORF3;SCD;HMGCS1;ACSL3;ST6GALNAC5;TGS1;LEPR;LSS;CDK4;GPCPD1;ABHD4;ADM;BTN2A1;WNT4;RAN;AJUBA;CROT;AKR1C2;HACD2;PDGFB;UGT8;NFE2L1;CLU;PIK3R3;MBOAT1;SRD5A1;SCD5;MTMR2;GPER1;MMAA;HADHB;EBP;AKR1B1;TPRA1;RBL1;GLIPR1;ESR1;ARV1;TNF;PDSS1;STARD7;PLBD1;CD74;HIBCH;PPARGC1B;GPX4
8949,GO:0034979,0.727762772152327,0.640617188581635,1,17,NAD-dependent protein deacetylase activity,MF,HDAC9
4980,GO:0015095,0.727824887450828,0.640538165047181,1,17,magnesium ion transmembrane transporter activity,MF,SLC41A2
5157,GO:0015693,0.727824887450828,0.640538165047181,1,17,magnesium ion transport,BP,SLC41A2
18611,GO:1903830,0.727824887450828,0.640538165047181,1,17,magnesium ion transmembrane transport,BP,SLC41A2
4157,GO:0009218,0.728159341276647,0.637981433651796,1,20,pyrimidine ribonucleotide metabolic process,BP,UMPS
1129,GO:0002715,0.728214354070791,0.639251090482326,1,18,regulation of natural killer cell mediated immunity,BP,SERPINB9
10841,GO:0044325,0.728355831448249,0.436339688427943,5,80,ion channel binding,MF,ABCC9;HSP90AB1;NEDD4L;KCNE4;PANX1
3198,GO:0006829,0.728405191834595,0.639799201052265,1,17,zinc ion transport,BP,SLC30A6
13592,GO:0060039,0.728410892953632,0.642866515552236,1,14,pericardium development,BP,SETD2
18280,GO:1903077,0.728685987116729,0.639441181896002,1,17,negative regulation of protein localization to plasma membrane,BP,GBP1
9019,GO:0035176,0.728823269504071,0.534673501687116,2,31,social behavior,BP,CNTNAP2;DNAJC9
13157,GO:0051703,0.728823269504071,0.534673501687116,2,31,intraspecies interaction between organisms,BP,CNTNAP2;DNAJC9
8481,GO:0033617,0.729154984993402,0.63670709260723,1,20,mitochondrial respiratory chain complex IV assembly,BP,FASTKD3
12401,GO:0048799,0.729297916445751,0.641740318533892,1,14,animal organ maturation,BP,FAT4
4110,GO:0009164,0.729783982590688,0.635900115164766,1,20,nucleoside catabolic process,BP,DPYD
4961,GO:0015031,0.729941758086995,0.307218888841289,101,1501,protein transport,BP,SAA1;NRG1;TRIM16;FN1;PML;TFRC;GNPTAB;TAP1;IL1R2;IRS1;VPS13B;TP53;GBP1;ACSL3;PTPN14;CHP1;AKAP8;TGFB2;RBM22;SRSF2;NUP50;PHAX;SYK;NUP153;RAB32;ARFRP1;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;VPS8;AP5M1;ADAMTS9;KCNS3;PTGER4;LSG1;IMMP2L;NDC1;CADPS2;CASC3;GBP5;AKAP8L;HSPB1;LCP1;THOC1;RAN;RANBP2;RAB26;ITGAV;SOCS1;ARNTL;SNX11;SNX5;GDAP1;TBC1D15;CLU;NUP160;USP6;SDAD1;FRAS1;NUP54;SETD2;TIMM23B;HSPA8;SYT11;HSP90AB1;NSF;M6PR;TRAK2;CENPF;GOSR1;SCFD2;BBS5;GPER1;WDR75;RABEP2;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;TAP2;AP3B1;CLOCK;PARD3;EHD1;TNF;SRSF7;STARD7;CCL5;CD74;PANX1;TRAM2;CDKN1A;ITGB1BP1;ASTN2;TSGA13;RBM8A;RPS12;BUD13
12801,GO:0051057,0.729998936669697,0.532810452482255,2,32,positive regulation of small GTPase mediated signal transduction,BP,NRG1;CSF1
9057,GO:0035268,0.730224386279662,0.63667982834286,1,18,protein mannosylation,BP,DPY19L2P2
7950,GO:0032535,0.730388091836288,0.354949576105589,18,267,regulation of cellular component size,BP,NEFL;NRG1;FN1;EDN1;SLC9A3R1;IL7R;CDK4;KANK4;RHOG;CDC42EP2;BAIAP2;SRF;HSP90AB1;ZFYVE27;L1CAM;NTN1;SHTN1;WDR36
5941,GO:0018230,0.730714263242103,0.636050868908405,1,18,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC6
5942,GO:0018231,0.730714263242103,0.636050868908405,1,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC6
6395,GO:0021591,0.730758082658707,0.636790066589436,1,17,ventricular system development,BP,CENPF
12092,GO:0048025,0.731218161996864,0.635402961814318,1,18,negative regulation of mRNA splicing, via spliceosome,BP,SRSF7
323,GO:0000902,0.7314303040718,0.320050695481572,50,692,cell morphogenesis,BP,NEFL;NRG1;MAP2;FN1;TENM3;FGFR2;TFCP2L1;DAPK3;GBP1;DOCK10;SIPA1L3;PDPN;TGFB2;CNTNAP1;LRFN4;SLC9A3R1;IL7R;PALM2;TPM1;OPHN1;SLC1A3;RHOG;PTPRM;CORO1C;ITGAV;CDC42EP2;BAIAP2;CDH13;SRF;UGT8;ANTXR1;CLU;FGD6;WEE1;SLC11A2;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;WDPCP;L1CAM;MYO10;NTN1;SHTN1;KIF14;PARD3;WDR36;NRAS;ITGB1BP1
7333,GO:0031338,0.731921175363293,0.481205573910134,3,49,regulation of vesicle fusion,BP,VPS41;TBC1D15;USP6
20144,GO:2000785,0.732014427142085,0.529569709496532,2,34,regulation of autophagosome assembly,BP,UBQLN2;RAB3GAP1
12363,GO:0048710,0.732135723909013,0.63501849346902,1,17,regulation of astrocyte differentiation,BP,IL6ST
6755,GO:0030173,0.732148358143155,0.528823434436431,2,36,integral component of Golgi membrane,CC,TPST1;LFNG
10083,GO:0042572,0.732161137950587,0.634187913437573,1,18,retinol metabolic process,BP,CYP1B1
13916,GO:0060538,0.732280866353297,0.41685577970066,6,95,skeletal muscle organ development,BP,HDAC9;TSC22D3;DDX17;GPCPD1;ARNTL;CFLAR
11446,GO:0045851,0.732284838009695,0.528136181542916,2,38,pH reduction,BP,CLN6;TMEM199
15539,GO:0071901,0.732407951145106,0.4050371740743,7,116,negative regulation of protein serine/threonine kinase activity,BP,DUSP14;CDKN2A;CDK4;SFRP1;HSPB1;CDKN1A;IRAK3
6698,GO:0030072,0.732445311616191,0.388509184990127,9,142,peptide hormone secretion,BP,IRS1;EDN1;SFRP1;KCNS3;ARNTL;GPER1;CLOCK;TNF;CCL5
6654,GO:0023061,0.732512016510404,0.357693475546393,16,243,signal release,BP,IRS1;EDN1;C1QTNF1;INHBA;SFRP1;KCNS3;ADM;CADPS2;ARNTL;HSPA8;SYT11;RAB3GAP1;GPER1;CLOCK;TNF;CCL5
12452,GO:0050000,0.732695889536107,0.450709623816912,4,67,chromosome localization,BP,CDCA5;CENPF;KIF14;HNRNPU
117,GO:0000245,0.732784828054619,0.479314605857575,3,54,spliceosomal complex assembly,BP,LUC7L;LUC7L2;NCBP1
16812,GO:0098631,0.732813881644497,0.528242418750026,2,35,cell adhesion mediator activity,MF,PDLIM1;BAIAP2
2523,GO:0005776,0.732881671553068,0.430558820887664,5,83,autophagosome,CC,FTL;FTH1;VMP1;UBQLN2;HSPA8
10860,GO:0044346,0.733416200041168,0.633365406582508,1,17,fibroblast apoptotic process,BP,SFRP1
16829,GO:0098656,0.734133102436267,0.380279216442092,10,153,anion transmembrane transport,BP,SLC7A2;SLC7A5P2;SLC4A11;LRRC8D;SLC5A6;SLC1A3;ARL6IP5;CLCC1;SLC43A2;SLC25A22
6941,GO:0030544,0.734310138161473,0.526027434043555,2,36,Hsp70 protein binding,MF,SACS;METTL21A
13790,GO:0060348,0.734346312626092,0.394123350292088,8,119,bone development,BP,FGFR2;FBN1;FAT4;COL27A1;TJP2;PTGER4;SRF;SRD5A1
9512,GO:0036151,0.734383933488442,0.63131040901319,1,18,phosphatidylcholine acyl-chain remodeling,BP,PLBD1
7818,GO:0032366,0.734634081544117,0.631787321770763,1,17,intracellular sterol transport,BP,ARV1
7819,GO:0032367,0.734634081544117,0.631787321770763,1,17,intracellular cholesterol transport,BP,ARV1
858,GO:0002183,0.734643497108072,0.630973162411171,1,18,cytoplasmic translational initiation,BP,RBM4
17850,GO:1901984,0.73486510817386,0.630685022574283,1,18,negative regulation of protein acetylation,BP,SET
18835,GO:1904358,0.734995490271506,0.525417359936797,2,35,positive regulation of telomere maintenance via telomere lengthening,BP,DKC1;ATR
12879,GO:0051180,0.735461961651074,0.629908053171507,1,18,vitamin transport,BP,SLC5A6
291,GO:0000795,0.73547203217429,0.630698234553889,1,17,synaptonemal complex,CC,BRCA2
17023,GO:0099086,0.73547203217429,0.630698234553889,1,17,synaptonemal structure,CC,BRCA2
4685,GO:0010831,0.735498805029795,0.629860046496195,1,18,positive regulation of myotube differentiation,BP,EHD1
4075,GO:0009127,0.735769618230022,0.400990418480951,7,116,purine nucleoside monophosphate biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
4114,GO:0009168,0.735769618230022,0.400990418480951,7,116,purine ribonucleoside monophosphate biosynthetic process,BP,NUP50;NUP153;NDC1;RANBP2;PGK1;NUP160;NUP54
6636,GO:0022904,0.735875302338186,0.444716171773343,4,94,respiratory electron transport chain,BP,IMMP2L;SDHD;UQCRB;NDUFB9
8468,GO:0033599,0.736121572945315,0.629852165347087,1,17,regulation of mammary gland epithelial cell proliferation,BP,BRCA2
20318,GO:2001257,0.736783082518824,0.426075178969595,5,79,regulation of cation channel activity,BP,JPH2;MMP9;SHISA9;NETO1;JPH1
5586,GO:0016601,0.736843601670619,0.523310623698786,2,34,Rac protein signal transduction,BP,RHOG;CDH13
6913,GO:0030496,0.737034040611431,0.376770418880042,10,156,midbody,CC,KIF23;CYLD;KEAP1;RAN;KLHL9;ANLN;URB2;CENPF;KIF14;HNRNPU
6420,GO:0021680,0.737088163050191,0.630534074337688,1,15,cerebellar Purkinje cell layer development,BP,KIF14
9698,GO:0038083,0.737304458134678,0.523361213822368,2,32,peptidyl-tyrosine autophosphorylation,BP,SYK;FRK
17490,GO:1900274,0.737401426065839,0.628180304649252,1,17,regulation of phospholipase C activity,BP,ESR1
4982,GO:0015101,0.737565272751244,0.627159072246575,1,18,organic cation transmembrane transporter activity,MF,SLC22A5
2623,GO:0005942,0.737815675880869,0.628548700108542,1,16,phosphatidylinositol 3-kinase complex,CC,PIK3R3
10011,GO:0042417,0.73794082375617,0.626666434525307,1,18,dopamine metabolic process,BP,TGFB2
13008,GO:0051393,0.737967790831285,0.635493077367437,1,11,alpha-actinin binding,MF,SYNPO2
16357,GO:0090575,0.737968925831753,0.389295155788248,8,131,RNA polymerase II transcription factor complex,CC,PBX1;TP53;TAF2;TAF6L;HNRNPU;TAF1;TBPL1;GTF2H3
12132,GO:0048169,0.738004920490993,0.627389762927841,1,17,regulation of long-term neuronal synaptic plasticity,BP,NETO1
13255,GO:0051899,0.738071523843484,0.473043929295427,3,51,membrane depolarization,BP,GCLC;EDN1;NEDD4L
12181,GO:0048284,0.738199410657415,0.381553096658014,9,146,organelle fusion,BP,TAP1;VPS41;VPS8;GDAP1;TBC1D15;USP6;SYT11;GOSR1;TAP2
5745,GO:0016889,0.738213177795633,0.624940994587009,1,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,APEX1
19741,GO:2000050,0.73833205938112,0.627872483360596,1,16,regulation of non-canonical Wnt signaling pathway,BP,SFRP1
7238,GO:0031128,0.738369914973851,0.626910954878519,1,17,developmental induction,BP,WNT4
14527,GO:0065005,0.738370801426143,0.626101728719862,1,18,protein-lipid complex assembly,BP,ACSL3
5735,GO:0016878,0.738600876989507,0.625799266516451,1,18,acid-thiol ligase activity,MF,ACSL3
18730,GO:1904064,0.738622173526017,0.443403963242654,4,66,positive regulation of cation transmembrane transport,BP,JPH2;G6PD;CHP1;GPER1
997,GO:0002456,0.738625210963423,0.471734035071327,3,55,T cell mediated immunity,BP,IL7R;EMP2;TRAF2
9494,GO:0036120,0.739582984183864,0.626230054431152,1,16,cellular response to platelet-derived growth factor stimulus,BP,CCNA2
2853,GO:0006342,0.739605102677841,0.420858467071118,5,107,chromatin silencing,BP,H3F3A;HELLS;SETDB1;RIF1;HIST1H4A
5724,GO:0016860,0.740321842336969,0.517209618593613,2,40,intramolecular oxidoreductase activity,MF,PTGES;EBP
17583,GO:1901137,0.740842183415128,0.317599975332496,37,557,carbohydrate derivative biosynthetic process,BP,HSPG2;B4GALT1;G6PD;SPON1;PANK2;CHP1;ST6GALNAC5;NUP50;GALNT18;NUP153;UAP1L1;TK1;ADM;NDC1;MUC16;RANBP2;HS3ST1;LFNG;PGK1;PDGFB;UGT8;NUP160;RRM2;NUP54;DPY19L2P2;PDCL3;TET3;UMPS;BACE2;TRAK2;TMEM165;GPER1;RRM1;TYMS;TBPL1;MUC5B;MUC6
16931,GO:0098876,0.740949877522071,0.440474000981092,4,66,vesicle-mediated transport to the plasma membrane,BP,ACSL3;ARFRP1;RAB26;NSF
16693,GO:0097581,0.74118295183382,0.440291828456323,4,65,lamellipodium organization,BP,PDPN;CORO1C;AJUBA;CDH13
7450,GO:0031579,0.741366261092947,0.621422314608095,1,19,membrane raft organization,BP,EMP2
8013,GO:0032635,0.741588343017087,0.439353558501383,4,69,interleukin-6 production,BP,SYT11;TLR3;TNF;IRAK3
16839,GO:0098693,0.741759149284955,0.517191050004437,2,33,regulation of synaptic vesicle cycle,BP,SYT11;RAB3GAP1
3888,GO:0008519,0.742326760803355,0.620872305635944,1,18,ammonium transmembrane transporter activity,MF,SLC22A5
17718,GO:1901575,0.742880824390255,0.29222272693732,109,1628,organic substance catabolic process,BP,NRG1;PML;CYP1B1;GCLC;CYP24A1;HSPG2;CYP1A1;CLN6;ENC1;IRS1;TP53;C9ORF3;PABPC4;PRUNE2;CHP1;CYLD;PPP1R3B;DKC1;NUP50;NUP153;CDK4;POP1;GPCPD1;TARDBP;ABHD4;USP16;KEAP1;ADAMTS9;OPHN1;MGAM;USP43;NDC1;FOXRED2;CASC3;PLK2;UBQLN2;HSPB1;EXOG;RANBP2;ANAPC15;RNF115;SET;ARNTL;MRTO4;ODC1;FASTKD3;CROT;PGK1;FEN1;MDM4;QDPR;CHID1;CLU;NUP160;USP6;ENPP1;NUP54;LRPPRC;METTL16;ERAP1;APEX1;PDCL3;TET3;HSPA8;TMEM199;HSP90AB1;SMUG1;BACE2;NSF;NEDD4L;ANAPC7;SYNCRIP;DPYD;MTMR2;CCDC47;FAF1;MMAA;SENP1;PSME2;HADHB;PSMB9;UGT1A4;NCBP1;UPF3B;SPSB1;UBE2J2;VPS36;TRAF2;HNRNPR;CLOCK;KIF14;AZIN1;RNF19B;USP11;DNASE1;TNF;ZFP36L2;RC3H1;PLBD1;HNRNPU;PSMB10;TAF1;HIBCH;SMARCC1;USP1;RBM8A;RPS12;IRAK3;COPS3
7371,GO:0031410,0.743215707768946,0.291622965480043,111,1610,cytoplasmic vesicle,CC,KRT1;SAA1;FTL;FTH1;FN1;PML;AMOT;TFRC;C3;GPRC5A;FGFR2;S100P;HLA-B;MMP9;TAP1;MYO1B;B4GALT1;ACTG1;TRAF3;SPG21;EDN1;LGALS3;CHP1;PDPN;TGFB2;IKBKE;PCDH7;IL7R;SYK;EMP2;RAB32;VEZT;HLA-F;VPS41;AP3M2;HLA-DOB;DST;VPS8;HRNR;AP5M1;PTPRB;ABCC4;MGAM;CD109;CADPS2;RRAGB;SLCO4C1;MME;UBQLN2;FRK;GBP5;RHOG;WNT4;SIRPA;RAN;DDX3X;RAB26;NAP1L1;ITGAV;SOCS1;QPCT;SNX11;SNX5;CDC42EP2;BAIAP2;WDR7;PDGFB;CHID1;KREMEN2;ANTXR1;CLU;USP6;COMMD9;ACKR3;IFNAR1;SLC11A2;CNTNAP2;HSPA8;SYT11;TMEM199;HSP90AB1;BACE2;LAIR1;MYH11;NEDD4L;M6PR;ZFYVE27;BRCA2;TRAK2;MTMR2;GOSR1;TMEM165;STEAP4;GPER1;ANKRD13A;LILRB3;ABCA5;RABEP2;DPYSL3;EBP;VPS36;SLC9A9;TAP2;AP3B1;GLIPR1;TLR3;EHD1;TNF;CD74;NRAS;ASTN2
7497,GO:0031663,0.743352384420263,0.513929996644972,2,37,lipopolysaccharide-mediated signaling pathway,BP,TNF;CCL5
18394,GO:1903364,0.743489548186712,0.39163833985526,7,116,positive regulation of cellular protein catabolic process,BP,GCLC;KEAP1;PLK2;UBQLN2;CLU;RNF19B;TAF1
10600,GO:0043555,0.743667372496171,0.619086150167001,1,18,regulation of translation in response to stress,BP,RBM4
18307,GO:1903170,0.743681214044256,0.618339000336023,1,19,negative regulation of calcium ion transmembrane transport,BP,THADA
10647,GO:0043647,0.743714387005847,0.465959781989999,3,50,inositol phosphate metabolic process,BP,PPIP5K1;MTMR2;GPER1
3611,GO:0008053,0.743870619090609,0.61743140473405,1,20,mitochondrial fusion,BP,GDAP1
9833,GO:0042036,0.743998153847173,0.617915212103283,1,19,negative regulation of cytokine biosynthetic process,BP,INHBA
13112,GO:0051603,0.744006401521895,0.312603367914967,39,591,proteolysis involved in cellular protein catabolic process,BP,PML;GCLC;ENC1;TP53;CYLD;USP16;KEAP1;OPHN1;USP43;FOXRED2;PLK2;UBQLN2;RANBP2;ANAPC15;RNF115;ARNTL;CLU;USP6;PDCL3;HSP90AB1;NEDD4L;ANAPC7;CCDC47;FAF1;SENP1;PSME2;PSMB9;SPSB1;UBE2J2;VPS36;CLOCK;KIF14;RNF19B;USP11;PSMB10;TAF1;SMARCC1;USP1;COPS3
19797,GO:2000171,0.744234462134105,0.619146041849796,1,17,negative regulation of dendrite development,BP,PLK2
10090,GO:0042581,0.744305643787261,0.401749801316013,6,102,specific granule,CC,PTPRB;SLCO4C1;FRK;ITGAV;QPCT;LAIR1
6689,GO:0030054,0.744454534720569,0.30122823922233,61,872,cell junction,CC,TNS3;KIF23;AMOT;HSPG2;SLC7A2;B4GALT1;ACTG1;SIPA1L3;CHP1;PDPN;CNTNAP1;PDLIM1;TJP2;SHISA9;VEZT;CDK4;LAYN;DST;CSRP1;G3BP1;PARD3B;OPHN1;CADPS2;SYNPO2L;MME;NEXN;HSPB1;RHOG;LCP1;PTPRM;CORO1C;ARMC5;GPHN;ITGAV;AJUBA;CGNL1;NETO1;BAIAP2;CDH13;SDK1;FZD1;TPM4;TJP1;TNC;CNTNAP2;HSPA8;SYT11;PLEKHA7;L1CAM;GPER1;ADAM17;SENP1;CSRP2;AKR1B1;IFI30;MPP5;SYNPO2;PARD3;GJC1;NEDD9;PANX1
3245,GO:0006904,0.744744823425411,0.512087661691174,2,37,vesicle docking involved in exocytosis,BP,RAB26;SCFD2
4271,GO:0009620,0.744818324438838,0.615569281349458,1,21,response to fungus,BP,SYK
9880,GO:0042130,0.745008846129515,0.512003249068446,2,36,negative regulation of T cell proliferation,BP,CD274;RC3H1
12395,GO:0048771,0.745502935633675,0.400560087389299,6,97,tissue remodeling,BP,TFRC;B4GALT1;SYK;LEPR;SFRP1;PPARGC1B
15242,GO:0071378,0.745614492698495,0.617299004398835,1,17,cellular response to growth hormone stimulus,BP,STAT5A
74,GO:0000151,0.746173511233103,0.339205151669893,17,265,ubiquitin ligase complex,CC,ENC1;KBTBD8;KEAP1;ANAPC15;KLHL21;BRCC3;KLHL9;HSPA8;ANAPC7;RAD18;CBLL1;SPSB1;UBE2J2;TRAF2;MPHOSPH8;RNF19B;RING1
12317,GO:0048640,0.746217584559418,0.433917193815137,4,65,negative regulation of developmental growth,BP,G6PD;SFRP1;MIR17HG;NTN1
10334,GO:0043114,0.746340450451811,0.616324316228987,1,17,regulation of vascular permeability,BP,ADM
15734,GO:0072273,0.746360863469969,0.616296878600396,1,17,metanephric nephron morphogenesis,BP,WNT4
5401,GO:0016235,0.74649975070033,0.510604311415187,2,34,aggresome,CC,TRIM37;URB2
14699,GO:0070301,0.746603681353373,0.432712021513938,4,72,cellular response to hydrogen peroxide,BP,CYP1B1;TP53;NQO1;APEX1
2747,GO:0006144,0.746891386045018,0.614028061671824,1,19,purine nucleobase metabolic process,BP,DPYD
17026,GO:0099094,0.746895872374009,0.510733851957737,2,32,ligand-gated cation channel activity,MF,JPH2;JPH1
418,GO:0001105,0.746899714321729,0.510390224719354,2,33,RNA polymerase II transcription coactivator activity,MF,MKL1;CITED2
10788,GO:0044232,0.747220341174983,0.61431770798333,1,18,organelle membrane contact site,CC,RAB32
3552,GO:0007589,0.747436627409138,0.460812068207724,3,52,body fluid secretion,BP,STAT5A;EDN1;UMPS
18129,GO:1902743,0.747635629393351,0.509092590341466,2,34,regulation of lamellipodium organization,BP,PDPN;CORO1C
9435,GO:0035994,0.747828257428203,0.618925723605509,1,13,response to muscle stretch,BP,EDN1
4031,GO:0009062,0.747846922103403,0.411632229934758,5,88,fatty acid catabolic process,BP,IRS1;CROT;MMAA;HADHB;HIBCH
18673,GO:1903959,0.747993397392122,0.614097108603758,1,17,regulation of anion transmembrane transport,BP,ARL6IP5
12440,GO:0048873,0.748029417631521,0.612489868410451,1,19,homeostasis of number of cells within a tissue,BP,CSF1
3109,GO:0006687,0.748265400694399,0.459580670405807,3,53,glycosphingolipid metabolic process,BP,CLN6;ST6GALNAC5;UGT8
18195,GO:1902936,0.74833659774984,0.430894730942944,4,68,phosphatidylinositol bisphosphate binding,MF,JPH2;MYO1B;ARRDC1-AS1;PARD3
16735,GO:0097708,0.748463201915843,0.286022256226252,111,1612,intracellular vesicle,CC,KRT1;SAA1;FTL;FTH1;FN1;PML;AMOT;TFRC;C3;GPRC5A;FGFR2;S100P;HLA-B;MMP9;TAP1;MYO1B;B4GALT1;ACTG1;TRAF3;SPG21;EDN1;LGALS3;CHP1;PDPN;TGFB2;IKBKE;PCDH7;IL7R;SYK;EMP2;RAB32;VEZT;HLA-F;VPS41;AP3M2;HLA-DOB;DST;VPS8;HRNR;AP5M1;PTPRB;ABCC4;MGAM;CD109;CADPS2;RRAGB;SLCO4C1;MME;UBQLN2;FRK;GBP5;RHOG;WNT4;SIRPA;RAN;DDX3X;RAB26;NAP1L1;ITGAV;SOCS1;QPCT;SNX11;SNX5;CDC42EP2;BAIAP2;WDR7;PDGFB;CHID1;KREMEN2;ANTXR1;CLU;USP6;COMMD9;ACKR3;IFNAR1;SLC11A2;CNTNAP2;HSPA8;SYT11;TMEM199;HSP90AB1;BACE2;LAIR1;MYH11;NEDD4L;M6PR;ZFYVE27;BRCA2;TRAK2;MTMR2;GOSR1;TMEM165;STEAP4;GPER1;ANKRD13A;LILRB3;ABCA5;RABEP2;DPYSL3;EBP;VPS36;SLC9A9;TAP2;AP3B1;GLIPR1;TLR3;EHD1;TNF;CD74;NRAS;ASTN2
6102,GO:0019319,0.748533448116639,0.458941969993961,3,55,hexose biosynthetic process,BP,LEPR;PGK1;AKR1B1
20212,GO:2001024,0.748535435547805,0.611804240484976,1,19,negative regulation of response to drug,BP,ARL6IP5
11614,GO:0046189,0.748990997674507,0.61192233934837,1,18,phenol-containing compound biosynthetic process,BP,TGFB2
4582,GO:0010665,0.74922934023999,0.611598935159336,1,18,regulation of cardiac muscle cell apoptotic process,BP,CFLAR
3451,GO:0007265,0.749540861660683,0.32043401241836,25,366,Ras protein signal transduction,BP,NRG1;TP53;CDKN2A;PDPN;TGFB2;RAB32;TRIO;SETDB1;G3BP1;OPHN1;PLK2;RHOG;RAB26;ARHGEF28;CDC42EP2;CDH13;PHACTR4;FGD6;NTN1;SHTN1;CCNA2;CSF1;KIF14;NRAS;CDKN1A
10068,GO:0042542,0.749749705639861,0.394767255388755,6,107,response to hydrogen peroxide,BP,CRYAB;CYP1B1;TP53;NQO1;APTX;APEX1
4132,GO:0009190,0.749766390723456,0.505947392177392,2,35,cyclic nucleotide biosynthetic process,BP,ADM;GPER1
13403,GO:0052652,0.749766390723456,0.505947392177392,2,35,cyclic purine nucleotide metabolic process,BP,ADM;GPER1
12978,GO:0051341,0.749851872221485,0.457223248217172,3,55,regulation of oxidoreductase activity,BP,EDN1;DHFR;TNF
5344,GO:0016079,0.749978476960971,0.457828093579157,3,50,synaptic vesicle exocytosis,BP,CADPS2;SYT11;RAB3GAP1
94,GO:0000184,0.750353062511804,0.406961654073306,5,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,CASC3;NCBP1;UPF3B;RBM8A;RPS12
6205,GO:0019693,0.75099037107294,0.321435585076249,23,383,ribose phosphate metabolic process,BP,G6PD;PANK2;TPST1;PGD;NUP50;TJP2;NUP153;ADM;NDC1;RAN;RANBP2;GPHN;CROT;PGK1;NUP160;ENPP1;NUP54;UMPS;HSPA8;GPER1;SDHD;UQCRB;NDUFB9
13755,GO:0060306,0.751266089515709,0.610590186248633,1,16,regulation of membrane repolarization,BP,NEDD4L
4944,GO:0014904,0.751366126827529,0.609518214044751,1,17,myotube cell development,BP,HDAC9
14698,GO:0070300,0.751879546600541,0.607987274870778,1,18,phosphatidic acid binding,MF,JPH2
11895,GO:0046887,0.751996681206817,0.426014605912989,4,70,positive regulation of hormone secretion,BP,EDN1;C1QTNF1;INHBA;GPER1
8245,GO:0033006,0.752122723946878,0.606913764870298,1,19,regulation of mast cell activation involved in immune response,BP,SYK
10457,GO:0043304,0.752122723946878,0.606913764870298,1,19,regulation of mast cell degranulation,BP,SYK
5924,GO:0018196,0.752592494217611,0.501111202808087,2,39,peptidyl-asparagine modification,BP,ST6GALNAC5;HIF1AN
16158,GO:0090150,0.753136832249006,0.339319650277148,14,266,establishment of protein localization to membrane,BP,TP53;ACSL3;CHP1;ARFRP1;ZDHHC6;REEP1;DYNLL2;RAB26;NSF;RAB3GAP1;PARD3;TRAM2;ITGB1BP1;RPS12
17336,GO:0140142,0.75315371623804,0.606240588638522,1,18,nucleocytoplasmic carrier activity,MF,RAN
18473,GO:1903532,0.753199081640028,0.3398667189242,14,220,positive regulation of secretion by cell,BP,SAA1;TRIM16;EDN1;C1QTNF1;TGFB2;INHBA;SYK;CD274;PTGER4;CADPS2;RAB3GAP1;GPER1;TNF;PANX1
10809,GO:0044275,0.753321933701612,0.501169442362334,2,35,cellular carbohydrate catabolic process,BP,PPP1R3B;MGAM
2537,GO:0005793,0.753330802858306,0.390575407167165,6,102,endoplasmic reticulum-Golgi intermediate compartment,CC,FN1;VMP1;TAP1;CHP1;TMEM199;TAP2
2514,GO:0005766,0.753380369993695,0.379280934158563,7,122,primary lysosome,CC,FTL;C3;B4GALT1;HRNR;SLCO4C1;FRK;GLIPR1
10091,GO:0042582,0.753380369993695,0.379280934158563,7,122,azurophil granule,CC,FTL;C3;B4GALT1;HRNR;SLCO4C1;FRK;GLIPR1
11271,GO:0045499,0.753581290903487,0.606485459734847,1,17,chemorepellent activity,MF,NRG1
8119,GO:0032799,0.753633127540252,0.604838867658267,1,19,low-density lipoprotein receptor particle metabolic process,BP,ITGAV
12787,GO:0051043,0.753636541039505,0.604834167730694,1,19,regulation of membrane protein ectodomain proteolysis,BP,TNF
18714,GO:1904037,0.753699986128529,0.60548968353417,1,18,positive regulation of epithelial cell apoptotic process,BP,GPER1
10416,GO:0043242,0.753877149054016,0.453077399850187,3,48,negative regulation of protein complex disassembly,BP,MID1;TNF;IRAK3
13086,GO:0051570,0.75396643051959,0.605956097427707,1,17,regulation of histone H3-K9 methylation,BP,RIF1
6573,GO:0022029,0.754468423368638,0.499921643793955,2,34,telencephalon cell migration,BP,NRG1;SRF
11581,GO:0046112,0.754642573224042,0.603446891278334,1,19,nucleobase biosynthetic process,BP,UMPS
3227,GO:0006882,0.754645625100512,0.60217166762812,1,21,cellular zinc ion homeostasis,BP,SLC30A6
13522,GO:0055069,0.754645625100512,0.60217166762812,1,21,zinc ion homeostasis,BP,SLC30A6
5860,GO:0017156,0.754665940869657,0.422890500265218,4,67,calcium ion regulated exocytosis,BP,CHP1;CADPS2;SYT11;RAB3GAP1
10487,GO:0043370,0.75483909747736,0.603175401586848,1,19,regulation of CD4-positive, alpha-beta T cell differentiation,BP,RC3H1
7271,GO:0031234,0.754884643332605,0.422608895446754,4,67,extrinsic component of cytoplasmic side of plasma membrane,CC,CYLD;SYK;FRK;SNX5
9318,GO:0035767,0.755016709175137,0.603674618125561,1,18,endothelial cell chemotaxis,BP,HSPB1
6506,GO:0021872,0.75538049531395,0.498386552850055,2,35,forebrain generation of neurons,BP,FGFR2;INHBA
14852,GO:0070577,0.755435823247342,0.604873736384861,1,16,lysine-acetylated histone binding,MF,TAF1
17305,GO:0140033,0.755435823247342,0.604873736384861,1,16,acetylation-dependent protein binding,MF,TAF1
14562,GO:0070063,0.755559878242461,0.450026619218093,3,53,RNA polymerase binding,MF,RRN3;SMYD2;HNRNPU
13111,GO:0051602,0.755572667876415,0.602906076195666,1,18,response to electrical stimulus,BP,NQO1
953,GO:0002369,0.75576341881909,0.601226913661802,1,20,T cell cytokine production,BP,TRAF2
6760,GO:0030178,0.755774232923589,0.360219284059338,9,154,negative regulation of Wnt signaling pathway,BP,CYLD;SFRP1;G3BP1;WNT4;KREMEN2;RBMS3;PSME2;PSMB9;PSMB10
9699,GO:0038084,0.75596002414711,0.602369842020564,1,18,vascular endothelial growth factor signaling pathway,BP,HSPB1
13590,GO:0060037,0.755998413375318,0.603152969766485,1,17,pharyngeal system development,BP,TGFB2
18466,GO:1903523,0.756115309532641,0.602991185924858,1,17,negative regulation of blood circulation,BP,ADM
13145,GO:0051668,0.756285484482932,0.401277224015025,5,84,localization within membrane,BP,NDC1;GPHN;NETO1;CDH13;ITGB1BP1
11609,GO:0046174,0.756378425739291,0.60178992456148,1,18,polyol catabolic process,BP,MTMR2
5079,GO:0015301,0.756413375146762,0.601741450392961,1,18,anion:anion antiporter activity,MF,SLC4A11
7850,GO:0032402,0.756446242986096,0.60094915409779,1,19,melanosome transport,BP,BBS5
13260,GO:0051904,0.756446242986096,0.60094915409779,1,19,pigment granule transport,BP,BBS5
12298,GO:0048596,0.756448914675847,0.604548605302941,1,15,embryonic camera-type eye morphogenesis,BP,PHACTR4
17731,GO:1901616,0.756470930191646,0.496356107305626,2,37,organic hydroxy compound catabolic process,BP,CYP24A1;MTMR2
16646,GO:0097484,0.756790196402058,0.602056023297883,1,17,dendrite extension,BP,NEDD4L
12878,GO:0051179,0.757424070920097,0.266197625331204,305,4312,localization,BP,CRYAB;IGFBP3;HEPHL1;KRT1;SAA1;FTL;FTH1;NEFL;NRG1;HDAC9;TRIM16;FN1;TNS3;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;KRT2;TFRC;CYR61;C3;STAT5A;TRIM22;STARD13;S100P;SLC16A2;CTGF;MMP9;FBN1;GNPTAB;VMP1;TAP1;HSPG2;SLC7A2;MYO1B;IL1R2;B4GALT1;ACTG1;G6PD;TSC22D3;IRS1;VPS13B;DYNC2H1;MID1;SLC16A9;TP53;DAPK3;SLC7A5P2;EDN1;GBP1;DOCK10;ABCF1;C1QTNF1;RBM4;ACSL3;PTPN14;GEMIN5;LGALS3;CHP1;SLC4A11;ACO1;PDPN;AKAP8;TGFB2;CNTNAP1;RBM22;CYLD;IKBKE;IL16;SRSF2;PCDH7;SLC30A6;SLC9A3R1;DKC1;INHBA;NUP50;SLC22A5;PHAX;SYK;EMP2;TJP2;NUP153;RAB32;LEPR;SHISA9;SHQ1;ABCG2;ARFRP1;LRRC8D;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;GEMIN4;DST;VPS8;ATP2B1;APOL6;KEAP1;SLC5A6;HRNR;RPA1;AP5M1;POLR1A;TPM1;PTPRB;ULK4;ABCC4;REEP1;ADAMTS9;KCNS3;PTGER4;LSG1;OPHN1;ADM;MGAM;IMMP2L;CD109;NDC1;CADPS2;DYNLL2;HNRNPA1L2;SLC35A4;SLC1A3;CASC3;CCL20;PLK2;RRAGB;SLCO4C1;MME;UBQLN2;NEXN;FRK;GBP5;AKAP8L;NOP58;HSPB1;RHOG;WNT4;CXCL16;LCP1;PTPRM;SIRPA;THOC1;RAN;RANBP2;SOD2;CORO1C;ATP2C1;DDX3X;RAB26;IL24;GPHN;KLHL21;ITGAV;SOCS1;SET;ARNTL;QPCT;SNX11;TRPM7;AJUBA;KCNQ5;CROT;SNX5;NETO1;CDCA5;GNL3L;YRDC;BAIAP2;CDH13;PHACTR4;SRF;GDAP1;NPNT;PDGFB;UGT8;CHID1;TBC1D15;ANTXR1;RTKN2;CLU;NUP160;USP6;SDAD1;ENPP1;FRAS1;PIK3R3;COMMD9;NUP54;LRPPRC;SPNS1;ACKR3;SETD2;GLIS2;ANLN;TIMM23B;RPF2;THBD;ABCC9;GLIPR2;JPH1;NNT;THADA;SLC11A2;BLOC1S2;APEX1;RIC3;CXCR5;CNTNAP2;UMPS;HSPA8;SYT11;HSP90AB1;ARL6IP5;NSF;LAIR1;NEDD4L;SGK1;M6PR;ZFYVE27;BRCA2;GEMIN8;TRAK2;CCAR1;WDPCP;MTMR2;CENPF;GOSR1;TMEM165;L1CAM;STEAP4;RAB3GAP1;SCFD2;BBS5;GPER1;FAF1;WDR75;ADAM17;MYO10;ATR;NTN1;PSME2;CEP152;LILRB3;PSMB9;ABCA5;NFKBIE;CBLL1;SHTN1;RABEP2;DPYSL3;EBP;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;CITED2;SLC9A9;TAP2;CSF1;AP3B1;CLOCK;GLIPR1;KIF14;MPP5;AZIN1;ESR1;PARD3;CLCC1;GJC1;EHD1;KCNE4;ARV1;TNF;NEDD9;SRSF7;STARD7;CCL5;CD74;HNRNPU;FGFR1OP;PSMB10;DCTN5;SLC43A2;PANX1;TRAM2;ZNHIT6;FTO;NRAS;ABCA11P;CDKN1A;ITGB1BP1;SLC25A22;CTCF;SLC41A2;ASTN2;TSGA13;RBM8A;RPS12;BUD13
20319,GO:2001258,0.757437026000127,0.598899819804651,1,20,negative regulation of cation channel activity,BP,MMP9
16380,GO:0090662,0.75771019297566,0.597912474788718,1,21,ATP hydrolysis coupled transmembrane transport,BP,ABCC4
17035,GO:0099131,0.75771019297566,0.597912474788718,1,21,ATP hydrolysis coupled ion transmembrane transport,BP,ABCC4
6294,GO:0019901,0.75774471785698,0.299673638950008,36,526,protein kinase binding,MF,NRG1;HDAC9;FGFR2;TRIM22;TRAF3;IRS1;TP53;CDKN2A;ACSL3;PTPN14;CYLD;SRSF2;SYK;EMP2;RELB;POLA1;HSPB1;RHOG;CDC25A;ITGAV;SOCS1;HSP90AB1;EPHB6;NSF;IL12RB2;FAF1;CEP152;TRAF2;TELO2;CCNA2;KIF14;ESR1;FGFR1OP;DAXX;CDKN1A;ITGB1BP1
5512,GO:0016460,0.757877718737199,0.605240756956814,1,13,myosin II complex,CC,MYH11
8272,GO:0033046,0.758275451111434,0.494168207125639,2,36,negative regulation of sister chromatid segregation,BP,ANAPC15;CENPF
13310,GO:0051985,0.758275451111434,0.494168207125639,2,36,negative regulation of chromosome segregation,BP,ANAPC15;CENPF
9493,GO:0036119,0.758413649885585,0.599798611109642,1,17,response to platelet-derived growth factor,BP,CCNA2
2954,GO:0006486,0.758557777125539,0.337156471937621,13,204,protein glycosylation,BP,B4GALT1;SPON1;CHP1;ST6GALNAC5;GALNT18;MUC16;LFNG;DPY19L2P2;TET3;TRAK2;TMEM165;MUC5B;MUC6
10519,GO:0043413,0.758557777125539,0.337156471937621,13,204,macromolecule glycosylation,BP,B4GALT1;SPON1;CHP1;ST6GALNAC5;GALNT18;MUC16;LFNG;DPY19L2P2;TET3;TRAK2;TMEM165;MUC5B;MUC6
9705,GO:0038093,0.758584548217913,0.356755574547861,9,156,Fc receptor signaling pathway,BP,ACTG1;SYK;BAIAP2;HSP90AB1;MYO10;PSME2;PSMB9;PSMB10;NRAS
8520,GO:0033692,0.758675254599864,0.446222893361721,3,51,cellular polysaccharide biosynthetic process,BP,IRS1;PPP1R3B;ENPP1
4823,GO:0014015,0.758708536112659,0.493577440897491,2,36,positive regulation of gliogenesis,BP,IL6ST;CSF1
9250,GO:0035637,0.758881587515659,0.384307028138204,6,91,multicellular organismal signaling,BP,CNTNAP1;ATP2B1;ABCC9;CNTNAP2;GPER1;GJC1
9204,GO:0035580,0.758980443008801,0.49221682388676,2,40,specific granule lumen,CC,FRK;QPCT
8038,GO:0032677,0.759427690734397,0.491833244229372,2,39,regulation of interleukin-8 production,BP,TLR3;TNF
12843,GO:0051129,0.759435644994405,0.300258971769421,33,492,negative regulation of cellular component organization,BP,CRYAB;SACS;MID1;GBP1;LGALS3;RAD1;NBN;PTGER4;PLK2;UBQLN2;KANK4;ANAPC15;CORO1C;DDX3X;SET;TRIM37;GNL3L;ANTXR1;CLU;HSPA8;SYT11;TRAK2;MTMR2;CENPF;CHEK1;NTN1;CFLAR;DPYSL3;KIF14;TNF;HNRNPU;ITGB1BP1;IRAK3
15295,GO:0071459,0.759482964876508,0.596038998928472,1,20,protein localization to chromosome, centromeric region,BP,CTCF
9084,GO:0035327,0.759588358327516,0.595891148325183,1,20,transcriptionally active chromatin,CC,ESR1
6727,GO:0030135,0.759622314087388,0.335823347745236,13,208,coated vesicle,CC,TFRC;HLA-B;SPG21;EDN1;IL7R;HLA-F;VPS41;HSPA8;TMEM199;M6PR;AP3B1;CD74;ASTN2
792,GO:0002053,0.75985058580899,0.596948943224605,1,18,positive regulation of mesenchymal cell proliferation,BP,FGFR2
2572,GO:0005856,0.760137879021948,0.273442858151333,112,1566,cytoskeleton,CC,CRYAB;KRT1;SAA1;NEFL;KRT34;KRT4;MAP2;KRT13;KIF23;AMOT;MTUS1;KRT2;KRT15;NLRC5;TAP1;MYO1B;ACTG1;NEFM;KRTAP2-3;ENC1;DYNC2H1;MID1;DAPK3;SIPA1L3;KBTBD8;TCP11L1;ZNF397;PTPN14;STAG1;CHP1;CYLD;PDLIM1;SLC9A3R1;NUAK1;PHAX;DNHD1;RELB;VPS41;KRT9;MCM2;DST;KEAP1;TCHH;TPM1;OPHN1;NDC1;DYNLL2;MDN1;SYNPO2L;PLK2;NEXN;KANK4;HSPB1;RHOG;LCP1;RAN;RANBP2;TOPBP1;CORO1C;GPHN;KLHL21;TAF1D;AJUBA;CGNL1;KRT24;MCM3;CDC42EP2;BAIAP2;BRCC3;ODF2L;RTKN2;CEP95;CLU;LRPPRC;EYA3;TPM4;RIF1;FGD6;ANLN;SRPRB;TJP1;BLOC1S2;APEX1;ARL6IP5;MYH11;BRCA2;KRT10;SKA2;WDPCP;CENPF;PLEKHA7;CHEK1;BBS5;GPER1;RAD18;ADAM17;MYO10;CEP152;NOL9;ZNF12;SHTN1;DPYSL3;UPF3B;ORC2;KIF14;SYNPO2;PARD3;NEDD9;HNRNPU;FGFR1OP;DCTN5;ITGB1BP1
16443,GO:0097061,0.760719338905073,0.443675759267117,3,50,dendritic spine organization,BP,DOCK10;BAIAP2;MTMR2
10923,GO:0044463,0.760738315530309,0.282820274005911,63,896,cell projection part,CC,CRYAB;NEFL;NRG1;MAP2;SACS;S100P;B4GALT1;DYNC2H1;DOCK10;NQO1;PDPN;CNTNAP1;CYLD;IL6ST;SLC9A3R1;SLC22A5;DNHD1;SHISA9;AP3M2;DST;ATP2B1;SLC5A6;TPM1;OPHN1;DYNLL2;CASC3;PLK2;MME;HSPB1;LCP1;GPRIN1;GPHN;ITGAV;BAIAP2;ANTXR1;CLU;SLC11A2;BLOC1S2;CNTNAP2;HSPA8;SYT11;HSP90AB1;NSF;ZFYVE27;TRAK2;WDPCP;MTMR2;CENPF;L1CAM;BBS5;GPER1;ADAM17;MYO10;SHTN1;DPYSL3;AKR1B1;HNRNPR;AP3B1;PARD3;EHD1;PHLPP2;PHLPP1;RBM8A
17278,GO:0120038,0.760738315530309,0.282820274005911,63,896,plasma membrane bounded cell projection part,CC,CRYAB;NEFL;NRG1;MAP2;SACS;S100P;B4GALT1;DYNC2H1;DOCK10;NQO1;PDPN;CNTNAP1;CYLD;IL6ST;SLC9A3R1;SLC22A5;DNHD1;SHISA9;AP3M2;DST;ATP2B1;SLC5A6;TPM1;OPHN1;DYNLL2;CASC3;PLK2;MME;HSPB1;LCP1;GPRIN1;GPHN;ITGAV;BAIAP2;ANTXR1;CLU;SLC11A2;BLOC1S2;CNTNAP2;HSPA8;SYT11;HSP90AB1;NSF;ZFYVE27;TRAK2;WDPCP;MTMR2;CENPF;L1CAM;BBS5;GPER1;ADAM17;MYO10;SHTN1;DPYSL3;AKR1B1;HNRNPR;AP3B1;PARD3;EHD1;PHLPP2;PHLPP1;RBM8A
15896,GO:0072604,0.760937214335625,0.594670535347673,1,19,interleukin-6 secretion,BP,SYT11
1499,GO:0003841,0.761239745698745,0.594997800291371,1,18,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT1
6288,GO:0019894,0.761328596591452,0.490578147550969,2,34,kinesin binding,MF,TRAK2;SHTN1
7049,GO:0030817,0.761345204375672,0.594095896533293,1,19,regulation of cAMP biosynthetic process,BP,GPER1
6999,GO:0030674,0.761411046483245,0.360912678948511,8,129,protein binding, bridging,MF,NEFL;TRIM22;CBX5;IRS1;CNTNAP1;TJP2;NUFIP1;BAIAP2
4400,GO:0010107,0.76182298655774,0.594176148024563,1,18,potassium ion import,BP,ABCC9
10895,GO:0044425,0.762320504482188,0.262032362426766,260,3707,membrane part,CC,CRYAB;HEPHL1;NRG1;FN1;TENM3;PTGES;PML;CYP1B1;AMOT;JPH2;TFRC;GPRC5A;FGFR2;UGT1A6;EPGN;FADS3;S100P;SLC16A2;HLA-B;GNPTAB;VMP1;TAP1;HSPG2;SLC7A2;CYP1A1;ERVFRD-1;CLN6;IL1R2;FAT4;B4GALT1;G6PD;SPACA6;FAM69B;TRAF3;PLD5;IRS1;SLC16A9;DAPK3;SLC7A5P2;TPST1;SCD;SIPA1L3;TMEM106A;C1QTNF1;TMPPE;ACSL3;MEGF11;LGALS3;IFNGR1;SLC4A11;PDPN;ST6GALNAC5;CNTNAP1;CYLD;PKMYT1;CDKAL1;IL27RA;PCDH7;LRFN4;SLC30A6;IL6ST;SLC9A3R1;IL7R;SLC22A5;GALNT18;SYK;EMP2;NAIP;GPR132;LEPR;SHISA9;VEZT;ABCG2;LSS;LRRC8D;HLA-F;SFRP1;VPS41;AP3M2;HLA-DOB;ZDHHC6;CD274;LAYN;ABHD4;DST;ATP2B1;SLC5A6;AP5M1;TPM1;PTPRB;RCE1;ABCC4;REEP1;DRAM1;KCNS3;PTGER4;TMEM97;TMEM248;PARD3B;MGAM;IMMP2L;CD109;GGCX;NDC1;CADPS2;SLC35A4;SLC1A3;RRAGB;SLCO4C1;MME;TMEM212;MUC16;FRK;BTN2A1;RHOG;CXCL16;LCP1;PTPRM;SIRPA;RANBP2;HS3ST1;CORO1C;ATP2C1;RAB26;GPHN;RRP12;ITGAV;ABCF2;SNX11;TRPM7;KCNQ5;LFNG;PGK1;SNX5;NETO1;HACD2;FRRS1;BAIAP2;CDH13;GDAP1;FNDC3B;NPNT;APMAP;PDGFB;UGT8;KREMEN2;SDK1;FZD1;NFE2L1;ANTXR1;ENPP1;BIRC3;FRAS1;PIK3R3;MBOAT1;LRPPRC;SPNS1;ACKR3;FAM173B;SRD5A1;TMEM14EP;TIMM23B;TMEM51;THBD;UPK3B;ABCC9;JPH1;SRPRB;DPY19L2P2;NNT;IFNAR1;TJP1;LRRN3;THADA;ERAP1;SLC11A2;RIC3;CXCR5;CNTNAP2;HSPA8;GLIPR1L2;SYT11;ERVMER34-1;TMEM199;HSP90AB1;ARL6IP5;EPHB6;BACE2;SCD5;LYSMD4;GREB1;LAIR1;MFSD12;SGK1;M6PR;ZFYVE27;PXMP2;TMEM138;HCAR1;CYB561D2;WDPCP;MTMR2;GOSR1;TMEM165;L1CAM;STEAP4;CCDC47;RAB3GAP1;IL12RB2;BBS5;GPER1;FAF1;ADAM17;MYO10;LILRB3;CFLAR;CMTM3;ABCA5;SDHD;UGT1A4;ARIH2OS;EBP;UBE2J2;VPS36;TRAF2;TPRA1;CYP20A1;SLC9A9;TAP2;UQCRB;CSF1;AP3B1;GLIPR1;TLR3;ERVK13-1;ESR1;PARD3;CLCC1;GJC1;RNF19B;EHD1;KCNE4;ARV1;TNF;CD74;SLC43A2;PHLPP2;PANX1;TRAM2;SMIM7;PHLPP1;HNRNPM;ABCA11P;SLC25A22;TREX1;SLC41A2;ASTN2;NDUFB9;TMEM234;IFI27L1
10904,GO:0044438,0.762913043340264,0.411534503546639,4,74,microbody part,CC,ACSL3;CROT;TTC1;PXMP2
10905,GO:0044439,0.762913043340264,0.411534503546639,4,74,peroxisomal part,CC,ACSL3;CROT;TTC1;PXMP2
17965,GO:1902275,0.763637666605435,0.351048705540351,9,141,regulation of chromatin organization,BP,TP53;AKAP8;SETDB1;AKAP8L;SET;RIF1;CHEK1;HNRNPU;CTCF
15453,GO:0071709,0.763674601533635,0.591557944901994,1,18,membrane assembly,BP,EMP2
17259,GO:0110053,0.763838972322369,0.334875750323432,12,189,regulation of actin filament organization,BP,CTGF;SFRP1;TPM1;PTGER4;SYNPO2L;KANK4;RHOG;WNT4;CDC42EP2;BAIAP2;SYNPO2;ITGB1BP1
12612,GO:0050769,0.764185346252876,0.311891987455764,20,296,positive regulation of neurogenesis,BP,NEFL;NRG1;FN1;TENM3;ENC1;IL6ST;RRN3;BAIAP2;SRF;FZD1;NEDD4L;ZFYVE27;L1CAM;GPER1;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;CSF1
10193,GO:0042775,0.764278163698601,0.435849710331188,3,79,mitochondrial ATP synthesis coupled electron transport,BP,SDHD;UQCRB;NDUFB9
14855,GO:0070584,0.764413946134515,0.588456981211896,1,21,mitochondrion morphogenesis,BP,PANK2
12912,GO:0051234,0.764493905804654,0.260355505634601,239,3436,establishment of localization,BP,CRYAB;HEPHL1;KRT1;SAA1;FTL;FTH1;NEFL;NRG1;TRIM16;FN1;PML;KIF23;JPH2;TFRC;C3;STAT5A;S100P;SLC16A2;CTGF;MMP9;GNPTAB;VMP1;TAP1;HSPG2;SLC7A2;MYO1B;IL1R2;B4GALT1;ACTG1;G6PD;TSC22D3;IRS1;VPS13B;DYNC2H1;SLC16A9;TP53;SLC7A5P2;EDN1;GBP1;ABCF1;C1QTNF1;RBM4;ACSL3;PTPN14;GEMIN5;LGALS3;CHP1;SLC4A11;ACO1;AKAP8;TGFB2;RBM22;IL16;SRSF2;PCDH7;SLC30A6;SLC9A3R1;DKC1;INHBA;NUP50;SLC22A5;PHAX;SYK;EMP2;TJP2;NUP153;RAB32;LEPR;SHISA9;ABCG2;ARFRP1;LRRC8D;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;GEMIN4;DST;VPS8;ATP2B1;APOL6;SLC5A6;HRNR;AP5M1;PTPRB;ABCC4;REEP1;ADAMTS9;KCNS3;PTGER4;LSG1;OPHN1;ADM;MGAM;IMMP2L;CD109;NDC1;CADPS2;DYNLL2;HNRNPA1L2;SLC35A4;SLC1A3;CASC3;SLCO4C1;MME;UBQLN2;FRK;GBP5;AKAP8L;HSPB1;RHOG;CXCL16;LCP1;SIRPA;THOC1;RAN;RANBP2;CORO1C;ATP2C1;DDX3X;RAB26;ITGAV;SOCS1;SET;ARNTL;QPCT;SNX11;TRPM7;KCNQ5;CROT;SNX5;NETO1;CDCA5;YRDC;BAIAP2;CDH13;GDAP1;NPNT;PDGFB;CHID1;TBC1D15;ANTXR1;CLU;NUP160;USP6;SDAD1;ENPP1;FRAS1;PIK3R3;COMMD9;NUP54;LRPPRC;SPNS1;ACKR3;SETD2;TIMM23B;ABCC9;JPH1;NNT;THADA;SLC11A2;BLOC1S2;UMPS;HSPA8;SYT11;HSP90AB1;ARL6IP5;NSF;LAIR1;NEDD4L;SGK1;M6PR;ZFYVE27;BRCA2;GEMIN8;TRAK2;WDPCP;MTMR2;CENPF;GOSR1;TMEM165;STEAP4;RAB3GAP1;SCFD2;BBS5;GPER1;WDR75;MYO10;ATR;NTN1;PSME2;LILRB3;PSMB9;ABCA5;NFKBIE;CBLL1;RABEP2;EBP;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;SLC9A9;TAP2;AP3B1;CLOCK;GLIPR1;KIF14;AZIN1;PARD3;CLCC1;GJC1;EHD1;KCNE4;ARV1;TNF;SRSF7;STARD7;CCL5;CD74;HNRNPU;PSMB10;DCTN5;SLC43A2;PANX1;TRAM2;NRAS;ABCA11P;CDKN1A;ITGB1BP1;SLC25A22;SLC41A2;ASTN2;TSGA13;RBM8A;RPS12;BUD13
797,GO:0002063,0.764604681537428,0.591086784720961,1,17,chondrocyte development,BP,COL27A1
3431,GO:0007221,0.76476555968053,0.591817480106601,1,16,positive regulation of transcription of Notch receptor target,BP,PBX1
15333,GO:0071514,0.765002770366275,0.589670759494412,1,18,genetic imprinting,BP,CTCF
11537,GO:0046037,0.765110626472398,0.588758621391659,1,19,GMP metabolic process,BP,TJP2
683,GO:0001890,0.765220784106541,0.364858187148702,7,116,placenta development,BP,CYR61;FGFR2;ADM;PDGFB;SETD2;HSP90AB1;E2F8
4859,GO:0014069,0.765257220558961,0.343161996808156,10,150,postsynaptic density,CC,CRYAB;MAP2;SHISA9;NETO1;BAIAP2;SYT11;NSF;DGCR8;MTMR2;GPER1
8092,GO:0032768,0.765334383341371,0.483705424032557,2,39,regulation of monooxygenase activity,BP,DHFR;TNF
4678,GO:0010824,0.765452461558298,0.484037412412465,2,37,regulation of centrosome duplication,BP,PLK2;TRIM37
1932,GO:0004623,0.765660269557842,0.587292879663946,1,20,phospholipase A2 activity,MF,PLBD1
2441,GO:0005640,0.765665609080276,0.589577252288252,1,17,nuclear outer membrane,CC,LRPPRC
3558,GO:0007600,0.766092330286103,0.328134914116856,13,208,sensory perception,BP,CYP1B1;CLN6;EDN1;SLC9A3R1;SLC1A3;MME;EYA3;NAV2;BBS5;GJC1;WDR36;CCDC50;NDUFB9
8364,GO:0033233,0.766296307639488,0.586382974341794,1,20,regulation of protein sumoylation,BP,GNL3L
13820,GO:0060389,0.766314425233909,0.482842562774263,2,37,pathway-restricted SMAD protein phosphorylation,BP,TGFB2;INHBA
2103,GO:0004867,0.7665102494714,0.481629181514498,2,41,serine-type endopeptidase inhibitor activity,MF,CD109;SERPINB9
15892,GO:0072595,0.766527171512515,0.482292634258562,2,38,maintenance of protein localization in organelle,BP,PML;HNRNPU
11883,GO:0046872,0.766685494511683,0.259134112852135,210,2926,metal ion binding,MF,CRYAB;IGFBP3;HEPHL1;TRIM47;FTL;FTH1;DTX2;HDAC9;C1R;TRIM16;PML;CYP1B1;GCLC;CYP24A1;TRIM22;S100P;MMP9;FBN1;GNPTAB;HSPG2;XAF1;CYP1A1;FAT4;B4GALT1;MAT2A;SPON1;TRIM56;OVCH2;TRAF3;COL27A1;MID1;TP53;SVEP1;EXO1;C9ORF3;SCD;TMPPE;RBM4;ZBED1;ZNF397;PRUNE2;CHP1;ACO1;AKAP8;ZNF208;RBM22;CARS2;CYLD;PKMYT1;PDLIM1;CDKAL1;PCDH7;P3H2;NUAK1;GALNT18;NUP153;NAIP;ZFP42;BRIP1;VPS41;MCM2;DST;VPS8;ATP2B1;USP16;TCHH;ZNF827;HRNR;RPA1;POLR1A;ZMAT2;GLIS3;CSRP1;POLA1;ADAMTS9;SETDB1;TK1;ZNF584;TRAF1;P4HA2;ZNF407;CADPS2;SLC1A3;ZNF512;MME;ZNF587;HSCB;AKAP8L;DOHH;SUV39H2;LCP1;EXOG;KDM6A;RAN;RANBP2;SOD2;ATP2C1;NUFIP1;CPA4;ARHGEF28;GPHN;RNF115;ITGAV;QPCT;TRPM7;AJUBA;ZNF267;LFNG;ZC3H7B;TRIM37;FEN1;FRRS1;ZNF586;SH3RF2;APTX;CDH13;COL5A2;MDM4;HIF1AN;NPNT;ZNF234;BRCC3;UTY;ANTXR1;SMYD2;ENPP1;BIRC3;FRAS1;ZNF316;RRM2;ZNF670;EYA3;ZNF106;TPM4;TYW1;FGD6;SETD2;GLIS2;THBD;TTF2;DTX4;WEE1;ZNF484;ERAP1;SLC11A2;APEX1;ZNF57;TET3;SYT11;SCD5;ZBTB24;NSF;DNPEP;PRIM2;ZBTB12;ZFYVE27;TRMT1;DGCR8;DPYD;LIMCH1;CYB561D2;MAZ;ZNF33A;ZNFX1;STEAP4;CCDC47;LNX2;MLLT10;RAD18;RPTN;ADAM17;MSH6;ZNF12;RFWD3;BAZ2B;SDHD;CBLL1;ZNF608;CSRP2;MYNN;TRAF2;CYP20A1;POLR3B;ZNF286A;ESR1;RNF19B;EHD1;CAPN12;PDSS1;ZFP36L2;SRSF7;RC3H1;RING1;ZSCAN31;METAP2;PHF14;PHLPP2;YPEL4;PHLPP1;ZNHIT6;FTO;THTPA;CDKN1A;TREX1;ZNF471;CTCF;ASTN2;GTF2H3;ZBTB9;IRAK3
17412,GO:1900117,0.76670804392897,0.585793008253721,1,20,regulation of execution phase of apoptosis,BP,TP53
1311,GO:0003156,0.766805167728953,0.585653733886846,1,20,regulation of animal organ formation,BP,CITED2
18837,GO:1904376,0.766889112309702,0.586216310436789,1,19,negative regulation of protein localization to cell periphery,BP,GBP1
20310,GO:2001244,0.767204792525005,0.480073487118369,2,44,positive regulation of intrinsic apoptotic signaling pathway,BP,TP53;SLC9A3R1
20051,GO:2000637,0.767405634318759,0.585475355142187,1,19,positive regulation of gene silencing by miRNA,BP,AJUBA
7312,GO:0031307,0.76748936553045,0.584054358096333,1,21,integral component of mitochondrial outer membrane,CC,GDAP1
12080,GO:0048013,0.76776247119493,0.405365832842373,4,72,ephrin receptor signaling pathway,BP,MMP9;ACTG1;ARHGEF28;EPHB6
18530,GO:1903649,0.767793314237499,0.584918453844896,1,19,regulation of cytoplasmic transport,BP,MTMR2
4184,GO:0009260,0.768177315576527,0.333954168615161,11,184,ribonucleotide biosynthetic process,BP,PANK2;NUP50;NUP153;ADM;NDC1;RANBP2;PGK1;NUP160;NUP54;UMPS;GPER1
5004,GO:0015144,0.768534936979543,0.58385126759842,1,19,carbohydrate transmembrane transporter activity,MF,M6PR
1125,GO:0002711,0.768687474373002,0.582327987739937,1,21,positive regulation of T cell mediated immunity,BP,TRAF2
724,GO:0001947,0.768790046970378,0.47995383575644,2,35,heart looping,BP,SRF;BBS5
8142,GO:0032835,0.769249799325656,0.479312298092396,2,35,glomerulus development,BP,PDGFB;CFLAR
12179,GO:0048278,0.769467801402887,0.431038571523376,3,56,vesicle docking,BP,RAB26;NSF;SCFD2
14405,GO:0061640,0.769778469386988,0.402999689435885,4,69,cytoskeleton-dependent cytokinesis,BP,KIF23;RTKN2;ANLN;BRCA2
18323,GO:1903203,0.770275740372823,0.581336701061998,1,19,regulation of oxidative stress-induced neuron death,BP,FZD1
4165,GO:0009226,0.770428824637793,0.57980754016251,1,21,nucleotide-sugar biosynthetic process,BP,UAP1L1
19071,GO:1904886,0.770556601732094,0.581695543712122,1,18,beta-catenin destruction complex disassembly,BP,FZD1
17043,GO:0099173,0.770790390178788,0.401870785264923,4,67,postsynapse organization,BP,DOCK10;GPHN;BAIAP2;MTMR2
13712,GO:0060236,0.771049381784665,0.476794940445926,2,35,regulation of mitotic spindle organization,BP,STAG1;HNRNPU
3312,GO:0007017,0.771159000151119,0.280585876329458,42,605,microtubule-based process,BP,CRYAB;NEFL;MAP2;KIF23;MYO1B;DYNC2H1;MID1;STAG1;CHP1;CYLD;DNHD1;NAIP;AP3M2;DST;ULK4;PARD3B;NDC1;DYNLL2;PLK2;MYBL2;HSPB1;RAN;RANBP2;TRIM37;BIRC3;LRPPRC;SETD2;WEE1;BLOC1S2;HSPA8;MYH11;BRCA2;TRAK2;SKA2;CHEK1;MYO10;CEP152;AP3B1;KIF14;PARD3;HNRNPU;FGFR1OP
4565,GO:0010644,0.771250569062628,0.579922680144333,1,19,cell communication by electrical coupling,BP,GJC1
3798,GO:0008374,0.771317897988358,0.475862294801438,2,37,O-acyltransferase activity,MF,CROT;MBOAT1
2383,GO:0005516,0.771696111890109,0.341556280629302,9,130,calmodulin binding,MF,MAP2;MYO1B;CAMK1G;ATP2B1;KCNQ5;USP6;TJP1;MYH11;MYO10
4047,GO:0009083,0.771742436882839,0.578518866706879,1,20,branched-chain amino acid catabolic process,BP,HIBCH
5236,GO:0015850,0.771761921106111,0.367408359292734,6,101,organic hydroxy compound transport,BP,C1QTNF1;SYK;ABCG2;CLU;ABCA5;ARV1
2085,GO:0004842,0.771961275067349,0.294812162454783,25,376,ubiquitin-protein transferase activity,MF,TRIM56;TRAF3;KBTBD8;NAIP;KEAP1;HERC6;ZNF738;KLHL21;RNF115;TRIM37;MDM4;BIRC3;KLHL9;DTX4;NEDD4L;RAD18;RFWD3;CBLL1;SPSB1;UBE2J2;TRAF2;MPHOSPH8;RNF19B;RC3H1;TAF1
591,GO:0001750,0.772169974993936,0.47522236010985,2,35,photoreceptor outer segment,CC,PHLPP2;PHLPP1
156,GO:0000314,0.772218875895671,0.574114024650495,1,28,organellar small ribosomal subunit,CC,MRPS7
2511,GO:0005763,0.772218875895671,0.574114024650495,1,28,mitochondrial small ribosomal subunit,CC,MRPS7
7938,GO:0032509,0.77277276328841,0.577016236112151,1,20,endosome transport via multivesicular body sorting pathway,BP,VPS36
12581,GO:0050714,0.772781300934247,0.339634376001816,9,147,positive regulation of protein secretion,BP,SAA1;TRIM16;TGFB2;SYK;CD274;PTGER4;GPER1;TNF;PANX1
19540,GO:1990391,0.772790296223094,0.474063840284841,2,36,DNA repair complex,CC,MSH6;MSH3
585,GO:0001736,0.772872266710218,0.365589457362587,6,109,establishment of planar polarity,BP,SFRP1;FZD1;PSME2;PSMB9;PSMB10;ASTN2
3385,GO:0007164,0.772872266710218,0.365589457362587,6,109,establishment of tissue polarity,BP,SFRP1;FZD1;PSME2;PSMB9;PSMB10;ASTN2
6558,GO:0021987,0.773113898117091,0.379916186058797,5,81,cerebral cortex development,BP,NEFL;FAT4;SRD5A1;CNTNAP2;KIF14
7166,GO:0031023,0.773640755512237,0.354338895922069,7,115,microtubule organizing center organization,BP,NDC1;PLK2;RANBP2;TRIM37;BRCA2;CHEK1;CEP152
6606,GO:0022624,0.774396321830408,0.572459915943528,1,24,proteasome accessory complex,CC,PSME2
2371,GO:0005496,0.774809182282011,0.423923694893794,3,55,steroid binding,MF,AKR1C2;GPER1;ESR1
10191,GO:0042773,0.774912280964785,0.421412742142276,3,80,ATP synthesis coupled electron transport,BP,SDHD;UQCRB;NDUFB9
12502,GO:0050434,0.775045987191137,0.469883728048143,2,40,positive regulation of viral transcription,BP,NUCKS1;POLR2F
10511,GO:0043403,0.775366880441027,0.573211739856338,1,20,skeletal muscle tissue regeneration,BP,CFLAR
5164,GO:0015701,0.775414095177568,0.573835208557887,1,19,bicarbonate transport,BP,SLC4A11
13601,GO:0060048,0.775506884489576,0.395840003251498,4,65,cardiac muscle contraction,BP,CTGF;TPM1;NEDD4L;GJC1
5267,GO:0015909,0.77565021285831,0.469756217505137,2,37,long-chain fatty acid transport,BP,ACSL3;SYK
14859,GO:0070588,0.776055162278426,0.329804274527565,10,156,calcium ion transmembrane transport,BP,JPH2;G6PD;ATP2B1;ATP2C1;ITGAV;TRPM7;JPH1;THADA;GPER1;PANX1
16487,GO:0097150,0.776484403598538,0.573898331764989,1,17,neuronal stem cell population maintenance,BP,FANCD2
9599,GO:0036442,0.776594921066132,0.570205015873997,1,22,proton-exporting ATPase activity,MF,ATP2C1
335,GO:0000930,0.776885890422996,0.571664447966923,1,19,gamma-tubulin complex,CC,BLOC1S2
8659,GO:0034198,0.776903502922774,0.467480522682461,2,39,cellular response to amino acid starvation,BP,RRAGB;CDKN1A
11861,GO:0046824,0.776970164259325,0.421414020378428,3,52,positive regulation of nucleocytoplasmic transport,BP,TP53;RBM22;HSP90AB1
3425,GO:0007215,0.777138543189855,0.467915822984477,2,36,glutamate receptor signaling pathway,BP,SHISA9;NETO1
9499,GO:0036126,0.77724854053501,0.466990274595113,2,39,sperm flagellum,CC,SLC9A3R1;RAN
16744,GO:0097729,0.77724854053501,0.466990274595113,2,39,9+2 motile cilium,CC,SLC9A3R1;RAN
16795,GO:0098586,0.77744370911308,0.467211286722053,2,37,cellular response to virus,BP,IKBKE;BIRC3
18325,GO:1903205,0.777913225084042,0.568819469888695,1,21,regulation of hydrogen peroxide-induced cell death,BP,TP53
253,GO:0000717,0.777991084145505,0.568134151507904,1,22,nucleotide-excision repair, DNA duplex unwinding,BP,GTF2H3
13765,GO:0060317,0.77813101220575,0.569820235729384,1,19,cardiac epithelial to mesenchymal transition,BP,TGFB2
13294,GO:0051962,0.778308900967563,0.291953257341369,22,327,positive regulation of nervous system development,BP,NEFL;NRG1;FN1;TENM3;ENC1;IL6ST;RRN3;BAIAP2;SRF;FZD1;LRRN3;NEDD4L;ZFYVE27;L1CAM;GPER1;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;CSF1;PARD3
9901,GO:0042171,0.778327669741933,0.569528301843375,1,19,lysophosphatidic acid acyltransferase activity,MF,MBOAT1
15393,GO:0071617,0.778327669741933,0.569528301843375,1,19,lysophospholipid acyltransferase activity,MF,MBOAT1
1344,GO:0003203,0.778522323143327,0.570015293987744,1,18,endocardial cushion morphogenesis,BP,TGFB2
5322,GO:0016042,0.778724368244984,0.316681709212236,12,203,lipid catabolic process,BP,CYP1B1;CYP24A1;IRS1;CDK4;GPCPD1;ABHD4;CROT;MMAA;HADHB;TNF;PLBD1;HIBCH
12906,GO:0051225,0.778725401211174,0.358600369718438,6,99,spindle assembly,BP,KIF23;STAG1;NAIP;MYBL2;BIRC3;HNRNPU
9391,GO:0035914,0.779237415762578,0.464655916183519,2,37,skeletal muscle cell differentiation,BP,DDX17;ARNTL
7849,GO:0032401,0.779422104472454,0.567202788261525,1,20,establishment of melanosome localization,BP,BBS5
13261,GO:0051905,0.779422104472454,0.567202788261525,1,20,establishment of pigment granule localization,BP,BBS5
363,GO:0000981,0.779471644469548,0.267582806470386,49,714,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,MAFB;FOSL2;STAT5A;RUNX1;PBX1;TSC22D3;TFCP2L1;TP53;ZBED1;STAG1;IRX2;FOXD2;ZFP42;RELB;NUCKS1;AHR;TAF2;ELMSAN1;MYBL2;UBTF;ARNTL;ZNF267;SRF;IRX4;NFE2L1;MACC1;VGLL3;GLIS2;UBP1;MYBL1;ZBTB24;MAZ;E2F8;ETV6;ZNFX1;HSF2;GPER1;ZNF12;RBL1;CLOCK;PURB;ESR1;ZFP36L2;TAF1;TBPL1;SPIB;ARID3B;IRF1;CTCF
7383,GO:0031430,0.779674748536156,0.574054454542935,1,13,M band,CC,CRYAB
9997,GO:0042391,0.780006161620669,0.315291184562442,12,194,regulation of membrane potential,BP,GCLC;PANK2;EDN1;CNTNAP1;NETO1;BAIAP2;ARL6IP5;NEDD4L;MTMR2;RAB3GAP1;GPER1;GJC1
252,GO:0000715,0.78024697406899,0.564248163174883,1,23,nucleotide-excision repair, DNA damage recognition,BP,COPS3
7768,GO:0032279,0.780526594951941,0.324416940383804,10,152,asymmetric synapse,CC,CRYAB;MAP2;SHISA9;NETO1;BAIAP2;SYT11;NSF;DGCR8;MTMR2;GPER1
7946,GO:0032528,0.780541792939794,0.566229089285054,1,19,microvillus organization,BP,SLC9A3R1
2664,GO:0006007,0.781126891443505,0.564022673313338,1,21,glucose catabolic process,BP,PGK1
8026,GO:0032653,0.781370165295858,0.563084832326006,1,22,regulation of interleukin-10 production,BP,CD274
9620,GO:0036475,0.781547523199548,0.564022949334384,1,20,neuron death in response to oxidative stress,BP,FZD1
4675,GO:0010821,0.78177963918329,0.317286274234409,11,190,regulation of mitochondrion organization,BP,NRG1;MMP9;TP53;DYNLL2;CLU;GPER1;WDR75;UBE2J2;STARD7;PPARGC1B;TSGA13
3462,GO:0007281,0.78180686033944,0.335395893819787,8,133,germ cell development,BP,PANK2;BRIP1;WNT4;RAN;DND1;DPY19L2P2;BRCA2;TBPL1
10906,GO:0044440,0.78189646443544,0.283238920758264,25,396,endosomal part,CC,PML;TFRC;HLA-B;MYO1B;SPG21;IKBKE;HLA-F;VPS41;HLA-DOB;VPS8;AP5M1;RRAGB;SNX5;KREMEN2;ANTXR1;SLC11A2;ZFYVE27;MTMR2;TMEM165;STEAP4;ABCA5;VPS36;SLC9A9;TLR3;EHD1
10741,GO:0044088,0.783091550043647,0.458873916644187,2,38,regulation of vacuole organization,BP,UBQLN2;RAB3GAP1
3774,GO:0008328,0.783098147566323,0.562391383360717,1,19,ionotropic glutamate receptor complex,CC,SHISA9
16933,GO:0098878,0.783098147566323,0.562391383360717,1,19,neurotransmitter receptor complex,CC,SHISA9
19866,GO:2000300,0.783162376467293,0.562294563249515,1,19,regulation of synaptic vesicle exocytosis,BP,RAB3GAP1
550,GO:0001671,0.783181328981907,0.560356484362523,1,22,ATPase activator activity,MF,HSCB
6057,GO:0019201,0.7833059512839,0.561376141242706,1,20,nucleotide kinase activity,MF,TJP2
11151,GO:0045182,0.783557618602208,0.457959459287929,2,39,translation regulator activity,MF,DHFR;TYMS
8270,GO:0033044,0.78381155105121,0.292915507187668,18,279,regulation of chromosome organization,BP,PML;TP53;AKAP8;DKC1;NBN;SETDB1;AKAP8L;ANAPC15;SET;FEN1;CDCA5;GNL3L;RIF1;CENPF;CHEK1;ATR;HNRNPU;CTCF
7266,GO:0031228,0.783945743885108,0.457169278072838,2,40,intrinsic component of Golgi membrane,CC,TPST1;LFNG
8562,GO:0033962,0.784049883529045,0.561737775874531,1,18,cytoplasmic mRNA processing body assembly,BP,RC3H1
15881,GO:0072583,0.784283090777798,0.457684203712741,2,36,clathrin-dependent endocytosis,BP,UBQLN2;SYT11
17221,GO:0106027,0.784515659688473,0.411006853460643,3,52,neuron projection organization,BP,DOCK10;BAIAP2;MTMR2
1992,GO:0004709,0.784586345211801,0.411068757676497,3,51,MAP kinase kinase kinase activity,MF,MAP3K14;FGFR2;EPHB6
18131,GO:1902745,0.784714252960952,0.559949273464708,1,19,positive regulation of lamellipodium organization,BP,CORO1C
4579,GO:0010662,0.784725096292467,0.559229355248292,1,20,regulation of striated muscle cell apoptotic process,BP,CFLAR
4377,GO:0010001,0.784729128410042,0.33178236819079,8,131,glial cell differentiation,BP,NRG1;CNTNAP1;IL6ST;CLU;EIF2B5;MPP5;PARD3;EIF2B1
14151,GO:0060997,0.7849186615865,0.456766055464293,2,36,dendritic spine morphogenesis,BP,DOCK10;BAIAP2
11056,GO:0045022,0.785354089317828,0.455607801052269,2,38,early endosome to late endosome transport,BP,EMP2;MTMR2
3318,GO:0007026,0.785362760122346,0.559750492417178,1,18,negative regulation of microtubule depolymerization,BP,MID1
17668,GO:1901379,0.785364293797196,0.456121509141864,2,36,regulation of potassium ion transmembrane transport,BP,NETO1;NEDD4L
15837,GO:0072521,0.785373905880123,0.281828511097413,23,392,purine-containing compound metabolic process,BP,SLC16A9;PANK2;TPST1;NUP50;TJP2;NUP153;ABCG2;ADM;NDC1;RAN;RANBP2;GPHN;CROT;PGK1;NUP160;ENPP1;NUP54;HSPA8;DPYD;GPER1;SDHD;UQCRB;NDUFB9
8014,GO:0032637,0.785394897445493,0.454856075842918,2,41,interleukin-8 production,BP,TLR3;TNF
13826,GO:0060395,0.785714184858284,0.455614985417557,2,36,SMAD protein signal transduction,BP,TGFB2;INHBA
2645,GO:0005980,0.785757792453509,0.558365753783991,1,19,glycogen catabolic process,BP,PPP1R3B
7311,GO:0031306,0.785944358439019,0.556164352626539,1,22,intrinsic component of mitochondrial outer membrane,CC,GDAP1
16,GO:0000030,0.785953645575768,0.556150200631193,1,22,mannosyltransferase activity,MF,DPY19L2P2
5375,GO:0016180,0.786128441223925,0.555883765184195,1,22,snRNA processing,BP,USB1
11698,GO:0046466,0.786315341126999,0.55559871768923,1,22,membrane lipid catabolic process,BP,CYP1B1
13663,GO:0060148,0.786794752482574,0.556081287308271,1,20,positive regulation of posttranscriptional gene silencing,BP,AJUBA
719,GO:0001941,0.787038335850972,0.555709429777038,1,20,postsynaptic membrane organization,BP,GPHN
3185,GO:0006810,0.787450422938258,0.236272950875156,232,3352,transport,BP,CRYAB;HEPHL1;KRT1;SAA1;FTL;FTH1;NEFL;NRG1;TRIM16;FN1;PML;KIF23;JPH2;TFRC;C3;STAT5A;S100P;SLC16A2;CTGF;MMP9;GNPTAB;VMP1;TAP1;HSPG2;SLC7A2;MYO1B;IL1R2;B4GALT1;ACTG1;G6PD;TSC22D3;IRS1;VPS13B;DYNC2H1;SLC16A9;TP53;SLC7A5P2;EDN1;GBP1;ABCF1;C1QTNF1;RBM4;ACSL3;PTPN14;GEMIN5;LGALS3;CHP1;SLC4A11;ACO1;AKAP8;TGFB2;RBM22;IL16;SRSF2;PCDH7;SLC30A6;SLC9A3R1;INHBA;NUP50;SLC22A5;PHAX;SYK;EMP2;TJP2;NUP153;RAB32;LEPR;SHISA9;ABCG2;ARFRP1;LRRC8D;SFRP1;VPS41;AP3M2;ZDHHC6;CD274;GEMIN4;DST;VPS8;ATP2B1;APOL6;SLC5A6;HRNR;AP5M1;PTPRB;ABCC4;REEP1;ADAMTS9;KCNS3;PTGER4;LSG1;OPHN1;ADM;MGAM;IMMP2L;CD109;NDC1;CADPS2;DYNLL2;HNRNPA1L2;SLC35A4;SLC1A3;CASC3;SLCO4C1;MME;UBQLN2;FRK;GBP5;AKAP8L;HSPB1;RHOG;CXCL16;LCP1;SIRPA;THOC1;RAN;RANBP2;CORO1C;ATP2C1;DDX3X;RAB26;ITGAV;SOCS1;SET;ARNTL;QPCT;SNX11;TRPM7;KCNQ5;CROT;SNX5;NETO1;YRDC;BAIAP2;CDH13;GDAP1;PDGFB;CHID1;TBC1D15;ANTXR1;CLU;NUP160;USP6;SDAD1;ENPP1;FRAS1;PIK3R3;COMMD9;NUP54;LRPPRC;SPNS1;ACKR3;SETD2;TIMM23B;ABCC9;JPH1;NNT;THADA;SLC11A2;BLOC1S2;UMPS;HSPA8;SYT11;HSP90AB1;ARL6IP5;NSF;LAIR1;NEDD4L;SGK1;M6PR;ZFYVE27;GEMIN8;TRAK2;MTMR2;CENPF;GOSR1;TMEM165;STEAP4;RAB3GAP1;SCFD2;BBS5;GPER1;WDR75;MYO10;NTN1;PSME2;LILRB3;PSMB9;ABCA5;NFKBIE;CBLL1;RABEP2;EBP;NCBP1;UPF3B;UBE2J2;VPS36;TRAF2;SLC9A9;TAP2;AP3B1;CLOCK;GLIPR1;KIF14;AZIN1;PARD3;CLCC1;GJC1;EHD1;KCNE4;ARV1;TNF;SRSF7;STARD7;CCL5;CD74;PSMB10;DCTN5;SLC43A2;PANX1;TRAM2;NRAS;ABCA11P;CDKN1A;ITGB1BP1;SLC25A22;SLC41A2;ASTN2;TSGA13;RBM8A;RPS12;BUD13
18186,GO:1902911,0.787471016411672,0.36057704582503,5,88,protein kinase complex,CC,IRS1;CDK4;CCNA2;CDKN1A;GTF2H3
5515,GO:0016469,0.787595965085847,0.55263213656946,1,24,proton-transporting two-sector ATPase complex,CC,TMEM199
468,GO:0001508,0.787644156258779,0.379320220248812,4,67,action potential,BP,CNTNAP1;NEDD4L;GPER1;GJC1
12077,GO:0048010,0.78785119515627,0.378550959701415,4,72,vascular endothelial growth factor receptor signaling pathway,BP,ACTG1;HSPB1;ITGAV;BAIAP2
14884,GO:0070647,0.787885630747332,0.252910635285756,63,945,protein modification by small protein conjugation or removal,BP,DTX2;GCLC;TRIM22;TRIM56;TRAF3;ENC1;TP53;KBTBD8;ZBED1;CHP1;CYLD;NUP50;NUP153;NAIP;USP16;KEAP1;RCE1;USP43;NDC1;HERC6;RANBP2;ZNF738;KLHL21;RNF115;CDC25A;SOCS1;TRIM37;GNL3L;SH3RF2;MDM4;BRCC3;NUP160;USP6;BIRC3;NUP54;KLHL9;DTX4;HSP90AB1;NEDD4L;ANAPC7;RAD18;SENP1;PSME2;PSMB9;RFWD3;CBLL1;SPSB1;UBE2J2;TRAF2;CCNA2;MPHOSPH8;ESR1;RNF19B;USP11;FEM1C;RC3H1;RING1;PSMB10;DAXX;TAF1;USP1;COPS3;UFC1
3231,GO:0006886,0.787930017748069,0.254419017719793,58,919,intracellular protein transport,BP,NRG1;PML;GNPTAB;TP53;PTPN14;CHP1;RBM22;SRSF2;NUP50;NUP153;RAB32;VPS41;AP3M2;ZDHHC6;IMMP2L;NDC1;CASC3;AKAP8L;HSPB1;LCP1;THOC1;RAN;RANBP2;RAB26;ARNTL;SNX11;SNX5;GDAP1;TBC1D15;CLU;NUP160;USP6;SDAD1;NUP54;SETD2;TIMM23B;HSPA8;HSP90AB1;NSF;TRAK2;WDR75;NCBP1;UPF3B;UBE2J2;VPS36;AP3B1;PARD3;EHD1;TNF;SRSF7;STARD7;CD74;CDKN1A;ITGB1BP1;TSGA13;RBM8A;RPS12;BUD13
18227,GO:1902991,0.78793142739806,0.554343574172221,1,20,regulation of amyloid precursor protein catabolic process,BP,CLU
2474,GO:0005689,0.787986123632102,0.551182432236298,1,26,U12-type spliceosomal complex,CC,DHX15
2672,GO:0006022,0.788169251663054,0.335724393351179,7,118,aminoglycan metabolic process,BP,HSPG2;CLN6;B4GALT1;CHP1;HS3ST1;PDGFB;CHID1
702,GO:0001919,0.788170774309178,0.553976871597353,1,20,regulation of receptor recycling,BP,NSF
4813,GO:0014002,0.788749539637372,0.553796867111968,1,19,astrocyte development,BP,EIF2B5
9808,GO:0040018,0.788956523706039,0.553479163840245,1,19,positive regulation of multicellular organism growth,BP,CSF1
4576,GO:0010659,0.789022446115481,0.552669772729252,1,20,cardiac muscle cell apoptotic process,BP,CFLAR
18465,GO:1903522,0.789023106793892,0.326381641006303,8,130,regulation of blood circulation,BP,CTGF;EDN1;TGFB2;ATP2B1;TPM1;ADM;ABCC9;GJC1
606,GO:0001772,0.78928178490797,0.552271052925799,1,20,immunological synapse,CC,LGALS3
2969,GO:0006508,0.789901852653168,0.24576800855784,83,1256,proteolysis,BP,CRYAB;C1R;FN1;TENM3;PML;GCLC;CYR61;C3;CTGF;MMP9;CLN6;IL1R2;OVCH2;TRAF3;ENC1;TP53;C9ORF3;PRSS23;CYLD;NAIP;SFRP1;USP16;KEAP1;RCE1;ADAMTS9;OPHN1;IMMP2L;CD109;USP43;FOXRED2;PLK2;MME;UBQLN2;RANBP2;ANAPC15;DDX3X;CPA4;RNF115;CDC25A;ARNTL;PGK1;MDM4;BRCC3;ANTXR1;CLU;USP6;BIRC3;ERAP1;PDCL3;HSP90AB1;ARL6IP5;BACE2;DNPEP;NEDD4L;ANAPC7;CCDC47;SERPINB9;GPER1;FAF1;ADAM17;SENP1;PSME2;CFLAR;PSMB9;SPSB1;UBE2J2;VPS36;TRAF2;CCNA2;CLOCK;KIF14;ESR1;RNF19B;USP11;TNF;CAPN12;PSMB10;METAP2;TAF1;SMARCC1;USP1;COPS3;IFI27L1
16009,GO:0086001,0.790214916240633,0.449351825328172,2,35,cardiac muscle cell action potential,BP,NEDD4L;GJC1
15020,GO:0070932,0.790501903865914,0.550390775523336,1,20,histone H3 deacetylation,BP,HDAC9
15986,GO:0080025,0.790879279496775,0.549807739903928,1,20,phosphatidylinositol-3,5-bisphosphate binding,MF,JPH2
14965,GO:0070840,0.791059604269567,0.551030800561819,1,18,dynein complex binding,MF,CENPF
3047,GO:0006605,0.791194657659177,0.279757384993524,20,367,protein targeting,BP,NRG1;GNPTAB;CHP1;VPS41;ZDHHC6;IMMP2L;GDAP1;CLU;NUP54;TIMM23B;HSPA8;TRAK2;WDR75;UBE2J2;AP3B1;PARD3;STARD7;ITGB1BP1;TSGA13;RPS12
9958,GO:0042310,0.79145734160292,0.446713807750702,2,38,vasoconstriction,BP,EDN1;ADM
14574,GO:0070085,0.791476416386336,0.297495971448241,13,210,glycosylation,BP,B4GALT1;SPON1;CHP1;ST6GALNAC5;GALNT18;MUC16;LFNG;DPY19L2P2;TET3;TRAK2;TMEM165;MUC5B;MUC6
9843,GO:0042059,0.791513221643972,0.446157239245031,2,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,GPRC5A;RNF115
4099,GO:0009152,0.791539952301729,0.310245750690204,10,172,purine ribonucleotide biosynthetic process,BP,PANK2;NUP50;NUP153;ADM;NDC1;RANBP2;PGK1;NUP160;NUP54;GPER1
3084,GO:0006658,0.791584514801876,0.548074799803702,1,21,phosphatidylserine metabolic process,BP,MBOAT1
17556,GO:1901028,0.791784063517983,0.445133278312047,2,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TP53;DYNLL2
6082,GO:0019233,0.791845338110627,0.445669617845338,2,40,sensory perception of pain,BP,EDN1;MME
8932,GO:0034767,0.791920859741971,0.373103694195716,4,71,positive regulation of ion transmembrane transport,BP,JPH2;G6PD;CHP1;GPER1
5912,GO:0018146,0.792259306981036,0.547027531322147,1,21,keratan sulfate biosynthetic process,BP,B4GALT1
3952,GO:0008652,0.792530841895823,0.398952471846585,3,58,cellular amino acid biosynthetic process,BP,SLC1A3;SEPHS2;DPYD
12078,GO:0048011,0.792582765106462,0.547167166655692,1,20,neurotrophin TRK receptor signaling pathway,BP,ZFYVE27
18053,GO:1902532,0.793458376582476,0.269844407182054,25,393,negative regulation of intracellular signal transduction,BP,MMP9;GBP1;DUSP14;CHP1;TGFB2;SLC9A3R1;SFRP1;HSPB1;SOD2;DDX3X;RRN3;SOCS1;PARP14;ARNTL;AJUBA;CGNL1;CLU;ACKR3;GPER1;ESR1;CD74;PHLPP2;PHLPP1;ITGB1BP1;IRAK3
7180,GO:0031056,0.793592580944909,0.328779746938982,7,117,regulation of histone modification,BP,TP53;AKAP8;AKAP8L;SET;RIF1;CHEK1;CTCF
16990,GO:0098984,0.793625363928462,0.308091369812469,10,154,neuron to neuron synapse,CC,CRYAB;MAP2;SHISA9;NETO1;BAIAP2;SYT11;NSF;DGCR8;MTMR2;GPER1
2621,GO:0005938,0.793716078447825,0.288635220675771,15,227,cell cortex,CC,FGFR2;CTGF;DST;PARD3B;RTKN2;TPM4;ANLN;WDPCP;MYO10;TRAF2;NCL;PARD3;ARV1;NEDD9;ASTN2
14012,GO:0060706,0.793977700158785,0.544350424184929,1,21,cell differentiation involved in embryonic placenta development,BP,E2F8
6513,GO:0021885,0.793985666396001,0.443250534463338,2,37,forebrain cell migration,BP,NRG1;SRF
9303,GO:0035735,0.794222690388989,0.442399449494015,2,39,intraciliary transport involved in cilium assembly,BP,DYNC2H1;DYNLL2
12632,GO:0050794,0.794712571825864,0.226313721758494,510,7127,regulation of cellular process,BP,IL32;CRYAB;IGFBP3;MAFB;SAA1;FTH1;DTX2;NEFL;NRG1;HDAC9;KRT4;TRIM16;MAP2;FN1;TNS3;TENM3;PTGES;PML;CYP1B1;KIF23;AMOT;MTUS1;JPH2;MAP3K14;GCLC;TFRC;CYR61;C3;GPRC5A;CYP24A1;MKL1;FOSL2;COL16A1;NLRC5;TXNRD1;FGFR2;STAT5A;EPGN;SACS;TRIM22;STARD13;CBX5;CTGF;HLA-B;UTP20;MMP9;FBN1;XAF1;SLC7A2;RUNX1;CYP1A1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;PBX1;G6PD;TSC22D3;FST;DDX17;TFCP2L1;TRAF3;ENC1;IRS1;SPG21;MID1;TP53;DAPK3;TUFT1;PANK2;EXO1;EDN1;GBP1;DOCK10;DDX47;SIPA1L3;C1QTNF1;DUSP14;KBTBD8;CDKN2A;RBM4;ACSL3;ZBED1;ZNF397;PTPN14;JRK;GEMIN5;NQO1;PABPC4;STAG1;LGALS3;IFNGR1;CHP1;ACO1;PDPN;AKAP8;TGFB2;IRX2;CNTNAP1;ZNF208;RBM22;CYLD;IKBKE;PKMYT1;TGS1;PDLIM1;IL27RA;IL16;IFIT3;SRSF2;FOXD2;PPP1R3B;SLC30A6;P3H2;RAD1;IL6ST;HNRNPF;BAG1;SLC9A3R1;NUAK1;DKC1;INHBA;IL7R;NUP50;PALM2;PUM3;CAMK1G;SYK;EMP2;TJP2;NUP153;NAIP;ZFP42;RAB32;RELB;GPR132;NBN;LEPR;TRIO;SHISA9;PARP15;BRIP1;SHQ1;UTP15;ARFRP1;LRRC8D;HLA-F;CDK4;SFRP1;VPS41;HLA-DOB;RIPK4;NUCKS1;HEATR1;CD274;WNT10A;TARDBP;MIR17HG;DST;POLQ;H3F3A;COL4A1;USP16;AHR;KEAP1;NAA15;ZNF827;DHFR;RPA1;TPM1;GLIS3;HELLS;TAF2;ULK4;POLA1;ABCC4;DRAM1;ADAMTS9;KCNS3;SETDB1;PTGER4;TMEM97;G3BP1;ZNF584;TRAF1;OPHN1;ADM;CD109;ZNF407;ELMSAN1;NDC1;CADPS2;DYNLL2;SLC1A3;EIF5;CASC3;CCL20;SYNPO2L;PLK2;RRAGB;ZNF512;ZNF587;MUC16;UBQLN2;NEXN;FRK;DNTTIP2;GBP5;BTN2A1;KANK4;RFC3;AKAP8L;MYBL2;WDR76;HSPB1;RHOG;WNT4;CXCL16;NOP2;SUV39H2;LCP1;PTPRM;SIRPA;KDM6A;THOC1;RAN;UBTF;RANBP2;TOPBP1;ANAPC15;SOD2;SUPT16H;CORO1C;ATP2C1;ZNF738;DDX3X;RAB26;NAP1L1;NUFIP1;IL24;ARHGEF28;KLHL21;RRN3;RNF115;CDC25A;ITGAV;SOCS1;SET;PARP14;ARNTL;TAF1D;ODC1;AJUBA;FASTKD3;CGNL1;DND1;ZNF267;AKR1C2;LFNG;ZC3H7B;SNX5;TRIM37;NETO1;FEN1;CDC42EP2;CDCA5;PPP4R4;GNL3L;ZNF586;BAIAP2;NVL;GADD45B;SH3RF2;CDH13;COL5A2;COMMD4;PHACTR4;SRF;MDM4;HIF1AN;NPNT;ZNF234;WDR43;PDGFB;BRCC3;KREMEN2;SDK1;FZD1;TBC1D15;IRX4;NFE2L1;ANTXR1;RTKN2;CLU;NUP160;USP6;SMYD2;MACC1;ENPP1;BIRC3;ZNF316;IL20;PIK3R3;RRM2;COMMD9;NUP54;LRPPRC;ZNF670;NFKBIB;SPNS1;EYA3;ZNF106;VGLL3;ACKR3;RIF1;METTL16;FGD6;KLHL9;SETD2;GLIS2;ANLN;RPF2;UBP1;THBD;ABCC9;TTF2;DTX4;GLIPR2;JPH1;SRPRB;IFNAR1;WEE1;TJP1;LRRN3;ZNF484;ERAP1;BLOC1S2;APEX1;PDCL3;CXCR5;TNC;ZNF57;TET3;ORC1;MYBL1;HSPA8;SYT11;HSP90AB1;ARL6IP5;EPHB6;BACE2;ZBTB24;NSF;NEDD4L;SGK1;M6PR;ZBTB12;ZFYVE27;BRCA2;SYNCRIP;TRAK2;HCAR1;DGCR8;SS18L2;CCAR1;SKA2;MAZ;WDPCP;FANCD2;ZNF33A;E2F8;MTMR2;CENPF;GOSR1;ETV6;L1CAM;ZNFX1;HSF2;POLR2F;CCDC47;RAB3GAP1;CHEK1;IL12RB2;SRFBP1;SERPINB9;GPER1;FAF1;MLLT10;RAD18;WDR75;ADAM17;MYO10;SENP1;RBMS3;ATR;NTN1;PSME2;MSH6;CEP152;LILRB3;CFLAR;PSMC3IP;PSMB9;EIF2B5;ZNF12;CMTM3;RFWD3;ABCA5;NOL11;BAZ2B;NFKBIE;CBLL1;HNRNPDL;SHTN1;RABEP2;DPYSL3;ESF1;ZNF608;TAF6L;DPH2;EBP;NCBP1;MYNN;UPF3B;AKR1B1;UBE2J2;VPS36;TRAF2;TPRA1;MSH3;TELO2;EDRF1;RBBP5;CITED2;HNRNPR;NCL;CCNA2;DDX56;TIMELESS;ORC2;IFI30;CSF1;AP3B1;RBL1;NAA16;MPHOSPH8;ZNF286A;CLOCK;KIF14;PURB;TLR3;AZIN1;SYNPO2;ESR1;PARD3;RNF19B;RAD51B;EHD1;TNF;ATAD5;ZFP36L2;NEDD9;SRSF7;RC3H1;TYMS;STARD7;CCL5;ARGLU1;CD74;WDR36;HNRNPU;RING1;FGFR1OP;PSMB10;EIF2B1;DAXX;ZSCAN31;METAP2;PHF14;PHLPP2;PANX1;HIST1H4A;TAF1;TBPL1;SPIB;PHLPP1;FTO;NRAS;PSPC1;SMARCC1;MUC5B;PPARGC1B;ARID3B;HNRNPM;CDKN1A;ITGB1BP1;USP1;MUC6;ZNF471;IRF1;CTCF;TSGA13;RBM8A;GTF2H3;ZBTB9;GPX4;IRAK3;COPS3;IFI27L1
16886,GO:0098796,0.794892688556402,0.251616424819799,46,730,membrane protein complex,CC,TFRC;HLA-B;TAP1;HSPG2;TRAF3;IRS1;CNTNAP1;IL6ST;SYK;SHISA9;LRRC8D;HLA-F;VPS41;AP3M2;HLA-DOB;AP5M1;KCNS3;IMMP2L;RRAGB;CORO1C;ITGAV;ABCF2;KCNQ5;SNX5;CDH13;NPNT;PIK3R3;TIMM23B;ABCC9;SRPRB;CNTNAP2;TMEM199;M6PR;GOSR1;FAF1;CFLAR;SDHD;VPS36;TRAF2;TAP2;UQCRB;AP3B1;CLCC1;GJC1;CD74;NDUFB9
6811,GO:0030258,0.794959110918148,0.296962266285816,12,196,lipid modification,BP,NRG1;FGFR2;CYP1A1;IRS1;CROT;PDGFB;PIK3R3;MTMR2;HADHB;ESR1;HIBCH;PPARGC1B
14174,GO:0061035,0.79537083707591,0.441203033518939,2,37,regulation of cartilage development,BP,CYR61;CTGF
14175,GO:0061036,0.795857351921535,0.542766052243721,1,19,positive regulation of cartilage development,BP,CYR61
6915,GO:0030500,0.795906998505957,0.440408750500506,2,37,regulation of bone mineralization,BP,WNT4;ENPP1
11305,GO:0045601,0.795975565925767,0.541864996599183,1,20,regulation of endothelial cell differentiation,BP,TNF
2806,GO:0006266,0.796027228068578,0.540019209461841,1,23,DNA ligation,BP,APTX
2427,GO:0005605,0.79709759325423,0.542509545710948,1,17,basal lamina,CC,FN1
4379,GO:0010008,0.797135563503183,0.268222577649128,23,369,endosome membrane,CC,PML;TFRC;HLA-B;MYO1B;SPG21;IKBKE;HLA-F;VPS41;HLA-DOB;AP5M1;SNX5;KREMEN2;ANTXR1;SLC11A2;ZFYVE27;MTMR2;TMEM165;STEAP4;ABCA5;VPS36;SLC9A9;TLR3;EHD1
4192,GO:0009268,0.797347616624004,0.538470888703941,1,22,response to pH,BP,CHP1
6607,GO:0022625,0.797350367969219,0.434286778524362,2,63,cytosolic large ribosomal subunit,CC,GEMIN5;MRTO4
3291,GO:0006984,0.797842394287627,0.436800626345568,2,40,ER-nucleus signaling pathway,BP,TP53;CCDC47
563,GO:0001701,0.797996154452426,0.28065437175399,16,251,in utero embryonic development,BP,AMOT;CYR61;FGFR2;EDN1;NBN;KEAP1;ADM;KDM6A;RRN3;GINS4;SRF;PDGFB;SETD2;BRCA2;E2F8;COPS3
14308,GO:0061371,0.798160935843205,0.437058949365344,2,37,determination of heart left/right asymmetry,BP,SRF;BBS5
18143,GO:1902803,0.798515816033793,0.537857205183963,1,20,regulation of synaptic vesicle transport,BP,RAB3GAP1
3899,GO:0008535,0.798625896606566,0.53542197752711,1,24,respiratory chain complex IV assembly,BP,FASTKD3
9614,GO:0036465,0.79876319990787,0.436160905725458,2,37,synaptic vesicle recycling,BP,OPHN1;SYT11
6729,GO:0030137,0.799000161074016,0.535317346649233,1,23,COPI-coated vesicle,CC,TMEM199
12552,GO:0050681,0.799047266650339,0.435235271715892,2,39,androgen receptor binding,MF,RAN;DAXX
18836,GO:1904375,0.799286643264621,0.362803027079797,4,73,regulation of protein localization to cell periphery,BP,GBP1;ACSL3;RHOG;GPER1
419,GO:0001106,0.799391868377248,0.535818712277541,1,21,RNA polymerase II transcription corepressor activity,MF,CITED2
12427,GO:0048857,0.799456899558557,0.434172354365343,2,41,neural nucleus development,BP,G6PD;RAD1
5314,GO:0016020,0.799886849440409,0.220494815636221,403,5750,membrane,CC,IL32;CRYAB;HEPHL1;SPRR3;KRT1;FTL;DTX2;NRG1;SPRR2A;TRIM16;FN1;TRIM16L;TENM3;PTGES;PML;CYP1B1;AMOT;MTUS1;JPH2;KRT2;TFRC;C3;GPRC5A;CYP24A1;FGFR2;UGT1A6;EPGN;STARD13;FADS3;S100P;SLC16A2;CTGF;HLA-B;UTP20;GNPTAB;VMP1;TAP1;HSPG2;SLC7A2;MYO1B;CYP1A1;ERVFRD-1;CLN6;IL1R2;FAT4;B4GALT1;ACTG1;G6PD;SPACA6;DDX17;FAM69B;TFCP2L1;TRAF3;PLD5;IRS1;DYNC2H1;SPG21;SLC16A9;DAPK3;SVEP1;SLC7A5P2;EXO1;TPST1;SCD;GBP1;DOCK10;DDX47;SIPA1L3;ABCF1;TMEM106A;C1QTNF1;RBM19;TMPPE;ACSL3;ZNF397;GEMIN5;MEGF11;LGALS3;IFNGR1;CHP1;SLC4A11;PDPN;AKAP8;ST6GALNAC5;CNTNAP1;CYLD;IKBKE;PKMYT1;CDKAL1;IL27RA;IL16;PCDH7;LRFN4;SLC30A6;IL6ST;HNRNPF;SLC9A3R1;IL7R;NUP50;SLC22A5;PALM2;GALNT18;CAMK1G;SYK;EMP2;TJP2;NUP153;NAIP;RAB32;GPR132;LEPR;SHISA9;VEZT;BRIP1;MCM5;ABCG2;LSS;ARFRP1;LRRC8D;HLA-F;CDK4;SFRP1;VPS41;KRT9;AP3M2;HLA-DOB;RIPK4;HEATR1;ZDHHC6;CD274;LAYN;GEMIN4;ABHD4;DST;ATP2B1;APOL6;NAA15;TCHH;SLC5A6;HRNR;AP5M1;TPM1;PTPRB;RCE1;ABCC4;REEP1;DRAM1;KCNS3;SETDB1;PTGER4;TMEM97;LSG1;G3BP1;TMEM248;PARD3B;MGAM;IMMP2L;CD109;GGCX;NDC1;CADPS2;DYNLL2;SLC35A4;MDN1;SLC1A3;EIF5;CASC3;RRAGB;CDV3;MRPL27;SLCO4C1;MME;TMEM212;MUC16;UBQLN2;FRK;GBP5;BTN2A1;NOP58;HSPB1;RHOG;WNT4;CXCL16;LCP1;GPRIN1;EXOG;PTPRM;SIRPA;RAN;RANBP2;HS3ST1;SOD2;CORO1C;ATP2C1;DDX3X;RAB26;NAP1L1;ARHGEF28;GPHN;RRP12;ITGAV;PARP14;ABCF2;SNX11;TRPM7;AJUBA;KCNQ5;LFNG;PGK1;SNX5;NETO1;FEN1;MCM3;CDC42EP2;HACD2;FRRS1;GNL3L;TTC1;YRDC;BAIAP2;NVL;CDH13;RARS;GDAP1;FNDC3B;NPNT;WDR3;APMAP;PDGFB;UGT8;UTP18;CHID1;KREMEN2;SDK1;FZD1;NFE2L1;ANTXR1;CLU;USP6;ENPP1;BIRC3;FRAS1;PIK3R3;MBOAT1;NUP54;LRPPRC;SPNS1;EFTUD2;ZNF106;DDX24;TPM4;ACKR3;FAM173B;RIF1;SRD5A1;TMEM14EP;TIMM23B;TMEM51;THBD;UPK3B;ABCC9;GLIPR2;JPH1;SRPRB;DPY19L2P2;NNT;IFNAR1;TJP1;LRRN3;THADA;KCTD3;ERAP1;SLC11A2;BLOC1S2;RIC3;CXCR5;TNC;CNTNAP2;ORC1;HSPA8;GLIPR1L2;SYT11;ERVMER34-1;TMEM199;HSP90AB1;DDX21;ARL6IP5;EPHB6;BACE2;SCD5;NSF;LYSMD4;GREB1;LAIR1;MFSD12;NEDD4L;SGK1;M6PR;ZFYVE27;PXMP2;TMEM138;SYNCRIP;TRAK2;HCAR1;KRT10;CYB561D2;PPIP5K1;WDPCP;MTMR2;GOSR1;TMEM165;L1CAM;STEAP4;FKBP5;CCDC47;RAB3GAP1;IL12RB2;SERPINB9;BBS5;GPER1;FAF1;RPTN;ANKRD13A;MCM4;ADAM17;MYO10;SENP1;PSME2;HADHB;LILRB3;CFLAR;NOL9;DNAJC9;CMTM3;ABCA5;SDHD;UGT1A4;ARIH2OS;MRPS7;EBP;UBE2J2;VPS36;TRAF2;TPRA1;MSH3;TELO2;CYP20A1;NCL;NOP56;SLC9A9;DDX56;TAP2;ORC2;UQCRB;CSF1;AP3B1;MPHOSPH8;GLIPR1;KIF14;TLR3;MPP5;ERVK13-1;ESR1;PARD3;CLCC1;GJC1;RNF19B;EHD1;KCNE4;ARV1;TNF;SURF2;NEDD9;TYMS;STARD7;CD74;HNRNPU;FLAD1;EIF2B1;DCTN5;METAP2;SLC43A2;PHLPP2;PANX1;HIST1H4A;TRAM2;SMIM7;PHLPP1;NRAS;MUC5B;HNRNPM;ABCA11P;ITGB1BP1;MUC6;SLC25A22;TREX1;SLC41A2;ASTN2;NDUFB9;RPS12;IRAK3;TMEM234;IFI27L1
8298,GO:0033119,0.800170164783109,0.533454581895195,1,23,negative regulation of RNA splicing,BP,SRSF7
2296,GO:0005253,0.80071268333227,0.432512289867615,2,40,anion channel activity,MF,LRRC8D;CLCC1
3450,GO:0007264,0.800813402433227,0.254998314464401,31,457,small GTPase mediated signal transduction,BP,NRG1;AMOT;STARD13;TP53;DOCK10;SIPA1L3;CDKN2A;CHP1;PDPN;TGFB2;RAB32;TRIO;SETDB1;G3BP1;OPHN1;PLK2;RHOG;RAB26;ARHGEF28;CGNL1;CDC42EP2;CDH13;PHACTR4;FGD6;NTN1;SHTN1;CCNA2;CSF1;KIF14;NRAS;CDKN1A
8479,GO:0033613,0.800836549914078,0.387545541436338,3,55,activating transcription factor binding,MF,SRF;TAF6L;RBL1
5935,GO:0018210,0.800860394090292,0.329527544368594,6,102,peptidyl-threonine modification,BP,DAPK3;GALNT18;CAMK1G;CHEK1;PARD3;TAF1
9108,GO:0035371,0.801618443552282,0.534442179831389,1,18,microtubule plus-end,CC,DST
10500,GO:0043388,0.801708124295511,0.430589824004672,2,42,positive regulation of DNA binding,BP,MMP9;CDCA5
4333,GO:0009880,0.802374098068135,0.431022903569325,2,36,embryonic pattern specification,BP,FGFR2;KDM6A
11589,GO:0046128,0.802876051876782,0.383761448588921,3,62,purine ribonucleoside metabolic process,BP,TJP2;RAN;GPHN
8242,GO:0033003,0.803024513810813,0.529419138755755,1,22,regulation of mast cell activation,BP,SYK
4314,GO:0009790,0.803309405321492,0.242265852528729,46,671,embryo development,BP,MAFB;NRG1;FN1;AMOT;CYR61;TXNRD1;FGFR2;MMP9;FBN1;PBX1;EDN1;RBM19;KBTBD8;TGFB2;IRX2;COL12A1;SLC9A3R1;INHBA;NBN;ARFRP1;SFRP1;KEAP1;ADM;WNT4;KDM6A;RRN3;ITGAV;LFNG;COL5A2;GINS4;PHACTR4;SRF;PDGFB;FZD1;FRAS1;SETD2;TET3;BRCA2;WDPCP;E2F8;BBS5;NTN1;TPRA1;CITED2;TNF;COPS3
16636,GO:0097458,0.803390960598911,0.235182506678302,65,943,neuron part,CC,CRYAB;NEFL;NRG1;MAP2;TENM3;SACS;NEFM;ENC1;DOCK10;NQO1;TGFB2;CNTNAP1;IL6ST;SLC9A3R1;CAMK1G;PHAX;NAIP;SHISA9;AP3M2;DST;ATP2B1;OPHN1;CADPS2;SLC1A3;CASC3;PLK2;MME;HSPB1;GPRIN1;RAB26;NUFIP1;GPHN;NETO1;BAIAP2;WDR7;CDH13;QDPR;CLU;SRD5A1;BLOC1S2;RIC3;CNTNAP2;HSPA8;SYT11;EPHB6;NSF;ZFYVE27;TRAK2;DGCR8;MTMR2;L1CAM;IQCJ-SCHIP1;GPER1;RRM1;MYO10;SHTN1;DPYSL3;HNRNPR;AP3B1;PARD3;PHLPP2;PHLPP1;SMARCC1;ASTN2;RBM8A
9619,GO:0036474,0.803701307070072,0.527789825429985,1,23,cell death in response to hydrogen peroxide,BP,TP53
17275,GO:0120034,0.804443181457869,0.355732120966707,4,72,positive regulation of plasma membrane bounded cell projection assembly,BP,CDC42EP2;SRF;ANLN;DPYSL3
1463,GO:0003707,0.804448719905563,0.427363027304306,2,38,steroid hormone receptor activity,MF,GPER1;ESR1
17449,GO:1900182,0.804450739039867,0.382083771050532,3,57,positive regulation of protein localization to nucleus,BP,RBM22;GLIS2;HSP90AB1
19246,GO:1905332,0.804931706607303,0.526933306806408,1,21,positive regulation of morphogenesis of an epithelium,BP,WNT4
2604,GO:0005901,0.805346567617399,0.381345671529515,3,53,caveola,CC,IRS1;CORO1C;CDH13
10413,GO:0043236,0.805614349359754,0.525827288249588,1,21,laminin binding,MF,LGALS3
114,GO:0000242,0.805726290832104,0.527025059536524,1,19,pericentriolar material,CC,CEP152
6710,GO:0030117,0.805842787201989,0.335644148238374,5,92,membrane coat,CC,VPS41;AP3M2;AP5M1;KCNQ5;AP3B1
12237,GO:0048475,0.805842787201989,0.335644148238374,5,92,coated membrane,CC,VPS41;AP3M2;AP5M1;KCNQ5;AP3B1
8664,GO:0034205,0.80613357226819,0.524984389258368,1,21,amyloid-beta formation,BP,CLU
7578,GO:0031935,0.80620557234082,0.525522054995524,1,20,regulation of chromatin silencing,BP,SETDB1
7934,GO:0032504,0.806618077403213,0.249085892193979,30,465,multicellular organism reproduction,BP,CYP1A1;B4GALT1;SPACA6;PANK2;EDN1;TGFB2;INHBA;BRIP1;SFRP1;IMMP2L;NDC1;SLCO4C1;WNT4;RAN;ARNTL;DND1;MCM8;BIRC3;DPY19L2P2;MYBL1;BRCA2;FANCD2;ETV6;HSF2;AKR1B1;CLOCK;ESR1;TBPL1;DIAPH3;GPX4
638,GO:0001825,0.80665021765884,0.523550252392644,1,22,blastocyst formation,BP,SRF
14621,GO:0070167,0.806732321848152,0.423900716655223,2,38,regulation of biomineral tissue development,BP,WNT4;ENPP1
7182,GO:0031058,0.806745682169439,0.352341217146765,4,74,positive regulation of histone modification,BP,TP53;AKAP8;AKAP8L;RIF1
11548,GO:0046058,0.807024607172871,0.423456218825322,2,38,cAMP metabolic process,BP,ADM;GPER1
16371,GO:0090630,0.80783206400307,0.351176592949864,4,70,activation of GTPase activity,BP,RHOG;CORO1C;TBC1D15;USP6
98,GO:0000188,0.807981086191595,0.520836478174933,1,23,inactivation of MAPK activity,BP,DUSP14
3920,GO:0008589,0.808279362411289,0.376949046671311,3,54,regulation of smoothened signaling pathway,BP,FGFR2;SFRP1;GLIS2
20211,GO:2001023,0.808710517635029,0.419783160786287,2,43,regulation of response to drug,BP,TP53;ARL6IP5
1914,GO:0004601,0.808786630823064,0.517396755536766,1,28,peroxidase activity,MF,GPX4
9773,GO:0039528,0.808900373387615,0.520468541111627,1,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,BIRC3
1287,GO:0003091,0.808966778905862,0.521016632369379,1,20,renal water homeostasis,BP,AKR1B1
10209,GO:0042805,0.809263450574438,0.52517979979132,1,15,actinin binding,MF,SYNPO2
7848,GO:0032400,0.809486030477262,0.518911245900385,1,22,melanosome localization,BP,BBS5
13236,GO:0051875,0.809486030477262,0.518911245900385,1,22,pigment granule localization,BP,BBS5
10366,GO:0043169,0.809648753169753,0.213345604402737,211,2968,cation binding,MF,CRYAB;IGFBP3;HEPHL1;TRIM47;FTL;FTH1;DTX2;HDAC9;C1R;TRIM16;PML;CYP1B1;GCLC;CYP24A1;TRIM22;S100P;MMP9;FBN1;GNPTAB;HSPG2;XAF1;CYP1A1;FAT4;B4GALT1;MAT2A;SPON1;TRIM56;OVCH2;TRAF3;COL27A1;MID1;TP53;SVEP1;EXO1;C9ORF3;SCD;TMPPE;RBM4;ZBED1;ZNF397;PRUNE2;CHP1;ACO1;AKAP8;ZNF208;RBM22;CARS2;CYLD;PKMYT1;PDLIM1;CDKAL1;PCDH7;P3H2;NUAK1;GALNT18;NUP153;NAIP;ZFP42;BRIP1;VPS41;MCM2;DST;VPS8;ATP2B1;USP16;TCHH;ZNF827;HRNR;RPA1;POLR1A;ZMAT2;GLIS3;CSRP1;POLA1;ADAMTS9;SETDB1;TK1;ZNF584;TRAF1;P4HA2;ZNF407;CADPS2;SLC1A3;ZNF512;MME;ZNF587;HSCB;AKAP8L;DOHH;SUV39H2;LCP1;EXOG;KDM6A;RAN;RANBP2;SOD2;ATP2C1;NUFIP1;CPA4;ARHGEF28;GPHN;RNF115;ITGAV;QPCT;TRPM7;AJUBA;ZNF267;LFNG;ZC3H7B;TRIM37;FEN1;FRRS1;ZNF586;SH3RF2;APTX;CDH13;COL5A2;RARS;MDM4;HIF1AN;NPNT;ZNF234;BRCC3;UTY;ANTXR1;SMYD2;ENPP1;BIRC3;FRAS1;ZNF316;RRM2;ZNF670;EYA3;ZNF106;TPM4;TYW1;FGD6;SETD2;GLIS2;THBD;TTF2;DTX4;WEE1;ZNF484;ERAP1;SLC11A2;APEX1;ZNF57;TET3;SYT11;SCD5;ZBTB24;NSF;DNPEP;PRIM2;ZBTB12;ZFYVE27;TRMT1;DGCR8;DPYD;LIMCH1;CYB561D2;MAZ;ZNF33A;ZNFX1;STEAP4;CCDC47;LNX2;MLLT10;RAD18;RPTN;ADAM17;MSH6;ZNF12;RFWD3;BAZ2B;SDHD;CBLL1;ZNF608;CSRP2;MYNN;TRAF2;CYP20A1;POLR3B;ZNF286A;ESR1;RNF19B;EHD1;CAPN12;PDSS1;ZFP36L2;SRSF7;RC3H1;RING1;ZSCAN31;METAP2;PHF14;PHLPP2;YPEL4;PHLPP1;ZNHIT6;FTO;THTPA;CDKN1A;TREX1;ZNF471;CTCF;ASTN2;GTF2H3;ZBTB9;IRAK3
2585,GO:0005876,0.809729832119062,0.374561615928418,3,56,spindle microtubule,CC,KLHL21;SKA2;HNRNPU
16214,GO:0090224,0.809788897455419,0.419237143544136,2,38,regulation of spindle organization,BP,STAG1;HNRNPU
5801,GO:0017048,0.809905560564353,0.29309246706027,9,140,Rho GTPase binding,MF,DAPK3;TRIO;CORO1C;ARHGEF28;CDC42EP2;RTKN2;FGD6;ANLN;DIAPH3
17311,GO:0140053,0.810472495876857,0.305595457415742,7,153,mitochondrial gene expression,BP,MRPL27;FASTKD3;GATC;LRPPRC;TRMT5;MRPS7;PPARGC1B
11457,GO:0045879,0.810527242365757,0.51845225641263,1,20,negative regulation of smoothened signaling pathway,BP,GLIS2
12688,GO:0050873,0.81069680821672,0.51637351598271,1,23,brown fat cell differentiation,BP,FTO
10648,GO:0043648,0.810801020622486,0.346251745174626,4,79,dicarboxylic acid metabolic process,BP,GCLC;STAT5A;DHFR;SLC1A3
4107,GO:0009161,0.811126087766333,0.269677584229623,14,259,ribonucleoside monophosphate metabolic process,BP,NUP50;TJP2;NUP153;NDC1;RANBP2;PGK1;NUP160;ENPP1;NUP54;UMPS;HSPA8;SDHD;UQCRB;NDUFB9
4259,GO:0009584,0.811518577944392,0.515559561469158,1,22,detection of visible light,BP,METAP2
8001,GO:0032613,0.811599762158693,0.514382743432354,1,24,interleukin-10 production,BP,CD274
1973,GO:0004683,0.812362751468281,0.514759132520705,1,21,calmodulin-dependent protein kinase activity,MF,CAMK1G
2755,GO:0006164,0.812713293946616,0.28344556742787,10,176,purine nucleotide biosynthetic process,BP,PANK2;NUP50;NUP153;ADM;NDC1;RANBP2;PGK1;NUP160;NUP54;GPER1
12405,GO:0048813,0.812910866564354,0.313464485208722,6,101,dendrite morphogenesis,BP,MAP2;DOCK10;BAIAP2;SLC11A2;NEDD4L;TRAK2
16017,GO:0086009,0.812910967879984,0.5145093054812,1,20,membrane repolarization,BP,NEDD4L
11592,GO:0046131,0.813618311931944,0.510147625129598,1,26,pyrimidine ribonucleoside metabolic process,BP,UMPS
10257,GO:0042982,0.813707836087194,0.41230388195185,2,42,amyloid precursor protein metabolic process,BP,CLU;BACE2
2865,GO:0006357,0.814006880149358,0.215349983152803,110,1595,regulation of transcription by RNA polymerase II,BP,MAFB;NRG1;HDAC9;PML;CYR61;MKL1;FOSL2;NLRC5;FGFR2;STAT5A;CBX5;FBN1;RUNX1;PBX1;TSC22D3;FST;DDX17;TFCP2L1;TP53;EDN1;ZBED1;STAG1;TGFB2;IRX2;FOXD2;INHBA;RELB;PARP15;BRIP1;SFRP1;NUCKS1;USP16;AHR;GLIS3;TAF2;ELMSAN1;FRK;AKAP8L;MYBL2;NOP2;SUV39H2;UBTF;SOD2;SUPT16H;DDX3X;NUFIP1;ARNTL;AJUBA;ZNF267;TRIM37;CDH13;SRF;MDM4;HIF1AN;NPNT;PDGFB;FZD1;IRX4;NFE2L1;SMYD2;MACC1;VGLL3;RIF1;GLIS2;UBP1;TET3;MYBL1;ZBTB24;NEDD4L;TRAK2;SS18L2;MAZ;E2F8;ETV6;ZNFX1;HSF2;CHEK1;GPER1;MLLT10;SENP1;PSME2;PSMB9;ZNF12;ZNF608;TAF6L;CITED2;NCL;TIMELESS;ORC2;RBL1;CLOCK;PURB;TLR3;ESR1;TNF;ZFP36L2;HNRNPU;PSMB10;PHF14;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;CDKN1A;ITGB1BP1;IRF1;CTCF;GTF2H3
7393,GO:0031440,0.814292879530713,0.510948210595266,1,22,regulation of mRNA 3'-end processing,BP,NCBP1
13138,GO:0051656,0.814847619983965,0.248743240190138,22,349,establishment of organelle localization,BP,NEFL;KIF23;SLC9A3R1;SYK;AP3M2;CADPS2;RAN;CDCA5;SDAD1;LRPPRC;BLOC1S2;SYT11;NSF;TRAK2;CENPF;GOSR1;RAB3GAP1;BBS5;NTN1;AP3B1;KIF14;HNRNPU
13202,GO:0051788,0.814889782474318,0.509950493919388,1,22,response to misfolded protein,BP,CLU
599,GO:0001764,0.815006143394966,0.323517933989631,5,85,neuron migration,BP,NRG1;ULK4;SRF;NTN1;SHTN1
6208,GO:0019706,0.815065774582336,0.509109250380605,1,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC6
6209,GO:0019707,0.815065774582336,0.509109250380605,1,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC6
3654,GO:0008137,0.815181923243034,0.504217519736575,1,38,NADH dehydrogenase (ubiquinone) activity,MF,NDUFB9
12464,GO:0050136,0.815181923243034,0.504217519736575,1,38,NADH dehydrogenase (quinone) activity,MF,NDUFB9
7856,GO:0032411,0.815255184095953,0.366335520215197,3,57,positive regulation of transporter activity,BP,JPH2;CHP1;SGK1
6734,GO:0030145,0.815424107448435,0.409854570919299,2,41,manganese ion binding,MF,B4GALT1;SOD2
16884,GO:0098794,0.815822733497734,0.256705248899356,17,261,postsynapse,CC,CRYAB;MAP2;DOCK10;SHISA9;ATP2B1;OPHN1;CADPS2;GPHN;NETO1;BAIAP2;HSPA8;SYT11;NSF;DGCR8;MTMR2;RAB3GAP1;GPER1
1173,GO:0002793,0.815849931438141,0.284991777048428,9,155,positive regulation of peptide secretion,BP,SAA1;TRIM16;TGFB2;SYK;CD274;PTGER4;GPER1;TNF;PANX1
10512,GO:0043405,0.816087351792219,0.258522322895495,16,261,regulation of MAP kinase activity,BP,SAA1;NRG1;MAP3K14;EPGN;EDN1;DUSP14;SYK;SFRP1;AJUBA;GADD45B;PDGFB;TRAF2;TNF;CD74;DAXX;IRAK3
1996,GO:0004714,0.816480563351065,0.408907877917123,2,38,transmembrane receptor protein tyrosine kinase activity,MF,FGFR2;EPHB6
8870,GO:0034661,0.816905555908139,0.50601858633795,1,23,ncRNA catabolic process,BP,POP1
16758,GO:0097756,0.817612289360833,0.406669136580919,2,40,negative regulation of blood vessel diameter,BP,EDN1;ADM
6815,GO:0030262,0.817790557847684,0.504525089469056,1,23,apoptotic nuclear changes,BP,GPER1
19848,GO:2000272,0.81783199131243,0.505003485109032,1,22,negative regulation of signaling receptor activity,BP,GPRC5A
13621,GO:0060071,0.817837507204477,0.318774297304809,5,99,Wnt signaling pathway, planar cell polarity pathway,BP,SFRP1;FZD1;PSME2;PSMB9;PSMB10
3762,GO:0008306,0.8181229319686,0.405871909746742,2,40,associative learning,BP,NETO1;SRF
3091,GO:0006665,0.818139557134154,0.296125491715571,7,128,sphingolipid metabolic process,BP,CYR61;CLN6;ST6GALNAC5;HACD2;UGT8;ARV1;TNF
9941,GO:0042278,0.818450165730003,0.360821940733135,3,64,purine nucleoside metabolic process,BP,TJP2;RAN;GPHN
4575,GO:0010658,0.818891112041557,0.503210723650062,1,22,striated muscle cell apoptotic process,BP,CFLAR
13159,GO:0051705,0.819193115361065,0.404673089573971,2,38,multi-organism behavior,BP,CNTNAP2;DNAJC9
1393,GO:0003300,0.819373873891033,0.361266259412543,3,50,cardiac muscle hypertrophy,BP,G6PD;EDN1;IL6ST
4939,GO:0014897,0.819373873891033,0.361266259412543,3,50,striated muscle hypertrophy,BP,G6PD;EDN1;IL6ST
14166,GO:0061024,0.81966373236976,0.225054455064871,43,664,membrane organization,BP,TFRC;C3;TAP1;ERVFRD-1;FAT4;ACTG1;SPACA6;TP53;CHP1;TGFB2;IL7R;NUP50;EMP2;NUP153;VPS41;TARDBP;VPS8;REEP1;NDC1;DYNLL2;AKAP8L;RHOG;RANBP2;GPHN;BAIAP2;GDAP1;TBC1D15;CLU;NUP160;USP6;NUP54;BLOC1S2;CNTNAP2;HSPA8;SYT11;NSF;M6PR;GOSR1;GPER1;TAP2;MPP5;ARV1;TRAM2
3560,GO:0007602,0.819784336560386,0.501144190768598,1,23,phototransduction,BP,METAP2
18059,GO:1902554,0.81981896668752,0.333592434099418,4,77,serine/threonine protein kinase complex,CC,CDK4;CCNA2;CDKN1A;GTF2H3
6813,GO:0030260,0.819851529362656,0.316183763812469,5,95,entry into host cell,BP,TFRC;NUP153;ITGAV;CBLL1;CD74
10884,GO:0044409,0.819851529362656,0.316183763812469,5,95,entry into host,BP,TFRC;NUP153;ITGAV;CBLL1;CD74
13215,GO:0051806,0.819851529362656,0.316183763812469,5,95,entry into cell of other organism involved in symbiotic interaction,BP,TFRC;NUP153;ITGAV;CBLL1;CD74
13222,GO:0051828,0.819851529362656,0.316183763812469,5,95,entry into other organism involved in symbiotic interaction,BP,TFRC;NUP153;ITGAV;CBLL1;CD74
12536,GO:0050660,0.820111629653004,0.358783729711163,3,60,flavin adenine dinucleotide binding,MF,TXNRD1;FOXRED2;DPYD
9829,GO:0042026,0.820236717563263,0.499870958332512,1,24,protein refolding,BP,HSPA8
11515,GO:0045981,0.820858284334453,0.401156379286947,2,42,positive regulation of nucleotide metabolic process,BP,ADM;GPER1
17525,GO:1900544,0.820858284334453,0.401156379286947,2,42,positive regulation of purine nucleotide metabolic process,BP,ADM;GPER1
11339,GO:0045648,0.821024351309942,0.49958036191275,1,22,positive regulation of erythrocyte differentiation,BP,INHBA
14743,GO:0070382,0.821080791981413,0.30178699721048,6,114,exocytic vesicle,CC,MME;RAB26;WDR7;SYT11;MTMR2;DPYSL3
11839,GO:0046718,0.821766090561832,0.330650722537293,4,79,viral entry into host cell,BP,TFRC;NUP153;ITGAV;CD74
5481,GO:0016411,0.821929378993714,0.498032262531605,1,22,acylglycerol O-acyltransferase activity,MF,MBOAT1
5750,GO:0016894,0.82223620632858,0.49556208081195,1,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,APEX1
3780,GO:0008334,0.822497772532102,0.496002180036963,1,24,histone mRNA metabolic process,BP,NCBP1
2733,GO:0006111,0.822612785488232,0.496860110123324,1,22,regulation of gluconeogenesis,BP,LEPR
2095,GO:0004857,0.822709305938595,0.258493446401485,13,232,enzyme inhibitor activity,MF,C3;CDKN2A;CHP1;NAIP;CD109;HSPB1;SOCS1;SET;SH3RF2;BIRC3;SERPINB9;FGFR1OP;CDKN1A
12361,GO:0048708,0.82294366610207,0.398296636707538,2,40,astrocyte differentiation,BP,IL6ST;EIF2B5
10699,GO:0043967,0.822981115726569,0.354619599792902,3,59,histone H4 acetylation,BP,TRIM16;NAA50;BRCA2
18182,GO:1902904,0.823105828948121,0.311927721672087,5,90,negative regulation of supramolecular fiber organization,BP,CRYAB;MID1;KANK4;CLU;HSPA8
21,GO:0000038,0.823189659627761,0.494812412360547,1,24,very long-chain fatty acid metabolic process,BP,HACD2
17554,GO:1901021,0.823617601869091,0.495131743177397,1,22,positive regulation of calcium ion transmembrane transporter activity,BP,JPH2
2061,GO:0004812,0.823636299163895,0.396385353322691,2,44,aminoacyl-tRNA ligase activity,MF,CARS2;RARS
5733,GO:0016875,0.823636299163895,0.396385353322691,2,44,ligase activity, forming carbon-oxygen bonds,MF,CARS2;RARS
4938,GO:0014896,0.823772705267341,0.354535730919845,3,51,muscle hypertrophy,BP,G6PD;EDN1;IL6ST
4621,GO:0010737,0.823838235514843,0.497592650444098,1,18,protein kinase A signaling,BP,LCP1
7031,GO:0030799,0.824120862969925,0.396213846192346,2,41,regulation of cyclic nucleotide metabolic process,BP,ADM;GPER1
16442,GO:0097060,0.824186707191321,0.269057384707144,10,160,synaptic membrane,CC,CRYAB;SHISA9;ATP2B1;CADPS2;GPHN;NETO1;BAIAP2;SYT11;MTMR2;GPER1
16966,GO:0098927,0.824354755681755,0.395842971508243,2,41,vesicle-mediated transport between endosomal compartments,BP,EMP2;MTMR2
3193,GO:0006821,0.824489060291575,0.39542143107305,2,42,chloride transport,BP,SLC1A3;CLCC1
15909,GO:0072657,0.824763160095156,0.231600204329544,26,454,protein localization to membrane,BP,TP53;GBP1;ACSL3;CHP1;SLC9A3R1;EMP2;RAB32;ARFRP1;ZDHHC6;REEP1;DYNLL2;RHOG;WNT4;RAB26;GPHN;NUP54;NSF;ZFYVE27;RAB3GAP1;GPER1;MPP5;PARD3;TNF;TRAM2;ITGB1BP1;RPS12
15623,GO:0072091,0.824805275418547,0.395347282993731,2,40,regulation of stem cell proliferation,BP,DGCR8;HNRNPU
11869,GO:0046835,0.825125530086982,0.491974156508219,1,23,carbohydrate phosphorylation,BP,GNPTAB
2676,GO:0006027,0.825184191149257,0.394526042057873,2,41,glycosaminoglycan catabolic process,BP,HSPG2;CHP1
4183,GO:0009259,0.825565058270554,0.237134366316045,21,370,ribonucleotide metabolic process,BP,PANK2;TPST1;NUP50;TJP2;NUP153;ADM;NDC1;RAN;RANBP2;GPHN;CROT;PGK1;NUP160;ENPP1;NUP54;UMPS;HSPA8;GPER1;SDHD;UQCRB;NDUFB9
20224,GO:2001038,0.826180142971626,0.489637731923362,1,24,regulation of cellular response to drug,BP,TP53
9050,GO:0035258,0.826204156744409,0.324475336911516,4,76,steroid hormone receptor binding,MF,RAN;ESR1;DAXX;PPARGC1B
6884,GO:0030374,0.826364323824356,0.349784889140696,3,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,CCAR1;PSMC3IP;PPARGC1B
7161,GO:0031016,0.826391221054227,0.392604761539369,2,41,pancreas development,BP,ARNTL;CLOCK
2494,GO:0005741,0.826558597354736,0.277083465395513,8,148,mitochondrial outer membrane,CC,CYP24A1;ACSL3;RAB32;DDX3X;GDAP1;SLC11A2;HADHB;STARD7
13135,GO:0051651,0.826558920266747,0.32412223252742,4,74,maintenance of location in cell,BP,FTL;FTH1;PML;HNRNPU
11458,GO:0045880,0.826629337148702,0.489915719509717,1,22,positive regulation of smoothened signaling pathway,BP,SFRP1
12643,GO:0050808,0.827369371840593,0.260394716293891,11,175,synapse organization,BP,NRG1;DOCK10;COL4A1;GPHN;BAIAP2;SDK1;FZD1;LRRN3;TNC;MTMR2;L1CAM
4943,GO:0014902,0.827916497670565,0.347442388693086,3,57,myotube differentiation,BP,HDAC9;CFLAR;EHD1
7300,GO:0031293,0.827944697586188,0.487066467582885,1,23,membrane protein intracellular domain proteolysis,BP,ADAM17
5904,GO:0018107,0.828057072757408,0.304968755772421,5,90,peptidyl-threonine phosphorylation,BP,DAPK3;CAMK1G;CHEK1;PARD3;TAF1
3360,GO:0007098,0.828888729301603,0.291324800627438,6,108,centrosome cycle,BP,PLK2;RANBP2;TRIM37;BRCA2;CHEK1;CEP152
20131,GO:2000765,0.828948753283903,0.48530709096311,1,23,regulation of cytoplasmic translation,BP,DPH2
3324,GO:0007033,0.829064613702266,0.273909198400199,8,142,vacuole organization,BP,GNPTAB;CLN6;VPS41;UBQLN2;TMEM199;TMEM165;RAB3GAP1;SYNPO2
10281,GO:0043014,0.829067791713866,0.485098100242896,1,23,alpha-tubulin binding,MF,SETD2
11903,GO:0046902,0.82916164124044,0.3445807068154,3,66,regulation of mitochondrial membrane permeability,BP,TP53;DYNLL2;BLOC1S2
15194,GO:0071312,0.829464936188887,0.48495528895002,1,22,cellular response to alkaloid,BP,CCNA2
11881,GO:0046856,0.829631026356269,0.485272749144695,1,21,phosphatidylinositol dephosphorylation,BP,MTMR2
1306,GO:0003143,0.829859795504216,0.387270439728621,2,40,embryonic heart tube morphogenesis,BP,SRF;BBS5
5232,GO:0015844,0.830011275144168,0.482930710834972,1,24,monoamine transport,BP,SYK
6071,GO:0019217,0.830030981093255,0.344115044522929,3,58,regulation of fatty acid metabolic process,BP,IRS1;PANK2;PPARGC1B
8163,GO:0032886,0.830280382444574,0.261001370606186,10,166,regulation of microtubule-based process,BP,MAP2;MID1;STAG1;CYLD;PLK2;RANBP2;TRIM37;SKA2;CHEK1;HNRNPU
15762,GO:0072329,0.830757682346074,0.300661129870871,5,99,monocarboxylic acid catabolic process,BP,IRS1;CROT;MMAA;HADHB;HIBCH
8082,GO:0032755,0.830877863774381,0.384817651612784,2,44,positive regulation of interleukin-6 production,BP,TLR3;TNF
7221,GO:0031110,0.830949811621563,0.342842760521941,3,57,regulation of microtubule polymerization or depolymerization,BP,MAP2;MID1;SKA2
4392,GO:0010043,0.83127282955392,0.47980576702883,1,26,response to zinc ion,BP,SLC30A6
110,GO:0000226,0.831392984475882,0.221929078388302,28,427,microtubule cytoskeleton organization,BP,CRYAB;NEFL;MAP2;KIF23;MID1;STAG1;CHP1;CYLD;DNHD1;NAIP;ULK4;PARD3B;NDC1;PLK2;MYBL2;RAN;RANBP2;TRIM37;BIRC3;SETD2;WEE1;BRCA2;SKA2;CHEK1;CEP152;PARD3;HNRNPU;FGFR1OP
4645,GO:0010765,0.831483981960424,0.481393582448703,1,22,positive regulation of sodium ion transport,BP,CHP1
15052,GO:0070979,0.831526907724046,0.478958028345554,1,27,protein K11-linked ubiquitination,BP,ANAPC7
2197,GO:0005057,0.831566595790662,0.278359119171904,7,119,signal transducer activity, downstream of receptor,MF,MAP3K14;FGFR2;IKBKE;BAG1;SYK;EPHB6;DAXX
5736,GO:0016879,0.831918834510449,0.383326207721707,2,43,ligase activity, forming carbon-nitrogen bonds,MF,GCLC;GATC
10744,GO:0044091,0.832292796941963,0.47940327456372,1,23,membrane biogenesis,BP,EMP2
16174,GO:0090175,0.832348708430482,0.298308215132003,5,101,regulation of establishment of planar polarity,BP,SFRP1;FZD1;PSME2;PSMB9;PSMB10
4097,GO:0009150,0.832441888328277,0.230340783346889,20,356,purine ribonucleotide metabolic process,BP,PANK2;TPST1;NUP50;TJP2;NUP153;ADM;NDC1;RAN;RANBP2;GPHN;CROT;PGK1;NUP160;ENPP1;NUP54;HSPA8;GPER1;SDHD;UQCRB;NDUFB9
17725,GO:1901605,0.832914802151749,0.268547908643194,8,150,alpha-amino acid metabolic process,BP,GCLC;STAT5A;SLC1A3;ODC1;QDPR;SEPHS2;AZIN1;HIBCH
10169,GO:0042743,0.833327449877734,0.4757564288213,1,27,hydrogen peroxide metabolic process,BP,CYP1A1
11389,GO:0045740,0.833380854290079,0.380959039204164,2,43,positive regulation of DNA replication,BP,PDGFB;E2F8
7602,GO:0031968,0.833612123208281,0.261546420898123,9,163,organelle outer membrane,CC,CYP24A1;ACSL3;RAB32;DDX3X;GDAP1;LRPPRC;SLC11A2;HADHB;STARD7
5441,GO:0016301,0.833777800862652,0.208893701368929,43,634,kinase activity,MF,NRG1;MAP3K14;FGFR2;STAT5A;IRS1;DAPK3;PANK2;IKBKE;PKMYT1;NUAK1;CAMK1G;SYK;TJP2;TRIO;CDK4;RIPK4;ULK4;TK1;PLK2;FRK;HMGXB3;TRPM7;FASTKD3;PGK1;PDGFB;SGK494;PIK3R3;SEPHS2;WEE1;EPHB6;SGK1;PPIP5K1;CHEK1;ATR;NOL9;CCNA2;ESR1;CCL5;FGFR1OP;TAF1;CDKN1A;GTF2H3;IRAK3
11384,GO:0045732,0.834005658863087,0.255925178573262,10,176,positive regulation of protein catabolic process,BP,GCLC;KEAP1;PLK2;UBQLN2;CLU;NSF;NEDD4L;RNF19B;TNF;TAF1
6916,GO:0030501,0.834012748851216,0.476897312550101,1,22,positive regulation of bone mineralization,BP,WNT4
14623,GO:0070169,0.834012748851216,0.476897312550101,1,22,positive regulation of biomineral tissue development,BP,WNT4
332,GO:0000922,0.834015516419753,0.267282811753976,8,142,spindle pole,CC,STAG1;TOPBP1;KLHL21;BRCC3;CEP95;CENPF;NEDD9;HNRNPU
4074,GO:0009126,0.834489262920148,0.243400221113562,13,248,purine nucleoside monophosphate metabolic process,BP,NUP50;TJP2;NUP153;NDC1;RANBP2;PGK1;NUP160;ENPP1;NUP54;HSPA8;SDHD;UQCRB;NDUFB9
4113,GO:0009167,0.834489262920148,0.243400221113562,13,248,purine ribonucleoside monophosphate metabolic process,BP,NUP50;TJP2;NUP153;NDC1;RANBP2;PGK1;NUP160;ENPP1;NUP54;HSPA8;SDHD;UQCRB;NDUFB9
9054,GO:0035264,0.834600313571013,0.28354060130626,6,105,multicellular organism growth,BP,FGFR2;STAT5A;CDK4;KDM6A;CSF1;FTO
3236,GO:0006892,0.834688812973281,0.295558631649266,5,90,post-Golgi vesicle-mediated transport,BP,MYO1B;ACSL3;ARFRP1;RAB26;NSF
9605,GO:0036452,0.834763778237026,0.47358683694143,1,26,ESCRT complex,CC,VPS36
200,GO:0000421,0.834773184723563,0.474001394229495,1,25,autophagosome membrane,CC,VMP1
10799,GO:0044257,0.834992426214976,0.208921857851639,40,634,cellular protein catabolic process,BP,PML;GCLC;ENC1;TP53;CYLD;USP16;KEAP1;OPHN1;USP43;FOXRED2;PLK2;UBQLN2;RANBP2;ANAPC15;RNF115;ARNTL;CLU;USP6;PDCL3;TMEM199;HSP90AB1;NEDD4L;ANAPC7;CCDC47;FAF1;SENP1;PSME2;PSMB9;SPSB1;UBE2J2;VPS36;CLOCK;KIF14;RNF19B;USP11;PSMB10;TAF1;SMARCC1;USP1;COPS3
8206,GO:0032945,0.835333344001676,0.377784071666952,2,43,negative regulation of mononuclear cell proliferation,BP,CD274;RC3H1
12547,GO:0050672,0.835333344001676,0.377784071666952,2,43,negative regulation of lymphocyte proliferation,BP,CD274;RC3H1
17753,GO:1901658,0.835526624929697,0.471818806191931,1,27,glycosyl compound catabolic process,BP,DPYD
17711,GO:1901565,0.835829617940502,0.199260976668932,63,980,organonitrogen compound catabolic process,BP,NRG1;PML;GCLC;HSPG2;CLN6;ENC1;TP53;C9ORF3;CHP1;CYLD;USP16;KEAP1;ADAMTS9;OPHN1;USP43;FOXRED2;PLK2;UBQLN2;RANBP2;ANAPC15;RNF115;ARNTL;ODC1;MDM4;QDPR;CHID1;CLU;USP6;ERAP1;PDCL3;TET3;HSPA8;TMEM199;HSP90AB1;SMUG1;BACE2;NSF;NEDD4L;ANAPC7;DPYD;CCDC47;FAF1;SENP1;PSME2;PSMB9;UGT1A4;SPSB1;UBE2J2;VPS36;TRAF2;CLOCK;KIF14;AZIN1;RNF19B;USP11;TNF;PSMB10;TAF1;HIBCH;SMARCC1;USP1;IRAK3;COPS3
1428,GO:0003382,0.836030199389338,0.473281576347527,1,22,epithelial cell morphogenesis,BP,SIPA1L3
8742,GO:0034383,0.836341511334756,0.471183301830115,1,25,low-density lipoprotein particle clearance,BP,EHD1
6620,GO:0022839,0.836873304957037,0.280278033077207,6,107,ion gated channel activity,MF,JPH2;KCNS3;ITGAV;KCNQ5;JPH1;KCNE4
7865,GO:0032420,0.836918977537552,0.470610858370863,1,24,stereocilium,CC,SLC9A3R1
4933,GO:0014888,0.837683711105669,0.470298917510307,1,22,striated muscle adaptation,BP,CFLAR
8986,GO:0035082,0.837804039120954,0.469522082050526,1,23,axoneme assembly,BP,DNHD1
11644,GO:0046332,0.837900750405962,0.332319064826967,3,56,SMAD binding,MF,PML;COL5A2;PURB
1558,GO:0003954,0.837983097163608,0.464034226136486,1,40,NADH dehydrogenase activity,MF,NDUFB9
6926,GO:0030513,0.838023141407013,0.469684485567753,1,22,positive regulation of BMP signaling pathway,BP,CYR61
10594,GO:0043548,0.838342363251255,0.469720128126438,1,21,phosphatidylinositol 3-kinase binding,MF,IRS1
18288,GO:1903115,0.838900037972003,0.468093718740333,1,22,regulation of actin filament-based movement,BP,PDPN
18713,GO:1904036,0.838938786106191,0.46746370855125,1,23,negative regulation of epithelial cell apoptotic process,BP,CFLAR
6545,GO:0021954,0.839100667109663,0.371810412966129,2,42,central nervous system neuron development,BP,MAP2;FGFR2
2561,GO:0005840,0.839684718797007,0.252510784420143,9,225,ribosome,CC,ABCF1;GEMIN5;MRPL27;DDX3X;NUFIP1;MRTO4;APEX1;MRPS7;RPS12
6149,GO:0019432,0.839693016907535,0.465578916459888,1,24,triglyceride biosynthetic process,BP,C3
4354,GO:0009925,0.839817489357635,0.467038954321915,1,21,basal plasma membrane,CC,DST
11408,GO:0045776,0.839989878173501,0.465037499786973,1,24,negative regulation of blood pressure,BP,SOD2
243,GO:0000578,0.840473788557523,0.465226352793678,1,22,embryonic axis specification,BP,KDM6A
8592,GO:0034067,0.840631223048325,0.465553881915197,1,21,protein localization to Golgi apparatus,BP,ARFRP1
13832,GO:0060401,0.840836204550041,0.286741793179348,5,90,cytosolic calcium ion transport,BP,PML;JPH2;CTGF;JPH1;GPER1
3255,GO:0006921,0.84106926414633,0.462593518152319,1,25,cellular component disassembly involved in execution phase of apoptosis,BP,GPER1
13850,GO:0060428,0.841193531521943,0.463349062305077,1,23,lung epithelium development,BP,FGFR2
5399,GO:0016233,0.841281361632518,0.366724542278126,2,51,telomere capping,BP,NBN;HIST1H4A
19990,GO:2000514,0.841371841893385,0.462038863609229,1,25,regulation of CD4-positive, alpha-beta T cell activation,BP,RC3H1
10432,GO:0043266,0.841949625092486,0.367310500564666,2,41,regulation of potassium ion transport,BP,NETO1;NEDD4L
4476,GO:0010470,0.84199307432783,0.461882040906801,1,23,regulation of gastrulation,BP,COL5A2
7885,GO:0032446,0.84201473440229,0.19629550463961,50,785,protein modification by small protein conjugation,BP,DTX2;GCLC;TRIM22;TRIM56;TRAF3;ENC1;KBTBD8;ZBED1;CHP1;NUP50;NUP153;NAIP;KEAP1;NDC1;HERC6;RANBP2;ZNF738;KLHL21;RNF115;SOCS1;TRIM37;GNL3L;SH3RF2;MDM4;NUP160;BIRC3;NUP54;KLHL9;DTX4;HSP90AB1;NEDD4L;ANAPC7;RAD18;SENP1;PSME2;PSMB9;RFWD3;CBLL1;SPSB1;UBE2J2;TRAF2;MPHOSPH8;RNF19B;FEM1C;RC3H1;RING1;PSMB10;DAXX;TAF1;UFC1
13134,GO:0051650,0.842034835087125,0.241123150655866,11,188,establishment of vesicle localization,BP,KIF23;AP3M2;CADPS2;BLOC1S2;SYT11;NSF;TRAK2;GOSR1;RAB3GAP1;BBS5;AP3B1
8273,GO:0033047,0.842065529769578,0.325268642221847,3,61,regulation of mitotic sister chromatid segregation,BP,ANAPC15;CENPF;HNRNPU
10514,GO:0043407,0.842422049573096,0.324404479857429,3,64,negative regulation of MAP kinase activity,BP,DUSP14;SFRP1;IRAK3
14930,GO:0070741,0.842450102611475,0.46104158994594,1,23,response to interleukin-6,BP,IL6ST
15225,GO:0071354,0.842450102611475,0.46104158994594,1,23,cellular response to interleukin-6,BP,IL6ST
5862,GO:0017158,0.842607283972416,0.365815327368735,2,43,regulation of calcium ion-dependent exocytosis,BP,SYT11;RAB3GAP1
6618,GO:0022836,0.842854022201963,0.271836013605327,6,108,gated channel activity,MF,JPH2;KCNS3;ITGAV;KCNQ5;JPH1;KCNE4
5065,GO:0015276,0.843132803600172,0.36556282105111,2,40,ligand-gated ion channel activity,MF,JPH2;JPH1
6616,GO:0022834,0.843132803600172,0.36556282105111,2,40,ligand-gated channel activity,MF,JPH2;JPH1
6773,GO:0030203,0.843344358890487,0.271059372263211,6,110,glycosaminoglycan metabolic process,BP,HSPG2;CLN6;B4GALT1;CHP1;HS3ST1;PDGFB
4196,GO:0009301,0.84370552649823,0.322122528296286,3,67,snRNA transcription,BP,PHAX;POLR2F;NCBP1
10202,GO:0042795,0.84370552649823,0.322122528296286,3,67,snRNA transcription by RNA polymerase II,BP,PHAX;POLR2F;NCBP1
12328,GO:0048663,0.843706361296812,0.458724296567834,1,23,neuron fate commitment,BP,NRG1
8126,GO:0032806,0.843740248016157,0.457676625012376,1,25,carboxy-terminal domain protein kinase complex,CC,GTF2H3
10679,GO:0043900,0.844234789313165,0.223297278844145,16,285,regulation of multi-organism process,BP,PML;B4GALT1;TRAF3;INHBA;FAM111A;NUCKS1;TARDBP;DDX3X;ITGAV;BIRC3;HSPA8;SYT11;POLR2F;TNF;CCL5;CD74
19906,GO:2000351,0.844579864831466,0.457106860916798,1,23,regulation of endothelial cell apoptotic process,BP,GPER1
2380,GO:0005509,0.844810199558713,0.210075439311534,24,367,calcium ion binding,MF,C1R;S100P;FBN1;GNPTAB;HSPG2;FAT4;SVEP1;CHP1;PCDH7;DST;TCHH;HRNR;LCP1;CDH13;NPNT;ENPP1;TPM4;THBD;SYT11;CCDC47;RPTN;EHD1;CAPN12;ASTN2
13114,GO:0051606,0.844868709147334,0.26874539866331,6,114,detection of stimulus,BP,RPA1;RFC3;RAD18;TIMELESS;METAP2;USP1
524,GO:0001618,0.845668346571022,0.36052356809508,2,44,virus receptor activity,MF,TFRC;ITGAV
17209,GO:0104005,0.845668346571022,0.36052356809508,2,44,hijacked molecular function,MF,TFRC;ITGAV
12152,GO:0048232,0.84571049629799,0.219482007887425,17,285,male gamete generation,BP,PANK2;BRIP1;IMMP2L;NDC1;SLCO4C1;RAN;ARNTL;MCM8;BIRC3;DPY19L2P2;MYBL1;BRCA2;HSF2;CLOCK;TBPL1;DIAPH3;GPX4
6276,GO:0019867,0.84657520392112,0.244200167769221,9,165,outer membrane,CC,CYP24A1;ACSL3;RAB32;DDX3X;GDAP1;LRPPRC;SLC11A2;HADHB;STARD7
1879,GO:0004553,0.846825320928086,0.317610863348571,3,63,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,MGAM;GANC;CHID1
10586,GO:0043539,0.847349755119146,0.450521498433598,1,26,protein serine/threonine kinase activator activity,MF,DDX3X
3140,GO:0006734,0.847503746851428,0.450232821114267,1,26,NADH metabolic process,BP,PGK1
20061,GO:2000648,0.847583745627777,0.451505592177834,1,23,positive regulation of stem cell proliferation,BP,HNRNPU
3336,GO:0007051,0.847656166683791,0.242966364146741,9,155,spindle organization,BP,KIF23;STAG1;NAIP;PLK2;MYBL2;RAN;RANBP2;BIRC3;HNRNPU
18587,GO:1903779,0.84779643917082,0.357756582756477,2,40,regulation of cardiac conduction,BP,ATP2B1;ABCC9
13770,GO:0060324,0.84780179065621,0.357324769758948,2,42,face development,BP,SRF;RAB3GAP1
16883,GO:0098793,0.848183952151966,0.229308807008159,12,209,presynapse,CC,OPHN1;CADPS2;MME;RAB26;NUFIP1;BAIAP2;WDR7;HSPA8;SYT11;MTMR2;GPER1;HNRNPR
17330,GO:0140104,0.849139777002336,0.446753183278284,1,27,molecular carrier activity,MF,RAN
15514,GO:0071868,0.850120572589528,0.446211781467328,1,24,cellular response to monoamine stimulus,BP,SRD5A1
15516,GO:0071870,0.850120572589528,0.446211781467328,1,24,cellular response to catecholamine stimulus,BP,SRD5A1
20168,GO:2000826,0.850343119986381,0.445790421644578,1,24,regulation of heart morphogenesis,BP,TGFB2
3422,GO:0007212,0.850653683321621,0.444292309466024,1,26,dopamine receptor signaling pathway,BP,SLC9A3R1
14892,GO:0070664,0.850691037819939,0.351880868764354,2,45,negative regulation of leukocyte proliferation,BP,CD274;RC3H1
11702,GO:0046471,0.850706867568104,0.4446275458468,1,25,phosphatidylglycerol metabolic process,BP,HADHB
4817,GO:0014009,0.850720834729686,0.445590239699277,1,23,glial cell proliferation,BP,CLU
10417,GO:0043243,0.850737093581985,0.445559404394376,1,23,positive regulation of protein complex disassembly,BP,TNF
2500,GO:0005747,0.85099165867915,0.439539329740479,1,42,mitochondrial respiratory chain complex I,CC,NDUFB9
7140,GO:0030964,0.85099165867915,0.439539329740479,1,42,NADH dehydrogenase complex,CC,NDUFB9
11194,GO:0045271,0.85099165867915,0.439539329740479,1,42,respiratory chain complex I,CC,NDUFB9
4608,GO:0010721,0.851112316217225,0.225600288346601,12,201,negative regulation of cell development,BP,NRG1;FBN1;PBX1;G6PD;GBP1;TJP2;PLK2;CORO1C;TRAK2;NTN1;DPYSL3;ITGB1BP1
10680,GO:0043901,0.851214390333092,0.259472317927101,6,121,negative regulation of multi-organism process,BP,PML;FAM111A;TARDBP;ITGAV;TNF;CCL5
3656,GO:0008139,0.851404286741753,0.444292465364563,1,23,nuclear localization sequence binding,MF,NUP153
2904,GO:0006414,0.851673881638563,0.269534480913617,5,125,translational elongation,BP,USP16;MRPL27;EFTUD2;MRPS7;DPH2
2879,GO:0006379,0.852041466185762,0.441249998863029,1,27,mRNA cleavage,BP,NCBP1
7387,GO:0031434,0.85232814692303,0.34965665718962,2,42,mitogen-activated protein kinase kinase binding,MF,FGFR2;EPHB6
6261,GO:0019842,0.852461089720365,0.284962991681808,4,84,vitamin binding,MF,P3H2;DHFR;P4HA2;TYMS
5627,GO:0016684,0.853077437379842,0.437639296631932,1,32,oxidoreductase activity, acting on peroxide as acceptor,MF,GPX4
18712,GO:1904035,0.853276337827608,0.347657247598705,2,44,regulation of epithelial cell apoptotic process,BP,GPER1;CFLAR
15530,GO:0071889,0.853875670854649,0.439055695784501,1,24,14-3-3 protein binding,MF,SYNPO2
11424,GO:0045814,0.85392017318153,0.266353955195032,5,121,negative regulation of gene expression, epigenetic,BP,H3F3A;HELLS;SETDB1;RIF1;HIST1H4A
13127,GO:0051642,0.854269227518779,0.439381613957204,1,22,centrosome localization,BP,RANBP2
6995,GO:0030669,0.854603730528435,0.437182372926828,1,25,clathrin-coated endocytic vesicle membrane,CC,CD74
7225,GO:0031114,0.855099379604184,0.437784224004995,1,22,regulation of microtubule depolymerization,BP,MID1
13056,GO:0051493,0.855107828643882,0.196329787154597,25,396,regulation of cytoskeleton organization,BP,MAP2;CTGF;MID1;DAPK3;EDN1;STAG1;CYLD;SFRP1;TPM1;PTGER4;SYNPO2L;PLK2;NEXN;KANK4;RHOG;WNT4;RANBP2;TRIM37;CDC42EP2;BAIAP2;SKA2;CHEK1;SYNPO2;HNRNPU;ITGB1BP1
2438,GO:0005637,0.85519426158373,0.344194935362071,2,45,nuclear inner membrane,CC,LRPPRC;DPY19L2P2
10919,GO:0044455,0.855341282314667,0.244234575352553,7,166,mitochondrial membrane part,CC,IMMP2L;GDAP1;TIMM23B;NNT;SDHD;UQCRB;NDUFB9
796,GO:0002062,0.855363508613389,0.304477532239773,3,59,chondrocyte differentiation,BP,CTGF;RUNX1;COL27A1
5566,GO:0016575,0.85565312694586,0.28041625278367,4,79,histone deacetylation,BP,HDAC9;TP53;AKAP8;AKAP8L
8826,GO:0034593,0.855873749967555,0.435724273334344,1,23,phosphatidylinositol bisphosphate phosphatase activity,MF,MTMR2
12633,GO:0050795,0.856134427379907,0.434228398147035,1,25,regulation of behavior,BP,LEPR
16616,GO:0097421,0.856153505834971,0.433350192046988,1,27,liver regeneration,BP,TYMS
9971,GO:0042339,0.85620178693722,0.433660786332909,1,26,keratan sulfate metabolic process,BP,B4GALT1
10516,GO:0043409,0.856219547365718,0.243812461083231,7,131,negative regulation of MAPK cascade,BP,GBP1;DUSP14;SLC9A3R1;SFRP1;GPER1;ITGB1BP1;IRAK3
13169,GO:0051721,0.856421279642718,0.433672947691107,1,25,protein phosphatase 2A binding,MF,TP53
6697,GO:0030071,0.856892336684865,0.34110340425664,2,46,regulation of mitotic metaphase/anaphase transition,BP,ANAPC15;CENPF
17890,GO:1902099,0.856892336684865,0.34110340425664,2,46,regulation of metaphase/anaphase transition of cell cycle,BP,ANAPC15;CENPF
9845,GO:0042063,0.856988738683782,0.225441972767596,10,174,gliogenesis,BP,NRG1;TGFB2;CNTNAP1;IL6ST;CLU;EIF2B5;CSF1;MPP5;PARD3;EIF2B1
6312,GO:0019953,0.85729388403935,0.191623010331991,27,440,sexual reproduction,BP,B4GALT1;SPACA6;PANK2;INHBA;LEPR;BRIP1;IMMP2L;NDC1;SLCO4C1;WNT4;RAN;ARNTL;DND1;MCM8;BIRC3;DPY19L2P2;MYBL1;GLIPR1L2;BRCA2;FANCD2;ETV6;HSF2;UBAP2L;CLOCK;TBPL1;DIAPH3;GPX4
2319,GO:0005319,0.857591387946299,0.277374988561424,4,80,lipid transporter activity,MF,ABCG2;SPNS1;ABCA5;ARV1
4742,GO:0010907,0.858052106705288,0.431496201310106,1,23,positive regulation of glucose metabolic process,BP,IRS1
6922,GO:0030509,0.858075095250495,0.261452082513956,5,91,BMP signaling pathway,BP,CYR61;FBN1;TGFB2;SFRP1;FZD1
2907,GO:0006418,0.858164567721588,0.338441672900063,2,49,tRNA aminoacylation for protein translation,BP,CARS2;RARS
7034,GO:0030802,0.858314838045339,0.429553756996271,1,26,regulation of cyclic nucleotide biosynthetic process,BP,GPER1
1410,GO:0003341,0.858660287058892,0.429316861370179,1,25,cilium movement,BP,DNHD1
3602,GO:0008038,0.858792503422119,0.430617307981029,1,22,neuron recognition,BP,CNTNAP2
3748,GO:0008287,0.85918315077957,0.337139371162371,2,46,protein serine/threonine phosphatase complex,CC,PPP1R3B;PPP4R4
18359,GO:1903293,0.85918315077957,0.337139371162371,2,46,phosphatase complex,CC,PPP1R3B;PPP4R4
3593,GO:0008021,0.859418739543032,0.258826203296982,5,104,synaptic vesicle,CC,MME;RAB26;WDR7;SYT11;MTMR2
18807,GO:1904292,0.859492081806565,0.427251455437043,1,26,regulation of ERAD pathway,BP,UBQLN2
15838,GO:0072522,0.860034266288469,0.221117911625956,10,186,purine-containing compound biosynthetic process,BP,PANK2;NUP50;NUP153;ADM;NDC1;RANBP2;PGK1;NUP160;NUP54;GPER1
15513,GO:0071867,0.860369628096179,0.425966481836879,1,25,response to monoamine,BP,SRD5A1
15515,GO:0071869,0.860369628096179,0.425966481836879,1,25,response to catecholamine,BP,SRD5A1
4690,GO:0010837,0.860986294212739,0.425227922376731,1,24,regulation of keratinocyte proliferation,BP,CD109
2524,GO:0005777,0.861084291636578,0.256301812501686,5,105,peroxisome,CC,ACSL3;CROT;TRIM37;TTC1;PXMP2
10089,GO:0042579,0.861084291636578,0.256301812501686,5,105,microbody,CC,ACSL3;CROT;TRIM37;TTC1;PXMP2
11692,GO:0046460,0.861152660082567,0.423986481665295,1,26,neutral lipid biosynthetic process,BP,C3
11695,GO:0046463,0.861152660082567,0.423986481665295,1,26,acylglycerol biosynthetic process,BP,C3
6530,GO:0021915,0.862062850966159,0.235750781768345,7,124,neural tube development,BP,TGFB2;SFRP1;ADM;KDM6A;PHACTR4;FZD1;SETD2
15163,GO:0071248,0.862096404882842,0.255003994326511,5,100,cellular response to metal ion,BP,MMP9;CYP1A1;EDN1;NQO1;DAXX
12424,GO:0048854,0.862344291627897,0.42306278762611,1,23,brain morphogenesis,BP,FANCD2
5681,GO:0016790,0.862410550463701,0.420370619502706,1,29,thiolester hydrolase activity,MF,HIBCH
7823,GO:0032371,0.862546424188629,0.421230198166287,1,26,regulation of sterol transport,BP,ARV1
7826,GO:0032374,0.862546424188629,0.421230198166287,1,26,regulation of cholesterol transport,BP,ARV1
2538,GO:0005794,0.863154691791835,0.165312551753724,77,1150,Golgi apparatus,CC,CRYAB;SPRR3;MTUS1;FGFR2;TRIM22;CTGF;HLA-B;GNPTAB;HSPG2;MYO1B;B4GALT1;DYNC2H1;SPG21;TPST1;GBP1;KBTBD8;ACSL3;CHP1;ACO1;AKAP8;ST6GALNAC5;PKMYT1;SLC30A6;P3H2;GALNT18;CAMK1G;EMP2;RAB32;ARFRP1;HLA-F;VPS41;AP3M2;ZDHHC6;KCNS3;SLC35A4;MUC16;GBP5;WNT4;HS3ST1;ATP2C1;RAB26;AJUBA;LFNG;BAIAP2;PDGFB;CHID1;CLU;COMMD9;FGD6;GLIPR2;RIC3;CNTNAP2;BACE2;NSF;NEDD4L;M6PR;GOSR1;TMEM165;STEAP4;RAB3GAP1;SERPINB9;GPER1;ATR;MSH6;ABCA5;NFKBIE;AP3B1;TLR3;ESR1;CLCC1;ARV1;NEDD9;CD74;NRAS;MUC5B;MUC6;RPS12
5964,GO:0018345,0.863348247677732,0.419232924388666,1,27,protein palmitoylation,BP,ZDHHC6
8782,GO:0034453,0.86359815080529,0.4205730011781,1,23,microtubule anchoring,BP,FGFR1OP
3463,GO:0007283,0.864045624477795,0.198157252676361,16,275,spermatogenesis,BP,PANK2;BRIP1;IMMP2L;NDC1;SLCO4C1;RAN;ARNTL;BIRC3;DPY19L2P2;MYBL1;BRCA2;HSF2;CLOCK;TBPL1;DIAPH3;GPX4
14558,GO:0070059,0.86421901444804,0.327876216328217,2,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PML;TRAF2
6761,GO:0030182,0.864311712794057,0.168113306576355,58,854,neuron differentiation,BP,NEFL;NRG1;HDAC9;MAP2;FN1;TENM3;FGFR2;RUNX1;FAT4;PBX1;NEFM;ENC1;DAPK3;DOCK10;TGFB2;CNTNAP1;LRFN4;SLC9A3R1;INHBA;SFRP1;WNT10A;DHFR;ULK4;OPHN1;ADM;SLC1A3;PLK2;RHOG;WNT4;GPRIN1;PTPRM;RRN3;BAIAP2;SRF;UGT8;SDK1;FZD1;WEE1;SLC11A2;BLOC1S2;TNC;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;WDPCP;MTMR2;L1CAM;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;PARD3;EHD1;WDR36;NRAS
2246,GO:0005154,0.864400274930483,0.41754127423076,1,26,epidermal growth factor receptor binding,MF,EPGN
18700,GO:1904019,0.864578768471277,0.289119431584342,3,63,epithelial cell apoptotic process,BP,GPER1;CFLAR;TNF
20314,GO:2001251,0.864747483981737,0.240269628110885,6,111,negative regulation of chromosome organization,BP,NBN;ANAPC15;SET;GNL3L;CENPF;HNRNPU
18830,GO:1904353,0.864834574606804,0.417111635717832,1,25,regulation of telomere capping,BP,NBN
11027,GO:0044853,0.865379796231543,0.288114453049253,3,60,plasma membrane raft,CC,IRS1;CORO1C;CDH13
7609,GO:0031984,0.865751676923047,0.16136467707827,83,1278,organelle subcompartment,CC,PTGES;PML;CYP1B1;JPH2;UGT1A6;FADS3;HLA-B;GNPTAB;TAP1;MYO1B;CYP1A1;CLN6;B4GALT1;FAM69B;TPST1;SCD;GBP1;ACSL3;CHP1;ST6GALNAC5;PKMYT1;CDKAL1;SLC30A6;GALNT18;CAMK1G;EMP2;RAB32;LSS;ARFRP1;LRRC8D;HLA-F;ZDHHC6;ABHD4;DST;RCE1;REEP1;TMEM97;GGCX;SLC35A4;GBP5;RHOG;ATP2C1;RAB26;LFNG;HACD2;PDGFB;CHID1;NFE2L1;MBOAT1;SRD5A1;GLIPR2;JPH1;SRPRB;THADA;ERAP1;RIC3;TMEM199;ARL6IP5;SCD5;NSF;SGK1;M6PR;ZFYVE27;GOSR1;TMEM165;STEAP4;RAB3GAP1;GPER1;FAF1;ABCA5;UGT1A4;EBP;UBE2J2;TRAF2;TAP2;TLR3;GJC1;RNF19B;ARV1;CD74;PANX1;NRAS;TREX1
15936,GO:0072698,0.865924175457455,0.326045726632916,2,42,protein localization to microtubule cytoskeleton,BP,MID1;HNRNPU
2492,GO:0005739,0.866267223850101,0.160409085983667,85,1426,mitochondrion,CC,CRYAB;PTGES;CYP1B1;MTUS1;CYP24A1;TXNRD1;SACS;STARD13;TAP1;XAF1;CYP1A1;TFCP2L1;TRAF3;TP53;PANK2;ACSL3;LGALS3;ACO1;AKAP8;CARS2;IKBKE;IFIT3;RAB32;ABCG2;LDHAL6B;HEATR1;COA7;DHFR;REEP1;IMMP2L;DYNLL2;MRPL27;HSCB;EXOG;DDX28;RANBP2;SOD2;DDX3X;ABCF2;FASTKD3;CROT;FEN1;YRDC;GATC;IBA57;RARS;GDAP1;QDPR;TBC1D15;CLU;MACC1;LRPPRC;SPNS1;TRUB2;TIMM23B;TRMT5;NNT;SLC11A2;BLOC1S2;APEX1;HSP90AB1;SGK1;PXMP2;TRAK2;TRMT1;GPER1;MMAA;HADHB;SDHD;MRPS7;NCBP1;LRRC75A-AS1;GTF3C4;UQCRB;PDSS1;TYMS;STARD7;ARGLU1;FLAD1;HIBCH;PPARGC1B;SLC25A22;NDUFB9;GPX4;IFI27L1
11369,GO:0045687,0.866291160322298,0.413751510819915,1,26,positive regulation of glial cell differentiation,BP,IL6ST
17001,GO:0099023,0.866413451401906,0.285919246623432,3,65,tethering complex,CC,VPS41;VPS8;SYNPO2
9538,GO:0036258,0.866443590346217,0.412315026082774,1,29,multivesicular body assembly,BP,VPS36
7954,GO:0032543,0.866577045023278,0.247276662548655,5,129,mitochondrial translation,BP,MRPL27;FASTKD3;GATC;LRPPRC;MRPS7
2543,GO:0005801,0.866702254397552,0.323949540975333,2,46,cis-Golgi network,CC,CTGF;GOSR1
5486,GO:0016417,0.866780847480959,0.412360345223103,1,27,S-acyltransferase activity,MF,ZDHHC6
6692,GO:0030057,0.867153151253236,0.412929295664471,1,24,desmosome,CC,B4GALT1
903,GO:0002279,0.867464450816225,0.410980775165966,1,27,mast cell activation involved in immune response,BP,SYK
10456,GO:0043303,0.867464450816225,0.410980775165966,1,27,mast cell degranulation,BP,SYK
6726,GO:0030134,0.867815982600187,0.283348016900052,3,68,COPII-coated ER to Golgi transport vesicle,CC,HLA-B;HLA-F;CD74
12239,GO:0048477,0.86783217699057,0.321943172784909,2,46,oogenesis,BP,WNT4;BRCA2
16745,GO:0097730,0.867998210259394,0.283496075112945,3,63,non-motile cilium,CC,GLIS2;PHLPP2;PHLPP1
324,GO:0000904,0.868559088107078,0.174107817245708,32,485,cell morphogenesis involved in differentiation,BP,NEFL;NRG1;MAP2;FN1;FGFR2;GBP1;DOCK10;SIPA1L3;PDPN;LRFN4;SLC9A3R1;OPHN1;SLC1A3;PTPRM;CORO1C;ITGAV;BAIAP2;SRF;ANTXR1;SLC11A2;NEDD4L;ZFYVE27;TRAK2;WDPCP;L1CAM;NTN1;SHTN1;KIF14;PARD3;WDR36;NRAS;ITGB1BP1
1341,GO:0003197,0.868588996975672,0.410023412352652,1,24,endocardial cushion development,BP,TGFB2
5565,GO:0016574,0.868657409427193,0.320640308185254,2,45,histone ubiquitination,BP,TRIM37;RING1
12614,GO:0050771,0.868892631921131,0.320395147598381,2,44,negative regulation of axonogenesis,BP,TRAK2;NTN1
10453,GO:0043300,0.869226367819903,0.407408138131787,1,27,regulation of leukocyte degranulation,BP,SYK
5680,GO:0016788,0.869438654191811,0.171630761760516,34,556,hydrolase activity, acting on ester bonds,MF,EXO1;DUSP14;PTPN14;PPP1R3B;RAD1;POP1;GPCPD1;ABHD4;POLQ;PTPRB;TSN;G3BP1;EXOG;PTPRM;CDC25A;FEN1;APTX;USB1;APMAP;ISG20L2;ENPP1;LRPPRC;EYA3;APEX1;DGCR8;MTMR2;RAD51B;DNASE1;CCL5;PLBD1;PHLPP2;PHLPP1;HIBCH;TREX1
4315,GO:0009791,0.869593988147346,0.25897313780534,4,76,post-embryonic development,BP,FGFR2;FBN1;ACO1;CCDC47
6798,GO:0030234,0.869648951818953,0.165633332096668,46,734,enzyme regulator activity,MF,IGFBP3;NRG1;FN1;C3;STARD13;SIPA1L3;CDKN2A;CHP1;PPP1R3B;BAG1;NAIP;CDK4;OPHN1;CD109;HSCB;HSPB1;RANBP2;DDX3X;SOCS1;SET;CDC42EP2;PPP4R4;SH3RF2;PHACTR4;PDGFB;BRCC3;TBC1D15;USP6;BIRC3;PIK3R3;HSP90AB1;RAB3GAP1;SERPINB9;FAF1;PSME2;CFLAR;RABEP2;GTF3C4;AZIN1;ESR1;CCL5;RING1;FGFR1OP;DAXX;CDKN1A;ITGB1BP1
4033,GO:0009064,0.869736846788835,0.318235237437136,2,48,glutamine family amino acid metabolic process,BP,GCLC;SLC1A3
16660,GO:0097502,0.869766213984993,0.405932913355692,1,28,mannosylation,BP,DPY19L2P2
14155,GO:0061001,0.869817360701623,0.407048215510059,1,25,regulation of dendritic spine morphogenesis,BP,BAIAP2
5159,GO:0015695,0.869863179231567,0.406110822872782,1,27,organic cation transport,BP,SLC22A5
13132,GO:0051648,0.869932098070419,0.203897560127782,11,194,vesicle localization,BP,KIF23;AP3M2;CADPS2;BLOC1S2;SYT11;NSF;TRAK2;GOSR1;RAB3GAP1;BBS5;AP3B1
8455,GO:0033572,0.87062391640503,0.403831984818006,1,29,transferrin transport,BP,TFRC
12618,GO:0050775,0.870791600942911,0.405057602621895,1,25,positive regulation of dendrite morphogenesis,BP,BAIAP2
856,GO:0002181,0.870809177626571,0.277280095185549,3,85,cytoplasmic translation,BP,RBM4;MRTO4;DPH2
7795,GO:0032330,0.87099620172653,0.404638581197247,1,25,regulation of chondrocyte differentiation,BP,CTGF
9644,GO:0036503,0.871220931110068,0.255769667829474,4,86,ERAD pathway,BP,FOXRED2;UBQLN2;CCDC47;UBE2J2
18369,GO:1903307,0.871247368283285,0.402904080123941,1,28,positive regulation of regulated secretory pathway,BP,SYK
10071,GO:0042551,0.871278580778902,0.404059714132732,1,25,neuron maturation,BP,CNTNAP2
17324,GO:0140096,0.871422178611583,0.151278100401268,116,1701,catalytic activity, acting on a protein,MF,NRG1;HDAC9;C1R;MAP3K14;C3;FGFR2;STAT5A;MMP9;TRIM56;OVCH2;TRAF3;DAPK3;TPST1;C9ORF3;DUSP14;KBTBD8;ZBED1;PTPN14;PRSS23;CYLD;IKBKE;PKMYT1;PPP1R3B;P3H2;NUAK1;GALNT18;CAMK1G;SYK;NAIP;TRIO;CDK4;SFRP1;RIPK4;ZDHHC6;USP16;KEAP1;METTL21A;PTPRB;ULK4;RCE1;ADAMTS9;SETDB1;IMMP2L;P4HA2;USP43;HERC6;PLK2;MME;FRK;SUV39H2;PTPRM;KDM6A;SETD4;RANBP2;VCPKMT;ZNF738;CPA4;KLHL21;RNF115;CDC25A;QPCT;TRPM7;FASTKD3;TRIM37;MDM4;HIF1AN;BRCC3;SGK494;UTY;USP6;SMYD2;BIRC3;EYA3;KLHL9;SETD2;DTX4;WEE1;ERAP1;EPHB6;BACE2;DNPEP;NEDD4L;SGK1;MTMR2;FKBP5;CHEK1;RAD18;ADAM17;SENP1;ATR;CFLAR;PSMB9;RFWD3;CBLL1;SPSB1;UBE2J2;TRAF2;RBBP5;CCNA2;MPHOSPH8;RNF19B;USP11;CAPN12;RC3H1;CCL5;FGFR1OP;PSMB10;METAP2;PHLPP2;TAF1;PHLPP1;CDKN1A;USP1;GTF2H3;IRAK3;UFC1
13987,GO:0060674,0.871478008437338,0.403211853198274,1,26,placenta blood vessel development,BP,CYR61
10681,GO:0043902,0.872737991599373,0.219919347476008,7,142,positive regulation of multi-organism process,BP,INHBA;NUCKS1;DDX3X;HSPA8;POLR2F;CCL5;CD74
17057,GO:0099504,0.872744535885277,0.253783018540122,4,79,synaptic vesicle cycle,BP,OPHN1;CADPS2;SYT11;RAB3GAP1
5840,GO:0017124,0.872821581703059,0.23897507834434,5,96,SH3 domain binding,MF,CNTNAP1;SIRPA;ZNF106;ADAM17;DPYSL3
17581,GO:1901135,0.872858177181797,0.15862612972375,56,912,carbohydrate derivative metabolic process,BP,GNPTAB;HSPG2;CLN6;B4GALT1;G6PD;SPON1;PANK2;TPST1;CHP1;ST6GALNAC5;PGD;NUP50;GALNT18;TJP2;NUP153;UAP1L1;ADAMTS9;TK1;ADM;NDC1;MUC16;RAN;RANBP2;HS3ST1;GPHN;CROT;AKR1C2;LFNG;PGK1;PDGFB;UGT8;CHID1;NUP160;ENPP1;RRM2;NUP54;DPY19L2P2;PDCL3;TET3;UMPS;HSPA8;SMUG1;BACE2;TRAK2;DPYD;TMEM165;GPER1;RRM1;SDHD;AKR1B1;UQCRB;TYMS;TBPL1;MUC5B;MUC6;NDUFB9
13638,GO:0060090,0.873049817126382,0.213263747618981,8,147,molecular adaptor activity,MF,NEFL;TRIM22;CBX5;IRS1;CNTNAP1;TJP2;NUFIP1;BAIAP2
3506,GO:0007416,0.873079354134524,0.253531486643853,4,75,synapse assembly,BP,NRG1;SDK1;FZD1;LRRN3
1242,GO:0002931,0.873158141984546,0.399346184652964,1,27,response to ischemia,BP,PANX1
7863,GO:0032418,0.873516464211421,0.311295806443346,2,49,lysosome localization,BP,SYK;BLOC1S2
4222,GO:0009395,0.873541825967013,0.398177086623909,1,28,phospholipid catabolic process,BP,GPCPD1
2674,GO:0006024,0.873598177183656,0.252298574882557,4,81,glycosaminoglycan biosynthetic process,BP,HSPG2;B4GALT1;HS3ST1;PDGFB
2544,GO:0005802,0.873865990912638,0.206718110457755,9,167,trans-Golgi network,CC,MYO1B;RAB32;ARFRP1;ATP2C1;CHID1;M6PR;TMEM165;GPER1;CD74
6725,GO:0030133,0.874000465441157,0.189507632926468,14,254,transport vesicle,CC,HLA-B;SPG21;EDN1;CHP1;HLA-F;MME;RAB26;WDR7;SYT11;M6PR;MTMR2;GOSR1;DPYSL3;CD74
7603,GO:0031970,0.874167095736768,0.27208053852152,3,78,organelle envelope lumen,CC,PTGES;PANK2;COA7
818,GO:0002088,0.874471113320918,0.310359852372255,2,44,lens development in camera-type eye,BP,CRYAB;CDK4
12556,GO:0050686,0.875300008561705,0.394525672645445,1,28,negative regulation of mRNA processing,BP,SRSF7
9537,GO:0036257,0.876004083365005,0.392382004016161,1,30,multivesicular body organization,BP,VPS36
9707,GO:0038095,0.876008854537267,0.233479376355957,5,111,Fc-epsilon receptor signaling pathway,BP,SYK;PSME2;PSMB9;PSMB10;NRAS
2754,GO:0006163,0.876080673838409,0.175895192253378,20,371,purine nucleotide metabolic process,BP,PANK2;TPST1;NUP50;TJP2;NUP153;ADM;NDC1;RAN;RANBP2;GPHN;CROT;PGK1;NUP160;ENPP1;NUP54;HSPA8;GPER1;SDHD;UQCRB;NDUFB9
1966,GO:0004672,0.876377933654344,0.165264033962105,31,475,protein kinase activity,MF,NRG1;MAP3K14;FGFR2;STAT5A;DAPK3;IKBKE;PKMYT1;NUAK1;CAMK1G;SYK;TRIO;CDK4;RIPK4;ULK4;PLK2;FRK;TRPM7;FASTKD3;SGK494;WEE1;EPHB6;SGK1;CHEK1;ATR;CCNA2;CCL5;FGFR1OP;TAF1;CDKN1A;GTF2H3;IRAK3
96,GO:0000186,0.876482677108024,0.306528271236082,2,45,activation of MAPKK activity,BP,MAP3K14;GADD45B
17279,GO:0120039,0.876621497054521,0.1664121033582,29,445,plasma membrane bounded cell projection morphogenesis,BP,NEFL;NRG1;MAP2;FN1;FGFR2;DOCK10;PDPN;CNTNAP1;LRFN4;OPHN1;RHOG;PTPRM;CORO1C;BAIAP2;SRF;UGT8;WEE1;SLC11A2;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;L1CAM;NTN1;SHTN1;PARD3;WDR36;NRAS
4607,GO:0010720,0.877054271567099,0.17360676522085,21,340,positive regulation of cell development,BP,NEFL;NRG1;FN1;TENM3;ENC1;EDN1;IL6ST;RRN3;BAIAP2;SRF;FZD1;NEDD4L;ZFYVE27;L1CAM;GPER1;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;CSF1
5136,GO:0015630,0.877147204978118,0.151776523598007,64,967,microtubule cytoskeleton,CC,CRYAB;SAA1;MAP2;KIF23;MTUS1;NLRC5;TAP1;DYNC2H1;MID1;KBTBD8;TCP11L1;ZNF397;STAG1;CHP1;CYLD;NUAK1;PHAX;DNHD1;RELB;VPS41;MCM2;DST;KEAP1;NDC1;DYNLL2;PLK2;KANK4;HSPB1;RAN;RANBP2;TOPBP1;KLHL21;TAF1D;AJUBA;MCM3;CDC42EP2;BAIAP2;BRCC3;ODF2L;CEP95;LRPPRC;EYA3;RIF1;SRPRB;BLOC1S2;APEX1;BRCA2;SKA2;CENPF;PLEKHA7;CHEK1;BBS5;RAD18;CEP152;ZNF12;SHTN1;UPF3B;ORC2;KIF14;NEDD9;HNRNPU;FGFR1OP;DCTN5;ITGB1BP1
5734,GO:0016877,0.877700949815517,0.38949765216156,1,28,ligase activity, forming carbon-sulfur bonds,MF,ACSL3
15569,GO:0071985,0.87771268660327,0.389472953449805,1,28,multivesicular body sorting pathway,BP,VPS36
10166,GO:0042737,0.87791605235133,0.2660350946689,3,74,drug catabolic process,BP,QDPR;CHID1;DPYD
7866,GO:0032421,0.877930013650267,0.389015401818426,1,28,stereocilium bundle,CC,SLC9A3R1
3563,GO:0007606,0.877970452530193,0.388581321712644,1,29,sensory perception of chemical stimulus,BP,NAV2
4175,GO:0009247,0.878119419942152,0.302400518802483,2,53,glycolipid biosynthetic process,BP,ST6GALNAC5;UGT8
10878,GO:0044391,0.878492329967786,0.218339485816042,6,182,ribosomal subunit,CC,GEMIN5;MRPL27;DDX3X;MRTO4;MRPS7;RPS12
4258,GO:0009583,0.878674997698306,0.387443881407032,1,28,detection of light stimulus,BP,METAP2
6989,GO:0030660,0.878928312377886,0.243381695952441,4,88,Golgi-associated vesicle membrane,CC,HLA-B;HLA-F;TMEM199;CD74
12428,GO:0048858,0.878962520292331,0.163526893609953,29,446,cell projection morphogenesis,BP,NEFL;NRG1;MAP2;FN1;FGFR2;DOCK10;PDPN;CNTNAP1;LRFN4;OPHN1;RHOG;PTPRM;CORO1C;BAIAP2;SRF;UGT8;WEE1;SLC11A2;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;L1CAM;NTN1;SHTN1;PARD3;WDR36;NRAS
13771,GO:0060325,0.879094297106634,0.38733759764895,1,26,face morphogenesis,BP,RAB3GAP1
16621,GO:0097431,0.879597239610483,0.386272052972861,1,26,mitotic spindle pole,CC,STAG1
3929,GO:0008608,0.879715391306809,0.385241227640561,1,28,attachment of spindle microtubules to kinetochore,BP,HNRNPU
16318,GO:0090407,0.879863882313633,0.161555180003834,30,500,organophosphate biosynthetic process,BP,FGFR2;G6PD;IRS1;PANK2;HMGCS1;ACSL3;NUP50;NUP153;TK1;ADM;NDC1;RANBP2;GPHN;AJUBA;PGK1;PDGFB;NUP160;PIK3R3;MBOAT1;RRM2;NUP54;UMPS;PPIP5K1;MTMR2;GPER1;RRM1;TYMS;STARD7;FLAD1;TBPL1
6000,GO:0019003,0.880052280913186,0.298972440897357,2,52,GDP binding,MF,GBP1;RAN
2581,GO:0005871,0.880464382060171,0.29939254185477,2,44,kinesin complex,CC,KIF23;KIF14
2740,GO:0006120,0.880489212438651,0.379810076772344,1,45,mitochondrial electron transport, NADH to ubiquinone,BP,NDUFB9
9738,GO:0038179,0.880960285545081,0.382968430700818,1,27,neurotrophin signaling pathway,BP,ZFYVE27
8236,GO:0032990,0.881345347170705,0.159853196238499,30,464,cell part morphogenesis,BP,NEFL;NRG1;MAP2;FN1;FGFR2;PANK2;DOCK10;PDPN;CNTNAP1;LRFN4;OPHN1;RHOG;PTPRM;CORO1C;BAIAP2;SRF;UGT8;WEE1;SLC11A2;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;L1CAM;NTN1;SHTN1;PARD3;WDR36;NRAS
15024,GO:0070936,0.881382363481176,0.296912412928359,2,49,protein K48-linked ubiquitination,BP,RNF115;NEDD4L
13833,GO:0060402,0.881426041749612,0.239814549117868,4,80,calcium ion transport into cytosol,BP,PML;JPH2;JPH1;GPER1
14370,GO:0061564,0.881698480581035,0.167735964250638,21,334,axon development,BP,NEFL;NRG1;MAP2;FN1;FGFR2;NEFM;LRFN4;DHFR;OPHN1;PTPRM;BAIAP2;SRF;TNC;ZFYVE27;TRAK2;L1CAM;NTN1;SHTN1;PARD3;WDR36;NRAS
9847,GO:0042073,0.881751817449872,0.296228453631085,2,49,intraciliary transport,BP,DYNC2H1;DYNLL2
11641,GO:0046329,0.882117894868323,0.380118854419885,1,28,negative regulation of JNK cascade,BP,SFRP1
8210,GO:0032956,0.882738527794632,0.178008305901375,14,242,regulation of actin cytoskeleton organization,BP,CTGF;DAPK3;EDN1;SFRP1;TPM1;PTGER4;SYNPO2L;KANK4;RHOG;WNT4;CDC42EP2;BAIAP2;SYNPO2;ITGB1BP1
3354,GO:0007091,0.882758150047169,0.29436155026048,2,49,metaphase/anaphase transition of mitotic cell cycle,BP,ANAPC15;CENPF
10997,GO:0044784,0.882758150047169,0.29436155026048,2,49,metaphase/anaphase transition of cell cycle,BP,ANAPC15;CENPF
16426,GO:0097035,0.882962103432093,0.37908626096934,1,26,regulation of membrane lipid distribution,BP,ARV1
16516,GO:0097194,0.88389982885367,0.2561313587902,3,70,execution phase of apoptosis,BP,TP53;GPER1;CFLAR
12303,GO:0048609,0.884026948334491,0.157917033995151,28,460,multicellular organismal reproductive process,BP,CYP1A1;B4GALT1;PANK2;EDN1;TGFB2;INHBA;BRIP1;IMMP2L;NDC1;SLCO4C1;WNT4;RAN;ARNTL;DND1;MCM8;BIRC3;DPY19L2P2;MYBL1;BRCA2;FANCD2;ETV6;HSF2;AKR1B1;CLOCK;ESR1;TBPL1;DIAPH3;GPX4
10323,GO:0043094,0.884480834806875,0.373771876871887,1,32,cellular metabolic compound salvage,BP,TK1
15468,GO:0071772,0.885078451201531,0.220018637116237,5,96,response to BMP,BP,CYR61;FBN1;TGFB2;SFRP1;FZD1
15469,GO:0071773,0.885078451201531,0.220018637116237,5,96,cellular response to BMP stimulus,BP,CYR61;FBN1;TGFB2;SFRP1;FZD1
674,GO:0001881,0.885320859762007,0.37321026020718,1,28,receptor recycling,BP,NSF
4359,GO:0009953,0.885567931737537,0.289260249991815,2,48,dorsal/ventral pattern formation,BP,EDN1;SFRP1
15113,GO:0071108,0.885636702321297,0.373739883966482,1,25,protein K48-linked deubiquitination,BP,CYLD
6731,GO:0030140,0.88595996623485,0.371820663971713,1,28,trans-Golgi network transport vesicle,CC,SPG21
4781,GO:0010965,0.886237273895489,0.287726731769023,2,50,regulation of mitotic sister chromatid separation,BP,ANAPC15;CENPF
2527,GO:0005782,0.886444781003886,0.36978939231711,1,31,peroxisomal matrix,CC,CROT
7570,GO:0031907,0.886444781003886,0.36978939231711,1,31,microbody lumen,CC,CROT
13467,GO:0052866,0.887010916056422,0.370305491169223,1,26,phosphatidylinositol phosphate phosphatase activity,MF,MTMR2
2718,GO:0006094,0.88713144286139,0.285790279396629,2,52,gluconeogenesis,BP,LEPR;PGK1
7403,GO:0031461,0.88742184475962,0.1924099642385,8,156,cullin-RING ubiquitin ligase complex,CC,ENC1;KBTBD8;KEAP1;ANAPC15;KLHL21;KLHL9;ANAPC7;SPSB1
7193,GO:0031076,0.887594932876083,0.369463442907251,1,25,embryonic camera-type eye development,BP,PHACTR4
3268,GO:0006941,0.887627889067583,0.229715331482633,4,80,striated muscle contraction,BP,CTGF;TPM1;NEDD4L;GJC1
59,GO:0000122,0.88774548678213,0.147404581432969,38,602,negative regulation of transcription by RNA polymerase II,BP,HDAC9;FGFR2;CBX5;TSC22D3;FST;TFCP2L1;TP53;EDN1;IRX2;RELB;PARP15;GLIS3;FRK;SUV39H2;AJUBA;TRIM37;SRF;MDM4;HIF1AN;PDGFB;SMYD2;RIF1;GLIS2;NEDD4L;E2F8;ETV6;ZNF608;CITED2;TIMELESS;ORC2;RBL1;PURB;ESR1;TNF;HNRNPU;PHF14;TAF1;CTCF
1254,GO:0003002,0.888504991851001,0.17837419348361,11,196,regionalization,BP,MAFB;FGFR2;PBX1;EDN1;IRX2;SFRP1;KDM6A;LFNG;SRF;CITED2;RING1
6930,GO:0030517,0.889221487746007,0.365044283570793,1,27,negative regulation of axon extension,BP,NTN1
10262,GO:0042987,0.889280173592922,0.364193660592405,1,29,amyloid precursor protein catabolic process,BP,CLU
17921,GO:1902186,0.889554113098572,0.363588494214958,1,29,regulation of viral release from host cell,BP,PML
12755,GO:0050999,0.890068822826424,0.362126095798394,1,30,regulation of nitric-oxide synthase activity,BP,DHFR
2297,GO:0005254,0.890345562888999,0.361836094821002,1,29,chloride channel activity,MF,CLCC1
15011,GO:0070911,0.890517641391743,0.360546344918991,1,32,global genome nucleotide-excision repair,BP,GTF2H3
2207,GO:0005089,0.890568909422028,0.245555971115471,3,59,Rho guanyl-nucleotide exchange factor activity,MF,TRIO;ARHGEF28;FGD6
6290,GO:0019897,0.890674145897564,0.210989712914586,5,101,extrinsic component of plasma membrane,CC,CYLD;SYK;FRK;SNX5;CDH13
7222,GO:0031111,0.890719129416997,0.361727275386092,1,27,negative regulation of microtubule polymerization or depolymerization,BP,MID1
3566,GO:0007611,0.89110168279073,0.193124982177851,7,133,learning or memory,BP,PLK2;NETO1;FEN1;SRF;SLC11A2;CNTNAP2;SGK1
10807,GO:0044272,0.891259459530306,0.192650732804535,7,143,sulfur compound biosynthetic process,BP,GCLC;B4GALT1;MAT2A;SCD;ACSL3;HACD2;SCD5
9889,GO:0042147,0.891562981295373,0.242997936962251,3,68,retrograde transport, endosome to Golgi,BP,ARFRP1;SNX5;GOSR1
7065,GO:0030838,0.892157379241288,0.241661407832583,3,72,positive regulation of actin filament polymerization,BP,RHOG;CDC42EP2;BAIAP2
11906,GO:0046907,0.892550256493081,0.129564921917972,93,1460,intracellular transport,BP,CRYAB;NEFL;NRG1;PML;KIF23;GNPTAB;TAP1;DYNC2H1;TP53;RBM4;PTPN14;GEMIN5;CHP1;RBM22;SRSF2;SLC9A3R1;NUP50;PHAX;SYK;EMP2;NUP153;RAB32;ARFRP1;VPS41;AP3M2;ZDHHC6;GEMIN4;DST;AP5M1;REEP1;LSG1;IMMP2L;NDC1;CADPS2;DYNLL2;CASC3;AKAP8L;HSPB1;LCP1;THOC1;RAN;RANBP2;RAB26;SET;ARNTL;SNX11;SNX5;GDAP1;TBC1D15;CLU;NUP160;USP6;SDAD1;NUP54;LRPPRC;SETD2;TIMM23B;BLOC1S2;HSPA8;SYT11;HSP90AB1;NSF;M6PR;GEMIN8;TRAK2;MTMR2;GOSR1;RAB3GAP1;BBS5;WDR75;MYO10;NTN1;NCBP1;UPF3B;UBE2J2;VPS36;TAP2;AP3B1;KIF14;PARD3;EHD1;ARV1;TNF;SRSF7;STARD7;CD74;DCTN5;CDKN1A;ITGB1BP1;TSGA13;RBM8A;RPS12;BUD13
2739,GO:0006119,0.89272833383129,0.239424359885705,3,96,oxidative phosphorylation,BP,SDHD;UQCRB;NDUFB9
5861,GO:0017157,0.893499154595741,0.196743319156976,6,122,regulation of exocytosis,BP,SYK;CADPS2;RAB26;SYT11;NSF;RAB3GAP1
11285,GO:0045576,0.893639675187918,0.354155255970849,1,30,mast cell activation,BP,SYK
44,GO:0000096,0.893984496517613,0.35337899438056,1,30,sulfur amino acid metabolic process,BP,GCLC
1149,GO:0002753,0.893985275145129,0.272998229116118,2,50,cytoplasmic pattern recognition receptor signaling pathway,BP,CYLD;BIRC3
12802,GO:0051058,0.894004033928495,0.273380464815909,2,47,negative regulation of small GTPase mediated signal transduction,BP,TGFB2;CGNL1
11603,GO:0046164,0.894595460240878,0.352000717484105,1,30,alcohol catabolic process,BP,MTMR2
6293,GO:0019900,0.89479446148579,0.139291795466178,37,586,kinase binding,MF,NRG1;HDAC9;FGFR2;TRIM22;TRAF3;IRS1;TP53;CDKN2A;ACSL3;PTPN14;CHP1;CYLD;SRSF2;SYK;EMP2;RELB;POLA1;HSPB1;RHOG;CDC25A;ITGAV;SOCS1;HSP90AB1;EPHB6;NSF;IL12RB2;FAF1;CEP152;TRAF2;TELO2;CCNA2;KIF14;ESR1;FGFR1OP;DAXX;CDKN1A;ITGB1BP1
15652,GO:0072132,0.895010910577618,0.352101676653711,1,27,mesenchyme morphogenesis,BP,TGFB2
17582,GO:1901136,0.895349432414904,0.193695731240811,6,129,carbohydrate derivative catabolic process,BP,HSPG2;CHP1;ADAMTS9;CHID1;SMUG1;DPYD
10088,GO:0042578,0.895720256324464,0.158388366853605,15,267,phosphoric ester hydrolase activity,MF,DUSP14;PTPN14;PPP1R3B;GPCPD1;PTPRB;PTPRM;CDC25A;APTX;ENPP1;EYA3;APEX1;MTMR2;CCL5;PHLPP2;PHLPP1
17902,GO:1902116,0.895892991090665,0.349061324429163,1,30,negative regulation of organelle assembly,BP,TRIM37
17272,GO:0120031,0.89596937172027,0.14453035662982,26,428,plasma membrane bounded cell projection assembly,BP,DYNC2H1;CYLD;SLC9A3R1;DNHD1;EMP2;ABCC4;OPHN1;DYNLL2;RHOG;CORO1C;AJUBA;CDC42EP2;CDH13;SRF;FGD6;ANLN;TMEM138;WDPCP;BBS5;MYO10;NTN1;CEP152;SHTN1;DPYSL3;EHD1;FGFR1OP
10793,GO:0044242,0.896150422051773,0.185218507923666,7,147,cellular lipid catabolic process,BP,CYP1B1;IRS1;GPCPD1;CROT;MMAA;HADHB;HIBCH
6339,GO:0021510,0.89657944148874,0.268399959529085,2,47,spinal cord development,BP,NEFL;SRD5A1
3461,GO:0007276,0.897033069691373,0.146796218749871,22,376,gamete generation,BP,PANK2;INHBA;BRIP1;IMMP2L;NDC1;SLCO4C1;WNT4;RAN;ARNTL;DND1;MCM8;BIRC3;DPY19L2P2;MYBL1;BRCA2;FANCD2;ETV6;HSF2;CLOCK;TBPL1;DIAPH3;GPX4
17727,GO:1901607,0.897605310338681,0.265623483845531,2,53,alpha-amino acid biosynthetic process,BP,SLC1A3;SEPHS2
7471,GO:0031624,0.897605382836646,0.345822748833326,1,28,ubiquitin conjugating enzyme binding,MF,RNF19B
6675,GO:0030032,0.897905814577782,0.265536323806363,2,49,lamellipodium assembly,BP,AJUBA;CDH13
2712,GO:0006084,0.897960690457996,0.344663582889918,1,29,acetyl-CoA metabolic process,BP,HMGCS1
11726,GO:0046503,0.897974364515465,0.344010780991749,1,31,glycerolipid catabolic process,BP,GPCPD1
12616,GO:0050773,0.898023369630655,0.199295337494278,5,100,regulation of dendrite development,BP,NRG1;PLK2;BAIAP2;SDK1;NEDD4L
16533,GO:0097223,0.898158572779775,0.211651917154206,4,91,sperm part,CC,SLC9A3R1;VEZT;RAN;HSP90AB1
13269,GO:0051926,0.898422061296785,0.342983346407491,1,31,negative regulation of calcium ion transport,BP,THADA
2673,GO:0006023,0.898475195606505,0.211361389227589,4,86,aminoglycan biosynthetic process,BP,HSPG2;B4GALT1;HS3ST1;PDGFB
8759,GO:0034405,0.898701004985133,0.342642028055946,1,30,response to fluid shear stress,BP,CITED2
12966,GO:0051306,0.898923182109827,0.263169168834418,2,52,mitotic sister chromatid separation,BP,ANAPC15;CENPF
19642,GO:1990752,0.899055715017207,0.343695081377067,1,25,microtubule end,CC,DST
14350,GO:0061512,0.899162443110336,0.341579431961656,1,30,protein localization to cilium,BP,EHD1
5283,GO:0015932,0.899635635942813,0.339907481883992,1,32,nucleobase-containing compound transmembrane transporter activity,MF,SLC35A4
12885,GO:0051187,0.899683434441208,0.339054146403608,1,35,cofactor catabolic process,BP,UGT1A4
3073,GO:0006641,0.899725831802584,0.261597440952696,2,52,triglyceride metabolic process,BP,C3;PANK2
2551,GO:0005819,0.900587588187953,0.148424444241951,17,299,spindle,CC,KIF23;MTUS1;MID1;KBTBD8;STAG1;CYLD;HSPB1;TOPBP1;KLHL21;BRCC3;CEP95;RIF1;SKA2;CENPF;KIF14;NEDD9;HNRNPU
4303,GO:0009749,0.900740432982259,0.1853857644571,6,126,response to glucose,BP,GCLC;CTGF;SRF;GPER1;EIF2B5;EIF2B1
17687,GO:1901505,0.901500199055956,0.335583158622873,1,32,carbohydrate derivative transmembrane transporter activity,MF,SLC35A4
3454,GO:0007268,0.902248167272626,0.146236282648667,17,294,chemical synaptic transmission,BP,EDN1;NQO1;SHISA9;OPHN1;CADPS2;SLC1A3;PLK2;NETO1;BAIAP2;SRF;RIC3;HSPA8;SYT11;MTMR2;RAB3GAP1;GPER1;GJC1
16958,GO:0098916,0.902248167272626,0.146236282648667,17,294,anterograde trans-synaptic signaling,BP,EDN1;NQO1;SHISA9;OPHN1;CADPS2;SLC1A3;PLK2;NETO1;BAIAP2;SRF;RIC3;HSPA8;SYT11;MTMR2;RAB3GAP1;GPER1;GJC1
6587,GO:0022411,0.902664197792264,0.135175928344829,27,475,cellular component disassembly,BP,FN1;MMP9;FBN1;HSPG2;MID1;PDPN;NUP50;NUP153;GRWD1;NDC1;MRPL27;AKAP8L;LCP1;RANBP2;SUPT16H;SET;FZD1;NUP160;NUP54;HSPA8;NSF;GPER1;WDR75;MRPS7;TNF;SMARCC1;IRAK3
12898,GO:0051209,0.903049521122649,0.222709462125868,3,66,release of sequestered calcium ion into cytosol,BP,JPH2;JPH1;GPER1
12947,GO:0051283,0.903049521122649,0.222709462125868,3,66,negative regulation of sequestering of calcium ion,BP,JPH2;JPH1;GPER1
556,GO:0001678,0.903207905760561,0.203071156470023,4,92,cellular glucose homeostasis,BP,GCLC;NUCKS1;SRF;GPER1
9077,GO:0035307,0.903313676910411,0.331919500469297,1,30,positive regulation of protein dephosphorylation,BP,HSP90AB1
5467,GO:0016358,0.903587463555306,0.164180193911536,9,164,dendrite development,BP,NRG1;MAP2;DOCK10;PLK2;BAIAP2;SDK1;SLC11A2;NEDD4L;TRAK2
7817,GO:0032365,0.903599681731529,0.331566505117594,1,29,intracellular lipid transport,BP,ARV1
2965,GO:0006501,0.903888593652837,0.329728385706832,1,33,C-terminal protein lipidation,BP,CD109
7859,GO:0032414,0.904589002033437,0.252226776263245,2,50,positive regulation of ion transmembrane transporter activity,BP,JPH2;CHP1
7220,GO:0031109,0.905271608869185,0.199829857017869,4,86,microtubule polymerization or depolymerization,BP,CRYAB;MAP2;MID1;SKA2
19401,GO:1905818,0.90552895407951,0.24999104564901,2,53,regulation of chromosome separation,BP,ANAPC15;CENPF
6253,GO:0019827,0.905641984071067,0.177809140474617,6,121,stem cell population maintenance,BP,PBX1;SFRP1;RIF1;FANCD2;POLR2F;ZFP36L2
11872,GO:0046839,0.905869970742033,0.326197056803204,1,29,phospholipid dephosphorylation,BP,MTMR2
12558,GO:0050688,0.906796959570385,0.247449706486649,2,53,regulation of defense response to virus,BP,TRAF3;BIRC3
2369,GO:0005484,0.906932202655453,0.322267127653452,1,34,SNAP receptor activity,MF,GOSR1
14289,GO:0061337,0.906958021983735,0.215596901712613,3,66,cardiac conduction,BP,ATP2B1;ABCC9;GJC1
4164,GO:0009225,0.907318465601703,0.32158883882753,1,33,nucleotide-sugar metabolic process,BP,UAP1L1
6009,GO:0019048,0.907770688018552,0.321340076143893,1,30,modulation by virus of host morphology or physiology,BP,TYMS
17127,GO:0099738,0.907947257988499,0.321574494197172,1,28,cell cortex region,CC,ANLN
12946,GO:0051282,0.908146729924743,0.213339968415499,3,67,regulation of sequestering of calcium ion,BP,JPH2;JPH1;GPER1
5682,GO:0016791,0.908675227842022,0.149727632204866,11,208,phosphatase activity,MF,DUSP14;PTPN14;PPP1R3B;PTPRB;PTPRM;CDC25A;APTX;EYA3;MTMR2;PHLPP2;PHLPP1
15159,GO:0071242,0.908762150470615,0.318383298523652,1,32,cellular response to ammonium ion,BP,CCNA2
4302,GO:0009746,0.908775688997017,0.172654027531395,6,128,response to hexose,BP,GCLC;CTGF;SRF;GPER1;EIF2B5;EIF2B1
13792,GO:0060350,0.908795306775657,0.318876461069505,1,30,endochondral bone morphogenesis,BP,COL27A1
14515,GO:0061971,0.908795306775657,0.318876461069505,1,30,replacement bone morphogenesis,BP,COL27A1
3488,GO:0007368,0.90909053595439,0.211456969296001,3,69,determination of left/right symmetry,BP,SRF;BBS5;CITED2
9930,GO:0042267,0.909244295057743,0.316716798638636,1,34,natural killer cell mediated cytotoxicity,BP,SERPINB9
7309,GO:0031304,0.909455859202606,0.315759573034049,1,36,intrinsic component of mitochondrial inner membrane,CC,TIMM23B
7310,GO:0031305,0.909455859202606,0.315759573034049,1,36,integral component of mitochondrial inner membrane,CC,TIMM23B
7185,GO:0031062,0.909653754280355,0.316803104007686,1,30,positive regulation of histone methylation,BP,RIF1
8395,GO:0033293,0.90984094507391,0.315274590138479,1,34,monocarboxylic acid binding,MF,AKR1C2
8740,GO:0034381,0.909978478687338,0.3149415637958,1,34,plasma lipoprotein particle clearance,BP,EHD1
9920,GO:0042246,0.910074148786144,0.315212768365793,1,32,tissue regeneration,BP,CFLAR
8867,GO:0034656,0.910231886177357,0.314098002821701,1,35,nucleobase-containing small molecule catabolic process,BP,DPYD
17077,GO:0099537,0.911064022820681,0.134343791490125,17,297,trans-synaptic signaling,BP,EDN1;NQO1;SHISA9;OPHN1;CADPS2;SLC1A3;PLK2;NETO1;BAIAP2;SRF;RIC3;HSPA8;SYT11;MTMR2;RAB3GAP1;GPER1;GJC1
16746,GO:0097731,0.911220546608577,0.238723748794574,2,51,9+0 non-motile cilium,CC,PHLPP2;PHLPP1
16748,GO:0097733,0.911220546608577,0.238723748794574,2,51,photoreceptor cell cilium,CC,PHLPP2;PHLPP1
2955,GO:0006487,0.911282899205266,0.206846365474131,3,78,protein N-linked glycosylation,BP,B4GALT1;ST6GALNAC5;TMEM165
7915,GO:0032482,0.911500969254803,0.237419481559723,2,58,Rab protein signal transduction,BP,RAB32;RAB26
12332,GO:0048667,0.912419427250324,0.125091564654125,24,387,cell morphogenesis involved in neuron differentiation,BP,NEFL;NRG1;MAP2;FN1;FGFR2;DOCK10;LRFN4;SLC9A3R1;OPHN1;SLC1A3;PTPRM;BAIAP2;SRF;SLC11A2;NEDD4L;ZFYVE27;TRAK2;WDPCP;L1CAM;NTN1;SHTN1;PARD3;WDR36;NRAS
17851,GO:1901985,0.912700986734009,0.308546224844001,1,33,positive regulation of protein acetylation,BP,ARNTL
18367,GO:1903305,0.913200860742143,0.203577110139066,3,73,regulation of regulated secretory pathway,BP,SYK;SYT11;RAB3GAP1
3078,GO:0006650,0.913456574246511,0.13414000830132,15,272,glycerophospholipid metabolic process,BP,NRG1;FGFR2;IRS1;ACSL3;GPCPD1;ABHD4;AJUBA;PDGFB;PIK3R3;MBOAT1;MTMR2;HADHB;ESR1;STARD7;PLBD1
3495,GO:0007389,0.913499222003706,0.135934412637231,14,249,pattern specification process,BP,MAFB;FGFR2;PBX1;MID1;EDN1;IRX2;SFRP1;KDM6A;LFNG;SRF;IRX4;BBS5;CITED2;RING1
8991,GO:0035091,0.913824368299533,0.145372742378502,10,186,phosphatidylinositol binding,MF,JPH2;MYO1B;ARRDC1-AS1;PARD3B;SNX11;SNX5;BBS5;MYO10;VPS36;PARD3
16053,GO:0086065,0.91406000935269,0.30573106919151,1,31,cell communication involved in cardiac conduction,BP,GJC1
16851,GO:0098727,0.914073857830067,0.164291950360557,6,123,maintenance of cell number,BP,PBX1;SFRP1;RIF1;FANCD2;POLR2F;ZFP36L2
17076,GO:0099536,0.914145370673581,0.130152802946164,17,298,synaptic signaling,BP,EDN1;NQO1;SHISA9;OPHN1;CADPS2;SLC1A3;PLK2;NETO1;BAIAP2;SRF;RIC3;HSPA8;SYT11;MTMR2;RAB3GAP1;GPER1;GJC1
12823,GO:0051098,0.914407156358945,0.1327589929525,15,282,regulation of binding,BP,NRG1;MMP9;CYLD;NUCKS1;PLK2;RAN;LFNG;CDCA5;GNL3L;PDGFB;HSP90AB1;NCBP1;TRAF2;TAF1;ITGB1BP1
11355,GO:0045664,0.914530753946541,0.121527094788192,25,411,regulation of neuron differentiation,BP,NEFL;NRG1;MAP2;FN1;TENM3;PBX1;ENC1;SFRP1;ULK4;PLK2;RRN3;BAIAP2;SRF;SDK1;FZD1;NEDD4L;ZFYVE27;TRAK2;L1CAM;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;WDR36
13769,GO:0060323,0.914644527204899,0.304283964328093,1,31,head morphogenesis,BP,RAB3GAP1
7667,GO:0032091,0.914651533829343,0.200578486178483,3,78,negative regulation of protein binding,BP,GNL3L;PDGFB;ITGB1BP1
5479,GO:0016409,0.914651931773288,0.303734226754683,1,33,palmitoyltransferase activity,MF,ZDHHC6
4257,GO:0009582,0.914720741359777,0.231909465480719,2,48,detection of abiotic stimulus,BP,TIMELESS;METAP2
3606,GO:0008047,0.915706280014484,0.121551305577154,23,392,enzyme activator activity,MF,IGFBP3;NRG1;FN1;STARD13;SIPA1L3;OPHN1;HSCB;RANBP2;DDX3X;CDC42EP2;PHACTR4;PDGFB;TBC1D15;USP6;RAB3GAP1;PSME2;CFLAR;RABEP2;GTF3C4;AZIN1;CCL5;DAXX;CDKN1A
8222,GO:0032970,0.915777100776044,0.130959232879569,15,267,regulation of actin filament-based process,BP,CTGF;DAPK3;EDN1;PDPN;SFRP1;TPM1;PTGER4;SYNPO2L;KANK4;RHOG;WNT4;CDC42EP2;BAIAP2;SYNPO2;ITGB1BP1
10981,GO:0044743,0.915842663455849,0.299698574707039,1,38,protein transmembrane import into intracellular organelle,BP,TIMM23B
11699,GO:0046467,0.915849982302293,0.169454429120499,5,117,membrane lipid biosynthetic process,BP,CYR61;ST6GALNAC5;HACD2;UGT8;TNF
9194,GO:0035567,0.916451050183863,0.160237116753339,6,132,non-canonical Wnt signaling pathway,BP,SFRP1;WNT4;FZD1;PSME2;PSMB9;PSMB10
12404,GO:0048812,0.916611532583556,0.11745224181707,27,433,neuron projection morphogenesis,BP,NEFL;NRG1;MAP2;FN1;FGFR2;DOCK10;CNTNAP1;LRFN4;OPHN1;RHOG;PTPRM;BAIAP2;SRF;UGT8;WEE1;SLC11A2;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;L1CAM;NTN1;SHTN1;PARD3;WDR36;NRAS
6023,GO:0019076,0.916614682212895,0.298846007901177,1,33,viral release from host cell,BP,PML
9379,GO:0035890,0.916614682212895,0.298846007901177,1,33,exit from host,BP,PML
9380,GO:0035891,0.916614682212895,0.298846007901177,1,33,exit from host cell,BP,PML
13330,GO:0052126,0.916614682212895,0.298846007901177,1,33,movement in host environment,BP,PML
13339,GO:0052192,0.916614682212895,0.298846007901177,1,33,movement in environment of other organism involved in symbiotic interaction,BP,PML
7183,GO:0031060,0.916994801296049,0.226810047617853,2,51,regulation of histone methylation,BP,RIF1;CTCF
8121,GO:0032801,0.917011364820858,0.298108172619753,1,32,receptor catabolic process,BP,MTMR2
5667,GO:0016773,0.917167739144812,0.111655201042083,37,580,phosphotransferase activity, alcohol group as acceptor,MF,NRG1;MAP3K14;FGFR2;STAT5A;IRS1;DAPK3;PANK2;IKBKE;PKMYT1;NUAK1;CAMK1G;SYK;TRIO;CDK4;RIPK4;ULK4;PLK2;FRK;TRPM7;FASTKD3;PDGFB;SGK494;PIK3R3;WEE1;EPHB6;SGK1;CHEK1;ATR;NOL9;CCNA2;ESR1;CCL5;FGFR1OP;TAF1;CDKN1A;GTF2H3;IRAK3
6674,GO:0030031,0.917734863153183,0.116607812734414,26,438,cell projection assembly,BP,DYNC2H1;CYLD;SLC9A3R1;DNHD1;EMP2;ABCC4;OPHN1;DYNLL2;RHOG;CORO1C;AJUBA;CDC42EP2;CDH13;SRF;FGD6;ANLN;TMEM138;WDPCP;BBS5;MYO10;NTN1;CEP152;SHTN1;DPYSL3;EHD1;FGFR1OP
3203,GO:0006839,0.917766285186332,0.133840687806278,12,250,mitochondrial transport,BP,NRG1;TP53;IMMP2L;DYNLL2;GDAP1;TIMM23B;BLOC1S2;WDR75;UBE2J2;STARD7;SLC25A22;TSGA13
11481,GO:0045921,0.917836724731102,0.224522111690847,2,56,positive regulation of exocytosis,BP,SYK;CADPS2
17277,GO:0120036,0.917942420312643,0.103230644599406,68,1030,plasma membrane bounded cell projection organization,BP,NEFL;NRG1;MAP2;FN1;TENM3;FGFR2;FAT4;NEFM;ENC1;DYNC2H1;DOCK10;PDPN;CNTNAP1;CYLD;LRFN4;SLC9A3R1;DNHD1;EMP2;SFRP1;DHFR;TPM1;ULK4;ABCC4;OPHN1;ADM;DYNLL2;PLK2;RHOG;GPRIN1;PTPRM;CORO1C;RRN3;AJUBA;CDC42EP2;BAIAP2;CDH13;SRF;UGT8;SDK1;FZD1;FGD6;ANLN;WEE1;SLC11A2;BLOC1S2;TNC;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TMEM138;TRAK2;WDPCP;MTMR2;L1CAM;BBS5;MYO10;NTN1;CEP152;CFLAR;SHTN1;DPYSL3;DDX56;PARD3;EHD1;WDR36;FGFR1OP;NRAS
6192,GO:0019637,0.917995741549084,0.106510132045156,50,847,organophosphate metabolic process,BP,NRG1;FGFR2;G6PD;IRS1;PANK2;TPST1;HMGCS1;ACSL3;PGD;NUP50;TJP2;NUP153;GPCPD1;ABHD4;TK1;ADM;NDC1;RAN;RANBP2;GPHN;AJUBA;CROT;PGK1;PDGFB;NUP160;ENPP1;PIK3R3;MBOAT1;RRM2;NUP54;NNT;UMPS;HSPA8;SMUG1;PPIP5K1;MTMR2;GPER1;RRM1;HADHB;SDHD;UQCRB;ESR1;TYMS;STARD7;PLBD1;FLAD1;TBPL1;THTPA;NDUFB9;GPX4
2947,GO:0006476,0.91802585769354,0.177444631037744,4,90,protein deacetylation,BP,HDAC9;TP53;AKAP8;AKAP8L
190,GO:0000407,0.91825026539302,0.294990939712861,1,32,phagophore assembly site,CC,VMP1
4238,GO:0009435,0.918319921759006,0.294320044379129,1,34,NAD biosynthetic process,BP,PGK1
3800,GO:0008376,0.918368697647682,0.294436733469483,1,33,acetylgalactosaminyltransferase activity,MF,GALNT18
3409,GO:0007193,0.918416037040033,0.29484441972138,1,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,EDN1
5661,GO:0016758,0.919000762234414,0.149860484211936,7,151,transferase activity, transferring hexosyl groups,MF,UGT1A6;B4GALT1;GALNT18;LFNG;UGT8;DPY19L2P2;UGT1A4
1985,GO:0004702,0.919018226894976,0.175816551989819,4,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,MAP3K14;FGFR2;IKBKE;EPHB6
13791,GO:0060349,0.91902858430038,0.222438226268818,2,52,bone morphogenesis,BP,FGFR2;COL27A1
3904,GO:0008542,0.919470574304408,0.292172649410481,1,31,visual learning,BP,NETO1
19425,GO:1905898,0.919544424887035,0.291219943859964,1,34,positive regulation of response to endoplasmic reticulum stress,BP,UBQLN2
20320,GO:2001259,0.919643513453507,0.291733110942872,1,31,positive regulation of cation channel activity,BP,JPH2
6862,GO:0030326,0.920118647965978,0.173813438727455,4,88,embryonic limb morphogenesis,BP,PBX1;TGFB2;FRAS1;WDPCP
9003,GO:0035113,0.920118647965978,0.173813438727455,4,88,embryonic appendage morphogenesis,BP,PBX1;TGFB2;FRAS1;WDPCP
7042,GO:0030810,0.920768803358965,0.288339122939916,1,33,positive regulation of nucleotide biosynthetic process,BP,GPER1
17501,GO:1900373,0.920768803358965,0.288339122939916,1,33,positive regulation of purine nucleotide biosynthetic process,BP,GPER1
6055,GO:0019199,0.921290291803762,0.21789464453112,2,50,transmembrane receptor protein kinase activity,MF,FGFR2;EPHB6
5757,GO:0016903,0.921930527983576,0.285122649149046,1,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,AKR1B1
12897,GO:0051208,0.92207998425292,0.186985096089563,3,70,sequestering of calcium ion,BP,JPH2;JPH1;GPER1
2401,GO:0005544,0.922127017396169,0.284854857057011,1,33,calcium-dependent phospholipid binding,MF,SYT11
9000,GO:0035107,0.922302144469347,0.158920107367416,5,104,appendage morphogenesis,BP,FGFR2;PBX1;TGFB2;FRAS1;WDPCP
9001,GO:0035108,0.922302144469347,0.158920107367416,5,104,limb morphogenesis,BP,FGFR2;PBX1;TGFB2;FRAS1;WDPCP
8692,GO:0034284,0.922440016707349,0.150465866153855,6,132,response to monosaccharide,BP,GCLC;CTGF;SRF;GPER1;EIF2B5;EIF2B1
879,GO:0002228,0.922527475568749,0.28315102870738,1,36,natural killer cell mediated immunity,BP,SERPINB9
343,GO:0000956,0.922853120544873,0.138594319142646,8,200,nuclear-transcribed mRNA catabolic process,BP,CASC3;MRTO4;NCBP1;UPF3B;ZFP36L2;RC3H1;RBM8A;RPS12
16796,GO:0098588,0.922865715271188,0.094165659957174,98,1522,bounding membrane of organelle,CC,PML;JPH2;TFRC;CYP24A1;HLA-B;GNPTAB;VMP1;TAP1;MYO1B;B4GALT1;SPG21;TPST1;GBP1;ACSL3;LGALS3;CHP1;ST6GALNAC5;IKBKE;PKMYT1;PCDH7;SLC30A6;IL7R;GALNT18;CAMK1G;EMP2;RAB32;ARFRP1;HLA-F;VPS41;HLA-DOB;AP5M1;PTPRB;ABCC4;DRAM1;TMEM97;MGAM;CD109;SLC35A4;RRAGB;SLCO4C1;MME;GBP5;RHOG;WNT4;SIRPA;ATP2C1;DDX3X;RAB26;ITGAV;LFNG;SNX5;TTC1;GDAP1;PDGFB;KREMEN2;ANTXR1;ENPP1;LRPPRC;SPNS1;THBD;GLIPR2;JPH1;SRPRB;SLC11A2;BLOC1S2;RIC3;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;LAIR1;MFSD12;M6PR;ZFYVE27;PXMP2;TMEM138;MTMR2;GOSR1;TMEM165;STEAP4;BBS5;GPER1;HADHB;LILRB3;ABCA5;VPS36;SLC9A9;TAP2;AP3B1;GLIPR1;TLR3;EHD1;STARD7;CD74;PHLPP2;PHLPP1;NRAS
4657,GO:0010799,0.923523423105837,0.281246689424292,1,33,regulation of peptidyl-threonine phosphorylation,BP,PARD3
128,GO:0000266,0.923877167884307,0.280328418593428,1,33,mitochondrial fission,BP,GDAP1
17357,GO:1900006,0.923963393847054,0.211967791094544,2,52,positive regulation of dendrite development,BP,NRG1;BAIAP2
20087,GO:2000677,0.924197710122602,0.279258449035509,1,34,regulation of transcription regulatory region DNA binding,BP,TAF1
5284,GO:0015934,0.924372734111112,0.18083120688442,3,115,large ribosomal subunit,CC,GEMIN5;MRPL27;MRTO4
4358,GO:0009952,0.924589353788961,0.147149769799849,6,122,anterior/posterior pattern specification,BP,PBX1;SFRP1;KDM6A;LFNG;SRF;RING1
10877,GO:0044390,0.924931289157623,0.277581799702996,1,33,ubiquitin-like protein conjugating enzyme binding,MF,RNF19B
1477,GO:0003735,0.92507058877121,0.163331564132083,4,154,structural constituent of ribosome,MF,MRPL27;MRTO4;MRPS7;RPS12
11714,GO:0046488,0.925074614939396,0.135616539953141,8,160,phosphatidylinositol metabolic process,BP,NRG1;FGFR2;IRS1;PDGFB;PIK3R3;MTMR2;ESR1;PLBD1
5578,GO:0016592,0.925964043336176,0.274419070534883,1,35,mediator complex,CC,PPARGC1B
7181,GO:0031057,0.926314462988316,0.274204262616323,1,32,negative regulation of histone modification,BP,SET
19168,GO:1905114,0.926346455390038,0.105993958812126,25,434,cell surface receptor signaling pathway involved in cell-cell signaling,BP,FGFR2;RUNX1;DAPK3;JRK;CYLD;SLC9A3R1;NAIP;SFRP1;WNT10A;G3BP1;WNT4;KDM6A;DDX3X;ARNTL;NETO1;BAIAP2;KREMEN2;FZD1;MTMR2;RAB3GAP1;RBMS3;PSME2;PSMB9;ESR1;PSMB10
7894,GO:0032456,0.926778838627773,0.272730164516983,1,33,endocytic recycling,BP,EHD1
17726,GO:1901606,0.92741214717093,0.203707385513324,2,61,alpha-amino acid catabolic process,BP,QDPR;HIBCH
18500,GO:1903573,0.927578350578027,0.269953127057843,1,36,negative regulation of response to endoplasmic reticulum stress,BP,CLU
2493,GO:0005740,0.927764531638916,0.100585212459815,31,617,mitochondrial envelope,CC,CYP24A1;STARD13;PANK2;ACSL3;LGALS3;IKBKE;RAB32;ABCG2;COA7;REEP1;IMMP2L;MRPL27;EXOG;SOD2;DDX3X;ABCF2;GDAP1;CLU;SPNS1;TIMM23B;NNT;SLC11A2;GPER1;HADHB;SDHD;MRPS7;UQCRB;TYMS;STARD7;SLC25A22;NDUFB9
12354,GO:0048699,0.928162702309517,0.0919167956155735,62,946,generation of neurons,BP,NEFL;NRG1;HDAC9;MAP2;FN1;TENM3;FGFR2;RUNX1;FAT4;PBX1;NEFM;ENC1;DAPK3;DOCK10;TGFB2;CNTNAP1;LRFN4;IL6ST;SLC9A3R1;INHBA;SFRP1;WNT10A;DHFR;ULK4;OPHN1;ADM;SLC1A3;PLK2;RHOG;WNT4;GPRIN1;PTPRM;RRN3;ARNTL;BAIAP2;SRF;UGT8;SDK1;FZD1;WEE1;SLC11A2;BLOC1S2;TNC;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;WDPCP;MTMR2;L1CAM;GPER1;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;CSF1;PARD3;EHD1;WDR36;NRAS
4332,GO:0009855,0.928610649333439,0.174080054893156,3,74,determination of bilateral symmetry,BP,SRF;BBS5;CITED2
5902,GO:0018105,0.928906858813852,0.120127975354074,11,209,peptidyl-serine phosphorylation,BP,DAPK3;IKBKE;CAMK1G;SYK;PLK2;IL24;PDGFB;SGK1;ATR;TNF;TAF1
6565,GO:0022008,0.928922236183244,0.0902652791607243,67,1018,neurogenesis,BP,NEFL;NRG1;HDAC9;MAP2;FN1;TENM3;FGFR2;RUNX1;FAT4;PBX1;NEFM;ENC1;DAPK3;DOCK10;TGFB2;CNTNAP1;LRFN4;IL6ST;SLC9A3R1;INHBA;SFRP1;WNT10A;DHFR;ULK4;OPHN1;ADM;SLC1A3;PLK2;RHOG;WNT4;GPRIN1;PTPRM;RRN3;ARNTL;BAIAP2;SRF;UGT8;SDK1;FZD1;CLU;WEE1;SLC11A2;BLOC1S2;TNC;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TRAK2;WDPCP;MTMR2;ETV6;L1CAM;GPER1;NTN1;CFLAR;EIF2B5;SHTN1;DPYSL3;DDX56;CSF1;MPP5;PARD3;EHD1;WDR36;EIF2B1;NRAS
7621,GO:0032006,0.929125785984902,0.172960490820742,3,76,regulation of TOR signaling,BP,RRAGB;ARNTL;TELO2
5949,GO:0018279,0.92921170770115,0.265227216054036,1,38,protein N-linked glycosylation via asparagine,BP,ST6GALNAC5
4025,GO:0009056,0.929739363942869,0.084468902299342,126,1987,catabolic process,BP,NRG1;PML;CYP1B1;GCLC;CYP24A1;TRIM22;COL5A3;MMP9;VMP1;HSPG2;CYP1A1;CLN6;ENC1;IRS1;TP53;DAPK3;C9ORF3;PABPC4;PRUNE2;CHP1;CYLD;PPP1R3B;COL12A1;DKC1;NUP50;NUP153;LEPR;CDK4;VPS41;POP1;GPCPD1;TARDBP;ABHD4;COL4A1;USP16;KEAP1;DRAM1;ADAMTS9;OPHN1;MGAM;USP43;NDC1;DYNLL2;FOXRED2;CASC3;PLK2;RRAGB;UBQLN2;HSPB1;EXOG;RANBP2;ANAPC15;RNF115;SET;ARNTL;MRTO4;ODC1;FASTKD3;CROT;PGK1;SNX5;FEN1;COL5A2;MDM4;QDPR;CHID1;CLU;NUP160;USP6;ENPP1;NUP54;LRPPRC;METTL16;ERAP1;APEX1;PDCL3;TET3;HSPA8;TMEM199;HSP90AB1;SMUG1;BACE2;NSF;NEDD4L;ANAPC7;SYNCRIP;DPYD;MTMR2;CCDC47;RAB3GAP1;FAF1;MMAA;WDR75;SENP1;PSME2;HADHB;PSMB9;UGT1A4;NCBP1;UPF3B;SPSB1;UBE2J2;VPS36;TRAF2;HNRNPR;CLOCK;KIF14;AZIN1;SYNPO2;RNF19B;USP11;DNASE1;TNF;ZFP36L2;RC3H1;PLBD1;HNRNPU;PSMB10;TAF1;HIBCH;SMARCC1;USP1;RBM8A;RPS12;IRAK3;COPS3
2542,GO:0005798,0.930301784889617,0.137336602864239,6,136,Golgi-associated vesicle,CC,HLA-B;SPG21;HLA-F;VPS41;TMEM199;CD74
15839,GO:0072523,0.930869831054952,0.2609611068603,1,37,purine-containing compound catabolic process,BP,DPYD
4057,GO:0009101,0.930922436843,0.111159515130887,14,260,glycoprotein biosynthetic process,BP,B4GALT1;SPON1;CHP1;ST6GALNAC5;GALNT18;MUC16;LFNG;DPY19L2P2;TET3;BACE2;TRAK2;TMEM165;MUC5B;MUC6
4865,GO:0014704,0.931126230529683,0.261364591591141,1,32,intercalated disc,CC,GJC1
8694,GO:0034308,0.931466399372063,0.259349577776124,1,37,primary alcohol metabolic process,BP,CYP1B1
16687,GO:0097553,0.93160325699378,0.168295364558985,3,72,calcium ion transmembrane import into cytosol,BP,JPH2;JPH1;GPER1
5934,GO:0018209,0.931603939519788,0.113852711610214,12,227,peptidyl-serine modification,BP,DAPK3;IKBKE;GALNT18;CAMK1G;SYK;PLK2;IL24;PDGFB;SGK1;ATR;TNF;TAF1
4319,GO:0009799,0.931840202719784,0.167658071418168,3,75,specification of symmetry,BP,SRF;BBS5;CITED2
13297,GO:0051965,0.932017569780218,0.258702325404766,1,33,positive regulation of synapse assembly,BP,LRRN3
5926,GO:0018198,0.932539989504803,0.256252932823466,1,38,peptidyl-cysteine modification,BP,ZDHHC6
14402,GO:0061630,0.932760954265248,0.116853118242568,10,198,ubiquitin protein ligase activity,MF,HERC6;RNF115;TRIM37;MDM4;NEDD4L;RAD18;CBLL1;UBE2J2;RNF19B;RC3H1
7426,GO:0031514,0.932776406172196,0.165695028144254,3,77,motile cilium,CC,DYNC2H1;SLC9A3R1;RAN
3582,GO:0007631,0.932788289681075,0.255952265638213,1,36,feeding behavior,BP,LEPR
157,GO:0000315,0.933147521544727,0.252887934630048,1,51,organellar large ribosomal subunit,CC,MRPL27
2510,GO:0005762,0.933147521544727,0.252887934630048,1,51,mitochondrial large ribosomal subunit,CC,MRPL27
3314,GO:0007019,0.933596424366223,0.254636877696057,1,32,microtubule depolymerization,BP,MID1
12360,GO:0048706,0.933853420338329,0.163651258350885,3,75,embryonic skeletal system development,BP,FGFR2;PBX1;SETD2
7984,GO:0032592,0.934202289105931,0.188489475869371,2,65,integral component of mitochondrial membrane,CC,GDAP1;TIMM23B
3502,GO:0007409,0.934228804802549,0.101291876532413,18,309,axonogenesis,BP,NEFL;NRG1;MAP2;FN1;FGFR2;LRFN4;OPHN1;PTPRM;BAIAP2;SRF;ZFYVE27;TRAK2;L1CAM;NTN1;SHTN1;PARD3;WDR36;NRAS
5974,GO:0018410,0.93431897794098,0.251386122631215,1,38,C-terminal protein amino acid modification,BP,CD109
155,GO:0000313,0.93458362238227,0.186686262934543,2,84,organellar ribosome,CC,MRPL27;MRPS7
2509,GO:0005761,0.93458362238227,0.186686262934543,2,84,mitochondrial ribosome,CC,MRPL27;MRPS7
99,GO:0000209,0.934680196881349,0.105644426770238,14,275,protein polyubiquitination,BP,TRIM56;HERC6;ZNF738;RNF115;NEDD4L;ANAPC7;PSME2;PSMB9;SPSB1;UBE2J2;TRAF2;RNF19B;PSMB10;TAF1
2506,GO:0005758,0.935394346090142,0.185467889422467,2,71,mitochondrial intermembrane space,CC,PANK2;COA7
3075,GO:0006643,0.935534170908495,0.118819864754929,8,178,membrane lipid metabolic process,BP,CYP1B1;CYR61;CLN6;ST6GALNAC5;HACD2;UGT8;ARV1;TNF
17331,GO:0140110,0.935946549394145,0.0793987955569709,91,1398,transcription regulator activity,MF,MAFB;NRG1;HDAC9;MKL1;FOSL2;STAT5A;TRIM22;RUNX1;PBX1;TSC22D3;DDX17;TFCP2L1;TP53;ZBED1;ZNF397;PTPN14;STAG1;IRX2;PDLIM1;SRSF2;FOXD2;ZFP42;RELB;PARP15;NUCKS1;TARDBP;USP16;AHR;TAF2;ZNF584;ELMSAN1;ZNF587;MYBL2;WNT4;KDM6A;RAN;UBTF;RRN3;ARNTL;AJUBA;ZNF267;ZNF586;SRF;ZNF234;IRX4;UTY;NFE2L1;MACC1;ZNF670;NFKBIB;VGLL3;GLIS2;UBP1;ZNF484;APEX1;MYBL1;ZBTB24;SS18L2;CCAR1;MAZ;ZNF33A;E2F8;ETV6;ZNFX1;HSF2;GPER1;MLLT10;PSMC3IP;ZNF12;TAF6L;MYNN;CITED2;RBL1;ZNF286A;CLOCK;PURB;ESR1;ZFP36L2;HNRNPU;DAXX;ZSCAN31;TAF1;TBPL1;SPIB;SMARCC1;PPARGC1B;ARID3B;ZNF471;IRF1;CTCF;GTF2H3
6103,GO:0019320,0.936385974080448,0.245667871457633,1,38,hexose catabolic process,BP,PGK1
9891,GO:0042149,0.936486101106877,0.245759484657162,1,36,cellular response to glucose starvation,BP,TP53
2199,GO:0005070,0.936979352752142,0.244584120751444,1,35,SH3/SH2 adaptor activity,MF,CNTNAP1
3567,GO:0007612,0.937027178067132,0.157273018410976,3,75,learning,BP,NETO1;SRF;CNTNAP2
8269,GO:0033043,0.93728246006671,0.0805528496048989,64,1019,regulation of organelle organization,BP,NRG1;MAP2;PML;EPGN;CTGF;MMP9;MID1;TP53;DAPK3;EDN1;STAG1;AKAP8;CYLD;PKMYT1;RAD1;DKC1;NBN;SFRP1;VPS41;TPM1;SETDB1;PTGER4;DYNLL2;SYNPO2L;PLK2;UBQLN2;NEXN;KANK4;AKAP8L;RHOG;WNT4;LCP1;RANBP2;ANAPC15;SET;TRIM37;FEN1;CDC42EP2;CDCA5;GNL3L;BAIAP2;PDGFB;TBC1D15;CLU;USP6;RIF1;ANLN;SYT11;SKA2;CENPF;RAB3GAP1;CHEK1;GPER1;WDR75;ATR;UBE2J2;SYNPO2;TNF;STARD7;HNRNPU;PPARGC1B;ITGB1BP1;CTCF;TSGA13
9215,GO:0035591,0.937382299847133,0.182107002127252,2,55,signaling adaptor activity,MF,IRS1;CNTNAP1
12374,GO:0048736,0.93765253666022,0.125077515435058,6,126,appendage development,BP,FGFR2;PBX1;TGFB2;KREMEN2;FRAS1;WDPCP
13680,GO:0060173,0.93765253666022,0.125077515435058,6,126,limb development,BP,FGFR2;PBX1;TGFB2;KREMEN2;FRAS1;WDPCP
8686,GO:0034260,0.937681351299245,0.24241706487812,1,36,negative regulation of GTPase activity,BP,AMOT
12358,GO:0048704,0.937910972888546,0.180733015150624,2,57,embryonic skeletal system morphogenesis,BP,FGFR2;SETD2
3583,GO:0007632,0.938381552384666,0.240647739876125,1,35,visual behavior,BP,NETO1
16788,GO:0098573,0.938505089011583,0.178735831830905,2,66,intrinsic component of mitochondrial membrane,CC,GDAP1;TIMM23B
1994,GO:0004712,0.938844958009546,0.239139962298119,1,36,protein serine/threonine/tyrosine kinase activity,MF,SGK1
4430,GO:0010257,0.9388486891577,0.236740569776778,1,55,NADH dehydrogenase complex assembly,BP,NDUFB9
8230,GO:0032981,0.9388486891577,0.236740569776778,1,55,mitochondrial respiratory chain complex I assembly,BP,NDUFB9
6371,GO:0021549,0.939501824496875,0.177190175373422,2,56,cerebellum development,BP,OPHN1;KIF14
17045,GO:0099175,0.939581756158344,0.237251731836955,1,35,regulation of postsynapse organization,BP,BAIAP2
5559,GO:0016567,0.940034357506386,0.0814482530291487,41,705,protein ubiquitination,BP,DTX2;GCLC;TRIM22;TRIM56;TRAF3;ENC1;KBTBD8;CHP1;NAIP;KEAP1;HERC6;ZNF738;KLHL21;RNF115;SOCS1;TRIM37;GNL3L;SH3RF2;MDM4;BIRC3;KLHL9;DTX4;HSP90AB1;NEDD4L;ANAPC7;RAD18;PSME2;PSMB9;RFWD3;CBLL1;SPSB1;UBE2J2;TRAF2;MPHOSPH8;RNF19B;FEM1C;RC3H1;RING1;PSMB10;DAXX;TAF1
10341,GO:0043124,0.940063671088235,0.235881093773341,1,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,ESR1
8153,GO:0032873,0.940135508713613,0.235290684616985,1,37,negative regulation of stress-activated MAPK cascade,BP,SFRP1
14701,GO:0070303,0.940135508713613,0.235290684616985,1,37,negative regulation of stress-activated protein kinase signaling cascade,BP,SFRP1
18456,GO:1903510,0.940203067506416,0.150666464191331,3,78,mucopolysaccharide metabolic process,BP,B4GALT1;CHP1;PDGFB
4986,GO:0015108,0.940224319496973,0.235224989091329,1,36,chloride transmembrane transporter activity,MF,CLCC1
2206,GO:0005088,0.940444445212565,0.107855850108348,9,173,Ras guanyl-nucleotide exchange factor activity,MF,NEFL;NRG1;FGFR2;IRS1;TRIO;ARHGEF28;PDGFB;FGD6;RAB3GAP1
17865,GO:1902017,0.941120180951701,0.232477870199628,1,37,regulation of cilium assembly,BP,CYLD
11218,GO:0045334,0.941215251146529,0.232205379867352,1,37,clathrin-coated endocytic vesicle,CC,CD74
7622,GO:0032007,0.941311764219352,0.232114946498673,1,36,negative regulation of TOR signaling,BP,ARNTL
3500,GO:0007405,0.941390657741601,0.232294866593544,1,34,neuroblast proliferation,BP,FGFR2
15209,GO:0071333,0.941850834554286,0.1470285619385,3,84,cellular response to glucose stimulus,BP,GCLC;SRF;GPER1
6673,GO:0030030,0.94192369982151,0.0744316013190487,68,1051,cell projection organization,BP,NEFL;NRG1;MAP2;FN1;TENM3;FGFR2;FAT4;NEFM;ENC1;DYNC2H1;DOCK10;PDPN;CNTNAP1;CYLD;LRFN4;SLC9A3R1;DNHD1;EMP2;SFRP1;DHFR;TPM1;ULK4;ABCC4;OPHN1;ADM;DYNLL2;PLK2;RHOG;GPRIN1;PTPRM;CORO1C;RRN3;AJUBA;CDC42EP2;BAIAP2;CDH13;SRF;UGT8;SDK1;FZD1;FGD6;ANLN;WEE1;SLC11A2;BLOC1S2;TNC;CNTNAP2;NEDD4L;SGK1;ZFYVE27;TMEM138;TRAK2;WDPCP;MTMR2;L1CAM;BBS5;MYO10;NTN1;CEP152;CFLAR;SHTN1;DPYSL3;DDX56;PARD3;EHD1;WDR36;FGFR1OP;NRAS
3433,GO:0007224,0.942456875454951,0.132269912121373,4,97,smoothened signaling pathway,BP,FGFR2;SFRP1;GLIS2;WDPCP
4129,GO:0009187,0.942539150167801,0.17010461624935,2,57,cyclic nucleotide metabolic process,BP,ADM;GPER1
14598,GO:0070125,0.942713378075813,0.168158707039858,2,86,mitochondrial translational elongation,BP,MRPL27;MRPS7
7224,GO:0031113,0.942751966745224,0.2279632697771,1,36,regulation of microtubule polymerization,BP,MAP2
1929,GO:0004620,0.943311475073101,0.168006801088147,2,61,phospholipase activity,MF,CCL5;PLBD1
14415,GO:0061659,0.943494634356316,0.100202049625736,10,203,ubiquitin-like protein ligase activity,MF,HERC6;RNF115;TRIM37;MDM4;NEDD4L;RAD18;CBLL1;UBE2J2;RNF19B;RC3H1
2002,GO:0004722,0.943969731505289,0.166402957413158,2,62,protein serine/threonine phosphatase activity,MF,PHLPP2;PHLPP1
7359,GO:0031396,0.943976433216412,0.108974409076591,7,162,regulation of protein ubiquitination,BP,GCLC;CHP1;GNL3L;BIRC3;HSP90AB1;DAXX;TAF1
11712,GO:0046486,0.944417848462546,0.0878259447058315,17,319,glycerolipid metabolic process,BP,NRG1;C3;FGFR2;IRS1;PANK2;ACSL3;GPCPD1;ABHD4;AJUBA;PDGFB;PIK3R3;MBOAT1;MTMR2;HADHB;ESR1;STARD7;PLBD1
7703,GO:0032155,0.944527436252715,0.165311225535447,2,59,cell division site part,CC,RTKN2;ANLN
15205,GO:0071326,0.944875417657603,0.140727826471834,3,85,cellular response to monosaccharide stimulus,BP,GCLC;SRF;GPER1
15207,GO:0071331,0.944875417657603,0.140727826471834,3,85,cellular response to hexose stimulus,BP,GCLC;SRF;GPER1
12359,GO:0048705,0.945106887870895,0.112087712788013,6,130,skeletal system morphogenesis,BP,FGFR2;CTGF;COL27A1;SFRP1;SETD2;PPARGC1B
12406,GO:0048814,0.945134443366613,0.163962180962717,2,58,regulation of dendrite morphogenesis,BP,BAIAP2;NEDD4L
7327,GO:0031331,0.945444913290084,0.0886087565654192,15,283,positive regulation of cellular catabolic process,BP,GCLC;TRIM22;IRS1;KEAP1;PLK2;UBQLN2;CLU;METTL16;RAB3GAP1;HNRNPR;RNF19B;TNF;ZFP36L2;RC3H1;TAF1
2607,GO:0005905,0.946232379930428,0.161373782018075,2,58,clathrin-coated pit,CC,TFRC;ACKR3
11304,GO:0045600,0.946287691566705,0.217253063822737,1,38,positive regulation of fat cell differentiation,BP,SFRP1
9221,GO:0035601,0.946332501978154,0.124740741987934,4,99,protein deacylation,BP,HDAC9;TP53;AKAP8;AKAP8L
137,GO:0000287,0.946724984853609,0.104397389823272,7,156,magnesium ion binding,MF,GCLC;S100P;RAN;WEE1;MSH6;THTPA;IRAK3
4677,GO:0010823,0.946842861293172,0.215143396729563,1,41,negative regulation of mitochondrion organization,BP,CLU
7064,GO:0030837,0.947066760514544,0.214940092646536,1,38,negative regulation of actin filament polymerization,BP,KANK4
7600,GO:0031966,0.94764879881892,0.075839438613947,28,578,mitochondrial membrane,CC,CYP24A1;STARD13;ACSL3;LGALS3;IKBKE;RAB32;ABCG2;REEP1;IMMP2L;MRPL27;EXOG;SOD2;DDX3X;GDAP1;CLU;SPNS1;TIMM23B;NNT;SLC11A2;GPER1;HADHB;SDHD;MRPS7;UQCRB;TYMS;STARD7;SLC25A22;NDUFB9
2548,GO:0005815,0.947688735969675,0.0730344576362715,36,610,microtubule organizing center,CC,KIF23;MTUS1;NLRC5;TAP1;CYLD;PHAX;RELB;KEAP1;NDC1;DYNLL2;PLK2;RAN;RANBP2;TOPBP1;TAF1D;AJUBA;MCM3;ODF2L;CEP95;EYA3;BLOC1S2;APEX1;BRCA2;CENPF;PLEKHA7;CHEK1;BBS5;RAD18;CEP152;ZNF12;UPF3B;ORC2;HNRNPU;FGFR1OP;DCTN5;ITGB1BP1
16853,GO:0098732,0.948585671229182,0.120320032503682,4,100,macromolecule deacylation,BP,HDAC9;TP53;AKAP8;AKAP8L
13292,GO:0051960,0.948811454610318,0.0725351685718369,33,547,regulation of nervous system development,BP,NEFL;NRG1;MAP2;FN1;TENM3;PBX1;ENC1;IL6ST;SFRP1;ULK4;PLK2;RRN3;ARNTL;BAIAP2;SRF;SDK1;FZD1;LRRN3;NEDD4L;ZFYVE27;TRAK2;MTMR2;L1CAM;GPER1;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;CSF1;KIF14;PARD3;WDR36
14599,GO:0070126,0.948828139493079,0.153737402921254,2,88,mitochondrial translational termination,BP,MRPL27;MRPS7
12141,GO:0048199,0.949612036540695,0.152912275154559,2,64,vesicle targeting, to, from or within Golgi,BP,NSF;GOSR1
7463,GO:0031594,0.94983054052497,0.206804242382309,1,37,neuromuscular junction,CC,NRG1
7263,GO:0031225,0.950218991804664,0.151173229331519,2,69,anchored component of membrane,CC,CD109;CDH13
402,GO:0001078,0.950482148720881,0.116565940274402,4,101,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,ZFP42;E2F8;RBL1;CTCF
10501,GO:0043392,0.950537532273911,0.20417683221784,1,40,negative regulation of DNA binding,BP,TAF1
19098,GO:1904949,0.950765774009739,0.128447198231014,3,81,ATPase complex,CC,ABCF2;DAXX;SMARCC1
5381,GO:0016192,0.95092729458962,0.0615706335151733,91,1440,vesicle-mediated transport,BP,KRT1;SAA1;FTL;FTH1;FN1;KIF23;TFRC;C3;S100P;MMP9;VMP1;TAP1;HSPG2;MYO1B;B4GALT1;ACTG1;ACSL3;LGALS3;CHP1;TGFB2;PCDH7;SYK;EMP2;RAB32;LEPR;ARFRP1;VPS41;AP3M2;VPS8;HRNR;AP5M1;PTPRB;ABCC4;ADAMTS9;OPHN1;ADM;MGAM;CD109;CADPS2;DYNLL2;SLCO4C1;MME;UBQLN2;FRK;RHOG;CXCL16;SIRPA;CORO1C;DDX3X;RAB26;ITGAV;QPCT;SNX11;SNX5;BAIAP2;CDH13;PDGFB;CHID1;TBC1D15;CLU;USP6;ENPP1;COMMD9;ACKR3;BLOC1S2;HSPA8;SYT11;HSP90AB1;NSF;LAIR1;NEDD4L;M6PR;ZFYVE27;TRAK2;MTMR2;GOSR1;RAB3GAP1;SCFD2;MYO10;LILRB3;CBLL1;RABEP2;VPS36;TAP2;AP3B1;GLIPR1;EHD1;TNF;CCL5;DCTN5;NRAS
14298,GO:0061351,0.951134797356588,0.127737218331777,3,79,neural precursor cell proliferation,BP,FGFR2;RRM1;KIF14
2192,GO:0005048,0.9513756946987,0.201765895122264,1,39,signal sequence binding,MF,NUP153
417,GO:0001104,0.951410225485575,0.12706635435671,3,81,RNA polymerase II transcription cofactor activity,MF,MKL1;CITED2;PPARGC1B
13411,GO:0052689,0.952186318021825,0.125149606582787,3,88,carboxylic ester hydrolase activity,MF,ABHD4;APMAP;PLBD1
7252,GO:0031201,0.952553859210506,0.197587431706789,1,43,SNARE complex,CC,GOSR1
7936,GO:0032507,0.952790858560617,0.145395496226372,2,61,maintenance of protein location in cell,BP,PML;HNRNPU
23,GO:0000045,0.952834736357925,0.123888443878553,3,84,autophagosome assembly,BP,UBQLN2;RAB3GAP1;SYNPO2
14522,GO:0062014,0.952942852283828,0.144838420268223,2,64,negative regulation of small molecule metabolic process,BP,LEPR;WNT4
6298,GO:0019905,0.953585933501053,0.143321911288012,2,63,syntaxin binding,MF,SYT11;NSF
3087,GO:0006661,0.953937625430228,0.101892039610095,5,119,phosphatidylinositol biosynthetic process,BP,FGFR2;IRS1;PDGFB;PIK3R3;MTMR2
10798,GO:0044255,0.953986295276129,0.0629322401600224,44,761,cellular lipid metabolic process,BP,NRG1;PTGES;CYP1B1;CYR61;C3;FGFR2;STAT5A;FADS3;HSPG2;CYP1A1;CLN6;IRS1;PANK2;EDN1;C9ORF3;SCD;HMGCS1;ACSL3;ST6GALNAC5;GPCPD1;ABHD4;AJUBA;CROT;AKR1C2;HACD2;PDGFB;UGT8;PIK3R3;MBOAT1;SRD5A1;SCD5;MTMR2;MMAA;HADHB;ESR1;ARV1;TNF;PDSS1;STARD7;PLBD1;CD74;HIBCH;PPARGC1B;GPX4
3052,GO:0006612,0.95476200727118,0.0997291009084133,5,164,protein targeting to membrane,BP,CHP1;ZDHHC6;PARD3;ITGB1BP1;RPS12
6987,GO:0030658,0.955532420341704,0.0987503213137823,5,126,transport vesicle membrane,CC,HLA-B;HLA-F;RAB26;SYT11;CD74
12698,GO:0050890,0.955570627222012,0.089158544181125,7,155,cognition,BP,PLK2;NETO1;FEN1;SRF;SLC11A2;CNTNAP2;SGK1
1968,GO:0004674,0.955691341778316,0.0674267574923264,23,396,protein serine/threonine kinase activity,MF,MAP3K14;FGFR2;DAPK3;IKBKE;PKMYT1;NUAK1;CAMK1G;SYK;TRIO;CDK4;RIPK4;ULK4;PLK2;TRPM7;SGK494;EPHB6;SGK1;CHEK1;ATR;TAF1;CDKN1A;GTF2H3;IRAK3
19424,GO:1905897,0.955754232281754,0.137743348350813,2,67,regulation of response to endoplasmic reticulum stress,BP,UBQLN2;CLU
7081,GO:0030864,0.955889766630935,0.137880214074376,2,59,cortical actin cytoskeleton,CC,RTKN2;ANLN
4821,GO:0014013,0.956221178013949,0.136802534151335,2,63,regulation of gliogenesis,BP,IL6ST;CSF1
6575,GO:0022037,0.956298917479519,0.136730086116663,2,61,metencephalon development,BP,OPHN1;KIF14
15893,GO:0072599,0.956473240183025,0.134737477460558,2,104,establishment of protein localization to endoplasmic reticulum,BP,RAB3GAP1;RPS12
4300,GO:0009743,0.956560336642196,0.0914038315772708,6,146,response to carbohydrate,BP,GCLC;CTGF;SRF;GPER1;EIF2B5;EIF2B1
16888,GO:0098798,0.956620766595999,0.0868110865920122,7,218,mitochondrial protein complex,CC,IMMP2L;MRPL27;TIMM23B;SDHD;MRPS7;UQCRB;NDUFB9
13743,GO:0060291,0.956853606004185,0.184636061174655,1,39,long-term synaptic potentiation,BP,PLK2
8966,GO:0035023,0.956891925389136,0.103905640751435,4,95,regulation of Rho protein signal transduction,BP,TRIO;OPHN1;ARHGEF28;FGD6
5332,GO:0016055,0.95759276165216,0.0658083260229496,21,393,Wnt signaling pathway,BP,FGFR2;RUNX1;DAPK3;JRK;CYLD;SLC9A3R1;NAIP;SFRP1;WNT10A;G3BP1;WNT4;KDM6A;DDX3X;ARNTL;KREMEN2;FZD1;RBMS3;PSME2;PSMB9;ESR1;PSMB10
4790,GO:0010977,0.958157374144839,0.101128938492599,4,103,negative regulation of neuron projection development,BP,PLK2;TRAK2;NTN1;DPYSL3
15203,GO:0071322,0.958220659197134,0.111919197752338,3,90,cellular response to carbohydrate stimulus,BP,GCLC;SRF;GPER1
11367,GO:0045685,0.958420653815454,0.179327224611205,1,41,regulation of glial cell differentiation,BP,IL6ST
3453,GO:0007267,0.958628971694464,0.0553011658776607,55,911,cell-cell signaling,BP,CYR61;FGFR2;CTGF;RUNX1;IRS1;DAPK3;EDN1;C1QTNF1;JRK;NQO1;TGFB2;CYLD;SLC9A3R1;INHBA;NAIP;SHISA9;SFRP1;WNT10A;KCNS3;G3BP1;OPHN1;ADM;CADPS2;SLC1A3;CCL20;PLK2;WNT4;KDM6A;DDX3X;ARNTL;NETO1;BAIAP2;SRF;PDGFB;KREMEN2;FZD1;TJP1;ERAP1;RIC3;TNC;HSPA8;SYT11;MTMR2;RAB3GAP1;GPER1;RBMS3;PSME2;PSMB9;CLOCK;ESR1;GJC1;TNF;CCL5;PSMB10;PANX1
19475,GO:1990089,0.95869180796402,0.178727294957862,1,39,response to nerve growth factor,BP,EHD1
19476,GO:1990090,0.95869180796402,0.178727294957862,1,39,cellular response to nerve growth factor stimulus,BP,EHD1
9892,GO:0042157,0.958692495700823,0.0926385260066507,5,131,lipoprotein metabolic process,BP,ZDHHC6;APOL6;CD109;ITGAV;RAB3GAP1
10418,GO:0043244,0.958743448568902,0.111122902478081,3,79,regulation of protein complex disassembly,BP,MID1;TNF;IRAK3
11660,GO:0046365,0.958760032837441,0.177753067352256,1,45,monosaccharide catabolic process,BP,PGK1
6291,GO:0019898,0.958998090630233,0.0774846078141203,9,189,extrinsic component of membrane,CC,PML;CYLD;SYK;MUC16;FRK;SNX11;SNX5;CDH13;PIK3R3
8430,GO:0033500,0.959206310737268,0.0865512911601536,6,147,carbohydrate homeostasis,BP,GCLC;IRS1;LEPR;NUCKS1;SRF;GPER1
10101,GO:0042593,0.959206310737268,0.0865512911601536,6,147,glucose homeostasis,BP,GCLC;IRS1;LEPR;NUCKS1;SRF;GPER1
7206,GO:0031090,0.959398491263832,0.0495181632460011,139,2227,organelle membrane,CC,DTX2;PML;CYP1B1;JPH2;TFRC;GPRC5A;CYP24A1;STARD13;HLA-B;GNPTAB;VMP1;TAP1;MYO1B;CYP1A1;B4GALT1;SPG21;TPST1;GBP1;ACSL3;LGALS3;CHP1;ST6GALNAC5;IKBKE;PKMYT1;PCDH7;SLC30A6;IL7R;NUP50;GALNT18;CAMK1G;EMP2;NUP153;RAB32;BRIP1;ABCG2;ARFRP1;HLA-F;CDK4;VPS41;AP3M2;HLA-DOB;SLC5A6;AP5M1;PTPRB;ABCC4;REEP1;DRAM1;TMEM97;MGAM;IMMP2L;CD109;NDC1;CADPS2;SLC35A4;CASC3;RRAGB;MRPL27;SLCO4C1;MME;GBP5;RHOG;WNT4;EXOG;SIRPA;RANBP2;SOD2;ATP2C1;DDX3X;RAB26;RRP12;ITGAV;LFNG;SNX5;TTC1;GDAP1;WDR3;PDGFB;UTP18;KREMEN2;ANTXR1;CLU;ENPP1;NUP54;LRPPRC;SPNS1;RIF1;SRD5A1;TIMM23B;THBD;GLIPR2;JPH1;SRPRB;DPY19L2P2;NNT;SLC11A2;BLOC1S2;RIC3;HSPA8;SYT11;TMEM199;HSP90AB1;NSF;LAIR1;MFSD12;M6PR;ZFYVE27;PXMP2;TMEM138;MTMR2;GOSR1;TMEM165;STEAP4;BBS5;GPER1;SENP1;HADHB;LILRB3;CMTM3;ABCA5;SDHD;MRPS7;VPS36;TRAF2;SLC9A9;TAP2;UQCRB;AP3B1;GLIPR1;TLR3;EHD1;TYMS;STARD7;CD74;DCTN5;PHLPP2;PHLPP1;NRAS;SLC25A22;NDUFB9
3072,GO:0006639,0.959534735431378,0.128298593858615,2,66,acylglycerol metabolic process,BP,C3;PANK2
17354,GO:0198738,0.959979630615165,0.0623913117556166,21,395,cell-cell signaling by wnt,BP,FGFR2;RUNX1;DAPK3;JRK;CYLD;SLC9A3R1;NAIP;SFRP1;WNT10A;G3BP1;WNT4;KDM6A;DDX3X;ARNTL;KREMEN2;FZD1;RBMS3;PSME2;PSMB9;ESR1;PSMB10
12610,GO:0050767,0.960230711566095,0.0585467653545971,29,498,regulation of neurogenesis,BP,NEFL;NRG1;MAP2;FN1;TENM3;PBX1;ENC1;IL6ST;SFRP1;ULK4;PLK2;RRN3;ARNTL;BAIAP2;SRF;SDK1;FZD1;NEDD4L;ZFYVE27;TRAK2;L1CAM;GPER1;NTN1;CFLAR;SHTN1;DPYSL3;DDX56;CSF1;WDR36
13126,GO:0051641,0.960461878708236,0.0482489292347191,140,2189,cellular localization,BP,CRYAB;FTL;FTH1;NEFL;NRG1;PML;KIF23;AMOT;JPH2;GNPTAB;TAP1;DYNC2H1;MID1;TP53;GBP1;RBM4;ACSL3;PTPN14;GEMIN5;CHP1;CNTNAP1;RBM22;CYLD;SRSF2;SLC9A3R1;DKC1;NUP50;PHAX;SYK;EMP2;NUP153;RAB32;ARFRP1;VPS41;AP3M2;ZDHHC6;GEMIN4;DST;RPA1;AP5M1;POLR1A;REEP1;LSG1;OPHN1;IMMP2L;NDC1;CADPS2;DYNLL2;CASC3;RRAGB;AKAP8L;HSPB1;RHOG;WNT4;LCP1;THOC1;RAN;RANBP2;DDX3X;RAB26;GPHN;KLHL21;SET;ARNTL;SNX11;AJUBA;SNX5;NETO1;CDCA5;GNL3L;CDH13;GDAP1;UGT8;TBC1D15;RTKN2;CLU;NUP160;USP6;SDAD1;NUP54;LRPPRC;SETD2;GLIS2;ANLN;TIMM23B;RPF2;JPH1;BLOC1S2;RIC3;CNTNAP2;HSPA8;SYT11;HSP90AB1;NSF;NEDD4L;M6PR;ZFYVE27;BRCA2;GEMIN8;TRAK2;MTMR2;CENPF;GOSR1;RAB3GAP1;SCFD2;BBS5;GPER1;WDR75;MYO10;ATR;NTN1;CEP152;NCBP1;UPF3B;UBE2J2;VPS36;TAP2;AP3B1;KIF14;MPP5;ESR1;PARD3;EHD1;ARV1;TNF;SRSF7;STARD7;CD74;HNRNPU;FGFR1OP;DCTN5;TRAM2;CDKN1A;ITGB1BP1;CTCF;ASTN2;TSGA13;RBM8A;RPS12;BUD13
68,GO:0000139,0.96049020996,0.0569351851336843,33,585,Golgi membrane,CC,HLA-B;GNPTAB;MYO1B;B4GALT1;TPST1;GBP1;CHP1;ST6GALNAC5;PKMYT1;SLC30A6;GALNT18;CAMK1G;EMP2;ARFRP1;HLA-F;SLC35A4;GBP5;ATP2C1;RAB26;LFNG;PDGFB;GLIPR2;RIC3;NSF;M6PR;GOSR1;TMEM165;STEAP4;GPER1;ABCA5;TLR3;CD74;NRAS
2583,GO:0005874,0.960508918584821,0.0635991789402545,18,333,microtubule,CC,SAA1;MAP2;KIF23;MTUS1;DYNC2H1;MID1;TCP11L1;CYLD;DST;DYNLL2;KLHL21;BAIAP2;LRPPRC;SRPRB;SKA2;SHTN1;KIF14;HNRNPU
4056,GO:0009100,0.960519442344453,0.0651526105204858,16,312,glycoprotein metabolic process,BP,GNPTAB;B4GALT1;SPON1;CHP1;ST6GALNAC5;GALNT18;ADAMTS9;MUC16;LFNG;DPY19L2P2;TET3;BACE2;TRAK2;TMEM165;MUC5B;MUC6
12826,GO:0051101,0.960734695450516,0.106286186069912,3,91,regulation of DNA binding,BP,MMP9;CDCA5;TAF1
6681,GO:0030041,0.960752088457474,0.0887066846789846,5,128,actin filament polymerization,BP,COBLL1;KANK4;RHOG;CDC42EP2;BAIAP2
19136,GO:1905037,0.960851582417425,0.106138753422873,3,87,autophagosome organization,BP,UBQLN2;RAB3GAP1;SYNPO2
7080,GO:0030863,0.960901082049244,0.106293571603269,3,79,cortical cytoskeleton,CC,RTKN2;TPM4;ANLN
2546,GO:0005813,0.961074383167077,0.0593101231783502,24,440,centrosome,CC,KIF23;NLRC5;CYLD;PHAX;RELB;DYNLL2;PLK2;RANBP2;MCM3;ODF2L;CEP95;EYA3;APEX1;BRCA2;CENPF;PLEKHA7;CHEK1;RAD18;CEP152;ZNF12;ORC2;HNRNPU;FGFR1OP;DCTN5
13554,GO:0055117,0.961413924863402,0.169547066698135,1,41,regulation of cardiac muscle contraction,BP,CTGF
454,GO:0001227,0.961948148720352,0.0778073001165987,7,161,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,IRX2;ZFP42;E2F8;ETV6;RBL1;PURB;CTCF
3071,GO:0006638,0.962030768052097,0.121856917551895,2,67,neutral lipid metabolic process,BP,C3;PANK2
10278,GO:0043009,0.962196013176644,0.0582054262551475,23,415,chordate embryonic development,BP,AMOT;CYR61;FGFR2;PBX1;EDN1;KBTBD8;TGFB2;NBN;SFRP1;KEAP1;ADM;KDM6A;RRN3;LFNG;GINS4;PHACTR4;SRF;PDGFB;FZD1;SETD2;BRCA2;E2F8;COPS3
10321,GO:0043087,0.962529840580499,0.0593293644471082,20,363,regulation of GTPase activity,BP,AMOT;STARD13;DOCK10;SIPA1L3;SFRP1;OPHN1;CCL20;RHOG;WNT4;RANBP2;CORO1C;AJUBA;CDC42EP2;TBC1D15;USP6;FGD6;RAB3GAP1;RABEP2;CCL5;ITGB1BP1
2203,GO:0005085,0.962556276414075,0.0664232965162976,12,231,guanyl-nucleotide exchange factor activity,MF,NEFL;NRG1;FGFR2;IRS1;DOCK10;TRIO;ARHGEF28;PDGFB;FGD6;RAB3GAP1;EIF2B5;EIF2B1
3304,GO:0007006,0.962559050763535,0.101975163112115,3,99,mitochondrial membrane organization,BP,TP53;DYNLL2;BLOC1S2
3912,GO:0008565,0.962640462274688,0.120099259258242,2,71,protein transporter activity,MF,TIMM23B;ITGB1BP1
1788,GO:0004407,0.962653829386615,0.165301432401751,1,42,histone deacetylase activity,MF,HDAC9
19216,GO:1905268,0.963235301685293,0.163605769454891,1,40,negative regulation of chromatin organization,BP,SET
14524,GO:0065002,0.963755838366981,0.160805783713124,1,50,intracellular protein transmembrane transport,BP,TIMM23B
7630,GO:0032024,0.963992516951111,0.160471526736707,1,45,positive regulation of insulin secretion,BP,GPER1
3497,GO:0007399,0.964251979220883,0.0452541908982356,96,1471,nervous system development,BP,MAFB;NEFL;NRG1;HDAC9;MAP2;FN1;TENM3;FGFR2;HSPG2;RUNX1;FAT4;PBX1;NEFM;G6PD;ENC1;DAPK3;HMGCS1;DOCK10;ACSL3;TGFB2;CNTNAP1;LRFN4;RAD1;IL6ST;SLC9A3R1;INHBA;NAIP;SFRP1;WNT10A;H3F3A;ATP2B1;COL4A1;DHFR;ULK4;OPHN1;ADM;IMMP2L;SLC1A3;PLK2;RHOG;WNT4;GPRIN1;PTPRM;KDM6A;RAN;RRN3;ARNTL;BAIAP2;PHACTR4;SRF;UGT8;SDK1;FZD1;CLU;SRD5A1;SETD2;GLIS2;WEE1;LRRN3;SLC11A2;BLOC1S2;TNC;CNTNAP2;NEDD4L;SGK1;ZFYVE27;BRCA2;NAV2;TRAK2;WDPCP;FANCD2;MTMR2;CENPF;ETV6;L1CAM;RAB3GAP1;GPER1;RRM1;NTN1;CFLAR;EIF2B5;SHTN1;DPYSL3;JRKL;DDX56;CSF1;KIF14;MPP5;PARD3;EHD1;WDR36;EIF2B1;PHLPP2;TAF1;NRAS;SMARCC1
5327,GO:0016050,0.964344772336098,0.0593554483536967,16,319,vesicle organization,BP,TAP1;RAB32;VPS41;VPS8;SNX11;SNX5;TBC1D15;USP6;BLOC1S2;SYT11;NSF;GOSR1;VPS36;TAP2;AP3B1;TBPL1
3565,GO:0007610,0.964438047110111,0.0592373419393903,16,311,behavior,BP,NRG1;CLN6;TP53;LEPR;SLC1A3;PLK2;NETO1;FEN1;SRF;SDK1;SRD5A1;SLC11A2;CNTNAP2;SGK1;NAV2;DNAJC9
1461,GO:0003700,0.96512554817554,0.045918397151827,67,1081,DNA binding transcription factor activity,MF,MAFB;FOSL2;STAT5A;TRIM22;RUNX1;PBX1;TSC22D3;TFCP2L1;TP53;ZBED1;ZNF397;STAG1;IRX2;FOXD2;ZFP42;RELB;NUCKS1;TARDBP;AHR;TAF2;ZNF584;ELMSAN1;ZNF587;MYBL2;UBTF;ARNTL;ZNF267;ZNF586;SRF;ZNF234;IRX4;NFE2L1;MACC1;ZNF670;VGLL3;GLIS2;UBP1;ZNF484;MYBL1;ZBTB24;MAZ;ZNF33A;E2F8;ETV6;ZNFX1;HSF2;GPER1;MLLT10;ZNF12;TAF6L;MYNN;CITED2;RBL1;ZNF286A;CLOCK;PURB;ESR1;ZFP36L2;ZSCAN31;TAF1;TBPL1;SPIB;ARID3B;ZNF471;IRF1;CTCF;GTF2H3
18301,GO:1903146,0.96513972327765,0.156683359746893,1,44,regulation of autophagy of mitochondrion,BP,WDR75
7111,GO:0030902,0.965273003908765,0.096137845666616,3,85,hindbrain development,BP,MAFB;OPHN1;KIF14
11759,GO:0046580,0.965296854858311,0.156490244236629,1,41,negative regulation of Ras protein signal transduction,BP,TGFB2
8446,GO:0033558,0.965390988282298,0.155934120680548,1,43,protein deacetylase activity,MF,HDAC9
10593,GO:0043547,0.965394439558647,0.0578070398486976,16,303,positive regulation of GTPase activity,BP,STARD13;DOCK10;SIPA1L3;SFRP1;OPHN1;CCL20;RHOG;WNT4;RANBP2;CORO1C;CDC42EP2;TBC1D15;USP6;RAB3GAP1;RABEP2;CCL5
10898,GO:0044429,0.96560281869262,0.0479538550027357,43,851,mitochondrial part,CC,CYP24A1;STARD13;TP53;PANK2;ACSL3;LGALS3;CARS2;IKBKE;RAB32;ABCG2;LDHAL6B;COA7;REEP1;IMMP2L;MRPL27;EXOG;DDX28;SOD2;DDX3X;ABCF2;IBA57;GDAP1;CLU;LRPPRC;SPNS1;TRUB2;TIMM23B;TRMT5;NNT;SLC11A2;GPER1;MMAA;HADHB;SDHD;MRPS7;UQCRB;PDSS1;TYMS;STARD7;FLAD1;HIBCH;SLC25A22;NDUFB9
8948,GO:0034976,0.965727758600919,0.0625607454863562,11,242,response to endoplasmic reticulum stress,BP,PML;TP53;FOXRED2;UBQLN2;CLU;SRPRB;CCDC47;EIF2B5;UBE2J2;TRAF2;UFC1
4346,GO:0009896,0.965904181241968,0.0562464638617706,17,330,positive regulation of catabolic process,BP,GCLC;TRIM22;IRS1;KEAP1;PLK2;UBQLN2;CLU;METTL16;NSF;NEDD4L;RAB3GAP1;HNRNPR;RNF19B;TNF;ZFP36L2;RC3H1;TAF1
8232,GO:0032984,0.966173316813634,0.0604343308917317,12,275,protein-containing complex disassembly,BP,MID1;GRWD1;MRPL27;SUPT16H;SET;FZD1;HSPA8;NSF;MRPS7;TNF;SMARCC1;IRAK3
4414,GO:0010171,0.96634511760844,0.152769743345732,1,42,body morphogenesis,BP,RAB3GAP1
6937,GO:0030534,0.966753097874185,0.109568527576056,2,65,adult behavior,BP,SDK1;CNTNAP2
10900,GO:0044431,0.966832891503668,0.0465622645129562,42,723,Golgi apparatus part,CC,CTGF;HLA-B;GNPTAB;HSPG2;MYO1B;B4GALT1;TPST1;GBP1;CHP1;ST6GALNAC5;PKMYT1;SLC30A6;GALNT18;CAMK1G;EMP2;RAB32;ARFRP1;HLA-F;SLC35A4;MUC16;GBP5;WNT4;HS3ST1;ATP2C1;RAB26;LFNG;PDGFB;CHID1;GLIPR2;RIC3;NSF;M6PR;GOSR1;TMEM165;STEAP4;GPER1;ABCA5;TLR3;CD74;NRAS;MUC5B;MUC6
12964,GO:0051304,0.966837099308752,0.109163019359582,2,69,chromosome separation,BP,ANAPC15;CENPF
14864,GO:0070603,0.966846678872615,0.10922540602524,2,67,SWI/SNF superfamily-type complex,CC,DAXX;SMARCC1
15932,GO:0072686,0.967152415244442,0.0916981028808755,3,88,mitotic spindle,CC,KIF23;STAG1;HNRNPU
2507,GO:0005759,0.967472222444177,0.0537408298594858,17,393,mitochondrial matrix,CC,TP53;CARS2;LDHAL6B;MRPL27;DDX28;SOD2;IBA57;LRPPRC;TRUB2;TRMT5;MMAA;HADHB;MRPS7;PDSS1;TYMS;FLAD1;HIBCH
3269,GO:0006942,0.968370023766917,0.1455004651291,1,44,regulation of striated muscle contraction,BP,CTGF
3588,GO:0008013,0.968663466001073,0.104486958142038,2,64,beta-catenin binding,MF,SLC9A3R1;ESR1
10796,GO:0044248,0.969039665128942,0.0389304127518895,109,1801,cellular catabolic process,BP,PML;CYP1B1;GCLC;CYP24A1;TRIM22;VMP1;CYP1A1;CLN6;ENC1;IRS1;TP53;DAPK3;C9ORF3;PABPC4;PRUNE2;CHP1;CYLD;PPP1R3B;DKC1;NUP50;NUP153;LEPR;VPS41;POP1;GPCPD1;TARDBP;USP16;KEAP1;DRAM1;ADAMTS9;OPHN1;MGAM;USP43;NDC1;DYNLL2;FOXRED2;CASC3;PLK2;RRAGB;UBQLN2;HSPB1;EXOG;RANBP2;ANAPC15;RNF115;SET;ARNTL;MRTO4;FASTKD3;CROT;PGK1;SNX5;FEN1;QDPR;CHID1;CLU;NUP160;USP6;ENPP1;NUP54;LRPPRC;METTL16;ERAP1;APEX1;PDCL3;TET3;HSPA8;TMEM199;HSP90AB1;SMUG1;NEDD4L;ANAPC7;SYNCRIP;DPYD;MTMR2;CCDC47;RAB3GAP1;FAF1;MMAA;WDR75;SENP1;PSME2;HADHB;PSMB9;UGT1A4;NCBP1;UPF3B;SPSB1;UBE2J2;VPS36;HNRNPR;CLOCK;KIF14;SYNPO2;RNF19B;USP11;DNASE1;TNF;ZFP36L2;RC3H1;HNRNPU;PSMB10;TAF1;HIBCH;SMARCC1;USP1;RBM8A;RPS12;COPS3
9416,GO:0035966,0.969126953301816,0.0646550823282617,7,174,response to topologically incorrect protein,BP,HSPB1;CLU;SRPRB;HSPA8;HSP90AB1;UBE2J2;DAXX
72,GO:0000149,0.969277523748899,0.0865917052454818,3,93,SNARE binding,MF,SYT11;NSF;GOSR1
6200,GO:0019674,0.969875816296017,0.139802335374608,1,48,NAD metabolic process,BP,PGK1
138,GO:0000288,0.969954469759066,0.100642346045263,2,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L2;RC3H1
7307,GO:0031301,0.970142355756502,0.069937454868062,5,141,integral component of organelle membrane,CC,TPST1;LFNG;GDAP1;TIMM23B;PXMP2
5732,GO:0016874,0.970412753921573,0.0694532599468055,5,135,ligase activity,MF,GCLC;ACSL3;CARS2;GATC;RARS
4032,GO:0009063,0.970751253022539,0.0983584937838741,2,75,cellular amino acid catabolic process,BP,QDPR;HIBCH
9470,GO:0036064,0.970838598540225,0.0829122703720276,3,92,ciliary basal body,CC,CYLD;CENPF;BBS5
13295,GO:0051963,0.970905054970867,0.136582535102713,1,43,regulation of synapse assembly,BP,LRRN3
3303,GO:0007005,0.970988947809461,0.0454655745443452,23,487,mitochondrion organization,BP,NRG1;GCLC;MMP9;TP53;PANK2;RAB32;IMMP2L;DYNLL2;SOD2;FASTKD3;GDAP1;CLU;TIMM23B;BLOC1S2;TRAK2;GPER1;WDR75;UBE2J2;UQCRB;STARD7;PPARGC1B;TSGA13;NDUFB9
3799,GO:0008375,0.971007477263146,0.135749870583179,1,48,acetylglucosaminyltransferase activity,MF,LFNG
1187,GO:0002831,0.971054961465957,0.0823299753661806,3,95,regulation of response to biotic stimulus,BP,TRAF3;BIRC3;SYT11
17820,GO:1901880,0.971344824591122,0.135099664588423,1,42,negative regulation of protein depolymerization,BP,MID1
3292,GO:0006986,0.971616428192354,0.0630182082824758,6,157,response to unfolded protein,BP,HSPB1;SRPRB;HSPA8;HSP90AB1;UBE2J2;DAXX
15177,GO:0071277,0.971681392910629,0.133773247642148,1,43,cellular response to calcium ion,BP,EDN1
7573,GO:0031929,0.971919206397455,0.0803263139508293,3,92,TOR signaling,BP,RRAGB;ARNTL;TELO2
4316,GO:0009792,0.972535847545379,0.0432929457858319,23,425,embryo development ending in birth or egg hatching,BP,AMOT;CYR61;FGFR2;PBX1;EDN1;KBTBD8;TGFB2;NBN;SFRP1;KEAP1;ADM;KDM6A;RRN3;LFNG;GINS4;PHACTR4;SRF;PDGFB;FZD1;SETD2;BRCA2;E2F8;COPS3
7762,GO:0032273,0.97256971398279,0.0786961749473496,3,95,positive regulation of protein polymerization,BP,RHOG;CDC42EP2;BAIAP2
3076,GO:0006644,0.972599356289669,0.0460080391078286,17,344,phospholipid metabolic process,BP,NRG1;FGFR2;IRS1;HMGCS1;ACSL3;GPCPD1;ABHD4;AJUBA;PDGFB;PIK3R3;MBOAT1;MTMR2;HADHB;ESR1;STARD7;PLBD1;GPX4
3090,GO:0006664,0.972727422012343,0.078217976357286,3,100,glycolipid metabolic process,BP,CLN6;ST6GALNAC5;UGT8
18455,GO:1903509,0.972727422012343,0.078217976357286,3,100,liposaccharide metabolic process,BP,CLN6;ST6GALNAC5;UGT8
5457,GO:0016328,0.972927402592546,0.129024436731218,1,45,lateral plasma membrane,CC,CORO1C
6292,GO:0019899,0.973487104238914,0.0333317807640076,117,1826,enzyme binding,MF,NEFL;NRG1;HDAC9;FN1;PML;FGFR2;TRIM22;CBX5;CYP1A1;ACTG1;TRAF3;IRS1;MID1;TP53;DAPK3;GBP1;DOCK10;CDKN2A;ACSL3;PTPN14;CHP1;AKAP8;CYLD;IKBKE;SRSF2;PPP1R3B;SLC9A3R1;NUP50;SYK;EMP2;RELB;TRIO;VPS41;MCM2;METTL21A;POLA1;TRAF1;CASC3;RRAGB;AKAP8L;NOP58;HSPB1;RHOG;LCP1;RANBP2;VCPKMT;CORO1C;NUFIP1;ARHGEF28;RRN3;CDC25A;ITGAV;SOCS1;PARP14;TRIM37;CDC42EP2;HACD2;SH3RF2;PHACTR4;SRF;MDM4;LUC7L2;PDGFB;TBC1D15;RTKN2;CLU;USP6;SMYD2;LRPPRC;KANSL1L;FGD6;ANLN;CNTNAP2;HSPA8;SYT11;HSP90AB1;EPHB6;NSF;ANAPC7;BRCA2;TRAK2;FANCD2;RAB3GAP1;IL12RB2;SERPINB9;FAF1;RAD18;CEP152;CFLAR;EIF2B5;UBE2J2;TRAF2;MSH3;TELO2;CITED2;NCL;CCNA2;NOP56;AP3B1;MPHOSPH8;KIF14;ESR1;PARD3;RNF19B;EHD1;TNF;CD74;HNRNPU;FGFR1OP;EIF2B1;DAXX;PANX1;ZNHIT6;CCDC50;CDKN1A;ITGB1BP1;DIAPH3
5270,GO:0015914,0.973536920542413,0.126686469139435,1,46,phospholipid transport,BP,STARD7
7060,GO:0030833,0.974367797717459,0.0664458656083644,4,117,regulation of actin filament polymerization,BP,KANK4;RHOG;CDC42EP2;BAIAP2
7701,GO:0032153,0.974445558088996,0.0882138704652801,2,71,cell division site,CC,RTKN2;ANLN
7761,GO:0032272,0.974628754170051,0.122458408343828,1,48,negative regulation of protein polymerization,BP,KANK4
2547,GO:0005814,0.975333072083849,0.0643751125962282,4,111,centriole,CC,PLK2;RAN;CEP152;FGFR1OP
5521,GO:0016482,0.975457811041863,0.0590946256649559,5,131,cytosolic transport,BP,EMP2;ARFRP1;SNX5;MTMR2;GOSR1
6001,GO:0019005,0.975690226855278,0.118245690585031,1,51,SCF ubiquitin ligase complex,CC,SPSB1
2905,GO:0006415,0.975986199740945,0.0831334493479918,2,100,translational termination,BP,MRPL27;MRPS7
10815,GO:0044291,0.976159925804862,0.116921411759061,1,45,cell-cell contact zone,CC,GJC1
6822,GO:0030276,0.976168722478907,0.11672193138752,1,47,clathrin binding,MF,SYT11
12825,GO:0051100,0.976236773895095,0.0622021345106268,4,122,negative regulation of binding,BP,GNL3L;PDGFB;TAF1;ITGB1BP1
337,GO:0000932,0.976351213146484,0.0826819512332423,2,74,P-body,CC,AJUBA;RC3H1
10374,GO:0043178,0.976449448932849,0.115573219042535,1,48,alcohol binding,MF,ASTN2
10164,GO:0042733,0.976503344944264,0.115444334504462,1,47,embryonic digit morphogenesis,BP,WDPCP
5835,GO:0017112,0.977950520601449,0.10971291201467,1,49,Rab guanyl-nucleotide exchange factor activity,MF,RAB3GAP1
6997,GO:0030672,0.978768666541883,0.106318905710049,1,52,synaptic vesicle membrane,CC,SYT11
17055,GO:0099501,0.978768666541883,0.106318905710049,1,52,exocytic vesicle membrane,CC,SYT11
3244,GO:0006903,0.97883983264814,0.0753597572048866,2,77,vesicle targeting,BP,NSF;GOSR1
3234,GO:0006890,0.979032474530168,0.0747925047894848,2,77,retrograde vesicle-mediated transport, Golgi to ER,BP,KIF23;NSF
3953,GO:0008654,0.979295154668665,0.0407511339576203,10,231,phospholipid biosynthetic process,BP,FGFR2;IRS1;HMGCS1;ACSL3;AJUBA;PDGFB;PIK3R3;MBOAT1;MTMR2;STARD7
17625,GO:1901264,0.979380502897335,0.103736544098894,1,55,carbohydrate derivative transport,BP,SLC35A4
16246,GO:0090277,0.979809438836073,0.102146749701405,1,53,positive regulation of peptide hormone secretion,BP,GPER1
11054,GO:0045017,0.979851100652149,0.0410009404365386,9,212,glycerolipid biosynthetic process,BP,C3;FGFR2;IRS1;ACSL3;AJUBA;PDGFB;PIK3R3;MTMR2;STARD7
5439,GO:0016298,0.980122328517127,0.0715622504162321,2,77,lipase activity,MF,CCL5;PLBD1
6068,GO:0019213,0.980203284403706,0.100694325952612,1,51,deacetylase activity,MF,HDAC9
11704,GO:0046474,0.980555627653191,0.0411537131124532,8,194,glycerophospholipid biosynthetic process,BP,FGFR2;IRS1;ACSL3;AJUBA;PDGFB;PIK3R3;MTMR2;STARD7
549,GO:0001669,0.981128384741924,0.0968533657675213,1,53,acrosomal vesicle,CC,VEZT
10920,GO:0044456,0.98114189481332,0.0308003237580696,22,423,synapse part,CC,CRYAB;MAP2;DOCK10;SHISA9;ATP2B1;OPHN1;CADPS2;MME;RAB26;NUFIP1;GPHN;NETO1;BAIAP2;WDR7;HSPA8;SYT11;NSF;DGCR8;MTMR2;RAB3GAP1;GPER1;HNRNPR
4488,GO:0010508,0.981162522278432,0.0572359551139891,3,97,positive regulation of autophagy,BP,TRIM22;PLK2;RAB3GAP1
18376,GO:1903320,0.981773134258649,0.0404727835907556,7,188,regulation of protein modification by small protein conjugation or removal,BP,GCLC;CHP1;GNL3L;BIRC3;HSP90AB1;DAXX;TAF1
8208,GO:0032947,0.981859705444685,0.0664669242711437,2,72,protein-containing complex scaffold activity,MF,SLC9A3R1;TELO2
3054,GO:0006614,0.981975266026132,0.0922126723339364,1,91,SRP-dependent cotranslational protein targeting to membrane,BP,RPS12
5331,GO:0016054,0.982106694622365,0.0397993715565936,7,191,organic acid catabolic process,BP,IRS1;CHP1;CROT;QDPR;MMAA;HADHB;HIBCH
11671,GO:0046395,0.982106694622365,0.0397993715565936,7,191,carboxylic acid catabolic process,BP,IRS1;CHP1;CROT;QDPR;MMAA;HADHB;HIBCH
4256,GO:0009581,0.982559440017952,0.0913622518704447,1,47,detection of external stimulus,BP,METAP2
13057,GO:0051494,0.982584259502865,0.0535200129005334,3,98,negative regulation of cytoskeleton organization,BP,MID1;KANK4;TRIM37
6582,GO:0022406,0.982777624917084,0.0405577975896563,6,163,membrane docking,BP,CHP1;RAB26;NSF;SCFD2;CEP152;FGFR1OP
2961,GO:0006497,0.982864411120519,0.0526520684134612,3,108,protein lipidation,BP,ZDHHC6;CD109;RAB3GAP1
13133,GO:0051649,0.983103110484696,0.0219268243649058,100,1674,establishment of localization in cell,BP,CRYAB;NEFL;NRG1;PML;KIF23;JPH2;GNPTAB;TAP1;DYNC2H1;TP53;RBM4;PTPN14;GEMIN5;CHP1;RBM22;SRSF2;SLC9A3R1;NUP50;PHAX;SYK;EMP2;NUP153;RAB32;ARFRP1;VPS41;AP3M2;ZDHHC6;GEMIN4;DST;AP5M1;REEP1;LSG1;OPHN1;IMMP2L;NDC1;CADPS2;DYNLL2;CASC3;AKAP8L;HSPB1;LCP1;THOC1;RAN;RANBP2;RAB26;SET;ARNTL;SNX11;SNX5;CDCA5;GDAP1;TBC1D15;CLU;NUP160;USP6;SDAD1;NUP54;LRPPRC;SETD2;TIMM23B;JPH1;BLOC1S2;HSPA8;SYT11;HSP90AB1;NSF;M6PR;GEMIN8;TRAK2;MTMR2;CENPF;GOSR1;RAB3GAP1;BBS5;GPER1;WDR75;MYO10;NTN1;NCBP1;UPF3B;UBE2J2;VPS36;TAP2;AP3B1;KIF14;PARD3;EHD1;ARV1;TNF;SRSF7;STARD7;CD74;HNRNPU;DCTN5;CDKN1A;ITGB1BP1;TSGA13;RBM8A;RPS12;BUD13
12800,GO:0051056,0.983810145018945,0.0303519877763624,13,267,regulation of small GTPase mediated signal transduction,BP,NRG1;AMOT;STARD13;SIPA1L3;TGFB2;TRIO;OPHN1;RHOG;ARHGEF28;CGNL1;FGD6;CSF1;KIF14
9893,GO:0042158,0.984240044879511,0.0489945990105537,3,110,lipoprotein biosynthetic process,BP,ZDHHC6;CD109;RAB3GAP1
12145,GO:0048207,0.984598081451062,0.0822982238705738,1,56,vesicle targeting, rough ER to cis-Golgi,BP,NSF
12146,GO:0048208,0.984598081451062,0.0822982238705738,1,56,COPII vesicle coating,BP,NSF
7306,GO:0031300,0.9846669229493,0.0390071210470191,5,155,intrinsic component of organelle membrane,CC,TPST1;LFNG;GDAP1;TIMM23B;PXMP2
7232,GO:0031122,0.985098675696811,0.0803995090052057,1,51,cytoplasmic microtubule organization,BP,CHP1
13125,GO:0051640,0.985204227796212,0.0235250284761745,27,523,organelle localization,BP,NEFL;KIF23;SLC9A3R1;SYK;AP3M2;CADPS2;RAN;RANBP2;RAB26;CDCA5;SDAD1;LRPPRC;BLOC1S2;SYT11;NSF;TRAK2;CENPF;GOSR1;RAB3GAP1;SCFD2;BBS5;NTN1;CEP152;AP3B1;KIF14;HNRNPU;FGFR1OP
12934,GO:0051261,0.985242830477712,0.0558935168687955,2,75,protein depolymerization,BP,MID1;HSPA8
7340,GO:0031345,0.985908914453252,0.0395477696251108,4,124,negative regulation of cell projection organization,BP,PLK2;TRAK2;NTN1;DPYSL3
11170,GO:0045211,0.986285932986425,0.0386831893482701,4,117,postsynaptic membrane,CC,SHISA9;CADPS2;GPHN;NETO1
3580,GO:0007626,0.986464407382494,0.0431104690152742,3,100,locomotory behavior,BP,NRG1;CLN6;NAV2
12212,GO:0048365,0.986982857045479,0.072060337732973,1,53,Rac GTPase binding,MF,CORO1C
2496,GO:0005743,0.987002724856073,0.0237681956412638,15,407,mitochondrial inner membrane,CC,LGALS3;IMMP2L;MRPL27;EXOG;SOD2;SPNS1;TIMM23B;NNT;HADHB;SDHD;MRPS7;UQCRB;TYMS;SLC25A22;NDUFB9
12931,GO:0051258,0.987012903265104,0.0286014286902203,8,207,protein polymerization,BP,NEFL;MAP2;COBLL1;KANK4;RHOG;CDC42EP2;BAIAP2;GPX4
11356,GO:0045665,0.987192590776865,0.0333478283155789,5,143,negative regulation of neuron differentiation,BP,PBX1;PLK2;TRAK2;NTN1;DPYSL3
16881,GO:0098791,0.987930841538151,0.0184697457826388,35,661,Golgi subcompartment,CC,HLA-B;GNPTAB;MYO1B;B4GALT1;TPST1;GBP1;CHP1;ST6GALNAC5;PKMYT1;SLC30A6;GALNT18;CAMK1G;EMP2;RAB32;ARFRP1;HLA-F;SLC35A4;GBP5;ATP2C1;RAB26;LFNG;PDGFB;CHID1;GLIPR2;RIC3;NSF;M6PR;GOSR1;TMEM165;STEAP4;GPER1;ABCA5;TLR3;CD74;NRAS
3053,GO:0006613,0.987967303348131,0.0666073434773077,1,96,cotranslational protein targeting to membrane,BP,RPS12
3664,GO:0008154,0.988019080492923,0.0314026077474685,5,150,actin polymerization or depolymerization,BP,COBLL1;KANK4;RHOG;CDC42EP2;BAIAP2
8312,GO:0033138,0.988341951544762,0.0656725187675399,1,60,positive regulation of peptidyl-serine phosphorylation,BP,TNF
5790,GO:0017016,0.988406483451008,0.0197787489892604,21,407,Ras GTPase binding,MF,NEFL;NRG1;FGFR2;IRS1;DAPK3;NUP50;TRIO;RANBP2;CORO1C;ARHGEF28;CDC42EP2;PDGFB;TBC1D15;RTKN2;USP6;FGD6;ANLN;NSF;RAB3GAP1;EHD1;DIAPH3
3243,GO:0006901,0.988575339667515,0.0646079278623852,1,60,vesicle coating,BP,NSF
11757,GO:0046578,0.988629576817162,0.0254149300267543,8,191,regulation of Ras protein signal transduction,BP,NRG1;TGFB2;TRIO;OPHN1;ARHGEF28;FGD6;CSF1;KIF14
7610,GO:0031985,0.989090986484233,0.0431768664528868,2,86,Golgi cisterna,CC,B4GALT1;GOSR1
15047,GO:0070972,0.989141294756431,0.0426240840404849,2,125,protein localization to endoplasmic reticulum,BP,RAB3GAP1;RPS12
9049,GO:0035257,0.989861937318681,0.0296101548676802,4,131,nuclear hormone receptor binding,MF,RAN;ESR1;DAXX;PPARGC1B
10812,GO:0044282,0.989969133135525,0.0199383486737258,12,302,small molecule catabolic process,BP,CYP24A1;CYP1A1;IRS1;CHP1;CROT;PGK1;QDPR;DPYD;MTMR2;MMAA;HADHB;HIBCH
3615,GO:0008064,0.989971033616439,0.0293188446207574,4,133,regulation of actin polymerization or depolymerization,BP,KANK4;RHOG;CDC42EP2;BAIAP2
4560,GO:0010639,0.990048484553693,0.0198188965979541,12,282,negative regulation of organelle organization,BP,MID1;RAD1;NBN;KANK4;ANAPC15;SET;TRIM37;GNL3L;CLU;CENPF;CHEK1;HNRNPU
19587,GO:1990542,0.990092224036822,0.0573674296611558,1,67,mitochondrial transmembrane transport,BP,TIMM23B
17819,GO:1901879,0.990268472041238,0.0568925769186886,1,55,regulation of protein depolymerization,BP,MID1
10914,GO:0044450,0.990441686924078,0.0257195075024609,5,147,microtubule organizing center part,CC,PLK2;RAN;BLOC1S2;CEP152;FGFR1OP
5404,GO:0016239,0.990591762048269,0.0552485845955165,1,58,positive regulation of macroautophagy,BP,RAB3GAP1
11068,GO:0045047,0.990677565646561,0.0540583541584983,1,101,protein targeting to ER,BP,RPS12
17312,GO:0140056,0.990704441593407,0.0250574698169718,5,155,organelle localization by membrane tethering,BP,RAB26;NSF;SCFD2;CEP152;FGFR1OP
7760,GO:0032271,0.990780454307681,0.024875335036374,5,155,regulation of protein polymerization,BP,MAP2;KANK4;RHOG;CDC42EP2;BAIAP2
6275,GO:0019866,0.990985376775929,0.0163976233175904,17,451,organelle inner membrane,CC,LGALS3;IMMP2L;MRPL27;EXOG;SOD2;LRPPRC;SPNS1;TIMM23B;DPY19L2P2;NNT;HADHB;SDHD;MRPS7;UQCRB;TYMS;SLC25A22;NDUFB9
11852,GO:0046785,0.991002292723956,0.0532445968503602,1,59,microtubule polymerization,BP,MAP2
4487,GO:0010507,0.991014747146641,0.0531547704835387,1,60,negative regulation of autophagy,BP,LEPR
2400,GO:0005543,0.991156579410468,0.0173782615356352,13,297,phospholipid binding,MF,JPH2;MYO1B;ARRDC1-AS1;PARD3B;OPHN1;SNX11;SNX5;HSPA8;SYT11;BBS5;MYO10;VPS36;PARD3
5382,GO:0016197,0.991232538544808,0.0221881594096666,6,175,endosomal transport,BP,ARFRP1;AP5M1;SNX5;GOSR1;VPS36;EHD1
7059,GO:0030832,0.991355185129809,0.0257241159119553,4,134,regulation of actin filament length,BP,KANK4;RHOG;CDC42EP2;BAIAP2
13293,GO:0051961,0.991379980984941,0.0206813026396128,7,188,negative regulation of nervous system development,BP,NRG1;PBX1;PLK2;TRAK2;MTMR2;NTN1;DPYSL3
16142,GO:0090114,0.991447649627988,0.0509723235237058,1,63,COPII-coated vesicle budding,BP,NSF
3749,GO:0008289,0.991454971576708,0.0146914997907012,22,457,lipid binding,MF,JPH2;STARD13;MYO1B;APOL6;ARRDC1-AS1;PARD3B;OPHN1;CADPS2;SNX11;AKR1C2;SNX5;NFE2L1;HSPA8;SYT11;BBS5;GPER1;MYO10;VPS36;TRAF2;ESR1;PARD3;STARD7
10912,GO:0044448,0.991542275267076,0.0252694109020334,4,127,cell cortex part,CC,RTKN2;TPM4;ANLN;ARV1
4486,GO:0010506,0.992101668259048,0.0164402189110791,11,272,regulation of autophagy,BP,TRIM22;DAPK3;LEPR;DRAM1;PLK2;RRAGB;UBQLN2;HSPB1;SNX5;RAB3GAP1;WDR75
10907,GO:0044441,0.992452067821235,0.0157726990705399,11,269,ciliary part,CC,DYNC2H1;CYLD;SLC9A3R1;DNHD1;DYNLL2;WDPCP;CENPF;BBS5;EHD1;PHLPP2;PHLPP1
13103,GO:0051592,0.99248720267799,0.0314631521991053,2,85,response to calcium ion,BP,PTGES;EDN1
10636,GO:0043624,0.992653470169001,0.0202530045172718,5,179,cellular protein complex disassembly,BP,MID1;MRPL27;HSPA8;NSF;MRPS7
2539,GO:0005795,0.992682702250407,0.0252146414718417,3,115,Golgi stack,CC,B4GALT1;NSF;GOSR1
9639,GO:0036498,0.993207771773767,0.042098068668984,1,67,IRE1-mediated unfolded protein response,BP,SRPRB
13947,GO:0060589,0.993402148619579,0.0135743031014482,12,284,nucleoside-triphosphatase regulator activity,MF,STARD13;SIPA1L3;BAG1;OPHN1;HSCB;RANBP2;CDC42EP2;TBC1D15;USP6;RAB3GAP1;RABEP2;ITGB1BP1
3252,GO:0006914,0.993464752035631,0.0118345485409508,19,427,autophagy,BP,TRIM22;VMP1;TP53;DAPK3;LEPR;VPS41;DRAM1;DYNLL2;PLK2;RRAGB;UBQLN2;HSPB1;SNX5;CLU;HSPA8;RAB3GAP1;WDR75;VPS36;SYNPO2
14506,GO:0061919,0.993464752035631,0.0118345485409508,19,427,process utilizing autophagic mechanism,BP,TRIM22;VMP1;TP53;DAPK3;LEPR;VPS41;DRAM1;DYNLL2;PLK2;RRAGB;UBQLN2;HSPB1;SNX5;CLU;HSPA8;RAB3GAP1;WDR75;VPS36;SYNPO2
2213,GO:0005096,0.993640187309953,0.0143871625338524,9,226,GTPase activator activity,MF,STARD13;SIPA1L3;OPHN1;RANBP2;CDC42EP2;TBC1D15;USP6;RAB3GAP1;RABEP2
7975,GO:0032580,0.993974207359814,0.0381301794442865,1,67,Golgi cisterna membrane,CC,B4GALT1
12611,GO:0050768,0.994026948257303,0.0157125698216199,6,176,negative regulation of neurogenesis,BP,NRG1;PBX1;PLK2;TRAK2;NTN1;DPYSL3
5187,GO:0015748,0.994106698813542,0.0374340582429125,1,67,organophosphate ester transport,BP,STARD7
16737,GO:0097711,0.994375005804292,0.0244757145118056,2,94,ciliary basal body-plasma membrane docking,BP,CEP152;FGFR1OP
3323,GO:0007032,0.994398602897808,0.0358547958605341,1,69,endosome organization,BP,VPS36
5694,GO:0016811,0.994418768068363,0.0357312161581497,1,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,HDAC9
12771,GO:0051020,0.994490758488882,0.00928112473914048,27,524,GTPase binding,MF,NEFL;NRG1;FGFR2;IRS1;DAPK3;DOCK10;NUP50;TRIO;VPS41;RRAGB;LCP1;RANBP2;CORO1C;ARHGEF28;CDC42EP2;PDGFB;TBC1D15;RTKN2;USP6;FGD6;ANLN;NSF;RAB3GAP1;EIF2B5;EHD1;EIF2B1;DIAPH3
7014,GO:0030695,0.994553041238975,0.0120486639556991,10,249,GTPase regulator activity,MF,STARD13;SIPA1L3;OPHN1;RANBP2;CDC42EP2;TBC1D15;USP6;RAB3GAP1;RABEP2;ITGB1BP1
13021,GO:0051427,0.99472164987684,0.0165968406747127,4,143,hormone receptor binding,MF,RAN;ESR1;DAXX;PPARGC1B
5849,GO:0017137,0.994867059930751,0.0147389015168687,5,158,Rab GTPase binding,MF,TBC1D15;USP6;NSF;RAB3GAP1;EHD1
12642,GO:0050807,0.995047752830407,0.0219319237135027,2,94,regulation of synapse organization,BP,BAIAP2;LRRN3
12140,GO:0048194,0.99546364480553,0.0300482156959262,1,71,Golgi vesicle budding,BP,NSF
13732,GO:0060271,0.996251197031467,0.00826302609148025,11,285,cilium assembly,BP,DYNC2H1;CYLD;DNHD1;ABCC4;DYNLL2;TMEM138;WDPCP;BBS5;CEP152;EHD1;FGFR1OP
11165,GO:0045202,0.996264615008816,0.00653932041055671,25,514,synapse,CC,CRYAB;NRG1;MAP2;FGFR2;DOCK10;SHISA9;ATP2B1;OPHN1;CADPS2;MME;RAB26;NUFIP1;GPHN;NETO1;BAIAP2;WDR7;SDK1;HSPA8;SYT11;NSF;DGCR8;MTMR2;RAB3GAP1;GPER1;HNRNPR
2619,GO:0005929,0.996361422865413,0.0074522879216033,14,340,cilium,CC,DYNC2H1;CYLD;SLC9A3R1;DNHD1;DYNLL2;RAN;GLIS2;TMEM138;WDPCP;CENPF;BBS5;EHD1;PHLPP2;PHLPP1
5406,GO:0016241,0.996382507325114,0.0118336838744206,4,151,regulation of macroautophagy,BP,RRAGB;UBQLN2;SNX5;RAB3GAP1
201,GO:0000422,0.996666333796846,0.0231366284234613,1,77,autophagy of mitochondrion,BP,WDR75
14438,GO:0061726,0.996666333796846,0.0231366284234613,1,77,mitochondrion disassembly,BP,WDR75
8842,GO:0034620,0.996682623012335,0.0125350844376182,3,131,cellular response to unfolded protein,BP,SRPRB;HSPA8;DAXX
12638,GO:0050803,0.997165306289171,0.0134787507832979,2,102,regulation of synapse structure or activity,BP,BAIAP2;LRRN3
10995,GO:0044782,0.997169365774171,0.00636670594672053,11,291,cilium organization,BP,DYNC2H1;CYLD;DNHD1;ABCC4;DYNLL2;TMEM138;WDPCP;BBS5;CEP152;EHD1;FGFR1OP
5693,GO:0016810,0.997410369409455,0.0124224664398677,2,111,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,HDAC9;DPYSL3
7287,GO:0031267,0.997419843456175,0.00481767123482953,21,447,small GTPase binding,MF,NEFL;NRG1;FGFR2;IRS1;DAPK3;NUP50;TRIO;RANBP2;CORO1C;ARHGEF28;CDC42EP2;PDGFB;TBC1D15;RTKN2;USP6;FGD6;ANLN;NSF;RAB3GAP1;EHD1;DIAPH3
5804,GO:0017053,0.997637694208405,0.0173115996714527,1,73,transcriptional repressor complex,CC,CBX5
8310,GO:0033135,0.998393091678405,0.0123872084680183,1,85,regulation of peptidyl-serine phosphorylation,BP,TNF
3242,GO:0006900,0.998457647666648,0.0119536528927709,1,86,vesicle budding from membrane,BP,NSF
9996,GO:0042383,0.998621427795777,0.0108901256314625,1,78,sarcolemma,CC,ABCC9
3503,GO:0007411,0.998693108260879,0.00426283381336193,5,173,axon guidance,BP,OPHN1;PTPRM;L1CAM;NTN1;NRAS
7361,GO:0031398,0.998700569590869,0.0102938443772504,1,91,positive regulation of protein ubiquitination,BP,BIRC3
9417,GO:0035967,0.998700575334062,0.00541778090082503,3,146,cellular response to topologically incorrect protein,BP,SRPRB;HSPA8;DAXX
16647,GO:0097485,0.998764015943691,0.00405061314860981,5,174,neuron projection guidance,BP,OPHN1;PTPRM;L1CAM;NTN1;NRAS
3233,GO:0006888,0.998789948510201,0.00439851988863933,4,170,ER to Golgi vesicle-mediated transport,BP,DYNLL2;NSF;GOSR1;DCTN5
3321,GO:0007030,0.998888343531466,0.00589337775537749,2,113,Golgi organization,BP,VMP1;DYNC2H1
5402,GO:0016236,0.99914656866962,0.00234535292220017,8,270,macroautophagy,BP,VMP1;DYNLL2;RRAGB;UBQLN2;SNX5;RAB3GAP1;VPS36;SYNPO2
18241,GO:1903008,0.999210084063496,0.00667292815828328,1,96,organelle disassembly,BP,WDR75
18378,GO:1903322,0.999598902908194,0.00367089536340591,1,107,positive regulation of protein modification by small protein conjugation or removal,BP,BIRC3
12139,GO:0048193,0.999829123482092,0.000496255894645437,9,309,Golgi vesicle transport,BP,KIF23;MYO1B;ACSL3;ARFRP1;DYNLL2;RAB26;NSF;GOSR1;DCTN5
7141,GO:0030968,0.999850130549826,0.00152771943911514,1,117,endoplasmic reticulum unfolded protein response,BP,SRPRB
11541,GO:0046041,0.999999999963293,0.884886276583161,0,2,ITP metabolic process,BP,
16708,GO:0097636,0.999999999968157,0.856716187967577,0,2,intrinsic component of autophagosome membrane,CC,
16709,GO:0097637,0.999999999968157,0.856716187967577,0,2,integral component of autophagosome membrane,CC,
9272,GO:0035674,0.999999999969929,0.871814244403435,0,2,tricarboxylic acid transmembrane transport,BP,
7093,GO:0030882,0.999999999970097,0.924445711931268,0,1,lipid antigen binding,MF,
7094,GO:0030883,0.999999999970097,0.924445711931268,0,1,endogenous lipid antigen binding,MF,
7095,GO:0030884,0.999999999970097,0.924445711931268,0,1,exogenous lipid antigen binding,MF,
12073,GO:0048006,0.999999999970097,0.924445711931268,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
9627,GO:0036483,0.99999999997023,0.921027730183862,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
18403,GO:1903381,0.99999999997023,0.921027730183862,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18404,GO:1903382,0.99999999997023,0.921027730183862,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
16117,GO:0090080,0.99999999997224,0.835855069281937,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
11996,GO:0047280,0.999999999972632,0.920911437976232,0,1,nicotinamide phosphoribosyltransferase activity,MF,
1355,GO:0003220,0.999999999972986,0.898904996529027,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1369,GO:0003251,0.999999999972986,0.898904996529027,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
6967,GO:0030616,0.999999999972986,0.898904996529027,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
9053,GO:0035262,0.999999999972986,0.898904996529027,0,1,gonad morphogenesis,BP,
14178,GO:0061040,0.999999999972986,0.898904996529027,0,1,female gonad morphogenesis,BP,
19232,GO:1905304,0.999999999972986,0.898904996529027,0,1,regulation of cardiac myofibril assembly,BP,
19233,GO:1905305,0.999999999972986,0.898904996529027,0,1,negative regulation of cardiac myofibril assembly,BP,
6083,GO:0019236,0.999999999973647,0.874907286280967,0,2,response to pheromone,BP,
18501,GO:1903575,0.999999999973776,0.873659038541123,0,2,cornified envelope assembly,BP,
7217,GO:0031104,0.999999999973782,0.923178284439086,0,1,dendrite regeneration,BP,
17117,GO:0099631,0.999999999973978,0.903670008417071,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
8133,GO:0032815,0.999999999974289,0.728119580065264,0,5,negative regulation of natural killer cell activation,BP,
5023,GO:0015184,0.999999999974543,0.850766128727345,0,2,L-cystine transmembrane transporter activity,MF,
5214,GO:0015811,0.999999999974543,0.850766128727345,0,2,L-cystine transport,BP,
2360,GO:0005457,0.999999999975135,0.842511704050509,0,2,GDP-fucose transmembrane transporter activity,MF,
5196,GO:0015783,0.999999999975135,0.842511704050509,0,2,GDP-fucose transmembrane transport,BP,
9476,GO:0036080,0.999999999975135,0.842511704050509,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
19452,GO:1990005,0.999999999975749,0.87137451806594,0,2,granular vesicle,CC,
1513,GO:0003870,0.999999999975892,0.93144002711265,0,1,5-aminolevulinate synthase activity,MF,
5657,GO:0016749,0.999999999975892,0.93144002711265,0,1,N-succinyltransferase activity,MF,
17252,GO:0110021,0.999999999976056,0.863587037523679,0,2,cardiac muscle myoblast proliferation,BP,
17253,GO:0110022,0.999999999976056,0.863587037523679,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17254,GO:0110024,0.999999999976056,0.863587037523679,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
11853,GO:0046786,0.999999999976455,0.919278498000054,0,1,viral replication complex formation and maintenance,BP,
20072,GO:2000661,0.999999999976455,0.919278498000054,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
9675,GO:0038025,0.999999999976558,0.853515677203713,0,2,reelin receptor activity,MF,
15686,GO:0072190,0.999999999976572,0.866327049749319,0,2,ureter urothelium development,BP,
15687,GO:0072191,0.999999999976572,0.866327049749319,0,2,ureter smooth muscle development,BP,
15689,GO:0072193,0.999999999976572,0.866327049749319,0,2,ureter smooth muscle cell differentiation,BP,
15691,GO:0072197,0.999999999976572,0.866327049749319,0,2,ureter morphogenesis,BP,
18923,GO:1904580,0.999999999977244,0.870373672313196,0,2,regulation of intracellular mRNA localization,BP,
18924,GO:1904582,0.999999999977244,0.870373672313196,0,2,positive regulation of intracellular mRNA localization,BP,
4888,GO:0014806,0.999999999977269,0.87635269484434,0,2,smooth muscle hyperplasia,BP,
3843,GO:0008449,0.999999999977288,0.846969063353932,0,2,N-acetylglucosamine-6-sulfatase activity,MF,
10865,GO:0044355,0.999999999977643,0.943952641884795,0,1,clearance of foreign intracellular DNA,BP,
10866,GO:0044356,0.999999999977643,0.943952641884795,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
17005,GO:0099046,0.999999999977643,0.943952641884795,0,1,clearance of foreign intracellular nucleic acids,BP,
12166,GO:0048257,0.999999999977698,0.864002151760855,0,2,3'-flap endonuclease activity,MF,
1037,GO:0002543,0.999999999977996,0.856748810103748,0,2,activation of blood coagulation via clotting cascade,BP,
3820,GO:0008413,0.999999999978091,0.899899810523989,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9182,GO:0035539,0.999999999978091,0.899899810523989,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
19203,GO:1905222,0.999999999978129,0.927037479972485,0,1,atrioventricular canal morphogenesis,BP,
2700,GO:0006064,0.999999999978222,0.733925635616365,0,5,glucuronate catabolic process,BP,
6193,GO:0019640,0.999999999978222,0.733925635616365,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
12868,GO:0051167,0.999999999978222,0.733925635616365,0,5,xylulose 5-phosphate metabolic process,BP,
17588,GO:1901159,0.999999999978222,0.733925635616365,0,5,xylulose 5-phosphate biosynthetic process,BP,
5468,GO:0016361,0.999999999978296,0.869993000792533,0,2,activin receptor activity, type I,MF,
12135,GO:0048179,0.999999999978296,0.869993000792533,0,2,activin receptor complex,CC,
18217,GO:1902962,0.999999999978353,0.820617075150105,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18218,GO:1902963,0.999999999978353,0.820617075150105,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
8877,GO:0034673,0.99999999997846,0.836052756752687,0,2,inhibin-betaglycan-ActRII complex,CC,
18446,GO:1903464,0.999999999978483,0.866617997155561,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
1518,GO:0003876,0.999999999978542,0.852520282744182,0,2,AMP deaminase activity,MF,
12037,GO:0047623,0.999999999978542,0.852520282744182,0,2,adenosine-phosphate deaminase activity,MF,
19313,GO:1905502,0.999999999978642,0.949785118346504,0,1,acetyl-CoA binding,MF,
17805,GO:1901841,0.999999999978729,0.701792057356628,0,5,regulation of high voltage-gated calcium channel activity,BP,
3973,GO:0008781,0.999999999978781,0.890096083500238,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4931,GO:0014886,0.999999999978818,0.853631193557578,0,2,transition between slow and fast fiber,BP,
9670,GO:0038016,0.99999999997883,0.862349675172923,0,2,insulin receptor internalization,BP,
13872,GO:0060455,0.999999999978899,0.885091659305208,0,2,negative regulation of gastric acid secretion,BP,
293,GO:0000797,0.999999999979086,0.919680529085952,0,1,condensin core heterodimer,CC,
3079,GO:0006651,0.999999999979097,0.866397534150899,0,2,diacylglycerol biosynthetic process,BP,
1970,GO:0004676,0.99999999997914,0.907905634578207,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1910,GO:0004595,0.999999999979234,0.931770940692439,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
681,GO:0001888,0.999999999979243,0.84708704621106,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
2964,GO:0006500,0.999999999979342,0.933254861601994,0,1,N-terminal protein palmitoylation,BP,
5882,GO:0018009,0.999999999979342,0.933254861601994,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
970,GO:0002414,0.99999999997938,0.865188837866986,0,2,immunoglobulin transcytosis in epithelial cells,BP,
6224,GO:0019763,0.99999999997938,0.865188837866986,0,2,immunoglobulin receptor activity,MF,
1834,GO:0004486,0.999999999979461,0.925663630042261,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
10469,GO:0043317,0.999999999979461,0.925663630042261,0,1,regulation of cytotoxic T cell degranulation,BP,
10470,GO:0043318,0.999999999979461,0.925663630042261,0,1,negative regulation of cytotoxic T cell degranulation,BP,
12251,GO:0048499,0.999999999979495,0.817418667136776,0,3,synaptic vesicle membrane organization,BP,
8253,GO:0033018,0.999999999979539,0.866480226877184,0,2,sarcoplasmic reticulum lumen,CC,
1397,GO:0003308,0.999999999979598,0.868959552646486,0,2,negative regulation of Wnt signaling pathway involved in heart development,BP,
6092,GO:0019255,0.999999999979618,0.87228150917444,0,2,glucose 1-phosphate metabolic process,BP,
7358,GO:0031394,0.999999999979626,0.870424421432711,0,2,positive regulation of prostaglandin biosynthetic process,BP,
20331,GO:2001280,0.999999999979626,0.870424421432711,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
16684,GO:0097543,0.999999999979688,0.850992340142338,0,2,ciliary inversin compartment,CC,
2055,GO:0004802,0.999999999979716,0.933521972002701,0,1,transketolase activity,MF,
14780,GO:0070458,0.999999999979748,0.830948087190166,0,3,cellular detoxification of nitrogen compound,BP,
8293,GO:0033091,0.999999999979762,0.929726763973307,0,1,positive regulation of immature T cell proliferation,BP,
7145,GO:0030974,0.999999999979828,0.873660119252063,0,2,thiamine pyrophosphate transmembrane transport,BP,
16323,GO:0090422,0.999999999979828,0.873660119252063,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
2373,GO:0005499,0.999999999979857,0.859593308038597,0,2,vitamin D binding,MF,
7402,GO:0031460,0.999999999979866,0.919370474730521,0,1,glycine betaine transport,BP,
9226,GO:0035606,0.99999999997988,0.915781260331096,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
2072,GO:0004823,0.99999999998,0.84830348225276,0,2,leucine-tRNA ligase activity,MF,
2918,GO:0006429,0.99999999998,0.84830348225276,0,2,leucyl-tRNA aminoacylation,BP,
15739,GO:0072284,0.999999999980002,0.738266624193962,0,4,metanephric S-shaped body morphogenesis,BP,
15664,GO:0072156,0.999999999980033,0.792770412953001,0,2,distal tubule morphogenesis,BP,
1596,GO:0004008,0.999999999980035,0.820764078095942,0,2,copper-exporting ATPase activity,MF,
10659,GO:0043682,0.999999999980035,0.820764078095942,0,2,copper-transporting ATPase activity,MF,
13563,GO:0060003,0.999999999980035,0.820764078095942,0,2,copper ion export,BP,
3183,GO:0006808,0.999999999980041,0.887310783381496,0,2,regulation of nitrogen utilization,BP,
11811,GO:0046666,0.999999999980041,0.887310783381496,0,2,retinal cell programmed cell death,BP,
11605,GO:0046166,0.999999999980043,0.880881581677956,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
8124,GO:0032804,0.999999999980081,0.867513109323968,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
1167,GO:0002785,0.999999999980177,0.924902719422188,0,1,negative regulation of antimicrobial peptide production,BP,
1169,GO:0002787,0.999999999980177,0.924902719422188,0,1,negative regulation of antibacterial peptide production,BP,
3786,GO:0008348,0.999999999980177,0.924902719422188,0,1,negative regulation of antimicrobial humoral response,BP,
11398,GO:0045759,0.999999999980223,0.863594980895628,0,2,negative regulation of action potential,BP,
9855,GO:0042091,0.999999999980233,0.866320952868435,0,2,interleukin-10 biosynthetic process,BP,
11088,GO:0045074,0.999999999980233,0.866320952868435,0,2,regulation of interleukin-10 biosynthetic process,BP,
1319,GO:0003164,0.999999999980299,0.842147878206283,0,2,His-Purkinje system development,BP,
16060,GO:0086073,0.99999999998054,0.644238651905994,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16068,GO:0086083,0.99999999998054,0.644238651905994,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
1840,GO:0004492,0.999999999980541,0.933459566948831,0,1,methylmalonyl-CoA decarboxylase activity,MF,
8166,GO:0032889,0.999999999980544,0.930119147268994,0,1,regulation of vacuole fusion, non-autophagic,BP,
10993,GO:0044778,0.999999999980592,0.867945637743811,0,2,meiotic DNA integrity checkpoint,BP,
1794,GO:0004420,0.999999999980628,0.921249085626236,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
9943,GO:0042282,0.999999999980628,0.921249085626236,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
18559,GO:1903722,0.999999999980666,0.886577218255892,0,2,regulation of centriole elongation,BP,
180,GO:0000390,0.999999999980669,0.881318734070379,0,2,spliceosomal complex disassembly,BP,
4100,GO:0009153,0.999999999980763,0.892098084769146,0,2,purine deoxyribonucleotide biosynthetic process,BP,
9299,GO:0035730,0.999999999980815,0.955871771890655,0,1,S-nitrosoglutathione binding,MF,
9300,GO:0035731,0.999999999980815,0.955871771890655,0,1,dinitrosyl-iron complex binding,MF,
9301,GO:0035732,0.999999999980815,0.955871771890655,0,1,nitric oxide storage,BP,
9374,GO:0035880,0.999999999980878,0.862183953505368,0,2,embryonic nail plate morphogenesis,BP,
13301,GO:0051969,0.999999999980998,0.728654133768597,0,4,regulation of transmission of nerve impulse,BP,
2089,GO:0004850,0.999999999981001,0.937285862881082,0,1,uridine phosphorylase activity,MF,
2785,GO:0006218,0.999999999981001,0.937285862881082,0,1,uridine catabolic process,BP,
11578,GO:0046108,0.999999999981001,0.937285862881082,0,1,uridine metabolic process,BP,
19465,GO:1990047,0.999999999981063,0.93192154473312,0,1,spindle matrix,CC,
5656,GO:0016748,0.999999999981107,0.864681041786103,0,2,succinyltransferase activity,MF,
8945,GO:0034970,0.999999999981236,0.862284999095937,0,2,histone H3-R2 methylation,BP,
2147,GO:0004960,0.999999999981269,0.932010948018837,0,1,thromboxane receptor activity,MF,
2148,GO:0004961,0.999999999981269,0.932010948018837,0,1,thromboxane A2 receptor activity,MF,
5321,GO:0016036,0.999999999981269,0.932010948018837,0,1,cellular response to phosphate starvation,BP,
7331,GO:0031335,0.999999999981269,0.932010948018837,0,1,regulation of sulfur amino acid metabolic process,BP,
7332,GO:0031337,0.999999999981269,0.932010948018837,0,1,positive regulation of sulfur amino acid metabolic process,BP,
9343,GO:0035814,0.999999999981269,0.932010948018837,0,1,negative regulation of renal sodium excretion,BP,
9748,GO:0038193,0.999999999981269,0.932010948018837,0,1,thromboxane A2 signaling pathway,BP,
12542,GO:0050666,0.999999999981269,0.932010948018837,0,1,regulation of homocysteine metabolic process,BP,
12544,GO:0050668,0.999999999981269,0.932010948018837,0,1,positive regulation of homocysteine metabolic process,BP,
15427,GO:0071673,0.999999999981287,0.92708039942867,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
18910,GO:1904565,0.999999999981287,0.92708039942867,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18911,GO:1904566,0.999999999981287,0.92708039942867,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
8308,GO:0033132,0.999999999981331,0.879783802103245,0,2,negative regulation of glucokinase activity,BP,
18365,GO:1903300,0.999999999981331,0.879783802103245,0,2,negative regulation of hexokinase activity,BP,
18293,GO:1903126,0.999999999981392,0.933285245502622,0,1,negative regulation of centriole-centriole cohesion,BP,
20265,GO:2001173,0.999999999981392,0.933285245502622,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
18510,GO:1903589,0.999999999981424,0.871603450586513,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
3204,GO:0006842,0.999999999981429,0.74288403550059,0,4,tricarboxylic acid transport,BP,
4999,GO:0015137,0.999999999981429,0.74288403550059,0,4,citrate transmembrane transporter activity,MF,
5002,GO:0015142,0.999999999981429,0.74288403550059,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5185,GO:0015746,0.999999999981429,0.74288403550059,0,4,citrate transport,BP,
14959,GO:0070829,0.99999999998143,0.835034486567155,0,2,heterochromatin maintenance,BP,
6045,GO:0019145,0.999999999981456,0.93024733412708,0,1,aminobutyraldehyde dehydrogenase activity,MF,
8525,GO:0033737,0.999999999981456,0.93024733412708,0,1,1-pyrroline dehydrogenase activity,MF,
11971,GO:0047105,0.999999999981456,0.93024733412708,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
18254,GO:1903031,0.999999999981458,0.870423185944053,0,2,regulation of microtubule plus-end binding,BP,
18255,GO:1903033,0.999999999981458,0.870423185944053,0,2,positive regulation of microtubule plus-end binding,BP,
15493,GO:0071819,0.999999999981462,0.894957054752661,0,2,DUBm complex,CC,
13515,GO:0055056,0.999999999981475,0.679526689948344,0,5,D-glucose transmembrane transporter activity,MF,
14471,GO:0061792,0.999999999981573,0.913056829042831,0,1,secretory granule maturation,BP,
19579,GO:1990502,0.999999999981573,0.913056829042831,0,1,dense core granule maturation,BP,
8112,GO:0032792,0.999999999981578,0.752510895917718,0,4,negative regulation of CREB transcription factor activity,BP,
9406,GO:0035936,0.999999999981615,0.908767438170279,0,1,testosterone secretion,BP,
20177,GO:2000843,0.999999999981615,0.908767438170279,0,1,regulation of testosterone secretion,BP,
20178,GO:2000845,0.999999999981615,0.908767438170279,0,1,positive regulation of testosterone secretion,BP,
8043,GO:0032685,0.999999999981672,0.926494665833569,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
1673,GO:0004133,0.999999999981679,0.907072068624952,0,1,glycogen debranching enzyme activity,MF,
1674,GO:0004134,0.999999999981679,0.907072068624952,0,1,4-alpha-glucanotransferase activity,MF,
1675,GO:0004135,0.999999999981679,0.907072068624952,0,1,amylo-alpha-1,6-glucosidase activity,MF,
10297,GO:0043033,0.999999999981679,0.907072068624952,0,1,isoamylase complex,CC,
17178,GO:0102500,0.999999999981679,0.907072068624952,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
1661,GO:0004113,0.999999999981809,0.917670521191061,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1948,GO:0004648,0.999999999981834,0.933413065857835,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
7273,GO:0031247,0.999999999981888,0.868006061005013,0,2,actin rod assembly,BP,
6550,GO:0021965,0.999999999981891,0.835799115379443,0,2,spinal cord ventral commissure morphogenesis,BP,
14479,GO:0061825,0.999999999981902,0.923858698145861,0,1,podosome core,CC,
16564,GO:0097298,0.999999999981902,0.923858698145861,0,1,regulation of nucleus size,BP,
5994,GO:0018963,0.999999999981908,0.86973422162381,0,2,phthalate metabolic process,BP,
13394,GO:0052593,0.999999999981936,0.858402405018397,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13395,GO:0052594,0.999999999981936,0.858402405018397,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13396,GO:0052595,0.999999999981936,0.858402405018397,0,2,aliphatic-amine oxidase activity,MF,
13397,GO:0052596,0.999999999981936,0.858402405018397,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
13016,GO:0051414,0.999999999982068,0.667693614380427,0,5,response to cortisol,BP,
3837,GO:0008441,0.99999999998212,0.843984797181838,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
15036,GO:0070950,0.999999999982152,0.928202297577512,0,1,regulation of neutrophil mediated killing of bacterium,BP,
15037,GO:0070951,0.999999999982152,0.928202297577512,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15041,GO:0070962,0.999999999982152,0.928202297577512,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15042,GO:0070963,0.999999999982152,0.928202297577512,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16196,GO:0090198,0.999999999982152,0.928202297577512,0,1,negative regulation of chemokine secretion,BP,
16425,GO:0097029,0.999999999982152,0.928202297577512,0,1,mature conventional dendritic cell differentiation,BP,
17425,GO:1900135,0.999999999982152,0.928202297577512,0,1,positive regulation of renin secretion into blood stream,BP,
19113,GO:1904977,0.999999999982152,0.928202297577512,0,1,lymphatic endothelial cell migration,BP,
1200,GO:0002857,0.999999999982179,0.850265583420392,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1203,GO:0002860,0.999999999982179,0.850265583420392,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
840,GO:0002143,0.999999999982185,0.762878903033806,0,4,tRNA wobble position uridine thiolation,BP,
15736,GO:0072278,0.999999999982201,0.866528603571565,0,2,metanephric comma-shaped body morphogenesis,BP,
17694,GO:1901529,0.99999999998222,0.856623173873506,0,2,positive regulation of anion channel activity,BP,
7146,GO:0030976,0.999999999982244,0.681544010570974,0,5,thiamine pyrophosphate binding,MF,
19121,GO:1904995,0.999999999982302,0.890843171104422,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
6482,GO:0021822,0.999999999982367,0.933209496744976,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
19661,GO:1990796,0.99999999998239,0.927890628169575,0,1,photoreceptor cell terminal bouton,CC,
15848,GO:0072534,0.999999999982413,0.901982745194238,0,1,perineuronal net,CC,
5547,GO:0016533,0.999999999982416,0.87872853550574,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
1921,GO:0004611,0.999999999982459,0.935147637786083,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1922,GO:0004613,0.999999999982459,0.935147637786083,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
6179,GO:0019543,0.999999999982459,0.935147637786083,0,1,propionate catabolic process,BP,
11639,GO:0046327,0.999999999982459,0.935147637786083,0,1,glycerol biosynthetic process from pyruvate,BP,
13606,GO:0060053,0.999999999982547,0.846144296491985,0,2,neurofilament cytoskeleton,CC,
16800,GO:0098594,0.999999999982593,0.962185475495869,0,1,mucin granule,CC,
1817,GO:0004464,0.999999999982594,0.926407793637854,0,2,leukotriene-C4 synthase activity,MF,
885,GO:0002248,0.99999999998272,0.699035625775448,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
17518,GO:1900453,0.999999999982727,0.872321502951292,0,2,negative regulation of long term synaptic depression,BP,
7350,GO:0031372,0.999999999982738,0.876373003440023,0,2,UBC13-MMS2 complex,CC,
14957,GO:0070827,0.999999999982765,0.710061445047411,0,4,chromatin maintenance,BP,
9432,GO:0035990,0.999999999982785,0.8703139449523,0,2,tendon cell differentiation,BP,
9433,GO:0035992,0.999999999982785,0.8703139449523,0,2,tendon formation,BP,
15872,GO:0072572,0.999999999982804,0.93321452481561,0,1,poly-ADP-D-ribose binding,MF,
7205,GO:0031089,0.999999999982856,0.697620464624474,0,5,platelet dense granule lumen,CC,
6976,GO:0030626,0.999999999982878,0.865208175826871,0,2,U12 snRNA binding,MF,
11512,GO:0045976,0.999999999982885,0.855408591906883,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
1236,GO:0002921,0.999999999982997,0.677713176669233,0,5,negative regulation of humoral immune response,BP,
4613,GO:0010728,0.999999999983001,0.738301708834712,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
6139,GO:0019402,0.999999999983012,0.94571975209608,0,1,galactitol metabolic process,BP,
14396,GO:0061623,0.999999999983012,0.94571975209608,0,1,glycolytic process from galactose,BP,
7663,GO:0032079,0.999999999983034,0.763845023616156,0,4,positive regulation of endodeoxyribonuclease activity,BP,
3981,GO:0008803,0.999999999983102,0.955076528108651,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
20204,GO:2001013,0.999999999983151,0.842916698456713,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
17107,GO:0099609,0.999999999983216,0.836067423363441,0,2,microtubule lateral binding,MF,
1957,GO:0004658,0.9999999999833,0.871943236101547,0,2,propionyl-CoA carboxylase activity,MF,
19226,GO:1905286,0.999999999983355,0.867005556761902,0,2,serine-type peptidase complex,CC,
4444,GO:0010335,0.999999999983368,0.921335138568285,0,1,response to non-ionic osmotic stress,BP,
8560,GO:0033925,0.999999999983368,0.921335138568285,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
15304,GO:0071471,0.999999999983368,0.921335138568285,0,1,cellular response to non-ionic osmotic stress,BP,
10325,GO:0043096,0.999999999983462,0.744813962871653,0,5,purine nucleobase salvage,BP,
245,GO:0000701,0.999999999983528,0.886494815147841,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
1092,GO:0002677,0.999999999983573,0.866619706478373,0,2,negative regulation of chronic inflammatory response,BP,
12808,GO:0051083,0.999999999983646,0.874632788193855,0,2,'de novo' cotranslational protein folding,BP,
16947,GO:0098904,0.999999999983653,0.862469723173287,0,2,regulation of AV node cell action potential,BP,
1220,GO:0002887,0.999999999983665,0.727496501343016,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
19248,GO:1905335,0.999999999983669,0.875092657660892,0,1,regulation of aggrephagy,BP,
19249,GO:1905337,0.999999999983669,0.875092657660892,0,1,positive regulation of aggrephagy,BP,
9179,GO:0035526,0.999999999983691,0.848463880231894,0,2,retrograde transport, plasma membrane to Golgi,BP,
4334,GO:0009881,0.99999999998372,0.737098056698268,0,4,photoreceptor activity,MF,
3485,GO:0007352,0.999999999983757,0.890370834391641,0,1,zygotic specification of dorsal/ventral axis,BP,
17469,GO:1900224,0.999999999983757,0.890370834391641,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
19927,GO:2000382,0.999999999983757,0.890370834391641,0,1,positive regulation of mesoderm development,BP,
1248,GO:0002945,0.999999999983804,0.846928765280253,0,2,cyclin K-CDK13 complex,CC,
17242,GO:0106088,0.999999999983925,0.90885213437015,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17243,GO:0106089,0.999999999983925,0.90885213437015,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17289,GO:0120077,0.999999999983925,0.90885213437015,0,1,angiogenic sprout fusion,BP,
17290,GO:0120078,0.999999999983925,0.90885213437015,0,1,cell adhesion involved in sprouting angiogenesis,BP,
14086,GO:0060844,0.999999999983925,0.862645733948325,0,2,arterial endothelial cell fate commitment,BP,
1763,GO:0004363,0.999999999983941,0.935927499599414,0,1,glutathione synthase activity,MF,
4853,GO:0014063,0.999999999983945,0.950333976302033,0,1,negative regulation of serotonin secretion,BP,
14300,GO:0061355,0.999999999983961,0.740754434744988,0,4,Wnt protein secretion,BP,
14301,GO:0061356,0.999999999983961,0.740754434744988,0,4,regulation of Wnt protein secretion,BP,
2054,GO:0004801,0.999999999984018,0.948464925621092,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2320,GO:0005324,0.99999999998402,0.861757937809645,0,2,long-chain fatty acid transporter activity,MF,
5268,GO:0015910,0.99999999998402,0.861757937809645,0,2,peroxisomal long-chain fatty acid import,BP,
17247,GO:0110008,0.999999999984021,0.92740321617767,0,1,ncRNA deadenylation,BP,
20042,GO:2000620,0.999999999984034,0.82924865780642,0,2,positive regulation of histone H4-K16 acetylation,BP,
1775,GO:0004377,0.999999999984058,0.930062362518734,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1049,GO:0002572,0.999999999984082,0.856547006174308,0,2,pro-T cell differentiation,BP,
18586,GO:1903778,0.9999999999841,0.847405082789552,0,2,protein localization to vacuolar membrane,BP,
13094,GO:0051582,0.999999999984253,0.877848804822707,0,2,positive regulation of neurotransmitter uptake,BP,
16309,GO:0090386,0.999999999984266,0.834133913709847,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16310,GO:0090387,0.999999999984266,0.834133913709847,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
1725,GO:0004314,0.999999999984282,0.842175851167221,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5488,GO:0016419,0.999999999984282,0.842175851167221,0,2,S-malonyltransferase activity,MF,
5489,GO:0016420,0.999999999984282,0.842175851167221,0,2,malonyltransferase activity,MF,
5469,GO:0016362,0.999999999984321,0.781390508156103,0,2,activin receptor activity, type II,MF,
18091,GO:1902626,0.999999999984324,0.869484388079257,0,3,assembly of large subunit precursor of preribosome,BP,
7173,GO:0031048,0.999999999984333,0.855033406004276,0,2,chromatin silencing by small RNA,BP,
9100,GO:0035356,0.999999999984639,0.715019537857198,0,5,cellular triglyceride homeostasis,BP,
11550,GO:0046061,0.999999999984647,0.840697123277686,0,3,dATP catabolic process,BP,
14395,GO:0061622,0.999999999984656,0.876407475449599,0,2,glycolytic process through glucose-1-phosphate,BP,
17214,GO:0106014,0.999999999984657,0.877876268409021,0,2,regulation of inflammatory response to wounding,BP,
17215,GO:0106015,0.999999999984657,0.877876268409021,0,2,negative regulation of inflammatory response to wounding,BP,
9147,GO:0035482,0.999999999984696,0.902120354321555,0,2,gastric motility,BP,
19247,GO:1905333,0.999999999984696,0.902120354321555,0,2,regulation of gastric motility,BP,
19218,GO:1905271,0.999999999984699,0.965599362084703,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19219,GO:1905273,0.999999999984699,0.965599362084703,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
4282,GO:0009646,0.999999999984705,0.926384138328269,0,1,response to absence of light,BP,
6960,GO:0030586,0.999999999984705,0.926384138328269,0,1,[methionine synthase] reductase activity,MF,
7352,GO:0031380,0.999999999984705,0.926384138328269,0,1,nuclear RNA-directed RNA polymerase complex,CC,
12505,GO:0050444,0.999999999984705,0.926384138328269,0,1,aquacobalamin reductase (NADPH) activity,MF,
15317,GO:0071485,0.999999999984705,0.926384138328269,0,1,cellular response to absence of light,BP,
18715,GO:1904041,0.999999999984705,0.926384138328269,0,1,regulation of cystathionine beta-synthase activity,BP,
18716,GO:1904042,0.999999999984705,0.926384138328269,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19605,GO:1990603,0.999999999984705,0.926384138328269,0,1,dark adaptation,BP,
10839,GO:0044323,0.999999999984745,0.848500178980843,0,2,retinoic acid-responsive element binding,MF,
16576,GO:0097338,0.99999999998475,0.921387566840412,0,1,response to clozapine,BP,
15900,GO:0072611,0.999999999984797,0.693091232572957,0,5,interleukin-13 secretion,BP,
20076,GO:2000665,0.999999999984797,0.693091232572957,0,5,regulation of interleukin-13 secretion,BP,
19010,GO:1904768,0.999999999984824,0.881379556854525,0,2,all-trans-retinol binding,MF,
1983,GO:0004698,0.99999999998484,0.898874032219126,0,1,calcium-dependent protein kinase C activity,MF,
9120,GO:0035403,0.99999999998484,0.898874032219126,0,1,histone kinase activity (H3-T6 specific),MF,
9125,GO:0035408,0.99999999998484,0.898874032219126,0,1,histone H3-T6 phosphorylation,BP,
20103,GO:2000707,0.99999999998484,0.898874032219126,0,1,positive regulation of dense core granule biogenesis,BP,
17704,GO:1901551,0.999999999984845,0.922695568862632,0,1,negative regulation of endothelial cell development,BP,
18298,GO:1903141,0.999999999984845,0.922695568862632,0,1,negative regulation of establishment of endothelial barrier,BP,
15742,GO:0072289,0.999999999984871,0.853745049207975,0,2,metanephric nephron tubule formation,BP,
11183,GO:0045234,0.999999999984891,0.937665326824826,0,1,protein palmitoleylation,BP,
14492,GO:0061857,0.999999999984913,0.857674102949001,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
1653,GO:0004098,0.999999999984918,0.935967658933333,0,1,cerebroside-sulfatase activity,MF,
660,GO:0001849,0.999999999984925,0.832131985541149,0,3,complement component C1q binding,MF,
17491,GO:1900275,0.999999999984931,0.847507253003019,0,2,negative regulation of phospholipase C activity,BP,
9719,GO:0038114,0.999999999984949,0.715690437612956,0,4,interleukin-21-mediated signaling pathway,BP,
16866,GO:0098756,0.999999999984949,0.715690437612956,0,4,response to interleukin-21,BP,
16867,GO:0098757,0.999999999984949,0.715690437612956,0,4,cellular response to interleukin-21,BP,
16575,GO:0097332,0.999999999985025,0.880622945162797,0,2,response to antipsychotic drug,BP,
10849,GO:0044334,0.999999999985112,0.855138462608937,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
16184,GO:0090186,0.999999999985132,0.656541018940471,0,5,regulation of pancreatic juice secretion,BP,
9172,GO:0035519,0.999999999985141,0.782957011455555,0,4,protein K29-linked ubiquitination,BP,
1732,GO:0004324,0.999999999985153,0.93604840892831,0,1,ferredoxin-NADP+ reductase activity,MF,
4966,GO:0015039,0.999999999985153,0.93604840892831,0,1,NADPH-adrenodoxin reductase activity,MF,
5647,GO:0016730,0.999999999985153,0.93604840892831,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5648,GO:0016731,0.999999999985153,0.93604840892831,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
198,GO:0000416,0.999999999985208,0.92466699873713,0,1,positive regulation of histone H3-K36 methylation,BP,
18613,GO:1903837,0.999999999985309,0.93045841066115,0,1,regulation of mRNA 3'-UTR binding,BP,
18614,GO:1903839,0.999999999985309,0.93045841066115,0,1,positive regulation of mRNA 3'-UTR binding,BP,
14282,GO:0061317,0.999999999985353,0.872990683091265,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17632,GO:1901295,0.999999999985353,0.872990683091265,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19153,GO:1905066,0.999999999985353,0.872990683091265,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
1726,GO:0004315,0.999999999985435,0.853285973872334,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
16756,GO:0097753,0.999999999985464,0.924378199573575,0,1,membrane bending,BP,
5826,GO:0017095,0.999999999985506,0.851061269807752,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
15699,GO:0072205,0.999999999985521,0.63211950509137,0,5,metanephric collecting duct development,BP,
7662,GO:0032077,0.999999999985528,0.722811015731739,0,5,positive regulation of deoxyribonuclease activity,BP,
17453,GO:1900195,0.999999999985581,0.872077647748619,0,2,positive regulation of oocyte maturation,BP,
18595,GO:1903796,0.999999999985619,0.834293111531472,0,2,negative regulation of inorganic anion transmembrane transport,BP,
7492,GO:0031651,0.999999999985638,0.922863351560114,0,1,negative regulation of heat generation,BP,
7519,GO:0031699,0.999999999985638,0.922863351560114,0,1,beta-3 adrenergic receptor binding,MF,
14472,GO:0061798,0.999999999985638,0.922863351560114,0,1,GTP 3',8'-cyclase activity,MF,
14473,GO:0061799,0.999999999985638,0.922863351560114,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
16286,GO:0090327,0.999999999985638,0.922863351560114,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
3939,GO:0008623,0.999999999985672,0.8503270561638,0,2,CHRAC,CC,
18179,GO:1902897,0.999999999985682,0.861778558203143,0,2,regulation of postsynaptic density protein 95 clustering,BP,
19414,GO:1905874,0.999999999985682,0.861778558203143,0,2,regulation of postsynaptic density organization,BP,
2421,GO:0005594,0.999999999985689,0.863516618674223,0,2,collagen type IX trimer,CC,
1301,GO:0003131,0.999999999985699,0.928447894182352,0,1,mesodermal-endodermal cell signaling,BP,
7174,GO:0031049,0.999999999985699,0.928447894182352,0,1,programmed DNA elimination,BP,
7176,GO:0031052,0.999999999985699,0.928447894182352,0,1,chromosome breakage,BP,
9157,GO:0035501,0.999999999985699,0.928447894182352,0,1,MH1 domain binding,MF,
9423,GO:0035978,0.999999999985699,0.928447894182352,0,1,histone H2A-S139 phosphorylation,BP,
20091,GO:2000685,0.999999999985699,0.928447894182352,0,1,positive regulation of cellular response to X-ray,BP,
19435,GO:1905936,0.999999999985723,0.914171544345897,0,2,regulation of germ cell proliferation,BP,
19839,GO:2000254,0.999999999985723,0.914171544345897,0,2,regulation of male germ cell proliferation,BP,
19265,GO:1905371,0.99999999998573,0.860442020392808,0,2,ceramide phosphoethanolamine metabolic process,BP,
19266,GO:1905373,0.99999999998573,0.860442020392808,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
5812,GO:0017064,0.999999999985752,0.933574330658039,0,1,fatty acid amide hydrolase activity,MF,
17143,GO:0102077,0.999999999985752,0.933574330658039,0,1,oleamide hydrolase activity,MF,
17207,GO:0103073,0.999999999985752,0.933574330658039,0,1,anandamide amidohydrolase activity,MF,
13153,GO:0051694,0.999999999985767,0.837333810448842,0,2,pointed-end actin filament capping,BP,
13257,GO:0051901,0.999999999985794,0.743555533106351,0,5,positive regulation of mitochondrial depolarization,BP,
1367,GO:0003249,0.999999999985805,0.793033281639033,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1368,GO:0003250,0.999999999985805,0.793033281639033,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
20148,GO:2000793,0.999999999985805,0.793033281639033,0,2,cell proliferation involved in heart valve development,BP,
5914,GO:0018153,0.999999999985821,0.866177681559813,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5945,GO:0018262,0.999999999985821,0.866177681559813,0,2,isopeptide cross-linking,BP,
15586,GO:0072019,0.999999999985844,0.933224590297686,0,1,proximal convoluted tubule development,BP,
15714,GO:0072229,0.999999999985844,0.933224590297686,0,1,metanephric proximal convoluted tubule development,BP,
18163,GO:1902858,0.999999999985844,0.933224590297686,0,1,propionyl-CoA metabolic process,BP,
18164,GO:1902860,0.999999999985844,0.933224590297686,0,1,propionyl-CoA biosynthetic process,BP,
6890,GO:0030389,0.999999999985875,0.963894460750557,0,1,fructosamine metabolic process,BP,
11826,GO:0046696,0.999999999985893,0.863787288953501,0,2,lipopolysaccharide receptor complex,CC,
1718,GO:0004307,0.999999999985918,0.888100513272911,0,2,ethanolaminephosphotransferase activity,MF,
5952,GO:0018293,0.999999999985956,0.949414515027396,0,1,protein-FAD linkage,BP,
663,GO:0001855,0.999999999986018,0.941130306479014,0,1,complement component C4b binding,MF,
4571,GO:0010650,0.999999999986026,0.892903177904488,0,1,positive regulation of cell communication by electrical coupling,BP,
15910,GO:0072658,0.999999999986026,0.892903177904488,0,1,maintenance of protein location in membrane,BP,
15912,GO:0072660,0.999999999986026,0.892903177904488,0,1,maintenance of protein location in plasma membrane,BP,
17544,GO:1900827,0.999999999986026,0.892903177904488,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
7149,GO:0030984,0.999999999986083,0.88214666310058,0,2,kininogen binding,MF,
11503,GO:0045950,0.999999999986119,0.86359063009314,0,2,negative regulation of mitotic recombination,BP,
7101,GO:0030891,0.99999999998612,0.769609011483227,0,4,VCB complex,CC,
7648,GO:0032053,0.99999999998612,0.84443676629493,0,2,ciliary basal body organization,BP,
12224,GO:0048387,0.999999999986153,0.683064520019566,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
10970,GO:0044715,0.999999999986219,0.894684818954433,0,2,8-oxo-dGDP phosphatase activity,MF,
16430,GO:0097039,0.999999999986265,0.664094386132216,0,5,protein linear polyubiquitination,BP,
3968,GO:0008753,0.99999999998627,0.925742616228879,0,1,NADPH dehydrogenase (quinone) activity,MF,
9340,GO:0035811,0.999999999986273,0.912233654309183,0,1,negative regulation of urine volume,BP,
772,GO:0002024,0.999999999986273,0.684846094515127,0,5,diet induced thermogenesis,BP,
12491,GO:0050353,0.999999999986282,0.92830364656328,0,1,trimethyllysine dioxygenase activity,MF,
16589,GO:0097360,0.999999999986338,0.846477913236081,0,2,chorionic trophoblast cell proliferation,BP,
17671,GO:1901382,0.999999999986338,0.846477913236081,0,2,regulation of chorionic trophoblast cell proliferation,BP,
7384,GO:0031431,0.999999999986379,0.857883409384528,0,2,Dbf4-dependent protein kinase complex,CC,
517,GO:0001582,0.999999999986384,0.929913564771097,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
8268,GO:0033041,0.999999999986384,0.929913564771097,0,1,sweet taste receptor activity,MF,
10673,GO:0043843,0.999999999986384,0.929913564771097,0,1,ADP-specific glucokinase activity,MF,
18580,GO:1903767,0.999999999986384,0.929913564771097,0,1,sweet taste receptor complex,CC,
18581,GO:1903768,0.999999999986384,0.929913564771097,0,1,taste receptor complex,CC,
2242,GO:0005150,0.999999999986422,0.867532652742153,0,2,interleukin-1, Type I receptor binding,MF,
5830,GO:0017102,0.999999999986441,0.861965055298615,0,2,methionyl glutamyl tRNA synthetase complex,CC,
18903,GO:1904535,0.999999999986465,0.920942987102468,0,1,positive regulation of telomeric loop disassembly,BP,
11997,GO:0047288,0.999999999986479,0.864665188069707,0,2,monosialoganglioside sialyltransferase activity,MF,
349,GO:0000962,0.999999999986586,0.856725475935862,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
11058,GO:0045025,0.999999999986586,0.856725475935862,0,2,mitochondrial degradosome,CC,
5501,GO:0016436,0.999999999986617,0.858161201100345,0,2,rRNA (uridine) methyltransferase activity,MF,
18769,GO:1904210,0.999999999986644,0.945207981178336,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18786,GO:1904239,0.999999999986644,0.945207981178336,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18787,GO:1904240,0.999999999986644,0.945207981178336,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
15430,GO:0071676,0.999999999986647,0.858563212110457,0,2,negative regulation of mononuclear cell migration,BP,
16088,GO:0090027,0.999999999986647,0.858563212110457,0,2,negative regulation of monocyte chemotaxis,BP,
1601,GO:0004017,0.999999999986661,0.684028318428535,0,5,adenylate kinase activity,MF,
15298,GO:0071462,0.999999999986706,0.849831688838673,0,2,cellular response to water stimulus,BP,
9649,GO:0036509,0.999999999986707,0.869230872987253,0,2,trimming of terminal mannose on B branch,BP,
9651,GO:0036511,0.999999999986707,0.869230872987253,0,2,trimming of first mannose on A branch,BP,
9652,GO:0036512,0.999999999986707,0.869230872987253,0,2,trimming of second mannose on A branch,BP,
4922,GO:0014858,0.999999999986756,0.842924812485784,0,2,positive regulation of skeletal muscle cell proliferation,BP,
18119,GO:1902724,0.999999999986756,0.842924812485784,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18121,GO:1902728,0.999999999986756,0.842924812485784,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
8164,GO:0032887,0.999999999986775,0.907103690693868,0,1,regulation of spindle elongation,BP,
8165,GO:0032888,0.999999999986775,0.907103690693868,0,1,regulation of mitotic spindle elongation,BP,
13510,GO:0055028,0.999999999986775,0.907103690693868,0,1,cortical microtubule,CC,
13514,GO:0055048,0.999999999986775,0.907103690693868,0,1,anastral spindle assembly,BP,
15572,GO:0071988,0.999999999986775,0.907103690693868,0,1,protein localization to spindle pole body,BP,
17257,GO:0110028,0.999999999986775,0.907103690693868,0,1,positive regulation of mitotic spindle organization,BP,
17994,GO:1902363,0.999999999986775,0.907103690693868,0,1,regulation of protein localization to spindle pole body,BP,
17995,GO:1902365,0.999999999986775,0.907103690693868,0,1,positive regulation of protein localization to spindle pole body,BP,
18157,GO:1902846,0.999999999986775,0.907103690693868,0,1,positive regulation of mitotic spindle elongation,BP,
19383,GO:1905720,0.999999999986775,0.907103690693868,0,1,cytoplasmic microtubule bundle,CC,
1536,GO:0003918,0.999999999986784,0.839644958496952,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
14347,GO:0061505,0.999999999986784,0.839644958496952,0,2,DNA topoisomerase II activity,MF,
5487,GO:0016418,0.999999999986787,0.830132254467473,0,2,S-acetyltransferase activity,MF,
18351,GO:1903279,0.999999999986801,0.862276734368989,0,2,regulation of calcium:sodium antiporter activity,BP,
18352,GO:1903281,0.999999999986801,0.862276734368989,0,2,positive regulation of calcium:sodium antiporter activity,BP,
18161,GO:1902856,0.999999999986825,0.849134683357862,0,2,negative regulation of non-motile cilium assembly,BP,
16284,GO:0090325,0.999999999986839,0.854912395771909,0,2,regulation of locomotion involved in locomotory behavior,BP,
4852,GO:0014062,0.999999999986856,0.875371351300047,0,2,regulation of serotonin secretion,BP,
3932,GO:0008611,0.999999999986857,0.687441618751398,0,5,ether lipid biosynthetic process,BP,
11727,GO:0046504,0.999999999986857,0.687441618751398,0,5,glycerol ether biosynthetic process,BP,
17686,GO:1901503,0.999999999986857,0.687441618751398,0,5,ether biosynthetic process,BP,
7847,GO:0032398,0.99999999998688,0.939416164695563,0,1,MHC class Ib protein complex,CC,
8015,GO:0032639,0.99999999998688,0.939416164695563,0,1,TRAIL production,BP,
8039,GO:0032679,0.99999999998688,0.939416164695563,0,1,regulation of TRAIL production,BP,
8084,GO:0032759,0.99999999998688,0.939416164695563,0,1,positive regulation of TRAIL production,BP,
20012,GO:2000566,0.99999999998688,0.939416164695563,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20276,GO:2001187,0.99999999998688,0.939416164695563,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
2190,GO:0005046,0.999999999986908,0.874736248399218,0,2,KDEL sequence binding,MF,
6404,GO:0021615,0.999999999986916,0.926544051546764,0,1,glossopharyngeal nerve morphogenesis,BP,
1320,GO:0003165,0.999999999986918,0.915315662292814,0,1,Purkinje myocyte development,BP,
17846,GO:1901979,0.99999999998695,0.829152456328344,0,2,regulation of inward rectifier potassium channel activity,BP,
3094,GO:0006668,0.999999999986955,0.85945447470453,0,2,sphinganine-1-phosphate metabolic process,BP,
7509,GO:0031682,0.999999999986972,0.92746539037546,0,1,G-protein gamma-subunit binding,MF,
18140,GO:1902773,0.999999999986972,0.92746539037546,0,1,GTPase activator complex,CC,
15626,GO:0072095,0.999999999987007,0.855526442737104,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
3021,GO:0006567,0.999999999987026,0.889279669248245,0,2,threonine catabolic process,BP,
20038,GO:2000616,0.999999999987034,0.859394645493201,0,2,negative regulation of histone H3-K9 acetylation,BP,
15490,GO:0071816,0.999999999987045,0.760954023368923,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
7884,GO:0032444,0.99999999998705,0.800347612714589,0,2,activin responsive factor complex,CC,
7577,GO:0031933,0.999999999987074,0.777510085803194,0,3,telomeric heterochromatin,CC,
14197,GO:0061073,0.999999999987114,0.8486645918816,0,2,ciliary body morphogenesis,BP,
5984,GO:0018773,0.999999999987124,0.939398852466942,0,1,acetylpyruvate hydrolase activity,MF,
8818,GO:0034545,0.999999999987124,0.939398852466942,0,1,fumarylpyruvate hydrolase activity,MF,
12036,GO:0047621,0.999999999987124,0.939398852466942,0,1,acylpyruvate hydrolase activity,MF,
13384,GO:0052550,0.999999999987124,0.939398852466942,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13390,GO:0052567,0.999999999987124,0.939398852466942,0,1,response to defense-related host reactive oxygen species production,BP,
6872,GO:0030337,0.999999999987133,0.87828220702357,0,2,DNA polymerase processivity factor activity,MF,
4880,GO:0014740,0.999999999987149,0.863475357838813,0,2,negative regulation of muscle hyperplasia,BP,
19696,GO:1990923,0.999999999987171,0.857622783741123,0,2,PET complex,CC,
6889,GO:0030388,0.999999999987173,0.76164170428801,0,4,fructose 1,6-bisphosphate metabolic process,BP,
10017,GO:0042426,0.999999999987209,0.852279930943816,0,2,choline catabolic process,BP,
12674,GO:0050859,0.999999999987235,0.805752111033004,0,3,negative regulation of B cell receptor signaling pathway,BP,
19566,GO:1990441,0.999999999987241,0.748963777738234,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
4425,GO:0010232,0.999999999987246,0.927082549588172,0,1,vascular transport,BP,
13669,GO:0060156,0.999999999987246,0.927082549588172,0,1,milk ejection reflex,BP,
18396,GO:1903367,0.999999999987246,0.927082549588172,0,1,positive regulation of fear response,BP,
20202,GO:2000987,0.999999999987246,0.927082549588172,0,1,positive regulation of behavioral fear response,BP,
8392,GO:0033290,0.999999999987248,0.922850172319612,0,1,eukaryotic 48S preinitiation complex,CC,
10771,GO:0044207,0.999999999987248,0.922850172319612,0,1,translation initiation ternary complex,CC,
18985,GO:1904720,0.999999999987266,0.863143552163845,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
558,GO:0001681,0.999999999987274,0.928376714447974,0,1,sialate O-acetylesterase activity,MF,
3649,GO:0008126,0.999999999987274,0.928376714447974,0,1,acetylesterase activity,MF,
10138,GO:0042663,0.9999999999873,0.871490732240405,0,2,regulation of endodermal cell fate specification,BP,
11655,GO:0046356,0.999999999987309,0.890715112715805,0,2,acetyl-CoA catabolic process,BP,
6451,GO:0021764,0.999999999987315,0.802169507426173,0,2,amygdala development,BP,
18433,GO:1903435,0.999999999987346,0.928576914974603,0,1,positive regulation of constitutive secretory pathway,BP,
18805,GO:1904289,0.999999999987356,0.854558365293102,0,2,regulation of mitotic DNA damage checkpoint,BP,
6553,GO:0021978,0.99999999998736,0.690909553332509,0,5,telencephalon regionalization,BP,
6003,GO:0019034,0.999999999987373,0.847484989223877,0,2,viral replication complex,CC,
18770,GO:1904211,0.999999999987392,0.861637350265411,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
1740,GO:0004335,0.999999999987404,0.876580402333778,0,2,galactokinase activity,MF,
16023,GO:0086015,0.999999999987409,0.836349945121835,0,2,SA node cell action potential,BP,
16026,GO:0086018,0.999999999987409,0.836349945121835,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
13166,GO:0051715,0.999999999987426,0.864286390504983,0,3,cytolysis in other organism,BP,
8460,GO:0033590,0.999999999987478,0.813634041586896,0,3,response to cobalamin,BP,
12706,GO:0050904,0.999999999987551,0.847056286875872,0,2,diapedesis,BP,
17563,GO:1901069,0.999999999987554,0.890128331484203,0,2,guanosine-containing compound catabolic process,BP,
9927,GO:0042262,0.999999999987566,0.762102686426963,0,5,DNA protection,BP,
8123,GO:0032803,0.999999999987607,0.706965618984529,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
7116,GO:0030910,0.999999999987635,0.844799145990079,0,2,olfactory placode formation,BP,
15445,GO:0071698,0.999999999987635,0.844799145990079,0,2,olfactory placode development,BP,
15446,GO:0071699,0.999999999987635,0.844799145990079,0,2,olfactory placode morphogenesis,BP,
12329,GO:0048664,0.999999999987685,0.833894620655823,0,3,neuron fate determination,BP,
8473,GO:0033604,0.99999999998769,0.852307656437747,0,2,negative regulation of catecholamine secretion,BP,
7367,GO:0031404,0.99999999998771,0.804547984304523,0,3,chloride ion binding,MF,
19116,GO:1904980,0.999999999987726,0.907683880895031,0,1,positive regulation of endosome organization,BP,
1507,GO:0003858,0.999999999987727,0.859286715132824,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
2626,GO:0005947,0.99999999998773,0.684143759661492,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
14554,GO:0070052,0.999999999987738,0.847685207491471,0,2,collagen V binding,MF,
3487,GO:0007356,0.999999999987754,0.869794541692625,0,2,thorax and anterior abdomen determination,BP,
20237,GO:2001074,0.999999999987754,0.869794541692625,0,2,regulation of metanephric ureteric bud development,BP,
20238,GO:2001076,0.999999999987754,0.869794541692625,0,2,positive regulation of metanephric ureteric bud development,BP,
2738,GO:0006117,0.999999999987778,0.929795374685065,0,1,acetaldehyde metabolic process,BP,
9178,GO:0035525,0.999999999987778,0.929795374685065,0,1,NF-kappaB p50/p65 complex,CC,
10943,GO:0044565,0.999999999987798,0.875591821483901,0,2,dendritic cell proliferation,BP,
1246,GO:0002943,0.999999999987815,0.760043188819225,0,4,tRNA dihydrouridine synthesis,BP,
5856,GO:0017150,0.999999999987815,0.760043188819225,0,4,tRNA dihydrouridine synthase activity,MF,
835,GO:0002127,0.999999999987822,0.944122748678819,0,1,tRNA wobble base cytosine methylation,BP,
1249,GO:0002946,0.999999999987822,0.944122748678819,0,1,tRNA C5-cytosine methylation,BP,
11818,GO:0046684,0.999999999987832,0.860341650536867,0,2,response to pyrethroid,BP,
14076,GO:0060830,0.999999999987835,0.813775840378493,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
6442,GO:0021730,0.999999999987848,0.902086798028365,0,1,trigeminal sensory nucleus development,BP,
6443,GO:0021740,0.999999999987848,0.902086798028365,0,1,principal sensory nucleus of trigeminal nerve development,BP,
14230,GO:0061141,0.999999999987848,0.902086798028365,0,1,lung ciliated cell differentiation,BP,
20150,GO:2000795,0.999999999987848,0.902086798028365,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
6345,GO:0021516,0.999999999987878,0.851658384375545,0,2,dorsal spinal cord development,BP,
2764,GO:0006177,0.999999999987896,0.718338302564418,0,5,GMP biosynthetic process,BP,
847,GO:0002159,0.999999999987905,0.712507628657255,0,4,desmosome assembly,BP,
11510,GO:0045967,0.999999999987907,0.793330613252122,0,2,negative regulation of growth rate,BP,
6466,GO:0021784,0.999999999987916,0.964015408921044,0,1,postganglionic parasympathetic fiber development,BP,
18865,GO:1904430,0.999999999987959,0.791276946248917,0,3,negative regulation of t-circle formation,BP,
8186,GO:0032916,0.999999999987994,0.81697325042445,0,2,positive regulation of transforming growth factor beta3 production,BP,
1603,GO:0004019,0.999999999988014,0.928771608406428,0,1,adenylosuccinate synthase activity,MF,
13982,GO:0060668,0.999999999988073,0.925090744548782,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
1356,GO:0003221,0.999999999988094,0.8902345617171,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1359,GO:0003226,0.999999999988094,0.8902345617171,0,1,right ventricular compact myocardium morphogenesis,BP,
6372,GO:0021553,0.999999999988094,0.8902345617171,0,1,olfactory nerve development,BP,
2050,GO:0004795,0.999999999988115,0.933469935691838,0,1,threonine synthase activity,MF,
4051,GO:0009088,0.999999999988115,0.933469935691838,0,1,threonine biosynthetic process,BP,
11657,GO:0046360,0.999999999988115,0.933469935691838,0,1,2-oxobutyrate biosynthetic process,BP,
11658,GO:0046361,0.999999999988115,0.933469935691838,0,1,2-oxobutyrate metabolic process,BP,
19157,GO:1905071,0.999999999988124,0.844871833142114,0,2,occluding junction disassembly,BP,
19158,GO:1905073,0.999999999988124,0.844871833142114,0,2,regulation of occluding junction disassembly,BP,
19159,GO:1905075,0.999999999988124,0.844871833142114,0,2,positive regulation of occluding junction disassembly,BP,
1655,GO:0004104,0.99999999998813,0.864707962080609,0,2,cholinesterase activity,MF,
8377,GO:0033265,0.99999999998813,0.864707962080609,0,2,choline binding,MF,
7396,GO:0031443,0.999999999988217,0.908791257131715,0,1,fast-twitch skeletal muscle fiber contraction,BP,
1935,GO:0004631,0.999999999988231,0.947207638488492,0,1,phosphomevalonate kinase activity,MF,
15238,GO:0071374,0.999999999988242,0.832295524560184,0,2,cellular response to parathyroid hormone stimulus,BP,
3528,GO:0007512,0.999999999988252,0.665353652693614,0,5,adult heart development,BP,
5960,GO:0018335,0.999999999988262,0.734319679574712,0,4,protein succinylation,BP,
17239,GO:0106077,0.999999999988262,0.734319679574712,0,4,histone succinylation,BP,
4911,GO:0014843,0.999999999988266,0.909387200699076,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
10135,GO:0042660,0.999999999988266,0.909387200699076,0,1,positive regulation of cell fate specification,BP,
14055,GO:0060764,0.999999999988272,0.868955089600081,0,2,cell-cell signaling involved in mammary gland development,BP,
3612,GO:0008057,0.999999999988284,0.905809273572357,0,1,eye pigment granule organization,BP,
6529,GO:0021914,0.999999999988329,0.859017332879835,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
12523,GO:0050613,0.999999999988338,0.869891212730107,0,2,delta14-sterol reductase activity,MF,
19374,GO:1905696,0.999999999988344,0.844839745306657,0,2,regulation of polysome binding,BP,
19117,GO:1904983,0.999999999988346,0.93335658137786,0,1,glycine import into mitochondrion,BP,
8402,GO:0033316,0.999999999988361,0.927496616637908,0,1,meiotic spindle assembly checkpoint,BP,
10994,GO:0044779,0.999999999988361,0.927496616637908,0,1,meiotic spindle checkpoint,BP,
10998,GO:0044785,0.999999999988361,0.927496616637908,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
17893,GO:1902102,0.999999999988361,0.927496616637908,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17894,GO:1902103,0.999999999988361,0.927496616637908,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
18285,GO:1903096,0.999999999988361,0.927496616637908,0,1,protein localization to meiotic spindle midzone,BP,
19170,GO:1905132,0.999999999988361,0.927496616637908,0,1,regulation of meiotic chromosome separation,BP,
19171,GO:1905133,0.999999999988361,0.927496616637908,0,1,negative regulation of meiotic chromosome separation,BP,
19258,GO:1905359,0.999999999988361,0.927496616637908,0,1,protein localization to meiotic spindle,BP,
11078,GO:0045062,0.999999999988366,0.938904498198895,0,1,extrathymic T cell selection,BP,
15080,GO:0071021,0.999999999988366,0.938904498198895,0,1,U2-type post-spliceosomal complex,CC,
1621,GO:0004047,0.999999999988367,0.880389567711858,0,2,aminomethyltransferase activity,MF,
12006,GO:0047341,0.999999999988379,0.925853547700976,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
11455,GO:0045875,0.999999999988459,0.641837170310991,0,5,negative regulation of sister chromatid cohesion,BP,
2324,GO:0005330,0.999999999988468,0.92112422324582,0,1,dopamine:sodium symporter activity,MF,
2326,GO:0005335,0.999999999988468,0.92112422324582,0,1,serotonin:sodium symporter activity,MF,
4854,GO:0014064,0.999999999988468,0.92112422324582,0,1,positive regulation of serotonin secretion,BP,
6248,GO:0019811,0.999999999988468,0.92112422324582,0,1,cocaine binding,MF,
6540,GO:0021941,0.999999999988468,0.92112422324582,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
16107,GO:0090067,0.999999999988468,0.92112422324582,0,1,regulation of thalamus size,BP,
15495,GO:0071821,0.999999999988482,0.907414776921305,0,1,FANCM-MHF complex,CC,
8058,GO:0032713,0.999999999988493,0.738219290408864,0,4,negative regulation of interleukin-4 production,BP,
13693,GO:0060199,0.999999999988499,0.858200892411464,0,2,clathrin-sculpted glutamate transport vesicle,CC,
13696,GO:0060203,0.999999999988499,0.858200892411464,0,2,clathrin-sculpted glutamate transport vesicle membrane,CC,
2363,GO:0005462,0.999999999988511,0.848305527671105,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
19591,GO:1990569,0.999999999988511,0.848305527671105,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
1649,GO:0004090,0.999999999988544,0.820938905759117,0,4,carbonyl reductase (NADPH) activity,MF,
1849,GO:0004505,0.999999999988546,0.888890944573324,0,2,phenylalanine 4-monooxygenase activity,MF,
3648,GO:0008124,0.999999999988546,0.888890944573324,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
11169,GO:0045210,0.999999999988551,0.837615456318683,0,2,FasL biosynthetic process,BP,
626,GO:0001807,0.999999999988553,0.882965361184756,0,2,regulation of type IV hypersensitivity,BP,
17983,GO:1902311,0.999999999988575,0.937882656178322,0,1,regulation of copper ion transmembrane transport,BP,
1730,GO:0004320,0.999999999988584,0.844622410768956,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5436,GO:0016295,0.999999999988584,0.844622410768956,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5437,GO:0016296,0.999999999988584,0.844622410768956,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5438,GO:0016297,0.999999999988584,0.844622410768956,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
4497,GO:0010520,0.999999999988584,0.861587654015078,0,2,regulation of reciprocal meiotic recombination,BP,
11306,GO:0045602,0.999999999988604,0.672629783487438,0,5,negative regulation of endothelial cell differentiation,BP,
16437,GO:0097055,0.999999999988618,0.865617195744578,0,2,agmatine biosynthetic process,BP,
17590,GO:1901162,0.999999999988618,0.865617195744578,0,2,primary amino compound biosynthetic process,BP,
17000,GO:0099022,0.999999999988627,0.873099750667398,0,2,vesicle tethering,BP,
17004,GO:0099044,0.999999999988627,0.873099750667398,0,2,vesicle tethering to endoplasmic reticulum,BP,
13980,GO:0060666,0.999999999988635,0.636852007507988,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
13665,GO:0060151,0.99999999998864,0.849203409445936,0,2,peroxisome localization,BP,
13666,GO:0060152,0.99999999998864,0.849203409445936,0,2,microtubule-based peroxisome localization,BP,
4595,GO:0010701,0.999999999988649,0.860724065415483,0,2,positive regulation of norepinephrine secretion,BP,
1239,GO:0002924,0.999999999988654,0.932118899176767,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9866,GO:0042105,0.999999999988654,0.932118899176767,0,1,alpha-beta T cell receptor complex,CC,
13855,GO:0060434,0.999999999988659,0.855987874781579,0,2,bronchus morphogenesis,BP,
2052,GO:0004798,0.99999999998868,0.882369330380157,0,2,thymidylate kinase activity,MF,
2790,GO:0006227,0.99999999998868,0.882369330380157,0,2,dUDP biosynthetic process,BP,
2793,GO:0006233,0.99999999998868,0.882369330380157,0,2,dTDP biosynthetic process,BP,
4086,GO:0009139,0.99999999998868,0.882369330380157,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4137,GO:0009196,0.99999999998868,0.882369330380157,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4138,GO:0009197,0.99999999998868,0.882369330380157,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
11557,GO:0046072,0.99999999998868,0.882369330380157,0,2,dTDP metabolic process,BP,
11560,GO:0046077,0.99999999998868,0.882369330380157,0,2,dUDP metabolic process,BP,
19692,GO:1990911,0.99999999998869,0.871739135049759,0,2,response to psychosocial stress,BP,
543,GO:0001661,0.999999999988697,0.853767148212941,0,2,conditioned taste aversion,BP,
8761,GO:0034416,0.999999999988704,0.861631143741981,0,2,bisphosphoglycerate phosphatase activity,MF,
1069,GO:0002625,0.999999999988705,0.935418315019536,0,1,regulation of T cell antigen processing and presentation,BP,
1070,GO:0002626,0.999999999988705,0.935418315019536,0,1,negative regulation of T cell antigen processing and presentation,BP,
4399,GO:0010106,0.999999999988705,0.935418315019536,0,1,cellular response to iron ion starvation,BP,
18802,GO:1904282,0.999999999988705,0.935418315019536,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18803,GO:1904283,0.999999999988705,0.935418315019536,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20275,GO:2001186,0.999999999988705,0.935418315019536,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
4818,GO:0014010,0.999999999988725,0.639143721257962,0,5,Schwann cell proliferation,BP,
6186,GO:0019563,0.999999999988736,0.659329422311553,0,5,glycerol catabolic process,BP,
12738,GO:0050955,0.999999999988776,0.922979264036247,0,1,thermoception,BP,
12740,GO:0050960,0.999999999988776,0.922979264036247,0,1,detection of temperature stimulus involved in thermoception,BP,
12745,GO:0050968,0.999999999988776,0.922979264036247,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
13871,GO:0060454,0.999999999988776,0.922979264036247,0,1,positive regulation of gastric acid secretion,BP,
16208,GO:0090212,0.999999999988776,0.922979264036247,0,1,negative regulation of establishment of blood-brain barrier,BP,
16696,GO:0097603,0.999999999988776,0.922979264036247,0,1,temperature-gated ion channel activity,MF,
17724,GO:1901594,0.999999999988776,0.922979264036247,0,1,response to capsazepine,BP,
9397,GO:0035926,0.999999999988792,0.687914090037388,0,5,chemokine (C-C motif) ligand 2 secretion,BP,
8639,GO:0034150,0.999999999988807,0.914166011743792,0,1,toll-like receptor 6 signaling pathway,BP,
9099,GO:0035355,0.999999999988807,0.914166011743792,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
19499,GO:1990172,0.999999999988807,0.914166011743792,0,1,G-protein coupled receptor catabolic process,BP,
20295,GO:2001225,0.999999999988856,0.693048712351906,0,5,regulation of chloride transport,BP,
3841,GO:0008446,0.99999999998887,0.939450841960854,0,1,GDP-mannose 4,6-dehydratase activity,MF,
16631,GO:0097450,0.999999999988873,0.85651953661926,0,2,astrocyte end-foot,CC,
16632,GO:0097451,0.999999999988873,0.85651953661926,0,2,glial limiting end-foot,CC,
900,GO:0002276,0.99999999998888,0.861400035650054,0,2,basophil activation involved in immune response,BP,
11284,GO:0045575,0.99999999998888,0.861400035650054,0,2,basophil activation,BP,
16460,GO:0097102,0.999999999988906,0.861808912983475,0,2,endothelial tip cell fate specification,BP,
9934,GO:0042271,0.999999999988938,0.843809540859705,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
3374,GO:0007147,0.999999999988974,0.925047676877086,0,1,female meiosis II,BP,
10942,GO:0044557,0.999999999988978,0.714591368988872,0,5,relaxation of smooth muscle,BP,
7774,GO:0032289,0.999999999988983,0.801805280401909,0,3,central nervous system myelin formation,BP,
19456,GO:1990026,0.999999999989002,0.925429598187729,0,1,hippocampal mossy fiber expansion,CC,
2235,GO:0005137,0.999999999989023,0.932947415409792,0,1,interleukin-5 receptor binding,MF,
2599,GO:0005895,0.999999999989023,0.932947415409792,0,1,interleukin-5 receptor complex,CC,
17249,GO:0110011,0.999999999989032,0.627232170637716,0,5,regulation of basement membrane organization,BP,
18793,GO:1904259,0.999999999989032,0.627232170637716,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18794,GO:1904261,0.999999999989032,0.627232170637716,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20279,GO:2001197,0.999999999989032,0.627232170637716,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
1736,GO:0004331,0.999999999989034,0.72631005313877,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
2661,GO:0006003,0.999999999989034,0.72631005313877,0,4,fructose 2,6-bisphosphate metabolic process,BP,
18788,GO:1904245,0.999999999989052,0.870132185458046,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
11099,GO:0045085,0.999999999989068,0.938360266272578,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
16860,GO:0098745,0.999999999989068,0.938360266272578,0,1,Dcp1-Dcp2 complex,CC,
17800,GO:1901834,0.999999999989068,0.938360266272578,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17801,GO:1901835,0.999999999989068,0.938360266272578,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18789,GO:1904246,0.999999999989068,0.938360266272578,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
15790,GO:0072368,0.999999999989073,0.832866348299876,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
6938,GO:0030538,0.999999999989077,0.857046415552686,0,2,embryonic genitalia morphogenesis,BP,
4058,GO:0009106,0.999999999989087,0.869214170213162,0,2,lipoate metabolic process,BP,
11136,GO:0045155,0.999999999989098,0.869702021627327,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
7557,GO:0031862,0.999999999989103,0.843889199778276,0,2,prostanoid receptor binding,MF,
6977,GO:0030627,0.999999999989109,0.881514999130635,0,2,pre-mRNA 5'-splice site binding,MF,
8853,GO:0034640,0.999999999989112,0.926655798525981,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
17028,GO:0099098,0.999999999989112,0.926655798525981,0,1,microtubule polymerization based movement,BP,
19585,GO:1990523,0.999999999989112,0.926655798525981,0,1,bone regeneration,BP,
4451,GO:0010385,0.999999999989143,0.681648056415364,0,5,double-stranded methylated DNA binding,MF,
16993,GO:0098989,0.999999999989154,0.8549934553669,0,2,NMDA selective glutamate receptor signaling pathway,BP,
1300,GO:0003130,0.999999999989161,0.869242773651048,0,2,BMP signaling pathway involved in heart induction,BP,
1302,GO:0003133,0.999999999989161,0.869242773651048,0,2,endodermal-mesodermal cell signaling,BP,
1303,GO:0003134,0.999999999989161,0.869242773651048,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
15658,GO:0072138,0.999999999989161,0.869242773651048,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
3924,GO:0008594,0.999999999989165,0.852629010376282,0,2,photoreceptor cell morphogenesis,BP,
2254,GO:0005166,0.999999999989173,0.9549131569947,0,1,neurotrophin p75 receptor binding,MF,
3498,GO:0007402,0.999999999989173,0.9549131569947,0,1,ganglion mother cell fate determination,BP,
3610,GO:0008052,0.999999999989173,0.9549131569947,0,1,sensory organ boundary specification,BP,
4410,GO:0010160,0.999999999989173,0.9549131569947,0,1,formation of animal organ boundary,BP,
12435,GO:0048867,0.999999999989173,0.9549131569947,0,1,stem cell fate determination,BP,
14252,GO:0061193,0.999999999989173,0.9549131569947,0,1,taste bud development,BP,
17020,GO:0099082,0.999999999989173,0.9549131569947,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
17021,GO:0099083,0.999999999989173,0.9549131569947,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17078,GO:0099538,0.999999999989173,0.9549131569947,0,1,synaptic signaling via neuropeptide,BP,
17079,GO:0099540,0.999999999989173,0.9549131569947,0,1,trans-synaptic signaling by neuropeptide,BP,
17087,GO:0099551,0.999999999989173,0.9549131569947,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
7108,GO:0030899,0.99999999998923,0.907895714792536,0,2,calcium-dependent ATPase activity,MF,
8342,GO:0033181,0.999999999989231,0.939520407463363,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
12154,GO:0048239,0.999999999989232,0.866364245786118,0,2,negative regulation of DNA recombination at telomere,BP,
15934,GO:0072695,0.999999999989232,0.866364245786118,0,2,regulation of DNA recombination at telomere,BP,
969,GO:0002408,0.999999999989234,0.916201322563544,0,1,myeloid dendritic cell chemotaxis,BP,
1981,GO:0004694,0.999999999989255,0.721799379840674,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
1838,GO:0004490,0.999999999989263,0.94100752905044,0,1,methylglutaconyl-CoA hydratase activity,MF,
12453,GO:0050011,0.999999999989263,0.94100752905044,0,1,itaconyl-CoA hydratase activity,MF,
11280,GO:0045541,0.999999999989264,0.727848692964283,0,5,negative regulation of cholesterol biosynthetic process,BP,
16203,GO:0090206,0.999999999989264,0.727848692964283,0,5,negative regulation of cholesterol metabolic process,BP,
10174,GO:0042749,0.999999999989276,0.725464361410568,0,5,regulation of circadian sleep/wake cycle,BP,
11156,GO:0045187,0.999999999989276,0.725464361410568,0,5,regulation of circadian sleep/wake cycle, sleep,BP,
9006,GO:0035120,0.99999999998928,0.886825894042218,0,1,post-embryonic appendage morphogenesis,BP,
9007,GO:0035127,0.99999999998928,0.886825894042218,0,1,post-embryonic limb morphogenesis,BP,
9008,GO:0035128,0.99999999998928,0.886825894042218,0,1,post-embryonic forelimb morphogenesis,BP,
16605,GO:0097393,0.99999999998928,0.886825894042218,0,1,telomeric repeat-containing RNA transcription,BP,
16606,GO:0097394,0.99999999998928,0.886825894042218,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17720,GO:1901580,0.99999999998928,0.886825894042218,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17721,GO:1901581,0.99999999998928,0.886825894042218,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17722,GO:1901582,0.99999999998928,0.886825894042218,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19557,GO:1990421,0.99999999998928,0.886825894042218,0,1,subtelomeric heterochromatin,CC,
19624,GO:1990707,0.99999999998928,0.886825894042218,0,1,nuclear subtelomeric heterochromatin,CC,
12712,GO:0050910,0.999999999989285,0.842867625918203,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
3864,GO:0008482,0.999999999989292,0.93147950346982,0,1,sulfite oxidase activity,MF,
9878,GO:0042128,0.999999999989292,0.93147950346982,0,1,nitrate assimilation,BP,
6002,GO:0019008,0.99999999998932,0.871528791138802,0,2,molybdopterin synthase complex,CC,
10674,GO:0043849,0.999999999989325,0.928014553947306,0,1,Ras palmitoyltransferase activity,MF,
836,GO:0002133,0.999999999989347,0.800906618596325,0,2,polycystin complex,CC,
15587,GO:0072021,0.999999999989347,0.800906618596325,0,2,ascending thin limb development,BP,
15678,GO:0072177,0.999999999989347,0.800906618596325,0,2,mesonephric duct development,BP,
15709,GO:0072218,0.999999999989347,0.800906618596325,0,2,metanephric ascending thin limb development,BP,
1430,GO:0003400,0.99999999998935,0.932937693020523,0,1,regulation of COPII vesicle coating,BP,
2208,GO:0005090,0.99999999998935,0.932937693020523,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13976,GO:0060661,0.99999999998935,0.932937693020523,0,1,submandibular salivary gland formation,BP,
15210,GO:0071335,0.99999999998935,0.932937693020523,0,1,hair follicle cell proliferation,BP,
15211,GO:0071336,0.99999999998935,0.932937693020523,0,1,regulation of hair follicle cell proliferation,BP,
15212,GO:0071338,0.99999999998935,0.932937693020523,0,1,positive regulation of hair follicle cell proliferation,BP,
16141,GO:0090113,0.99999999998935,0.932937693020523,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
13566,GO:0060007,0.999999999989363,0.922801750000255,0,1,linear vestibuloocular reflex,BP,
162,GO:0000333,0.999999999989368,0.886340597100073,0,2,telomerase catalytic core complex,CC,
8135,GO:0032817,0.999999999989383,0.781846807140845,0,4,regulation of natural killer cell proliferation,BP,
8136,GO:0032819,0.999999999989383,0.781846807140845,0,4,positive regulation of natural killer cell proliferation,BP,
13050,GO:0051481,0.999999999989394,0.665183298579871,0,4,negative regulation of cytosolic calcium ion concentration,BP,
9441,GO:0036004,0.999999999989407,0.948754935063367,0,1,GAF domain binding,MF,
9830,GO:0042030,0.999999999989416,0.832628636101974,0,2,ATPase inhibitor activity,MF,
12846,GO:0051132,0.999999999989418,0.726783417571519,0,5,NK T cell activation,BP,
5320,GO:0016035,0.999999999989428,0.845493418011399,0,2,zeta DNA polymerase complex,CC,
7988,GO:0032596,0.999999999989429,0.691573517969532,0,5,protein transport into membrane raft,BP,
1025,GO:0002523,0.999999999989432,0.746910251271122,0,5,leukocyte migration involved in inflammatory response,BP,
2312,GO:0005308,0.999999999989439,0.92538840963183,0,1,creatine transmembrane transporter activity,MF,
2313,GO:0005309,0.999999999989439,0.92538840963183,0,1,creatine:sodium symporter activity,MF,
5256,GO:0015881,0.999999999989439,0.92538840963183,0,1,creatine transmembrane transport,BP,
10855,GO:0044341,0.999999999989449,0.79083562546622,0,3,sodium-dependent phosphate transport,BP,
10821,GO:0044299,0.999999999989464,0.910720079632972,0,1,C-fiber,CC,
7666,GO:0032090,0.999999999989478,0.886270303707859,0,2,Pyrin domain binding,MF,
3501,GO:0007406,0.999999999989492,0.70408913117262,0,4,negative regulation of neuroblast proliferation,BP,
9296,GO:0035727,0.999999999989505,0.860829807856398,0,2,lysophosphatidic acid binding,MF,
13741,GO:0060287,0.999999999989527,0.745391882226771,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
15971,GO:0075341,0.999999999989533,0.931791659536761,0,1,host cell PML body,CC,
19708,GO:1990967,0.999999999989548,0.870662958352619,0,2,multi-organism toxin transport,BP,
104,GO:0000215,0.999999999989561,0.885965766310674,0,2,tRNA 2'-phosphotransferase activity,MF,
6394,GO:0021590,0.999999999989579,0.83421184388867,0,2,cerebellum maturation,BP,
6428,GO:0021691,0.999999999989579,0.83421184388867,0,2,cerebellar Purkinje cell layer maturation,BP,
6436,GO:0021699,0.999999999989579,0.83421184388867,0,2,cerebellar cortex maturation,BP,
15651,GO:0072131,0.999999999989582,0.772996087799313,0,3,kidney mesenchyme morphogenesis,BP,
15653,GO:0072133,0.999999999989582,0.772996087799313,0,3,metanephric mesenchyme morphogenesis,BP,
5713,GO:0016841,0.999999999989618,0.814924722579576,0,3,ammonia-lyase activity,MF,
8757,GO:0034402,0.999999999989644,0.851236084005381,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
18828,GO:1904351,0.999999999989649,0.797593868785992,0,3,negative regulation of protein catabolic process in the vacuole,BP,
19184,GO:1905166,0.999999999989649,0.797593868785992,0,3,negative regulation of lysosomal protein catabolic process,BP,
3043,GO:0006597,0.999999999989651,0.870141937765028,0,2,spermine biosynthetic process,BP,
16481,GO:0097134,0.999999999989676,0.872974877620977,0,2,cyclin E1-CDK2 complex,CC,
2092,GO:0004854,0.999999999989715,0.840767819930267,0,2,xanthine dehydrogenase activity,MF,
4066,GO:0009115,0.999999999989715,0.840767819930267,0,2,xanthine catabolic process,BP,
5644,GO:0016726,0.999999999989715,0.840767819930267,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
9331,GO:0035795,0.999999999989718,0.728581343434777,0,5,negative regulation of mitochondrial membrane permeability,BP,
19377,GO:1905709,0.999999999989718,0.728581343434777,0,5,negative regulation of membrane permeability,BP,
17348,GO:0150018,0.999999999989727,0.783394300748741,0,3,basal dendrite development,BP,
17349,GO:0150019,0.999999999989727,0.783394300748741,0,3,basal dendrite morphogenesis,BP,
17350,GO:0150020,0.999999999989727,0.783394300748741,0,3,basal dendrite arborization,BP,
1511,GO:0003867,0.999999999989727,0.919247791648417,0,1,4-aminobutyrate transaminase activity,MF,
4848,GO:0014053,0.999999999989727,0.919247791648417,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
7697,GO:0032144,0.999999999989727,0.919247791648417,0,1,4-aminobutyrate transaminase complex,CC,
7698,GO:0032145,0.999999999989727,0.919247791648417,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8471,GO:0033602,0.999999999989727,0.919247791648417,0,1,negative regulation of dopamine secretion,BP,
8745,GO:0034386,0.999999999989727,0.919247791648417,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
12001,GO:0047298,0.999999999989727,0.919247791648417,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
14358,GO:0061528,0.999999999989727,0.919247791648417,0,1,aspartate secretion,BP,
18872,GO:1904448,0.999999999989727,0.919247791648417,0,1,regulation of aspartate secretion,BP,
18873,GO:1904450,0.999999999989727,0.919247791648417,0,1,positive regulation of aspartate secretion,BP,
1614,GO:0004034,0.999999999989774,0.930391636731485,0,1,aldose 1-epimerase activity,MF,
9408,GO:0035945,0.999999999989774,0.930391636731485,0,1,mitochondrial ncRNA surveillance,BP,
9409,GO:0035946,0.999999999989774,0.930391636731485,0,1,mitochondrial mRNA surveillance,BP,
15082,GO:0071026,0.999999999989774,0.930391636731485,0,1,cytoplasmic RNA surveillance,BP,
20169,GO:2000827,0.999999999989774,0.930391636731485,0,1,mitochondrial RNA surveillance,BP,
9730,GO:0038158,0.999999999989804,0.87000088121306,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
13118,GO:0051611,0.999999999989807,0.841052270672325,0,2,regulation of serotonin uptake,BP,
13119,GO:0051612,0.999999999989807,0.841052270672325,0,2,negative regulation of serotonin uptake,BP,
2310,GO:0005295,0.999999999989807,0.926684918270764,0,1,neutral amino acid:sodium symporter activity,MF,
5100,GO:0015375,0.999999999989807,0.926684918270764,0,1,glycine:sodium symporter activity,MF,
7523,GO:0031704,0.999999999989807,0.926684918270764,0,1,apelin receptor binding,MF,
10505,GO:0043396,0.999999999989807,0.926684918270764,0,1,corticotropin-releasing hormone secretion,BP,
10506,GO:0043397,0.999999999989807,0.926684918270764,0,1,regulation of corticotropin-releasing hormone secretion,BP,
13048,GO:0051466,0.999999999989807,0.926684918270764,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13571,GO:0060012,0.999999999989807,0.926684918270764,0,1,synaptic transmission, glycinergic,BP,
13640,GO:0060092,0.999999999989807,0.926684918270764,0,1,regulation of synaptic transmission, glycinergic,BP,
13685,GO:0060183,0.999999999989807,0.926684918270764,0,1,apelin receptor signaling pathway,BP,
14361,GO:0061536,0.999999999989807,0.926684918270764,0,1,glycine secretion,BP,
14362,GO:0061537,0.999999999989807,0.926684918270764,0,1,glycine secretion, neurotransmission,BP,
18703,GO:1904022,0.999999999989807,0.926684918270764,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20254,GO:2001151,0.999999999989807,0.926684918270764,0,1,regulation of renal water transport,BP,
20255,GO:2001153,0.999999999989807,0.926684918270764,0,1,positive regulation of renal water transport,BP,
10748,GO:0044105,0.999999999989817,0.959487797014638,0,1,L-xylulose reductase (NAD+) activity,MF,
12455,GO:0050038,0.999999999989817,0.959487797014638,0,1,L-xylulose reductase (NADP+) activity,MF,
11062,GO:0045031,0.999999999989825,0.867010672760475,0,2,ATP-activated adenosine receptor activity,MF,
11661,GO:0046368,0.999999999989852,0.760365093357255,0,4,GDP-L-fucose metabolic process,BP,
58,GO:0000121,0.999999999989864,0.927052483728741,0,1,glycerol-1-phosphatase activity,MF,
10349,GO:0043136,0.999999999989864,0.927052483728741,0,1,glycerol-3-phosphatase activity,MF,
12587,GO:0050720,0.999999999989864,0.927052483728741,0,1,interleukin-1 beta biosynthetic process,BP,
12589,GO:0050722,0.999999999989864,0.927052483728741,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12590,GO:0050725,0.999999999989864,0.927052483728741,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
15748,GO:0072303,0.999999999989864,0.927052483728741,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
8282,GO:0033078,0.999999999989879,0.863078171605952,0,2,extrathymic T cell differentiation,BP,
1496,GO:0003835,0.999999999989885,0.838689304188842,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
7276,GO:0031251,0.999999999989903,0.839554585898448,0,2,PAN complex,CC,
1949,GO:0004649,0.999999999989921,0.866338692622352,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
6093,GO:0019262,0.99999999998994,0.724041002160902,0,5,N-acetylneuraminate catabolic process,BP,
9279,GO:0035694,0.999999999989946,0.742796163671009,0,4,mitochondrial protein catabolic process,BP,
9631,GO:0036488,0.999999999989958,0.896942456707149,0,2,CHOP-C/EBP complex,CC,
5095,GO:0015367,0.999999999989972,0.937758039620102,0,1,oxoglutarate:malate antiporter activity,MF,
5182,GO:0015742,0.999999999989972,0.937758039620102,0,1,alpha-ketoglutarate transport,BP,
1943,GO:0004642,0.99999999998998,0.916682682577942,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
17267,GO:0120012,0.99999999998998,0.916682682577942,0,1,intermembrane sphingolipid transfer,BP,
17269,GO:0120016,0.99999999998998,0.916682682577942,0,1,intermembrane sphingolipid transfer activity,MF,
17270,GO:0120017,0.99999999998998,0.916682682577942,0,1,intermembrane ceramide transfer activity,MF,
10523,GO:0043418,0.999999999990012,0.801610538141347,0,3,homocysteine catabolic process,BP,
4923,GO:0014859,0.999999999990028,0.926241988961139,0,1,negative regulation of skeletal muscle cell proliferation,BP,
18118,GO:1902723,0.999999999990028,0.926241988961139,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
14466,GO:0061772,0.999999999990036,0.925881352012347,0,1,drug transport across blood-nerve barrier,BP,
18482,GO:1903544,0.999999999990036,0.925881352012347,0,1,response to butyrate,BP,
18483,GO:1903545,0.999999999990036,0.925881352012347,0,1,cellular response to butyrate,BP,
13728,GO:0060265,0.99999999999004,0.958998014462639,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
14459,GO:0061762,0.999999999990044,0.841573513528069,0,2,CAMKK-AMPK signaling cascade,BP,
16997,GO:0099004,0.999999999990044,0.841573513528069,0,2,calmodulin dependent kinase signaling pathway,BP,
9615,GO:0036466,0.999999999990059,0.847130263086446,0,2,synaptic vesicle recycling via endosome,BP,
16078,GO:0089709,0.999999999990094,0.86481261843838,0,2,L-histidine transmembrane transport,BP,
15964,GO:0075044,0.999999999990099,0.711409491163004,0,4,autophagy of host cells involved in interaction with symbiont,BP,
15965,GO:0075071,0.999999999990099,0.711409491163004,0,4,autophagy involved in symbiotic interaction,BP,
3584,GO:0007634,0.999999999990104,0.930684227232184,0,1,optokinetic behavior,BP,
14097,GO:0060876,0.999999999990104,0.930684227232184,0,1,semicircular canal formation,BP,
13003,GO:0051387,0.999999999990112,0.869046584234101,0,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
6059,GO:0019203,0.99999999999012,0.682831313471943,0,5,carbohydrate phosphatase activity,MF,
12483,GO:0050308,0.99999999999012,0.682831313471943,0,5,sugar-phosphatase activity,MF,
10250,GO:0042954,0.999999999990131,0.62713525512964,0,5,lipoprotein transporter activity,MF,
297,GO:0000801,0.999999999990134,0.922909387806972,0,1,central element,CC,
5334,GO:0016062,0.999999999990149,0.929870864717264,0,1,adaptation of rhodopsin mediated signaling,BP,
9578,GO:0036367,0.999999999990149,0.929870864717264,0,1,light adaption,BP,
3435,GO:0007227,0.999999999990152,0.785027658961712,0,3,signal transduction downstream of smoothened,BP,
16628,GO:0097444,0.999999999990193,0.918115058367347,0,1,spine apparatus,CC,
19257,GO:1905355,0.999999999990193,0.918115058367347,0,1,spine apparatus assembly,BP,
5092,GO:0015350,0.999999999990212,0.845665419697353,0,2,methotrexate transmembrane transporter activity,MF,
13290,GO:0051958,0.999999999990212,0.845665419697353,0,2,methotrexate transport,BP,
15858,GO:0072553,0.999999999990239,0.740793721665542,0,4,terminal button organization,BP,
11962,GO:0047021,0.999999999990258,0.948513125303943,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12474,GO:0050221,0.999999999990258,0.948513125303943,0,1,prostaglandin-E2 9-reductase activity,MF,
5131,GO:0015562,0.999999999990317,0.719365832659729,0,4,efflux transmembrane transporter activity,MF,
4773,GO:0010956,0.999999999990317,0.858828856768875,0,2,negative regulation of calcidiol 1-monooxygenase activity,BP,
9348,GO:0035838,0.999999999990341,0.842217938898842,0,2,growing cell tip,CC,
17083,GO:0099545,0.999999999990346,0.919454595988276,0,1,trans-synaptic signaling by trans-synaptic complex,BP,
17090,GO:0099557,0.999999999990346,0.919454595988276,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
17222,GO:0106028,0.999999999990346,0.919454595988276,0,1,neuron projection retraction,BP,
17515,GO:1900450,0.999999999990346,0.919454595988276,0,1,negative regulation of glutamate receptor signaling pathway,BP,
19017,GO:1904782,0.999999999990346,0.919454595988276,0,1,negative regulation of NMDA glutamate receptor activity,BP,
13586,GO:0060029,0.999999999990348,0.721638096392524,0,4,convergent extension involved in organogenesis,BP,
11351,GO:0045660,0.999999999990362,0.934847640497092,0,1,positive regulation of neutrophil differentiation,BP,
16096,GO:0090038,0.999999999990363,0.856615628838353,0,2,negative regulation of protein kinase C signaling,BP,
2364,GO:0005464,0.999999999990368,0.909138118852882,0,1,UDP-xylose transmembrane transporter activity,MF,
5199,GO:0015790,0.999999999990368,0.909138118852882,0,1,UDP-xylose transmembrane transport,BP,
9229,GO:0035609,0.999999999990376,0.921610185372474,0,1,C-terminal protein deglutamylation,BP,
9230,GO:0035610,0.999999999990376,0.921610185372474,0,1,protein side chain deglutamylation,BP,
9392,GO:0035915,0.999999999990387,0.934245428057839,0,1,pore formation in membrane of other organism,BP,
19921,GO:2000374,0.999999999990387,0.934245428057839,0,1,regulation of oxygen metabolic process,BP,
850,GO:0002169,0.999999999990409,0.860083959097913,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1833,GO:0004485,0.999999999990409,0.860083959097913,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
19192,GO:1905202,0.999999999990409,0.860083959097913,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
377,GO:0001007,0.999999999990419,0.696235852306827,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
10141,GO:0042668,0.999999999990458,0.893845591443762,0,2,auditory receptor cell fate determination,BP,
20196,GO:2000977,0.999999999990458,0.893845591443762,0,2,regulation of forebrain neuron differentiation,BP,
20197,GO:2000978,0.999999999990458,0.893845591443762,0,2,negative regulation of forebrain neuron differentiation,BP,
922,GO:0002314,0.99999999999046,0.877227932141788,0,2,germinal center B cell differentiation,BP,
17471,GO:1900226,0.999999999990474,0.732231336790956,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
14997,GO:0070889,0.999999999990482,0.865621017218164,0,2,platelet alpha granule organization,BP,
5779,GO:0016998,0.999999999990487,0.872989062414841,0,2,cell wall macromolecule catabolic process,BP,
6857,GO:0030321,0.999999999990517,0.844595809433396,0,2,transepithelial chloride transport,BP,
16293,GO:0090341,0.999999999990519,0.941599413982141,0,1,negative regulation of secretion of lysosomal enzymes,BP,
6601,GO:0022615,0.99999999999052,0.767428059621918,0,4,protein to membrane docking,BP,
1881,GO:0004557,0.999999999990526,0.873304450147819,0,2,alpha-galactosidase activity,MF,
13657,GO:0060136,0.999999999990529,0.73168935585641,0,4,embryonic process involved in female pregnancy,BP,
4450,GO:0010370,0.999999999990532,0.863776764529406,0,2,perinucleolar chromocenter,CC,
2883,GO:0006386,0.999999999990534,0.960563354321877,0,1,termination of RNA polymerase III transcription,BP,
5809,GO:0017060,0.999999999990543,0.864735692038395,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
3341,GO:0007060,0.999999999990564,0.86361276875972,0,2,male meiosis chromosome segregation,BP,
9643,GO:0036502,0.999999999990568,0.927048194967869,0,1,Derlin-1-VIMP complex,CC,
1971,GO:0004677,0.999999999990568,0.720667146130953,0,3,DNA-dependent protein kinase activity,MF,
2341,GO:0005368,0.999999999990585,0.91076795598845,0,1,taurine transmembrane transporter activity,MF,
2342,GO:0005369,0.999999999990585,0.91076795598845,0,1,taurine:sodium symporter activity,MF,
5179,GO:0015734,0.999999999990585,0.91076795598845,0,1,taurine transport,BP,
7078,GO:0030860,0.999999999990585,0.852064478950134,0,2,regulation of polarized epithelial cell differentiation,BP,
1772,GO:0004373,0.999999999990608,0.925774266680956,0,1,glycogen (starch) synthase activity,MF,
14364,GO:0061547,0.999999999990608,0.925774266680956,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
13612,GO:0060059,0.999999999990631,0.634448737092488,0,4,embryonic retina morphogenesis in camera-type eye,BP,
584,GO:0001735,0.999999999990642,0.85261773070953,0,2,prenylcysteine oxidase activity,MF,
6864,GO:0030328,0.999999999990642,0.85261773070953,0,2,prenylcysteine catabolic process,BP,
6865,GO:0030329,0.999999999990642,0.85261773070953,0,2,prenylcysteine metabolic process,BP,
19404,GO:1905832,0.999999999990649,0.677131325689573,0,4,positive regulation of spindle assembly,BP,
15389,GO:0071612,0.999999999990653,0.883799503197733,0,1,IP-10 production,BP,
15420,GO:0071658,0.999999999990653,0.883799503197733,0,1,regulation of IP-10 production,BP,
15421,GO:0071660,0.999999999990653,0.883799503197733,0,1,positive regulation of IP-10 production,BP,
557,GO:0001680,0.999999999990656,0.931955466987418,0,1,tRNA 3'-terminal CCA addition,BP,
2060,GO:0004810,0.999999999990656,0.931955466987418,0,1,tRNA adenylyltransferase activity,MF,
13484,GO:0052927,0.999999999990656,0.931955466987418,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13485,GO:0052928,0.999999999990656,0.931955466987418,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13486,GO:0052929,0.999999999990656,0.931955466987418,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19664,GO:1990817,0.999999999990656,0.931955466987418,0,1,RNA adenylyltransferase activity,MF,
3618,GO:0008073,0.999999999990663,0.889893467435021,0,2,ornithine decarboxylase inhibitor activity,MF,
17962,GO:1902268,0.999999999990663,0.889893467435021,0,2,negative regulation of polyamine transmembrane transport,BP,
5955,GO:0018312,0.999999999990667,0.864747942045001,0,2,peptidyl-serine ADP-ribosylation,BP,
19546,GO:1990404,0.999999999990667,0.864747942045001,0,2,protein ADP-ribosylase activity,MF,
10927,GO:0044501,0.999999999990672,0.850205500277921,0,2,modulation of signal transduction in other organism,BP,
13316,GO:0052027,0.999999999990672,0.850205500277921,0,2,modulation by symbiont of host signal transduction pathway,BP,
13350,GO:0052250,0.999999999990672,0.850205500277921,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
6091,GO:0019254,0.999999999990685,0.863092048240483,0,2,carnitine metabolic process, CoA-linked,BP,
4628,GO:0010746,0.999999999990687,0.707305256458269,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4629,GO:0010748,0.999999999990687,0.707305256458269,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
12161,GO:0048250,0.999999999990693,0.881955312268312,0,2,iron import into the mitochondrion,BP,
3128,GO:0006710,0.999999999990709,0.936363331804289,0,1,androgen catabolic process,BP,
12062,GO:0047874,0.999999999990714,0.933490711652849,0,1,dolichyldiphosphatase activity,MF,
9684,GO:0038037,0.999999999990728,0.810970338811813,0,3,G-protein coupled receptor dimeric complex,CC,
16718,GO:0097648,0.999999999990728,0.810970338811813,0,3,G-protein coupled receptor complex,CC,
5153,GO:0015688,0.999999999990751,0.895240117548514,0,2,iron chelate transport,BP,
5263,GO:0015891,0.999999999990751,0.895240117548514,0,2,siderophore transport,BP,
11740,GO:0046532,0.999999999990771,0.662391748526332,0,5,regulation of photoreceptor cell differentiation,BP,
6156,GO:0019470,0.999999999990787,0.746209232512964,0,4,4-hydroxyproline catabolic process,BP,
10690,GO:0043932,0.99999999999079,0.864379539388351,0,2,ossification involved in bone remodeling,BP,
3641,GO:0008113,0.999999999990803,0.892537908731201,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
13367,GO:0052405,0.999999999990806,0.786226386404483,0,4,negative regulation by host of symbiont molecular function,BP,
3101,GO:0006679,0.999999999990814,0.863360885662541,0,2,glucosylceramide biosynthetic process,BP,
515,GO:0001579,0.999999999990815,0.858570561479808,0,2,medium-chain fatty acid transport,BP,
10629,GO:0043615,0.999999999990825,0.693050192211386,0,5,astrocyte cell migration,BP,
496,GO:0001550,0.999999999990848,0.84323506207424,0,2,ovarian cumulus expansion,BP,
12129,GO:0048165,0.999999999990848,0.84323506207424,0,2,fused antrum stage,BP,
12739,GO:0050957,0.999999999990856,0.923681931298484,0,1,equilibrioception,BP,
13205,GO:0051792,0.999999999990888,0.748916767925865,0,4,medium-chain fatty acid biosynthetic process,BP,
8777,GO:0034447,0.999999999990888,0.803238511633298,0,4,very-low-density lipoprotein particle clearance,BP,
4887,GO:0014805,0.999999999990888,0.796221656461201,0,4,smooth muscle adaptation,BP,
4297,GO:0009726,0.9999999999909,0.852079499660018,0,2,detection of endogenous stimulus,BP,
15030,GO:0070943,0.999999999990942,0.822958770221663,0,3,neutrophil mediated killing of symbiont cell,BP,
12412,GO:0048822,0.999999999990946,0.772907053222234,0,3,enucleate erythrocyte development,BP,
6027,GO:0019082,0.999999999990967,0.92274432537648,0,1,viral protein processing,BP,
16327,GO:0090472,0.999999999990967,0.92274432537648,0,1,dibasic protein processing,BP,
5451,GO:0016320,0.999999999990977,0.854992828796647,0,2,endoplasmic reticulum membrane fusion,BP,
1752,GO:0004349,0.999999999990987,0.925667574888728,0,1,glutamate 5-kinase activity,MF,
1753,GO:0004350,0.999999999990987,0.925667574888728,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
3040,GO:0006592,0.999999999990987,0.925667574888728,0,1,ornithine biosynthetic process,BP,
5821,GO:0017084,0.999999999990987,0.925667574888728,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6058,GO:0019202,0.999999999990987,0.925667574888728,0,1,amino acid kinase activity,MF,
3836,GO:0008440,0.999999999991004,0.730892840556342,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
1757,GO:0004356,0.999999999991016,0.921955949459603,0,1,glutamate-ammonia ligase activity,MF,
2996,GO:0006542,0.999999999991016,0.921955949459603,0,1,glutamine biosynthetic process,BP,
5389,GO:0016211,0.999999999991016,0.921955949459603,0,1,ammonia ligase activity,MF,
6201,GO:0019676,0.999999999991016,0.921955949459603,0,1,ammonia assimilation cycle,BP,
10723,GO:0044028,0.999999999991052,0.854519391963903,0,2,DNA hypomethylation,BP,
10724,GO:0044029,0.999999999991052,0.854519391963903,0,2,hypomethylation of CpG island,BP,
18444,GO:1903461,0.99999999999106,0.927168889930671,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
10773,GO:0044209,0.999999999991066,0.898817849702106,0,2,AMP salvage,BP,
14640,GO:0070194,0.99999999999107,0.866431714846969,0,2,synaptonemal complex disassembly,BP,
5954,GO:0018307,0.999999999991076,0.890196129236829,0,2,enzyme active site formation,BP,
8259,GO:0033029,0.999999999991076,0.679620889541374,0,5,regulation of neutrophil apoptotic process,BP,
5097,GO:0015369,0.99999999999108,0.916351255610884,0,1,calcium:proton antiporter activity,MF,
12851,GO:0051139,0.99999999999108,0.916351255610884,0,1,metal ion:proton antiporter activity,MF,
13490,GO:0055005,0.99999999999108,0.916351255610884,0,1,ventricular cardiac myofibril assembly,BP,
6413,GO:0021648,0.999999999991117,0.850714774694552,0,2,vestibulocochlear nerve morphogenesis,BP,
13042,GO:0051458,0.999999999991129,0.852045516229477,0,2,corticotropin secretion,BP,
13043,GO:0051459,0.999999999991129,0.852045516229477,0,2,regulation of corticotropin secretion,BP,
13044,GO:0051461,0.999999999991129,0.852045516229477,0,2,positive regulation of corticotropin secretion,BP,
2461,GO:0005673,0.999999999991134,0.873722114645135,0,2,transcription factor TFIIE complex,CC,
18116,GO:1902715,0.999999999991138,0.841209867311256,0,2,positive regulation of interferon-gamma secretion,BP,
216,GO:0000451,0.999999999991142,0.860159764021359,0,2,rRNA 2'-O-methylation,BP,
217,GO:0000453,0.999999999991142,0.860159764021359,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
14549,GO:0070039,0.999999999991142,0.860159764021359,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13604,GO:0060051,0.999999999991152,0.871794752387715,0,2,negative regulation of protein glycosylation,BP,
16253,GO:0090285,0.999999999991152,0.871794752387715,0,2,negative regulation of protein glycosylation in Golgi,BP,
13237,GO:0051877,0.999999999991164,0.86172187178173,0,2,pigment granule aggregation in cell center,BP,
745,GO:0001973,0.999999999991173,0.713323684349578,0,5,adenosine receptor signaling pathway,BP,
902,GO:0002278,0.999999999991191,0.760954516482845,0,4,eosinophil activation involved in immune response,BP,
993,GO:0002447,0.999999999991191,0.760954516482845,0,4,eosinophil mediated immunity,BP,
10460,GO:0043307,0.999999999991191,0.760954516482845,0,4,eosinophil activation,BP,
10461,GO:0043308,0.999999999991191,0.760954516482845,0,4,eosinophil degranulation,BP,
3524,GO:0007500,0.999999999991206,0.870150148487081,0,2,mesodermal cell fate determination,BP,
1747,GO:0004344,0.999999999991213,0.897169654746264,0,1,glucose dehydrogenase activity,MF,
12067,GO:0047936,0.999999999991213,0.897169654746264,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
4308,GO:0009757,0.999999999991285,0.715991469484281,0,5,hexose mediated signaling,BP,
4417,GO:0010182,0.999999999991285,0.715991469484281,0,5,sugar mediated signaling pathway,BP,
4428,GO:0010255,0.999999999991285,0.715991469484281,0,5,glucose mediated signaling pathway,BP,
11239,GO:0045358,0.999999999991292,0.887076092918917,0,2,negative regulation of interferon-beta biosynthetic process,BP,
519,GO:0001595,0.999999999991314,0.950008892825518,0,1,angiotensin receptor activity,MF,
2138,GO:0004945,0.999999999991314,0.950008892825518,0,1,angiotensin type II receptor activity,MF,
5495,GO:0016428,0.999999999991326,0.739121949891517,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
8457,GO:0033577,0.999999999991329,0.86316088723203,0,2,protein glycosylation in endoplasmic reticulum,BP,
16768,GO:0098519,0.999999999991338,0.690509895407954,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
14032,GO:0060733,0.999999999991369,0.846805013909973,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
15169,GO:0071262,0.999999999991369,0.846805013909973,0,2,regulation of translational initiation in response to starvation,BP,
15170,GO:0071264,0.999999999991369,0.846805013909973,0,2,positive regulation of translational initiation in response to starvation,BP,
18990,GO:1904732,0.999999999991372,0.875122691865075,0,2,regulation of electron transfer activity,BP,
19106,GO:1904959,0.999999999991372,0.875122691865075,0,2,regulation of cytochrome-c oxidase activity,BP,
12030,GO:0047555,0.999999999991383,0.710824749942011,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
17908,GO:1902162,0.999999999991478,0.900687606887554,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17909,GO:1902164,0.999999999991478,0.900687606887554,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
8540,GO:0033842,0.999999999991479,0.856938644202883,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
16333,GO:0090498,0.999999999991498,0.84888920276595,0,2,extrinsic component of Golgi membrane,CC,
841,GO:0002144,0.999999999991501,0.933584841232681,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
20157,GO:2000809,0.999999999991508,0.836590803335957,0,2,positive regulation of synaptic vesicle clustering,BP,
18790,GO:1904247,0.99999999999151,0.927295280249102,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
10758,GO:0044128,0.999999999991523,0.918347849582284,0,1,positive regulation of growth of symbiont in host,BP,
10764,GO:0044148,0.999999999991523,0.918347849582284,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
1900,GO:0004581,0.999999999991526,0.950296355420196,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
6741,GO:0030156,0.999999999991545,0.962244969740733,0,1,benzodiazepine receptor binding,MF,
54,GO:0000111,0.999999999991575,0.925094659486097,0,1,nucleotide-excision repair factor 2 complex,CC,
7255,GO:0031208,0.999999999991587,0.845487061970738,0,2,POZ domain binding,MF,
18804,GO:1904288,0.99999999999159,0.719311271125668,0,4,BAT3 complex binding,MF,
6233,GO:0019781,0.999999999991602,0.874755896267596,0,2,NEDD8 activating enzyme activity,MF,
509,GO:0001572,0.99999999999164,0.919761418104975,0,1,lactosylceramide biosynthetic process,BP,
11708,GO:0046478,0.99999999999164,0.919761418104975,0,1,lactosylceramide metabolic process,BP,
3861,GO:0008478,0.999999999991683,0.906145621097261,0,1,pyridoxal kinase activity,MF,
4245,GO:0009443,0.999999999991683,0.906145621097261,0,1,pyridoxal 5'-phosphate salvage,BP,
7629,GO:0032021,0.999999999991689,0.742026707931245,0,4,NELF complex,CC,
19513,GO:1990246,0.999999999991689,0.742026707931245,0,4,uniplex complex,CC,
12476,GO:0050253,0.999999999991703,0.85254306538681,0,2,retinyl-palmitate esterase activity,MF,
6308,GO:0019934,0.999999999991707,0.683208617467104,0,5,cGMP-mediated signaling,BP,
2153,GO:0004969,0.999999999991712,0.855468302043426,0,2,histamine receptor activity,MF,
2994,GO:0006540,0.999999999991714,0.854852839702039,0,2,glutamate decarboxylation to succinate,BP,
18767,GO:1904207,0.999999999991729,0.863699814224612,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18768,GO:1904209,0.999999999991729,0.863699814224612,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
2149,GO:0004962,0.99999999999173,0.924282568817473,0,1,endothelin receptor activity,MF,
16074,GO:0086100,0.99999999999173,0.924282568817473,0,1,endothelin receptor signaling pathway,BP,
18618,GO:1903847,0.999999999991736,0.826347240809565,0,2,regulation of aorta morphogenesis,BP,
18619,GO:1903849,0.999999999991736,0.826347240809565,0,2,positive regulation of aorta morphogenesis,BP,
1830,GO:0004482,0.999999999991737,0.912377853185002,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
7437,GO:0031533,0.999999999991737,0.912377853185002,0,1,mRNA cap methyltransferase complex,CC,
17213,GO:0106005,0.999999999991737,0.912377853185002,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
19699,GO:1990928,0.999999999991756,0.841122194559024,0,2,response to amino acid starvation,BP,
18207,GO:1902952,0.999999999991757,0.874961633093118,0,2,positive regulation of dendritic spine maintenance,BP,
17405,GO:1900109,0.999999999991758,0.890666574901179,0,2,regulation of histone H3-K9 dimethylation,BP,
17406,GO:1900110,0.999999999991758,0.890666574901179,0,2,negative regulation of histone H3-K9 dimethylation,BP,
1291,GO:0003097,0.999999999991764,0.750276155892244,0,4,renal water transport,BP,
19063,GO:1904877,0.999999999991777,0.933480317254904,0,1,positive regulation of DNA ligase activity,BP,
2886,GO:0006391,0.999999999991779,0.810837777585389,0,3,transcription initiation from mitochondrial promoter,BP,
17190,GO:0102758,0.999999999991783,0.950308892498929,0,1,very-long-chain enoyl-CoA reductase activity,MF,
9315,GO:0035754,0.999999999991793,0.682641676452086,0,5,B cell chemotaxis,BP,
2684,GO:0006045,0.999999999991796,0.847898415747276,0,2,N-acetylglucosamine biosynthetic process,BP,
17567,GO:1901073,0.999999999991796,0.847898415747276,0,2,glucosamine-containing compound biosynthetic process,BP,
14541,GO:0070022,0.999999999991803,0.716256120765476,0,4,transforming growth factor beta receptor complex,CC,
14493,GO:0061880,0.999999999991803,0.939022456544296,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14494,GO:0061881,0.999999999991803,0.939022456544296,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
3996,GO:0008893,0.99999999999181,0.953620872903481,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5684,GO:0016794,0.99999999999181,0.953620872903481,0,1,diphosphoric monoester hydrolase activity,MF,
1939,GO:0004637,0.999999999991817,0.925768329641112,0,1,phosphoribosylamine-glycine ligase activity,MF,
1942,GO:0004641,0.999999999991817,0.925768329641112,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1945,GO:0004644,0.999999999991817,0.925768329641112,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
4353,GO:0009922,0.999999999991823,0.694674744934605,0,5,fatty acid elongase activity,MF,
6122,GO:0019367,0.999999999991823,0.694674744934605,0,5,fatty acid elongation, saturated fatty acid,BP,
6123,GO:0019368,0.999999999991823,0.694674744934605,0,5,fatty acid elongation, unsaturated fatty acid,BP,
8844,GO:0034625,0.999999999991823,0.694674744934605,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8845,GO:0034626,0.999999999991823,0.694674744934605,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
17156,GO:0102336,0.999999999991823,0.694674744934605,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17157,GO:0102337,0.999999999991823,0.694674744934605,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17158,GO:0102338,0.999999999991823,0.694674744934605,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17189,GO:0102756,0.999999999991823,0.694674744934605,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
5783,GO:0017002,0.999999999991827,0.623687619054729,0,5,activin-activated receptor activity,MF,
19322,GO:1905535,0.999999999991839,0.917601865553937,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19323,GO:1905537,0.999999999991839,0.917601865553937,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19354,GO:1905610,0.999999999991839,0.917601865553937,0,1,regulation of mRNA cap binding,BP,
19355,GO:1905612,0.999999999991839,0.917601865553937,0,1,positive regulation of mRNA cap binding,BP,
1847,GO:0004500,0.999999999991842,0.927436478001239,0,1,dopamine beta-monooxygenase activity,MF,
3037,GO:0006589,0.999999999991842,0.927436478001239,0,1,octopamine biosynthetic process,BP,
11645,GO:0046333,0.999999999991842,0.927436478001239,0,1,octopamine metabolic process,BP,
15593,GO:0072038,0.999999999991849,0.853327461092666,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15594,GO:0072039,0.999999999991849,0.853327461092666,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15595,GO:0072040,0.999999999991849,0.853327461092666,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17586,GO:1901145,0.999999999991849,0.853327461092666,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18956,GO:1904673,0.999999999991849,0.853327461092666,0,2,negative regulation of somatic stem cell population maintenance,BP,
18698,GO:1904017,0.999999999991855,0.829209186623696,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
3508,GO:0007418,0.999999999991855,0.840799787317427,0,2,ventral midline development,BP,
6537,GO:0021937,0.999999999991855,0.840799787317427,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6538,GO:0021938,0.999999999991855,0.840799787317427,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6539,GO:0021940,0.999999999991855,0.840799787317427,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
7015,GO:0030696,0.999999999991862,0.926926616715538,0,1,tRNA (m5U54) methyltransferase activity,MF,
7016,GO:0030697,0.999999999991862,0.926926616715538,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
13794,GO:0060352,0.999999999991897,0.698399771818112,0,5,cell adhesion molecule production,BP,
10108,GO:0042608,0.999999999991899,0.816697427621966,0,3,T cell receptor binding,MF,
8924,GO:0034757,0.9999999999919,0.900306132534849,0,1,negative regulation of iron ion transport,BP,
8925,GO:0034759,0.9999999999919,0.900306132534849,0,1,regulation of iron ion transmembrane transport,BP,
8926,GO:0034760,0.9999999999919,0.900306132534849,0,1,negative regulation of iron ion transmembrane transport,BP,
477,GO:0001520,0.999999999991901,0.846184861283587,0,2,outer dense fiber,CC,
19078,GO:1904895,0.999999999991916,0.939642822409532,0,1,ESCRT complex assembly,BP,
19080,GO:1904902,0.999999999991916,0.939642822409532,0,1,ESCRT III complex assembly,BP,
16016,GO:0086008,0.999999999991919,0.928125802801647,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16069,GO:0086089,0.999999999991919,0.928125802801647,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17966,GO:1902282,0.999999999991919,0.928125802801647,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
9263,GO:0035663,0.999999999991948,0.857204237895441,0,2,Toll-like receptor 2 binding,MF,
3046,GO:0006601,0.999999999991971,0.954587626173885,0,1,creatine biosynthetic process,BP,
7024,GO:0030731,0.999999999991971,0.954587626173885,0,1,guanidinoacetate N-methyltransferase activity,MF,
9935,GO:0042272,0.999999999991977,0.815491488513793,0,2,nuclear RNA export factor complex,CC,
12393,GO:0048769,0.999999999992006,0.574818778175698,0,2,sarcomerogenesis,BP,
17618,GO:1901252,0.99999999999201,0.881759733233334,0,2,regulation of intracellular transport of viral material,BP,
3436,GO:0007228,0.999999999992014,0.849818758307761,0,2,positive regulation of hh target transcription factor activity,BP,
5220,GO:0015820,0.999999999992015,0.85934547216413,0,2,leucine transport,BP,
7658,GO:0032072,0.999999999992022,0.925857517899021,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7868,GO:0032423,0.999999999992022,0.925857517899021,0,1,regulation of mismatch repair,BP,
7869,GO:0032425,0.999999999992022,0.925857517899021,0,1,positive regulation of mismatch repair,BP,
9287,GO:0035711,0.999999999992022,0.925857517899021,0,1,T-helper 1 cell activation,BP,
19960,GO:2000426,0.999999999992022,0.925857517899021,0,1,negative regulation of apoptotic cell clearance,BP,
12996,GO:0051379,0.999999999992028,0.870559045043047,0,2,epinephrine binding,MF,
10180,GO:0042758,0.999999999992034,0.750005729423168,0,4,long-chain fatty acid catabolic process,BP,
16940,GO:0098888,0.999999999992041,0.906782318441864,0,1,extrinsic component of presynaptic membrane,CC,
16941,GO:0098890,0.999999999992041,0.906782318441864,0,1,extrinsic component of postsynaptic membrane,CC,
17050,GO:0099243,0.999999999992041,0.906782318441864,0,1,extrinsic component of synaptic membrane,CC,
13823,GO:0060392,0.999999999992043,0.883409661761579,0,2,negative regulation of SMAD protein signal transduction,BP,
17355,GO:1900003,0.999999999992054,0.832799910273323,0,3,regulation of serine-type endopeptidase activity,BP,
17356,GO:1900004,0.999999999992054,0.832799910273323,0,3,negative regulation of serine-type endopeptidase activity,BP,
18070,GO:1902571,0.999999999992054,0.832799910273323,0,3,regulation of serine-type peptidase activity,BP,
18071,GO:1902572,0.999999999992054,0.832799910273323,0,3,negative regulation of serine-type peptidase activity,BP,
13005,GO:0051389,0.999999999992057,0.814911125226515,0,2,inactivation of MAPKK activity,BP,
17684,GO:1901491,0.999999999992075,0.845537689943818,0,2,negative regulation of lymphangiogenesis,BP,
6015,GO:0019061,0.999999999992088,0.931963973664997,0,1,uncoating of virus,BP,
16145,GO:0090119,0.999999999992091,0.921162712667923,0,1,vesicle-mediated cholesterol transport,BP,
18806,GO:1904290,0.999999999992091,0.921162712667923,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
19697,GO:1990926,0.999999999992091,0.921162712667923,0,1,short-term synaptic potentiation,BP,
9678,GO:0038028,0.999999999992099,0.731021774970677,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
15634,GO:0072103,0.999999999992101,0.846203226764633,0,2,glomerulus vasculature morphogenesis,BP,
15635,GO:0072104,0.999999999992101,0.846203226764633,0,2,glomerular capillary formation,BP,
10217,GO:0042823,0.999999999992106,0.838803768890627,0,2,pyridoxal phosphate biosynthetic process,BP,
4404,GO:0010138,0.999999999992125,0.777279368265816,0,4,pyrimidine ribonucleotide salvage,BP,
10770,GO:0044206,0.999999999992125,0.777279368265816,0,4,UMP salvage,BP,
17180,GO:0102522,0.999999999992131,0.932512424437506,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
13954,GO:0060598,0.999999999992135,0.948682250445091,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
8760,GO:0034414,0.999999999992163,0.861766893351867,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10195,GO:0042779,0.999999999992163,0.861766893351867,0,2,tRNA 3'-trailer cleavage,BP,
10197,GO:0042781,0.999999999992163,0.861766893351867,0,2,3'-tRNA processing endoribonuclease activity,MF,
19215,GO:1905267,0.999999999992163,0.861766893351867,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
19547,GO:1990405,0.999999999992165,0.694153540694548,0,4,protein antigen binding,MF,
18338,GO:1903236,0.999999999992172,0.80893603737033,0,3,regulation of leukocyte tethering or rolling,BP,
14207,GO:0061086,0.999999999992179,0.735955536941347,0,4,negative regulation of histone H3-K27 methylation,BP,
9479,GO:0036090,0.999999999992183,0.873400202507071,0,2,cleavage furrow ingression,BP,
5145,GO:0015670,0.99999999999219,0.939607759146728,0,1,carbon dioxide transport,BP,
8148,GO:0032849,0.99999999999219,0.939607759146728,0,1,positive regulation of cellular pH reduction,BP,
20324,GO:2001270,0.999999999992192,0.754950899417079,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
2071,GO:0004822,0.999999999992206,0.8525693337336,0,2,isoleucine-tRNA ligase activity,MF,
2917,GO:0006428,0.999999999992206,0.8525693337336,0,2,isoleucyl-tRNA aminoacylation,BP,
7316,GO:0031314,0.999999999992207,0.676314205688957,0,5,extrinsic component of mitochondrial inner membrane,CC,
9500,GO:0036128,0.99999999999221,0.868920953462623,0,2,CatSper complex,CC,
1962,GO:0004663,0.999999999992259,0.764407790564318,0,4,Rab geranylgeranyltransferase activity,MF,
8542,GO:0033858,0.999999999992277,0.926896942862578,0,1,N-acetylgalactosamine kinase activity,MF,
1562,GO:0003958,0.999999999992278,0.669066308499208,0,5,NADPH-hemoprotein reductase activity,MF,
17568,GO:1901074,0.999999999992293,0.908931553636884,0,1,regulation of engulfment of apoptotic cell,BP,
17569,GO:1901076,0.999999999992293,0.908931553636884,0,1,positive regulation of engulfment of apoptotic cell,BP,
2058,GO:0004807,0.9999999999923,0.94361539405932,0,1,triose-phosphate isomerase activity,MF,
18469,GO:1903526,0.999999999992304,0.852547278321368,0,2,negative regulation of membrane tubulation,BP,
963,GO:0002384,0.999999999992308,0.87685082943539,0,2,hepatic immune response,BP,
4667,GO:0010813,0.999999999992314,0.866097171550756,0,2,neuropeptide catabolic process,BP,
3592,GO:0008020,0.999999999992315,0.862004125229934,0,2,G-protein coupled photoreceptor activity,MF,
9602,GO:0036446,0.99999999999232,0.78214250086412,0,3,myofibroblast differentiation,BP,
19005,GO:1904760,0.99999999999232,0.78214250086412,0,3,regulation of myofibroblast differentiation,BP,
9597,GO:0036438,0.999999999992328,0.742644239495001,0,4,maintenance of lens transparency,BP,
17409,GO:1900114,0.999999999992337,0.842171172526148,0,2,positive regulation of histone H3-K9 trimethylation,BP,
13684,GO:0060180,0.999999999992357,0.7824524233371,0,3,female mating behavior,BP,
8787,GO:0034458,0.999999999992369,0.856616426659587,0,2,3'-5' RNA helicase activity,MF,
10468,GO:0043316,0.99999999999237,0.859544194080134,0,2,cytotoxic T cell degranulation,BP,
942,GO:0002349,0.999999999992374,0.719326073249945,0,5,histamine production involved in inflammatory response,BP,
987,GO:0002441,0.999999999992374,0.719326073249945,0,5,histamine secretion involved in inflammatory response,BP,
1042,GO:0002553,0.999999999992374,0.719326073249945,0,5,histamine secretion by mast cell,BP,
7508,GO:0031681,0.999999999992378,0.687512567142126,0,5,G-protein beta-subunit binding,MF,
5970,GO:0018395,0.999999999992389,0.925075084368031,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6562,GO:0021998,0.999999999992389,0.925075084368031,0,1,neural plate mediolateral regionalization,BP,
8528,GO:0033746,0.999999999992389,0.925075084368031,0,1,histone demethylase activity (H3-R2 specific),MF,
8529,GO:0033749,0.999999999992389,0.925075084368031,0,1,histone demethylase activity (H4-R3 specific),MF,
12206,GO:0048338,0.999999999992389,0.925075084368031,0,1,mesoderm structural organization,BP,
12210,GO:0048352,0.999999999992389,0.925075084368031,0,1,paraxial mesoderm structural organization,BP,
14569,GO:0070077,0.999999999992389,0.925075084368031,0,1,histone arginine demethylation,BP,
14570,GO:0070078,0.999999999992389,0.925075084368031,0,1,histone H3-R2 demethylation,BP,
14571,GO:0070079,0.999999999992389,0.925075084368031,0,1,histone H4-R3 demethylation,BP,
18856,GO:1904412,0.999999999992389,0.925075084368031,0,1,regulation of cardiac ventricle development,BP,
18857,GO:1904414,0.999999999992389,0.925075084368031,0,1,positive regulation of cardiac ventricle development,BP,
19225,GO:1905285,0.999999999992389,0.925075084368031,0,1,fibrous ring of heart morphogenesis,BP,
18636,GO:1903893,0.999999999992394,0.930299400621511,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
14945,GO:0070780,0.999999999992396,0.87963578766747,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
19196,GO:1905206,0.999999999992401,0.687750533245545,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
13482,GO:0052925,0.999999999992403,0.942416548963717,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
19386,GO:1905767,0.999999999992404,0.909413708054108,0,1,regulation of double-stranded telomeric DNA binding,BP,
19387,GO:1905768,0.999999999992404,0.909413708054108,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
5471,GO:0016401,0.999999999992406,0.8484534807346,0,2,palmitoyl-CoA oxidase activity,MF,
11736,GO:0046525,0.999999999992434,0.93862168281588,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
16316,GO:0090402,0.999999999992446,0.868127548740261,0,2,oncogene-induced cell senescence,BP,
6350,GO:0021523,0.999999999992453,0.875337015468971,0,2,somatic motor neuron differentiation,BP,
13185,GO:0051754,0.999999999992475,0.796730201908438,0,3,meiotic sister chromatid cohesion, centromeric,BP,
19162,GO:1905089,0.999999999992502,0.881215661688395,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19163,GO:1905090,0.999999999992502,0.881215661688395,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
11133,GO:0045144,0.999999999992503,0.710344453256445,0,5,meiotic sister chromatid segregation,BP,
3878,GO:0008507,0.999999999992517,0.925223851836935,0,1,sodium:iodide symporter activity,MF,
14538,GO:0070012,0.999999999992517,0.864313074988886,0,2,oligopeptidase activity,MF,
17236,GO:0106073,0.999999999992518,0.827219360772297,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
9061,GO:0035276,0.99999999999252,0.916029807330496,0,1,ethanol binding,MF,
9267,GO:0035668,0.99999999999252,0.916029807330496,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9268,GO:0035669,0.99999999999252,0.916029807330496,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
20217,GO:2001029,0.99999999999252,0.916029807330496,0,1,regulation of cellular glucuronidation,BP,
20218,GO:2001031,0.99999999999252,0.916029807330496,0,1,positive regulation of cellular glucuronidation,BP,
16039,GO:0086040,0.999999999992528,0.920945412326003,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16071,GO:0086092,0.999999999992528,0.920945412326003,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
19631,GO:1990730,0.999999999992538,0.855107278116036,0,2,VCP-NSFL1C complex,CC,
15993,GO:0080121,0.999999999992541,0.864045585834917,0,2,AMP transport,BP,
14555,GO:0070053,0.999999999992543,0.852591233712408,0,2,thrombospondin receptor activity,MF,
2479,GO:0005712,0.99999999999255,0.840806262283438,0,2,chiasma,CC,
9261,GO:0035659,0.999999999992565,0.938837486696419,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
11142,GO:0045167,0.999999999992565,0.938837486696419,0,1,asymmetric protein localization involved in cell fate determination,BP,
14746,GO:0070390,0.999999999992565,0.938837486696419,0,1,transcription export complex 2,CC,
19073,GO:1904889,0.999999999992565,0.938837486696419,0,1,regulation of excitatory synapse assembly,BP,
19074,GO:1904891,0.999999999992565,0.938837486696419,0,1,positive regulation of excitatory synapse assembly,BP,
2410,GO:0005579,0.999999999992578,0.916195965223823,0,1,membrane attack complex,CC,
9248,GO:0035634,0.999999999992578,0.960388064058183,0,1,response to stilbenoid,BP,
5580,GO:0016594,0.999999999992579,0.692085537052707,0,5,glycine binding,MF,
17498,GO:1900370,0.999999999992585,0.916773401363075,0,1,positive regulation of RNA interference,BP,
8279,GO:0033065,0.999999999992587,0.889198520886066,0,2,Rad51C-XRCC3 complex,CC,
16505,GO:0097176,0.999999999992587,0.763910479257733,0,4,epoxide metabolic process,BP,
12238,GO:0048476,0.999999999992637,0.728409093603421,0,5,Holliday junction resolvase complex,CC,
15547,GO:0071920,0.999999999992648,0.868098257096627,0,2,cleavage body,CC,
10823,GO:0044301,0.999999999992649,0.921389947042357,0,1,climbing fiber,CC,
19459,GO:1990032,0.999999999992649,0.921389947042357,0,1,parallel fiber,CC,
8146,GO:0032847,0.999999999992652,0.86837352314541,0,2,regulation of cellular pH reduction,BP,
1750,GO:0004347,0.999999999992657,0.933754786055739,0,1,glucose-6-phosphate isomerase activity,MF,
6088,GO:0019242,0.999999999992657,0.933754786055739,0,1,methylglyoxal biosynthetic process,BP,
17598,GO:1901187,0.999999999992662,0.848895257171541,0,2,regulation of ephrin receptor signaling pathway,BP,
5000,GO:0015140,0.999999999992687,0.87788437979846,0,2,malate transmembrane transporter activity,MF,
13751,GO:0060300,0.999999999992704,0.819003243818555,0,3,regulation of cytokine activity,BP,
11854,GO:0046790,0.999999999992709,0.712217548949578,0,4,virion binding,MF,
8653,GO:0034188,0.999999999992728,0.809243868013724,0,2,apolipoprotein A-I receptor activity,MF,
16349,GO:0090554,0.999999999992728,0.809243868013724,0,2,phosphatidylcholine-translocating ATPase activity,MF,
16350,GO:0090556,0.999999999992728,0.809243868013724,0,2,phosphatidylserine-translocating ATPase activity,MF,
13076,GO:0051548,0.999999999992739,0.829306182647217,0,2,negative regulation of keratinocyte migration,BP,
8917,GO:0034750,0.999999999992746,0.849662373531361,0,2,Scrib-APC-beta-catenin complex,CC,
356,GO:0000973,0.999999999992778,0.798542993203356,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
5213,GO:0015810,0.999999999992784,0.855886842859209,0,2,aspartate transmembrane transport,BP,
10552,GO:0043490,0.999999999992784,0.855886842859209,0,2,malate-aspartate shuttle,BP,
8393,GO:0033291,0.999999999992791,0.973590679575319,0,1,eukaryotic 80S initiation complex,CC,
8790,GO:0034463,0.999999999992791,0.973590679575319,0,1,90S preribosome assembly,BP,
9968,GO:0042328,0.999999999992809,0.773022230474238,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
15048,GO:0070973,0.99999999999281,0.704176816669753,0,4,protein localization to endoplasmic reticulum exit site,BP,
13024,GO:0051430,0.999999999992817,0.861206893980784,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
4298,GO:0009737,0.999999999992817,0.92200221408177,0,1,response to abscisic acid,BP,
4299,GO:0009738,0.999999999992817,0.92200221408177,0,1,abscisic acid-activated signaling pathway,BP,
4312,GO:0009787,0.999999999992817,0.92200221408177,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4313,GO:0009789,0.999999999992817,0.92200221408177,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
15142,GO:0071215,0.999999999992817,0.92200221408177,0,1,cellular response to abscisic acid stimulus,BP,
17679,GO:1901419,0.999999999992817,0.92200221408177,0,1,regulation of response to alcohol,BP,
17680,GO:1901421,0.999999999992817,0.92200221408177,0,1,positive regulation of response to alcohol,BP,
19446,GO:1905957,0.999999999992817,0.92200221408177,0,1,regulation of cellular response to alcohol,BP,
19447,GO:1905959,0.999999999992817,0.92200221408177,0,1,positive regulation of cellular response to alcohol,BP,
18391,GO:1903361,0.999999999992826,0.701481377431395,0,5,protein localization to basolateral plasma membrane,BP,
15976,GO:0075525,0.999999999992829,0.70771927017847,0,5,viral translational termination-reinitiation,BP,
124,GO:0000254,0.99999999999283,0.861420805685568,0,2,C-4 methylsterol oxidase activity,MF,
1831,GO:0004483,0.99999999999283,0.861420805685568,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2887,GO:0006393,0.99999999999283,0.861420805685568,0,2,termination of mitochondrial transcription,BP,
3208,GO:0006850,0.99999999999283,0.861420805685568,0,2,mitochondrial pyruvate transmembrane transport,BP,
5540,GO:0016524,0.99999999999283,0.861420805685568,0,2,latrotoxin receptor activity,MF,
6022,GO:0019075,0.99999999999283,0.861420805685568,0,2,virus maturation,BP,
7731,GO:0032217,0.99999999999283,0.861420805685568,0,2,riboflavin transmembrane transporter activity,MF,
7732,GO:0032218,0.99999999999283,0.861420805685568,0,2,riboflavin transport,BP,
8118,GO:0032798,0.99999999999283,0.861420805685568,0,2,Swi5-Sfr1 complex,CC,
9604,GO:0036451,0.99999999999283,0.861420805685568,0,2,cap mRNA methylation,BP,
15376,GO:0071595,0.99999999999283,0.861420805685568,0,2,Nem1-Spo7 phosphatase complex,CC,
16568,GO:0097309,0.99999999999283,0.861420805685568,0,2,cap1 mRNA methylation,BP,
19479,GO:1990112,0.99999999999283,0.861420805685568,0,2,RQC complex,CC,
19480,GO:1990116,0.99999999999283,0.861420805685568,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19683,GO:1990879,0.99999999999283,0.861420805685568,0,2,CST complex,CC,
20002,GO:2000543,0.99999999999283,0.861420805685568,0,2,positive regulation of gastrulation,BP,
1665,GO:0004118,0.99999999999283,0.922682245310667,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
6918,GO:0030504,0.99999999999286,0.901821518214848,0,1,inorganic diphosphate transmembrane transporter activity,MF,
10521,GO:0043415,0.99999999999287,0.746017153990193,0,4,positive regulation of skeletal muscle tissue regeneration,BP,
10522,GO:0043416,0.99999999999287,0.746017153990193,0,4,regulation of skeletal muscle tissue regeneration,BP,
20074,GO:2000663,0.999999999992877,0.925032013845185,0,1,negative regulation of interleukin-5 secretion,BP,
10701,GO:0043969,0.999999999992905,0.898853390718707,0,1,histone H2B acetylation,BP,
14507,GO:0061920,0.999999999992905,0.898853390718707,0,1,protein propionyltransferase activity,MF,
14508,GO:0061921,0.999999999992905,0.898853390718707,0,1,peptidyl-lysine propionylation,BP,
17315,GO:0140064,0.999999999992905,0.898853390718707,0,1,peptide crotonyltransferase activity,MF,
17316,GO:0140065,0.999999999992905,0.898853390718707,0,1,peptide butyryltransferase activity,MF,
17318,GO:0140067,0.999999999992905,0.898853390718707,0,1,peptidyl-lysine butyrylation,BP,
17319,GO:0140068,0.999999999992905,0.898853390718707,0,1,histone crotonyltransferase activity,MF,
17320,GO:0140069,0.999999999992905,0.898853390718707,0,1,histone butyryltransferase activity,MF,
19962,GO:2000434,0.999999999992931,0.921573532677193,0,2,regulation of protein neddylation,BP,
19963,GO:2000435,0.999999999992931,0.921573532677193,0,2,negative regulation of protein neddylation,BP,
3883,GO:0008513,0.99999999999295,0.932679691644152,0,1,secondary active organic cation transmembrane transporter activity,MF,
1679,GO:0004140,0.999999999992952,0.870503156139889,0,2,dephospho-CoA kinase activity,MF,
13614,GO:0060061,0.999999999992966,0.858495728025699,0,2,Spemann organizer formation,BP,
6886,GO:0030377,0.999999999992975,0.944058843269105,0,1,urokinase plasminogen activator receptor activity,MF,
9750,GO:0038195,0.999999999992975,0.944058843269105,0,1,urokinase plasminogen activator signaling pathway,BP,
15056,GO:0070984,0.999999999992992,0.922836981553059,0,1,SET domain binding,MF,
13182,GO:0051747,0.999999999992997,0.900204705071682,0,2,cytosine C-5 DNA demethylase activity,MF,
3644,GO:0008118,0.999999999993,0.932407495080003,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
12028,GO:0047536,0.999999999993,0.932407495080003,0,1,2-aminoadipate transaminase activity,MF,
8289,GO:0033085,0.999999999993017,0.713957918507706,0,5,negative regulation of T cell differentiation in thymus,BP,
18749,GO:1904167,0.999999999993044,0.890163920859172,0,1,regulation of thyroid hormone receptor activity,BP,
18750,GO:1904168,0.999999999993044,0.890163920859172,0,1,negative regulation of thyroid hormone receptor activity,BP,
11401,GO:0045762,0.999999999993077,0.814494994280137,0,2,positive regulation of adenylate cyclase activity,BP,
4172,GO:0009237,0.999999999993109,0.927988702446376,0,1,siderophore metabolic process,BP,
6098,GO:0019290,0.999999999993109,0.927988702446376,0,1,siderophore biosynthetic process,BP,
8257,GO:0033026,0.99999999999311,0.916749394691292,0,1,negative regulation of mast cell apoptotic process,BP,
4458,GO:0010428,0.999999999993122,0.914026523218583,0,1,methyl-CpNpG binding,MF,
14193,GO:0061055,0.999999999993126,0.840347352986308,0,2,myotome development,BP,
19691,GO:1990910,0.999999999993126,0.826943115414825,0,3,response to hypobaric hypoxia,BP,
1409,GO:0003340,0.999999999993131,0.856659334994698,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
20095,GO:2000697,0.999999999993131,0.856659334994698,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
19522,GO:1990264,0.999999999993141,0.863518300678896,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
2150,GO:0004965,0.999999999993143,0.85071467820648,0,2,G-protein coupled GABA receptor activity,MF,
271,GO:0000773,0.999999999993145,0.954940357575054,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
1918,GO:0004608,0.999999999993145,0.954940357575054,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
11965,GO:0047035,0.999999999993145,0.954940357575054,0,1,testosterone dehydrogenase (NAD+) activity,MF,
15990,GO:0080101,0.999999999993145,0.954940357575054,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
14452,GO:0061749,0.99999999999315,0.842544124770666,0,2,forked DNA-dependent helicase activity,MF,
14489,GO:0061849,0.99999999999315,0.842544124770666,0,2,telomeric G-quadruplex DNA binding,MF,
13849,GO:0060426,0.999999999993158,0.815511955922298,0,3,lung vasculature development,BP,
11192,GO:0045259,0.999999999993158,0.88139903196558,0,2,proton-transporting ATP synthase complex,CC,
12306,GO:0048619,0.999999999993159,0.928386500107261,0,1,embryonic hindgut morphogenesis,BP,
4194,GO:0009298,0.999999999993166,0.778708848355173,0,4,GDP-mannose biosynthetic process,BP,
16733,GO:0097699,0.999999999993168,0.921501529204482,0,1,vascular endothelial cell response to fluid shear stress,BP,
18050,GO:1902528,0.999999999993173,0.900777760257652,0,1,regulation of protein linear polyubiquitination,BP,
18051,GO:1902530,0.999999999993173,0.900777760257652,0,1,positive regulation of protein linear polyubiquitination,BP,
6534,GO:0021934,0.999999999993179,0.810407370203355,0,2,hindbrain tangential cell migration,BP,
6535,GO:0021935,0.999999999993179,0.810407370203355,0,2,cerebellar granule cell precursor tangential migration,BP,
17504,GO:1900378,0.999999999993215,0.834588205437521,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
2335,GO:0005350,0.999999999993216,0.864851793191003,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
5239,GO:0015855,0.999999999993216,0.864851793191003,0,2,pyrimidine nucleobase transport,BP,
19036,GO:1904823,0.999999999993216,0.864851793191003,0,2,purine nucleobase transmembrane transport,BP,
4668,GO:0010814,0.999999999993242,0.918149121230671,0,1,substance P catabolic process,BP,
4670,GO:0010816,0.999999999993242,0.918149121230671,0,1,calcitonin catabolic process,BP,
7308,GO:0031302,0.999999999993242,0.918149121230671,0,1,intrinsic component of endosome membrane,CC,
8940,GO:0034959,0.999999999993242,0.918149121230671,0,1,endothelin maturation,BP,
4169,GO:0009234,0.99999999999328,0.924969345231143,0,1,menaquinone biosynthetic process,BP,
7713,GO:0032194,0.99999999999328,0.924969345231143,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
9989,GO:0042371,0.99999999999328,0.924969345231143,0,1,vitamin K biosynthetic process,BP,
7534,GO:0031749,0.999999999993282,0.857061448241745,0,2,D2 dopamine receptor binding,MF,
16207,GO:0090210,0.9999999999933,0.856639359716834,0,2,regulation of establishment of blood-brain barrier,BP,
14420,GO:0061673,0.999999999993305,0.675226777641901,0,5,mitotic spindle astral microtubule,CC,
12830,GO:0051106,0.999999999993326,0.69340170149993,0,5,positive regulation of DNA ligation,BP,
18428,GO:1903430,0.999999999993329,0.770372734065263,0,4,negative regulation of cell maturation,BP,
16640,GO:0097470,0.999999999993336,0.648417635780945,0,5,ribbon synapse,CC,
11986,GO:0047220,0.999999999993336,0.928659786057913,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
8458,GO:0033578,0.999999999993341,0.680820620358044,0,5,protein glycosylation in Golgi,BP,
17423,GO:1900133,0.999999999993341,0.795272044813329,0,3,regulation of renin secretion into blood stream,BP,
863,GO:0002191,0.999999999993341,0.803143051714746,0,3,cap-dependent translational initiation,BP,
9063,GO:0035279,0.99999999999336,0.858691899001153,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
16885,GO:0098795,0.99999999999336,0.858691899001153,0,2,mRNA cleavage involved in gene silencing,BP,
7368,GO:0031405,0.999999999993363,0.888497549147678,0,1,lipoic acid binding,MF,
10668,GO:0043754,0.999999999993363,0.888497549147678,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
7535,GO:0031752,0.999999999993364,0.840614947867487,0,2,D5 dopamine receptor binding,MF,
673,GO:0001880,0.999999999993389,0.840059361729762,0,2,Mullerian duct regression,BP,
16929,GO:0098871,0.999999999993394,0.939158335088496,0,1,postsynaptic actin cytoskeleton,CC,
17095,GO:0099571,0.999999999993394,0.939158335088496,0,1,postsynaptic cytoskeleton,CC,
8076,GO:0032741,0.999999999993414,0.852536712661549,0,2,positive regulation of interleukin-18 production,BP,
18155,GO:1902824,0.999999999993429,0.891873978920386,0,2,positive regulation of late endosome to lysosome transport,BP,
18383,GO:1903337,0.999999999993429,0.891873978920386,0,2,positive regulation of vacuolar transport,BP,
817,GO:0002087,0.999999999993434,0.662337777259321,0,5,regulation of respiratory gaseous exchange by neurological system process,BP,
928,GO:0002322,0.999999999993443,0.845266685549248,0,2,B cell proliferation involved in immune response,BP,
19687,GO:1990889,0.999999999993458,0.936531071117217,0,1,H4K20me3 modified histone binding,MF,
14319,GO:0061419,0.999999999993464,0.662515450268339,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
10677,GO:0043890,0.999999999993469,0.931192950691119,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
12012,GO:0047391,0.999999999993472,0.869284608165854,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
14754,GO:0070408,0.999999999993478,0.914821182868452,0,1,carbamoyl phosphate metabolic process,BP,
14755,GO:0070409,0.999999999993478,0.914821182868452,0,1,carbamoyl phosphate biosynthetic process,BP,
18555,GO:1903717,0.999999999993478,0.914821182868452,0,1,response to ammonia,BP,
18556,GO:1903718,0.999999999993478,0.914821182868452,0,1,cellular response to ammonia,BP,
7153,GO:0030997,0.999999999993485,0.778600710308145,0,3,regulation of centriole-centriole cohesion,BP,
14978,GO:0070856,0.999999999993497,0.913051478216463,0,1,myosin VI light chain binding,MF,
9693,GO:0038062,0.999999999993502,0.92423460065383,0,1,protein tyrosine kinase collagen receptor activity,MF,
16470,GO:0097113,0.999999999993515,0.671781387365658,0,5,AMPA glutamate receptor clustering,BP,
16727,GO:0097688,0.999999999993515,0.671781387365658,0,5,glutamate receptor clustering,BP,
371,GO:0000992,0.999999999993516,0.844582324686517,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0001002,0.999999999993516,0.844582324686517,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
376,GO:0001003,0.999999999993516,0.844582324686517,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
2571,GO:0005854,0.999999999993529,0.876002667101658,0,2,nascent polypeptide-associated complex,CC,
15519,GO:0071873,0.999999999993532,0.925651798168265,0,1,response to norepinephrine,BP,
15520,GO:0071874,0.999999999993532,0.925651798168265,0,1,cellular response to norepinephrine stimulus,BP,
19595,GO:1990575,0.999999999993541,0.859954469926731,0,2,mitochondrial L-ornithine transmembrane transport,BP,
14339,GO:0061474,0.999999999993546,0.930006121197049,0,1,phagolysosome membrane,CC,
1247,GO:0002944,0.999999999993549,0.84012331739714,0,2,cyclin K-CDK12 complex,CC,
12209,GO:0048341,0.999999999993561,0.727102424569162,0,4,paraxial mesoderm formation,BP,
6419,GO:0021679,0.99999999999357,0.859028231446619,0,2,cerebellar molecular layer development,BP,
6426,GO:0021687,0.99999999999357,0.859028231446619,0,2,cerebellar molecular layer morphogenesis,BP,
19700,GO:1990930,0.99999999999358,0.941330131058122,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
7461,GO:0031592,0.99999999999358,0.90320712400555,0,1,centrosomal corona,CC,
18874,GO:1904454,0.99999999999358,0.90320712400555,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
3986,GO:0008832,0.999999999993583,0.926768470313621,0,1,dGTPase activity,MF,
5683,GO:0016793,0.999999999993583,0.926768470313621,0,1,triphosphoric monoester hydrolase activity,MF,
7967,GO:0032560,0.999999999993583,0.926768470313621,0,1,guanyl deoxyribonucleotide binding,MF,
7970,GO:0032567,0.999999999993583,0.926768470313621,0,1,dGTP binding,MF,
6883,GO:0030372,0.999999999993601,0.919842119008652,0,1,high molecular weight B cell growth factor receptor binding,MF,
7245,GO:0031161,0.999999999993601,0.926996852149096,0,1,phosphatidylinositol catabolic process,BP,
15057,GO:0070985,0.999999999993602,0.890795310777945,0,2,TFIIK complex,CC,
18964,GO:1904685,0.99999999999361,0.856560007005974,0,2,positive regulation of metalloendopeptidase activity,BP,
9565,GO:0036324,0.999999999993636,0.876393243914197,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
3887,GO:0008518,0.999999999993638,0.928396296034579,0,1,reduced folate carrier activity,MF,
16913,GO:0098838,0.999999999993638,0.928396296034579,0,1,reduced folate transmembrane transport,BP,
2210,GO:0005093,0.999999999993639,0.866519880941149,0,2,Rab GDP-dissociation inhibitor activity,MF,
13867,GO:0060448,0.999999999993641,0.765951622134693,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
11761,GO:0046586,0.999999999993645,0.888026514602704,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
4408,GO:0010157,0.999999999993653,0.903797239121243,0,1,response to chlorate,BP,
16465,GO:0097108,0.999999999993653,0.903797239121243,0,1,hedgehog family protein binding,MF,
438,GO:0001172,0.999999999993655,0.889539180695694,0,2,transcription, RNA-templated,BP,
1567,GO:0003968,0.999999999993655,0.889539180695694,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
3988,GO:0008852,0.999999999993674,0.928425745694142,0,1,exodeoxyribonuclease I activity,MF,
8955,GO:0034991,0.999999999993676,0.860044457266299,0,2,nuclear meiotic cohesin complex,CC,
7715,GO:0032197,0.999999999993677,0.923850522267738,0,1,transposition, RNA-mediated,BP,
19502,GO:1990175,0.999999999993677,0.923850522267738,0,1,EH domain binding,MF,
470,GO:0001512,0.999999999993683,0.951041506774993,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
18855,GO:1904408,0.999999999993683,0.951041506774993,0,1,melatonin binding,MF,
19344,GO:1905594,0.999999999993683,0.951041506774993,0,1,resveratrol binding,MF,
1697,GO:0004169,0.999999999993692,0.742105814641499,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
16907,GO:0098829,0.9999999999937,0.910895654715063,0,1,intestinal folate absorption,BP,
18871,GO:1904447,0.9999999999937,0.910895654715063,0,1,folic acid import across plasma membrane,BP,
4908,GO:0014839,0.999999999993701,0.884969338141998,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
4182,GO:0009258,0.999999999993706,0.905383997662713,0,1,10-formyltetrahydrofolate catabolic process,BP,
5369,GO:0016155,0.999999999993706,0.905383997662713,0,1,formyltetrahydrofolate dehydrogenase activity,MF,
19343,GO:1905590,0.999999999993715,0.927065359527368,0,1,fibronectin fibril organization,BP,
19890,GO:2000329,0.999999999993715,0.927065359527368,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
2361,GO:0005459,0.999999999993716,0.891540103241957,0,2,UDP-galactose transmembrane transporter activity,MF,
15766,GO:0072334,0.999999999993716,0.891540103241957,0,2,UDP-galactose transmembrane transport,BP,
7269,GO:0031232,0.999999999993716,0.81452062007312,0,3,extrinsic component of external side of plasma membrane,CC,
4478,GO:0010481,0.999999999993719,0.80910119145261,0,3,epidermal cell division,BP,
4479,GO:0010482,0.999999999993719,0.80910119145261,0,3,regulation of epidermal cell division,BP,
12847,GO:0051133,0.999999999993738,0.838710574177715,0,3,regulation of NK T cell activation,BP,
12848,GO:0051135,0.999999999993738,0.838710574177715,0,3,positive regulation of NK T cell activation,BP,
18993,GO:1904742,0.999999999993748,0.724451021254789,0,4,regulation of telomeric DNA binding,BP,
102,GO:0000213,0.999999999993759,0.761005969368502,0,4,tRNA-intron endonuclease activity,MF,
1067,GO:0002605,0.999999999993763,0.914541802248772,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
4634,GO:0010754,0.999999999993763,0.914541802248772,0,1,negative regulation of cGMP-mediated signaling,BP,
19567,GO:1990442,0.999999999993768,0.862572937804965,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
3961,GO:0008721,0.999999999993771,0.930418256165003,0,1,D-serine ammonia-lyase activity,MF,
5721,GO:0016855,0.999999999993771,0.930418256165003,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5906,GO:0018114,0.999999999993771,0.930418256165003,0,1,threonine racemase activity,MF,
6887,GO:0030378,0.999999999993771,0.930418256165003,0,1,serine racemase activity,MF,
9576,GO:0036361,0.999999999993771,0.930418256165003,0,1,racemase activity, acting on amino acids and derivatives,MF,
11676,GO:0046416,0.999999999993771,0.930418256165003,0,1,D-amino acid metabolic process,BP,
11681,GO:0046437,0.999999999993771,0.930418256165003,0,1,D-amino acid biosynthetic process,BP,
12041,GO:0047661,0.999999999993771,0.930418256165003,0,1,amino-acid racemase activity,MF,
14628,GO:0070178,0.999999999993771,0.930418256165003,0,1,D-serine metabolic process,BP,
14629,GO:0070179,0.999999999993771,0.930418256165003,0,1,D-serine biosynthetic process,BP,
3022,GO:0006568,0.999999999993774,0.696695426350906,0,5,tryptophan metabolic process,BP,
3036,GO:0006586,0.999999999993774,0.696695426350906,0,5,indolalkylamine metabolic process,BP,
7571,GO:0031914,0.999999999993785,0.806614380678401,0,3,negative regulation of synaptic plasticity,BP,
2069,GO:0004820,0.999999999993788,0.87393077119644,0,2,glycine-tRNA ligase activity,MF,
2915,GO:0006426,0.999999999993788,0.87393077119644,0,2,glycyl-tRNA aminoacylation,BP,
14612,GO:0070150,0.999999999993788,0.87393077119644,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
8654,GO:0034189,0.999999999993802,0.855741605794722,0,2,very-low-density lipoprotein particle binding,MF,
16453,GO:0097086,0.999999999993819,0.924926240154787,0,1,amniotic stem cell differentiation,BP,
20102,GO:2000706,0.999999999993819,0.924926240154787,0,1,negative regulation of dense core granule biogenesis,BP,
20118,GO:2000740,0.999999999993819,0.924926240154787,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20151,GO:2000797,0.999999999993819,0.924926240154787,0,1,regulation of amniotic stem cell differentiation,BP,
20152,GO:2000798,0.999999999993819,0.924926240154787,0,1,negative regulation of amniotic stem cell differentiation,BP,
7354,GO:0031389,0.999999999993842,0.928111528409634,0,1,Rad17 RFC-like complex,CC,
12831,GO:0051107,0.999999999993842,0.928111528409634,0,1,negative regulation of DNA ligation,BP,
12989,GO:0051352,0.999999999993842,0.928111528409634,0,1,negative regulation of ligase activity,BP,
19062,GO:1904876,0.999999999993842,0.928111528409634,0,1,negative regulation of DNA ligase activity,BP,
9671,GO:0038018,0.999999999993855,0.83867789636566,0,2,Wnt receptor catabolic process,BP,
5772,GO:0016964,0.999999999993858,0.868202446416362,0,1,alpha-2 macroglobulin receptor activity,MF,
12907,GO:0051228,0.999999999993875,0.917910273120233,0,1,mitotic spindle disassembly,BP,
12908,GO:0051230,0.999999999993875,0.917910273120233,0,1,spindle disassembly,BP,
17192,GO:0102773,0.999999999993881,0.921548838711781,0,1,dihydroceramide kinase activity,MF,
10507,GO:0043398,0.999999999993888,0.806021166160553,0,3,HLH domain binding,MF,
17644,GO:1901317,0.999999999993903,0.783998685916855,0,4,regulation of flagellated sperm motility,BP,
9938,GO:0042275,0.999999999993934,0.942366531753735,0,1,error-free postreplication DNA repair,BP,
9711,GO:0038101,0.999999999993934,0.938572314216806,0,1,sequestering of nodal from receptor via nodal binding,BP,
17404,GO:1900108,0.999999999993934,0.938572314216806,0,1,negative regulation of nodal signaling pathway,BP,
17431,GO:1900146,0.999999999993934,0.938572314216806,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17446,GO:1900176,0.999999999993934,0.938572314216806,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
9764,GO:0039506,0.999999999993942,0.852358318401033,0,2,modulation by virus of host molecular function,BP,
9765,GO:0039507,0.999999999993942,0.852358318401033,0,2,suppression by virus of host molecular function,BP,
13325,GO:0052055,0.999999999993942,0.852358318401033,0,2,modulation by symbiont of host molecular function,BP,
13326,GO:0052056,0.999999999993942,0.852358318401033,0,2,negative regulation by symbiont of host molecular function,BP,
3145,GO:0006741,0.999999999993956,0.74743401151367,0,4,NADP biosynthetic process,BP,
5737,GO:0016880,0.999999999993969,0.855689517847258,0,2,acid-ammonia (or amide) ligase activity,MF,
9072,GO:0035299,0.99999999999397,0.921751073265551,0,1,inositol pentakisphosphate 2-kinase activity,MF,
13551,GO:0055108,0.999999999993976,0.935017977201189,0,1,Golgi to transport vesicle transport,BP,
19538,GO:1990386,0.999999999993976,0.935017977201189,0,1,mitotic cleavage furrow ingression,BP,
19598,GO:1990583,0.999999999993976,0.935017977201189,0,1,phospholipase D activator activity,MF,
2899,GO:0006407,0.99999999999398,0.809552026892917,0,3,rRNA export from nucleus,BP,
1804,GO:0004445,0.999999999993986,0.682575324858809,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
91,GO:0000179,0.999999999993994,0.765316190379254,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
14263,GO:0061218,0.999999999994001,0.812163924044244,0,3,negative regulation of mesonephros development,BP,
10205,GO:0042799,0.999999999994006,0.703233626167186,0,4,histone methyltransferase activity (H4-K20 specific),MF,
6569,GO:0022012,0.999999999994024,0.901774722881013,0,1,subpallium cell proliferation in forebrain,BP,
6570,GO:0022018,0.999999999994024,0.901774722881013,0,1,lateral ganglionic eminence cell proliferation,BP,
13800,GO:0060366,0.999999999994024,0.901774722881013,0,1,lambdoid suture morphogenesis,BP,
13801,GO:0060367,0.999999999994024,0.901774722881013,0,1,sagittal suture morphogenesis,BP,
14095,GO:0060873,0.999999999994024,0.901774722881013,0,1,anterior semicircular canal development,BP,
14096,GO:0060875,0.999999999994024,0.901774722881013,0,1,lateral semicircular canal development,BP,
6738,GO:0030151,0.999999999994032,0.745335443446038,0,4,molybdenum ion binding,MF,
3829,GO:0008427,0.999999999994038,0.889787660568928,0,2,calcium-dependent protein kinase inhibitor activity,MF,
4702,GO:0010858,0.999999999994038,0.889787660568928,0,2,calcium-dependent protein kinase regulator activity,MF,
2178,GO:0005011,0.999999999994047,0.91992765377417,0,1,macrophage colony-stimulating factor receptor activity,MF,
8486,GO:0033625,0.999999999994053,0.856966824804257,0,2,positive regulation of integrin activation,BP,
2351,GO:0005412,0.999999999994054,0.857968125497261,0,2,glucose:sodium symporter activity,MF,
17697,GO:1901534,0.999999999994058,0.855110750179704,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
10638,GO:0043626,0.999999999994061,0.946296215823921,0,1,PCNA complex,CC,
11006,GO:0044796,0.999999999994061,0.946296215823921,0,1,DNA polymerase processivity factor complex,CC,
16902,GO:0098821,0.999999999994068,0.748797549947104,0,3,BMP receptor activity,MF,
12481,GO:0050291,0.999999999994069,0.688679943041726,0,5,sphingosine N-acyltransferase activity,MF,
13960,GO:0060605,0.99999999999407,0.795309537017804,0,3,tube lumen cavitation,BP,
13977,GO:0060662,0.99999999999407,0.795309537017804,0,3,salivary gland cavitation,BP,
3881,GO:0008510,0.99999999999407,0.65138250513753,0,5,sodium:bicarbonate symporter activity,MF,
13767,GO:0060319,0.999999999994076,0.857523473451604,0,2,primitive erythrocyte differentiation,BP,
701,GO:0001918,0.999999999994079,0.928639620826666,0,1,farnesylated protein binding,MF,
9860,GO:0042097,0.99999999999408,0.860810767845214,0,2,interleukin-4 biosynthetic process,BP,
11246,GO:0045402,0.99999999999408,0.860810767845214,0,2,regulation of interleukin-4 biosynthetic process,BP,
1676,GO:0004137,0.999999999994081,0.853916685742242,0,2,deoxycytidine kinase activity,MF,
16301,GO:0090362,0.999999999994081,0.860114730221169,0,2,positive regulation of platelet-derived growth factor production,BP,
9088,GO:0035332,0.999999999994086,0.814261719654649,0,2,positive regulation of hippo signaling,BP,
17698,GO:1901535,0.999999999994087,0.630245723931803,0,5,regulation of DNA demethylation,BP,
1619,GO:0004045,0.999999999994095,0.804898684279584,0,4,aminoacyl-tRNA hydrolase activity,MF,
15654,GO:0072134,0.9999999999941,0.830065342020317,0,2,nephrogenic mesenchyme morphogenesis,BP,
19806,GO:2000182,0.9999999999941,0.853418958594902,0,2,regulation of progesterone biosynthetic process,BP,
10561,GO:0043504,0.999999999994115,0.790002876021085,0,3,mitochondrial DNA repair,BP,
7517,GO:0031697,0.999999999994158,0.710307436091469,0,4,beta-1 adrenergic receptor binding,MF,
9456,GO:0036034,0.999999999994158,0.865457026688542,0,2,mediator complex assembly,BP,
20266,GO:2001176,0.999999999994158,0.865457026688542,0,2,regulation of mediator complex assembly,BP,
20267,GO:2001178,0.999999999994158,0.865457026688542,0,2,positive regulation of mediator complex assembly,BP,
1637,GO:0004077,0.999999999994186,0.913415499505957,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1638,GO:0004078,0.999999999994186,0.913415499505957,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1639,GO:0004079,0.999999999994186,0.913415499505957,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1640,GO:0004080,0.999999999994186,0.913415499505957,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
4199,GO:0009305,0.999999999994186,0.913415499505957,0,1,protein biotinylation,BP,
5946,GO:0018271,0.999999999994186,0.913415499505957,0,1,biotin-protein ligase activity,MF,
14946,GO:0070781,0.999999999994186,0.913415499505957,0,1,response to biotin,BP,
15115,GO:0071110,0.999999999994186,0.913415499505957,0,1,histone biotinylation,BP,
18661,GO:1903929,0.999999999994193,0.926913890508385,0,1,primary palate development,BP,
452,GO:0001225,0.999999999994194,0.82435189792999,0,2,RNA polymerase II transcription coactivator binding,MF,
20260,GO:2001166,0.999999999994202,0.682328803820118,0,5,regulation of histone H2B ubiquitination,BP,
7066,GO:0030846,0.999999999994203,0.887414024714457,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7443,GO:0031554,0.999999999994203,0.887414024714457,0,1,regulation of DNA-templated transcription, termination,BP,
13933,GO:0060566,0.999999999994203,0.887414024714457,0,1,positive regulation of DNA-templated transcription, termination,BP,
18931,GO:1904594,0.999999999994203,0.887414024714457,0,1,regulation of termination of RNA polymerase II transcription,BP,
18932,GO:1904595,0.999999999994203,0.887414024714457,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20153,GO:2000804,0.999999999994203,0.887414024714457,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20154,GO:2000806,0.999999999994203,0.887414024714457,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
11160,GO:0045196,0.999999999994209,0.8390850816437,0,2,establishment or maintenance of neuroblast polarity,BP,
11164,GO:0045200,0.999999999994209,0.8390850816437,0,2,establishment of neuroblast polarity,BP,
7115,GO:0030906,0.999999999994216,0.758348058210064,0,4,retromer, cargo-selective complex,CC,
8764,GO:0034421,0.999999999994228,0.795169806823757,0,3,post-translational protein acetylation,BP,
13707,GO:0060228,0.99999999999424,0.922351479877085,0,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
6081,GO:0019230,0.999999999994246,0.828973104379076,0,2,proprioception,BP,
783,GO:0002038,0.999999999994248,0.932049618958308,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4719,GO:0010879,0.999999999994248,0.932049618958308,0,1,cholesterol transport involved in cholesterol storage,BP,
9097,GO:0035352,0.999999999994248,0.932049618958308,0,1,NAD transmembrane transport,BP,
10348,GO:0043132,0.999999999994248,0.932049618958308,0,1,NAD transport,BP,
10955,GO:0044610,0.999999999994248,0.932049618958308,0,1,FMN transmembrane transporter activity,MF,
13172,GO:0051724,0.999999999994248,0.932049618958308,0,1,NAD transmembrane transporter activity,MF,
7389,GO:0031436,0.999999999994249,0.843663406843893,0,2,BRCA1-BARD1 complex,CC,
6858,GO:0030322,0.999999999994261,0.867146879680077,0,2,stabilization of membrane potential,BP,
5965,GO:0018352,0.999999999994265,0.873759308841632,0,2,protein-pyridoxal-5-phosphate linkage,BP,
8008,GO:0032625,0.999999999994285,0.925304140277408,0,1,interleukin-21 production,BP,
15903,GO:0072619,0.999999999994285,0.925304140277408,0,1,interleukin-21 secretion,BP,
4128,GO:0009186,0.999999999994293,0.79413419925094,0,4,deoxyribonucleoside diphosphate metabolic process,BP,
1754,GO:0004351,0.999999999994314,0.858520124539293,0,2,glutamate decarboxylase activity,MF,
2183,GO:0005030,0.999999999994315,0.908005992890806,0,1,neurotrophin receptor activity,MF,
4471,GO:0010465,0.999999999994315,0.908005992890806,0,1,nerve growth factor receptor activity,MF,
6888,GO:0030379,0.999999999994315,0.908005992890806,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
15718,GO:0072237,0.999999999994317,0.813758088026563,0,2,metanephric proximal tubule development,BP,
8652,GO:0034186,0.999999999994327,0.728999171949646,0,4,apolipoprotein A-I binding,MF,
7625,GO:0032010,0.999999999994329,0.803003833163265,0,3,phagolysosome,CC,
926,GO:0002318,0.99999999999433,0.799927328147014,0,3,myeloid progenitor cell differentiation,BP,
1323,GO:0003169,0.999999999994334,0.829304417908641,0,2,coronary vein morphogenesis,BP,
14126,GO:0060948,0.999999999994334,0.829304417908641,0,2,cardiac vascular smooth muscle cell development,BP,
15259,GO:0071400,0.999999999994339,0.851314774867827,0,2,cellular response to oleic acid,BP,
13015,GO:0051413,0.999999999994345,0.930215024659762,0,1,response to cortisone,BP,
4544,GO:0010615,0.999999999994349,0.920574157629564,0,1,positive regulation of cardiac muscle adaptation,BP,
18343,GO:1903244,0.999999999994349,0.920574157629564,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19195,GO:1905205,0.999999999994349,0.920574157629564,0,1,positive regulation of connective tissue replacement,BP,
8355,GO:0033204,0.999999999994351,0.93039495762806,0,1,ribonuclease P RNA binding,MF,
6548,GO:0021957,0.999999999994359,0.708877473723456,0,4,corticospinal tract morphogenesis,BP,
17044,GO:0099174,0.999999999994362,0.78788993558411,0,3,regulation of presynapse organization,BP,
19353,GO:1905606,0.999999999994362,0.78788993558411,0,3,regulation of presynapse assembly,BP,
13994,GO:0060684,0.99999999999437,0.751197116665141,0,4,epithelial-mesenchymal cell signaling,BP,
2795,GO:0006238,0.999999999994393,0.948440846124271,0,1,CMP salvage,BP,
4163,GO:0009224,0.999999999994393,0.948440846124271,0,1,CMP biosynthetic process,BP,
11535,GO:0046035,0.999999999994393,0.948440846124271,0,1,CMP metabolic process,BP,
15364,GO:0071573,0.9999999999944,0.927939541199889,0,1,shelterin complex assembly,BP,
19020,GO:1904790,0.9999999999944,0.927939541199889,0,1,regulation of shelterin complex assembly,BP,
19021,GO:1904792,0.9999999999944,0.927939541199889,0,1,positive regulation of shelterin complex assembly,BP,
19050,GO:1904850,0.9999999999944,0.927939541199889,0,1,negative regulation of establishment of protein localization to telomere,BP,
19084,GO:1904910,0.9999999999944,0.927939541199889,0,1,regulation of establishment of RNA localization to telomere,BP,
19085,GO:1904911,0.9999999999944,0.927939541199889,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19086,GO:1904913,0.9999999999944,0.927939541199889,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19087,GO:1904914,0.9999999999944,0.927939541199889,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
2080,GO:0004831,0.9999999999944,0.864990531539848,0,2,tyrosine-tRNA ligase activity,MF,
2926,GO:0006437,0.9999999999944,0.864990531539848,0,2,tyrosyl-tRNA aminoacylation,BP,
196,GO:0000414,0.999999999994404,0.687663831241459,0,4,regulation of histone H3-K36 methylation,BP,
7022,GO:0030729,0.999999999994443,0.926213700473293,0,1,acetoacetate-CoA ligase activity,MF,
12056,GO:0047760,0.999999999994443,0.926213700473293,0,1,butyrate-CoA ligase activity,MF,
15795,GO:0072382,0.999999999994444,0.870863760225302,0,1,minus-end-directed vesicle transport along microtubule,BP,
17443,GO:1900169,0.999999999994454,0.813155594762785,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
5360,GO:0016128,0.99999999999446,0.809640772716832,0,3,phytosteroid metabolic process,BP,
5361,GO:0016129,0.99999999999446,0.809640772716832,0,3,phytosteroid biosynthetic process,BP,
6260,GO:0019841,0.999999999994461,0.805739076678343,0,4,retinol binding,MF,
15809,GO:0072414,0.999999999994485,0.907778902846643,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15816,GO:0072432,0.999999999994485,0.907778902846643,0,1,response to G1 DNA damage checkpoint signaling,BP,
5262,GO:0015889,0.99999999999449,0.815017313628899,0,3,cobalamin transport,BP,
18046,GO:1902523,0.999999999994499,0.851896746763541,0,2,positive regulation of protein K63-linked ubiquitination,BP,
4797,GO:0010986,0.999999999994516,0.741741808464429,0,4,positive regulation of lipoprotein particle clearance,BP,
8655,GO:0034190,0.999999999994518,0.725030955890135,0,4,apolipoprotein receptor binding,MF,
14618,GO:0070164,0.999999999994522,0.730367010655965,0,4,negative regulation of adiponectin secretion,BP,
18230,GO:1902994,0.999999999994524,0.863578841171091,0,2,regulation of phospholipid efflux,BP,
18231,GO:1902995,0.999999999994524,0.863578841171091,0,2,positive regulation of phospholipid efflux,BP,
2216,GO:0005105,0.999999999994535,0.931951217572132,0,1,type 1 fibroblast growth factor receptor binding,MF,
2257,GO:0005169,0.999999999994555,0.875719705438096,0,2,neurotrophin TRKB receptor binding,MF,
18209,GO:1902954,0.999999999994557,0.803445422870569,0,2,regulation of early endosome to recycling endosome transport,BP,
20170,GO:2000828,0.999999999994571,0.856942823613377,0,2,regulation of parathyroid hormone secretion,BP,
18123,GO:1902731,0.999999999994582,0.808001257433584,0,2,negative regulation of chondrocyte proliferation,BP,
6974,GO:0030623,0.999999999994591,0.906429639185514,0,1,U5 snRNA binding,MF,
640,GO:0001827,0.999999999994593,0.842724447463234,0,2,inner cell mass cell fate commitment,BP,
641,GO:0001828,0.999999999994593,0.842724447463234,0,2,inner cell mass cellular morphogenesis,BP,
2259,GO:0005171,0.999999999994596,0.934239765021247,0,1,hepatocyte growth factor receptor binding,MF,
7201,GO:0031085,0.999999999994613,0.856943120901985,0,2,BLOC-3 complex,CC,
423,GO:0001128,0.999999999994622,0.946103011021426,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
19382,GO:1905719,0.999999999994633,0.861895758091718,0,2,protein localization to perinuclear region of cytoplasm,BP,
15973,GO:0075519,0.999999999994652,0.963502286597736,0,1,microtubule-dependent intracellular transport of viral material,BP,
15974,GO:0075521,0.999999999994652,0.963502286597736,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15978,GO:0075606,0.999999999994652,0.963502286597736,0,1,transport of viral material towards nucleus,BP,
7883,GO:0032440,0.999999999994652,0.948296654555774,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19359,GO:1905636,0.999999999994652,0.948296654555774,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
4839,GO:0014043,0.999999999994653,0.865904012048923,0,2,negative regulation of neuron maturation,BP,
17993,GO:1902362,0.999999999994654,0.928589419342899,0,1,melanocyte apoptotic process,BP,
18896,GO:1904527,0.999999999994674,0.788910261190586,0,3,negative regulation of microtubule binding,BP,
16431,GO:0097045,0.999999999994675,0.919917602217027,0,1,phosphatidylserine exposure on blood platelet,BP,
17976,GO:1902304,0.999999999994675,0.919917602217027,0,1,positive regulation of potassium ion export,BP,
17637,GO:1901300,0.999999999994677,0.744250063188943,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
2111,GO:0004887,0.999999999994678,0.67161374857588,0,5,thyroid hormone receptor activity,MF,
828,GO:0002101,0.999999999994683,0.810852800163352,0,3,tRNA wobble cytosine modification,BP,
9350,GO:0035844,0.999999999994701,0.790687178301685,0,3,cloaca development,BP,
10833,GO:0044316,0.999999999994703,0.924694559699378,0,1,cone cell pedicle,CC,
5243,GO:0015864,0.999999999994706,0.868548325020479,0,2,pyrimidine nucleoside transport,BP,
1589,GO:0003997,0.999999999994708,0.787638169653965,0,3,acyl-CoA oxidase activity,MF,
4801,GO:0010991,0.999999999994718,0.8313594370041,0,2,negative regulation of SMAD protein complex assembly,BP,
9107,GO:0035370,0.999999999994719,0.866366572188662,0,2,UBC13-UEV1A complex,CC,
1946,GO:0004645,0.999999999994721,0.740269484323955,0,4,phosphorylase activity,MF,
20200,GO:2000983,0.999999999994725,0.91485980708267,0,2,regulation of ATP citrate synthase activity,BP,
20201,GO:2000984,0.999999999994725,0.91485980708267,0,2,negative regulation of ATP citrate synthase activity,BP,
17539,GO:1900748,0.999999999994729,0.695046293604993,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
3681,GO:0008184,0.99999999999473,0.85699335266709,0,2,glycogen phosphorylase activity,MF,
17155,GO:0102250,0.99999999999473,0.85699335266709,0,2,linear malto-oligosaccharide phosphorylase activity,MF,
17177,GO:0102499,0.99999999999473,0.85699335266709,0,2,SHG alpha-glucan phosphorylase activity,MF,
108,GO:0000224,0.999999999994735,0.930043555549049,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
583,GO:0001733,0.999999999994735,0.930043555549049,0,1,galactosylceramide sulfotransferase activity,MF,
12564,GO:0050694,0.999999999994735,0.930043555549049,0,1,galactose 3-O-sulfotransferase activity,MF,
12565,GO:0050698,0.999999999994735,0.930043555549049,0,1,proteoglycan sulfotransferase activity,MF,
11915,GO:0046923,0.999999999994741,0.768678457533419,0,4,ER retention sequence binding,MF,
16987,GO:0098978,0.999999999994747,0.831564948919603,0,2,glutamatergic synapse,CC,
16991,GO:0098985,0.999999999994747,0.831564948919603,0,2,asymmetric, glutamatergic, excitatory synapse,CC,
222,GO:0000461,0.999999999994757,0.925726095346601,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
16611,GO:0097409,0.999999999994757,0.935260091764104,0,1,glial cytoplasmic inclusion,CC,
16614,GO:0097414,0.999999999994757,0.935260091764104,0,1,classical Lewy body,CC,
16637,GO:0097462,0.999999999994757,0.935260091764104,0,1,Lewy neurite,CC,
19463,GO:1990038,0.999999999994757,0.935260091764104,0,1,Lewy body corona,CC,
1338,GO:0003192,0.999999999994768,0.737921395236466,0,3,mitral valve formation,BP,
4220,GO:0009386,0.999999999994769,0.931688696766701,0,1,translational attenuation,BP,
14488,GO:0061847,0.999999999994769,0.931688696766701,0,1,response to cholecystokinin,BP,
15338,GO:0071538,0.999999999994769,0.931688696766701,0,1,SH2 domain-mediated complex assembly,BP,
15962,GO:0072755,0.999999999994769,0.924528878041966,0,1,cellular response to benomyl,BP,
17708,GO:1901561,0.999999999994769,0.924528878041966,0,1,response to benomyl,BP,
19674,GO:1990839,0.999999999994769,0.931688696766701,0,1,response to endothelin,BP,
19678,GO:1990859,0.999999999994769,0.931688696766701,0,1,cellular response to endothelin,BP,
19279,GO:1905407,0.999999999994785,0.926412717617247,0,1,regulation of creatine transmembrane transporter activity,BP,
19280,GO:1905408,0.999999999994785,0.926412717617247,0,1,negative regulation of creatine transmembrane transporter activity,BP,
1963,GO:0004666,0.999999999994798,0.846332091833066,0,2,prostaglandin-endoperoxide synthase activity,MF,
444,GO:0001192,0.999999999994801,0.958311388564784,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
445,GO:0001193,0.999999999994801,0.958311388564784,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
866,GO:0002196,0.999999999994803,0.936041657737798,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
4981,GO:0015098,0.999999999994803,0.936041657737798,0,1,molybdate ion transmembrane transporter activity,MF,
5154,GO:0015689,0.999999999994803,0.936041657737798,0,1,molybdate ion transport,BP,
1812,GO:0004458,0.999999999994817,0.929720835124508,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
2007,GO:0004728,0.999999999994817,0.929720835124508,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
4012,GO:0008995,0.999999999994817,0.929720835124508,0,1,ribonuclease E activity,MF,
5753,GO:0016898,0.999999999994817,0.929720835124508,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6166,GO:0019516,0.999999999994817,0.929720835124508,0,1,lactate oxidation,BP,
16230,GO:0090247,0.999999999994817,0.929720835124508,0,1,cell motility involved in somitogenic axis elongation,BP,
16231,GO:0090249,0.999999999994817,0.929720835124508,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17614,GO:1901229,0.999999999994817,0.929720835124508,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17615,GO:1901231,0.999999999994817,0.929720835124508,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17616,GO:1901232,0.999999999994817,0.929720835124508,0,1,regulation of convergent extension involved in axis elongation,BP,
17617,GO:1901233,0.999999999994817,0.929720835124508,0,1,negative regulation of convergent extension involved in axis elongation,BP,
1829,GO:0004479,0.999999999994823,0.928848791574091,0,1,methionyl-tRNA formyltransferase activity,MF,
6326,GO:0019988,0.999999999994823,0.928848791574091,0,1,charged-tRNA amino acid modification,BP,
15562,GO:0071951,0.999999999994823,0.928848791574091,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
17836,GO:1901917,0.999999999994823,0.928848791574091,0,1,regulation of exoribonuclease activity,BP,
17837,GO:1901919,0.999999999994823,0.928848791574091,0,1,positive regulation of exoribonuclease activity,BP,
19395,GO:1905779,0.999999999994823,0.928848791574091,0,1,positive regulation of exonuclease activity,BP,
7247,GO:0031166,0.999999999994833,0.791204539137553,0,3,integral component of vacuolar membrane,CC,
7313,GO:0031310,0.999999999994833,0.791204539137553,0,3,intrinsic component of vacuolar membrane,CC,
19856,GO:2000282,0.999999999994844,0.859602187753473,0,2,regulation of cellular amino acid biosynthetic process,BP,
1564,GO:0003962,0.999999999994854,0.938319839669666,0,1,cystathionine gamma-synthase activity,MF,
1667,GO:0004123,0.999999999994854,0.938319839669666,0,1,cystathionine gamma-lyase activity,MF,
5947,GO:0018272,0.999999999994854,0.938319839669666,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
9378,GO:0035887,0.999999999994854,0.938319839669666,0,1,aortic smooth muscle cell differentiation,BP,
10928,GO:0044524,0.999999999994854,0.938319839669666,0,1,protein sulfhydration,BP,
10935,GO:0044540,0.999999999994854,0.938319839669666,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
12070,GO:0047982,0.999999999994854,0.938319839669666,0,1,homocysteine desulfhydrase activity,MF,
15172,GO:0071266,0.999999999994854,0.938319839669666,0,1,'de novo' L-methionine biosynthetic process,BP,
15999,GO:0080146,0.999999999994854,0.938319839669666,0,1,L-cysteine desulfhydrase activity,MF,
19039,GO:1904829,0.999999999994854,0.938319839669666,0,1,regulation of aortic smooth muscle cell differentiation,BP,
19040,GO:1904831,0.999999999994854,0.938319839669666,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
3807,GO:0008391,0.99999999999486,0.870566712918134,0,2,arachidonic acid monooxygenase activity,MF,
3808,GO:0008392,0.99999999999486,0.870566712918134,0,2,arachidonic acid epoxygenase activity,MF,
15919,GO:0072672,0.999999999994865,0.724758060768971,0,4,neutrophil extravasation,BP,
17014,GO:0099074,0.999999999994869,0.860888699966617,0,2,mitochondrion to lysosome transport,BP,
17015,GO:0099075,0.999999999994869,0.860888699966617,0,2,mitochondrion-derived vesicle mediated transport,BP,
16961,GO:0098920,0.999999999994871,0.84978118714026,0,2,retrograde trans-synaptic signaling by lipid,BP,
16962,GO:0098921,0.999999999994871,0.84978118714026,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
18884,GO:1904481,0.999999999994873,0.930559998914397,0,1,response to tetrahydrofolate,BP,
18885,GO:1904482,0.999999999994873,0.930559998914397,0,1,cellular response to tetrahydrofolate,BP,
19399,GO:1905799,0.999999999994888,0.964166777278203,0,1,regulation of intraciliary retrograde transport,BP,
14416,GO:0061663,0.999999999994891,0.906235011990074,0,1,NEDD8 ligase activity,MF,
15189,GO:0071301,0.999999999994891,0.906235011990074,0,1,cellular response to vitamin B1,BP,
18852,GO:1904404,0.999999999994891,0.906235011990074,0,1,response to formaldehyde,BP,
934,GO:0002329,0.999999999994897,0.679823319234067,0,4,pre-B cell differentiation,BP,
9555,GO:0036302,0.999999999994901,0.629581059995443,0,5,atrioventricular canal development,BP,
9288,GO:0035712,0.999999999994911,0.9264659335492,0,1,T-helper 2 cell activation,BP,
20015,GO:2000569,0.999999999994911,0.9264659335492,0,1,regulation of T-helper 2 cell activation,BP,
20016,GO:2000570,0.999999999994911,0.9264659335492,0,1,positive regulation of T-helper 2 cell activation,BP,
2737,GO:0006116,0.999999999994915,0.854618408175155,0,2,NADH oxidation,BP,
4815,GO:0014004,0.999999999994918,0.857111557537983,0,2,microglia differentiation,BP,
4816,GO:0014005,0.999999999994918,0.857111557537983,0,2,microglia development,BP,
14221,GO:0061110,0.999999999994918,0.831384280355344,0,2,dense core granule biogenesis,BP,
20101,GO:2000705,0.999999999994918,0.831384280355344,0,2,regulation of dense core granule biogenesis,BP,
7187,GO:0031064,0.999999999994922,0.812626647528159,0,2,negative regulation of histone deacetylation,BP,
18407,GO:1903385,0.999999999994924,0.849144096326806,0,2,regulation of homophilic cell adhesion,BP,
1964,GO:0004668,0.99999999999496,0.926781049352454,0,1,protein-arginine deiminase activity,MF,
5900,GO:0018101,0.99999999999496,0.926781049352454,0,1,protein citrullination,BP,
9595,GO:0036414,0.99999999999496,0.926781049352454,0,1,histone citrullination,BP,
1776,GO:0004378,0.999999999994967,0.928073567594633,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
17185,GO:0102704,0.999999999994967,0.928073567594633,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
3504,GO:0007412,0.999999999994975,0.878994927250157,0,2,axon target recognition,BP,
6095,GO:0019276,0.999999999994983,0.928250422955981,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
9040,GO:0035248,0.999999999994983,0.928250422955981,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
1517,GO:0003875,0.999999999994992,0.925801989109303,0,1,ADP-ribosylarginine hydrolase activity,MF,
17688,GO:1901509,0.999999999994994,0.855260465982248,0,2,regulation of endothelial tube morphogenesis,BP,
130,GO:0000270,0.999999999995009,0.890239966898401,0,2,peptidoglycan metabolic process,BP,
3964,GO:0008745,0.999999999995009,0.890239966898401,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
4179,GO:0009253,0.999999999995009,0.890239966898401,0,2,peptidoglycan catabolic process,BP,
5313,GO:0016019,0.999999999995009,0.890239966898401,0,2,peptidoglycan receptor activity,MF,
13163,GO:0051710,0.999999999995009,0.890239966898401,0,2,regulation of cytolysis in other organism,BP,
13165,GO:0051714,0.999999999995009,0.890239966898401,0,2,positive regulation of cytolysis in other organism,BP,
1420,GO:0003357,0.999999999995011,0.826813435678565,0,2,noradrenergic neuron differentiation,BP,
13064,GO:0051525,0.999999999995013,0.82310521038901,0,2,NFAT protein binding,MF,
6480,GO:0021817,0.999999999995048,0.752691791080945,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
10472,GO:0043321,0.999999999995056,0.845295333091955,0,2,regulation of natural killer cell degranulation,BP,
10473,GO:0043323,0.999999999995056,0.845295333091955,0,2,positive regulation of natural killer cell degranulation,BP,
7688,GO:0032127,0.999999999995061,0.926979787446918,0,1,dense core granule membrane,CC,
15102,GO:0071065,0.999999999995061,0.926979787446918,0,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15116,GO:0071133,0.999999999995061,0.926979787446918,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
15849,GO:0072535,0.999999999995061,0.926979787446918,0,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,
15927,GO:0072680,0.999999999995061,0.926979787446918,0,1,extracellular matrix-dependent thymocyte migration,BP,
15928,GO:0072681,0.999999999995061,0.926979787446918,0,1,fibronectin-dependent thymocyte migration,BP,
19871,GO:2000307,0.999999999995061,0.926979787446918,0,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19872,GO:2000309,0.999999999995061,0.926979787446918,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19948,GO:2000410,0.999999999995061,0.926979787446918,0,1,regulation of thymocyte migration,BP,
19949,GO:2000412,0.999999999995061,0.926979787446918,0,1,positive regulation of thymocyte migration,BP,
19950,GO:2000413,0.999999999995061,0.926979787446918,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
19951,GO:2000415,0.999999999995061,0.926979787446918,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
12757,GO:0051001,0.999999999995061,0.750845846888773,0,4,negative regulation of nitric-oxide synthase activity,BP,
16479,GO:0097125,0.999999999995061,0.876088392912791,0,2,cyclin B1-CDK1 complex,CC,
254,GO:0000718,0.999999999995077,0.938605208560362,0,1,nucleotide-excision repair, DNA damage removal,BP,
1678,GO:0004139,0.999999999995077,0.938605208560362,0,1,deoxyribose-phosphate aldolase activity,MF,
10861,GO:0044349,0.999999999995077,0.938605208560362,0,1,DNA excision,BP,
11673,GO:0046403,0.999999999995077,0.938605208560362,0,1,polynucleotide 3'-phosphatase activity,MF,
16761,GO:0098503,0.999999999995077,0.938605208560362,0,1,DNA 3' dephosphorylation,BP,
16762,GO:0098504,0.999999999995077,0.938605208560362,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16764,GO:0098506,0.999999999995077,0.938605208560362,0,1,polynucleotide 3' dephosphorylation,BP,
1975,GO:0004687,0.999999999995081,0.817248025780446,0,2,myosin light chain kinase activity,MF,
1924,GO:0004615,0.999999999995093,0.882630423749768,0,2,phosphomannomutase activity,MF,
2165,GO:0004996,0.999999999995095,0.924094047206518,0,1,thyroid-stimulating hormone receptor activity,MF,
9749,GO:0038194,0.999999999995095,0.924094047206518,0,1,thyroid-stimulating hormone signaling pathway,BP,
9754,GO:0039003,0.999999999995095,0.924094047206518,0,1,pronephric field specification,BP,
9757,GO:0039017,0.999999999995095,0.924094047206518,0,1,pattern specification involved in pronephros development,BP,
10160,GO:0042728,0.999999999995095,0.924094047206518,0,1,flavin-containing compound catabolic process,BP,
14782,GO:0070460,0.999999999995095,0.924094047206518,0,1,thyroid-stimulating hormone secretion,BP,
15575,GO:0072003,0.999999999995095,0.924094047206518,0,1,kidney rudiment formation,BP,
15576,GO:0072004,0.999999999995095,0.924094047206518,0,1,kidney field specification,BP,
15588,GO:0072025,0.999999999995095,0.924094047206518,0,1,distal convoluted tubule development,BP,
15607,GO:0072069,0.999999999995095,0.924094047206518,0,1,DCT cell differentiation,BP,
15711,GO:0072221,0.999999999995095,0.924094047206518,0,1,metanephric distal convoluted tubule development,BP,
15720,GO:0072240,0.999999999995095,0.924094047206518,0,1,metanephric DCT cell differentiation,BP,
15749,GO:0072304,0.999999999995095,0.924094047206518,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15750,GO:0072305,0.999999999995095,0.924094047206518,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15753,GO:0072309,0.999999999995095,0.924094047206518,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15802,GO:0072389,0.999999999995095,0.924094047206518,0,1,flavin adenine dinucleotide catabolic process,BP,
17454,GO:1900200,0.999999999995095,0.924094047206518,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17455,GO:1900204,0.999999999995095,0.924094047206518,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17456,GO:1900205,0.999999999995095,0.924094047206518,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17459,GO:1900211,0.999999999995095,0.924094047206518,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17460,GO:1900212,0.999999999995095,0.924094047206518,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17461,GO:1900214,0.999999999995095,0.924094047206518,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17462,GO:1900215,0.999999999995095,0.924094047206518,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17463,GO:1900217,0.999999999995095,0.924094047206518,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17464,GO:1900218,0.999999999995095,0.924094047206518,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17587,GO:1901147,0.999999999995095,0.924094047206518,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18238,GO:1903004,0.999999999995095,0.924094047206518,0,1,regulation of protein K63-linked deubiquitination,BP,
18239,GO:1903006,0.999999999995095,0.924094047206518,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18240,GO:1903007,0.999999999995095,0.924094047206518,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
20029,GO:2000592,0.999999999995095,0.924094047206518,0,1,regulation of metanephric DCT cell differentiation,BP,
20030,GO:2000594,0.999999999995095,0.924094047206518,0,1,positive regulation of metanephric DCT cell differentiation,BP,
20036,GO:2000612,0.999999999995095,0.924094047206518,0,1,regulation of thyroid-stimulating hormone secretion,BP,
1902,GO:0004583,0.999999999995107,0.719141026391175,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
5962,GO:0018343,0.999999999995118,0.811138118182383,0,3,protein farnesylation,BP,
2762,GO:0006172,0.999999999995123,0.931879375847905,0,1,ADP biosynthetic process,BP,
16536,GO:0097226,0.999999999995123,0.931879375847905,0,1,sperm mitochondrial sheath,CC,
16619,GO:0097427,0.999999999995128,0.657407521272311,0,5,microtubule bundle,CC,
19091,GO:1904928,0.99999999999513,0.819049286386089,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
16226,GO:0090241,0.999999999995156,0.756095098455502,0,4,negative regulation of histone H4 acetylation,BP,
15388,GO:0071611,0.999999999995162,0.865468006130383,0,2,granulocyte colony-stimulating factor production,BP,
15417,GO:0071655,0.999999999995162,0.865468006130383,0,2,regulation of granulocyte colony-stimulating factor production,BP,
16213,GO:0090222,0.999999999995167,0.821514747600585,0,2,centrosome-templated microtubule nucleation,BP,
18890,GO:1904502,0.999999999995168,0.642567910707033,0,5,regulation of lipophagy,BP,
18891,GO:1904504,0.999999999995168,0.642567910707033,0,5,positive regulation of lipophagy,BP,
2132,GO:0004931,0.999999999995173,0.934365156095385,0,1,extracellularly ATP-gated cation channel activity,MF,
5538,GO:0016519,0.999999999995173,0.934365156095385,0,1,gastric inhibitory peptide receptor activity,MF,
9113,GO:0035381,0.999999999995173,0.934365156095385,0,1,ATP-gated ion channel activity,MF,
9747,GO:0038192,0.999999999995173,0.934365156095385,0,1,gastric inhibitory peptide signaling pathway,BP,
11981,GO:0047179,0.999999999995176,0.904854549117775,0,2,platelet-activating factor acetyltransferase activity,MF,
17512,GO:1900425,0.999999999995178,0.683265794373885,0,5,negative regulation of defense response to bacterium,BP,
15867,GO:0072563,0.99999999999518,0.87208439842343,0,2,endothelial microparticle,CC,
15386,GO:0071608,0.999999999995192,0.743887517172229,0,4,macrophage inflammatory protein-1 alpha production,BP,
15409,GO:0071640,0.999999999995192,0.743887517172229,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
2167,GO:0004999,0.999999999995195,0.928599435914842,0,1,vasoactive intestinal polypeptide receptor activity,MF,
13454,GO:0052836,0.999999999995198,0.872835883714224,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13455,GO:0052839,0.999999999995198,0.872835883714224,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
17227,GO:0106049,0.999999999995208,0.693249412924066,0,5,regulation of cellular response to osmotic stress,BP,
17932,GO:1902218,0.999999999995208,0.693249412924066,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4593,GO:0010698,0.999999999995213,0.895233241782185,0,2,acetyltransferase activator activity,MF,
12981,GO:0051344,0.999999999995216,0.799240599143482,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
1365,GO:0003245,0.999999999995217,0.871908002946371,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
13046,GO:0051463,0.999999999995227,0.911934742962432,0,1,negative regulation of cortisol secretion,BP,
13650,GO:0060125,0.999999999995227,0.911934742962432,0,1,negative regulation of growth hormone secretion,BP,
19629,GO:1990726,0.999999999995229,0.797996115193798,0,5,Lsm1-7-Pat1 complex,CC,
4734,GO:0010896,0.999999999995231,0.797957336597129,0,3,regulation of triglyceride catabolic process,BP,
2638,GO:0005969,0.999999999995232,0.902795095120156,0,1,serine-pyruvate aminotransferase complex,CC,
5379,GO:0016189,0.999999999995232,0.902795095120156,0,1,synaptic vesicle to endosome fusion,BP,
18875,GO:1904455,0.999999999995241,0.83811504392592,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
1894,GO:0004573,0.999999999995262,0.928945116555666,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
462,GO:0001405,0.999999999995263,0.708488906865104,0,5,presequence translocase-associated import motor,CC,
15458,GO:0071723,0.999999999995271,0.782508712103614,0,3,lipopeptide binding,MF,
7516,GO:0031694,0.999999999995272,0.95139898626813,0,1,alpha-2A adrenergic receptor binding,MF,
17600,GO:1901193,0.999999999995272,0.95139898626813,0,1,regulation of formation of translation preinitiation complex,BP,
17601,GO:1901194,0.999999999995272,0.95139898626813,0,1,negative regulation of formation of translation preinitiation complex,BP,
18966,GO:1904689,0.999999999995272,0.95139898626813,0,1,negative regulation of cytoplasmic translational initiation,BP,
5450,GO:0016316,0.999999999995292,0.839838982017253,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5864,GO:0017161,0.999999999995292,0.839838982017253,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
8830,GO:0034597,0.999999999995292,0.839838982017253,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
13446,GO:0052828,0.999999999995292,0.839838982017253,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
7871,GO:0032427,0.999999999995303,0.859350335729358,0,2,GBD domain binding,MF,
13919,GO:0060542,0.999999999995306,0.914708336749204,0,1,regulation of strand invasion,BP,
14722,GO:0070337,0.999999999995306,0.914708336749204,0,1,3'-flap-structured DNA binding,MF,
16770,GO:0098530,0.999999999995306,0.914708336749204,0,1,positive regulation of strand invasion,BP,
1375,GO:0003263,0.999999999995316,0.724214575800954,0,5,cardioblast proliferation,BP,
5150,GO:0015680,0.999999999995316,0.843416710509844,0,3,intracellular copper ion transport,BP,
8557,GO:0033897,0.99999999999532,0.948344663985231,0,1,ribonuclease T2 activity,MF,
9626,GO:0036482,0.999999999995323,0.888971508491817,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18213,GO:1902958,0.999999999995323,0.888971508491817,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18405,GO:1903383,0.999999999995323,0.888971508491817,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18406,GO:1903384,0.999999999995323,0.888971508491817,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
2375,GO:0005502,0.999999999995325,0.920406419031206,0,1,11-cis retinal binding,MF,
2376,GO:0005503,0.999999999995325,0.920406419031206,0,1,all-trans retinal binding,MF,
14500,GO:0061896,0.999999999995325,0.920406419031206,0,1,all-trans retinol 3,4-desaturase activity,MF,
14501,GO:0061897,0.999999999995325,0.920406419031206,0,1,all-trans retinal 3,4-desaturase activity,MF,
14502,GO:0061898,0.999999999995325,0.920406419031206,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14503,GO:0061899,0.999999999995325,0.920406419031206,0,1,11-cis-retinal 3,4-desaturase activity,MF,
1163,GO:0002774,0.999999999995334,0.927350213605985,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
14895,GO:0070667,0.999999999995334,0.927350213605985,0,1,negative regulation of mast cell proliferation,BP,
15942,GO:0072709,0.999999999995336,0.865500436443709,0,2,cellular response to sorbitol,BP,
9975,GO:0042352,0.999999999995338,0.923875037108581,0,1,GDP-L-fucose salvage,BP,
12471,GO:0050201,0.999999999995338,0.923875037108581,0,1,fucokinase activity,MF,
6522,GO:0021896,0.999999999995355,0.807423529775413,0,2,forebrain astrocyte differentiation,BP,
6523,GO:0021897,0.999999999995355,0.807423529775413,0,2,forebrain astrocyte development,BP,
10717,GO:0043997,0.999999999995362,0.927086851113138,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
17238,GO:0106075,0.999999999995362,0.927086851113138,0,1,peptide N-succinyltransferase activity,MF,
17240,GO:0106078,0.999999999995362,0.927086851113138,0,1,histone succinyltransferase activity,MF,
809,GO:0002079,0.999999999995399,0.836136385359427,0,2,inner acrosomal membrane,CC,
7706,GO:0032173,0.999999999995405,0.927636053912718,0,1,septin collar,CC,
20298,GO:2001229,0.999999999995408,0.87506841238544,0,1,negative regulation of response to gamma radiation,BP,
13683,GO:0060179,0.999999999995411,0.798710006587814,0,3,male mating behavior,BP,
1571,GO:0003975,0.999999999995426,0.933164383888379,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
4007,GO:0008963,0.999999999995426,0.933164383888379,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
5269,GO:0015911,0.999999999995427,0.658624288360257,0,5,plasma membrane long-chain fatty acid transport,BP,
2205,GO:0005087,0.999999999995431,0.780104989253116,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
15407,GO:0071638,0.999999999995435,0.880833463723379,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
11392,GO:0045743,0.999999999995443,0.68640189282218,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
20220,GO:2001033,0.999999999995446,0.706532170027825,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
11329,GO:0045632,0.99999999999545,0.741910543746289,0,4,negative regulation of mechanoreceptor differentiation,BP,
20199,GO:2000981,0.99999999999545,0.741910543746289,0,4,negative regulation of inner ear receptor cell differentiation,BP,
13753,GO:0060302,0.999999999995457,0.880293665477156,0,2,negative regulation of cytokine activity,BP,
2173,GO:0005006,0.999999999995465,0.863823587425955,0,2,epidermal growth factor-activated receptor activity,MF,
1846,GO:0004499,0.999999999995474,0.933184403021475,0,1,N,N-dimethylaniline monooxygenase activity,MF,
19938,GO:2000395,0.999999999995494,0.899226939693844,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19939,GO:2000397,0.999999999995494,0.899226939693844,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
11459,GO:0045887,0.999999999995499,0.906334943606597,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
18594,GO:1903795,0.999999999995508,0.715277179182111,0,4,regulation of inorganic anion transmembrane transport,BP,
16942,GO:0098895,0.999999999995508,0.922726613321681,0,1,postsynaptic endosome membrane,CC,
16995,GO:0098999,0.999999999995508,0.922726613321681,0,1,extrinsic component of postsynaptic endosome membrane,CC,
17949,GO:1902238,0.999999999995508,0.922726613321681,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17950,GO:1902239,0.999999999995508,0.922726613321681,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19484,GO:1990127,0.999999999995508,0.922726613321681,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
15563,GO:0071953,0.999999999995516,0.864163849874415,0,2,elastic fiber,CC,
13900,GO:0060510,0.99999999999553,0.8562054807459,0,2,Type II pneumocyte differentiation,BP,
15285,GO:0071442,0.999999999995534,0.801715605408844,0,3,positive regulation of histone H3-K14 acetylation,BP,
15117,GO:0071139,0.99999999999554,0.847695712695974,0,2,resolution of recombination intermediates,BP,
15118,GO:0071140,0.99999999999554,0.847695712695974,0,2,resolution of mitotic recombination intermediates,BP,
2077,GO:0004828,0.999999999995546,0.874144198196739,0,2,serine-tRNA ligase activity,MF,
2923,GO:0006434,0.999999999995546,0.874144198196739,0,2,seryl-tRNA aminoacylation,BP,
19019,GO:1904784,0.999999999995556,0.916233462980126,0,1,NLRP1 inflammasome complex assembly,BP,
4301,GO:0009744,0.999999999995557,0.792216086142961,0,3,response to sucrose,BP,
8693,GO:0034285,0.999999999995557,0.792216086142961,0,3,response to disaccharide,BP,
20090,GO:2000683,0.999999999995558,0.860978513639478,0,2,regulation of cellular response to X-ray,BP,
4700,GO:0010856,0.999999999995567,0.926416804630378,0,1,adenylate cyclase activator activity,MF,
7972,GO:0032571,0.999999999995592,0.862007592167364,0,2,response to vitamin K,BP,
15192,GO:0071307,0.999999999995592,0.862007592167364,0,2,cellular response to vitamin K,BP,
8630,GO:0034140,0.999999999995596,0.789591412006496,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
4278,GO:0009637,0.999999999995601,0.855121010825586,0,2,response to blue light,BP,
4310,GO:0009785,0.999999999995601,0.855121010825586,0,2,blue light signaling pathway,BP,
4335,GO:0009882,0.999999999995601,0.855121010825586,0,2,blue light photoreceptor activity,MF,
15315,GO:0071483,0.999999999995601,0.855121010825586,0,2,cellular response to blue light,BP,
18072,GO:1902576,0.999999999995612,0.74633149207139,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
8990,GO:0035090,0.999999999995614,0.686589084093837,0,5,maintenance of apical/basal cell polarity,BP,
11163,GO:0045199,0.999999999995614,0.686589084093837,0,5,maintenance of epithelial cell apical/basal polarity,BP,
2009,GO:0004730,0.999999999995615,0.939625282030989,0,1,pseudouridylate synthase activity,MF,
15007,GO:0070902,0.999999999995615,0.939625282030989,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
6087,GO:0019240,0.999999999995624,0.69046580614262,0,4,citrulline biosynthetic process,BP,
17887,GO:1902083,0.999999999995631,0.640280161904871,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19796,GO:2000169,0.999999999995631,0.640280161904871,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,
18448,GO:1903487,0.999999999995632,0.867407204492559,0,2,regulation of lactation,BP,
10498,GO:0043385,0.999999999995633,0.928900698751741,0,1,mycotoxin metabolic process,BP,
10499,GO:0043387,0.999999999995633,0.928900698751741,0,1,mycotoxin catabolic process,BP,
11621,GO:0046222,0.999999999995633,0.928900698751741,0,1,aflatoxin metabolic process,BP,
11622,GO:0046223,0.999999999995633,0.928900698751741,0,1,aflatoxin catabolic process,BP,
17666,GO:1901376,0.999999999995633,0.928900698751741,0,1,organic heteropentacyclic compound metabolic process,BP,
17667,GO:1901377,0.999999999995633,0.928900698751741,0,1,organic heteropentacyclic compound catabolic process,BP,
18589,GO:1903786,0.999999999995633,0.928900698751741,0,1,regulation of glutathione biosynthetic process,BP,
18590,GO:1903788,0.999999999995633,0.928900698751741,0,1,positive regulation of glutathione biosynthetic process,BP,
18773,GO:1904217,0.999999999995639,0.810619780014828,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18774,GO:1904219,0.999999999995639,0.810619780014828,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18776,GO:1904222,0.999999999995639,0.810619780014828,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
17376,GO:1900042,0.99999999999565,0.81866652924947,0,2,positive regulation of interleukin-2 secretion,BP,
9307,GO:0035744,0.999999999995651,0.950914432190909,0,1,T-helper 1 cell cytokine production,BP,
9917,GO:0042231,0.999999999995651,0.950914432190909,0,1,interleukin-13 biosynthetic process,BP,
15184,GO:0071286,0.999999999995655,0.710144880425037,0,3,cellular response to magnesium ion,BP,
17781,GO:1901723,0.999999999995659,0.691949561444142,0,5,negative regulation of cell proliferation involved in kidney development,BP,
12110,GO:0048073,0.999999999995661,0.850259575436955,0,2,regulation of eye pigmentation,BP,
2911,GO:0006422,0.999999999995669,0.931487427531085,0,1,aspartyl-tRNA aminoacylation,BP,
20215,GO:2001027,0.999999999995671,0.819504655987202,0,2,negative regulation of endothelial cell chemotaxis,BP,
5636,GO:0016714,0.999999999995683,0.831941754350183,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
4713,GO:0010873,0.99999999999569,0.859671503581316,0,3,positive regulation of cholesterol esterification,BP,
4437,GO:0010286,0.999999999995705,0.728570835229002,0,5,heat acclimation,BP,
14734,GO:0070370,0.999999999995705,0.728570835229002,0,5,cellular heat acclimation,BP,
8127,GO:0032807,0.99999999999574,0.750135902722782,0,4,DNA ligase IV complex,CC,
17134,GO:0101006,0.999999999995746,0.82830157209647,0,3,protein histidine phosphatase activity,MF,
12214,GO:0048369,0.999999999995769,0.846828447568231,0,2,lateral mesoderm morphogenesis,BP,
12215,GO:0048370,0.999999999995769,0.846828447568231,0,2,lateral mesoderm formation,BP,
12216,GO:0048371,0.999999999995769,0.846828447568231,0,2,lateral mesodermal cell differentiation,BP,
12217,GO:0048372,0.999999999995769,0.846828447568231,0,2,lateral mesodermal cell fate commitment,BP,
12218,GO:0048377,0.999999999995769,0.846828447568231,0,2,lateral mesodermal cell fate specification,BP,
12219,GO:0048378,0.999999999995769,0.846828447568231,0,2,regulation of lateral mesodermal cell fate specification,BP,
8240,GO:0032996,0.999999999995769,0.936474894054253,0,1,Bcl3-Bcl10 complex,CC,
11096,GO:0045082,0.999999999995769,0.936474894054253,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
16418,GO:0097018,0.999999999995774,0.930240858037598,0,1,renal albumin absorption,BP,
17428,GO:1900141,0.999999999995774,0.930240858037598,0,1,regulation of oligodendrocyte apoptotic process,BP,
17429,GO:1900142,0.999999999995774,0.930240858037598,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
19995,GO:2000532,0.999999999995774,0.930240858037598,0,1,regulation of renal albumin absorption,BP,
19996,GO:2000533,0.999999999995774,0.930240858037598,0,1,negative regulation of renal albumin absorption,BP,
14947,GO:0070782,0.999999999995775,0.933055160548036,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
7254,GO:0031205,0.999999999995776,0.886082190354749,0,2,endoplasmic reticulum Sec complex,CC,
5310,GO:0016013,0.99999999999578,0.843975259151001,0,2,syntrophin complex,CC,
19657,GO:1990784,0.999999999995785,0.923401946458615,0,1,response to dsDNA,BP,
19659,GO:1990786,0.999999999995785,0.923401946458615,0,1,cellular response to dsDNA,BP,
199,GO:0000417,0.999999999995787,0.923427266405795,0,1,HIR complex,CC,
5867,GO:0017168,0.999999999995787,0.923427266405795,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
7017,GO:0030702,0.999999999995787,0.923427266405795,0,1,chromatin silencing at centromere,BP,
19156,GO:1905069,0.999999999995787,0.923427266405795,0,1,allantois development,BP,
2343,GO:0005372,0.999999999995812,0.762582693286248,0,4,water transmembrane transporter activity,MF,
4275,GO:0009631,0.999999999995812,0.918248573863496,0,1,cold acclimation,BP,
5056,GO:0015250,0.999999999995812,0.762582693286248,0,4,water channel activity,MF,
11630,GO:0046317,0.999999999995812,0.918248573863496,0,1,regulation of glucosylceramide biosynthetic process,BP,
11631,GO:0046318,0.999999999995812,0.918248573863496,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
18286,GO:1903108,0.999999999995812,0.918248573863496,0,1,regulation of mitochondrial transcription,BP,
18287,GO:1903109,0.999999999995812,0.918248573863496,0,1,positive regulation of mitochondrial transcription,BP,
5218,GO:0015817,0.999999999995819,0.928629556576344,0,1,histidine transport,BP,
7536,GO:0031753,0.999999999995819,0.928629556576344,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7537,GO:0031755,0.999999999995819,0.928629556576344,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
16201,GO:0090204,0.999999999995825,0.819954773526284,0,3,protein localization to nuclear pore,BP,
2462,GO:0005674,0.999999999995835,0.877593607562039,0,2,transcription factor TFIIF complex,CC,
17516,GO:1900451,0.999999999995844,0.672082562224944,0,5,positive regulation of glutamate receptor signaling pathway,BP,
19553,GO:1990414,0.999999999995846,0.717719389992463,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
18554,GO:1903715,0.99999999999586,0.745254840711819,0,4,regulation of aerobic respiration,BP,
13097,GO:0051585,0.999999999995861,0.926901177573649,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13121,GO:0051620,0.999999999995861,0.926901177573649,0,1,norepinephrine uptake,BP,
13122,GO:0051621,0.999999999995861,0.926901177573649,0,1,regulation of norepinephrine uptake,BP,
13123,GO:0051622,0.999999999995861,0.926901177573649,0,1,negative regulation of norepinephrine uptake,BP,
13282,GO:0051945,0.999999999995861,0.926901177573649,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
18212,GO:1902957,0.999999999995861,0.926901177573649,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18353,GO:1903282,0.999999999995861,0.926901177573649,0,1,regulation of glutathione peroxidase activity,BP,
18354,GO:1903284,0.999999999995861,0.926901177573649,0,1,positive regulation of glutathione peroxidase activity,BP,
18355,GO:1903285,0.999999999995861,0.926901177573649,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19294,GO:1905447,0.999999999995861,0.926901177573649,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19862,GO:2000295,0.999999999995861,0.926901177573649,0,1,regulation of hydrogen peroxide catabolic process,BP,
19973,GO:2000468,0.999999999995861,0.926901177573649,0,1,regulation of peroxidase activity,BP,
19974,GO:2000470,0.999999999995861,0.926901177573649,0,1,positive regulation of peroxidase activity,BP,
11418,GO:0045794,0.999999999995864,0.702954141459629,0,4,negative regulation of cell volume,BP,
10431,GO:0043262,0.999999999995864,0.808408766984776,0,3,adenosine-diphosphatase activity,MF,
11694,GO:0046462,0.999999999995873,0.870328295899075,0,2,monoacylglycerol metabolic process,BP,
13402,GO:0052651,0.999999999995873,0.870328295899075,0,2,monoacylglycerol catabolic process,BP,
1783,GO:0004394,0.999999999995879,0.922845776676868,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
3802,GO:0008379,0.999999999995883,0.788670262396844,0,5,thioredoxin peroxidase activity,MF,
19883,GO:2000321,0.9999999999959,0.891600181733504,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19891,GO:2000330,0.9999999999959,0.891600181733504,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
17361,GO:1900019,0.999999999995902,0.728496256552004,0,4,regulation of protein kinase C activity,BP,
17362,GO:1900020,0.999999999995902,0.728496256552004,0,4,positive regulation of protein kinase C activity,BP,
7366,GO:0031403,0.999999999995908,0.839040966981525,0,2,lithium ion binding,MF,
9882,GO:0042134,0.999999999995912,0.891375864502995,0,2,rRNA primary transcript binding,MF,
3636,GO:0008107,0.999999999995913,0.855383060748022,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
7237,GO:0031127,0.999999999995913,0.855383060748022,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
17659,GO:1901355,0.999999999995915,0.849321014303907,0,2,response to rapamycin,BP,
11028,GO:0044854,0.999999999995925,0.753179470779181,0,4,plasma membrane raft assembly,BP,
11031,GO:0044857,0.999999999995925,0.753179470779181,0,4,plasma membrane raft organization,BP,
10458,GO:0043305,0.999999999995928,0.872562219654986,0,2,negative regulation of mast cell degranulation,BP,
8429,GO:0033499,0.999999999995933,0.880411371579833,0,2,galactose catabolic process via UDP-galactose,BP,
3870,GO:0008493,0.999999999995934,0.936524034498462,0,1,tetracycline transmembrane transporter activity,MF,
5265,GO:0015904,0.999999999995934,0.936524034498462,0,1,tetracycline transport,BP,
3527,GO:0007509,0.999999999995935,0.910517999135172,0,1,mesoderm migration involved in gastrulation,BP,
3621,GO:0008078,0.999999999995935,0.910517999135172,0,1,mesodermal cell migration,BP,
14592,GO:0070119,0.999999999995945,0.922996681006522,0,1,ciliary neurotrophic factor binding,MF,
8104,GO:0032783,0.999999999995951,0.704746893703358,0,4,ELL-EAF complex,CC,
12784,GO:0051036,0.999999999995957,0.70840754142001,0,5,regulation of endosome size,BP,
17621,GO:1901255,0.999999999995957,0.855862483882312,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
2240,GO:0005146,0.999999999995963,0.868243972815613,0,2,leukemia inhibitory factor receptor binding,MF,
5448,GO:0016312,0.999999999995966,0.726655016797037,0,4,inositol bisphosphate phosphatase activity,MF,
13617,GO:0060066,0.999999999995967,0.869217376576943,0,2,oviduct development,BP,
13078,GO:0051552,0.999999999995972,0.931299874662699,0,1,flavone metabolic process,BP,
15053,GO:0070980,0.999999999995972,0.931299874662699,0,1,biphenyl catabolic process,BP,
15100,GO:0071051,0.999999999995975,0.761790668313006,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
14909,GO:0070695,0.999999999995979,0.638570933893284,0,5,FHF complex,CC,
9283,GO:0035700,0.999999999995982,0.937742542981487,0,1,astrocyte chemotaxis,BP,
9507,GO:0036145,0.999999999995982,0.937742542981487,0,1,dendritic cell homeostasis,BP,
19968,GO:2000458,0.999999999995982,0.937742542981487,0,1,regulation of astrocyte chemotaxis,BP,
816,GO:0002086,0.999999999995991,0.925145551558149,0,1,diaphragm contraction,BP,
1895,GO:0004574,0.999999999995991,0.925145551558149,0,1,oligo-1,6-glucosidase activity,MF,
2650,GO:0005985,0.999999999995991,0.925145551558149,0,1,sucrose metabolic process,BP,
10376,GO:0043181,0.999999999995991,0.925145551558149,0,1,vacuolar sequestering,BP,
9787,GO:0039656,0.999999999995997,0.869437840292548,0,2,modulation by virus of host gene expression,BP,
11849,GO:0046778,0.999999999995997,0.869437840292548,0,2,modification by virus of host mRNA processing,BP,
5545,GO:0016531,0.999999999995998,0.774459316607406,0,5,copper chaperone activity,MF,
16938,GO:0098886,0.999999999996005,0.852124398714122,0,2,modification of dendritic spine,BP,
3667,GO:0008158,0.999999999996006,0.864661932863968,0,2,hedgehog receptor activity,MF,
1416,GO:0003350,0.999999999996008,0.855722226280736,0,2,pulmonary myocardium development,BP,
13071,GO:0051542,0.999999999996014,0.838440874212517,0,2,elastin biosynthetic process,BP,
8755,GO:0034398,0.999999999996023,0.672073168143798,0,5,telomere tethering at nuclear periphery,BP,
12250,GO:0048496,0.999999999996025,0.786782415492833,0,3,maintenance of animal organ identity,BP,
5810,GO:0017061,0.999999999996031,0.919227307724691,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
17959,GO:1902262,0.999999999996032,0.760892989754481,0,4,apoptotic process involved in blood vessel morphogenesis,BP,
11856,GO:0046811,0.999999999996033,0.915068420353713,0,1,histone deacetylase inhibitor activity,MF,
3723,GO:0008251,0.999999999996033,0.847317100008837,0,2,tRNA-specific adenosine deaminase activity,MF,
10783,GO:0044220,0.999999999996034,0.919645081860334,0,1,host cell perinuclear region of cytoplasm,CC,
1959,GO:0004660,0.999999999996041,0.873479369390176,0,2,protein farnesyltransferase activity,MF,
2635,GO:0005965,0.999999999996041,0.873479369390176,0,2,protein farnesyltransferase complex,CC,
14937,GO:0070772,0.999999999996046,0.927160226200405,0,1,PAS complex,CC,
1629,GO:0004062,0.999999999996083,0.790522763048652,0,4,aryl sulfotransferase activity,MF,
15783,GO:0072361,0.99999999999609,0.806141973579794,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16836,GO:0098679,0.99999999999609,0.806141973579794,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
453,GO:0001226,0.999999999996094,0.926396380242168,0,1,RNA polymerase II transcription corepressor binding,MF,
3826,GO:0008424,0.999999999996094,0.926396380242168,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
9473,GO:0036071,0.999999999996094,0.926396380242168,0,1,N-glycan fucosylation,BP,
11913,GO:0046921,0.999999999996094,0.926396380242168,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
3414,GO:0007198,0.999999999996107,0.880541875070611,0,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
8316,GO:0033142,0.999999999996119,0.932717371469166,0,1,progesterone receptor binding,MF,
12718,GO:0050917,0.999999999996119,0.834454757475493,0,2,sensory perception of umami taste,BP,
3521,GO:0007497,0.999999999996127,0.919337285719582,0,1,posterior midgut development,BP,
181,GO:0000393,0.999999999996129,0.711353815015265,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
11571,GO:0046098,0.999999999996144,0.751004214040451,0,4,guanine metabolic process,BP,
5897,GO:0018076,0.999999999996145,0.677815383607057,0,4,N-terminal peptidyl-lysine acetylation,BP,
19492,GO:1990164,0.999999999996148,0.860866772808985,0,2,histone H2A phosphorylation,BP,
7455,GO:0031585,0.999999999996152,0.654659806962006,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
2752,GO:0006154,0.999999999996155,0.875938111452143,0,2,adenosine catabolic process,BP,
11576,GO:0046103,0.999999999996155,0.875938111452143,0,2,inosine biosynthetic process,BP,
12775,GO:0051024,0.999999999996178,0.7382098659332,0,5,positive regulation of immunoglobulin secretion,BP,
13835,GO:0060406,0.99999999999618,0.854853144085773,0,2,positive regulation of penile erection,BP,
1862,GO:0004522,0.999999999996184,0.941502868941258,0,1,ribonuclease A activity,MF,
3975,GO:0008785,0.999999999996184,0.941502868941258,0,1,alkyl hydroperoxide reductase activity,MF,
4309,GO:0009758,0.999999999996195,0.8988998356391,0,1,carbohydrate utilization,BP,
4875,GO:0014734,0.999999999996195,0.8988998356391,0,1,skeletal muscle hypertrophy,BP,
10627,GO:0043610,0.999999999996195,0.8988998356391,0,1,regulation of carbohydrate utilization,BP,
18034,GO:1902488,0.999999999996195,0.8988998356391,0,1,cholangiocyte apoptotic process,BP,
18696,GO:1904000,0.999999999996195,0.8988998356391,0,1,positive regulation of eating behavior,BP,
18723,GO:1904054,0.999999999996195,0.8988998356391,0,1,regulation of cholangiocyte proliferation,BP,
18724,GO:1904056,0.999999999996195,0.8988998356391,0,1,positive regulation of cholangiocyte proliferation,BP,
18757,GO:1904192,0.999999999996195,0.8988998356391,0,1,regulation of cholangiocyte apoptotic process,BP,
18758,GO:1904193,0.999999999996195,0.8988998356391,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18759,GO:1904195,0.999999999996195,0.8988998356391,0,1,regulation of granulosa cell proliferation,BP,
18760,GO:1904197,0.999999999996195,0.8988998356391,0,1,positive regulation of granulosa cell proliferation,BP,
18762,GO:1904200,0.999999999996195,0.8988998356391,0,1,iodide transmembrane transport,BP,
18763,GO:1904201,0.999999999996195,0.8988998356391,0,1,regulation of iodide transport,BP,
18764,GO:1904202,0.999999999996195,0.8988998356391,0,1,negative regulation of iodide transport,BP,
18765,GO:1904204,0.999999999996195,0.8988998356391,0,1,regulation of skeletal muscle hypertrophy,BP,
18766,GO:1904206,0.999999999996195,0.8988998356391,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18771,GO:1904212,0.999999999996195,0.8988998356391,0,1,regulation of iodide transmembrane transport,BP,
18772,GO:1904213,0.999999999996195,0.8988998356391,0,1,negative regulation of iodide transmembrane transport,BP,
19623,GO:1990705,0.999999999996195,0.8988998356391,0,1,cholangiocyte proliferation,BP,
19635,GO:1990739,0.999999999996195,0.8988998356391,0,1,granulosa cell proliferation,BP,
9129,GO:0035426,0.999999999996207,0.714028959719814,0,4,extracellular matrix-cell signaling,BP,
19064,GO:1904878,0.999999999996212,0.890315310053182,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
14204,GO:0061083,0.999999999996212,0.740710686391833,0,4,regulation of protein refolding,BP,
14205,GO:0061084,0.999999999996212,0.740710686391833,0,4,negative regulation of protein refolding,BP,
7392,GO:0031439,0.999999999996218,0.857974670860411,0,2,positive regulation of mRNA cleavage,BP,
12726,GO:0050925,0.999999999996227,0.827982802331634,0,2,negative regulation of negative chemotaxis,BP,
19571,GO:1990452,0.999999999996235,0.856802343693828,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
1519,GO:0003877,0.999999999996238,0.933516753896516,0,1,ATP adenylyltransferase activity,MF,
2073,GO:0004824,0.999999999996238,0.933516753896516,0,1,lysine-tRNA ligase activity,MF,
2919,GO:0006430,0.999999999996238,0.933516753896516,0,1,lysyl-tRNA aminoacylation,BP,
14432,GO:0061709,0.999999999996246,0.909872568241877,0,1,reticulophagy,BP,
10213,GO:0042816,0.999999999996248,0.672543125957146,0,5,vitamin B6 metabolic process,BP,
4000,GO:0008903,0.99999999999625,0.951862186944189,0,1,hydroxypyruvate isomerase activity,MF,
6772,GO:0030202,0.999999999996272,0.70858038431166,0,4,heparin metabolic process,BP,
6780,GO:0030210,0.999999999996272,0.70858038431166,0,4,heparin biosynthetic process,BP,
8513,GO:0033684,0.999999999996275,0.834216870037467,0,2,regulation of luteinizing hormone secretion,BP,
8514,GO:0033686,0.999999999996275,0.834216870037467,0,2,positive regulation of luteinizing hormone secretion,BP,
16973,GO:0098943,0.999999999996287,0.868710202316946,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
1087,GO:0002669,0.999999999996308,0.911369565653878,0,1,positive regulation of T cell anergy,BP,
1234,GO:0002913,0.999999999996308,0.911369565653878,0,1,positive regulation of lymphocyte anergy,BP,
6033,GO:0019089,0.999999999996308,0.911369565653878,0,1,transmission of virus,BP,
10721,GO:0044007,0.999999999996308,0.911369565653878,0,1,dissemination or transmission of symbiont from host,BP,
13220,GO:0051821,0.999999999996308,0.911369565653878,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
11150,GO:0045180,0.999999999996317,0.629547919062027,0,5,basal cortex,CC,
19821,GO:2000211,0.999999999996319,0.918608214097741,0,1,regulation of glutamate metabolic process,BP,
19822,GO:2000212,0.999999999996319,0.918608214097741,0,1,negative regulation of glutamate metabolic process,BP,
4049,GO:0009085,0.999999999996344,0.848539631135952,0,2,lysine biosynthetic process,BP,
6280,GO:0019878,0.999999999996344,0.848539631135952,0,2,lysine biosynthetic process via aminoadipic acid,BP,
2062,GO:0004813,0.999999999996345,0.79738613474704,0,3,alanine-tRNA ligase activity,MF,
2908,GO:0006419,0.999999999996345,0.79738613474704,0,3,alanyl-tRNA aminoacylation,BP,
4537,GO:0010606,0.99999999999635,0.632521533622226,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
8387,GO:0033278,0.99999999999635,0.724680151910715,0,4,cell proliferation in midbrain,BP,
18747,GO:1904155,0.999999999996361,0.926179409817973,0,1,DN2 thymocyte differentiation,BP,
18748,GO:1904156,0.999999999996361,0.926179409817973,0,1,DN3 thymocyte differentiation,BP,
12192,GO:0048298,0.999999999996363,0.749985271094914,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13738,GO:0060283,0.999999999996371,0.839481957736163,0,2,negative regulation of oocyte development,BP,
19417,GO:1905880,0.999999999996371,0.839481957736163,0,2,negative regulation of oogenesis,BP,
1683,GO:0004145,0.999999999996381,0.909490474013978,0,2,diamine N-acetyltransferase activity,MF,
6246,GO:0019809,0.999999999996381,0.909490474013978,0,2,spermidine binding,MF,
8187,GO:0032917,0.999999999996381,0.909490474013978,0,2,polyamine acetylation,BP,
8188,GO:0032918,0.999999999996381,0.909490474013978,0,2,spermidine acetylation,BP,
1724,GO:0004313,0.999999999996388,0.900357931783124,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1727,GO:0004316,0.999999999996388,0.900357931783124,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1728,GO:0004317,0.999999999996388,0.900357931783124,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1729,GO:0004319,0.999999999996388,0.900357931783124,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
6050,GO:0019171,0.999999999996388,0.900357931783124,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
11973,GO:0047117,0.999999999996388,0.900357931783124,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12018,GO:0047451,0.999999999996388,0.900357931783124,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
17148,GO:0102131,0.999999999996388,0.900357931783124,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17149,GO:0102132,0.999999999996388,0.900357931783124,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
5122,GO:0015467,0.9999999999964,0.861559041141628,0,2,G-protein activated inward rectifier potassium channel activity,MF,
10129,GO:0042640,0.9999999999964,0.718752555974147,0,4,anagen,BP,
13243,GO:0051884,0.9999999999964,0.718752555974147,0,4,regulation of timing of anagen,BP,
604,GO:0001770,0.999999999996408,0.90769443775357,0,1,establishment of natural killer cell polarity,BP,
11426,GO:0045819,0.999999999996408,0.923838250380377,0,1,positive regulation of glycogen catabolic process,BP,
5986,GO:0018872,0.999999999996434,0.930485331903034,0,1,arsonoacetate metabolic process,BP,
7029,GO:0030791,0.999999999996434,0.930485331903034,0,1,arsenite methyltransferase activity,MF,
7030,GO:0030792,0.999999999996434,0.930485331903034,0,1,methylarsonite methyltransferase activity,MF,
18829,GO:1904352,0.999999999996436,0.69740707318503,0,4,positive regulation of protein catabolic process in the vacuole,BP,
1404,GO:0003335,0.999999999996449,0.930012343723264,0,1,corneocyte development,BP,
1405,GO:0003336,0.999999999996449,0.930012343723264,0,1,corneocyte desquamation,BP,
19380,GO:1905715,0.999999999996449,0.930012343723264,0,1,regulation of cornification,BP,
19381,GO:1905716,0.999999999996449,0.930012343723264,0,1,negative regulation of cornification,BP,
15265,GO:0071409,0.99999999999645,0.778150750807076,0,3,cellular response to cycloheximide,BP,
16440,GO:0097058,0.999999999996453,0.937489410228408,0,1,CRLF-CLCF1 complex,CC,
16441,GO:0097059,0.999999999996453,0.937489410228408,0,1,CNTFR-CLCF1 complex,CC,
8031,GO:0032661,0.999999999996462,0.68816822183513,0,5,regulation of interleukin-18 production,BP,
14367,GO:0061550,0.999999999996467,0.719305273193432,0,4,cranial ganglion development,BP,
8493,GO:0033633,0.999999999996469,0.919584233765264,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
8197,GO:0032929,0.999999999996479,0.878250420982578,0,2,negative regulation of superoxide anion generation,BP,
12710,GO:0050908,0.999999999996481,0.726513892541165,0,4,detection of light stimulus involved in visual perception,BP,
12742,GO:0050962,0.999999999996481,0.726513892541165,0,4,detection of light stimulus involved in sensory perception,BP,
11250,GO:0045409,0.999999999996493,0.852088374364675,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
126,GO:0000257,0.999999999996498,0.945697339018494,0,1,nitrilase activity,MF,
5698,GO:0016815,0.999999999996498,0.945697339018494,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6040,GO:0019118,0.999999999996498,0.945697339018494,0,1,phenanthrene-epoxide hydrolase activity,MF,
6041,GO:0019119,0.999999999996498,0.945697339018494,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
9978,GO:0042356,0.999999999996498,0.945697339018494,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
12521,GO:0050577,0.999999999996498,0.945697339018494,0,1,GDP-L-fucose synthase activity,MF,
15091,GO:0071038,0.999999999996507,0.749171370578683,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16500,GO:0097165,0.99999999999651,0.688651487049041,0,5,nuclear stress granule,CC,
2659,GO:0006001,0.999999999996512,0.747355148547065,0,4,fructose catabolic process,BP,
14397,GO:0061624,0.999999999996512,0.747355148547065,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
16807,GO:0098619,0.999999999996545,0.936007961907555,0,1,selenocysteine-tRNA ligase activity,MF,
574,GO:0001714,0.999999999996562,0.768822747871424,0,4,endodermal cell fate specification,BP,
11070,GO:0045053,0.999999999996568,0.556779873295529,0,5,protein retention in Golgi apparatus,BP,
725,GO:0001951,0.999999999996572,0.78792218999815,0,3,intestinal D-glucose absorption,BP,
17210,GO:0106001,0.999999999996572,0.78792218999815,0,3,intestinal hexose absorption,BP,
11920,GO:0046933,0.999999999996589,0.855027046220808,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12188,GO:0048294,0.999999999996594,0.856171039761624,0,2,negative regulation of isotype switching to IgE isotypes,BP,
815,GO:0002085,0.999999999996595,0.783369304117262,0,3,inhibition of neuroepithelial cell differentiation,BP,
11312,GO:0045608,0.999999999996595,0.783369304117262,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
15532,GO:0071894,0.999999999996606,0.864083836664981,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
19356,GO:1905616,0.999999999996622,0.851648052701007,0,2,regulation of miRNA mediated inhibition of translation,BP,
19357,GO:1905618,0.999999999996622,0.851648052701007,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
18215,GO:1902960,0.99999999999663,0.827014220112865,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19210,GO:1905246,0.99999999999663,0.827014220112865,0,2,negative regulation of aspartic-type peptidase activity,BP,
6014,GO:0019060,0.999999999996633,0.902456203607362,0,2,intracellular transport of viral protein in host cell,BP,
6959,GO:0030581,0.999999999996633,0.902456203607362,0,2,symbiont intracellular protein transport in host,BP,
13161,GO:0051708,0.999999999996633,0.902456203607362,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
237,GO:0000494,0.999999999996642,0.950359072958188,0,1,box C/D snoRNA 3'-end processing,BP,
8563,GO:0033967,0.999999999996642,0.950359072958188,0,1,box C/D snoRNA metabolic process,BP,
8941,GO:0034963,0.999999999996642,0.950359072958188,0,1,box C/D snoRNA processing,BP,
9444,GO:0036009,0.999999999996642,0.950359072958188,0,1,protein-glutamine N-methyltransferase activity,MF,
19518,GO:1990258,0.999999999996642,0.950359072958188,0,1,histone glutamine methylation,BP,
19519,GO:1990259,0.999999999996642,0.950359072958188,0,1,histone-glutamine methyltransferase activity,MF,
9991,GO:0042374,0.999999999996647,0.882209884109688,0,2,phylloquinone metabolic process,BP,
9992,GO:0042376,0.999999999996647,0.882209884109688,0,2,phylloquinone catabolic process,BP,
17757,GO:1901662,0.999999999996647,0.882209884109688,0,2,quinone catabolic process,BP,
13006,GO:0051391,0.999999999996669,0.92375001075343,0,1,tRNA acetylation,BP,
13007,GO:0051392,0.999999999996669,0.92375001075343,0,1,tRNA N-acetyltransferase activity,MF,
19031,GO:1904812,0.999999999996669,0.92375001075343,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19684,GO:1990882,0.999999999996669,0.92375001075343,0,1,rRNA acetylation,BP,
19685,GO:1990883,0.999999999996669,0.92375001075343,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19686,GO:1990884,0.999999999996669,0.92375001075343,0,1,RNA acetylation,BP,
1606,GO:0004022,0.999999999996671,0.929409066771645,0,1,alcohol dehydrogenase (NAD) activity,MF,
5978,GO:0018467,0.999999999996671,0.929409066771645,0,1,formaldehyde dehydrogenase activity,MF,
13259,GO:0051903,0.999999999996671,0.929409066771645,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
4609,GO:0010722,0.999999999996672,0.907293476672751,0,1,regulation of ferrochelatase activity,BP,
8952,GO:0034986,0.999999999996672,0.907293476672751,0,1,iron chaperone activity,MF,
18779,GO:1904229,0.999999999996672,0.907293476672751,0,1,regulation of succinate dehydrogenase activity,BP,
18780,GO:1904231,0.999999999996672,0.907293476672751,0,1,positive regulation of succinate dehydrogenase activity,BP,
18781,GO:1904232,0.999999999996672,0.907293476672751,0,1,regulation of aconitate hydratase activity,BP,
18782,GO:1904234,0.999999999996672,0.907293476672751,0,1,positive regulation of aconitate hydratase activity,BP,
16977,GO:0098960,0.999999999996674,0.734717643654017,0,4,postsynaptic neurotransmitter receptor activity,MF,
17073,GO:0099529,0.999999999996674,0.734717643654017,0,4,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18817,GO:1904315,0.999999999996674,0.734717643654017,0,4,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
4558,GO:0010637,0.999999999996677,0.701872271421844,0,5,negative regulation of mitochondrial fusion,BP,
9990,GO:0042373,0.999999999996688,0.739539501550488,0,5,vitamin K metabolic process,BP,
7398,GO:0031445,0.999999999996689,0.84039533506659,0,2,regulation of heterochromatin assembly,BP,
7399,GO:0031453,0.999999999996689,0.84039533506659,0,2,positive regulation of heterochromatin assembly,BP,
11420,GO:0045799,0.999999999996689,0.84039533506659,0,2,positive regulation of chromatin assembly or disassembly,BP,
10728,GO:0044036,0.999999999996696,0.818725678943555,0,3,cell wall macromolecule metabolic process,BP,
15351,GO:0071554,0.999999999996696,0.818725678943555,0,3,cell wall organization or biogenesis,BP,
9584,GO:0036378,0.999999999996707,0.875024291363082,0,2,calcitriol biosynthetic process from calciol,BP,
1796,GO:0004422,0.999999999996716,0.8837219529317,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2765,GO:0006178,0.999999999996716,0.8837219529317,0,2,guanine salvage,BP,
7754,GO:0032263,0.999999999996716,0.8837219529317,0,2,GMP salvage,BP,
11572,GO:0046099,0.999999999996716,0.8837219529317,0,2,guanine biosynthetic process,BP,
10613,GO:0043578,0.999999999996716,0.724784374887626,0,3,nuclear matrix organization,BP,
16260,GO:0090292,0.999999999996716,0.724784374887626,0,3,nuclear matrix anchoring at nuclear membrane,BP,
1275,GO:0003064,0.99999999999672,0.936815954488032,0,1,regulation of heart rate by hormone,BP,
19431,GO:1905912,0.99999999999672,0.936815954488032,0,1,regulation of calcium ion export across plasma membrane,BP,
19432,GO:1905913,0.99999999999672,0.936815954488032,0,1,negative regulation of calcium ion export across plasma membrane,BP,
19600,GO:1990589,0.999999999996725,0.839117433160541,0,2,ATF4-CREB1 transcription factor complex,CC,
661,GO:0001850,0.999999999996739,0.937034041515348,0,1,complement component C3a binding,MF,
662,GO:0001851,0.999999999996739,0.937034041515348,0,1,complement component C3b binding,MF,
4743,GO:0010908,0.999999999996765,0.793669450389065,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4744,GO:0010909,0.999999999996765,0.793669450389065,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
18122,GO:1902730,0.999999999996765,0.793669450389065,0,3,positive regulation of proteoglycan biosynthetic process,BP,
5378,GO:0016188,0.999999999996767,0.685934253025564,0,5,synaptic vesicle maturation,BP,
15941,GO:0072708,0.999999999996769,0.746417276131446,0,4,response to sorbitol,BP,
123,GO:0000253,0.99999999999677,0.799777337010469,0,4,3-keto sterol reductase activity,MF,
14377,GO:0061580,0.999999999996778,0.923042300772058,0,1,colon epithelial cell migration,BP,
14968,GO:0070843,0.999999999996778,0.923042300772058,0,1,misfolded protein transport,BP,
14969,GO:0070844,0.999999999996778,0.923042300772058,0,1,polyubiquitinated protein transport,BP,
14970,GO:0070845,0.999999999996778,0.923042300772058,0,1,polyubiquitinated misfolded protein transport,BP,
14971,GO:0070846,0.999999999996778,0.923042300772058,0,1,Hsp90 deacetylation,BP,
13811,GO:0060378,0.999999999996786,0.904063866696337,0,1,regulation of brood size,BP,
18625,GO:1903862,0.999999999996795,0.719671071683117,0,5,positive regulation of oxidative phosphorylation,BP,
5115,GO:0015432,0.999999999996796,0.925398214155085,0,1,bile acid-exporting ATPase activity,MF,
8389,GO:0033283,0.999999999996796,0.925398214155085,0,1,organic acid-transporting ATPase activity,MF,
8390,GO:0033284,0.999999999996796,0.925398214155085,0,1,carboxylic acid-transporting ATPase activity,MF,
8391,GO:0033285,0.999999999996796,0.925398214155085,0,1,monocarboxylic acid-transporting ATPase activity,MF,
12835,GO:0051121,0.999999999996799,0.745772400125978,0,4,hepoxilin metabolic process,BP,
12836,GO:0051122,0.999999999996799,0.745772400125978,0,4,hepoxilin biosynthetic process,BP,
4083,GO:0009136,0.999999999996804,0.889961905564663,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4122,GO:0009180,0.999999999996804,0.889961905564663,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4130,GO:0009188,0.999999999996804,0.889961905564663,0,2,ribonucleoside diphosphate biosynthetic process,BP,
16334,GO:0090500,0.999999999996811,0.87288675904819,0,2,endocardial cushion to mesenchymal transition,BP,
16014,GO:0086006,0.999999999996817,0.847180275589869,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
5539,GO:0016520,0.999999999996831,0.920853090490592,0,1,growth hormone-releasing hormone receptor activity,MF,
3650,GO:0008127,0.99999999999684,0.947184291382616,0,1,quercetin 2,3-dioxygenase activity,MF,
7284,GO:0031262,0.999999999996848,0.796613047725427,0,4,Ndc80 complex,CC,
11857,GO:0046813,0.999999999996855,0.812607356925422,0,3,receptor-mediated virion attachment to host cell,BP,
14024,GO:0060720,0.999999999996855,0.863736823398418,0,2,spongiotrophoblast cell proliferation,BP,
14025,GO:0060721,0.999999999996855,0.863736823398418,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14026,GO:0060722,0.999999999996855,0.863736823398418,0,2,cell proliferation involved in embryonic placenta development,BP,
14027,GO:0060723,0.999999999996855,0.863736823398418,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
16209,GO:0090214,0.999999999996855,0.863736823398418,0,2,spongiotrophoblast layer developmental growth,BP,
4418,GO:0010189,0.999999999996864,0.939442166046384,0,1,vitamin E biosynthetic process,BP,
9981,GO:0042360,0.999999999996864,0.939442166046384,0,1,vitamin E metabolic process,BP,
18740,GO:1904121,0.999999999996864,0.939442166046384,0,1,phosphatidylethanolamine transporter activity,MF,
13565,GO:0060005,0.999999999996865,0.846383868581101,0,2,vestibular reflex,BP,
9069,GO:0035290,0.999999999996866,0.788072830020877,0,3,trunk segmentation,BP,
9628,GO:0036484,0.999999999996866,0.788072830020877,0,3,trunk neural crest cell migration,BP,
9629,GO:0036486,0.999999999996866,0.788072830020877,0,3,ventral trunk neural crest cell migration,BP,
17594,GO:1901166,0.999999999996866,0.788072830020877,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
1089,GO:0002674,0.999999999996872,0.73905838713128,0,4,negative regulation of acute inflammatory response,BP,
17495,GO:1900365,0.999999999996876,0.786328397330147,0,3,positive regulation of mRNA polyadenylation,BP,
1786,GO:0004397,0.999999999996877,0.926958490895379,0,1,histidine ammonia-lyase activity,MF,
2113,GO:0004890,0.999999999996877,0.926958490895379,0,1,GABA-A receptor activity,MF,
2285,GO:0005237,0.999999999996877,0.926958490895379,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
6184,GO:0019556,0.999999999996877,0.926958490895379,0,1,histidine catabolic process to glutamate and formamide,BP,
6185,GO:0019557,0.999999999996877,0.926958490895379,0,1,histidine catabolic process to glutamate and formate,BP,
6627,GO:0022851,0.999999999996877,0.926958490895379,0,1,GABA-gated chloride ion channel activity,MF,
10626,GO:0043606,0.999999999996877,0.926958490895379,0,1,formamide metabolic process,BP,
17027,GO:0099095,0.999999999996877,0.926958490895379,0,1,ligand-gated anion channel activity,MF,
18112,GO:1902710,0.999999999996877,0.926958490895379,0,1,GABA receptor complex,CC,
18113,GO:1902711,0.999999999996877,0.926958490895379,0,1,GABA-A receptor complex,CC,
1908,GO:0004591,0.99999999999688,0.741131008931435,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
14417,GO:0061665,0.999999999996883,0.695172660491003,0,5,SUMO ligase activity,MF,
9534,GO:0036245,0.999999999996887,0.867386915954923,0,2,cellular response to menadione,BP,
10602,GO:0043559,0.99999999999689,0.618238938100012,0,5,insulin binding,MF,
19621,GO:1990698,0.999999999996908,0.866159363419699,0,2,palmitoleoyltransferase activity,MF,
8295,GO:0033106,0.999999999996909,0.881424332658687,0,2,cis-Golgi network membrane,CC,
10832,GO:0044314,0.999999999996911,0.795474104464794,0,4,protein K27-linked ubiquitination,BP,
11748,GO:0046544,0.99999999999692,0.91826948890775,0,1,development of secondary male sexual characteristics,BP,
4585,GO:0010668,0.999999999996921,0.671769821218194,0,5,ectodermal cell differentiation,BP,
7303,GO:0031296,0.999999999996928,0.949872016430895,0,1,B cell costimulation,BP,
16409,GO:0097003,0.999999999996935,0.862077224962039,0,2,adipokinetic hormone receptor activity,MF,
17919,GO:1902177,0.999999999996937,0.724359601828101,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
10153,GO:0042713,0.999999999996938,0.779205897020148,0,3,sperm ejaculation,BP,
8091,GO:0032767,0.999999999996942,0.807379724283279,0,3,copper-dependent protein binding,MF,
5186,GO:0015747,0.999999999996957,0.870788558691824,0,2,urate transport,BP,
1622,GO:0004052,0.999999999996968,0.866233828003804,0,2,arachidonate 12-lipoxygenase activity,MF,
6329,GO:0020012,0.999999999996982,0.852612636288678,0,2,evasion or tolerance of host immune response,BP,
7004,GO:0030682,0.999999999996982,0.852612636288678,0,2,evasion or tolerance of host defense response,BP,
7005,GO:0030683,0.999999999996982,0.852612636288678,0,2,evasion or tolerance by virus of host immune response,BP,
13214,GO:0051805,0.999999999996982,0.852612636288678,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13216,GO:0051807,0.999999999996982,0.852612636288678,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
19108,GO:1904970,0.999999999996982,0.859062111632704,0,2,brush border assembly,BP,
1735,GO:0004329,0.999999999996988,0.856320541601173,0,2,formate-tetrahydrofolate ligase activity,MF,
4181,GO:0009257,0.999999999996988,0.856320541601173,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
11624,GO:0046292,0.999999999996993,0.811974277059295,0,3,formaldehyde metabolic process,BP,
3646,GO:0008120,0.999999999997,0.940231408266717,0,1,ceramide glucosyltransferase activity,MF,
17191,GO:0102769,0.999999999997,0.940231408266717,0,1,dihydroceramide glucosyltransferase activity,MF,
9373,GO:0035879,0.999999999997003,0.795267994271417,0,3,plasma membrane lactate transport,BP,
13561,GO:0060001,0.999999999997023,0.899338756511854,0,1,minus-end directed microfilament motor activity,MF,
6460,GO:0021778,0.999999999997026,0.898020906483971,0,1,oligodendrocyte cell fate specification,BP,
6461,GO:0021779,0.999999999997026,0.898020906483971,0,1,oligodendrocyte cell fate commitment,BP,
6462,GO:0021780,0.999999999997026,0.898020906483971,0,1,glial cell fate specification,BP,
19102,GO:1904954,0.999999999997028,0.87295230528619,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
9514,GO:0036153,0.999999999997029,0.928544487086649,0,1,triglyceride acyl-chain remodeling,BP,
12936,GO:0051264,0.999999999997029,0.928544487086649,0,1,mono-olein transacylation activity,MF,
12937,GO:0051265,0.999999999997029,0.928544487086649,0,1,diolein transacylation activity,MF,
793,GO:0002054,0.999999999997037,0.831691206450297,0,3,nucleobase binding,MF,
795,GO:0002060,0.999999999997037,0.831691206450297,0,3,purine nucleobase binding,MF,
6099,GO:0019303,0.999999999997039,0.949365324970599,0,1,D-ribose catabolic process,BP,
19250,GO:1905340,0.999999999997044,0.754993753294902,0,4,regulation of protein localization to kinetochore,BP,
19252,GO:1905342,0.999999999997044,0.754993753294902,0,4,positive regulation of protein localization to kinetochore,BP,
5701,GO:0016822,0.999999999997048,0.886506292307841,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5702,GO:0016823,0.999999999997048,0.886506292307841,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
15708,GO:0072217,0.999999999997062,0.688557066628741,0,5,negative regulation of metanephros development,BP,
7244,GO:0031151,0.999999999997067,0.905767250441457,0,1,histone methyltransferase activity (H3-K79 specific),MF,
708,GO:0001928,0.99999999999707,0.932110201721926,0,1,regulation of exocyst assembly,BP,
13682,GO:0060178,0.99999999999707,0.932110201721926,0,1,regulation of exocyst localization,BP,
19558,GO:1990423,0.999999999997071,0.780932008703178,0,3,RZZ complex,CC,
18495,GO:1903567,0.999999999997092,0.862238337933992,0,2,regulation of protein localization to ciliary membrane,BP,
2084,GO:0004839,0.999999999997114,0.667515150795412,0,5,ubiquitin activating enzyme activity,MF,
19780,GO:2000124,0.999999999997121,0.858185474480246,0,2,regulation of endocannabinoid signaling pathway,BP,
5377,GO:0016185,0.999999999997123,0.719666029314761,0,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
16918,GO:0098844,0.999999999997123,0.719666029314761,0,4,postsynaptic endocytic zone membrane,CC,
16936,GO:0098884,0.999999999997123,0.719666029314761,0,4,postsynaptic neurotransmitter receptor internalization,BP,
1570,GO:0003974,0.999999999997139,0.94059725268088,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1574,GO:0003978,0.999999999997139,0.94059725268088,0,1,UDP-glucose 4-epimerase activity,MF,
14731,GO:0070358,0.999999999997142,0.695799179581703,0,5,actin polymerization-dependent cell motility,BP,
15335,GO:0071528,0.999999999997145,0.924037533199085,0,1,tRNA re-export from nucleus,BP,
5030,GO:0015193,0.999999999997149,0.666228186102656,0,5,L-proline transmembrane transporter activity,MF,
9177,GO:0035524,0.999999999997149,0.666228186102656,0,5,proline transmembrane transport,BP,
18899,GO:1904530,0.999999999997149,0.927197093448466,0,1,negative regulation of actin filament binding,BP,
18941,GO:1904617,0.999999999997149,0.927197093448466,0,1,negative regulation of actin binding,BP,
2439,GO:0005638,0.99999999999715,0.743906033120658,0,4,lamin filament,CC,
768,GO:0002017,0.99999999999715,0.93629413878477,0,1,regulation of blood volume by renal aldosterone,BP,
13853,GO:0060431,0.999999999997152,0.798749528621702,0,3,primary lung bud formation,BP,
11756,GO:0046577,0.999999999997158,0.924507119641462,0,1,long-chain-alcohol oxidase activity,MF,
8731,GO:0034370,0.999999999997162,0.898704366143447,0,2,triglyceride-rich lipoprotein particle remodeling,BP,
8733,GO:0034372,0.999999999997162,0.898704366143447,0,2,very-low-density lipoprotein particle remodeling,BP,
18571,GO:1903753,0.999999999997165,0.734283399749992,0,4,negative regulation of p38MAPK cascade,BP,
11081,GO:0045065,0.999999999997166,0.86931347414477,0,2,cytotoxic T cell differentiation,BP,
11292,GO:0045583,0.999999999997166,0.86931347414477,0,2,regulation of cytotoxic T cell differentiation,BP,
11293,GO:0045585,0.999999999997166,0.86931347414477,0,2,positive regulation of cytotoxic T cell differentiation,BP,
8116,GO:0032796,0.999999999997171,0.8513518006871,0,2,uropod organization,BP,
12019,GO:0047464,0.999999999997173,0.91860301987192,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12494,GO:0050379,0.999999999997173,0.91860301987192,0,1,UDP-glucuronate 5'-epimerase activity,MF,
2428,GO:0005606,0.999999999997174,0.738975897134241,0,3,laminin-1 complex,CC,
12003,GO:0047323,0.999999999997186,0.93329539855956,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13365,GO:0052381,0.999999999997186,0.93329539855956,0,1,tRNA dimethylallyltransferase activity,MF,
1690,GO:0004157,0.999999999997187,0.921085672007352,0,1,dihydropyrimidinase activity,MF,
18721,GO:1904048,0.999999999997187,0.921085672007352,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18722,GO:1904050,0.999999999997187,0.921085672007352,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19230,GO:1905301,0.999999999997187,0.921085672007352,0,1,regulation of macropinocytosis,BP,
19231,GO:1905302,0.999999999997187,0.921085672007352,0,1,negative regulation of macropinocytosis,BP,
6536,GO:0021936,0.999999999997192,0.774468398774259,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
15028,GO:0070940,0.999999999997203,0.692183027351351,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
1652,GO:0004096,0.999999999997205,0.826956550692138,0,3,catalase activity,MF,
16051,GO:0086057,0.999999999997216,0.924154407566761,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
19501,GO:1990174,0.999999999997216,0.924154407566761,0,1,phosphodiesterase decapping endonuclease activity,MF,
4656,GO:0010797,0.999999999997223,0.94921807236515,0,1,regulation of multivesicular body size involved in endosome transport,BP,
28,GO:0000053,0.999999999997228,0.937056061082196,0,1,argininosuccinate metabolic process,BP,
1624,GO:0004055,0.999999999997228,0.937056061082196,0,1,argininosuccinate synthase activity,MF,
6891,GO:0030395,0.999999999997236,0.967795110626767,0,1,lactose binding,MF,
8615,GO:0034117,0.999999999997236,0.967795110626767,0,1,erythrocyte aggregation,BP,
8616,GO:0034118,0.999999999997236,0.967795110626767,0,1,regulation of erythrocyte aggregation,BP,
8617,GO:0034120,0.999999999997236,0.967795110626767,0,1,positive regulation of erythrocyte aggregation,BP,
12096,GO:0048030,0.999999999997236,0.967795110626767,0,1,disaccharide binding,MF,
18641,GO:1903898,0.999999999997236,0.689914104102573,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
896,GO:0002266,0.999999999997238,0.868429011282999,0,2,follicular dendritic cell activation,BP,
897,GO:0002268,0.999999999997238,0.868429011282999,0,2,follicular dendritic cell differentiation,BP,
8373,GO:0033257,0.999999999997238,0.868429011282999,0,2,Bcl3/NF-kappaB2 complex,CC,
7973,GO:0032574,0.999999999997252,0.923714979759336,0,1,5'-3' RNA helicase activity,MF,
7974,GO:0032575,0.999999999997252,0.923714979759336,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
4730,GO:0010890,0.999999999997259,0.880114377720661,0,2,positive regulation of sequestering of triglyceride,BP,
14548,GO:0070037,0.999999999997275,0.953408074335128,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
11403,GO:0045764,0.999999999997275,0.891551396090181,0,2,positive regulation of cellular amino acid metabolic process,BP,
18775,GO:1904220,0.999999999997284,0.752347337086126,0,4,regulation of serine C-palmitoyltransferase activity,BP,
7612,GO:0031990,0.999999999997304,0.832730228350597,0,2,mRNA export from nucleus in response to heat stress,BP,
5805,GO:0017055,0.999999999997306,0.861809427230254,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
5983,GO:0018738,0.999999999997316,0.949661255846709,0,1,S-formylglutathione hydrolase activity,MF,
5797,GO:0017034,0.999999999997317,0.645939424008895,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
5761,GO:0016918,0.999999999997334,0.746468769154072,0,5,retinal binding,MF,
8431,GO:0033503,0.999999999997337,0.742568809900678,0,4,HULC complex,CC,
15385,GO:0071606,0.999999999997337,0.934981232821373,0,1,chemokine (C-C motif) ligand 4 production,BP,
15412,GO:0071643,0.999999999997337,0.934981232821373,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15413,GO:0071644,0.999999999997337,0.934981232821373,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15901,GO:0072615,0.999999999997337,0.934981232821373,0,1,interleukin-17 secretion,BP,
19160,GO:1905076,0.999999999997337,0.934981232821373,0,1,regulation of interleukin-17 secretion,BP,
19161,GO:1905077,0.999999999997337,0.934981232821373,0,1,negative regulation of interleukin-17 secretion,BP,
19275,GO:1905403,0.999999999997337,0.934981232821373,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
2268,GO:0005184,0.999999999997347,0.850520714601215,0,3,neuropeptide hormone activity,MF,
18136,GO:1902766,0.999999999997357,0.885713408020484,0,2,skeletal muscle satellite cell migration,BP,
6110,GO:0019344,0.999999999997368,0.812316146771246,0,3,cysteine biosynthetic process,BP,
7661,GO:0032076,0.999999999997372,0.929032152109267,0,1,negative regulation of deoxyribonuclease activity,BP,
9563,GO:0036316,0.999999999997372,0.929032152109267,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
14011,GO:0060703,0.999999999997372,0.929032152109267,0,1,deoxyribonuclease inhibitor activity,MF,
14729,GO:0070346,0.999999999997372,0.929032152109267,0,1,positive regulation of fat cell proliferation,BP,
17639,GO:1901303,0.999999999997372,0.929032152109267,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18042,GO:1902511,0.999999999997372,0.929032152109267,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18522,GO:1903625,0.999999999997372,0.929032152109267,0,1,negative regulation of DNA catabolic process,BP,
17723,GO:1901585,0.999999999997381,0.92847009550745,0,1,regulation of acid-sensing ion channel activity,BP,
4793,GO:0010982,0.999999999997381,0.860038473808937,0,2,regulation of high-density lipoprotein particle clearance,BP,
4794,GO:0010983,0.999999999997381,0.860038473808937,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
18492,GO:1903564,0.999999999997385,0.701033502773132,0,4,regulation of protein localization to cilium,BP,
2354,GO:0005427,0.999999999997402,0.927009666835383,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
5086,GO:0015322,0.999999999997402,0.927009666835383,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
8644,GO:0034163,0.99999999999741,0.779773651292689,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
17159,GO:0102339,0.999999999997422,0.930018572843283,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17160,GO:0102340,0.999999999997422,0.930018572843283,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17161,GO:0102341,0.999999999997422,0.930018572843283,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17162,GO:0102342,0.999999999997422,0.930018572843283,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
13023,GO:0051429,0.999999999997422,0.812246043553909,0,3,corticotropin-releasing hormone receptor binding,MF,
20005,GO:2000551,0.999999999997428,0.718258855900772,0,5,regulation of T-helper 2 cell cytokine production,BP,
3152,GO:0006751,0.999999999997437,0.719176065186029,0,5,glutathione catabolic process,BP,
12562,GO:0050692,0.999999999997437,0.857965879418543,0,2,DBD domain binding,MF,
17915,GO:1902173,0.99999999999744,0.926844131187536,0,1,negative regulation of keratinocyte apoptotic process,BP,
7618,GO:0031999,0.999999999997444,0.831945477953984,0,2,negative regulation of fatty acid beta-oxidation,BP,
4838,GO:0014042,0.999999999997448,0.696092743779311,0,4,positive regulation of neuron maturation,BP,
12625,GO:0050785,0.999999999997469,0.946216534313286,0,1,advanced glycation end-product receptor activity,MF,
18933,GO:1904596,0.999999999997469,0.946216534313286,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18934,GO:1904597,0.999999999997469,0.946216534313286,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18935,GO:1904599,0.999999999997469,0.946216534313286,0,1,advanced glycation end-product binding,MF,
18936,GO:1904603,0.999999999997469,0.946216534313286,0,1,regulation of advanced glycation end-product receptor activity,BP,
18937,GO:1904604,0.999999999997469,0.946216534313286,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19194,GO:1905204,0.999999999997469,0.946216534313286,0,1,negative regulation of connective tissue replacement,BP,
18462,GO:1903518,0.999999999997493,0.862117095778416,0,2,positive regulation of single strand break repair,BP,
2366,GO:0005476,0.999999999997494,0.86475292272148,0,2,carnitine:acyl carnitine antiporter activity,MF,
3168,GO:0006781,0.999999999997501,0.93292798267153,0,1,succinyl-CoA pathway,BP,
8418,GO:0033385,0.999999999997506,0.928534533085747,0,1,geranylgeranyl diphosphate metabolic process,BP,
8419,GO:0033386,0.999999999997506,0.928534533085747,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
17266,GO:0120009,0.999999999997513,0.687547969072405,0,5,intermembrane lipid transfer,BP,
17268,GO:0120013,0.999999999997513,0.687547969072405,0,5,intermembrane lipid transfer activity,MF,
1590,GO:0003998,0.99999999999752,0.915950462035066,0,2,acylphosphatase activity,MF,
9110,GO:0035373,0.999999999997524,0.798874863406591,0,2,chondroitin sulfate proteoglycan binding,MF,
12701,GO:0050893,0.999999999997533,0.867765407907149,0,2,sensory processing,BP,
3006,GO:0006552,0.999999999997534,0.702451461534157,0,5,leucine catabolic process,BP,
4280,GO:0009644,0.999999999997539,0.856646208444297,0,2,response to high light intensity,BP,
6370,GO:0021548,0.999999999997547,0.679232937986036,0,5,pons development,BP,
3019,GO:0006565,0.999999999997558,0.817421080321851,0,3,L-serine catabolic process,BP,
16008,GO:0085032,0.999999999997575,0.926441349388882,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
2133,GO:0004935,0.999999999997579,0.871526500968761,0,2,adrenergic receptor activity,MF,
16043,GO:0086045,0.99999999999758,0.851903906149616,0,2,membrane depolarization during AV node cell action potential,BP,
15106,GO:0071074,0.999999999997581,0.935860885474763,0,1,eukaryotic initiation factor eIF2 binding,MF,
18539,GO:1903674,0.999999999997581,0.935860885474763,0,1,regulation of cap-dependent translational initiation,BP,
18540,GO:1903676,0.999999999997581,0.935860885474763,0,1,positive regulation of cap-dependent translational initiation,BP,
5384,GO:0016199,0.999999999997588,0.705808655566525,0,4,axon midline choice point recognition,BP,
19300,GO:1905458,0.999999999997589,0.923669518242831,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19800,GO:2000174,0.999999999997589,0.923669518242831,0,1,regulation of pro-T cell differentiation,BP,
19801,GO:2000176,0.999999999997589,0.923669518242831,0,1,positive regulation of pro-T cell differentiation,BP,
14067,GO:0060800,0.999999999997593,0.846462941854931,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
1666,GO:0004122,0.9999999999976,0.929656004242896,0,1,cystathionine beta-synthase activity,MF,
2990,GO:0006535,0.9999999999976,0.929656004242896,0,1,cysteine biosynthetic process from serine,BP,
4053,GO:0009093,0.9999999999976,0.929656004242896,0,1,cysteine catabolic process,BP,
5617,GO:0016662,0.9999999999976,0.929656004242896,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6154,GO:0019448,0.9999999999976,0.929656004242896,0,1,L-cysteine catabolic process,BP,
12496,GO:0050421,0.9999999999976,0.929656004242896,0,1,nitrite reductase (NO-forming) activity,MF,
14542,GO:0070025,0.9999999999976,0.929656004242896,0,1,carbon monoxide binding,MF,
16896,GO:0098809,0.9999999999976,0.929656004242896,0,1,nitrite reductase activity,MF,
9424,GO:0035981,0.999999999997622,0.867793403653671,0,2,tongue muscle cell differentiation,BP,
18150,GO:1902811,0.999999999997622,0.867793403653671,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
20222,GO:2001035,0.999999999997622,0.867793403653671,0,2,regulation of tongue muscle cell differentiation,BP,
20223,GO:2001037,0.999999999997622,0.867793403653671,0,2,positive regulation of tongue muscle cell differentiation,BP,
20077,GO:2000666,0.999999999997625,0.86488232014272,0,2,negative regulation of interleukin-13 secretion,BP,
6363,GO:0021541,0.999999999997638,0.922590901468325,0,1,ammon gyrus development,BP,
9713,GO:0038108,0.999999999997639,0.802964410429106,0,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,
19345,GO:1905595,0.99999999999764,0.86963087661609,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19618,GO:1990667,0.99999999999764,0.86963087661609,0,2,PCSK9-AnxA2 complex,CC,
13914,GO:0060536,0.999999999997642,0.728387380095751,0,4,cartilage morphogenesis,BP,
6626,GO:0022849,0.999999999997647,0.918306071207755,0,1,glutamate-gated calcium ion channel activity,MF,
9135,GO:0035442,0.99999999999765,0.873220062590462,0,2,dipeptide transmembrane transport,BP,
10243,GO:0042938,0.99999999999765,0.873220062590462,0,2,dipeptide transport,BP,
16125,GO:0090088,0.99999999999765,0.873220062590462,0,2,regulation of oligopeptide transport,BP,
16126,GO:0090089,0.99999999999765,0.873220062590462,0,2,regulation of dipeptide transport,BP,
20190,GO:2000878,0.99999999999765,0.873220062590462,0,2,positive regulation of oligopeptide transport,BP,
20191,GO:2000880,0.99999999999765,0.873220062590462,0,2,positive regulation of dipeptide transport,BP,
20252,GO:2001148,0.99999999999765,0.873220062590462,0,2,regulation of dipeptide transmembrane transport,BP,
20253,GO:2001150,0.99999999999765,0.873220062590462,0,2,positive regulation of dipeptide transmembrane transport,BP,
19755,GO:2000077,0.999999999997652,0.846613270834483,0,2,negative regulation of type B pancreatic cell development,BP,
8916,GO:0034739,0.999999999997657,0.878111505343651,0,2,histone deacetylase activity (H4-K16 specific),MF,
2430,GO:0005608,0.999999999997664,0.818214511681616,0,2,laminin-3 complex,CC,
3107,GO:0006685,0.999999999997672,0.685240718197329,0,5,sphingomyelin catabolic process,BP,
1765,GO:0004365,0.999999999997673,0.946835778552004,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6254,GO:0019828,0.999999999997673,0.946835778552004,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9225,GO:0035605,0.999999999997673,0.946835778552004,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10678,GO:0043891,0.999999999997673,0.946835778552004,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
12201,GO:0048318,0.999999999997701,0.713185810144226,0,5,axial mesoderm development,BP,
2033,GO:0004771,0.999999999997712,0.679148950414833,0,5,sterol esterase activity,MF,
5390,GO:0016212,0.999999999997713,0.86770080928144,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9503,GO:0036137,0.999999999997713,0.86770080928144,0,2,kynurenine aminotransferase activity,MF,
16436,GO:0097052,0.999999999997713,0.86770080928144,0,2,L-kynurenine metabolic process,BP,
6163,GO:0019509,0.999999999997713,0.709464884977406,0,5,L-methionine salvage from methylthioadenosine,BP,
18634,GO:1903891,0.999999999997725,0.738836192624822,0,4,regulation of ATF6-mediated unfolded protein response,BP,
2724,GO:0006102,0.99999999999773,0.719760118020031,0,5,isocitrate metabolic process,BP,
9548,GO:0036292,0.999999999997733,0.873639297735031,0,2,DNA rewinding,BP,
4126,GO:0009184,0.999999999997747,0.942406537460005,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4134,GO:0009192,0.999999999997747,0.942406537460005,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
10971,GO:0044716,0.999999999997747,0.942406537460005,0,1,8-oxo-GDP phosphatase activity,MF,
10972,GO:0044717,0.999999999997747,0.942406537460005,0,1,8-hydroxy-dADP phosphatase activity,MF,
11546,GO:0046056,0.999999999997747,0.942406537460005,0,1,dADP metabolic process,BP,
11547,GO:0046057,0.999999999997747,0.942406537460005,0,1,dADP catabolic process,BP,
11553,GO:0046067,0.999999999997747,0.942406537460005,0,1,dGDP catabolic process,BP,
11834,GO:0046712,0.999999999997747,0.942406537460005,0,1,GDP catabolic process,BP,
9567,GO:0036335,0.999999999997751,0.917474945707995,0,1,intestinal stem cell homeostasis,BP,
9766,GO:0039513,0.999999999997751,0.928786981878944,0,1,suppression by virus of host catalytic activity,BP,
9768,GO:0039516,0.999999999997751,0.928786981878944,0,1,modulation by virus of host catalytic activity,BP,
9786,GO:0039650,0.999999999997751,0.928786981878944,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13324,GO:0052053,0.999999999997751,0.928786981878944,0,1,negative regulation by symbiont of host catalytic activity,BP,
13331,GO:0052148,0.999999999997751,0.928786981878944,0,1,modulation by symbiont of host catalytic activity,BP,
4052,GO:0009092,0.999999999997757,0.761672523805667,0,4,homoserine metabolic process,BP,
6111,GO:0019346,0.999999999997757,0.761672523805667,0,4,transsulfuration,BP,
8267,GO:0033038,0.999999999997758,0.817606875717655,0,4,bitter taste receptor activity,MF,
1154,GO:0002759,0.999999999997765,0.765556082959616,0,4,regulation of antimicrobial humoral response,BP,
3074,GO:0006642,0.999999999997769,0.789072730067131,0,3,triglyceride mobilization,BP,
9314,GO:0035752,0.999999999997776,0.935960955746941,0,1,lysosomal lumen pH elevation,BP,
17480,GO:1900246,0.999999999997776,0.637349579166449,0,5,positive regulation of RIG-I signaling pathway,BP,
5695,GO:0016812,0.999999999997784,0.653304393783902,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
5112,GO:0015420,0.999999999997787,0.911316288818213,0,1,cobalamin-transporting ATPase activity,MF,
5114,GO:0015431,0.999999999997787,0.911316288818213,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
8849,GO:0034634,0.999999999997787,0.911316288818213,0,1,glutathione transmembrane transporter activity,MF,
8936,GO:0034775,0.999999999997787,0.911316288818213,0,1,glutathione transmembrane transport,BP,
9136,GO:0035443,0.999999999997787,0.911316288818213,0,1,tripeptide transmembrane transport,BP,
10242,GO:0042937,0.999999999997787,0.911316288818213,0,1,tripeptide transmembrane transporter activity,MF,
11781,GO:0046623,0.999999999997787,0.911316288818213,0,1,sphingolipid-translocating ATPase activity,MF,
15573,GO:0071997,0.999999999997787,0.911316288818213,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
17003,GO:0099039,0.999999999997787,0.911316288818213,0,1,sphingolipid translocation,BP,
3205,GO:0006843,0.999999999997787,0.940782728357674,0,1,mitochondrial citrate transmembrane transport,BP,
16099,GO:0090044,0.999999999997787,0.940782728357674,0,1,positive regulation of tubulin deacetylation,BP,
19588,GO:1990546,0.999999999997787,0.940782728357674,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
19034,GO:1904815,0.999999999997788,0.868294783068755,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
11980,GO:0047166,0.99999999999779,0.935807879381576,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
13672,GO:0060159,0.999999999997791,0.754247097121121,0,4,regulation of dopamine receptor signaling pathway,BP,
18642,GO:1903899,0.999999999997797,0.789480944355576,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
7391,GO:0031438,0.9999999999978,0.927308438759091,0,1,negative regulation of mRNA cleavage,BP,
12776,GO:0051025,0.9999999999978,0.927308438759091,0,1,negative regulation of immunoglobulin secretion,BP,
18986,GO:1904721,0.9999999999978,0.927308438759091,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
19564,GO:1990439,0.999999999997811,0.927879018365983,0,1,MAP kinase serine/threonine phosphatase activity,MF,
17736,GO:1901622,0.999999999997811,0.929768432415627,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
13899,GO:0060509,0.999999999997818,0.638959277661204,0,5,Type I pneumocyte differentiation,BP,
14708,GO:0070315,0.999999999997823,0.858814068560509,0,2,G1 to G0 transition involved in cell differentiation,BP,
14691,GO:0070290,0.999999999997829,0.672749114698273,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
6232,GO:0019780,0.999999999997849,0.910970164751903,0,1,FAT10 activating enzyme activity,MF,
9590,GO:0036398,0.999999999997853,0.92643316346041,0,1,TCR signalosome,CC,
9591,GO:0036399,0.999999999997853,0.92643316346041,0,1,TCR signalosome assembly,BP,
17373,GO:1900039,0.999999999997867,0.950158660122053,0,1,positive regulation of cellular response to hypoxia,BP,
17883,GO:1902071,0.999999999997867,0.950158660122053,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17884,GO:1902073,0.999999999997867,0.950158660122053,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
5354,GO:0016103,0.999999999997871,0.92118193406366,0,1,diterpenoid catabolic process,BP,
5356,GO:0016115,0.999999999997871,0.92118193406366,0,1,terpenoid catabolic process,BP,
8864,GO:0034653,0.999999999997871,0.92118193406366,0,1,retinoic acid catabolic process,BP,
20162,GO:2000819,0.999999999997881,0.859051083321255,0,2,regulation of nucleotide-excision repair,BP,
2083,GO:0004835,0.999999999997884,0.917986491396869,0,1,tubulin-tyrosine ligase activity,MF,
5917,GO:0018166,0.999999999997884,0.917986491396869,0,1,C-terminal protein-tyrosinylation,BP,
5958,GO:0018322,0.999999999997884,0.917986491396869,0,1,protein tyrosinylation,BP,
3651,GO:0008131,0.999999999997886,0.792482297315901,0,3,primary amine oxidase activity,MF,
2630,GO:0005955,0.999999999997894,0.705920033682815,0,4,calcineurin complex,CC,
18623,GO:1903860,0.999999999997907,0.859695287329173,0,2,negative regulation of dendrite extension,BP,
19798,GO:2000172,0.999999999997907,0.859695287329173,0,2,regulation of branching morphogenesis of a nerve,BP,
5472,GO:0016402,0.999999999997911,0.928335239318424,0,1,pristanoyl-CoA oxidase activity,MF,
19658,GO:1990785,0.999999999997915,0.761069991883988,0,3,response to water-immersion restraint stress,BP,
212,GO:0000444,0.999999999997934,0.724311972001654,0,4,MIS12/MIND type complex,CC,
14349,GO:0061511,0.999999999997935,0.742008805195805,0,4,centriole elongation,BP,
11127,GO:0045134,0.999999999997941,0.745273344905649,0,4,uridine-diphosphatase activity,MF,
4323,GO:0009814,0.999999999997945,0.932623520938445,0,1,defense response, incompatible interaction,BP,
4324,GO:0009817,0.999999999997945,0.932623520938445,0,1,defense response to fungus, incompatible interaction,BP,
19237,GO:1905313,0.999999999997945,0.932623520938445,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19544,GO:1990402,0.999999999997945,0.932623520938445,0,1,embryonic liver development,BP,
18898,GO:1904529,0.99999999999796,0.848793579986978,0,2,regulation of actin filament binding,BP,
18940,GO:1904616,0.99999999999796,0.848793579986978,0,2,regulation of actin binding,BP,
16180,GO:0090182,0.999999999997971,0.879392240251454,0,2,regulation of secretion of lysosomal enzymes,BP,
5044,GO:0015222,0.999999999997977,0.86212470902085,0,2,serotonin transmembrane transporter activity,MF,
1905,GO:0004587,0.999999999997983,0.934962910629991,0,1,ornithine-oxo-acid transaminase activity,MF,
4401,GO:0010121,0.999999999997983,0.934962910629991,0,1,arginine catabolic process to proline via ornithine,BP,
6162,GO:0019493,0.999999999997983,0.934962910629991,0,1,arginine catabolic process to proline,BP,
6180,GO:0019544,0.999999999997983,0.934962910629991,0,1,arginine catabolic process to glutamate,BP,
10875,GO:0044388,0.999999999997988,0.741238705862158,0,5,small protein activating enzyme binding,MF,
15818,GO:0072487,0.99999999999799,0.684044721353629,0,5,MSL complex,CC,
7824,GO:0032372,0.999999999997991,0.764413578711019,0,4,negative regulation of sterol transport,BP,
7827,GO:0032375,0.999999999997991,0.764413578711019,0,4,negative regulation of cholesterol transport,BP,
18968,GO:1904691,0.999999999998002,0.93332593320681,0,1,negative regulation of type B pancreatic cell proliferation,BP,
19726,GO:2000017,0.999999999998005,0.859014981858037,0,2,positive regulation of determination of dorsal identity,BP,
17785,GO:1901727,0.99999999999801,0.724684787412888,0,4,positive regulation of histone deacetylase activity,BP,
1825,GO:0004475,0.999999999998011,0.940745497731196,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
4001,GO:0008905,0.999999999998011,0.940745497731196,0,1,mannose-phosphate guanylyltransferase activity,MF,
11053,GO:0045016,0.999999999998011,0.926165308707827,0,1,mitochondrial magnesium ion transmembrane transport,BP,
19018,GO:1904783,0.999999999998011,0.854456075885965,0,2,positive regulation of NMDA glutamate receptor activity,BP,
4265,GO:0009608,0.999999999998012,0.880250185705279,0,2,response to symbiont,BP,
4266,GO:0009609,0.999999999998012,0.880250185705279,0,2,response to symbiotic bacterium,BP,
8304,GO:0033128,0.999999999998023,0.869744165136207,0,2,negative regulation of histone phosphorylation,BP,
16113,GO:0090074,0.999999999998028,0.672439771081286,0,5,negative regulation of protein homodimerization activity,BP,
16963,GO:0098923,0.999999999998029,0.907388404111015,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
16964,GO:0098924,0.999999999998029,0.907388404111015,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
17040,GO:0099163,0.999999999998029,0.907388404111015,0,1,synaptic signaling by nitric oxide,BP,
17082,GO:0099543,0.999999999998029,0.907388404111015,0,1,trans-synaptic signaling by soluble gas,BP,
17085,GO:0099548,0.999999999998029,0.907388404111015,0,1,trans-synaptic signaling by nitric oxide,BP,
17341,GO:0140196,0.999999999998029,0.907388404111015,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
1769,GO:0004370,0.99999999999803,0.823821190851045,0,2,glycerol kinase activity,MF,
11606,GO:0046167,0.99999999999803,0.823821190851045,0,2,glycerol-3-phosphate biosynthetic process,BP,
7755,GO:0032264,0.99999999999804,0.753373615197677,0,4,IMP salvage,BP,
4847,GO:0014052,0.99999999999804,0.782030393079651,0,3,regulation of gamma-aminobutyric acid secretion,BP,
16794,GO:0098582,0.999999999998042,0.845234394981551,0,2,innate vocalization behavior,BP,
8345,GO:0033184,0.999999999998046,0.677919193161612,0,5,positive regulation of histone ubiquitination,BP,
4984,GO:0015105,0.999999999998064,0.947559527250941,0,1,arsenite transmembrane transporter activity,MF,
5163,GO:0015700,0.999999999998064,0.947559527250941,0,1,arsenite transport,BP,
3093,GO:0006667,0.999999999998064,0.849143159540097,0,2,sphinganine metabolic process,BP,
11728,GO:0046511,0.999999999998064,0.849143159540097,0,2,sphinganine biosynthetic process,BP,
9637,GO:0036496,0.999999999998065,0.878386673534575,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
4325,GO:0009820,0.999999999998069,0.758091411187592,0,4,alkaloid metabolic process,BP,
218,GO:0000454,0.999999999998079,0.863954788034858,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
410,GO:0001096,0.999999999998085,0.924867424635601,0,1,TFIIF-class transcription factor binding,MF,
1140,GO:0002729,0.999999999998109,0.8847566661091,0,2,positive regulation of natural killer cell cytokine production,BP,
8881,GO:0034680,0.999999999998128,0.848527074819347,0,2,integrin alpha10-beta1 complex,CC,
19470,GO:1990071,0.999999999998128,0.873157174182485,0,2,TRAPPII protein complex,CC,
1548,GO:0003940,0.999999999998129,0.932689094097589,0,1,L-iduronidase activity,MF,
3840,GO:0008444,0.999999999998129,0.932689094097589,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
6779,GO:0030209,0.999999999998129,0.932689094097589,0,1,dermatan sulfate catabolic process,BP,
9609,GO:0036458,0.999999999998129,0.932689094097589,0,1,hepatocyte growth factor binding,MF,
14825,GO:0070539,0.999999999998129,0.925494379812505,0,1,linoleic acid binding,MF,
8874,GO:0034667,0.999999999998131,0.849580613142238,0,2,integrin alpha3-beta1 complex,CC,
12472,GO:0050211,0.999999999998139,0.861006042508478,0,2,procollagen galactosyltransferase activity,MF,
16785,GO:0098560,0.999999999998144,0.863141532519691,0,2,cytoplasmic side of late endosome membrane,CC,
14145,GO:0060988,0.999999999998152,0.859516528117936,0,2,lipid tube assembly,BP,
4614,GO:0010729,0.999999999998152,0.934445833252602,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
15601,GO:0072053,0.999999999998162,0.855416127407411,0,2,renal inner medulla development,BP,
15602,GO:0072054,0.999999999998162,0.855416127407411,0,2,renal outer medulla development,BP,
603,GO:0001768,0.999999999998172,0.652001539278372,0,5,establishment of T cell polarity,BP,
19524,GO:1990269,0.999999999998179,0.857186244024116,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
19761,GO:2000097,0.999999999998181,0.862166345571963,0,2,regulation of smooth muscle cell-matrix adhesion,BP,
19783,GO:2000137,0.999999999998184,0.827274109412496,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
11807,GO:0046657,0.999999999998189,0.881670754381618,0,2,folic acid catabolic process,BP,
12972,GO:0051316,0.999999999998196,0.865147063187679,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
767,GO:0002016,0.999999999998222,0.963713284160813,0,1,regulation of blood volume by renin-angiotensin,BP,
769,GO:0002019,0.999999999998222,0.963713284160813,0,1,regulation of renal output by angiotensin,BP,
1284,GO:0003083,0.999999999998222,0.963713284160813,0,1,negative regulation of renal output by angiotensin,BP,
1296,GO:0003106,0.999999999998222,0.963713284160813,0,1,negative regulation of glomerular filtration by angiotensin,BP,
4937,GO:0014895,0.999999999998222,0.963713284160813,0,1,smooth muscle hypertrophy,BP,
10116,GO:0042624,0.999999999998222,0.963713284160813,0,1,ATPase activity, uncoupled,MF,
6909,GO:0030479,0.999999999998237,0.649395553736266,0,5,actin cortical patch,CC,
14409,GO:0061645,0.999999999998237,0.649395553736266,0,5,endocytic patch,CC,
3289,GO:0006982,0.999999999998249,0.897821442503342,0,2,response to lipid hydroperoxide,BP,
14272,GO:0061302,0.999999999998256,0.796833218805282,0,3,smooth muscle cell-matrix adhesion,BP,
370,GO:0000991,0.999999999998261,0.862569079184199,0,2,transcription factor activity, core RNA polymerase II binding,MF,
12383,GO:0048752,0.999999999998266,0.715850248408283,0,4,semicircular canal morphogenesis,BP,
11538,GO:0046038,0.999999999998271,0.944530680200152,0,1,GMP catabolic process,BP,
13407,GO:0052657,0.999999999998271,0.944530680200152,0,1,guanine phosphoribosyltransferase activity,MF,
19679,GO:1990868,0.99999999999828,0.667744304607771,0,5,response to chemokine,BP,
19680,GO:1990869,0.99999999999828,0.667744304607771,0,5,cellular response to chemokine,BP,
18282,GO:1903093,0.999999999998282,0.822642562485166,0,3,regulation of protein K48-linked deubiquitination,BP,
1212,GO:0002875,0.999999999998294,0.940304029831917,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2237,GO:0005141,0.999999999998294,0.940304029831917,0,1,interleukin-10 receptor binding,MF,
18725,GO:1904057,0.999999999998294,0.940304029831917,0,1,negative regulation of sensory perception of pain,BP,
2997,GO:0006543,0.999999999998295,0.792336320145876,0,3,glutamine catabolic process,BP,
1884,GO:0004560,0.999999999998312,0.871518508492856,0,2,alpha-L-fucosidase activity,MF,
5280,GO:0015928,0.999999999998312,0.871518508492856,0,2,fucosidase activity,MF,
16471,GO:0097114,0.999999999998315,0.862047460965347,0,2,NMDA glutamate receptor clustering,BP,
7533,GO:0031748,0.999999999998316,0.68387311393894,0,5,D1 dopamine receptor binding,MF,
15889,GO:0072592,0.999999999998327,0.870904792717969,0,2,oxygen metabolic process,BP,
18967,GO:1904690,0.999999999998331,0.73045136289477,0,4,positive regulation of cytoplasmic translational initiation,BP,
8855,GO:0034642,0.999999999998339,0.924306513628767,0,1,mitochondrion migration along actin filament,BP,
11842,GO:0046725,0.999999999998347,0.925274761072807,0,1,negative regulation by virus of viral protein levels in host cell,BP,
15682,GO:0072183,0.999999999998347,0.925274761072807,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15752,GO:0072308,0.999999999998347,0.925274761072807,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
972,GO:0002416,0.99999999999836,0.938032131913748,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
6225,GO:0019770,0.99999999999836,0.938032131913748,0,1,IgG receptor activity,MF,
6273,GO:0019864,0.99999999999836,0.938032131913748,0,1,IgG binding,MF,
19649,GO:1990769,0.999999999998365,0.864217078788197,0,2,proximal neuron projection,CC,
16714,GO:0097643,0.999999999998388,0.957376737938252,0,1,amylin receptor activity,MF,
18437,GO:1903440,0.999999999998388,0.957376737938252,0,1,amylin receptor complex,CC,
19549,GO:1990407,0.999999999998388,0.957376737938252,0,1,calcitonin gene-related peptide binding,MF,
10983,GO:0044753,0.999999999998389,0.928087785201263,0,1,amphisome,CC,
18736,GO:1904106,0.999999999998389,0.928087785201263,0,1,protein localization to microvillus,BP,
12231,GO:0048406,0.999999999998393,0.718626492090646,0,4,nerve growth factor binding,MF,
10508,GO:0043400,0.999999999998404,0.876395048004491,0,2,cortisol secretion,BP,
13045,GO:0051462,0.999999999998404,0.876395048004491,0,2,regulation of cortisol secretion,BP,
12760,GO:0051006,0.999999999998405,0.74958302469756,0,4,positive regulation of lipoprotein lipase activity,BP,
14305,GO:0061365,0.999999999998405,0.74958302469756,0,4,positive regulation of triglyceride lipase activity,BP,
13313,GO:0051990,0.999999999998418,0.866018075444772,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
18576,GO:1903760,0.999999999998427,0.848580675345261,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19130,GO:1905024,0.999999999998427,0.848580675345261,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
13540,GO:0055091,0.999999999998448,0.694768097879382,0,4,phospholipid homeostasis,BP,
14596,GO:0070123,0.999999999998452,0.911215082657189,0,1,transforming growth factor beta receptor activity, type III,MF,
5774,GO:0016972,0.999999999998471,0.7320446690227,0,4,thiol oxidase activity,MF,
16223,GO:0090238,0.999999999998473,0.760531201098689,0,4,positive regulation of arachidonic acid secretion,BP,
14070,GO:0060816,0.999999999998479,0.823868835817703,0,2,random inactivation of X chromosome,BP,
5231,GO:0015842,0.999999999998487,0.875993361229591,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
16841,GO:0098700,0.999999999998487,0.875993361229591,0,2,neurotransmitter loading into synaptic vesicle,BP,
11071,GO:0045054,0.99999999999849,0.806942525135339,0,3,constitutive secretory pathway,BP,
582,GO:0001732,0.999999999998493,0.857765215698727,0,2,formation of cytoplasmic translation initiation complex,BP,
5412,GO:0016250,0.999999999998502,0.928746054223838,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5703,GO:0016826,0.999999999998502,0.928746054223838,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
13342,GO:0052203,0.999999999998506,0.815298229745748,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14890,GO:0070662,0.999999999998507,0.850141337705806,0,2,mast cell proliferation,BP,
14894,GO:0070666,0.999999999998507,0.850141337705806,0,2,regulation of mast cell proliferation,BP,
14896,GO:0070668,0.999999999998507,0.850141337705806,0,2,positive regulation of mast cell proliferation,BP,
14115,GO:0060923,0.999999999998507,0.691257998677332,0,5,cardiac muscle cell fate commitment,BP,
17367,GO:1900028,0.999999999998514,0.751281274708643,0,4,negative regulation of ruffle assembly,BP,
3413,GO:0007197,0.999999999998515,0.856384723026434,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
5758,GO:0016907,0.999999999998515,0.856384723026434,0,2,G-protein coupled acetylcholine receptor activity,MF,
979,GO:0002430,0.999999999998529,0.931841644685153,0,1,complement receptor mediated signaling pathway,BP,
1930,GO:0004621,0.999999999998529,0.931841644685153,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2968,GO:0006507,0.999999999998529,0.931841644685153,0,1,GPI anchor release,BP,
4735,GO:0010897,0.999999999998529,0.931841644685153,0,1,negative regulation of triglyceride catabolic process,BP,
8569,GO:0034014,0.999999999998529,0.931841644685153,0,1,response to triglyceride,BP,
15260,GO:0071401,0.999999999998529,0.931841644685153,0,1,cellular response to triglyceride,BP,
13229,GO:0051852,0.999999999998531,0.779197035530028,0,4,disruption by host of symbiont cells,BP,
13235,GO:0051873,0.999999999998531,0.779197035530028,0,4,killing by host of symbiont cells,BP,
15741,GO:0072287,0.999999999998534,0.871994675515311,0,1,metanephric distal tubule morphogenesis,BP,
4993,GO:0015125,0.999999999998535,0.755966590636045,0,4,bile acid transmembrane transporter activity,MF,
5261,GO:0015888,0.999999999998538,0.858541090107087,0,2,thiamine transport,BP,
18206,GO:1902951,0.999999999998555,0.867509778879462,0,2,negative regulation of dendritic spine maintenance,BP,
19367,GO:1905664,0.999999999998555,0.867509778879462,0,2,regulation of calcium ion import across plasma membrane,BP,
9158,GO:0035502,0.99999999999857,0.79888544282393,0,3,metanephric part of ureteric bud development,BP,
6337,GO:0021503,0.999999999998572,0.900572972455542,0,1,neural fold bending,BP,
15340,GO:0071540,0.999999999998574,0.917140801359521,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
62,GO:0000125,0.999999999998599,0.694080854700879,0,5,PCAF complex,CC,
10834,GO:0044317,0.999999999998607,0.945518563564781,0,1,rod spherule,CC,
6361,GO:0021539,0.999999999998614,0.877450155863408,0,2,subthalamus development,BP,
13445,GO:0052827,0.999999999998615,0.860150526851095,0,2,inositol pentakisphosphate phosphatase activity,MF,
6158,GO:0019474,0.999999999998617,0.791215589309248,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6159,GO:0019477,0.999999999998617,0.791215589309248,0,3,L-lysine catabolic process,BP,
8434,GO:0033512,0.999999999998617,0.791215589309248,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
11683,GO:0046440,0.999999999998617,0.791215589309248,0,3,L-lysine metabolic process,BP,
4738,GO:0010900,0.999999999998632,0.970787056982955,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
15854,GO:0072540,0.999999999998632,0.721609329841386,0,5,T-helper 17 cell lineage commitment,BP,
15121,GO:0071148,0.999999999998638,0.82141272951129,0,2,TEAD-1-YAP complex,CC,
11987,GO:0047223,0.999999999998648,0.802330509663492,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
2890,GO:0006398,0.99999999999866,0.688486097225719,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
10295,GO:0043031,0.999999999998664,0.74707164056883,0,4,negative regulation of macrophage activation,BP,
8956,GO:0034992,0.999999999998665,0.592664523230823,0,5,microtubule organizing center attachment site,CC,
8957,GO:0034993,0.999999999998665,0.592664523230823,0,5,meiotic nuclear membrane microtubule tethering complex,CC,
16254,GO:0090286,0.999999999998665,0.592664523230823,0,5,cytoskeletal anchoring at nuclear membrane,BP,
17241,GO:0106083,0.999999999998665,0.592664523230823,0,5,nuclear membrane protein complex,CC,
17244,GO:0106094,0.999999999998665,0.592664523230823,0,5,nuclear membrane microtubule tethering complex,CC,
3890,GO:0008521,0.999999999998666,0.929325214670672,0,1,acetyl-CoA transmembrane transporter activity,MF,
5252,GO:0015876,0.999999999998666,0.929325214670672,0,1,acetyl-CoA transport,BP,
5271,GO:0015916,0.999999999998666,0.929325214670672,0,1,fatty-acyl-CoA transport,BP,
5350,GO:0016095,0.999999999998666,0.929325214670672,0,1,polyprenol catabolic process,BP,
17166,GO:0102389,0.999999999998666,0.929325214670672,0,1,polyprenol reductase activity,MF,
17650,GO:1901337,0.999999999998666,0.929325214670672,0,1,thioester transport,BP,
19880,GO:2000318,0.999999999998667,0.771953971394185,0,4,positive regulation of T-helper 17 type immune response,BP,
1771,GO:0004372,0.999999999998669,0.867518343121134,0,2,glycine hydroxymethyltransferase activity,MF,
2048,GO:0004793,0.999999999998669,0.867518343121134,0,2,threonine aldolase activity,MF,
2999,GO:0006545,0.999999999998669,0.867518343121134,0,2,glycine biosynthetic process,BP,
3963,GO:0008732,0.999999999998669,0.867518343121134,0,2,L-allo-threonine aldolase activity,MF,
6094,GO:0019264,0.999999999998669,0.867518343121134,0,2,glycine biosynthetic process from serine,BP,
18178,GO:1902896,0.999999999998673,0.857172261367695,0,2,terminal web assembly,BP,
5842,GO:0017126,0.999999999998707,0.917069028692066,0,1,nucleologenesis,BP,
11899,GO:0046898,0.999999999998707,0.724092915345641,0,4,response to cycloheximide,BP,
18340,GO:1903238,0.999999999998714,0.842640417009137,0,2,positive regulation of leukocyte tethering or rolling,BP,
1142,GO:0002731,0.999999999998714,0.876535331304958,0,2,negative regulation of dendritic cell cytokine production,BP,
13786,GO:0060342,0.999999999998715,0.936280349205351,0,1,photoreceptor inner segment membrane,CC,
1576,GO:0003980,0.999999999998718,0.816223288344049,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
16588,GO:0097359,0.999999999998718,0.816223288344049,0,2,UDP-glucosylation,BP,
18019,GO:1902442,0.999999999998731,0.924615761387356,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
18020,GO:1902443,0.999999999998731,0.924615761387356,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
6908,GO:0030478,0.999999999998732,0.72880633294377,0,4,actin cap,CC,
19933,GO:2000389,0.999999999998732,0.790751278764449,0,3,regulation of neutrophil extravasation,BP,
19934,GO:2000391,0.999999999998732,0.790751278764449,0,3,positive regulation of neutrophil extravasation,BP,
9281,GO:0035697,0.999999999998742,0.876470430415158,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9282,GO:0035698,0.999999999998742,0.876470430415158,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
15930,GO:0072683,0.999999999998742,0.876470430415158,0,2,T cell extravasation,BP,
19946,GO:2000407,0.999999999998742,0.876470430415158,0,2,regulation of T cell extravasation,BP,
19964,GO:2000449,0.999999999998742,0.876470430415158,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19966,GO:2000452,0.999999999998742,0.876470430415158,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
512,GO:0001575,0.999999999998751,0.87394336718518,0,2,globoside metabolic process,BP,
1424,GO:0003366,0.999999999998756,0.912981924064015,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
8875,GO:0034669,0.999999999998756,0.912981924064015,0,1,integrin alpha4-beta7 complex,CC,
19650,GO:1990771,0.999999999998756,0.912981924064015,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
17847,GO:1901980,0.999999999998758,0.892278672921156,0,1,positive regulation of inward rectifier potassium channel activity,BP,
12007,GO:0047349,0.999999999998768,0.916434189976078,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
7079,GO:0030862,0.999999999998771,0.915903754913599,0,1,positive regulation of polarized epithelial cell differentiation,BP,
9755,GO:0039007,0.999999999998771,0.915903754913599,0,1,pronephric nephron morphogenesis,BP,
9756,GO:0039008,0.999999999998771,0.915903754913599,0,1,pronephric nephron tubule morphogenesis,BP,
9759,GO:0039020,0.999999999998771,0.915903754913599,0,1,pronephric nephron tubule development,BP,
9760,GO:0039022,0.999999999998771,0.915903754913599,0,1,pronephric duct development,BP,
9761,GO:0039023,0.999999999998771,0.915903754913599,0,1,pronephric duct morphogenesis,BP,
14594,GO:0070121,0.999999999998771,0.915903754913599,0,1,Kupffer's vesicle development,BP,
15643,GO:0072114,0.999999999998771,0.915903754913599,0,1,pronephros morphogenesis,BP,
14950,GO:0070815,0.999999999998773,0.734998912486006,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
12744,GO:0050966,0.99999999999878,0.843737791141956,0,2,detection of mechanical stimulus involved in sensory perception of pain,BP,
1947,GO:0004647,0.999999999998784,0.872496814839244,0,2,phosphoserine phosphatase activity,MF,
4803,GO:0010994,0.999999999998816,0.7213853871587,0,5,free ubiquitin chain polymerization,BP,
18226,GO:1902990,0.999999999998818,0.803187462808524,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
6820,GO:0030274,0.999999999998823,0.725815176480749,0,4,LIM domain binding,MF,
204,GO:0000429,0.999999999998829,0.801391361609864,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
209,GO:0000436,0.999999999998829,0.801391361609864,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
19140,GO:1905041,0.999999999998829,0.844096779790489,0,2,regulation of epithelium regeneration,BP,
19542,GO:1990399,0.999999999998829,0.844096779790489,0,2,epithelium regeneration,BP,
5677,GO:0016784,0.999999999998861,0.943313205246397,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6264,GO:0019853,0.999999999998861,0.943313205246397,0,1,L-ascorbic acid biosynthetic process,BP,
6708,GO:0030108,0.999999999998861,0.943313205246397,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7846,GO:0032397,0.999999999998861,0.943313205246397,0,1,activating MHC class I receptor activity,MF,
10225,GO:0042839,0.999999999998861,0.943313205246397,0,1,D-glucuronate metabolic process,BP,
10226,GO:0042840,0.999999999998861,0.943313205246397,0,1,D-glucuronate catabolic process,BP,
12068,GO:0047939,0.999999999998861,0.943313205246397,0,1,L-glucuronate reductase activity,MF,
3994,GO:0008890,0.999999999998862,0.94113978020196,0,1,glycine C-acetyltransferase activity,MF,
6167,GO:0019518,0.999999999998862,0.94113978020196,0,1,L-threonine catabolic process to glycine,BP,
17648,GO:1901329,0.999999999998864,0.868491019267811,0,2,regulation of odontoblast differentiation,BP,
11046,GO:0045004,0.999999999998865,0.836380760320942,0,2,DNA replication proofreading,BP,
16243,GO:0090271,0.999999999998868,0.826330006087754,0,2,positive regulation of fibroblast growth factor production,BP,
17016,GO:0099077,0.999999999998879,0.914748636446229,0,1,histone-dependent DNA binding,MF,
19372,GO:1905687,0.999999999998879,0.914748636446229,0,1,regulation of diacylglycerol kinase activity,BP,
19373,GO:1905689,0.999999999998879,0.914748636446229,0,1,positive regulation of diacylglycerol kinase activity,BP,
2302,GO:0005275,0.999999999998879,0.927539146210525,0,1,amine transmembrane transporter activity,MF,
5059,GO:0015265,0.999999999998879,0.927539146210525,0,1,urea channel activity,MF,
17638,GO:1901301,0.999999999998882,0.855432740480669,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
9982,GO:0042361,0.999999999998892,0.926804142992168,0,1,menaquinone catabolic process,BP,
9993,GO:0042377,0.999999999998892,0.926804142992168,0,1,vitamin K catabolic process,BP,
18585,GO:1903775,0.999999999998897,0.864269906878288,0,2,regulation of DNA double-strand break processing,BP,
3838,GO:0008442,0.999999999998902,0.935005714242931,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
8147,GO:0032848,0.999999999998903,0.924192538887126,0,1,negative regulation of cellular pH reduction,BP,
10492,GO:0043375,0.999999999998903,0.924192538887126,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11812,GO:0046668,0.999999999998903,0.924192538887126,0,1,regulation of retinal cell programmed cell death,BP,
11813,GO:0046671,0.999999999998903,0.924192538887126,0,1,negative regulation of retinal cell programmed cell death,BP,
1380,GO:0003273,0.999999999998909,0.689297484722785,0,4,cell migration involved in endocardial cushion formation,BP,
10270,GO:0042999,0.999999999998917,0.920874986381981,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10273,GO:0043002,0.999999999998917,0.920874986381981,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10274,GO:0043004,0.999999999998917,0.920874986381981,0,1,cytoplasmic sequestering of CFTR protein,BP,
5099,GO:0015373,0.99999999999892,0.840845331400821,0,2,anion:sodium symporter activity,MF,
2027,GO:0004757,0.999999999998936,0.943678325547233,0,1,sepiapterin reductase activity,MF,
18487,GO:1903553,0.999999999998938,0.735690744991426,0,4,positive regulation of extracellular exosome assembly,BP,
13993,GO:0060683,0.999999999998947,0.928730762047944,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
19543,GO:1990401,0.999999999998947,0.928730762047944,0,1,embryonic lung development,BP,
19612,GO:1990635,0.999999999998972,0.727369780663124,0,4,proximal dendrite,CC,
12066,GO:0047933,0.999999999998978,0.900280235499329,0,1,glucose-1,6-bisphosphate synthase activity,MF,
1954,GO:0004655,0.999999999998986,0.92681465394305,0,1,porphobilinogen synthase activity,MF,
19052,GO:1904854,0.999999999998986,0.92681465394305,0,1,proteasome core complex binding,MF,
2586,GO:0005879,0.999999999998996,0.66743602379643,0,5,axonemal microtubule,CC,
10414,GO:0043237,0.999999999999002,0.711067487003697,0,4,laminin-1 binding,MF,
1967,GO:0004673,0.999999999999012,0.868666028984939,0,2,protein histidine kinase activity,MF,
11009,GO:0044803,0.99999999999902,0.74318855458253,0,4,multi-organism membrane organization,BP,
8558,GO:0033906,0.999999999999021,0.872382904887309,0,2,hyaluronoglucuronidase activity,MF,
15378,GO:0071598,0.999999999999024,0.704198813621232,0,5,neuronal ribonucleoprotein granule,CC,
19255,GO:1905349,0.999999999999024,0.949574746990121,0,1,ciliary transition zone assembly,BP,
9105,GO:0035363,0.999999999999025,0.74826154384101,0,4,histone locus body,CC,
17705,GO:1901552,0.999999999999025,0.854463065335395,0,2,positive regulation of endothelial cell development,BP,
18299,GO:1903142,0.999999999999025,0.854463065335395,0,2,positive regulation of establishment of endothelial barrier,BP,
17653,GO:1901340,0.999999999999041,0.923009729993448,0,1,negative regulation of store-operated calcium channel activity,BP,
16219,GO:0090233,0.999999999999042,0.92922058261344,0,1,negative regulation of spindle checkpoint,BP,
18017,GO:1902426,0.999999999999042,0.92922058261344,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19251,GO:1905341,0.999999999999042,0.92922058261344,0,1,negative regulation of protein localization to kinetochore,BP,
18362,GO:1903297,0.999999999999044,0.70312020310799,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18363,GO:1903298,0.999999999999044,0.70312020310799,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
4244,GO:0009441,0.999999999999046,0.867434392822155,0,2,glycolate metabolic process,BP,
7598,GO:0031962,0.999999999999048,0.913991658767357,0,1,mineralocorticoid receptor binding,MF,
13742,GO:0060290,0.999999999999048,0.913991658767357,0,1,transdifferentiation,BP,
14461,GO:0061767,0.999999999999048,0.913991658767357,0,1,negative regulation of lung blood pressure,BP,
8459,GO:0033588,0.999999999999053,0.698990786161797,0,5,Elongator holoenzyme complex,CC,
9515,GO:0036155,0.999999999999059,0.687791404429984,0,5,acylglycerol acyl-chain remodeling,BP,
11478,GO:0045918,0.999999999999061,0.915101654103375,0,2,negative regulation of cytolysis,BP,
168,GO:0000349,0.999999999999066,0.865484310841624,0,2,generation of catalytic spliceosome for first transesterification step,BP,
14469,GO:0061783,0.999999999999074,0.839032551566053,0,3,peptidoglycan muralytic activity,MF,
8125,GO:0032805,0.99999999999908,0.878843345654128,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
2637,GO:0005968,0.999999999999098,0.737653965692075,0,4,Rab-protein geranylgeranyltransferase complex,CC,
15645,GO:0072125,0.999999999999117,0.803221317570024,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16192,GO:0090194,0.999999999999117,0.803221317570024,0,3,negative regulation of glomerulus development,BP,
16321,GO:0090416,0.999999999999123,0.92987694582142,0,1,nicotinate transmembrane transporter activity,MF,
20249,GO:2001142,0.999999999999123,0.92987694582142,0,1,nicotinate transport,BP,
3917,GO:0008582,0.999999999999144,0.826896915762568,0,2,regulation of synaptic growth at neuromuscular junction,BP,
19006,GO:1904761,0.999999999999172,0.84689318812726,0,2,negative regulation of myofibroblast differentiation,BP,
19556,GO:1990418,0.999999999999174,0.870111887595,0,2,response to insulin-like growth factor stimulus,BP,
1805,GO:0004446,0.999999999999177,0.928357173824764,0,1,inositol-hexakisphosphate phosphatase activity,MF,
6879,GO:0030351,0.999999999999177,0.928357173824764,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
8536,GO:0033787,0.999999999999177,0.928357173824764,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8762,GO:0034417,0.999999999999177,0.928357173824764,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
13444,GO:0052826,0.999999999999177,0.928357173824764,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
18039,GO:1902499,0.999999999999177,0.928357173824764,0,1,positive regulation of protein autoubiquitination,BP,
15772,GO:0072345,0.999999999999184,0.677249939154287,0,5,NAADP-sensitive calcium-release channel activity,MF,
18963,GO:1904684,0.999999999999185,0.692972006623966,0,4,negative regulation of metalloendopeptidase activity,BP,
19705,GO:1990948,0.999999999999191,0.800256393732378,0,5,ubiquitin ligase inhibitor activity,MF,
4436,GO:0010273,0.999999999999199,0.789503020485034,0,5,detoxification of copper ion,BP,
19497,GO:1990169,0.999999999999199,0.789503020485034,0,5,stress response to copper ion,BP,
12046,GO:0047708,0.999999999999203,0.934027122084225,0,1,biotinidase activity,MF,
13813,GO:0060380,0.999999999999203,0.934027122084225,0,1,regulation of single-stranded telomeric DNA binding,BP,
13814,GO:0060381,0.999999999999203,0.934027122084225,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
2088,GO:0004849,0.999999999999211,0.715949320982622,0,5,uridine kinase activity,MF,
8811,GO:0034506,0.999999999999215,0.923448328039614,0,1,chromosome, centromeric core domain,CC,
15779,GO:0072356,0.999999999999215,0.923448328039614,0,1,chromosome passenger complex localization to kinetochore,BP,
2359,GO:0005456,0.999999999999215,0.937241061260057,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5195,GO:0015782,0.999999999999215,0.937241061260057,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
8403,GO:0033319,0.999999999999218,0.93370131763187,0,1,UDP-D-xylose metabolic process,BP,
8404,GO:0033320,0.999999999999218,0.93370131763187,0,1,UDP-D-xylose biosynthetic process,BP,
12102,GO:0048040,0.999999999999218,0.93370131763187,0,1,UDP-glucuronate decarboxylase activity,MF,
9015,GO:0035166,0.999999999999233,0.790922587465444,0,3,post-embryonic hemopoiesis,BP,
8578,GO:0034038,0.999999999999233,0.949884443479321,0,1,deoxyhypusine synthase activity,MF,
18026,GO:1902463,0.999999999999238,0.889670515055571,0,2,protein localization to cell leading edge,BP,
8662,GO:0034203,0.999999999999248,0.918285170013298,0,1,glycolipid translocation,BP,
1880,GO:0004556,0.999999999999248,0.932783762284799,0,1,alpha-amylase activity,MF,
17200,GO:0103025,0.999999999999248,0.932783762284799,0,1,alpha-amylase activity (releasing maltohexaose),MF,
18797,GO:1904265,0.999999999999268,0.912100183774114,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
12852,GO:0051140,0.99999999999927,0.906859950093363,0,2,regulation of NK T cell proliferation,BP,
12853,GO:0051142,0.99999999999927,0.906859950093363,0,2,positive regulation of NK T cell proliferation,BP,
19471,GO:1990072,0.999999999999273,0.892261000013433,0,2,TRAPPIII protein complex,CC,
255,GO:0000720,0.999999999999294,0.810860872434526,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
2800,GO:0006258,0.999999999999298,0.882666125521756,0,2,UDP-glucose catabolic process,BP,
1434,GO:0003406,0.999999999999306,0.777323667633821,0,3,retinal pigment epithelium development,BP,
12515,GO:0050542,0.999999999999308,0.817475919279774,0,4,icosanoid binding,MF,
12516,GO:0050543,0.999999999999308,0.817475919279774,0,4,icosatetraenoic acid binding,MF,
12517,GO:0050544,0.999999999999308,0.817475919279774,0,4,arachidonic acid binding,MF,
16257,GO:0090289,0.999999999999309,0.878967862432591,0,2,regulation of osteoclast proliferation,BP,
503,GO:0001560,0.999999999999334,0.839701959293408,0,2,regulation of cell growth by extracellular stimulus,BP,
10718,GO:0043998,0.999999999999343,0.926205626263128,0,1,H2A histone acetyltransferase activity,MF,
10616,GO:0043585,0.999999999999347,0.825176954483712,0,2,nose morphogenesis,BP,
1923,GO:0004614,0.999999999999353,0.72547951412477,0,4,phosphoglucomutase activity,MF,
9028,GO:0035226,0.999999999999356,0.927299664642882,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9029,GO:0035227,0.999999999999356,0.927299664642882,0,1,regulation of glutamate-cysteine ligase activity,BP,
9030,GO:0035229,0.999999999999356,0.927299664642882,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
4548,GO:0010624,0.999999999999373,0.699496711902428,0,4,regulation of Schwann cell proliferation,BP,
4549,GO:0010626,0.999999999999373,0.699496711902428,0,4,negative regulation of Schwann cell proliferation,BP,
13572,GO:0060013,0.999999999999375,0.655270344588135,0,5,righting reflex,BP,
143,GO:0000294,0.99999999999939,0.8518345525558,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
18822,GO:1904327,0.999999999999403,0.844298857716265,0,2,protein localization to cytosolic proteasome complex,BP,
18840,GO:1904379,0.999999999999403,0.844298857716265,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
7562,GO:0031893,0.999999999999409,0.932609543389558,0,1,vasopressin receptor binding,MF,
7563,GO:0031896,0.999999999999409,0.932609543389558,0,1,V2 vasopressin receptor binding,MF,
5113,GO:0015421,0.999999999999415,0.925415865820175,0,1,oligopeptide-transporting ATPase activity,MF,
639,GO:0001826,0.999999999999422,0.646136829678026,0,5,inner cell mass cell differentiation,BP,
5609,GO:0016647,0.999999999999427,0.877038863505074,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
11764,GO:0046592,0.999999999999427,0.877038863505074,0,2,polyamine oxidase activity,MF,
13472,GO:0052901,0.999999999999427,0.877038863505074,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
9452,GO:0036021,0.999999999999428,0.751972786439452,0,4,endolysosome lumen,CC,
3894,GO:0008527,0.999999999999429,0.760290619076515,0,5,taste receptor activity,MF,
11816,GO:0046680,0.999999999999432,0.933722665463973,0,1,response to DDT,BP,
20138,GO:2000775,0.999999999999432,0.933722665463973,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
2093,GO:0004855,0.999999999999436,0.914853428167658,0,1,xanthine oxidase activity,MF,
5645,GO:0016727,0.999999999999436,0.914853428167658,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
20290,GO:2001213,0.999999999999436,0.914853428167658,0,1,negative regulation of vasculogenesis,BP,
4229,GO:0009405,0.99999999999944,0.837547788338736,0,2,pathogenesis,BP,
5466,GO:0016344,0.999999999999461,0.858264182349157,0,2,meiotic chromosome movement towards spindle pole,BP,
17699,GO:1901536,0.999999999999462,0.86035034180116,0,2,negative regulation of DNA demethylation,BP,
5386,GO:0016206,0.999999999999467,0.864334324451338,0,2,catechol O-methyltransferase activity,MF,
17144,GO:0102084,0.999999999999467,0.864334324451338,0,2,L-dopa O-methyltransferase activity,MF,
17196,GO:0102938,0.999999999999467,0.864334324451338,0,2,orcinol O-methyltransferase activity,MF,
1064,GO:0002589,0.99999999999947,0.87665236952868,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1065,GO:0002590,0.99999999999947,0.87665236952868,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
2110,GO:0004886,0.999999999999471,0.850264536561951,0,2,9-cis retinoic acid receptor activity,MF,
9654,GO:0036514,0.999999999999476,0.634438256508741,0,5,dopaminergic neuron axon guidance,BP,
19095,GO:1904938,0.999999999999476,0.634438256508741,0,5,planar cell polarity pathway involved in axon guidance,BP,
320,GO:0000836,0.999999999999492,0.675438700321954,0,5,Hrd1p ubiquitin ligase complex,CC,
14624,GO:0070170,0.999999999999492,0.844372552221968,0,2,regulation of tooth mineralization,BP,
18198,GO:1902939,0.999999999999504,0.92813533098046,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
3411,GO:0007195,0.999999999999505,0.837731797468267,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
12604,GO:0050757,0.999999999999511,0.929440099060994,0,1,thymidylate synthase biosynthetic process,BP,
12605,GO:0050758,0.999999999999511,0.929440099060994,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12606,GO:0050760,0.999999999999511,0.929440099060994,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
5520,GO:0016480,0.999999999999513,0.837980055921562,0,3,negative regulation of transcription by RNA polymerase III,BP,
3023,GO:0006569,0.999999999999514,0.824279032249053,0,3,tryptophan catabolic process,BP,
6153,GO:0019441,0.999999999999514,0.824279032249053,0,3,tryptophan catabolic process to kynurenine,BP,
10020,GO:0042436,0.999999999999514,0.824279032249053,0,3,indole-containing compound catabolic process,BP,
11620,GO:0046218,0.999999999999514,0.824279032249053,0,3,indolalkylamine catabolic process,BP,
6389,GO:0021577,0.999999999999516,0.92369846510735,0,1,hindbrain structural organization,BP,
6393,GO:0021589,0.999999999999516,0.92369846510735,0,1,cerebellum structural organization,BP,
14104,GO:0060904,0.999999999999516,0.92369846510735,0,1,regulation of protein folding in endoplasmic reticulum,BP,
18816,GO:1904313,0.999999999999516,0.92369846510735,0,1,response to methamphetamine hydrochloride,BP,
18006,GO:1902396,0.999999999999519,0.923940226261874,0,1,protein localization to bicellular tight junction,BP,
18419,GO:1903416,0.999999999999534,0.80714325363632,0,3,response to glycoside,BP,
16269,GO:0090306,0.999999999999545,0.712368250049761,0,4,spindle assembly involved in meiosis,BP,
19007,GO:1904762,0.999999999999545,0.923557295750144,0,1,positive regulation of myofibroblast differentiation,BP,
161,GO:0000332,0.999999999999548,0.971200867063581,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
239,GO:0000496,0.999999999999548,0.971200867063581,0,1,base pairing,MF,
240,GO:0000497,0.999999999999548,0.971200867063581,0,1,base pairing with DNA,MF,
1469,GO:0003721,0.999999999999548,0.971200867063581,0,1,telomerase RNA reverse transcriptase activity,MF,
16789,GO:0098574,0.999999999999551,0.741406307155758,0,4,cytoplasmic side of lysosomal membrane,CC,
14144,GO:0060987,0.999999999999555,0.931583271600192,0,1,lipid tube,CC,
2222,GO:0005119,0.999999999999562,0.836931266531998,0,2,smoothened binding,MF,
19533,GO:1990357,0.999999999999569,0.815958562679362,0,3,terminal web,CC,
14177,GO:0061038,0.999999999999576,0.674224247879431,0,4,uterus morphogenesis,BP,
14578,GO:0070092,0.999999999999582,0.788883112497729,0,3,regulation of glucagon secretion,BP,
10671,GO:0043812,0.999999999999603,0.778114111301124,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
15536,GO:0071898,0.999999999999609,0.808435911073564,0,3,regulation of estrogen receptor binding,BP,
15537,GO:0071899,0.999999999999609,0.808435911073564,0,3,negative regulation of estrogen receptor binding,BP,
5622,GO:0016672,0.999999999999626,0.906036074636556,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
11145,GO:0045174,0.999999999999626,0.906036074636556,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12522,GO:0050610,0.999999999999626,0.906036074636556,0,2,methylarsonate reductase activity,MF,
17370,GO:1900036,0.999999999999632,0.931463684180803,0,1,positive regulation of cellular response to heat,BP,
10154,GO:0042719,0.999999999999642,0.761965455852964,0,5,mitochondrial intermembrane space protein transporter complex,CC,
1259,GO:0003010,0.99999999999965,0.867467198894083,0,2,voluntary skeletal muscle contraction,BP,
4870,GO:0014721,0.99999999999965,0.867467198894083,0,2,twitch skeletal muscle contraction,BP,
14799,GO:0070489,0.999999999999657,0.923661236775651,0,1,T cell aggregation,BP,
6525,GO:0021902,0.999999999999664,0.829467070158178,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
15957,GO:0072740,0.99999999999967,0.936102563063801,0,1,cellular response to anisomycin,BP,
17483,GO:1900259,0.99999999999967,0.936102563063801,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17484,GO:1900260,0.99999999999967,0.936102563063801,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
4631,GO:0010750,0.999999999999683,0.929895226854766,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
8464,GO:0033594,0.999999999999683,0.929895226854766,0,1,response to hydroxyisoflavone,BP,
10276,GO:0043006,0.999999999999683,0.929895226854766,0,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
16650,GO:0097489,0.999999999999683,0.929895226854766,0,1,multivesicular body, internal vesicle lumen,CC,
15491,GO:0071817,0.999999999999684,0.724517041560727,0,5,MMXD complex,CC,
4210,GO:0009331,0.999999999999684,0.844360223211367,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
2701,GO:0006065,0.999999999999697,0.787869769037336,0,3,UDP-glucuronate biosynthetic process,BP,
11672,GO:0046398,0.999999999999697,0.787869769037336,0,3,UDP-glucuronate metabolic process,BP,
3728,GO:0008263,0.999999999999698,0.862134483011117,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
16715,GO:0097644,0.9999999999997,0.879638873992108,0,2,calcitonin family binding,MF,
18436,GO:1903439,0.9999999999997,0.879638873992108,0,2,calcitonin family receptor complex,CC,
19548,GO:1990406,0.9999999999997,0.879638873992108,0,2,CGRP receptor complex,CC,
19550,GO:1990408,0.9999999999997,0.879638873992108,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
20086,GO:2000676,0.999999999999708,0.712554572930369,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
10672,GO:0043813,0.999999999999713,0.641771203767845,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
15728,GO:0072262,0.999999999999721,0.859949066073639,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15746,GO:0072301,0.999999999999721,0.859949066073639,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
15655,GO:0072135,0.999999999999734,0.8544178531787,0,2,kidney mesenchymal cell proliferation,BP,
15656,GO:0072136,0.999999999999734,0.8544178531787,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
10120,GO:0042628,0.99999999999976,0.932079844976136,0,1,mating plug formation,BP,
11208,GO:0045297,0.99999999999976,0.932079844976136,0,1,post-mating behavior,BP,
14219,GO:0061107,0.99999999999976,0.932079844976136,0,1,seminal vesicle development,BP,
14220,GO:0061108,0.99999999999976,0.932079844976136,0,1,seminal vesicle epithelium development,BP,
1161,GO:0002767,0.999999999999768,0.872814319697675,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
8975,GO:0035037,0.999999999999775,0.921220329955631,0,1,sperm entry,BP,
15283,GO:0071440,0.999999999999782,0.6876660043218,0,5,regulation of histone H3-K14 acetylation,BP,
14140,GO:0060978,0.999999999999785,0.84811143956687,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
3812,GO:0008401,0.999999999999785,0.856258852109953,0,2,retinoic acid 4-hydroxylase activity,MF,
3982,GO:0008808,0.999999999999794,0.924372233944291,0,1,cardiolipin synthase activity,MF,
6952,GO:0030572,0.999999999999794,0.924372233944291,0,1,phosphatidyltransferase activity,MF,
10480,GO:0043337,0.999999999999794,0.924372233944291,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
19379,GO:1905711,0.999999999999794,0.924372233944291,0,1,response to phosphatidylethanolamine,BP,
1399,GO:0003310,0.999999999999797,0.943783522091509,0,1,pancreatic A cell differentiation,BP,
6376,GO:0021558,0.999999999999797,0.943783522091509,0,1,trochlear nerve development,BP,
11513,GO:0045977,0.999999999999797,0.943783522091509,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
13674,GO:0060164,0.999999999999797,0.943783522091509,0,1,regulation of timing of neuron differentiation,BP,
14216,GO:0061102,0.999999999999797,0.943783522091509,0,1,stomach neuroendocrine cell differentiation,BP,
14217,GO:0061105,0.999999999999797,0.943783522091509,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14218,GO:0061106,0.999999999999797,0.943783522091509,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15494,GO:0071820,0.999999999999797,0.943783522091509,0,1,N-box binding,MF,
15609,GO:0072071,0.999999999999797,0.943783522091509,0,1,kidney interstitial fibroblast differentiation,BP,
15660,GO:0072141,0.999999999999797,0.943783522091509,0,1,renal interstitial fibroblast development,BP,
19825,GO:2000226,0.999999999999797,0.943783522091509,0,1,regulation of pancreatic A cell differentiation,BP,
19826,GO:2000227,0.999999999999797,0.943783522091509,0,1,negative regulation of pancreatic A cell differentiation,BP,
13213,GO:0051800,0.999999999999804,0.91591716822486,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
20156,GO:2000808,0.999999999999804,0.91591716822486,0,1,negative regulation of synaptic vesicle clustering,BP,
6790,GO:0030222,0.99999999999981,0.925055507921058,0,1,eosinophil differentiation,BP,
11335,GO:0045643,0.99999999999981,0.925055507921058,0,1,regulation of eosinophil differentiation,BP,
11336,GO:0045645,0.99999999999981,0.925055507921058,0,1,positive regulation of eosinophil differentiation,BP,
8498,GO:0033647,0.999999999999813,0.685846463338869,0,5,host intracellular organelle,CC,
8499,GO:0033648,0.999999999999813,0.685846463338869,0,5,host intracellular membrane-bounded organelle,CC,
11900,GO:0046899,0.999999999999822,0.862623206059198,0,2,nucleoside triphosphate adenylate kinase activity,MF,
2028,GO:0004758,0.999999999999829,0.675964371017316,0,5,serine C-palmitoyltransferase activity,MF,
5509,GO:0016454,0.999999999999829,0.675964371017316,0,5,C-palmitoyltransferase activity,MF,
17751,GO:1901656,0.999999999999831,0.855719588763612,0,2,glycoside transport,BP,
5754,GO:0016899,0.999999999999854,0.844046426125435,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
16952,GO:0098909,0.999999999999854,0.653095604979,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
17543,GO:1900825,0.999999999999864,0.731918444903042,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
2498,GO:0005745,0.999999999999872,0.861977954551162,0,2,m-AAA complex,CC,
1937,GO:0004633,0.999999999999876,0.932457492315878,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1956,GO:0004657,0.999999999999876,0.932457492315878,0,1,proline dehydrogenase activity,MF,
16234,GO:0090258,0.999999999999876,0.850082435734767,0,2,negative regulation of mitochondrial fission,BP,
16988,GO:0098982,0.999999999999881,0.844705236957093,0,2,GABA-ergic synapse,CC,
16989,GO:0098983,0.999999999999881,0.844705236957093,0,2,symmetric, GABA-ergic, inhibitory synapse,CC,
12089,GO:0048022,0.999999999999884,0.831198196640499,0,2,negative regulation of melanin biosynthetic process,BP,
17503,GO:1900377,0.999999999999884,0.831198196640499,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
13098,GO:0051586,0.999999999999917,0.941852358660281,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13281,GO:0051944,0.999999999999917,0.941852358660281,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
588,GO:0001740,0.99999999999992,0.784871860910377,0,3,Barr body,CC,
3835,GO:0008434,0.999999999999936,0.920260090683953,0,1,calcitriol receptor activity,MF,
9740,GO:0038181,0.999999999999936,0.920260090683953,0,1,bile acid receptor activity,MF,
9741,GO:0038183,0.999999999999936,0.920260090683953,0,1,bile acid signaling pathway,BP,
9742,GO:0038186,0.999999999999936,0.920260090683953,0,1,lithocholic acid receptor activity,MF,
17889,GO:1902098,0.999999999999936,0.920260090683953,0,1,calcitriol binding,MF,
17904,GO:1902121,0.999999999999936,0.920260090683953,0,1,lithocholic acid binding,MF,
17964,GO:1902271,0.999999999999936,0.920260090683953,0,1,D3 vitamins binding,MF,
1656,GO:0004105,0.999999999999941,0.862300700480501,0,2,choline-phosphate cytidylyltransferase activity,MF,
17384,GO:1900063,0.999999999999947,0.760777742332609,0,3,regulation of peroxisome organization,BP,
16151,GO:0090135,0.999999999999955,0.799250276630181,0,3,actin filament branching,BP,
14378,GO:0061582,0.99999999999996,0.841747225297812,0,2,intestinal epithelial cell migration,BP,
1260,GO:0003011,0.999999999999962,0.849863871391133,0,2,involuntary skeletal muscle contraction,BP,
16600,GO:0097381,0.999999999999983,0.647034563957503,0,5,photoreceptor disc membrane,CC,
2368,GO:0005483,0.999999999999983,0.800426380536434,0,3,soluble NSF attachment protein activity,MF,
8505,GO:0033676,0.999999999999986,0.944747584808848,0,1,double-stranded DNA-dependent ATPase activity,MF,
7133,GO:0030951,0.999999999999989,0.726698237134467,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
18055,GO:1902544,0.99999999999999,0.888787528933193,0,2,regulation of DNA N-glycosylase activity,BP,
3004,GO:0006550,0.999999999999993,0.877655356023786,0,2,isoleucine catabolic process,BP,
794,GO:0002055,0.999999999999997,0.962215218252976,0,1,adenine binding,MF,
1591,GO:0003999,0.999999999999997,0.962215218252976,0,1,adenine phosphoribosyltransferase activity,MF,
10066,GO:0042539,0.999999999999998,0.839397073688029,0,2,hypotonic salinity response,BP,
15309,GO:0071477,0.999999999999998,0.839397073688029,0,2,cellular hypotonic salinity response,BP,
1,GO:0000002,1,0.168152784633983,0,24,mitochondrial genome maintenance,BP,
7,GO:0000014,1,0.574607099747136,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
26,GO:0000050,1,0.486510953179218,0,10,urea cycle,BP,
27,GO:0000052,1,0.56547269675027,0,7,citrulline metabolic process,BP,
33,GO:0000062,1,0.315749614429343,0,17,fatty-acyl-CoA binding,MF,
45,GO:0000097,1,0.356498969450101,0,14,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.592954630213196,0,7,sulfur amino acid catabolic process,BP,
52,GO:0000109,1,0.483018963982438,0,10,nucleotide-excision repair complex,CC,
65,GO:0000132,1,0.245977178834525,0,18,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.460874952443896,0,10,Golgi cis cisterna,CC,
69,GO:0000145,1,0.288674013412453,0,16,exocyst,CC,
76,GO:0000153,1,0.453790305871475,0,11,cytoplasmic ubiquitin ligase complex,CC,
79,GO:0000159,1,0.224174101505602,0,20,protein phosphatase type 2A complex,CC,
88,GO:0000176,1,0.464711477299298,0,13,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.363846782709949,0,15,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.226541480690503,0,22,exosome (RNase complex),CC,
92,GO:0000182,1,0.428176804835703,0,10,rDNA binding,MF,
101,GO:0000212,1,0.4246579378068,0,10,meiotic spindle organization,BP,
113,GO:0000235,1,0.518128637487295,0,8,astral microtubule,CC,
115,GO:0000243,1,0.60315035493552,0,8,commitment complex,CC,
116,GO:0000244,1,0.395843887034758,0,12,spliceosomal tri-snRNP complex assembly,BP,
139,GO:0000289,1,0.0579860700479122,0,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,
140,GO:0000290,1,0.505033373204001,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
141,GO:0000291,1,0.0990840685046681,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000295,1,0.45776914980018,0,11,adenine nucleotide transmembrane transporter activity,MF,
179,GO:0000389,1,0.645354406588296,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000394,1,0.329920985777507,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
183,GO:0000395,1,0.652591667221447,0,6,mRNA 5'-splice site recognition,BP,
188,GO:0000405,1,0.573080304126904,0,7,bubble DNA binding,MF,
202,GO:0000423,1,0.22464552484678,0,19,mitophagy,BP,
220,GO:0000459,1,0.641697351038832,0,7,exonucleolytic trimming involved in rRNA processing,BP,
226,GO:0000467,1,0.641697351038832,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
242,GO:0000506,1,0.575759574062603,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
251,GO:0000712,1,0.490878383214358,0,9,resolution of meiotic recombination intermediates,BP,
276,GO:0000778,1,0.427816829002983,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000780,1,0.228930276256072,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000782,1,0.482015909520247,0,10,telomere cap complex,CC,
281,GO:0000783,1,0.482015909520247,0,10,nuclear telomere cap complex,CC,
287,GO:0000791,1,0.150828128692615,0,27,euchromatin,CC,
299,GO:0000805,1,0.557878043332514,0,7,X chromosome,CC,
303,GO:0000812,1,0.46202220447565,0,10,Swr1 complex,CC,
304,GO:0000813,1,0.571704814064087,0,8,ESCRT I complex,CC,
306,GO:0000815,1,0.441031955420765,0,12,ESCRT III complex,CC,
319,GO:0000835,1,0.621841163025409,0,6,ER ubiquitin ligase complex,CC,
330,GO:0000920,1,0.316118922687101,0,17,cell separation after cytokinesis,BP,
333,GO:0000923,1,0.622425743771415,0,6,equatorial microtubule organizing center,CC,
336,GO:0000931,1,0.518622442468047,0,8,gamma-tubulin large complex,CC,
355,GO:0000972,1,0.593744382256589,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
378,GO:0001010,1,0.318735397600752,0,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001016,1,0.582643802056379,0,7,RNA polymerase III regulatory region DNA binding,MF,
426,GO:0001133,1,0.343512835445761,0,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
449,GO:0001222,1,0.369455634689441,0,13,transcription corepressor binding,MF,
457,GO:0001302,1,0.655751468490978,0,6,replicative cell aging,BP,
471,GO:0001514,1,0.592072546929939,0,7,selenocysteine incorporation,BP,
475,GO:0001518,1,0.562012777607643,0,6,voltage-gated sodium channel complex,CC,
482,GO:0001530,1,0.516376521721648,0,10,lipopolysaccharide binding,MF,
487,GO:0001539,1,0.279886658381596,0,15,cilium or flagellum-dependent cell motility,BP,
490,GO:0001542,1,0.601842872457425,0,6,ovulation from ovarian follicle,BP,
504,GO:0001561,1,0.652499034902441,0,6,fatty acid alpha-oxidation,BP,
505,GO:0001562,1,0.51826753662479,0,9,response to protozoan,BP,
523,GO:0001614,1,0.655108212171377,0,6,purinergic nucleotide receptor activity,MF,
544,GO:0001662,1,0.260737419981131,0,18,behavioral fear response,BP,
551,GO:0001672,1,0.554217392327269,0,7,regulation of chromatin assembly or disassembly,BP,
569,GO:0001708,1,0.0631560338005386,0,34,cell fate specification,BP,
570,GO:0001709,1,0.278241964194775,0,17,cell fate determination,BP,
571,GO:0001710,1,0.640819046344275,0,6,mesodermal cell fate commitment,BP,
572,GO:0001711,1,0.479675410011603,0,10,endodermal cell fate commitment,BP,
581,GO:0001731,1,0.540253592275932,0,8,formation of translation preinitiation complex,BP,
592,GO:0001754,1,0.231651228473506,0,18,eye photoreceptor cell differentiation,BP,
597,GO:0001759,1,0.453373248986624,0,11,organ induction,BP,
601,GO:0001766,1,0.664138007326491,0,6,membrane raft polarization,BP,
602,GO:0001767,1,0.591790187071584,0,6,establishment of lymphocyte polarity,BP,
613,GO:0001779,1,0.350347806670373,0,14,natural killer cell differentiation,BP,
614,GO:0001780,1,0.470815556094451,0,10,neutrophil homeostasis,BP,
615,GO:0001781,1,0.645630870715942,0,6,neutrophil apoptotic process,BP,
652,GO:0001840,1,0.513221733134586,0,8,neural plate development,BP,
657,GO:0001845,1,0.527916730275973,0,9,phagolysosome assembly,BP,
659,GO:0001848,1,0.616967817776235,0,7,complement binding,MF,
679,GO:0001886,1,0.563427006551941,0,7,endothelial cell morphogenesis,BP,
686,GO:0001893,1,0.128780104981879,0,26,maternal placenta development,BP,
695,GO:0001912,1,0.302406668496748,0,17,positive regulation of leukocyte mediated cytotoxicity,BP,
699,GO:0001916,1,0.589629084963208,0,8,positive regulation of T cell mediated cytotoxicity,BP,
709,GO:0001931,1,0.527615414834426,0,8,uropod,CC,
732,GO:0001958,1,0.290364763564074,0,16,endochondral ossification,BP,
736,GO:0001963,1,0.392468889273587,0,14,synaptic transmission, dopaminergic,BP,
738,GO:0001965,1,0.320234923092712,0,16,G-protein alpha-subunit binding,MF,
739,GO:0001967,1,0.577045537414557,0,7,suckling behavior,BP,
744,GO:0001972,1,0.494235482344343,0,9,retinoic acid binding,MF,
746,GO:0001974,1,0.129169489158545,0,25,blood vessel remodeling,BP,
771,GO:0002021,1,0.487651062278995,0,10,response to dietary excess,BP,
791,GO:0002052,1,0.364116683500171,0,12,positive regulation of neuroblast proliferation,BP,
808,GO:0002076,1,0.400359379548895,0,11,osteoblast development,BP,
810,GO:0002080,1,0.463213881148354,0,10,acrosomal membrane,CC,
812,GO:0002082,1,0.363441671076619,0,14,regulation of oxidative phosphorylation,BP,
814,GO:0002084,1,0.524120132248217,0,9,protein depalmitoylation,BP,
819,GO:0002089,1,0.344496141770378,0,12,lens morphogenesis in camera-type eye,BP,
831,GO:0002115,1,0.365743303725166,0,13,store-operated calcium entry,BP,
832,GO:0002116,1,0.386984664377959,0,10,semaphorin receptor complex,CC,
842,GO:0002151,1,0.614252038983311,0,6,G-quadruplex RNA binding,MF,
848,GO:0002161,1,0.436926092862051,0,11,aminoacyl-tRNA editing activity,MF,
855,GO:0002178,1,0.449230058564924,0,11,palmitoyltransferase complex,CC,
867,GO:0002199,1,0.614552640096347,0,7,zona pellucida receptor complex,CC,
871,GO:0002209,1,0.260737419981131,0,18,behavioral defense response,BP,
878,GO:0002227,1,0.710312582109967,0,10,innate immune response in mucosa,BP,
880,GO:0002230,1,0.278626044430259,0,17,positive regulation of defense response to virus by host,BP,
884,GO:0002246,1,0.658330856379533,0,6,wound healing involved in inflammatory response,BP,
888,GO:0002251,1,0.485771140973953,0,15,organ or tissue specific immune response,BP,
913,GO:0002295,1,0.561158185243724,0,8,T-helper cell lineage commitment,BP,
927,GO:0002320,1,0.336463761016445,0,13,lymphoid progenitor cell differentiation,BP,
929,GO:0002323,1,0.539238860026585,0,9,natural killer cell activation involved in immune response,BP,
932,GO:0002327,1,0.566518867639488,0,6,immature B cell differentiation,BP,
933,GO:0002328,1,0.453405559996883,0,9,pro-B cell differentiation,BP,
949,GO:0002363,1,0.485256322736673,0,10,alpha-beta T cell lineage commitment,BP,
964,GO:0002385,1,0.554046340985507,0,13,mucosal immune response,BP,
973,GO:0002418,1,0.554881803147675,0,8,immune response to tumor cell,BP,
1041,GO:0002551,1,0.571475081426312,0,8,mast cell chemotaxis,BP,
1103,GO:0002689,1,0.648981668418416,0,7,negative regulation of leukocyte chemotaxis,BP,
1107,GO:0002693,1,0.538334934161494,0,8,positive regulation of cellular extravasation,BP,
1131,GO:0002717,1,0.479091759389875,0,10,positive regulation of natural killer cell mediated immunity,BP,
1148,GO:0002741,1,0.585597432271475,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1188,GO:0002832,1,0.0711204428270434,0,36,negative regulation of response to biotic stimulus,BP,
1189,GO:0002833,1,0.139229620621923,0,26,positive regulation of response to biotic stimulus,BP,
1190,GO:0002834,1,0.632367913052797,0,6,regulation of response to tumor cell,BP,
1193,GO:0002837,1,0.632367913052797,0,6,regulation of immune response to tumor cell,BP,
1244,GO:0002934,1,0.46667799047824,0,9,desmosome organization,BP,
1258,GO:0003009,1,0.255478547667913,0,19,skeletal muscle contraction,BP,
1285,GO:0003084,1,0.648273767702206,0,6,positive regulation of systemic arterial blood pressure,BP,
1326,GO:0003174,1,0.448567888228276,0,9,mitral valve development,BP,
1333,GO:0003183,1,0.483963142669778,0,8,mitral valve morphogenesis,BP,
1336,GO:0003188,1,0.49663047552394,0,8,heart valve formation,BP,
1352,GO:0003214,1,0.599431116437066,0,6,cardiac left ventricle morphogenesis,BP,
1358,GO:0003223,1,0.575337485552501,0,6,ventricular compact myocardium morphogenesis,BP,
1376,GO:0003264,1,0.648936624408484,0,6,regulation of cardioblast proliferation,BP,
1392,GO:0003299,1,0.351420990026626,0,12,muscle hypertrophy in response to stress,BP,
1395,GO:0003306,1,0.628165585615047,0,6,Wnt signaling pathway involved in heart development,BP,
1406,GO:0003337,1,0.611244145879979,0,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1413,GO:0003344,1,0.562049159829143,0,6,pericardium morphogenesis,BP,
1417,GO:0003351,1,0.517127253469584,0,10,epithelial cilium movement,BP,
1425,GO:0003373,1,0.519438826597195,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1426,GO:0003374,1,0.519438826597195,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1452,GO:0003680,1,0.640560733796251,0,6,AT DNA binding,MF,
1479,GO:0003746,1,0.320449966479775,0,16,translation elongation factor activity,MF,
1480,GO:0003747,1,0.631678190346942,0,6,translation release factor activity,MF,
1482,GO:0003756,1,0.283595411647367,0,17,protein disulfide isomerase activity,MF,
1497,GO:0003836,1,0.637310744863441,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1532,GO:0003909,1,0.595841849657429,0,7,DNA ligase activity,MF,
1533,GO:0003910,1,0.638324342122121,0,6,DNA ligase (ATP) activity,MF,
1534,GO:0003916,1,0.621632129304896,0,6,DNA topoisomerase activity,MF,
1555,GO:0003951,1,0.353069418218302,0,13,NAD+ kinase activity,MF,
1585,GO:0003993,1,0.675290446458256,0,6,acid phosphatase activity,MF,
1587,GO:0003995,1,0.378696072943768,0,13,acyl-CoA dehydrogenase activity,MF,
1592,GO:0004000,1,0.621114520762745,0,6,adenosine deaminase activity,MF,
1597,GO:0004012,1,0.292705504390765,0,13,phospholipid-translocating ATPase activity,MF,
1600,GO:0004016,1,0.565358023636141,0,6,adenylate cyclase activity,MF,
1608,GO:0004028,1,0.594309103033308,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1609,GO:0004029,1,0.369143709700652,0,13,aldehyde dehydrogenase (NAD) activity,MF,
1631,GO:0004065,1,0.582324458887375,0,7,arylsulfatase activity,MF,
1660,GO:0004112,1,0.409281028235487,0,11,cyclic-nucleotide phosphodiesterase activity,MF,
1662,GO:0004114,1,0.44603549458242,0,10,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1668,GO:0004126,1,0.601133366211159,0,8,cytidine deaminase activity,MF,
1671,GO:0004129,1,0.456667051090664,0,18,cytochrome-c oxidase activity,MF,
1681,GO:0004143,1,0.512882172942186,0,8,diacylglycerol kinase activity,MF,
1705,GO:0004185,1,0.538631049953524,0,8,serine-type carboxypeptidase activity,MF,
1714,GO:0004303,1,0.652061850978634,0,7,estradiol 17-beta-dehydrogenase activity,MF,
1723,GO:0004312,1,0.520058601202613,0,9,fatty acid synthase activity,MF,
1779,GO:0004383,1,0.565358023636141,0,6,guanylate cyclase activity,MF,
1799,GO:0004430,1,0.630311280689914,0,6,1-phosphatidylinositol 4-kinase activity,MF,
1802,GO:0004439,1,0.519273465652751,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1873,GO:0004535,1,0.372086558792927,0,12,poly(A)-specific ribonuclease activity,MF,
1877,GO:0004550,1,0.518519559869695,0,11,nucleoside diphosphate kinase activity,MF,
1883,GO:0004559,1,0.346008132773547,0,13,alpha-mannosidase activity,MF,
1892,GO:0004571,1,0.566903407504912,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
1896,GO:0004576,1,0.529754642620563,0,10,oligosaccharyl transferase activity,MF,
1899,GO:0004579,1,0.557482204022825,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1951,GO:0004652,1,0.520081532441011,0,8,polynucleotide adenylyltransferase activity,MF,
1958,GO:0004659,1,0.330354040813961,0,15,prenyltransferase activity,MF,
1969,GO:0004675,1,0.340451953394622,0,12,transmembrane receptor protein serine/threonine kinase activity,MF,
1972,GO:0004679,1,0.568378051586107,0,7,AMP-activated protein kinase activity,MF,
1977,GO:0004690,1,0.545884136566096,0,7,cyclic nucleotide-dependent protein kinase activity,MF,
1978,GO:0004691,1,0.590623543607108,0,6,cAMP-dependent protein kinase activity,MF,
1982,GO:0004697,1,0.373325320651091,0,12,protein kinase C activity,MF,
1990,GO:0004707,1,0.415927084246152,0,12,MAP kinase activity,MF,
1991,GO:0004708,1,0.408765653101203,0,12,MAP kinase kinase activity,MF,
1993,GO:0004711,1,0.551116174222053,0,7,ribosomal protein S6 kinase activity,MF,
2003,GO:0004723,1,0.565567416130926,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2005,GO:0004726,1,0.551695551223692,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2020,GO:0004745,1,0.620949732221919,0,7,retinol dehydrogenase activity,MF,
2057,GO:0004806,1,0.46706080755523,0,10,triglyceride lipase activity,MF,
2096,GO:0004859,1,0.660594927409886,0,7,phospholipase inhibitor activity,MF,
2099,GO:0004862,1,0.614306213683817,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2101,GO:0004865,1,0.662041569495961,0,7,protein serine/threonine phosphatase inhibitor activity,MF,
2180,GO:0005024,1,0.547668029973403,0,7,transforming growth factor beta-activated receptor activity,MF,
2184,GO:0005031,1,0.286098421400479,0,18,tumor necrosis factor-activated receptor activity,MF,
2186,GO:0005035,1,0.286098421400479,0,18,death receptor activity,MF,
2193,GO:0005049,1,0.503514142012558,0,8,nuclear export signal receptor activity,MF,
2200,GO:0005072,1,0.493071252139891,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2201,GO:0005078,1,0.524921151646862,0,7,MAP-kinase scaffold activity,MF,
2204,GO:0005086,1,0.249381831151779,0,16,ARF guanyl-nucleotide exchange factor activity,MF,
2212,GO:0005095,1,0.448093525166056,0,11,GTPase inhibitor activity,MF,
2215,GO:0005104,1,0.431931771653881,0,10,fibroblast growth factor receptor binding,MF,
2253,GO:0005165,1,0.573169730483221,0,7,neurotrophin receptor binding,MF,
2255,GO:0005167,1,0.573169730483221,0,7,neurotrophin TRK receptor binding,MF,
2256,GO:0005168,1,0.600248954619919,0,6,neurotrophin TRKA receptor binding,MF,
2280,GO:0005227,1,0.376946622942519,0,13,calcium activated cation channel activity,MF,
2281,GO:0005229,1,0.455858189137766,0,10,intracellular calcium activated chloride channel activity,MF,
2282,GO:0005230,1,0.496966138773344,0,9,extracellular ligand-gated ion channel activity,MF,
2283,GO:0005231,1,0.581526332508263,0,7,excitatory extracellular ligand-gated ion channel activity,MF,
2286,GO:0005242,1,0.594821172422589,0,7,inward rectifier potassium channel activity,MF,
2291,GO:0005247,1,0.569540402435708,0,7,voltage-gated chloride channel activity,MF,
2292,GO:0005248,1,0.446493292661148,0,9,voltage-gated sodium channel activity,MF,
2333,GO:0005346,1,0.45776914980018,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2334,GO:0005347,1,0.564177009354848,0,8,ATP transmembrane transporter activity,MF,
2336,GO:0005351,1,0.537191535761649,0,8,carbohydrate:proton symporter activity,MF,
2337,GO:0005355,1,0.49573283983787,0,9,glucose transmembrane transporter activity,MF,
2350,GO:0005402,1,0.418577738015327,0,11,carbohydrate:cation symporter activity,MF,
2374,GO:0005501,1,0.419319643813909,0,12,retinoid binding,MF,
2377,GO:0005504,1,0.417525893176244,0,14,fatty acid binding,MF,
2381,GO:0005513,1,0.611125290590467,0,7,detection of calcium ion,BP,
2389,GO:0005523,1,0.587402052892729,0,8,tropomyosin binding,MF,
2402,GO:0005545,1,0.366251517968827,0,12,1-phosphatidylinositol binding,MF,
2405,GO:0005548,1,0.0330278818570445,0,42,phospholipid transporter activity,MF,
2440,GO:0005639,1,0.540038080804295,0,8,integral component of nuclear inner membrane,CC,
2445,GO:0005652,1,0.499340560232882,0,9,nuclear lamina,CC,
2464,GO:0005677,1,0.457371891485098,0,9,chromatin silencing complex,CC,
2467,GO:0005682,1,0.193075181215064,0,22,U5 snRNP,CC,
2468,GO:0005683,1,0.702720945088715,0,7,U7 snRNP,CC,
2471,GO:0005686,1,0.284886000367925,0,20,U2 snRNP,CC,
2472,GO:0005687,1,0.509906429620698,0,11,U4 snRNP,CC,
2473,GO:0005688,1,0.656178704319361,0,8,U6 snRNP,CC,
2482,GO:0005719,1,0.240156193247455,0,21,nuclear euchromatin,CC,
2495,GO:0005742,1,0.628431312429145,0,8,mitochondrial outer membrane translocase complex,CC,
2503,GO:0005751,1,0.664036895434817,0,10,mitochondrial respiratory chain complex IV,CC,
2531,GO:0005786,1,0.687631009770698,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2535,GO:0005790,1,0.152452243141125,0,24,smooth endoplasmic reticulum,CC,
2550,GO:0005818,1,0.518128637487295,0,8,aster,CC,
2554,GO:0005828,1,0.534932252698389,0,7,kinetochore microtubule,CC,
2556,GO:0005832,1,0.476490109528761,0,10,chaperonin-containing T-complex,CC,
2558,GO:0005834,1,0.25286603583743,0,19,heterotrimeric G-protein complex,CC,
2559,GO:0005838,1,0.266471199115583,0,21,proteasome regulatory particle,CC,
2562,GO:0005844,1,0.0131628979459462,0,69,polysome,CC,
2565,GO:0005847,1,0.297709528030457,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2566,GO:0005849,1,0.255234286826942,0,18,mRNA cleavage factor complex,CC,
2580,GO:0005869,1,0.588420762646057,0,8,dynactin complex,CC,
2592,GO:0005885,1,0.539910383375662,0,10,Arp2/3 protein complex,CC,
2597,GO:0005891,1,0.409175817326418,0,11,voltage-gated calcium channel complex,CC,
2612,GO:0005916,1,0.605318100179741,0,6,fascia adherens,CC,
2622,GO:0005940,1,0.494269089339065,0,9,septin ring,CC,
2660,GO:0006002,1,0.63876025297686,0,6,fructose 6-phosphate metabolic process,BP,
2662,GO:0006004,1,0.370508602761312,0,13,fucose metabolic process,BP,
2665,GO:0006011,1,0.623028848819812,0,6,UDP-glucose metabolic process,BP,
2667,GO:0006013,1,0.548732398038935,0,8,mannose metabolic process,BP,
2677,GO:0006029,1,0.0080125831249283,0,59,proteoglycan metabolic process,BP,
2683,GO:0006044,1,0.373366945546778,0,13,N-acetylglucosamine metabolic process,BP,
2691,GO:0006054,1,0.482787671064952,0,10,N-acetylneuraminate metabolic process,BP,
2703,GO:0006067,1,0.463279945952907,0,11,ethanol metabolic process,BP,
2704,GO:0006068,1,0.62476455588724,0,7,ethanol catabolic process,BP,
2705,GO:0006069,1,0.640369167249883,0,6,ethanol oxidation,BP,
2706,GO:0006071,1,0.442297652668039,0,11,glycerol metabolic process,BP,
2707,GO:0006072,1,0.546809241103926,0,7,glycerol-3-phosphate metabolic process,BP,
2713,GO:0006085,1,0.244523692174781,0,18,acetyl-CoA biosynthetic process,BP,
2714,GO:0006086,1,0.356652629481446,0,13,acetyl-CoA biosynthetic process from pyruvate,BP,
2715,GO:0006089,1,0.454448218187971,0,11,lactate metabolic process,BP,
2726,GO:0006104,1,0.659943244224657,0,6,succinyl-CoA metabolic process,BP,
2730,GO:0006108,1,0.669147516372361,0,6,malate metabolic process,BP,
2743,GO:0006123,1,0.525286601244661,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2751,GO:0006152,1,0.676272428238968,0,6,purine nucleoside catabolic process,BP,
2766,GO:0006182,1,0.313078390500355,0,14,cGMP biosynthetic process,BP,
2767,GO:0006183,1,0.608095540941337,0,9,GTP biosynthetic process,BP,
2769,GO:0006188,1,0.482005594685162,0,10,IMP biosynthetic process,BP,
2770,GO:0006189,1,0.639890000743556,0,6,'de novo' IMP biosynthetic process,BP,
2772,GO:0006195,1,0.0937251772772593,0,33,purine nucleotide catabolic process,BP,
2774,GO:0006198,1,0.503959566397975,0,8,cAMP catabolic process,BP,
2784,GO:0006216,1,0.686022856931042,0,6,cytidine catabolic process,BP,
2791,GO:0006228,1,0.631649905912317,0,8,UTP biosynthetic process,BP,
2796,GO:0006241,1,0.494879424249346,0,12,CTP biosynthetic process,BP,
2804,GO:0006264,1,0.468114914508387,0,10,mitochondrial DNA replication,BP,
2805,GO:0006265,1,0.504273951500431,0,9,DNA topological change,BP,
2825,GO:0006290,1,0.588816705348019,0,7,pyrimidine dimer repair,BP,
2840,GO:0006309,1,0.304375399129568,0,16,apoptotic DNA fragmentation,BP,
2866,GO:0006359,1,0.151821355139282,0,24,regulation of transcription by RNA polymerase III,BP,
2878,GO:0006378,1,0.0512393333834464,0,39,mRNA polyadenylation,BP,
2884,GO:0006388,1,0.414008690220108,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2931,GO:0006449,1,0.590820351066245,0,7,regulation of translational termination,BP,
2933,GO:0006451,1,0.592072546929939,0,7,translational readthrough,BP,
2956,GO:0006488,1,0.23174497797103,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
2957,GO:0006489,1,0.603013544903227,0,7,dolichyl diphosphate biosynthetic process,BP,
2958,GO:0006490,1,0.21551079104809,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
2966,GO:0006505,1,0.105304966679575,0,33,GPI anchor metabolic process,BP,
2967,GO:0006506,1,0.113027614087847,0,32,GPI anchor biosynthetic process,BP,
2973,GO:0006515,1,0.158652550738089,0,24,protein quality control for misfolded or incompletely synthesized proteins,BP,
2975,GO:0006517,1,0.0844440837161595,0,32,protein deglycosylation,BP,
2981,GO:0006525,1,0.326841941723366,0,15,arginine metabolic process,BP,
2983,GO:0006527,1,0.51625558480294,0,9,arginine catabolic process,BP,
2986,GO:0006531,1,0.639970594087519,0,6,aspartate metabolic process,BP,
2993,GO:0006538,1,0.633562322936468,0,6,glutamate catabolic process,BP,
2995,GO:0006541,1,0.254180443856064,0,17,glutamine metabolic process,BP,
2998,GO:0006544,1,0.570387774342096,0,8,glycine metabolic process,BP,
3005,GO:0006551,1,0.595527429453616,0,7,leucine metabolic process,BP,
3007,GO:0006553,1,0.505187644175023,0,9,lysine metabolic process,BP,
3008,GO:0006554,1,0.54424502105494,0,8,lysine catabolic process,BP,
3009,GO:0006555,1,0.280623348998306,0,17,methionine metabolic process,BP,
3014,GO:0006560,1,0.6573563740179,0,6,proline metabolic process,BP,
3017,GO:0006563,1,0.503726739104302,0,10,L-serine metabolic process,BP,
3018,GO:0006564,1,0.662422834008833,0,6,L-serine biosynthetic process,BP,
3031,GO:0006578,1,0.647018737020892,0,6,amino-acid betaine biosynthetic process,BP,
3033,GO:0006582,1,0.476357236222536,0,9,melanin metabolic process,BP,
3038,GO:0006590,1,0.480070895438643,0,9,thyroid hormone generation,BP,
3050,GO:0006610,1,0.53161366267508,0,8,ribosomal protein import into nucleus,BP,
3055,GO:0006616,1,0.712330461774003,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3057,GO:0006620,1,0.605765904126691,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3058,GO:0006621,1,0.565273643690861,0,8,protein retention in ER lumen,BP,
3062,GO:0006625,1,0.283368688192111,0,17,protein targeting to peroxisome,BP,
3077,GO:0006646,1,0.434017914425716,0,11,phosphatidylethanolamine biosynthetic process,BP,
3080,GO:0006654,1,0.097121988518983,0,29,phosphatidic acid biosynthetic process,BP,
3081,GO:0006655,1,0.477916922017368,0,10,phosphatidylglycerol biosynthetic process,BP,
3083,GO:0006657,1,0.608905562115036,0,7,CDP-choline pathway,BP,
3088,GO:0006662,1,0.547344429753786,0,9,glycerol ether metabolic process,BP,
3096,GO:0006670,1,0.499055005638617,0,10,sphingosine metabolic process,BP,
3100,GO:0006678,1,0.593192425024188,0,7,glucosylceramide metabolic process,BP,
3106,GO:0006684,1,0.38846617816948,0,13,sphingomyelin metabolic process,BP,
3108,GO:0006686,1,0.645019407924603,0,6,sphingomyelin biosynthetic process,BP,
3119,GO:0006699,1,0.246298763250998,0,19,bile acid biosynthetic process,BP,
3123,GO:0006703,1,0.605917499913059,0,8,estrogen biosynthetic process,BP,
3169,GO:0006782,1,0.634627877677628,0,7,protoporphyrinogen IX biosynthetic process,BP,
3191,GO:0006817,1,0.376894501743294,0,12,phosphate ion transport,BP,
3199,GO:0006833,1,0.646718229235635,0,6,water transport,BP,
3209,GO:0006851,1,0.234040926849376,0,20,mitochondrial calcium ion transmembrane transport,BP,
3210,GO:0006853,1,0.42457713729398,0,10,carnitine shuttle,BP,
3214,GO:0006862,1,0.321282138036144,0,16,nucleotide transport,BP,
3215,GO:0006863,1,0.671491687374535,0,6,purine nucleobase transport,BP,
3224,GO:0006878,1,0.410499115033995,0,13,cellular copper ion homeostasis,BP,
3229,GO:0006884,1,0.258607566704171,0,17,cell volume homeostasis,BP,
3238,GO:0006895,1,0.185628596323248,0,19,Golgi to endosome transport,BP,
3239,GO:0006896,1,0.342948201133295,0,14,Golgi to vacuole transport,BP,
3249,GO:0006910,1,0.627753214719579,0,6,phagocytosis, recognition,BP,
3280,GO:0006968,1,0.235500570670901,0,19,cellular defense response,BP,
3282,GO:0006971,1,0.520531119290197,0,8,hypotonic response,BP,
3293,GO:0006987,1,0.560687275242581,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3295,GO:0006991,1,0.505552103309866,0,9,response to sterol depletion,BP,
3296,GO:0006995,1,0.534377213772578,0,10,cellular response to nitrogen starvation,BP,
3305,GO:0007007,1,0.246135982072878,0,22,inner mitochondrial membrane organization,BP,
3311,GO:0007016,1,0.460530737210101,0,8,cytoskeletal anchoring at plasma membrane,BP,
3315,GO:0007020,1,0.121380411369081,0,26,microtubule nucleation,BP,
3322,GO:0007031,1,0.128622703676653,0,28,peroxisome organization,BP,
3351,GO:0007084,1,0.509175225038844,0,10,mitotic nuclear envelope reassembly,BP,
3366,GO:0007130,1,0.584407314881361,0,7,synaptonemal complex assembly,BP,
3368,GO:0007135,1,0.65708220026532,0,6,meiosis II,BP,
3371,GO:0007143,1,0.257819938854989,0,18,female meiotic nuclear division,BP,
3372,GO:0007144,1,0.649857298715457,0,6,female meiosis I,BP,
3379,GO:0007158,1,0.612068533181215,0,6,neuron cell-cell adhesion,BP,
3392,GO:0007172,1,0.585788599971253,0,7,signal complex assembly,BP,
3401,GO:0007183,1,0.4005347387755,0,11,SMAD protein complex assembly,BP,
3407,GO:0007190,1,0.318032292593813,0,14,activation of adenylate cyclase activity,BP,
3410,GO:0007194,1,0.579527129992608,0,7,negative regulation of adenylate cyclase activity,BP,
3416,GO:0007202,1,0.501229145863554,0,10,activation of phospholipase C activity,BP,
3423,GO:0007213,1,0.486821539820479,0,10,G-protein coupled acetylcholine receptor signaling pathway,BP,
3424,GO:0007214,1,0.627960820245483,0,6,gamma-aminobutyric acid signaling pathway,BP,
3426,GO:0007216,1,0.630503945363327,0,6,G-protein coupled glutamate receptor signaling pathway,BP,
3428,GO:0007218,1,0.330515534089663,0,17,neuropeptide signaling pathway,BP,
3432,GO:0007223,1,0.0693504482807835,0,32,Wnt signaling pathway, calcium modulating pathway,BP,
3444,GO:0007256,1,0.588247204641278,0,6,activation of JNKK activity,BP,
3449,GO:0007263,1,0.535753825893961,0,8,nitric oxide mediated signal transduction,BP,
3456,GO:0007270,1,0.588419102470624,0,6,neuron-neuron synaptic transmission,BP,
3459,GO:0007274,1,0.473328406872479,0,9,neuromuscular synaptic transmission,BP,
3466,GO:0007288,1,0.4576237609291,0,10,sperm axoneme assembly,BP,
3483,GO:0007350,1,0.384736697077035,0,12,blastoderm segmentation,BP,
3484,GO:0007351,1,0.488295421051468,0,9,tripartite regional subdivision,BP,
3496,GO:0007398,1,0.301515960708029,0,15,ectoderm development,BP,
3505,GO:0007413,1,0.28779366040995,0,14,axonal fasciculation,BP,
3515,GO:0007440,1,0.544390696006431,0,6,foregut morphogenesis,BP,
3519,GO:0007494,1,0.567655756830464,0,7,midgut development,BP,
3571,GO:0007617,1,0.433114790292861,0,11,mating behavior,BP,
3572,GO:0007618,1,0.262122275768035,0,18,mating,BP,
3574,GO:0007620,1,0.564348519188838,0,8,copulation,BP,
3579,GO:0007625,1,0.685333176603202,0,6,grooming behavior,BP,
3581,GO:0007628,1,0.359293858129832,0,12,adult walking behavior,BP,
3585,GO:0007635,1,0.587253092418984,0,6,chemosensory behavior,BP,
3596,GO:0008024,1,0.522156345542591,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3604,GO:0008045,1,0.308482044514106,0,14,motor neuron axon guidance,BP,
3619,GO:0008074,1,0.565358023636141,0,6,guanylate cyclase complex, soluble,CC,
3622,GO:0008079,1,0.631678190346942,0,6,translation termination factor activity,MF,
3629,GO:0008091,1,0.537683900082682,0,6,spectrin,CC,
3672,GO:0008171,1,0.224582325492378,0,21,O-methyltransferase activity,MF,
3679,GO:0008179,1,0.443801485228235,0,10,adenylate cyclase binding,MF,
3686,GO:0008191,1,0.625764774526523,0,7,metalloendopeptidase inhibitor activity,MF,
3690,GO:0008195,1,0.492757230364203,0,9,phosphatidate phosphatase activity,MF,
3706,GO:0008215,1,0.694040248646377,0,6,spermine metabolic process,BP,
3707,GO:0008216,1,0.664348940025874,0,7,spermidine metabolic process,BP,
3711,GO:0008227,1,0.568483811356424,0,8,G-protein coupled amine receptor activity,MF,
3719,GO:0008239,1,0.64849564290876,0,6,dipeptidyl-peptidase activity,MF,
3721,GO:0008242,1,0.556745312444701,0,8,omega peptidase activity,MF,
3722,GO:0008250,1,0.485882034917909,0,12,oligosaccharyltransferase complex,CC,
3724,GO:0008252,1,0.46288495260263,0,10,nucleotidase activity,MF,
3725,GO:0008253,1,0.54851609977574,0,8,5'-nucleotidase activity,MF,
3735,GO:0008272,1,0.574423454901441,0,7,sulfate transport,BP,
3737,GO:0008274,1,0.518622442468047,0,8,gamma-tubulin ring complex,CC,
3750,GO:0008290,1,0.654091981347821,0,6,F-actin capping protein complex,CC,
3760,GO:0008301,1,0.364268673569512,0,13,DNA binding, bending,MF,
3764,GO:0008308,1,0.41453027129903,0,12,voltage-gated anion channel activity,MF,
3768,GO:0008312,1,0.641300573799411,0,7,7S RNA binding,MF,
3769,GO:0008318,1,0.588275230973327,0,7,protein prenyltransferase activity,MF,
3773,GO:0008327,1,0.297294488552752,0,16,methyl-CpG binding,MF,
3775,GO:0008329,1,0.609230731620151,0,7,signaling pattern recognition receptor activity,MF,
3784,GO:0008344,1,0.0498777602152881,0,38,adult locomotory behavior,BP,
3787,GO:0008349,1,0.433442628260361,0,10,MAP kinase kinase kinase kinase activity,MF,
3790,GO:0008354,1,0.58315321370007,0,7,germ cell migration,BP,
3806,GO:0008385,1,0.511486921018021,0,9,IkappaB kinase complex,CC,
3821,GO:0008417,1,0.464440988681871,0,10,fucosyltransferase activity,MF,
3824,GO:0008420,1,0.560553210204382,0,8,CTD phosphatase activity,MF,
3831,GO:0008429,1,0.566346399987476,0,8,phosphatidylethanolamine binding,MF,
3834,GO:0008432,1,0.546193217811433,0,8,JUN kinase binding,MF,
3839,GO:0008443,1,0.624733249519535,0,6,phosphofructokinase activity,MF,
3856,GO:0008469,1,0.567702245162932,0,8,histone-arginine N-methyltransferase activity,MF,
3858,GO:0008474,1,0.491655278513117,0,10,palmitoyl-(protein) hydrolase activity,MF,
3865,GO:0008483,1,0.396626028859548,0,12,transaminase activity,MF,
3866,GO:0008484,1,0.385290265848789,0,12,sulfuric ester hydrolase activity,MF,
3871,GO:0008494,1,0.623618333241709,0,7,translation activator activity,MF,
3874,GO:0008499,1,0.48906410863832,0,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3892,GO:0008525,1,0.608788850338245,0,6,phosphatidylcholine transporter activity,MF,
3893,GO:0008526,1,0.527002162175361,0,8,phosphatidylinositol transporter activity,MF,
3897,GO:0008532,1,0.529831109005601,0,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
3902,GO:0008540,1,0.464384799051593,0,12,proteasome regulatory particle, base subcomplex,CC,
3903,GO:0008541,1,0.645230992152513,0,7,proteasome regulatory particle, lid subcomplex,CC,
3913,GO:0008568,1,0.461360095337256,0,10,microtubule-severing ATPase activity,MF,
3925,GO:0008595,1,0.488295421051468,0,9,anterior/posterior axis specification, embryo,BP,
3942,GO:0008627,1,0.579198128021924,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
3945,GO:0008635,1,0.523522695964388,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3947,GO:0008641,1,0.468414466982815,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3955,GO:0008656,1,0.368923086898375,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3984,GO:0008821,1,0.531824179827716,0,9,crossover junction endodeoxyribonuclease activity,MF,
4009,GO:0008970,1,0.591722270351142,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4034,GO:0009065,1,0.223707400990651,0,20,glutamine family amino acid catabolic process,BP,
4035,GO:0009066,1,0.0489663257380631,0,41,aspartate family amino acid metabolic process,BP,
4036,GO:0009067,1,0.209222478882282,0,21,aspartate family amino acid biosynthetic process,BP,
4037,GO:0009068,1,0.42027925019741,0,12,aspartate family amino acid catabolic process,BP,
4040,GO:0009071,1,0.620840309808995,0,7,serine family amino acid catabolic process,BP,
4050,GO:0009086,1,0.442018519562228,0,11,methionine biosynthetic process,BP,
4061,GO:0009109,1,0.472372309086155,0,11,coenzyme catabolic process,BP,
4065,GO:0009113,1,0.40834919459581,0,13,purine nucleobase biosynthetic process,BP,
4073,GO:0009125,1,0.532451566667542,0,9,nucleoside monophosphate catabolic process,BP,
4076,GO:0009128,1,0.573709324900774,0,8,purine nucleoside monophosphate catabolic process,BP,
4081,GO:0009134,1,0.619494178721231,0,7,nucleoside diphosphate catabolic process,BP,
4093,GO:0009146,1,0.683147216435682,0,6,purine nucleoside triphosphate catabolic process,BP,
4098,GO:0009151,1,0.575716100724267,0,9,purine deoxyribonucleotide metabolic process,BP,
4101,GO:0009154,1,0.197187607493051,0,22,purine ribonucleotide catabolic process,BP,
4102,GO:0009155,1,0.676201998226779,0,6,purine deoxyribonucleotide catabolic process,BP,
4105,GO:0009158,1,0.573709324900774,0,8,ribonucleoside monophosphate catabolic process,BP,
4115,GO:0009169,1,0.573709324900774,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4133,GO:0009191,1,0.667150686250497,0,6,ribonucleoside diphosphate catabolic process,BP,
4144,GO:0009204,1,0.639404892991597,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4148,GO:0009208,1,0.417304861303282,0,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4149,GO:0009209,1,0.449022734513587,0,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4153,GO:0009214,1,0.420347634277682,0,10,cyclic nucleotide catabolic process,BP,
4154,GO:0009215,1,0.610920953790625,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
4176,GO:0009249,1,0.699858455035058,0,7,protein lipoylation,BP,
4185,GO:0009261,1,0.182954762048407,0,23,ribonucleotide catabolic process,BP,
4203,GO:0009310,1,0.457809275290197,0,12,amine catabolic process,BP,
4206,GO:0009313,1,0.510778112586852,0,9,oligosaccharide catabolic process,BP,
4260,GO:0009593,1,0.194611556799777,0,24,detection of chemical stimulus,BP,
4261,GO:0009595,1,0.507925810677094,0,9,detection of biotic stimulus,BP,
4274,GO:0009629,1,0.649920077977336,0,6,response to gravity,BP,
4307,GO:0009756,1,0.66642911820914,0,6,carbohydrate mediated signaling,BP,
4355,GO:0009931,1,0.582772515195733,0,7,calcium-dependent protein serine/threonine kinase activity,MF,
4367,GO:0009972,1,0.686022856931042,0,6,cytidine deamination,BP,
4368,GO:0009975,1,0.454256951969033,0,9,cyclase activity,MF,
4391,GO:0010042,1,0.411471698838615,0,12,response to manganese ion,BP,
4415,GO:0010172,1,0.422332189740776,0,10,embryonic body morphogenesis,BP,
4427,GO:0010248,1,0.671730857042948,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
4433,GO:0010265,1,0.648692452907878,0,6,SCF complex assembly,BP,
4440,GO:0010310,1,0.515622821661735,0,9,regulation of hydrogen peroxide metabolic process,BP,
4445,GO:0010340,1,0.600527555032737,0,7,carboxyl-O-methyltransferase activity,MF,
4447,GO:0010359,1,0.631187669367924,0,6,regulation of anion channel activity,BP,
4457,GO:0010421,1,0.458506606598671,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4465,GO:0010457,1,0.385998891836449,0,11,centriole-centriole cohesion,BP,
4490,GO:0010510,1,0.414091192238938,0,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4496,GO:0010519,1,0.649997599617893,0,6,negative regulation of phospholipase activity,BP,
4500,GO:0010523,1,0.406444606881059,0,13,negative regulation of calcium ion transport into cytosol,BP,
4520,GO:0010571,1,0.587904519094958,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4528,GO:0010591,1,0.137435361580517,0,25,regulation of lamellipodium assembly,BP,
4529,GO:0010592,1,0.32686760393288,0,14,positive regulation of lamellipodium assembly,BP,
4534,GO:0010603,1,0.537996902952147,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4541,GO:0010612,1,0.594442689401211,0,6,regulation of cardiac muscle adaptation,BP,
4547,GO:0010623,1,0.575010328788688,0,7,programmed cell death involved in cell development,BP,
4556,GO:0010635,1,0.552567440755297,0,8,regulation of mitochondrial fusion,BP,
4570,GO:0010649,1,0.480234005717217,0,9,regulation of cell communication by electrical coupling,BP,
4580,GO:0010663,1,0.624835277648263,0,6,positive regulation of striated muscle cell apoptotic process,BP,
4583,GO:0010666,1,0.624835277648263,0,6,positive regulation of cardiac muscle cell apoptotic process,BP,
4600,GO:0010713,1,0.642765325903472,0,7,negative regulation of collagen metabolic process,BP,
4622,GO:0010738,1,0.384009329927005,0,12,regulation of protein kinase A signaling,BP,
4635,GO:0010755,1,0.605153360964849,0,7,regulation of plasminogen activation,BP,
4643,GO:0010763,1,0.486550716163138,0,9,positive regulation of fibroblast migration,BP,
4652,GO:0010792,1,0.637780286959376,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4658,GO:0010800,1,0.194217919369802,0,21,positive regulation of peptidyl-threonine phosphorylation,BP,
4661,GO:0010804,1,0.408772384992891,0,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4662,GO:0010807,1,0.626659247094338,0,6,regulation of synaptic vesicle priming,BP,
4679,GO:0010825,1,0.620062765354985,0,6,positive regulation of centrosome duplication,BP,
4701,GO:0010857,1,0.541553943552199,0,8,calcium-dependent protein kinase activity,MF,
4707,GO:0010867,1,0.514483382121538,0,9,positive regulation of triglyceride biosynthetic process,BP,
4714,GO:0010874,1,0.309567971236081,0,14,regulation of cholesterol efflux,BP,
4715,GO:0010875,1,0.361756955942012,0,12,positive regulation of cholesterol efflux,BP,
4720,GO:0010880,1,0.302942273172342,0,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4721,GO:0010881,1,0.45325202806939,0,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4722,GO:0010882,1,0.316247245946079,0,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,
4727,GO:0010887,1,0.607162754585783,0,6,negative regulation of cholesterol storage,BP,
4729,GO:0010889,1,0.571352003999393,0,7,regulation of sequestering of triglyceride,BP,
4750,GO:0010918,1,0.610932605271834,0,7,positive regulation of mitochondrial membrane potential,BP,
4766,GO:0010944,1,0.604079816129027,0,7,negative regulation of transcription by competitive promoter binding,BP,
4784,GO:0010968,1,0.652452434981299,0,6,regulation of microtubule nucleation,BP,
4795,GO:0010984,1,0.476351378967793,0,11,regulation of lipoprotein particle clearance,BP,
4798,GO:0010988,1,0.660800321644479,0,6,regulation of low-density lipoprotein particle clearance,BP,
4802,GO:0010992,1,0.608405822564811,0,7,ubiquitin recycling,BP,
4806,GO:0010998,1,0.462156942710881,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
4812,GO:0012510,1,0.379467248846376,0,13,trans-Golgi network transport vesicle membrane,CC,
4822,GO:0014014,1,0.192069488726211,0,21,negative regulation of gliogenesis,BP,
4837,GO:0014041,1,0.57445565971449,0,7,regulation of neuron maturation,BP,
4842,GO:0014046,1,0.530781911700833,0,9,dopamine secretion,BP,
4850,GO:0014059,1,0.530781911700833,0,9,regulation of dopamine secretion,BP,
4861,GO:0014072,1,0.27800657161448,0,17,response to isoquinoline alkaloid,BP,
4872,GO:0014731,1,0.571730202383343,0,6,spectrin-associated cytoskeleton,CC,
4874,GO:0014733,1,0.513011798781788,0,8,regulation of skeletal muscle adaptation,BP,
4885,GO:0014745,1,0.473724779533199,0,9,negative regulation of muscle adaptation,BP,
4890,GO:0014808,1,0.247865845956271,0,17,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4918,GO:0014854,1,0.53750038465471,0,7,response to inactivity,BP,
4926,GO:0014874,1,0.573121092094209,0,6,response to stimulus involved in regulation of muscle adaptation,BP,
4932,GO:0014887,1,0.351420990026626,0,12,cardiac muscle adaptation,BP,
4940,GO:0014898,1,0.351420990026626,0,12,cardiac muscle hypertrophy in response to stress,BP,
4951,GO:0015002,1,0.456667051090664,0,18,heme-copper terminal oxidase activity,MF,
4952,GO:0015012,1,0.198879224370513,0,20,heparan sulfate proteoglycan biosynthetic process,BP,
4964,GO:0015037,1,0.486946590971492,0,12,peptide disulfide oxidoreductase activity,MF,
4968,GO:0015074,1,0.455952114951731,0,10,DNA integration,BP,
4989,GO:0015114,1,0.555892380825907,0,7,phosphate ion transmembrane transporter activity,MF,
4990,GO:0015116,1,0.620194519428719,0,6,sulfate transmembrane transporter activity,MF,
5031,GO:0015194,1,0.605997248258166,0,7,L-serine transmembrane transporter activity,MF,
5036,GO:0015205,1,0.646028436823155,0,6,nucleobase transmembrane transporter activity,MF,
5039,GO:0015215,1,0.346584033348324,0,15,nucleotide transmembrane transporter activity,MF,
5040,GO:0015216,1,0.45776914980018,0,11,purine nucleotide transmembrane transporter activity,MF,
5041,GO:0015217,1,0.524655784546809,0,9,ADP transmembrane transporter activity,MF,
5061,GO:0015269,1,0.60413133183506,0,7,calcium-activated potassium channel activity,MF,
5069,GO:0015288,1,0.675079261030519,0,6,porin activity,MF,
5075,GO:0015296,1,0.550961899534446,0,7,anion:cation symporter activity,MF,
5096,GO:0015368,1,0.610294001428893,0,6,calcium:cation antiporter activity,MF,
5101,GO:0015377,1,0.595517945483287,0,6,cation:chloride symporter activity,MF,
5103,GO:0015379,1,0.595517945483287,0,6,potassium:chloride symporter activity,MF,
5121,GO:0015464,1,0.635958293288725,0,6,acetylcholine receptor activity,MF,
5123,GO:0015485,1,0.102807432853826,0,30,cholesterol binding,MF,
5130,GO:0015556,1,0.596966967534904,0,7,C4-dicarboxylate transmembrane transporter activity,MF,
5133,GO:0015605,1,0.199597981886941,0,22,organophosphate ester transmembrane transporter activity,MF,
5171,GO:0015721,1,0.372651102323776,0,13,bile acid and bile salt transport,BP,
5200,GO:0015791,1,0.575586467072688,0,6,polyol transport,BP,
5215,GO:0015812,1,0.585942656019293,0,6,gamma-aminobutyric acid transport,BP,
5217,GO:0015816,1,0.627672014131125,0,6,glycine transport,BP,
5223,GO:0015824,1,0.614234409773571,0,6,proline transport,BP,
5224,GO:0015825,1,0.605997248258166,0,7,L-serine transport,BP,
5237,GO:0015851,1,0.609932897549115,0,7,nucleobase transport,BP,
5244,GO:0015865,1,0.424360707156185,0,12,purine nucleotide transport,BP,
5245,GO:0015866,1,0.524655784546809,0,9,ADP transport,BP,
5246,GO:0015867,1,0.523012414148303,0,9,ATP transport,BP,
5247,GO:0015868,1,0.424360707156185,0,12,purine ribonucleotide transport,BP,
5249,GO:0015871,1,0.57201602798503,0,7,choline transport,BP,
5250,GO:0015872,1,0.352238208739158,0,15,dopamine transport,BP,
5274,GO:0015919,1,0.302618388947669,0,16,peroxisomal membrane transport,BP,
5276,GO:0015923,1,0.320465643696215,0,14,mannosidase activity,MF,
5277,GO:0015924,1,0.474586159112101,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5278,GO:0015925,1,0.650259453170932,0,6,galactosidase activity,MF,
5281,GO:0015929,1,0.418045700191434,0,12,hexosaminidase activity,MF,
5294,GO:0015959,1,0.607226535699924,0,7,diadenosine polyphosphate metabolic process,BP,
5300,GO:0015985,1,0.597589936689557,0,8,energy coupled proton transport, down electrochemical gradient,BP,
5301,GO:0015986,1,0.597589936689557,0,8,ATP synthesis coupled proton transport,BP,
5302,GO:0015988,1,0.252637214154896,0,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5304,GO:0015991,1,0.262978209833327,0,20,ATP hydrolysis coupled proton transport,BP,
5307,GO:0016010,1,0.365879399752372,0,12,dystrophin-associated glycoprotein complex,CC,
5312,GO:0016018,1,0.505291748393665,0,10,cyclosporin A binding,MF,
5316,GO:0016024,1,0.380178271039359,0,12,CDP-diacylglycerol biosynthetic process,BP,
5324,GO:0016045,1,0.591261427956893,0,7,detection of bacterium,BP,
5325,GO:0016048,1,0.605089930384145,0,7,detection of temperature stimulus,BP,
5341,GO:0016075,1,0.359509814404696,0,15,rRNA catabolic process,BP,
5346,GO:0016081,1,0.620057873689668,0,6,synaptic vesicle docking,BP,
5348,GO:0016093,1,0.663499663986745,0,6,polyprenol metabolic process,BP,
5365,GO:0016139,1,0.609134120739487,0,7,glycoside catabolic process,BP,
5387,GO:0016208,1,0.55088622189844,0,9,AMP binding,MF,
5407,GO:0016242,1,0.106560180660694,0,29,negative regulation of macroautophagy,BP,
5413,GO:0016254,1,0.323914010637926,0,17,preassembly of GPI anchor in ER membrane,BP,
5414,GO:0016255,1,0.583631139798671,0,7,attachment of GPI anchor to protein,BP,
5424,GO:0016272,1,0.717509491576877,0,7,prefoldin complex,CC,
5425,GO:0016273,1,0.455980513694861,0,11,arginine N-methyltransferase activity,MF,
5426,GO:0016274,1,0.455980513694861,0,11,protein-arginine N-methyltransferase activity,MF,
5430,GO:0016281,1,0.535907849316375,0,8,eukaryotic translation initiation factor 4F complex,CC,
5435,GO:0016290,1,0.599726851960381,0,8,palmitoyl-CoA hydrolase activity,MF,
5443,GO:0016307,1,0.320275660486463,0,14,phosphatidylinositol phosphate kinase activity,MF,
5444,GO:0016308,1,0.620927058780138,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5453,GO:0016322,1,0.621183465481516,0,6,neuron remodeling,BP,
5462,GO:0016338,1,0.552940922983704,0,9,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5482,GO:0016413,1,0.631669667041011,0,6,O-acetyltransferase activity,MF,
5490,GO:0016421,1,0.600634952695456,0,6,CoA carboxylase activity,MF,
5494,GO:0016427,1,0.541022393179821,0,8,tRNA (cytosine) methyltransferase activity,MF,
5503,GO:0016442,1,0.396922843551989,0,11,RISC complex,CC,
5528,GO:0016500,1,0.59825023910749,0,6,protein-hormone receptor activity,MF,
5529,GO:0016502,1,0.655108212171377,0,6,nucleotide receptor activity,MF,
5532,GO:0016505,1,0.317103825270702,0,16,peptidase activator activity involved in apoptotic process,MF,
5544,GO:0016530,1,0.702641511299693,0,6,metallochaperone activity,MF,
5550,GO:0016540,1,0.482514096055953,0,10,protein autoprocessing,BP,
5551,GO:0016553,1,0.407219542358132,0,12,base conversion or substitution editing,BP,
5552,GO:0016554,1,0.624660432694164,0,7,cytidine to uridine editing,BP,
5555,GO:0016558,1,0.414342479999825,0,12,protein import into peroxisome matrix,BP,
5556,GO:0016559,1,0.651354049969454,0,7,peroxisome fission,BP,
5571,GO:0016580,1,0.407538591020338,0,11,Sin3 complex,CC,
5572,GO:0016581,1,0.285189832776471,0,15,NuRD complex,CC,
5575,GO:0016589,1,0.567168299342359,0,7,NURF complex,CC,
5579,GO:0016593,1,0.536398512072372,0,8,Cdc73/Paf1 complex,CC,
5593,GO:0016615,1,0.666956077401131,0,6,malate dehydrogenase activity,MF,
5596,GO:0016620,1,0.14049834322882,0,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5598,GO:0016624,1,0.563552438736219,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5601,GO:0016634,1,0.638687439883762,0,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5603,GO:0016638,1,0.40000042656016,0,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5605,GO:0016641,1,0.467617736696713,0,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5620,GO:0016670,1,0.581331093505732,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5621,GO:0016671,1,0.458931961181355,0,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5623,GO:0016675,1,0.424775824974169,0,19,oxidoreductase activity, acting on a heme group of donors,MF,
5624,GO:0016676,1,0.456667051090664,0,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5651,GO:0016742,1,0.630522173577787,0,6,hydroxymethyl-, formyl- and related transferase activity,MF,
5665,GO:0016769,1,0.37551749738786,0,13,transferase activity, transferring nitrogenous groups,MF,
5669,GO:0016775,1,0.65429321585374,0,6,phosphotransferase activity, nitrogenous group as acceptor,MF,
5691,GO:0016805,1,0.588881846489645,0,7,dipeptidase activity,MF,
5696,GO:0016813,1,0.666659851495346,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
5697,GO:0016814,1,0.176732504383358,0,24,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
5707,GO:0016832,1,0.611973899285869,0,7,aldehyde-lyase activity,MF,
5714,GO:0016842,1,0.642772110635239,0,7,amidine-lyase activity,MF,
5717,GO:0016846,1,0.669247999391174,0,7,carbon-sulfur lyase activity,MF,
5718,GO:0016849,1,0.456533612150146,0,9,phosphorus-oxygen lyase activity,MF,
5720,GO:0016854,1,0.395998037671113,0,13,racemase and epimerase activity,MF,
5722,GO:0016857,1,0.474996706619537,0,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
5725,GO:0016861,1,0.595686664259018,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
5728,GO:0016864,1,0.283595411647367,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
5730,GO:0016868,1,0.528226054067452,0,9,intramolecular transferase activity, phosphotransferases,MF,
5741,GO:0016885,1,0.517586008282234,0,8,ligase activity, forming carbon-carbon bonds,MF,
5742,GO:0016886,1,0.47875606653234,0,10,ligase activity, forming phosphoric ester bonds,MF,
5748,GO:0016892,1,0.679451551486388,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5763,GO:0016922,1,0.217173993726657,0,18,ligand-dependent nuclear receptor binding,MF,
5775,GO:0016973,1,0.486011288074976,0,10,poly(A)+ mRNA export from nucleus,BP,
5782,GO:0017001,1,0.157558738165179,0,28,antibiotic catabolic process,BP,
5788,GO:0017014,1,0.480830320597475,0,10,protein nitrosylation,BP,
5808,GO:0017059,1,0.557362733315861,0,8,serine C-palmitoyltransferase complex,CC,
5833,GO:0017110,1,0.379050357776051,0,13,nucleoside-diphosphatase activity,MF,
5838,GO:0017119,1,0.399740497041694,0,12,Golgi transport complex,CC,
5839,GO:0017121,1,0.59830599638854,0,7,phospholipid scrambling,BP,
5844,GO:0017128,1,0.641256159018027,0,6,phospholipid scramblase activity,MF,
5859,GO:0017154,1,0.386984664377959,0,10,semaphorin receptor activity,MF,
5863,GO:0017160,1,0.323811868292242,0,14,Ral GTPase binding,MF,
5866,GO:0017166,1,0.407060410743384,0,10,vinculin binding,MF,
5868,GO:0017169,1,0.625835965060412,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5870,GO:0017176,1,0.65866114150765,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
5875,GO:0017185,1,0.546043086587854,0,8,peptidyl-lysine hydroxylation,BP,
5896,GO:0018065,1,0.547661500846377,0,11,protein-cofactor linkage,BP,
5899,GO:0018095,1,0.544252040377993,0,8,protein polyglutamylation,BP,
5908,GO:0018119,1,0.480830320597475,0,10,peptidyl-cysteine S-nitrosylation,BP,
5915,GO:0018158,1,0.549694516414081,0,9,protein oxidation,BP,
5923,GO:0018195,1,0.310937120036113,0,17,peptidyl-arginine modification,BP,
5939,GO:0018216,1,0.390452666108314,0,13,peptidyl-arginine methylation,BP,
5961,GO:0018342,1,0.495906092569274,0,9,protein prenylation,BP,
5963,GO:0018344,1,0.64462977018082,0,6,protein geranylgeranylation,BP,
5989,GO:0018904,1,0.418043004015998,0,13,ether metabolic process,BP,
6006,GO:0019043,1,0.538142733384935,0,9,establishment of viral latency,BP,
6012,GO:0019054,1,0.218607350749601,0,20,modulation by virus of host process,BP,
6019,GO:0019068,1,0.083447171167469,0,36,virion assembly,BP,
6026,GO:0019081,1,0.351460193942493,0,14,viral translation,BP,
6034,GO:0019098,1,0.275611521057674,0,17,reproductive behavior,BP,
6056,GO:0019200,1,0.255476662004284,0,18,carbohydrate kinase activity,MF,
6069,GO:0019215,1,0.41615953954923,0,11,intermediate filament binding,MF,
6084,GO:0019237,1,0.621688149089757,0,6,centromeric DNA binding,MF,
6085,GO:0019238,1,0.649195173028378,0,6,cyclohydrolase activity,MF,
6086,GO:0019239,1,0.172741887125844,0,25,deaminase activity,MF,
6100,GO:0019317,1,0.620965194785914,0,6,fucose catabolic process,BP,
6132,GO:0019377,1,0.454362988828831,0,11,glycolipid catabolic process,BP,
6133,GO:0019388,1,0.565345496951638,0,8,galactose catabolic process,BP,
6140,GO:0019405,1,0.613221050122446,0,6,alditol catabolic process,BP,
6150,GO:0019433,1,0.45269328307084,0,11,triglyceride catabolic process,BP,
6157,GO:0019471,1,0.417725281561829,0,12,4-hydroxyproline metabolic process,BP,
6191,GO:0019627,1,0.486510953179218,0,10,urea metabolic process,BP,
6194,GO:0019646,1,0.525286601244661,0,14,aerobic electron transport chain,BP,
6199,GO:0019673,1,0.660676794851978,0,7,GDP-mannose metabolic process,BP,
6215,GO:0019731,1,0.460525321816282,0,17,antibacterial humoral response,BP,
6226,GO:0019773,1,0.70897384100005,0,7,proteasome core complex, alpha-subunit complex,CC,
6236,GO:0019784,1,0.638998692845976,0,7,NEDD8-specific protease activity,MF,
6239,GO:0019788,1,0.687521351070929,0,6,NEDD8 transferase activity,MF,
6257,GO:0019835,1,0.353021446880213,0,17,cytolysis,BP,
6259,GO:0019840,1,0.389497123103638,0,13,isoprenoid binding,MF,
6265,GO:0019855,1,0.577544564997171,0,8,calcium channel inhibitor activity,MF,
6277,GO:0019869,1,0.603857178491299,0,7,chloride channel inhibitor activity,MF,
6299,GO:0019907,1,0.602415811292231,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6300,GO:0019908,1,0.296775860451964,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6301,GO:0019911,1,0.574042831446778,0,8,structural constituent of myelin sheath,MF,
6305,GO:0019919,1,0.610002014284832,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6327,GO:0019992,1,0.533171672341235,0,8,diacylglycerol binding,MF,
6340,GO:0021511,1,0.511662833973075,0,8,spinal cord patterning,BP,
6342,GO:0021513,1,0.554708712072452,0,7,spinal cord dorsal/ventral patterning,BP,
6344,GO:0021515,1,0.24473968873293,0,17,cell differentiation in spinal cord,BP,
6346,GO:0021517,1,0.252683658938118,0,17,ventral spinal cord development,BP,
6347,GO:0021520,1,0.614047352754471,0,6,spinal cord motor neuron cell fate specification,BP,
6349,GO:0021522,1,0.273163212348366,0,16,spinal cord motor neuron differentiation,BP,
6354,GO:0021532,1,0.116192290230051,0,27,neural tube patterning,BP,
6357,GO:0021535,1,0.418051387100186,0,10,cell migration in hindbrain,BP,
6364,GO:0021542,1,0.531365083238024,0,8,dentate gyrus development,BP,
6377,GO:0021559,1,0.61671583905298,0,6,trigeminal nerve development,BP,
6379,GO:0021561,1,0.619701900002686,0,6,facial nerve development,BP,
6402,GO:0021610,1,0.619701900002686,0,6,facial nerve morphogenesis,BP,
6416,GO:0021670,1,0.531207529216812,0,8,lateral ventricle development,BP,
6467,GO:0021785,1,0.569184162679556,0,6,branchiomotor neuron axon guidance,BP,
6469,GO:0021795,1,0.0863695723078919,0,30,cerebral cortex cell migration,BP,
6473,GO:0021799,1,0.182100853439142,0,21,cerebral cortex radially oriented cell migration,BP,
6475,GO:0021801,1,0.252527941260757,0,17,cerebral cortex radial glia guided migration,BP,
6477,GO:0021814,1,0.548697363987867,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6481,GO:0021819,1,0.465384300712776,0,10,layer formation in cerebral cortex,BP,
6502,GO:0021861,1,0.609423216682306,0,7,forebrain radial glial cell differentiation,BP,
6505,GO:0021871,1,0.404985024394368,0,11,forebrain regionalization,BP,
6516,GO:0021889,1,0.61239437874167,0,6,olfactory bulb interneuron differentiation,BP,
6527,GO:0021904,1,0.237317045174391,0,18,dorsal/ventral neural tube patterning,BP,
6528,GO:0021910,1,0.598699360560744,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6533,GO:0021932,1,0.557605314654099,0,7,hindbrain radial glia guided cell migration,BP,
6543,GO:0021952,1,0.29324912147279,0,15,central nervous system projection neuron axonogenesis,BP,
6546,GO:0021955,1,0.199801498176706,0,20,central nervous system neuron axonogenesis,BP,
6574,GO:0022030,1,0.252527941260757,0,17,telencephalon glial cell migration,BP,
6576,GO:0022038,1,0.382103645272058,0,13,corpus callosum development,BP,
6590,GO:0022417,1,0.57789666368234,0,9,protein maturation by protein folding,BP,
6613,GO:0022824,1,0.576317591461778,0,7,transmitter-gated ion channel activity,MF,
6617,GO:0022835,1,0.576317591461778,0,7,transmitter-gated channel activity,MF,
6632,GO:0022889,1,0.605997248258166,0,7,serine transmembrane transporter activity,MF,
6639,GO:0023019,1,0.492102627078703,0,9,signal transduction involved in regulation of gene expression,BP,
6659,GO:0030007,1,0.580472117604824,0,7,cellular potassium ion homeostasis,BP,
6660,GO:0030008,1,0.444232945758422,0,13,TRAPP complex,CC,
6663,GO:0030014,1,0.301454647593605,0,15,CCR4-NOT complex,CC,
6682,GO:0030042,1,0.0563226493515779,0,35,actin filament depolymerization,BP,
6688,GO:0030050,1,0.591377833313142,0,6,vesicle transport along actin filament,BP,
6695,GO:0030062,1,0.637128340661297,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6700,GO:0030091,1,0.658412604630296,0,7,protein repair,BP,
6705,GO:0030101,1,0.0636774269123967,0,39,natural killer cell activation,BP,
6713,GO:0030120,1,0.0202410190293901,0,52,vesicle coat,CC,
6714,GO:0030121,1,0.618444863658392,0,6,AP-1 adaptor complex,CC,
6715,GO:0030122,1,0.390169986147472,0,12,AP-2 adaptor complex,CC,
6718,GO:0030125,1,0.154834398840221,0,24,clathrin vesicle coat,CC,
6719,GO:0030126,1,0.349538066835218,0,15,COPI vesicle coat,CC,
6720,GO:0030127,1,0.34721754764424,0,14,COPII vesicle coat,CC,
6721,GO:0030128,1,0.359121286099869,0,13,clathrin coat of endocytic vesicle,CC,
6722,GO:0030130,1,0.426460776447731,0,11,clathrin coat of trans-Golgi network vesicle,CC,
6724,GO:0030132,1,0.267290648980594,0,17,clathrin coat of coated pit,CC,
6736,GO:0030149,1,0.25971217031013,0,19,sphingolipid catabolic process,BP,
6742,GO:0030157,1,0.600854877526104,0,6,pancreatic juice secretion,BP,
6744,GO:0030159,1,0.208766946940513,0,19,receptor signaling complex scaffold activity,MF,
6749,GO:0030166,1,0.0255364985721394,0,44,proteoglycan biosynthetic process,BP,
6753,GO:0030170,1,0.0859007285243491,0,33,pyridoxal phosphate binding,MF,
6771,GO:0030201,1,0.147725202542129,0,24,heparan sulfate proteoglycan metabolic process,BP,
6774,GO:0030204,1,0.10947891897346,0,27,chondroitin sulfate metabolic process,BP,
6775,GO:0030205,1,0.474796745659356,0,9,dermatan sulfate metabolic process,BP,
6776,GO:0030206,1,0.222833244296635,0,18,chondroitin sulfate biosynthetic process,BP,
6777,GO:0030207,1,0.491004304454693,0,9,chondroitin sulfate catabolic process,BP,
6778,GO:0030208,1,0.509089841462808,0,8,dermatan sulfate biosynthetic process,BP,
6784,GO:0030215,1,0.237060931980893,0,17,semaphorin receptor binding,MF,
6791,GO:0030223,1,0.664749383841856,0,6,neutrophil differentiation,BP,
6801,GO:0030238,1,0.57828607311734,0,7,male sex determination,BP,
6810,GO:0030252,1,0.546201320199342,0,7,growth hormone secretion,BP,
6830,GO:0030285,1,0.57534829728387,0,7,integral component of synaptic vesicle membrane,CC,
6845,GO:0030306,1,0.577768797785496,0,6,ADP-ribosylation factor binding,MF,
6848,GO:0030309,1,0.570886051580681,0,8,poly-N-acetyllactosamine metabolic process,BP,
6849,GO:0030311,1,0.570886051580681,0,8,poly-N-acetyllactosamine biosynthetic process,BP,
6852,GO:0030315,1,0.0635382873003186,0,31,T-tubule,CC,
6854,GO:0030317,1,0.109212771588542,0,29,flagellated sperm motility,BP,
6876,GO:0030346,1,0.635918481400989,0,6,protein phosphatase 2B binding,MF,
6917,GO:0030502,1,0.619122362186018,0,6,negative regulation of bone mineralization,BP,
6920,GO:0030506,1,0.283100564988125,0,13,ankyrin binding,MF,
6945,GO:0030548,1,0.681974245928843,0,6,acetylcholine receptor regulator activity,MF,
6948,GO:0030551,1,0.2777908564076,0,16,cyclic nucleotide binding,MF,
6949,GO:0030552,1,0.401603767130774,0,11,cAMP binding,MF,
6962,GO:0030594,1,0.226800705254902,0,21,neurotransmitter receptor activity,MF,
6971,GO:0030620,1,0.692439305744309,0,6,U2 snRNA binding,MF,
6978,GO:0030628,1,0.689826610836445,0,6,pre-mRNA 3'-splice site binding,MF,
7000,GO:0030676,1,0.368544084846125,0,12,Rac guanyl-nucleotide exchange factor activity,MF,
7032,GO:0030800,1,0.453230950966073,0,10,negative regulation of cyclic nucleotide metabolic process,BP,
7035,GO:0030803,1,0.538077163123596,0,8,negative regulation of cyclic nucleotide biosynthetic process,BP,
7041,GO:0030809,1,0.258376451565097,0,17,negative regulation of nucleotide biosynthetic process,BP,
7044,GO:0030812,1,0.507774765526048,0,8,negative regulation of nucleotide catabolic process,BP,
7045,GO:0030813,1,0.351703563233354,0,12,positive regulation of nucleotide catabolic process,BP,
7047,GO:0030815,1,0.453230950966073,0,10,negative regulation of cAMP metabolic process,BP,
7050,GO:0030818,1,0.538077163123596,0,8,negative regulation of cAMP biosynthetic process,BP,
7055,GO:0030823,1,0.362824918399148,0,13,regulation of cGMP metabolic process,BP,
7056,GO:0030825,1,0.550941266978145,0,8,positive regulation of cGMP metabolic process,BP,
7057,GO:0030826,1,0.594195100313183,0,7,regulation of cGMP biosynthetic process,BP,
7058,GO:0030828,1,0.644472070847151,0,6,positive regulation of cGMP biosynthetic process,BP,
7061,GO:0030834,1,0.0730553003453725,0,32,regulation of actin filament depolymerization,BP,
7062,GO:0030835,1,0.133980327808262,0,24,negative regulation of actin filament depolymerization,BP,
7063,GO:0030836,1,0.587324681291507,0,7,positive regulation of actin filament depolymerization,BP,
7075,GO:0030857,1,0.139208820945875,0,25,negative regulation of epithelial cell differentiation,BP,
7088,GO:0030877,1,0.427850493474206,0,10,beta-catenin destruction complex,CC,
7092,GO:0030881,1,0.672470016622201,0,6,beta-2-microglobulin binding,MF,
7120,GO:0030915,1,0.627866507781505,0,7,Smc5-Smc6 complex,CC,
7129,GO:0030947,1,0.230768495631435,0,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7130,GO:0030948,1,0.53883895714876,0,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7131,GO:0030949,1,0.58273743148494,0,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7132,GO:0030950,1,0.407477859308345,0,12,establishment or maintenance of actin cytoskeleton polarity,BP,
7134,GO:0030952,1,0.296015498519029,0,16,establishment or maintenance of cytoskeleton polarity,BP,
7135,GO:0030953,1,0.551594679682111,0,7,astral microtubule organization,BP,
7136,GO:0030955,1,0.472920070403164,0,9,potassium ion binding,MF,
7138,GO:0030957,1,0.489169558012254,0,10,Tat protein binding,MF,
7143,GO:0030970,1,0.162095850893162,0,25,retrograde protein transport, ER to cytosol,BP,
7150,GO:0030990,1,0.106615098587674,0,30,intraciliary transport particle,CC,
7151,GO:0030991,1,0.518925148957134,0,8,intraciliary transport particle A,CC,
7152,GO:0030992,1,0.257165285365485,0,19,intraciliary transport particle B,CC,
7156,GO:0031010,1,0.442689727992778,0,10,ISWI-type complex,CC,
7157,GO:0031011,1,0.370431849291071,0,15,Ino80 complex,CC,
7171,GO:0031045,1,0.613329200568295,0,6,dense core granule,CC,
7178,GO:0031054,1,0.364521694066625,0,13,pre-miRNA processing,BP,
7184,GO:0031061,1,0.276627047965767,0,16,negative regulation of histone methylation,BP,
7194,GO:0031077,1,0.599806980095037,0,7,post-embryonic camera-type eye development,BP,
7202,GO:0031086,1,0.548289702933038,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7203,GO:0031087,1,0.591141414935751,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7218,GO:0031105,1,0.494269089339065,0,9,septin complex,CC,
7223,GO:0031112,1,0.143822459690987,0,24,positive regulation of microtubule polymerization or depolymerization,BP,
7226,GO:0031115,1,0.509750850429264,0,9,negative regulation of microtubule polymerization,BP,
7227,GO:0031116,1,0.167010156762946,0,22,positive regulation of microtubule polymerization,BP,
7235,GO:0031125,1,0.510165337327303,0,12,rRNA 3'-end processing,BP,
7241,GO:0031143,1,0.412137177425947,0,12,pseudopodium,CC,
7256,GO:0031209,1,0.517767206815736,0,8,SCAR complex,CC,
7257,GO:0031210,1,0.416428009681737,0,12,phosphatidylcholine binding,MF,
7258,GO:0031211,1,0.557362733315861,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7267,GO:0031229,1,0.540038080804295,0,8,intrinsic component of nuclear inner membrane,CC,
7270,GO:0031233,1,0.427417127358772,0,12,intrinsic component of external side of plasma membrane,CC,
7272,GO:0031235,1,0.371377644647763,0,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7279,GO:0031254,1,0.527615414834426,0,8,cell trailing edge,CC,
7292,GO:0031279,1,0.244073848880432,0,18,regulation of cyclase activity,BP,
7293,GO:0031280,1,0.579527129992608,0,7,negative regulation of cyclase activity,BP,
7294,GO:0031281,1,0.489266664581152,0,9,positive regulation of cyclase activity,BP,
7328,GO:0031332,1,0.396922843551989,0,11,RNAi effector complex,CC,
7335,GO:0031340,1,0.635717904420275,0,6,positive regulation of vesicle fusion,BP,
7338,GO:0031343,1,0.223021743772888,0,22,positive regulation of cell killing,BP,
7345,GO:0031362,1,0.521089898752265,0,9,anchored component of external side of plasma membrane,CC,
7349,GO:0031371,1,0.570292051147013,0,8,ubiquitin conjugating enzyme complex,CC,
7353,GO:0031386,1,0.506600039174352,0,12,protein tag,MF,
7365,GO:0031402,1,0.507339523847799,0,8,sodium ion binding,MF,
7377,GO:0031419,1,0.625815420445304,0,6,cobalamin binding,MF,
7378,GO:0031420,1,0.335908478799268,0,13,alkali metal ion binding,MF,
7385,GO:0031432,1,0.540494291268631,0,7,titin binding,MF,
7394,GO:0031441,1,0.500927575660718,0,9,negative regulation of mRNA 3'-end processing,BP,
7404,GO:0031462,1,0.420102215165003,0,12,Cul2-RING ubiquitin ligase complex,CC,
7406,GO:0031464,1,0.425124886559095,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7410,GO:0031468,1,0.288848315486178,0,18,nuclear envelope reassembly,BP,
7412,GO:0031489,1,0.399946926792546,0,13,myosin V binding,MF,
7448,GO:0031573,1,0.371742792412771,0,14,intra-S DNA damage checkpoint,BP,
7451,GO:0031580,1,0.664138007326491,0,6,membrane raft distribution,BP,
7452,GO:0031581,1,0.379916220566425,0,11,hemidesmosome assembly,BP,
7457,GO:0031588,1,0.486805178304104,0,9,nucleotide-activated protein kinase complex,CC,
7464,GO:0031595,1,0.609444548068212,0,8,nuclear proteasome complex,CC,
7465,GO:0031597,1,0.451818522631019,0,12,cytosolic proteasome complex,CC,
7466,GO:0031616,1,0.540351588477896,0,9,spindle pole centrosome,CC,
7476,GO:0031629,1,0.492699768347865,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7489,GO:0031648,1,0.0493084154756129,0,38,protein destabilization,BP,
7498,GO:0031664,1,0.329558210992601,0,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7499,GO:0031665,1,0.569840649412525,0,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7510,GO:0031683,1,0.415076017706272,0,12,G-protein beta/gamma-subunit complex binding,MF,
7521,GO:0031701,1,0.529250691654192,0,8,angiotensin receptor binding,MF,
7522,GO:0031702,1,0.567520334619565,0,7,type 1 angiotensin receptor binding,MF,
7548,GO:0031821,1,0.644176428951359,0,6,G-protein coupled serotonin receptor binding,MF,
7552,GO:0031848,1,0.465260376366547,0,10,protection from non-homologous end joining at telomere,BP,
7567,GO:0031904,1,0.307288422067096,0,17,endosome lumen,CC,
7579,GO:0031936,1,0.499978018171719,0,8,negative regulation of chromatin silencing,BP,
7594,GO:0031957,1,0.591206002583206,0,7,very long-chain fatty acid-CoA ligase activity,MF,
7626,GO:0032011,1,0.0324272737383902,0,41,ARF protein signal transduction,BP,
7627,GO:0032012,1,0.0324272737383902,0,41,regulation of ARF protein signal transduction,BP,
7628,GO:0032020,1,0.694180476915276,0,6,ISG15-protein conjugation,BP,
7631,GO:0032025,1,0.481514717315594,0,10,response to cobalt ion,BP,
7632,GO:0032026,1,0.467272244162861,0,8,response to magnesium ion,BP,
7637,GO:0032039,1,0.332630785329488,0,13,integrator complex,CC,
7640,GO:0032042,1,0.348975281698702,0,14,mitochondrial DNA metabolic process,BP,
7642,GO:0032045,1,0.535288516497496,0,8,guanyl-nucleotide exchange factor complex,CC,
7644,GO:0032049,1,0.558536019452384,0,8,cardiolipin biosynthetic process,BP,
7645,GO:0032050,1,0.560701690895626,0,7,clathrin heavy chain binding,MF,
7650,GO:0032056,1,0.629536986006672,0,6,positive regulation of translation in response to stress,BP,
7655,GO:0032069,1,0.12736855203216,0,29,regulation of nuclease activity,BP,
7656,GO:0032070,1,0.543296861084847,0,9,regulation of deoxyribonuclease activity,BP,
7657,GO:0032071,1,0.618034662839379,0,7,regulation of endodeoxyribonuclease activity,BP,
7659,GO:0032074,1,0.64076900094773,0,6,negative regulation of nuclease activity,BP,
7660,GO:0032075,1,0.330433966505763,0,16,positive regulation of nuclease activity,BP,
7671,GO:0032095,1,0.549455171304047,0,8,regulation of response to food,BP,
7672,GO:0032096,1,0.652757829114785,0,6,negative regulation of response to food,BP,
7674,GO:0032098,1,0.559603413140329,0,8,regulation of appetite,BP,
7675,GO:0032099,1,0.652757829114785,0,6,negative regulation of appetite,BP,
7680,GO:0032104,1,0.340735171041263,0,14,regulation of response to extracellular stimulus,BP,
7681,GO:0032105,1,0.559672277003713,0,8,negative regulation of response to extracellular stimulus,BP,
7683,GO:0032107,1,0.340735171041263,0,14,regulation of response to nutrient levels,BP,
7684,GO:0032108,1,0.559672277003713,0,8,negative regulation of response to nutrient levels,BP,
7702,GO:0032154,1,0.0209388629746677,0,49,cleavage furrow,CC,
7704,GO:0032156,1,0.455979453022403,0,10,septin cytoskeleton,CC,
7705,GO:0032160,1,0.494269089339065,0,9,septin filament array,CC,
7735,GO:0032225,1,0.461102004980575,0,11,regulation of synaptic transmission, dopaminergic,BP,
7738,GO:0032228,1,0.285622090307939,0,15,regulation of synaptic transmission, GABAergic,BP,
7740,GO:0032230,1,0.57546049730635,0,7,positive regulation of synaptic transmission, GABAergic,BP,
7742,GO:0032232,1,0.319213839307233,0,14,negative regulation of actin filament bundle assembly,BP,
7747,GO:0032241,1,0.567741426752377,0,7,positive regulation of nucleobase-containing compound transport,BP,
7752,GO:0032261,1,0.637850823873225,0,7,purine nucleotide salvage,BP,
7793,GO:0032328,1,0.620419040795817,0,6,alanine transport,BP,
7796,GO:0032331,1,0.40707026057926,0,12,negative regulation of chondrocyte differentiation,BP,
7797,GO:0032332,1,0.425342114094954,0,10,positive regulation of chondrocyte differentiation,BP,
7825,GO:0032373,1,0.274997861204578,0,16,positive regulation of sterol transport,BP,
7828,GO:0032376,1,0.274997861204578,0,16,positive regulation of cholesterol transport,BP,
7841,GO:0032389,1,0.584866091594472,0,7,MutLalpha complex,CC,
7842,GO:0032391,1,0.170687028788154,0,23,photoreceptor connecting cilium,CC,
7873,GO:0032429,1,0.574629167375374,0,7,regulation of phospholipase A2 activity,BP,
7891,GO:0032453,1,0.578565746096264,0,6,histone demethylase activity (H3-K4 specific),MF,
7892,GO:0032454,1,0.358574468847331,0,12,histone demethylase activity (H3-K9 specific),MF,
7926,GO:0032495,1,0.377043731983102,0,12,response to muramyl dipeptide,BP,
7939,GO:0032510,1,0.60494266370109,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7945,GO:0032527,1,0.076378695249785,0,34,protein exit from endoplasmic reticulum,BP,
7947,GO:0032530,1,0.454706139708537,0,10,regulation of microvillus organization,BP,
7949,GO:0032534,1,0.6095838045001,0,6,regulation of microvillus assembly,BP,
7978,GO:0032585,1,0.502686894767676,0,10,multivesicular body membrane,CC,
7985,GO:0032593,1,0.626571942947498,0,6,insulin-responsive compartment,CC,
7986,GO:0032594,1,0.211848895883453,0,21,protein transport within lipid bilayer,BP,
8003,GO:0032616,1,0.490537633627908,0,10,interleukin-13 production,BP,
8005,GO:0032620,1,0.419197881113553,0,13,interleukin-17 production,BP,
8011,GO:0032633,1,0.284277456254275,0,17,interleukin-4 production,BP,
8012,GO:0032634,1,0.529938274512476,0,8,interleukin-5 production,BP,
8028,GO:0032656,1,0.515879099592255,0,9,regulation of interleukin-13 production,BP,
8030,GO:0032660,1,0.476749952493377,0,11,regulation of interleukin-17 production,BP,
8035,GO:0032673,1,0.368650098826617,0,14,regulation of interleukin-4 production,BP,
8036,GO:0032674,1,0.529938274512476,0,8,regulation of interleukin-5 production,BP,
8042,GO:0032682,1,0.477358827625364,0,11,negative regulation of chemokine production,BP,
8061,GO:0032717,1,0.423373614741199,0,12,negative regulation of interleukin-8 production,BP,
8073,GO:0032736,1,0.644537129158029,0,6,positive regulation of interleukin-13 production,BP,
8075,GO:0032740,1,0.629679485832075,0,7,positive regulation of interleukin-17 production,BP,
8080,GO:0032753,1,0.499499494445356,0,10,positive regulation of interleukin-4 production,BP,
8081,GO:0032754,1,0.619029084178208,0,6,positive regulation of interleukin-5 production,BP,
8093,GO:0032769,1,0.597657245846056,0,7,negative regulation of monooxygenase activity,BP,
8111,GO:0032790,1,0.5496338171827,0,8,ribosome disassembly,BP,
8113,GO:0032793,1,0.433529520334792,0,11,positive regulation of CREB transcription factor activity,BP,
8114,GO:0032794,1,0.311689109260228,0,14,GTPase activating protein binding,MF,
8122,GO:0032802,1,0.391290346286041,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8132,GO:0032814,1,0.284548186423215,0,18,regulation of natural killer cell activation,BP,
8134,GO:0032816,1,0.42531305396687,0,12,positive regulation of natural killer cell activation,BP,
8137,GO:0032823,1,0.521674845442379,0,9,regulation of natural killer cell differentiation,BP,
8139,GO:0032825,1,0.597307977545544,0,7,positive regulation of natural killer cell differentiation,BP,
8143,GO:0032836,1,0.51391864387283,0,8,glomerular basement membrane development,BP,
8175,GO:0032905,1,0.628931063218584,0,6,transforming growth factor beta1 production,BP,
8178,GO:0032908,1,0.628931063218584,0,6,regulation of transforming growth factor beta1 production,BP,
8195,GO:0032927,1,0.597882909271503,0,6,positive regulation of activin receptor signaling pathway,BP,
8198,GO:0032930,1,0.601964792527664,0,8,positive regulation of superoxide anion generation,BP,
8199,GO:0032933,1,0.545186519094081,0,8,SREBP signaling pathway,BP,
8200,GO:0032934,1,0.078568161753156,0,33,sterol binding,MF,
8203,GO:0032941,1,0.281381988639986,0,17,secretion by tissue,BP,
8219,GO:0032966,1,0.66873836844347,0,6,negative regulation of collagen biosynthetic process,BP,
8234,GO:0032988,1,0.383907623335421,0,13,ribonucleoprotein complex disassembly,BP,
8305,GO:0033129,1,0.538988396468205,0,8,positive regulation of histone phosphorylation,BP,
8311,GO:0033137,1,0.194016359010831,0,22,negative regulation of peptidyl-serine phosphorylation,BP,
8313,GO:0033139,1,0.662882589500774,0,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8321,GO:0033147,1,0.416641516136107,0,11,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8322,GO:0033148,1,0.537077107654555,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8324,GO:0033151,1,0.357910906745155,0,12,V(D)J recombination,BP,
8334,GO:0033169,1,0.333392754617991,0,13,histone H3-K9 demethylation,BP,
8338,GO:0033177,1,0.56157872210683,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8339,GO:0033178,1,0.517640586952611,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8340,GO:0033179,1,0.594263762654555,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8341,GO:0033180,1,0.585114250422498,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8343,GO:0033182,1,0.446746356431952,0,10,regulation of histone ubiquitination,BP,
8351,GO:0033194,1,0.400483543852605,0,13,response to hydroperoxide,BP,
8354,GO:0033202,1,0.370431849291071,0,15,DNA helicase complex,CC,
8366,GO:0033235,1,0.486158762477425,0,10,positive regulation of protein sumoylation,BP,
8369,GO:0033240,1,0.624785330575983,0,7,positive regulation of cellular amine metabolic process,BP,
8375,GO:0033262,1,0.386216957352613,0,12,regulation of nuclear cell cycle DNA replication,BP,
8379,GO:0033268,1,0.43360063096807,0,9,node of Ranvier,CC,
8406,GO:0033327,1,0.629383447501303,0,6,Leydig cell differentiation,BP,
8436,GO:0033523,1,0.397526960932769,0,12,histone H2B ubiquitination,BP,
8438,GO:0033539,1,0.422496768209281,0,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8444,GO:0033555,1,0.0859329628345366,0,32,multicellular organismal response to stress,BP,
8470,GO:0033601,1,0.50378829806732,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8495,GO:0033643,1,0.496965582083453,0,9,host cell part,CC,
8497,GO:0033646,1,0.58536019104587,0,7,host intracellular part,CC,
8524,GO:0033700,1,0.622888882241488,0,6,phospholipid efflux,BP,
8577,GO:0034036,1,0.62670405850227,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8582,GO:0034045,1,0.274468627128356,0,16,phagophore assembly site membrane,CC,
8595,GO:0034086,1,0.376785478489037,0,12,maintenance of sister chromatid cohesion,BP,
8597,GO:0034088,1,0.376785478489037,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8598,GO:0034091,1,0.531101363473242,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8613,GO:0034115,1,0.611064248472102,0,7,negative regulation of heterotypic cell-cell adhesion,BP,
8624,GO:0034134,1,0.489177898502065,0,10,toll-like receptor 2 signaling pathway,BP,
8625,GO:0034135,1,0.655310499606573,0,6,regulation of toll-like receptor 2 signaling pathway,BP,
8629,GO:0034139,1,0.548654350076028,0,8,regulation of toll-like receptor 3 signaling pathway,BP,
8631,GO:0034141,1,0.645013143419138,0,6,positive regulation of toll-like receptor 3 signaling pathway,BP,
8632,GO:0034142,1,0.36094695953982,0,14,toll-like receptor 4 signaling pathway,BP,
8633,GO:0034143,1,0.51013106048202,0,9,regulation of toll-like receptor 4 signaling pathway,BP,
8643,GO:0034162,1,0.338789886510453,0,14,toll-like receptor 9 signaling pathway,BP,
8648,GO:0034182,1,0.531101363473242,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8651,GO:0034185,1,0.338230716261568,0,12,apolipoprotein binding,MF,
8660,GO:0034199,1,0.41903870877728,0,10,activation of protein kinase A activity,BP,
8663,GO:0034204,1,0.247589923343821,0,15,lipid translocation,BP,
8673,GO:0034236,1,0.440808902899684,0,11,protein kinase A catalytic subunit binding,MF,
8696,GO:0034310,1,0.62476455588724,0,7,primary alcohol catabolic process,BP,
8699,GO:0034314,1,0.121995740335578,0,29,Arp2/3 complex-mediated actin nucleation,BP,
8700,GO:0034315,1,0.341583138253023,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8720,GO:0034356,1,0.403929808716923,0,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
8722,GO:0034361,1,0.64542495284744,0,7,very-low-density lipoprotein particle,CC,
8723,GO:0034362,1,0.644744696133294,0,6,low-density lipoprotein particle,CC,
8739,GO:0034380,1,0.499391193767709,0,9,high-density lipoprotein particle assembly,BP,
8743,GO:0034384,1,0.651213040900422,0,6,high-density lipoprotein particle clearance,BP,
8744,GO:0034385,1,0.64542495284744,0,7,triglyceride-rich plasma lipoprotein particle,CC,
8754,GO:0034397,1,0.478361907761256,0,9,telomere localization,BP,
8766,GO:0034427,1,0.549447482724791,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8769,GO:0034433,1,0.648250195096418,0,7,steroid esterification,BP,
8770,GO:0034434,1,0.648250195096418,0,7,sterol esterification,BP,
8771,GO:0034435,1,0.648250195096418,0,7,cholesterol esterification,BP,
8779,GO:0034450,1,0.409048754109059,0,12,ubiquitin-ubiquitin ligase activity,MF,
8780,GO:0034451,1,0.15622248883649,0,22,centriolar satellite,CC,
8783,GO:0034454,1,0.441126735017622,0,9,microtubule anchoring at centrosome,BP,
8798,GO:0034475,1,0.643451013804519,0,8,U4 snRNA 3'-end processing,BP,
8804,GO:0034497,1,0.391354131100658,0,12,protein localization to phagophore assembly site,BP,
8805,GO:0034498,1,0.537157548566513,0,8,early endosome to Golgi transport,BP,
8807,GO:0034501,1,0.319517589761341,0,16,protein localization to kinetochore,BP,
8810,GO:0034505,1,0.395646607239304,0,11,tooth mineralization,BP,
8828,GO:0034595,1,0.344849750812435,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
8829,GO:0034596,1,0.505652751596526,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8839,GO:0034616,1,0.365987172035806,0,13,response to laminar fluid shear stress,BP,
8852,GO:0034638,1,0.677255998021743,0,6,phosphatidylcholine catabolic process,BP,
8871,GO:0034663,1,0.537411751288034,0,9,endoplasmic reticulum chaperone complex,CC,
8895,GO:0034704,1,0.129491745515942,0,25,calcium channel complex,CC,
8897,GO:0034706,1,0.480543076576597,0,8,sodium channel complex,CC,
8900,GO:0034709,1,0.528740948486915,0,12,methylosome,CC,
8902,GO:0034713,1,0.534912128627561,0,8,type I transforming growth factor beta receptor binding,MF,
8904,GO:0034715,1,0.730501342631529,0,6,pICln-Sm protein complex,CC,
8907,GO:0034720,1,0.578565746096264,0,6,histone H3-K4 demethylation,BP,
8933,GO:0034770,1,0.454852612202532,0,9,histone H4-K20 methylation,BP,
8934,GO:0034773,1,0.614056999005006,0,6,histone H4-K20 trimethylation,BP,
8944,GO:0034969,1,0.486138239985226,0,10,histone arginine methylation,BP,
8947,GO:0034975,1,0.347427354466691,0,14,protein folding in endoplasmic reticulum,BP,
8960,GO:0035005,1,0.588853150077567,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8963,GO:0035020,1,0.29758207796609,0,15,regulation of Rac protein signal transduction,BP,
8967,GO:0035024,1,0.248529897405528,0,17,negative regulation of Rho protein signal transduction,BP,
8968,GO:0035025,1,0.391123023974064,0,12,positive regulation of Rho protein signal transduction,BP,
8970,GO:0035032,1,0.640155714306066,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8983,GO:0035066,1,0.147647486088159,0,26,positive regulation of histone acetylation,BP,
8985,GO:0035068,1,0.474415932459499,0,9,micro-ribonucleoprotein complex,CC,
9002,GO:0035112,1,0.581172873575091,0,6,genitalia morphogenesis,BP,
9004,GO:0035115,1,0.209253114062163,0,21,embryonic forelimb morphogenesis,BP,
9005,GO:0035116,1,0.261565919782143,0,17,embryonic hindlimb morphogenesis,BP,
9009,GO:0035136,1,0.137044898221353,0,25,forelimb morphogenesis,BP,
9010,GO:0035137,1,0.1760797528439,0,21,hindlimb morphogenesis,BP,
9017,GO:0035174,1,0.635652620351085,0,6,histone serine kinase activity,MF,
9026,GO:0035197,1,0.479187886174896,0,9,siRNA binding,MF,
9031,GO:0035234,1,0.622202716174522,0,6,ectopic germ cell programmed cell death,BP,
9032,GO:0035235,1,0.485427289861988,0,9,ionotropic glutamate receptor signaling pathway,BP,
9036,GO:0035242,1,0.610002014284832,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9038,GO:0035246,1,0.455980513694861,0,11,peptidyl-arginine N-methylation,BP,
9039,GO:0035247,1,0.526876019220318,0,9,peptidyl-arginine omega-N-methylation,BP,
9043,GO:0035251,1,0.587302124122955,0,7,UDP-glucosyltransferase activity,MF,
9044,GO:0035252,1,0.609274637032792,0,6,UDP-xylosyltransferase activity,MF,
9045,GO:0035253,1,0.485808025903421,0,9,ciliary rootlet,CC,
9048,GO:0035256,1,0.638030005961386,0,6,G-protein coupled glutamate receptor binding,MF,
9051,GO:0035259,1,0.358625749956126,0,13,glucocorticoid receptor binding,MF,
9056,GO:0035267,1,0.243938036038316,0,19,NuA4 histone acetyltransferase complex,CC,
9058,GO:0035269,1,0.449380937008497,0,12,protein O-linked mannosylation,BP,
9064,GO:0035280,1,0.568332310117091,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9089,GO:0035333,1,0.400581675852277,0,12,Notch receptor processing, ligand-dependent,BP,
9116,GO:0035385,1,0.543714386086104,0,7,Roundabout signaling pathway,BP,
9121,GO:0035404,1,0.508908767123914,0,9,histone-serine phosphorylation,BP,
9131,GO:0035435,1,0.520379194002447,0,8,phosphate ion transmembrane transport,BP,
9132,GO:0035437,1,0.446615037340102,0,11,maintenance of protein localization in endoplasmic reticulum,BP,
9142,GO:0035459,1,0.205066469464011,0,20,cargo loading into vesicle,BP,
9154,GO:0035497,1,0.422410849751725,0,11,cAMP response element binding,MF,
9191,GO:0035561,1,0.198990121215138,0,21,regulation of chromatin binding,BP,
9192,GO:0035562,1,0.522945924359707,0,8,negative regulation of chromatin binding,BP,
9193,GO:0035563,1,0.411322454314725,0,12,positive regulation of chromatin binding,BP,
9210,GO:0035586,1,0.613336024588178,0,7,purinergic receptor activity,MF,
9211,GO:0035587,1,0.495758980519647,0,10,purinergic receptor signaling pathway,BP,
9212,GO:0035588,1,0.576832629683519,0,8,G-protein coupled purinergic receptor signaling pathway,BP,
9214,GO:0035590,1,0.602621010361226,0,7,purinergic nucleotide receptor signaling pathway,BP,
9232,GO:0035612,1,0.475424602529631,0,8,AP-2 adaptor complex binding,MF,
9235,GO:0035615,1,0.430435349504605,0,11,clathrin adaptor activity,MF,
9244,GO:0035627,1,0.624099619289983,0,6,ceramide transport,BP,
9253,GO:0035640,1,0.399870228532931,0,12,exploration behavior,BP,
9254,GO:0035641,1,0.585763345725433,0,7,locomotory exploration behavior,BP,
9270,GO:0035672,1,0.62541980650043,0,6,oligopeptide transmembrane transport,BP,
9306,GO:0035743,1,0.548923215226204,0,9,CD4-positive, alpha-beta T cell cytokine production,BP,
9308,GO:0035745,1,0.621889518853403,0,7,T-helper 2 cell cytokine production,BP,
9310,GO:0035748,1,0.619577039634335,0,6,myelin sheath abaxonal region,CC,
9322,GO:0035773,1,0.0567282542380358,0,40,insulin secretion involved in cellular response to glucose stimulus,BP,
9323,GO:0035774,1,0.264044913543984,0,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9351,GO:0035845,1,0.584495913819447,0,7,photoreceptor cell outer segment organization,BP,
9356,GO:0035859,1,0.386149242901214,0,13,Seh1-associated complex,CC,
9361,GO:0035864,1,0.663553586547013,0,6,response to potassium ion,BP,
9366,GO:0035869,1,0.026298529404112,0,49,ciliary transition zone,CC,
9368,GO:0035871,1,0.455765090626301,0,9,protein K11-linked deubiquitination,BP,
9372,GO:0035878,1,0.581008531468958,0,7,nail development,BP,
9383,GO:0035900,1,0.673075717920462,0,6,response to isolation stress,BP,
9414,GO:0035964,1,0.639930363413551,0,6,COPI-coated vesicle budding,BP,
9418,GO:0035970,1,0.329293259483033,0,15,peptidyl-threonine dephosphorylation,BP,
9420,GO:0035973,1,0.561827790146233,0,7,aggrephagy,BP,
9445,GO:0036010,1,0.227687165339183,0,18,protein localization to endosome,BP,
9459,GO:0036038,1,0.406498669564308,0,13,MKS complex,CC,
9460,GO:0036041,1,0.714511069571045,0,6,long-chain fatty acid binding,MF,
9475,GO:0036075,1,0.290364763564074,0,16,replacement ossification,BP,
9478,GO:0036089,1,0.591456608156434,0,7,cleavage furrow formation,BP,
9485,GO:0036109,1,0.452174804749914,0,11,alpha-linolenic acid metabolic process,BP,
9509,GO:0036148,1,0.420072683629941,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9518,GO:0036158,1,0.616083827617079,0,6,outer dynein arm assembly,BP,
9546,GO:0036289,1,0.6058543706674,0,6,peptidyl-serine autophosphorylation,BP,
9558,GO:0036310,1,0.546244733584134,0,8,annealing helicase activity,MF,
9559,GO:0036312,1,0.453382864547358,0,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
9570,GO:0036342,1,0.393493220295243,0,11,post-anal tail morphogenesis,BP,
9583,GO:0036376,1,0.580421189907139,0,7,sodium ion export across plasma membrane,BP,
9592,GO:0036402,1,0.702148296237408,0,6,proteasome-activating ATPase activity,MF,
9600,GO:0036444,1,0.539019566289265,0,8,calcium import into the mitochondrion,BP,
9603,GO:0036449,1,0.517114702467113,0,7,microtubule minus-end,CC,
9612,GO:0036462,1,0.612082495939564,0,7,TRAIL-activated apoptotic signaling pathway,BP,
9624,GO:0036480,1,0.600683694901231,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9625,GO:0036481,1,0.677165572625264,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9632,GO:0036490,1,0.532225523770341,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
9633,GO:0036491,1,0.57503397230309,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9634,GO:0036492,1,0.617593480205425,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
9640,GO:0036499,1,0.268607761533872,0,18,PERK-mediated unfolded protein response,BP,
9641,GO:0036500,1,0.489204633805613,0,10,ATF6-mediated unfolded protein response,BP,
9647,GO:0036507,1,0.181571844116983,0,22,protein demannosylation,BP,
9648,GO:0036508,1,0.181571844116983,0,22,protein alpha-1,2-demannosylation,BP,
9653,GO:0036513,1,0.466382442262117,0,10,Derlin-1 retrotranslocation complex,CC,
9683,GO:0038036,1,0.640430487798805,0,6,sphingosine-1-phosphate receptor activity,MF,
9729,GO:0038155,1,0.644491886802535,0,6,interleukin-23-mediated signaling pathway,BP,
9739,GO:0038180,1,0.521609863264257,0,8,nerve growth factor signaling pathway,BP,
9743,GO:0038187,1,0.609230731620151,0,7,pattern recognition receptor activity,MF,
9746,GO:0038191,1,0.236741844596122,0,17,neuropilin binding,MF,
9775,GO:0039530,1,0.505074171886264,0,9,MDA-5 signaling pathway,BP,
9777,GO:0039532,1,0.471659845669018,0,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9778,GO:0039533,1,0.620406926508099,0,6,regulation of MDA-5 signaling pathway,BP,
9781,GO:0039536,1,0.589363187442516,0,7,negative regulation of RIG-I signaling pathway,BP,
9790,GO:0039692,1,0.486168258189011,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
9791,GO:0039694,1,0.16194935017352,0,24,viral RNA genome replication,BP,
9793,GO:0039702,1,0.256365484443703,0,20,viral budding via host ESCRT complex,BP,
9794,GO:0039706,1,0.642630478533646,0,6,co-receptor binding,MF,
9797,GO:0040001,1,0.173526551892515,0,22,establishment of mitotic spindle localization,BP,
9805,GO:0040015,1,0.485572595723815,0,9,negative regulation of multicellular organism growth,BP,
9816,GO:0040034,1,0.59688655377393,0,7,regulation of development, heterochronic,BP,
9835,GO:0042043,1,0.482792872530419,0,9,neurexin family protein binding,MF,
9839,GO:0042053,1,0.484342975446399,0,10,regulation of dopamine metabolic process,BP,
9846,GO:0042069,1,0.484342975446399,0,10,regulation of catecholamine metabolic process,BP,
9858,GO:0042094,1,0.459265147986097,0,11,interleukin-2 biosynthetic process,BP,
9865,GO:0042104,1,0.317227934372131,0,17,positive regulation of activated T cell proliferation,BP,
9874,GO:0042118,1,0.524801102620469,0,8,endothelial cell activation,BP,
9883,GO:0042135,1,0.415759688238239,0,12,neurotransmitter catabolic process,BP,
9894,GO:0042159,1,0.405148602610148,0,12,lipoprotein catabolic process,BP,
9896,GO:0042165,1,0.269264270588332,0,18,neurotransmitter binding,MF,
9910,GO:0042219,1,0.296005575736936,0,17,cellular modified amino acid catabolic process,BP,
9915,GO:0042226,1,0.472697461538534,0,10,interleukin-6 biosynthetic process,BP,
9931,GO:0042268,1,0.713575933560853,0,6,regulation of cytolysis,BP,
9945,GO:0042285,1,0.609274637032792,0,6,xylosyltransferase activity,MF,
9952,GO:0042301,1,0.644301182076913,0,6,phosphate ion binding,MF,
9954,GO:0042304,1,0.123917077546051,0,28,regulation of fatty acid biosynthetic process,BP,
9972,GO:0042340,1,0.597765590623963,0,7,keratan sulfate catabolic process,BP,
9976,GO:0042354,1,0.620965194785914,0,6,L-fucose metabolic process,BP,
9977,GO:0042355,1,0.620965194785914,0,6,L-fucose catabolic process,BP,
10002,GO:0042402,1,0.50950417354818,0,11,cellular biogenic amine catabolic process,BP,
10003,GO:0042403,1,0.444434959386107,0,10,thyroid hormone metabolic process,BP,
10006,GO:0042407,1,0.372562111547603,0,15,cristae formation,BP,
10021,GO:0042438,1,0.515461708099498,0,8,melanin biosynthetic process,BP,
10022,GO:0042439,1,0.638581057087096,0,6,ethanolamine-containing compound metabolic process,BP,
10027,GO:0042447,1,0.650023837984636,0,6,hormone catabolic process,BP,
10030,GO:0042451,1,0.295456393004984,0,20,purine nucleoside biosynthetic process,BP,
10031,GO:0042454,1,0.403390582543731,0,14,ribonucleoside catabolic process,BP,
10033,GO:0042461,1,0.248427712540678,0,18,photoreceptor cell development,BP,
10034,GO:0042462,1,0.395079378447173,0,12,eye photoreceptor cell development,BP,
10038,GO:0042473,1,0.651108977680763,0,6,outer ear morphogenesis,BP,
10055,GO:0042500,1,0.638130608862209,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10064,GO:0042537,1,0.426607624997416,0,13,benzene-containing compound metabolic process,BP,
10087,GO:0042577,1,0.595107708010097,0,7,lipid phosphatase activity,MF,
10097,GO:0042588,1,0.519200233228096,0,9,zymogen granule,CC,
10098,GO:0042589,1,0.602668710424662,0,7,zymogen granule membrane,CC,
10104,GO:0042596,1,0.260737419981131,0,18,fear response,BP,
10105,GO:0042599,1,0.433313686058588,0,12,lamellar body,CC,
10134,GO:0042659,1,0.568509786828152,0,7,regulation of cell fate specification,BP,
10144,GO:0042693,1,0.651182019526155,0,6,muscle cell fate commitment,BP,
10152,GO:0042711,1,0.634602221525101,0,6,maternal behavior,BP,
10167,GO:0042738,1,0.512738768223783,0,9,exogenous drug catabolic process,BP,
10170,GO:0042744,1,0.453771811464955,0,12,hydrogen peroxide catabolic process,BP,
10178,GO:0042755,1,0.362816050586112,0,14,eating behavior,BP,
10181,GO:0042759,1,0.48137556459246,0,9,long-chain fatty acid biosynthetic process,BP,
10184,GO:0042762,1,0.300577949094523,0,15,regulation of sulfur metabolic process,BP,
10196,GO:0042780,1,0.62117996656208,0,7,tRNA 3'-end processing,BP,
10198,GO:0042788,1,0.240048552317274,0,29,polysomal ribosome,CC,
10203,GO:0042796,1,0.640064811995236,0,6,snRNA transcription by RNA polymerase III,BP,
10211,GO:0042809,1,0.29935854929777,0,15,vitamin D receptor binding,MF,
10222,GO:0042832,1,0.51826753662479,0,9,defense response to protozoan,BP,
10223,GO:0042834,1,0.609752579878473,0,7,peptidoglycan binding,MF,
10232,GO:0042891,1,0.59607901291648,0,7,antibiotic transport,BP,
10233,GO:0042895,1,0.646541129258428,0,6,antibiotic transmembrane transporter activity,MF,
10249,GO:0042953,1,0.584946842504815,0,6,lipoprotein transport,BP,
10251,GO:0042974,1,0.194908488214849,0,20,retinoic acid receptor binding,MF,
10252,GO:0042975,1,0.478839583443485,0,9,peroxisome proliferator activated receptor binding,MF,
10264,GO:0042989,1,0.731879723972676,0,6,sequestering of actin monomers,BP,
10288,GO:0043023,1,0.465235799246068,0,11,ribosomal large subunit binding,MF,
10296,GO:0043032,1,0.444831565259719,0,11,positive regulation of macrophage activation,BP,
10298,GO:0043034,1,0.197246822096548,0,17,costamere,CC,
10306,GO:0043046,1,0.591957591727037,0,7,DNA methylation involved in gamete generation,BP,
10327,GO:0043101,1,0.421485417550727,0,13,purine-containing compound salvage,BP,
10328,GO:0043102,1,0.663206605888162,0,6,amino acid salvage,BP,
10352,GO:0043139,1,0.604357052609413,0,7,5'-3' DNA helicase activity,MF,
10353,GO:0043140,1,0.561552701746733,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10369,GO:0043173,1,0.399719150445684,0,14,nucleotide salvage,BP,
10380,GO:0043186,1,0.605443293252803,0,7,P granule,CC,
10381,GO:0043189,1,0.243938036038316,0,19,H4/H2A histone acetyltransferase complex,CC,
10383,GO:0043194,1,0.442077609230395,0,9,axon initial segment,CC,
10390,GO:0043201,1,0.426112431625685,0,10,response to leucine,BP,
10392,GO:0043203,1,0.671654292479355,0,6,axon hillock,CC,
10415,GO:0043240,1,0.430793874495542,0,11,Fanconi anaemia nuclear complex,CC,
10420,GO:0043248,1,0.49808287235808,0,12,proteasome assembly,BP,
10427,GO:0043256,1,0.457683337998489,0,8,laminin complex,CC,
10434,GO:0043268,1,0.272200374710972,0,15,positive regulation of potassium ion transport,BP,
10440,GO:0043276,1,0.124663553522713,0,27,anoikis,BP,
10442,GO:0043278,1,0.27800657161448,0,17,response to morphine,BP,
10471,GO:0043320,1,0.632452333167576,0,6,natural killer cell degranulation,BP,
10475,GO:0043325,1,0.265367590452938,0,17,phosphatidylinositol-3,4-bisphosphate binding,MF,
10481,GO:0043353,1,0.599254281566473,0,6,enucleate erythrocyte differentiation,BP,
10489,GO:0043372,1,0.477380344292441,0,11,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10490,GO:0043373,1,0.561158185243724,0,8,CD4-positive, alpha-beta T cell lineage commitment,BP,
10524,GO:0043422,1,0.464915580750172,0,10,protein kinase B binding,MF,
10533,GO:0043455,1,0.531119809427514,0,8,regulation of secondary metabolic process,BP,
10535,GO:0043457,1,0.325061633765173,0,16,regulation of cellular respiration,BP,
10601,GO:0043558,1,0.351596040888182,0,14,regulation of translational initiation in response to stress,BP,
10603,GO:0043560,1,0.418578331600291,0,10,insulin receptor substrate binding,MF,
10604,GO:0043562,1,0.534377213772578,0,10,cellular response to nitrogen levels,BP,
10611,GO:0043574,1,0.262056432010201,0,18,peroxisomal transport,BP,
10615,GO:0043584,1,0.412052769562506,0,10,nose development,BP,
10632,GO:0043619,1,0.48011890710375,0,9,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10643,GO:0043631,1,0.0428213570636526,0,41,RNA polyadenylation,BP,
10645,GO:0043633,1,0.578230258182594,0,8,polyadenylation-dependent RNA catabolic process,BP,
10646,GO:0043634,1,0.627973395272911,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10649,GO:0043649,1,0.396618488436992,0,13,dicarboxylic acid catabolic process,BP,
10651,GO:0043651,1,0.373425260654376,0,14,linoleic acid metabolic process,BP,
10653,GO:0043653,1,0.610856289297608,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
10655,GO:0043656,1,0.58536019104587,0,7,intracellular region of host,CC,
10688,GO:0043928,1,0.111639673920956,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10694,GO:0043949,1,0.278549483316859,0,16,regulation of cAMP-mediated signaling,BP,
10696,GO:0043951,1,0.50330247642472,0,9,negative regulation of cAMP-mediated signaling,BP,
10700,GO:0043968,1,0.301221097662333,0,16,histone H2A acetylation,BP,
10706,GO:0043981,1,0.317491599560983,0,15,histone H4-K5 acetylation,BP,
10707,GO:0043982,1,0.317491599560983,0,15,histone H4-K8 acetylation,BP,
10708,GO:0043983,1,0.605942956362637,0,7,histone H4-K12 acetylation,BP,
10709,GO:0043984,1,0.223647407796881,0,19,histone H4-K16 acetylation,BP,
10710,GO:0043985,1,0.651238728659345,0,6,histone H4-R3 methylation,BP,
10726,GO:0044033,1,0.655070015723884,0,6,multi-organism metabolic process,BP,
10765,GO:0044154,1,0.594843899587051,0,7,histone H3-K14 acetylation,BP,
10808,GO:0044273,1,0.104569465154155,0,31,sulfur compound catabolic process,BP,
10816,GO:0044292,1,0.468124407253113,0,10,dendrite terminus,CC,
10817,GO:0044294,1,0.562910097618193,0,7,dendritic growth cone,CC,
10838,GO:0044322,1,0.135577446775818,0,26,endoplasmic reticulum quality control compartment,CC,
10862,GO:0044351,1,0.651434264348629,0,6,macropinocytosis,BP,
10868,GO:0044362,1,0.670116631724422,0,6,negative regulation of molecular function in other organism,BP,
10917,GO:0044453,1,0.540038080804295,0,8,nuclear membrane part,CC,
10939,GO:0044548,1,0.447296189735367,0,11,S100 protein binding,MF,
10941,GO:0044550,1,0.330057028842172,0,14,secondary metabolite biosynthetic process,BP,
10987,GO:0044769,1,0.307491837895395,0,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11010,GO:0044804,1,0.254705416242134,0,18,autophagy of nucleus,BP,
11012,GO:0044806,1,0.56755104377843,0,7,G-quadruplex DNA unwinding,BP,
11025,GO:0044849,1,0.526031791138168,0,9,estrous cycle,BP,
11041,GO:0044872,1,0.584946842504815,0,6,lipoprotein localization,BP,
11044,GO:0045002,1,0.596831793099887,0,7,double-strand break repair via single-strand annealing,BP,
11048,GO:0045006,1,0.545234007547266,0,10,DNA deamination,BP,
11052,GO:0045010,1,0.0583375905552918,0,38,actin nucleation,BP,
11055,GO:0045019,1,0.480413278499603,0,10,negative regulation of nitric oxide biosynthetic process,BP,
11064,GO:0045039,1,0.725198936202439,0,6,protein import into mitochondrial inner membrane,BP,
11065,GO:0045040,1,0.707555154991342,0,6,protein import into mitochondrial outer membrane,BP,
11067,GO:0045046,1,0.637510817376526,0,6,protein import into peroxisome membrane,BP,
11073,GO:0045056,1,0.324829667461295,0,14,transcytosis,BP,
11080,GO:0045064,1,0.497425686255439,0,10,T-helper 2 cell differentiation,BP,
11090,GO:0045076,1,0.558698871658331,0,8,regulation of interleukin-2 biosynthetic process,BP,
11100,GO:0045086,1,0.595421982237885,0,7,positive regulation of interleukin-2 biosynthetic process,BP,
11104,GO:0045091,1,0.517674599552719,0,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11116,GO:0045116,1,0.409341480811188,0,14,protein neddylation,BP,
11122,GO:0045125,1,0.485999727640134,0,10,bioactive lipid receptor activity,MF,
11130,GO:0045141,1,0.521370538968773,0,8,meiotic telomere clustering,BP,
11146,GO:0045176,1,0.440693653920566,0,9,apical protein localization,BP,
11184,GO:0045236,1,0.627331426358378,0,7,CXCR chemokine receptor binding,MF,
11185,GO:0045239,1,0.37228880300298,0,13,tricarboxylic acid cycle enzyme complex,CC,
11186,GO:0045240,1,0.426424518741919,0,11,dihydrolipoyl dehydrogenase complex,CC,
11189,GO:0045252,1,0.590091441234386,0,7,oxoglutarate dehydrogenase complex,CC,
11190,GO:0045254,1,0.593431621672363,0,7,pyruvate dehydrogenase complex,CC,
11199,GO:0045277,1,0.644755397874012,0,11,respiratory chain complex IV,CC,
11206,GO:0045295,1,0.441094656326756,0,9,gamma-catenin binding,MF,
11216,GO:0045332,1,0.2696564871443,0,14,phospholipid translocation,BP,
11249,GO:0045408,1,0.509846954322182,0,9,regulation of interleukin-6 biosynthetic process,BP,
11251,GO:0045410,1,0.638689339875366,0,6,positive regulation of interleukin-6 biosynthetic process,BP,
11267,GO:0045475,1,0.539266570019263,0,7,locomotor rhythm,BP,
11269,GO:0045494,1,0.228948482602285,0,19,photoreceptor cell maintenance,BP,
11270,GO:0045495,1,0.605443293252803,0,7,pole plasm,CC,
11273,GO:0045504,1,0.469263601809573,0,10,dynein heavy chain binding,MF,
11307,GO:0045603,1,0.563247190195811,0,7,positive regulation of endothelial cell differentiation,BP,
11309,GO:0045605,1,0.462648447548072,0,10,negative regulation of epidermal cell differentiation,BP,
11314,GO:0045617,1,0.635518613281048,0,6,negative regulation of keratinocyte differentiation,BP,
11321,GO:0045624,1,0.513086158017929,0,10,positive regulation of T-helper cell differentiation,BP,
11325,GO:0045628,1,0.572844371392435,0,8,regulation of T-helper 2 cell differentiation,BP,
11365,GO:0045683,1,0.362094384886232,0,13,negative regulation of epidermis development,BP,
11368,GO:0045686,1,0.387986628190673,0,12,negative regulation of glial cell differentiation,BP,
11374,GO:0045717,1,0.418277631266794,0,12,negative regulation of fatty acid biosynthetic process,BP,
11377,GO:0045722,1,0.480470697871725,0,9,positive regulation of gluconeogenesis,BP,
11378,GO:0045723,1,0.514775317113806,0,9,positive regulation of fatty acid biosynthetic process,BP,
11379,GO:0045724,1,0.23757299172024,0,18,positive regulation of cilium assembly,BP,
11383,GO:0045730,1,0.400436447236598,0,13,respiratory burst,BP,
11399,GO:0045760,1,0.608888749301635,0,6,positive regulation of action potential,BP,
11400,GO:0045761,1,0.406482634143135,0,11,regulation of adenylate cyclase activity,BP,
11411,GO:0045779,1,0.600059706136442,0,7,negative regulation of bone resorption,BP,
11416,GO:0045792,1,0.553907664516545,0,7,negative regulation of cell size,BP,
11427,GO:0045820,1,0.602818064022394,0,6,negative regulation of glycolytic process,BP,
11428,GO:0045821,1,0.385050932576465,0,11,positive regulation of glycolytic process,BP,
11429,GO:0045822,1,0.452146824020309,0,10,negative regulation of heart contraction,BP,
11439,GO:0045838,1,0.478732177750242,0,10,positive regulation of membrane potential,BP,
11443,GO:0045842,1,0.555013724247237,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11452,GO:0045869,1,0.609651262963987,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11469,GO:0045907,1,0.301994736187436,0,16,positive regulation of vasoconstriction,BP,
11480,GO:0045920,1,0.252019563546531,0,18,negative regulation of exocytosis,BP,
11482,GO:0045922,1,0.323741486914387,0,15,negative regulation of fatty acid metabolic process,BP,
11490,GO:0045932,1,0.352695378431161,0,14,negative regulation of muscle contraction,BP,
11500,GO:0045945,1,0.437556948330521,0,10,positive regulation of transcription by RNA polymerase III,BP,
11505,GO:0045954,1,0.535796664943835,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11506,GO:0045955,1,0.573173719061488,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11507,GO:0045956,1,0.417557072199804,0,12,positive regulation of calcium ion-dependent exocytosis,BP,
11514,GO:0045980,1,0.138353343113971,0,26,negative regulation of nucleotide metabolic process,BP,
11516,GO:0045986,1,0.468206338663262,0,10,negative regulation of smooth muscle contraction,BP,
11530,GO:0046030,1,0.410831976131982,0,11,inositol trisphosphate phosphatase activity,MF,
11533,GO:0046033,1,0.537693573131327,0,9,AMP metabolic process,BP,
11536,GO:0046036,1,0.494879424249346,0,12,CTP metabolic process,BP,
11540,GO:0046040,1,0.410510039174427,0,12,IMP metabolic process,BP,
11544,GO:0046051,1,0.587048731161665,0,9,UTP metabolic process,BP,
11554,GO:0046068,1,0.156529191452548,0,22,cGMP metabolic process,BP,
11566,GO:0046085,1,0.643013966402707,0,6,adenosine metabolic process,BP,
11568,GO:0046087,1,0.686022856931042,0,6,cytidine metabolic process,BP,
11590,GO:0046129,1,0.295456393004984,0,20,purine ribonucleoside biosynthetic process,BP,
11591,GO:0046130,1,0.676272428238968,0,6,purine ribonucleoside catabolic process,BP,
11594,GO:0046133,1,0.596632203155054,0,8,pyrimidine ribonucleoside catabolic process,BP,
11613,GO:0046185,1,0.546870620788518,0,9,aldehyde catabolic process,BP,
11646,GO:0046337,1,0.317702687845588,0,15,phosphatidylethanolamine metabolic process,BP,
11648,GO:0046339,1,0.365514110915097,0,13,diacylglycerol metabolic process,BP,
11650,GO:0046341,1,0.355964029797974,0,13,CDP-diacylglycerol metabolic process,BP,
11693,GO:0046461,1,0.279780301031914,0,17,neutral lipid catabolic process,BP,
11696,GO:0046464,1,0.279780301031914,0,17,acylglycerol catabolic process,BP,
11697,GO:0046465,1,0.603013544903227,0,7,dolichyl diphosphate metabolic process,BP,
11703,GO:0046473,1,0.0895925037216825,0,30,phosphatidic acid metabolic process,BP,
11707,GO:0046477,1,0.648115401316706,0,6,glycosylceramide catabolic process,BP,
11709,GO:0046479,1,0.486790494670857,0,10,glycosphingolipid catabolic process,BP,
11711,GO:0046485,1,0.596743159923444,0,7,ether lipid metabolic process,BP,
11713,GO:0046487,1,0.663589076045009,0,6,glyoxylate metabolic process,BP,
11721,GO:0046498,1,0.667365911410889,0,6,S-adenosylhomocysteine metabolic process,BP,
11724,GO:0046501,1,0.530187308812616,0,9,protoporphyrinogen IX metabolic process,BP,
11729,GO:0046512,1,0.567390849689853,0,8,sphingosine biosynthetic process,BP,
11731,GO:0046514,1,0.46995565790017,0,11,ceramide catabolic process,BP,
11732,GO:0046519,1,0.423227495834479,0,12,sphingoid metabolic process,BP,
11733,GO:0046520,1,0.524338763839253,0,9,sphingoid biosynthetic process,BP,
11738,GO:0046527,1,0.337149509437059,0,14,glucosyltransferase activity,MF,
11739,GO:0046530,1,0.104332438630049,0,28,photoreceptor cell differentiation,BP,
11747,GO:0046543,1,0.587207508576194,0,7,development of secondary female sexual characteristics,BP,
11766,GO:0046597,1,0.415862565546603,0,13,negative regulation of viral entry into host cell,BP,
11808,GO:0046658,1,0.180575668251275,0,24,anchored component of plasma membrane,CC,
11827,GO:0046697,1,0.2837829969285,0,16,decidualization,BP,
11829,GO:0046703,1,0.610881326993507,0,9,natural killer cell lectin-like receptor binding,MF,
11840,GO:0046719,1,0.609315447361552,0,7,regulation by virus of viral protein levels in host cell,BP,
11847,GO:0046755,1,0.207450019409077,0,23,viral budding,BP,
11863,GO:0046826,1,0.643632965832706,0,7,negative regulation of protein export from nucleus,BP,
11867,GO:0046833,1,0.567741426752377,0,7,positive regulation of RNA export from nucleus,BP,
11886,GO:0046875,1,0.182860491590877,0,22,ephrin receptor binding,MF,
11918,GO:0046930,1,0.478114937586757,0,11,pore complex,CC,
11930,GO:0046950,1,0.603232735912564,0,7,cellular ketone body metabolic process,BP,
11931,GO:0046951,1,0.651966618735791,0,6,ketone body biosynthetic process,BP,
11934,GO:0046961,1,0.307491837895395,0,18,proton-transporting ATPase activity, rotational mechanism,MF,
11937,GO:0046965,1,0.372642390902257,0,12,retinoid X receptor binding,MF,
11938,GO:0046966,1,0.116231645922031,0,27,thyroid hormone receptor binding,MF,
12009,GO:0047372,1,0.496883288875949,0,9,acylglycerol lipase activity,MF,
12020,GO:0047484,1,0.642585400730283,0,6,regulation of response to osmotic stress,BP,
12025,GO:0047498,1,0.629732686257567,0,6,calcium-dependent phospholipase A2 activity,MF,
12034,GO:0047617,1,0.448101815707711,0,12,acyl-CoA hydrolase activity,MF,
12060,GO:0047844,1,0.679169131532015,0,6,deoxycytidine deaminase activity,MF,
12079,GO:0048012,1,0.44314616002559,0,11,hepatocyte growth factor receptor signaling pathway,BP,
12114,GO:0048102,1,0.598683191242915,0,7,autophagic cell death,BP,
12119,GO:0048143,1,0.500819437195207,0,8,astrocyte activation,BP,
12142,GO:0048200,1,0.639930363413551,0,6,Golgi transport vesicle coating,BP,
12144,GO:0048205,1,0.639930363413551,0,6,COPI coating of Golgi vesicle,BP,
12151,GO:0048227,1,0.561207146803394,0,8,plasma membrane to endosome transport,BP,
12155,GO:0048240,1,0.610926321247265,0,7,sperm capacitation,BP,
12173,GO:0048265,1,0.53568432751598,0,8,response to pain,BP,
12175,GO:0048268,1,0.306277797628752,0,15,clathrin coat assembly,BP,
12178,GO:0048273,1,0.627378642067578,0,6,mitogen-activated protein kinase p38 binding,MF,
12180,GO:0048280,1,0.497663665817381,0,10,vesicle fusion with Golgi apparatus,BP,
12197,GO:0048308,1,0.335089177589287,0,15,organelle inheritance,BP,
12199,GO:0048312,1,0.599860635148841,0,6,intracellular distribution of mitochondria,BP,
12200,GO:0048313,1,0.361068449054234,0,14,Golgi inheritance,BP,
12207,GO:0048339,1,0.311592883166908,0,14,paraxial mesoderm development,BP,
12208,GO:0048340,1,0.54730273938795,0,7,paraxial mesoderm morphogenesis,BP,
12243,GO:0048485,1,0.338580986632307,0,13,sympathetic nervous system development,BP,
12252,GO:0048500,1,0.562287202927729,0,9,signal recognition particle,CC,
12253,GO:0048505,1,0.630187889217374,0,6,regulation of timing of cell differentiation,BP,
12267,GO:0048531,1,0.428821887724996,0,12,beta-1,3-galactosyltransferase activity,MF,
12278,GO:0048548,1,0.506148077661487,0,9,regulation of pinocytosis,BP,
12330,GO:0048665,1,0.568766800207137,0,7,neuron fate specification,BP,
12333,GO:0048668,1,0.279241000421082,0,17,collateral sprouting,BP,
12335,GO:0048670,1,0.419679571298833,0,12,regulation of collateral sprouting,BP,
12337,GO:0048672,1,0.543965131864493,0,9,positive regulation of collateral sprouting,BP,
12342,GO:0048679,1,0.257075000854368,0,18,regulation of axon regeneration,BP,
12344,GO:0048681,1,0.433756088203343,0,11,negative regulation of axon regeneration,BP,
12356,GO:0048702,1,0.563015541365062,0,7,embryonic neurocranium morphogenesis,BP,
12357,GO:0048703,1,0.54977014004717,0,7,embryonic viscerocranium morphogenesis,BP,
12366,GO:0048713,1,0.163475767425307,0,23,regulation of oligodendrocyte differentiation,BP,
12367,GO:0048714,1,0.389585062668925,0,12,positive regulation of oligodendrocyte differentiation,BP,
12368,GO:0048715,1,0.5285143135298,0,8,negative regulation of oligodendrocyte differentiation,BP,
12415,GO:0048841,1,0.11570291546388,0,24,regulation of axon extension involved in axon guidance,BP,
12416,GO:0048842,1,0.540466548697647,0,6,positive regulation of axon extension involved in axon guidance,BP,
12417,GO:0048843,1,0.221784385871151,0,18,negative regulation of axon extension involved in axon guidance,BP,
12419,GO:0048845,1,0.506502013654543,0,8,venous blood vessel morphogenesis,BP,
12420,GO:0048846,1,0.0821421425261614,0,28,axon extension involved in axon guidance,BP,
12423,GO:0048853,1,0.544353947434191,0,7,forebrain morphogenesis,BP,
12442,GO:0048875,1,0.575153383279773,0,7,chemical homeostasis within a tissue,BP,
12457,GO:0050072,1,0.585878170485741,0,7,m7G(5')pppN diphosphatase activity,MF,
12486,GO:0050321,1,0.420600967804699,0,11,tau-protein kinase activity,MF,
12498,GO:0050428,1,0.62670405850227,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12500,GO:0050432,1,0.354969427168958,0,14,catecholamine secretion,BP,
12501,GO:0050433,1,0.423515602763045,0,12,regulation of catecholamine secretion,BP,
12526,GO:0050650,1,0.195194028869923,0,20,chondroitin sulfate proteoglycan biosynthetic process,BP,
12527,GO:0050651,1,0.44434109171168,0,10,dermatan sulfate proteoglycan biosynthetic process,BP,
12530,GO:0050654,1,0.101591386116667,0,28,chondroitin sulfate proteoglycan metabolic process,BP,
12531,GO:0050655,1,0.414404999668505,0,11,dermatan sulfate proteoglycan metabolic process,BP,
12540,GO:0050664,1,0.651145451201869,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12543,GO:0050667,1,0.439137317741954,0,11,homocysteine metabolic process,BP,
12557,GO:0050687,1,0.213157173374027,0,21,negative regulation of defense response to virus,BP,
12560,GO:0050690,1,0.216999025608253,0,21,regulation of defense response to virus by virus,BP,
12561,GO:0050691,1,0.12778321116477,0,28,regulation of defense response to virus by host,BP,
12566,GO:0050699,1,0.181663356159126,0,23,WW domain binding,MF,
12567,GO:0050700,1,0.4412734890883,0,11,CARD domain binding,MF,
12617,GO:0050774,1,0.496021008963515,0,9,negative regulation of dendrite morphogenesis,BP,
12646,GO:0050812,1,0.383791989338261,0,12,regulation of acyl-CoA biosynthetic process,BP,
12647,GO:0050815,1,0.648013619237993,0,6,phosphoserine residue binding,MF,
12656,GO:0050829,1,0.292085399557576,0,22,defense response to Gram-negative bacterium,BP,
12658,GO:0050832,1,0.43318605600546,0,14,defense response to fungus,BP,
12662,GO:0050847,1,0.558015395904612,0,7,progesterone receptor signaling pathway,BP,
12687,GO:0050872,1,0.497794877551571,0,9,white fat cell differentiation,BP,
12691,GO:0050879,1,0.117958301542249,0,27,multicellular organismal movement,BP,
12693,GO:0050881,1,0.117958301542249,0,27,musculoskeletal movement,BP,
12694,GO:0050882,1,0.554088000486107,0,6,voluntary musculoskeletal movement,BP,
12708,GO:0050906,1,0.160214761465537,0,26,detection of stimulus involved in sensory perception,BP,
12709,GO:0050907,1,0.548925220883722,0,10,detection of chemical stimulus involved in sensory perception,BP,
12711,GO:0050909,1,0.433194256921118,0,12,sensory perception of taste,BP,
12714,GO:0050912,1,0.701235974178632,0,6,detection of chemical stimulus involved in sensory perception of taste,BP,
12715,GO:0050913,1,0.631736116835589,0,7,sensory perception of bitter taste,BP,
12723,GO:0050922,1,0.0750818830815684,0,33,negative regulation of chemotaxis,BP,
12735,GO:0050951,1,0.544153847712287,0,8,sensory perception of temperature stimulus,BP,
12741,GO:0050961,1,0.605089930384145,0,7,detection of temperature stimulus involved in sensory perception,BP,
12743,GO:0050965,1,0.605089930384145,0,7,detection of temperature stimulus involved in sensory perception of pain,BP,
12747,GO:0050982,1,0.238880660521366,0,12,detection of mechanical stimulus,BP,
12753,GO:0050997,1,0.416428009681737,0,12,quaternary ammonium group binding,MF,
12758,GO:0051004,1,0.489850601886583,0,10,regulation of lipoprotein lipase activity,BP,
12762,GO:0051011,1,0.403470527266804,0,10,microtubule minus-end binding,MF,
12764,GO:0051013,1,0.628000878591708,0,6,microtubule severing,BP,
12765,GO:0051014,1,0.61510209515267,0,6,actin filament severing,BP,
12767,GO:0051016,1,0.414539524853707,0,12,barbed-end actin filament capping,BP,
12770,GO:0051019,1,0.128360102085955,0,26,mitogen-activated protein kinase binding,MF,
12779,GO:0051029,1,0.677618326746947,0,6,rRNA transport,BP,
12789,GO:0051045,1,0.583294119870374,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
12828,GO:0051103,1,0.463577450536378,0,11,DNA ligation involved in DNA repair,BP,
12829,GO:0051105,1,0.643533767293759,0,6,regulation of DNA ligation,BP,
12838,GO:0051124,1,0.560704355267019,0,6,synaptic growth at neuromuscular junction,BP,
12839,GO:0051125,1,0.175886882265178,0,22,regulation of actin nucleation,BP,
12840,GO:0051126,1,0.648330863910557,0,6,negative regulation of actin nucleation,BP,
12841,GO:0051127,1,0.362752380035741,0,12,positive regulation of actin nucleation,BP,
12883,GO:0051185,1,0.632404445347413,0,6,coenzyme transmembrane transporter activity,MF,
12890,GO:0051194,1,0.30971570594889,0,14,positive regulation of cofactor metabolic process,BP,
12891,GO:0051195,1,0.478325786866658,0,9,negative regulation of cofactor metabolic process,BP,
12893,GO:0051197,1,0.385050932576465,0,11,positive regulation of coenzyme metabolic process,BP,
12894,GO:0051198,1,0.602818064022394,0,6,negative regulation of coenzyme metabolic process,BP,
12944,GO:0051280,1,0.522774018760812,0,10,negative regulation of release of sequestered calcium ion into cytosol,BP,
12948,GO:0051284,1,0.522774018760812,0,10,positive regulation of sequestering of calcium ion,BP,
12955,GO:0051293,1,0.0840297980279981,0,30,establishment of spindle localization,BP,
12956,GO:0051294,1,0.160815669663517,0,23,establishment of spindle orientation,BP,
12967,GO:0051307,1,0.384466943180725,0,12,meiotic chromosome separation,BP,
12976,GO:0051339,1,0.228359540022827,0,19,regulation of lyase activity,BP,
12977,GO:0051340,1,0.585054800690843,0,8,regulation of ligase activity,BP,
12979,GO:0051342,1,0.650840447727792,0,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12986,GO:0051349,1,0.520740373827209,0,8,positive regulation of lyase activity,BP,
12987,GO:0051350,1,0.509478956630176,0,9,negative regulation of lyase activity,BP,
12988,GO:0051351,1,0.630396444585062,0,7,positive regulation of ligase activity,BP,
12991,GO:0051354,1,0.478121323121475,0,10,negative regulation of oxidoreductase activity,BP,
13002,GO:0051386,1,0.579291660221217,0,7,regulation of neurotrophin TRK receptor signaling pathway,BP,
13009,GO:0051400,1,0.563802628533153,0,8,BH domain binding,MF,
13017,GO:0051415,1,0.622425743771415,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
13019,GO:0051418,1,0.511277393125639,0,8,microtubule nucleation by microtubule organizing center,BP,
13022,GO:0051428,1,0.530492337102414,0,9,peptide hormone receptor binding,MF,
13028,GO:0051438,1,0.0333256832793098,0,48,regulation of ubiquitin-protein transferase activity,BP,
13029,GO:0051443,1,0.113998230472866,0,30,positive regulation of ubiquitin-protein transferase activity,BP,
13030,GO:0051444,1,0.444796445217772,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
13034,GO:0051450,1,0.508475966057238,0,9,myoblast proliferation,BP,
13060,GO:0051497,1,0.351861528085622,0,13,negative regulation of stress fiber assembly,BP,
13063,GO:0051503,1,0.424360707156185,0,12,adenine nucleotide transport,BP,
13066,GO:0051537,1,0.28747073461435,0,19,2 iron, 2 sulfur cluster binding,MF,
13079,GO:0051560,1,0.270606020087668,0,18,mitochondrial calcium ion homeostasis,BP,
13080,GO:0051561,1,0.543865537343438,0,9,positive regulation of mitochondrial calcium ion concentration,BP,
13085,GO:0051569,1,0.192295723289588,0,21,regulation of histone H3-K4 methylation,BP,
13087,GO:0051571,1,0.323676530730994,0,14,positive regulation of histone H3-K4 methylation,BP,
13089,GO:0051573,1,0.493675732930631,0,9,negative regulation of histone H3-K9 methylation,BP,
13095,GO:0051583,1,0.692254754050753,0,6,dopamine uptake involved in synaptic transmission,BP,
13107,GO:0051597,1,0.613661816646247,0,6,response to methylmercury,BP,
13110,GO:0051601,1,0.596191470799496,0,7,exocyst localization,BP,
13136,GO:0051653,1,0.0589677040070618,0,34,spindle localization,BP,
13139,GO:0051657,1,0.475974276324765,0,8,maintenance of organelle location,BP,
13143,GO:0051665,1,0.616716486376547,0,7,membrane raft localization,BP,
13152,GO:0051693,1,0.173580438786245,0,21,actin filament capping,BP,
13162,GO:0051709,1,0.646327061722795,0,7,regulation of killing of cells of other organism,BP,
13164,GO:0051712,1,0.646327061722795,0,7,positive regulation of killing of cells of other organism,BP,
13219,GO:0051818,1,0.682030970776461,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13230,GO:0051861,1,0.420103811525816,0,12,glycolipid binding,MF,
13231,GO:0051864,1,0.509301796655828,0,8,histone demethylase activity (H3-K36 specific),MF,
13239,GO:0051880,1,0.544406571296891,0,7,G-quadruplex DNA binding,MF,
13242,GO:0051883,1,0.682030970776461,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13266,GO:0051920,1,0.658322899511298,0,8,peroxiredoxin activity,MF,
13273,GO:0051932,1,0.215841848570088,0,19,synaptic transmission, GABAergic,BP,
13275,GO:0051934,1,0.692254754050753,0,6,catecholamine uptake involved in synaptic transmission,BP,
13277,GO:0051937,1,0.235520304645808,0,20,catecholamine transport,BP,
13315,GO:0051998,1,0.600527555032737,0,7,protein carboxyl O-methyltransferase activity,MF,
13336,GO:0052173,1,0.643855156244036,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13341,GO:0052200,1,0.643855156244036,0,6,response to host defenses,BP,
13343,GO:0052204,1,0.670116631724422,0,6,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13400,GO:0052646,1,0.512477027077451,0,8,alditol phosphate metabolic process,BP,
13401,GO:0052650,1,0.628763993109149,0,7,NADP-retinol dehydrogenase activity,MF,
13408,GO:0052658,1,0.615396099099906,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13409,GO:0052659,1,0.482400680448181,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
13426,GO:0052743,1,0.41012561361177,0,11,inositol tetrakisphosphate phosphatase activity,MF,
13428,GO:0052745,1,0.218402456307456,0,19,inositol phosphate phosphatase activity,MF,
13497,GO:0055012,1,0.512154031106172,0,9,ventricular cardiac muscle cell differentiation,BP,
13500,GO:0055015,1,0.603656982173393,0,7,ventricular cardiac muscle cell development,BP,
13519,GO:0055064,1,0.476934738897444,0,9,chloride ion homeostasis,BP,
13523,GO:0055070,1,0.33663886582648,0,16,copper ion homeostasis,BP,
13526,GO:0055075,1,0.316068455792769,0,14,potassium ion homeostasis,BP,
13538,GO:0055089,1,0.424956082661772,0,11,fatty acid homeostasis,BP,
13539,GO:0055090,1,0.358762082605862,0,14,acylglycerol homeostasis,BP,
13547,GO:0055102,1,0.608532551492984,0,8,lipase inhibitor activity,MF,
13549,GO:0055105,1,0.747617870719148,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13556,GO:0055119,1,0.417203425168771,0,11,relaxation of cardiac muscle,BP,
13567,GO:0060008,1,0.336850526869409,0,14,Sertoli cell differentiation,BP,
13568,GO:0060009,1,0.455931691405469,0,10,Sertoli cell development,BP,
13576,GO:0060019,1,0.532437612003693,0,9,radial glial cell differentiation,BP,
13577,GO:0060020,1,0.627076282390745,0,6,Bergmann glial cell differentiation,BP,
13589,GO:0060033,1,0.615084180088498,0,6,anatomical structure regression,BP,
13624,GO:0060074,1,0.483789673165358,0,9,synapse maturation,BP,
13630,GO:0060080,1,0.591409520930219,0,6,inhibitory postsynaptic potential,BP,
13631,GO:0060081,1,0.61088574098067,0,7,membrane hyperpolarization,BP,
13689,GO:0060192,1,0.499192386021526,0,10,negative regulation of lipase activity,BP,
13698,GO:0060211,1,0.399379333579801,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13700,GO:0060213,1,0.399379333579801,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13705,GO:0060219,1,0.591219229947796,0,6,camera-type eye photoreceptor cell differentiation,BP,
13713,GO:0060242,1,0.601826144001842,0,7,contact inhibition,BP,
13719,GO:0060251,1,0.236256532419136,0,17,regulation of glial cell proliferation,BP,
13720,GO:0060252,1,0.529890860577619,0,8,positive regulation of glial cell proliferation,BP,
13721,GO:0060253,1,0.479966756971624,0,9,negative regulation of glial cell proliferation,BP,
13726,GO:0060263,1,0.598871029225401,0,7,regulation of respiratory burst,BP,
13733,GO:0060272,1,0.568786618427341,0,8,embryonic skeletal joint morphogenesis,BP,
13736,GO:0060281,1,0.575291743456208,0,7,regulation of oocyte development,BP,
13740,GO:0060285,1,0.279886658381596,0,15,cilium-dependent cell motility,BP,
13745,GO:0060293,1,0.605443293252803,0,7,germ plasm,CC,
13746,GO:0060294,1,0.523191693919965,0,9,cilium movement involved in cell motility,BP,
13756,GO:0060307,1,0.426146347492268,0,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
13760,GO:0060312,1,0.644270325635886,0,6,regulation of blood vessel remodeling,BP,
13763,GO:0060315,1,0.607352668792625,0,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
13798,GO:0060363,1,0.58872609112074,0,7,cranial suture morphogenesis,BP,
13802,GO:0060368,1,0.639146799928309,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13817,GO:0060384,1,0.292797128820239,0,15,innervation,BP,
13821,GO:0060390,1,0.333729875364881,0,14,regulation of SMAD protein signal transduction,BP,
13822,GO:0060391,1,0.411319247801266,0,11,positive regulation of SMAD protein signal transduction,BP,
13825,GO:0060394,1,0.608377744662958,0,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
13859,GO:0060439,1,0.501781503709112,0,9,trachea morphogenesis,BP,
13860,GO:0060440,1,0.643267579223801,0,6,trachea formation,BP,
13874,GO:0060457,1,0.622188502599734,0,6,negative regulation of digestive system process,BP,
13883,GO:0060479,1,0.330923643582814,0,14,lung cell differentiation,BP,
13890,GO:0060487,1,0.357459679702254,0,13,lung epithelial cell differentiation,BP,
13902,GO:0060513,1,0.620503140946188,0,6,prostatic bud formation,BP,
13956,GO:0060600,1,0.431226745963248,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
13964,GO:0060613,1,0.629400357335247,0,6,fat pad development,BP,
13969,GO:0060628,1,0.392656104012997,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
13971,GO:0060632,1,0.367023998451913,0,14,regulation of microtubule-based movement,BP,
13974,GO:0060644,1,0.410370504302167,0,12,mammary gland epithelial cell differentiation,BP,
14008,GO:0060700,1,0.520778924839064,0,9,regulation of ribonuclease activity,BP,
14043,GO:0060746,1,0.583069663640298,0,7,parental behavior,BP,
14048,GO:0060753,1,0.669615997535772,0,6,regulation of mast cell chemotaxis,BP,
14058,GO:0060767,1,0.51226968536915,0,9,epithelial cell proliferation involved in prostate gland development,BP,
14059,GO:0060768,1,0.554506855700083,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14061,GO:0060770,1,0.668429560308434,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14064,GO:0060788,1,0.460912300121881,0,10,ectodermal placode formation,BP,
14065,GO:0060789,1,0.652562605599841,0,6,hair follicle placode formation,BP,
14066,GO:0060795,1,0.280143722867684,0,17,cell fate commitment involved in formation of primary germ layer,BP,
14077,GO:0060831,1,0.342117139278326,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14079,GO:0060837,1,0.617352960679052,0,6,blood vessel endothelial cell differentiation,BP,
14083,GO:0060841,1,0.363162693016326,0,11,venous blood vessel development,BP,
14090,GO:0060850,1,0.625183767785521,0,6,regulation of transcription involved in cell fate commitment,BP,
14092,GO:0060856,1,0.516811162467448,0,9,establishment of blood-brain barrier,BP,
14099,GO:0060896,1,0.515864322405139,0,8,neural plate pattern specification,BP,
14100,GO:0060897,1,0.62602042652835,0,6,neural plate regionalization,BP,
14106,GO:0060911,1,0.596011575411733,0,7,cardiac cell fate commitment,BP,
14109,GO:0060914,1,0.478608839567767,0,11,heart formation,BP,
14137,GO:0060973,1,0.400314794765605,0,11,cell migration involved in heart development,BP,
14142,GO:0060982,1,0.549259552909165,0,7,coronary artery morphogenesis,BP,
14176,GO:0061037,1,0.352942779019492,0,14,negative regulation of cartilage development,BP,
14180,GO:0061042,1,0.642541424316718,0,6,vascular wound healing,BP,
14196,GO:0061072,1,0.599906837433867,0,6,iris morphogenesis,BP,
14206,GO:0061085,1,0.499503726634359,0,9,regulation of histone H3-K27 methylation,BP,
14208,GO:0061087,1,0.629897993549236,0,6,positive regulation of histone H3-K27 methylation,BP,
14245,GO:0061178,1,0.0774096661143924,0,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14246,GO:0061179,1,0.65102635902796,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14260,GO:0061213,1,0.35929673055341,0,14,positive regulation of mesonephros development,BP,
14262,GO:0061217,1,0.314626893513205,0,16,regulation of mesonephros development,BP,
14275,GO:0061307,1,0.553007736985945,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
14276,GO:0061308,1,0.553007736985945,0,8,cardiac neural crest cell development involved in heart development,BP,
14277,GO:0061309,1,0.638744392148862,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
14278,GO:0061311,1,0.27691588589766,0,16,cell surface receptor signaling pathway involved in heart development,BP,
14283,GO:0061318,1,0.375564578509781,0,12,renal filtration cell differentiation,BP,
14284,GO:0061323,1,0.431874009199093,0,11,cell proliferation involved in heart morphogenesis,BP,
14333,GO:0061450,1,0.601960436096659,0,8,trophoblast cell migration,BP,
14365,GO:0061548,1,0.524273684901841,0,8,ganglion development,BP,
14366,GO:0061549,1,0.618007954321751,0,6,sympathetic ganglion development,BP,
14387,GO:0061608,1,0.514813953756684,0,9,nuclear import signal receptor activity,MF,
14391,GO:0061617,1,0.607217576384835,0,8,MICOS complex,CC,
14424,GO:0061687,1,0.677622554284646,0,7,detoxification of inorganic compound,BP,
14430,GO:0061700,1,0.519107737709565,0,9,GATOR2 complex,CC,
14431,GO:0061702,1,0.626234209340852,0,7,inflammasome complex,CC,
14437,GO:0061724,1,0.599064512792897,0,6,lipophagy,BP,
14441,GO:0061732,1,0.646131686834583,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14467,GO:0061778,1,0.455858189137766,0,10,intracellular chloride channel activity,MF,
14477,GO:0061820,1,0.494877272095455,0,9,telomeric D-loop disassembly,BP,
14505,GO:0061912,1,0.0397240675578885,0,41,selective autophagy,BP,
14518,GO:0061983,1,0.65708220026532,0,6,meiosis II cell cycle process,BP,
14536,GO:0070008,1,0.456550060829354,0,10,serine-type exopeptidase activity,MF,
14540,GO:0070016,1,0.443223728093492,0,10,armadillo repeat domain binding,MF,
14576,GO:0070087,1,0.57846587256224,0,6,chromo shadow domain binding,MF,
14600,GO:0070127,1,0.554722560615015,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14609,GO:0070142,1,0.618834654871549,0,6,synaptic vesicle budding,BP,
14620,GO:0070166,1,0.512960826141786,0,8,enamel mineralization,BP,
14622,GO:0070168,1,0.575909851139557,0,7,negative regulation of biomineral tissue development,BP,
14631,GO:0070181,1,0.641902659957944,0,8,small ribosomal subunit rRNA binding,MF,
14635,GO:0070187,1,0.647799240379658,0,6,shelterin complex,CC,
14639,GO:0070193,1,0.470576490255428,0,10,synaptonemal complex organization,BP,
14668,GO:0070244,1,0.641266796807639,0,6,negative regulation of thymocyte apoptotic process,BP,
14671,GO:0070254,1,0.591955851281774,0,8,mucus secretion,BP,
14672,GO:0070255,1,0.615233924234508,0,7,regulation of mucus secretion,BP,
14674,GO:0070257,1,0.653113824876378,0,6,positive regulation of mucus secretion,BP,
14677,GO:0070262,1,0.369207750465958,0,14,peptidyl-serine dephosphorylation,BP,
14686,GO:0070279,1,0.0859007285243491,0,33,vitamin B6 binding,MF,
14697,GO:0070296,1,0.223452678689166,0,18,sarcoplasmic reticulum calcium ion transport,BP,
14704,GO:0070306,1,0.234649991312818,0,18,lens fiber cell differentiation,BP,
14705,GO:0070307,1,0.544996595876914,0,8,lens fiber cell development,BP,
14717,GO:0070328,1,0.358762082605862,0,14,triglyceride homeostasis,BP,
14744,GO:0070383,1,0.667577099709748,0,6,DNA cytosine deamination,BP,
14752,GO:0070405,1,0.157889176140961,0,26,ammonium ion binding,MF,
14756,GO:0070410,1,0.504219817198801,0,7,co-SMAD binding,MF,
14757,GO:0070411,1,0.461384081531022,0,9,I-SMAD binding,MF,
14758,GO:0070412,1,0.273430292104617,0,15,R-SMAD binding,MF,
14760,GO:0070417,1,0.572133379014974,0,7,cellular response to cold,BP,
14762,GO:0070419,1,0.566181234819768,0,7,nonhomologous end joining complex,CC,
14770,GO:0070431,1,0.555262325862062,0,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14796,GO:0070486,1,0.468669585872973,0,11,leukocyte aggregation,BP,
14802,GO:0070493,1,0.5828040587841,0,7,thrombin-activated receptor signaling pathway,BP,
14812,GO:0070513,1,0.588351036159991,0,8,death domain binding,MF,
14818,GO:0070530,1,0.222357313784596,0,19,K63-linked polyubiquitin modification-dependent protein binding,MF,
14828,GO:0070544,1,0.509301796655828,0,8,histone H3-K36 demethylation,BP,
14839,GO:0070562,1,0.620337497951411,0,6,regulation of vitamin D receptor signaling pathway,BP,
14843,GO:0070567,1,0.523144268137779,0,9,cytidylyltransferase activity,MF,
14846,GO:0070570,1,0.21710298588603,0,20,regulation of neuron projection regeneration,BP,
14847,GO:0070571,1,0.366349607668094,0,13,negative regulation of neuron projection regeneration,BP,
14853,GO:0070578,1,0.505229623148987,0,9,RISC-loading complex,CC,
14857,GO:0070586,1,0.567713591039116,0,8,cell-cell adhesion involved in gastrulation,BP,
14858,GO:0070587,1,0.611064248472102,0,7,regulation of cell-cell adhesion involved in gastrulation,BP,
14888,GO:0070652,1,0.561751713547229,0,8,HAUS complex,CC,
14904,GO:0070679,1,0.552474617223382,0,6,inositol 1,4,5 trisphosphate binding,MF,
14923,GO:0070728,1,0.616783763871738,0,6,leucine binding,MF,
14925,GO:0070734,1,0.271799825830448,0,18,histone H3-K27 methylation,BP,
14928,GO:0070739,1,0.631857407034083,0,6,protein-glutamic acid ligase activity,MF,
14929,GO:0070740,1,0.631857407034083,0,6,tubulin-glutamic acid ligase activity,MF,
14931,GO:0070742,1,0.39517996267283,0,12,C2H2 zinc finger domain binding,MF,
14936,GO:0070765,1,0.650389562225289,0,6,gamma-secretase complex,CC,
14940,GO:0070775,1,0.570837068602695,0,7,H3 histone acetyltransferase complex,CC,
14941,GO:0070776,1,0.570837068602695,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14955,GO:0070822,1,0.330368571990697,0,14,Sin3-type complex,CC,
14961,GO:0070831,1,0.534330437659466,0,7,basement membrane assembly,BP,
14972,GO:0070847,1,0.591497275690447,0,8,core mediator complex,CC,
14982,GO:0070861,1,0.220672433300595,0,19,regulation of protein exit from endoplasmic reticulum,BP,
14983,GO:0070862,1,0.483637548308073,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
14984,GO:0070863,1,0.502631718184536,0,8,positive regulation of protein exit from endoplasmic reticulum,BP,
15012,GO:0070914,1,0.450457643154832,0,11,UV-damage excision repair,BP,
15016,GO:0070922,1,0.490923782709367,0,9,small RNA loading onto RISC,BP,
15046,GO:0070971,1,0.303445355684748,0,15,endoplasmic reticulum exit site,CC,
15062,GO:0070990,1,0.692682771855708,0,6,snRNP binding,MF,
15075,GO:0071011,1,0.124873951821867,0,31,precatalytic spliceosome,CC,
15081,GO:0071025,1,0.376397724889159,0,15,RNA surveillance,BP,
15083,GO:0071027,1,0.435998776682732,0,13,nuclear RNA surveillance,BP,
15084,GO:0071028,1,0.435998776682732,0,13,nuclear mRNA surveillance,BP,
15085,GO:0071029,1,0.695704156692865,0,6,nuclear ncRNA surveillance,BP,
15090,GO:0071035,1,0.695704156692865,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15094,GO:0071044,1,0.398993550005619,0,11,histone mRNA catabolic process,BP,
15096,GO:0071046,1,0.695704156692865,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15119,GO:0071141,1,0.528932352671573,0,7,SMAD protein complex,CC,
15131,GO:0071169,1,0.57876892858924,0,8,establishment of protein localization to chromatin,BP,
15134,GO:0071203,1,0.615696687914125,0,6,WASH complex,CC,
15144,GO:0071218,1,0.213521179324514,0,20,cellular response to misfolded protein,BP,
15156,GO:0071233,1,0.501138990813079,0,8,cellular response to leucine,BP,
15171,GO:0071265,1,0.622280917897602,0,7,L-methionine biosynthetic process,BP,
15173,GO:0071267,1,0.663206605888162,0,6,L-methionine salvage,BP,
15180,GO:0071281,1,0.655215082653464,0,6,cellular response to iron ion,BP,
15183,GO:0071285,1,0.59282380429484,0,7,cellular response to lithium ion,BP,
15185,GO:0071287,1,0.636693545848679,0,6,cellular response to manganese ion,BP,
15186,GO:0071294,1,0.620602277289788,0,8,cellular response to zinc ion,BP,
15214,GO:0071340,1,0.626885990425712,0,6,skeletal muscle acetylcholine-gated channel clustering,BP,
15231,GO:0071361,1,0.486942636457937,0,8,cellular response to ethanol,BP,
15241,GO:0071377,1,0.178259489217875,0,22,cellular response to glucagon stimulus,BP,
15292,GO:0071455,1,0.62747738754432,0,6,cellular response to hyperoxia,BP,
15308,GO:0071476,1,0.576171279915694,0,7,cellular hypotonic response,BP,
15324,GO:0071498,1,0.285350848353648,0,17,cellular response to fluid shear stress,BP,
15325,GO:0071499,1,0.605093013406784,0,7,cellular response to laminar fluid shear stress,BP,
15327,GO:0071501,1,0.545186519094081,0,8,cellular response to sterol depletion,BP,
15334,GO:0071526,1,0.081537527492785,0,29,semaphorin-plexin signaling pathway,BP,
15339,GO:0071539,1,0.105803145138482,0,26,protein localization to centrosome,BP,
15341,GO:0071541,1,0.639709501312084,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15366,GO:0071578,1,0.633155287483202,0,6,zinc ion import across plasma membrane,BP,
15384,GO:0071605,1,0.626773531850141,0,7,monocyte chemotactic protein-1 production,BP,
15405,GO:0071636,1,0.51921292488077,0,8,positive regulation of transforming growth factor beta production,BP,
15406,GO:0071637,1,0.626773531850141,0,7,regulation of monocyte chemotactic protein-1 production,BP,
15433,GO:0071679,1,0.506271038622539,0,8,commissural neuron axon guidance,BP,
15443,GO:0071696,1,0.428798167922692,0,11,ectodermal placode development,BP,
15444,GO:0071697,1,0.460912300121881,0,10,ectodermal placode morphogenesis,BP,
15455,GO:0071712,1,0.437144652674564,0,11,ER-associated misfolded protein catabolic process,BP,
15501,GO:0071837,1,0.536185571375154,0,8,HMG box domain binding,MF,
15521,GO:0071875,1,0.37589814034205,0,11,adrenergic receptor signaling pathway,BP,
15525,GO:0071880,1,0.461673957949932,0,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15554,GO:0071933,1,0.571273799380478,0,7,Arp2/3 complex binding,MF,
15556,GO:0071936,1,0.504524736619003,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
15557,GO:0071941,1,0.453148085911263,0,11,nitrogen cycle metabolic process,BP,
15561,GO:0071949,1,0.204465699313452,0,21,FAD binding,MF,
15568,GO:0071971,1,0.642950593925387,0,6,extracellular exosome assembly,BP,
15570,GO:0071986,1,0.640456493161879,0,6,Ragulator complex,CC,
15581,GO:0072010,1,0.347660747510594,0,13,glomerular epithelium development,BP,
15584,GO:0072015,1,0.462953016640684,0,9,glomerular visceral epithelial cell development,BP,
15585,GO:0072017,1,0.503708379984104,0,7,distal tubule development,BP,
15600,GO:0072050,1,0.659870079656609,0,6,S-shaped body morphogenesis,BP,
15642,GO:0072112,1,0.375564578509781,0,12,glomerular visceral epithelial cell differentiation,BP,
15677,GO:0072176,1,0.536133345270072,0,7,nephric duct development,BP,
15685,GO:0072189,1,0.561905611860437,0,7,ureter development,BP,
15697,GO:0072203,1,0.618363264251984,0,6,cell proliferation involved in metanephros development,BP,
15737,GO:0072282,1,0.610455342801705,0,6,metanephric nephron tubule morphogenesis,BP,
15738,GO:0072283,1,0.488039908966285,0,9,metanephric renal vesicle morphogenesis,BP,
15754,GO:0072310,1,0.462953016640684,0,9,glomerular epithelial cell development,BP,
15755,GO:0072311,1,0.375564578509781,0,12,glomerular epithelial cell differentiation,BP,
15775,GO:0072349,1,0.465467984577382,0,9,modified amino acid transmembrane transporter activity,MF,
15780,GO:0072357,1,0.578175779903419,0,7,PTW/PP1 phosphatase complex,CC,
15793,GO:0072378,1,0.624479605174078,0,7,blood coagulation, fibrin clot formation,BP,
15803,GO:0072393,1,0.374051365032421,0,11,microtubule anchoring at microtubule organizing center,BP,
15805,GO:0072396,1,0.606070442288504,0,6,response to cell cycle checkpoint signaling,BP,
15807,GO:0072402,1,0.606070442288504,0,6,response to DNA integrity checkpoint signaling,BP,
15811,GO:0072423,1,0.606070442288504,0,6,response to DNA damage checkpoint signaling,BP,
15822,GO:0072498,1,0.499625862272575,0,10,embryonic skeletal joint development,BP,
15846,GO:0072530,1,0.564158298869618,0,8,purine-containing compound transmembrane transport,BP,
15847,GO:0072531,1,0.607026259496029,0,7,pyrimidine-containing compound transmembrane transport,BP,
15852,GO:0072538,1,0.47585506672206,0,10,T-helper 17 type immune response,BP,
15853,GO:0072539,1,0.549652751458246,0,8,T-helper 17 cell differentiation,BP,
15857,GO:0072546,1,0.472593405282146,0,10,ER membrane protein complex,CC,
15864,GO:0072559,1,0.683513942873897,0,6,NLRP3 inflammasome complex,CC,
15897,GO:0072606,1,0.377792663033302,0,14,interleukin-8 secretion,BP,
15904,GO:0072641,1,0.593305179930785,0,6,type I interferon secretion,BP,
15905,GO:0072642,1,0.593305179930785,0,6,interferon-alpha secretion,BP,
15906,GO:0072643,1,0.495250436380958,0,9,interferon-gamma secretion,BP,
15913,GO:0072662,1,0.283368688192111,0,17,protein localization to peroxisome,BP,
15914,GO:0072663,1,0.283368688192111,0,17,establishment of protein localization to peroxisome,BP,
15917,GO:0072669,1,0.662634943349212,0,7,tRNA-splicing ligase complex,CC,
15970,GO:0075136,1,0.643855156244036,0,6,response to host,BP,
15975,GO:0075522,1,0.468554184551522,0,10,IRES-dependent viral translational initiation,BP,
15979,GO:0075713,1,0.575559980167197,0,8,establishment of integrated proviral latency,BP,
15982,GO:0080008,1,0.0873628732740548,0,32,Cul4-RING E3 ubiquitin ligase complex,CC,
16006,GO:0085020,1,0.622662869094905,0,7,protein K6-linked ubiquitination,BP,
16012,GO:0086004,1,0.182365053863583,0,20,regulation of cardiac muscle cell contraction,BP,
16018,GO:0086010,1,0.179278390376183,0,20,membrane depolarization during action potential,BP,
16019,GO:0086011,1,0.458565109547025,0,10,membrane repolarization during action potential,BP,
16020,GO:0086012,1,0.402135955029049,0,11,membrane depolarization during cardiac muscle cell action potential,BP,
16021,GO:0086013,1,0.574829405401033,0,7,membrane repolarization during cardiac muscle cell action potential,BP,
16040,GO:0086042,1,0.599424059187659,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16057,GO:0086069,1,0.488833855221274,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16066,GO:0086080,1,0.487668267173543,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16070,GO:0086091,1,0.235646051323463,0,17,regulation of heart rate by cardiac conduction,BP,
16075,GO:0086103,1,0.523093251825488,0,7,G-protein coupled receptor signaling pathway involved in heart process,BP,
16079,GO:0089717,1,0.592411701893912,0,6,spanning component of membrane,CC,
16081,GO:0089720,1,0.678627906675161,0,6,caspase binding,MF,
16095,GO:0090037,1,0.638406063299787,0,6,positive regulation of protein kinase C signaling,BP,
16097,GO:0090042,1,0.488256676137276,0,9,tubulin deacetylation,BP,
16098,GO:0090043,1,0.565550346747538,0,7,regulation of tubulin deacetylation,BP,
16100,GO:0090045,1,0.643885570758486,0,6,positive regulation of deacetylase activity,BP,
16114,GO:0090075,1,0.298936846527231,0,16,relaxation of muscle,BP,
16122,GO:0090085,1,0.449469809982946,0,11,regulation of protein deubiquitination,BP,
16136,GO:0090103,1,0.388824696477622,0,12,cochlea morphogenesis,BP,
16140,GO:0090110,1,0.352059584031558,0,13,cargo loading into COPII-coated vesicle,BP,
16146,GO:0090128,1,0.635346192749742,0,6,regulation of synapse maturation,BP,
16154,GO:0090140,1,0.227733288956737,0,19,regulation of mitochondrial fission,BP,
16155,GO:0090141,1,0.37928455676801,0,13,positive regulation of mitochondrial fission,BP,
16156,GO:0090148,1,0.38043913207772,0,12,membrane fission,BP,
16159,GO:0090151,1,0.513050615166271,0,12,establishment of protein localization to mitochondrial membrane,BP,
16165,GO:0090160,1,0.535084465564104,0,8,Golgi to lysosome transport,BP,
16166,GO:0090161,1,0.403419171052989,0,11,Golgi ribbon formation,BP,
16169,GO:0090166,1,0.646358591529072,0,6,Golgi disassembly,BP,
16183,GO:0090185,1,0.511532037599225,0,9,negative regulation of kidney development,BP,
16187,GO:0090189,1,0.390165442799475,0,13,regulation of branching involved in ureteric bud morphogenesis,BP,
16188,GO:0090190,1,0.445545224822346,0,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,
16193,GO:0090195,1,0.522289855029451,0,9,chemokine secretion,BP,
16194,GO:0090196,1,0.608693381784003,0,7,regulation of chemokine secretion,BP,
16195,GO:0090197,1,0.655800534908671,0,6,positive regulation of chemokine secretion,BP,
16202,GO:0090205,1,0.62453131630117,0,6,positive regulation of cholesterol metabolic process,BP,
16205,GO:0090208,1,0.440517003380142,0,11,positive regulation of triglyceride metabolic process,BP,
16212,GO:0090220,1,0.521370538968773,0,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
16218,GO:0090232,1,0.539886072143735,0,8,positive regulation of spindle checkpoint,BP,
16224,GO:0090239,1,0.451420240887954,0,11,regulation of histone H4 acetylation,BP,
16225,GO:0090240,1,0.610504030428741,0,7,positive regulation of histone H4 acetylation,BP,
16240,GO:0090267,1,0.582809905081471,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16307,GO:0090383,1,0.251272998311194,0,21,phagosome acidification,BP,
16308,GO:0090385,1,0.649772368575051,0,6,phagosome-lysosome fusion,BP,
16331,GO:0090493,1,0.692254754050753,0,6,catecholamine uptake,BP,
16332,GO:0090494,1,0.692254754050753,0,6,dopamine uptake,BP,
16344,GO:0090533,1,0.588015108923381,0,7,cation-transporting ATPase complex,CC,
16348,GO:0090545,1,0.285189832776471,0,15,CHD-type complex,CC,
16355,GO:0090568,1,0.106090814941247,0,27,nuclear transcriptional repressor complex,CC,
16360,GO:0090594,1,0.610763838010938,0,7,inflammatory response to wounding,BP,
16373,GO:0090647,1,0.643641423806856,0,6,modulation of age-related behavioral decline,BP,
16377,GO:0090657,1,0.423627224128771,0,11,telomeric loop disassembly,BP,
16378,GO:0090659,1,0.325033905021089,0,13,walking behavior,BP,
16381,GO:0090665,1,0.365879399752372,0,12,glycoprotein complex,CC,
16407,GO:0095500,1,0.445418672706315,0,11,acetylcholine receptor signaling pathway,BP,
16408,GO:0097001,1,0.560497666979733,0,8,ceramide binding,MF,
16429,GO:0097038,1,0.465668656596908,0,10,perinuclear endoplasmic reticulum,CC,
16434,GO:0097050,1,0.520813101420648,0,9,type B pancreatic cell apoptotic process,BP,
16457,GO:0097094,1,0.405619501183662,0,11,craniofacial suture morphogenesis,BP,
16463,GO:0097106,1,0.545211406338912,0,7,postsynaptic density organization,BP,
16483,GO:0097136,1,0.654932779915065,0,6,Bcl-2 family protein complex,CC,
16488,GO:0097151,1,0.591409520930219,0,6,positive regulation of inhibitory postsynaptic potential,BP,
16510,GO:0097186,1,0.32149364727007,0,14,amelogenesis,BP,
16524,GO:0097202,1,0.432589275385293,0,12,activation of cysteine-type endopeptidase activity,BP,
16538,GO:0097228,1,0.411799755454235,0,12,sperm principal piece,CC,
16570,GO:0097320,1,0.335696805352641,0,14,plasma membrane tubulation,BP,
16583,GO:0097346,1,0.193425614520097,0,23,INO80-type complex,CC,
16585,GO:0097352,1,0.0872744743673554,0,34,autophagosome maturation,BP,
16586,GO:0097354,1,0.495906092569274,0,9,prenylation,BP,
16603,GO:0097384,1,0.598863483213935,0,7,cellular lipid biosynthetic process,BP,
16613,GO:0097413,1,0.618048321534448,0,7,Lewy body,CC,
16630,GO:0097449,1,0.636206713172357,0,6,astrocyte projection,CC,
16639,GO:0097468,1,0.458506606598671,0,11,programmed cell death in response to reactive oxygen species,BP,
16657,GO:0097499,1,0.647503477037717,0,6,protein localization to non-motile cilium,BP,
16659,GO:0097501,1,0.681517767457085,0,7,stress response to metal ion,BP,
16675,GO:0097531,1,0.524739233525897,0,9,mast cell migration,BP,
16685,GO:0097546,1,0.150964715607043,0,25,ciliary base,CC,
16695,GO:0097602,1,0.293481331103286,0,17,cullin family protein binding,MF,
16723,GO:0097677,1,0.648779870469079,0,6,STAT family protein binding,MF,
16736,GO:0097709,1,0.643492123926118,0,6,connective tissue replacement,BP,
16741,GO:0097722,1,0.0964730917361611,0,30,sperm motility,BP,
16749,GO:0097734,1,0.301431767695703,0,17,extracellular exosome biogenesis,BP,
16772,GO:0098532,1,0.693104008606583,0,6,histone H3-K27 trimethylation,BP,
16778,GO:0098543,1,0.591261427956893,0,7,detection of other organism,BP,
16787,GO:0098563,1,0.335437186893996,0,15,intrinsic component of synaptic vesicle membrane,CC,
16793,GO:0098581,1,0.549371642481279,0,8,detection of external biotic stimulus,BP,
16805,GO:0098599,1,0.491655278513117,0,10,palmitoyl hydrolase activity,MF,
16842,GO:0098703,1,0.614009881569373,0,6,calcium ion import across plasma membrane,BP,
16849,GO:0098722,1,0.630958628865305,0,6,asymmetric stem cell division,BP,
16854,GO:0098734,1,0.491655278513117,0,10,macromolecule depalmitoylation,BP,
16862,GO:0098748,1,0.430435349504605,0,11,endocytic adaptor activity,MF,
16876,GO:0098779,1,0.532857388387184,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
16877,GO:0098780,1,0.267112107446213,0,17,response to mitochondrial depolarisation,BP,
16882,GO:0098792,1,0.468167748256771,0,10,xenophagy,BP,
16889,GO:0098799,1,0.469860432074295,0,12,outer mitochondrial membrane protein complex,CC,
16897,GO:0098810,1,0.572553078133345,0,8,neurotransmitter reuptake,BP,
16906,GO:0098828,1,0.591409520930219,0,6,modulation of inhibitory postsynaptic potential,BP,
16917,GO:0098843,1,0.650315195113827,0,6,postsynaptic endocytic zone,CC,
16919,GO:0098845,1,0.601071399431287,0,7,postsynaptic endosome,CC,
16932,GO:0098877,1,0.469106538222871,0,10,neurotransmitter receptor transport to plasma membrane,BP,
16943,GO:0098900,1,0.0870108541160067,0,29,regulation of action potential,BP,
16944,GO:0098901,1,0.18976808480228,0,19,regulation of cardiac muscle cell action potential,BP,
16946,GO:0098903,1,0.609369113383607,0,6,regulation of membrane repolarization during action potential,BP,
16954,GO:0098911,1,0.46893829863626,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16980,GO:0098969,1,0.506419365295918,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
16994,GO:0098993,1,0.583217345576534,0,8,anchored component of synaptic vesicle membrane,CC,
17011,GO:0099068,1,0.442046187814216,0,9,postsynapse assembly,BP,
17022,GO:0099084,1,0.545211406338912,0,7,postsynaptic specialization organization,BP,
17054,GO:0099500,1,0.492699768347865,0,10,vesicle fusion to plasma membrane,BP,
17061,GO:0099515,1,0.44487955906035,0,9,actin filament-based transport,BP,
17072,GO:0099528,1,0.519644166327492,0,9,G-protein coupled neurotransmitter receptor activity,MF,
17091,GO:0099563,1,0.3828688633634,0,12,modification of synaptic structure,BP,
17101,GO:0099590,1,0.621817239177264,0,6,neurotransmitter receptor internalization,BP,
17103,GO:0099602,1,0.681974245928843,0,6,neurotransmitter receptor regulator activity,MF,
17110,GO:0099622,1,0.288582949749261,0,15,cardiac muscle cell membrane repolarization,BP,
17111,GO:0099623,1,0.383544607836435,0,11,regulation of cardiac muscle cell membrane repolarization,BP,
17113,GO:0099625,1,0.395488442880818,0,11,ventricular cardiac muscle cell membrane repolarization,BP,
17118,GO:0099632,1,0.369446944899913,0,13,protein transport within plasma membrane,BP,
17120,GO:0099637,1,0.369446944899913,0,13,neurotransmitter receptor transport,BP,
17121,GO:0099638,1,0.631972886341715,0,6,endosome to plasma membrane protein transport,BP,
17122,GO:0099639,1,0.631972886341715,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
17138,GO:0101031,1,0.447639748597742,0,11,chaperone complex,CC,
17182,GO:0102567,1,0.404338369439103,0,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
17183,GO:0102568,1,0.404338369439103,0,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
17218,GO:0106019,1,0.43604888893058,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17223,GO:0106030,1,0.28779366040995,0,14,neuron projection fasciculation,BP,
17232,GO:0106068,1,0.627866507781505,0,7,SUMO ligase complex,CC,
17237,GO:0106074,1,0.436926092862051,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
17274,GO:0120033,1,0.242646165660012,0,19,negative regulation of plasma membrane bounded cell projection assembly,BP,
17294,GO:0120103,1,0.481521503850727,0,9,centriolar subdistal appendage,CC,
17307,GO:0140035,1,0.619579244337715,0,6,ubiquitination-like modification-dependent protein binding,MF,
17308,GO:0140036,1,0.619579244337715,0,6,ubiquitin-dependent protein binding,MF,
17313,GO:0140058,1,0.367282996158947,0,12,neuron projection arborization,BP,
17329,GO:0140103,1,0.241080502378421,0,19,catalytic activity, acting on a glycoprotein,MF,
17332,GO:0140112,1,0.261786585455499,0,19,extracellular vesicle biogenesis,BP,
17333,GO:0140115,1,0.533214630477876,0,8,export across plasma membrane,BP,
17345,GO:0150005,1,0.490898336685182,0,10,enzyme activator complex,CC,
17346,GO:0150011,1,0.555788495608816,0,7,regulation of neuron projection arborization,BP,
17347,GO:0150012,1,0.555788495608816,0,7,positive regulation of neuron projection arborization,BP,
17365,GO:1900026,1,0.129498251656516,0,27,positive regulation of substrate adhesion-dependent cell spreading,BP,
17368,GO:1900029,1,0.456009378792873,0,11,positive regulation of ruffle assembly,BP,
17372,GO:1900038,1,0.64934929076607,0,6,negative regulation of cellular response to hypoxia,BP,
17377,GO:1900044,1,0.497543820172029,0,8,regulation of protein K63-linked ubiquitination,BP,
17398,GO:1900101,1,0.159375319840975,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
17399,GO:1900102,1,0.438705132847606,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
17400,GO:1900103,1,0.380024250370952,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
17407,GO:1900112,1,0.485195642153061,0,9,regulation of histone H3-K9 trimethylation,BP,
17413,GO:1900118,1,0.628598145259761,0,6,negative regulation of execution phase of apoptosis,BP,
17416,GO:1900121,1,0.493461791461429,0,10,negative regulation of receptor binding,BP,
17468,GO:1900223,1,0.573110342114542,0,6,positive regulation of amyloid-beta clearance,BP,
17487,GO:1900271,1,0.217172453488423,0,19,regulation of long-term synaptic potentiation,BP,
17488,GO:1900272,1,0.645044695072501,0,6,negative regulation of long-term synaptic potentiation,BP,
17489,GO:1900273,1,0.436155755373985,0,10,positive regulation of long-term synaptic potentiation,BP,
17493,GO:1900363,1,0.398515307863644,0,12,regulation of mRNA polyadenylation,BP,
17494,GO:1900364,1,0.53885240186642,0,8,negative regulation of mRNA polyadenylation,BP,
17500,GO:1900372,1,0.258376451565097,0,17,negative regulation of purine nucleotide biosynthetic process,BP,
17507,GO:1900402,1,0.496330069490618,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17513,GO:1900426,1,0.627011497268514,0,7,positive regulation of defense response to bacterium,BP,
17524,GO:1900543,1,0.144742868344459,0,25,negative regulation of purine nucleotide metabolic process,BP,
17537,GO:1900746,1,0.45311910060332,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
17551,GO:1901018,1,0.454326013923026,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17557,GO:1901029,1,0.632236744598432,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17560,GO:1901032,1,0.374466772060898,0,14,negative regulation of response to reactive oxygen species,BP,
17564,GO:1901070,1,0.477480152116397,0,13,guanosine-containing compound biosynthetic process,BP,
17577,GO:1901096,1,0.434421866891127,0,10,regulation of autophagosome maturation,BP,
17579,GO:1901098,1,0.585722568218361,0,6,positive regulation of autophagosome maturation,BP,
17584,GO:1901142,1,0.611723341258094,0,6,insulin metabolic process,BP,
17591,GO:1901163,1,0.601960436096659,0,8,regulation of trophoblast cell migration,BP,
17604,GO:1901203,1,0.493886521798979,0,8,positive regulation of extracellular matrix assembly,BP,
17611,GO:1901223,1,0.569147475546828,0,8,negative regulation of NIK/NF-kappaB signaling,BP,
17635,GO:1901298,1,0.518677989687577,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
17652,GO:1901339,1,0.62073105691219,0,6,regulation of store-operated calcium channel activity,BP,
17670,GO:1901381,1,0.3761316531416,0,11,positive regulation of potassium ion transmembrane transport,BP,
17672,GO:1901385,1,0.336009829246251,0,14,regulation of voltage-gated calcium channel activity,BP,
17677,GO:1901407,1,0.521834881684869,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17678,GO:1901409,1,0.610193941595286,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17689,GO:1901522,1,0.19395482172075,0,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
17691,GO:1901524,1,0.327984123088833,0,14,regulation of mitophagy,BP,
17692,GO:1901525,1,0.615735942448689,0,6,negative regulation of mitophagy,BP,
17693,GO:1901526,1,0.532857388387184,0,8,positive regulation of mitophagy,BP,
17696,GO:1901533,1,0.641783538800145,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17713,GO:1901567,1,0.25804684179405,0,21,fatty acid derivative binding,MF,
17728,GO:1901611,1,0.530579565257349,0,9,phosphatidylglycerol binding,MF,
17729,GO:1901612,1,0.653696489003742,0,6,cardiolipin binding,MF,
17733,GO:1901618,1,0.308293366880698,0,15,organic hydroxy compound transmembrane transporter activity,MF,
17734,GO:1901620,1,0.584790078308831,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17738,GO:1901626,1,0.623461548320334,0,6,regulation of postsynaptic membrane organization,BP,
17768,GO:1901679,1,0.564819067655537,0,8,nucleotide transmembrane transport,BP,
17771,GO:1901682,1,0.222027859365496,0,19,sulfur compound transmembrane transporter activity,MF,
17772,GO:1901685,1,0.439694015734704,0,16,glutathione derivative metabolic process,BP,
17773,GO:1901687,1,0.439694015734704,0,16,glutathione derivative biosynthetic process,BP,
17783,GO:1901725,1,0.593938013930427,0,6,regulation of histone deacetylase activity,BP,
17808,GO:1901844,1,0.588970658658659,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17821,GO:1901881,1,0.50588993277153,0,9,positive regulation of protein depolymerization,BP,
17842,GO:1901970,1,0.555013724247237,0,8,positive regulation of mitotic sister chromatid separation,BP,
17845,GO:1901978,1,0.501058149275009,0,9,positive regulation of cell cycle checkpoint,BP,
17861,GO:1902001,1,0.279522076407738,0,15,fatty acid transmembrane transport,BP,
17866,GO:1902018,1,0.514825893691812,0,9,negative regulation of cilium assembly,BP,
17870,GO:1902031,1,0.653161141454665,0,6,regulation of NADP metabolic process,BP,
17892,GO:1902101,1,0.555013724247237,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17923,GO:1902188,1,0.336902497192777,0,15,positive regulation of viral release from host cell,BP,
17937,GO:1902224,1,0.603232735912564,0,7,ketone body metabolic process,BP,
17943,GO:1902231,1,0.702529178120427,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17946,GO:1902235,1,0.172891044567233,0,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17947,GO:1902236,1,0.397014363927452,0,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17948,GO:1902237,1,0.501151785891737,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17956,GO:1902259,1,0.47585108415049,0,9,regulation of delayed rectifier potassium channel activity,BP,
17968,GO:1902284,1,0.0821421425261614,0,28,neuron projection extension involved in neuron projection guidance,BP,
17969,GO:1902285,1,0.327736743826214,0,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
17970,GO:1902287,1,0.357502975010546,0,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,
17991,GO:1902358,1,0.620194519428719,0,6,sulfate transmembrane transport,BP,
18010,GO:1902410,1,0.63987311406432,0,6,mitotic cytokinetic process,BP,
18012,GO:1902414,1,0.508609225219199,0,8,protein localization to cell junction,BP,
18013,GO:1902415,1,0.530368538883075,0,9,regulation of mRNA binding,BP,
18014,GO:1902416,1,0.609262777268217,0,7,positive regulation of mRNA binding,BP,
18023,GO:1902459,1,0.602341807887238,0,6,positive regulation of stem cell population maintenance,BP,
18029,GO:1902473,1,0.574919942510362,0,7,regulation of protein localization to synapse,BP,
18030,GO:1902474,1,0.619464178825334,0,6,positive regulation of protein localization to synapse,BP,
18041,GO:1902510,1,0.669941684892798,0,6,regulation of apoptotic DNA fragmentation,BP,
18044,GO:1902513,1,0.63471376583464,0,6,regulation of organelle transport along microtubule,BP,
18057,GO:1902547,1,0.45311910060332,0,10,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
18098,GO:1902656,1,0.614009881569373,0,6,calcium ion import into cytosol,BP,
18101,GO:1902667,1,0.0778182023203194,0,29,regulation of axon guidance,BP,
18102,GO:1902668,1,0.203772061949821,0,19,negative regulation of axon guidance,BP,
18103,GO:1902669,1,0.505069143158461,0,7,positive regulation of axon guidance,BP,
18111,GO:1902692,1,0.256266473554068,0,16,regulation of neuroblast proliferation,BP,
18126,GO:1902739,1,0.593305179930785,0,6,regulation of interferon-alpha secretion,BP,
18127,GO:1902741,1,0.593305179930785,0,6,positive regulation of interferon-alpha secretion,BP,
18160,GO:1902855,1,0.471277732523295,0,10,regulation of non-motile cilium assembly,BP,
18162,GO:1902857,1,0.596701034365743,0,7,positive regulation of non-motile cilium assembly,BP,
18180,GO:1902902,1,0.45942213375276,0,11,negative regulation of autophagosome assembly,BP,
18189,GO:1902914,1,0.296017149339514,0,15,regulation of protein polyubiquitination,BP,
18190,GO:1902915,1,0.595545661598872,0,6,negative regulation of protein polyubiquitination,BP,
18191,GO:1902916,1,0.54987648415801,0,8,positive regulation of protein polyubiquitination,BP,
18193,GO:1902931,1,0.62506231157653,0,7,negative regulation of alcohol biosynthetic process,BP,
18201,GO:1902946,1,0.498322479245051,0,8,protein localization to early endosome,BP,
18205,GO:1902950,1,0.652568820974739,0,6,regulation of dendritic spine maintenance,BP,
18214,GO:1902959,1,0.520234555154734,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18216,GO:1902961,1,0.62911499466776,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18219,GO:1902965,1,0.58369236781818,0,6,regulation of protein localization to early endosome,BP,
18220,GO:1902966,1,0.58369236781818,0,6,positive regulation of protein localization to early endosome,BP,
18237,GO:1903003,1,0.640910740754695,0,6,positive regulation of protein deubiquitination,BP,
18262,GO:1903044,1,0.559575638494236,0,8,protein localization to membrane raft,BP,
18302,GO:1903147,1,0.550214858836674,0,8,negative regulation of autophagy of mitochondrion,BP,
18326,GO:1903206,1,0.374466772060898,0,14,negative regulation of hydrogen peroxide-induced cell death,BP,
18329,GO:1903209,1,0.455321266173481,0,11,positive regulation of oxidative stress-induced cell death,BP,
18341,GO:1903242,1,0.594442689401211,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
18368,GO:1903306,1,0.385876186190443,0,12,negative regulation of regulated secretory pathway,BP,
18379,GO:1903332,1,0.615643966324109,0,7,regulation of protein folding,BP,
18386,GO:1903349,1,0.637233932662222,0,6,omegasome membrane,CC,
18387,GO:1903350,1,0.433939241562535,0,11,response to dopamine,BP,
18388,GO:1903351,1,0.433939241562535,0,11,cellular response to dopamine,BP,
18390,GO:1903358,1,0.310754825393768,0,15,regulation of Golgi organization,BP,
18400,GO:1903376,1,0.600683694901231,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18415,GO:1903405,1,0.535050667949223,0,9,protein localization to nuclear body,BP,
18429,GO:1903431,1,0.557220852347044,0,7,positive regulation of cell maturation,BP,
18438,GO:1903441,1,0.584727139755108,0,7,protein localization to ciliary membrane,BP,
18457,GO:1903513,1,0.162095850893162,0,25,endoplasmic reticulum to cytosol transport,BP,
18458,GO:1903514,1,0.247865845956271,0,17,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
18477,GO:1903539,1,0.506419365295918,0,9,protein localization to postsynaptic membrane,BP,
18478,GO:1903540,1,0.506419365295918,0,9,establishment of protein localization to postsynaptic membrane,BP,
18479,GO:1903541,1,0.369824837381266,0,14,regulation of exosomal secretion,BP,
18481,GO:1903543,1,0.369824837381266,0,14,positive regulation of exosomal secretion,BP,
18486,GO:1903551,1,0.642950593925387,0,6,regulation of extracellular exosome assembly,BP,
18504,GO:1903579,1,0.319690747358705,0,15,negative regulation of ATP metabolic process,BP,
18505,GO:1903580,1,0.182261503157621,0,22,positive regulation of ATP metabolic process,BP,
18515,GO:1903599,1,0.26138360780855,0,17,positive regulation of autophagy of mitochondrion,BP,
18521,GO:1903624,1,0.594244806784348,0,7,regulation of DNA catabolic process,BP,
18543,GO:1903689,1,0.554303357676996,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18599,GO:1903800,1,0.608820813712363,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18612,GO:1903831,1,0.445418672706315,0,11,signal transduction involved in cellular response to ammonium ion,BP,
18637,GO:1903894,1,0.387612306436921,0,13,regulation of IRE1-mediated unfolded protein response,BP,
18639,GO:1903896,1,0.591335576407077,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
18640,GO:1903897,1,0.503035617977258,0,9,regulation of PERK-mediated unfolded protein response,BP,
18744,GO:1904152,1,0.418827384237087,0,12,regulation of retrograde protein transport, ER to cytosol,BP,
18745,GO:1904153,1,0.520611124325087,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18756,GO:1904181,1,0.612925063749974,0,7,positive regulation of membrane depolarization,BP,
18795,GO:1904262,1,0.429142395630522,0,11,negative regulation of TORC1 signaling,BP,
18808,GO:1904293,1,0.389623989735725,0,13,negative regulation of ERAD pathway,BP,
18827,GO:1904350,1,0.517763962151815,0,8,regulation of protein catabolic process in the vacuole,BP,
18832,GO:1904355,1,0.296945819488348,0,16,positive regulation of telomere capping,BP,
18841,GO:1904380,1,0.235896598676827,0,19,endoplasmic reticulum mannose trimming,BP,
18853,GO:1904406,1,0.480413278499603,0,10,negative regulation of nitric oxide metabolic process,BP,
18858,GO:1904415,1,0.638107152540415,0,6,regulation of xenophagy,BP,
18859,GO:1904417,1,0.638107152540415,0,6,positive regulation of xenophagy,BP,
18860,GO:1904424,1,0.481759313954519,0,9,regulation of GTP binding,BP,
18864,GO:1904429,1,0.585941908834875,0,7,regulation of t-circle formation,BP,
18881,GO:1904469,1,0.537464072471497,0,7,positive regulation of tumor necrosis factor secretion,BP,
18895,GO:1904526,1,0.508692378074904,0,9,regulation of microtubule binding,BP,
18897,GO:1904528,1,0.646892869069734,0,6,positive regulation of microtubule binding,BP,
18948,GO:1904645,1,0.20632066564242,0,19,response to amyloid-beta,BP,
18949,GO:1904646,1,0.220956366940015,0,18,cellular response to amyloid-beta,BP,
18952,GO:1904666,1,0.340300801676708,0,18,regulation of ubiquitin protein ligase activity,BP,
18953,GO:1904667,1,0.770269005752534,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18954,GO:1904668,1,0.441906961805951,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18962,GO:1904683,1,0.593533438313536,0,6,regulation of metalloendopeptidase activity,BP,
18980,GO:1904714,1,0.643445118625527,0,6,regulation of chaperone-mediated autophagy,BP,
19012,GO:1904776,1,0.61220065557347,0,6,regulation of protein localization to cell cortex,BP,
19015,GO:1904779,1,0.579878552290797,0,6,regulation of protein localization to centrosome,BP,
19053,GO:1904861,1,0.547323500848211,0,7,excitatory synapse assembly,BP,
19055,GO:1904867,1,0.535050667949223,0,9,protein localization to Cajal body,BP,
19057,GO:1904869,1,0.571288205855315,0,8,regulation of protein localization to Cajal body,BP,
19058,GO:1904871,1,0.571288205855315,0,8,positive regulation of protein localization to Cajal body,BP,
19079,GO:1904896,1,0.498123502165948,0,10,ESCRT complex disassembly,BP,
19081,GO:1904903,1,0.498123502165948,0,10,ESCRT III complex disassembly,BP,
19088,GO:1904923,1,0.389956271457429,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19090,GO:1904925,1,0.418919225864424,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19092,GO:1904929,1,0.616056326521751,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
19145,GO:1905049,1,0.613422346842546,0,6,negative regulation of metallopeptidase activity,BP,
19164,GO:1905097,1,0.610459200517737,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
19173,GO:1905144,1,0.445418672706315,0,11,response to acetylcholine,BP,
19174,GO:1905145,1,0.445418672706315,0,11,cellular response to acetylcholine,BP,
19183,GO:1905165,1,0.591332903481957,0,6,regulation of lysosomal protein catabolic process,BP,
19208,GO:1905244,1,0.521370731639147,0,8,regulation of modification of synaptic structure,BP,
19209,GO:1905245,1,0.520234555154734,0,8,regulation of aspartic-type peptidase activity,BP,
19211,GO:1905247,1,0.62911499466776,0,6,positive regulation of aspartic-type peptidase activity,BP,
19227,GO:1905288,1,0.605915128321618,0,6,vascular associated smooth muscle cell apoptotic process,BP,
19256,GO:1905354,1,0.226541480690503,0,22,exoribonuclease complex,CC,
19259,GO:1905360,1,0.25286603583743,0,19,GTPase complex,CC,
19298,GO:1905456,1,0.563801632198923,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19301,GO:1905459,1,0.605915128321618,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
19314,GO:1905508,1,0.0959504202830806,0,27,protein localization to microtubule organizing center,BP,
19315,GO:1905515,1,0.0280321507720391,0,47,non-motile cilium assembly,BP,
19368,GO:1905666,1,0.466597821204153,0,9,regulation of protein localization to endosome,BP,
19369,GO:1905668,1,0.466597821204153,0,9,positive regulation of protein localization to endosome,BP,
19400,GO:1905809,1,0.420742431933709,0,11,negative regulation of synapse organization,BP,
19403,GO:1905820,1,0.503421838359126,0,9,positive regulation of chromosome separation,BP,
19416,GO:1905879,1,0.575291743456208,0,7,regulation of oogenesis,BP,
19448,GO:1905961,1,0.557362733315861,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19467,GO:1990050,1,0.681451022236377,0,6,phosphatidic acid transporter activity,MF,
19482,GO:1990124,1,0.568364996037458,0,7,messenger ribonucleoprotein complex,CC,
19483,GO:1990126,1,0.29330164798053,0,16,retrograde transport, endosome to plasma membrane,BP,
19490,GO:1990144,1,0.662385038997871,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
19500,GO:1990173,1,0.491321226372091,0,10,protein localization to nucleoplasm,BP,
19505,GO:1990182,1,0.301431767695703,0,17,exosomal secretion,BP,
19514,GO:1990247,1,0.562842169656456,0,7,N6-methyladenosine-containing RNA binding,MF,
19529,GO:1990316,1,0.508674618068107,0,8,Atg1/ULK1 kinase complex,CC,
19536,GO:1990381,1,0.363546215935533,0,13,ubiquitin-specific protease binding,MF,
19545,GO:1990403,1,0.536102148721552,0,8,embryonic brain development,BP,
19555,GO:1990416,1,0.606705689949108,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19574,GO:1990459,1,0.640855053445023,0,6,transferrin receptor binding,MF,
19576,GO:1990462,1,0.590019958490297,0,7,omegasome,CC,
19689,GO:1990907,1,0.397255994083456,0,11,beta-catenin-TCF complex,CC,
19733,GO:2000036,1,0.21274295826161,0,19,regulation of stem cell population maintenance,BP,
19760,GO:2000096,1,0.624135867011238,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19782,GO:2000136,1,0.415081417884061,0,11,regulation of cell proliferation involved in heart morphogenesis,BP,
19802,GO:2000177,1,0.0351699634522903,0,41,regulation of neural precursor cell proliferation,BP,
19803,GO:2000178,1,0.353254083197346,0,13,negative regulation of neural precursor cell proliferation,BP,
19804,GO:2000179,1,0.182226911890907,0,21,positive regulation of neural precursor cell proliferation,BP,
19810,GO:2000194,1,0.611174669732645,0,7,regulation of female gonad development,BP,
19819,GO:2000209,1,0.235603015645788,0,19,regulation of anoikis,BP,
19820,GO:2000210,1,0.677449560956115,0,6,positive regulation of anoikis,BP,
19860,GO:2000288,1,0.653570172364392,0,6,positive regulation of myoblast proliferation,BP,
19861,GO:2000291,1,0.587997313967544,0,7,regulation of myoblast proliferation,BP,
19873,GO:2000310,1,0.495370251207098,0,9,regulation of NMDA receptor activity,BP,
19878,GO:2000316,1,0.613844310818513,0,7,regulation of T-helper 17 type immune response,BP,
19907,GO:2000352,1,0.300550534640858,0,15,negative regulation of endothelial cell apoptotic process,BP,
19925,GO:2000380,1,0.550658928775999,0,7,regulation of mesoderm development,BP,
19970,GO:2000465,1,0.605405776063277,0,6,regulation of glycogen (starch) synthase activity,BP,
19976,GO:2000479,1,0.402860797227812,0,12,regulation of cAMP-dependent protein kinase activity,BP,
19977,GO:2000480,1,0.612457780705582,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19979,GO:2000482,1,0.406212959337001,0,13,regulation of interleukin-8 secretion,BP,
19981,GO:2000484,1,0.57582581204232,0,8,positive regulation of interleukin-8 secretion,BP,
19992,GO:2000516,1,0.377848495773501,0,14,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
20031,GO:2000601,1,0.614493842463787,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
20039,GO:2000617,1,0.622661446647168,0,6,positive regulation of histone H3-K9 acetylation,BP,
20047,GO:2000628,1,0.600267976555477,0,7,regulation of miRNA metabolic process,BP,
20060,GO:2000647,1,0.454825972958507,0,10,negative regulation of stem cell proliferation,BP,
20084,GO:2000674,1,0.520813101420648,0,9,regulation of type B pancreatic cell apoptotic process,BP,
20089,GO:2000679,1,0.309450530616078,0,16,positive regulation of transcription regulatory region DNA binding,BP,
20128,GO:2000758,1,0.135734148327935,0,27,positive regulation of peptidyl-lysine acetylation,BP,
20132,GO:2000766,1,0.612970482062963,0,6,negative regulation of cytoplasmic translation,BP,
20133,GO:2000767,1,0.536912185060621,0,8,positive regulation of cytoplasmic translation,BP,
20140,GO:2000778,1,0.301590451042551,0,16,positive regulation of interleukin-6 secretion,BP,
20159,GO:2000811,1,0.365190359865553,0,13,negative regulation of anoikis,BP,
20194,GO:2000973,1,0.610420759215238,0,6,regulation of pro-B cell differentiation,BP,
20213,GO:2001025,1,0.441317084225116,0,12,positive regulation of response to drug,BP,
20225,GO:2001039,1,0.374466772060898,0,14,negative regulation of cellular response to drug,BP,
20226,GO:2001040,1,0.638301682357809,0,6,positive regulation of cellular response to drug,BP,
20230,GO:2001053,1,0.639612623860132,0,6,regulation of mesenchymal cell apoptotic process,BP,
20246,GO:2001138,1,0.664765406580788,0,6,regulation of phospholipid transport,BP,
20247,GO:2001140,1,0.664765406580788,0,6,positive regulation of phospholipid transport,BP,
20263,GO:2001170,1,0.480436160208415,0,9,negative regulation of ATP biosynthetic process,BP,
20264,GO:2001171,1,0.239108034102025,0,18,positive regulation of ATP biosynthetic process,BP,
20317,GO:2001256,1,0.549317474217283,0,8,regulation of store-operated calcium entry,BP,
11324,GO:0045627,1,0.809393552393918,0,3,positive regulation of T-helper 1 cell differentiation,BP,
10401,GO:0043221,1.00000000000002,0.924114188682933,0,1,SMC family protein binding,MF,
6504,GO:0021870,1.00000000000003,0.913019374778939,0,1,Cajal-Retzius cell differentiation,BP,
19024,GO:1904797,1.00000000000003,0.913019374778939,0,1,negative regulation of core promoter binding,BP,
12184,GO:0048289,1.00000000000004,0.74130431019327,0,4,isotype switching to IgE isotypes,BP,
12187,GO:0048293,1.00000000000004,0.74130431019327,0,4,regulation of isotype switching to IgE isotypes,BP,
5799,GO:0017040,1.00000000000007,0.768254572531527,0,4,N-acylsphingosine amidohydrolase activity,MF,
5093,GO:0015355,1.00000000000008,0.763411357937083,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
10870,GO:0044375,1.00000000000009,0.894256398120121,0,2,regulation of peroxisome size,BP,
1749,GO:0004346,1.00000000000009,0.940159061550146,0,1,glucose-6-phosphatase activity,MF,
12484,GO:0050309,1.00000000000009,0.940159061550146,0,1,sugar-terminal-phosphatase activity,MF,
9580,GO:0036371,1.0000000000001,0.902294987107001,0,1,protein localization to T-tubule,BP,
16044,GO:0086046,1.0000000000001,0.902294987107001,0,1,membrane depolarization during SA node cell action potential,BP,
16950,GO:0098907,1.0000000000001,0.902294987107001,0,1,regulation of SA node cell action potential,BP,
14453,GO:0061750,1.0000000000001,0.93154316642678,0,1,acid sphingomyelin phosphodiesterase activity,MF,
2194,GO:0005052,1.0000000000001,0.857529097523136,0,2,peroxisome matrix targeting signal-1 binding,MF,
2822,GO:0006287,1.00000000000011,0.679181998518054,0,5,base-excision repair, gap-filling,BP,
17378,GO:1900045,1.00000000000011,0.645894630672686,0,5,negative regulation of protein K63-linked ubiquitination,BP,
3171,GO:0006784,1.00000000000012,0.842105520435031,0,2,heme a biosynthetic process,BP,
11602,GO:0046160,1.00000000000012,0.842105520435031,0,2,heme a metabolic process,BP,
6664,GO:0030015,1.00000000000013,0.677995894349838,0,5,CCR4-NOT core complex,CC,
13128,GO:0051643,1.00000000000013,0.6355372760359,0,5,endoplasmic reticulum localization,BP,
6410,GO:0021636,1.00000000000013,0.716640604771972,0,4,trigeminal nerve morphogenesis,BP,
6411,GO:0021637,1.00000000000013,0.716640604771972,0,4,trigeminal nerve structural organization,BP,
309,GO:0000820,1.00000000000014,0.825465225730908,0,2,regulation of glutamine family amino acid metabolic process,BP,
11402,GO:0045763,1.00000000000014,0.825465225730908,0,2,negative regulation of cellular amino acid metabolic process,BP,
51,GO:0000105,1.00000000000014,0.862043587850795,0,2,histidine biosynthetic process,BP,
8681,GO:0034245,1.00000000000014,0.924314489591528,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
17899,GO:1902109,1.00000000000014,0.833139272825884,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
9357,GO:0035860,1.00000000000015,0.85546982735093,0,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
17958,GO:1902261,1.00000000000015,0.822643306518736,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
5449,GO:0016314,1.00000000000016,0.842258208286829,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
2631,GO:0005956,1.00000000000017,0.883739740050236,0,2,protein kinase CK2 complex,CC,
1611,GO:0004031,1.00000000000017,0.919027054906271,0,1,aldehyde oxidase activity,MF,
5597,GO:0016623,1.00000000000017,0.919027054906271,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
17193,GO:0102797,1.00000000000017,0.919027054906271,0,1,geranial:oxygen oxidoreductase activity,MF,
17194,GO:0102798,1.00000000000017,0.919027054906271,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
19023,GO:1904796,1.00000000000019,0.682580761550644,0,5,regulation of core promoter binding,BP,
1584,GO:0003991,1.0000000000002,0.933917181497806,0,1,acetylglutamate kinase activity,MF,
1616,GO:0004042,1.0000000000002,0.933917181497806,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
17201,GO:0103045,1.0000000000002,0.933917181497806,0,1,methione N-acyltransferase activity,MF,
5907,GO:0018117,1.0000000000002,0.939943676441106,0,1,protein adenylylation,BP,
5919,GO:0018175,1.0000000000002,0.939943676441106,0,1,protein nucleotidylation,BP,
10951,GO:0044601,1.0000000000002,0.939943676441106,0,1,protein denucleotidylation,BP,
10952,GO:0044602,1.0000000000002,0.939943676441106,0,1,protein deadenylylation,BP,
10953,GO:0044603,1.0000000000002,0.939943676441106,0,1,protein adenylylhydrolase activity,MF,
14924,GO:0070733,1.0000000000002,0.939943676441106,0,1,protein adenylyltransferase activity,MF,
17321,GO:0140074,1.00000000000021,0.917855023130077,0,1,cardiac endothelial to mesenchymal transition,BP,
19485,GO:1990130,1.00000000000021,0.6905469338286,0,5,GATOR1 complex,CC,
19293,GO:1905446,1.00000000000022,0.721857838592006,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
1073,GO:0002636,1.00000000000023,0.942029096952555,0,1,positive regulation of germinal center formation,BP,
2753,GO:0006157,1.00000000000023,0.942029096952555,0,1,deoxyadenosine catabolic process,BP,
9963,GO:0042321,1.00000000000023,0.942029096952555,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9964,GO:0042323,1.00000000000023,0.942029096952555,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11569,GO:0046090,1.00000000000023,0.942029096952555,0,1,deoxyadenosine metabolic process,BP,
11580,GO:0046111,1.00000000000023,0.942029096952555,0,1,xanthine biosynthetic process,BP,
11586,GO:0046124,1.00000000000023,0.942029096952555,0,1,purine deoxyribonucleoside catabolic process,BP,
13676,GO:0060167,1.00000000000023,0.942029096952555,0,1,regulation of adenosine receptor signaling pathway,BP,
13677,GO:0060169,1.00000000000023,0.942029096952555,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13836,GO:0060407,1.00000000000023,0.942029096952555,0,1,negative regulation of penile erection,BP,
14673,GO:0070256,1.00000000000023,0.942029096952555,0,1,negative regulation of mucus secretion,BP,
5012,GO:0015168,1.00000000000024,0.869226438861902,0,2,glycerol transmembrane transporter activity,MF,
5058,GO:0015254,1.00000000000024,0.869226438861902,0,2,glycerol channel activity,MF,
5201,GO:0015793,1.00000000000024,0.869226438861902,0,2,glycerol transport,BP,
15164,GO:0071253,1.00000000000025,0.682131326749031,0,5,connexin binding,MF,
1577,GO:0003983,1.00000000000025,0.933174387258518,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
13183,GO:0051748,1.00000000000025,0.933174387258518,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
2238,GO:0005142,1.00000000000026,0.931323022274434,0,1,interleukin-11 receptor binding,MF,
5846,GO:0017133,1.00000000000026,0.931323022274434,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10669,GO:0043783,1.00000000000026,0.931323022274434,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11188,GO:0045251,1.00000000000026,0.931323022274434,0,1,electron transfer flavoprotein complex,CC,
17879,GO:1902044,1.00000000000028,0.857657304277199,0,2,regulation of Fas signaling pathway,BP,
2854,GO:0006343,1.00000000000028,0.92420456531271,0,1,establishment of chromatin silencing,BP,
10103,GO:0042595,1.00000000000028,0.92420456531271,0,1,behavioral response to starvation,BP,
15284,GO:0071441,1.00000000000028,0.92420456531271,0,1,negative regulation of histone H3-K14 acetylation,BP,
20066,GO:2000654,1.00000000000028,0.92420456531271,0,1,regulation of cellular response to testosterone stimulus,BP,
20067,GO:2000655,1.00000000000028,0.92420456531271,0,1,negative regulation of cellular response to testosterone stimulus,BP,
9404,GO:0035933,1.00000000000029,0.811969442903602,0,3,glucocorticoid secretion,BP,
20182,GO:2000849,1.00000000000029,0.811969442903602,0,3,regulation of glucocorticoid secretion,BP,
19756,GO:2000078,1.0000000000003,0.882795487750835,0,2,positive regulation of type B pancreatic cell development,BP,
3419,GO:0007206,1.0000000000003,0.922628838956848,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
16509,GO:0097180,1.00000000000031,0.902701139602045,0,2,serine protease inhibitor complex,CC,
15963,GO:0072757,1.00000000000031,0.737026460223367,0,4,cellular response to camptothecin,BP,
13582,GO:0060025,1.00000000000031,0.854881725296678,0,2,regulation of synaptic activity,BP,
10704,GO:0043973,1.00000000000031,0.932590947019027,0,1,histone H3-K4 acetylation,BP,
11311,GO:0045607,1.00000000000031,0.688572121325225,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11328,GO:0045631,1.00000000000031,0.688572121325225,0,5,regulation of mechanoreceptor differentiation,BP,
20198,GO:2000980,1.00000000000031,0.688572121325225,0,5,regulation of inner ear receptor cell differentiation,BP,
17803,GO:1901837,1.00000000000032,0.87284582234549,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17395,GO:1900095,1.00000000000033,0.889626971194026,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
5894,GO:0018057,1.00000000000033,0.795288684380893,0,3,peptidyl-lysine oxidation,BP,
173,GO:0000379,1.00000000000033,0.813658523195456,0,3,tRNA-type intron splice site recognition and cleavage,BP,
16592,GO:0097363,1.00000000000034,0.850412697796497,0,2,protein O-GlcNAc transferase activity,MF,
5678,GO:0016785,1.00000000000034,0.91538015104175,0,1,transferase activity, transferring selenium-containing groups,MF,
16808,GO:0098621,1.00000000000034,0.91538015104175,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
14693,GO:0070292,1.00000000000034,0.851750964064666,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
1912,GO:0004597,1.00000000000035,0.925037887639005,0,1,peptide-aspartate beta-dioxygenase activity,MF,
6478,GO:0021815,1.00000000000035,0.638185510002862,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
17871,GO:1902033,1.00000000000035,0.68612983214242,0,5,regulation of hematopoietic stem cell proliferation,BP,
19516,GO:1990254,1.00000000000035,0.742452631552555,0,4,keratin filament binding,MF,
5792,GO:0017018,1.00000000000035,0.839619965347495,0,2,myosin phosphatase activity,MF,
13613,GO:0060060,1.00000000000037,0.907456977105723,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14861,GO:0070593,1.00000000000037,0.907456977105723,0,1,dendrite self-avoidance,BP,
8627,GO:0034137,1.00000000000037,0.838778945534635,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
1396,GO:0003307,1.00000000000038,0.80924249751075,0,3,regulation of Wnt signaling pathway involved in heart development,BP,
2067,GO:0004818,1.00000000000039,0.848695130657615,0,2,glutamate-tRNA ligase activity,MF,
2913,GO:0006424,1.00000000000039,0.848695130657615,0,2,glutamyl-tRNA aminoacylation,BP,
11585,GO:0046122,1.00000000000039,0.899119012241925,0,2,purine deoxyribonucleoside metabolic process,BP,
17482,GO:1900248,1.0000000000004,0.837261153477308,0,2,negative regulation of cytoplasmic translational elongation,BP,
14844,GO:0070568,1.0000000000004,0.701566479682242,0,5,guanylyltransferase activity,MF,
4835,GO:0014038,1.0000000000004,0.777526611020485,0,3,regulation of Schwann cell differentiation,BP,
18583,GO:1903772,1.00000000000041,0.719081236904803,0,5,regulation of viral budding via host ESCRT complex,BP,
1774,GO:0004376,1.00000000000041,0.749625855392656,0,4,glycolipid mannosyltransferase activity,MF,
19272,GO:1905395,1.00000000000041,0.886311352262224,0,2,response to flavonoid,BP,
1699,GO:0004174,1.00000000000042,0.862944836144464,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5610,GO:0016649,1.00000000000042,0.862944836144464,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
10965,GO:0044691,1.00000000000043,0.913656580344365,0,1,tooth eruption,BP,
18087,GO:1902618,1.00000000000043,0.913656580344365,0,1,cellular response to fluoride,BP,
14379,GO:0061588,1.00000000000043,0.73296415753436,0,4,calcium activated phospholipid scrambling,BP,
14380,GO:0061589,1.00000000000043,0.73296415753436,0,4,calcium activated phosphatidylserine scrambling,BP,
14381,GO:0061590,1.00000000000043,0.73296415753436,0,4,calcium activated phosphatidylcholine scrambling,BP,
14382,GO:0061591,1.00000000000043,0.73296415753436,0,4,calcium activated galactosylceramide scrambling,BP,
8876,GO:0034670,1.00000000000044,0.893862214277309,0,1,chemotaxis to arachidonic acid,BP,
6017,GO:0019064,1.00000000000044,0.80846435879317,0,3,fusion of virus membrane with host plasma membrane,BP,
9788,GO:0039663,1.00000000000044,0.80846435879317,0,3,membrane fusion involved in viral entry into host cell,BP,
11008,GO:0044800,1.00000000000044,0.80846435879317,0,3,multi-organism membrane fusion,BP,
2624,GO:0005943,1.00000000000044,0.84563437432876,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
16719,GO:0097651,1.00000000000044,0.84563437432876,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
15679,GO:0072178,1.00000000000045,0.669476037589018,0,5,nephric duct morphogenesis,BP,
17088,GO:0099552,1.00000000000045,0.924354328290613,0,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
17089,GO:0099553,1.00000000000045,0.924354328290613,0,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
17424,GO:1900134,1.00000000000045,0.924354328290613,0,1,negative regulation of renin secretion into blood stream,BP,
11912,GO:0046920,1.00000000000048,0.682654722533931,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
80,GO:0000160,1.00000000000048,0.834618313364837,0,2,phosphorelay signal transduction system,BP,
2598,GO:0005892,1.00000000000049,0.722350071164631,0,4,acetylcholine-gated channel complex,CC,
15013,GO:0070915,1.00000000000049,0.758972367911286,0,4,lysophosphatidic acid receptor activity,MF,
18520,GO:1903621,1.0000000000005,0.9354246935774,0,1,protein localization to photoreceptor connecting cilium,BP,
19900,GO:2000344,1.0000000000005,0.766132950521354,0,4,positive regulation of acrosome reaction,BP,
18291,GO:1903121,1.00000000000051,0.749967276794402,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
2284,GO:0005234,1.00000000000052,0.850829529085778,0,2,extracellularly glutamate-gated ion channel activity,MF,
5038,GO:0015211,1.00000000000052,0.930444995629086,0,1,purine nucleoside transmembrane transporter activity,MF,
20296,GO:2001226,1.00000000000053,0.860337301457478,0,2,negative regulation of chloride transport,BP,
3294,GO:0006990,1.00000000000054,0.789158743415876,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
1870,GO:0004531,1.00000000000054,0.93464465755084,0,1,deoxyribonuclease II activity,MF,
19316,GO:1905516,1.00000000000055,0.703753633536468,0,5,positive regulation of fertilization,BP,
16528,GO:0097210,1.00000000000055,0.851518505657884,0,2,response to gonadotropin-releasing hormone,BP,
16529,GO:0097211,1.00000000000055,0.851518505657884,0,2,cellular response to gonadotropin-releasing hormone,BP,
15049,GO:0070975,1.00000000000057,0.906192943146142,0,1,FHA domain binding,MF,
6479,GO:0021816,1.00000000000057,0.84791640392517,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
4945,GO:0014908,1.00000000000059,0.912009449580719,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
16046,GO:0086048,1.00000000000059,0.853226326700701,0,2,membrane depolarization during bundle of His cell action potential,BP,
2024,GO:0004751,1.00000000000059,0.936902730664447,0,1,ribose-5-phosphate isomerase activity,MF,
2037,GO:0004775,1.00000000000059,0.880301507635625,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
17542,GO:1900756,1.0000000000006,0.840977420076353,0,2,protein processing in phagocytic vesicle,BP,
18656,GO:1903921,1.0000000000006,0.840977420076353,0,2,regulation of protein processing in phagocytic vesicle,BP,
18657,GO:1903923,1.0000000000006,0.840977420076353,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
11994,GO:0047275,1.0000000000006,0.925384488198397,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
19792,GO:2000156,1.00000000000061,0.857763079745262,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
12305,GO:0048617,1.00000000000063,0.607554001069429,0,5,embryonic foregut morphogenesis,BP,
19397,GO:1905794,1.00000000000063,0.892096082552467,0,1,response to puromycin,BP,
19398,GO:1905795,1.00000000000063,0.892096082552467,0,1,cellular response to puromycin,BP,
16261,GO:0090296,1.00000000000063,0.749148027999981,0,4,regulation of mitochondrial DNA replication,BP,
17811,GO:1901858,1.00000000000063,0.749148027999981,0,4,regulation of mitochondrial DNA metabolic process,BP,
5026,GO:0015187,1.00000000000063,0.684643447556961,0,5,glycine transmembrane transporter activity,MF,
7127,GO:0030942,1.00000000000064,0.824960733557493,0,3,endoplasmic reticulum signal peptide binding,MF,
14696,GO:0070295,1.00000000000064,0.809649657479928,0,3,renal water absorption,BP,
3751,GO:0008291,1.00000000000064,0.929397820886854,0,1,acetylcholine metabolic process,BP,
3752,GO:0008292,1.00000000000064,0.929397820886854,0,1,acetylcholine biosynthetic process,BP,
5248,GO:0015870,1.00000000000064,0.929397820886854,0,1,acetylcholine transport,BP,
7911,GO:0032475,1.00000000000064,0.929397820886854,0,1,otolith formation,BP,
9273,GO:0035675,1.00000000000064,0.929397820886854,0,1,neuromast hair cell development,BP,
12445,GO:0048882,1.00000000000064,0.929397820886854,0,1,lateral line development,BP,
12446,GO:0048884,1.00000000000064,0.929397820886854,0,1,neuromast development,BP,
12447,GO:0048886,1.00000000000064,0.929397820886854,0,1,neuromast hair cell differentiation,BP,
12448,GO:0048925,1.00000000000064,0.929397820886854,0,1,lateral line system development,BP,
14357,GO:0061526,1.00000000000064,0.929397820886854,0,1,acetylcholine secretion,BP,
17526,GO:1900619,1.00000000000064,0.929397820886854,0,1,acetate ester metabolic process,BP,
17527,GO:1900620,1.00000000000064,0.929397820886854,0,1,acetate ester biosynthetic process,BP,
17665,GO:1901374,1.00000000000064,0.929397820886854,0,1,acetate ester transport,BP,
5769,GO:0016939,1.00000000000064,0.772370704816144,0,3,kinesin II complex,CC,
11626,GO:0046294,1.00000000000065,0.882619856989111,0,2,formaldehyde catabolic process,BP,
13340,GO:0052199,1.00000000000066,0.868930545875735,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13846,GO:0060423,1.00000000000066,0.863114374024496,0,2,foregut regionalization,BP,
13847,GO:0060424,1.00000000000066,0.863114374024496,0,2,lung field specification,BP,
13895,GO:0060492,1.00000000000066,0.863114374024496,0,2,lung induction,BP,
17025,GO:0099093,1.00000000000066,0.85048723556342,0,2,calcium export from the mitochondrion,BP,
4493,GO:0010513,1.00000000000067,0.881173730470458,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
1934,GO:0004630,1.00000000000069,0.693169863369776,0,5,phospholipase D activity,MF,
1549,GO:0003941,1.00000000000069,0.879148295195348,0,2,L-serine ammonia-lyase activity,MF,
15361,GO:0071567,1.0000000000007,0.889288266820313,0,2,UFM1 hydrolase activity,MF,
7641,GO:0032044,1.0000000000007,0.871963975884439,0,2,DSIF complex,CC,
2161,GO:0004985,1.00000000000071,0.820022358944588,0,3,opioid receptor activity,MF,
16559,GO:0097283,1.00000000000071,0.703144875183609,0,5,keratinocyte apoptotic process,BP,
17914,GO:1902172,1.00000000000071,0.703144875183609,0,5,regulation of keratinocyte apoptotic process,BP,
4467,GO:0010459,1.00000000000072,0.77626624873759,0,4,negative regulation of heart rate,BP,
18650,GO:1903911,1.00000000000073,0.783622785493005,0,3,positive regulation of receptor clustering,BP,
20041,GO:2000619,1.00000000000073,0.812102042223891,0,3,negative regulation of histone H4-K16 acetylation,BP,
15814,GO:0072429,1.00000000000076,0.804759902175177,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16366,GO:0090615,1.00000000000076,0.861664750399838,0,2,mitochondrial mRNA processing,BP,
18485,GO:1903547,1.00000000000076,0.905002909053289,0,2,regulation of growth hormone activity,BP,
8763,GO:0034418,1.00000000000077,0.868544003256564,0,2,urate biosynthetic process,BP,
17709,GO:1901563,1.00000000000079,0.676753236312078,0,5,response to camptothecin,BP,
16986,GO:0098976,1.00000000000079,0.722082992966212,0,4,excitatory chemical synaptic transmission,BP,
2934,GO:0006452,1.00000000000079,0.867353025786201,0,2,translational frameshifting,BP,
11467,GO:0045905,1.00000000000079,0.867353025786201,0,2,positive regulation of translational termination,BP,
1816,GO:0004463,1.00000000000079,0.933906261605052,0,1,leukotriene-A4 hydrolase activity,MF,
13804,GO:0060370,1.0000000000008,0.91480774773928,0,1,susceptibility to T cell mediated cytotoxicity,BP,
14286,GO:0061325,1.00000000000081,0.809401413278451,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
5068,GO:0015280,1.00000000000082,0.778657959220604,0,3,ligand-gated sodium channel activity,MF,
2185,GO:0005034,1.00000000000082,0.926947856801491,0,1,osmosensor activity,MF,
6706,GO:0030103,1.00000000000082,0.926947856801491,0,1,vasopressin secretion,BP,
16655,GO:0097497,1.00000000000082,0.926947856801491,0,1,blood vessel endothelial cell delamination,BP,
18440,GO:1903444,1.00000000000082,0.926947856801491,0,1,negative regulation of brown fat cell differentiation,BP,
18575,GO:1903759,1.00000000000082,0.926947856801491,0,1,signal transduction involved in regulation of aerobic respiration,BP,
16149,GO:0090131,1.00000000000084,0.94118721150351,0,1,mesenchyme migration,BP,
6047,GO:0019153,1.00000000000084,0.940876100497869,0,1,protein-disulfide reductase (glutathione) activity,MF,
15860,GO:0072555,1.00000000000084,0.940876100497869,0,1,17-beta-ketosteroid reductase activity,MF,
15880,GO:0072582,1.00000000000084,0.940876100497869,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
1191,GO:0002835,1.00000000000085,0.862319846774439,0,2,negative regulation of response to tumor cell,BP,
1194,GO:0002838,1.00000000000085,0.862319846774439,0,2,negative regulation of immune response to tumor cell,BP,
1199,GO:0002856,1.00000000000085,0.862319846774439,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1202,GO:0002859,1.00000000000085,0.862319846774439,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
18380,GO:1903333,1.00000000000085,0.716755284970479,0,5,negative regulation of protein folding,BP,
5990,GO:0018916,1.00000000000086,0.785611713027025,0,4,nitrobenzene metabolic process,BP,
6353,GO:0021527,1.00000000000086,0.916709372110997,0,1,spinal cord association neuron differentiation,BP,
16694,GO:0097598,1.00000000000086,0.916709372110997,0,1,sperm cytoplasmic droplet,CC,
15018,GO:0070926,1.00000000000087,0.9241101621204,0,1,regulation of ATP:ADP antiporter activity,BP,
6455,GO:0021771,1.00000000000087,0.915020044952801,0,1,lateral geniculate nucleus development,BP,
9962,GO:0042320,1.00000000000087,0.915020044952801,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
13633,GO:0060084,1.00000000000087,0.915020044952801,0,1,synaptic transmission involved in micturition,BP,
6321,GO:0019964,1.00000000000087,0.925679412140009,0,1,interferon-gamma binding,MF,
19539,GO:1990390,1.00000000000087,0.925679412140009,0,1,protein K33-linked ubiquitination,BP,
19474,GO:1990086,1.00000000000089,0.784943659191564,0,3,lens fiber cell apoptotic process,BP,
17506,GO:1900390,1.00000000000089,0.893469377057445,0,2,regulation of iron ion import,BP,
18867,GO:1904432,1.00000000000089,0.893469377057445,0,2,regulation of ferrous iron binding,BP,
18868,GO:1904434,1.00000000000089,0.893469377057445,0,2,positive regulation of ferrous iron binding,BP,
18869,GO:1904435,1.00000000000089,0.893469377057445,0,2,regulation of transferrin receptor binding,BP,
18870,GO:1904437,1.00000000000089,0.893469377057445,0,2,positive regulation of transferrin receptor binding,BP,
4208,GO:0009328,1.0000000000009,0.752552921369397,0,4,phenylalanine-tRNA ligase complex,CC,
18263,GO:1903045,1.0000000000009,0.915299539249764,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
7162,GO:0031017,1.0000000000009,0.752562142240558,0,4,exocrine pancreas development,BP,
19613,GO:1990637,1.00000000000091,0.788948614950387,0,3,response to prolactin,BP,
16676,GO:0097532,1.00000000000091,0.869957315514847,0,2,stress response to acid chemical,BP,
16677,GO:0097533,1.00000000000091,0.869957315514847,0,2,cellular stress response to acid chemical,BP,
3530,GO:0007518,1.00000000000091,0.931204321014549,0,1,myoblast fate determination,BP,
6803,GO:0030240,1.00000000000092,0.636661829959369,0,1,skeletal muscle thin filament assembly,BP,
7386,GO:0031433,1.00000000000092,0.636661829959369,0,1,telethonin binding,MF,
9436,GO:0035995,1.00000000000092,0.636661829959369,0,1,detection of muscle stretch,BP,
7572,GO:0031915,1.00000000000092,0.688046446202375,0,5,positive regulation of synaptic plasticity,BP,
811,GO:0002081,1.00000000000093,0.902388708494785,0,1,outer acrosomal membrane,CC,
13070,GO:0051541,1.00000000000093,0.744256569914508,0,4,elastin metabolic process,BP,
14447,GO:0061739,1.00000000000093,0.790730543276552,0,3,protein lipidation involved in autophagosome assembly,BP,
5311,GO:0016015,1.00000000000093,0.876927237527734,0,2,morphogen activity,MF,
19185,GO:1905167,1.00000000000094,0.796464851796748,0,2,positive regulation of lysosomal protein catabolic process,BP,
14707,GO:0070314,1.00000000000095,0.668062030537944,0,5,G1 to G0 transition,BP,
6175,GO:0019534,1.00000000000096,0.700739678382843,0,4,toxin transmembrane transporter activity,MF,
11215,GO:0045329,1.00000000000096,0.699270784104144,0,5,carnitine biosynthetic process,BP,
14071,GO:0060819,1.00000000000096,0.830596278866679,0,2,inactivation of X chromosome by genetic imprinting,BP,
2177,GO:0005010,1.00000000000098,0.728010352764935,0,3,insulin-like growth factor-activated receptor activity,MF,
4166,GO:0009227,1.00000000000099,0.819107734799345,0,3,nucleotide-sugar catabolic process,BP,
14906,GO:0070682,1.00000000000099,0.813011654763278,0,3,proteasome regulatory particle assembly,BP,
1408,GO:0003339,1.000000000001,0.705042885681645,0,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
6683,GO:0030043,1.000000000001,0.766305513971793,0,4,actin filament fragmentation,BP,
16311,GO:0090389,1.000000000001,0.904752188330429,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
11518,GO:0045988,1.00000000000101,0.789377984757892,0,3,negative regulation of striated muscle contraction,BP,
13555,GO:0055118,1.00000000000101,0.789377984757892,0,3,negative regulation of cardiac muscle contraction,BP,
384,GO:0001025,1.00000000000102,0.725621107230807,0,3,RNA polymerase III transcription factor binding,MF,
430,GO:0001156,1.00000000000102,0.725621107230807,0,3,TFIIIC-class transcription factor binding,MF,
4632,GO:0010751,1.00000000000103,0.821810701543077,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
8004,GO:0032618,1.00000000000103,0.880866547296182,0,2,interleukin-15 production,BP,
13761,GO:0060313,1.00000000000103,0.80139697394017,0,3,negative regulation of blood vessel remodeling,BP,
16451,GO:0097070,1.00000000000103,0.91472982954444,0,1,ductus arteriosus closure,BP,
16552,GO:0097272,1.00000000000103,0.91472982954444,0,1,ammonia homeostasis,BP,
16553,GO:0097273,1.00000000000103,0.91472982954444,0,1,creatinine homeostasis,BP,
16555,GO:0097275,1.00000000000103,0.91472982954444,0,1,cellular ammonia homeostasis,BP,
16556,GO:0097276,1.00000000000103,0.91472982954444,0,1,cellular creatinine homeostasis,BP,
16557,GO:0097277,1.00000000000103,0.91472982954444,0,1,cellular urea homeostasis,BP,
18115,GO:1902714,1.00000000000103,0.862252734453511,0,2,negative regulation of interferon-gamma secretion,BP,
14034,GO:0060735,1.00000000000103,0.945652556904617,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18092,GO:1902629,1.00000000000103,0.945652556904617,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
17742,GO:1901631,1.00000000000103,0.902868081169479,0,1,positive regulation of presynaptic membrane organization,BP,
18848,GO:1904393,1.00000000000103,0.902868081169479,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18849,GO:1904395,1.00000000000103,0.902868081169479,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
9133,GO:0035438,1.00000000000105,0.939226700548172,0,1,cyclic-di-GMP binding,MF,
14348,GO:0061507,1.00000000000105,0.939226700548172,0,1,cyclic-GMP-AMP binding,MF,
16590,GO:0097361,1.00000000000105,0.766410326783466,0,4,CIA complex,CC,
843,GO:0002153,1.00000000000105,0.930828896985188,0,1,steroid receptor RNA activator RNA binding,MF,
11485,GO:0045925,1.00000000000105,0.930828896985188,0,1,positive regulation of female receptivity,BP,
13302,GO:0051971,1.00000000000106,0.84109418133348,0,2,positive regulation of transmission of nerve impulse,BP,
1039,GO:0002545,1.00000000000106,0.936266575932365,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1214,GO:0002880,1.00000000000106,0.936266575932365,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1215,GO:0002882,1.00000000000106,0.936266575932365,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1538,GO:0003920,1.00000000000106,0.936266575932365,0,1,GMP reductase activity,MF,
5292,GO:0015950,1.00000000000106,0.936266575932365,0,1,purine nucleotide interconversion,BP,
5293,GO:0015951,1.00000000000106,0.936266575932365,0,1,purine ribonucleotide interconversion,BP,
5615,GO:0016657,1.00000000000106,0.936266575932365,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18062,GO:1902560,1.00000000000106,0.936266575932365,0,1,GMP reductase complex,CC,
8243,GO:0033004,1.00000000000107,0.809552002606145,0,3,negative regulation of mast cell activation,BP,
8246,GO:0033007,1.00000000000107,0.809552002606145,0,3,negative regulation of mast cell activation involved in immune response,BP,
19647,GO:1990763,1.00000000000107,0.668964226390621,0,5,arrestin family protein binding,MF,
18981,GO:1904715,1.00000000000108,0.808450628592718,0,3,negative regulation of chaperone-mediated autophagy,BP,
19626,GO:1990715,1.00000000000108,0.923312934131801,0,1,mRNA CDS binding,MF,
1898,GO:0004578,1.00000000000108,0.923813677224553,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
6053,GO:0019187,1.00000000000108,0.923813677224553,0,1,beta-1,4-mannosyltransferase activity,MF,
12782,GO:0051032,1.00000000000108,0.923813677224553,0,1,nucleic acid transmembrane transporter activity,MF,
12783,GO:0051033,1.00000000000108,0.923813677224553,0,1,RNA transmembrane transporter activity,MF,
13691,GO:0060197,1.00000000000109,0.863299143354754,0,2,cloacal septation,BP,
15613,GO:0072076,1.0000000000011,0.773671921642524,0,3,nephrogenic mesenchyme development,BP,
14015,GO:0060709,1.00000000000111,0.928269742145218,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
17128,GO:0100002,1.00000000000111,0.928269742145218,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
7764,GO:0032275,1.00000000000111,0.650086631564856,0,5,luteinizing hormone secretion,BP,
2116,GO:0004900,1.00000000000112,0.936701197658203,0,1,erythropoietin receptor activity,MF,
9732,GO:0038162,1.00000000000112,0.936701197658203,0,1,erythropoietin-mediated signaling pathway,BP,
7374,GO:0031416,1.00000000000112,0.871405447155251,0,2,NatB complex,CC,
16365,GO:0090611,1.00000000000112,0.696369903404478,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16549,GO:0097255,1.00000000000113,0.723680922679693,0,5,R2TP complex,CC,
9557,GO:0036309,1.00000000000113,0.753256760506927,0,2,protein localization to M-band,BP,
14979,GO:0070857,1.00000000000114,0.689477162965803,0,5,regulation of bile acid biosynthetic process,BP,
12763,GO:0051012,1.00000000000114,0.861793700946212,0,2,microtubule sliding,BP,
7102,GO:0030893,1.00000000000115,0.768818699959106,0,3,meiotic cohesin complex,CC,
5242,GO:0015862,1.00000000000116,0.931503304559373,0,1,uridine transport,BP,
5987,GO:0018879,1.00000000000117,0.807421037504042,0,3,biphenyl metabolic process,BP,
1693,GO:0004164,1.00000000000117,0.937573252902927,0,1,diphthine synthase activity,MF,
1738,GO:0004333,1.00000000000117,0.937573252902927,0,1,fumarate hydratase activity,MF,
1503,GO:0003846,1.00000000000117,0.860514475952261,0,2,2-acylglycerol O-acyltransferase activity,MF,
1682,GO:0004144,1.00000000000117,0.860514475952261,0,2,diacylglycerol O-acyltransferase activity,MF,
12475,GO:0050252,1.00000000000117,0.860514475952261,0,2,retinol O-fatty-acyltransferase activity,MF,
9422,GO:0035977,1.00000000000117,0.721926247133481,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
16638,GO:0097466,1.00000000000117,0.721926247133481,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
18843,GO:1904382,1.00000000000117,0.721926247133481,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
18927,GO:1904587,1.00000000000117,0.721926247133481,0,4,response to glycoprotein,BP,
19413,GO:1905867,1.00000000000118,0.818390723354081,0,3,epididymis development,BP,
3438,GO:0007231,1.00000000000118,0.871249214173443,0,2,osmosensory signaling pathway,BP,
1610,GO:0004030,1.00000000000119,0.687667269398477,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
11209,GO:0045298,1.00000000000119,0.750945533874139,0,4,tubulin complex,CC,
15415,GO:0071650,1.0000000000012,0.818128576473492,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
9398,GO:0035927,1.0000000000012,0.775127809997109,0,4,RNA import into mitochondrion,BP,
1984,GO:0004699,1.00000000000121,0.787276506330997,0,3,calcium-independent protein kinase C activity,MF,
1044,GO:0002560,1.00000000000122,0.922753173844853,0,1,basophil mediated immunity,BP,
1045,GO:0002561,1.00000000000122,0.922753173844853,0,1,basophil degranulation,BP,
8496,GO:0033644,1.00000000000122,0.922753173844853,0,1,host cell membrane,CC,
10782,GO:0044218,1.00000000000122,0.922753173844853,0,1,other organism cell membrane,CC,
10784,GO:0044221,1.00000000000122,0.922753173844853,0,1,host cell synapse,CC,
10787,GO:0044231,1.00000000000122,0.922753173844853,0,1,host cell presynaptic membrane,CC,
10810,GO:0044279,1.00000000000122,0.922753173844853,0,1,other organism membrane,CC,
15861,GO:0072556,1.00000000000122,0.922753173844853,0,1,other organism presynaptic membrane,CC,
1974,GO:0004686,1.00000000000122,0.905945879909711,0,1,elongation factor-2 kinase activity,MF,
15291,GO:0071454,1.00000000000122,0.905945879909711,0,1,cellular response to anoxia,BP,
10122,GO:0042631,1.00000000000122,0.92525713678716,0,1,cellular response to water deprivation,BP,
2982,GO:0006526,1.00000000000122,0.679076817351555,0,5,arginine biosynthetic process,BP,
6696,GO:0030070,1.00000000000123,0.779804237165822,0,3,insulin processing,BP,
11901,GO:0046900,1.00000000000123,0.87726748032125,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
9112,GO:0035376,1.00000000000123,0.698227680420095,0,5,sterol import,BP,
14808,GO:0070508,1.00000000000123,0.698227680420095,0,5,cholesterol import,BP,
16595,GO:0097368,1.00000000000124,0.736836787624568,0,4,establishment of Sertoli cell barrier,BP,
2529,GO:0005784,1.00000000000124,0.820197890185132,0,4,Sec61 translocon complex,CC,
15165,GO:0071256,1.00000000000124,0.820197890185132,0,4,translocon complex,CC,
12957,GO:0051295,1.00000000000124,0.768902443028295,0,3,establishment of meiotic spindle localization,BP,
17740,GO:1901629,1.00000000000124,0.857817583061329,0,2,regulation of presynaptic membrane organization,BP,
1377,GO:0003266,1.00000000000125,0.698505619136339,0,5,regulation of secondary heart field cardioblast proliferation,BP,
6177,GO:0019541,1.00000000000125,0.799320675035712,0,3,propionate metabolic process,BP,
1803,GO:0004441,1.00000000000125,0.933717323570255,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13447,GO:0052829,1.00000000000125,0.933717323570255,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
374,GO:0000995,1.00000000000127,0.690896224341099,0,4,transcription factor activity, core RNA polymerase III binding,MF,
1886,GO:0004563,1.00000000000127,0.689843455325556,0,5,beta-N-acetylhexosaminidase activity,MF,
18982,GO:1904716,1.00000000000128,0.931223317080584,0,1,positive regulation of chaperone-mediated autophagy,BP,
2157,GO:0004977,1.00000000000128,0.868340213992455,0,2,melanocortin receptor activity,MF,
1789,GO:0004408,1.00000000000128,0.931854198581118,0,1,holocytochrome-c synthase activity,MF,
5784,GO:0017003,1.00000000000128,0.931854198581118,0,1,protein-heme linkage,BP,
5787,GO:0017006,1.00000000000128,0.931854198581118,0,1,protein-tetrapyrrole linkage,BP,
5895,GO:0018063,1.00000000000128,0.931854198581118,0,1,cytochrome c-heme linkage,BP,
8946,GO:0034971,1.00000000000129,0.927738473898446,0,1,histone H3-R17 methylation,BP,
9255,GO:0035642,1.00000000000129,0.927738473898446,0,1,histone methyltransferase activity (H3-R17 specific),MF,
1761,GO:0004361,1.00000000000129,0.938854212711802,0,1,glutaryl-CoA dehydrogenase activity,MF,
2267,GO:0005183,1.00000000000129,0.938854212711802,0,1,gonadotropin hormone-releasing hormone activity,MF,
7434,GO:0031530,1.00000000000129,0.938854212711802,0,1,gonadotropin-releasing hormone receptor binding,MF,
19453,GO:1990008,1.00000000000129,0.938854212711802,0,1,neurosecretory vesicle,CC,
3738,GO:0008275,1.0000000000013,0.729406051242027,0,4,gamma-tubulin small complex,CC,
11278,GO:0045519,1.0000000000013,0.953674189274353,0,1,interleukin-23 receptor binding,MF,
14932,GO:0070743,1.0000000000013,0.953674189274353,0,1,interleukin-23 complex,CC,
7543,GO:0031775,1.00000000000131,0.901655160348856,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7907,GO:0032470,1.00000000000131,0.901655160348856,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
16038,GO:0086039,1.00000000000131,0.901655160348856,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
18459,GO:1903515,1.00000000000131,0.901655160348856,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19461,GO:1990036,1.00000000000131,0.901655160348856,0,1,calcium ion import into sarcoplasmic reticulum,BP,
13151,GO:0051686,1.00000000000134,0.881528742433797,0,1,establishment of ER localization,BP,
17024,GO:0099089,1.00000000000134,0.881528742433797,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
7728,GO:0032213,1.00000000000134,0.861221418424507,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7729,GO:0032214,1.00000000000134,0.861221418424507,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
18902,GO:1904534,1.00000000000134,0.861221418424507,0,2,negative regulation of telomeric loop disassembly,BP,
19394,GO:1905778,1.00000000000134,0.861221418424507,0,2,negative regulation of exonuclease activity,BP,
19405,GO:1905838,1.00000000000134,0.861221418424507,0,2,regulation of telomeric D-loop disassembly,BP,
19406,GO:1905839,1.00000000000134,0.861221418424507,0,2,negative regulation of telomeric D-loop disassembly,BP,
19630,GO:1990729,1.00000000000135,0.935241264549835,0,1,primary miRNA modification,BP,
19638,GO:1990744,1.00000000000135,0.935241264549835,0,1,primary miRNA methylation,BP,
8879,GO:0034677,1.00000000000135,0.924517011789895,0,1,integrin alpha7-beta1 complex,CC,
8882,GO:0034681,1.00000000000135,0.924517011789895,0,1,integrin alpha11-beta1 complex,CC,
15745,GO:0072300,1.00000000000136,0.852267665075975,0,2,positive regulation of metanephric glomerulus development,BP,
13694,GO:0060200,1.00000000000136,0.919771516075647,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13695,GO:0060201,1.00000000000136,0.919771516075647,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
16861,GO:0098746,1.00000000000136,0.919771516075647,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
14610,GO:0070143,1.00000000000137,0.919852193224374,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
6245,GO:0019808,1.00000000000137,0.842636479763065,0,3,polyamine binding,MF,
11960,GO:0047016,1.00000000000137,0.932755238538817,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
3882,GO:0008511,1.00000000000138,0.908809783988745,0,1,sodium:potassium:chloride symporter activity,MF,
4289,GO:0009674,1.00000000000138,0.908809783988745,0,1,potassium:sodium symporter activity,MF,
5102,GO:0015378,1.00000000000138,0.908809783988745,0,1,sodium:chloride symporter activity,MF,
11419,GO:0045795,1.00000000000138,0.908809783988745,0,1,positive regulation of cell volume,BP,
5837,GO:0017116,1.00000000000139,0.792336335696766,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
12143,GO:0048203,1.0000000000014,0.868512820093289,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12994,GO:0051377,1.0000000000014,0.789408784762447,0,3,mannose-ethanolamine phosphotransferase activity,MF,
6563,GO:0021999,1.0000000000014,0.67674763459314,0,5,neural plate anterior/posterior regionalization,BP,
4376,GO:0009996,1.0000000000014,0.866336719093173,0,2,negative regulation of cell fate specification,BP,
7750,GO:0032258,1.00000000000141,0.86604695177166,0,2,protein localization by the Cvt pathway,BP,
3709,GO:0008218,1.00000000000141,0.925616325753079,0,1,bioluminescence,BP,
8937,GO:0034776,1.00000000000142,0.843204097815932,0,2,response to histamine,BP,
15269,GO:0071420,1.00000000000142,0.843204097815932,0,2,cellular response to histamine,BP,
1979,GO:0004692,1.00000000000142,0.924294544421055,0,1,cGMP-dependent protein kinase activity,MF,
1036,GO:0002542,1.00000000000143,0.934082601013705,0,1,Factor XII activation,BP,
13265,GO:0051919,1.00000000000143,0.934082601013705,0,1,positive regulation of fibrinolysis,BP,
16433,GO:0097049,1.00000000000143,0.684130905393925,0,5,motor neuron apoptotic process,BP,
9184,GO:0035544,1.00000000000143,0.921430371664565,0,1,negative regulation of SNARE complex assembly,BP,
13299,GO:0051967,1.00000000000144,0.817013829750048,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
17478,GO:1900244,1.00000000000144,0.859900825003828,0,2,positive regulation of synaptic vesicle endocytosis,BP,
14721,GO:0070336,1.00000000000144,0.848962277177308,0,2,flap-structured DNA binding,MF,
5423,GO:0016269,1.00000000000145,0.930332177084012,0,1,O-glycan processing, core 3,BP,
11988,GO:0047224,1.00000000000145,0.930332177084012,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
14279,GO:0061312,1.00000000000145,0.702650062139271,0,5,BMP signaling pathway involved in heart development,BP,
14654,GO:0070213,1.00000000000145,0.702146165685151,0,4,protein auto-ADP-ribosylation,BP,
17960,GO:1902263,1.00000000000147,0.790841070714596,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
5393,GO:0016222,1.00000000000148,0.863114536549671,0,2,procollagen-proline 4-dioxygenase complex,CC,
9247,GO:0035633,1.00000000000148,0.858740245613345,0,2,maintenance of permeability of blood-brain barrier,BP,
11157,GO:0045188,1.00000000000149,0.861970202832386,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
1266,GO:0003017,1.0000000000015,0.896892309378362,0,1,lymph circulation,BP,
2327,GO:0005337,1.0000000000015,0.697629288795269,0,5,nucleoside transmembrane transporter activity,MF,
5240,GO:0015858,1.0000000000015,0.697629288795269,0,5,nucleoside transport,BP,
17746,GO:1901642,1.0000000000015,0.697629288795269,0,5,nucleoside transmembrane transport,BP,
16258,GO:0090290,1.0000000000015,0.95370086491677,0,1,positive regulation of osteoclast proliferation,BP,
5966,GO:0018364,1.00000000000151,0.919100638308636,0,2,peptidyl-glutamine methylation,BP,
3927,GO:0008603,1.00000000000152,0.697056216196329,0,5,cAMP-dependent protein kinase regulator activity,MF,
11475,GO:0045915,1.00000000000152,0.713870779176982,0,5,positive regulation of catecholamine metabolic process,BP,
11509,GO:0045964,1.00000000000152,0.713870779176982,0,5,positive regulation of dopamine metabolic process,BP,
4630,GO:0010749,1.00000000000152,0.764185341114722,0,3,regulation of nitric oxide mediated signal transduction,BP,
13173,GO:0051725,1.00000000000153,0.87770922180731,0,2,protein de-ADP-ribosylation,BP,
9468,GO:0036056,1.00000000000153,0.636167654192761,0,5,filtration diaphragm,CC,
9469,GO:0036057,1.00000000000153,0.636167654192761,0,5,slit diaphragm,CC,
12042,GO:0047676,1.00000000000154,0.917831330066196,0,1,arachidonate-CoA ligase activity,MF,
14980,GO:0070859,1.00000000000154,0.804393713785186,0,3,positive regulation of bile acid biosynthetic process,BP,
18792,GO:1904253,1.00000000000154,0.804393713785186,0,3,positive regulation of bile acid metabolic process,BP,
15534,GO:0071896,1.00000000000155,0.68517416196848,0,4,protein localization to adherens junction,BP,
3731,GO:0008267,1.00000000000155,0.902800307956329,0,1,poly-glutamine tract binding,MF,
4439,GO:0010309,1.00000000000156,0.939502989739466,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19590,GO:1990565,1.00000000000156,0.939502989739466,0,1,HSP90-CDC37 chaperone complex,CC,
18423,GO:1903423,1.00000000000156,0.662436562697395,0,5,positive regulation of synaptic vesicle recycling,BP,
4930,GO:0014883,1.0000000000016,0.723117196118736,0,4,transition between fast and slow fiber,BP,
11149,GO:0045179,1.0000000000016,0.664935053926261,0,5,apical cortex,CC,
5418,GO:0016262,1.0000000000016,0.796332769218426,0,3,protein N-acetylglucosaminyltransferase activity,MF,
9284,GO:0035701,1.00000000000161,0.784012400246513,0,3,hematopoietic stem cell migration,BP,
16206,GO:0090209,1.00000000000162,0.7533298141127,0,4,negative regulation of triglyceride metabolic process,BP,
19570,GO:1990450,1.00000000000162,0.933733359133928,0,1,linear polyubiquitin binding,MF,
18734,GO:1904098,1.00000000000162,0.800380738420552,0,3,regulation of protein O-linked glycosylation,BP,
18735,GO:1904100,1.00000000000162,0.800380738420552,0,3,positive regulation of protein O-linked glycosylation,BP,
7456,GO:0031587,1.00000000000163,0.742672926253582,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
3600,GO:0008035,1.00000000000163,0.742379456072653,0,4,high-density lipoprotein particle binding,MF,
6877,GO:0030348,1.00000000000164,0.860938947279595,0,2,syntaxin-3 binding,MF,
15817,GO:0072434,1.00000000000164,0.822917483370998,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
13641,GO:0060099,1.00000000000164,0.656702714750993,0,5,regulation of phagocytosis, engulfment,BP,
13642,GO:0060100,1.00000000000164,0.656702714750993,0,5,positive regulation of phagocytosis, engulfment,BP,
19180,GO:1905155,1.00000000000164,0.656702714750993,0,5,positive regulation of membrane invagination,BP,
8803,GO:0034485,1.00000000000165,0.730981218046796,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
1565,GO:0003963,1.00000000000167,0.865837836155677,0,2,RNA-3'-phosphate cyclase activity,MF,
5419,GO:0016263,1.00000000000167,0.876917347970746,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5422,GO:0016267,1.00000000000167,0.876917347970746,0,2,O-glycan processing, core 1,BP,
3317,GO:0007023,1.00000000000168,0.781081976627493,0,4,post-chaperonin tubulin folding pathway,BP,
4695,GO:0010847,1.00000000000168,0.711563923726139,0,4,regulation of chromatin assembly,BP,
19864,GO:2000298,1.0000000000017,0.86221102769563,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
15502,GO:0071838,1.0000000000017,0.753862242149541,0,4,cell proliferation in bone marrow,BP,
476,GO:0001519,1.00000000000172,0.924657150859982,0,1,peptide amidation,BP,
1848,GO:0004504,1.00000000000172,0.924657150859982,0,1,peptidylglycine monooxygenase activity,MF,
1913,GO:0004598,1.00000000000172,0.924657150859982,0,1,peptidylamidoglycolate lyase activity,MF,
5893,GO:0018032,1.00000000000172,0.924657150859982,0,1,protein amidation,BP,
7251,GO:0031179,1.00000000000172,0.924657150859982,0,1,peptide modification,BP,
2070,GO:0004821,1.00000000000173,0.869928123257383,0,2,histidine-tRNA ligase activity,MF,
2916,GO:0006427,1.00000000000173,0.869928123257383,0,2,histidyl-tRNA aminoacylation,BP,
18842,GO:1904381,1.00000000000173,0.846160439537881,0,2,Golgi apparatus mannose trimming,BP,
13141,GO:0051661,1.00000000000174,0.615954265256017,0,5,maintenance of centrosome location,BP,
2504,GO:0005753,1.00000000000174,0.932670300834996,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
4697,GO:0010849,1.00000000000174,0.932670300834996,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
19851,GO:2000276,1.00000000000174,0.932670300834996,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
19186,GO:1905168,1.00000000000174,0.924733900863483,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
1716,GO:0004305,1.00000000000175,0.749956208116071,0,4,ethanolamine kinase activity,MF,
1360,GO:0003228,1.00000000000176,0.809119821226318,0,3,atrial cardiac muscle tissue development,BP,
13494,GO:0055009,1.00000000000176,0.809119821226318,0,3,atrial cardiac muscle tissue morphogenesis,BP,
17636,GO:1901299,1.00000000000177,0.696999695572227,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
6020,GO:0019072,1.00000000000177,0.842430292337189,0,2,viral genome packaging,BP,
6021,GO:0019074,1.00000000000177,0.842430292337189,0,2,viral RNA genome packaging,BP,
14094,GO:0060872,1.00000000000177,0.645510219114809,0,5,semicircular canal development,BP,
11016,GO:0044821,1.00000000000179,0.732473463692157,0,4,meiotic telomere tethering at nuclear periphery,BP,
14642,GO:0070197,1.00000000000179,0.732473463692157,0,4,meiotic attachment of telomere to nuclear envelope,BP,
16545,GO:0097240,1.00000000000179,0.732473463692157,0,4,chromosome attachment to the nuclear envelope,BP,
18401,GO:1903377,1.00000000000179,0.761281786650789,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
14616,GO:0070162,1.00000000000179,0.677857607750984,0,5,adiponectin secretion,BP,
14617,GO:0070163,1.00000000000179,0.677857607750984,0,5,regulation of adiponectin secretion,BP,
4791,GO:0010979,1.0000000000018,0.856153760717751,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
4792,GO:0010980,1.0000000000018,0.856153760717751,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
16546,GO:0097241,1.0000000000018,0.866832037626499,0,2,hematopoietic stem cell migration to bone marrow,BP,
15883,GO:0072586,1.00000000000181,0.921282588955185,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15884,GO:0072587,1.00000000000181,0.921282588955185,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
2425,GO:0005600,1.00000000000182,0.927370058650258,0,1,collagen type XIII trimer,CC,
7126,GO:0030936,1.00000000000182,0.927370058650258,0,1,transmembrane collagen trimer,CC,
9838,GO:0042048,1.00000000000184,0.63628459422188,0,5,olfactory behavior,BP,
3909,GO:0008555,1.00000000000184,0.916842724218069,0,1,chloride-transporting ATPase activity,MF,
6832,GO:0030289,1.00000000000184,0.76562150701571,0,4,protein phosphatase 4 complex,CC,
3575,GO:0007621,1.00000000000184,0.905709476001744,0,1,negative regulation of female receptivity,BP,
1644,GO:0004084,1.00000000000185,0.847841538503186,0,2,branched-chain-amino-acid transaminase activity,MF,
4046,GO:0009082,1.00000000000185,0.847841538503186,0,2,branched-chain amino acid biosynthetic process,BP,
4054,GO:0009098,1.00000000000185,0.847841538503186,0,2,leucine biosynthetic process,BP,
4055,GO:0009099,1.00000000000185,0.847841538503186,0,2,valine biosynthetic process,BP,
13404,GO:0052654,1.00000000000185,0.847841538503186,0,2,L-leucine transaminase activity,MF,
13405,GO:0052655,1.00000000000185,0.847841538503186,0,2,L-valine transaminase activity,MF,
13406,GO:0052656,1.00000000000185,0.847841538503186,0,2,L-isoleucine transaminase activity,MF,
18022,GO:1902455,1.00000000000185,0.732616722418028,0,4,negative regulation of stem cell population maintenance,BP,
19176,GO:1905150,1.00000000000185,0.842352327030339,0,2,regulation of voltage-gated sodium channel activity,BP,
8724,GO:0034363,1.00000000000186,0.950108685914014,0,1,intermediate-density lipoprotein particle,CC,
8726,GO:0034365,1.00000000000186,0.950108685914014,0,1,discoidal high-density lipoprotein particle,CC,
8732,GO:0034371,1.00000000000186,0.950108685914014,0,1,chylomicron remodeling,BP,
11907,GO:0046911,1.00000000000186,0.950108685914014,0,1,metal chelating activity,MF,
16401,GO:0090731,1.00000000000186,0.950108685914014,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17741,GO:1901630,1.00000000000186,0.950108685914014,0,1,negative regulation of presynaptic membrane organization,BP,
18235,GO:1903000,1.00000000000186,0.950108685914014,0,1,regulation of lipid transport across blood brain barrier,BP,
18236,GO:1903002,1.00000000000186,0.950108685914014,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19408,GO:1905853,1.00000000000186,0.950108685914014,0,1,regulation of heparan sulfate binding,BP,
19409,GO:1905855,1.00000000000186,0.950108685914014,0,1,positive regulation of heparan sulfate binding,BP,
19410,GO:1905858,1.00000000000186,0.950108685914014,0,1,regulation of heparan sulfate proteoglycan binding,BP,
19411,GO:1905860,1.00000000000186,0.950108685914014,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
19419,GO:1905890,1.00000000000186,0.950108685914014,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
1739,GO:0004334,1.00000000000186,0.943699333807828,0,1,fumarylacetoacetase activity,MF,
8827,GO:0034594,1.00000000000186,0.669497089885395,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
170,GO:0000354,1.00000000000186,0.840160110985832,0,2,cis assembly of pre-catalytic spliceosome,BP,
16220,GO:0090234,1.00000000000187,0.783704026803406,0,3,regulation of kinetochore assembly,BP,
16916,GO:0098842,1.00000000000187,0.868217672088595,0,2,postsynaptic early endosome,CC,
17298,GO:0140007,1.00000000000187,0.7546041981198,0,4,KICSTOR complex,CC,
6223,GO:0019755,1.00000000000188,0.753695720662745,0,4,one-carbon compound transport,BP,
17916,GO:1902174,1.00000000000188,0.871670929433529,0,2,positive regulation of keratinocyte apoptotic process,BP,
13992,GO:0060681,1.00000000000189,0.790759177709014,0,3,branch elongation involved in ureteric bud branching,BP,
11995,GO:0047277,1.00000000000189,0.935380124088667,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1695,GO:0004167,1.00000000000189,0.933877242205267,0,2,dopachrome isomerase activity,MF,
5726,GO:0016862,1.00000000000189,0.933877242205267,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
12469,GO:0050178,1.00000000000189,0.933877242205267,0,2,phenylpyruvate tautomerase activity,MF,
10008,GO:0042414,1.0000000000019,0.842626570477675,0,2,epinephrine metabolic process,BP,
14314,GO:0061394,1.0000000000019,0.877014175707253,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
2000,GO:0004720,1.00000000000192,0.684261931000439,0,5,protein-lysine 6-oxidase activity,MF,
5584,GO:0016598,1.00000000000193,0.873692276708852,0,2,protein arginylation,BP,
16743,GO:0097726,1.00000000000193,0.951565790452087,0,1,LEM domain binding,MF,
4904,GO:0014831,1.00000000000195,0.762060236943168,0,4,gastro-intestinal system smooth muscle contraction,BP,
6526,GO:0021903,1.00000000000196,0.673817778825244,0,5,rostrocaudal neural tube patterning,BP,
2937,GO:0006463,1.00000000000198,0.924599981361368,0,1,steroid hormone receptor complex assembly,BP,
14577,GO:0070091,1.00000000000199,0.749435278192165,0,4,glucagon secretion,BP,
16635,GO:0097457,1.000000000002,0.816881024138532,0,2,hippocampal mossy fiber,CC,
16024,GO:0086016,1.00000000000201,0.67711732393727,0,5,AV node cell action potential,BP,
16033,GO:0086027,1.00000000000201,0.67711732393727,0,5,AV node cell to bundle of His cell signaling,BP,
1514,GO:0003872,1.00000000000201,0.798362490156796,0,3,6-phosphofructokinase activity,MF,
1389,GO:0003292,1.00000000000202,0.914998544985504,0,1,cardiac septum cell differentiation,BP,
14114,GO:0060922,1.00000000000202,0.914998544985504,0,1,atrioventricular node cell differentiation,BP,
14117,GO:0060928,1.00000000000202,0.914998544985504,0,1,atrioventricular node cell development,BP,
3886,GO:0008517,1.00000000000202,0.725543867541279,0,4,folic acid transmembrane transporter activity,MF,
4156,GO:0009217,1.00000000000203,0.717543421719345,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
10587,GO:0043541,1.00000000000203,0.857579138618416,0,2,UDP-N-acetylglucosamine transferase complex,CC,
13438,GO:0052812,1.00000000000203,0.849281095756671,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14636,GO:0070189,1.00000000000206,0.767068248709824,0,4,kynurenine metabolic process,BP,
5272,GO:0015917,1.00000000000206,0.70370695681357,0,4,aminophospholipid transport,BP,
15110,GO:0071105,1.00000000000206,0.919930166187176,0,1,response to interleukin-11,BP,
15219,GO:0071348,1.00000000000206,0.919930166187176,0,1,cellular response to interleukin-11,BP,
2025,GO:0004753,1.00000000000207,0.914101626315876,0,1,saccharopine dehydrogenase activity,MF,
11974,GO:0047130,1.00000000000207,0.914101626315876,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11975,GO:0047131,1.00000000000207,0.914101626315876,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
1751,GO:0004348,1.00000000000207,0.861194788643825,0,2,glucosylceramidase activity,MF,
20328,GO:2001274,1.00000000000208,0.85307628062561,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
11634,GO:0046322,1.00000000000208,0.72154163492655,0,4,negative regulation of fatty acid oxidation,BP,
15716,GO:0072235,1.00000000000209,0.740098247626333,0,3,metanephric distal tubule development,BP,
15482,GO:0071802,1.00000000000209,0.922722182163297,0,1,negative regulation of podosome assembly,BP,
16050,GO:0086056,1.00000000000209,0.922722182163297,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16955,GO:0098912,1.00000000000209,0.922722182163297,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
1164,GO:0002775,1.0000000000021,0.817176806596142,0,3,antimicrobial peptide production,BP,
1165,GO:0002778,1.0000000000021,0.817176806596142,0,3,antibacterial peptide production,BP,
1166,GO:0002784,1.0000000000021,0.817176806596142,0,3,regulation of antimicrobial peptide production,BP,
1168,GO:0002786,1.0000000000021,0.817176806596142,0,3,regulation of antibacterial peptide production,BP,
12460,GO:0050115,1.00000000000211,0.919411283826105,0,1,myosin-light-chain-phosphatase activity,MF,
19291,GO:1905443,1.00000000000211,0.921320818842508,0,1,regulation of clathrin coat assembly,BP,
19292,GO:1905445,1.00000000000211,0.921320818842508,0,1,positive regulation of clathrin coat assembly,BP,
2596,GO:0005890,1.00000000000212,0.74591722216606,0,4,sodium:potassium-exchanging ATPase complex,CC,
7646,GO:0032051,1.00000000000212,0.639339295490389,0,5,clathrin light chain binding,MF,
18144,GO:1902804,1.00000000000212,0.801092876768352,0,3,negative regulation of synaptic vesicle transport,BP,
19867,GO:2000301,1.00000000000212,0.801092876768352,0,3,negative regulation of synaptic vesicle exocytosis,BP,
3517,GO:0007468,1.00000000000212,0.934160845748521,0,1,regulation of rhodopsin gene expression,BP,
11454,GO:0045872,1.00000000000212,0.934160845748521,0,1,positive regulation of rhodopsin gene expression,BP,
2595,GO:0005889,1.00000000000213,0.856062199732781,0,2,potassium:proton exchanging ATPase complex,CC,
8174,GO:0032902,1.00000000000213,0.854772056140712,0,2,nerve growth factor production,BP,
18567,GO:1903748,1.00000000000213,0.743325426039075,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
7636,GO:0032036,1.00000000000214,0.681951644329617,0,5,myosin heavy chain binding,MF,
10814,GO:0044284,1.00000000000214,0.957545846433632,0,1,mitochondrial crista junction,CC,
7356,GO:0031392,1.00000000000214,0.745775029394535,0,4,regulation of prostaglandin biosynthetic process,BP,
20330,GO:2001279,1.00000000000214,0.745775029394535,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
15297,GO:0071461,1.00000000000215,0.881347411411608,0,2,cellular response to redox state,BP,
8412,GO:0033353,1.00000000000218,0.73212948398729,0,4,S-adenosylmethionine cycle,BP,
9701,GO:0038086,1.00000000000218,0.925476704543044,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9703,GO:0038091,1.00000000000218,0.925476704543044,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
18498,GO:1903570,1.00000000000218,0.925476704543044,0,1,regulation of protein kinase D signaling,BP,
18499,GO:1903572,1.00000000000218,0.925476704543044,0,1,positive regulation of protein kinase D signaling,BP,
10345,GO:0043129,1.00000000000218,0.665899619813485,0,5,surfactant homeostasis,BP,
15286,GO:0071447,1.0000000000022,0.684903660574499,0,5,cellular response to hydroperoxide,BP,
579,GO:0001729,1.0000000000022,0.855129130176387,0,2,ceramide kinase activity,MF,
17828,GO:1901897,1.0000000000022,0.770041808300205,0,3,regulation of relaxation of cardiac muscle,BP,
9446,GO:0036015,1.0000000000022,0.823065578075154,0,3,response to interleukin-3,BP,
9447,GO:0036016,1.0000000000022,0.823065578075154,0,3,cellular response to interleukin-3,BP,
14720,GO:0070335,1.00000000000221,0.907409502217442,0,1,aspartate binding,MF,
14588,GO:0070103,1.00000000000222,0.938988664920767,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14589,GO:0070104,1.00000000000222,0.938988664920767,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17925,GO:1902205,1.00000000000222,0.938988664920767,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17926,GO:1902206,1.00000000000222,0.938988664920767,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17930,GO:1902215,1.00000000000222,0.938988664920767,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17939,GO:1902227,1.00000000000222,0.938988664920767,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17945,GO:1902233,1.00000000000222,0.938988664920767,0,1,negative regulation of positive thymic T cell selection,BP,
18680,GO:1903970,1.00000000000222,0.938988664920767,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18683,GO:1903973,1.00000000000222,0.938988664920767,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
15377,GO:0071596,1.00000000000222,0.748770309839505,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
15197,GO:0071315,1.00000000000222,0.794615526922272,0,3,cellular response to morphine,BP,
15199,GO:0071317,1.00000000000222,0.794615526922272,0,3,cellular response to isoquinoline alkaloid,BP,
2047,GO:0004792,1.00000000000222,0.835212334685267,0,3,thiosulfate sulfurtransferase activity,MF,
19507,GO:1990189,1.00000000000223,0.887247682309312,0,2,peptide-serine-N-acetyltransferase activity,MF,
19889,GO:2000328,1.00000000000224,0.826563250616052,0,3,regulation of T-helper 17 cell lineage commitment,BP,
13856,GO:0060435,1.00000000000224,0.946490463218766,0,1,bronchiole development,BP,
13884,GO:0060480,1.00000000000224,0.946490463218766,0,1,lung goblet cell differentiation,BP,
1790,GO:0004415,1.00000000000224,0.69497557086234,0,5,hyalurononglucosaminidase activity,MF,
3851,GO:0008459,1.00000000000225,0.846289940881045,0,2,chondroitin 6-sulfotransferase activity,MF,
13245,GO:0051886,1.00000000000226,0.917991744382101,0,1,negative regulation of timing of anagen,BP,
20285,GO:2001203,1.00000000000226,0.917991744382101,0,1,positive regulation of transforming growth factor-beta secretion,BP,
15138,GO:0071208,1.00000000000226,0.810474961867752,0,4,histone pre-mRNA DCP binding,MF,
4612,GO:0010727,1.00000000000226,0.729289479768026,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
13816,GO:0060383,1.00000000000226,0.923163240535296,0,1,positive regulation of DNA strand elongation,BP,
19306,GO:1905464,1.00000000000226,0.923163240535296,0,1,positive regulation of DNA duplex unwinding,BP,
19391,GO:1905774,1.00000000000226,0.923163240535296,0,1,regulation of DNA helicase activity,BP,
19392,GO:1905776,1.00000000000226,0.923163240535296,0,1,positive regulation of DNA helicase activity,BP,
19706,GO:1990955,1.00000000000226,0.923163240535296,0,1,G-rich single-stranded DNA binding,MF,
8820,GO:0034552,1.00000000000227,0.77806005085253,0,4,respiratory chain complex II assembly,BP,
8821,GO:0034553,1.00000000000227,0.77806005085253,0,4,mitochondrial respiratory chain complex II assembly,BP,
12654,GO:0050822,1.00000000000227,0.925541544694829,0,1,peptide stabilization,BP,
12655,GO:0050823,1.00000000000227,0.925541544694829,0,1,peptide antigen stabilization,BP,
6955,GO:0030576,1.00000000000227,0.800662731719223,0,3,Cajal body organization,BP,
7652,GO:0032058,1.00000000000229,0.721999886244882,0,4,positive regulation of translational initiation in response to stress,BP,
1272,GO:0003056,1.00000000000231,0.657743553911004,0,5,regulation of vascular smooth muscle contraction,BP,
16390,GO:0090675,1.00000000000231,0.925632087062292,0,1,intermicrovillar adhesion,BP,
4696,GO:0010848,1.00000000000231,0.926445443993151,0,1,regulation of chromatin disassembly,BP,
3537,GO:0007538,1.00000000000232,0.846786255027167,0,2,primary sex determination,BP,
3538,GO:0007542,1.00000000000232,0.846786255027167,0,2,primary sex determination, germ-line,BP,
5995,GO:0018992,1.00000000000232,0.846786255027167,0,2,germ-line sex determination,BP,
6035,GO:0019100,1.00000000000232,0.846786255027167,0,2,male germ-line sex determination,BP,
14049,GO:0060754,1.00000000000234,0.709770412130116,0,5,positive regulation of mast cell chemotaxis,BP,
14053,GO:0060762,1.00000000000234,0.743240551625793,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
13699,GO:0060212,1.00000000000236,0.937137129645318,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17437,GO:1900152,1.00000000000236,0.937137129645318,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
2038,GO:0004776,1.00000000000236,0.87877241316608,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
11664,GO:0046380,1.00000000000236,0.924402047779369,0,1,N-acetylneuraminate biosynthetic process,BP,
12462,GO:0050124,1.00000000000236,0.924402047779369,0,1,N-acylneuraminate-9-phosphatase activity,MF,
824,GO:0002094,1.00000000000236,0.870851980545756,0,2,polyprenyltransferase activity,MF,
7511,GO:0031685,1.00000000000236,0.856053405614981,0,2,adenosine receptor binding,MF,
15089,GO:0071034,1.00000000000236,0.74534032421241,0,4,CUT catabolic process,BP,
15093,GO:0071043,1.00000000000236,0.74534032421241,0,4,CUT metabolic process,BP,
12156,GO:0048243,1.00000000000238,0.732183198440883,0,4,norepinephrine secretion,BP,
9480,GO:0036091,1.00000000000238,0.718730374487976,0,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
456,GO:0001300,1.00000000000239,0.859291976679925,0,2,chronological cell aging,BP,
2367,GO:0005477,1.00000000000239,0.925400175224289,0,1,pyruvate secondary active transmembrane transporter activity,MF,
14713,GO:0070324,1.00000000000239,0.683118880779198,0,5,thyroid hormone binding,MF,
9636,GO:0036494,1.0000000000024,0.915718576749381,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
2294,GO:0005250,1.0000000000024,0.920242682036149,0,1,A-type (transient outward) potassium channel activity,MF,
3766,GO:0008310,1.00000000000241,0.744278460512257,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
11097,GO:0045083,1.00000000000242,0.923135258287362,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
1299,GO:0003129,1.00000000000243,0.814824873947746,0,3,heart induction,BP,
16215,GO:0090226,1.00000000000244,0.959574519605271,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
6427,GO:0021688,1.00000000000246,0.926298703881368,0,1,cerebellar molecular layer formation,BP,
14091,GO:0060853,1.00000000000246,0.926298703881368,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
1744,GO:0004340,1.00000000000246,0.775779403928877,0,3,glucokinase activity,MF,
1785,GO:0004396,1.00000000000246,0.775779403928877,0,3,hexokinase activity,MF,
3991,GO:0008865,1.00000000000246,0.775779403928877,0,3,fructokinase activity,MF,
6048,GO:0019158,1.00000000000246,0.775779403928877,0,3,mannokinase activity,MF,
71,GO:0000147,1.00000000000247,0.777359435862811,0,3,actin cortical patch assembly,BP,
10881,GO:0044396,1.00000000000247,0.777359435862811,0,3,actin cortical patch organization,BP,
13144,GO:0051666,1.00000000000247,0.777359435862811,0,3,actin cortical patch localization,BP,
15956,GO:0072739,1.00000000000247,0.86882042999972,0,2,response to anisomycin,BP,
1628,GO:0004061,1.00000000000247,0.939107247287859,0,1,arylformamidase activity,MF,
4783,GO:0010967,1.00000000000247,0.939107247287859,0,1,regulation of polyamine biosynthetic process,BP,
12040,GO:0047658,1.00000000000247,0.939107247287859,0,1,alpha-amino-acid esterase activity,MF,
13471,GO:0052899,1.00000000000247,0.939107247287859,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13473,GO:0052902,1.00000000000247,0.939107247287859,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13474,GO:0052903,1.00000000000247,0.939107247287859,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13475,GO:0052904,1.00000000000247,0.939107247287859,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
17640,GO:1901304,1.00000000000247,0.939107247287859,0,1,regulation of spermidine biosynthetic process,BP,
17641,GO:1901307,1.00000000000247,0.939107247287859,0,1,positive regulation of spermidine biosynthetic process,BP,
2181,GO:0005025,1.00000000000247,0.774603181285127,0,3,transforming growth factor beta receptor activity, type I,MF,
5786,GO:0017005,1.00000000000248,0.924988932463902,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6446,GO:0021757,1.00000000000248,0.924988932463902,0,1,caudate nucleus development,BP,
6447,GO:0021758,1.00000000000248,0.924988932463902,0,1,putamen development,BP,
12772,GO:0051021,1.00000000000248,0.741188339411298,0,4,GDP-dissociation inhibitor binding,MF,
12773,GO:0051022,1.00000000000248,0.741188339411298,0,4,Rho GDP-dissociation inhibitor binding,MF,
20048,GO:2000630,1.00000000000248,0.698099820335186,0,5,positive regulation of miRNA metabolic process,BP,
14005,GO:0060697,1.00000000000248,0.928637103624275,0,1,positive regulation of phospholipid catabolic process,BP,
17439,GO:1900161,1.00000000000248,0.928637103624275,0,1,regulation of phospholipid scramblase activity,BP,
17440,GO:1900163,1.00000000000248,0.928637103624275,0,1,positive regulation of phospholipid scramblase activity,BP,
20122,GO:2000752,1.00000000000248,0.928637103624275,0,1,regulation of glucosylceramide catabolic process,BP,
20123,GO:2000753,1.00000000000248,0.928637103624275,0,1,positive regulation of glucosylceramide catabolic process,BP,
20124,GO:2000754,1.00000000000248,0.928637103624275,0,1,regulation of sphingomyelin catabolic process,BP,
20125,GO:2000755,1.00000000000248,0.928637103624275,0,1,positive regulation of sphingomyelin catabolic process,BP,
8657,GO:0034196,1.00000000000248,0.929697178618204,0,1,acylglycerol transport,BP,
8658,GO:0034197,1.00000000000248,0.929697178618204,0,1,triglyceride transport,BP,
10880,GO:0044395,1.00000000000248,0.929697178618204,0,1,protein targeting to vacuolar membrane,BP,
17520,GO:1900483,1.00000000000248,0.929697178618204,0,1,regulation of protein targeting to vacuolar membrane,BP,
5,GO:0000011,1.00000000000249,0.928130565697019,0,1,vacuole inheritance,BP,
334,GO:0000928,1.00000000000249,0.928130565697019,0,1,gamma-tubulin small complex, spindle pole body,CC,
1568,GO:0003972,1.00000000000249,0.928130565697019,0,1,RNA ligase (ATP) activity,MF,
1643,GO:0004083,1.00000000000249,0.928130565697019,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1770,GO:0004371,1.00000000000249,0.928130565697019,0,1,glycerone kinase activity,MF,
1856,GO:0004516,1.00000000000249,0.928130565697019,0,1,nicotinate phosphoribosyltransferase activity,MF,
2019,GO:0004743,1.00000000000249,0.928130565697019,0,1,pyruvate kinase activity,MF,
2735,GO:0006113,1.00000000000249,0.928130565697019,0,1,fermentation,BP,
2951,GO:0006480,1.00000000000249,0.928130565697019,0,1,N-terminal protein amino acid methylation,BP,
3373,GO:0007146,1.00000000000249,0.928130565697019,0,1,meiotic recombination nodule assembly,BP,
3844,GO:0008452,1.00000000000249,0.928130565697019,0,1,RNA ligase activity,MF,
3845,GO:0008453,1.00000000000249,0.928130565697019,0,1,alanine-glyoxylate transaminase activity,MF,
3958,GO:0008700,1.00000000000249,0.928130565697019,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3976,GO:0008792,1.00000000000249,0.928130565697019,0,1,arginine decarboxylase activity,MF,
4106,GO:0009159,1.00000000000249,0.928130565697019,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4239,GO:0009436,1.00000000000249,0.928130565697019,0,1,glyoxylate catabolic process,BP,
4432,GO:0010260,1.00000000000249,0.928130565697019,0,1,animal organ senescence,BP,
4446,GO:0010348,1.00000000000249,0.928130565697019,0,1,lithium:proton antiporter activity,MF,
4819,GO:0014011,1.00000000000249,0.928130565697019,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5034,GO:0015203,1.00000000000249,0.928130565697019,0,1,polyamine transmembrane transporter activity,MF,
5071,GO:0015292,1.00000000000249,0.928130565697019,0,1,uniporter activity,MF,
5124,GO:0015489,1.00000000000249,0.928130565697019,0,1,putrescine transmembrane transporter activity,MF,
5234,GO:0015847,1.00000000000249,0.928130565697019,0,1,putrescine transport,BP,
5497,GO:0016430,1.00000000000249,0.928130565697019,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5582,GO:0016596,1.00000000000249,0.928130565697019,0,1,thienylcyclohexylpiperidine binding,MF,
5692,GO:0016807,1.00000000000249,0.928130565697019,0,1,cysteine-type carboxypeptidase activity,MF,
5872,GO:0017178,1.00000000000249,0.928130565697019,0,1,diphthine-ammonia ligase activity,MF,
5883,GO:0018011,1.00000000000249,0.928130565697019,0,1,N-terminal peptidyl-alanine methylation,BP,
5884,GO:0018012,1.00000000000249,0.928130565697019,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5885,GO:0018013,1.00000000000249,0.928130565697019,0,1,N-terminal peptidyl-glycine methylation,BP,
5886,GO:0018016,1.00000000000249,0.928130565697019,0,1,N-terminal peptidyl-proline dimethylation,BP,
5890,GO:0018025,1.00000000000249,0.928130565697019,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5922,GO:0018194,1.00000000000249,0.928130565697019,0,1,peptidyl-alanine modification,BP,
6115,GO:0019357,1.00000000000249,0.928130565697019,0,1,nicotinate nucleotide biosynthetic process,BP,
6116,GO:0019358,1.00000000000249,0.928130565697019,0,1,nicotinate nucleotide salvage,BP,
6121,GO:0019365,1.00000000000249,0.928130565697019,0,1,pyridine nucleotide salvage,BP,
6195,GO:0019659,1.00000000000249,0.928130565697019,0,1,glucose catabolic process to lactate,BP,
6196,GO:0019660,1.00000000000249,0.928130565697019,0,1,glycolytic fermentation,BP,
6197,GO:0019661,1.00000000000249,0.928130565697019,0,1,glucose catabolic process to lactate via pyruvate,BP,
6198,GO:0019666,1.00000000000249,0.928130565697019,0,1,nitrogenous compound fermentation,BP,
6243,GO:0019799,1.00000000000249,0.928130565697019,0,1,tubulin N-acetyltransferase activity,MF,
6328,GO:0020003,1.00000000000249,0.928130565697019,0,1,symbiont-containing vacuole,CC,
7025,GO:0030735,1.00000000000249,0.928130565697019,0,1,carnosine N-methyltransferase activity,MF,
7139,GO:0030961,1.00000000000249,0.928130565697019,0,1,peptidyl-arginine hydroxylation,BP,
7669,GO:0032093,1.00000000000249,0.928130565697019,0,1,SAM domain binding,MF,
7749,GO:0032253,1.00000000000249,0.928130565697019,0,1,dense core granule localization,BP,
8275,GO:0033058,1.00000000000249,0.928130565697019,0,1,directional locomotion,BP,
8476,GO:0033608,1.00000000000249,0.928130565697019,0,1,formyl-CoA transferase activity,MF,
8477,GO:0033609,1.00000000000249,0.928130565697019,0,1,oxalate metabolic process,BP,
8568,GO:0034012,1.00000000000249,0.928130565697019,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8718,GO:0034353,1.00000000000249,0.928130565697019,0,1,RNA pyrophosphohydrolase activity,MF,
8719,GO:0034355,1.00000000000249,0.928130565697019,0,1,NAD salvage,BP,
8814,GO:0034512,1.00000000000249,0.928130565697019,0,1,box C/D snoRNA binding,MF,
8958,GO:0034998,1.00000000000249,0.928130565697019,0,1,oligosaccharyltransferase I complex,CC,
9155,GO:0035498,1.00000000000249,0.928130565697019,0,1,carnosine metabolic process,BP,
9195,GO:0035568,1.00000000000249,0.928130565697019,0,1,N-terminal peptidyl-proline methylation,BP,
9196,GO:0035570,1.00000000000249,0.928130565697019,0,1,N-terminal peptidyl-serine methylation,BP,
9197,GO:0035572,1.00000000000249,0.928130565697019,0,1,N-terminal peptidyl-serine dimethylation,BP,
9198,GO:0035573,1.00000000000249,0.928130565697019,0,1,N-terminal peptidyl-serine trimethylation,BP,
9209,GO:0035585,1.00000000000249,0.928130565697019,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9564,GO:0036317,1.00000000000249,0.928130565697019,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9731,GO:0038161,1.00000000000249,0.928130565697019,0,1,prolactin signaling pathway,BP,
9887,GO:0042140,1.00000000000249,0.928130565697019,0,1,late meiotic recombination nodule assembly,BP,
10192,GO:0042774,1.00000000000249,0.928130565697019,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10210,GO:0042806,1.00000000000249,0.928130565697019,0,1,fucose binding,MF,
10247,GO:0042946,1.00000000000249,0.928130565697019,0,1,glucoside transport,BP,
10248,GO:0042947,1.00000000000249,0.928130565697019,0,1,glucoside transmembrane transporter activity,MF,
10538,GO:0043465,1.00000000000249,0.928130565697019,0,1,regulation of fermentation,BP,
10844,GO:0044328,1.00000000000249,0.928130565697019,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10845,GO:0044329,1.00000000000249,0.928130565697019,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10846,GO:0044330,1.00000000000249,0.928130565697019,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10950,GO:0044599,1.00000000000249,0.928130565697019,0,1,AP-5 adaptor complex,CC,
10961,GO:0044648,1.00000000000249,0.928130565697019,0,1,histone H3-K4 dimethylation,BP,
10979,GO:0044732,1.00000000000249,0.928130565697019,0,1,mitotic spindle pole body,CC,
10980,GO:0044736,1.00000000000249,0.928130565697019,0,1,acid-sensing ion channel activity,MF,
11152,GO:0045183,1.00000000000249,0.928130565697019,0,1,translation factor activity, non-nucleic acid binding,MF,
11610,GO:0046176,1.00000000000249,0.928130565697019,0,1,aldonic acid catabolic process,BP,
11611,GO:0046177,1.00000000000249,0.928130565697019,0,1,D-gluconate catabolic process,BP,
11629,GO:0046316,1.00000000000249,0.928130565697019,0,1,gluconokinase activity,MF,
11720,GO:0046497,1.00000000000249,0.928130565697019,0,1,nicotinate nucleotide metabolic process,BP,
11846,GO:0046745,1.00000000000249,0.928130565697019,0,1,viral capsid secondary envelopment,BP,
11956,GO:0046996,1.00000000000249,0.928130565697019,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11961,GO:0047017,1.00000000000249,0.928130565697019,0,1,prostaglandin-F synthase activity,MF,
12008,GO:0047369,1.00000000000249,0.928130565697019,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12050,GO:0047734,1.00000000000249,0.928130565697019,0,1,CDP-glycerol diphosphatase activity,MF,
12456,GO:0050046,1.00000000000249,0.928130565697019,0,1,lathosterol oxidase activity,MF,
12465,GO:0050144,1.00000000000249,0.928130565697019,0,1,nucleoside deoxyribosyltransferase activity,MF,
12477,GO:0050262,1.00000000000249,0.928130565697019,0,1,ribosylnicotinamide kinase activity,MF,
12489,GO:0050346,1.00000000000249,0.928130565697019,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12492,GO:0050354,1.00000000000249,0.928130565697019,0,1,triokinase activity,MF,
12716,GO:0050915,1.00000000000249,0.928130565697019,0,1,sensory perception of sour taste,BP,
12968,GO:0051308,1.00000000000249,0.928130565697019,0,1,male meiosis chromosome separation,BP,
13018,GO:0051417,1.00000000000249,0.928130565697019,0,1,microtubule nucleation by spindle pole body,BP,
13039,GO:0051455,1.00000000000249,0.928130565697019,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13150,GO:0051685,1.00000000000249,0.928130565697019,0,1,maintenance of ER location,BP,
13479,GO:0052909,1.00000000000249,0.928130565697019,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13966,GO:0060620,1.00000000000249,0.928130565697019,0,1,regulation of cholesterol import,BP,
14098,GO:0060887,1.00000000000249,0.928130565697019,0,1,limb epidermis development,BP,
14107,GO:0060912,1.00000000000249,0.928130565697019,0,1,cardiac cell fate specification,BP,
14194,GO:0061056,1.00000000000249,0.928130565697019,0,1,sclerotome development,BP,
14316,GO:0061400,1.00000000000249,0.928130565697019,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14345,GO:0061495,1.00000000000249,0.928130565697019,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14423,GO:0061685,1.00000000000249,0.928130565697019,0,1,diphthine methylesterase activity,MF,
14463,GO:0061769,1.00000000000249,0.928130565697019,0,1,ribosylnicotinate kinase activity,MF,
14531,GO:0065010,1.00000000000249,0.928130565697019,0,1,extracellular membrane-bounded organelle,CC,
14534,GO:0070004,1.00000000000249,0.928130565697019,0,1,cysteine-type exopeptidase activity,MF,
14602,GO:0070130,1.00000000000249,0.928130565697019,0,1,negative regulation of mitochondrial translation,BP,
14619,GO:0070165,1.00000000000249,0.928130565697019,0,1,positive regulation of adiponectin secretion,BP,
14676,GO:0070260,1.00000000000249,0.928130565697019,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14832,GO:0070551,1.00000000000249,0.928130565697019,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14834,GO:0070553,1.00000000000249,0.928130565697019,0,1,nicotinic acid receptor activity,MF,
14837,GO:0070560,1.00000000000249,0.928130565697019,0,1,protein secretion by platelet,BP,
14849,GO:0070573,1.00000000000249,0.928130565697019,0,1,metallodipeptidase activity,MF,
14908,GO:0070694,1.00000000000249,0.928130565697019,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15273,GO:0071424,1.00000000000249,0.928130565697019,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15527,GO:0071885,1.00000000000249,0.928130565697019,0,1,N-terminal protein N-methyltransferase activity,MF,
15553,GO:0071931,1.00000000000249,0.928130565697019,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15951,GO:0072720,1.00000000000249,0.928130565697019,0,1,response to dithiothreitol,BP,
16037,GO:0086038,1.00000000000249,0.928130565697019,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16368,GO:0090624,1.00000000000249,0.928130565697019,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16369,GO:0090625,1.00000000000249,0.928130565697019,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16569,GO:0097310,1.00000000000249,0.928130565697019,0,1,cap2 mRNA methylation,BP,
16704,GO:0097630,1.00000000000249,0.928130565697019,0,1,intrinsic component of omegasome membrane,CC,
16705,GO:0097631,1.00000000000249,0.928130565697019,0,1,integral component of omegasome membrane,CC,
16720,GO:0097655,1.00000000000249,0.928130565697019,0,1,serpin family protein binding,MF,
16738,GO:0097712,1.00000000000249,0.928130565697019,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16811,GO:0098629,1.00000000000249,0.928130565697019,0,1,trans-Golgi network membrane organization,BP,
16850,GO:0098725,1.00000000000249,0.928130565697019,0,1,symmetric cell division,BP,
17065,GO:0099519,1.00000000000249,0.928130565697019,0,1,dense core granule cytoskeletal transport,BP,
17114,GO:0099627,1.00000000000249,0.928130565697019,0,1,neurotransmitter receptor cycle,BP,
17116,GO:0099630,1.00000000000249,0.928130565697019,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17181,GO:0102524,1.00000000000249,0.928130565697019,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17433,GO:1900148,1.00000000000249,0.928130565697019,0,1,negative regulation of Schwann cell migration,BP,
17444,GO:1900170,1.00000000000249,0.928130565697019,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17546,GO:1901003,1.00000000000249,0.928130565697019,0,1,negative regulation of fermentation,BP,
17645,GO:1901318,1.00000000000249,0.928130565697019,0,1,negative regulation of flagellated sperm motility,BP,
17690,GO:1901523,1.00000000000249,0.928130565697019,0,1,icosanoid catabolic process,BP,
17838,GO:1901950,1.00000000000249,0.928130565697019,0,1,dense core granule transport,BP,
17905,GO:1902145,1.00000000000249,0.928130565697019,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17906,GO:1902151,1.00000000000249,0.928130565697019,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17907,GO:1902153,1.00000000000249,0.928130565697019,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17927,GO:1902211,1.00000000000249,0.928130565697019,0,1,regulation of prolactin signaling pathway,BP,
17928,GO:1902213,1.00000000000249,0.928130565697019,0,1,positive regulation of prolactin signaling pathway,BP,
18003,GO:1902387,1.00000000000249,0.928130565697019,0,1,ceramide 1-phosphate binding,MF,
18004,GO:1902388,1.00000000000249,0.928130565697019,0,1,ceramide 1-phosphate transporter activity,MF,
18005,GO:1902389,1.00000000000249,0.928130565697019,0,1,ceramide 1-phosphate transport,BP,
18109,GO:1902688,1.00000000000249,0.928130565697019,0,1,regulation of NAD metabolic process,BP,
18110,GO:1902689,1.00000000000249,0.928130565697019,0,1,negative regulation of NAD metabolic process,BP,
18187,GO:1902912,1.00000000000249,0.928130565697019,0,1,pyruvate kinase complex,CC,
18347,GO:1903259,1.00000000000249,0.928130565697019,0,1,exon-exon junction complex disassembly,BP,
18704,GO:1904023,1.00000000000249,0.928130565697019,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18705,GO:1904024,1.00000000000249,0.928130565697019,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18708,GO:1904028,1.00000000000249,0.928130565697019,0,1,positive regulation of collagen fibril organization,BP,
18979,GO:1904713,1.00000000000249,0.928130565697019,0,1,beta-catenin destruction complex binding,MF,
19013,GO:1904777,1.00000000000249,0.928130565697019,0,1,negative regulation of protein localization to cell cortex,BP,
19029,GO:1904806,1.00000000000249,0.928130565697019,0,1,regulation of protein oxidation,BP,
19030,GO:1904808,1.00000000000249,0.928130565697019,0,1,positive regulation of protein oxidation,BP,
19142,GO:1905044,1.00000000000249,0.928130565697019,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19143,GO:1905045,1.00000000000249,0.928130565697019,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19224,GO:1905279,1.00000000000249,0.928130565697019,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19253,GO:1905344,1.00000000000249,0.928130565697019,0,1,prostaglandin catabolic process,BP,
19288,GO:1905435,1.00000000000249,0.928130565697019,0,1,regulation of histone H3-K4 trimethylation,BP,
19289,GO:1905437,1.00000000000249,0.928130565697019,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19360,GO:1905642,1.00000000000249,0.928130565697019,0,1,negative regulation of DNA methylation,BP,
19466,GO:1990048,1.00000000000249,0.928130565697019,0,1,anterograde neuronal dense core vesicle transport,BP,
19520,GO:1990261,1.00000000000249,0.928130565697019,0,1,pre-mRNA catabolic process,BP,
19592,GO:1990570,1.00000000000249,0.928130565697019,0,1,GDP-mannose transmembrane transport,BP,
19634,GO:1990738,1.00000000000249,0.928130565697019,0,1,pseudouridine 5'-phosphatase activity,MF,
19643,GO:1990755,1.00000000000249,0.928130565697019,0,1,mitotic spindle microtubule depolymerization,BP,
19715,GO:2000003,1.00000000000249,0.928130565697019,0,1,positive regulation of DNA damage checkpoint,BP,
20192,GO:2000909,1.00000000000249,0.928130565697019,0,1,regulation of sterol import,BP,
1354,GO:0003219,1.00000000000249,0.841627061513183,0,2,cardiac right ventricle formation,BP,
4080,GO:0009133,1.00000000000249,0.785261613230864,0,4,nucleoside diphosphate biosynthetic process,BP,
5306,GO:0016005,1.0000000000025,0.8544332051885,0,2,phospholipase A2 activator activity,MF,
11946,GO:0046976,1.0000000000025,0.681780982429979,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12559,GO:0050689,1.00000000000251,0.719892844323422,0,5,negative regulation of defense response to virus by host,BP,
3875,GO:0008503,1.00000000000251,0.891380551272103,0,2,benzodiazepine receptor activity,MF,
2633,GO:0005960,1.00000000000251,0.871285067354202,0,2,glycine cleavage complex,CC,
12535,GO:0050659,1.00000000000252,0.842058620674872,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
20010,GO:2000563,1.00000000000252,0.854509194890574,0,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
13333,GO:0052151,1.00000000000252,0.875333770273433,0,2,positive regulation by symbiont of host apoptotic process,BP,
13659,GO:0060139,1.00000000000252,0.875333770273433,0,2,positive regulation of apoptotic process by virus,BP,
3,GO:0000009,1.00000000000253,0.931155196868604,0,1,alpha-1,6-mannosyltransferase activity,MF,
13480,GO:0052917,1.00000000000253,0.931155196868604,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
11682,GO:0046439,1.00000000000255,0.680610681250889,0,5,L-cysteine metabolic process,BP,
9018,GO:0035175,1.00000000000258,0.938887718472369,0,1,histone kinase activity (H3-S10 specific),MF,
15777,GO:0072354,1.00000000000258,0.938887718472369,0,1,histone kinase activity (H3-T3 specific),MF,
15778,GO:0072355,1.00000000000258,0.938887718472369,0,1,histone H3-T3 phosphorylation,BP,
14728,GO:0070345,1.00000000000259,0.723694381264853,0,4,negative regulation of fat cell proliferation,BP,
12171,GO:0048263,1.00000000000259,0.768304134627596,0,4,determination of dorsal identity,BP,
7875,GO:0032431,1.0000000000026,0.888397097457818,0,2,activation of phospholipase A2 activity,BP,
3638,GO:0008109,1.00000000000261,0.852891408598667,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
11236,GO:0045355,1.00000000000261,0.886851691310161,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11181,GO:0045226,1.00000000000261,0.860843988422787,0,2,extracellular polysaccharide biosynthetic process,BP,
11663,GO:0046379,1.00000000000261,0.860843988422787,0,2,extracellular polysaccharide metabolic process,BP,
10354,GO:0043141,1.00000000000262,0.702882738838691,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
6541,GO:0021942,1.00000000000262,0.78180449706792,0,3,radial glia guided migration of Purkinje cell,BP,
13679,GO:0060171,1.00000000000262,0.92004302581245,0,1,stereocilium membrane,CC,
595,GO:0001757,1.00000000000262,0.849559558894965,0,2,somite specification,BP,
9367,GO:0035870,1.00000000000264,0.869583570680895,0,2,dITP diphosphatase activity,MF,
15939,GO:0072706,1.00000000000264,0.929849630077487,0,1,response to sodium dodecyl sulfate,BP,
15940,GO:0072707,1.00000000000264,0.929849630077487,0,1,cellular response to sodium dodecyl sulfate,BP,
1760,GO:0004360,1.00000000000264,0.89952997134632,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
14830,GO:0070548,1.00000000000264,0.89952997134632,0,1,L-glutamine aminotransferase activity,MF,
9849,GO:0042078,1.00000000000264,0.878571434817695,0,2,germ-line stem cell division,BP,
12118,GO:0048133,1.00000000000264,0.878571434817695,0,2,male germ-line stem cell asymmetric division,BP,
16852,GO:0098728,1.00000000000264,0.878571434817695,0,2,germline stem cell asymmetric division,BP,
1515,GO:0003873,1.00000000000266,0.782568090359714,0,3,6-phosphofructo-2-kinase activity,MF,
351,GO:0000964,1.00000000000266,0.75958758803443,0,4,mitochondrial RNA 5'-end processing,BP,
9721,GO:0038124,1.00000000000266,0.846475335745325,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10051,GO:0042494,1.00000000000266,0.846475335745325,0,2,detection of bacterial lipoprotein,BP,
10053,GO:0042496,1.00000000000266,0.846475335745325,0,2,detection of diacyl bacterial lipopeptide,BP,
14724,GO:0070340,1.00000000000266,0.846475335745325,0,2,detection of bacterial lipopeptide,BP,
15459,GO:0071724,1.00000000000266,0.846475335745325,0,2,response to diacyl bacterial lipopeptide,BP,
15461,GO:0071726,1.00000000000266,0.846475335745325,0,2,cellular response to diacyl bacterial lipopeptide,BP,
12379,GO:0048743,1.00000000000266,0.854066337340394,0,2,positive regulation of skeletal muscle fiber development,BP,
9234,GO:0035614,1.00000000000267,0.827958258739924,0,3,snRNA stem-loop binding,MF,
16540,GO:0097231,1.00000000000268,0.938787416221127,0,1,cell motility in response to calcium ion,BP,
19627,GO:1990716,1.00000000000268,0.938787416221127,0,1,axonemal central apparatus,CC,
4361,GO:0009955,1.00000000000268,0.93259559179264,0,1,adaxial/abaxial pattern specification,BP,
9285,GO:0035709,1.00000000000268,0.93259559179264,0,1,memory T cell activation,BP,
16324,GO:0090427,1.00000000000268,0.93259559179264,0,1,activation of meiosis,BP,
19723,GO:2000011,1.00000000000268,0.93259559179264,0,1,regulation of adaxial/abaxial pattern formation,BP,
20013,GO:2000567,1.00000000000268,0.93259559179264,0,1,regulation of memory T cell activation,BP,
20014,GO:2000568,1.00000000000268,0.93259559179264,0,1,positive regulation of memory T cell activation,BP,
20232,GO:2001055,1.00000000000268,0.93259559179264,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
16356,GO:0090571,1.00000000000268,0.814653724265698,0,3,RNA polymerase II transcription repressor complex,CC,
8029,GO:0032658,1.00000000000269,0.937696159941332,0,1,regulation of interleukin-15 production,BP,
8074,GO:0032738,1.00000000000269,0.937696159941332,0,1,positive regulation of interleukin-15 production,BP,
9264,GO:0035664,1.00000000000269,0.937696159941332,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9265,GO:0035665,1.00000000000269,0.937696159941332,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
743,GO:0001971,1.0000000000027,0.904663135519329,0,1,negative regulation of activation of membrane attack complex,BP,
14236,GO:0061152,1.0000000000027,0.879237748352565,0,2,trachea submucosa development,BP,
14237,GO:0061153,1.0000000000027,0.879237748352565,0,2,trachea gland development,BP,
10013,GO:0042420,1.00000000000271,0.752226877405811,0,4,dopamine catabolic process,BP,
14767,GO:0070427,1.00000000000272,0.806704210953692,0,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
11567,GO:0046086,1.00000000000272,0.862479976115425,0,2,adenosine biosynthetic process,BP,
8394,GO:0033292,1.00000000000272,0.8135491202083,0,2,T-tubule organization,BP,
1850,GO:0004506,1.00000000000273,0.92767007787901,0,1,squalene monooxygenase activity,MF,
5452,GO:0016321,1.00000000000273,0.805086852047883,0,3,female meiosis chromosome segregation,BP,
560,GO:0001692,1.00000000000273,0.957404896876328,0,1,histamine metabolic process,BP,
561,GO:0001695,1.00000000000273,0.957404896876328,0,1,histamine catabolic process,BP,
11744,GO:0046539,1.00000000000273,0.957404896876328,0,1,histamine N-methyltransferase activity,MF,
18560,GO:1903723,1.00000000000273,0.957404896876328,0,1,negative regulation of centriole elongation,BP,
13436,GO:0052810,1.00000000000274,0.924631534342336,0,1,1-phosphatidylinositol-5-kinase activity,MF,
19330,GO:1905555,1.00000000000274,0.8606441374865,0,2,positive regulation blood vessel branching,BP,
705,GO:0001922,1.00000000000274,0.779190727635719,0,3,B-1 B cell homeostasis,BP,
2669,GO:0006015,1.00000000000276,0.805755977845576,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
11669,GO:0046391,1.00000000000276,0.805755977845576,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
2068,GO:0004819,1.00000000000276,0.855678340780492,0,2,glutamine-tRNA ligase activity,MF,
2914,GO:0006425,1.00000000000276,0.855678340780492,0,2,glutaminyl-tRNA aminoacylation,BP,
2775,GO:0006203,1.00000000000276,0.833990922808609,0,3,dGTP catabolic process,BP,
10082,GO:0042568,1.00000000000276,0.955706481401502,0,1,insulin-like growth factor binary complex,CC,
7791,GO:0032311,1.00000000000276,0.894288902677238,0,2,angiogenin-PRI complex,CC,
16468,GO:0097111,1.00000000000277,0.828055218681544,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
19001,GO:1904751,1.00000000000277,0.829543024280935,0,3,positive regulation of protein localization to nucleolus,BP,
9317,GO:0035766,1.00000000000277,0.769442782540734,0,3,cell chemotaxis to fibroblast growth factor,BP,
9319,GO:0035768,1.00000000000277,0.769442782540734,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,
19048,GO:1904847,1.00000000000277,0.769442782540734,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,
20003,GO:2000544,1.00000000000277,0.769442782540734,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
3345,GO:0007066,1.00000000000278,0.956508990482735,0,1,female meiosis sister chromatid cohesion,BP,
8414,GO:0033364,1.00000000000279,0.87515085268829,0,1,mast cell secretory granule organization,BP,
14273,GO:0061303,1.0000000000028,0.73533625676848,0,4,cornea development in camera-type eye,BP,
4014,GO:0009007,1.00000000000281,0.924863501890198,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
8098,GO:0032775,1.00000000000281,0.924863501890198,0,1,DNA methylation on adenine,BP,
2158,GO:0004979,1.00000000000281,0.936502949490203,0,1,beta-endorphin receptor activity,MF,
7478,GO:0031635,1.00000000000281,0.936502949490203,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7673,GO:0032097,1.00000000000281,0.936502949490203,0,1,positive regulation of response to food,BP,
7676,GO:0032100,1.00000000000281,0.936502949490203,0,1,positive regulation of appetite,BP,
9688,GO:0038047,1.00000000000281,0.936502949490203,0,1,morphine receptor activity,MF,
11734,GO:0046521,1.00000000000281,0.936502949490203,0,1,sphingoid catabolic process,BP,
14303,GO:0061358,1.00000000000281,0.936502949490203,0,1,negative regulation of Wnt protein secretion,BP,
17981,GO:1902309,1.00000000000281,0.861475724160229,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
4435,GO:0010269,1.00000000000282,0.834264053013066,0,3,response to selenium ion,BP,
17578,GO:1901097,1.00000000000284,0.729255193338419,0,4,negative regulation of autophagosome maturation,BP,
19988,GO:2000508,1.00000000000284,0.766308521703296,0,4,regulation of dendritic cell chemotaxis,BP,
19989,GO:2000510,1.00000000000284,0.766308521703296,0,4,positive regulation of dendritic cell chemotaxis,BP,
2372,GO:0005497,1.00000000000285,0.897762981697079,0,2,androgen binding,MF,
12202,GO:0048319,1.00000000000286,0.843091710803092,0,2,axial mesoderm morphogenesis,BP,
6422,GO:0021682,1.00000000000287,0.915111420872172,0,1,nerve maturation,BP,
6625,GO:0022848,1.00000000000288,0.792627285368666,0,3,acetylcholine-gated cation-selective channel activity,MF,
17573,GO:1901090,1.00000000000289,0.867200915364231,0,2,regulation of protein tetramerization,BP,
17574,GO:1901091,1.00000000000289,0.867200915364231,0,2,negative regulation of protein tetramerization,BP,
17575,GO:1901093,1.00000000000289,0.867200915364231,0,2,regulation of protein homotetramerization,BP,
17576,GO:1901094,1.00000000000289,0.867200915364231,0,2,negative regulation of protein homotetramerization,BP,
1965,GO:0004671,1.0000000000029,0.919781611100295,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
952,GO:0002368,1.0000000000029,0.931623621897032,0,1,B cell cytokine production,BP,
1197,GO:0002842,1.0000000000029,0.931623621897032,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9573,GO:0036351,1.0000000000029,0.931623621897032,0,1,histone H2A-K13 ubiquitination,BP,
9574,GO:0036352,1.0000000000029,0.931623621897032,0,1,histone H2A-K15 ubiquitination,BP,
4774,GO:0010957,1.00000000000292,0.801852509087888,0,3,negative regulation of vitamin D biosynthetic process,BP,
11598,GO:0046137,1.00000000000292,0.801852509087888,0,3,negative regulation of vitamin metabolic process,BP,
15959,GO:0072749,1.00000000000294,0.937315817432587,0,1,cellular response to cytochalasin B,BP,
16960,GO:0098918,1.00000000000294,0.937315817432587,0,1,structural constituent of synapse,MF,
16984,GO:0098973,1.00000000000294,0.937315817432587,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16985,GO:0098974,1.00000000000294,0.937315817432587,0,1,postsynaptic actin cytoskeleton organization,BP,
17047,GO:0099186,1.00000000000294,0.937315817432587,0,1,structural constituent of postsynapse,MF,
17048,GO:0099188,1.00000000000294,0.937315817432587,0,1,postsynaptic cytoskeleton organization,BP,
17647,GO:1901328,1.00000000000294,0.937315817432587,0,1,response to cytochalasin B,BP,
7569,GO:0031906,1.00000000000295,0.873995324151227,0,2,late endosome lumen,CC,
16648,GO:0097486,1.00000000000295,0.873995324151227,0,2,multivesicular body lumen,CC,
16137,GO:0090107,1.00000000000295,0.786517035957885,0,3,regulation of high-density lipoprotein particle assembly,BP,
1615,GO:0004040,1.00000000000296,0.861727159051872,0,2,amidase activity,MF,
2245,GO:0005153,1.00000000000296,0.860452028056687,0,2,interleukin-8 receptor binding,MF,
15551,GO:0071929,1.00000000000296,0.860452028056687,0,2,alpha-tubulin acetylation,BP,
20007,GO:2000553,1.00000000000297,0.761022027707498,0,4,positive regulation of T-helper 2 cell cytokine production,BP,
5977,GO:0018455,1.00000000000297,0.947653894576271,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
19537,GO:1990384,1.00000000000297,0.947653894576271,0,1,hyaloid vascular plexus regression,BP,
14882,GO:0070644,1.00000000000297,0.777539213064534,0,3,vitamin D response element binding,MF,
3645,GO:0008119,1.00000000000299,0.926560550866993,0,1,thiopurine S-methyltransferase activity,MF,
6396,GO:0021592,1.00000000000299,0.917353114995538,0,1,fourth ventricle development,BP,
6560,GO:0021993,1.00000000000299,0.917353114995538,0,1,initiation of neural tube closure,BP,
10317,GO:0043083,1.00000000000299,0.678101112064432,0,4,synaptic cleft,CC,
6315,GO:0019957,1.000000000003,0.869085028168496,0,2,C-C chemokine binding,MF,
1623,GO:0004053,1.000000000003,0.882455300926243,0,2,arginase activity,MF,
6181,GO:0019547,1.000000000003,0.882455300926243,0,2,arginine catabolic process to ornithine,BP,
13891,GO:0060488,1.00000000000301,0.811991586399638,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13892,GO:0060489,1.00000000000301,0.811991586399638,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13893,GO:0060490,1.00000000000301,0.811991586399638,0,2,lateral sprouting involved in lung morphogenesis,BP,
13999,GO:0060689,1.00000000000301,0.783678280070998,0,3,cell differentiation involved in salivary gland development,BP,
14040,GO:0060743,1.00000000000302,0.929938104482444,0,1,epithelial cell maturation involved in prostate gland development,BP,
19469,GO:1990070,1.00000000000305,0.961356262559172,0,1,TRAPPI protein complex,CC,
8474,GO:0033605,1.00000000000306,0.7055368199766,0,5,positive regulation of catecholamine secretion,BP,
352,GO:0000965,1.00000000000306,0.708486216264575,0,5,mitochondrial RNA 3'-end processing,BP,
8661,GO:0034201,1.00000000000306,0.69395918189111,0,5,response to oleic acid,BP,
17075,GO:0099532,1.00000000000306,0.830302371187638,0,2,synaptic vesicle endosomal processing,BP,
4603,GO:0010716,1.00000000000308,0.8323941683954,0,3,negative regulation of extracellular matrix disassembly,BP,
19177,GO:1905152,1.00000000000308,0.913994340539223,0,1,positive regulation of voltage-gated sodium channel activity,BP,
14444,GO:0061736,1.00000000000309,0.915049607644693,0,1,engulfment of target by autophagosome,BP,
14455,GO:0061753,1.00000000000309,0.915049607644693,0,1,substrate localization to autophagosome,BP,
2758,GO:0006167,1.00000000000309,0.732269065298224,0,5,AMP biosynthetic process,BP,
18991,GO:1904734,1.00000000000309,0.97203142659488,0,1,positive regulation of electron transfer activity,BP,
19107,GO:1904960,1.00000000000309,0.97203142659488,0,1,positive regulation of cytochrome-c oxidase activity,BP,
10944,GO:0044571,1.0000000000031,0.804500803772215,0,4,[2Fe-2S] cluster assembly,BP,
16909,GO:0098831,1.0000000000031,0.556521162730296,0,5,presynaptic active zone cytoplasmic component,CC,
9381,GO:0035897,1.00000000000312,0.69678990740438,0,5,proteolysis in other organism,BP,
6819,GO:0030272,1.00000000000313,0.95802699183595,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
9745,GO:0038190,1.00000000000313,0.86104408047969,0,2,VEGF-activated neuropilin signaling pathway,BP,
17986,GO:1902336,1.00000000000313,0.86104408047969,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
1734,GO:0004326,1.00000000000313,0.930345338768346,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1845,GO:0004498,1.00000000000313,0.930345338768346,0,1,calcidiol 1-monooxygenase activity,MF,
3987,GO:0008841,1.00000000000313,0.930345338768346,0,1,dihydrofolate synthase activity,MF,
11902,GO:0046901,1.00000000000313,0.930345338768346,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
2244,GO:0005152,1.00000000000314,0.791148977926887,0,3,interleukin-1 receptor antagonist activity,MF,
8646,GO:0034165,1.00000000000315,0.856880947611335,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
925,GO:0002317,1.00000000000315,0.850885091417172,0,3,plasma cell differentiation,BP,
18048,GO:1902525,1.00000000000315,0.73106790728283,0,5,regulation of protein monoubiquitination,BP,
16164,GO:0090158,1.00000000000316,0.698053493158555,0,5,endoplasmic reticulum membrane organization,BP,
7409,GO:0031467,1.00000000000316,0.715606991152977,0,5,Cul7-RING ubiquitin ligase complex,CC,
9762,GO:0039502,1.00000000000316,0.917718012636961,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9763,GO:0039503,1.00000000000316,0.917718012636961,0,1,suppression by virus of host innate immune response,BP,
9767,GO:0039514,1.00000000000316,0.917718012636961,0,1,suppression by virus of host JAK-STAT cascade,BP,
9783,GO:0039562,1.00000000000316,0.917718012636961,0,1,suppression by virus of host STAT activity,BP,
9784,GO:0039563,1.00000000000316,0.917718012636961,0,1,suppression by virus of host STAT1 activity,BP,
9785,GO:0039564,1.00000000000316,0.917718012636961,0,1,suppression by virus of host STAT2 activity,BP,
10886,GO:0044414,1.00000000000316,0.917718012636961,0,1,suppression of host defenses,BP,
13224,GO:0051833,1.00000000000316,0.917718012636961,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13317,GO:0052029,1.00000000000316,0.917718012636961,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13319,GO:0052037,1.00000000000316,0.917718012636961,0,1,negative regulation by symbiont of host defense response,BP,
13334,GO:0052167,1.00000000000316,0.917718012636961,0,1,modulation by symbiont of host innate immune response,BP,
13335,GO:0052170,1.00000000000316,0.917718012636961,0,1,negative regulation by symbiont of host innate immune response,BP,
13353,GO:0052261,1.00000000000316,0.917718012636961,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13354,GO:0052306,1.00000000000316,0.917718012636961,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13355,GO:0052309,1.00000000000316,0.917718012636961,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13377,GO:0052493,1.00000000000316,0.917718012636961,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13387,GO:0052561,1.00000000000316,0.917718012636961,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13388,GO:0052562,1.00000000000316,0.917718012636961,0,1,negative regulation by symbiont of host immune response,BP,
15966,GO:0075109,1.00000000000316,0.917718012636961,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15967,GO:0075111,1.00000000000316,0.917718012636961,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15968,GO:0075112,1.00000000000316,0.917718012636961,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15969,GO:0075114,1.00000000000316,0.917718012636961,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
16979,GO:0098968,1.00000000000316,0.917718012636961,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
6517,GO:0021891,1.00000000000316,0.648421520920964,0,5,olfactory bulb interneuron development,BP,
651,GO:0001839,1.00000000000317,0.672718521351192,0,5,neural plate morphogenesis,BP,
10338,GO:0043121,1.00000000000317,0.664009193052821,0,5,neurotrophin binding,MF,
1328,GO:0003176,1.00000000000317,0.734132873846633,0,4,aortic valve development,BP,
1331,GO:0003180,1.00000000000317,0.734132873846633,0,4,aortic valve morphogenesis,BP,
18047,GO:1902524,1.00000000000318,0.872054268457038,0,2,positive regulation of protein K48-linked ubiquitination,BP,
2325,GO:0005332,1.00000000000318,0.934775520010724,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
5024,GO:0015185,1.00000000000318,0.934775520010724,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
6547,GO:0021956,1.00000000000318,0.934775520010724,0,1,central nervous system interneuron axonogenesis,BP,
17264,GO:0110095,1.00000000000318,0.844301972986045,0,3,cellular detoxification of aldehyde,BP,
3972,GO:0008775,1.00000000000318,0.937078119192607,0,1,acetate CoA-transferase activity,MF,
4330,GO:0009850,1.00000000000318,0.937078119192607,0,1,auxin metabolic process,BP,
4331,GO:0009852,1.00000000000318,0.937078119192607,0,1,auxin catabolic process,BP,
4402,GO:0010124,1.00000000000318,0.937078119192607,0,1,phenylacetate catabolic process,BP,
20256,GO:2001160,1.00000000000319,0.875740508434219,0,2,regulation of histone H3-K79 methylation,BP,
20257,GO:2001162,1.00000000000319,0.875740508434219,0,2,positive regulation of histone H3-K79 methylation,BP,
6271,GO:0019862,1.00000000000319,0.941445140396745,0,1,IgA binding,MF,
11095,GO:0045081,1.0000000000032,0.925092702022189,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
2757,GO:0006166,1.0000000000032,0.730119038707307,0,5,purine ribonucleoside salvage,BP,
18151,GO:1902816,1.00000000000321,0.731894870765068,0,4,regulation of protein localization to microtubule,BP,
18152,GO:1902817,1.00000000000321,0.731894870765068,0,4,negative regulation of protein localization to microtubule,BP,
13991,GO:0060678,1.00000000000322,0.932075518984383,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15647,GO:0072127,1.00000000000322,0.932075518984383,0,1,renal capsule development,BP,
15648,GO:0072128,1.00000000000322,0.932075518984383,0,1,renal capsule morphogenesis,BP,
15649,GO:0072129,1.00000000000322,0.932075518984383,0,1,renal capsule formation,BP,
15650,GO:0072130,1.00000000000322,0.932075518984383,0,1,renal capsule specification,BP,
15704,GO:0072213,1.00000000000322,0.932075518984383,0,1,metanephric capsule development,BP,
15729,GO:0072265,1.00000000000322,0.932075518984383,0,1,metanephric capsule morphogenesis,BP,
15730,GO:0072266,1.00000000000322,0.932075518984383,0,1,metanephric capsule formation,BP,
15731,GO:0072267,1.00000000000322,0.932075518984383,0,1,metanephric capsule specification,BP,
16163,GO:0090156,1.00000000000323,0.82461686912094,0,3,cellular sphingolipid homeostasis,BP,
2151,GO:0004966,1.00000000000324,0.838553266185719,0,3,galanin receptor activity,MF,
19327,GO:1905550,1.00000000000324,0.882547572804222,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19328,GO:1905552,1.00000000000324,0.882547572804222,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
16689,GO:0097574,1.00000000000324,0.841286067317147,0,2,lateral part of cell,CC,
16690,GO:0097575,1.00000000000324,0.841286067317147,0,2,lateral cell cortex,CC,
12458,GO:0050080,1.00000000000326,0.932698508209671,0,1,malonyl-CoA decarboxylase activity,MF,
16485,GO:0097145,1.00000000000326,0.932698508209671,0,1,BAK complex,CC,
20336,GO:2001294,1.00000000000326,0.932698508209671,0,1,malonyl-CoA catabolic process,BP,
17971,GO:1902292,1.00000000000327,0.950083718211863,0,1,cell cycle DNA replication initiation,BP,
17984,GO:1902315,1.00000000000327,0.950083718211863,0,1,nuclear cell cycle DNA replication initiation,BP,
18222,GO:1902975,1.00000000000327,0.950083718211863,0,1,mitotic DNA replication initiation,BP,
789,GO:0002046,1.00000000000331,0.955431871966155,0,1,opsin binding,MF,
9581,GO:0036372,1.00000000000331,0.955431871966155,0,1,opsin transport,BP,
4317,GO:0009794,1.00000000000331,0.750609325001747,0,4,regulation of mitotic cell cycle, embryonic,BP,
11262,GO:0045448,1.00000000000331,0.750609325001747,0,4,mitotic cell cycle, embryonic,BP,
5043,GO:0015220,1.00000000000332,0.683888425356765,0,5,choline transmembrane transporter activity,MF,
2340,GO:0005367,1.00000000000332,0.884738475609395,0,1,myo-inositol:sodium symporter activity,MF,
10778,GO:0044214,1.00000000000332,0.701371656871556,0,4,spanning component of plasma membrane,CC,
4998,GO:0015136,1.00000000000333,0.926278427037564,0,1,sialic acid transmembrane transporter activity,MF,
5129,GO:0015538,1.00000000000333,0.926278427037564,0,1,sialic acid:proton symporter activity,MF,
5180,GO:0015739,1.00000000000333,0.926278427037564,0,1,sialic acid transport,BP,
901,GO:0002277,1.00000000000333,0.957687053222824,0,1,myeloid dendritic cell activation involved in immune response,BP,
1057,GO:0002582,1.00000000000333,0.957687053222824,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1060,GO:0002585,1.00000000000333,0.957687053222824,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1063,GO:0002588,1.00000000000333,0.957687053222824,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
5795,GO:0017024,1.00000000000333,0.957687053222824,0,1,myosin I binding,MF,
7780,GO:0032299,1.00000000000333,0.831278470425196,0,3,ribonuclease H2 complex,CC,
15931,GO:0072684,1.00000000000334,0.924302524597989,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
4796,GO:0010985,1.00000000000334,0.729248897452895,0,5,negative regulation of lipoprotein particle clearance,BP,
7723,GO:0032207,1.00000000000335,0.928106775032382,0,1,regulation of telomere maintenance via recombination,BP,
7724,GO:0032208,1.00000000000335,0.928106775032382,0,1,negative regulation of telomere maintenance via recombination,BP,
18461,GO:1903517,1.00000000000335,0.928106775032382,0,1,negative regulation of single strand break repair,BP,
18582,GO:1903770,1.00000000000335,0.928106775032382,0,1,negative regulation of beta-galactosidase activity,BP,
18604,GO:1903823,1.00000000000335,0.928106775032382,0,1,telomere single strand break repair,BP,
18605,GO:1903824,1.00000000000335,0.928106775032382,0,1,negative regulation of telomere single strand break repair,BP,
12343,GO:0048680,1.00000000000336,0.768233180987993,0,4,positive regulation of axon regeneration,BP,
14848,GO:0070572,1.00000000000336,0.768233180987993,0,4,positive regulation of neuron projection regeneration,BP,
12429,GO:0048859,1.00000000000336,0.858371270824471,0,2,formation of anatomical boundary,BP,
1855,GO:0004515,1.00000000000336,0.775093964811348,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
4180,GO:0009256,1.00000000000338,0.721990071555074,0,4,10-formyltetrahydrofolate metabolic process,BP,
5824,GO:0017089,1.00000000000338,0.870746099648298,0,2,glycolipid transporter activity,MF,
5047,GO:0015228,1.00000000000339,0.803547074586791,0,3,coenzyme A transmembrane transporter activity,MF,
5255,GO:0015880,1.00000000000339,0.803547074586791,0,3,coenzyme A transport,BP,
9095,GO:0035349,1.00000000000339,0.803547074586791,0,3,coenzyme A transmembrane transport,BP,
15107,GO:0071077,1.00000000000339,0.803547074586791,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15111,GO:0071106,1.00000000000339,0.803547074586791,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15994,GO:0080122,1.00000000000339,0.803547074586791,0,3,AMP transmembrane transporter activity,MF,
6767,GO:0030197,1.00000000000339,0.855464565985195,0,2,extracellular matrix constituent, lubricant activity,MF,
578,GO:0001727,1.00000000000339,0.672267064534899,0,5,lipid kinase activity,MF,
16948,GO:0098905,1.00000000000339,0.88944777701479,0,2,regulation of bundle of His cell action potential,BP,
11283,GO:0045569,1.00000000000339,0.757650871032116,0,4,TRAIL binding,MF,
12352,GO:0048696,1.0000000000034,0.942871218562912,0,1,regulation of collateral sprouting in absence of injury,BP,
12353,GO:0048697,1.0000000000034,0.942871218562912,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13615,GO:0060064,1.0000000000034,0.942871218562912,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
19309,GO:1905474,1.0000000000034,0.942871218562912,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
17199,GO:0102991,1.0000000000034,0.729105019759023,0,5,myristoyl-CoA hydrolase activity,MF,
307,GO:0000818,1.0000000000034,0.867174975861074,0,2,nuclear MIS12/MIND complex,CC,
9455,GO:0036033,1.00000000000341,0.663788904649138,0,4,mediator complex binding,MF,
833,GO:0002118,1.00000000000341,0.925829739133812,0,1,aggressive behavior,BP,
834,GO:0002121,1.00000000000341,0.925829739133812,0,1,inter-male aggressive behavior,BP,
7922,GO:0032489,1.00000000000341,0.720449343411469,0,4,regulation of Cdc42 protein signal transduction,BP,
194,GO:0000412,1.00000000000342,0.928159193335422,0,1,histone peptidyl-prolyl isomerization,BP,
15120,GO:0071144,1.00000000000343,0.813781877802493,0,2,heteromeric SMAD protein complex,CC,
17683,GO:1901490,1.00000000000343,0.720143782199851,0,4,regulation of lymphangiogenesis,BP,
492,GO:0001544,1.00000000000344,0.906461209465516,0,1,initiation of primordial ovarian follicle growth,BP,
8773,GO:0034437,1.00000000000344,0.858246565120702,0,2,glycoprotein transporter activity,MF,
1547,GO:0003939,1.00000000000344,0.930100157989877,0,1,L-iditol 2-dehydrogenase activity,MF,
2698,GO:0006062,1.00000000000344,0.930100157989877,0,1,sorbitol catabolic process,BP,
6142,GO:0019407,1.00000000000344,0.930100157989877,0,1,hexitol catabolic process,BP,
6168,GO:0019519,1.00000000000344,0.930100157989877,0,1,pentitol metabolic process,BP,
6171,GO:0019527,1.00000000000344,0.930100157989877,0,1,pentitol catabolic process,BP,
7318,GO:0031320,1.00000000000344,0.930100157989877,0,1,hexitol dehydrogenase activity,MF,
11737,GO:0046526,1.00000000000344,0.930100157989877,0,1,D-xylulose reductase activity,MF,
12866,GO:0051160,1.00000000000344,0.930100157989877,0,1,L-xylitol catabolic process,BP,
12867,GO:0051164,1.00000000000344,0.930100157989877,0,1,L-xylitol metabolic process,BP,
13819,GO:0060386,1.00000000000344,0.91495554571519,0,1,synapse assembly involved in innervation,BP,
6476,GO:0021812,1.00000000000344,0.914171377668877,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
10428,GO:0043257,1.00000000000344,0.914171377668877,0,1,laminin-8 complex,CC,
19506,GO:1990188,1.00000000000344,0.929519806614055,0,1,euchromatin binding,MF,
10402,GO:0043224,1.00000000000345,0.911733408564202,0,2,nuclear SCF ubiquitin ligase complex,CC,
11020,GO:0044830,1.00000000000346,0.855598287424075,0,2,modulation by host of viral RNA genome replication,BP,
1651,GO:0004095,1.00000000000346,0.739056808560063,0,4,carnitine O-palmitoyltransferase activity,MF,
5485,GO:0016416,1.00000000000346,0.739056808560063,0,4,O-palmitoyltransferase activity,MF,
11993,GO:0047273,1.00000000000346,0.926290590235009,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
13200,GO:0051786,1.00000000000346,0.926290590235009,0,1,all-trans-retinol 13,14-reductase activity,MF,
7317,GO:0031315,1.00000000000347,0.908159220844058,0,1,extrinsic component of mitochondrial outer membrane,CC,
11760,GO:0046581,1.00000000000347,0.776720088118337,0,3,intercellular canaliculus,CC,
12189,GO:0048295,1.00000000000347,0.865859096788902,0,2,positive regulation of isotype switching to IgE isotypes,BP,
11914,GO:0046922,1.00000000000349,0.858755204405817,0,2,peptide-O-fucosyltransferase activity,MF,
11347,GO:0045656,1.00000000000349,0.657139895816103,0,5,negative regulation of monocyte differentiation,BP,
16970,GO:0098936,1.00000000000349,0.837786599853205,0,2,intrinsic component of postsynaptic membrane,CC,
17008,GO:0099055,1.00000000000349,0.837786599853205,0,2,integral component of postsynaptic membrane,CC,
17049,GO:0099240,1.00000000000349,0.837786599853205,0,2,intrinsic component of synaptic membrane,CC,
17126,GO:0099699,1.00000000000349,0.837786599853205,0,2,integral component of synaptic membrane,CC,
17810,GO:1901857,1.00000000000349,0.739703926492439,0,5,positive regulation of cellular respiration,BP,
7814,GO:0032358,1.0000000000035,0.959228150527601,0,1,oxidized pyrimidine DNA binding,MF,
14342,GO:0061481,1.0000000000035,0.959228150527601,0,1,response to TNF agonist,BP,
18056,GO:1902546,1.0000000000035,0.959228150527601,0,1,positive regulation of DNA N-glycosylase activity,BP,
20326,GO:2001272,1.0000000000035,0.959228150527601,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20075,GO:2000664,1.0000000000035,0.801400393004334,0,3,positive regulation of interleukin-5 secretion,BP,
20078,GO:2000667,1.0000000000035,0.801400393004334,0,3,positive regulation of interleukin-13 secretion,BP,
3569,GO:0007614,1.00000000000351,0.718359649916732,0,5,short-term memory,BP,
9407,GO:0035938,1.00000000000351,0.91134292633632,0,1,estradiol secretion,BP,
20189,GO:2000864,1.00000000000351,0.91134292633632,0,1,regulation of estradiol secretion,BP,
11615,GO:0046203,1.00000000000351,0.892039955154847,0,2,spermidine catabolic process,BP,
6444,GO:0021747,1.00000000000352,0.780943695841141,0,3,cochlear nucleus development,BP,
4382,GO:0010025,1.00000000000353,0.856455050833801,0,2,wax biosynthetic process,BP,
4413,GO:0010166,1.00000000000353,0.856455050833801,0,2,wax metabolic process,BP,
15984,GO:0080019,1.00000000000353,0.856455050833801,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17198,GO:0102965,1.00000000000353,0.856455050833801,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
15638,GO:0072108,1.00000000000353,0.823043102279225,0,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1599,GO:0004014,1.00000000000353,0.926500829967343,0,1,adenosylmethionine decarboxylase activity,MF,
3011,GO:0006557,1.00000000000353,0.926500829967343,0,1,S-adenosylmethioninamine biosynthetic process,BP,
6247,GO:0019810,1.00000000000353,0.926500829967343,0,1,putrescine binding,MF,
11722,GO:0046499,1.00000000000353,0.926500829967343,0,1,S-adenosylmethioninamine metabolic process,BP,
14880,GO:0070640,1.00000000000354,0.801006571173454,0,3,vitamin D3 metabolic process,BP,
219,GO:0000455,1.00000000000354,0.875223839996331,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
5371,GO:0016165,1.00000000000354,0.865584370101823,0,2,linoleate 13S-lipoxygenase activity,MF,
3637,GO:0008108,1.00000000000354,0.946284821918891,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
5319,GO:0016034,1.00000000000354,0.946284821918891,0,1,maleylacetoacetate isomerase activity,MF,
17137,GO:0101030,1.00000000000354,0.946284821918891,0,1,tRNA-guanine transglycosylation,BP,
1701,GO:0004176,1.00000000000355,0.735334475598995,0,4,ATP-dependent peptidase activity,MF,
11579,GO:0046110,1.00000000000355,0.792018225175379,0,3,xanthine metabolic process,BP,
3898,GO:0008534,1.00000000000358,0.801348307333095,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
10448,GO:0043293,1.00000000000358,0.851498173359363,0,2,apoptosome,CC,
646,GO:0001834,1.00000000000358,0.841622453716181,0,2,trophectodermal cell proliferation,BP,
4241,GO:0009438,1.0000000000036,0.728817355506563,0,5,methylglyoxal metabolic process,BP,
18475,GO:1903537,1.0000000000036,0.864542251728215,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18476,GO:1903538,1.0000000000036,0.864542251728215,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
16872,GO:0098770,1.00000000000362,0.817604403887419,0,2,FBXO family protein binding,MF,
7097,GO:0030886,1.00000000000363,0.875959481864546,0,2,negative regulation of myeloid dendritic cell activation,BP,
11957,GO:0047006,1.00000000000363,0.94529642247528,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11966,GO:0047042,1.00000000000363,0.94529642247528,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12048,GO:0047718,1.00000000000363,0.94529642247528,0,1,indanol dehydrogenase activity,MF,
63,GO:0000126,1.00000000000363,0.820569084954804,0,2,transcription factor TFIIIB complex,CC,
385,GO:0001026,1.00000000000363,0.820569084954804,0,2,TFIIIB-type transcription factor activity,MF,
6957,GO:0030579,1.00000000000365,0.682906858433474,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7011,GO:0030690,1.00000000000365,0.928524590089918,0,1,Noc1p-Noc2p complex,CC,
7012,GO:0030691,1.00000000000365,0.928524590089918,0,1,Noc2p-Noc3p complex,CC,
12528,GO:0050652,1.00000000000365,0.924678812904404,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12529,GO:0050653,1.00000000000365,0.924678812904404,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4846,GO:0014051,1.00000000000366,0.626849890088645,0,5,gamma-aminobutyric acid secretion,BP,
4929,GO:0014878,1.00000000000367,0.917114225500603,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
15402,GO:0071633,1.00000000000367,0.928327939223282,0,1,dihydroceramidase activity,MF,
13625,GO:0060075,1.00000000000367,0.791710083335575,0,3,regulation of resting membrane potential,BP,
19663,GO:1990812,1.00000000000367,0.793137381049293,0,3,growth cone filopodium,CC,
4242,GO:0009439,1.00000000000369,0.897512489473921,0,2,cyanate metabolic process,BP,
4243,GO:0009440,1.00000000000369,0.897512489473921,0,2,cyanate catabolic process,BP,
2855,GO:0006344,1.00000000000369,0.704703240926659,0,4,maintenance of chromatin silencing,BP,
4876,GO:0014735,1.0000000000037,0.849740811849678,0,2,regulation of muscle atrophy,BP,
4877,GO:0014736,1.0000000000037,0.849740811849678,0,2,negative regulation of muscle atrophy,BP,
16466,GO:0097109,1.0000000000037,0.849855057688966,0,2,neuroligin family protein binding,MF,
12081,GO:0048014,1.00000000000371,0.917432591390659,0,1,Tie signaling pathway,BP,
12729,GO:0050928,1.00000000000371,0.917432591390659,0,1,negative regulation of positive chemotaxis,BP,
7165,GO:0031022,1.00000000000371,0.814035830240017,0,2,nuclear migration along microfilament,BP,
4539,GO:0010609,1.00000000000373,0.865142442050291,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
15567,GO:0071963,1.00000000000373,0.938295638346196,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
590,GO:0001743,1.00000000000374,0.841590749130098,0,2,optic placode formation,BP,
16162,GO:0090155,1.00000000000374,0.757188843443113,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17382,GO:1900060,1.00000000000374,0.757188843443113,0,4,negative regulation of ceramide biosynthetic process,BP,
19284,GO:1905424,1.00000000000375,0.868199268062163,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19285,GO:1905426,1.00000000000375,0.868199268062163,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
11830,GO:0046707,1.00000000000375,0.860463670970665,0,2,IDP metabolic process,BP,
11831,GO:0046709,1.00000000000375,0.860463670970665,0,2,IDP catabolic process,BP,
16382,GO:0090666,1.00000000000375,0.759397158316688,0,4,scaRNA localization to Cajal body,BP,
13437,GO:0052811,1.00000000000376,0.718119600336464,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
12877,GO:0051177,1.00000000000376,0.762070480244583,0,4,meiotic sister chromatid cohesion,BP,
19784,GO:2000138,1.00000000000377,0.673747425863699,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
976,GO:0002424,1.00000000000378,0.862545287669652,0,2,T cell mediated immune response to tumor cell,BP,
1196,GO:0002840,1.00000000000378,0.862545287669652,0,2,regulation of T cell mediated immune response to tumor cell,BP,
11349,GO:0045658,1.00000000000378,0.795229723374104,0,3,regulation of neutrophil differentiation,BP,
5203,GO:0015798,1.00000000000378,0.712589374503447,0,3,myo-inositol transport,BP,
14551,GO:0070044,1.00000000000378,0.753986664578999,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
8711,GO:0034342,1.00000000000378,0.866271603571361,0,2,response to type III interferon,BP,
8172,GO:0032899,1.00000000000379,0.924025399835419,0,1,regulation of neurotrophin production,BP,
8173,GO:0032901,1.00000000000379,0.924025399835419,0,1,positive regulation of neurotrophin production,BP,
8861,GO:0034649,1.00000000000379,0.924025399835419,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
12230,GO:0048403,1.00000000000379,0.924025399835419,0,1,brain-derived neurotrophic factor binding,MF,
19396,GO:1905793,1.00000000000379,0.814998718225699,0,2,protein localization to pericentriolar material,BP,
966,GO:0002396,1.0000000000038,0.935821107197808,0,1,MHC protein complex assembly,BP,
967,GO:0002397,1.0000000000038,0.935821107197808,0,1,MHC class I protein complex assembly,BP,
1015,GO:0002501,1.0000000000038,0.935821107197808,0,1,peptide antigen assembly with MHC protein complex,BP,
1016,GO:0002502,1.0000000000038,0.935821107197808,0,1,peptide antigen assembly with MHC class I protein complex,BP,
151,GO:0000306,1.0000000000038,0.73010853750382,0,4,extrinsic component of vacuolar membrane,CC,
1439,GO:0003415,1.00000000000382,0.728727450098621,0,4,chondrocyte hypertrophy,BP,
5351,GO:0016098,1.00000000000382,0.927069654643473,0,1,monoterpenoid metabolic process,BP,
8522,GO:0033695,1.00000000000382,0.927069654643473,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8939,GO:0034875,1.00000000000382,0.927069654643473,0,1,caffeine oxidase activity,MF,
15391,GO:0071615,1.00000000000382,0.927069654643473,0,1,oxidative deethylation,BP,
15487,GO:0071812,1.00000000000382,0.927069654643473,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15506,GO:0071848,1.00000000000382,0.927069654643473,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
14414,GO:0061656,1.00000000000382,0.94953772101587,0,1,SUMO conjugating enzyme activity,MF,
18313,GO:1903182,1.00000000000382,0.94953772101587,0,1,regulation of SUMO transferase activity,BP,
18572,GO:1903755,1.00000000000382,0.94953772101587,0,1,positive regulation of SUMO transferase activity,BP,
19532,GO:1990356,1.00000000000382,0.94953772101587,0,1,sumoylated E2 ligase complex,CC,
11406,GO:0045769,1.00000000000383,0.888045707716329,0,1,negative regulation of asymmetric cell division,BP,
16458,GO:0097100,1.00000000000384,0.717365894062646,0,5,supercoiled DNA binding,MF,
17766,GO:1901676,1.00000000000384,0.923907664601144,0,1,positive regulation of histone H3-K27 acetylation,BP,
11700,GO:0046469,1.00000000000385,0.687308694701274,0,5,platelet activating factor metabolic process,BP,
8332,GO:0033167,1.00000000000386,0.891262847518025,0,1,ARC complex,CC,
8333,GO:0033168,1.00000000000386,0.891262847518025,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
9594,GO:0036404,1.00000000000386,0.891262847518025,0,1,conversion of ds siRNA to ss siRNA,BP,
4059,GO:0009107,1.00000000000387,0.93947689608027,0,1,lipoate biosynthetic process,BP,
5777,GO:0016992,1.00000000000387,0.93947689608027,0,1,lipoate synthase activity,MF,
14688,GO:0070283,1.00000000000387,0.93947689608027,0,1,radical SAM enzyme activity,MF,
19812,GO:2000196,1.00000000000387,0.872634477384653,0,2,positive regulation of female gonad development,BP,
19930,GO:2000386,1.00000000000387,0.872634477384653,0,2,positive regulation of ovarian follicle development,BP,
4557,GO:0010636,1.00000000000388,0.84751044643456,0,2,positive regulation of mitochondrial fusion,BP,
15178,GO:0071279,1.00000000000388,0.741454135547856,0,4,cellular response to cobalt ion,BP,
14253,GO:0061196,1.00000000000389,0.717646757679874,0,4,fungiform papilla development,BP,
14254,GO:0061197,1.00000000000389,0.717646757679874,0,4,fungiform papilla morphogenesis,BP,
643,GO:0001831,1.0000000000039,0.909265289871036,0,1,trophectodermal cellular morphogenesis,BP,
12108,GO:0048069,1.0000000000039,0.676181581867348,0,5,eye pigmentation,BP,
1782,GO:0004392,1.00000000000391,0.883737866601123,0,2,heme oxygenase (decyclizing) activity,MF,
3173,GO:0006788,1.00000000000391,0.883737866601123,0,2,heme oxidation,BP,
2219,GO:0005113,1.00000000000394,0.671391110653264,0,5,patched binding,MF,
1853,GO:0004513,1.00000000000395,0.93167236837599,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
11999,GO:0047291,1.00000000000395,0.93167236837599,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
13885,GO:0060481,1.00000000000395,0.874492315801253,0,2,lobar bronchus epithelium development,BP,
5309,GO:0016012,1.00000000000396,0.865912050554914,0,2,sarcoglycan complex,CC,
153,GO:0000308,1.00000000000396,0.84896453349259,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
14579,GO:0070094,1.00000000000397,0.929762461841093,0,1,positive regulation of glucagon secretion,BP,
13803,GO:0060369,1.00000000000398,0.736749777087189,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
1832,GO:0004484,1.00000000000398,0.921444621616371,0,1,mRNA guanylyltransferase activity,MF,
12493,GO:0050355,1.00000000000398,0.921444621616371,0,1,triphosphatase activity,MF,
1719,GO:0004308,1.00000000000399,0.752231851066493,0,4,exo-alpha-sialidase activity,MF,
5778,GO:0016997,1.00000000000399,0.752231851066493,0,4,alpha-sialidase activity,MF,
17806,GO:1901842,1.00000000000399,0.880525721603574,0,2,negative regulation of high voltage-gated calcium channel activity,BP,
499,GO:0001554,1.000000000004,0.658703645407839,0,5,luteolysis,BP,
7473,GO:0031626,1.000000000004,0.917765471169768,0,1,beta-endorphin binding,MF,
15249,GO:0071387,1.000000000004,0.917765471169768,0,1,cellular response to cortisol stimulus,BP,
19114,GO:1904978,1.00000000000401,0.778604110194264,0,3,regulation of endosome organization,BP,
2221,GO:0005115,1.00000000000401,0.914375336736599,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
6415,GO:0021650,1.00000000000401,0.914375336736599,0,1,vestibulocochlear nerve formation,BP,
9656,GO:0036517,1.00000000000401,0.914375336736599,0,1,chemoattraction of serotonergic neuron axon,BP,
13244,GO:0051885,1.00000000000401,0.914375336736599,0,1,positive regulation of timing of anagen,BP,
13587,GO:0060031,1.00000000000401,0.914375336736599,0,1,mediolateral intercalation,BP,
13618,GO:0060067,1.00000000000401,0.914375336736599,0,1,cervix development,BP,
13955,GO:0060599,1.00000000000401,0.914375336736599,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14062,GO:0060775,1.00000000000401,0.914375336736599,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14069,GO:0060809,1.00000000000401,0.914375336736599,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14294,GO:0061347,1.00000000000401,0.914375336736599,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14295,GO:0061348,1.00000000000401,0.914375336736599,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14296,GO:0061349,1.00000000000401,0.914375336736599,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14297,GO:0061350,1.00000000000401,0.914375336736599,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14299,GO:0061354,1.00000000000401,0.914375336736599,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14407,GO:0061642,1.00000000000401,0.914375336736599,0,1,chemoattraction of axon,BP,
18001,GO:1902379,1.00000000000401,0.914375336736599,0,1,chemoattractant activity involved in axon guidance,MF,
19093,GO:1904933,1.00000000000401,0.914375336736599,0,1,regulation of cell proliferation in midbrain,BP,
19094,GO:1904934,1.00000000000401,0.914375336736599,0,1,negative regulation of cell proliferation in midbrain,BP,
19103,GO:1904955,1.00000000000401,0.914375336736599,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19290,GO:1905438,1.00000000000401,0.914375336736599,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
14084,GO:0060842,1.00000000000402,0.77299579059762,0,3,arterial endothelial cell differentiation,BP,
11193,GO:0045263,1.00000000000402,0.945031813528381,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
1777,GO:0004379,1.00000000000403,0.844705596988019,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
5881,GO:0018008,1.00000000000403,0.844705596988019,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6039,GO:0019107,1.00000000000403,0.844705596988019,0,2,myristoyltransferase activity,MF,
1654,GO:0004103,1.00000000000403,0.873565033402581,0,2,choline kinase activity,MF,
4124,GO:0009182,1.00000000000403,0.900016068701477,0,2,purine deoxyribonucleoside diphosphate metabolic process,BP,
11552,GO:0046066,1.00000000000403,0.900016068701477,0,2,dGDP metabolic process,BP,
8701,GO:0034316,1.00000000000404,0.742862383942633,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
12480,GO:0050290,1.00000000000404,0.920108053849928,0,1,sphingomyelin phosphodiesterase D activity,MF,
860,GO:0002188,1.00000000000404,0.760511665359931,0,3,translation reinitiation,BP,
10429,GO:0043259,1.00000000000404,0.730941380562997,0,3,laminin-10 complex,CC,
15394,GO:0071619,1.00000000000405,0.931976753326142,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20258,GO:2001163,1.00000000000405,0.931976753326142,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20259,GO:2001165,1.00000000000405,0.931976753326142,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
5762,GO:0016920,1.00000000000406,0.907736668027756,0,1,pyroglutamyl-peptidase activity,MF,
1698,GO:0004170,1.00000000000406,0.936391123684122,0,1,dUTP diphosphatase activity,MF,
6338,GO:0021508,1.00000000000406,0.909365996101227,0,1,floor plate formation,BP,
8433,GO:0033505,1.00000000000406,0.909365996101227,0,1,floor plate morphogenesis,BP,
11562,GO:0046080,1.00000000000406,0.936391123684122,0,1,dUTP metabolic process,BP,
11563,GO:0046081,1.00000000000406,0.936391123684122,0,1,dUTP catabolic process,BP,
13588,GO:0060032,1.00000000000406,0.909365996101227,0,1,notochord regression,BP,
16400,GO:0090725,1.00000000000407,0.885116368385773,0,2,peripheral region of growth cone,CC,
9770,GO:0039520,1.00000000000408,0.915938627860238,0,1,induction by virus of host autophagy,BP,
3578,GO:0007624,1.00000000000408,0.922942183684075,0,1,ultradian rhythm,BP,
516,GO:0001580,1.00000000000408,0.754105375511304,0,5,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
3990,GO:0008859,1.00000000000409,0.955982182955483,0,1,exoribonuclease II activity,MF,
5823,GO:0017087,1.0000000000041,0.923870953958789,0,1,mitochondrial processing peptidase complex,CC,
10683,GO:0043914,1.0000000000041,0.923870953958789,0,1,NADPH:sulfur oxidoreductase activity,MF,
9035,GO:0035241,1.00000000000412,0.803071851502459,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
15166,GO:0071257,1.00000000000412,0.672486770362704,0,5,cellular response to electrical stimulus,BP,
8868,GO:0034657,1.00000000000412,0.73965178185217,0,4,GID complex,CC,
16482,GO:0097135,1.00000000000414,0.86600283056492,0,2,cyclin E2-CDK2 complex,CC,
2168,GO:0005000,1.00000000000415,0.854390892855693,0,2,vasopressin receptor activity,MF,
7228,GO:0031117,1.00000000000415,0.861425331727296,0,2,positive regulation of microtubule depolymerization,BP,
974,GO:0002420,1.00000000000416,0.733180567952185,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
975,GO:0002423,1.00000000000416,0.733180567952185,0,4,natural killer cell mediated immune response to tumor cell,BP,
1198,GO:0002855,1.00000000000416,0.733180567952185,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1201,GO:0002858,1.00000000000416,0.733180567952185,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1604,GO:0004020,1.00000000000417,0.859440629309548,0,2,adenylylsulfate kinase activity,MF,
2041,GO:0004779,1.00000000000417,0.859440629309548,0,2,sulfate adenylyltransferase activity,MF,
2042,GO:0004781,1.00000000000417,0.859440629309548,0,2,sulfate adenylyltransferase (ATP) activity,MF,
12746,GO:0050974,1.00000000000418,0.662816818968588,0,5,detection of mechanical stimulus involved in sensory perception,BP,
2017,GO:0004741,1.00000000000418,0.769855770224771,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
5372,GO:0016174,1.00000000000419,0.725403301908315,0,4,NAD(P)H oxidase activity,MF,
154,GO:0000309,1.00000000000419,0.846697566513616,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
6114,GO:0019355,1.00000000000419,0.846697566513616,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
8846,GO:0034627,1.00000000000419,0.846697566513616,0,2,'de novo' NAD biosynthetic process,BP,
8847,GO:0034628,1.00000000000419,0.846697566513616,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
13120,GO:0051615,1.0000000000042,0.915492989764908,0,1,histamine uptake,BP,
9522,GO:0036179,1.00000000000421,0.92881267384452,0,1,osteoclast maturation,BP,
19335,GO:1905573,1.00000000000421,0.868833941425609,0,2,ganglioside GM1 binding,MF,
19338,GO:1905576,1.00000000000421,0.868833941425609,0,2,ganglioside GT1b binding,MF,
19850,GO:2000275,1.00000000000421,0.892182157726454,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
13020,GO:0051425,1.00000000000421,0.707576419416071,0,4,PTB domain binding,MF,
14597,GO:0070124,1.00000000000422,0.885499240678154,0,2,mitochondrial translational initiation,BP,
6207,GO:0019695,1.00000000000422,0.736953468025381,0,4,choline metabolic process,BP,
3135,GO:0006726,1.00000000000423,0.919710884295744,0,1,eye pigment biosynthetic process,BP,
5376,GO:0016182,1.00000000000423,0.919710884295744,0,1,synaptic vesicle budding from endosome,BP,
10024,GO:0042441,1.00000000000423,0.919710884295744,0,1,eye pigment metabolic process,BP,
10474,GO:0043324,1.00000000000423,0.919710884295744,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10543,GO:0043474,1.00000000000423,0.919710884295744,0,1,pigment metabolic process involved in pigmentation,BP,
16908,GO:0098830,1.00000000000423,0.919710884295744,0,1,presynaptic endosome,CC,
122,GO:0000252,1.00000000000424,0.940838701018497,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
11958,GO:0047012,1.00000000000424,0.940838701018497,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17204,GO:0103066,1.00000000000424,0.940838701018497,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17205,GO:0103067,1.00000000000424,0.940838701018497,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
16153,GO:0090138,1.00000000000424,0.924894877617871,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
18296,GO:1903136,1.00000000000424,0.720773544191132,0,5,cuprous ion binding,MF,
2355,GO:0005432,1.00000000000424,0.790053590875393,0,3,calcium:sodium antiporter activity,MF,
534,GO:0001652,1.00000000000425,0.757089430361166,0,4,granular component,CC,
891,GO:0002254,1.00000000000426,0.871345862102173,0,2,kinin cascade,BP,
945,GO:0002353,1.00000000000426,0.871345862102173,0,2,plasma kallikrein-kinin cascade,BP,
2768,GO:0006185,1.00000000000426,0.955022026406854,0,1,dGDP biosynthetic process,BP,
4116,GO:0009170,1.00000000000426,0.955022026406854,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4125,GO:0009183,1.00000000000426,0.955022026406854,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
11545,GO:0046054,1.00000000000426,0.955022026406854,0,1,dGMP metabolic process,BP,
11833,GO:0046711,1.00000000000426,0.955022026406854,0,1,GDP biosynthetic process,BP,
389,GO:0001034,1.00000000000426,0.937383469779243,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
1297,GO:0003127,1.00000000000427,0.918488610102598,0,1,detection of nodal flow,BP,
15299,GO:0071464,1.00000000000427,0.918488610102598,0,1,cellular response to hydrostatic pressure,BP,
15603,GO:0072055,1.00000000000427,0.918488610102598,0,1,renal cortex development,BP,
15604,GO:0072059,1.00000000000427,0.918488610102598,0,1,cortical collecting duct development,BP,
15690,GO:0072194,1.00000000000427,0.918488610102598,0,1,kidney smooth muscle tissue development,BP,
15701,GO:0072208,1.00000000000427,0.918488610102598,0,1,metanephric smooth muscle tissue development,BP,
15705,GO:0072214,1.00000000000427,0.918488610102598,0,1,metanephric cortex development,BP,
15710,GO:0072219,1.00000000000427,0.918488610102598,0,1,metanephric cortical collecting duct development,BP,
10261,GO:0042986,1.00000000000428,0.866078172641883,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
17957,GO:1902260,1.00000000000428,0.778831693353932,0,3,negative regulation of delayed rectifier potassium channel activity,BP,
6109,GO:0019343,1.0000000000043,0.872309955244982,0,2,cysteine biosynthetic process via cystathionine,BP,
14074,GO:0060825,1.00000000000431,0.879723975403048,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19876,GO:2000313,1.00000000000431,0.879723975403048,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
16895,GO:0098808,1.00000000000432,0.868044278342686,0,2,mRNA cap binding,MF,
4747,GO:0010915,1.00000000000432,0.913847660726378,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4748,GO:0010916,1.00000000000432,0.913847660726378,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
1686,GO:0004149,1.00000000000432,0.928332805321096,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
5658,GO:0016751,1.00000000000432,0.928332805321096,0,1,S-succinyltransferase activity,MF,
13013,GO:0051410,1.00000000000432,0.71577292757909,0,5,detoxification of nitrogen compound,BP,
11763,GO:0046588,1.00000000000433,0.957348589347074,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
9260,GO:0035658,1.00000000000433,0.803765966173226,0,3,Mon1-Ccz1 complex,CC,
17570,GO:1901077,1.00000000000433,0.719746432238493,0,4,regulation of relaxation of muscle,BP,
18027,GO:1902464,1.00000000000434,0.921737027711116,0,1,regulation of histone H3-K27 trimethylation,BP,
18028,GO:1902466,1.00000000000434,0.921737027711116,0,1,positive regulation of histone H3-K27 trimethylation,BP,
2016,GO:0004740,1.00000000000435,0.777968530131779,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
3427,GO:0007217,1.00000000000435,0.929858721282727,0,1,tachykinin receptor signaling pathway,BP,
4168,GO:0009233,1.00000000000435,0.857259557354726,0,2,menaquinone metabolic process,BP,
14784,GO:0070463,1.00000000000435,0.925655741685355,0,1,tubulin-dependent ATPase activity,MF,
9942,GO:0042281,1.00000000000437,0.869373984147723,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
12004,GO:0047325,1.00000000000437,0.926535808968944,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
13420,GO:0052725,1.00000000000437,0.926535808968944,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13421,GO:0052726,1.00000000000437,0.926535808968944,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13443,GO:0052825,1.00000000000437,0.926535808968944,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13448,GO:0052830,1.00000000000437,0.926535808968944,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13449,GO:0052831,1.00000000000437,0.926535808968944,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13453,GO:0052835,1.00000000000437,0.926535808968944,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
2984,GO:0006528,1.00000000000437,0.821463989621803,0,3,asparagine metabolic process,BP,
19918,GO:2000370,1.00000000000438,0.725103269963243,0,4,positive regulation of clathrin-dependent endocytosis,BP,
16030,GO:0086023,1.00000000000439,0.64450873532002,0,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
19304,GO:1905462,1.00000000000439,0.844666292647489,0,2,regulation of DNA duplex unwinding,BP,
13423,GO:0052739,1.0000000000044,0.933971982862418,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13424,GO:0052740,1.0000000000044,0.933971982862418,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18906,GO:1904550,1.0000000000044,0.933971982862418,0,1,response to arachidonic acid,BP,
19886,GO:2000324,1.0000000000044,0.933971982862418,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
9295,GO:0035726,1.0000000000044,0.696581488560304,0,5,common myeloid progenitor cell proliferation,BP,
5308,GO:0016011,1.00000000000441,0.792394355750426,0,3,dystroglycan complex,CC,
19462,GO:1990037,1.00000000000442,0.819026616766401,0,3,Lewy body core,CC,
5853,GO:0017146,1.00000000000442,0.724175126494481,0,4,NMDA selective glutamate receptor complex,CC,
6256,GO:0019834,1.00000000000442,0.835268850321384,0,3,phospholipase A2 inhibitor activity,MF,
8408,GO:0033341,1.00000000000442,0.840351080133151,0,2,regulation of collagen binding,BP,
4311,GO:0009786,1.00000000000442,0.839108153009976,0,2,regulation of asymmetric cell division,BP,
8600,GO:0034093,1.00000000000442,0.698947599987526,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8650,GO:0034184,1.00000000000442,0.698947599987526,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
3822,GO:0008418,1.00000000000443,0.951733118382873,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
6622,GO:0022841,1.00000000000443,0.813219192431557,0,3,potassium ion leak channel activity,MF,
1634,GO:0004070,1.00000000000443,0.830109250169384,0,2,aspartate carbamoyltransferase activity,MF,
1646,GO:0004087,1.00000000000443,0.830109250169384,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1647,GO:0004088,1.00000000000443,0.830109250169384,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1687,GO:0004151,1.00000000000443,0.830109250169384,0,2,dihydroorotase activity,MF,
5652,GO:0016743,1.00000000000443,0.830109250169384,0,2,carboxyl- or carbamoyltransferase activity,MF,
6600,GO:0022614,1.00000000000444,0.721869819528202,0,4,membrane to membrane docking,BP,
1762,GO:0004362,1.00000000000444,0.932006664465767,0,1,glutathione-disulfide reductase activity,MF,
5197,GO:0015786,1.00000000000444,0.932006664465767,0,1,UDP-glucose transmembrane transport,BP,
3024,GO:0006570,1.00000000000444,0.783555036916126,0,4,tyrosine metabolic process,BP,
9571,GO:0036343,1.00000000000444,0.968263587910165,0,1,psychomotor behavior,BP,
4763,GO:0010940,1.00000000000444,0.742269619082509,0,5,positive regulation of necrotic cell death,BP,
17585,GO:1901143,1.00000000000446,0.849535644774334,0,2,insulin catabolic process,BP,
1550,GO:0003943,1.00000000000446,0.859524813881444,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
805,GO:0002071,1.00000000000447,0.860444044183548,0,2,glandular epithelial cell maturation,BP,
16665,GO:0097510,1.00000000000447,0.934155234529302,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
11741,GO:0046533,1.00000000000447,0.718843832808286,0,4,negative regulation of photoreceptor cell differentiation,BP,
2263,GO:0005175,1.0000000000045,0.964227381346885,0,1,CD27 receptor binding,MF,
13979,GO:0060665,1.0000000000045,0.915423139995566,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
16244,GO:0090272,1.0000000000045,0.915423139995566,0,1,negative regulation of fibroblast growth factor production,BP,
18447,GO:1903465,1.0000000000045,0.915423139995566,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
20171,GO:2000830,1.0000000000045,0.915423139995566,0,1,positive regulation of parathyroid hormone secretion,BP,
1504,GO:0003847,1.0000000000045,0.784816424710253,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
6743,GO:0030158,1.0000000000045,0.769443258293993,0,3,protein xylosyltransferase activity,MF,
5807,GO:0017057,1.0000000000045,0.85579417606063,0,2,6-phosphogluconolactonase activity,MF,
4405,GO:0010139,1.00000000000451,0.940541940902037,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4411,GO:0010164,1.00000000000451,0.940541940902037,0,1,response to cesium ion,BP,
6874,GO:0030343,1.00000000000451,0.940541940902037,0,1,vitamin D3 25-hydroxylase activity,MF,
14881,GO:0070643,1.00000000000451,0.940541940902037,0,1,vitamin D 25-hydroxylase activity,MF,
4805,GO:0010997,1.00000000000451,0.68493234652603,0,5,anaphase-promoting complex binding,MF,
15533,GO:0071895,1.00000000000451,0.694087063985832,0,5,odontoblast differentiation,BP,
13852,GO:0060430,1.00000000000451,0.825321323247172,0,2,lung saccule development,BP,
9621,GO:0036476,1.00000000000453,0.766667499507133,0,4,neuron death in response to hydrogen peroxide,BP,
18327,GO:1903207,1.00000000000453,0.766667499507133,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
18328,GO:1903208,1.00000000000453,0.766667499507133,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
15191,GO:0071306,1.00000000000453,0.855732901019399,0,2,cellular response to vitamin E,BP,
11555,GO:0046069,1.00000000000453,0.838764920490532,0,2,cGMP catabolic process,BP,
19909,GO:2000354,1.00000000000453,0.766399110787546,0,4,regulation of ovarian follicle development,BP,
13109,GO:0051599,1.00000000000454,0.707078779061192,0,4,response to hydrostatic pressure,BP,
15092,GO:0071042,1.00000000000454,0.777813201960657,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15097,GO:0071047,1.00000000000454,0.777813201960657,0,4,polyadenylation-dependent mRNA catabolic process,BP,
12125,GO:0048149,1.00000000000454,0.71032004081425,0,4,behavioral response to ethanol,BP,
16034,GO:0086028,1.00000000000455,0.758883811379782,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16041,GO:0086043,1.00000000000455,0.758883811379782,0,4,bundle of His cell action potential,BP,
2064,GO:0004815,1.00000000000455,0.862657200099127,0,2,aspartate-tRNA ligase activity,MF,
1989,GO:0004706,1.00000000000455,0.784295532745187,0,3,JUN kinase kinase kinase activity,MF,
19975,GO:2000474,1.00000000000457,0.92334691530648,0,1,regulation of opioid receptor signaling pathway,BP,
3781,GO:0008336,1.00000000000457,0.9361569749671,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4991,GO:0015117,1.00000000000457,0.9361569749671,0,1,thiosulfate transmembrane transporter activity,MF,
4997,GO:0015131,1.00000000000457,0.9361569749671,0,1,oxaloacetate transmembrane transporter activity,MF,
5167,GO:0015709,1.00000000000457,0.9361569749671,0,1,thiosulfate transport,BP,
5177,GO:0015729,1.00000000000457,0.9361569749671,0,1,oxaloacetate transport,BP,
5183,GO:0015743,1.00000000000457,0.9361569749671,0,1,malate transport,BP,
15272,GO:0071423,1.00000000000457,0.9361569749671,0,1,malate transmembrane transport,BP,
17990,GO:1902356,1.00000000000457,0.9361569749671,0,1,oxaloacetate(2-) transmembrane transport,BP,
4018,GO:0009020,1.00000000000458,0.935253812242674,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13410,GO:0052666,1.00000000000458,0.935253812242674,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17228,GO:0106050,1.00000000000458,0.935253812242674,0,1,tRNA 2'-O-methyltransferase activity,MF,
1531,GO:0003908,1.00000000000459,0.947985925696447,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
19061,GO:1904875,1.0000000000046,0.866368683285163,0,2,regulation of DNA ligase activity,BP,
19016,GO:1904781,1.0000000000046,0.622987190076806,0,5,positive regulation of protein localization to centrosome,BP,
6693,GO:0030060,1.0000000000046,0.838784907152428,0,3,L-malate dehydrogenase activity,MF,
4530,GO:0010593,1.0000000000046,0.837827215813768,0,2,negative regulation of lamellipodium assembly,BP,
9710,GO:0038098,1.00000000000461,0.934325075692815,0,1,sequestering of BMP from receptor via BMP binding,BP,
14792,GO:0070478,1.00000000000461,0.922735471866587,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15127,GO:0071163,1.00000000000463,0.825299056744217,0,3,DNA replication preinitiation complex assembly,BP,
3015,GO:0006561,1.00000000000464,0.760891617992318,0,4,proline biosynthetic process,BP,
13559,GO:0055129,1.00000000000464,0.760891617992318,0,4,L-proline biosynthetic process,BP,
4950,GO:0014916,1.00000000000464,0.754180546434986,0,3,regulation of lung blood pressure,BP,
4545,GO:0010616,1.00000000000465,0.645757157310172,0,5,negative regulation of cardiac muscle adaptation,BP,
18342,GO:1903243,1.00000000000465,0.645757157310172,0,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
16572,GO:0097325,1.00000000000465,0.849072789199053,0,2,melanocyte proliferation,BP,
8816,GO:0034515,1.00000000000466,0.859782867226972,0,2,proteasome storage granule,CC,
10828,GO:0044307,1.00000000000467,0.880174740310526,0,1,dendritic branch,CC,
16216,GO:0090230,1.00000000000468,0.720902630984571,0,4,regulation of centromere complex assembly,BP,
5530,GO:0016503,1.00000000000468,0.946998021878794,0,1,pheromone receptor activity,MF,
11753,GO:0046554,1.00000000000468,0.946998021878794,0,1,malate dehydrogenase (NADP+) activity,MF,
18468,GO:1903525,1.00000000000469,0.654903165860923,0,5,regulation of membrane tubulation,BP,
8872,GO:0034665,1.00000000000469,0.850319320743351,0,2,integrin alpha1-beta1 complex,CC,
1516,GO:0003874,1.00000000000469,0.956592523554187,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
5959,GO:0018323,1.00000000000469,0.956592523554187,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8695,GO:0034309,1.00000000000469,0.956592523554187,0,1,primary alcohol biosynthetic process,BP,
9616,GO:0036470,1.00000000000469,0.956592523554187,0,1,tyrosine 3-monooxygenase activator activity,MF,
9617,GO:0036471,1.00000000000469,0.956592523554187,0,1,cellular response to glyoxal,BP,
9623,GO:0036478,1.00000000000469,0.956592523554187,0,1,L-dopa decarboxylase activator activity,MF,
9658,GO:0036524,1.00000000000469,0.956592523554187,0,1,protein deglycase activity,MF,
9659,GO:0036525,1.00000000000469,0.956592523554187,0,1,protein deglycation,BP,
9660,GO:0036526,1.00000000000469,0.956592523554187,0,1,peptidyl-cysteine deglycation,BP,
9661,GO:0036527,1.00000000000469,0.956592523554187,0,1,peptidyl-arginine deglycation,BP,
9662,GO:0036528,1.00000000000469,0.956592523554187,0,1,peptidyl-lysine deglycation,BP,
9663,GO:0036529,1.00000000000469,0.956592523554187,0,1,protein deglycation, glyoxal removal,BP,
9664,GO:0036530,1.00000000000469,0.956592523554187,0,1,protein deglycation, methylglyoxal removal,BP,
9665,GO:0036531,1.00000000000469,0.956592523554187,0,1,glutathione deglycation,BP,
11222,GO:0045340,1.00000000000469,0.956592523554187,0,1,mercury ion binding,MF,
11627,GO:0046295,1.00000000000469,0.956592523554187,0,1,glycolate biosynthetic process,BP,
17224,GO:0106044,1.00000000000469,0.956592523554187,0,1,guanine deglycation,BP,
17225,GO:0106045,1.00000000000469,0.956592523554187,0,1,guanine deglycation, methylglyoxal removal,BP,
17226,GO:0106046,1.00000000000469,0.956592523554187,0,1,guanine deglycation, glyoxal removal,BP,
17309,GO:0140041,1.00000000000469,0.956592523554187,0,1,cellular detoxification of methylglyoxal,BP,
18277,GO:1903072,1.00000000000469,0.956592523554187,0,1,regulation of death-inducing signaling complex assembly,BP,
18278,GO:1903073,1.00000000000469,0.956592523554187,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18292,GO:1903122,1.00000000000469,0.956592523554187,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18304,GO:1903167,1.00000000000469,0.956592523554187,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18305,GO:1903168,1.00000000000469,0.956592523554187,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18309,GO:1903176,1.00000000000469,0.956592523554187,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18310,GO:1903178,1.00000000000469,0.956592523554187,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18314,GO:1903184,1.00000000000469,0.956592523554187,0,1,L-dopa metabolic process,BP,
18315,GO:1903185,1.00000000000469,0.956592523554187,0,1,L-dopa biosynthetic process,BP,
18316,GO:1903189,1.00000000000469,0.956592523554187,0,1,glyoxal metabolic process,BP,
18317,GO:1903195,1.00000000000469,0.956592523554187,0,1,regulation of L-dopa biosynthetic process,BP,
18318,GO:1903197,1.00000000000469,0.956592523554187,0,1,positive regulation of L-dopa biosynthetic process,BP,
18319,GO:1903198,1.00000000000469,0.956592523554187,0,1,regulation of L-dopa decarboxylase activity,BP,
18320,GO:1903200,1.00000000000469,0.956592523554187,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19852,GO:2000277,1.00000000000469,0.956592523554187,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19858,GO:2000284,1.00000000000469,0.956592523554187,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
1579,GO:0003986,1.00000000000469,0.851659742524849,0,3,acetyl-CoA hydrolase activity,MF,
16172,GO:0090170,1.0000000000047,0.755504483481689,0,4,regulation of Golgi inheritance,BP,
3877,GO:0008506,1.00000000000471,0.857527307015456,0,2,sucrose:proton symporter activity,MF,
3885,GO:0008515,1.00000000000471,0.857527307015456,0,2,sucrose transmembrane transporter activity,MF,
4288,GO:0009669,1.00000000000471,0.857527307015456,0,2,sucrose:cation symporter activity,MF,
5008,GO:0015154,1.00000000000471,0.857527307015456,0,2,disaccharide transmembrane transporter activity,MF,
5009,GO:0015157,1.00000000000471,0.857527307015456,0,2,oligosaccharide transmembrane transporter activity,MF,
5191,GO:0015766,1.00000000000471,0.857527307015456,0,2,disaccharide transport,BP,
5192,GO:0015770,1.00000000000471,0.857527307015456,0,2,sucrose transport,BP,
5193,GO:0015772,1.00000000000471,0.857527307015456,0,2,oligosaccharide transport,BP,
16755,GO:0097752,1.00000000000471,0.799921939394922,0,3,regulation of DNA stability,BP,
8645,GO:0034164,1.00000000000472,0.9100291805647,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
16974,GO:0098948,1.00000000000472,0.9100291805647,0,1,intrinsic component of postsynaptic specialization membrane,CC,
17009,GO:0099060,1.00000000000472,0.9100291805647,0,1,integral component of postsynaptic specialization membrane,CC,
17010,GO:0099061,1.00000000000472,0.9100291805647,0,1,integral component of postsynaptic density membrane,CC,
17038,GO:0099146,1.00000000000472,0.9100291805647,0,1,intrinsic component of postsynaptic density membrane,CC,
16399,GO:0090724,1.00000000000473,0.737843299180802,0,4,central region of growth cone,CC,
6520,GO:0021894,1.00000000000475,0.953143132371474,0,1,cerebral cortex GABAergic interneuron development,BP,
10127,GO:0042636,1.00000000000475,0.724741398570543,0,4,negative regulation of hair cycle,BP,
14156,GO:0061002,1.00000000000475,0.780739266200973,0,3,negative regulation of dendritic spine morphogenesis,BP,
16077,GO:0089701,1.00000000000475,0.745550560288109,0,5,U2AF,CC,
6418,GO:0021678,1.00000000000475,0.853072881358022,0,3,third ventricle development,BP,
4916,GO:0014852,1.00000000000476,0.928257663004652,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4917,GO:0014853,1.00000000000476,0.928257663004652,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5793,GO:0017020,1.00000000000476,0.928257663004652,0,1,myosin phosphatase regulator activity,MF,
2234,GO:0005136,1.00000000000476,0.927091154248708,0,1,interleukin-4 receptor binding,MF,
12014,GO:0047408,1.00000000000477,0.868117083757127,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12015,GO:0047409,1.00000000000477,0.868117083757127,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
15181,GO:0071283,1.00000000000477,0.891849684418142,0,2,cellular response to iron(III) ion,BP,
7635,GO:0032029,1.00000000000478,0.883680434095602,0,1,myosin tail binding,MF,
5460,GO:0016333,1.00000000000478,0.927911560753369,0,1,morphogenesis of follicular epithelium,BP,
5461,GO:0016334,1.00000000000478,0.927911560753369,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
9921,GO:0042247,1.00000000000478,0.927911560753369,0,1,establishment of planar polarity of follicular epithelium,BP,
10131,GO:0042643,1.00000000000478,0.927911560753369,0,1,actomyosin, actin portion,CC,
20206,GO:2001015,1.00000000000479,0.845370534396303,0,2,negative regulation of skeletal muscle cell differentiation,BP,
16518,GO:0097196,1.0000000000048,0.86825063190493,0,2,Shu complex,CC,
16235,GO:0090259,1.00000000000481,0.791218099628013,0,3,regulation of retinal ganglion cell axon guidance,BP,
1505,GO:0003854,1.00000000000482,0.815015127396817,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
3002,GO:0006548,1.00000000000482,0.823680517593136,0,3,histidine catabolic process,BP,
13435,GO:0052805,1.00000000000482,0.823680517593136,0,3,imidazole-containing compound catabolic process,BP,
16455,GO:0097090,1.00000000000483,0.66363502980584,0,5,presynaptic membrane organization,BP,
20080,GO:2000669,1.00000000000483,0.855967253608138,0,2,negative regulation of dendritic cell apoptotic process,BP,
1578,GO:0003985,1.00000000000484,0.815041451540327,0,3,acetyl-CoA C-acetyltransferase activity,MF,
13569,GO:0060010,1.00000000000485,0.926276400680943,0,1,Sertoli cell fate commitment,BP,
939,GO:0002337,1.00000000000485,0.87453017873521,0,2,B-1a B cell differentiation,BP,
1488,GO:0003810,1.00000000000485,0.799470269597692,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
13737,GO:0060282,1.00000000000485,0.792757826998242,0,3,positive regulation of oocyte development,BP,
19418,GO:1905881,1.00000000000485,0.792757826998242,0,3,positive regulation of oogenesis,BP,
1791,GO:0004416,1.00000000000485,0.873421214702016,0,2,hydroxyacylglutathione hydrolase activity,MF,
6089,GO:0019243,1.00000000000485,0.873421214702016,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
13106,GO:0051596,1.00000000000485,0.873421214702016,0,2,methylglyoxal catabolic process,BP,
14439,GO:0061727,1.00000000000485,0.873421214702016,0,2,methylglyoxal catabolic process to lactate,BP,
10628,GO:0043614,1.00000000000486,0.846376801317399,0,2,multi-eIF complex,CC,
15079,GO:0071020,1.00000000000487,0.880696165737614,0,2,post-spliceosomal complex,CC,
17235,GO:0106072,1.00000000000487,0.841547422331619,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17034,GO:0099130,1.00000000000488,0.932412026231438,0,1,estrogen binding,MF,
18658,GO:1903924,1.00000000000488,0.932412026231438,0,1,estradiol binding,MF,
3966,GO:0008747,1.00000000000488,0.941618772526635,0,1,N-acetylneuraminate lyase activity,MF,
15150,GO:0071224,1.00000000000489,0.796458118709722,0,3,cellular response to peptidoglycan,BP,
6643,GO:0023025,1.0000000000049,0.864310521199945,0,2,MHC class Ib protein complex binding,MF,
6646,GO:0023030,1.0000000000049,0.864310521199945,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
8792,GO:0034465,1.00000000000491,0.758155107390365,0,4,response to carbon monoxide,BP,
18719,GO:1904046,1.00000000000491,0.896638177873569,0,2,negative regulation of vascular endothelial growth factor production,BP,
2030,GO:0004767,1.00000000000492,0.693133522614186,0,5,sphingomyelin phosphodiesterase activity,MF,
15050,GO:0070976,1.00000000000492,0.929048095927906,0,1,TIR domain binding,MF,
13593,GO:0060040,1.00000000000493,0.862606925690044,0,2,retinal bipolar neuron differentiation,BP,
3001,GO:0006547,1.00000000000493,0.710024725196077,0,5,histidine metabolic process,BP,
13434,GO:0052803,1.00000000000493,0.710024725196077,0,5,imidazole-containing compound metabolic process,BP,
4623,GO:0010739,1.00000000000493,0.706416916526836,0,5,positive regulation of protein kinase A signaling,BP,
15798,GO:0072385,1.00000000000494,0.683823199642487,0,4,minus-end-directed organelle transport along microtubule,BP,
14325,GO:0061438,1.00000000000494,0.723094357058011,0,4,renal system vasculature morphogenesis,BP,
14326,GO:0061439,1.00000000000494,0.723094357058011,0,4,kidney vasculature morphogenesis,BP,
11322,GO:0045625,1.00000000000495,0.69059616654385,0,5,regulation of T-helper 1 cell differentiation,BP,
5950,GO:0018282,1.00000000000495,0.844803846397039,0,2,metal incorporation into metallo-sulfur cluster,BP,
5951,GO:0018283,1.00000000000495,0.844803846397039,0,2,iron incorporation into metallo-sulfur cluster,BP,
15088,GO:0071033,1.00000000000497,0.725997642488241,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
14575,GO:0070086,1.00000000000497,0.759679285307163,0,4,ubiquitin-dependent endocytosis,BP,
12519,GO:0050561,1.00000000000498,0.92389951396589,0,1,glutamate-tRNA(Gln) ligase activity,MF,
1582,GO:0003989,1.00000000000498,0.80098370820484,0,2,acetyl-CoA carboxylase activity,MF,
20337,GO:2001295,1.00000000000498,0.80098370820484,0,2,malonyl-CoA biosynthetic process,BP,
19926,GO:2000381,1.00000000000499,0.730415531495899,0,4,negative regulation of mesoderm development,BP,
1143,GO:0002732,1.00000000000499,0.921358984710578,0,1,positive regulation of dendritic cell cytokine production,BP,
7929,GO:0032498,1.00000000000499,0.921358984710578,0,1,detection of muramyl dipeptide,BP,
7930,GO:0032499,1.00000000000499,0.921358984710578,0,1,detection of peptidoglycan,BP,
7931,GO:0032500,1.00000000000499,0.921358984710578,0,1,muramyl dipeptide binding,MF,
19913,GO:2000361,1.00000000000499,0.921358984710578,0,1,regulation of prostaglandin-E synthase activity,BP,
19914,GO:2000363,1.00000000000499,0.921358984710578,0,1,positive regulation of prostaglandin-E synthase activity,BP,
14786,GO:0070470,1.000000000005,0.792167629733374,0,4,plasma membrane respiratory chain,CC,
14840,GO:0070563,1.000000000005,0.857461600777745,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
9410,GO:0035947,1.00000000000501,0.671638716842031,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
386,GO:0001030,1.00000000000501,0.64787732015061,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
387,GO:0001031,1.00000000000501,0.64787732015061,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
15988,GO:0080084,1.00000000000501,0.64787732015061,0,5,5S rDNA binding,MF,
6011,GO:0019050,1.00000000000501,0.822990833619479,0,3,suppression by virus of host apoptotic process,BP,
9772,GO:0039526,1.00000000000501,0.822990833619479,0,3,modulation by virus of host apoptotic process,BP,
16262,GO:0090297,1.00000000000501,0.947677521141386,0,1,positive regulation of mitochondrial DNA replication,BP,
17813,GO:1901860,1.00000000000501,0.947677521141386,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19464,GO:1990046,1.00000000000501,0.947677521141386,0,1,stress-induced mitochondrial fusion,BP,
15425,GO:0071671,1.00000000000503,0.762053602547561,0,4,regulation of smooth muscle cell chemotaxis,BP,
1473,GO:0003726,1.00000000000503,0.8369313324512,0,2,double-stranded RNA adenosine deaminase activity,MF,
2488,GO:0005731,1.00000000000504,0.938754125640124,0,1,nucleolus organizer region,CC,
3346,GO:0007072,1.00000000000504,0.938754125640124,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7087,GO:0030874,1.00000000000504,0.938754125640124,0,1,nucleolar chromatin,CC,
16597,GO:0097372,1.00000000000504,0.938754125640124,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
14007,GO:0060699,1.00000000000505,0.75310484620927,0,4,regulation of endoribonuclease activity,BP,
19791,GO:2000152,1.00000000000506,0.791646514227845,0,4,regulation of ubiquitin-specific protease activity,BP,
14543,GO:0070026,1.00000000000506,0.888628465707325,0,2,nitric oxide binding,MF,
2045,GO:0004790,1.00000000000507,0.929925821842254,0,1,thioether S-methyltransferase activity,MF,
7027,GO:0030748,1.00000000000507,0.929925821842254,0,1,amine N-methyltransferase activity,MF,
17186,GO:0102707,1.00000000000507,0.929925821842254,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
7549,GO:0031826,1.00000000000509,0.821583639055847,0,3,type 2A serotonin receptor binding,MF,
12627,GO:0050787,1.0000000000051,0.878550635747132,0,2,detoxification of mercury ion,BP,
1872,GO:0004534,1.0000000000051,0.741565716558873,0,3,5'-3' exoribonuclease activity,MF,
19415,GO:1905878,1.0000000000051,0.893706876665806,0,1,invadopodium disassembly,BP,
19433,GO:1905927,1.0000000000051,0.893706876665806,0,1,regulation of invadopodium disassembly,BP,
19434,GO:1905929,1.0000000000051,0.893706876665806,0,1,positive regulation of invadopodium disassembly,BP,
7558,GO:0031867,1.00000000000512,0.924226595469296,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
15151,GO:0071225,1.00000000000512,0.728179075871559,0,4,cellular response to muramyl dipeptide,BP,
10635,GO:0043622,1.00000000000512,0.722751850426626,0,4,cortical microtubule organization,BP,
566,GO:0001705,1.00000000000513,0.854754905100759,0,2,ectoderm formation,BP,
573,GO:0001712,1.00000000000513,0.854754905100759,0,2,ectodermal cell fate commitment,BP,
12055,GO:0047757,1.00000000000515,0.827725975000983,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
14124,GO:0060940,1.00000000000516,0.861146924708361,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
10840,GO:0044324,1.00000000000516,0.957292323243849,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
19725,GO:2000016,1.00000000000516,0.957292323243849,0,1,negative regulation of determination of dorsal identity,BP,
13026,GO:0051433,1.00000000000517,0.921090494278015,0,1,BH2 domain binding,MF,
18402,GO:1903378,1.00000000000517,0.854427694104762,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
1304,GO:0003139,1.00000000000518,0.761983555607431,0,4,secondary heart field specification,BP,
4708,GO:0010868,1.00000000000518,0.850905888501843,0,2,negative regulation of triglyceride biosynthetic process,BP,
18892,GO:1904505,1.00000000000518,0.7241541773004,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18893,GO:1904506,1.00000000000518,0.7241541773004,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
7923,GO:0032490,1.00000000000518,0.72465837868315,0,4,detection of molecule of bacterial origin,BP,
1659,GO:0004111,1.0000000000052,0.753250973732843,0,4,creatine kinase activity,MF,
1563,GO:0003960,1.0000000000052,0.826442551285371,0,3,NADPH:quinone reductase activity,MF,
1837,GO:0004489,1.00000000000521,0.907351485155284,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
8383,GO:0033274,1.00000000000521,0.907351485155284,0,1,response to vitamin B2,BP,
5574,GO:0016586,1.00000000000524,0.83407715346753,0,2,RSC-type complex,CC,
3520,GO:0007495,1.00000000000524,0.926831489633451,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
14795,GO:0070483,1.00000000000524,0.926831489633451,0,1,detection of hypoxia,BP,
15560,GO:0071947,1.00000000000525,0.771907326246811,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
8347,GO:0033186,1.00000000000527,0.779494642811681,0,3,CAF-1 complex,CC,
3609,GO:0008050,1.00000000000528,0.843053683724482,0,2,female courtship behavior,BP,
11484,GO:0045924,1.00000000000528,0.843053683724482,0,2,regulation of female receptivity,BP,
4349,GO:0009912,1.00000000000528,0.685187193239297,0,5,auditory receptor cell fate commitment,BP,
13646,GO:0060120,1.00000000000528,0.685187193239297,0,5,inner ear receptor cell fate commitment,BP,
10493,GO:0043376,1.00000000000528,0.925110318903231,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
1773,GO:0004375,1.0000000000053,0.924270586728434,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
5606,GO:0016642,1.0000000000053,0.924270586728434,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
9536,GO:0036255,1.0000000000053,0.924270586728434,0,1,response to methylamine,BP,
14687,GO:0070280,1.0000000000053,0.924270586728434,0,1,pyridoxal binding,MF,
18439,GO:1903442,1.0000000000053,0.924270586728434,0,1,response to lipoic acid,BP,
1759,GO:0004359,1.00000000000531,0.797550242314474,0,3,glutaminase activity,MF,
18654,GO:1903918,1.00000000000531,0.905336773301221,0,1,regulation of actin filament severing,BP,
18655,GO:1903919,1.00000000000531,0.905336773301221,0,1,negative regulation of actin filament severing,BP,
3977,GO:0008794,1.00000000000532,0.95723609864323,0,1,arsenate reductase (glutaredoxin) activity,MF,
6964,GO:0030611,1.00000000000532,0.95723609864323,0,1,arsenate reductase activity,MF,
7546,GO:0031811,1.00000000000532,0.923986921716538,0,1,G-protein coupled nucleotide receptor binding,MF,
7547,GO:0031812,1.00000000000532,0.923986921716538,0,1,P2Y1 nucleotide receptor binding,MF,
2163,GO:0004992,1.00000000000532,0.922961826177012,0,1,platelet activating factor receptor activity,MF,
4996,GO:0015130,1.00000000000532,0.922961826177012,0,1,mevalonate transmembrane transporter activity,MF,
5176,GO:0015728,1.00000000000532,0.922961826177012,0,1,mevalonate transport,BP,
10467,GO:0043315,1.00000000000532,0.922961826177012,0,1,positive regulation of neutrophil degranulation,BP,
13194,GO:0051780,1.00000000000532,0.922961826177012,0,1,behavioral response to nutrient,BP,
15167,GO:0071258,1.00000000000532,0.922961826177012,0,1,cellular response to gravity,BP,
18066,GO:1902565,1.00000000000532,0.922961826177012,0,1,positive regulation of neutrophil activation,BP,
18199,GO:1902941,1.00000000000532,0.922961826177012,0,1,regulation of voltage-gated chloride channel activity,BP,
18200,GO:1902943,1.00000000000532,0.922961826177012,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18596,GO:1903797,1.00000000000532,0.922961826177012,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18810,GO:1904298,1.00000000000532,0.922961826177012,0,1,regulation of transcytosis,BP,
18811,GO:1904300,1.00000000000532,0.922961826177012,0,1,positive regulation of transcytosis,BP,
18812,GO:1904301,1.00000000000532,0.922961826177012,0,1,regulation of maternal process involved in parturition,BP,
18813,GO:1904303,1.00000000000532,0.922961826177012,0,1,positive regulation of maternal process involved in parturition,BP,
18818,GO:1904316,1.00000000000532,0.922961826177012,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18819,GO:1904317,1.00000000000532,0.922961826177012,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18950,GO:1904647,1.00000000000533,0.896982168055723,0,1,response to rotenone,BP,
16473,GO:0097117,1.00000000000534,0.907319843101326,0,1,guanylate kinase-associated protein clustering,BP,
500,GO:0001555,1.00000000000535,0.861341565082755,0,2,oocyte growth,BP,
7459,GO:0031590,1.00000000000535,0.861341565082755,0,2,wybutosine metabolic process,BP,
7460,GO:0031591,1.00000000000535,0.861341565082755,0,2,wybutosine biosynthetic process,BP,
16092,GO:0090034,1.00000000000535,0.868377317704407,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16093,GO:0090035,1.00000000000535,0.868377317704407,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
13248,GO:0051892,1.00000000000535,0.922456296859381,0,1,negative regulation of cardioblast differentiation,BP,
20092,GO:2000690,1.00000000000535,0.922456296859381,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20093,GO:2000691,1.00000000000535,0.922456296859381,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
1491,GO:0003826,1.00000000000536,0.87166611673543,0,2,alpha-ketoacid dehydrogenase activity,MF,
1509,GO:0003863,1.00000000000536,0.87166611673543,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
12759,GO:0051005,1.00000000000536,0.825717121768108,0,3,negative regulation of lipoprotein lipase activity,BP,
2318,GO:0005316,1.00000000000536,0.926404546800966,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
12389,GO:0048763,1.00000000000536,0.687768113443525,0,3,calcium-induced calcium release activity,MF,
1917,GO:0004607,1.00000000000537,0.945899583983792,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
11967,GO:0047045,1.00000000000538,0.94856137917624,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
17233,GO:0106070,1.0000000000054,0.640194007510448,0,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
8656,GO:0034191,1.0000000000054,0.783837124956168,0,3,apolipoprotein A-I receptor binding,MF,
16527,GO:0097209,1.00000000000541,0.735139379036865,0,4,epidermal lamellar body,CC,
15862,GO:0072557,1.00000000000541,0.90178713810715,0,2,IPAF inflammasome complex,CC,
5459,GO:0016332,1.00000000000542,0.923932091925706,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
15605,GO:0072060,1.00000000000542,0.923932091925706,0,1,outer medullary collecting duct development,BP,
1778,GO:0004382,1.00000000000542,0.864629220680247,0,2,guanosine-diphosphatase activity,MF,
2688,GO:0006049,1.00000000000542,0.928002794653757,0,1,UDP-N-acetylglucosamine catabolic process,BP,
9607,GO:0036455,1.00000000000542,0.951488738667812,0,1,iron-sulfur transferase activity,MF,
20096,GO:2000698,1.00000000000543,0.767772157556859,0,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,
16492,GO:0097155,1.00000000000543,0.809101056052006,0,2,fasciculation of sensory neuron axon,BP,
18339,GO:1903237,1.00000000000543,0.960009424020638,0,1,negative regulation of leukocyte tethering or rolling,BP,
2657,GO:0005999,1.00000000000544,0.885409053740897,0,2,xylulose biosynthetic process,BP,
5653,GO:0016744,1.00000000000544,0.885409053740897,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
8964,GO:0035021,1.00000000000545,0.698794314025084,0,4,negative regulation of Rac protein signal transduction,BP,
10110,GO:0042610,1.00000000000545,0.933873582420468,0,1,CD8 receptor binding,MF,
19286,GO:1905429,1.00000000000545,0.933873582420468,0,1,response to glycine,BP,
19287,GO:1905430,1.00000000000545,0.933873582420468,0,1,cellular response to glycine,BP,
19936,GO:2000393,1.00000000000548,0.852017251520162,0,2,negative regulation of lamellipodium morphogenesis,BP,
15960,GO:0072750,1.00000000000548,0.947512427080361,0,1,cellular response to leptomycin B,BP,
17657,GO:1901344,1.00000000000548,0.947512427080361,0,1,response to leptomycin B,BP,
17779,GO:1901707,1.00000000000548,0.947512427080361,0,1,leptomycin B binding,MF,
18547,GO:1903699,1.00000000000548,0.883625873202149,0,1,tarsal gland development,BP,
18553,GO:1903709,1.00000000000548,0.883625873202149,0,1,uterine gland development,BP,
1607,GO:0004027,1.00000000000549,0.948900667297962,0,1,alcohol sulfotransferase activity,MF,
807,GO:0002074,1.00000000000549,0.7852589945385,0,3,extraocular skeletal muscle development,BP,
6268,GO:0019858,1.00000000000549,0.884007427530482,0,2,cytosine metabolic process,BP,
20059,GO:2000646,1.0000000000055,0.678621889980137,0,5,positive regulation of receptor catabolic process,BP,
17383,GO:1900062,1.0000000000055,0.924710300485582,0,1,regulation of replicative cell aging,BP,
461,GO:0001401,1.00000000000552,0.868894526668425,0,2,mitochondrial sorting and assembly machinery complex,CC,
17674,GO:1901387,1.00000000000553,0.787871944154054,0,3,positive regulation of voltage-gated calcium channel activity,BP,
4463,GO:0010454,1.00000000000553,0.803140660397257,0,3,negative regulation of cell fate commitment,BP,
5405,GO:0016240,1.00000000000553,0.748497685938728,0,4,autophagosome membrane docking,BP,
19739,GO:2000048,1.00000000000555,0.892818947573811,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
15195,GO:0071313,1.00000000000555,0.647069132018543,0,4,cellular response to caffeine,BP,
15266,GO:0071415,1.00000000000555,0.647069132018543,0,4,cellular response to purine-containing compound,BP,
20160,GO:2000812,1.0000000000056,0.92405369811484,0,1,regulation of barbed-end actin filament capping,BP,
1920,GO:0004610,1.00000000000561,0.934751596435443,0,1,phosphoacetylglucosamine mutase activity,MF,
5898,GO:0018094,1.00000000000561,0.925917145928241,0,1,protein polyglycylation,BP,
14926,GO:0070735,1.00000000000561,0.925917145928241,0,1,protein-glycine ligase activity,MF,
14927,GO:0070736,1.00000000000561,0.925917145928241,0,1,protein-glycine ligase activity, initiating,MF,
4594,GO:0010700,1.00000000000561,0.927186237510746,0,1,negative regulation of norepinephrine secretion,BP,
7512,GO:0031686,1.00000000000561,0.927186237510746,0,1,A1 adenosine receptor binding,MF,
11063,GO:0045032,1.00000000000561,0.927186237510746,0,1,ADP-activated adenosine receptor activity,MF,
16383,GO:0090667,1.00000000000561,0.90361175283633,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16384,GO:0090668,1.00000000000561,0.90361175283633,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
3218,GO:0006867,1.00000000000562,0.928690127446997,0,1,asparagine transport,BP,
5021,GO:0015182,1.00000000000562,0.928690127446997,0,1,L-asparagine transmembrane transporter activity,MF,
5028,GO:0015190,1.00000000000562,0.928690127446997,0,1,L-leucine transmembrane transporter activity,MF,
5029,GO:0015191,1.00000000000562,0.928690127446997,0,1,L-methionine transmembrane transporter activity,MF,
5141,GO:0015658,1.00000000000562,0.928690127446997,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5221,GO:0015821,1.00000000000562,0.928690127446997,0,1,methionine transport,BP,
10675,GO:0043865,1.00000000000562,0.928690127446997,0,1,methionine transmembrane transporter activity,MF,
19473,GO:1990075,1.00000000000562,0.792549227446112,0,3,periciliary membrane compartment,CC,
7240,GO:0031134,1.00000000000563,0.799926672730701,0,3,sister chromatid biorientation,BP,
18909,GO:1904562,1.00000000000563,0.820514130396032,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
8260,GO:0033030,1.00000000000563,0.912623646678736,0,1,negative regulation of neutrophil apoptotic process,BP,
11224,GO:0045342,1.00000000000563,0.685904424421308,0,5,MHC class II biosynthetic process,BP,
11227,GO:0045346,1.00000000000563,0.685904424421308,0,5,regulation of MHC class II biosynthetic process,BP,
4957,GO:0015019,1.00000000000563,0.917644123055091,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
13808,GO:0060374,1.00000000000564,0.787544211682518,0,3,mast cell differentiation,BP,
14359,GO:0061534,1.00000000000564,0.880577973628638,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
2159,GO:0004980,1.00000000000564,0.927221013902139,0,1,melanocyte-stimulating hormone receptor activity,MF,
15833,GO:0072513,1.00000000000565,0.960271390431621,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
12170,GO:0048262,1.00000000000565,0.712660693691053,0,5,determination of dorsal/ventral asymmetry,BP,
6145,GO:0019417,1.00000000000566,0.85497147971999,0,2,sulfur oxidation,BP,
8314,GO:0033140,1.00000000000567,0.869718566013417,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
1502,GO:0003845,1.00000000000568,0.884486490665654,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
8156,GO:0032876,1.00000000000569,0.696265636984372,0,4,negative regulation of DNA endoreduplication,BP,
1893,GO:0004572,1.0000000000057,0.837252024539994,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
10069,GO:0042543,1.00000000000572,0.968076012162401,0,1,protein N-linked glycosylation via arginine,BP,
2413,GO:0005584,1.00000000000572,0.837276590807463,0,2,collagen type I trimer,CC,
6409,GO:0021631,1.00000000000572,0.758658641036052,0,3,optic nerve morphogenesis,BP,
1593,GO:0004001,1.00000000000573,0.934116052201029,0,1,adenosine kinase activity,MF,
2006,GO:0004727,1.00000000000573,0.934116052201029,0,1,prenylated protein tyrosine phosphatase activity,MF,
2760,GO:0006169,1.00000000000573,0.934116052201029,0,1,adenosine salvage,BP,
2763,GO:0006175,1.00000000000573,0.934116052201029,0,1,dATP biosynthetic process,BP,
4155,GO:0009216,1.00000000000573,0.934116052201029,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
11043,GO:0044878,1.00000000000574,0.772514778405087,0,4,mitotic cytokinesis checkpoint,BP,
16654,GO:0097494,1.00000000000574,0.732604171769861,0,4,regulation of vesicle size,BP,
1808,GO:0004450,1.00000000000574,0.874172199332907,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
2720,GO:0006097,1.00000000000574,0.874172199332907,0,2,glyoxylate cycle,BP,
3133,GO:0006722,1.00000000000574,0.930929707628201,0,1,triterpenoid metabolic process,BP,
6218,GO:0019742,1.00000000000574,0.930929707628201,0,1,pentacyclic triterpenoid metabolic process,BP,
19089,GO:1904924,1.00000000000574,0.930929707628201,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19264,GO:1905370,1.00000000000574,0.930929707628201,0,1,serine-type endopeptidase complex,CC,
2231,GO:0005132,1.00000000000576,0.897399606911987,0,2,type I interferon receptor binding,MF,
11011,GO:0044805,1.00000000000576,0.849605485222328,0,2,late nucleophagy,BP,
10454,GO:0043301,1.00000000000577,0.673397979571548,0,5,negative regulation of leukocyte degranulation,BP,
14462,GO:0061768,1.00000000000577,0.919543611830798,0,1,magnesium:sodium antiporter activity,MF,
11003,GO:0044793,1.00000000000577,0.674057300388185,0,5,negative regulation by host of viral process,BP,
13258,GO:0051902,1.00000000000578,0.708450180049486,0,5,negative regulation of mitochondrial depolarization,BP,
18755,GO:1904180,1.00000000000578,0.708450180049486,0,5,negative regulation of membrane depolarization,BP,
2039,GO:0004777,1.00000000000579,0.918018002550299,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
4016,GO:0009013,1.00000000000579,0.918018002550299,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
10347,GO:0043131,1.00000000000579,0.918018002550299,0,1,erythrocyte enucleation,BP,
10482,GO:0043354,1.00000000000579,0.918018002550299,0,1,enucleate erythrocyte maturation,BP,
14509,GO:0061930,1.00000000000579,0.918018002550299,0,1,regulation of erythrocyte enucleation,BP,
14510,GO:0061931,1.00000000000579,0.918018002550299,0,1,positive regulation of erythrocyte enucleation,BP,
16364,GO:0090601,1.00000000000579,0.918018002550299,0,1,enucleation,BP,
18156,GO:1902838,1.00000000000579,0.918018002550299,0,1,regulation of nuclear migration along microtubule,BP,
6946,GO:0030549,1.00000000000579,0.950825667882633,0,1,acetylcholine receptor activator activity,MF,
15564,GO:0071955,1.0000000000058,0.835180035751243,0,2,recycling endosome to Golgi transport,BP,
18114,GO:1902713,1.0000000000058,0.725314113519153,0,4,regulation of interferon-gamma secretion,BP,
15347,GO:0071547,1.0000000000058,0.92876649078085,0,1,piP-body,CC,
10162,GO:0042731,1.00000000000581,0.744489834285115,0,4,PH domain binding,MF,
17435,GO:1900150,1.00000000000581,0.875837467919056,0,2,regulation of defense response to fungus,BP,
2230,GO:0005131,1.00000000000581,0.724620995700042,0,4,growth hormone receptor binding,MF,
19149,GO:1905062,1.00000000000582,0.929064077381641,0,1,positive regulation of cardioblast proliferation,BP,
8565,GO:0033981,1.00000000000582,0.965079193642528,0,1,D-dopachrome decarboxylase activity,MF,
14412,GO:0061649,1.00000000000583,0.783763101337697,0,3,ubiquitin modification-dependent histone binding,MF,
12220,GO:0048382,1.00000000000584,0.85805001082613,0,2,mesendoderm development,BP,
14141,GO:0060979,1.00000000000584,0.740430912588927,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
1635,GO:0004074,1.00000000000584,0.913361852374249,0,2,biliverdin reductase activity,MF,
14419,GO:0061669,1.00000000000584,0.844265033062835,0,2,spontaneous neurotransmitter secretion,BP,
16420,GO:0097021,1.00000000000585,0.861926584909429,0,2,lymphocyte migration into lymphoid organs,BP,
16170,GO:0090168,1.00000000000585,0.739689374785184,0,4,Golgi reassembly,BP,
19572,GO:1990454,1.00000000000585,0.792240630930593,0,3,L-type voltage-gated calcium channel complex,CC,
14745,GO:0070384,1.00000000000586,0.793875840866042,0,3,Harderian gland development,BP,
6217,GO:0019740,1.00000000000586,0.818052209101598,0,3,nitrogen utilization,BP,
18957,GO:1904674,1.00000000000587,0.854295278180363,0,2,positive regulation of somatic stem cell population maintenance,BP,
4295,GO:0009720,1.00000000000587,0.927704217400835,0,1,detection of hormone stimulus,BP,
8581,GO:0034041,1.00000000000587,0.927704217400835,0,1,sterol-transporting ATPase activity,MF,
2108,GO:0004882,1.00000000000588,0.926449539695218,0,1,androgen receptor activity,MF,
9405,GO:0035935,1.00000000000588,0.926449539695218,0,1,androgen secretion,BP,
16498,GO:0097162,1.00000000000588,0.926449539695218,0,1,MADS box domain binding,MF,
20175,GO:2000834,1.00000000000588,0.926449539695218,0,1,regulation of androgen secretion,BP,
20176,GO:2000836,1.00000000000588,0.926449539695218,0,1,positive regulation of androgen secretion,BP,
11843,GO:0046726,1.00000000000588,0.729756770596937,0,4,positive regulation by virus of viral protein levels in host cell,BP,
2176,GO:0005009,1.00000000000589,0.897454911366151,0,1,insulin-activated receptor activity,MF,
3032,GO:0006580,1.0000000000059,0.929136470027129,0,1,ethanolamine metabolic process,BP,
18303,GO:1903165,1.0000000000059,0.929136470027129,0,1,response to polycyclic arene,BP,
18961,GO:1904681,1.0000000000059,0.929136470027129,0,1,response to 3-methylcholanthrene,BP,
5082,GO:0015317,1.0000000000059,0.939347021509246,0,1,phosphate:proton symporter activity,MF,
11751,GO:0046548,1.00000000000591,0.797346336240305,0,3,retinal rod cell development,BP,
3555,GO:0007597,1.00000000000591,0.721213249291839,0,5,blood coagulation, intrinsic pathway,BP,
16283,GO:0090324,1.00000000000592,0.692225287090821,0,5,negative regulation of oxidative phosphorylation,BP,
8859,GO:0034647,1.00000000000594,0.809317791432792,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8908,GO:0034721,1.00000000000594,0.809317791432792,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
7500,GO:0031666,1.00000000000594,0.731615521869775,0,4,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
18197,GO:1902938,1.00000000000594,0.862178867850978,0,2,regulation of intracellular calcium activated chloride channel activity,BP,
5207,GO:0015803,1.00000000000596,0.798055308993543,0,3,branched-chain amino acid transport,BP,
1897,GO:0004577,1.00000000000597,0.884061408726653,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
7739,GO:0032229,1.00000000000598,0.878010880915889,0,2,negative regulation of synaptic transmission, GABAergic,BP,
15894,GO:0072602,1.00000000000599,0.715295721417419,0,4,interleukin-4 secretion,BP,
3127,GO:0006707,1.000000000006,0.746365475427756,0,4,cholesterol catabolic process,BP,
5359,GO:0016127,1.000000000006,0.746365475427756,0,4,sterol catabolic process,BP,
18311,GO:1903179,1.000000000006,0.886160777436454,0,2,regulation of dopamine biosynthetic process,BP,
18312,GO:1903181,1.000000000006,0.886160777436454,0,2,positive regulation of dopamine biosynthetic process,BP,
4928,GO:0014877,1.00000000000601,0.661114460943043,0,4,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4936,GO:0014894,1.00000000000601,0.661114460943043,0,4,response to denervation involved in regulation of muscle adaptation,BP,
6453,GO:0021768,1.00000000000602,0.925553343409765,0,1,nucleus accumbens development,BP,
12876,GO:0051176,1.00000000000602,0.783390063724935,0,3,positive regulation of sulfur metabolic process,BP,
12057,GO:0047800,1.00000000000602,0.924698495450894,0,1,cysteamine dioxygenase activity,MF,
1048,GO:0002568,1.00000000000603,0.627885319810208,0,5,somatic diversification of T cell receptor genes,BP,
1095,GO:0002681,1.00000000000603,0.627885319810208,0,5,somatic recombination of T cell receptor gene segments,BP,
8326,GO:0033153,1.00000000000603,0.627885319810208,0,5,T cell receptor V(D)J recombination,BP,
20235,GO:2001069,1.00000000000603,0.863537915645235,0,2,glycogen binding,MF,
5526,GO:0016493,1.00000000000603,0.8645842283143,0,2,C-C chemokine receptor activity,MF,
3216,GO:0006864,1.00000000000604,0.868589700327015,0,2,pyrimidine nucleotide transport,BP,
5042,GO:0015218,1.00000000000604,0.868589700327015,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19584,GO:1990519,1.00000000000604,0.868589700327015,0,2,pyrimidine nucleotide import into mitochondrion,BP,
3206,GO:0006844,1.00000000000604,0.872010438165312,0,2,acyl carnitine transport,BP,
5046,GO:0015227,1.00000000000604,0.872010438165312,0,2,acyl carnitine transmembrane transporter activity,MF,
760,GO:0001998,1.00000000000605,0.935768290551493,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
780,GO:0002034,1.00000000000605,0.935768290551493,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1281,GO:0003072,1.00000000000605,0.935768290551493,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18538,GO:1903673,1.00000000000605,0.935768290551493,0,1,mitotic cleavage furrow formation,BP,
18971,GO:1904695,1.00000000000605,0.935768290551493,0,1,positive regulation of vascular smooth muscle contraction,BP,
14580,GO:0070095,1.00000000000605,0.926875791159732,0,1,fructose-6-phosphate binding,MF,
8325,GO:0033152,1.00000000000606,0.706408492089159,0,4,immunoglobulin V(D)J recombination,BP,
15035,GO:0070949,1.00000000000606,0.876056781585836,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
15039,GO:0070960,1.00000000000606,0.876056781585836,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15040,GO:0070961,1.00000000000606,0.876056781585836,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
3475,GO:0007320,1.00000000000606,0.726267395361695,0,4,insemination,BP,
3788,GO:0008352,1.00000000000608,0.929319664367143,0,1,katanin complex,CC,
49,GO:0000103,1.00000000000609,0.81551618219606,0,3,sulfate assimilation,BP,
4836,GO:0014040,1.00000000000609,0.828684139163771,0,2,positive regulation of Schwann cell differentiation,BP,
15760,GO:0072320,1.0000000000061,0.786604446318758,0,3,volume-sensitive chloride channel activity,MF,
55,GO:0000117,1.0000000000061,0.915439260018242,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
18432,GO:1903434,1.0000000000061,0.924142350732071,0,1,negative regulation of constitutive secretory pathway,BP,
3434,GO:0007225,1.00000000000611,0.920118046322209,0,1,patched ligand maturation,BP,
9251,GO:0035638,1.00000000000611,0.920118046322209,0,1,signal maturation,BP,
14004,GO:0060696,1.00000000000611,0.715784803576526,0,5,regulation of phospholipid catabolic process,BP,
12340,GO:0048677,1.00000000000611,0.914391443244203,0,1,axon extension involved in regeneration,BP,
15722,GO:0072244,1.00000000000611,0.914391443244203,0,1,metanephric glomerular epithelium development,BP,
15723,GO:0072248,1.00000000000611,0.914391443244203,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
15724,GO:0072249,1.00000000000611,0.914391443244203,0,1,metanephric glomerular visceral epithelial cell development,BP,
15735,GO:0072274,1.00000000000611,0.914391443244203,0,1,metanephric glomerular basement membrane development,BP,
15756,GO:0072312,1.00000000000611,0.914391443244203,0,1,metanephric glomerular epithelial cell differentiation,BP,
15757,GO:0072313,1.00000000000611,0.914391443244203,0,1,metanephric glomerular epithelial cell development,BP,
13570,GO:0060011,1.00000000000611,0.815109363517578,0,3,Sertoli cell proliferation,BP,
7712,GO:0032190,1.00000000000612,0.892264725297329,0,2,acrosin binding,MF,
9336,GO:0035803,1.00000000000612,0.892264725297329,0,2,egg coat formation,BP,
6484,GO:0021824,1.00000000000612,0.851574701712435,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6488,GO:0021828,1.00000000000612,0.851574701712435,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6499,GO:0021856,1.00000000000612,0.851574701712435,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
13082,GO:0051563,1.00000000000612,0.845131209064058,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13818,GO:0060385,1.00000000000612,0.851574701712435,0,2,axonogenesis involved in innervation,BP,
18399,GO:1903375,1.00000000000612,0.851574701712435,0,2,facioacoustic ganglion development,BP,
18688,GO:1903978,1.00000000000614,0.712723614567743,0,4,regulation of microglial cell activation,BP,
16406,GO:0093001,1.00000000000614,0.926714101325712,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
731,GO:0001957,1.00000000000614,0.718911387019883,0,4,intramembranous ossification,BP,
9474,GO:0036072,1.00000000000614,0.718911387019883,0,4,direct ossification,BP,
17593,GO:1901165,1.00000000000615,0.708162907212231,0,5,positive regulation of trophoblast cell migration,BP,
20045,GO:2000625,1.00000000000616,0.855468630861515,0,2,regulation of miRNA catabolic process,BP,
20046,GO:2000627,1.00000000000616,0.855468630861515,0,2,positive regulation of miRNA catabolic process,BP,
2448,GO:0005656,1.00000000000616,0.817801945423737,0,3,nuclear pre-replicative complex,CC,
2807,GO:0006267,1.00000000000616,0.817801945423737,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
9586,GO:0036387,1.00000000000616,0.817801945423737,0,3,pre-replicative complex,CC,
9587,GO:0036388,1.00000000000616,0.817801945423737,0,3,pre-replicative complex assembly,BP,
17974,GO:1902299,1.00000000000616,0.817801945423737,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
3753,GO:0008294,1.00000000000617,0.880096110624594,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
1443,GO:0003419,1.00000000000617,0.863002818525823,0,2,growth plate cartilage chondrocyte proliferation,BP,
1444,GO:0003420,1.00000000000617,0.863002818525823,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
3720,GO:0008240,1.00000000000618,0.851532121053389,0,2,tripeptidyl-peptidase activity,MF,
19124,GO:1904998,1.00000000000618,0.927955900509769,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
6880,GO:0030366,1.00000000000618,0.887634805700643,0,2,molybdopterin synthase activity,MF,
15835,GO:0072518,1.00000000000619,0.911209756736726,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17351,GO:0150031,1.00000000000619,0.911209756736726,0,1,regulation of protein localization to lysosome,BP,
17352,GO:0150033,1.00000000000619,0.911209756736726,0,1,negative regulation of protein localization to lysosome,BP,
6029,GO:0019085,1.00000000000622,0.85322336319367,0,2,early viral transcription,BP,
4894,GO:0014816,1.00000000000622,0.823505318605392,0,2,skeletal muscle satellite cell differentiation,BP,
6745,GO:0030160,1.00000000000622,0.759701613355293,0,3,GKAP/Homer scaffold activity,MF,
8056,GO:0032707,1.00000000000623,0.931200528634095,0,1,negative regulation of interleukin-23 production,BP,
12051,GO:0047747,1.00000000000623,0.931200528634095,0,1,cholate-CoA ligase activity,MF,
16587,GO:0097356,1.00000000000623,0.905446972345872,0,1,perinucleolar compartment,CC,
5383,GO:0016198,1.00000000000623,0.654051113551282,0,5,axon choice point recognition,BP,
9199,GO:0035574,1.00000000000624,0.847474049631137,0,2,histone H4-K20 demethylation,BP,
9200,GO:0035575,1.00000000000624,0.847474049631137,0,2,histone demethylase activity (H4-K20 specific),MF,
16461,GO:0097104,1.00000000000624,0.69301584022812,0,4,postsynaptic membrane assembly,BP,
14478,GO:0061821,1.00000000000625,0.718856668931574,0,4,telomeric D-loop binding,MF,
300,GO:0000806,1.00000000000625,0.855866713770901,0,2,Y chromosome,CC,
729,GO:0001955,1.00000000000626,0.679892438105645,0,5,blood vessel maturation,BP,
19472,GO:1990074,1.00000000000626,0.9254904514551,0,1,polyuridylation-dependent mRNA catabolic process,BP,
4965,GO:0015038,1.00000000000627,0.764475231780299,0,5,glutathione disulfide oxidoreductase activity,MF,
4925,GO:0014870,1.00000000000628,0.613578857405135,0,5,response to muscle inactivity,BP,
1919,GO:0004609,1.00000000000629,0.867230741073586,0,2,phosphatidylserine decarboxylase activity,MF,
13187,GO:0051765,1.00000000000629,0.868661919250584,0,2,inositol tetrakisphosphate kinase activity,MF,
14451,GO:0061744,1.0000000000063,0.889937171413207,0,2,motor behavior,BP,
19363,GO:1905651,1.0000000000063,0.767960611390649,0,3,regulation of artery morphogenesis,BP,
19364,GO:1905653,1.0000000000063,0.767960611390649,0,3,positive regulation of artery morphogenesis,BP,
16104,GO:0090063,1.0000000000063,0.729508476372233,0,4,positive regulation of microtubule nucleation,BP,
16531,GO:0097213,1.0000000000063,0.932277303598233,0,1,regulation of lysosomal membrane permeability,BP,
17872,GO:1902035,1.00000000000631,0.738536280166727,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
18145,GO:1902805,1.00000000000631,0.839426884931347,0,2,positive regulation of synaptic vesicle transport,BP,
19868,GO:2000302,1.00000000000631,0.839426884931347,0,2,positive regulation of synaptic vesicle exocytosis,BP,
1522,GO:0003881,1.00000000000631,0.936377219538275,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
13880,GO:0060467,1.00000000000633,0.881022152462761,0,2,negative regulation of fertilization,BP,
19911,GO:2000359,1.00000000000633,0.881022152462761,0,2,regulation of binding of sperm to zona pellucida,BP,
19912,GO:2000360,1.00000000000633,0.881022152462761,0,2,negative regulation of binding of sperm to zona pellucida,BP,
5019,GO:0015180,1.00000000000633,0.674855935913925,0,5,L-alanine transmembrane transporter activity,MF,
5211,GO:0015808,1.00000000000633,0.674855935913925,0,5,L-alanine transport,BP,
6630,GO:0022858,1.00000000000633,0.674855935913925,0,5,alanine transmembrane transporter activity,MF,
19165,GO:1905098,1.00000000000633,0.736078708595201,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
8641,GO:0034155,1.00000000000634,0.925506166716446,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8642,GO:0034157,1.00000000000634,0.925506166716446,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
16554,GO:0097274,1.00000000000636,0.846754324072924,0,2,urea homeostasis,BP,
11823,GO:0046689,1.00000000000637,0.7097250130551,0,5,response to mercury ion,BP,
15422,GO:0071664,1.00000000000637,0.713617763026165,0,4,catenin-TCF7L2 complex,CC,
10446,GO:0043291,1.00000000000637,0.788504046434352,0,2,RAVE complex,CC,
11989,GO:0047237,1.00000000000638,0.858327721668517,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
7190,GO:0031071,1.00000000000638,0.931132652766444,0,1,cysteine desulfurase activity,MF,
11674,GO:0046404,1.00000000000639,0.80061604401706,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
13179,GO:0051733,1.00000000000639,0.80061604401706,0,3,polydeoxyribonucleotide kinase activity,MF,
13180,GO:0051734,1.00000000000639,0.80061604401706,0,3,ATP-dependent polynucleotide kinase activity,MF,
12511,GO:0050508,1.0000000000064,0.856334166010745,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12512,GO:0050509,1.0000000000064,0.856334166010745,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
9393,GO:0035921,1.0000000000064,0.933669394432012,0,1,desmosome disassembly,BP,
17505,GO:1900387,1.0000000000064,0.933669394432012,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
3025,GO:0006572,1.0000000000064,0.837195887794832,0,3,tyrosine catabolic process,BP,
14356,GO:0061525,1.0000000000064,0.638089837944927,0,5,hindgut development,BP,
18295,GO:1903135,1.0000000000064,0.820667678857545,0,3,cupric ion binding,MF,
4636,GO:0010756,1.0000000000064,0.812463715584664,0,3,positive regulation of plasminogen activation,BP,
19487,GO:1990134,1.00000000000642,0.918621197265427,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
13389,GO:0052564,1.00000000000642,0.704468712591931,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13391,GO:0052572,1.00000000000642,0.704468712591931,0,5,response to host immune response,BP,
7407,GO:0031465,1.00000000000642,0.707462884923981,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
3992,GO:0008887,1.00000000000642,0.926610164075831,0,1,glycerate kinase activity,MF,
8509,GO:0033680,1.00000000000644,0.855614060688335,0,2,ATP-dependent DNA/RNA helicase activity,MF,
17809,GO:1901856,1.00000000000645,0.863577979157584,0,2,negative regulation of cellular respiration,BP,
18972,GO:1904700,1.00000000000646,0.929673615645005,0,1,granulosa cell apoptotic process,BP,
18977,GO:1904708,1.00000000000646,0.929673615645005,0,1,regulation of granulosa cell apoptotic process,BP,
18153,GO:1902822,1.00000000000646,0.826202186683759,0,3,regulation of late endosome to lysosome transport,BP,
8993,GO:0035093,1.00000000000647,0.83122536964025,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
2636,GO:0005967,1.00000000000648,0.791183550506203,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2587,GO:0005880,1.00000000000648,0.943646842302083,0,1,nuclear microtubule,CC,
15161,GO:0071245,1.00000000000649,0.924998724870167,0,1,cellular response to carbon monoxide,BP,
18416,GO:1903406,1.00000000000649,0.924998724870167,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18417,GO:1903408,1.00000000000649,0.924998724870167,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
4363,GO:0009957,1.0000000000065,0.841688869828157,0,2,epidermal cell fate specification,BP,
1033,GO:0002538,1.00000000000651,0.926928739046923,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1034,GO:0002540,1.00000000000651,0.926928739046923,0,1,leukotriene production involved in inflammatory response,BP,
9150,GO:0035490,1.00000000000651,0.926928739046923,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9151,GO:0035491,1.00000000000651,0.926928739046923,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
14182,GO:0061044,1.00000000000651,0.926928739046923,0,1,negative regulation of vascular wound healing,BP,
17649,GO:1901331,1.00000000000651,0.926928739046923,0,1,positive regulation of odontoblast differentiation,BP,
18188,GO:1902913,1.00000000000651,0.926928739046923,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19762,GO:2000098,1.00000000000651,0.926928739046923,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
3971,GO:0008768,1.00000000000651,0.958539628543885,0,1,UDP-sugar diphosphatase activity,MF,
14240,GO:0061156,1.00000000000651,0.788691019535336,0,3,pulmonary artery morphogenesis,BP,
10395,GO:0043208,1.00000000000651,0.746164612329489,0,4,glycosphingolipid binding,MF,
9800,GO:0040009,1.00000000000654,0.676163440073204,0,4,regulation of growth rate,BP,
19711,GO:1990983,1.00000000000654,0.929750538689458,0,1,tRNA demethylation,BP,
19712,GO:1990984,1.00000000000654,0.929750538689458,0,1,tRNA demethylase activity,MF,
10568,GO:0043515,1.00000000000654,0.662019735567659,0,5,kinetochore binding,MF,
17920,GO:1902178,1.00000000000654,0.922254640983553,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
9421,GO:0035976,1.00000000000657,0.726196208493697,0,5,transcription factor AP-1 complex,CC,
9973,GO:0042350,1.00000000000658,0.820791660536442,0,3,GDP-L-fucose biosynthetic process,BP,
15477,GO:0071797,1.00000000000658,0.747770587322251,0,4,LUBAC complex,CC,
18970,GO:1904694,1.00000000000659,0.756747013418167,0,3,negative regulation of vascular smooth muscle contraction,BP,
5258,GO:0015884,1.00000000000659,0.695846621355518,0,5,folic acid transport,BP,
14523,GO:0065001,1.00000000000659,0.83484839140469,0,2,specification of axis polarity,BP,
14553,GO:0070051,1.00000000000659,0.850303003044538,0,2,fibrinogen binding,MF,
3533,GO:0007525,1.0000000000066,0.76008205949756,0,2,somatic muscle development,BP,
311,GO:0000822,1.00000000000661,0.75057385459001,0,3,inositol hexakisphosphate binding,MF,
865,GO:0002193,1.00000000000661,0.76356393716532,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
10676,GO:0043874,1.00000000000661,0.934585751395353,0,1,acireductone synthase activity,MF,
7924,GO:0032493,1.00000000000661,0.793726810139385,0,3,response to bacterial lipoprotein,BP,
14723,GO:0070339,1.00000000000661,0.793726810139385,0,3,response to bacterial lipopeptide,BP,
15146,GO:0071220,1.00000000000661,0.793726810139385,0,3,cellular response to bacterial lipoprotein,BP,
15147,GO:0071221,1.00000000000661,0.793726810139385,0,3,cellular response to bacterial lipopeptide,BP,
2799,GO:0006256,1.00000000000662,0.927951223598566,0,1,UDP catabolic process,BP,
4087,GO:0009140,1.00000000000662,0.927951223598566,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4135,GO:0009193,1.00000000000662,0.927951223598566,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4136,GO:0009195,1.00000000000662,0.927951223598566,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4161,GO:0009222,1.00000000000662,0.927951223598566,0,1,pyrimidine ribonucleotide catabolic process,BP,
11542,GO:0046048,1.00000000000662,0.927951223598566,0,1,UDP metabolic process,BP,
14271,GO:0061301,1.00000000000662,0.906182426641163,0,1,cerebellum vasculature morphogenesis,BP,
53,GO:0000110,1.00000000000662,0.792773411489025,0,3,nucleotide-excision repair factor 1 complex,CC,
15558,GO:0071942,1.00000000000663,0.813430379616256,0,3,XPC complex,CC,
19495,GO:1990167,1.00000000000663,0.780293404546948,0,3,protein K27-linked deubiquitination,BP,
19026,GO:1904799,1.00000000000663,0.92374383494015,0,1,regulation of neuron remodeling,BP,
19027,GO:1904800,1.00000000000663,0.92374383494015,0,1,negative regulation of neuron remodeling,BP,
19799,GO:2000173,1.00000000000663,0.92374383494015,0,1,negative regulation of branching morphogenesis of a nerve,BP,
19586,GO:1990535,1.00000000000664,0.704541270617615,0,4,neuron projection maintenance,BP,
17314,GO:0140059,1.00000000000665,0.726491389024929,0,4,dendrite arborization,BP,
20035,GO:2000611,1.00000000000665,0.856940717955135,0,2,positive regulation of thyroid hormone generation,BP,
19944,GO:2000405,1.00000000000665,0.916249530823322,0,1,negative regulation of T cell migration,BP,
19887,GO:2000325,1.00000000000665,0.912527448398145,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19888,GO:2000327,1.00000000000665,0.912527448398145,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
4385,GO:0010034,1.00000000000665,0.92540409753022,0,1,response to acetate,BP,
5089,GO:0015333,1.00000000000666,0.788712040381438,0,3,peptide:proton symporter activity,MF,
6336,GO:0021502,1.00000000000666,0.852820201244817,0,2,neural fold elevation formation,BP,
15054,GO:0070981,1.00000000000666,0.931527192584915,0,1,L-asparagine biosynthetic process,BP,
15055,GO:0070982,1.00000000000666,0.931527192584915,0,1,L-asparagine metabolic process,BP,
14443,GO:0061734,1.00000000000667,0.634066347198694,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
9487,GO:0036112,1.00000000000667,0.875424703705858,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
11953,GO:0046984,1.00000000000667,0.7530261680268,0,4,regulation of hemoglobin biosynthetic process,BP,
10534,GO:0043456,1.00000000000668,0.765739681295155,0,4,regulation of pentose-phosphate shunt,BP,
18995,GO:1904744,1.0000000000067,0.890530374580613,0,2,positive regulation of telomeric DNA binding,BP,
7416,GO:0031493,1.00000000000671,0.804817325433447,0,3,nucleosomal histone binding,MF,
1632,GO:0004066,1.00000000000671,0.866760969731817,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
2985,GO:0006529,1.00000000000671,0.866760969731817,0,2,asparagine biosynthetic process,BP,
18208,GO:1902953,1.00000000000671,0.713651609433544,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19898,GO:2000342,1.00000000000671,0.864146520879652,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
7334,GO:0031339,1.00000000000671,0.789769977660619,0,3,negative regulation of vesicle fusion,BP,
13805,GO:0060371,1.00000000000671,0.789910423362664,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
19169,GO:1905123,1.00000000000671,0.849722186324874,0,2,regulation of glucosylceramidase activity,BP,
20173,GO:2000832,1.00000000000671,0.844899599572086,0,2,negative regulation of steroid hormone secretion,BP,
20180,GO:2000847,1.00000000000671,0.844899599572086,0,2,negative regulation of corticosteroid hormone secretion,BP,
20183,GO:2000850,1.00000000000671,0.844899599572086,0,2,negative regulation of glucocorticoid secretion,BP,
1020,GO:0002514,1.00000000000672,0.920515069066934,0,1,B cell tolerance induction,BP,
1079,GO:0002649,1.00000000000672,0.920515069066934,0,1,regulation of tolerance induction to self antigen,BP,
1080,GO:0002651,1.00000000000672,0.920515069066934,0,1,positive regulation of tolerance induction to self antigen,BP,
1082,GO:0002661,1.00000000000672,0.920515069066934,0,1,regulation of B cell tolerance induction,BP,
1083,GO:0002663,1.00000000000672,0.920515069066934,0,1,positive regulation of B cell tolerance induction,BP,
2182,GO:0005026,1.00000000000672,0.920515069066934,0,1,transforming growth factor beta receptor activity, type II,MF,
19239,GO:1905317,1.00000000000672,0.920515069066934,0,1,inferior endocardial cushion morphogenesis,BP,
19213,GO:1905258,1.00000000000672,0.901059835044058,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19214,GO:1905259,1.00000000000672,0.901059835044058,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
10695,GO:0043950,1.00000000000672,0.646147904082352,0,5,positive regulation of cAMP-mediated signaling,BP,
7555,GO:0031859,1.00000000000672,0.935954256548625,0,1,platelet activating factor receptor binding,MF,
9885,GO:0042137,1.00000000000672,0.935954256548625,0,1,sequestering of neurotransmitter,BP,
1797,GO:0004423,1.00000000000672,0.914509577655703,0,1,iduronate-2-sulfatase activity,MF,
1694,GO:0004165,1.00000000000674,0.795881734332207,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
4927,GO:0014876,1.00000000000674,0.945318569935399,0,1,response to injury involved in regulation of muscle adaptation,BP,
5440,GO:0016300,1.00000000000674,0.794270490182917,0,3,tRNA (uracil) methyltransferase activity,MF,
1669,GO:0004127,1.00000000000675,0.86118830938913,0,2,cytidylate kinase activity,MF,
1766,GO:0004366,1.00000000000676,0.729684186896653,0,4,glycerol-3-phosphate O-acyltransferase activity,MF,
12504,GO:0050436,1.00000000000677,0.848023111286139,0,2,microfibril binding,MF,
13025,GO:0051431,1.00000000000678,0.943158194594996,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
14739,GO:0070375,1.00000000000679,0.791991066881707,0,3,ERK5 cascade,BP,
16508,GO:0097179,1.00000000000679,0.827963848515492,0,4,protease inhibitor complex,CC,
18733,GO:1904090,1.00000000000679,0.827963848515492,0,4,peptidase inhibitor complex,CC,
5637,GO:0016715,1.00000000000679,0.857554931840207,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
2394,GO:0005534,1.0000000000068,0.81261346846161,0,3,galactose binding,MF,
106,GO:0000220,1.0000000000068,0.710410272841971,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
13701,GO:0060214,1.0000000000068,0.941715812420595,0,1,endocardium formation,BP,
19172,GO:1905143,1.0000000000068,0.941715812420595,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
11556,GO:0046070,1.00000000000681,0.795996667217734,0,4,dGTP metabolic process,BP,
4807,GO:0010999,1.00000000000681,0.921456489549936,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
11523,GO:0045993,1.00000000000681,0.921456489549936,0,1,negative regulation of translational initiation by iron,BP,
11955,GO:0046986,1.00000000000681,0.921456489549936,0,1,negative regulation of hemoglobin biosynthetic process,BP,
14869,GO:0070618,1.00000000000681,0.92917161074546,0,1,Grb2-Sos complex,CC,
8860,GO:0034648,1.00000000000682,0.693399281861527,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
13580,GO:0060023,1.00000000000682,0.720690337286437,0,4,soft palate development,BP,
8054,GO:0032701,1.00000000000683,0.871181900932217,0,2,negative regulation of interleukin-18 production,BP,
17109,GO:0099617,1.00000000000684,0.925972932505793,0,1,matrix side of mitochondrial inner membrane,CC,
3956,GO:0008670,1.00000000000684,0.892350175045966,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
8672,GO:0034235,1.00000000000685,0.696382161088413,0,5,GPI anchor binding,MF,
4826,GO:0014022,1.00000000000685,0.789233488154784,0,3,neural plate elongation,BP,
6564,GO:0022007,1.00000000000685,0.789233488154784,0,3,convergent extension involved in neural plate elongation,BP,
19141,GO:1905042,1.00000000000685,0.932250657656863,0,1,negative regulation of epithelium regeneration,BP,
12065,GO:0047915,1.00000000000686,0.939364280864523,0,1,ganglioside galactosyltransferase activity,MF,
6030,GO:0019086,1.00000000000687,0.752486422351621,0,4,late viral transcription,BP,
12400,GO:0048793,1.00000000000687,0.706858675973318,0,4,pronephros development,BP,
19,GO:0000035,1.00000000000687,0.930700360642692,0,2,acyl binding,MF,
20,GO:0000036,1.00000000000687,0.930700360642692,0,2,acyl carrier activity,MF,
4174,GO:0009245,1.00000000000687,0.930700360642692,0,2,lipid A biosynthetic process,BP,
10960,GO:0044620,1.00000000000687,0.930700360642692,0,2,ACP phosphopantetheine attachment site binding,MF,
11717,GO:0046493,1.00000000000687,0.930700360642692,0,2,lipid A metabolic process,BP,
12888,GO:0051192,1.00000000000687,0.930700360642692,0,2,prosthetic group binding,MF,
17627,GO:1901269,1.00000000000687,0.930700360642692,0,2,lipooligosaccharide metabolic process,BP,
17628,GO:1901271,1.00000000000687,0.930700360642692,0,2,lipooligosaccharide biosynthetic process,BP,
18132,GO:1902746,1.00000000000687,0.930897123052336,0,1,regulation of lens fiber cell differentiation,BP,
20065,GO:2000653,1.00000000000687,0.791061755566987,0,3,regulation of genetic imprinting,BP,
7351,GO:0031379,1.00000000000688,0.905277993161818,0,2,RNA-directed RNA polymerase complex,CC,
2476,GO:0005691,1.00000000000688,0.921867740523173,0,1,U6atac snRNP,CC,
6975,GO:0030624,1.00000000000688,0.921867740523173,0,1,U6atac snRNA binding,MF,
18506,GO:1903584,1.00000000000688,0.921867740523173,0,1,regulation of histone deubiquitination,BP,
18507,GO:1903586,1.00000000000688,0.921867740523173,0,1,positive regulation of histone deubiquitination,BP,
1888,GO:0004566,1.00000000000689,0.873950981309014,0,2,beta-glucuronidase activity,MF,
8201,GO:0032937,1.00000000000691,0.796542631749925,0,3,SREBP-SCAP-Insig complex,CC,
4328,GO:0009838,1.00000000000691,0.716978524461937,0,5,abscission,BP,
19971,GO:2000466,1.00000000000692,0.784532298869227,0,3,negative regulation of glycogen (starch) synthase activity,BP,
1784,GO:0004395,1.00000000000692,0.947962119487615,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3827,GO:0008425,1.00000000000692,0.947962119487615,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3957,GO:0008689,1.00000000000692,0.947962119487615,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4456,GO:0010420,1.00000000000692,0.947962119487615,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4654,GO:0010795,1.00000000000692,0.947962119487615,0,1,regulation of ubiquinone biosynthetic process,BP,
6958,GO:0030580,1.00000000000692,0.947962119487615,0,1,quinone cofactor methyltransferase activity,MF,
10946,GO:0044595,1.00000000000692,0.947962119487615,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10947,GO:0044596,1.00000000000692,0.947962119487615,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
13184,GO:0051750,1.00000000000692,0.947962119487615,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14363,GO:0061542,1.00000000000692,0.947962119487615,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
981,GO:0002432,1.00000000000693,0.921718285269379,0,1,granuloma formation,BP,
9412,GO:0035962,1.00000000000693,0.924218587216792,0,1,response to interleukin-13,BP,
9413,GO:0035963,1.00000000000693,0.924218587216792,0,1,cellular response to interleukin-13,BP,
12479,GO:0050277,1.00000000000693,0.924218587216792,0,1,sedoheptulokinase activity,MF,
15545,GO:0071914,1.00000000000693,0.924218587216792,0,1,prominosome,CC,
7348,GO:0031370,1.00000000000694,0.920093059200054,0,1,eukaryotic initiation factor 4G binding,MF,
518,GO:0001588,1.00000000000694,0.899613615845041,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
2142,GO:0004952,1.00000000000694,0.899613615845041,0,2,dopamine neurotransmitter receptor activity,MF,
9185,GO:0035546,1.00000000000694,0.693067292450651,0,4,interferon-beta secretion,BP,
9186,GO:0035547,1.00000000000694,0.693067292450651,0,4,regulation of interferon-beta secretion,BP,
9187,GO:0035549,1.00000000000694,0.693067292450651,0,4,positive regulation of interferon-beta secretion,BP,
3930,GO:0008609,1.00000000000694,0.904602905414053,0,1,alkylglycerone-phosphate synthase activity,MF,
8466,GO:0033597,1.00000000000694,0.933079853530931,0,1,mitotic checkpoint complex,CC,
19527,GO:1990298,1.00000000000694,0.933079853530931,0,1,bub1-bub3 complex,CC,
14637,GO:0070191,1.00000000000696,0.868262555157924,0,2,methionine-R-sulfoxide reductase activity,MF,
8356,GO:0033206,1.00000000000696,0.728916260056122,0,4,meiotic cytokinesis,BP,
750,GO:0001978,1.00000000000697,0.932798063976435,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
751,GO:0001983,1.00000000000697,0.932798063976435,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
752,GO:0001985,1.00000000000697,0.932798063976435,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
757,GO:0001994,1.00000000000697,0.932798063976435,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
759,GO:0001997,1.00000000000697,0.932798063976435,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1292,GO:0003099,1.00000000000697,0.932798063976435,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2134,GO:0004936,1.00000000000697,0.932798063976435,0,1,alpha-adrenergic receptor activity,MF,
2135,GO:0004937,1.00000000000697,0.932798063976435,0,1,alpha1-adrenergic receptor activity,MF,
18692,GO:1903995,1.00000000000697,0.932798063976435,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18693,GO:1903997,1.00000000000697,0.932798063976435,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
3922,GO:0008592,1.00000000000697,0.926606022946967,0,1,regulation of Toll signaling pathway,BP,
9918,GO:0042241,1.00000000000697,0.926606022946967,0,1,interleukin-18 biosynthetic process,BP,
11243,GO:0045381,1.00000000000697,0.926606022946967,0,1,regulation of interleukin-18 biosynthetic process,BP,
11397,GO:0045751,1.00000000000697,0.926606022946967,0,1,negative regulation of Toll signaling pathway,BP,
3832,GO:0008430,1.00000000000698,0.938071738678651,0,1,selenium binding,MF,
4527,GO:0010587,1.00000000000699,0.671800396754781,0,5,miRNA catabolic process,BP,
16999,GO:0099011,1.000000000007,0.841988978522902,0,2,neuronal dense core vesicle exocytosis,BP,
17069,GO:0099525,1.000000000007,0.841988978522902,0,2,presynaptic dense core vesicle exocytosis,BP,
18545,GO:1903691,1.00000000000701,0.809037388293263,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
5144,GO:0015669,1.00000000000701,0.818452931574336,0,3,gas transport,BP,
12261,GO:0048520,1.00000000000701,0.657133411348703,0,5,positive regulation of behavior,BP,
8090,GO:0032765,1.00000000000701,0.850409641681851,0,2,positive regulation of mast cell cytokine production,BP,
16769,GO:0098528,1.00000000000701,0.734855395020445,0,4,skeletal muscle fiber differentiation,BP,
13711,GO:0060235,1.00000000000702,0.738845934124201,0,3,lens induction in camera-type eye,BP,
14774,GO:0070435,1.00000000000702,0.861294937001826,0,2,Shc-EGFR complex,CC,
6044,GO:0019144,1.00000000000702,0.894392063993336,0,2,ADP-sugar diphosphatase activity,MF,
8550,GO:0033871,1.00000000000703,0.935405569399199,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
11942,GO:0046970,1.00000000000703,0.935405569399199,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
14322,GO:0061433,1.00000000000703,0.935405569399199,0,1,cellular response to caloric restriction,BP,
14778,GO:0070446,1.00000000000703,0.935405569399199,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
2728,GO:0006106,1.00000000000703,0.814316964297522,0,3,fumarate metabolic process,BP,
18223,GO:1902977,1.00000000000703,0.935715725659972,0,1,mitotic DNA replication preinitiation complex assembly,BP,
11066,GO:0045041,1.00000000000703,0.878010553523707,0,2,protein import into mitochondrial intermembrane space,BP,
9635,GO:0036493,1.00000000000703,0.79847720156814,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
6844,GO:0030305,1.00000000000704,0.937992638307292,0,1,heparanase activity,MF,
15908,GO:0072656,1.00000000000704,0.695873947050724,0,5,maintenance of protein location in mitochondrion,BP,
18332,GO:1903223,1.00000000000704,0.781076106800255,0,3,positive regulation of oxidative stress-induced neuron death,BP,
8095,GO:0032771,1.00000000000705,0.922313794249564,0,1,regulation of monophenol monooxygenase activity,BP,
8096,GO:0032773,1.00000000000705,0.922313794249564,0,1,positive regulation of monophenol monooxygenase activity,BP,
8182,GO:0032912,1.00000000000705,0.922313794249564,0,1,negative regulation of transforming growth factor beta2 production,BP,
12090,GO:0048023,1.00000000000705,0.922313794249564,0,1,positive regulation of melanin biosynthetic process,BP,
13209,GO:0051796,1.00000000000705,0.922313794249564,0,1,negative regulation of timing of catagen,BP,
14102,GO:0060901,1.00000000000705,0.922313794249564,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
18184,GO:1902908,1.00000000000705,0.922313794249564,0,1,regulation of melanosome transport,BP,
18185,GO:1902910,1.00000000000705,0.922313794249564,0,1,positive regulation of melanosome transport,BP,
9950,GO:0042296,1.00000000000705,0.777009074926313,0,4,ISG15 transferase activity,MF,
17052,GO:0099403,1.00000000000705,0.793318978583716,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17053,GO:0099404,1.00000000000705,0.793318978583716,0,2,mitotic sister chromatid cohesion, telomeric,BP,
19082,GO:1904907,1.00000000000705,0.793318978583716,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19083,GO:1904908,1.00000000000705,0.793318978583716,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
2789,GO:0006226,1.00000000000706,0.822922663418647,0,3,dUMP biosynthetic process,BP,
1192,GO:0002836,1.00000000000706,0.792116988616986,0,3,positive regulation of response to tumor cell,BP,
1195,GO:0002839,1.00000000000706,0.792116988616986,0,3,positive regulation of immune response to tumor cell,BP,
1569,GO:0003973,1.00000000000707,0.912976574251503,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
12029,GO:0047545,1.00000000000707,0.912976574251503,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
13170,GO:0051722,1.00000000000708,0.930546353411339,0,1,protein C-terminal methylesterase activity,MF,
13171,GO:0051723,1.00000000000708,0.930546353411339,0,1,protein methylesterase activity,MF,
5879,GO:0017198,1.00000000000709,0.957941869834157,0,1,N-terminal peptidyl-serine acetylation,BP,
5880,GO:0018002,1.00000000000709,0.957941869834157,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7123,GO:0030920,1.00000000000709,0.957941869834157,0,1,peptidyl-serine acetylation,BP,
14490,GO:0061850,1.00000000000709,0.957941869834157,0,1,growth cone leading edge,CC,
15565,GO:0071960,1.00000000000709,0.957941869834157,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19508,GO:1990190,1.00000000000709,0.957941869834157,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20104,GO:2000718,1.00000000000709,0.957941869834157,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20105,GO:2000719,1.00000000000709,0.957941869834157,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
3525,GO:0007501,1.00000000000709,0.793812267449781,0,3,mesodermal cell fate specification,BP,
10136,GO:0042661,1.00000000000709,0.793812267449781,0,3,regulation of mesodermal cell fate specification,BP,
19388,GO:1905770,1.00000000000709,0.793812267449781,0,3,regulation of mesodermal cell differentiation,BP,
19426,GO:1905902,1.00000000000709,0.793812267449781,0,3,regulation of mesoderm formation,BP,
2582,GO:0005873,1.0000000000071,0.779127519136095,0,3,plus-end kinesin complex,CC,
16428,GO:0097037,1.0000000000071,0.925809914821713,0,1,heme export,BP,
1464,GO:0003708,1.0000000000071,0.731180224642798,0,4,retinoic acid receptor activity,MF,
20164,GO:2000821,1.0000000000071,0.887005896085233,0,2,regulation of grooming behavior,BP,
18850,GO:1904396,1.00000000000711,0.746562360117741,0,3,regulation of neuromuscular junction development,BP,
8519,GO:0033691,1.00000000000711,0.836742036589933,0,2,sialic acid binding,MF,
14981,GO:0070860,1.00000000000711,0.931696875945866,0,1,RNA polymerase I core factor complex,CC,
2091,GO:0004853,1.00000000000712,0.945163849786102,0,1,uroporphyrinogen decarboxylase activity,MF,
12150,GO:0048213,1.00000000000712,0.928415918800965,0,1,Golgi vesicle prefusion complex stabilization,BP,
15122,GO:0071149,1.00000000000712,0.855771009303874,0,2,TEAD-2-YAP complex,CC,
1650,GO:0004092,1.00000000000712,0.928475036341561,0,1,carnitine O-acetyltransferase activity,MF,
3688,GO:0008193,1.00000000000715,0.874194609789056,0,2,tRNA guanylyltransferase activity,MF,
8580,GO:0034040,1.00000000000715,0.772309838167235,0,3,lipid-transporting ATPase activity,MF,
12010,GO:0047374,1.00000000000716,0.877387366156439,0,2,methylumbelliferyl-acetate deacetylase activity,MF,
3811,GO:0008398,1.00000000000716,0.927304050811657,0,1,sterol 14-demethylase activity,MF,
8426,GO:0033488,1.00000000000716,0.927304050811657,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
17700,GO:1901537,1.00000000000716,0.732584684352409,0,3,positive regulation of DNA demethylation,BP,
5548,GO:0016534,1.00000000000716,0.924178499006034,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
6391,GO:0021586,1.00000000000716,0.924178499006034,0,1,pons maturation,BP,
6440,GO:0021718,1.00000000000716,0.924178499006034,0,1,superior olivary nucleus development,BP,
6441,GO:0021722,1.00000000000716,0.924178499006034,0,1,superior olivary nucleus maturation,BP,
19334,GO:1905572,1.00000000000717,0.928411009236937,0,1,ganglioside GM1 transport to membrane,BP,
19336,GO:1905574,1.00000000000717,0.928411009236937,0,1,ganglioside GM2 binding,MF,
19337,GO:1905575,1.00000000000717,0.928411009236937,0,1,ganglioside GM3 binding,MF,
19339,GO:1905577,1.00000000000717,0.928411009236937,0,1,ganglioside GP1c binding,MF,
16784,GO:0098559,1.00000000000718,0.803998553923676,0,3,cytoplasmic side of early endosome membrane,CC,
3726,GO:0008254,1.00000000000719,0.906998293713555,0,1,3'-nucleotidase activity,MF,
3854,GO:0008466,1.00000000000719,0.93734584156918,0,1,glycogenin glucosyltransferase activity,MF,
17187,GO:0102751,1.00000000000719,0.93734584156918,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
2759,GO:0006168,1.0000000000072,0.850325834197042,0,3,adenine salvage,BP,
11564,GO:0046083,1.0000000000072,0.850325834197042,0,3,adenine metabolic process,BP,
11565,GO:0046084,1.0000000000072,0.850325834197042,0,3,adenine biosynthetic process,BP,
3213,GO:0006858,1.0000000000072,0.819715750264952,0,3,extracellular transport,BP,
8980,GO:0035063,1.00000000000721,0.924802667525321,0,1,nuclear speck organization,BP,
17739,GO:1901628,1.00000000000721,0.798317290781516,0,3,positive regulation of postsynaptic membrane organization,BP,
859,GO:0002184,1.00000000000722,0.842350748461866,0,2,cytoplasmic translational termination,BP,
13648,GO:0060123,1.00000000000723,0.689830395438689,0,4,regulation of growth hormone secretion,BP,
15281,GO:0071438,1.00000000000724,0.744756709857098,0,4,invadopodium membrane,CC,
18252,GO:1903027,1.00000000000724,0.90503781799724,0,1,regulation of opsonization,BP,
18253,GO:1903028,1.00000000000724,0.90503781799724,0,1,positive regulation of opsonization,BP,
5473,GO:0016403,1.00000000000725,0.874068296997722,0,2,dimethylargininase activity,MF,
3921,GO:0008591,1.00000000000725,0.937406099084257,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
10137,GO:0042662,1.00000000000725,0.937406099084257,0,1,negative regulation of mesodermal cell fate specification,BP,
11423,GO:0045813,1.00000000000725,0.937406099084257,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
14450,GO:0061743,1.00000000000725,0.937406099084257,0,1,motor learning,BP,
16118,GO:0090081,1.00000000000725,0.937406099084257,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16119,GO:0090082,1.00000000000725,0.937406099084257,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16305,GO:0090381,1.00000000000725,0.937406099084257,0,1,regulation of heart induction,BP,
16935,GO:0098883,1.00000000000725,0.937406099084257,0,1,synapse disassembly,BP,
17129,GO:0100012,1.00000000000725,0.937406099084257,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17633,GO:1901296,1.00000000000725,0.937406099084257,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17646,GO:1901321,1.00000000000725,0.937406099084257,0,1,positive regulation of heart induction,BP,
18973,GO:1904701,1.00000000000725,0.937406099084257,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18978,GO:1904711,1.00000000000725,0.937406099084257,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18988,GO:1904723,1.00000000000725,0.937406099084257,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
19154,GO:1905067,1.00000000000725,0.937406099084257,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19389,GO:1905771,1.00000000000725,0.937406099084257,0,1,negative regulation of mesodermal cell differentiation,BP,
19427,GO:1905903,1.00000000000725,0.937406099084257,0,1,negative regulation of mesoderm formation,BP,
10479,GO:0043335,1.00000000000725,0.874077034102297,0,2,protein unfolding,BP,
10871,GO:0044378,1.00000000000726,0.861042023065686,0,2,non-sequence-specific DNA binding, bending,MF,
2331,GO:0005344,1.00000000000726,0.935367424368402,0,1,oxygen carrier activity,MF,
12063,GO:0047888,1.00000000000726,0.935367424368402,0,1,fatty acid peroxidase activity,MF,
17457,GO:1900208,1.00000000000727,0.887512424020336,0,2,regulation of cardiolipin metabolic process,BP,
17458,GO:1900210,1.00000000000727,0.887512424020336,0,2,positive regulation of cardiolipin metabolic process,BP,
12272,GO:0048537,1.00000000000727,0.691004573130118,0,5,mucosal-associated lymphoid tissue development,BP,
12275,GO:0048541,1.00000000000727,0.691004573130118,0,5,Peyer's patch development,BP,
158,GO:0000320,1.00000000000728,0.850601789006457,0,2,re-entry into mitotic cell cycle,BP,
9477,GO:0036085,1.00000000000728,0.926722451130613,0,1,GDP-fucose import into Golgi lumen,BP,
10142,GO:0042670,1.00000000000728,0.793513136879013,0,3,retinal cone cell differentiation,BP,
11752,GO:0046549,1.00000000000728,0.793513136879013,0,3,retinal cone cell development,BP,
7917,GO:0032484,1.00000000000728,0.772238468366344,0,3,Ral protein signal transduction,BP,
7918,GO:0032485,1.00000000000728,0.772238468366344,0,3,regulation of Ral protein signal transduction,BP,
12992,GO:0051365,1.00000000000729,0.926282480471511,0,1,cellular response to potassium ion starvation,BP,
18049,GO:1902527,1.0000000000073,0.790564529828584,0,4,positive regulation of protein monoubiquitination,BP,
15112,GO:0071107,1.0000000000073,0.751953929318624,0,3,response to parathyroid hormone,BP,
7390,GO:0031437,1.00000000000731,0.795596530619685,0,3,regulation of mRNA cleavage,BP,
2010,GO:0004731,1.00000000000731,0.855680222064419,0,2,purine-nucleoside phosphorylase activity,MF,
12274,GO:0048539,1.00000000000732,0.740124263494491,0,4,bone marrow development,BP,
7071,GO:0030853,1.00000000000733,0.674262254454485,0,5,negative regulation of granulocyte differentiation,BP,
6351,GO:0021524,1.00000000000734,0.870941791135231,0,2,visceral motor neuron differentiation,BP,
15683,GO:0072185,1.00000000000734,0.931261480754591,0,1,metanephric cap development,BP,
15684,GO:0072186,1.00000000000734,0.931261480754591,0,1,metanephric cap morphogenesis,BP,
16130,GO:0090094,1.00000000000734,0.931261480754591,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16131,GO:0090095,1.00000000000734,0.931261480754591,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16132,GO:0090096,1.00000000000734,0.931261480754591,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
2175,GO:0005008,1.00000000000734,0.909960157285196,0,1,hepatocyte growth factor-activated receptor activity,MF,
9535,GO:0036250,1.00000000000734,0.935650372112635,0,1,peroxisome transport along microtubule,BP,
10973,GO:0044721,1.00000000000734,0.935650372112635,0,1,protein import into peroxisome matrix, substrate release,BP,
17538,GO:1900747,1.00000000000735,0.737654921367943,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18058,GO:1902548,1.00000000000735,0.737654921367943,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
8363,GO:0033227,1.00000000000735,0.802866874354149,0,3,dsRNA transport,BP,
2671,GO:0006021,1.00000000000736,0.737924819816654,0,4,inositol biosynthetic process,BP,
16211,GO:0090219,1.00000000000737,0.737843042391313,0,4,negative regulation of lipid kinase activity,BP,
522,GO:0001609,1.00000000000738,0.811744234281677,0,3,G-protein coupled adenosine receptor activity,MF,
3997,GO:0008894,1.00000000000738,0.928911125098864,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
3673,GO:0008172,1.00000000000738,0.679294313490277,0,5,S-methyltransferase activity,MF,
9529,GO:0036219,1.00000000000739,0.962961599255328,0,1,GTP diphosphatase activity,MF,
10968,GO:0044713,1.00000000000739,0.962961599255328,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10969,GO:0044714,1.00000000000739,0.962961599255328,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12044,GO:0047693,1.00000000000739,0.962961599255328,0,1,ATP diphosphatase activity,MF,
3998,GO:0008897,1.0000000000074,0.928284257627206,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
7976,GO:0032581,1.0000000000074,0.936779977289998,0,1,ER-dependent peroxisome organization,BP,
17245,GO:0106101,1.0000000000074,0.936779977289998,0,1,ER-dependent peroxisome localization,BP,
16374,GO:0090649,1.00000000000741,0.641858938204036,0,5,response to oxygen-glucose deprivation,BP,
16375,GO:0090650,1.00000000000741,0.641858938204036,0,5,cellular response to oxygen-glucose deprivation,BP,
4799,GO:0010989,1.00000000000741,0.798017523793617,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
19881,GO:2000319,1.00000000000741,0.709011974093041,0,5,regulation of T-helper 17 cell differentiation,BP,
15003,GO:0070898,1.00000000000742,0.887048526444201,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16304,GO:0090370,1.00000000000743,0.92217241083595,0,1,negative regulation of cholesterol efflux,BP,
5219,GO:0015819,1.00000000000743,0.936184277882792,0,1,lysine transport,BP,
19070,GO:1904885,1.00000000000743,0.642396262922721,0,5,beta-catenin destruction complex assembly,BP,
1854,GO:0004514,1.00000000000743,0.804994513911872,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
1737,GO:0004332,1.00000000000743,0.885385123368348,0,2,fructose-bisphosphate aldolase activity,MF,
12468,GO:0050152,1.00000000000743,0.947748484048594,0,1,omega-amidase activity,MF,
14810,GO:0070510,1.00000000000744,0.907496543901698,0,1,regulation of histone H4-K20 methylation,BP,
14811,GO:0070512,1.00000000000744,0.907496543901698,0,1,positive regulation of histone H4-K20 methylation,BP,
16438,GO:0097056,1.00000000000744,0.751318452912249,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
8059,GO:0032714,1.00000000000744,0.856153244399773,0,2,negative regulation of interleukin-5 production,BP,
1520,GO:0003878,1.00000000000744,0.921981408838818,0,1,ATP citrate synthase activity,MF,
4211,GO:0009346,1.00000000000744,0.921981408838818,0,1,citrate lyase complex,CC,
8171,GO:0032898,1.00000000000745,0.789819808994203,0,3,neurotrophin production,BP,
16783,GO:0098556,1.00000000000747,0.828456969009652,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
6113,GO:0019353,1.00000000000748,0.929058746024842,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8437,GO:0033526,1.00000000000748,0.929058746024842,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
15434,GO:0071680,1.00000000000748,0.661534097994088,0,5,response to indole-3-methanol,BP,
15435,GO:0071681,1.00000000000748,0.661534097994088,0,5,cellular response to indole-3-methanol,BP,
6018,GO:0019065,1.00000000000749,0.79215509447727,0,3,receptor-mediated endocytosis of virus by host cell,BP,
15972,GO:0075509,1.00000000000749,0.79215509447727,0,3,endocytosis involved in viral entry into host cell,BP,
5976,GO:0018444,1.0000000000075,0.779001176814347,0,3,translation release factor complex,CC,
11979,GO:0047159,1.0000000000075,0.923760298001365,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11984,GO:0047191,1.0000000000075,0.923760298001365,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
20312,GO:2001246,1.0000000000075,0.923760298001365,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
17972,GO:1902296,1.0000000000075,0.926392298550975,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17985,GO:1902319,1.0000000000075,0.926392298550975,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
18224,GO:1902983,1.0000000000075,0.926392298550975,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
6485,GO:0021825,1.00000000000751,0.70885007010938,0,4,substrate-dependent cerebral cortex tangential migration,BP,
8873,GO:0034666,1.00000000000751,0.774588120994784,0,3,integrin alpha2-beta1 complex,CC,
2094,GO:0004856,1.00000000000752,0.924784993694836,0,1,xylulokinase activity,MF,
2656,GO:0005998,1.00000000000752,0.924784993694836,0,1,xylulose catabolic process,BP,
12279,GO:0048549,1.00000000000752,0.72772022586368,0,4,positive regulation of pinocytosis,BP,
14761,GO:0070418,1.00000000000753,0.917912902879185,0,1,DNA-dependent protein kinase complex,CC,
6360,GO:0021538,1.00000000000754,0.925431560199309,0,1,epithalamus development,BP,
6557,GO:0021986,1.00000000000754,0.925431560199309,0,1,habenula development,BP,
13233,GO:0051866,1.00000000000754,0.925431560199309,0,1,general adaptation syndrome,BP,
6146,GO:0019418,1.00000000000754,0.805829045004997,0,4,sulfide oxidation,BP,
14655,GO:0070221,1.00000000000754,0.805829045004997,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
16526,GO:0097208,1.00000000000754,0.701846071917773,0,5,alveolar lamellar body,CC,
19941,GO:2000402,1.00000000000755,0.783778778413863,0,3,negative regulation of lymphocyte migration,BP,
15987,GO:0080058,1.00000000000755,0.945787079300011,0,1,protein deglutathionylation,BP,
16688,GO:0097573,1.00000000000755,0.945787079300011,0,1,glutathione oxidoreductase activity,MF,
15869,GO:0072566,1.00000000000755,0.869190515201529,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
19895,GO:2000338,1.00000000000755,0.869190515201529,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19896,GO:2000340,1.00000000000755,0.869190515201529,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
7910,GO:0032474,1.00000000000756,0.790157828821871,0,3,otolith morphogenesis,BP,
17,GO:0000032,1.00000000000756,0.937851394583318,0,1,cell wall mannoprotein biosynthetic process,BP,
1826,GO:0004476,1.00000000000756,0.937851394583318,0,1,mannose-6-phosphate isomerase activity,MF,
2693,GO:0006056,1.00000000000756,0.937851394583318,0,1,mannoprotein metabolic process,BP,
2694,GO:0006057,1.00000000000756,0.937851394583318,0,1,mannoprotein biosynthetic process,BP,
7421,GO:0031506,1.00000000000756,0.937851394583318,0,1,cell wall glycoprotein biosynthetic process,BP,
10070,GO:0042546,1.00000000000756,0.937851394583318,0,1,cell wall biogenesis,BP,
10729,GO:0044038,1.00000000000756,0.937851394583318,0,1,cell wall macromolecule biosynthetic process,BP,
14388,GO:0061611,1.00000000000756,0.937851394583318,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14860,GO:0070589,1.00000000000756,0.937851394583318,0,1,cellular component macromolecule biosynthetic process,BP,
13140,GO:0051660,1.00000000000756,0.720532374393675,0,4,establishment of centrosome localization,BP,
1999,GO:0004719,1.00000000000757,0.800227490737623,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
6850,GO:0030312,1.00000000000758,0.93220646668781,0,1,external encapsulating structure,CC,
9337,GO:0035805,1.00000000000758,0.93220646668781,0,1,egg coat,CC,
16801,GO:0098595,1.00000000000758,0.93220646668781,0,1,perivitelline space,CC,
12032,GO:0047578,1.00000000000758,0.93060800479441,0,1,4-hydroxyglutamate transaminase activity,MF,
10163,GO:0042732,1.00000000000759,0.887316506286469,0,2,D-xylose metabolic process,BP,
16537,GO:0097227,1.0000000000076,0.72863000039646,0,4,sperm annulus,CC,
1433,GO:0003404,1.0000000000076,0.926351539075847,0,1,optic vesicle morphogenesis,BP,
1437,GO:0003409,1.0000000000076,0.926351539075847,0,1,optic cup structural organization,BP,
6406,GO:0021622,1.0000000000076,0.926351539075847,0,1,oculomotor nerve morphogenesis,BP,
6407,GO:0021623,1.0000000000076,0.926351539075847,0,1,oculomotor nerve formation,BP,
14626,GO:0070172,1.0000000000076,0.926351539075847,0,1,positive regulation of tooth mineralization,BP,
14775,GO:0070436,1.00000000000761,0.85430003455931,0,2,Grb2-EGFR complex,CC,
16703,GO:0097629,1.00000000000763,0.686600161189444,0,5,extrinsic component of omegasome membrane,CC,
16541,GO:0097232,1.00000000000763,0.926189488622082,0,1,lamellar body membrane,CC,
16542,GO:0097233,1.00000000000763,0.926189488622082,0,1,alveolar lamellar body membrane,CC,
3420,GO:0007207,1.00000000000763,0.866895353779154,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
15208,GO:0071332,1.00000000000766,0.871124774971244,0,2,cellular response to fructose stimulus,BP,
4084,GO:0009137,1.00000000000767,0.757330177900525,0,4,purine nucleoside diphosphate catabolic process,BP,
4123,GO:0009181,1.00000000000767,0.757330177900525,0,4,purine ribonucleoside diphosphate catabolic process,BP,
14776,GO:0070444,1.00000000000767,0.729411719365391,0,4,oligodendrocyte progenitor proliferation,BP,
14777,GO:0070445,1.00000000000767,0.729411719365391,0,4,regulation of oligodendrocyte progenitor proliferation,BP,
18528,GO:1903644,1.00000000000767,0.899876970021739,0,2,regulation of chaperone-mediated protein folding,BP,
18573,GO:1903756,1.00000000000767,0.857409393410979,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18574,GO:1903758,1.00000000000767,0.857409393410979,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
6356,GO:0021534,1.00000000000768,0.655488699871321,0,5,cell proliferation in hindbrain,BP,
6531,GO:0021924,1.00000000000768,0.655488699871321,0,5,cell proliferation in external granule layer,BP,
6532,GO:0021930,1.00000000000768,0.655488699871321,0,5,cerebellar granule cell precursor proliferation,BP,
4252,GO:0009450,1.00000000000769,0.843879055119502,0,2,gamma-aminobutyric acid catabolic process,BP,
17874,GO:1902037,1.00000000000769,0.801316838227494,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
3130,GO:0006713,1.0000000000077,0.937619210210533,0,1,glucocorticoid catabolic process,BP,
14280,GO:0061314,1.0000000000077,0.626880402576561,0,5,Notch signaling involved in heart development,BP,
7719,GO:0032203,1.0000000000077,0.936608747875224,0,1,telomere formation via telomerase,BP,
14003,GO:0060694,1.0000000000077,0.936608747875224,0,1,regulation of cholesterol transporter activity,BP,
15770,GO:0072343,1.0000000000077,0.936608747875224,0,1,pancreatic stellate cell proliferation,BP,
17707,GO:1901558,1.0000000000077,0.936608747875224,0,1,response to metformin,BP,
19332,GO:1905563,1.0000000000077,0.936608747875224,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19827,GO:2000229,1.0000000000077,0.936608747875224,0,1,regulation of pancreatic stellate cell proliferation,BP,
19828,GO:2000230,1.0000000000077,0.936608747875224,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
8286,GO:0033082,1.00000000000771,0.919245231726113,0,1,regulation of extrathymic T cell differentiation,BP,
19616,GO:1990654,1.00000000000771,0.919245231726113,0,1,sebum secreting cell proliferation,BP,
19980,GO:2000483,1.00000000000771,0.70560213221827,0,5,negative regulation of interleukin-8 secretion,BP,
15063,GO:0070991,1.00000000000774,0.799689026174618,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
4956,GO:0015018,1.00000000000774,0.944016316524029,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
8500,GO:0033650,1.00000000000776,0.938183241657986,0,1,host cell mitochondrion,CC,
10767,GO:0044190,1.00000000000776,0.938183241657986,0,1,host cell mitochondrial envelope,CC,
15820,GO:0072492,1.00000000000776,0.938183241657986,0,1,host cell mitochondrial intermembrane space,CC,
5500,GO:0016435,1.00000000000777,0.769687407683657,0,4,rRNA (guanine) methyltransferase activity,MF,
10605,GO:0043564,1.00000000000778,0.863935044369963,0,2,Ku70:Ku80 complex,CC,
954,GO:0002370,1.00000000000778,0.815280464325318,0,3,natural killer cell cytokine production,BP,
1138,GO:0002727,1.00000000000778,0.815280464325318,0,3,regulation of natural killer cell cytokine production,BP,
14460,GO:0061763,1.00000000000778,0.862697018923159,0,2,multivesicular body-lysosome fusion,BP,
9974,GO:0042351,1.00000000000779,0.888432509158062,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
16157,GO:0090149,1.0000000000078,0.858022418831413,0,2,mitochondrial membrane fission,BP,
3493,GO:0007387,1.0000000000078,0.929045436021706,0,1,anterior compartment pattern formation,BP,
3494,GO:0007388,1.0000000000078,0.929045436021706,0,1,posterior compartment specification,BP,
13296,GO:0051964,1.00000000000781,0.713047796492172,0,4,negative regulation of synapse assembly,BP,
5165,GO:0015705,1.00000000000781,0.705233284246723,0,4,iodide transport,BP,
2229,GO:0005129,1.00000000000782,0.961003036320248,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
8570,GO:0034021,1.00000000000782,0.961003036320248,0,1,response to silicon dioxide,BP,
2557,GO:0005833,1.00000000000783,0.927697380183824,0,1,hemoglobin complex,CC,
8544,GO:0033862,1.00000000000783,0.927697380183824,0,1,UMP kinase activity,MF,
8634,GO:0034144,1.00000000000784,0.731355728780927,0,4,negative regulation of toll-like receptor 4 signaling pathway,BP,
14914,GO:0070701,1.00000000000785,0.899462777023615,0,1,mucus layer,CC,
14915,GO:0070702,1.00000000000785,0.899462777023615,0,1,inner mucus layer,CC,
14916,GO:0070703,1.00000000000785,0.899462777023615,0,1,outer mucus layer,CC,
16956,GO:0098914,1.00000000000785,0.835419231356188,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
17112,GO:0099624,1.00000000000785,0.835419231356188,0,2,atrial cardiac muscle cell membrane repolarization,BP,
9237,GO:0035617,1.00000000000785,0.79276248618091,0,3,stress granule disassembly,BP,
15524,GO:0071879,1.00000000000785,0.78108286749625,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
960,GO:0002378,1.00000000000786,0.921463607238335,0,1,immunoglobulin biosynthetic process,BP,
18955,GO:1904672,1.00000000000786,0.728972648453791,0,4,regulation of somatic stem cell population maintenance,BP,
18825,GO:1904339,1.00000000000787,0.907636378545607,0,1,negative regulation of dopaminergic neuron differentiation,BP,
1598,GO:0004013,1.00000000000787,0.790325145169725,0,3,adenosylhomocysteinase activity,MF,
5689,GO:0016802,1.00000000000787,0.790325145169725,0,3,trialkylsulfonium hydrolase activity,MF,
1633,GO:0004069,1.00000000000788,0.868546094421555,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2987,GO:0006532,1.00000000000788,0.868546094421555,0,2,aspartate biosynthetic process,BP,
2988,GO:0006533,1.00000000000788,0.868546094421555,0,2,aspartate catabolic process,BP,
6182,GO:0019550,1.00000000000788,0.868546094421555,0,2,glutamate catabolic process to aspartate,BP,
6183,GO:0019551,1.00000000000788,0.868546094421555,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
11735,GO:0046523,1.00000000000788,0.927166723371174,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
15008,GO:0070903,1.00000000000788,0.935129013941741,0,1,mitochondrial tRNA thio-modification,BP,
14948,GO:0070813,1.00000000000789,0.711607723362028,0,5,hydrogen sulfide metabolic process,BP,
13,GO:0000026,1.00000000000789,0.788008271474997,0,3,alpha-1,2-mannosyltransferase activity,MF,
7815,GO:0032361,1.00000000000789,0.934727730954963,0,1,pyridoxal phosphate catabolic process,BP,
10215,GO:0042820,1.00000000000789,0.934727730954963,0,1,vitamin B6 catabolic process,BP,
15624,GO:0072092,1.0000000000079,0.798538206463303,0,2,ureteric bud invasion,BP,
15933,GO:0072687,1.00000000000791,0.719257294525601,0,4,meiotic spindle,CC,
17317,GO:0140066,1.00000000000792,0.832414004432995,0,2,peptidyl-lysine crotonylation,BP,
8407,GO:0033328,1.00000000000793,0.925100531824526,0,1,peroxisome membrane targeting sequence binding,MF,
9484,GO:0036105,1.00000000000793,0.925100531824526,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
17421,GO:1900130,1.00000000000793,0.925100531824526,0,1,regulation of lipid binding,BP,
17422,GO:1900131,1.00000000000793,0.925100531824526,0,1,negative regulation of lipid binding,BP,
845,GO:0002155,1.00000000000793,0.788992690116431,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
13710,GO:0060232,1.00000000000794,0.74854025191568,0,4,delamination,BP,
24,GO:0000048,1.00000000000794,0.931234742116096,0,1,peptidyltransferase activity,MF,
1253,GO:0002951,1.00000000000794,0.931234742116096,0,1,leukotriene-C(4) hydrolase,MF,
19147,GO:1905051,1.00000000000795,0.899670628806641,0,2,regulation of base-excision repair,BP,
19148,GO:1905053,1.00000000000795,0.899670628806641,0,2,positive regulation of base-excision repair,BP,
14433,GO:0061711,1.00000000000796,0.877326185668887,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
17150,GO:0102148,1.00000000000796,0.812099250812153,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
2040,GO:0004778,1.00000000000797,0.940322228098589,0,1,succinyl-CoA hydrolase activity,MF,
8109,GO:0032788,1.00000000000797,0.940322228098589,0,1,saturated monocarboxylic acid metabolic process,BP,
8110,GO:0032789,1.00000000000797,0.940322228098589,0,1,unsaturated monocarboxylic acid metabolic process,BP,
19596,GO:1990578,1.00000000000797,0.914520318895295,0,1,perinuclear endoplasmic reticulum membrane,CC,
20085,GO:2000675,1.00000000000798,0.730999735578614,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
12172,GO:0048264,1.00000000000798,0.927597631318402,0,1,determination of ventral identity,BP,
20316,GO:2001253,1.00000000000798,0.927597631318402,0,1,regulation of histone H3-K36 trimethylation,BP,
1658,GO:0004109,1.00000000000799,0.864267186691518,0,2,coproporphyrinogen oxidase activity,MF,
2532,GO:0005787,1.00000000000799,0.740270038903214,0,5,signal peptidase complex,CC,
14161,GO:0061009,1.00000000000799,0.811709355856212,0,3,common bile duct development,BP,
1541,GO:0003923,1.00000000000799,0.697089847643232,0,5,GPI-anchor transamidase activity,MF,
10185,GO:0042765,1.00000000000799,0.697089847643232,0,5,GPI-anchor transamidase complex,CC,
4212,GO:0009353,1.000000000008,0.94655926897368,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7435,GO:0031531,1.000000000008,0.94655926897368,0,1,thyrotropin-releasing hormone receptor binding,MF,
11167,GO:0045208,1.00000000000801,0.925290429076644,0,1,MAPK phosphatase export from nucleus,BP,
11168,GO:0045209,1.00000000000801,0.925290429076644,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
14552,GO:0070050,1.00000000000802,0.74280915364305,0,4,neuron cellular homeostasis,BP,
4886,GO:0014802,1.00000000000802,0.766555145299942,0,3,terminal cisterna,CC,
4994,GO:0015127,1.00000000000803,0.918420883582839,0,1,bilirubin transmembrane transporter activity,MF,
5158,GO:0015694,1.00000000000803,0.918420883582839,0,1,mercury ion transport,BP,
5173,GO:0015723,1.00000000000803,0.918420883582839,0,1,bilirubin transport,BP,
6985,GO:0030653,1.00000000000803,0.918420883582839,0,1,beta-lactam antibiotic metabolic process,BP,
9961,GO:0042316,1.00000000000803,0.918420883582839,0,1,penicillin metabolic process,BP,
17572,GO:1901086,1.00000000000803,0.918420883582839,0,1,benzylpenicillin metabolic process,BP,
19984,GO:2000491,1.00000000000803,0.926886362470691,0,1,positive regulation of hepatic stellate cell activation,BP,
11933,GO:0046958,1.00000000000804,0.926482345236348,0,1,nonassociative learning,BP,
6401,GO:0021604,1.00000000000804,0.674267537416367,0,5,cranial nerve structural organization,BP,
6403,GO:0021612,1.00000000000804,0.674267537416367,0,5,facial nerve structural organization,BP,
15004,GO:0070899,1.00000000000804,0.927615694408908,0,1,mitochondrial tRNA wobble uridine modification,BP,
15871,GO:0072570,1.00000000000805,0.926595675491678,0,1,ADP-D-ribose binding,MF,
15859,GO:0072554,1.00000000000806,0.931288332207686,0,1,blood vessel lumenization,BP,
17599,GO:1901189,1.00000000000806,0.931288332207686,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17634,GO:1901297,1.00000000000806,0.931288332207686,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19155,GO:1905068,1.00000000000806,0.931288332207686,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
16957,GO:0098915,1.00000000000806,0.787578503339146,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
9162,GO:0035508,1.00000000000806,0.915638026473912,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
853,GO:0002176,1.00000000000808,0.849901514077268,0,3,male germ cell proliferation,BP,
9482,GO:0036093,1.00000000000808,0.849901514077268,0,3,germ cell proliferation,BP,
13574,GO:0060017,1.00000000000808,0.676661104679388,0,5,parathyroid gland development,BP,
8753,GO:0034395,1.00000000000808,0.941793740383625,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
7295,GO:0031282,1.00000000000809,0.736762762221737,0,4,regulation of guanylate cyclase activity,BP,
7296,GO:0031284,1.00000000000809,0.736762762221737,0,4,positive regulation of guanylate cyclase activity,BP,
10623,GO:0043602,1.0000000000081,0.930227927181438,0,1,nitrate catabolic process,BP,
11619,GO:0046210,1.0000000000081,0.930227927181438,0,1,nitric oxide catabolic process,BP,
12049,GO:0047726,1.0000000000081,0.930227927181438,0,1,iron-cytochrome-c reductase activity,MF,
16297,GO:0090345,1.0000000000081,0.930227927181438,0,1,cellular organohalogen metabolic process,BP,
16298,GO:0090346,1.0000000000081,0.930227927181438,0,1,cellular organofluorine metabolic process,BP,
1524,GO:0003883,1.00000000000811,0.857383393827269,0,2,CTP synthase activity,MF,
10774,GO:0044210,1.00000000000811,0.857383393827269,0,2,'de novo' CTP biosynthetic process,BP,
493,GO:0001545,1.00000000000811,0.923332059366905,0,1,primary ovarian follicle growth,BP,
15253,GO:0071393,1.00000000000811,0.923332059366905,0,1,cellular response to progesterone stimulus,BP,
5380,GO:0016191,1.00000000000811,0.711701104523271,0,4,synaptic vesicle uncoating,BP,
790,GO:0002051,1.00000000000813,0.697599633136556,0,4,osteoblast fate commitment,BP,
15424,GO:0071670,1.00000000000813,0.706509163555127,0,5,smooth muscle cell chemotaxis,BP,
18395,GO:1903365,1.00000000000813,0.801921223363768,0,3,regulation of fear response,BP,
20165,GO:2000822,1.00000000000813,0.801921223363768,0,3,regulation of behavioral fear response,BP,
2239,GO:0005143,1.00000000000813,0.857526632403207,0,2,interleukin-12 receptor binding,MF,
13702,GO:0060215,1.00000000000814,0.674910902069268,0,5,primitive hemopoiesis,BP,
10271,GO:0043000,1.00000000000815,0.869228289467315,0,2,Golgi to plasma membrane CFTR protein transport,BP,
4633,GO:0010752,1.00000000000815,0.843223675367484,0,2,regulation of cGMP-mediated signaling,BP,
6471,GO:0021797,1.00000000000815,0.925954986439814,0,1,forebrain anterior/posterior pattern specification,BP,
6510,GO:0021881,1.00000000000815,0.925954986439814,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
12203,GO:0048320,1.00000000000815,0.925954986439814,0,1,axial mesoderm formation,BP,
14073,GO:0060823,1.00000000000815,0.925954986439814,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
1961,GO:0004662,1.00000000000815,0.873933401786012,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2628,GO:0005953,1.00000000000815,0.873933401786012,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
17147,GO:0102121,1.00000000000815,0.863253661814237,0,2,ceramidase activity,MF,
169,GO:0000350,1.00000000000816,0.821941264968761,0,3,generation of catalytic spliceosome for second transesterification step,BP,
13989,GO:0060676,1.00000000000816,0.76354841131075,0,4,ureteric bud formation,BP,
15673,GO:0072172,1.00000000000816,0.76354841131075,0,4,mesonephric tubule formation,BP,
13730,GO:0060267,1.00000000000816,0.804648122624913,0,3,positive regulation of respiratory burst,BP,
16951,GO:0098908,1.00000000000816,0.858244002000377,0,2,regulation of neuronal action potential,BP,
338,GO:0000938,1.00000000000818,0.724357011741859,0,4,GARP complex,CC,
9106,GO:0035368,1.00000000000818,0.736457252303412,0,4,selenocysteine insertion sequence binding,MF,
14344,GO:0061485,1.00000000000818,0.90557295212612,0,1,memory T cell proliferation,BP,
20052,GO:2000638,1.0000000000082,0.85899204686688,0,2,regulation of SREBP signaling pathway,BP,
20053,GO:2000639,1.0000000000082,0.85899204686688,0,2,negative regulation of SREBP signaling pathway,BP,
17840,GO:1901963,1.0000000000082,0.868174894353638,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
8041,GO:0032681,1.00000000000821,0.929024194192321,0,1,regulation of lymphotoxin A production,BP,
8086,GO:0032761,1.00000000000821,0.929024194192321,0,1,positive regulation of lymphotoxin A production,BP,
10283,GO:0043016,1.00000000000821,0.929024194192321,0,1,regulation of lymphotoxin A biosynthetic process,BP,
10284,GO:0043017,1.00000000000821,0.929024194192321,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11248,GO:0045404,1.00000000000821,0.929024194192321,0,1,positive regulation of interleukin-4 biosynthetic process,BP,
15863,GO:0072558,1.00000000000822,0.836085149701991,0,3,NLRP1 inflammasome complex,CC,
2681,GO:0006041,1.00000000000823,0.752969827337164,0,4,glucosamine metabolic process,BP,
15360,GO:0071566,1.00000000000824,0.927876698062645,0,1,UFM1 activating enzyme activity,MF,
4096,GO:0009149,1.00000000000824,0.891142748709412,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4152,GO:0009213,1.00000000000824,0.891142748709412,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7963,GO:0032556,1.00000000000824,0.891142748709412,0,2,pyrimidine deoxyribonucleotide binding,MF,
11018,GO:0044828,1.00000000000824,0.720503954117678,0,4,negative regulation by host of viral genome replication,BP,
9819,GO:0040038,1.00000000000824,0.849315670429356,0,2,polar body extrusion after meiotic divisions,BP,
14885,GO:0070649,1.00000000000824,0.849315670429356,0,2,formin-nucleated actin cable assembly,BP,
17248,GO:0110009,1.00000000000824,0.849315670429356,0,2,formin-nucleated actin cable organization,BP,
13536,GO:0055087,1.00000000000826,0.804308040405688,0,3,Ski complex,CC,
1343,GO:0003199,1.00000000000826,0.942177387426854,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
4827,GO:0014028,1.00000000000826,0.942177387426854,0,1,notochord formation,BP,
9488,GO:0036114,1.00000000000826,0.942177387426854,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9489,GO:0036115,1.00000000000826,0.942177387426854,0,1,fatty-acyl-CoA catabolic process,BP,
9490,GO:0036116,1.00000000000826,0.942177387426854,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
17521,GO:1900533,1.00000000000826,0.942177387426854,0,1,palmitic acid metabolic process,BP,
17522,GO:1900535,1.00000000000826,0.942177387426854,0,1,palmitic acid biosynthetic process,BP,
13027,GO:0051434,1.00000000000826,0.762992885454429,0,4,BH3 domain binding,MF,
8923,GO:0034756,1.00000000000827,0.804384940811297,0,3,regulation of iron ion transport,BP,
9176,GO:0035523,1.00000000000827,0.711190125722831,0,4,protein K29-linked deubiquitination,BP,
4780,GO:0010963,1.00000000000828,0.943825709248235,0,1,regulation of L-arginine import,BP,
15033,GO:0070947,1.00000000000828,0.943825709248235,0,1,neutrophil mediated killing of fungus,BP,
15038,GO:0070953,1.00000000000828,0.943825709248235,0,1,regulation of neutrophil mediated killing of fungus,BP,
15043,GO:0070965,1.00000000000828,0.943825709248235,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
20006,GO:2000552,1.00000000000828,0.943825709248235,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
12226,GO:0048389,1.00000000000829,0.93771160315749,0,1,intermediate mesoderm development,BP,
12227,GO:0048390,1.00000000000829,0.93771160315749,0,1,intermediate mesoderm morphogenesis,BP,
12228,GO:0048391,1.00000000000829,0.93771160315749,0,1,intermediate mesoderm formation,BP,
12229,GO:0048392,1.00000000000829,0.93771160315749,0,1,intermediate mesodermal cell differentiation,BP,
13502,GO:0055018,1.00000000000829,0.93771160315749,0,1,regulation of cardiac muscle fiber development,BP,
13503,GO:0055020,1.00000000000829,0.93771160315749,0,1,positive regulation of cardiac muscle fiber development,BP,
13898,GO:0060503,1.00000000000829,0.93771160315749,0,1,bud dilation involved in lung branching,BP,
14233,GO:0061149,1.00000000000829,0.93771160315749,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14234,GO:0061150,1.00000000000829,0.93771160315749,0,1,renal system segmentation,BP,
14235,GO:0061151,1.00000000000829,0.93771160315749,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14239,GO:0061155,1.00000000000829,0.93771160315749,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14261,GO:0061216,1.00000000000829,0.93771160315749,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14264,GO:0061227,1.00000000000829,0.93771160315749,0,1,pattern specification involved in mesonephros development,BP,
15531,GO:0071893,1.00000000000829,0.93771160315749,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15627,GO:0072096,1.00000000000829,0.93771160315749,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15628,GO:0072097,1.00000000000829,0.93771160315749,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15629,GO:0072098,1.00000000000829,0.93771160315749,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15630,GO:0072099,1.00000000000829,0.93771160315749,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15631,GO:0072100,1.00000000000829,0.93771160315749,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15632,GO:0072101,1.00000000000829,0.93771160315749,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15688,GO:0072192,1.00000000000829,0.93771160315749,0,1,ureter epithelial cell differentiation,BP,
15692,GO:0072198,1.00000000000829,0.93771160315749,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15693,GO:0072199,1.00000000000829,0.93771160315749,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15694,GO:0072200,1.00000000000829,0.93771160315749,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
17841,GO:1901964,1.00000000000829,0.93771160315749,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19716,GO:2000004,1.00000000000829,0.93771160315749,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19717,GO:2000005,1.00000000000829,0.93771160315749,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19718,GO:2000006,1.00000000000829,0.93771160315749,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19719,GO:2000007,1.00000000000829,0.93771160315749,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
14949,GO:0070814,1.00000000000829,0.744578487751721,0,4,hydrogen sulfide biosynthetic process,BP,
17528,GO:1900623,1.00000000000829,0.780800127215574,0,3,regulation of monocyte aggregation,BP,
17529,GO:1900625,1.00000000000829,0.780800127215574,0,3,positive regulation of monocyte aggregation,BP,
7881,GO:0032437,1.0000000000083,0.774966769490377,0,3,cuticular plate,CC,
19222,GO:1905277,1.0000000000083,0.927337004000919,0,1,negative regulation of epithelial tube formation,BP,
20032,GO:2000606,1.0000000000083,0.927337004000919,0,1,regulation of cell proliferation involved in mesonephros development,BP,
20033,GO:2000607,1.0000000000083,0.927337004000919,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20097,GO:2000699,1.0000000000083,0.927337004000919,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20098,GO:2000701,1.0000000000083,0.927337004000919,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20099,GO:2000702,1.0000000000083,0.927337004000919,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20100,GO:2000703,1.0000000000083,0.927337004000919,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20112,GO:2000733,1.0000000000083,0.927337004000919,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20113,GO:2000734,1.0000000000083,0.927337004000919,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
1842,GO:0004494,1.0000000000083,0.927807343503744,0,1,methylmalonyl-CoA mutase activity,MF,
1390,GO:0003294,1.00000000000831,0.859327854098996,0,2,atrial ventricular junction remodeling,BP,
4566,GO:0010645,1.00000000000831,0.859327854098996,0,2,regulation of cell communication by chemical coupling,BP,
4572,GO:0010652,1.00000000000831,0.859327854098996,0,2,positive regulation of cell communication by chemical coupling,BP,
12061,GO:0047860,1.00000000000832,0.947819571576998,0,1,diiodophenylpyruvate reductase activity,MF,
1273,GO:0003057,1.00000000000832,0.806572156511076,0,3,regulation of the force of heart contraction by chemical signal,BP,
5557,GO:0016560,1.00000000000832,0.739145344417757,0,4,protein import into peroxisome matrix, docking,BP,
6431,GO:0021694,1.00000000000833,0.595571497867233,0,5,cerebellar Purkinje cell layer formation,BP,
6438,GO:0021702,1.00000000000833,0.595571497867233,0,5,cerebellar Purkinje cell differentiation,BP,
15784,GO:0072362,1.00000000000835,0.90316537975021,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
1852,GO:0004512,1.00000000000836,0.932066874997447,0,1,inositol-3-phosphate synthase activity,MF,
5731,GO:0016872,1.00000000000836,0.932066874997447,0,1,intramolecular lyase activity,MF,
3804,GO:0008381,1.00000000000836,0.794499848009753,0,3,mechanosensitive ion channel activity,MF,
8130,GO:0032810,1.00000000000836,0.865313862963849,0,2,sterol response element binding,MF,
8078,GO:0032747,1.00000000000836,0.82662870402578,0,3,positive regulation of interleukin-23 production,BP,
17497,GO:1900369,1.00000000000837,0.889850851060733,0,2,negative regulation of RNA interference,BP,
1641,GO:0004081,1.00000000000837,0.887068887835607,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
3978,GO:0008796,1.00000000000837,0.887068887835607,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
14633,GO:0070183,1.00000000000838,0.92849234997728,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
3092,GO:0006666,1.00000000000838,0.917770742282171,0,1,3-keto-sphinganine metabolic process,BP,
12031,GO:0047560,1.00000000000838,0.917770742282171,0,1,3-dehydrosphinganine reductase activity,MF,
18511,GO:1903593,1.00000000000838,0.831985231770745,0,3,regulation of histamine secretion by mast cell,BP,
18512,GO:1903595,1.00000000000838,0.831985231770745,0,3,positive regulation of histamine secretion by mast cell,BP,
14093,GO:0060857,1.00000000000839,0.931946970770078,0,1,establishment of glial blood-brain barrier,BP,
17592,GO:1901164,1.0000000000084,0.850087048374118,0,3,negative regulation of trophoblast cell migration,BP,
12488,GO:0050337,1.00000000000841,0.966924814842182,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
1422,GO:0003363,1.00000000000844,0.913581561668338,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
6412,GO:0021644,1.00000000000844,0.942048816141267,0,1,vagus nerve morphogenesis,BP,
3353,GO:0007089,1.00000000000844,0.731274437892594,0,4,traversing start control point of mitotic cell cycle,BP,
11281,GO:0045542,1.00000000000844,0.673061646281545,0,5,positive regulation of cholesterol biosynthetic process,BP,
3219,GO:0006868,1.00000000000846,0.736723811115573,0,4,glutamine transport,BP,
5025,GO:0015186,1.00000000000846,0.736723811115573,0,4,L-glutamine transmembrane transporter activity,MF,
7297,GO:0031289,1.00000000000848,0.927427597903676,0,1,actin phosphorylation,BP,
10585,GO:0043538,1.00000000000848,0.927427597903676,0,1,regulation of actin phosphorylation,BP,
7916,GO:0032483,1.00000000000848,0.717981204070308,0,4,regulation of Rab protein signal transduction,BP,
321,GO:0000839,1.0000000000085,0.79411807185893,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
16397,GO:0090722,1.0000000000085,0.832466115661746,0,2,receptor-receptor interaction,MF,
19049,GO:1904849,1.0000000000085,0.832466115661746,0,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20004,GO:2000546,1.0000000000085,0.832466115661746,0,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
4736,GO:0010898,1.00000000000851,0.856333746698381,0,2,positive regulation of triglyceride catabolic process,BP,
1889,GO:0004567,1.00000000000852,0.926266272486242,0,1,beta-mannosidase activity,MF,
4455,GO:0010412,1.00000000000852,0.926266272486242,0,1,mannan metabolic process,BP,
11654,GO:0046355,1.00000000000852,0.926266272486242,0,1,mannan catabolic process,BP,
8472,GO:0033603,1.00000000000854,0.81972990330586,0,3,positive regulation of dopamine secretion,BP,
11131,GO:0045142,1.00000000000855,0.850544406892047,0,2,triplex DNA binding,MF,
191,GO:0000408,1.00000000000855,0.732363416060472,0,5,EKC/KEOPS complex,CC,
7475,GO:0031628,1.00000000000856,0.721531447559214,0,4,opioid receptor binding,MF,
7554,GO:0031852,1.00000000000856,0.721531447559214,0,4,mu-type opioid receptor binding,MF,
9782,GO:0039552,1.00000000000856,0.916179892186772,0,1,RIG-I binding,MF,
4564,GO:0010643,1.00000000000856,0.79709804892884,0,3,cell communication by chemical coupling,BP,
5841,GO:0017125,1.00000000000857,0.920100557415218,0,1,deoxycytidyl transferase activity,MF,
6311,GO:0019948,1.00000000000857,0.864673832153627,0,2,SUMO activating enzyme activity,MF,
19352,GO:1905602,1.00000000000858,0.872386732292167,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
18130,GO:1902744,1.00000000000858,0.713820039925419,0,4,negative regulation of lamellipodium organization,BP,
2627,GO:0005952,1.00000000000858,0.686289455707663,0,5,cAMP-dependent protein kinase complex,CC,
3616,GO:0008065,1.00000000000858,0.854743517094313,0,2,establishment of blood-nerve barrier,BP,
861,GO:0002189,1.00000000000858,0.930046685867333,0,1,ribose phosphate diphosphokinase complex,CC,
19814,GO:2000199,1.00000000000858,0.927199265906432,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19815,GO:2000200,1.00000000000858,0.927199265906432,0,1,regulation of ribosomal subunit export from nucleus,BP,
19816,GO:2000202,1.00000000000858,0.927199265906432,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19817,GO:2000206,1.00000000000858,0.927199265906432,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19818,GO:2000208,1.00000000000858,0.927199265906432,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
8181,GO:0032911,1.00000000000859,0.788502824942428,0,3,negative regulation of transforming growth factor beta1 production,BP,
7408,GO:0031466,1.0000000000086,0.767153912801682,0,4,Cul5-RING ubiquitin ligase complex,CC,
10510,GO:0043402,1.0000000000086,0.74012579849966,0,3,glucocorticoid mediated signaling pathway,BP,
12334,GO:0048669,1.00000000000861,0.800456810678943,0,3,collateral sprouting in absence of injury,BP,
3916,GO:0008579,1.00000000000862,0.917331907903955,0,1,JUN kinase phosphatase activity,MF,
4895,GO:0014819,1.00000000000864,0.740461289845002,0,5,regulation of skeletal muscle contraction,BP,
9094,GO:0035339,1.00000000000864,0.772078177268537,0,4,SPOTS complex,CC,
447,GO:0001206,1.00000000000865,0.623005203394302,0,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1891,GO:0004569,1.00000000000866,0.920964805692213,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
3970,GO:0008761,1.00000000000866,0.917247024718238,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4219,GO:0009384,1.00000000000866,0.917247024718238,0,1,N-acylmannosamine kinase activity,MF,
513,GO:0001576,1.00000000000869,0.933744065992901,0,1,globoside biosynthetic process,BP,
1553,GO:0003948,1.00000000000869,0.933744065992901,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12514,GO:0050512,1.00000000000869,0.933744065992901,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
16319,GO:0090409,1.00000000000869,0.93184582674884,0,1,malonyl-CoA synthetase activity,MF,
16320,GO:0090410,1.00000000000869,0.93184582674884,0,1,malonate catabolic process,BP,
19610,GO:1990622,1.00000000000869,0.89432656131705,0,2,CHOP-ATF3 complex,CC,
17154,GO:0102200,1.0000000000087,0.917712737423859,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
16285,GO:0090326,1.0000000000087,0.926375982296134,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
18154,GO:1902823,1.0000000000087,0.926375982296134,0,1,negative regulation of late endosome to lysosome transport,BP,
18382,GO:1903336,1.0000000000087,0.926375982296134,0,1,negative regulation of vacuolar transport,BP,
19892,GO:2000331,1.0000000000087,0.926375982296134,0,1,regulation of terminal button organization,BP,
2171,GO:0005004,1.00000000000871,0.911582744996743,0,1,GPI-linked ephrin receptor activity,MF,
13274,GO:0051933,1.00000000000871,0.911582744996743,0,1,amino acid neurotransmitter reuptake,BP,
13276,GO:0051935,1.00000000000871,0.911582744996743,0,1,glutamate reuptake,BP,
13280,GO:0051941,1.00000000000871,0.911582744996743,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13283,GO:0051946,1.00000000000871,0.911582744996743,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
16493,GO:0097156,1.00000000000871,0.911582744996743,0,1,fasciculation of motor neuron axon,BP,
16497,GO:0097161,1.00000000000871,0.911582744996743,0,1,DH domain binding,MF,
18883,GO:1904477,1.00000000000871,0.911582744996743,0,1,positive regulation of Ras GTPase binding,BP,
19166,GO:1905099,1.00000000000871,0.911582744996743,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20240,GO:2001108,1.00000000000871,0.911582744996743,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
1887,GO:0004565,1.00000000000871,0.744631063186532,0,4,beta-galactosidase activity,MF,
1625,GO:0004056,1.00000000000871,0.934835583895733,0,1,argininosuccinate lyase activity,MF,
10029,GO:0042450,1.00000000000871,0.934835583895733,0,1,arginine biosynthetic process via ornithine,BP,
16945,GO:0098902,1.00000000000872,0.666239134985912,0,5,regulation of membrane depolarization during action potential,BP,
16076,GO:0089700,1.00000000000872,0.783659480034137,0,3,protein kinase D signaling,BP,
2008,GO:0004729,1.00000000000872,0.93830370089816,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
14952,GO:0070818,1.00000000000872,0.93830370089816,0,1,protoporphyrinogen oxidase activity,MF,
4224,GO:0009397,1.00000000000874,0.798239064138763,0,3,folic acid-containing compound catabolic process,BP,
10077,GO:0042560,1.00000000000874,0.798239064138763,0,3,pteridine-containing compound catabolic process,BP,
3959,GO:0008705,1.00000000000875,0.889679876501915,0,1,methionine synthase activity,MF,
9851,GO:0042084,1.00000000000875,0.889679876501915,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
4352,GO:0009918,1.00000000000875,0.929350252037407,0,1,sterol delta7 reductase activity,MF,
5126,GO:0015499,1.00000000000875,0.929350252037407,0,1,formate transmembrane transporter activity,MF,
5142,GO:0015660,1.00000000000875,0.929350252037407,0,1,formate efflux transmembrane transporter activity,MF,
5174,GO:0015724,1.00000000000875,0.929350252037407,0,1,formate transport,BP,
5202,GO:0015797,1.00000000000875,0.929350252037407,0,1,mannitol transport,BP,
5362,GO:0016131,1.00000000000875,0.929350252037407,0,1,brassinosteroid metabolic process,BP,
5363,GO:0016132,1.00000000000875,0.929350252037407,0,1,brassinosteroid biosynthetic process,BP,
11841,GO:0046724,1.00000000000875,0.929350252037407,0,1,oxalic acid secretion,BP,
12033,GO:0047598,1.00000000000875,0.929350252037407,0,1,7-dehydrocholesterol reductase activity,MF,
9695,GO:0038064,1.00000000000875,0.835028176646548,0,2,collagen receptor activity,MF,
1501,GO:0003844,1.00000000000875,0.92715156914088,0,1,1,4-alpha-glucan branching enzyme activity,MF,
17188,GO:0102752,1.00000000000875,0.92715156914088,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
7067,GO:0030849,1.00000000000875,0.918075730460507,0,1,autosome,CC,
11982,GO:0047184,1.00000000000876,0.691460405915301,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
6571,GO:0022027,1.00000000000876,0.653656835717403,0,4,interkinetic nuclear migration,BP,
12834,GO:0051120,1.00000000000877,0.862551044652688,0,2,hepoxilin A3 synthase activity,MF,
6107,GO:0019336,1.00000000000877,0.697591963391365,0,5,phenol-containing compound catabolic process,BP,
6189,GO:0019614,1.00000000000877,0.697591963391365,0,5,catechol-containing compound catabolic process,BP,
10016,GO:0042424,1.00000000000877,0.697591963391365,0,5,catecholamine catabolic process,BP,
19859,GO:2000286,1.00000000000878,0.798889764686732,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
6343,GO:0021514,1.00000000000881,0.691046306616533,0,4,ventral spinal cord interneuron differentiation,BP,
1605,GO:0004021,1.00000000000881,0.923887280240429,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
2979,GO:0006522,1.00000000000881,0.923887280240429,0,1,alanine metabolic process,BP,
2980,GO:0006524,1.00000000000881,0.923887280240429,0,1,alanine catabolic process,BP,
4043,GO:0009078,1.00000000000881,0.923887280240429,0,1,pyruvate family amino acid metabolic process,BP,
4044,GO:0009080,1.00000000000881,0.923887280240429,0,1,pyruvate family amino acid catabolic process,BP,
10227,GO:0042851,1.00000000000881,0.923887280240429,0,1,L-alanine metabolic process,BP,
10228,GO:0042853,1.00000000000881,0.923887280240429,0,1,L-alanine catabolic process,BP,
12039,GO:0047635,1.00000000000881,0.923887280240429,0,1,alanine-oxo-acid transaminase activity,MF,
14014,GO:0060708,1.00000000000882,0.813317365484433,0,3,spongiotrophoblast differentiation,BP,
3848,GO:0008456,1.00000000000883,0.924659120637281,0,1,alpha-N-acetylgalactosaminidase activity,MF,
9098,GO:0035354,1.00000000000883,0.925960966890441,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9720,GO:0038123,1.00000000000883,0.925960966890441,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10052,GO:0042495,1.00000000000883,0.925960966890441,0,1,detection of triacyl bacterial lipopeptide,BP,
10054,GO:0042497,1.00000000000883,0.925960966890441,0,1,triacyl lipopeptide binding,MF,
15460,GO:0071725,1.00000000000883,0.925960966890441,0,1,response to triacyl bacterial lipopeptide,BP,
15462,GO:0071727,1.00000000000883,0.925960966890441,0,1,cellular response to triacyl bacterial lipopeptide,BP,
14255,GO:0061198,1.00000000000883,0.786601146714232,0,3,fungiform papilla formation,BP,
1626,GO:0004057,1.00000000000884,0.932494068364423,0,1,arginyltransferase activity,MF,
159,GO:0000322,1.00000000000884,0.80833044217169,0,3,storage vacuole,CC,
844,GO:0002154,1.00000000000884,0.644601684064023,0,5,thyroid hormone mediated signaling pathway,BP,
1492,GO:0003827,1.00000000000884,0.861487643393134,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1663,GO:0004115,1.00000000000884,0.65498145734372,0,5,3',5'-cyclic-AMP phosphodiesterase activity,MF,
12043,GO:0047685,1.00000000000885,0.942658030950596,0,1,amine sulfotransferase activity,MF,
20231,GO:2001054,1.00000000000886,0.685862272722739,0,5,negative regulation of mesenchymal cell apoptotic process,BP,
10637,GO:0043625,1.00000000000887,0.769528835385747,0,4,delta DNA polymerase complex,CC,
17141,GO:0102008,1.00000000000887,0.918753427145608,0,1,cytosolic dipeptidase activity,MF,
17202,GO:0103046,1.00000000000887,0.918753427145608,0,1,alanylglutamate dipeptidase activity,MF,
1182,GO:0002826,1.00000000000888,0.794865345514518,0,3,negative regulation of T-helper 1 type immune response,BP,
4953,GO:0015014,1.00000000000889,0.713363371810575,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13496,GO:0055011,1.00000000000889,0.939073277605345,0,1,atrial cardiac muscle cell differentiation,BP,
13499,GO:0055014,1.00000000000889,0.939073277605345,0,1,atrial cardiac muscle cell development,BP,
11985,GO:0047192,1.0000000000089,0.792471861044953,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12133,GO:0048170,1.0000000000089,0.721561117711231,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
4019,GO:0009032,1.00000000000891,0.939730786389219,0,1,thymidine phosphorylase activity,MF,
5368,GO:0016154,1.00000000000891,0.939730786389219,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
7442,GO:0031547,1.00000000000891,0.836681234645401,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
2023,GO:0004750,1.00000000000892,0.931762670911766,0,1,ribulose-phosphate 3-epimerase activity,MF,
13517,GO:0055059,1.00000000000892,0.718199953313555,0,4,asymmetric neuroblast division,BP,
16698,GO:0097621,1.00000000000892,0.931762670911766,0,1,monoamine oxidase activity,MF,
13203,GO:0051790,1.00000000000892,0.756165995627936,0,4,short-chain fatty acid biosynthetic process,BP,
43,GO:0000095,1.00000000000892,0.932375855403341,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
5209,GO:0015805,1.00000000000892,0.932375855403341,0,1,S-adenosyl-L-methionine transport,BP,
17839,GO:1901962,1.00000000000892,0.932375855403341,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
14250,GO:0061187,1.00000000000892,0.837229378209519,0,2,regulation of chromatin silencing at rDNA,BP,
14251,GO:0061188,1.00000000000892,0.837229378209519,0,2,negative regulation of chromatin silencing at rDNA,BP,
18603,GO:1903818,1.00000000000892,0.73400858952847,0,3,positive regulation of voltage-gated potassium channel activity,BP,
14630,GO:0070180,1.00000000000893,0.967110838755401,0,1,large ribosomal subunit rRNA binding,MF,
14791,GO:0070476,1.00000000000893,0.967110838755401,0,1,rRNA (guanine-N7)-methylation,BP,
9241,GO:0035623,1.00000000000894,0.926597744371017,0,1,renal glucose absorption,BP,
3941,GO:0008626,1.00000000000894,0.80161201458218,0,3,granzyme-mediated apoptotic signaling pathway,BP,
8553,GO:0033878,1.00000000000896,0.924338400927792,0,1,hormone-sensitive lipase activity,MF,
19614,GO:1990641,1.00000000000896,0.861941827623915,0,2,response to iron ion starvation,BP,
9758,GO:0039019,1.00000000000897,0.847204937120647,0,2,pronephric nephron development,BP,
10888,GO:0044416,1.00000000000897,0.879588097331758,0,2,induction by symbiont of host defense response,BP,
11844,GO:0046730,1.00000000000897,0.879588097331758,0,2,induction of host immune response by virus,BP,
11845,GO:0046732,1.00000000000897,0.879588097331758,0,2,active induction of host immune response by virus,BP,
13351,GO:0052251,1.00000000000897,0.879588097331758,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13379,GO:0052509,1.00000000000897,0.879588097331758,0,2,positive regulation by symbiont of host defense response,BP,
13380,GO:0052510,1.00000000000897,0.879588097331758,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
4955,GO:0015016,1.00000000000897,0.833697583628,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
12461,GO:0050119,1.00000000000897,0.833697583628,0,2,N-acetylglucosamine deacetylase activity,MF,
9655,GO:0036515,1.00000000000897,0.683766531011029,0,4,serotonergic neuron axon guidance,BP,
15583,GO:0072014,1.00000000000898,0.711557224530047,0,4,proximal tubule development,BP,
15439,GO:0071691,1.000000000009,0.908497590797376,0,1,cardiac muscle thin filament assembly,BP,
15787,GO:0072365,1.000000000009,0.899517048458008,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
1986,GO:0004703,1.00000000000901,0.862741463412099,0,2,G-protein coupled receptor kinase activity,MF,
12045,GO:0047696,1.00000000000901,0.862741463412099,0,2,beta-adrenergic receptor kinase activity,MF,
16658,GO:0097500,1.00000000000902,0.787051341845062,0,3,receptor localization to non-motile cilium,BP,
13430,GO:0052794,1.00000000000902,0.867507286984779,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13431,GO:0052795,1.00000000000902,0.867507286984779,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13432,GO:0052796,1.00000000000902,0.867507286984779,0,2,exo-alpha-(2->8)-sialidase activity,MF,
474,GO:0001517,1.00000000000903,0.660905366667957,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
19324,GO:1905538,1.00000000000903,0.854534456106916,0,2,polysome binding,MF,
1685,GO:0004148,1.00000000000903,0.925216020929213,0,1,dihydrolipoyl dehydrogenase activity,MF,
10360,GO:0043159,1.00000000000903,0.925216020929213,0,1,acrosomal matrix,CC,
10590,GO:0043544,1.00000000000903,0.925216020929213,0,1,lipoamide binding,MF,
12805,GO:0051068,1.00000000000903,0.925216020929213,0,1,dihydrolipoamide metabolic process,BP,
1327,GO:0003175,1.00000000000903,0.696067738616633,0,4,tricuspid valve development,BP,
1335,GO:0003186,1.00000000000903,0.696067738616633,0,4,tricuspid valve morphogenesis,BP,
16462,GO:0097105,1.00000000000903,0.698498270978507,0,4,presynaptic membrane assembly,BP,
1950,GO:0004651,1.00000000000904,0.86621645157472,0,2,polynucleotide 5'-phosphatase activity,MF,
16765,GO:0098507,1.00000000000904,0.86621645157472,0,2,polynucleotide 5' dephosphorylation,BP,
9795,GO:0039713,1.00000000000904,0.925792085133595,0,1,viral factory,CC,
9796,GO:0039714,1.00000000000904,0.925792085133595,0,1,cytoplasmic viral factory,CC,
15834,GO:0072517,1.00000000000904,0.925792085133595,0,1,host cell viral assembly compartment,CC,
17492,GO:1900276,1.00000000000904,0.925792085133595,0,1,regulation of proteinase activated receptor activity,BP,
17531,GO:1900736,1.00000000000904,0.925792085133595,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17532,GO:1900737,1.00000000000904,0.925792085133595,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
13188,GO:0051766,1.00000000000904,0.677179703046389,0,5,inositol trisphosphate kinase activity,MF,
8017,GO:0032641,1.00000000000904,0.861376936404209,0,2,lymphotoxin A production,BP,
9869,GO:0042109,1.00000000000904,0.861376936404209,0,2,lymphotoxin A biosynthetic process,BP,
16899,GO:0098814,1.00000000000904,0.686279953657602,0,5,spontaneous synaptic transmission,BP,
15571,GO:0071987,1.00000000000905,0.71868486678564,0,4,WD40-repeat domain binding,MF,
3608,GO:0008049,1.00000000000905,0.935914145004715,0,1,male courtship behavior,BP,
3852,GO:0008460,1.00000000000905,0.935914145004715,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
16416,GO:0097016,1.00000000000906,0.844858900447731,0,2,L27 domain binding,MF,
16843,GO:0098705,1.00000000000906,0.919962810164948,0,1,copper ion import across plasma membrane,BP,
15633,GO:0072102,1.00000000000907,0.777430730711604,0,3,glomerulus morphogenesis,BP,
16742,GO:0097724,1.00000000000908,0.937012060441106,0,1,sperm flagellum movement,BP,
19281,GO:1905419,1.00000000000908,0.937012060441106,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
19361,GO:1905643,1.00000000000908,0.913686055860127,0,1,positive regulation of DNA methylation,BP,
20163,GO:2000820,1.00000000000908,0.913686055860127,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20244,GO:2001136,1.00000000000908,0.926153230501381,0,1,negative regulation of endocytic recycling,BP,
8635,GO:0034145,1.00000000000908,0.697605146571283,0,5,positive regulation of toll-like receptor 4 signaling pathway,BP,
4227,GO:0009403,1.00000000000909,0.690258293110687,0,5,toxin biosynthetic process,BP,
4967,GO:0015057,1.00000000000909,0.798175542359387,0,3,thrombin-activated receptor activity,MF,
10182,GO:0042760,1.00000000000909,0.692826916607461,0,5,very long-chain fatty acid catabolic process,BP,
18531,GO:1903650,1.0000000000091,0.911675461831189,0,2,negative regulation of cytoplasmic transport,BP,
20055,GO:2000642,1.0000000000091,0.911675461831189,0,2,negative regulation of early endosome to late endosome transport,BP,
9547,GO:0036290,1.00000000000911,0.923473556054022,0,1,protein trans-autophosphorylation,BP,
17967,GO:1902283,1.00000000000911,0.923473556054022,0,1,negative regulation of primary amine oxidase activity,BP,
19530,GO:1990332,1.00000000000911,0.923473556054022,0,1,Ire1 complex,CC,
19597,GO:1990579,1.00000000000911,0.923473556054022,0,1,peptidyl-serine trans-autophosphorylation,BP,
19611,GO:1990630,1.00000000000911,0.923473556054022,0,1,IRE1-RACK1-PP2A complex,CC,
11005,GO:0044795,1.00000000000911,0.950661231950861,0,1,trans-Golgi network to recycling endosome transport,BP,
13632,GO:0060083,1.00000000000912,0.841785787050463,0,2,smooth muscle contraction involved in micturition,BP,
388,GO:0001032,1.00000000000912,0.717300642517269,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
5767,GO:0016936,1.00000000000912,0.878552123577104,0,2,galactoside binding,MF,
17685,GO:1901492,1.00000000000913,0.851725558351894,0,2,positive regulation of lymphangiogenesis,BP,
19025,GO:1904798,1.00000000000915,0.747630944956663,0,4,positive regulation of core promoter binding,BP,
8266,GO:0033037,1.00000000000916,0.914845366718436,0,1,polysaccharide localization,BP,
3983,GO:0008817,1.00000000000916,0.922968367818697,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
1617,GO:0004043,1.00000000000917,0.925306099158613,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
3980,GO:0008802,1.00000000000917,0.925306099158613,0,1,betaine-aldehyde dehydrogenase activity,MF,
6096,GO:0019285,1.00000000000917,0.925306099158613,0,1,glycine betaine biosynthetic process from choline,BP,
7400,GO:0031455,1.00000000000917,0.925306099158613,0,1,glycine betaine metabolic process,BP,
7401,GO:0031456,1.00000000000917,0.925306099158613,0,1,glycine betaine biosynthetic process,BP,
8599,GO:0034092,1.00000000000917,0.75994460073685,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8649,GO:0034183,1.00000000000917,0.75994460073685,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
527,GO:0001635,1.00000000000917,0.817269560580604,0,3,calcitonin gene-related peptide receptor activity,MF,
16713,GO:0097642,1.00000000000917,0.817269560580604,0,3,calcitonin family receptor activity,MF,
956,GO:0002373,1.00000000000918,0.956453354972422,0,1,plasmacytoid dendritic cell cytokine production,BP,
1144,GO:0002736,1.00000000000918,0.956453354972422,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1145,GO:0002737,1.00000000000918,0.956453354972422,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
17619,GO:1901253,1.00000000000918,0.956453354972422,0,1,negative regulation of intracellular transport of viral material,BP,
19370,GO:1905671,1.00000000000919,0.800376101389029,0,3,regulation of lysosome organization,BP,
15010,GO:0070905,1.00000000000919,0.868644783387714,0,2,serine binding,MF,
5007,GO:0015152,1.0000000000092,0.933553348396586,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
7634,GO:0032028,1.0000000000092,0.933553348396586,0,1,myosin head/neck binding,MF,
18706,GO:1904026,1.0000000000092,0.863225571867593,0,2,regulation of collagen fibril organization,BP,
2036,GO:0004774,1.0000000000092,0.819822797210538,0,3,succinate-CoA ligase activity,MF,
7122,GO:0030917,1.00000000000922,0.721213055959536,0,4,midbrain-hindbrain boundary development,BP,
17605,GO:1901207,1.00000000000922,0.923665378121095,0,1,regulation of heart looping,BP,
18577,GO:1903762,1.00000000000922,0.923665378121095,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18668,GO:1903947,1.00000000000922,0.923665378121095,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18670,GO:1903952,1.00000000000922,0.923665378121095,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18671,GO:1903954,1.00000000000922,0.923665378121095,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19131,GO:1905026,1.00000000000922,0.923665378121095,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19133,GO:1905033,1.00000000000922,0.923665378121095,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
12307,GO:0048625,1.00000000000923,0.789462048156346,0,3,myoblast fate commitment,BP,
3823,GO:0008419,1.00000000000923,0.92936979515834,0,1,RNA lariat debranching enzyme activity,MF,
6679,GO:0030037,1.00000000000924,0.918954938629195,0,1,actin filament reorganization involved in cell cycle,BP,
11105,GO:0045092,1.00000000000925,0.925149466286844,0,1,interleukin-18 receptor complex,CC,
1136,GO:0002725,1.00000000000925,0.818639317265195,0,3,negative regulation of T cell cytokine production,BP,
17673,GO:1901386,1.00000000000927,0.698736429136328,0,5,negative regulation of voltage-gated calcium channel activity,BP,
16456,GO:0097091,1.00000000000927,0.710111557876691,0,4,synaptic vesicle clustering,BP,
11464,GO:0045900,1.00000000000928,0.739872543249713,0,4,negative regulation of translational elongation,BP,
20288,GO:2001206,1.0000000000093,0.804554236648018,0,3,positive regulation of osteoclast development,BP,
8708,GO:0034338,1.00000000000932,0.778660318299844,0,3,short-chain carboxylesterase activity,MF,
3617,GO:0008066,1.00000000000934,0.715995694610704,0,4,glutamate receptor activity,MF,
15087,GO:0071031,1.00000000000935,0.886927377137955,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15099,GO:0071049,1.00000000000935,0.886927377137955,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
14281,GO:0061316,1.00000000000935,0.808248250257444,0,3,canonical Wnt signaling pathway involved in heart development,BP,
4304,GO:0009750,1.00000000000936,0.747072227838114,0,4,response to fructose,BP,
5303,GO:0015990,1.00000000000936,0.960738978511503,0,1,electron transport coupled proton transport,BP,
5432,GO:0016286,1.00000000000938,0.930231157234623,0,1,small conductance calcium-activated potassium channel activity,MF,
103,GO:0000214,1.00000000000938,0.763427426528614,0,4,tRNA-intron endonuclease complex,CC,
1295,GO:0003105,1.00000000000938,0.825702742442411,0,3,negative regulation of glomerular filtration,BP,
9239,GO:0035621,1.00000000000938,0.857064113509148,0,2,ER to Golgi ceramide transport,BP,
5871,GO:0017177,1.00000000000938,0.923952420258224,0,1,glucosidase II complex,CC,
8559,GO:0033919,1.00000000000938,0.923952420258224,0,1,glucan 1,3-alpha-glucosidase activity,MF,
16363,GO:0090600,1.00000000000938,0.923952420258224,0,1,alpha-1,3-glucosidase activity,MF,
11268,GO:0045485,1.00000000000939,0.921694833128718,0,1,omega-6 fatty acid desaturase activity,MF,
8806,GO:0034499,1.00000000000939,0.83554444327906,0,2,late endosome to Golgi transport,BP,
19808,GO:2000192,1.0000000000094,0.649718210682631,0,5,negative regulation of fatty acid transport,BP,
5975,GO:0018423,1.00000000000943,0.879166736628225,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
7559,GO:0031870,1.00000000000943,0.913083584261786,0,1,thromboxane A2 receptor binding,MF,
12513,GO:0050510,1.00000000000943,0.730533342480598,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
18863,GO:1904428,1.00000000000943,0.771599696598215,0,3,negative regulation of tubulin deacetylation,BP,
3926,GO:0008597,1.00000000000943,0.874262165561941,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
146,GO:0000298,1.00000000000944,0.757401800403174,0,4,endopolyphosphatase activity,MF,
3867,GO:0008486,1.00000000000944,0.757401800403174,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
5296,GO:0015961,1.00000000000944,0.757401800403174,0,4,diadenosine polyphosphate catabolic process,BP,
8767,GO:0034431,1.00000000000944,0.757401800403174,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8768,GO:0034432,1.00000000000944,0.757401800403174,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
13306,GO:0051977,1.00000000000944,0.932731549627105,0,1,lysophospholipid transport,BP,
13307,GO:0051978,1.00000000000944,0.932731549627105,0,1,lysophospholipid transporter activity,MF,
13456,GO:0052840,1.00000000000944,0.757401800403174,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13457,GO:0052841,1.00000000000944,0.757401800403174,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13458,GO:0052842,1.00000000000944,0.757401800403174,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13459,GO:0052843,1.00000000000944,0.757401800403174,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13460,GO:0052844,1.00000000000944,0.757401800403174,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13461,GO:0052845,1.00000000000944,0.757401800403174,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13462,GO:0052846,1.00000000000944,0.757401800403174,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13463,GO:0052847,1.00000000000944,0.757401800403174,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13464,GO:0052848,1.00000000000944,0.757401800403174,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
15343,GO:0071543,1.00000000000944,0.757401800403174,0,4,diphosphoinositol polyphosphate metabolic process,BP,
17830,GO:1901906,1.00000000000944,0.757401800403174,0,4,diadenosine pentaphosphate metabolic process,BP,
17831,GO:1901907,1.00000000000944,0.757401800403174,0,4,diadenosine pentaphosphate catabolic process,BP,
17832,GO:1901908,1.00000000000944,0.757401800403174,0,4,diadenosine hexaphosphate metabolic process,BP,
17833,GO:1901909,1.00000000000944,0.757401800403174,0,4,diadenosine hexaphosphate catabolic process,BP,
17834,GO:1901910,1.00000000000944,0.757401800403174,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17835,GO:1901911,1.00000000000944,0.757401800403174,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
11350,GO:0045659,1.00000000000944,0.850662419234655,0,2,negative regulation of neutrophil differentiation,BP,
20068,GO:2000656,1.00000000000945,0.936307944685507,0,1,regulation of apolipoprotein binding,BP,
20069,GO:2000657,1.00000000000945,0.936307944685507,0,1,negative regulation of apolipoprotein binding,BP,
19559,GO:1990425,1.00000000000946,0.744740814332992,0,3,ryanodine receptor complex,CC,
9897,GO:0042166,1.00000000000947,0.736240961297035,0,4,acetylcholine binding,MF,
19014,GO:1904778,1.00000000000948,0.659629764669222,0,5,positive regulation of protein localization to cell cortex,BP,
8535,GO:0033768,1.00000000000948,0.860467387873765,0,2,SUMO-targeted ubiquitin ligase complex,CC,
8995,GO:0035095,1.00000000000948,0.707466489940109,0,4,behavioral response to nicotine,BP,
8288,GO:0033084,1.00000000000948,0.862816406690602,0,2,regulation of immature T cell proliferation in thymus,BP,
8291,GO:0033088,1.00000000000948,0.862816406690602,0,2,negative regulation of immature T cell proliferation in thymus,BP,
16868,GO:0098758,1.00000000000948,0.862534922292975,0,2,response to interleukin-8,BP,
16869,GO:0098759,1.00000000000948,0.862534922292975,0,2,cellular response to interleukin-8,BP,
16144,GO:0090118,1.00000000000949,0.660390184242234,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
9685,GO:0038039,1.00000000000949,0.921946683142704,0,1,G-protein coupled receptor heterodimeric complex,CC,
5587,GO:0016602,1.00000000000949,0.750600982740003,0,4,CCAAT-binding factor complex,CC,
5508,GO:0016453,1.00000000000949,0.767056796244475,0,4,C-acetyltransferase activity,MF,
4663,GO:0010808,1.0000000000095,0.911348254055842,0,1,positive regulation of synaptic vesicle priming,BP,
10826,GO:0044305,1.0000000000095,0.911348254055842,0,1,calyx of Held,CC,
14470,GO:0061789,1.0000000000095,0.911348254055842,0,1,dense core granule priming,BP,
15318,GO:0071486,1.00000000000951,0.917406108162193,0,1,cellular response to high light intensity,BP,
16642,GO:0097473,1.00000000000951,0.917406108162193,0,1,retinal rod cell apoptotic process,BP,
19454,GO:1990009,1.00000000000951,0.917406108162193,0,1,retinal cell apoptotic process,BP,
17219,GO:0106020,1.00000000000951,0.861172519726255,0,2,regulation of vesicle docking,BP,
10831,GO:0044313,1.00000000000951,0.760556181629792,0,3,protein K6-linked deubiquitination,BP,
670,GO:0001872,1.00000000000952,0.935559531911165,0,1,(1->3)-beta-D-glucan binding,MF,
3778,GO:0008332,1.00000000000952,0.935559531911165,0,1,low voltage-gated calcium channel activity,MF,
11035,GO:0044866,1.00000000000952,0.935559531911165,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11036,GO:0044867,1.00000000000952,0.935559531911165,0,1,modulation by host of viral catalytic activity,BP,
11038,GO:0044869,1.00000000000952,0.935559531911165,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11039,GO:0044870,1.00000000000952,0.935559531911165,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11040,GO:0044871,1.00000000000952,0.935559531911165,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
13366,GO:0052403,1.00000000000952,0.935559531911165,0,1,negative regulation by host of symbiont catalytic activity,BP,
18245,GO:1903015,1.00000000000952,0.935559531911165,0,1,regulation of exo-alpha-sialidase activity,BP,
18246,GO:1903016,1.00000000000952,0.935559531911165,0,1,negative regulation of exo-alpha-sialidase activity,BP,
5295,GO:0015960,1.00000000000952,0.801780227865654,0,3,diadenosine polyphosphate biosynthetic process,BP,
5297,GO:0015965,1.00000000000952,0.801780227865654,0,3,diadenosine tetraphosphate metabolic process,BP,
5298,GO:0015966,1.00000000000952,0.801780227865654,0,3,diadenosine tetraphosphate biosynthetic process,BP,
935,GO:0002331,1.00000000000953,0.807597034418931,0,2,pre-B cell allelic exclusion,BP,
16726,GO:0097682,1.00000000000953,0.933563833050916,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
16667,GO:0097513,1.00000000000954,0.744514470989918,0,3,myosin II filament,CC,
3102,GO:0006680,1.00000000000954,0.799727199596944,0,3,glucosylceramide catabolic process,BP,
205,GO:0000430,1.00000000000954,0.881954114542765,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000432,1.00000000000954,0.881954114542765,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
761,GO:0001999,1.00000000000954,0.736477692677281,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
762,GO:0002001,1.00000000000954,0.736477692677281,0,4,renin secretion into blood stream,BP,
9448,GO:0036017,1.00000000000956,0.833543666659416,0,4,response to erythropoietin,BP,
9449,GO:0036018,1.00000000000956,0.833543666659416,0,4,cellular response to erythropoietin,BP,
1688,GO:0004152,1.00000000000956,0.933960995620084,0,1,dihydroorotate dehydrogenase activity,MF,
18502,GO:1903576,1.00000000000956,0.933960995620084,0,1,response to L-arginine,BP,
14766,GO:0070426,1.00000000000956,0.865813359429577,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14773,GO:0070434,1.00000000000956,0.865813359429577,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
5546,GO:0016532,1.00000000000956,0.821455769492375,0,3,superoxide dismutase copper chaperone activity,MF,
2736,GO:0006114,1.00000000000957,0.80910626150158,0,3,glycerol biosynthetic process,BP,
18358,GO:1903292,1.00000000000957,0.858616893640381,0,2,protein localization to Golgi membrane,BP,
13635,GO:0060087,1.00000000000957,0.782447711402041,0,4,relaxation of vascular smooth muscle,BP,
5558,GO:0016561,1.00000000000957,0.865963404865665,0,2,protein import into peroxisome matrix, translocation,BP,
1940,GO:0004638,1.00000000000957,0.926177394717949,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1941,GO:0004639,1.00000000000957,0.926177394717949,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
14103,GO:0060903,1.00000000000957,0.859065173995303,0,2,positive regulation of meiosis I,BP,
8359,GO:0033211,1.00000000000958,0.701399634118791,0,5,adiponectin-activated signaling pathway,BP,
19645,GO:1990758,1.00000000000958,0.936946347660729,0,1,mitotic sister chromatid biorientation,BP,
8591,GO:0034066,1.00000000000958,0.879084863845354,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
1337,GO:0003190,1.00000000000958,0.663296891961179,0,4,atrioventricular valve formation,BP,
14779,GO:0070447,1.00000000000959,0.864550516305101,0,2,positive regulation of oligodendrocyte progenitor proliferation,BP,
1677,GO:0004138,1.00000000000959,0.954452468144456,0,1,deoxyguanosine kinase activity,MF,
3937,GO:0008617,1.00000000000959,0.954452468144456,0,1,guanosine metabolic process,BP,
5288,GO:0015938,1.00000000000959,0.954452468144456,0,1,coenzyme A catabolic process,BP,
8549,GO:0033869,1.00000000000959,0.954452468144456,0,1,nucleoside bisphosphate catabolic process,BP,
8572,GO:0034031,1.00000000000959,0.954452468144456,0,1,ribonucleoside bisphosphate catabolic process,BP,
8575,GO:0034034,1.00000000000959,0.954452468144456,0,1,purine nucleoside bisphosphate catabolic process,BP,
20026,GO:2000588,1.00000000000961,0.835429773794114,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
2278,GO:0005220,1.00000000000963,0.703915190625865,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
7568,GO:0031905,1.00000000000963,0.820933876580332,0,3,early endosome lumen,CC,
16422,GO:0097026,1.00000000000963,0.902310605773183,0,1,dendritic cell dendrite assembly,BP,
13412,GO:0052692,1.00000000000964,0.9444659042242,0,1,raffinose alpha-galactosidase activity,MF,
16599,GO:0097376,1.00000000000964,0.9444659042242,0,1,interneuron axon guidance,BP,
8772,GO:0034436,1.00000000000964,0.819637560088422,0,3,glycoprotein transport,BP,
8290,GO:0033087,1.00000000000965,0.810050035167347,0,3,negative regulation of immature T cell proliferation,BP,
11649,GO:0046340,1.00000000000966,0.785473807753582,0,3,diacylglycerol catabolic process,BP,
9645,GO:0036505,1.00000000000967,0.927853525290737,0,1,prosaposin receptor activity,MF,
16847,GO:0098713,1.00000000000967,0.93205824166026,0,1,leucine import across plasma membrane,BP,
18600,GO:1903801,1.00000000000967,0.93205824166026,0,1,L-leucine import across plasma membrane,BP,
9156,GO:0035500,1.00000000000967,0.858352750692368,0,2,MH2 domain binding,MF,
11166,GO:0045204,1.00000000000967,0.782892039753176,0,3,MAPK export from nucleus,BP,
1546,GO:0003938,1.00000000000968,0.873586619464881,0,2,IMP dehydrogenase activity,MF,
2090,GO:0004852,1.00000000000968,0.94583203731848,0,1,uroporphyrinogen-III synthase activity,MF,
15268,GO:0071418,1.00000000000968,0.94583203731848,0,1,cellular response to amine stimulus,BP,
10093,GO:0042584,1.00000000000968,0.725721409660947,0,4,chromaffin granule membrane,CC,
18649,GO:1903909,1.00000000000968,0.659680967677339,0,5,regulation of receptor clustering,BP,
18106,GO:1902683,1.00000000000968,0.859596528624737,0,2,regulation of receptor localization to synapse,BP,
8832,GO:0034602,1.0000000000097,0.922222707310573,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9280,GO:0035695,1.0000000000097,0.922222707310573,0,1,mitophagy by induced vacuole formation,BP,
14173,GO:0061034,1.0000000000097,0.922222707310573,0,1,olfactory bulb mitral cell layer development,BP,
1916,GO:0004605,1.0000000000097,0.794236835447358,0,3,phosphatidate cytidylyltransferase activity,MF,
12148,GO:0048210,1.0000000000097,0.815380786596848,0,3,Golgi vesicle fusion to target membrane,BP,
1139,GO:0002728,1.00000000000971,0.921484946447578,0,1,negative regulation of natural killer cell cytokine production,BP,
8442,GO:0033553,1.00000000000972,0.724275069986896,0,4,rDNA heterochromatin,CC,
16627,GO:0097443,1.00000000000972,0.670975896945912,0,5,sorting endosome,CC,
7733,GO:0032222,1.00000000000972,0.893943727899973,0,1,regulation of synaptic transmission, cholinergic,BP,
7734,GO:0032224,1.00000000000972,0.893943727899973,0,1,positive regulation of synaptic transmission, cholinergic,BP,
5595,GO:0016618,1.00000000000973,0.817631017695121,0,3,hydroxypyruvate reductase activity,MF,
6818,GO:0030267,1.00000000000973,0.817631017695121,0,3,glyoxylate reductase (NADP) activity,MF,
6143,GO:0019408,1.00000000000973,0.854807706379321,0,2,dolichol biosynthetic process,BP,
20009,GO:2000562,1.00000000000974,0.864437737859984,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
13372,GO:0052422,1.00000000000974,0.877819536545855,0,2,modulation by host of symbiont catalytic activity,BP,
268,GO:0000738,1.00000000000975,0.758031867462789,0,4,DNA catabolic process, exonucleolytic,BP,
18524,GO:1903630,1.00000000000976,0.949144625157209,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18525,GO:1903632,1.00000000000976,0.949144625157209,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
7370,GO:0031407,1.00000000000977,0.931230931483737,0,1,oxylipin metabolic process,BP,
12069,GO:0047977,1.00000000000977,0.931230931483737,0,1,hepoxilin-epoxide hydrolase activity,MF,
17792,GO:1901751,1.00000000000977,0.931230931483737,0,1,leukotriene A4 metabolic process,BP,
20338,GO:2001300,1.00000000000977,0.931230931483737,0,1,lipoxin metabolic process,BP,
20339,GO:2001301,1.00000000000977,0.931230931483737,0,1,lipoxin biosynthetic process,BP,
20340,GO:2001302,1.00000000000977,0.931230931483737,0,1,lipoxin A4 metabolic process,BP,
20341,GO:2001303,1.00000000000977,0.931230931483737,0,1,lipoxin A4 biosynthetic process,BP,
20342,GO:2001304,1.00000000000977,0.931230931483737,0,1,lipoxin B4 metabolic process,BP,
20343,GO:2001306,1.00000000000977,0.931230931483737,0,1,lipoxin B4 biosynthetic process,BP,
19879,GO:2000317,1.00000000000977,0.795237331260413,0,3,negative regulation of T-helper 17 type immune response,BP,
19882,GO:2000320,1.00000000000977,0.795237331260413,0,3,negative regulation of T-helper 17 cell differentiation,BP,
511,GO:0001574,1.00000000000978,0.752190290305419,0,4,ganglioside biosynthetic process,BP,
19902,GO:2000346,1.00000000000979,0.855877208030651,0,2,negative regulation of hepatocyte proliferation,BP,
18851,GO:1904398,1.00000000000979,0.81829155981688,0,2,positive regulation of neuromuscular junction development,BP,
16251,GO:0090283,1.00000000000979,0.790603114096228,0,3,regulation of protein glycosylation in Golgi,BP,
2065,GO:0004816,1.0000000000098,0.865048513512065,0,2,asparagine-tRNA ligase activity,MF,
5664,GO:0016768,1.0000000000098,0.939175399858545,0,1,spermine synthase activity,MF,
10772,GO:0044208,1.0000000000098,0.876012441871877,0,2,'de novo' AMP biosynthetic process,BP,
14560,GO:0070061,1.00000000000981,0.809157795821113,0,3,fructose binding,MF,
12174,GO:0048266,1.00000000000982,0.668504374267092,0,5,behavioral response to pain,BP,
310,GO:0000821,1.00000000000982,0.898613513844897,0,1,regulation of arginine metabolic process,BP,
8370,GO:0033241,1.00000000000982,0.898613513844897,0,1,regulation of cellular amine catabolic process,BP,
8371,GO:0033242,1.00000000000982,0.898613513844897,0,1,negative regulation of cellular amine catabolic process,BP,
9630,GO:0036487,1.00000000000982,0.898613513844897,0,1,nitric-oxide synthase inhibitor activity,MF,
15523,GO:0071878,1.00000000000982,0.898613513844897,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16856,GO:0098736,1.00000000000982,0.898613513844897,0,1,negative regulation of the force of heart contraction,BP,
17342,GO:0140199,1.00000000000982,0.898613513844897,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17388,GO:1900081,1.00000000000982,0.898613513844897,0,1,regulation of arginine catabolic process,BP,
17389,GO:1900082,1.00000000000982,0.898613513844897,0,1,negative regulation of arginine catabolic process,BP,
18344,GO:1903248,1.00000000000982,0.898613513844897,0,1,regulation of citrulline biosynthetic process,BP,
18345,GO:1903249,1.00000000000982,0.898613513844897,0,1,negative regulation of citrulline biosynthetic process,BP,
19857,GO:2000283,1.00000000000982,0.898613513844897,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
10145,GO:0042695,1.00000000000983,0.68904151109383,0,5,thelarche,BP,
14041,GO:0060744,1.00000000000983,0.68904151109383,0,5,mammary gland branching involved in thelarche,BP,
16982,GO:0098971,1.00000000000985,0.844925862636919,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
9744,GO:0038189,1.00000000000985,0.735354038253014,0,4,neuropilin signaling pathway,BP,
16699,GO:0097623,1.00000000000986,0.918717165113665,0,1,potassium ion export across plasma membrane,BP,
18579,GO:1903764,1.00000000000986,0.918717165113665,0,1,regulation of potassium ion export across plasma membrane,BP,
4380,GO:0010009,1.00000000000986,0.692554990500764,0,5,cytoplasmic side of endosome membrane,CC,
18349,GO:1903276,1.00000000000986,0.876976546415804,0,2,regulation of sodium ion export across plasma membrane,BP,
18350,GO:1903278,1.00000000000986,0.876976546415804,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18357,GO:1903288,1.00000000000986,0.876976546415804,0,2,positive regulation of potassium ion import,BP,
8741,GO:0034382,1.00000000000986,0.786567479080123,0,4,chylomicron remnant clearance,BP,
15500,GO:0071830,1.00000000000986,0.786567479080123,0,4,triglyceride-rich lipoprotein particle clearance,BP,
4477,GO:0010477,1.00000000000986,0.926568807663275,0,1,response to sulfur dioxide,BP,
10667,GO:0043739,1.00000000000986,0.926568807663275,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
12949,GO:0051286,1.00000000000987,0.661358418646377,0,5,cell tip,CC,
5433,GO:0016287,1.00000000000987,0.929160778099154,0,1,glycerone-phosphate O-acyltransferase activity,MF,
12345,GO:0048682,1.00000000000987,0.850990657236408,0,2,sprouting of injured axon,BP,
3523,GO:0007499,1.00000000000988,0.920650294486001,0,1,ectoderm and mesoderm interaction,BP,
12403,GO:0048807,1.00000000000988,0.920650294486001,0,1,female genitalia morphogenesis,BP,
1529,GO:0003905,1.00000000000988,0.952459840774932,0,1,alkylbase DNA N-glycosylase activity,MF,
3962,GO:0008725,1.00000000000988,0.952459840774932,0,1,DNA-3-methyladenine glycosylase activity,MF,
10665,GO:0043733,1.00000000000988,0.952459840774932,0,1,DNA-3-methylbase glycosylase activity,MF,
10684,GO:0043916,1.00000000000988,0.952459840774932,0,1,DNA-7-methylguanine glycosylase activity,MF,
13441,GO:0052821,1.00000000000988,0.952459840774932,0,1,DNA-7-methyladenine glycosylase activity,MF,
13442,GO:0052822,1.00000000000988,0.952459840774932,0,1,DNA-3-methylguanine glycosylase activity,MF,
16939,GO:0098887,1.00000000000989,0.682222160713662,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
3643,GO:0008117,1.00000000000989,0.914697590689899,0,1,sphinganine-1-phosphate aldolase activity,MF,
14550,GO:0070042,1.00000000000989,0.92747653185775,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
4892,GO:0014810,1.0000000000099,0.960914934530466,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
2014,GO:0004738,1.0000000000099,0.691595032593203,0,5,pyruvate dehydrogenase activity,MF,
8833,GO:0034603,1.0000000000099,0.691595032593203,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8834,GO:0034604,1.0000000000099,0.691595032593203,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
10337,GO:0043120,1.00000000000992,0.817521596586816,0,3,tumor necrosis factor binding,MF,
1691,GO:0004161,1.00000000000993,0.875655009295982,0,2,dimethylallyltranstransferase activity,MF,
1742,GO:0004337,1.00000000000993,0.875655009295982,0,2,geranyltranstransferase activity,MF,
8416,GO:0033383,1.00000000000993,0.875655009295982,0,2,geranyl diphosphate metabolic process,BP,
8417,GO:0033384,1.00000000000993,0.875655009295982,0,2,geranyl diphosphate biosynthetic process,BP,
8287,GO:0033083,1.00000000000993,0.75311178654709,0,4,regulation of immature T cell proliferation,BP,
16186,GO:0090188,1.00000000000993,0.703000113492236,0,4,negative regulation of pancreatic juice secretion,BP,
10179,GO:0042756,1.00000000000993,0.819778873218301,0,3,drinking behavior,BP,
10214,GO:0042819,1.00000000000994,0.78293945785289,0,3,vitamin B6 biosynthetic process,BP,
345,GO:0000958,1.00000000000994,0.791266686489891,0,3,mitochondrial mRNA catabolic process,BP,
1317,GO:0003162,1.00000000000996,0.819913984472965,0,2,atrioventricular node development,BP,
1618,GO:0004044,1.00000000000996,0.924580246061246,0,1,amidophosphoribosyltransferase activity,MF,
18901,GO:1904533,1.00000000001,0.793124579128212,0,3,regulation of telomeric loop disassembly,BP,
2074,GO:0004825,1.00000000001,0.861247024212093,0,2,methionine-tRNA ligase activity,MF,
2920,GO:0006431,1.00000000001,0.861247024212093,0,2,methionyl-tRNA aminoacylation,BP,
6968,GO:0030617,1.00000000001001,0.927260268602682,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
19488,GO:1990136,1.00000000001002,0.930208583988275,0,1,linoleate 9S-lipoxygenase activity,MF,
8647,GO:0034166,1.00000000001002,0.926314942929793,0,1,toll-like receptor 10 signaling pathway,BP,
8555,GO:0033883,1.00000000001002,0.889415381934201,0,2,pyridoxal phosphatase activity,MF,
1580,GO:0003987,1.00000000001003,0.854763881008517,0,2,acetate-CoA ligase activity,MF,
6144,GO:0019413,1.00000000001003,0.854763881008517,0,2,acetate biosynthetic process,BP,
6147,GO:0019427,1.00000000001003,0.854763881008517,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6178,GO:0019542,1.00000000001003,0.854763881008517,0,2,propionate biosynthetic process,BP,
19707,GO:1990966,1.00000000001003,0.747646211412254,0,4,ATP generation from poly-ADP-D-ribose,BP,
14149,GO:0060995,1.00000000001004,0.850802108517238,0,2,cell-cell signaling involved in kidney development,BP,
14266,GO:0061289,1.00000000001004,0.850802108517238,0,2,Wnt signaling pathway involved in kidney development,BP,
14267,GO:0061290,1.00000000001004,0.850802108517238,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15698,GO:0072204,1.00000000001004,0.850802108517238,0,2,cell-cell signaling involved in metanephros development,BP,
18635,GO:1903892,1.00000000001004,0.859824004162073,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
8226,GO:0032977,1.00000000001005,0.92120593884313,0,1,membrane insertase activity,MF,
8227,GO:0032978,1.00000000001005,0.92120593884313,0,1,protein insertion into membrane from inner side,BP,
8228,GO:0032979,1.00000000001005,0.92120593884313,0,1,protein insertion into mitochondrial membrane from inner side,BP,
4562,GO:0010641,1.00000000001006,0.718387942575093,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
17139,GO:0102005,1.00000000001006,0.942587359949494,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
1445,GO:0003430,1.00000000001006,0.854619307220423,0,2,growth plate cartilage chondrocyte growth,BP,
3389,GO:0007168,1.00000000001007,0.862834551349908,0,2,receptor guanylyl cyclase signaling pathway,BP,
16147,GO:0090129,1.00000000001007,0.692701720640751,0,5,positive regulation of synapse maturation,BP,
17170,GO:0102485,1.00000000001007,0.816878508354604,0,2,dATP phosphohydrolase activity,MF,
17171,GO:0102486,1.00000000001007,0.816878508354604,0,2,dCTP phosphohydrolase activity,MF,
17172,GO:0102487,1.00000000001007,0.816878508354604,0,2,dUTP phosphohydrolase activity,MF,
17173,GO:0102488,1.00000000001007,0.816878508354604,0,2,dTTP phosphohydrolase activity,MF,
17174,GO:0102489,1.00000000001007,0.816878508354604,0,2,GTP phosphohydrolase activity,MF,
17175,GO:0102490,1.00000000001007,0.816878508354604,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17176,GO:0102491,1.00000000001007,0.816878508354604,0,2,dGTP phosphohydrolase activity,MF,
8044,GO:0032687,1.00000000001008,0.685108222909237,0,5,negative regulation of interferon-alpha production,BP,
10063,GO:0042536,1.00000000001008,0.816345322981405,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
3783,GO:0008343,1.00000000001008,0.90290457931751,0,1,adult feeding behavior,BP,
7419,GO:0031501,1.00000000001009,0.812190584162254,0,4,mannosyltransferase complex,CC,
15426,GO:0071672,1.0000000000101,0.822007177610266,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
13985,GO:0060671,1.00000000001011,0.797899755009735,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13986,GO:0060672,1.00000000001011,0.797899755009735,0,3,epithelial cell morphogenesis involved in placental branching,BP,
342,GO:0000942,1.00000000001012,0.751934451744896,0,4,condensed nuclear chromosome outer kinetochore,CC,
14172,GO:0061032,1.00000000001013,0.927622476363672,0,1,visceral serous pericardium development,BP,
15670,GO:0072166,1.00000000001013,0.927622476363672,0,1,posterior mesonephric tubule development,BP,
15744,GO:0072299,1.00000000001013,0.927622476363672,0,1,negative regulation of metanephric glomerulus development,BP,
15747,GO:0072302,1.00000000001013,0.927622476363672,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
14329,GO:0061443,1.00000000001013,0.847517287934964,0,2,endocardial cushion cell differentiation,BP,
1494,GO:0003829,1.00000000001014,0.847763053265983,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
15346,GO:0071546,1.00000000001016,0.85839793111983,0,2,pi-body,CC,
6901,GO:0030430,1.00000000001016,0.741333533139302,0,4,host cell cytoplasm,CC,
8501,GO:0033655,1.00000000001016,0.741333533139302,0,4,host cell cytoplasm part,CC,
17465,GO:1900220,1.00000000001017,0.835332685648398,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
19350,GO:1905600,1.00000000001017,0.806944955496545,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
9236,GO:0035616,1.00000000001019,0.78210744604987,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
11742,GO:0046534,1.00000000001019,0.921496792562566,0,1,positive regulation of photoreceptor cell differentiation,BP,
14814,GO:0070524,1.0000000000102,0.944671496210379,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
16651,GO:0097490,1.0000000000102,0.722513284367686,0,4,sympathetic neuron projection extension,BP,
16652,GO:0097491,1.0000000000102,0.722513284367686,0,4,sympathetic neuron projection guidance,BP,
14692,GO:0070291,1.00000000001021,0.74110122430011,0,4,N-acylethanolamine metabolic process,BP,
11466,GO:0045903,1.00000000001021,0.853735162394412,0,3,positive regulation of translational fidelity,BP,
12470,GO:0050185,1.00000000001021,0.886923436096891,0,1,phosphatidylinositol deacylase activity,MF,
19811,GO:2000195,1.00000000001021,0.867769334357056,0,2,negative regulation of female gonad development,BP,
9103,GO:0035359,1.00000000001022,0.923329935714205,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
11139,GO:0045162,1.00000000001022,0.683824053567467,0,4,clustering of voltage-gated sodium channels,BP,
18408,GO:1903387,1.00000000001022,0.917342512144941,0,1,positive regulation of homophilic cell adhesion,BP,
14821,GO:0070535,1.00000000001023,0.648071738536755,0,5,histone H2A K63-linked ubiquitination,BP,
3754,GO:0008295,1.00000000001025,0.769041232503919,0,4,spermidine biosynthetic process,BP,
9593,GO:0036403,1.00000000001026,0.929511216517292,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
9657,GO:0036518,1.00000000001026,0.848431649007208,0,2,chemorepulsion of dopaminergic neuron axon,BP,
14408,GO:0061643,1.00000000001026,0.848431649007208,0,2,chemorepulsion of axon,BP,
19978,GO:2000481,1.00000000001026,0.705339534562265,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
20193,GO:2000969,1.00000000001026,0.786596060659366,0,3,positive regulation of AMPA receptor activity,BP,
2668,GO:0006014,1.00000000001026,0.88945940812595,0,2,D-ribose metabolic process,BP,
6794,GO:0030226,1.00000000001027,0.702563881474013,0,3,apolipoprotein receptor activity,MF,
6812,GO:0030259,1.00000000001027,0.749501954809289,0,4,lipid glycosylation,BP,
9680,GO:0038031,1.00000000001028,0.668560910144488,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
20081,GO:2000670,1.00000000001028,0.84299405147165,0,2,positive regulation of dendritic cell apoptotic process,BP,
7474,GO:0031627,1.00000000001028,0.796599443249944,0,3,telomeric loop formation,BP,
12280,GO:0048550,1.00000000001029,0.695618350181968,0,5,negative regulation of pinocytosis,BP,
7259,GO:0031213,1.00000000001029,0.848389141186871,0,2,RSF complex,CC,
15546,GO:0071918,1.0000000000103,0.855969622692725,0,2,urea transmembrane transport,BP,
1339,GO:0003193,1.0000000000103,0.926922373166142,0,1,pulmonary valve formation,BP,
9394,GO:0035922,1.0000000000103,0.926922373166142,0,1,foramen ovale closure,BP,
16042,GO:0086044,1.0000000000103,0.926922373166142,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16048,GO:0086054,1.0000000000103,0.926922373166142,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16049,GO:0086055,1.0000000000103,0.926922373166142,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16062,GO:0086076,1.0000000000103,0.926922373166142,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16064,GO:0086078,1.0000000000103,0.926922373166142,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16065,GO:0086079,1.0000000000103,0.926922373166142,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16949,GO:0098906,1.0000000000103,0.926922373166142,0,1,regulation of Purkinje myocyte action potential,BP,
19457,GO:1990029,1.0000000000103,0.926922373166142,0,1,vasomotion,BP,
17519,GO:1900477,1.00000000001031,0.933862716140969,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
7574,GO:0031930,1.00000000001031,0.94357351757171,0,1,mitochondria-nucleus signaling pathway,BP,
2261,GO:0005173,1.00000000001032,0.766812716965636,0,3,stem cell factor receptor binding,MF,
12422,GO:0048852,1.00000000001033,0.777567866360899,0,3,diencephalon morphogenesis,BP,
19672,GO:1990834,1.00000000001034,0.799656339500038,0,3,response to odorant,BP,
18120,GO:1902725,1.00000000001034,0.912361828486917,0,1,negative regulation of satellite cell differentiation,BP,
1627,GO:0004060,1.00000000001034,0.934550579605598,0,1,arylamine N-acetyltransferase activity,MF,
18289,GO:1903116,1.00000000001035,0.852774789801015,0,2,positive regulation of actin filament-based movement,BP,
18588,GO:1903781,1.00000000001035,0.852774789801015,0,2,positive regulation of cardiac conduction,BP,
18669,GO:1903949,1.00000000001035,0.852774789801015,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19118,GO:1904990,1.00000000001035,0.930694696383384,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19119,GO:1904992,1.00000000001035,0.930694696383384,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
6969,GO:0030618,1.00000000001035,0.685610033785918,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
8507,GO:0033678,1.00000000001036,0.929303042788718,0,1,5'-3' DNA/RNA helicase activity,MF,
8511,GO:0033682,1.00000000001036,0.929303042788718,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
14020,GO:0060715,1.00000000001036,0.790276956113259,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
8840,GO:0034617,1.00000000001036,0.790237868858338,0,3,tetrahydrobiopterin binding,MF,
136,GO:0000285,1.00000000001037,0.798447670975931,0,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
3974,GO:0008783,1.00000000001037,0.932651554090408,0,1,agmatinase activity,MF,
8421,GO:0033388,1.00000000001037,0.932651554090408,0,1,putrescine biosynthetic process from arginine,BP,
15636,GO:0072106,1.00000000001039,0.815609060492278,0,3,regulation of ureteric bud formation,BP,
15637,GO:0072107,1.00000000001039,0.815609060492278,0,3,positive regulation of ureteric bud formation,BP,
19223,GO:1905278,1.00000000001039,0.815609060492278,0,3,positive regulation of epithelial tube formation,BP,
17715,GO:1901569,1.00000000001039,0.699160199209394,0,5,fatty acid derivative catabolic process,BP,
11777,GO:0046619,1.0000000000104,0.908897136651076,0,1,optic placode formation involved in camera-type eye formation,BP,
3639,GO:0008111,1.0000000000104,0.935061014610174,0,1,alpha-methylacyl-CoA racemase activity,MF,
3863,GO:0008481,1.0000000000104,0.868885036511837,0,2,sphinganine kinase activity,MF,
4326,GO:0009822,1.0000000000104,0.938820778603285,0,1,alkaloid catabolic process,BP,
5803,GO:0017050,1.0000000000104,0.868885036511837,0,2,D-erythro-sphingosine kinase activity,MF,
13807,GO:0060373,1.00000000001041,0.736176618204188,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
20119,GO:2000741,1.00000000001045,0.764037143660141,0,3,positive regulation of mesenchymal stem cell differentiation,BP,
18965,GO:1904688,1.00000000001046,0.694937903022242,0,5,regulation of cytoplasmic translational initiation,BP,
2689,GO:0006050,1.00000000001046,0.941272850765666,0,1,mannosamine metabolic process,BP,
2690,GO:0006051,1.00000000001046,0.941272850765666,0,1,N-acetylmannosamine metabolic process,BP,
11123,GO:0045127,1.00000000001046,0.941272850765666,0,1,N-acetylglucosamine kinase activity,MF,
20335,GO:2001293,1.00000000001047,0.747063076721274,0,3,malonyl-CoA metabolic process,BP,
1298,GO:0003128,1.00000000001047,0.714273383731089,0,5,heart field specification,BP,
6216,GO:0019732,1.00000000001048,0.861271717126899,0,2,antifungal humoral response,BP,
7160,GO:0031014,1.0000000000105,0.918606761517731,0,2,troponin T binding,MF,
7748,GO:0032252,1.0000000000105,0.751808458311526,0,3,secretory granule localization,BP,
18494,GO:1903566,1.00000000001051,0.757122417111842,0,3,positive regulation of protein localization to cilium,BP,
6470,GO:0021796,1.00000000001052,0.794870339014332,0,3,cerebral cortex regionalization,BP,
17888,GO:1902093,1.00000000001052,0.844719765128731,0,3,positive regulation of flagellated sperm motility,BP,
13622,GO:0060072,1.00000000001052,0.912038802478562,0,1,large conductance calcium-activated potassium channel activity,MF,
11229,GO:0045348,1.00000000001055,0.814578041527468,0,3,positive regulation of MHC class II biosynthetic process,BP,
9650,GO:0036510,1.00000000001055,0.793292179447033,0,3,trimming of terminal mannose on C branch,BP,
7744,GO:0032237,1.00000000001055,0.725541051958912,0,4,activation of store-operated calcium channel activity,BP,
17654,GO:1901341,1.00000000001055,0.725541051958912,0,4,positive regulation of store-operated calcium channel activity,BP,
3056,GO:0006617,1.00000000001056,0.893026006484517,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
328,GO:0000916,1.00000000001056,0.932812392279737,0,1,actomyosin contractile ring contraction,BP,
9526,GO:0036213,1.00000000001056,0.932812392279737,0,1,contractile ring contraction,BP,
5062,GO:0015271,1.00000000001056,0.712976509661866,0,4,outward rectifier potassium channel activity,MF,
11990,GO:0047238,1.00000000001056,0.731312152958615,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
6511,GO:0021882,1.00000000001059,0.868329034178189,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6519,GO:0021893,1.00000000001059,0.868329034178189,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
9375,GO:0035881,1.00000000001059,0.868329034178189,0,2,amacrine cell differentiation,BP,
14198,GO:0061074,1.00000000001059,0.868329034178189,0,2,regulation of neural retina development,BP,
14199,GO:0061075,1.00000000001059,0.868329034178189,0,2,positive regulation of neural retina development,BP,
18165,GO:1902866,1.00000000001059,0.868329034178189,0,2,regulation of retina development in camera-type eye,BP,
18166,GO:1902868,1.00000000001059,0.868329034178189,0,2,positive regulation of retina development in camera-type eye,BP,
18167,GO:1902869,1.00000000001059,0.868329034178189,0,2,regulation of amacrine cell differentiation,BP,
18168,GO:1902871,1.00000000001059,0.868329034178189,0,2,positive regulation of amacrine cell differentiation,BP,
2082,GO:0004833,1.00000000001059,0.941368401084202,0,1,tryptophan 2,3-dioxygenase activity,MF,
8531,GO:0033754,1.00000000001059,0.941368401084202,0,1,indoleamine 2,3-dioxygenase activity,MF,
8690,GO:0034275,1.00000000001059,0.941368401084202,0,1,kynurenic acid metabolic process,BP,
8691,GO:0034276,1.00000000001059,0.941368401084202,0,1,kynurenic acid biosynthetic process,BP,
9543,GO:0036269,1.00000000001059,0.941368401084202,0,1,swimming behavior,BP,
13917,GO:0060539,1.00000000001059,0.685763559010445,0,5,diaphragm development,BP,
1436,GO:0003408,1.0000000000106,0.824302365276107,0,2,optic cup formation involved in camera-type eye development,BP,
4782,GO:0010966,1.00000000001061,0.765497026813268,0,3,regulation of phosphate transport,BP,
14315,GO:0061395,1.00000000001061,0.938762441549886,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
11213,GO:0045323,1.00000000001061,0.803406947741867,0,3,interleukin-1 receptor complex,CC,
16073,GO:0086098,1.00000000001061,0.858011303617475,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
19569,GO:1990448,1.00000000001061,0.910193823393098,0,1,exon-exon junction complex binding,MF,
4871,GO:0014722,1.00000000001061,0.764739160921756,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
9431,GO:0035989,1.00000000001061,0.710394248534577,0,4,tendon development,BP,
10750,GO:0044107,1.00000000001062,0.762305123544868,0,4,cellular alcohol metabolic process,BP,
10751,GO:0044108,1.00000000001062,0.762305123544868,0,4,cellular alcohol biosynthetic process,BP,
16232,GO:0090251,1.00000000001063,0.885500294220902,0,1,protein localization involved in establishment of planar polarity,BP,
9998,GO:0042392,1.00000000001063,0.703245940912369,0,5,sphingosine-1-phosphate phosphatase activity,MF,
2160,GO:0004984,1.00000000001064,0.848219318472623,0,3,olfactory receptor activity,MF,
12713,GO:0050911,1.00000000001064,0.848219318472623,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
7686,GO:0032116,1.00000000001064,0.827745390724468,0,2,SMC loading complex,CC,
16394,GO:0090694,1.00000000001064,0.827745390724468,0,2,Scc2-Scc4 cohesin loading complex,CC,
15865,GO:0072560,1.00000000001065,0.92707824967054,0,1,type B pancreatic cell maturation,BP,
19863,GO:2000297,1.00000000001065,0.917233753940672,0,1,negative regulation of synapse maturation,BP,
11327,GO:0045630,1.00000000001065,0.711097448605461,0,5,positive regulation of T-helper 2 cell differentiation,BP,
15552,GO:0071930,1.00000000001066,0.781878613074869,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
19390,GO:1905773,1.00000000001067,0.777793531755217,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
9149,GO:0035485,1.00000000001067,0.936808750615787,0,1,adenine/guanine mispair binding,MF,
10268,GO:0042997,1.00000000001068,0.796588399327357,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
18095,GO:1902636,1.0000000000107,0.888236305745117,0,2,kinociliary basal body,CC,
7948,GO:0032532,1.00000000001073,0.746053627184242,0,4,regulation of microvillus length,BP,
16953,GO:0098910,1.00000000001074,0.641936593214786,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16421,GO:0097025,1.00000000001074,0.775293698116529,0,3,MPP7-DLG1-LIN7 complex,CC,
5773,GO:0016971,1.00000000001075,0.795650662551041,0,3,flavin-linked sulfhydryl oxidase activity,MF,
15296,GO:0071460,1.00000000001077,0.900750041942967,0,2,cellular response to cell-matrix adhesion,BP,
1792,GO:0004418,1.00000000001079,0.94342744141391,0,1,hydroxymethylbilane synthase activity,MF,
5916,GO:0018160,1.00000000001079,0.94342744141391,0,1,peptidyl-pyrromethane cofactor linkage,BP,
18431,GO:1903433,1.0000000000108,0.858131462008383,0,2,regulation of constitutive secretory pathway,BP,
1648,GO:0004089,1.0000000000108,0.679878110725691,0,5,carbonate dehydratase activity,MF,
14454,GO:0061752,1.00000000001081,0.868563350224765,0,2,telomeric repeat-containing RNA binding,MF,
1960,GO:0004661,1.00000000001081,0.710078553879164,0,5,protein geranylgeranyltransferase activity,MF,
16105,GO:0090065,1.00000000001082,0.977218790334336,0,1,regulation of production of siRNA involved in RNA interference,BP,
16837,GO:0098680,1.00000000001082,0.977218790334336,0,1,template-free RNA nucleotidyltransferase,MF,
18549,GO:1903704,1.00000000001082,0.977218790334336,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19593,GO:1990572,1.00000000001082,0.977218790334336,0,1,TERT-RMRP complex,CC,
7895,GO:0032458,1.00000000001082,0.924077918271328,0,1,slow endocytic recycling,BP,
1936,GO:0004632,1.00000000001082,0.948021660794238,0,1,phosphopantothenate--cysteine ligase activity,MF,
10713,GO:0043990,1.00000000001086,0.927216660887061,0,1,histone H2A-S1 phosphorylation,BP,
9228,GO:0035608,1.00000000001087,0.855593198027496,0,2,protein deglutamylation,BP,
6965,GO:0030613,1.00000000001088,0.86728591926072,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6966,GO:0030614,1.00000000001088,0.86728591926072,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
14999,GO:0070893,1.00000000001089,0.851312146809761,0,2,transposon integration,BP,
15000,GO:0070894,1.00000000001089,0.851312146809761,0,2,regulation of transposon integration,BP,
15001,GO:0070895,1.00000000001089,0.851312146809761,0,2,negative regulation of transposon integration,BP,
16930,GO:0098875,1.0000000000109,0.92014301359069,0,1,epididymosome,CC,
8,GO:0000015,1.00000000001091,0.93716673809477,0,1,phosphopyruvate hydratase complex,CC,
1938,GO:0004634,1.00000000001091,0.93716673809477,0,1,phosphopyruvate hydratase activity,MF,
10462,GO:0043309,1.00000000001091,0.877237598311973,0,2,regulation of eosinophil degranulation,BP,
10463,GO:0043311,1.00000000001091,0.877237598311973,0,2,positive regulation of eosinophil degranulation,BP,
18067,GO:1902566,1.00000000001091,0.877237598311973,0,2,regulation of eosinophil activation,BP,
18068,GO:1902568,1.00000000001091,0.877237598311973,0,2,positive regulation of eosinophil activation,BP,
1715,GO:0004304,1.00000000001092,0.937727064165722,0,1,estrone sulfotransferase activity,MF,
3086,GO:0006660,1.00000000001092,0.937727064165722,0,1,phosphatidylserine catabolic process,BP,
3129,GO:0006711,1.00000000001092,0.937727064165722,0,1,estrogen catabolic process,BP,
11233,GO:0045352,1.00000000001092,0.937727064165722,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11234,GO:0045353,1.00000000001092,0.937727064165722,0,1,interleukin-1 Type II receptor antagonist activity,MF,
1810,GO:0004454,1.00000000001092,0.930846777541892,0,1,ketohexokinase activity,MF,
7785,GO:0032304,1.00000000001092,0.918613407776035,0,1,negative regulation of icosanoid secretion,BP,
17427,GO:1900139,1.00000000001092,0.918613407776035,0,1,negative regulation of arachidonic acid secretion,BP,
19660,GO:1990791,1.00000000001093,0.861391022143182,0,2,dorsal root ganglion development,BP,
667,GO:0001868,1.00000000001094,0.936122937268496,0,1,regulation of complement activation, lectin pathway,BP,
668,GO:0001869,1.00000000001094,0.936122937268496,0,1,negative regulation of complement activation, lectin pathway,BP,
9814,GO:0040032,1.00000000001094,0.936122937268496,0,1,post-embryonic body morphogenesis,BP,
8526,GO:0033743,1.00000000001095,0.759301626179948,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
3687,GO:0008192,1.00000000001095,0.805511666537613,0,3,RNA guanylyltransferase activity,MF,
10850,GO:0044335,1.00000000001095,0.892136650700403,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
19746,GO:2000055,1.00000000001095,0.892136650700403,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
4209,GO:0009330,1.00000000001096,0.845970162155814,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
10753,GO:0044111,1.00000000001097,0.85681845363267,0,2,development involved in symbiotic interaction,BP,
16302,GO:0090365,1.00000000001098,0.932802837118274,0,1,regulation of mRNA modification,BP,
16303,GO:0090367,1.00000000001098,0.932802837118274,0,1,negative regulation of mRNA modification,BP,
18331,GO:1903215,1.00000000001098,0.932802837118274,0,1,negative regulation of protein targeting to mitochondrion,BP,
20250,GO:2001144,1.00000000001098,0.932802837118274,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20251,GO:2001145,1.00000000001098,0.932802837118274,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
17260,GO:0110057,1.00000000001099,0.916254886415258,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17261,GO:0110059,1.00000000001099,0.916254886415258,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
11870,GO:0046836,1.00000000001099,0.71086390857826,0,5,glycolipid transport,BP,
1798,GO:0004427,1.00000000001099,0.837735062886583,0,3,inorganic diphosphatase activity,MF,
6352,GO:0021526,1.00000000001101,0.936418981271915,0,1,medial motor column neuron differentiation,BP,
18085,GO:1902616,1.00000000001101,0.936418981271915,0,1,acyl carnitine transmembrane transport,BP,
961,GO:0002380,1.00000000001102,0.921325593085833,0,1,immunoglobulin secretion involved in immune response,BP,
18509,GO:1903588,1.00000000001102,0.802266860343744,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
2880,GO:0006382,1.00000000001102,0.652057129383313,0,5,adenosine to inosine editing,BP,
15279,GO:0071435,1.00000000001102,0.845137232826238,0,2,potassium ion export,BP,
17975,GO:1902302,1.00000000001102,0.845137232826238,0,2,regulation of potassium ion export,BP,
14706,GO:0070309,1.00000000001103,0.851243076526936,0,2,lens fiber cell morphogenesis,BP,
107,GO:0000221,1.00000000001103,0.791787003079807,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
9362,GO:0035865,1.00000000001105,0.827649088320399,0,3,cellular response to potassium ion,BP,
1745,GO:0004342,1.00000000001105,0.871940213387139,0,2,glucosamine-6-phosphate deaminase activity,MF,
2682,GO:0006043,1.00000000001105,0.871940213387139,0,2,glucosamine catabolic process,BP,
6947,GO:0030550,1.00000000001106,0.809968419867723,0,3,acetylcholine receptor inhibitor activity,MF,
8185,GO:0032915,1.00000000001108,0.933438867863873,0,1,positive regulation of transforming growth factor beta2 production,BP,
12910,GO:0051232,1.00000000001108,0.931162729562536,0,1,meiotic spindle elongation,BP,
7585,GO:0031944,1.00000000001108,0.736280629640614,0,4,negative regulation of glucocorticoid metabolic process,BP,
7588,GO:0031947,1.00000000001108,0.736280629640614,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
16091,GO:0090032,1.00000000001108,0.736280629640614,0,4,negative regulation of steroid hormone biosynthetic process,BP,
647,GO:0001835,1.00000000001109,0.926556424257948,0,1,blastocyst hatching,BP,
1500,GO:0003842,1.00000000001109,0.926556424257948,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
9021,GO:0035188,1.00000000001109,0.926556424257948,0,1,hatching,BP,
15437,GO:0071684,1.00000000001109,0.926556424257948,0,1,organism emergence from protective structure,BP,
1539,GO:0003921,1.0000000000111,0.930519155604587,0,1,GMP synthase activity,MF,
1540,GO:0003922,1.0000000000111,0.930519155604587,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
15599,GO:0072049,1.0000000000111,0.774528176158676,0,4,comma-shaped body morphogenesis,BP,
4005,GO:0008948,1.00000000001111,0.746981479286442,0,4,oxaloacetate decarboxylase activity,MF,
18651,GO:1903912,1.00000000001111,0.732515741574376,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
10863,GO:0044352,1.00000000001113,0.731090151800326,0,4,pinosome,CC,
10864,GO:0044354,1.00000000001113,0.731090151800326,0,4,macropinosome,CC,
18969,GO:1904693,1.00000000001113,0.769754174242726,0,3,midbrain morphogenesis,BP,
7736,GO:0032226,1.00000000001113,0.702274272867783,0,5,positive regulation of synaptic transmission, dopaminergic,BP,
6554,GO:0021979,1.00000000001113,0.751959188203297,0,4,hypothalamus cell differentiation,BP,
2307,GO:0005290,1.00000000001114,0.862403635043573,0,2,L-histidine transmembrane transporter activity,MF,
10186,GO:0042766,1.00000000001115,0.901501862132647,0,1,nucleosome mobilization,BP,
18244,GO:1903012,1.00000000001115,0.740860928637845,0,4,positive regulation of bone development,BP,
9332,GO:0035799,1.00000000001116,0.789821228494507,0,3,ureter maturation,BP,
11001,GO:0044789,1.00000000001117,0.66504106365185,0,5,modulation by host of viral release from host cell,BP,
11002,GO:0044791,1.00000000001117,0.66504106365185,0,5,positive regulation by host of viral release from host cell,BP,
16503,GO:0097168,1.00000000001117,0.920926004002378,0,1,mesenchymal stem cell proliferation,BP,
18024,GO:1902460,1.00000000001117,0.920926004002378,0,1,regulation of mesenchymal stem cell proliferation,BP,
18025,GO:1902462,1.00000000001117,0.920926004002378,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
10241,GO:0042923,1.00000000001118,0.872509203600553,0,2,neuropeptide binding,MF,
3556,GO:0007598,1.00000000001118,0.931338500618869,0,1,blood coagulation, extrinsic pathway,BP,
18412,GO:1903394,1.00000000001118,0.931338500618869,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
1823,GO:0004471,1.00000000001118,0.795182931632909,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1824,GO:0004473,1.00000000001118,0.795182931632909,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
6833,GO:0030290,1.00000000001118,0.925243430447055,0,1,sphingolipid activator protein activity,MF,
7872,GO:0032428,1.00000000001118,0.925243430447055,0,1,beta-N-acetylgalactosaminidase activity,MF,
379,GO:0001011,1.00000000001118,0.901156512868127,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
406,GO:0001087,1.00000000001118,0.901156512868127,0,1,transcription factor activity, TFIIB-class binding,MF,
2123,GO:0004913,1.00000000001121,0.931058086142029,0,1,interleukin-4 receptor activity,MF,
2196,GO:0005055,1.00000000001121,0.885615510613511,0,2,laminin receptor activity,MF,
20129,GO:2000759,1.00000000001121,0.919482595190155,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20130,GO:2000761,1.00000000001121,0.919482595190155,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
2653,GO:0005991,1.00000000001122,0.92783502649611,0,1,trehalose metabolic process,BP,
14759,GO:0070413,1.00000000001122,0.92783502649611,0,1,trehalose metabolism in response to stress,BP,
4833,GO:0014036,1.00000000001122,0.923879119203131,0,1,neural crest cell fate specification,BP,
9240,GO:0035622,1.00000000001122,0.923879119203131,0,1,intrahepatic bile duct development,BP,
12434,GO:0048866,1.00000000001122,0.923879119203131,0,1,stem cell fate specification,BP,
13575,GO:0060018,1.00000000001122,0.923879119203131,0,1,astrocyte fate commitment,BP,
13706,GO:0060221,1.00000000001122,0.923879119203131,0,1,retinal rod cell differentiation,BP,
13903,GO:0060516,1.00000000001122,0.923879119203131,0,1,primary prostatic bud elongation,BP,
13904,GO:0060517,1.00000000001122,0.923879119203131,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14063,GO:0060784,1.00000000001122,0.923879119203131,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
9876,GO:0042126,1.00000000001122,0.746388078157757,0,4,nitrate metabolic process,BP,
1371,GO:0003253,1.00000000001124,0.740953491887226,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
3000,GO:0006546,1.00000000001125,0.813708701085797,0,3,glycine catabolic process,BP,
6155,GO:0019464,1.00000000001125,0.813708701085797,0,3,glycine decarboxylation via glycine cleavage system,BP,
13799,GO:0060364,1.00000000001125,0.726908377716448,0,4,frontal suture morphogenesis,BP,
1722,GO:0004311,1.00000000001126,0.804087001065252,0,3,farnesyltranstransferase activity,MF,
18546,GO:1903697,1.00000000001126,0.926141160008518,0,1,negative regulation of microvillus assembly,BP,
19646,GO:1990761,1.00000000001126,0.86033227777694,0,2,growth cone lamellipodium,CC,
19633,GO:1990737,1.00000000001128,0.797494848224508,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
3490,GO:0007371,1.00000000001128,0.924607872271612,0,1,ventral midline determination,BP,
13715,GO:0060245,1.00000000001128,0.924607872271612,0,1,detection of cell density,BP,
13716,GO:0060246,1.00000000001128,0.924607872271612,0,1,detection of cell density by contact stimulus,BP,
13717,GO:0060248,1.00000000001128,0.924607872271612,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14222,GO:0061113,1.00000000001128,0.924607872271612,0,1,pancreas morphogenesis,BP,
15592,GO:0072036,1.00000000001128,0.924607872271612,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15740,GO:0072285,1.00000000001128,0.924607872271612,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
1019,GO:0002513,1.00000000001129,0.79610870324916,0,3,tolerance induction to self antigen,BP,
4640,GO:0010760,1.00000000001129,0.802852595278288,0,4,negative regulation of macrophage chemotaxis,BP,
19319,GO:1905522,1.00000000001129,0.802852595278288,0,4,negative regulation of macrophage migration,BP,
16025,GO:0086017,1.0000000000113,0.855782080370387,0,2,Purkinje myocyte action potential,BP,
16035,GO:0086029,1.0000000000113,0.855782080370387,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16056,GO:0086068,1.0000000000113,0.855782080370387,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
9146,GO:0035473,1.00000000001131,0.867189588377075,0,2,lipase binding,MF,
2323,GO:0005329,1.00000000001131,0.843275758861249,0,2,dopamine transmembrane transporter activity,MF,
9144,GO:0035469,1.00000000001131,0.91676273237473,0,1,determination of pancreatic left/right asymmetry,BP,
15542,GO:0071908,1.00000000001131,0.91676273237473,0,1,determination of intestine left/right asymmetry,BP,
15543,GO:0071909,1.00000000001131,0.91676273237473,0,1,determination of stomach left/right asymmetry,BP,
19795,GO:2000167,1.00000000001131,0.91676273237473,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
12177,GO:0048270,1.00000000001132,0.933781644075984,0,1,methionine adenosyltransferase regulator activity,MF,
596,GO:0001758,1.00000000001133,0.800529745150236,0,3,retinal dehydrogenase activity,MF,
10318,GO:0043084,1.00000000001133,0.738853812091388,0,4,penile erection,BP,
10989,GO:0044771,1.00000000001133,0.860417892936194,0,2,meiotic cell cycle phase transition,BP,
17858,GO:1901993,1.00000000001133,0.860417892936194,0,2,regulation of meiotic cell cycle phase transition,BP,
17859,GO:1901994,1.00000000001133,0.860417892936194,0,2,negative regulation of meiotic cell cycle phase transition,BP,
9986,GO:0042365,1.00000000001135,0.824113916313833,0,3,water-soluble vitamin catabolic process,BP,
2429,GO:0005607,1.00000000001135,0.839548605064786,0,2,laminin-2 complex,CC,
13889,GO:0060486,1.00000000001136,0.840095842701733,0,2,Clara cell differentiation,BP,
14185,GO:0061047,1.00000000001137,0.809343446025387,0,3,positive regulation of branching involved in lung morphogenesis,BP,
6733,GO:0030144,1.00000000001137,0.799238645988074,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
6906,GO:0030473,1.00000000001139,0.638463611101921,0,5,nuclear migration along microtubule,BP,
2211,GO:0005094,1.00000000001139,0.888913211587731,0,2,Rho GDP-dissociation inhibitor activity,MF,
4637,GO:0010757,1.00000000001141,0.744890272245144,0,4,negative regulation of plasminogen activation,BP,
19682,GO:1990876,1.00000000001142,0.910135393862841,0,1,cytoplasmic side of nuclear pore,CC,
16724,GO:0097680,1.00000000001142,0.79091179655361,0,3,double-strand break repair via classical nonhomologous end joining,BP,
20117,GO:2000739,1.00000000001143,0.706660969717278,0,4,regulation of mesenchymal stem cell differentiation,BP,
2078,GO:0004829,1.00000000001144,0.800628800091121,0,3,threonine-tRNA ligase activity,MF,
2924,GO:0006435,1.00000000001144,0.800628800091121,0,3,threonyl-tRNA aminoacylation,BP,
7689,GO:0032129,1.00000000001145,0.868877704547701,0,2,histone deacetylase activity (H3-K9 specific),MF,
11941,GO:0046969,1.00000000001145,0.868877704547701,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19609,GO:1990619,1.00000000001145,0.868877704547701,0,2,histone H3-K9 deacetylation,BP,
9170,GO:0035517,1.00000000001145,0.774981699132185,0,3,PR-DUB complex,CC,
18647,GO:1903905,1.00000000001146,0.841681631029962,0,2,positive regulation of establishment of T cell polarity,BP,
15375,GO:0071593,1.00000000001146,0.795879486503554,0,3,lymphocyte aggregation,BP,
2179,GO:0005021,1.00000000001147,0.853000642366238,0,2,vascular endothelial growth factor-activated receptor activity,MF,
14210,GO:0061091,1.00000000001147,0.918634176998962,0,1,regulation of phospholipid translocation,BP,
14211,GO:0061092,1.00000000001147,0.918634176998962,0,1,positive regulation of phospholipid translocation,BP,
6524,GO:0021898,1.00000000001149,0.804023490256039,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
2011,GO:0004733,1.00000000001149,0.925691253529218,0,1,pyridoxamine-phosphate oxidase activity,MF,
9271,GO:0035673,1.00000000001149,0.716259914023768,0,4,oligopeptide transmembrane transporter activity,MF,
11549,GO:0046060,1.0000000000115,0.749966734133626,0,5,dATP metabolic process,BP,
13673,GO:0060161,1.0000000000115,0.799006813882812,0,3,positive regulation of dopamine receptor signaling pathway,BP,
627,GO:0001808,1.00000000001151,0.934262437991104,0,1,negative regulation of type IV hypersensitivity,BP,
1208,GO:0002865,1.00000000001151,0.934262437991104,0,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1217,GO:0002884,1.00000000001151,0.934262437991104,0,1,negative regulation of hypersensitivity,BP,
13212,GO:0051799,1.00000000001151,0.782825746602863,0,3,negative regulation of hair follicle development,BP,
112,GO:0000229,1.00000000001152,0.940932326089691,0,1,cytoplasmic chromosome,CC,
127,GO:0000262,1.00000000001152,0.940932326089691,0,1,mitochondrial chromosome,CC,
9371,GO:0035877,1.00000000001153,0.752240497111947,0,4,death effector domain binding,MF,
6004,GO:0019035,1.00000000001153,0.914977045222102,0,1,viral integration complex,CC,
11453,GO:0045870,1.00000000001153,0.914977045222102,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
19305,GO:1905463,1.00000000001153,0.914977045222102,0,1,negative regulation of DNA duplex unwinding,BP,
2570,GO:0005853,1.00000000001155,0.837264867581939,0,3,eukaryotic translation elongation factor 1 complex,CC,
8551,GO:0033872,1.00000000001156,0.934411172802973,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
5080,GO:0015307,1.00000000001156,0.872547317809029,0,2,drug:proton antiporter activity,MF,
11776,GO:0046618,1.00000000001156,0.872547317809029,0,2,drug export,BP,
11617,GO:0046208,1.00000000001157,0.834598858129702,0,3,spermine catabolic process,BP,
3830,GO:0008428,1.00000000001157,0.800891656365971,0,3,ribonuclease inhibitor activity,MF,
2352,GO:0005415,1.00000000001158,0.867561464058041,0,2,nucleoside:sodium symporter activity,MF,
5241,GO:0015860,1.00000000001158,0.867561464058041,0,2,purine nucleoside transmembrane transport,BP,
8953,GO:0034987,1.00000000001158,0.900122300941001,0,1,immunoglobulin receptor binding,MF,
8954,GO:0034988,1.00000000001158,0.900122300941001,0,1,Fc-gamma receptor I complex binding,MF,
13806,GO:0060372,1.00000000001158,0.900122300941001,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
19126,GO:1905000,1.00000000001158,0.900122300941001,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
13990,GO:0060677,1.00000000001159,0.631413384390786,0,5,ureteric bud elongation,BP,
18441,GO:1903445,1.0000000000116,0.829753569472297,0,3,protein transport from ciliary membrane to plasma membrane,BP,
9052,GO:0035261,1.0000000000116,0.79564056181475,0,2,external genitalia morphogenesis,BP,
2139,GO:0004947,1.00000000001161,0.874290499249611,0,2,bradykinin receptor activity,MF,
15321,GO:0071494,1.00000000001162,0.726440450611463,0,4,cellular response to UV-C,BP,
4217,GO:0009378,1.00000000001162,0.665953338036861,0,5,four-way junction helicase activity,MF,
895,GO:0002265,1.00000000001163,0.733725235483284,0,3,astrocyte activation involved in immune response,BP,
18945,GO:1904631,1.00000000001163,0.932263968276996,0,1,response to glucoside,BP,
15027,GO:0070939,1.00000000001163,0.78046117528496,0,3,Dsl1/NZR complex,CC,
5972,GO:0018401,1.00000000001163,0.679320854320433,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
14572,GO:0070081,1.00000000001165,0.803227341166347,0,3,clathrin-sculpted monoamine transport vesicle,CC,
14573,GO:0070083,1.00000000001165,0.803227341166347,0,3,clathrin-sculpted monoamine transport vesicle membrane,CC,
14675,GO:0070259,1.00000000001165,0.858504736718816,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
12478,GO:0050265,1.00000000001165,0.776936256832765,0,3,RNA uridylyltransferase activity,MF,
15065,GO:0070993,1.00000000001165,0.850261069116519,0,2,translation preinitiation complex,CC,
2577,GO:0005863,1.00000000001166,0.924716201774666,0,1,striated muscle myosin thick filament,CC,
3309,GO:0007014,1.00000000001166,0.924716201774666,0,1,actin ubiquitination,BP,
9588,GO:0036392,1.00000000001166,0.924716201774666,0,1,chemokine (C-C motif) ligand 20 production,BP,
18628,GO:1903881,1.00000000001166,0.924716201774666,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18629,GO:1903883,1.00000000001166,0.924716201774666,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18630,GO:1903884,1.00000000001166,0.924716201774666,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18631,GO:1903886,1.00000000001166,0.924716201774666,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
15401,GO:0071630,1.00000000001168,0.771193958507261,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
3873,GO:0008496,1.00000000001169,0.922454044190161,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4851,GO:0014061,1.0000000000117,0.7980410502481,0,3,regulation of norepinephrine secretion,BP,
13909,GO:0060528,1.0000000000117,0.764106532873072,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
17304,GO:0140031,1.00000000001171,0.864395350759327,0,2,phosphorylation-dependent protein binding,MF,
14229,GO:0061140,1.00000000001171,0.810382228037201,0,3,lung secretory cell differentiation,BP,
10216,GO:0042822,1.00000000001173,0.784042403374916,0,3,pyridoxal phosphate metabolic process,BP,
19601,GO:1990590,1.00000000001174,0.873693324960395,0,2,ATF1-ATF4 transcription factor complex,CC,
3833,GO:0008431,1.00000000001176,0.927407645030425,0,1,vitamin E binding,MF,
1926,GO:0004617,1.00000000001176,0.93450388360732,0,1,phosphoglycerate dehydrogenase activity,MF,
620,GO:0001787,1.00000000001176,0.721603321695801,0,5,natural killer cell proliferation,BP,
12106,GO:0048058,1.00000000001177,0.926284507549833,0,1,compound eye corneal lens development,BP,
12382,GO:0048749,1.00000000001177,0.926284507549833,0,1,compound eye development,BP,
2823,GO:0006288,1.00000000001179,0.819347018655877,0,3,base-excision repair, DNA ligation,BP,
5117,GO:0015439,1.00000000001179,0.927701937809142,0,1,heme-transporting ATPase activity,MF,
18040,GO:1902504,1.00000000001179,0.927701937809142,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
8445,GO:0033557,1.00000000001181,0.799500692804415,0,3,Slx1-Slx4 complex,CC,
13476,GO:0052905,1.00000000001181,0.799500692804415,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
17479,GO:1900245,1.00000000001181,0.761689650396634,0,3,positive regulation of MDA-5 signaling pathway,BP,
6640,GO:0023021,1.00000000001181,0.805316357368138,0,3,termination of signal transduction,BP,
8368,GO:0033239,1.00000000001182,0.713077197953537,0,4,negative regulation of cellular amine metabolic process,BP,
18584,GO:1903774,1.00000000001182,0.816240087604497,0,3,positive regulation of viral budding via host ESCRT complex,BP,
3934,GO:0008614,1.00000000001182,0.864046985186467,0,2,pyridoxine metabolic process,BP,
3935,GO:0008615,1.00000000001182,0.864046985186467,0,2,pyridoxine biosynthetic process,BP,
3547,GO:0007576,1.00000000001183,0.929993695868556,0,1,nucleolar fragmentation,BP,
5533,GO:0016507,1.00000000001183,0.927409860153305,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
9498,GO:0036125,1.00000000001183,0.927409860153305,0,1,fatty acid beta-oxidation multienzyme complex,CC,
3338,GO:0007056,1.00000000001184,0.869749541912561,0,2,spindle assembly involved in female meiosis,BP,
3339,GO:0007057,1.00000000001184,0.869749541912561,0,2,spindle assembly involved in female meiosis I,BP,
14740,GO:0070376,1.00000000001184,0.928121042290774,0,1,regulation of ERK5 cascade,BP,
14741,GO:0070377,1.00000000001184,0.928121042290774,0,1,negative regulation of ERK5 cascade,BP,
6551,GO:0021966,1.00000000001185,0.918918836019891,0,1,corticospinal neuron axon guidance,BP,
6552,GO:0021972,1.00000000001185,0.918918836019891,0,1,corticospinal neuron axon guidance through spinal cord,BP,
12725,GO:0050924,1.00000000001185,0.918918836019891,0,1,positive regulation of negative chemotaxis,BP,
12730,GO:0050929,1.00000000001185,0.918918836019891,0,1,induction of negative chemotaxis,BP,
15397,GO:0071623,1.00000000001185,0.918918836019891,0,1,negative regulation of granulocyte chemotaxis,BP,
16085,GO:0090024,1.00000000001185,0.918918836019891,0,1,negative regulation of neutrophil chemotaxis,BP,
16236,GO:0090260,1.00000000001185,0.918918836019891,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
18089,GO:1902623,1.00000000001185,0.918918836019891,0,1,negative regulation of neutrophil migration,BP,
19677,GO:1990851,1.00000000001185,0.759117842807186,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
4954,GO:0015015,1.00000000001186,0.733860091381177,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
8801,GO:0034481,1.00000000001186,0.723111166403578,0,4,chondroitin sulfotransferase activity,MF,
7425,GO:0031510,1.00000000001186,0.81607511898498,0,3,SUMO activating enzyme complex,CC,
11474,GO:0045914,1.00000000001186,0.863876697614858,0,2,negative regulation of catecholamine metabolic process,BP,
11508,GO:0045963,1.00000000001186,0.863876697614858,0,2,negative regulation of dopamine metabolic process,BP,
8452,GO:0033566,1.00000000001187,0.863935353961772,0,2,gamma-tubulin complex localization,BP,
2575,GO:0005861,1.00000000001187,0.797452098898848,0,4,troponin complex,CC,
521,GO:0001608,1.00000000001189,0.701146195943925,0,5,G-protein coupled nucleotide receptor activity,MF,
9213,GO:0035589,1.00000000001189,0.701146195943925,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
11061,GO:0045028,1.00000000001189,0.701146195943925,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
5003,GO:0015143,1.0000000000119,0.936460891120065,0,1,urate transmembrane transporter activity,MF,
15813,GO:0072428,1.0000000000119,0.936460891120065,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
17778,GO:1901702,1.0000000000119,0.936460891120065,0,1,salt transmembrane transporter activity,MF,
18659,GO:1903925,1.0000000000119,0.936460891120065,0,1,response to bisphenol A,BP,
18660,GO:1903926,1.0000000000119,0.936460891120065,0,1,cellular response to bisphenol A,BP,
5011,GO:0015166,1.0000000000119,0.698367034013807,0,4,polyol transmembrane transporter activity,MF,
5290,GO:0015942,1.00000000001191,0.821519450314909,0,3,formate metabolic process,BP,
10660,GO:0043686,1.00000000001192,0.821229521443085,0,3,co-translational protein modification,BP,
13634,GO:0060086,1.00000000001194,0.861006711408513,0,2,circadian temperature homeostasis,BP,
10977,GO:0044729,1.00000000001195,0.794235294809578,0,3,hemi-methylated DNA-binding,MF,
15447,GO:0071701,1.00000000001196,0.919569005808975,0,1,regulation of MAPK export from nucleus,BP,
7718,GO:0032202,1.00000000001196,0.754745288581021,0,4,telomere assembly,BP,
2188,GO:0005042,1.00000000001196,0.918774135770574,0,1,netrin receptor activity,MF,
3999,GO:0008900,1.00000000001197,0.925235598756547,0,1,potassium:proton exchanging ATPase activity,MF,
19407,GO:1905843,1.00000000001197,0.887058535440847,0,1,regulation of cellular response to gamma radiation,BP,
7038,GO:0030806,1.00000000001198,0.842418832360331,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7053,GO:0030821,1.00000000001198,0.842418832360331,0,2,negative regulation of cAMP catabolic process,BP,
8301,GO:0033122,1.00000000001198,0.842418832360331,0,2,negative regulation of purine nucleotide catabolic process,BP,
14483,GO:0061833,1.000000000012,0.859753185404212,0,2,protein localization to tricellular tight junction,BP,
8209,GO:0032954,1.000000000012,0.844478131346614,0,2,regulation of cytokinetic process,BP,
18434,GO:1903436,1.000000000012,0.844478131346614,0,2,regulation of mitotic cytokinetic process,BP,
18435,GO:1903438,1.000000000012,0.844478131346614,0,2,positive regulation of mitotic cytokinetic process,BP,
18450,GO:1903490,1.000000000012,0.844478131346614,0,2,positive regulation of mitotic cytokinesis,BP,
8687,GO:0034271,1.00000000001201,0.794751072976426,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8688,GO:0034272,1.00000000001201,0.794751072976426,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
5537,GO:0016517,1.00000000001201,0.93491421394567,0,1,interleukin-12 receptor activity,MF,
6717,GO:0030124,1.00000000001201,0.747217223038768,0,4,AP-4 adaptor complex,CC,
9824,GO:0042019,1.00000000001201,0.93491421394567,0,1,interleukin-23 binding,MF,
9825,GO:0042020,1.00000000001201,0.93491421394567,0,1,interleukin-23 receptor activity,MF,
9826,GO:0042022,1.00000000001201,0.93491421394567,0,1,interleukin-12 receptor complex,CC,
15850,GO:0072536,1.00000000001201,0.93491421394567,0,1,interleukin-23 receptor complex,CC,
10234,GO:0042903,1.00000000001202,0.863413560314392,0,2,tubulin deacetylase activity,MF,
19575,GO:1990460,1.00000000001202,0.78387733060693,0,3,leptin receptor binding,MF,
8009,GO:0032627,1.00000000001203,0.717866933138883,0,5,interleukin-23 production,BP,
8033,GO:0032667,1.00000000001203,0.717866933138883,0,5,regulation of interleukin-23 production,BP,
14346,GO:0061502,1.00000000001204,0.693396062214466,0,4,early endosome to recycling endosome transport,BP,
8636,GO:0034146,1.00000000001205,0.921643144698688,0,1,toll-like receptor 5 signaling pathway,BP,
8637,GO:0034147,1.00000000001205,0.921643144698688,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8638,GO:0034148,1.00000000001205,0.921643144698688,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
14765,GO:0070425,1.00000000001205,0.921643144698688,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14768,GO:0070428,1.00000000001205,0.921643144698688,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14769,GO:0070429,1.00000000001205,0.921643144698688,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14772,GO:0070433,1.00000000001205,0.921643144698688,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15873,GO:0072573,1.00000000001205,0.921643144698688,0,1,tolerance induction to lipopolysaccharide,BP,
16259,GO:0090291,1.00000000001205,0.921643144698688,0,1,negative regulation of osteoclast proliferation,BP,
19905,GO:2000349,1.00000000001205,0.921643144698688,0,1,negative regulation of CD40 signaling pathway,BP,
6841,GO:0030299,1.00000000001205,0.867195779689618,0,2,intestinal cholesterol absorption,BP,
10792,GO:0044241,1.00000000001205,0.867195779689618,0,2,lipid digestion,BP,
16922,GO:0098856,1.00000000001205,0.867195779689618,0,2,intestinal lipid absorption,BP,
1835,GO:0004487,1.00000000001206,0.803665491051772,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
6348,GO:0021521,1.00000000001207,0.753854728157675,0,3,ventral spinal cord interneuron specification,BP,
6458,GO:0021775,1.00000000001207,0.753854728157675,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6459,GO:0021776,1.00000000001207,0.753854728157675,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
13936,GO:0060573,1.00000000001207,0.753854728157675,0,3,cell fate specification involved in pattern specification,BP,
13942,GO:0060579,1.00000000001207,0.753854728157675,0,3,ventral spinal cord interneuron fate commitment,BP,
13943,GO:0060581,1.00000000001207,0.753854728157675,0,3,cell fate commitment involved in pattern specification,BP,
14753,GO:0070407,1.00000000001207,0.927095458998289,0,1,oxidation-dependent protein catabolic process,BP,
15492,GO:0071818,1.00000000001209,0.807435985538497,0,3,BAT3 complex,CC,
15794,GO:0072379,1.00000000001209,0.807435985538497,0,3,ER membrane insertion complex,CC,
8350,GO:0033192,1.00000000001209,0.659408795331695,0,5,calmodulin-dependent protein phosphatase activity,MF,
12507,GO:0050473,1.0000000000121,0.856385429411292,0,2,arachidonate 15-lipoxygenase activity,MF,
5397,GO:0016231,1.00000000001211,0.918133402385453,0,1,beta-N-acetylglucosaminidase activity,MF,
17152,GO:0102166,1.00000000001211,0.918133402385453,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17153,GO:0102167,1.00000000001211,0.918133402385453,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17184,GO:0102571,1.00000000001211,0.918133402385453,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18420,GO:1903420,1.00000000001211,0.911305634314724,0,1,protein localization to endoplasmic reticulum tubular network,BP,
1411,GO:0003342,1.00000000001213,0.927552613153802,0,1,proepicardium development,BP,
1412,GO:0003343,1.00000000001213,0.927552613153802,0,1,septum transversum development,BP,
16610,GO:0097403,1.00000000001213,0.927552613153802,0,1,cellular response to raffinose,BP,
17702,GO:1901545,1.00000000001213,0.927552613153802,0,1,response to raffinose,BP,
3111,GO:0006689,1.00000000001215,0.751194245739689,0,4,ganglioside catabolic process,BP,
13088,GO:0051572,1.00000000001218,0.774009073796039,0,3,negative regulation of histone H3-K4 methylation,BP,
5996,GO:0018993,1.00000000001219,0.928045195673146,0,1,somatic sex determination,BP,
6036,GO:0019101,1.00000000001219,0.928045195673146,0,1,female somatic sex determination,BP,
13573,GO:0060014,1.00000000001219,0.928045195673146,0,1,granulosa cell differentiation,BP,
6474,GO:0021800,1.00000000001219,0.648543606959746,0,5,cerebral cortex tangential migration,BP,
16706,GO:0097632,1.00000000001219,0.851598991014424,0,2,extrinsic component of phagophore assembly site membrane,CC,
18994,GO:1904743,1.00000000001219,0.813527641817014,0,2,negative regulation of telomeric DNA binding,BP,
7953,GO:0032542,1.00000000001219,0.860717272360349,0,2,sulfiredoxin activity,MF,
14330,GO:0061444,1.0000000000122,0.913458347582446,0,1,endocardial cushion cell development,BP,
9970,GO:0042335,1.0000000000122,0.778219810323519,0,3,cuticle development,BP,
9216,GO:0035594,1.0000000000122,0.804635356493728,0,3,ganglioside binding,MF,
4902,GO:0014827,1.0000000000122,0.932366840635541,0,1,intestine smooth muscle contraction,BP,
18717,GO:1904044,1.0000000000122,0.829983042447793,0,3,response to aldosterone,BP,
14841,GO:0070564,1.00000000001221,0.868281998383341,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
11746,GO:0046541,1.00000000001221,0.928879891312467,0,1,saliva secretion,BP,
5373,GO:0016175,1.00000000001222,0.89766871401302,0,2,superoxide-generating NADPH oxidase activity,MF,
10285,GO:0043020,1.00000000001222,0.89766871401302,0,2,NADPH oxidase complex,CC,
4327,GO:0009826,1.00000000001222,0.852903301260894,0,2,unidimensional cell growth,BP,
486,GO:0001537,1.00000000001223,0.853277434419827,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
2126,GO:0004918,1.00000000001223,0.93041159008987,0,1,interleukin-8 receptor activity,MF,
6317,GO:0019959,1.00000000001223,0.93041159008987,0,1,interleukin-8 binding,MF,
9717,GO:0038112,1.00000000001223,0.93041159008987,0,1,interleukin-8-mediated signaling pathway,BP,
6805,GO:0030242,1.00000000001224,0.664637893042568,0,5,autophagy of peroxisome,BP,
18099,GO:1902659,1.00000000001227,0.816724486432817,0,3,regulation of glucose mediated signaling pathway,BP,
18100,GO:1902661,1.00000000001227,0.816724486432817,0,3,positive regulation of glucose mediated signaling pathway,BP,
5366,GO:0016149,1.00000000001227,0.924808557508331,0,1,translation release factor activity, codon specific,MF,
6112,GO:0019348,1.00000000001227,0.716266900125055,0,5,dolichol metabolic process,BP,
19573,GO:1990456,1.00000000001228,0.924230598443406,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
11983,GO:0047186,1.00000000001229,0.924017306268714,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
3846,GO:0008454,1.0000000000123,0.848511827478588,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
7737,GO:0032227,1.00000000001231,0.786610396850704,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
3928,GO:0008607,1.00000000001231,0.808657218257602,0,3,phosphorylase kinase regulator activity,MF,
4615,GO:0010730,1.00000000001233,0.790110401518051,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
11326,GO:0045629,1.00000000001234,0.805646859942929,0,3,negative regulation of T-helper 2 cell differentiation,BP,
9274,GO:0035686,1.00000000001235,0.835767836972337,0,3,sperm fibrous sheath,CC,
19365,GO:1905661,1.00000000001235,0.8628792619647,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19366,GO:1905663,1.00000000001235,0.8628792619647,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
18882,GO:1904475,1.00000000001236,0.829394096028877,0,2,regulation of Ras GTPase binding,BP,
20239,GO:2001106,1.00000000001236,0.829394096028877,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
16612,GO:0097411,1.00000000001237,0.732635290460349,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
48,GO:0000101,1.00000000001237,0.79008720703212,0,3,sulfur amino acid transport,BP,
9725,GO:0038131,1.00000000001238,0.866948453384999,0,2,neuregulin receptor activity,MF,
17246,GO:0106104,1.00000000001239,0.843443909793197,0,2,regulation of glutamate receptor clustering,BP,
18983,GO:1904717,1.00000000001239,0.843443909793197,0,2,regulation of AMPA glutamate receptor clustering,BP,
13168,GO:0051717,1.00000000001239,0.85029188824749,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
7801,GO:0032345,1.0000000000124,0.796384058324762,0,3,negative regulation of aldosterone metabolic process,BP,
7804,GO:0032348,1.0000000000124,0.796384058324762,0,3,negative regulation of aldosterone biosynthetic process,BP,
19751,GO:2000065,1.0000000000124,0.796384058324762,0,3,negative regulation of cortisol biosynthetic process,BP,
16815,GO:0098634,1.00000000001241,0.705082081307322,0,4,cell-matrix adhesion mediator activity,MF,
16817,GO:0098639,1.00000000001241,0.705082081307322,0,4,collagen binding involved in cell-matrix adhesion,MF,
5980,GO:0018479,1.00000000001241,0.933595364789646,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
9718,GO:0038113,1.00000000001241,0.84170130739492,0,2,interleukin-9-mediated signaling pathway,BP,
15109,GO:0071104,1.00000000001241,0.84170130739492,0,2,response to interleukin-9,BP,
15226,GO:0071355,1.00000000001241,0.84170130739492,0,2,cellular response to interleukin-9,BP,
19554,GO:1990415,1.00000000001242,0.800945978270028,0,3,Pex17p-Pex14p docking complex,CC,
19562,GO:1990429,1.00000000001242,0.800945978270028,0,3,peroxisomal importomer complex,CC,
429,GO:0001147,1.00000000001242,0.82148380093687,0,2,transcription termination site sequence-specific DNA binding,MF,
432,GO:0001160,1.00000000001242,0.82148380093687,0,2,transcription termination site DNA binding,MF,
15743,GO:0072298,1.00000000001242,0.790571691226335,0,3,regulation of metanephric glomerulus development,BP,
3727,GO:0008260,1.00000000001242,0.925286511889142,0,1,3-oxoacid CoA-transferase activity,MF,
10302,GO:0043041,1.00000000001242,0.925286511889142,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
329,GO:0000917,1.00000000001243,0.936729786007007,0,1,division septum assembly,BP,
16343,GO:0090529,1.00000000001243,0.936729786007007,0,1,cell septum assembly,BP,
18275,GO:1903070,1.00000000001245,0.81278951523687,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
1351,GO:0003213,1.00000000001247,0.819355471188496,0,2,cardiac right atrium morphogenesis,BP,
12233,GO:0048408,1.00000000001247,0.773508343210482,0,4,epidermal growth factor binding,MF,
18445,GO:1903463,1.00000000001247,0.793310610163278,0,3,regulation of mitotic cell cycle DNA replication,BP,
6694,GO:0030061,1.00000000001248,0.685083875183473,0,5,mitochondrial crista,CC,
14259,GO:0061209,1.00000000001249,0.806071115672106,0,3,cell proliferation involved in mesonephros development,BP,
1602,GO:0004018,1.00000000001253,0.943199444167456,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
14871,GO:0070626,1.00000000001253,0.943199444167456,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
11575,GO:0046102,1.00000000001254,0.815380322077479,0,3,inosine metabolic process,BP,
6561,GO:0021997,1.00000000001254,0.824123026932566,0,2,neural plate axis specification,BP,
13795,GO:0060353,1.00000000001255,0.820819325397829,0,3,regulation of cell adhesion molecule production,BP,
13796,GO:0060355,1.00000000001255,0.820819325397829,0,3,positive regulation of cell adhesion molecule production,BP,
9245,GO:0035630,1.00000000001255,0.773257525789384,0,3,bone mineralization involved in bone maturation,BP,
18442,GO:1903450,1.00000000001255,0.899633369938738,0,1,regulation of G1 to G0 transition,BP,
18443,GO:1903452,1.00000000001255,0.899633369938738,0,1,positive regulation of G1 to G0 transition,BP,
15367,GO:0071579,1.00000000001255,0.934574013169828,0,1,regulation of zinc ion transport,BP,
15368,GO:0071580,1.00000000001255,0.934574013169828,0,1,regulation of zinc ion transmembrane transport,BP,
15369,GO:0071581,1.00000000001255,0.934574013169828,0,1,regulation of zinc ion transmembrane import,BP,
15370,GO:0071582,1.00000000001255,0.934574013169828,0,1,negative regulation of zinc ion transport,BP,
15371,GO:0071583,1.00000000001255,0.934574013169828,0,1,negative regulation of zinc ion transmembrane transport,BP,
15372,GO:0071584,1.00000000001255,0.934574013169828,0,1,negative regulation of zinc ion transmembrane import,BP,
15373,GO:0071585,1.00000000001255,0.934574013169828,0,1,detoxification of cadmium ion,BP,
19498,GO:1990170,1.00000000001255,0.934574013169828,0,1,stress response to cadmium ion,BP,
5918,GO:0018171,1.00000000001256,0.780949901906295,0,4,peptidyl-cysteine oxidation,BP,
13061,GO:0051499,1.00000000001256,0.877684760761953,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13062,GO:0051500,1.00000000001256,0.877684760761953,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
998,GO:0002457,1.00000000001258,0.736537673343486,0,4,T cell antigen processing and presentation,BP,
621,GO:0001792,1.00000000001259,0.922350097301818,0,1,polymeric immunoglobulin receptor activity,MF,
965,GO:0002386,1.00000000001259,0.922350097301818,0,1,immune response in mucosal-associated lymphoid tissue,BP,
971,GO:0002415,1.00000000001259,0.922350097301818,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
5172,GO:0015722,1.00000000001259,0.788303105172746,0,3,canalicular bile acid transport,BP,
3605,GO:0008046,1.00000000001262,0.702315888704233,0,4,axon guidance receptor activity,MF,
3097,GO:0006671,1.00000000001263,0.921825818665918,0,1,phytosphingosine metabolic process,BP,
14939,GO:0070774,1.00000000001263,0.921825818665918,0,1,phytoceramidase activity,MF,
15381,GO:0071602,1.00000000001263,0.921825818665918,0,1,phytosphingosine biosynthetic process,BP,
2431,GO:0005610,1.00000000001264,0.737704157638852,0,3,laminin-5 complex,CC,
7544,GO:0031798,1.00000000001264,0.904746949368124,0,1,type 1 metabotropic glutamate receptor binding,MF,
14481,GO:0061828,1.00000000001264,0.904746949368124,0,1,apical tubulobulbar complex,CC,
14482,GO:0061829,1.00000000001264,0.904746949368124,0,1,basal tubulobulbar complex,CC,
13921,GO:0060545,1.00000000001265,0.864674951340162,0,2,positive regulation of necroptotic process,BP,
12249,GO:0048495,1.00000000001265,0.714306246497336,0,4,Roundabout binding,MF,
19295,GO:1905448,1.00000000001265,0.778803394785551,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
4004,GO:0008941,1.00000000001265,0.87010001164644,0,2,nitric oxide dioxygenase activity,MF,
5632,GO:0016708,1.00000000001265,0.87010001164644,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
18753,GO:1904177,1.00000000001266,0.771398851599321,0,3,regulation of adipose tissue development,BP,
18754,GO:1904179,1.00000000001266,0.771398851599321,0,3,positive regulation of adipose tissue development,BP,
19496,GO:1990168,1.00000000001267,0.787427242798081,0,3,protein K33-linked deubiquitination,BP,
3736,GO:0008273,1.00000000001267,0.843059706514832,0,2,calcium, potassium:sodium antiporter activity,MF,
2655,GO:0005997,1.00000000001267,0.785624619326913,0,4,xylulose metabolic process,BP,
5920,GO:0018192,1.00000000001269,0.93059424951426,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7886,GO:0032447,1.00000000001269,0.93059424951426,0,1,protein urmylation,BP,
9949,GO:0042292,1.00000000001269,0.93059424951426,0,1,URM1 activating enzyme activity,MF,
14385,GO:0061604,1.00000000001269,0.93059424951426,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14386,GO:0061605,1.00000000001269,0.93059424951426,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16903,GO:0098822,1.00000000001269,0.93059424951426,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
19436,GO:1905937,1.0000000000127,0.956899626892833,0,1,negative regulation of germ cell proliferation,BP,
19840,GO:2000255,1.0000000000127,0.956899626892833,0,1,negative regulation of male germ cell proliferation,BP,
14475,GO:0061817,1.00000000001271,0.776828663410492,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
2385,GO:0005519,1.00000000001271,0.923657094203028,0,1,cytoskeletal regulatory protein binding,MF,
1721,GO:0004310,1.00000000001272,0.933542876680243,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
13314,GO:0051996,1.00000000001272,0.933542876680243,0,1,squalene synthase activity,MF,
17502,GO:1900376,1.00000000001272,0.693681750833142,0,4,regulation of secondary metabolite biosynthetic process,BP,
383,GO:0001018,1.00000000001273,0.867323982157877,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
16031,GO:0086024,1.00000000001273,0.902253340391041,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17343,GO:0140200,1.00000000001273,0.902253340391041,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17571,GO:1901078,1.00000000001273,0.902253340391041,0,1,negative regulation of relaxation of muscle,BP,
17829,GO:1901898,1.00000000001273,0.902253340391041,0,1,negative regulation of relaxation of cardiac muscle,BP,
1976,GO:0004689,1.00000000001273,0.708052669800825,0,4,phosphorylase kinase activity,MF,
2634,GO:0005964,1.00000000001273,0.708052669800825,0,4,phosphorylase kinase complex,CC,
10377,GO:0043183,1.00000000001273,0.880683686109818,0,2,vascular endothelial growth factor receptor 1 binding,MF,
553,GO:0001674,1.00000000001275,0.859875485277067,0,2,female germ cell nucleus,CC,
10094,GO:0042585,1.00000000001275,0.859875485277067,0,2,germinal vesicle,CC,
244,GO:0000700,1.00000000001276,0.76426181121788,0,4,mismatch base pair DNA N-glycosylase activity,MF,
8409,GO:0033342,1.00000000001277,0.930125490686803,0,1,negative regulation of collagen binding,BP,
11253,GO:0045415,1.00000000001277,0.809242501184253,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
11345,GO:0045654,1.00000000001277,0.877280051003167,0,2,positive regulation of megakaryocyte differentiation,BP,
9117,GO:0035400,1.00000000001278,0.917231099536848,0,1,histone tyrosine kinase activity,MF,
9118,GO:0035401,1.00000000001278,0.917231099536848,0,1,histone kinase activity (H3-Y41 specific),MF,
9123,GO:0035406,1.00000000001278,0.917231099536848,0,1,histone-tyrosine phosphorylation,BP,
9126,GO:0035409,1.00000000001278,0.917231099536848,0,1,histone H3-Y41 phosphorylation,BP,
14903,GO:0070678,1.00000000001279,0.929209667862688,0,1,preprotein binding,MF,
6414,GO:0021649,1.0000000000128,0.930385000519737,0,1,vestibulocochlear nerve structural organization,BP,
9700,GO:0038085,1.0000000000128,0.930385000519737,0,1,vascular endothelial growth factor binding,MF,
13752,GO:0060301,1.0000000000128,0.930385000519737,0,1,positive regulation of cytokine activity,BP,
14369,GO:0061552,1.0000000000128,0.930385000519737,0,1,ganglion morphogenesis,BP,
16598,GO:0097374,1.0000000000128,0.930385000519737,0,1,sensory neuron axon guidance,BP,
18000,GO:1902378,1.0000000000128,0.930385000519737,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19042,GO:1904835,1.0000000000128,0.930385000519737,0,1,dorsal root ganglion morphogenesis,BP,
19139,GO:1905040,1.0000000000128,0.930385000519737,0,1,otic placode development,BP,
4525,GO:0010585,1.0000000000128,0.935663411562849,0,1,glutamine secretion,BP,
18601,GO:1903803,1.0000000000128,0.935663411562849,0,1,L-glutamine import across plasma membrane,BP,
7753,GO:0032262,1.0000000000128,0.731050595877434,0,5,pyrimidine nucleotide salvage,BP,
9542,GO:0036266,1.0000000000128,0.929965834506406,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
15918,GO:0072671,1.0000000000128,0.929965834506406,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
15961,GO:0072752,1.00000000001281,0.910284140634166,0,1,cellular response to rapamycin,BP,
15895,GO:0072603,1.00000000001281,0.741306245398987,0,4,interleukin-5 secretion,BP,
20073,GO:2000662,1.00000000001281,0.741306245398987,0,4,regulation of interleukin-5 secretion,BP,
1768,GO:0004368,1.00000000001282,0.913892445984279,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
2744,GO:0006127,1.00000000001282,0.913892445984279,0,1,glycerophosphate shuttle,BP,
5756,GO:0016901,1.00000000001282,0.913892445984279,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
13392,GO:0052590,1.00000000001282,0.913892445984279,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13393,GO:0052591,1.00000000001282,0.913892445984279,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
10954,GO:0044609,1.00000000001282,0.866177187056683,0,2,DBIRD complex,CC,
15432,GO:0071678,1.00000000001282,0.904472002415438,0,1,olfactory bulb axon guidance,BP,
8938,GO:0034777,1.00000000001282,0.932308515685459,0,1,recycling endosome lumen,CC,
15786,GO:0072364,1.00000000001284,0.802885161659934,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
529,GO:0001640,1.00000000001284,0.912730561140325,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
530,GO:0001642,1.00000000001284,0.912730561140325,0,1,group III metabotropic glutamate receptor activity,MF,
3412,GO:0007196,1.00000000001284,0.912730561140325,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
9349,GO:0035841,1.00000000001284,0.912730561140325,0,1,new growing cell tip,CC,
16992,GO:0098988,1.00000000001284,0.912730561140325,0,1,G-protein coupled glutamate receptor activity,MF,
12038,GO:0047631,1.00000000001285,0.757347511620138,0,5,ADP-ribose diphosphatase activity,MF,
1252,GO:0002950,1.00000000001286,0.795506276923999,0,3,ceramide phosphoethanolamine synthase activity,MF,
8348,GO:0033188,1.00000000001286,0.795506276923999,0,3,sphingomyelin synthase activity,MF,
12022,GO:0047493,1.00000000001286,0.795506276923999,0,3,ceramide cholinephosphotransferase activity,MF,
5051,GO:0015234,1.00000000001287,0.869552172021236,0,2,thiamine transmembrane transporter activity,MF,
15555,GO:0071934,1.00000000001287,0.869552172021236,0,2,thiamine transmembrane transport,BP,
18083,GO:1902612,1.00000000001288,0.92885914345011,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18084,GO:1902613,1.00000000001288,0.92885914345011,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19521,GO:1990262,1.00000000001288,0.92885914345011,0,1,anti-Mullerian hormone signaling pathway,BP,
109,GO:0000225,1.00000000001289,0.950737058777544,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
17759,GO:1901664,1.00000000001289,0.808056095465581,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17760,GO:1901666,1.00000000001289,0.808056095465581,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
2228,GO:0005128,1.00000000001292,0.92647824063096,0,1,erythropoietin receptor binding,MF,
2233,GO:0005135,1.00000000001292,0.92647824063096,0,1,interleukin-3 receptor binding,MF,
14291,GO:0061341,1.00000000001293,0.838472187051927,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
14293,GO:0061346,1.00000000001293,0.838472187051927,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
6903,GO:0030432,1.00000000001293,0.885654215160473,0,2,peristalsis,BP,
20282,GO:2001200,1.00000000001295,0.876057327295772,0,2,positive regulation of dendritic cell differentiation,BP,
14302,GO:0061357,1.00000000001296,0.790993404364003,0,3,positive regulation of Wnt protein secretion,BP,
8410,GO:0033343,1.00000000001297,0.903489014607096,0,1,positive regulation of collagen binding,BP,
2075,GO:0004826,1.00000000001297,0.704988347997839,0,5,phenylalanine-tRNA ligase activity,MF,
2921,GO:0006432,1.00000000001297,0.704988347997839,0,5,phenylalanyl-tRNA aminoacylation,BP,
19617,GO:1990666,1.00000000001298,0.848571525938717,0,2,PCSK9-LDLR complex,CC,
1821,GO:0004468,1.00000000001299,0.710507606451504,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
14373,GO:0061574,1.000000000013,0.801241005724678,0,3,ASAP complex,CC,
1806,GO:0004448,1.000000000013,0.720102571297757,0,5,isocitrate dehydrogenase activity,MF,
18080,GO:1902605,1.00000000001302,0.92888508755123,0,1,heterotrimeric G-protein complex assembly,BP,
12058,GO:0047801,1.00000000001303,0.933315742396919,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
16707,GO:0097635,1.00000000001303,0.84465146420255,0,2,extrinsic component of autophagosome membrane,CC,
10525,GO:0043423,1.00000000001303,0.922025304362654,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
19999,GO:2000537,1.00000000001303,0.922025304362654,0,1,regulation of B cell chemotaxis,BP,
20000,GO:2000538,1.00000000001303,0.922025304362654,0,1,positive regulation of B cell chemotaxis,BP,
6090,GO:0019249,1.00000000001304,0.80932863534405,0,3,lactate biosynthetic process,BP,
9822,GO:0042008,1.00000000001305,0.925462961160109,0,1,interleukin-18 receptor activity,MF,
19607,GO:1990613,1.00000000001305,0.925462961160109,0,1,mitochondrial membrane fusion,BP,
2416,GO:0005589,1.00000000001306,0.869783035825784,0,2,collagen type VI trimer,CC,
16824,GO:0098647,1.00000000001306,0.869783035825784,0,2,collagen beaded filament,CC,
5345,GO:0016080,1.00000000001306,0.775394722657325,0,3,synaptic vesicle targeting,BP,
4546,GO:0010621,1.00000000001306,0.952121244476749,0,1,negative regulation of transcription by transcription factor localization,BP,
9520,GO:0036164,1.00000000001306,0.952121244476749,0,1,cell-abiotic substrate adhesion,BP,
16175,GO:0090176,1.00000000001307,0.915546713248334,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
18480,GO:1903542,1.00000000001308,0.863356199585391,0,2,negative regulation of exosomal secretion,BP,
10842,GO:0044326,1.00000000001309,0.861707019862819,0,2,dendritic spine neck,CC,
15175,GO:0071275,1.00000000001309,0.93311455241791,0,1,cellular response to aluminum ion,BP,
19371,GO:1905672,1.00000000001309,0.93311455241791,0,1,negative regulation of lysosome organization,BP,
11964,GO:0047025,1.00000000001311,0.884025270445586,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
1741,GO:0004336,1.00000000001311,0.928054643635367,0,1,galactosylceramidase activity,MF,
3105,GO:0006683,1.00000000001311,0.928054643635367,0,1,galactosylceramide catabolic process,BP,
6131,GO:0019376,1.00000000001311,0.928054643635367,0,1,galactolipid catabolic process,BP,
17169,GO:0102420,1.00000000001313,0.785331403721958,0,3,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
14328,GO:0061441,1.00000000001314,0.854541982848695,0,2,renal artery morphogenesis,BP,
15791,GO:0072369,1.00000000001315,0.828176631066636,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
8115,GO:0032795,1.00000000001315,0.952669222980023,0,1,heterotrimeric G-protein binding,MF,
1636,GO:0004075,1.00000000001317,0.744891106707247,0,3,biotin carboxylase activity,MF,
14962,GO:0070836,1.00000000001318,0.803904437271595,0,3,caveola assembly,BP,
17827,GO:1901896,1.00000000001319,0.876579377816576,0,2,positive regulation of calcium-transporting ATPase activity,BP,
2079,GO:0004830,1.00000000001319,0.862705698660875,0,2,tryptophan-tRNA ligase activity,MF,
2925,GO:0006436,1.00000000001319,0.862705698660875,0,2,tryptophanyl-tRNA aminoacylation,BP,
9908,GO:0042182,1.0000000000132,0.712940145509309,0,5,ketone catabolic process,BP,
5251,GO:0015874,1.00000000001322,0.678642936714154,0,5,norepinephrine transport,BP,
1807,GO:0004449,1.00000000001323,0.823778761769101,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
19662,GO:1990809,1.00000000001327,0.748194323712907,0,4,endoplasmic reticulum tubular network membrane organization,BP,
14988,GO:0070876,1.00000000001328,0.736546666342498,0,4,SOSS complex,CC,
17338,GO:0140192,1.00000000001329,0.815381877162236,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
7104,GO:0030895,1.0000000000133,0.928864324880481,0,1,apolipoprotein B mRNA editing enzyme complex,CC,
8878,GO:0034676,1.00000000001332,0.914759383528798,0,1,integrin alpha6-beta4 complex,CC,
17735,GO:1901621,1.00000000001333,0.675672064982526,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
9145,GO:0035470,1.00000000001334,0.937353358490242,0,1,positive regulation of vascular wound healing,BP,
14000,GO:0060690,1.00000000001334,0.937353358490242,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14001,GO:0060691,1.00000000001334,0.937353358490242,0,1,epithelial cell maturation involved in salivary gland development,BP,
17396,GO:1900098,1.00000000001334,0.937353358490242,0,1,regulation of plasma cell differentiation,BP,
17397,GO:1900100,1.00000000001334,0.937353358490242,0,1,positive regulation of plasma cell differentiation,BP,
18449,GO:1903489,1.00000000001334,0.937353358490242,0,1,positive regulation of lactation,BP,
2022,GO:0004749,1.00000000001335,0.756417948440318,0,4,ribose phosphate diphosphokinase activity,MF,
5671,GO:0016778,1.00000000001335,0.756417948440318,0,4,diphosphotransferase activity,MF,
15785,GO:0072363,1.00000000001337,0.892585721499811,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15788,GO:0072366,1.00000000001337,0.892585721499811,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
9491,GO:0036117,1.00000000001341,0.868698364331409,0,2,hyaluranon cable,CC,
5134,GO:0015616,1.00000000001344,0.686930733975277,0,4,DNA translocase activity,MF,
8329,GO:0033159,1.00000000001345,0.794327522157545,0,3,negative regulation of protein import into nucleus, translocation,BP,
9823,GO:0042015,1.00000000001346,0.80232641175288,0,3,interleukin-20 binding,MF,
12482,GO:0050294,1.00000000001346,0.843708828630806,0,3,steroid sulfotransferase activity,MF,
10014,GO:0042421,1.00000000001349,0.804937738739406,0,3,norepinephrine biosynthetic process,BP,
2749,GO:0006147,1.0000000000135,0.916517074637471,0,1,guanine catabolic process,BP,
3995,GO:0008892,1.0000000000135,0.916517074637471,0,1,guanine deaminase activity,MF,
665,GO:0001866,1.00000000001351,0.785848326639112,0,4,NK T cell proliferation,BP,
13655,GO:0060134,1.00000000001351,0.849915756111149,0,2,prepulse inhibition,BP,
1160,GO:0002765,1.00000000001352,0.815428849721633,0,3,immune response-inhibiting signal transduction,BP,
18638,GO:1903895,1.00000000001353,0.739733618128729,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
18861,GO:1904426,1.00000000001353,0.846488555833423,0,2,positive regulation of GTP binding,BP,
20333,GO:2001287,1.00000000001354,0.871021931753659,0,2,negative regulation of caveolin-mediated endocytosis,BP,
4030,GO:0009061,1.00000000001356,0.930999068422851,0,1,anaerobic respiration,BP,
11197,GO:0045274,1.00000000001356,0.930999068422851,0,1,plasma membrane respiratory chain complex II,CC,
11201,GO:0045282,1.00000000001356,0.930999068422851,0,1,plasma membrane succinate dehydrogenase complex,CC,
3468,GO:0007290,1.00000000001357,0.919970338789396,0,1,spermatid nucleus elongation,BP,
11625,GO:0046293,1.00000000001357,0.919970338789396,0,1,formaldehyde biosynthetic process,BP,
14072,GO:0060821,1.00000000001357,0.899225105840029,0,1,inactivation of X chromosome by DNA methylation,BP,
16501,GO:0097166,1.00000000001357,0.899225105840029,0,1,lens epithelial cell proliferation,BP,
20241,GO:2001109,1.00000000001357,0.899225105840029,0,1,regulation of lens epithelial cell proliferation,BP,
20242,GO:2001111,1.00000000001357,0.899225105840029,0,1,positive regulation of lens epithelial cell proliferation,BP,
2963,GO:0006499,1.00000000001357,0.708661482391059,0,4,N-terminal protein myristoylation,BP,
5967,GO:0018377,1.00000000001357,0.708661482391059,0,4,protein myristoylation,BP,
18691,GO:1903984,1.00000000001358,0.784008687256918,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
2277,GO:0005219,1.00000000001358,0.715532770330356,0,3,ryanodine-sensitive calcium-release channel activity,MF,
11532,GO:0046032,1.00000000001359,0.942098185344667,0,1,ADP catabolic process,BP,
14511,GO:0061944,1.00000000001361,0.922085207039526,0,1,negative regulation of protein K48-linked ubiquitination,BP,
18727,GO:1904059,1.00000000001361,0.870823005312568,0,1,regulation of locomotor rhythm,BP,
8344,GO:0033183,1.00000000001361,0.759452040026403,0,3,negative regulation of histone ubiquitination,BP,
17642,GO:1901314,1.00000000001361,0.759452040026403,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17643,GO:1901315,1.00000000001361,0.759452040026403,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
4841,GO:0014045,1.00000000001363,0.744477930342217,0,4,establishment of endothelial blood-brain barrier,BP,
6566,GO:0022009,1.00000000001363,0.744477930342217,0,4,central nervous system vasculogenesis,BP,
14559,GO:0070060,1.00000000001363,0.897066911065577,0,1,'de novo' actin filament nucleation,BP,
3842,GO:0008448,1.00000000001364,0.936924520044331,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
5981,GO:0018585,1.00000000001365,0.932991315552973,0,1,fluorene oxygenase activity,MF,
5991,GO:0018917,1.00000000001365,0.932991315552973,0,1,fluorene metabolic process,BP,
12451,GO:0048936,1.00000000001366,0.803598790641674,0,3,peripheral nervous system neuron axonogenesis,BP,
3960,GO:0008709,1.00000000001366,0.956106602414101,0,1,cholate 7-alpha-dehydrogenase activity,MF,
6828,GO:0030283,1.00000000001366,0.956106602414101,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
11959,GO:0047015,1.00000000001366,0.956106602414101,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
18866,GO:1904431,1.00000000001367,0.740561796598981,0,4,positive regulation of t-circle formation,BP,
3951,GO:0008650,1.00000000001368,0.925270844371578,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
3777,GO:0008331,1.00000000001369,0.803121484799197,0,3,high voltage-gated calcium channel activity,MF,
2567,GO:0005850,1.00000000001369,0.733841138229401,0,4,eukaryotic translation initiation factor 2 complex,CC,
4226,GO:0009400,1.00000000001369,0.928362055152002,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
9736,GO:0038171,1.0000000000137,0.729248958249112,0,4,cannabinoid signaling pathway,BP,
15550,GO:0071926,1.0000000000137,0.729248958249112,0,4,endocannabinoid signaling pathway,BP,
18011,GO:1902412,1.0000000000137,0.765418836948298,0,3,regulation of mitotic cytokinesis,BP,
5770,GO:0016941,1.00000000001371,0.925770308520098,0,1,natriuretic peptide receptor activity,MF,
13879,GO:0060465,1.00000000001371,0.925770308520098,0,1,pharynx development,BP,
17452,GO:1900194,1.00000000001371,0.925770308520098,0,1,negative regulation of oocyte maturation,BP,
8737,GO:0034378,1.00000000001371,0.80859149048074,0,3,chylomicron assembly,BP,
16015,GO:0086007,1.00000000001372,0.852731544905865,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17807,GO:1901843,1.00000000001372,0.852731544905865,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
16417,GO:0097017,1.00000000001372,0.86411302926379,0,2,renal protein absorption,BP,
13117,GO:0051610,1.00000000001375,0.7747009847297,0,3,serotonin uptake,BP,
4717,GO:0010877,1.00000000001375,0.88554468090654,0,2,lipid transport involved in lipid storage,BP,
18117,GO:1902722,1.00000000001376,0.820583140964078,0,3,positive regulation of prolactin secretion,BP,
15842,GO:0072526,1.00000000001376,0.758507219426042,0,4,pyridine-containing compound catabolic process,BP,
18569,GO:1903750,1.00000000001376,0.765989477989348,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18570,GO:1903751,1.00000000001376,0.765989477989348,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
4849,GO:0014054,1.00000000001376,0.923011903677695,0,1,positive regulation of gamma-aminobutyric acid secretion,BP,
5525,GO:0016492,1.00000000001376,0.923011903677695,0,1,G-protein coupled neurotensin receptor activity,MF,
8386,GO:0033277,1.00000000001377,0.850025268904269,0,2,abortive mitotic cell cycle,BP,
8978,GO:0035054,1.00000000001377,0.92698831673115,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
12785,GO:0051040,1.00000000001377,0.92698831673115,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12786,GO:0051042,1.00000000001377,0.92698831673115,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13653,GO:0060128,1.00000000001377,0.92698831673115,0,1,corticotropin hormone secreting cell differentiation,BP,
14068,GO:0060804,1.00000000001377,0.92698831673115,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14921,GO:0070724,1.00000000001377,0.92698831673115,0,1,BMP receptor complex,CC,
9569,GO:0036337,1.00000000001377,0.725329488518918,0,4,Fas signaling pathway,BP,
19568,GO:1990446,1.00000000001377,0.78280180968854,0,4,U1 snRNP binding,MF,
5275,GO:0015920,1.00000000001379,0.929193330287207,0,1,lipopolysaccharide transport,BP,
7928,GO:0032497,1.00000000001379,0.929193330287207,0,1,detection of lipopolysaccharide,BP,
14806,GO:0070506,1.00000000001379,0.929193330287207,0,1,high-density lipoprotein particle receptor activity,MF,
14813,GO:0070522,1.0000000000138,0.729807416428899,0,4,ERCC4-ERCC1 complex,CC,
10641,GO:0043629,1.00000000001381,0.902683035995029,0,1,ncRNA polyadenylation,BP,
10642,GO:0043630,1.00000000001381,0.902683035995029,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
15316,GO:0071484,1.00000000001382,0.849864026288178,0,2,cellular response to light intensity,BP,
10430,GO:0043260,1.00000000001382,0.731117381066829,0,3,laminin-11 complex,CC,
5175,GO:0015727,1.00000000001384,0.735926058999951,0,4,lactate transport,BP,
9370,GO:0035873,1.00000000001384,0.735926058999951,0,4,lactate transmembrane transport,BP,
6384,GO:0021569,1.00000000001385,0.940894825521474,0,1,rhombomere 3 development,BP,
6385,GO:0021570,1.00000000001385,0.940894825521474,0,1,rhombomere 4 development,BP,
2356,GO:0005436,1.00000000001385,0.856853609036964,0,2,sodium:phosphate symporter activity,MF,
5084,GO:0015319,1.00000000001385,0.856853609036964,0,2,sodium:inorganic phosphate symporter activity,MF,
5085,GO:0015321,1.00000000001385,0.856853609036964,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
12365,GO:0048712,1.00000000001386,0.659770956217871,0,5,negative regulation of astrocyte differentiation,BP,
16539,GO:0097229,1.00000000001386,0.946467556656793,0,1,sperm end piece,CC,
17419,GO:1900126,1.00000000001386,0.776746850181902,0,3,negative regulation of hyaluronan biosynthetic process,BP,
8527,GO:0033745,1.00000000001387,0.802356245650226,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
3207,GO:0006848,1.00000000001387,0.797148317550636,0,3,pyruvate transport,BP,
12659,GO:0050833,1.00000000001387,0.797148317550636,0,3,pyruvate transmembrane transporter activity,MF,
17682,GO:1901475,1.00000000001387,0.797148317550636,0,3,pyruvate transmembrane transport,BP,
1205,GO:0002862,1.00000000001387,0.801595210413639,0,4,negative regulation of inflammatory response to antigenic stimulus,BP,
851,GO:0002174,1.00000000001388,0.927932538518252,0,1,mammary stem cell proliferation,BP,
12013,GO:0047395,1.00000000001388,0.927932538518252,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12035,GO:0047620,1.00000000001388,0.927932538518252,0,1,acylglycerol kinase activity,MF,
18958,GO:1904675,1.00000000001388,0.927932538518252,0,1,regulation of somatic stem cell division,BP,
18959,GO:1904677,1.00000000001388,0.927932538518252,0,1,positive regulation of somatic stem cell division,BP,
19763,GO:2000101,1.00000000001388,0.927932538518252,0,1,regulation of mammary stem cell proliferation,BP,
19764,GO:2000103,1.00000000001388,0.927932538518252,0,1,positive regulation of mammary stem cell proliferation,BP,
2155,GO:0004972,1.0000000000139,0.846694711371531,0,2,NMDA glutamate receptor activity,MF,
10,GO:0000019,1.00000000001391,0.789571455705512,0,3,regulation of mitotic recombination,BP,
12965,GO:0051305,1.00000000001391,0.660540672036796,0,5,chromosome movement towards spindle pole,BP,
3118,GO:0006696,1.00000000001391,0.871200351897243,0,2,ergosterol biosynthetic process,BP,
3697,GO:0008204,1.00000000001391,0.871200351897243,0,2,ergosterol metabolic process,BP,
1645,GO:0004085,1.00000000001392,0.935741976696483,0,1,butyryl-CoA dehydrogenase activity,MF,
6188,GO:0019605,1.00000000001392,0.935741976696483,0,1,butyrate metabolic process,BP,
11656,GO:0046359,1.00000000001392,0.935741976696483,0,1,butyrate catabolic process,BP,
13468,GO:0052890,1.00000000001392,0.935741976696483,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
1953,GO:0004654,1.00000000001392,0.920828739901634,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
16367,GO:0090616,1.00000000001392,0.920828739901634,0,1,mitochondrial mRNA 3'-end processing,BP,
16532,GO:0097222,1.00000000001392,0.920828739901634,0,1,mitochondrial mRNA polyadenylation,BP,
5054,GO:0015247,1.00000000001393,0.776421955479943,0,3,aminophospholipid transmembrane transporter activity,MF,
4216,GO:0009374,1.00000000001394,0.654137378808897,0,5,biotin binding,MF,
9944,GO:0042284,1.00000000001395,0.936672676346881,0,1,sphingolipid delta-4 desaturase activity,MF,
11573,GO:0046100,1.00000000001396,0.72222826537354,0,5,hypoxanthine metabolic process,BP,
11049,GO:0045007,1.00000000001397,0.835002983669776,0,3,depurination,BP,
12262,GO:0048521,1.00000000001399,0.765874496054829,0,4,negative regulation of behavior,BP,
6498,GO:0021855,1.00000000001399,0.793923816282539,0,3,hypothalamus cell migration,BP,
8566,GO:0033989,1.00000000001399,0.929155368506892,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9486,GO:0036111,1.00000000001399,0.929155368506892,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10945,GO:0044594,1.00000000001399,0.929155368506892,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
4611,GO:0010726,1.000000000014,0.866133772635151,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
9582,GO:0036374,1.000000000014,0.804701917649763,0,3,glutathione hydrolase activity,MF,
17197,GO:0102953,1.000000000014,0.804701917649763,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17206,GO:0103068,1.000000000014,0.804701917649763,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17790,GO:1901748,1.000000000014,0.804701917649763,0,3,leukotriene D4 metabolic process,BP,
17791,GO:1901750,1.000000000014,0.804701917649763,0,3,leukotriene D4 biosynthetic process,BP,
1672,GO:0004132,1.00000000001401,0.934393890165293,0,1,dCMP deaminase activity,MF,
4464,GO:0010455,1.00000000001401,0.755075061170282,0,4,positive regulation of cell fate commitment,BP,
1487,GO:0003796,1.00000000001402,0.942486742224589,0,1,lysozyme activity,MF,
11212,GO:0045322,1.00000000001404,0.861099432504868,0,2,unmethylated CpG binding,MF,
13913,GO:0060535,1.00000000001404,0.780149518027043,0,3,trachea cartilage morphogenesis,BP,
1525,GO:0003886,1.00000000001404,0.780976853608501,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
8099,GO:0032776,1.00000000001404,0.780976853608501,0,3,DNA methylation on cytosine,BP,
16143,GO:0090116,1.00000000001404,0.780976853608501,0,3,C-5 methylation of cytosine,BP,
19644,GO:1990756,1.00000000001404,0.80955370814507,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
15887,GO:0072590,1.00000000001405,0.914402181279923,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15888,GO:0072591,1.00000000001405,0.914402181279923,0,1,citrate-L-glutamate ligase activity,MF,
16530,GO:0097212,1.00000000001405,0.871691258911983,0,2,lysosomal membrane organization,BP,
9238,GO:0035620,1.00000000001405,0.799263201924174,0,3,ceramide transporter activity,MF,
4906,GO:0014834,1.00000000001405,0.731278633692543,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
2270,GO:0005199,1.00000000001406,0.926076910594384,0,1,structural constituent of cell wall,MF,
15423,GO:0071665,1.00000000001406,0.926076910594384,0,1,gamma-catenin-TCF7L2 complex,CC,
7477,GO:0031630,1.00000000001406,0.923901552011927,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
17220,GO:0106022,1.00000000001406,0.923901552011927,0,1,positive regulation of vesicle docking,BP,
11195,GO:0045272,1.00000000001406,0.850890617415191,0,3,plasma membrane respiratory chain complex I,CC,
7651,GO:0032057,1.00000000001411,0.730439651426901,0,4,negative regulation of translational initiation in response to stress,BP,
20082,GO:2000671,1.00000000001411,0.794665533446155,0,3,regulation of motor neuron apoptotic process,BP,
20083,GO:2000672,1.00000000001411,0.794665533446155,0,3,negative regulation of motor neuron apoptotic process,BP,
877,GO:0002225,1.00000000001411,0.8835372390796,0,2,positive regulation of antimicrobial peptide production,BP,
1155,GO:0002760,1.00000000001411,0.8835372390796,0,2,positive regulation of antimicrobial humoral response,BP,
1174,GO:0002803,1.00000000001411,0.8835372390796,0,2,positive regulation of antibacterial peptide production,BP,
12518,GO:0050560,1.00000000001411,0.926113025015309,0,1,aspartate-tRNA(Asn) ligase activity,MF,
14611,GO:0070145,1.00000000001411,0.926113025015309,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
8675,GO:0034238,1.00000000001412,0.923615600262012,0,1,macrophage fusion,BP,
8676,GO:0034239,1.00000000001412,0.923615600262012,0,1,regulation of macrophage fusion,BP,
8677,GO:0034241,1.00000000001412,0.923615600262012,0,1,positive regulation of macrophage fusion,BP,
10388,GO:0043199,1.00000000001412,0.788292993462537,0,3,sulfate binding,MF,
18138,GO:1902769,1.00000000001414,0.887759817147875,0,1,regulation of choline O-acetyltransferase activity,BP,
18139,GO:1902771,1.00000000001414,0.887759817147875,0,1,positive regulation of choline O-acetyltransferase activity,BP,
18203,GO:1902948,1.00000000001414,0.887759817147875,0,1,negative regulation of tau-protein kinase activity,BP,
18210,GO:1902955,1.00000000001414,0.887759817147875,0,1,positive regulation of early endosome to recycling endosome transport,BP,
18233,GO:1902997,1.00000000001414,0.887759817147875,0,1,negative regulation of neurofibrillary tangle assembly,BP,
15771,GO:0072344,1.00000000001416,0.75079048941786,0,4,rescue of stalled ribosome,BP,
9304,GO:0035739,1.00000000001416,0.738650448194419,0,4,CD4-positive, alpha-beta T cell proliferation,BP,
20008,GO:2000561,1.00000000001416,0.738650448194419,0,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
14436,GO:0061723,1.00000000001417,0.846746915359726,0,2,glycophagy,BP,
13096,GO:0051584,1.00000000001417,0.785666430939501,0,4,regulation of dopamine uptake involved in synaptic transmission,BP,
13279,GO:0051940,1.00000000001417,0.785666430939501,0,4,regulation of catecholamine uptake involved in synaptic transmission,BP,
1746,GO:0004343,1.00000000001418,0.923862784480782,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
17451,GO:1900193,1.00000000001418,0.697948897146438,0,5,regulation of oocyte maturation,BP,
13422,GO:0052735,1.0000000000142,0.782753763248726,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
8089,GO:0032764,1.00000000001421,0.871553539938885,0,2,negative regulation of mast cell cytokine production,BP,
5396,GO:0016230,1.00000000001423,0.874503950089724,0,2,sphingomyelin phosphodiesterase activator activity,MF,
779,GO:0002032,1.00000000001424,0.874475601007386,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
5398,GO:0016232,1.00000000001425,0.928509695980744,0,1,HNK-1 sulfotransferase activity,MF,
20040,GO:2000618,1.00000000001426,0.673404318969763,0,5,regulation of histone H4-K16 acetylation,BP,
14715,GO:0070326,1.00000000001428,0.82729095681084,0,3,very-low-density lipoprotein particle receptor binding,MF,
14797,GO:0070487,1.00000000001432,0.67973222131616,0,5,monocyte aggregation,BP,
1000,GO:0002461,1.00000000001433,0.931575231013788,0,1,tolerance induction dependent upon immune response,BP,
1022,GO:0002519,1.00000000001433,0.931575231013788,0,1,natural killer cell tolerance induction,BP,
1081,GO:0002652,1.00000000001433,0.931575231013788,0,1,regulation of tolerance induction dependent upon immune response,BP,
8057,GO:0032712,1.00000000001433,0.931575231013788,0,1,negative regulation of interleukin-3 production,BP,
15418,GO:0071656,1.00000000001433,0.931575231013788,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17623,GO:1901257,1.00000000001433,0.931575231013788,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
4907,GO:0014835,1.00000000001434,0.922167831492197,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
8585,GO:0034057,1.00000000001434,0.858925956499509,0,2,RNA strand-exchange activity,MF,
7357,GO:0031393,1.00000000001434,0.85681597957568,0,2,negative regulation of prostaglandin biosynthetic process,BP,
12811,GO:0051086,1.00000000001434,0.935178752593433,0,1,chaperone mediated protein folding independent of cofactor,BP,
13481,GO:0052918,1.00000000001435,0.91192140398276,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13483,GO:0052926,1.00000000001435,0.91192140398276,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
12225,GO:0048388,1.00000000001435,0.871775388668018,0,2,endosomal lumen acidification,BP,
3814,GO:0008404,1.00000000001435,0.936573377930121,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3815,GO:0008405,1.00000000001435,0.936573377930121,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15390,GO:0071614,1.00000000001435,0.936573377930121,0,1,linoleic acid epoxygenase activity,MF,
19517,GO:1990256,1.00000000001439,0.883477110507041,0,1,signal clustering,BP,
18694,GO:1903998,1.0000000000144,0.791902750303815,0,3,regulation of eating behavior,BP,
2962,GO:0006498,1.00000000001441,0.661343613226145,0,5,N-terminal protein lipidation,BP,
15337,GO:0071535,1.00000000001442,0.752946009727619,0,4,RING-like zinc finger domain binding,MF,
118,GO:0000246,1.00000000001442,0.922300161120598,0,1,delta24(24-1) sterol reductase activity,MF,
12524,GO:0050614,1.00000000001442,0.922300161120598,0,1,delta24-sterol reductase activity,MF,
16326,GO:0090461,1.00000000001442,0.922300161120598,0,1,glutamate homeostasis,BP,
17216,GO:0106017,1.00000000001443,0.769209452192055,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
4329,GO:0009841,1.00000000001443,0.931284489355282,0,1,mitochondrial endopeptidase Clp complex,CC,
12414,GO:0048840,1.00000000001443,0.732130223642762,0,4,otolith development,BP,
14087,GO:0060846,1.00000000001445,0.80258274054535,0,3,blood vessel endothelial cell fate commitment,BP,
14088,GO:0060847,1.00000000001445,0.80258274054535,0,3,endothelial cell fate specification,BP,
16459,GO:0097101,1.00000000001445,0.80258274054535,0,3,blood vessel endothelial cell fate specification,BP,
17681,GO:1901474,1.00000000001446,0.696926284858437,0,5,azole transmembrane transporter activity,MF,
8053,GO:0032700,1.00000000001448,0.706208240264303,0,5,negative regulation of interleukin-17 production,BP,
16767,GO:0098518,1.00000000001449,0.8130266496606,0,3,polynucleotide phosphatase activity,MF,
10156,GO:0042721,1.00000000001449,0.743269121997675,0,5,mitochondrial inner membrane protein insertion complex,CC,
12088,GO:0048021,1.00000000001449,0.766612437672277,0,3,regulation of melanin biosynthetic process,BP,
10495,GO:0043380,1.00000000001451,0.764515373454375,0,4,regulation of memory T cell differentiation,BP,
3979,GO:0008798,1.00000000001452,0.914936733898103,0,1,beta-aspartyl-peptidase activity,MF,
15019,GO:0070931,1.00000000001452,0.914936733898103,0,1,Golgi-associated vesicle lumen,CC,
17310,GO:0140052,1.00000000001453,0.789082006843868,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
5576,GO:0016590,1.00000000001454,0.913568166973388,0,1,ACF complex,CC,
17924,GO:1902202,1.00000000001454,0.869760066542044,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
17006,GO:0099053,1.00000000001454,0.794701383101405,0,3,activating signal cointegrator 1 complex,CC,
18077,GO:1902595,1.00000000001455,0.877622874877191,0,2,regulation of DNA replication origin binding,BP,
18211,GO:1902956,1.00000000001459,0.823980147349118,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
1370,GO:0003252,1.00000000001459,0.882234737068887,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
4597,GO:0010710,1.0000000000146,0.825157945104961,0,3,regulation of collagen catabolic process,BP,
497,GO:0001552,1.0000000000146,0.935482273368854,0,1,ovarian follicle atresia,BP,
19910,GO:2000355,1.0000000000146,0.935482273368854,0,1,negative regulation of ovarian follicle development,BP,
9218,GO:0035597,1.0000000000146,0.934457414990112,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
12002,GO:0047322,1.0000000000146,0.822676098458141,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12495,GO:0050405,1.0000000000146,0.822676098458141,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
15410,GO:0071641,1.00000000001461,0.865358754874443,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
14680,GO:0070267,1.00000000001462,0.925212105576924,0,1,oncosis,BP,
11135,GO:0045153,1.00000000001462,0.94929163905413,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
9689,GO:0038049,1.00000000001464,0.805830887620944,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
15031,GO:0070944,1.00000000001464,0.871947443327322,0,2,neutrophil mediated killing of bacterium,BP,
15032,GO:0070945,1.00000000001464,0.871947443327322,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
10851,GO:0044336,1.00000000001464,0.791515940242144,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11799,GO:0046642,1.00000000001466,0.787810005569435,0,3,negative regulation of alpha-beta T cell proliferation,BP,
1885,GO:0004561,1.00000000001467,0.928685062646435,0,1,alpha-N-acetylglucosaminidase activity,MF,
707,GO:0001927,1.00000000001469,0.788781495966182,0,3,exocyst assembly,BP,
19132,GO:1905031,1.00000000001469,0.763811341928625,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
12648,GO:0050816,1.00000000001469,0.804613474755664,0,3,phosphothreonine residue binding,MF,
13206,GO:0051793,1.00000000001469,0.779674844143362,0,3,medium-chain fatty acid catabolic process,BP,
177,GO:0000386,1.00000000001469,0.787445566690726,0,3,second spliceosomal transesterification activity,MF,
10422,GO:0043250,1.00000000001469,0.942728897985394,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10423,GO:0043251,1.00000000001469,0.942728897985394,0,1,sodium-dependent organic anion transport,BP,
2505,GO:0005757,1.00000000001469,0.779789481211374,0,4,mitochondrial permeability transition pore complex,CC,
17344,GO:0150003,1.0000000000147,0.806734370040983,0,3,regulation of spontaneous synaptic transmission,BP,
8425,GO:0033484,1.0000000000147,0.817818463010279,0,3,nitric oxide homeostasis,BP,
9501,GO:0036132,1.00000000001471,0.807973117857857,0,3,13-prostaglandin reductase activity,MF,
12027,GO:0047522,1.00000000001471,0.807973117857857,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
7250,GO:0031177,1.00000000001473,0.837955936547894,0,3,phosphopantetheine binding,MF,
1901,GO:0004582,1.00000000001474,0.872157447907572,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
8346,GO:0033185,1.00000000001474,0.872157447907572,0,3,dolichol-phosphate-mannose synthase complex,CC,
11770,GO:0046601,1.00000000001475,0.792798434450125,0,3,positive regulation of centriole replication,BP,
18107,GO:1902685,1.00000000001476,0.922368220385814,0,1,positive regulation of receptor localization to synapse,BP,
19504,GO:1990180,1.00000000001476,0.826998182238014,0,3,mitochondrial tRNA 3'-end processing,BP,
6896,GO:0030423,1.00000000001476,0.726682183721244,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
16799,GO:0098592,1.00000000001477,0.794833074778245,0,3,cytoplasmic side of apical plasma membrane,CC,
1988,GO:0004705,1.00000000001477,0.804423874356508,0,3,JUN kinase activity,MF,
5759,GO:0016909,1.00000000001477,0.804423874356508,0,3,SAP kinase activity,MF,
16625,GO:0097441,1.00000000001479,0.774288705775988,0,3,basal dendrite,CC,
9828,GO:0042025,1.00000000001481,0.789668784858457,0,3,host cell nucleus,CC,
10747,GO:0044094,1.00000000001481,0.789668784858457,0,3,host cell nuclear part,CC,
9425,GO:0035983,1.00000000001481,0.803965863893253,0,3,response to trichostatin A,BP,
9426,GO:0035984,1.00000000001481,0.803965863893253,0,3,cellular response to trichostatin A,BP,
3163,GO:0006776,1.00000000001482,0.821066213542789,0,3,vitamin A metabolic process,BP,
2338,GO:0005365,1.00000000001484,0.803463337353658,0,2,myo-inositol transmembrane transporter activity,MF,
16766,GO:0098508,1.00000000001485,0.868329299918539,0,2,endothelial to hematopoietic transition,BP,
18470,GO:1903527,1.00000000001485,0.768209335406061,0,3,positive regulation of membrane tubulation,BP,
1903,GO:0004584,1.00000000001486,0.931253829659133,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
5948,GO:0018277,1.00000000001486,0.931253829659133,0,1,protein deamination,BP,
4213,GO:0009360,1.00000000001487,0.929106881526418,0,1,DNA polymerase III complex,CC,
4002,GO:0008934,1.00000000001487,0.733909801996034,0,4,inositol monophosphate 1-phosphatase activity,MF,
13450,GO:0052832,1.00000000001487,0.733909801996034,0,4,inositol monophosphate 3-phosphatase activity,MF,
13451,GO:0052833,1.00000000001487,0.733909801996034,0,4,inositol monophosphate 4-phosphatase activity,MF,
13452,GO:0052834,1.00000000001487,0.733909801996034,0,4,inositol monophosphate phosphatase activity,MF,
1340,GO:0003195,1.00000000001489,0.926581201852882,0,1,tricuspid valve formation,BP,
11247,GO:0045403,1.00000000001489,0.926581201852882,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12938,GO:0051267,1.00000000001489,0.926581201852882,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13548,GO:0055103,1.00000000001489,0.926581201852882,0,1,ligase regulator activity,MF,
13649,GO:0060124,1.00000000001489,0.849759848579519,0,2,positive regulation of growth hormone secretion,BP,
13809,GO:0060375,1.00000000001489,0.926581201852882,0,1,regulation of mast cell differentiation,BP,
13810,GO:0060377,1.00000000001489,0.926581201852882,0,1,negative regulation of mast cell differentiation,BP,
20049,GO:2000631,1.00000000001489,0.926581201852882,0,1,regulation of pre-miRNA processing,BP,
20050,GO:2000632,1.00000000001489,0.926581201852882,0,1,negative regulation of pre-miRNA processing,BP,
20155,GO:2000807,1.0000000000149,0.76623415280799,0,3,regulation of synaptic vesicle clustering,BP,
1822,GO:0004470,1.00000000001492,0.75367909579331,0,4,malic enzyme activity,MF,
197,GO:0000415,1.00000000001492,0.911510784086477,0,1,negative regulation of histone H3-K36 methylation,BP,
10044,GO:0042483,1.00000000001492,0.911510784086477,0,1,negative regulation of odontogenesis,BP,
14625,GO:0070171,1.00000000001492,0.911510784086477,0,1,negative regulation of tooth mineralization,BP,
2685,GO:0006046,1.00000000001494,0.816933659071762,0,3,N-acetylglucosamine catabolic process,BP,
3499,GO:0007403,1.00000000001495,0.925849578109491,0,1,glial cell fate determination,BP,
14060,GO:0060769,1.00000000001495,0.925849578109491,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14285,GO:0061324,1.00000000001495,0.925849578109491,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
18888,GO:1904499,1.00000000001495,0.925849578109491,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18889,GO:1904501,1.00000000001495,0.925849578109491,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
19022,GO:1904793,1.00000000001495,0.925849578109491,0,1,regulation of euchromatin binding,BP,
11479,GO:0045919,1.00000000001496,0.77979831917334,0,4,positive regulation of cytolysis,BP,
14829,GO:0070545,1.00000000001497,0.744509554459269,0,4,PeBoW complex,CC,
17517,GO:1900452,1.00000000001498,0.723971935659796,0,4,regulation of long term synaptic depression,BP,
11574,GO:0046101,1.00000000001499,0.77193673342156,0,4,hypoxanthine biosynthetic process,BP,
1347,GO:0003207,1.000000000015,0.695842511134506,0,4,cardiac chamber formation,BP,
1350,GO:0003211,1.000000000015,0.695842511134506,0,4,cardiac ventricle formation,BP,
5053,GO:0015245,1.00000000001501,0.692690598534091,0,5,fatty acid transmembrane transporter activity,MF,
14781,GO:0070459,1.00000000001501,0.718345721210292,0,5,prolactin secretion,BP,
8887,GO:0034693,1.00000000001502,0.93053273901328,0,1,U11/U12 snRNP,CC,
5431,GO:0016282,1.00000000001502,0.921349449268755,0,1,eukaryotic 43S preinitiation complex,CC,
9492,GO:0036118,1.00000000001503,0.802169354912728,0,3,hyaluranon cable assembly,BP,
17401,GO:1900104,1.00000000001503,0.802169354912728,0,3,regulation of hyaluranon cable assembly,BP,
17402,GO:1900106,1.00000000001503,0.802169354912728,0,3,positive regulation of hyaluranon cable assembly,BP,
11954,GO:0046985,1.00000000001504,0.817228557062461,0,3,positive regulation of hemoglobin biosynthetic process,BP,
8423,GO:0033477,1.00000000001504,0.934823541922375,0,1,S-methylmethionine metabolic process,BP,
11978,GO:0047150,1.00000000001504,0.934823541922375,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14399,GO:0061627,1.00000000001504,0.934823541922375,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
10829,GO:0044308,1.00000000001505,0.830930361243472,0,2,axonal spine,CC,
4013,GO:0009000,1.00000000001506,0.930512375485065,0,1,selenocysteine lyase activity,MF,
18484,GO:1903546,1.00000000001506,0.73791373436656,0,4,protein localization to photoreceptor outer segment,BP,
11033,GO:0044860,1.00000000001507,0.739372809586365,0,4,protein localization to plasma membrane raft,BP,
3684,GO:0008188,1.00000000001508,0.724822112092323,0,5,neuropeptide receptor activity,MF,
7769,GO:0032280,1.00000000001508,0.699771232914537,0,4,symmetric synapse,CC,
5403,GO:0016237,1.0000000000151,0.918949782916328,0,1,lysosomal microautophagy,BP,
6230,GO:0019778,1.0000000000151,0.918949782916328,0,1,Atg12 activating enzyme activity,MF,
6231,GO:0019779,1.0000000000151,0.918949782916328,0,1,Atg8 activating enzyme activity,MF,
8912,GO:0034727,1.0000000000151,0.918949782916328,0,1,piecemeal microautophagy of the nucleus,BP,
9771,GO:0039521,1.0000000000151,0.918949782916328,0,1,suppression by virus of host autophagy,BP,
13053,GO:0051490,1.0000000000151,0.809152316727587,0,3,negative regulation of filopodium assembly,BP,
15182,GO:0071284,1.00000000001513,0.711761719264461,0,4,cellular response to lead ion,BP,
7690,GO:0032133,1.00000000001514,0.765870962201731,0,4,chromosome passenger complex,CC,
16189,GO:0090191,1.00000000001514,0.875812520306166,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
9735,GO:0038166,1.00000000001516,0.707210668184453,0,5,angiotensin-activated signaling pathway,BP,
1230,GO:0002904,1.00000000001517,0.821865896690685,0,3,positive regulation of B cell apoptotic process,BP,
14793,GO:0070481,1.0000000000152,0.928026327649226,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14887,GO:0070651,1.0000000000152,0.928026327649226,0,1,nonfunctional rRNA decay,BP,
13731,GO:0060268,1.0000000000152,0.812503672757021,0,3,negative regulation of respiratory burst,BP,
9589,GO:0036396,1.0000000000152,0.81945902151235,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
11204,GO:0045293,1.0000000000152,0.81945902151235,0,3,mRNA editing complex,CC,
9290,GO:0035720,1.00000000001522,0.791776599707099,0,3,intraciliary anterograde transport,BP,
15137,GO:0071207,1.00000000001523,0.864205559521408,0,2,histone pre-mRNA stem-loop binding,MF,
9821,GO:0042007,1.00000000001523,0.944487481029915,0,1,interleukin-18 binding,MF,
16464,GO:0097107,1.00000000001525,0.684205321375174,0,4,postsynaptic density assembly,BP,
16840,GO:0098698,1.00000000001525,0.684205321375174,0,4,postsynaptic specialization assembly,BP,
2035,GO:0004773,1.00000000001526,0.911470811474954,0,1,steryl-sulfatase activity,MF,
16754,GO:0097749,1.00000000001526,0.911470811474954,0,1,membrane tubulation,BP,
9231,GO:0035611,1.00000000001527,0.928374269634204,0,1,protein branching point deglutamylation,BP,
10148,GO:0042700,1.00000000001527,0.92070175057375,0,1,luteinizing hormone signaling pathway,BP,
12127,GO:0048160,1.00000000001527,0.92070175057375,0,1,primary follicle stage,BP,
2349,GO:0005391,1.00000000001527,0.69013100040667,0,5,sodium:potassium-exchanging ATPase activity,MF,
3910,GO:0008556,1.00000000001527,0.69013100040667,0,5,potassium-transporting ATPase activity,MF,
4905,GO:0014832,1.00000000001527,0.780294135353932,0,3,urinary bladder smooth muscle contraction,BP,
4914,GO:0014848,1.00000000001527,0.780294135353932,0,3,urinary tract smooth muscle contraction,BP,
4731,GO:0010891,1.00000000001527,0.649220737140825,0,5,negative regulation of sequestering of triglyceride,BP,
20139,GO:2000777,1.00000000001528,0.871066655527088,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
78,GO:0000155,1.00000000001529,0.902557984771886,0,1,phosphorelay sensor kinase activity,MF,
5022,GO:0015183,1.00000000001529,0.79484309142156,0,3,L-aspartate transmembrane transporter activity,MF,
18844,GO:1904383,1.00000000001529,0.933035461147111,0,1,response to sodium phosphate,BP,
18925,GO:1904585,1.00000000001529,0.933035461147111,0,1,response to putrescine,BP,
18926,GO:1904586,1.00000000001529,0.933035461147111,0,1,cellular response to putrescine,BP,
19668,GO:1990828,1.00000000001529,0.933035461147111,0,1,hepatocyte dedifferentiation,BP,
13399,GO:0052642,1.0000000000153,0.937255977793212,0,1,lysophosphatidic acid phosphatase activity,MF,
20344,GO:2001311,1.0000000000153,0.937255977793212,0,1,lysobisphosphatidic acid metabolic process,BP,
7147,GO:0030981,1.00000000001531,0.761543662774125,0,3,cortical microtubule cytoskeleton,CC,
3819,GO:0008410,1.00000000001531,0.804735586988457,0,3,CoA-transferase activity,MF,
8543,GO:0033860,1.00000000001531,0.856488454048012,0,3,regulation of NAD(P)H oxidase activity,BP,
8545,GO:0033864,1.00000000001531,0.856488454048012,0,3,positive regulation of NAD(P)H oxidase activity,BP,
8626,GO:0034136,1.00000000001533,0.781306689373427,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
6542,GO:0021943,1.00000000001533,0.713296676298894,0,4,formation of radial glial scaffolds,BP,
18984,GO:1904719,1.00000000001533,0.930649460847602,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
15326,GO:0071500,1.00000000001535,0.708944702980374,0,5,cellular response to nitrosative stress,BP,
8579,GO:0034039,1.00000000001535,0.876687171717902,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
6885,GO:0030375,1.00000000001537,0.763886397575725,0,3,thyroid hormone receptor coactivator activity,MF,
10194,GO:0042776,1.00000000001538,0.824164544088683,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
15101,GO:0071062,1.0000000000154,0.922377274793583,0,1,alphav-beta3 integrin-vitronectin complex,CC,
2798,GO:0006253,1.0000000000154,0.95168157723766,0,1,dCTP catabolic process,BP,
11551,GO:0046065,1.0000000000154,0.95168157723766,0,1,dCTP metabolic process,BP,
12059,GO:0047840,1.0000000000154,0.95168157723766,0,1,dCTP diphosphatase activity,MF,
18460,GO:1903516,1.00000000001541,0.800126472868227,0,3,regulation of single strand break repair,BP,
1535,GO:0003917,1.00000000001541,0.740395905142321,0,4,DNA topoisomerase type I activity,MF,
1364,GO:0003241,1.00000000001542,0.781296491502201,0,3,growth involved in heart morphogenesis,BP,
6010,GO:0019049,1.00000000001543,0.726749085341324,0,4,evasion or tolerance of host defenses by virus,BP,
10885,GO:0044413,1.00000000001543,0.726749085341324,0,4,avoidance of host defenses,BP,
10887,GO:0044415,1.00000000001543,0.726749085341324,0,4,evasion or tolerance of host defenses,BP,
13223,GO:0051832,1.00000000001543,0.726749085341324,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13225,GO:0051834,1.00000000001543,0.726749085341324,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
16241,GO:0090269,1.00000000001543,0.756427063343802,0,3,fibroblast growth factor production,BP,
16242,GO:0090270,1.00000000001543,0.756427063343802,0,3,regulation of fibroblast growth factor production,BP,
14499,GO:0061890,1.00000000001544,0.875862660707358,0,2,positive regulation of astrocyte activation,BP,
18690,GO:1903980,1.00000000001544,0.875862660707358,0,2,positive regulation of microglial cell activation,BP,
1031,GO:0002536,1.00000000001545,0.894023399426218,0,2,respiratory burst involved in inflammatory response,BP,
13727,GO:0060264,1.00000000001545,0.894023399426218,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13729,GO:0060266,1.00000000001545,0.894023399426218,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
12814,GO:0051089,1.00000000001545,0.923821872660108,0,1,constitutive protein ectodomain proteolysis,BP,
8315,GO:0033141,1.00000000001545,0.762214183584991,0,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
19738,GO:2000047,1.00000000001546,0.709865883395019,0,5,regulation of cell-cell adhesion mediated by cadherin,BP,
3853,GO:0008465,1.00000000001547,0.948609687163292,0,1,glycerate dehydrogenase activity,MF,
9642,GO:0036501,1.00000000001548,0.92183514228744,0,1,UFD1-NPL4 complex,CC,
3016,GO:0006562,1.0000000000155,0.863969141537205,0,2,proline catabolic process,BP,
4403,GO:0010133,1.0000000000155,0.863969141537205,0,2,proline catabolic process to glutamate,BP,
19303,GO:1905461,1.00000000001551,0.668220062153551,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
15064,GO:0070992,1.00000000001551,0.902863716766286,0,2,translation initiation complex,CC,
6483,GO:0021823,1.00000000001553,0.832427266227484,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6487,GO:0021827,1.00000000001553,0.832427266227484,0,2,postnatal olfactory bulb interneuron migration,BP,
6490,GO:0021836,1.00000000001553,0.832427266227484,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
3044,GO:0006598,1.00000000001555,0.75766172988743,0,5,polyamine catabolic process,BP,
19494,GO:1990166,1.00000000001557,0.802201441393438,0,3,protein localization to site of double-strand break,BP,
8177,GO:0032907,1.00000000001561,0.762109651805131,0,3,transforming growth factor beta3 production,BP,
8180,GO:0032910,1.00000000001561,0.762109651805131,0,3,regulation of transforming growth factor beta3 production,BP,
7560,GO:0031871,1.00000000001562,0.794212490744568,0,3,proteinase activated receptor binding,MF,
1493,GO:0003828,1.00000000001563,0.825444782119149,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
14627,GO:0070176,1.00000000001564,0.937466636400042,0,1,DRM complex,CC,
7013,GO:0030692,1.00000000001564,0.872337893460662,0,2,Noc4p-Nop14p complex,CC,
3771,GO:0008321,1.00000000001565,0.837024494284596,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
4800,GO:0010990,1.00000000001566,0.767795153065654,0,3,regulation of SMAD protein complex assembly,BP,
5001,GO:0015141,1.00000000001567,0.800973854797982,0,3,succinate transmembrane transporter activity,MF,
5184,GO:0015744,1.00000000001567,0.800973854797982,0,3,succinate transport,BP,
15271,GO:0071422,1.00000000001567,0.800973854797982,0,3,succinate transmembrane transport,BP,
3791,GO:0008355,1.00000000001568,0.921746392489803,0,1,olfactory learning,BP,
14108,GO:0060913,1.00000000001569,0.92904277715911,0,1,cardiac cell fate determination,BP,
15419,GO:0071657,1.00000000001569,0.92904277715911,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
17624,GO:1901258,1.00000000001569,0.92904277715911,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
3889,GO:0008520,1.00000000001573,0.90836538033808,0,1,L-ascorbate:sodium symporter activity,MF,
5048,GO:0015229,1.00000000001573,0.90836538033808,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5257,GO:0015882,1.00000000001573,0.90836538033808,0,1,L-ascorbic acid transmembrane transport,BP,
14998,GO:0070890,1.00000000001573,0.90836538033808,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
15009,GO:0070904,1.00000000001573,0.90836538033808,0,1,transepithelial L-ascorbic acid transport,BP,
19561,GO:1990428,1.00000000001573,0.851299295261118,0,2,miRNA transport,BP,
17013,GO:0099073,1.00000000001574,0.853269935310297,0,2,mitochondrion-derived vesicle,CC,
6229,GO:0019777,1.00000000001574,0.883234112555011,0,2,Atg12 transferase activity,MF,
13149,GO:0051684,1.00000000001574,0.772870907113506,0,3,maintenance of Golgi location,BP,
14201,GO:0061078,1.00000000001582,0.967670445131288,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
16282,GO:0090323,1.00000000001582,0.967670445131288,0,1,prostaglandin secretion involved in immune response,BP,
18526,GO:1903636,1.00000000001582,0.967670445131288,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18527,GO:1903638,1.00000000001582,0.967670445131288,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18529,GO:1903645,1.00000000001582,0.967670445131288,0,1,negative regulation of chaperone-mediated protein folding,BP,
10336,GO:0043117,1.00000000001583,0.79763700715356,0,3,positive regulation of vascular permeability,BP,
100,GO:0000210,1.00000000001583,0.925600570946667,0,1,NAD+ diphosphatase activity,MF,
3146,GO:0006742,1.00000000001583,0.925600570946667,0,1,NADP catabolic process,BP,
6120,GO:0019364,1.00000000001583,0.925600570946667,0,1,pyridine nucleotide catabolic process,BP,
6202,GO:0019677,1.00000000001583,0.925600570946667,0,1,NAD catabolic process,BP,
17864,GO:1902010,1.00000000001583,0.925600570946667,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
17875,GO:1902038,1.00000000001583,0.925782184625597,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17955,GO:1902257,1.00000000001583,0.925782184625597,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
16472,GO:0097116,1.00000000001584,0.920623302334279,0,1,gephyrin clustering involved in postsynaptic density assembly,BP,
16814,GO:0098633,1.00000000001585,0.930074934019582,0,1,collagen fibril binding,MF,
18707,GO:1904027,1.00000000001585,0.930074934019582,0,1,negative regulation of collagen fibril organization,BP,
14771,GO:0070432,1.00000000001586,0.797960117736973,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
2332,GO:0005345,1.00000000001589,0.711225688202822,0,5,purine nucleobase transmembrane transporter activity,MF,
3759,GO:0008300,1.0000000000159,0.856071657511813,0,2,isoprenoid catabolic process,BP,
14112,GO:0060920,1.0000000000159,0.771409079837231,0,3,cardiac pacemaker cell differentiation,BP,
14116,GO:0060926,1.0000000000159,0.771409079837231,0,3,cardiac pacemaker cell development,BP,
3776,GO:0008330,1.00000000001592,0.759418119971499,0,4,protein tyrosine/threonine phosphatase activity,MF,
11228,GO:0045347,1.00000000001592,0.791792810388826,0,3,negative regulation of MHC class II biosynthetic process,BP,
936,GO:0002332,1.00000000001593,0.915447319847251,0,1,transitional stage B cell differentiation,BP,
937,GO:0002333,1.00000000001593,0.915447319847251,0,1,transitional one stage B cell differentiation,BP,
18900,GO:1904531,1.00000000001593,0.915447319847251,0,1,positive regulation of actin filament binding,BP,
18942,GO:1904618,1.00000000001593,0.915447319847251,0,1,positive regulation of actin binding,BP,
19468,GO:1990051,1.00000000001593,0.915447319847251,0,1,activation of protein kinase C activity,BP,
8972,GO:0035034,1.00000000001593,0.865469569330435,0,2,histone acetyltransferase regulator activity,MF,
10530,GO:0043435,1.00000000001594,0.789109986755219,0,3,response to corticotropin-releasing hormone,BP,
15240,GO:0071376,1.00000000001594,0.789109986755219,0,3,cellular response to corticotropin-releasing hormone stimulus,BP,
18697,GO:1904016,1.00000000001595,0.713365170072331,0,4,response to Thyroglobulin triiodothyronine,BP,
6374,GO:0021555,1.00000000001596,0.865777728754896,0,2,midbrain-hindbrain boundary morphogenesis,BP,
914,GO:0002296,1.00000000001597,0.839358698493529,0,2,T-helper 1 cell lineage commitment,BP,
373,GO:0000994,1.000000000016,0.937789086426359,0,1,RNA polymerase III core binding,MF,
4006,GO:0008962,1.000000000016,0.869055863980527,0,2,phosphatidylglycerophosphatase activity,MF,
19732,GO:2000035,1.00000000001601,0.740474796564616,0,4,regulation of stem cell division,BP,
19228,GO:1905292,1.00000000001602,0.794762401834861,0,3,regulation of neural crest cell differentiation,BP,
19229,GO:1905294,1.00000000001602,0.794762401834861,0,3,positive regulation of neural crest cell differentiation,BP,
19235,GO:1905310,1.00000000001602,0.794762401834861,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19236,GO:1905312,1.00000000001602,0.794762401834861,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
10712,GO:0043988,1.00000000001603,0.815368854618732,0,3,histone H3-S28 phosphorylation,BP,
931,GO:0002326,1.00000000001603,0.745930401017745,0,3,B cell lineage commitment,BP,
3642,GO:0008116,1.00000000001604,0.915616543064079,0,1,prostaglandin-I synthase activity,MF,
7775,GO:0032290,1.00000000001606,0.647299934440349,0,4,peripheral nervous system myelin formation,BP,
86,GO:0000173,1.00000000001608,0.939916928406646,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
16912,GO:0098837,1.00000000001608,0.808464685742267,0,3,postsynaptic recycling endosome,CC,
4669,GO:0010815,1.00000000001608,0.739530078610953,0,4,bradykinin catabolic process,BP,
930,GO:0002325,1.00000000001611,0.950183666609091,0,1,natural killer cell differentiation involved in immune response,BP,
8138,GO:0032824,1.00000000001611,0.950183666609091,0,1,negative regulation of natural killer cell differentiation,BP,
8140,GO:0032826,1.00000000001611,0.950183666609091,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8141,GO:0032827,1.00000000001611,0.950183666609091,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8914,GO:0034729,1.00000000001614,0.793205079617068,0,3,histone H3-K79 methylation,BP,
1250,GO:0002947,1.00000000001614,0.923029281335814,0,1,tumor necrosis factor receptor superfamily complex,CC,
2692,GO:0006055,1.00000000001614,0.948585526410192,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11665,GO:0046381,1.00000000001614,0.948585526410192,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12017,GO:0047444,1.00000000001614,0.948585526410192,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12506,GO:0050462,1.00000000001614,0.948585526410192,0,1,N-acetylneuraminate synthase activity,MF,
8461,GO:0033591,1.00000000001614,0.745901746485575,0,4,response to L-ascorbic acid,BP,
1321,GO:0003166,1.00000000001615,0.920070553901505,0,1,bundle of His development,BP,
1322,GO:0003167,1.00000000001615,0.920070553901505,0,1,atrioventricular bundle cell differentiation,BP,
13953,GO:0060596,1.00000000001615,0.920070553901505,0,1,mammary placode formation,BP,
14119,GO:0060932,1.00000000001615,0.920070553901505,0,1,His-Purkinje system cell differentiation,BP,
16910,GO:0098833,1.00000000001615,0.919078492895001,0,1,presynaptic endocytic zone,CC,
16911,GO:0098835,1.00000000001615,0.919078492895001,0,1,presynaptic endocytic zone membrane,CC,
16138,GO:0090108,1.00000000001617,0.933939061619168,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16185,GO:0090187,1.00000000001617,0.933939061619168,0,1,positive regulation of pancreatic juice secretion,BP,
16292,GO:0090340,1.00000000001617,0.933939061619168,0,1,positive regulation of secretion of lysosomal enzymes,BP,
10095,GO:0042586,1.00000000001617,0.950686494841508,0,1,peptide deformylase activity,MF,
12064,GO:0047894,1.00000000001618,0.889149963181665,0,2,flavonol 3-sulfotransferase activity,MF,
5711,GO:0016838,1.00000000001619,0.892947118455129,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
13670,GO:0060157,1.0000000000162,0.841812788230624,0,2,urinary bladder development,BP,
17105,GO:0099606,1.0000000000162,0.899524802139379,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17106,GO:0099607,1.0000000000162,0.899524802139379,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
3085,GO:0006659,1.00000000001621,0.746952073501565,0,4,phosphatidylserine biosynthetic process,BP,
13970,GO:0060631,1.00000000001624,0.79630350435896,0,3,regulation of meiosis I,BP,
7616,GO:0031997,1.00000000001624,0.814367038834184,0,3,N-terminal myristoylation domain binding,MF,
12980,GO:0051343,1.00000000001624,0.814367038834184,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
1418,GO:0003352,1.00000000001627,0.691664043347978,0,5,regulation of cilium movement,BP,
1419,GO:0003356,1.00000000001627,0.691664043347978,0,5,regulation of cilium beat frequency,BP,
13747,GO:0060295,1.00000000001627,0.691664043347978,0,5,regulation of cilium movement involved in cell motility,BP,
13748,GO:0060296,1.00000000001627,0.691664043347978,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
17867,GO:1902019,1.00000000001627,0.691664043347978,0,5,regulation of cilium-dependent cell motility,BP,
8548,GO:0033867,1.00000000001627,0.940015195042318,0,1,Fas-activated serine/threonine kinase activity,MF,
11125,GO:0045131,1.00000000001631,0.927715623165823,0,1,pre-mRNA branch point binding,MF,
9453,GO:0036022,1.00000000001632,0.867561112367639,0,2,limb joint morphogenesis,BP,
9454,GO:0036023,1.00000000001632,0.867561112367639,0,2,embryonic skeletal limb joint morphogenesis,BP,
6472,GO:0021798,1.00000000001632,0.828941579503751,0,2,forebrain dorsal/ventral pattern formation,BP,
16678,GO:0097534,1.00000000001632,0.840353769342858,0,2,lymphoid lineage cell migration,BP,
16679,GO:0097535,1.00000000001632,0.840353769342858,0,2,lymphoid lineage cell migration into thymus,BP,
10956,GO:0044611,1.00000000001633,0.769466445273026,0,3,nuclear pore inner ring,CC,
6950,GO:0030553,1.00000000001635,0.775253522487984,0,3,cGMP binding,MF,
14902,GO:0070676,1.00000000001636,0.825695624606755,0,3,intralumenal vesicle formation,BP,
18356,GO:1903286,1.00000000001638,0.80568303093596,0,3,regulation of potassium ion import,BP,
16959,GO:0098917,1.00000000001638,0.73629225350316,0,4,retrograde trans-synaptic signaling,BP,
12510,GO:0050501,1.00000000001639,0.804805859195538,0,3,hyaluronan synthase activity,MF,
13834,GO:0060405,1.00000000001639,0.805287749516832,0,3,regulation of penile erection,BP,
10692,GO:0043946,1.0000000000164,0.938287580351623,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10693,GO:0043947,1.0000000000164,0.938287580351623,0,1,positive regulation by host of symbiont catalytic activity,BP,
5205,GO:0015801,1.00000000001642,0.867267711768072,0,2,aromatic amino acid transport,BP,
5226,GO:0015827,1.00000000001642,0.867267711768072,0,2,tryptophan transport,BP,
18826,GO:1904340,1.00000000001643,0.813846624951136,0,3,positive regulation of dopaminergic neuron differentiation,BP,
19105,GO:1904958,1.00000000001643,0.813846624951136,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
4452,GO:0010387,1.00000000001644,0.931820772818099,0,1,COP9 signalosome assembly,BP,
6164,GO:0019510,1.00000000001644,0.931820772818099,0,1,S-adenosylhomocysteine catabolic process,BP,
15174,GO:0071268,1.00000000001644,0.931820772818099,0,1,homocysteine biosynthetic process,BP,
491,GO:0001543,1.00000000001644,0.905258078697791,0,1,ovarian follicle rupture,BP,
10930,GO:0044530,1.00000000001646,0.77978575048979,0,3,supraspliceosomal complex,CC,
8480,GO:0033615,1.00000000001648,0.809345278388923,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
5739,GO:0016882,1.00000000001648,0.88690756830032,0,2,cyclo-ligase activity,MF,
12309,GO:0048630,1.00000000001651,0.78645133026416,0,3,skeletal muscle tissue growth,BP,
12310,GO:0048631,1.00000000001651,0.78645133026416,0,3,regulation of skeletal muscle tissue growth,BP,
12311,GO:0048633,1.00000000001651,0.78645133026416,0,3,positive regulation of skeletal muscle tissue growth,BP,
15086,GO:0071030,1.00000000001654,0.871913375037109,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15098,GO:0071048,1.00000000001654,0.871913375037109,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
6638,GO:0023016,1.00000000001654,0.825357349103087,0,2,signal transduction by trans-phosphorylation,BP,
14006,GO:0060698,1.00000000001655,0.855607102140604,0,2,endoribonuclease inhibitor activity,MF,
14009,GO:0060701,1.00000000001655,0.855607102140604,0,2,negative regulation of ribonuclease activity,BP,
14010,GO:0060702,1.00000000001655,0.855607102140604,0,2,negative regulation of endoribonuclease activity,BP,
10106,GO:0042602,1.00000000001655,0.958768505488347,0,1,riboflavin reductase (NADPH) activity,MF,
11093,GO:0045079,1.00000000001655,0.892516282292354,0,2,negative regulation of chemokine biosynthetic process,BP,
6836,GO:0030294,1.00000000001657,0.932553892220308,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
15717,GO:0072236,1.00000000001658,0.739968507476701,0,3,metanephric loop of Henle development,BP,
940,GO:0002339,1.00000000001659,0.895477688913191,0,2,B cell selection,BP,
944,GO:0002352,1.00000000001659,0.895477688913191,0,2,B cell negative selection,BP,
5953,GO:0018298,1.00000000001661,0.794819402562209,0,3,protein-chromophore linkage,BP,
17280,GO:0120043,1.00000000001661,0.920113050482731,0,1,stereocilium shaft,CC,
17281,GO:0120044,1.00000000001661,0.920113050482731,0,1,stereocilium base,CC,
19594,GO:1990573,1.00000000001662,0.803422714614771,0,3,potassium ion import across plasma membrane,BP,
15215,GO:0071344,1.00000000001664,0.891106930189245,0,2,diphosphate metabolic process,BP,
18,GO:0000033,1.00000000001666,0.821110230609103,0,3,alpha-1,3-mannosyltransferase activity,MF,
12026,GO:0047499,1.00000000001667,0.701886414296588,0,5,calcium-independent phospholipase A2 activity,MF,
19954,GO:2000418,1.00000000001667,0.861595571537585,0,2,positive regulation of eosinophil migration,BP,
10263,GO:0042988,1.00000000001668,0.917836595936462,0,1,X11-like protein binding,MF,
10822,GO:0044300,1.0000000000167,0.767973376179593,0,3,cerebellar mossy fiber,CC,
3734,GO:0008271,1.0000000000167,0.662510718475451,0,5,secondary active sulfate transmembrane transporter activity,MF,
6173,GO:0019531,1.0000000000167,0.662510718475451,0,5,oxalate transmembrane transporter activity,MF,
6174,GO:0019532,1.0000000000167,0.662510718475451,0,5,oxalate transport,BP,
1642,GO:0004082,1.0000000000167,0.82504820743133,0,3,bisphosphoglycerate mutase activity,MF,
1928,GO:0004619,1.0000000000167,0.82504820743133,0,3,phosphoglycerate mutase activity,MF,
11743,GO:0046538,1.0000000000167,0.82504820743133,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
10599,GO:0043553,1.00000000001676,0.795925384266513,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
7710,GO:0032184,1.00000000001678,0.717484786677964,0,4,SUMO polymer binding,MF,
14458,GO:0061760,1.00000000001678,0.927969944836113,0,1,antifungal innate immune response,BP,
15153,GO:0071228,1.00000000001678,0.927969944836113,0,1,cellular response to tumor cell,BP,
19134,GO:1905034,1.00000000001678,0.927969944836113,0,1,regulation of antifungal innate immune response,BP,
19135,GO:1905035,1.00000000001678,0.927969944836113,0,1,negative regulation of antifungal innate immune response,BP,
11755,GO:0046573,1.00000000001678,0.940122991445917,0,1,lactonohydrolase activity,MF,
17140,GO:0102007,1.00000000001678,0.940122991445917,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18718,GO:1904045,1.0000000000168,0.932530826032586,0,1,cellular response to aldosterone,BP,
8399,GO:0033306,1.00000000001681,0.865643748906569,0,2,phytol metabolic process,BP,
18308,GO:1903173,1.00000000001681,0.865643748906569,0,2,fatty alcohol metabolic process,BP,
20297,GO:2001228,1.00000000001682,0.776222976606708,0,2,regulation of response to gamma radiation,BP,
16643,GO:0097475,1.00000000001682,0.780832210917309,0,3,motor neuron migration,BP,
18620,GO:1903850,1.00000000001682,0.929314118961818,0,1,regulation of cristae formation,BP,
18621,GO:1903852,1.00000000001682,0.929314118961818,0,1,positive regulation of cristae formation,BP,
18904,GO:1904542,1.00000000001682,0.929314118961818,0,1,regulation of free ubiquitin chain polymerization,BP,
18905,GO:1904544,1.00000000001682,0.929314118961818,0,1,positive regulation of free ubiquitin chain polymerization,BP,
19067,GO:1904881,1.00000000001682,0.929314118961818,0,1,cellular response to hydrogen sulfide,BP,
14374,GO:0061575,1.00000000001683,0.817446305806127,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
7159,GO:0031013,1.00000000001683,0.893222322759066,0,2,troponin I binding,MF,
11034,GO:0044861,1.00000000001684,0.856074485202059,0,2,protein transport into plasma membrane raft,BP,
4988,GO:0015112,1.00000000001685,0.929364205152279,0,1,nitrate transmembrane transporter activity,MF,
5166,GO:0015706,1.00000000001685,0.929364205152279,0,1,nitrate transport,BP,
1429,GO:0003383,1.00000000001686,0.761476082135316,0,3,apical constriction,BP,
8100,GO:0032777,1.00000000001689,0.751396058005078,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
19622,GO:1990700,1.00000000001689,0.923797273070551,0,1,nucleolar chromatin organization,BP,
13995,GO:0060685,1.0000000000169,0.79174888958421,0,3,regulation of prostatic bud formation,BP,
13996,GO:0060686,1.0000000000169,0.79174888958421,0,3,negative regulation of prostatic bud formation,BP,
8971,GO:0035033,1.0000000000169,0.864255699074007,0,2,histone deacetylase regulator activity,MF,
5067,GO:0015279,1.00000000001691,0.662503044250227,0,5,store-operated calcium channel activity,MF,
2771,GO:0006193,1.00000000001692,0.952082307882841,0,1,ITP catabolic process,BP,
4143,GO:0009203,1.00000000001692,0.952082307882841,0,1,ribonucleoside triphosphate catabolic process,BP,
4147,GO:0009207,1.00000000001692,0.952082307882841,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9530,GO:0036220,1.00000000001692,0.952082307882841,0,1,ITP diphosphatase activity,MF,
9531,GO:0036222,1.00000000001692,0.952082307882841,0,1,XTP diphosphatase activity,MF,
3658,GO:0008142,1.00000000001694,0.707218332215067,0,4,oxysterol binding,MF,
13429,GO:0052746,1.00000000001694,0.854029260184191,0,2,inositol phosphorylation,BP,
5035,GO:0015204,1.00000000001698,0.802151511386104,0,3,urea transmembrane transporter activity,MF,
5230,GO:0015840,1.00000000001698,0.802151511386104,0,3,urea transport,BP,
9399,GO:0035928,1.000000000017,0.8370655567215,0,3,rRNA import into mitochondrion,BP,
4015,GO:0009008,1.000000000017,0.684698245816197,0,5,DNA-methyltransferase activity,MF,
14733,GO:0070369,1.00000000001701,0.770599255092992,0,3,beta-catenin-TCF7L2 complex,CC,
7019,GO:0030718,1.00000000001704,0.92424060254479,0,1,germ-line stem cell population maintenance,BP,
8822,GO:0034584,1.00000000001704,0.92424060254479,0,1,piRNA binding,MF,
5776,GO:0016979,1.00000000001706,0.944617260515429,0,1,lipoate-protein ligase activity,MF,
12398,GO:0048788,1.00000000001706,0.610688607930371,0,4,cytoskeleton of presynaptic active zone,CC,
17094,GO:0099569,1.00000000001706,0.610688607930371,0,4,presynaptic cytoskeleton,CC,
827,GO:0002100,1.00000000001712,0.91214822796839,0,1,tRNA wobble adenosine to inosine editing,BP,
1318,GO:0003163,1.00000000001712,0.843086002130854,0,2,sinoatrial node development,BP,
2152,GO:0004968,1.00000000001712,0.91214822796839,0,1,gonadotropin-releasing hormone receptor activity,MF,
13416,GO:0052717,1.00000000001712,0.91214822796839,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13417,GO:0052718,1.00000000001712,0.91214822796839,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
14113,GO:0060921,1.00000000001712,0.843086002130854,0,2,sinoatrial node cell differentiation,BP,
14118,GO:0060931,1.00000000001712,0.843086002130854,0,2,sinoatrial node cell development,BP,
8775,GO:0034441,1.00000000001713,0.937459053900679,0,1,plasma lipoprotein particle oxidation,BP,
13623,GO:0060073,1.00000000001714,0.718460894815954,0,4,micturition,BP,
5929,GO:0018201,1.00000000001717,0.78398571959972,0,3,peptidyl-glycine modification,BP,
4249,GO:0009447,1.00000000001717,0.854103044915113,0,3,putrescine catabolic process,BP,
1857,GO:0004517,1.00000000001717,0.84433550726529,0,2,nitric-oxide synthase activity,MF,
3446,GO:0007258,1.00000000001718,0.745998667223677,0,4,JUN phosphorylation,BP,
10385,GO:0043196,1.00000000001718,0.797601195012206,0,3,varicosity,CC,
15789,GO:0072367,1.00000000001719,0.689733336890727,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
2618,GO:0005927,1.00000000001722,0.941832802843334,0,1,muscle tendon junction,CC,
8666,GO:0034213,1.00000000001722,0.941832802843334,0,1,quinolinate catabolic process,BP,
11885,GO:0046874,1.00000000001722,0.941832802843334,0,1,quinolinate metabolic process,BP,
8506,GO:0033677,1.00000000001724,0.794828171459323,0,3,DNA/RNA helicase activity,MF,
16855,GO:0098735,1.00000000001724,0.763183021493421,0,3,positive regulation of the force of heart contraction,BP,
1551,GO:0003944,1.00000000001724,0.932567766257468,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
12717,GO:0050916,1.00000000001726,0.779049525819024,0,3,sensory perception of sweet taste,BP,
9545,GO:0036284,1.00000000001728,0.852925269501461,0,2,tubulobulbar complex,CC,
4992,GO:0015119,1.00000000001732,0.798707433662847,0,3,hexose phosphate transmembrane transporter activity,MF,
5081,GO:0015315,1.00000000001732,0.798707433662847,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5128,GO:0015526,1.00000000001732,0.798707433662847,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
14351,GO:0061513,1.00000000001732,0.798707433662847,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
533,GO:0001651,1.00000000001732,0.882053364750805,0,2,dense fibrillar component,CC,
10711,GO:0043987,1.00000000001734,0.753511608629124,0,4,histone H3-S10 phosphorylation,BP,
9411,GO:0035948,1.00000000001735,0.79044913251974,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10824,GO:0044302,1.00000000001738,0.757552213447291,0,3,dentate gyrus mossy fiber,CC,
2109,GO:0004883,1.00000000001739,0.910209760224489,0,1,glucocorticoid receptor activity,MF,
9690,GO:0038051,1.00000000001739,0.910209760224489,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
17130,GO:0100057,1.0000000000174,0.904893666856172,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
19037,GO:1904826,1.0000000000174,0.904893666856172,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
19038,GO:1904828,1.0000000000174,0.904893666856172,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
13639,GO:0060091,1.00000000001742,0.70707879300067,0,5,kinocilium,CC,
16747,GO:0097732,1.00000000001742,0.70707879300067,0,5,9+2 non-motile cilium,CC,
671,GO:0001875,1.00000000001744,0.794097135792404,0,3,lipopolysaccharide receptor activity,MF,
17041,GO:0099170,1.00000000001745,0.794254416556392,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17084,GO:0099547,1.00000000001745,0.794254416556392,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17097,GO:0099578,1.00000000001745,0.794254416556392,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
20261,GO:2001168,1.00000000001747,0.731122550116441,0,4,positive regulation of histone H2B ubiquitination,BP,
16059,GO:0086072,1.00000000001747,0.930471856047323,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16067,GO:0086082,1.00000000001747,0.930471856047323,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
12724,GO:0050923,1.00000000001747,0.760835116612877,0,3,regulation of negative chemotaxis,BP,
20043,GO:2000622,1.00000000001748,0.717951044448505,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20044,GO:2000623,1.00000000001748,0.717951044448505,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19740,GO:2000049,1.00000000001748,0.795107959948232,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
2029,GO:0004766,1.00000000001749,0.947724815886982,0,1,spermidine synthase activity,MF,
1523,GO:0003882,1.00000000001749,0.930614894286777,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1271,GO:0003050,1.00000000001749,0.926802041844247,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
4995,GO:0015129,1.00000000001753,0.798024314735429,0,3,lactate transmembrane transporter activity,MF,
8537,GO:0033814,1.00000000001753,0.944444342617191,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12525,GO:0050632,1.00000000001753,0.944444342617191,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14824,GO:0070538,1.00000000001753,0.944444342617191,0,1,oleic acid binding,MF,
17664,GO:1901373,1.00000000001753,0.944444342617191,0,1,lipid hydroperoxide transport,BP,
2012,GO:0004735,1.00000000001754,0.879195366578406,0,2,pyrroline-5-carboxylate reductase activity,MF,
4434,GO:0010266,1.00000000001754,0.8076643028129,0,3,response to vitamin B1,BP,
12421,GO:0048850,1.00000000001755,0.833447781116713,0,2,hypophysis morphogenesis,BP,
654,GO:0001842,1.00000000001755,0.685793716308787,0,5,neural fold formation,BP,
16904,GO:0098826,1.00000000001755,0.748201247203888,0,4,endoplasmic reticulum tubular network membrane,CC,
11924,GO:0046940,1.00000000001756,0.76057956410436,0,4,nucleoside monophosphate phosphorylation,BP,
12466,GO:0050145,1.00000000001756,0.76057956410436,0,4,nucleoside phosphate kinase activity,MF,
312,GO:0000823,1.00000000001758,0.937542702998432,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
313,GO:0000824,1.00000000001758,0.937542702998432,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
314,GO:0000825,1.00000000001758,0.937542702998432,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
12005,GO:0047326,1.00000000001758,0.937542702998432,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
18695,GO:1903999,1.00000000001761,0.880982543774019,0,2,negative regulation of eating behavior,BP,
19837,GO:2000252,1.00000000001761,0.880982543774019,0,2,negative regulation of feeding behavior,BP,
919,GO:0002309,1.00000000001762,0.959516694923616,0,1,T cell proliferation involved in immune response,BP,
19541,GO:1990393,1.00000000001762,0.666890681971766,0,5,3M complex,CC,
830,GO:0002114,1.00000000001764,0.924340392433721,0,1,interleukin-33 receptor activity,MF,
9737,GO:0038172,1.00000000001764,0.924340392433721,0,1,interleukin-33-mediated signaling pathway,BP,
8965,GO:0035022,1.00000000001767,0.742084523883222,0,4,positive regulation of Rac protein signal transduction,BP,
18746,GO:1904154,1.00000000001768,0.804624163537049,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
19054,GO:1904862,1.00000000001769,0.841788105036023,0,2,inhibitory synapse assembly,BP,
20325,GO:2001271,1.00000000001769,0.787049288870104,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
12308,GO:0048627,1.00000000001771,0.875695651713284,0,2,myoblast development,BP,
145,GO:0000296,1.00000000001771,0.93183746518729,0,1,spermine transport,BP,
6754,GO:0030172,1.00000000001772,0.951143393111606,0,1,troponin C binding,MF,
8223,GO:0032971,1.00000000001772,0.951143393111606,0,1,regulation of muscle filament sliding,BP,
8224,GO:0032972,1.00000000001772,0.951143393111606,0,1,regulation of muscle filament sliding speed,BP,
19599,GO:1990584,1.00000000001772,0.951143393111606,0,1,cardiac Troponin complex,CC,
7164,GO:0031021,1.00000000001773,0.827221635452249,0,3,interphase microtubule organizing center,CC,
9181,GO:0035538,1.00000000001773,0.926525512333318,0,1,carbohydrate response element binding,MF,
6046,GO:0019150,1.00000000001774,0.934065921555401,0,1,D-ribulokinase activity,MF,
15126,GO:0071159,1.00000000001774,0.891882679279552,0,2,NF-kappaB complex,CC,
2419,GO:0005592,1.00000000001774,0.906634891488562,0,1,collagen type XI trimer,CC,
11754,GO:0046570,1.00000000001775,0.948105162853062,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
19393,GO:1905777,1.00000000001778,0.799934268938026,0,3,regulation of exonuclease activity,BP,
2317,GO:0005315,1.00000000001778,0.772714918956727,0,3,inorganic phosphate transmembrane transporter activity,MF,
14742,GO:0070381,1.00000000001779,0.855910056167599,0,2,endosome to plasma membrane transport vesicle,CC,
14355,GO:0061519,1.00000000001781,0.925188614676199,0,1,macrophage homeostasis,BP,
16728,GO:0097692,1.00000000001783,0.912153566573213,0,1,histone H3-K4 monomethylation,BP,
9022,GO:0035189,1.00000000001783,0.797148707679144,0,3,Rb-E2F complex,CC,
13557,GO:0055120,1.00000000001784,0.953514380084676,0,1,striated muscle dense body,CC,
525,GO:0001631,1.00000000001785,0.872560267605247,0,2,cysteinyl leukotriene receptor activity,MF,
526,GO:0001632,1.00000000001785,0.872560267605247,0,2,leukotriene B4 receptor activity,MF,
2156,GO:0004974,1.00000000001785,0.872560267605247,0,2,leukotriene receptor activity,MF,
14445,GO:0061737,1.00000000001785,0.872560267605247,0,2,leukotriene signaling pathway,BP,
17980,GO:1902308,1.00000000001785,0.802131830878573,0,3,regulation of peptidyl-serine dephosphorylation,BP,
13967,GO:0060623,1.00000000001786,0.801646525267736,0,3,regulation of chromosome condensation,BP,
18149,GO:1902809,1.00000000001786,0.805461322385815,0,3,regulation of skeletal muscle fiber differentiation,BP,
4598,GO:0010711,1.00000000001787,0.96117948614892,0,1,negative regulation of collagen catabolic process,BP,
13757,GO:0060309,1.00000000001787,0.96117948614892,0,1,elastin catabolic process,BP,
13758,GO:0060310,1.00000000001787,0.96117948614892,0,1,regulation of elastin catabolic process,BP,
13759,GO:0060311,1.00000000001787,0.96117948614892,0,1,negative regulation of elastin catabolic process,BP,
17933,GO:1902219,1.00000000001788,0.728034294005882,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
12111,GO:0048075,1.0000000000179,0.922204433901249,0,1,positive regulation of eye pigmentation,BP,
269,GO:0000741,1.00000000001791,0.938279526915854,0,1,karyogamy,BP,
3481,GO:0007344,1.00000000001791,0.938279526915854,0,1,pronuclear fusion,BP,
13178,GO:0051732,1.00000000001791,0.938279526915854,0,1,polyribonucleotide kinase activity,MF,
13181,GO:0051736,1.00000000001791,0.938279526915854,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
16534,GO:0097224,1.00000000001791,0.938279526915854,0,1,sperm connecting piece,CC,
6514,GO:0021886,1.00000000001791,0.81380161427103,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6515,GO:0021888,1.00000000001791,0.81380161427103,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
3607,GO:0008048,1.00000000001792,0.932023814517723,0,1,calcium sensitive guanylate cyclase activator activity,MF,
4698,GO:0010851,1.00000000001792,0.932023814517723,0,1,cyclase regulator activity,MF,
4699,GO:0010853,1.00000000001792,0.932023814517723,0,1,cyclase activator activity,MF,
6808,GO:0030249,1.00000000001792,0.932023814517723,0,1,guanylate cyclase regulator activity,MF,
6809,GO:0030250,1.00000000001792,0.932023814517723,0,1,guanylate cyclase activator activity,MF,
10466,GO:0043314,1.00000000001794,0.833771245003613,0,2,negative regulation of neutrophil degranulation,BP,
18065,GO:1902564,1.00000000001794,0.833771245003613,0,2,negative regulation of neutrophil activation,BP,
8987,GO:0035087,1.00000000001796,0.732539281697436,0,4,siRNA loading onto RISC involved in RNA interference,BP,
11029,GO:0044855,1.00000000001798,0.928918954852721,0,1,plasma membrane raft distribution,BP,
11030,GO:0044856,1.00000000001798,0.928918954852721,0,1,plasma membrane raft localization,BP,
11032,GO:0044858,1.00000000001798,0.928918954852721,0,1,plasma membrane raft polarization,BP,
18648,GO:1903906,1.00000000001798,0.928918954852721,0,1,regulation of plasma membrane raft polarization,BP,
13830,GO:0060399,1.000000000018,0.837766308145984,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
16419,GO:0097020,1.00000000001801,0.926088941472232,0,1,COPII adaptor activity,MF,
10379,GO:0043185,1.00000000001801,0.933830197441393,0,1,vascular endothelial growth factor receptor 3 binding,MF,
14870,GO:0070625,1.00000000001801,0.933830197441393,0,1,zymogen granule exocytosis,BP,
19046,GO:1904844,1.00000000001802,0.89916642307761,0,2,response to L-glutamine,BP,
19047,GO:1904845,1.00000000001802,0.89916642307761,0,2,cellular response to L-glutamine,BP,
14798,GO:0070488,1.00000000001805,0.940647690105151,0,2,neutrophil aggregation,BP,
16432,GO:0097048,1.00000000001807,0.721553271768324,0,4,dendritic cell apoptotic process,BP,
20079,GO:2000668,1.00000000001807,0.721553271768324,0,4,regulation of dendritic cell apoptotic process,BP,
1620,GO:0004046,1.00000000001808,0.819580552293815,0,3,aminoacylase activity,MF,
12047,GO:0047710,1.00000000001809,0.952420667468416,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
11373,GO:0045716,1.00000000001812,0.81243678973562,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
7037,GO:0030805,1.00000000001813,0.769523421754786,0,3,regulation of cyclic nucleotide catabolic process,BP,
7052,GO:0030820,1.00000000001813,0.769523421754786,0,3,regulation of cAMP catabolic process,BP,
8300,GO:0033121,1.00000000001813,0.769523421754786,0,3,regulation of purine nucleotide catabolic process,BP,
18544,GO:1903690,1.00000000001813,0.685201673862158,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
17255,GO:0110025,1.00000000001817,0.927383309236446,0,1,DNA strand resection involved in replication fork processing,BP,
17256,GO:0110026,1.00000000001817,0.927383309236446,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
7397,GO:0031444,1.00000000001819,0.954533528959834,0,1,slow-twitch skeletal muscle fiber contraction,BP,
13882,GO:0060478,1.00000000001821,0.884118293137853,0,2,acrosomal vesicle exocytosis,BP,
19915,GO:2000367,1.00000000001821,0.884118293137853,0,2,regulation of acrosomal vesicle exocytosis,BP,
19916,GO:2000368,1.00000000001821,0.884118293137853,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
4712,GO:0010872,1.00000000001821,0.74017900940148,0,5,regulation of cholesterol esterification,BP,
8640,GO:0034154,1.00000000001822,0.738009038860956,0,4,toll-like receptor 7 signaling pathway,BP,
13675,GO:0060166,1.00000000001822,0.87414906306862,0,2,olfactory pit development,BP,
2480,GO:0005713,1.00000000001823,0.930492081293129,0,1,recombination nodule,CC,
2481,GO:0005715,1.00000000001823,0.930492081293129,0,1,late recombination nodule,CC,
5015,GO:0015173,1.00000000001823,0.930492081293129,0,1,aromatic amino acid transmembrane transporter activity,MF,
5033,GO:0015196,1.00000000001823,0.930492081293129,0,1,L-tryptophan transmembrane transporter activity,MF,
10309,GO:0043060,1.00000000001823,0.930492081293129,0,1,meiotic metaphase I plate congression,BP,
12930,GO:0051257,1.00000000001823,0.930492081293129,0,1,meiotic spindle midzone assembly,BP,
12970,GO:0051311,1.00000000001823,0.930492081293129,0,1,meiotic metaphase plate congression,BP,
18800,GO:1904271,1.00000000001823,0.930492081293129,0,1,L-proline import across plasma membrane,BP,
18907,GO:1904555,1.00000000001823,0.930492081293129,0,1,L-proline transmembrane transport,BP,
18908,GO:1904556,1.00000000001823,0.930492081293129,0,1,L-tryptophan transmembrane transport,BP,
19362,GO:1905647,1.00000000001823,0.930492081293129,0,1,proline import across plasma membrane,BP,
3825,GO:0008422,1.00000000001825,0.844672538576403,0,2,beta-glucosidase activity,MF,
16123,GO:0090086,1.00000000001826,0.847887322441227,0,3,negative regulation of protein deubiquitination,BP,
2844,GO:0006313,1.00000000001826,0.923406169926577,0,1,transposition, DNA-mediated,BP,
4869,GO:0014719,1.00000000001828,0.822137017066647,0,3,skeletal muscle satellite cell activation,BP,
5094,GO:0015362,1.00000000001829,0.923295910613429,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
4010,GO:0008973,1.00000000001832,0.926572937857054,0,1,phosphopentomutase activity,MF,
120,GO:0000248,1.00000000001832,0.855447149356396,0,2,C-5 sterol desaturase activity,MF,
14917,GO:0070704,1.00000000001832,0.855447149356396,0,2,sterol desaturase activity,MF,
12454,GO:0050023,1.00000000001833,0.936545156790071,0,1,L-fuconate dehydratase activity,MF,
2013,GO:0004736,1.00000000001834,0.923477755888706,0,1,pyruvate carboxylase activity,MF,
10536,GO:0043461,1.00000000001835,0.762146188894568,0,4,proton-transporting ATP synthase complex assembly,BP,
6983,GO:0030644,1.00000000001835,0.867136313432467,0,2,cellular chloride ion homeostasis,BP,
16680,GO:0097536,1.00000000001837,0.92911762566846,0,1,thymus epithelium morphogenesis,BP,
1543,GO:0003933,1.00000000001838,0.935323095500749,0,1,GTP cyclohydrolase activity,MF,
1544,GO:0003934,1.00000000001838,0.935323095500749,0,1,GTP cyclohydrolase I activity,MF,
9437,GO:0035998,1.00000000001838,0.935323095500749,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
4912,GO:0014846,1.0000000000184,0.922508024823302,0,1,esophagus smooth muscle contraction,BP,
9333,GO:0035800,1.0000000000184,0.87355873433872,0,2,deubiquitinase activator activity,MF,
19794,GO:2000158,1.0000000000184,0.87355873433872,0,2,positive regulation of ubiquitin-specific protease activity,BP,
13667,GO:0060154,1.00000000001841,0.814532551792187,0,3,cellular process regulating host cell cycle in response to virus,BP,
8451,GO:0033565,1.00000000001844,0.78779651855083,0,3,ESCRT-0 complex,CC,
3471,GO:0007308,1.00000000001848,0.929834509106995,0,1,oocyte construction,BP,
3472,GO:0007309,1.00000000001848,0.929834509106995,0,1,oocyte axis specification,BP,
3473,GO:0007314,1.00000000001848,0.929834509106995,0,1,oocyte anterior/posterior axis specification,BP,
3474,GO:0007315,1.00000000001848,0.929834509106995,0,1,pole plasm assembly,BP,
3793,GO:0008358,1.00000000001848,0.929834509106995,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7020,GO:0030719,1.00000000001848,0.929834509106995,0,1,P granule organization,BP,
9316,GO:0035755,1.00000000001848,0.929834509106995,0,1,cardiolipin hydrolase activity,MF,
7514,GO:0031691,1.00000000001852,0.872875177121227,0,2,alpha-1A adrenergic receptor binding,MF,
7515,GO:0031692,1.00000000001852,0.872875177121227,0,2,alpha-1B adrenergic receptor binding,MF,
7538,GO:0031762,1.00000000001852,0.872875177121227,0,2,follicle-stimulating hormone receptor binding,MF,
10147,GO:0042699,1.00000000001852,0.872875177121227,0,2,follicle-stimulating hormone signaling pathway,BP,
18541,GO:1903677,1.00000000001853,0.81262657380945,0,3,regulation of cap-independent translational initiation,BP,
18542,GO:1903679,1.00000000001853,0.81262657380945,0,3,positive regulation of cap-independent translational initiation,BP,
4230,GO:0009407,1.00000000001854,0.788644232217609,0,4,toxin catabolic process,BP,
8796,GO:0034473,1.00000000001855,0.844701946908428,0,3,U1 snRNA 3'-end processing,BP,
8799,GO:0034476,1.00000000001855,0.844701946908428,0,3,U5 snRNA 3'-end processing,BP,
9461,GO:0036042,1.00000000001857,0.795037175249854,0,4,long-chain fatty acyl-CoA binding,MF,
16504,GO:0097169,1.00000000001857,0.863625212593362,0,3,AIM2 inflammasome complex,CC,
16005,GO:0080184,1.0000000000186,0.86637531075222,0,2,response to phenylpropanoid,BP,
16328,GO:0090480,1.0000000000186,0.781949361017012,0,3,purine nucleotide-sugar transmembrane transport,BP,
2258,GO:0005170,1.00000000001862,0.917071687942881,0,1,neurotrophin TRKC receptor binding,MF,
16967,GO:0098928,1.00000000001863,0.734654729629272,0,2,presynaptic signal transduction,BP,
17070,GO:0099526,1.00000000001863,0.734654729629272,0,2,presynapse to nucleus signaling pathway,BP,
12054,GO:0047756,1.00000000001864,0.8544742834235,0,2,chondroitin 4-sulfotransferase activity,MF,
18523,GO:1903626,1.00000000001865,0.755674358920696,0,4,positive regulation of DNA catabolic process,BP,
19329,GO:1905553,1.00000000001865,0.814406582092119,0,3,regulation of blood vessel branching,BP,
14464,GO:0061770,1.00000000001865,0.933025629734723,0,1,translation elongation factor binding,MF,
14634,GO:0070184,1.00000000001865,0.933025629734723,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15856,GO:0072545,1.00000000001865,0.933025629734723,0,1,tyrosine binding,MF,
18196,GO:1902937,1.00000000001865,0.933025629734723,0,1,inward rectifier potassium channel complex,CC,
19044,GO:1904842,1.00000000001865,0.933025629734723,0,1,response to nitroglycerin,BP,
19045,GO:1904843,1.00000000001865,0.933025629734723,0,1,cellular response to nitroglycerin,BP,
2362,GO:0005461,1.00000000001866,0.911007425053059,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
5198,GO:0015787,1.00000000001866,0.911007425053059,0,1,UDP-glucuronic acid transmembrane transport,BP,
12827,GO:0051102,1.00000000001867,0.923334182675917,0,1,DNA ligation involved in DNA recombination,BP,
3573,GO:0007619,1.00000000001867,0.789015549837105,0,3,courtship behavior,BP,
2049,GO:0004794,1.00000000001868,0.94490031571317,0,1,L-threonine ammonia-lyase activity,MF,
5238,GO:0015853,1.0000000000187,0.776457238381616,0,4,adenine transport,BP,
6106,GO:0019323,1.00000000001871,0.818036576798466,0,3,pentose catabolic process,BP,
15899,GO:0072610,1.00000000001872,0.743723605617125,0,4,interleukin-12 secretion,BP,
20271,GO:2001182,1.00000000001872,0.743723605617125,0,4,regulation of interleukin-12 secretion,BP,
18518,GO:1903613,1.00000000001873,0.916983892965945,0,1,regulation of protein tyrosine phosphatase activity,BP,
18519,GO:1903615,1.00000000001873,0.916983892965945,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
6341,GO:0021512,1.00000000001876,0.922449537947624,0,1,spinal cord anterior/posterior patterning,BP,
17651,GO:1901338,1.00000000001876,0.814783078769658,0,3,catecholamine binding,MF,
6863,GO:0030327,1.00000000001877,0.790319343411039,0,3,prenylated protein catabolic process,BP,
16036,GO:0086036,1.00000000001878,0.712051874548032,0,4,regulation of cardiac muscle cell membrane potential,BP,
1841,GO:0004493,1.00000000001879,0.958425428625291,0,1,methylmalonyl-CoA epimerase activity,MF,
11716,GO:0046491,1.00000000001879,0.958425428625291,0,1,L-methylmalonyl-CoA metabolic process,BP,
19636,GO:1990742,1.00000000001879,0.89326024776756,0,2,microvesicle,CC,
8189,GO:0032919,1.00000000001882,0.955734002569052,0,1,spermine acetylation,BP,
8190,GO:0032920,1.00000000001882,0.955734002569052,0,1,putrescine acetylation,BP,
11616,GO:0046204,1.00000000001882,0.955734002569052,0,1,nor-spermidine metabolic process,BP,
12485,GO:0050313,1.00000000001882,0.955734002569052,0,1,sulfur dioxygenase activity,MF,
1819,GO:0004466,1.00000000001883,0.761931217626359,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
5828,GO:0017099,1.00000000001883,0.761931217626359,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
11107,GO:0045098,1.00000000001885,0.939660380272915,0,1,type III intermediate filament,CC,
12157,GO:0048244,1.00000000001885,0.939660380272915,0,1,phytanoyl-CoA dioxygenase activity,MF,
16454,GO:0097089,1.00000000001885,0.939660380272915,0,1,methyl-branched fatty acid metabolic process,BP,
2750,GO:0006148,1.00000000001887,0.930875495699155,0,1,inosine catabolic process,BP,
3142,GO:0006738,1.00000000001887,0.930875495699155,0,1,nicotinamide riboside catabolic process,BP,
11718,GO:0046495,1.00000000001887,0.930875495699155,0,1,nicotinamide riboside metabolic process,BP,
14878,GO:0070637,1.00000000001887,0.930875495699155,0,1,pyridine nucleoside metabolic process,BP,
14879,GO:0070638,1.00000000001887,0.930875495699155,0,1,pyridine nucleoside catabolic process,BP,
18886,GO:1904491,1.00000000001891,0.770677695953154,0,4,protein localization to ciliary transition zone,BP,
4987,GO:0015111,1.00000000001892,0.784574717323738,0,3,iodide transmembrane transporter activity,MF,
18381,GO:1903335,1.00000000001896,0.768105390858258,0,4,regulation of vacuolar transport,BP,
11647,GO:0046338,1.00000000001896,0.859692599643191,0,2,phosphatidylethanolamine catabolic process,BP,
17291,GO:0120092,1.00000000001901,0.926092953367656,0,1,crotonyl-CoA hydratase activity,MF,
17292,GO:0120093,1.00000000001901,0.926092953367656,0,1,regulation of peptidyl-lysine crotonylation,BP,
17293,GO:0120094,1.00000000001901,0.926092953367656,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
6052,GO:0019185,1.00000000001901,0.855447295126417,0,2,snRNA-activating protein complex,CC,
17403,GO:1900107,1.00000000001905,0.835670347669827,0,2,regulation of nodal signaling pathway,BP,
17430,GO:1900145,1.00000000001905,0.835670347669827,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17445,GO:1900175,1.00000000001905,0.835670347669827,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
7253,GO:0031204,1.00000000001906,0.81167473697482,0,3,posttranslational protein targeting to membrane, translocation,BP,
11570,GO:0046092,1.00000000001907,0.918553647586258,0,1,deoxycytidine metabolic process,BP,
16863,GO:0098749,1.00000000001907,0.920726218931373,0,1,cerebellar neuron development,BP,
1421,GO:0003360,1.00000000001908,0.776942677738508,0,3,brainstem development,BP,
16168,GO:0090164,1.00000000001908,0.840992515669428,0,2,asymmetric Golgi ribbon formation,BP,
5149,GO:0015679,1.00000000001914,0.828239889636072,0,2,plasma membrane copper ion transport,BP,
17426,GO:1900138,1.00000000001914,0.810753989684078,0,3,negative regulation of phospholipase A2 activity,BP,
5760,GO:0016917,1.00000000001914,0.788566049500876,0,3,GABA receptor activity,MF,
1692,GO:0004163,1.00000000001915,0.937451475786547,0,1,diphosphomevalonate decarboxylase activity,MF,
6380,GO:0021562,1.00000000001917,0.718299891945747,0,4,vestibulocochlear nerve development,BP,
4214,GO:0009368,1.00000000001917,0.885426487686863,0,2,endopeptidase Clp complex,CC,
12338,GO:0048674,1.00000000001917,0.930670296583812,0,1,collateral sprouting of injured axon,BP,
12346,GO:0048686,1.00000000001917,0.930670296583812,0,1,regulation of sprouting of injured axon,BP,
12347,GO:0048687,1.00000000001917,0.930670296583812,0,1,positive regulation of sprouting of injured axon,BP,
12348,GO:0048688,1.00000000001917,0.930670296583812,0,1,negative regulation of sprouting of injured axon,BP,
12349,GO:0048689,1.00000000001917,0.930670296583812,0,1,formation of growth cone in injured axon,BP,
12350,GO:0048693,1.00000000001917,0.930670296583812,0,1,regulation of collateral sprouting of injured axon,BP,
12351,GO:0048694,1.00000000001917,0.930670296583812,0,1,positive regulation of collateral sprouting of injured axon,BP,
19340,GO:1905578,1.00000000001917,0.930670296583812,0,1,regulation of ERBB3 signaling pathway,BP,
19341,GO:1905580,1.00000000001917,0.930670296583812,0,1,positive regulation of ERBB3 signaling pathway,BP,
19441,GO:1905942,1.00000000001917,0.930670296583812,0,1,regulation of formation of growth cone in injured axon,BP,
19442,GO:1905943,1.00000000001917,0.930670296583812,0,1,negative regulation of formation of growth cone in injured axon,BP,
2625,GO:0005945,1.00000000001919,0.858943133004024,0,2,6-phosphofructokinase complex,CC,
2508,GO:0005760,1.00000000001921,0.849306484515238,0,2,gamma DNA polymerase complex,CC,
484,GO:0001534,1.00000000001922,0.924501182756164,0,1,radial spoke,CC,
485,GO:0001536,1.00000000001922,0.924501182756164,0,1,radial spoke stalk,CC,
1843,GO:0004496,1.00000000001924,0.933911719872308,0,1,mevalonate kinase activity,MF,
13469,GO:0052894,1.00000000001924,0.933911719872308,0,1,norspermine:oxygen oxidoreductase activity,MF,
13470,GO:0052895,1.00000000001924,0.933911719872308,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14613,GO:0070159,1.00000000001925,0.931095258325378,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
6304,GO:0019918,1.0000000000193,0.746336391313362,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
9037,GO:0035243,1.0000000000193,0.746336391313362,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
5064,GO:0015275,1.0000000000193,0.85603309941732,0,2,stretch-activated, cation-selective, calcium channel activity,MF,
17335,GO:0140135,1.0000000000193,0.85603309941732,0,2,mechanosensitive cation channel activity,MF,
7275,GO:0031249,1.00000000001931,0.930811068689216,0,1,denatured protein binding,MF,
18002,GO:1902380,1.00000000001931,0.930811068689216,0,1,positive regulation of endoribonuclease activity,BP,
18987,GO:1904722,1.00000000001931,0.930811068689216,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
11323,GO:0045626,1.00000000001932,0.853259785822715,0,2,negative regulation of T-helper 1 cell differentiation,BP,
16252,GO:0090284,1.00000000001932,0.906882389749856,0,1,positive regulation of protein glycosylation in Golgi,BP,
1028,GO:0002528,1.00000000001934,0.837654742392345,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
10119,GO:0042627,1.00000000001934,0.860014166382155,0,3,chylomicron,CC,
15541,GO:0071907,1.00000000001934,0.771598995125949,0,3,determination of digestive tract left/right asymmetry,BP,
2224,GO:0005124,1.00000000001935,0.930947885023894,0,1,scavenger receptor binding,MF,
5427,GO:0016277,1.00000000001935,0.930947885023894,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17798,GO:1901804,1.00000000001935,0.930947885023894,0,1,beta-glucoside metabolic process,BP,
17799,GO:1901805,1.00000000001935,0.930947885023894,0,1,beta-glucoside catabolic process,BP,
18876,GO:1904457,1.00000000001935,0.930947885023894,0,1,positive regulation of neuronal action potential,BP,
1459,GO:0003696,1.00000000001936,0.729921812643644,0,4,satellite DNA binding,MF,
4131,GO:0009189,1.00000000001939,0.842676366734395,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
14877,GO:0070634,1.0000000000194,0.79627444061828,0,3,transepithelial ammonium transport,BP,
7545,GO:0031802,1.00000000001944,0.784864009193619,0,3,type 5 metabotropic glutamate receptor binding,MF,
924,GO:0002316,1.00000000001946,0.922399889951298,0,1,follicular B cell differentiation,BP,
7142,GO:0030969,1.00000000001947,0.797079464266973,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
14556,GO:0070054,1.00000000001947,0.797079464266973,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14557,GO:0070055,1.00000000001947,0.797079464266973,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
5169,GO:0015712,1.00000000001949,0.750899896912451,0,4,hexose phosphate transport,BP,
5189,GO:0015760,1.00000000001949,0.750899896912451,0,4,glucose-6-phosphate transport,BP,
2121,GO:0004909,1.0000000000195,0.859626986485044,0,2,interleukin-1, Type I, activating receptor activity,MF,
18283,GO:1903094,1.00000000001951,0.906245845234426,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19793,GO:2000157,1.00000000001951,0.906245845234426,0,2,negative regulation of ubiquitin-specific protease activity,BP,
4691,GO:0010838,1.00000000001952,0.667092631642896,0,5,positive regulation of keratinocyte proliferation,BP,
8508,GO:0033679,1.00000000001953,0.920711540601404,0,1,3'-5' DNA/RNA helicase activity,MF,
8510,GO:0033681,1.00000000001953,0.920711540601404,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8788,GO:0034459,1.00000000001953,0.920711540601404,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9792,GO:0039695,1.00000000001953,0.920711540601404,0,1,DNA-templated viral transcription,BP,
19109,GO:1904971,1.00000000001953,0.920711540601404,0,1,regulation of viral translation,BP,
19110,GO:1904973,1.00000000001953,0.920711540601404,0,1,positive regulation of viral translation,BP,
19189,GO:1905172,1.00000000001953,0.920711540601404,0,1,RISC complex binding,MF,
19375,GO:1905698,1.00000000001953,0.920711540601404,0,1,positive regulation of polysome binding,BP,
19583,GO:1990518,1.00000000001953,0.920711540601404,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
4020,GO:0009041,1.00000000001953,0.819106353528382,0,3,uridylate kinase activity,MF,
18726,GO:1904058,1.00000000001954,0.796432983739072,0,3,positive regulation of sensory perception of pain,BP,
1269,GO:0003032,1.00000000001956,0.863919875024169,0,2,detection of oxygen,BP,
341,GO:0000941,1.0000000000196,0.932145056023572,0,1,condensed nuclear chromosome inner kinetochore,CC,
13040,GO:0051456,1.0000000000196,0.932145056023572,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
2632,GO:0005958,1.0000000000196,0.759306275120263,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
13881,GO:0060474,1.00000000001961,0.8991204908882,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
5445,GO:0016309,1.00000000001962,0.783927832995124,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
9676,GO:0038026,1.00000000001963,0.786409034208596,0,3,reelin-mediated signaling pathway,BP,
17541,GO:1900753,1.00000000001965,0.921988346439972,0,1,doxorubicin transport,BP,
397,GO:0001069,1.00000000001969,0.844718005234177,0,2,regulatory region RNA binding,MF,
14748,GO:0070401,1.00000000001969,0.875950793408674,0,2,NADP+ binding,MF,
15544,GO:0071910,1.0000000000197,0.84202900208024,0,2,determination of liver left/right asymmetry,BP,
6375,GO:0021557,1.0000000000197,0.874270800016707,0,2,oculomotor nerve development,BP,
1851,GO:0004511,1.00000000001971,0.935940870109063,0,1,tyrosine 3-monooxygenase activity,MF,
3035,GO:0006585,1.00000000001971,0.935940870109063,0,1,dopamine biosynthetic process from tyrosine,BP,
8280,GO:0033076,1.00000000001971,0.935940870109063,0,1,isoquinoline alkaloid metabolic process,BP,
9034,GO:0035240,1.00000000001971,0.935940870109063,0,1,dopamine binding,MF,
9909,GO:0042214,1.00000000001971,0.935940870109063,0,1,terpene metabolic process,BP,
10012,GO:0042418,1.00000000001971,0.935940870109063,0,1,epinephrine biosynthetic process,BP,
13357,GO:0052314,1.00000000001971,0.935940870109063,0,1,phytoalexin metabolic process,BP,
3879,GO:0008508,1.00000000001971,0.882538205124689,0,2,bile acid:sodium symporter activity,MF,
6684,GO:0030046,1.00000000001971,0.785952077216792,0,3,parallel actin filament bundle assembly,BP,
17337,GO:0140161,1.00000000001973,0.824966980946507,0,3,monocarboxylate:sodium symporter activity,MF,
1498,GO:0003839,1.00000000001973,0.788440999347586,0,4,gamma-glutamylcyclotransferase activity,MF,
2711,GO:0006083,1.00000000001976,0.784676528273509,0,3,acetate metabolic process,BP,
19534,GO:1990379,1.00000000001977,0.886192624008481,0,2,lipid transport across blood brain barrier,BP,
14368,GO:0061551,1.00000000001978,0.776931136202423,0,3,trigeminal ganglion development,BP,
15937,GO:0072702,1.00000000001979,0.915479557883417,0,1,response to methyl methanesulfonate,BP,
15938,GO:0072703,1.00000000001979,0.915479557883417,0,1,cellular response to methyl methanesulfonate,BP,
3399,GO:0007181,1.00000000001979,0.861282526378169,0,2,transforming growth factor beta receptor complex assembly,BP,
16250,GO:0090281,1.00000000001979,0.80473974587695,0,3,negative regulation of calcium ion import,BP,
8689,GO:0034274,1.00000000001981,0.786071072703124,0,3,Atg12-Atg5-Atg16 complex,CC,
19608,GO:1990617,1.00000000001984,0.898667119170984,0,2,CHOP-ATF4 complex,CC,
13072,GO:0051543,1.00000000001985,0.931292177375191,0,1,regulation of elastin biosynthetic process,BP,
13073,GO:0051545,1.00000000001985,0.931292177375191,0,1,negative regulation of elastin biosynthetic process,BP,
17912,GO:1902167,1.00000000001988,0.966986794102232,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19028,GO:1904803,1.00000000001988,0.966986794102232,0,1,regulation of translation involved in cellular response to UV,BP,
9382,GO:0035898,1.00000000001995,0.794664105010172,0,3,parathyroid hormone secretion,BP,
14703,GO:0070305,1.00000000001996,0.772580386156025,0,3,response to cGMP,BP,
15202,GO:0071321,1.00000000001996,0.772580386156025,0,3,cellular response to cGMP,BP,
9638,GO:0036497,1.00000000001997,0.93112515601058,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
17982,GO:1902310,1.00000000001997,0.93112515601058,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
18652,GO:1903916,1.00000000001997,0.93112515601058,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18653,GO:1903917,1.00000000001997,0.93112515601058,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
11155,GO:0045186,1.00000000001997,0.905525704955553,0,1,zonula adherens assembly,BP,
16511,GO:0097187,1.00000000001998,0.803569783512459,0,3,dentinogenesis,BP,
494,GO:0001546,1.00000000001998,0.939908021063961,0,1,preantral ovarian follicle growth,BP,
12128,GO:0048162,1.00000000001998,0.939908021063961,0,1,multi-layer follicle stage,BP,
17620,GO:1901254,1.00000000001998,0.92190957345819,0,1,positive regulation of intracellular transport of viral material,BP,
18125,GO:1902737,1.00000000001998,0.92190957345819,0,1,dendritic filopodium,CC,
11821,GO:0046687,1.00000000002,0.952238218742129,0,1,response to chromate,BP,
15162,GO:0071247,1.00000000002,0.952238218742129,0,1,cellular response to chromate,BP,
17934,GO:1902220,1.00000000002,0.952238218742129,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
1006,GO:0002477,1.00000000002004,0.955158364191648,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1010,GO:0002481,1.00000000002004,0.955158364191648,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
5342,GO:0016077,1.00000000002004,0.913353913528983,0,1,snoRNA catabolic process,BP,
9359,GO:0035862,1.00000000002004,0.913353913528983,0,1,dITP metabolic process,BP,
9360,GO:0035863,1.00000000002004,0.913353913528983,0,1,dITP catabolic process,BP,
12703,GO:0050897,1.00000000002004,0.913353913528983,0,1,cobalt ion binding,MF,
16601,GO:0097382,1.00000000002004,0.913353913528983,0,1,deoxynucleoside-diphosphatase activity,MF,
16602,GO:0097383,1.00000000002004,0.913353913528983,0,1,dIDP diphosphatase activity,MF,
17743,GO:1901639,1.00000000002004,0.913353913528983,0,1,XDP catabolic process,BP,
17744,GO:1901640,1.00000000002004,0.913353913528983,0,1,XTP binding,MF,
17745,GO:1901641,1.00000000002004,0.913353913528983,0,1,ITP binding,MF,
19451,GO:1990003,1.00000000002004,0.913353913528983,0,1,IDP phosphatase activity,MF,
7581,GO:0031938,1.00000000002004,0.879700512123306,0,2,regulation of chromatin silencing at telomere,BP,
17547,GO:1901004,1.00000000002006,0.947795861902973,0,1,ubiquinone-6 metabolic process,BP,
17548,GO:1901006,1.00000000002006,0.947795861902973,0,1,ubiquinone-6 biosynthetic process,BP,
12459,GO:0050104,1.00000000002006,0.942769481295758,0,1,L-gulonate 3-dehydrogenase activity,MF,
2076,GO:0004827,1.00000000002006,0.813944621521719,0,3,proline-tRNA ligase activity,MF,
2922,GO:0006433,1.00000000002006,0.813944621521719,0,3,prolyl-tRNA aminoacylation,BP,
18877,GO:1904464,1.00000000002013,0.938474065196815,0,1,regulation of matrix metallopeptidase secretion,BP,
18878,GO:1904465,1.00000000002013,0.938474065196815,0,1,negative regulation of matrix metallopeptidase secretion,BP,
19651,GO:1990773,1.00000000002013,0.938474065196815,0,1,matrix metallopeptidase secretion,BP,
8786,GO:0034457,1.00000000002014,0.84143339813849,0,3,Mpp10 complex,CC,
2365,GO:0005471,1.00000000002017,0.822394304523145,0,3,ATP:ADP antiporter activity,MF,
5037,GO:0015207,1.00000000002017,0.822394304523145,0,3,adenine transmembrane transporter activity,MF,
7830,GO:0032378,1.00000000002019,0.924996766449572,0,1,negative regulation of intracellular lipid transport,BP,
7833,GO:0032381,1.00000000002019,0.924996766449572,0,1,negative regulation of intracellular sterol transport,BP,
7836,GO:0032384,1.00000000002019,0.924996766449572,0,1,negative regulation of intracellular cholesterol transport,BP,
19346,GO:1905596,1.00000000002019,0.924996766449572,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19348,GO:1905598,1.00000000002019,0.924996766449572,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19351,GO:1905601,1.00000000002019,0.924996766449572,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
15066,GO:0070995,1.00000000002021,0.92693510827214,0,1,NADPH oxidation,BP,
19458,GO:1990031,1.00000000002021,0.92693510827214,0,1,pinceau fiber,CC,
15465,GO:0071733,1.00000000002025,0.779110491354228,0,3,transcriptional activation by promoter-enhancer looping,BP,
16200,GO:0090202,1.00000000002025,0.779110491354228,0,3,gene looping,BP,
16359,GO:0090579,1.00000000002025,0.779110491354228,0,3,dsDNA loop formation,BP,
17496,GO:1900368,1.00000000002029,0.815781976630688,0,3,regulation of RNA interference,BP,
13221,GO:0051823,1.00000000002029,0.740956286535035,0,4,regulation of synapse structural plasticity,BP,
6219,GO:0019747,1.00000000002029,0.957630539716232,0,1,regulation of isoprenoid metabolic process,BP,
6894,GO:0030421,1.00000000002029,0.957630539716232,0,1,defecation,BP,
1366,GO:0003247,1.0000000000203,0.940141017885775,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1560,GO:0003956,1.0000000000203,0.940141017885775,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2485,GO:0005724,1.0000000000203,0.940141017885775,0,1,nuclear telomeric heterochromatin,CC,
7424,GO:0031509,1.0000000000203,0.940141017885775,0,1,telomeric heterochromatin assembly,BP,
7582,GO:0031940,1.0000000000203,0.940141017885775,0,1,positive regulation of chromatin silencing at telomere,BP,
18124,GO:1902732,1.0000000000203,0.940141017885775,0,1,positive regulation of chondrocyte proliferation,BP,
19325,GO:1905547,1.0000000000203,0.940141017885775,0,1,regulation of telomeric heterochromatin assembly,BP,
19326,GO:1905549,1.0000000000203,0.940141017885775,0,1,positive regulation of telomeric heterochromatin assembly,BP,
6549,GO:0021960,1.00000000002031,0.766809377463649,0,3,anterior commissure morphogenesis,BP,
6134,GO:0019389,1.00000000002033,0.929425974093157,0,1,glucuronoside metabolic process,BP,
6135,GO:0019391,1.00000000002033,0.929425974093157,0,1,glucuronoside catabolic process,BP,
17167,GO:0102390,1.00000000002033,0.929425974093157,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
12299,GO:0048597,1.00000000002034,0.848176368566728,0,3,post-embryonic camera-type eye morphogenesis,BP,
8969,GO:0035026,1.00000000002034,0.852918748567078,0,2,leading edge cell differentiation,BP,
1717,GO:0004306,1.00000000002034,0.936601665563166,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
16475,GO:0097119,1.00000000002035,0.733658529915026,0,4,postsynaptic density protein 95 clustering,BP,
5903,GO:0018106,1.00000000002037,0.962453473794299,0,1,peptidyl-histidine phosphorylation,BP,
628,GO:0001809,1.00000000002038,0.945097764477571,0,1,positive regulation of type IV hypersensitivity,BP,
19931,GO:2000387,1.00000000002038,0.945097764477571,0,1,regulation of antral ovarian follicle growth,BP,
19932,GO:2000388,1.00000000002038,0.945097764477571,0,1,positive regulation of antral ovarian follicle growth,BP,
8909,GO:0034722,1.0000000000204,0.942952894726037,0,1,gamma-glutamyl-peptidase activity,MF,
13154,GO:0051697,1.00000000002041,0.759789122732546,0,4,protein delipidation,BP,
1545,GO:0003937,1.00000000002042,0.933648177825159,0,1,IMP cyclohydrolase activity,MF,
1944,GO:0004643,1.00000000002042,0.933648177825159,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
13433,GO:0052798,1.00000000002042,0.933648177825159,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
18602,GO:1903817,1.00000000002043,0.723723147078034,0,4,negative regulation of voltage-gated potassium channel activity,BP,
20269,GO:2001180,1.00000000002045,0.866020583167652,0,2,negative regulation of interleukin-10 secretion,BP,
4246,GO:0009444,1.00000000002048,0.917196584811111,0,1,pyruvate oxidation,BP,
9709,GO:0038097,1.00000000002048,0.917196584811111,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
20273,GO:2001184,1.00000000002051,0.858551998206911,0,2,positive regulation of interleukin-12 secretion,BP,
813,GO:0002083,1.00000000002052,0.94008699027699,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
12000,GO:0047293,1.00000000002052,0.94008699027699,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
18814,GO:1904304,1.00000000002053,0.886021782115456,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18815,GO:1904306,1.00000000002053,0.886021782115456,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
11143,GO:0045168,1.00000000002056,0.874220932038759,0,2,cell-cell signaling involved in cell fate commitment,BP,
11643,GO:0046331,1.00000000002056,0.874220932038759,0,2,lateral inhibition,BP,
4694,GO:0010845,1.00000000002057,0.929488368708713,0,1,positive regulation of reciprocal meiotic recombination,BP,
2417,GO:0005590,1.00000000002058,0.896302328143724,0,1,collagen type VII trimer,CC,
16825,GO:0098648,1.00000000002058,0.896302328143724,0,1,collagen anchoring fibril,CC,
16827,GO:0098652,1.00000000002058,0.896302328143724,0,1,collagen type VII anchoring fibril,CC,
15680,GO:0072179,1.0000000000206,0.869569763472115,0,2,nephric duct formation,BP,
5971,GO:0018400,1.00000000002061,0.910023870651921,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6362,GO:0021540,1.00000000002061,0.764399772533301,0,4,corpus callosum morphogenesis,BP,
2018,GO:0004742,1.00000000002062,0.922011453566608,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
6935,GO:0030523,1.00000000002062,0.922011453566608,0,1,dihydrolipoamide S-acyltransferase activity,MF,
580,GO:0001730,1.00000000002064,0.74458885631932,0,4,2'-5'-oligoadenylate synthetase activity,MF,
9159,GO:0035504,1.00000000002066,0.942789796883116,0,1,regulation of myosin light chain kinase activity,BP,
9160,GO:0035505,1.00000000002066,0.942789796883116,0,1,positive regulation of myosin light chain kinase activity,BP,
10343,GO:0043126,1.00000000002066,0.942789796883116,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10344,GO:0043128,1.00000000002066,0.942789796883116,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
5049,GO:0015230,1.00000000002068,0.864494669696982,0,2,FAD transmembrane transporter activity,MF,
9096,GO:0035350,1.00000000002068,0.864494669696982,0,2,FAD transmembrane transport,BP,
17408,GO:1900113,1.0000000000207,0.699531438357273,0,5,negative regulation of histone H3-K9 trimethylation,BP,
13146,GO:0051673,1.00000000002071,0.880926206207129,0,2,membrane disruption in other organism,BP,
16506,GO:0097177,1.00000000002074,0.828500099613479,0,3,mitochondrial ribosome binding,MF,
3729,GO:0008265,1.00000000002074,0.928916343979425,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
17195,GO:0102867,1.00000000002074,0.928916343979425,0,1,molybdenum cofactor sulfurtransferase activity,MF,
6796,GO:0030229,1.00000000002078,0.782990127033304,0,3,very-low-density lipoprotein particle receptor activity,MF,
20272,GO:2001183,1.00000000002081,0.936211645601874,0,1,negative regulation of interleukin-12 secretion,BP,
4085,GO:0009138,1.00000000002082,0.818786777531215,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
14232,GO:0061146,1.00000000002082,0.798850275829015,0,3,Peyer's patch morphogenesis,BP,
13081,GO:0051562,1.00000000002084,0.861129347391155,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
4489,GO:0010509,1.00000000002087,0.915992267678996,0,1,polyamine homeostasis,BP,
5534,GO:0016508,1.0000000000209,0.796141863789935,0,3,long-chain-enoyl-CoA hydratase activity,MF,
15287,GO:0071449,1.00000000002103,0.957095719219442,0,1,cellular response to lipid hydroperoxide,BP,
3516,GO:0007442,1.00000000002107,0.696090646003783,0,4,hindgut morphogenesis,BP,
14512,GO:0061945,1.00000000002108,0.804098010221098,0,3,regulation of protein K48-linked ubiquitination,BP,
7831,GO:0032379,1.00000000002108,0.823913170556386,0,3,positive regulation of intracellular lipid transport,BP,
7834,GO:0032382,1.00000000002108,0.823913170556386,0,3,positive regulation of intracellular sterol transport,BP,
7837,GO:0032385,1.00000000002108,0.823913170556386,0,3,positive regulation of intracellular cholesterol transport,BP,
3872,GO:0008495,1.00000000002109,0.927638318610602,0,1,protoheme IX farnesyltransferase activity,MF,
12097,GO:0048033,1.00000000002109,0.927638318610602,0,1,heme o metabolic process,BP,
12098,GO:0048034,1.00000000002109,0.927638318610602,0,1,heme O biosynthetic process,BP,
16291,GO:0090336,1.0000000000211,0.804148000092508,0,3,positive regulation of brown fat cell differentiation,BP,
18675,GO:1903961,1.0000000000211,0.798405238749175,0,3,positive regulation of anion transmembrane transport,BP,
10494,GO:0043379,1.0000000000211,0.68777691915485,0,5,memory T cell differentiation,BP,
16395,GO:0090713,1.0000000000211,0.68777691915485,0,5,immunological memory process,BP,
16396,GO:0090715,1.0000000000211,0.68777691915485,0,5,immunological memory formation process,BP,
2475,GO:0005690,1.00000000002113,0.865669527690636,0,2,U4atac snRNP,CC,
15070,GO:0071005,1.00000000002113,0.865669527690636,0,2,U2-type precatalytic spliceosome,CC,
10496,GO:0043382,1.00000000002114,0.826138897496211,0,3,positive regulation of memory T cell differentiation,BP,
9646,GO:0036506,1.00000000002118,0.782707554205501,0,3,maintenance of unfolded protein,BP,
18839,GO:1904378,1.00000000002118,0.782707554205501,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
17988,GO:1902338,1.00000000002119,0.789984224026103,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
18996,GO:1904746,1.00000000002119,0.789984224026103,0,3,negative regulation of apoptotic process involved in development,BP,
18385,GO:1903348,1.00000000002121,0.790379928114319,0,3,positive regulation of bicellular tight junction assembly,BP,
9419,GO:0035971,1.00000000002122,0.949071297683052,0,1,peptidyl-histidine dephosphorylation,BP,
13831,GO:0060400,1.00000000002124,0.920638028633181,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
1809,GO:0004452,1.00000000002124,0.882696520680218,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12748,GO:0050992,1.00000000002124,0.882696520680218,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12749,GO:0050993,1.00000000002124,0.882696520680218,0,2,dimethylallyl diphosphate metabolic process,BP,
4737,GO:0010899,1.00000000002125,0.827515211426968,0,3,regulation of phosphatidylcholine catabolic process,BP,
1414,GO:0003345,1.00000000002125,0.924088000510373,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
3907,GO:0008545,1.00000000002128,0.856200495168679,0,2,JUN kinase kinase activity,MF,
7844,GO:0032393,1.00000000002131,0.894266810222721,0,2,MHC class I receptor activity,MF,
20280,GO:2001198,1.00000000002131,0.824534527728992,0,3,regulation of dendritic cell differentiation,BP,
9667,GO:0038002,1.00000000002132,0.916935971074181,0,1,endocrine signaling,BP,
2164,GO:0004993,1.00000000002134,0.820979514211808,0,3,G-protein coupled serotonin receptor activity,MF,
3421,GO:0007210,1.00000000002134,0.820979514211808,0,3,serotonin receptor signaling pathway,BP,
10372,GO:0043176,1.00000000002134,0.820979514211808,0,3,amine binding,MF,
12995,GO:0051378,1.00000000002134,0.820979514211808,0,3,serotonin binding,MF,
16835,GO:0098664,1.00000000002134,0.820979514211808,0,3,G-protein coupled serotonin receptor signaling pathway,BP,
17100,GO:0099589,1.00000000002134,0.820979514211808,0,3,serotonin receptor activity,MF,
575,GO:0001715,1.00000000002138,0.924190533789485,0,1,ectodermal cell fate specification,BP,
10139,GO:0042665,1.00000000002138,0.924190533789485,0,1,regulation of ectodermal cell fate specification,BP,
10140,GO:0042666,1.00000000002138,0.924190533789485,0,1,negative regulation of ectodermal cell fate specification,BP,
19928,GO:2000383,1.00000000002138,0.924190533789485,0,1,regulation of ectoderm development,BP,
19929,GO:2000384,1.00000000002138,0.924190533789485,0,1,negative regulation of ectoderm development,BP,
672,GO:0001878,1.00000000002139,0.871645460083027,0,2,response to yeast,BP,
7893,GO:0032455,1.00000000002139,0.791583949694731,0,3,nerve growth factor processing,BP,
8052,GO:0032696,1.0000000000214,0.800477525602607,0,3,negative regulation of interleukin-13 production,BP,
3061,GO:0006624,1.00000000002143,0.896926166282398,0,2,vacuolar protein processing,BP,
6097,GO:0019287,1.00000000002148,0.829266055134316,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
5519,GO:0016479,1.00000000002155,0.785655080082808,0,3,negative regulation of transcription by RNA polymerase I,BP,
9554,GO:0036301,1.00000000002158,0.800810743873907,0,3,macrophage colony-stimulating factor production,BP,
17622,GO:1901256,1.00000000002158,0.800810743873907,0,3,regulation of macrophage colony-stimulating factor production,BP,
19268,GO:1905384,1.00000000002158,0.87118621982759,0,2,regulation of protein localization to presynapse,BP,
19269,GO:1905386,1.00000000002158,0.87118621982759,0,2,positive regulation of protein localization to presynapse,BP,
17706,GO:1901555,1.0000000000216,0.908455278608903,0,1,response to paclitaxel,BP,
19376,GO:1905705,1.0000000000216,0.908455278608903,0,1,cellular response to paclitaxel,BP,
625,GO:0001806,1.00000000002161,0.818797500607816,0,3,type IV hypersensitivity,BP,
14938,GO:0070773,1.00000000002162,0.946035071086864,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15344,GO:0071544,1.00000000002162,0.946035071086864,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15522,GO:0071877,1.00000000002162,0.946035071086864,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15526,GO:0071881,1.00000000002162,0.946035071086864,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16072,GO:0086096,1.00000000002162,0.946035071086864,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17339,GO:0140193,1.00000000002162,0.946035071086864,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17340,GO:0140194,1.00000000002162,0.946035071086864,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
14826,GO:0070541,1.00000000002166,0.794838060008272,0,3,response to platinum ion,BP,
1818,GO:0004465,1.00000000002166,0.80032462521413,0,3,lipoprotein lipase activity,MF,
3732,GO:0008269,1.00000000002167,0.932558514035317,0,1,JAK pathway signal transduction adaptor activity,MF,
4321,GO:0009810,1.00000000002167,0.932558514035317,0,1,stilbene metabolic process,BP,
8556,GO:0033885,1.00000000002167,0.932558514035317,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11623,GO:0046272,1.00000000002167,0.932558514035317,0,1,stilbene catabolic process,BP,
15998,GO:0080144,1.00000000002173,0.86343757422214,0,2,amino acid homeostasis,BP,
13840,GO:0060414,1.00000000002174,0.905137444378843,0,1,aorta smooth muscle tissue morphogenesis,BP,
4381,GO:0010015,1.00000000002176,0.961032421856681,0,1,root morphogenesis,BP,
4395,GO:0010053,1.00000000002176,0.961032421856681,0,1,root epidermal cell differentiation,BP,
4396,GO:0010054,1.00000000002176,0.961032421856681,0,1,trichoblast differentiation,BP,
6605,GO:0022622,1.00000000002176,0.961032421856681,0,1,root system development,BP,
7539,GO:0031763,1.00000000002176,0.961032421856681,0,1,galanin receptor binding,MF,
7540,GO:0031764,1.00000000002176,0.961032421856681,0,1,type 1 galanin receptor binding,MF,
7541,GO:0031765,1.00000000002176,0.961032421856681,0,1,type 2 galanin receptor binding,MF,
7542,GO:0031766,1.00000000002176,0.961032421856681,0,1,type 3 galanin receptor binding,MF,
12211,GO:0048364,1.00000000002176,0.961032421856681,0,1,root development,BP,
12390,GO:0048764,1.00000000002176,0.961032421856681,0,1,trichoblast maturation,BP,
12391,GO:0048765,1.00000000002176,0.961032421856681,0,1,root hair cell differentiation,BP,
12392,GO:0048767,1.00000000002176,0.961032421856681,0,1,root hair elongation,BP,
13047,GO:0051464,1.00000000002176,0.961032421856681,0,1,positive regulation of cortisol secretion,BP,
16000,GO:0080147,1.00000000002176,0.961032421856681,0,1,root hair cell development,BP,
16352,GO:0090558,1.00000000002176,0.961032421856681,0,1,plant epidermis development,BP,
16370,GO:0090627,1.00000000002176,0.961032421856681,0,1,plant epidermal cell differentiation,BP,
17051,GO:0099402,1.00000000002176,0.961032421856681,0,1,plant organ development,BP,
18081,GO:1902606,1.00000000002176,0.961032421856681,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18082,GO:1902608,1.00000000002176,0.961032421856681,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18173,GO:1902890,1.00000000002176,0.961032421856681,0,1,regulation of root hair elongation,BP,
18174,GO:1902891,1.00000000002176,0.961032421856681,0,1,negative regulation of root hair elongation,BP,
18632,GO:1903888,1.00000000002176,0.961032421856681,0,1,regulation of plant epidermal cell differentiation,BP,
18633,GO:1903889,1.00000000002176,0.961032421856681,0,1,negative regulation of plant epidermal cell differentiation,BP,
19270,GO:1905392,1.00000000002176,0.961032421856681,0,1,plant organ morphogenesis,BP,
19282,GO:1905421,1.00000000002176,0.961032421856681,0,1,regulation of plant organ morphogenesis,BP,
19283,GO:1905422,1.00000000002176,0.961032421856681,0,1,negative regulation of plant organ morphogenesis,BP,
19753,GO:2000067,1.00000000002176,0.961032421856681,0,1,regulation of root morphogenesis,BP,
19855,GO:2000280,1.00000000002176,0.961032421856681,0,1,regulation of root development,BP,
20184,GO:2000851,1.00000000002176,0.961032421856681,0,1,positive regulation of glucocorticoid secretion,BP,
11932,GO:0046952,1.00000000002178,0.799562342181631,0,3,ketone body catabolic process,BP,
18686,GO:1903976,1.00000000002178,0.812836663725267,0,3,negative regulation of glial cell migration,BP,
915,GO:0002299,1.00000000002179,0.941570407105208,0,1,alpha-beta intraepithelial T cell differentiation,BP,
916,GO:0002300,1.00000000002179,0.941570407105208,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
917,GO:0002304,1.00000000002179,0.941570407105208,0,1,gamma-delta intraepithelial T cell differentiation,BP,
918,GO:0002305,1.00000000002179,0.941570407105208,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
8538,GO:0033823,1.0000000000218,0.927683719741501,0,1,procollagen glucosyltransferase activity,MF,
13175,GO:0051728,1.0000000000218,0.927683719741501,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13176,GO:0051729,1.0000000000218,0.927683719741501,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13686,GO:0060184,1.0000000000218,0.927683719741501,0,1,cell cycle switching,BP,
13972,GO:0060633,1.0000000000218,0.733860168879925,0,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
19786,GO:2000143,1.0000000000218,0.733860168879925,0,4,negative regulation of DNA-templated transcription, initiation,BP,
9560,GO:0036313,1.0000000000218,0.862716570401826,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
7128,GO:0030943,1.00000000002181,0.808457770258065,0,3,mitochondrion targeting sequence binding,MF,
8797,GO:0034474,1.00000000002185,0.908090525056529,0,1,U2 snRNA 3'-end processing,BP,
4867,GO:0014717,1.0000000000219,0.875705414429906,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4868,GO:0014718,1.0000000000219,0.875705414429906,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4942,GO:0014901,1.0000000000219,0.875705414429906,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
7682,GO:0032106,1.00000000002191,0.813139877849615,0,3,positive regulation of response to extracellular stimulus,BP,
7685,GO:0032109,1.00000000002191,0.813139877849615,0,3,positive regulation of response to nutrient levels,BP,
19299,GO:1905457,1.00000000002191,0.800956658127892,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20195,GO:2000974,1.00000000002191,0.800956658127892,0,3,negative regulation of pro-B cell differentiation,BP,
10775,GO:0044211,1.00000000002197,0.829299186880069,0,3,CTP salvage,BP,
2601,GO:0005898,1.000000000022,0.92351967929668,0,1,interleukin-13 receptor complex,CC,
9495,GO:0036122,1.00000000002203,0.76413120755198,0,3,BMP binding,MF,
15044,GO:0070966,1.00000000002204,0.781634064567593,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
3640,GO:0008112,1.00000000002205,0.941291927551189,0,1,nicotinamide N-methyltransferase activity,MF,
7028,GO:0030760,1.00000000002205,0.941291927551189,0,1,pyridine N-methyltransferase activity,MF,
6750,GO:0030167,1.00000000002207,0.805645759019454,0,3,proteoglycan catabolic process,BP,
6770,GO:0030200,1.00000000002207,0.805645759019454,0,3,heparan sulfate proteoglycan catabolic process,BP,
7887,GO:0032449,1.00000000002208,0.689140854941012,0,5,CBM complex,CC,
706,GO:0001923,1.00000000002217,0.803421728609036,0,3,B-1 B cell differentiation,BP,
11476,GO:0045916,1.00000000002219,0.786138756277252,0,3,negative regulation of complement activation,BP,
19843,GO:2000258,1.00000000002219,0.786138756277252,0,3,negative regulation of protein activation cascade,BP,
10609,GO:0043569,1.0000000000222,0.778733321805649,0,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
8554,GO:0033882,1.00000000002222,0.950610744371611,0,1,choloyl-CoA hydrolase activity,MF,
11178,GO:0045222,1.00000000002222,0.950610744371611,0,1,CD4 biosynthetic process,BP,
11179,GO:0045223,1.00000000002222,0.950610744371611,0,1,regulation of CD4 biosynthetic process,BP,
11180,GO:0045225,1.00000000002222,0.950610744371611,0,1,negative regulation of CD4 biosynthetic process,BP,
13440,GO:0052815,1.00000000002222,0.950610744371611,0,1,medium-chain acyl-CoA hydrolase activity,MF,
19296,GO:1905449,1.00000000002223,0.854796387131741,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19297,GO:1905451,1.00000000002223,0.854796387131741,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
15945,GO:0072714,1.00000000002224,0.938392689428203,0,1,response to selenite ion,BP,
15946,GO:0072715,1.00000000002224,0.938392689428203,0,1,cellular response to selenite ion,BP,
18914,GO:1904569,1.00000000002224,0.938392689428203,0,1,regulation of selenocysteine incorporation,BP,
18915,GO:1904570,1.00000000002224,0.938392689428203,0,1,negative regulation of selenocysteine incorporation,BP,
18916,GO:1904572,1.00000000002224,0.938392689428203,0,1,negative regulation of mRNA binding,BP,
18917,GO:1904573,1.00000000002224,0.938392689428203,0,1,regulation of selenocysteine insertion sequence binding,BP,
18918,GO:1904574,1.00000000002224,0.938392689428203,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19201,GO:1905215,1.00000000002224,0.938392689428203,0,1,negative regulation of RNA binding,BP,
4362,GO:0009956,1.00000000002225,0.923930057712306,0,1,radial pattern formation,BP,
14089,GO:0060849,1.00000000002225,0.923930057712306,0,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
6797,GO:0030233,1.00000000002226,0.940033117939838,0,1,deoxynucleotide transmembrane transporter activity,MF,
6843,GO:0030302,1.00000000002226,0.940033117939838,0,1,deoxynucleotide transport,BP,
15095,GO:0071045,1.00000000002226,0.940033117939838,0,1,nuclear histone mRNA catabolic process,BP,
15400,GO:0071629,1.00000000002226,0.940033117939838,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
4409,GO:0010159,1.00000000002231,0.799370548732982,0,3,specification of animal organ position,BP,
17953,GO:1902255,1.00000000002233,0.889428090977765,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
13714,GO:0060244,1.00000000002234,0.805619886296884,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
1085,GO:0002666,1.00000000002238,0.743274174393493,0,4,positive regulation of T cell tolerance induction,BP,
4689,GO:0010836,1.00000000002238,0.81884280907606,0,3,negative regulation of protein ADP-ribosylation,BP,
10879,GO:0044393,1.00000000002239,0.795678390339342,0,3,microspike,CC,
7299,GO:0031291,1.00000000002247,0.821084198134433,0,3,Ran protein signal transduction,BP,
6450,GO:0021763,1.00000000002247,0.9323129855918,0,1,subthalamic nucleus development,BP,
13652,GO:0060127,1.00000000002247,0.9323129855918,0,1,prolactin secreting cell differentiation,BP,
13875,GO:0060459,1.00000000002247,0.9323129855918,0,1,left lung development,BP,
13876,GO:0060460,1.00000000002247,0.9323129855918,0,1,left lung morphogenesis,BP,
13940,GO:0060577,1.00000000002247,0.9323129855918,0,1,pulmonary vein morphogenesis,BP,
13941,GO:0060578,1.00000000002247,0.9323129855918,0,1,superior vena cava morphogenesis,BP,
14171,GO:0061031,1.00000000002247,0.9323129855918,0,1,endodermal digestive tract morphogenesis,BP,
9353,GO:0035851,1.0000000000225,0.927770553420889,0,1,Krueppel-associated box domain binding,MF,
6595,GO:0022605,1.00000000002253,0.760459805518638,0,4,mammalian oogenesis stage,BP,
1315,GO:0003160,1.00000000002253,0.785863957167039,0,3,endocardium morphogenesis,BP,
703,GO:0001920,1.00000000002256,0.794506207247593,0,3,negative regulation of receptor recycling,BP,
19096,GO:1904947,1.0000000000226,0.927525696877782,0,1,folic acid import into mitochondrion,BP,
13829,GO:0060398,1.00000000002263,0.771266588302327,0,3,regulation of growth hormone receptor signaling pathway,BP,
16607,GO:0097396,1.0000000000227,0.740217851788508,0,4,response to interleukin-17,BP,
16608,GO:0097398,1.0000000000227,0.740217851788508,0,4,cellular response to interleukin-17,BP,
16609,GO:0097400,1.0000000000227,0.740217851788508,0,4,interleukin-17-mediated signaling pathway,BP,
5768,GO:0016938,1.0000000000227,0.927855840098332,0,1,kinesin I complex,CC,
1378,GO:0003270,1.0000000000228,0.896092204460072,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
14085,GO:0060843,1.0000000000228,0.896092204460072,0,1,venous endothelial cell differentiation,BP,
19204,GO:1905223,1.00000000002283,0.911577414108739,0,1,epicardium morphogenesis,BP,
16965,GO:0098926,1.00000000002283,0.908391818870282,0,1,postsynaptic signal transduction,BP,
17071,GO:0099527,1.00000000002283,0.908391818870282,0,1,postsynapse to nucleus signaling pathway,BP,
9668,GO:0038003,1.00000000002284,0.75715122698093,0,4,opioid receptor signaling pathway,BP,
6049,GO:0019166,1.00000000002286,0.820512913389899,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
9517,GO:0036157,1.00000000002288,0.75829728865463,0,3,outer dynein arm,CC,
7002,GO:0030678,1.0000000000229,0.824910795958984,0,3,mitochondrial ribonuclease P complex,CC,
16751,GO:0097745,1.0000000000229,0.824910795958984,0,3,mitochondrial tRNA 5'-end processing,BP,
13226,GO:0051835,1.0000000000229,0.798238128940084,0,3,positive regulation of synapse structural plasticity,BP,
12407,GO:0048817,1.0000000000229,0.846669724609147,0,2,negative regulation of hair follicle maturation,BP,
5106,GO:0015389,1.00000000002292,0.932421096950723,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5107,GO:0015390,1.00000000002292,0.932421096950723,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5108,GO:0015391,1.00000000002292,0.932421096950723,0,1,nucleobase:cation symporter activity,MF,
18801,GO:1904274,1.00000000002292,0.932421096950723,0,1,tricellular tight junction assembly,BP,
10324,GO:0043095,1.00000000002296,0.963021540890636,0,1,regulation of GTP cyclohydrolase I activity,BP,
10330,GO:0043105,1.00000000002296,0.963021540890636,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10940,GO:0044549,1.00000000002296,0.963021540890636,0,1,GTP cyclohydrolase binding,MF,
451,GO:0001224,1.00000000002297,0.76366369209681,0,3,RNA polymerase II transcription cofactor binding,MF,
2232,GO:0005134,1.00000000002298,0.806384679948872,0,3,interleukin-2 receptor binding,MF,
1680,GO:0004142,1.00000000002306,0.808418878065768,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1094,GO:0002679,1.00000000002308,0.819421403450944,0,3,respiratory burst involved in defense response,BP,
8261,GO:0033031,1.00000000002315,0.744712174501653,0,4,positive regulation of neutrophil apoptotic process,BP,
8405,GO:0033326,1.00000000002316,0.919229868782619,0,1,cerebrospinal fluid secretion,BP,
14544,GO:0070032,1.00000000002317,0.87106115504846,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
14545,GO:0070033,1.00000000002317,0.87106115504846,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
19639,GO:1990745,1.0000000000232,0.727915280202204,0,4,EARP complex,CC,
9462,GO:0036046,1.00000000002322,0.926975525096634,0,1,protein demalonylation,BP,
9463,GO:0036047,1.00000000002322,0.926975525096634,0,1,peptidyl-lysine demalonylation,BP,
9464,GO:0036048,1.00000000002322,0.926975525096634,0,1,protein desuccinylation,BP,
9465,GO:0036049,1.00000000002322,0.926975525096634,0,1,peptidyl-lysine desuccinylation,BP,
9466,GO:0036054,1.00000000002322,0.926975525096634,0,1,protein-malonyllysine demalonylase activity,MF,
9467,GO:0036055,1.00000000002322,0.926975525096634,0,1,protein-succinyllysine desuccinylase activity,MF,
14427,GO:0061697,1.00000000002322,0.926975525096634,0,1,protein-glutaryllysine deglutarylase activity,MF,
14428,GO:0061698,1.00000000002322,0.926975525096634,0,1,protein deglutarylation,BP,
14429,GO:0061699,1.00000000002322,0.926975525096634,0,1,peptidyl-lysine deglutarylation,BP,
14465,GO:0061771,1.00000000002322,0.815300951907502,0,3,response to caloric restriction,BP,
4498,GO:0010521,1.00000000002324,0.817937470317144,0,3,telomerase inhibitor activity,MF,
16934,GO:0098881,1.00000000002326,0.795869676614283,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16978,GO:0098967,1.00000000002326,0.795869676614283,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
6508,GO:0021877,1.00000000002326,0.666879754184504,0,5,forebrain neuron fate commitment,BP,
2195,GO:0005053,1.00000000002328,0.943075884825739,0,1,peroxisome matrix targeting signal-2 binding,MF,
3363,GO:0007113,1.00000000002331,0.830495761041542,0,3,endomitotic cell cycle,BP,
8432,GO:0033504,1.00000000002334,0.766185744006694,0,3,floor plate development,BP,
14641,GO:0070195,1.00000000002335,0.92196058094779,0,1,growth hormone receptor complex,CC,
4023,GO:0009052,1.00000000002336,0.714327715367967,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
7375,GO:0031417,1.00000000002336,0.753527534597628,0,3,NatC complex,CC,
6518,GO:0021892,1.00000000002345,0.827635225798499,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
17203,GO:0103053,1.00000000002346,0.889130447627442,0,2,1-ethyladenine demethylase activity,MF,
9566,GO:0036333,1.00000000002349,0.929474132182664,0,1,hepatocyte homeostasis,BP,
19011,GO:1904772,1.00000000002349,0.929474132182664,0,1,response to tetrachloromethane,BP,
3859,GO:0008475,1.0000000000235,0.794545342228468,0,3,procollagen-lysine 5-dioxygenase activity,MF,
11927,GO:0046946,1.0000000000235,0.794545342228468,0,3,hydroxylysine metabolic process,BP,
11928,GO:0046947,1.0000000000235,0.794545342228468,0,3,hydroxylysine biosynthetic process,BP,
16045,GO:0086047,1.0000000000235,0.923257527773424,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
18761,GO:1904199,1.0000000000235,0.923257527773424,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19632,GO:1990736,1.0000000000235,0.923257527773424,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
16346,GO:0090541,1.00000000002351,0.855611960668181,0,2,MIT domain binding,MF,
7987,GO:0032595,1.00000000002351,0.932860346122565,0,1,B cell receptor transport within lipid bilayer,BP,
7989,GO:0032597,1.00000000002351,0.932860346122565,0,1,B cell receptor transport into membrane raft,BP,
7990,GO:0032599,1.00000000002351,0.932860346122565,0,1,protein transport out of membrane raft,BP,
7991,GO:0032600,1.00000000002351,0.932860346122565,0,1,chemokine receptor transport out of membrane raft,BP,
8183,GO:0032913,1.00000000002351,0.932860346122565,0,1,negative regulation of transforming growth factor beta3 production,BP,
8475,GO:0033606,1.00000000002351,0.932860346122565,0,1,chemokine receptor transport within lipid bilayer,BP,
15659,GO:0072139,1.00000000002351,0.932860346122565,0,1,glomerular parietal epithelial cell differentiation,BP,
20134,GO:2000768,1.00000000002351,0.932860346122565,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
5755,GO:0016900,1.00000000002353,0.909536077107345,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
11968,GO:0047057,1.00000000002353,0.909536077107345,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
2154,GO:0004970,1.00000000002357,0.784474526186361,0,3,ionotropic glutamate receptor activity,MF,
18738,GO:1904116,1.00000000002362,0.784626173342528,0,3,response to vasopressin,BP,
18739,GO:1904117,1.00000000002362,0.784626173342528,0,3,cellular response to vasopressin,BP,
15995,GO:0080129,1.00000000002365,0.952303310820896,0,1,proteasome core complex assembly,BP,
10151,GO:0042709,1.00000000002368,0.931307581232022,0,1,succinate-CoA ligase complex,CC,
11187,GO:0045244,1.00000000002368,0.931307581232022,0,1,succinate-CoA ligase complex (GDP-forming),CC,
17880,GO:1902045,1.00000000002368,0.931307581232022,0,1,negative regulation of Fas signaling pathway,BP,
19987,GO:2000504,1.00000000002368,0.931307581232022,0,1,positive regulation of blood vessel remodeling,BP,
16412,GO:0097010,1.00000000002371,0.788140206836547,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
15328,GO:0071502,1.00000000002374,0.817802238481909,0,3,cellular response to temperature stimulus,BP,
1035,GO:0002541,1.00000000002376,0.86994218396049,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
1575,GO:0003979,1.00000000002378,0.926785245099251,0,1,UDP-glucose 6-dehydrogenase activity,MF,
6642,GO:0023024,1.00000000002378,0.926785245099251,0,1,MHC class I protein complex binding,MF,
1793,GO:0004419,1.00000000002381,0.942718762136343,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
16474,GO:0097118,1.00000000002384,0.908730389321739,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
9769,GO:0039519,1.00000000002386,0.841694450016684,0,2,modulation by virus of host autophagy,BP,
14977,GO:0070853,1.00000000002386,0.819909045886319,0,2,myosin VI binding,MF,
1588,GO:0003996,1.00000000002388,0.932180082823566,0,1,acyl-CoA ligase activity,MF,
8789,GO:0034462,1.00000000002388,0.932180082823566,0,1,small-subunit processome assembly,BP,
16779,GO:0098547,1.00000000002388,0.932180082823566,0,1,lumenal side of Golgi membrane,CC,
15294,GO:0071458,1.00000000002392,0.689022595271238,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
17784,GO:1901726,1.00000000002396,0.88806076050698,0,1,negative regulation of histone deacetylase activity,BP,
15357,GO:0071561,1.00000000002397,0.918551047692173,0,1,nucleus-vacuole junction,CC,
4448,GO:0010360,1.00000000002401,0.79325370495272,0,3,negative regulation of anion channel activity,BP,
18033,GO:1902480,1.00000000002405,0.930789743399893,0,1,protein localization to mitotic spindle,BP,
1815,GO:0004462,1.00000000002405,0.934228449348469,0,1,lactoylglutathione lyase activity,MF,
9779,GO:0039534,1.00000000002406,0.757140171730963,0,4,negative regulation of MDA-5 signaling pathway,BP,
2773,GO:0006196,1.00000000002408,0.851341018967103,0,2,AMP catabolic process,BP,
15625,GO:0072093,1.00000000002411,0.738319866177257,0,3,metanephric renal vesicle formation,BP,
12444,GO:0048880,1.00000000002411,0.790298945396665,0,3,sensory system development,BP,
14712,GO:0070320,1.00000000002415,0.929261679171716,0,1,inward rectifier potassium channel inhibitor activity,MF,
17391,GO:1900085,1.00000000002415,0.929261679171716,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18513,GO:1903596,1.00000000002415,0.929261679171716,0,1,regulation of gap junction assembly,BP,
18514,GO:1903598,1.00000000002415,0.929261679171716,0,1,positive regulation of gap junction assembly,BP,
18517,GO:1903609,1.00000000002415,0.929261679171716,0,1,negative regulation of inward rectifier potassium channel activity,BP,
16998,GO:0099010,1.00000000002416,0.772870550268226,0,3,modification of postsynaptic structure,BP,
18508,GO:1903587,1.00000000002417,0.699233988533745,0,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19193,GO:1905203,1.00000000002419,0.871057838240063,0,2,regulation of connective tissue replacement,BP,
14803,GO:0070494,1.00000000002419,0.793246490154071,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14804,GO:0070495,1.00000000002419,0.793246490154071,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
1733,GO:0004325,1.00000000002421,0.906734925158866,0,1,ferrochelatase activity,MF,
14868,GO:0070615,1.00000000002422,0.923204035653357,0,1,nucleosome-dependent ATPase activity,MF,
16345,GO:0090537,1.00000000002422,0.923204035653357,0,1,CERF complex,CC,
9502,GO:0036135,1.00000000002426,0.841815594883319,0,2,Schwann cell migration,BP,
17432,GO:1900147,1.00000000002426,0.841815594883319,0,2,regulation of Schwann cell migration,BP,
6383,GO:0021566,1.00000000002427,0.919109325833426,0,1,hypoglossal nerve development,BP,
6405,GO:0021618,1.00000000002427,0.919109325833426,0,1,hypoglossal nerve morphogenesis,BP,
17629,GO:1901291,1.00000000002427,0.935827727027969,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
17080,GO:0099541,1.00000000002429,0.785487344774507,0,3,trans-synaptic signaling by lipid,BP,
17081,GO:0099542,1.00000000002429,0.785487344774507,0,3,trans-synaptic signaling by endocannabinoid,BP,
7010,GO:0030689,1.00000000002432,0.809977663506455,0,3,Noc complex,CC,
9523,GO:0036194,1.00000000002433,0.83567025868541,0,3,muscle cell projection,CC,
9524,GO:0036195,1.00000000002433,0.83567025868541,0,3,muscle cell projection membrane,CC,
8682,GO:0034247,1.00000000002439,0.947371461434261,0,1,snoRNA splicing,BP,
15476,GO:0071796,1.00000000002439,0.947371461434261,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
10722,GO:0044020,1.0000000000244,0.76046335803478,0,4,histone methyltransferase activity (H4-R3 specific),MF,
5349,GO:0016094,1.00000000002441,0.791846695288571,0,3,polyprenol biosynthetic process,BP,
8734,GO:0034374,1.00000000002444,0.826283388638528,0,3,low-density lipoprotein particle remodeling,BP,
17817,GO:1901873,1.00000000002447,0.844614153862793,0,2,regulation of post-translational protein modification,BP,
17818,GO:1901874,1.00000000002447,0.844614153862793,0,2,negative regulation of post-translational protein modification,BP,
14304,GO:0061364,1.0000000000245,0.76989180416824,0,3,apoptotic process involved in luteolysis,BP,
520,GO:0001605,1.00000000002452,0.91880518147181,0,1,adrenomedullin receptor activity,MF,
2140,GO:0004948,1.00000000002452,0.91880518147181,0,1,calcitonin receptor activity,MF,
15204,GO:0071324,1.00000000002452,0.91880518147181,0,1,cellular response to disaccharide stimulus,BP,
15206,GO:0071329,1.00000000002452,0.91880518147181,0,1,cellular response to sucrose stimulus,BP,
18300,GO:1903143,1.00000000002452,0.91880518147181,0,1,adrenomedullin receptor complex,CC,
19551,GO:1990409,1.00000000002452,0.91880518147181,0,1,adrenomedullin binding,MF,
19947,GO:2000409,1.00000000002459,0.936715483445335,0,1,positive regulation of T cell extravasation,BP,
19965,GO:2000451,1.00000000002459,0.936715483445335,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19967,GO:2000454,1.00000000002459,0.936715483445335,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
18731,GO:1904073,1.00000000002459,0.906800750710649,0,1,regulation of trophectodermal cell proliferation,BP,
18732,GO:1904075,1.00000000002459,0.906800750710649,0,1,positive regulation of trophectodermal cell proliferation,BP,
19302,GO:1905460,1.00000000002459,0.906800750710649,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
2910,GO:0006421,1.00000000002461,0.80112238576782,0,3,asparaginyl-tRNA aminoacylation,BP,
9262,GO:0035662,1.00000000002462,0.88203747757518,0,3,Toll-like receptor 4 binding,MF,
6390,GO:0021578,1.00000000002462,0.770948013759608,0,3,hindbrain maturation,BP,
6408,GO:0021626,1.00000000002462,0.770948013759608,0,3,central nervous system maturation,BP,
14476,GO:0061819,1.00000000002468,0.786336036145468,0,3,telomeric DNA-containing double minutes formation,BP,
19384,GO:1905764,1.00000000002468,0.786336036145468,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19385,GO:1905765,1.00000000002468,0.786336036145468,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19604,GO:1990599,1.00000000002468,0.786336036145468,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
7096,GO:0030885,1.0000000000247,0.835397095054817,0,3,regulation of myeloid dendritic cell activation,BP,
233,GO:0000481,1.00000000002474,0.925106404092083,0,1,maturation of 5S rRNA,BP,
4459,GO:0010430,1.00000000002476,0.920302327040403,0,1,fatty acid omega-oxidation,BP,
10224,GO:0042835,1.00000000002476,0.920302327040403,0,1,BRE binding,MF,
15456,GO:0071713,1.00000000002476,0.920302327040403,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
3095,GO:0006669,1.00000000002477,0.927802737235007,0,1,sphinganine-1-phosphate biosynthetic process,BP,
6496,GO:0021849,1.00000000002479,0.856198116839187,0,2,neuroblast division in subventricular zone,BP,
13004,GO:0051388,1.0000000000248,0.724296700040705,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
6335,GO:0021501,1.00000000002483,0.933776265851511,0,1,prechordal plate formation,BP,
6369,GO:0021547,1.00000000002483,0.933776265851511,0,1,midbrain-hindbrain boundary initiation,BP,
20120,GO:2000742,1.00000000002483,0.933776265851511,0,1,regulation of anterior head development,BP,
20121,GO:2000744,1.00000000002483,0.933776265851511,0,1,positive regulation of anterior head development,BP,
15408,GO:0071639,1.00000000002487,0.711604595516009,0,5,positive regulation of monocyte chemotactic protein-1 production,BP,
7779,GO:0032298,1.00000000002489,0.932246226264131,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16477,GO:0097123,1.00000000002489,0.932246226264131,0,1,cyclin A1-CDK2 complex,CC,
7874,GO:0032430,1.00000000002497,0.816446910432042,0,3,positive regulation of phospholipase A2 activity,BP,
6234,GO:0019782,1.00000000002498,0.926229859806744,0,1,ISG15 activating enzyme activity,MF,
755,GO:0001992,1.00000000002501,0.921992970108077,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
2162,GO:0004990,1.00000000002501,0.921992970108077,0,1,oxytocin receptor activity,MF,
2311,GO:0005298,1.00000000002501,0.921992970108077,0,1,proline:sodium symporter activity,MF,
10079,GO:0042564,1.00000000002501,0.921992970108077,0,1,NLS-dependent protein nuclear import complex,CC,
5146,GO:0015671,1.00000000002503,0.8710668308855,0,2,oxygen transport,BP,
1696,GO:0004168,1.00000000002514,0.932642198125768,0,1,dolichol kinase activity,MF,
10308,GO:0043048,1.00000000002514,0.932642198125768,0,1,dolichyl monophosphate biosynthetic process,BP,
14162,GO:0061010,1.00000000002517,0.891850229725582,0,1,gall bladder development,BP,
14468,GO:0061780,1.00000000002517,0.891850229725582,0,1,mitotic cohesin loading,BP,
14831,GO:0070550,1.00000000002517,0.891850229725582,0,1,rDNA condensation,BP,
19234,GO:1905309,1.00000000002517,0.891850229725582,0,1,positive regulation of cohesin loading,BP,
19277,GO:1905405,1.00000000002517,0.891850229725582,0,1,regulation of mitotic cohesin loading,BP,
19278,GO:1905406,1.00000000002517,0.891850229725582,0,1,positive regulation of mitotic cohesin loading,BP,
7730,GO:0032216,1.0000000000252,0.93216254780294,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
3849,GO:0008457,1.00000000002525,0.923059641567452,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
11991,GO:0047256,1.00000000002525,0.923059641567452,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
16273,GO:0090310,1.00000000002529,0.830852774159452,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
13886,GO:0060482,1.00000000002534,0.807961580498257,0,3,lobar bronchus development,BP,
8184,GO:0032914,1.00000000002535,0.797676331499397,0,3,positive regulation of transforming growth factor beta1 production,BP,
2339,GO:0005366,1.00000000002544,0.908148651479056,0,1,myo-inositol:proton symporter activity,MF,
12467,GO:0050146,1.0000000000255,0.917116883439217,0,1,nucleoside phosphotransferase activity,MF,
4173,GO:0009240,1.00000000002551,0.731970203821821,0,5,isopentenyl diphosphate biosynthetic process,BP,
11715,GO:0046490,1.00000000002551,0.731970203821821,0,5,isopentenyl diphosphate metabolic process,BP,
8765,GO:0034423,1.00000000002557,0.929471288854303,0,1,autophagosome lumen,CC,
19957,GO:2000422,1.00000000002557,0.929471288854303,0,1,regulation of eosinophil chemotaxis,BP,
19958,GO:2000424,1.00000000002557,0.929471288854303,0,1,positive regulation of eosinophil chemotaxis,BP,
3486,GO:0007354,1.00000000002559,0.8057184715246,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
7039,GO:0030807,1.00000000002563,0.91348512998803,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7054,GO:0030822,1.00000000002563,0.91348512998803,0,1,positive regulation of cAMP catabolic process,BP,
8302,GO:0033123,1.00000000002563,0.91348512998803,0,1,positive regulation of purine nucleotide catabolic process,BP,
7620,GO:0032002,1.00000000002587,0.868292425969483,0,2,interleukin-28 receptor complex,CC,
14033,GO:0060734,1.00000000002589,0.920554475308858,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
10786,GO:0044228,1.00000000002592,0.920162973040454,0,1,host cell surface,CC,
420,GO:0001112,1.00000000002593,0.927494383076454,0,1,DNA-templated transcriptional open complex formation,BP,
421,GO:0001113,1.00000000002593,0.927494383076454,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
422,GO:0001120,1.00000000002593,0.927494383076454,0,1,protein-DNA complex remodeling,BP,
18497,GO:1903569,1.00000000002593,0.931208115670213,0,1,positive regulation of protein localization to ciliary membrane,BP,
6677,GO:0030035,1.00000000002594,0.781083798249701,0,3,microspike assembly,BP,
8561,GO:0033961,1.00000000002594,0.93825539397161,0,1,cis-stilbene-oxide hydrolase activity,MF,
9733,GO:0038163,1.00000000002596,0.955349703525441,0,1,thrombopoietin-mediated signaling pathway,BP,
19437,GO:1905938,1.00000000002596,0.955349703525441,0,1,positive regulation of germ cell proliferation,BP,
19841,GO:2000256,1.00000000002596,0.955349703525441,0,1,positive regulation of male germ cell proliferation,BP,
17098,GO:0099580,1.00000000002596,0.913300368301638,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
10654,GO:0043654,1.00000000002597,0.790293641951081,0,3,recognition of apoptotic cell,BP,
3349,GO:0007079,1.00000000002602,0.769659352084273,0,3,mitotic chromosome movement towards spindle pole,BP,
2842,GO:0006311,1.0000000000261,0.926954236128332,0,1,meiotic gene conversion,BP,
5391,GO:0016213,1.0000000000261,0.926954236128332,0,1,linoleoyl-CoA desaturase activity,MF,
11124,GO:0045128,1.0000000000261,0.926954236128332,0,1,negative regulation of reciprocal meiotic recombination,BP,
17258,GO:0110029,1.0000000000261,0.926954236128332,0,1,negative regulation of meiosis I,BP,
5408,GO:0016243,1.0000000000261,0.923544768838426,0,1,regulation of autophagosome size,BP,
5940,GO:0018217,1.0000000000261,0.923544768838426,0,1,peptidyl-aspartic acid phosphorylation,BP,
14170,GO:0061030,1.0000000000261,0.923544768838426,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
19167,GO:1905103,1.0000000000261,0.923544768838426,0,1,integral component of lysosomal membrane,CC,
19703,GO:1990938,1.0000000000261,0.923544768838426,0,1,peptidyl-aspartic acid autophosphorylation,BP,
773,GO:0002025,1.00000000002611,0.934319363917048,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
2136,GO:0004939,1.00000000002611,0.934319363917048,0,1,beta-adrenergic receptor activity,MF,
2137,GO:0004941,1.00000000002611,0.934319363917048,0,1,beta2-adrenergic receptor activity,MF,
12997,GO:0051380,1.00000000002611,0.934319363917048,0,1,norepinephrine binding,MF,
14495,GO:0061884,1.00000000002611,0.934319363917048,0,1,regulation of mini excitatory postsynaptic potential,BP,
14496,GO:0061885,1.00000000002611,0.934319363917048,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
16901,GO:0098816,1.00000000002611,0.934319363917048,0,1,mini excitatory postsynaptic potential,BP,
192,GO:0000409,1.00000000002616,0.908666885135106,0,1,regulation of transcription by galactose,BP,
193,GO:0000411,1.00000000002616,0.908666885135106,0,1,positive regulation of transcription by galactose,BP,
206,GO:0000431,1.00000000002616,0.908666885135106,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000435,1.00000000002616,0.908666885135106,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
17142,GO:0102009,1.00000000002618,0.936089000401829,0,1,proline dipeptidase activity,MF,
3810,GO:0008396,1.00000000002618,0.93100641502885,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
691,GO:0001907,1.0000000000262,0.828790236328492,0,3,killing by symbiont of host cells,BP,
10720,GO:0044004,1.0000000000262,0.828790236328492,0,3,disruption by symbiont of host cell,BP,
10933,GO:0044533,1.0000000000262,0.828790236328492,0,3,positive regulation of apoptotic process in other organism,BP,
13322,GO:0052042,1.0000000000262,0.828790236328492,0,3,positive regulation by symbiont of host programmed cell death,BP,
13358,GO:0052330,1.0000000000262,0.828790236328492,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13378,GO:0052501,1.0000000000262,0.828790236328492,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
18021,GO:1902445,1.00000000002621,0.852340032747442,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19778,GO:2000118,1.00000000002621,0.922966187597188,0,1,regulation of sodium-dependent phosphate transport,BP,
4891,GO:0014809,1.00000000002632,0.823857450314953,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
6244,GO:0019800,1.00000000002639,0.942901817333874,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
2309,GO:0005294,1.00000000002646,0.894394911660111,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
5087,GO:0015327,1.00000000002646,0.894394911660111,0,1,cystine:glutamate antiporter activity,MF,
5088,GO:0015328,1.00000000002646,0.894394911660111,0,1,cystine secondary active transmembrane transporter activity,MF,
17769,GO:1901680,1.00000000002646,0.894394911660111,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
3020,GO:0006566,1.00000000002653,0.830107979728371,0,3,threonine metabolic process,BP,
611,GO:0001777,1.00000000002654,0.960096661367129,0,1,T cell homeostatic proliferation,BP,
947,GO:0002358,1.00000000002654,0.960096661367129,0,1,B cell homeostatic proliferation,BP,
8225,GO:0032976,1.00000000002654,0.960096661367129,0,1,release of matrix enzymes from mitochondria,BP,
16484,GO:0097144,1.00000000002654,0.960096661367129,0,1,BAX complex,CC,
19481,GO:1990117,1.00000000002654,0.960096661367129,0,1,B cell receptor apoptotic signaling pathway,BP,
19838,GO:2000253,1.00000000002656,0.765193164297649,0,3,positive regulation of feeding behavior,BP,
19972,GO:2000467,1.00000000002658,0.775776112513869,0,3,positive regulation of glycogen (starch) synthase activity,BP,
11176,GO:0045219,1.0000000000266,0.916447561911968,0,1,regulation of FasL biosynthetic process,BP,
11177,GO:0045221,1.0000000000266,0.916447561911968,0,1,negative regulation of FasL biosynthetic process,BP,
12336,GO:0048671,1.00000000002666,0.771659960666962,0,3,negative regulation of collateral sprouting,BP,
1657,GO:0004108,1.00000000002671,0.927720189122886,0,1,citrate (Si)-synthase activity,MF,
9598,GO:0036440,1.00000000002671,0.927720189122886,0,1,citrate synthase activity,MF,
5367,GO:0016150,1.00000000002672,0.940486782303489,0,1,translation release factor activity, codon nonspecific,MF,
1512,GO:0003868,1.00000000002674,0.937512223592015,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
8087,GO:0032762,1.000000000027,0.741158434700353,0,4,mast cell cytokine production,BP,
8088,GO:0032763,1.000000000027,0.741158434700353,0,4,regulation of mast cell cytokine production,BP,
2418,GO:0005591,1.00000000002709,0.929514078533898,0,1,collagen type VIII trimer,CC,
2424,GO:0005598,1.00000000002709,0.929514078533898,0,1,short-chain collagen trimer,CC,
7125,GO:0030935,1.00000000002709,0.929514078533898,0,1,sheet-forming collagen trimer,CC,
16823,GO:0098646,1.00000000002709,0.929514078533898,0,1,collagen sheet,CC,
5063,GO:0015272,1.00000000002712,0.927290897627273,0,1,ATP-activated inward rectifier potassium channel activity,MF,
16299,GO:0090360,1.00000000002726,0.803332407170854,0,3,platelet-derived growth factor production,BP,
16300,GO:0090361,1.00000000002726,0.803332407170854,0,3,regulation of platelet-derived growth factor production,BP,
3876,GO:0008504,1.00000000002728,0.732520722506924,0,4,monoamine transmembrane transporter activity,MF,
5032,GO:0015195,1.00000000002733,0.922234118748638,0,1,L-threonine transmembrane transporter activity,MF,
5225,GO:0015826,1.00000000002733,0.922234118748638,0,1,threonine transport,BP,
8824,GO:0034589,1.00000000002733,0.922234118748638,0,1,hydroxyproline transport,BP,
8825,GO:0034590,1.00000000002733,0.922234118748638,0,1,L-hydroxyproline transmembrane transporter activity,MF,
18086,GO:1902617,1.0000000000274,0.739147131732859,0,4,response to fluoride,BP,
14128,GO:0060957,1.00000000002741,0.927818868612438,0,1,endocardial cell fate commitment,BP,
14331,GO:0061445,1.00000000002741,0.927818868612438,0,1,endocardial cushion cell fate commitment,BP,
129,GO:0000268,1.00000000002743,0.748120516928258,0,4,peroxisome targeting sequence binding,MF,
17234,GO:0106071,1.00000000002749,0.76077534403617,0,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
11874,GO:0046848,1.00000000002752,0.945340732231043,0,1,hydroxyapatite binding,MF,
4397,GO:0010070,1.00000000002755,0.930868303512427,0,1,zygote asymmetric cell division,BP,
15452,GO:0071707,1.00000000002769,0.947914548367049,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
176,GO:0000384,1.00000000002771,0.883812929014972,0,2,first spliceosomal transesterification activity,MF,
8670,GO:0034224,1.00000000002774,0.932193262536618,0,1,cellular response to zinc ion starvation,BP,
3089,GO:0006663,1.00000000002776,0.800827399061811,0,3,platelet activating factor biosynthetic process,BP,
16264,GO:0090299,1.00000000002779,0.939695548417139,0,1,regulation of neural crest formation,BP,
16265,GO:0090301,1.00000000002779,0.939695548417139,0,1,negative regulation of neural crest formation,BP,
19877,GO:2000314,1.00000000002779,0.939695548417139,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
9789,GO:0039689,1.00000000002781,0.800560069404636,0,3,negative stranded viral RNA replication,BP,
8323,GO:0033149,1.00000000002783,0.840303349074922,0,2,FFAT motif binding,MF,
20034,GO:2000609,1.00000000002787,0.802303693241879,0,3,regulation of thyroid hormone generation,BP,
5554,GO:0016557,1.00000000002789,0.827056686990618,0,3,peroxisome membrane biogenesis,BP,
8992,GO:0035092,1.00000000002793,0.766316873535441,0,3,sperm chromatin condensation,BP,
16649,GO:0097487,1.00000000002793,0.82730578291068,0,3,multivesicular body, internal vesicle,CC,
19009,GO:1904766,1.00000000002801,0.908672176758722,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
1557,GO:0003953,1.0000000000281,0.942912024871262,0,1,NAD+ nucleosidase activity,MF,
12463,GO:0050135,1.0000000000281,0.942912024871262,0,1,NAD(P)+ nucleosidase activity,MF,
14474,GO:0061809,1.0000000000281,0.942912024871262,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
13318,GO:0052031,1.00000000002818,0.807203544739738,0,3,modulation by symbiont of host defense response,BP,
13352,GO:0052255,1.00000000002818,0.807203544739738,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13385,GO:0052552,1.00000000002818,0.807203544739738,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13386,GO:0052553,1.00000000002818,0.807203544739738,0,3,modulation by symbiont of host immune response,BP,
15977,GO:0075528,1.00000000002818,0.807203544739738,0,3,modulation by virus of host immune response,BP,
19637,GO:1990743,1.00000000002821,0.807192654565394,0,3,protein sialylation,BP,
15952,GO:0072733,1.00000000002822,0.814253762583985,0,3,response to staurosporine,BP,
15953,GO:0072734,1.00000000002822,0.814253762583985,0,3,cellular response to staurosporine,BP,
15411,GO:0071642,1.00000000002824,0.859650798317189,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
2081,GO:0004832,1.0000000000283,0.784344379460531,0,3,valine-tRNA ligase activity,MF,
2927,GO:0006438,1.0000000000283,0.784344379460531,0,3,valyl-tRNA aminoacylation,BP,
10173,GO:0042748,1.00000000002837,0.775198142152212,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
2015,GO:0004739,1.00000000002839,0.872448894685765,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
8397,GO:0033300,1.00000000002847,0.854395123812295,0,2,dehydroascorbic acid transmembrane transporter activity,MF,
14963,GO:0070837,1.00000000002847,0.854395123812295,0,2,dehydroascorbic acid transport,BP,
3857,GO:0008470,1.00000000002859,0.920709093429651,0,1,isovaleryl-CoA dehydrogenase activity,MF,
10329,GO:0043103,1.00000000002869,0.827343073253307,0,3,hypoxanthine salvage,BP,
4703,GO:0010859,1.00000000002869,0.921895639064522,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
19865,GO:2000299,1.00000000002872,0.926104993908732,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
10705,GO:0043974,1.00000000002876,0.780137743509563,0,3,histone H3-K27 acetylation,BP,
17764,GO:1901674,1.00000000002876,0.780137743509563,0,3,regulation of histone H3-K27 acetylation,BP,
1556,GO:0003952,1.00000000002883,0.930663343321429,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1583,GO:0003990,1.00000000002883,0.930663343321429,0,1,acetylcholinesterase activity,MF,
4824,GO:0014016,1.00000000002883,0.930663343321429,0,1,neuroblast differentiation,BP,
11686,GO:0046448,1.00000000002883,0.930663343321429,0,1,tropane alkaloid metabolic process,BP,
12624,GO:0050783,1.00000000002883,0.930663343321429,0,1,cocaine metabolic process,BP,
14497,GO:0061888,1.00000000002891,0.803492576162489,0,3,regulation of astrocyte activation,BP,
7085,GO:0030868,1.00000000002898,0.80375622924325,0,3,smooth endoplasmic reticulum membrane,CC,
16618,GO:0097425,1.00000000002898,0.80375622924325,0,3,smooth endoplasmic reticulum part,CC,
18093,GO:1902630,1.000000000029,0.908304578466757,0,1,regulation of membrane hyperpolarization,BP,
18094,GO:1902631,1.000000000029,0.908304578466757,0,1,negative regulation of membrane hyperpolarization,BP,
7561,GO:0031883,1.00000000002903,0.933616450909376,0,1,taste receptor binding,MF,
11060,GO:0045027,1.00000000002903,0.933616450909376,0,1,DNA end binding,MF,
12425,GO:0048855,1.00000000002905,0.911502789240094,0,1,adenohypophysis morphogenesis,BP,
9820,GO:0042000,1.00000000002907,0.930864710585366,0,1,translocation of peptides or proteins into host,BP,
10731,GO:0044053,1.00000000002907,0.930864710585366,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13217,GO:0051808,1.00000000002907,0.930864710585366,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
15068,GO:0071001,1.00000000002912,0.822277375784263,0,3,U4/U6 snRNP,CC,
16584,GO:0097350,1.00000000002915,0.804853584988331,0,3,neutrophil clearance,BP,
1827,GO:0004477,1.00000000002916,0.743452031182188,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1836,GO:0004488,1.00000000002916,0.743452031182188,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
1839,GO:0004491,1.00000000002917,0.932774242583574,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
4739,GO:0010904,1.00000000002917,0.932774242583574,0,1,regulation of UDP-glucose catabolic process,BP,
4740,GO:0010905,1.00000000002917,0.932774242583574,0,1,negative regulation of UDP-glucose catabolic process,BP,
5979,GO:0018478,1.00000000002917,0.932774242583574,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
18777,GO:1904226,1.00000000002917,0.932774242583574,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18778,GO:1904227,1.00000000002917,0.932774242583574,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
11935,GO:0046963,1.00000000002937,0.872602467026728,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11936,GO:0046964,1.00000000002937,0.872602467026728,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18061,GO:1902559,1.00000000002937,0.872602467026728,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
4374,GO:0009992,1.00000000002946,0.932826747244357,0,1,cellular water homeostasis,BP,
3394,GO:0007174,1.00000000002956,0.93233089288228,0,1,epidermal growth factor catabolic process,BP,
7864,GO:0032419,1.00000000002956,0.93233089288228,0,1,extrinsic component of lysosome membrane,CC,
19115,GO:1904979,1.00000000002956,0.93233089288228,0,1,negative regulation of endosome organization,BP,
19260,GO:1905365,1.00000000002956,0.93233089288228,0,1,regulation of intralumenal vesicle formation,BP,
19261,GO:1905366,1.00000000002956,0.93233089288228,0,1,negative regulation of intralumenal vesicle formation,BP,
9434,GO:0035993,1.00000000002956,0.811395811291361,0,3,deltoid tuberosity development,BP,
295,GO:0000799,1.00000000003,0.77563764605146,0,3,nuclear condensin complex,CC,
5909,GO:0018125,1.00000000003021,0.816549506417727,0,3,peptidyl-cysteine methylation,BP,
3167,GO:0006780,1.00000000003022,0.88238916956473,0,2,uroporphyrinogen III biosynthetic process,BP,
11725,GO:0046502,1.00000000003022,0.88238916956473,0,2,uroporphyrinogen III metabolic process,BP,
2034,GO:0004772,1.00000000003024,0.925941038087747,0,1,sterol O-acyltransferase activity,MF,
8915,GO:0034736,1.00000000003024,0.925941038087747,0,1,cholesterol O-acyltransferase activity,MF,
18493,GO:1903565,1.00000000003024,0.925941038087747,0,1,negative regulation of protein localization to cilium,BP,
18496,GO:1903568,1.00000000003024,0.925941038087747,0,1,negative regulation of protein localization to ciliary membrane,BP,
17944,GO:1902232,1.00000000003031,0.872426215514686,0,2,regulation of positive thymic T cell selection,BP,
10703,GO:0043972,1.0000000000306,0.920217795228109,0,1,histone H3-K23 acetylation,BP,
10714,GO:0043994,1.0000000000306,0.920217795228109,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
7633,GO:0032027,1.00000000003063,0.791834669847867,0,3,myosin light chain binding,MF,
11447,GO:0045852,1.00000000003065,0.803880767010707,0,3,pH elevation,BP,
13038,GO:0051454,1.00000000003065,0.803880767010707,0,3,intracellular pH elevation,BP,
1767,GO:0004367,1.00000000003068,0.92392395355455,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
11607,GO:0046168,1.00000000003068,0.92392395355455,0,1,glycerol-3-phosphate catabolic process,BP,
147,GO:0000301,1.00000000003072,0.799535292608928,0,3,retrograde transport, vesicle recycling within Golgi,BP,
17765,GO:1901675,1.0000000000308,0.909795612140823,0,1,negative regulation of histone H3-K27 acetylation,BP,
14865,GO:0070611,1.00000000003086,0.929454256570992,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14866,GO:0070612,1.00000000003086,0.929454256570992,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
4900,GO:0014825,1.00000000003092,0.959980363812025,0,1,stomach fundus smooth muscle contraction,BP,
4913,GO:0014847,1.00000000003092,0.959980363812025,0,1,proximal stomach smooth muscle contraction,BP,
7550,GO:0031839,1.00000000003092,0.959980363812025,0,1,type 1 neuromedin U receptor binding,MF,
7551,GO:0031840,1.00000000003092,0.959980363812025,0,1,type 2 neuromedin U receptor binding,MF,
9148,GO:0035483,1.00000000003092,0.959980363812025,0,1,gastric emptying,BP,
10240,GO:0042922,1.00000000003092,0.959980363812025,0,1,neuromedin U receptor binding,MF,
10925,GO:0044495,1.00000000003092,0.959980363812025,0,1,modulation of blood pressure in other organism,BP,
10926,GO:0044497,1.00000000003092,0.959980363812025,0,1,positive regulation of blood pressure in other organism,BP,
17284,GO:0120060,1.00000000003092,0.959980363812025,0,1,regulation of gastric emptying,BP,
17285,GO:0120061,1.00000000003092,0.959980363812025,0,1,negative regulation of gastric emptying,BP,
17286,GO:0120063,1.00000000003092,0.959980363812025,0,1,stomach smooth muscle contraction,BP,
17287,GO:0120068,1.00000000003092,0.959980363812025,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17288,GO:0120069,1.00000000003092,0.959980363812025,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
9886,GO:0042138,1.00000000003097,0.931471589024634,0,1,meiotic DNA double-strand break formation,BP,
15139,GO:0071209,1.00000000003177,0.842972184691659,0,3,U7 snRNA binding,MF,
3514,GO:0007439,1.00000000003178,0.927798133118293,0,1,ectodermal digestive tract development,BP,
9527,GO:0036215,1.00000000003178,0.927798133118293,0,1,response to stem cell factor,BP,
9528,GO:0036216,1.00000000003178,0.927798133118293,0,1,cellular response to stem cell factor stimulus,BP,
9714,GO:0038109,1.00000000003178,0.927798133118293,0,1,Kit signaling pathway,BP,
12304,GO:0048611,1.00000000003178,0.927798133118293,0,1,embryonic ectodermal digestive tract development,BP,
19724,GO:2000015,1.00000000003181,0.822321980685533,0,3,regulation of determination of dorsal identity,BP,
1755,GO:0004352,1.00000000003205,0.925620265462453,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1756,GO:0004353,1.00000000003205,0.925620265462453,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
5604,GO:0016639,1.00000000003205,0.925620265462453,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
6685,GO:0030047,1.00000000003233,0.789078708176364,0,3,actin modification,BP,
14120,GO:0060935,1.00000000003243,0.784677545368508,0,3,cardiac fibroblast cell differentiation,BP,
14121,GO:0060936,1.00000000003243,0.784677545368508,0,3,cardiac fibroblast cell development,BP,
14122,GO:0060938,1.00000000003243,0.784677545368508,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14123,GO:0060939,1.00000000003243,0.784677545368508,0,3,epicardium-derived cardiac fibroblast cell development,BP,
17086,GO:0099550,1.00000000003254,0.811569102654864,0,3,trans-synaptic signaling, modulating synaptic transmission,BP,
10727,GO:0044035,1.00000000003304,0.940150037565474,0,1,multi-organism catabolic process,BP,
10754,GO:0044115,1.00000000003304,0.940150037565474,0,1,development of symbiont involved in interaction with host,BP,
10761,GO:0044145,1.00000000003304,0.940150037565474,0,1,modulation of development of symbiont involved in interaction with host,BP,
10763,GO:0044147,1.00000000003304,0.940150037565474,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10978,GO:0044730,1.00000000003304,0.940150037565474,0,1,bone sialoprotein binding,MF,
13345,GO:0052214,1.00000000003304,0.940150037565474,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13346,GO:0052227,1.00000000003304,0.940150037565474,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13347,GO:0052229,1.00000000003304,0.940150037565474,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13359,GO:0052360,1.00000000003304,0.940150037565474,0,1,catabolism by host of symbiont macromolecule,BP,
13360,GO:0052361,1.00000000003304,0.940150037565474,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13361,GO:0052362,1.00000000003304,0.940150037565474,0,1,catabolism by host of symbiont protein,BP,
13362,GO:0052363,1.00000000003304,0.940150037565474,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13363,GO:0052364,1.00000000003304,0.940150037565474,0,1,catabolism by host of substance in symbiont,BP,
13368,GO:0052416,1.00000000003304,0.940150037565474,0,1,metabolism by host of symbiont macromolecule,BP,
13369,GO:0052417,1.00000000003304,0.940150037565474,0,1,metabolism by host of symbiont protein,BP,
13370,GO:0052418,1.00000000003304,0.940150037565474,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13371,GO:0052419,1.00000000003304,0.940150037565474,0,1,metabolism by host of substance in symbiont,BP,
19342,GO:1905581,1.00000000003304,0.940150037565474,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19347,GO:1905597,1.00000000003304,0.940150037565474,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19349,GO:1905599,1.00000000003304,0.940150037565474,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
18043,GO:1902512,1.00000000003323,0.851906753968884,0,3,positive regulation of apoptotic DNA fragmentation,BP,
3712,GO:0008228,1.00000000003324,0.776553234727278,0,3,opsonization,BP,
14498,GO:0061889,1.00000000003345,0.91738491513932,0,1,negative regulation of astrocyte activation,BP,
18689,GO:1903979,1.00000000003345,0.91738491513932,0,1,negative regulation of microglial cell activation,BP,
1664,GO:0004117,1.00000000003355,0.929074752783471,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2043,GO:0004782,1.00000000003355,0.929074752783471,0,1,sulfinoalanine decarboxylase activity,MF,
3847,GO:0008455,1.00000000003355,0.929074752783471,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3896,GO:0008531,1.00000000003355,0.929074752783471,0,1,riboflavin kinase activity,MF,
4167,GO:0009231,1.00000000003355,0.929074752783471,0,1,riboflavin biosynthetic process,BP,
4225,GO:0009398,1.00000000003355,0.929074752783471,0,1,FMN biosynthetic process,BP,
10007,GO:0042412,1.00000000003355,0.929074752783471,0,1,taurine biosynthetic process,BP,
11628,GO:0046305,1.00000000003355,0.929074752783471,0,1,alkanesulfonate biosynthetic process,BP,
11685,GO:0046444,1.00000000003355,0.929074752783471,0,1,FMN metabolic process,BP,
294,GO:0000798,1.0000000000336,0.795138684983171,0,3,nuclear cohesin complex,CC,
14181,GO:0061043,1.00000000003407,0.800763466065529,0,3,regulation of vascular wound healing,BP,
11762,GO:0046587,1.00000000003416,0.927593120555399,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
18912,GO:1904567,1.00000000003416,0.927593120555399,0,1,response to wortmannin,BP,
18913,GO:1904568,1.00000000003416,0.927593120555399,0,1,cellular response to wortmannin,BP,
19615,GO:1990646,1.00000000003416,0.927593120555399,0,1,cellular response to prolactin,BP,
16263,GO:0090298,1.00000000003435,0.790521134225975,0,3,negative regulation of mitochondrial DNA replication,BP,
17812,GO:1901859,1.00000000003435,0.790521134225975,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
6228,GO:0019776,1.0000000000346,0.809842352844732,0,3,Atg8 ligase activity,MF,
13552,GO:0055113,1.00000000003494,0.887589387602288,0,1,epiboly involved in gastrulation with mouth forming second,BP,
1521,GO:0003880,1.00000000003514,0.808631308649314,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2952,GO:0006481,1.00000000003514,0.808631308649314,0,3,C-terminal protein methylation,BP,
18646,GO:1903903,1.00000000003525,0.781842581904452,0,3,regulation of establishment of T cell polarity,BP,
3306,GO:0007008,1.00000000003536,0.926020859474355,0,1,outer mitochondrial membrane organization,BP,
5317,GO:0016031,1.00000000003536,0.926020859474355,0,1,tRNA import into mitochondrion,BP,
14581,GO:0070096,1.00000000003536,0.926020859474355,0,1,mitochondrial outer membrane translocase complex assembly,BP,
19207,GO:1905242,1.00000000003536,0.926020859474355,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
7282,GO:0031260,1.00000000003536,0.952538268832505,0,1,pseudopodium membrane,CC,
11998,GO:0047290,1.00000000003547,0.939979401125283,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
20281,GO:2001199,1.00000000003599,0.941196710293197,0,1,negative regulation of dendritic cell differentiation,BP,
16937,GO:0098885,1.00000000003717,0.907008832136855,0,1,modification of postsynaptic actin cytoskeleton,BP,
17039,GO:0099159,1.00000000003717,0.907008832136855,0,1,regulation of modification of postsynaptic structure,BP,
17434,GO:1900149,1.00000000003717,0.907008832136855,0,1,positive regulation of Schwann cell migration,BP,
18798,GO:1904266,1.00000000003717,0.907008832136855,0,1,regulation of Schwann cell chemotaxis,BP,
18799,GO:1904268,1.00000000003717,0.907008832136855,0,1,positive regulation of Schwann cell chemotaxis,BP,
19220,GO:1905274,1.00000000003717,0.907008832136855,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19641,GO:1990751,1.00000000003717,0.907008832136855,0,1,Schwann cell chemotaxis,BP,
18561,GO:1903724,1.00000000003878,0.926024858162951,0,1,positive regulation of centriole elongation,BP,
4655,GO:0010796,1.00000000004053,0.828574708628747,0,3,regulation of multivesicular body size,BP,
47,GO:0000099,1.000000000044,0.70662878698919,0,4,sulfur amino acid transmembrane transporter activity,MF,
